March. 21, 2025 Title 40 Protection of Environment Parts 300 to 399 Revised as of July 1, 2025 Containing a codification of documents of general applicability and future effect As of July 1, 2025

Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register

 U.S. GOVERNMENT OFFICIAL EDITION NOTICE Legal Status and Use of Seals and Logos e:\seals\archives.ai

The seal of the National Archives and Records Administration (NARA) authenticates the Code of Federal Regulations (CFR) as the official codification of Federal regulations established under the Federal Register Act. Under the provisions of 44 U.S.C. 1507, the contents of the CFR, a special edition of the Federal Register, shall be judicially noticed. The CFR is prima facie evidence of the original documents published in the Federal Register (44 U.S.C. 1510).

It is prohibited to use NARA's official seal and the stylized Code of Federal Regulations logo on any republication of this material without the express, written permission of the Archivist of the United States or the Archivist's designee. Any person using NARA's official seals and logos in a manner inconsistent with the provisions of 36 CFR part 1200 is subject to the penalties specified in 18 U.S.C. 506, 701, and 1017.

Use of ISBN Prefix

This is the Official U.S. Government edition of this publication and is herein identified to certify its authenticity. Use of the 0-16 ISBN prefix is for U.S. Government Publishing Office Official Editions only. The Superintendent of Documents of the U.S. Government Publishing Office requests that any reprinted edition clearly be labeled as a copy of the authentic work with a new ISBN.

 e:\seals\gpologo2.eps

U . S . G O V E R N M E N T P U B L I S H I N G O F F I C E

U.S. Superintendent of Documents • Washington, DC 20402-0001

http://bookstore.gpo.gov

Phone: toll-free (866) 512-1800; DC area (202) 512-1800

 Table of Contents Page Explanation v Title 40: Chapter I—Environmental Protection Agency (Continued) 3 Finding Aids: Table of CFR Titles and Chapters 525 Alphabetical List of Agencies Appearing in the CFR 545 List of CFR Sections Affected 555

Cite this Code:  CFR

To cite the regulations in this volume use title, part and section number. Thus, 40 CFR 300.1 refers to title 40, part 300, section 1. Explanation

The Code of Federal Regulations is a codification of the general and permanent rules published in the Federal Register by the Executive departments and agencies of the Federal Government. The Code is divided into 50 titles which represent broad areas subject to Federal regulation. Each title is divided into chapters which usually bear the name of the issuing agency. Each chapter is further subdivided into parts covering specific regulatory areas.

Each volume of the Code is revised at least once each calendar year and issued on a quarterly basis approximately as follows:

Title 1 through Title 16

as of January 1

Title 17 through Title 27

as of April 1

Title 28 through Title 41

as of July 1

Title 42 through Title 50

as of October 1

The appropriate revision date is printed on the cover of each volume.

LEGAL STATUS

The contents of the Federal Register are required to be judicially noticed (44 U.S.C. 1507). The Code of Federal Regulations is prima facie evidence of the text of the original documents (44 U.S.C. 1510).

 HOW TO USE THE CODE OF FEDERAL REGULATIONS

The Code of Federal Regulations is kept up to date by the individual issues of the Federal Register. These two publications must be used together to determine the latest version of any given rule.

To determine whether a Code volume has been amended since its revision date (in this case, July 1, 2025), consult the “List of CFR Sections Affected (LSA),” which is issued monthly, and the “Cumulative List of Parts Affected,” which appears in the Reader Aids section of the daily Federal Register. These two lists will identify the Federal Register page number of the latest amendment of any given rule.

 EFFECTIVE AND EXPIRATION DATES

Each volume of the Code contains amendments published in the Federal Register since the last revision of that volume of the Code. Source citations for the regulations are referred to by volume number and page number of the Federal Register and date of publication. Publication dates and effective dates are usually not the same and care must be exercised by the user in determining the actual effective date. In instances where the effective date is beyond the cut-off date for the Code a note has been inserted to reflect the future effective date. In those instances where a regulation published in the Federal Register states a date certain for expiration, an appropriate note will be inserted following the text.

 OMB CONTROL NUMBERS

The Paperwork Reduction Act of 1980 (Pub. L. 96-511) requires Federal agencies to display an OMB control number with their information collection request. Many agencies have begun publishing numerous OMB control numbers as amendments to existing regulations in the CFR. These OMB numbers are placed as close as possible to the applicable recordkeeping or reporting requirements.

PAST PROVISIONS OF THE CODE

Provisions of the Code that are no longer in force and effect as of the revision date stated on the cover of each volume are not carried. Code users may find the text of provisions in effect on any given date in the past by using the appropriate List of CFR Sections Affected (LSA). For the convenience of the reader, a “List of CFR Sections Affected” is published at the end of each CFR volume. For changes to the Code prior to the LSA listings at the end of the volume, consult previous annual editions of the LSA. For changes to the Code prior to 2001, consult the List of CFR Sections Affected compilations, published for 1949-1963, 1964-1972, 1973-1985, and 1986-2000.

 “[RESERVED]” TERMINOLOGY

The term “[Reserved]” is used as a place holder within the Code of Federal Regulations. An agency may add regulatory information at a “[Reserved]” location at any time. Occasionally “[Reserved]” is used editorially to indicate that a portion of the CFR was left vacant and not dropped in error.

 INCORPORATION BY REFERENCE

What is incorporation by reference? Incorporation by reference was established by statute and allows Federal agencies to meet the requirement to publish regulations in the Federal Register by referring to materials already published elsewhere. For an incorporation to be valid, the Director of the Federal Register must approve it. The legal effect of incorporation by reference is that the material is treated as if it were published in full in the Federal Register (5 U.S.C. 552(a)). This material, like any other properly issued regulation, has the force of law.

What is a proper incorporation by reference? The Director of the Federal Register will approve an incorporation by reference only when the requirements of 1 CFR part 51 are met. Some of the elements on which approval is based are:

(a) The incorporation will substantially reduce the volume of material published in the Federal Register.

(b) The matter incorporated is adequately summarized in the preamble of the final rule and is available to the extent necessary to afford fairness and uniformity in the administrative process.

(c) The incorporating document is drafted and submitted for publication in accordance with 1 CFR part 51.

What if the material incorporated by reference cannot be found? If you have any problem locating or obtaining a copy of material listed as an approved incorporation by reference, please contact the agency that issued the regulation containing that incorporation. If, after contacting the agency, you find the material is not available, please notify the Director of the Federal Register, National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740-6001, or email fr.inspection@nara.gov.

CFR INDEXES AND TABULAR GUIDES

A subject index to the Code of Federal Regulations is contained in a separate volume, revised annually as of January 1, entitled CFR Index and Finding Aids. This volume contains the Parallel Table of Authorities and Rules. A list of CFR titles, chapters, subchapters, and parts and an alphabetical list of agencies publishing in the CFR are also included in this volume.

An index to the text of “Title 3—The President” is carried within that volume.

The Federal Register Index is issued monthly in cumulative form. This index is based on a consolidation of the “Contents” entries in the daily Federal Register.

A List of CFR Sections Affected (LSA) is published monthly, keyed to the revision dates of the 50 CFR titles.

 REPUBLICATION OF MATERIAL

There are no restrictions on the republication of material appearing in the Code of Federal Regulations.

 INQUIRIES

For a legal interpretation or explanation of any regulation in this volume, contact the issuing agency. The issuing agency's name appears at the top of odd-numbered pages.

For inquiries concerning CFR reference assistance, call 202-741-6000 or write to the Director, Office of the Federal Register, National Archives and Records Administration, 8601 Adelphi Road, College Park, MD 20740-6001 or e-mail fedreg.info@nara.gov.

SALES

The Government Publishing Office (GPO) processes all sales and distribution of the CFR. For payment by credit card, call toll-free, 866-512-1800, or DC area, 202-512-1800, M-F 8 a.m. to 4 p.m. e.s.t. or fax your order to 202-512-2104, 24 hours a day. For payment by check, write to: U.S. Government Publishing Office Superintendent of Documents, P.O. Box 37082, Washington, DC 20013-7082.

 ELECTRONIC SERVICES

The full text of the Code of Federal Regulations, the LSA (List of CFR Sections Affected), The United States Government Manual, the Federal Register, Public Laws, Compilation of Presidential Documents and the Privacy Act Compilation are available in electronic format via www.govinfo.gov. For more information, contact the GPO Customer Contact Center, U.S. Government Publishing Office. Phone 202-512-1800, or 866-512-1800 (toll-free). E-mail, ContactCenter@gpo.gov.

The Office of the Federal Register also offers a free service on the National Archives and Records Administration's (NARA) website for public law numbers, Federal Register finding aids, and related information. Connect to NARA's website at www.archives.gov/federal-register.

The eCFR is a regularly updated, unofficial editorial compilation of CFR material and Federal Register amendments, produced by the Office of the Federal Register and the Government Publishing Office. It is available at www.ecfr.gov.

Oliver A. Potts,

Director,

Office of the Federal Register

July 1, 2025

        THIS TITLE

Title 40— Protection of Environment is composed of thirty-seven volumes. The parts in these volumes are arranged in the following order: Parts 1-49, parts 50-51, part 52 (52.01-52.1018), part 52 (52.1019-52.2019), part 52 (52.2020-end of part 52), parts 53-59, part 60 (60.1-60.499), part 60 (60.500-end of part 60, sections), part 60 (Appendices), parts 61-62, part 63 (63.1-63.599), part 63 (63.600-63.1199), part 63 (63.1200-63.1439), part 63 (63.1440-63.6175), part 63 (63.6580-63.8830), part 63 (63.8980-end of part 63), parts 64-71, parts 72-78, parts 79-80, part 81, parts 82-84, parts 85-96, parts 97-99, parts 100-135, parts 136-149, parts 150-189, parts 190-259, parts 260-265, parts 266-299, parts 300-399, parts 400-424, parts 425-699, parts 700-722, parts 723-789, parts 790-999, parts 1000-1059, and part 1060 to end. The contents of these volumes represent all current regulations codified under this title of the CFR as of July 1, 2025.

Chapter I—Environmental Protection Agency appears in all thirty-seven volumes. OMB control numbers for title 40 appear in § 9.1 of this chapter.

Chapters IV-IX—Regulations issued by the Environmental Protection Agency and Department of Justice, Council on Environmental Quality, Chemical Safety and Hazard Investigation Board, Environmental Protection Agency and Department of Defense; Uniform National Discharge Standards for Vessels of the Armed Forces, Gulf Coast Ecosystem Restoration Council, and the Federal Permitting Improvement Steering Council appear in volume thirty-seven.

For this volume, Michele Bugenhagen was Chief Editor. The Code of Federal Regulations publication program is under the direction of John Hyrum Martinez, assisted by Stephen J. Frattini.

 <LRH>40 CFR Ch. I (7-1-25 Edition)</LRH> <RRH>Environmental Protection Agency</RRH> <CFRTITLE> <TITLEHD> <PRTPAGE P="1"/> <HD SOURCE="HED">Title 40—Protection of Environment</HD> <P>(This book contains parts 300 to 399)</P> </TITLEHD> <CFRTOC> <PTHD>Part</PTHD> <CHAPTI> <SUBJECT> <E T="04">chapter i</E> —Environmental Protection Agency (Continued) </SUBJECT> <PG>300</PG> </CHAPTI> </CFRTOC> </CFRTITLE> <CHAPTER> <TOC> <TOCHD> <PRTPAGE P="3"/> <HD SOURCE="HED">CHAPTER I—ENVIRONMENTAL PROTECTION AGENCY (CONTINUED)</HD> </TOCHD> <EDNOTE> <HD SOURCE="HED">Editorial Note:</HD> <P>Nomenclature changes to chapter I appear at 65 FR 47324, 47325, Aug. 2, 2000.</P> </EDNOTE> <SUBCHAP> <HD SOURCE="HED">SUBCHAPTER J—SUPERFUND, EMERGENCY PLANNING, AND COMMUNITY RIGHT-TO-KNOW PROGRAMS</HD> </SUBCHAP> <PTHD>Part</PTHD> <PGHD>Page</PGHD> <CHAPTI> <PT>300</PT> <SUBJECT>National Oil and Hazardous Substances Pollution Contingency Plan</SUBJECT> <PG>5</PG> <PT>302</PT> <SUBJECT>Designation, reportable quantities, and notification</SUBJECT> <PG>284</PG> <PT>303</PT> <SUBJECT>Citizen awards for information on criminal violations under Superfund</SUBJECT> <PG>346</PG> <PT>304</PT> <SUBJECT>Arbitration procedures for small Superfund cost recovery claims</SUBJECT> <PG>348</PG> <PT>305</PT> <SUBJECT>Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) administrative hearing procedures for claims against the Superfund</SUBJECT> <PG>361</PG> <PT>307</PT> <SUBJECT>Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) claims procedures</SUBJECT> <PG>374</PG> <PT>310</PT> <SUBJECT>Reimbursement to local governments for emergency response to hazardous substance releases</SUBJECT> <PG>394</PG> <PT>311</PT> <SUBJECT>Worker protection</SUBJECT> <PG>407</PG> <PT>312</PT> <SUBJECT>Innocent landowners, standards for conducting all appropriate inquiries</SUBJECT> <PG>408</PG> <PT>350</PT> <SUBJECT>Trade secrecy claims for emergency planning and community right-to-know information: and trade secret disclosures to health professionals</SUBJECT> <PG>417</PG> <PT>355</PT> <SUBJECT>Emergency planning and notification</SUBJECT> <PG>434</PG> <PT>370</PT> <SUBJECT>Hazardous chemical reporting: Community right-to-know</SUBJECT> <PG>453</PG> <PT>372</PT> <SUBJECT>Toxic chemical release reporting: Community right-to-know</SUBJECT> <PG>465</PG> <PT>373</PT> <SUBJECT>Reporting hazardous substance activity when selling or transferring Federal real property</SUBJECT> <PG> 518 <PRTPAGE P="4"/> </PG> <PT>374</PT> <SUBJECT>Prior notice of citizen suits</SUBJECT> <PG>519</PG> <PT>375-399</PT> <RESERVED>[Reserved]</RESERVED> </CHAPTI> </TOC> <SUBCHAP TYPE="N"> <PRTPAGE P="5"/> <HD SOURCE="HED">SUBCHAPTER J—SUPERFUND, EMERGENCY PLANNING, AND COMMUNITY RIGHT-TO-KNOW PROGRAMS</HD> <PART> <EAR>Pt. 300</EAR> <HD SOURCE="HED">PART 300—NATIONAL OIL AND HAZARDOUS SUBSTANCES POLLUTION CONTINGENCY PLAN</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—Introduction</HD> <SECHD>Sec.</SECHD> <SECTNO>300.1</SECTNO> <SUBJECT>Purpose and objectives.</SUBJECT> <SECTNO>300.2</SECTNO> <SUBJECT>Authority and applicability.</SUBJECT> <SECTNO>300.3</SECTNO> <SUBJECT>Scope.</SUBJECT> <SECTNO>300.4</SECTNO> <SUBJECT>Abbreviations.</SUBJECT> <SECTNO>300.5</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>300.6</SECTNO> <SUBJECT>Use of number and gender.</SUBJECT> <SECTNO>300.7</SECTNO> <SUBJECT>Computation of time.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Responsibility and Organization for Response</HD> <SECTNO>300.100</SECTNO> <SUBJECT>Duties of President delegated to federal agencies.</SUBJECT> <SECTNO>300.105</SECTNO> <SUBJECT>General organization concepts.</SUBJECT> <SECTNO>300.110</SECTNO> <SUBJECT>National Response Team.</SUBJECT> <SECTNO>300.115</SECTNO> <SUBJECT>Regional Response Teams.</SUBJECT> <SECTNO>300.120</SECTNO> <SUBJECT>On-scene coordinators and remedial project managers: general responsibilities.</SUBJECT> <SECTNO>300.125</SECTNO> <SUBJECT>Notification and communications.</SUBJECT> <SECTNO>300.130</SECTNO> <SUBJECT>Determinations to initiate response and special conditions.</SUBJECT> <SECTNO>300.135</SECTNO> <SUBJECT>Response operations.</SUBJECT> <SECTNO>300.140</SECTNO> <SUBJECT>Multi-regional responses.</SUBJECT> <SECTNO>300.145</SECTNO> <SUBJECT>Special teams and other assistance available to OSCs/RPMs.</SUBJECT> <SECTNO>300.150</SECTNO> <SUBJECT>Worker health and safety.</SUBJECT> <SECTNO>300.155</SECTNO> <SUBJECT>Public information and community relations.</SUBJECT> <SECTNO>300.160</SECTNO> <SUBJECT>Documentation and cost recovery.</SUBJECT> <SECTNO>300.165</SECTNO> <SUBJECT>OSC reports.</SUBJECT> <SECTNO>300.170</SECTNO> <SUBJECT>Federal agency participation.</SUBJECT> <SECTNO>300.175</SECTNO> <SUBJECT>Federal agencies: additional responsibilities and assistance.</SUBJECT> <SECTNO>300.180</SECTNO> <SUBJECT>State and local participation in response.</SUBJECT> <SECTNO>300.185</SECTNO> <SUBJECT>Nongovernmental participation.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Planning and Preparedness</HD> <SECTNO>300.200</SECTNO> <SUBJECT>General.</SUBJECT> <SECTNO>300.205</SECTNO> <SUBJECT>Planning and coordination structure.</SUBJECT> <SECTNO>300.210</SECTNO> <SUBJECT>Federal contingency plans.</SUBJECT> <SECTNO>300.211</SECTNO> <SUBJECT>OPA facility and vessel response plans.</SUBJECT> <SECTNO>300.212</SECTNO> <SUBJECT>Area response drills.</SUBJECT> <SECTNO>300.215</SECTNO> <SUBJECT>Title III local emergency response plans.</SUBJECT> <SECTNO>300.220</SECTNO> <SUBJECT>Related Title III issues.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Operational Response Phases for Oil Removal</HD> <SECTNO>300.300</SECTNO> <SUBJECT>Phase I—Discovery or notification.</SUBJECT> <SECTNO>300.305</SECTNO> <SUBJECT>Phase II—Preliminary assessment and initiation of action.</SUBJECT> <SECTNO>300.310</SECTNO> <SUBJECT>Phase III—Containment, countermeasures, cleanup, and disposal.</SUBJECT> <SECTNO>300.315</SECTNO> <SUBJECT>Phase IV—Documentation and cost recovery.</SUBJECT> <SECTNO>300.317</SECTNO> <SUBJECT>National response priorities.</SUBJECT> <SECTNO>300.320</SECTNO> <SUBJECT>General pattern of response.</SUBJECT> <SECTNO>300.322</SECTNO> <SUBJECT>Response to substantial threats to public health or welfare of the United States.</SUBJECT> <SECTNO>300.323</SECTNO> <SUBJECT>Spills of national significance.</SUBJECT> <SECTNO>300.324</SECTNO> <SUBJECT>Response to worst case discharges.</SUBJECT> <SECTNO>300.335</SECTNO> <SUBJECT>Funding.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Hazardous Substance Response</HD> <SECTNO>300.400</SECTNO> <SUBJECT>General.</SUBJECT> <SECTNO>300.405</SECTNO> <SUBJECT>Discovery or notification.</SUBJECT> <SECTNO>300.410</SECTNO> <SUBJECT>Removal site evaluation.</SUBJECT> <SECTNO>300.411</SECTNO> <SUBJECT>Response to CWA hazardous substance worst case discharges.</SUBJECT> <SECTNO>300.415</SECTNO> <SUBJECT>Removal action.</SUBJECT> <SECTNO>300.420</SECTNO> <SUBJECT>Remedial site evaluation.</SUBJECT> <SECTNO>300.425</SECTNO> <SUBJECT>Establishing remedial priorities.</SUBJECT> <SECTNO>300.430</SECTNO> <SUBJECT>Remedial investigation/feasibility study and selection of remedy.</SUBJECT> <SECTNO>300.435</SECTNO> <SUBJECT>Remedial design/remedial action, operation and maintenance.</SUBJECT> <SECTNO>300.440</SECTNO> <SUBJECT>Procedures for planning and implementing off-site response actions.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart F—State Involvement in Hazardous Substance Response</HD> <SECTNO>300.500</SECTNO> <SUBJECT>General.</SUBJECT> <SECTNO>300.505</SECTNO> <SUBJECT>EPA/State Superfund Memorandum of Agreement (SMOA).</SUBJECT> <SECTNO>300.510</SECTNO> <SUBJECT>State assurances.</SUBJECT> <SECTNO>300.515</SECTNO> <SUBJECT>Requirements for state involvement in remedial and enforcement response.</SUBJECT> <SECTNO>300.520</SECTNO> <SUBJECT>State involvement in EPA-lead enforcement negotiations.</SUBJECT> <SECTNO>300.525</SECTNO> <SUBJECT>State involvement in removal actions.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart G—Trustees for Natural Resources</HD> <SECTNO>300.600</SECTNO> <SUBJECT>Designation of federal trustees.</SUBJECT> <SECTNO>300.605</SECTNO> <SUBJECT>State trustees.</SUBJECT> <SECTNO>300.610</SECTNO> <SUBJECT>Indian tribes.</SUBJECT> <SECTNO>300.612</SECTNO> <SUBJECT>Foreign trustees.</SUBJECT> <SECTNO>300.615</SECTNO> <SUBJECT>Responsibilities of trustees.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart H—Participation by Other Persons</HD> <SECTNO>300.700</SECTNO> <SUBJECT>Activities by other persons.</SUBJECT> </SUBPART> <SUBPART> <PRTPAGE P="6"/> <HD SOURCE="HED">Subpart I—Administrative Record for Selection of Response Action</HD> <SECTNO>300.800</SECTNO> <SUBJECT>Establishment of an administrative record.</SUBJECT> <SECTNO>300.805</SECTNO> <SUBJECT>Location of the administrative record file.</SUBJECT> <SECTNO>300.810</SECTNO> <SUBJECT>Contents of the administrative record file.</SUBJECT> <SECTNO>300.815</SECTNO> <SUBJECT>Administrative record file for a remedial action.</SUBJECT> <SECTNO>300.820</SECTNO> <SUBJECT>Administrative record file for a removal action.</SUBJECT> <SECTNO>300.825</SECTNO> <SUBJECT>Record requirements after the decision document is signed.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart J—Use of Dispersants, and Other Chemical and Biological Agents</HD> <SECTNO>300.900</SECTNO> <SUBJECT>General.</SUBJECT> <SECTNO>300.910</SECTNO> <SUBJECT>Authorization for agent use.</SUBJECT> <SECTNO>300.913</SECTNO> <SUBJECT>Monitoring the use of dispersants.</SUBJECT> <SECTNO>300.915</SECTNO> <SUBJECT>Data and information requirements for listing on the NCP Product Schedule or Sorbent Product List.</SUBJECT> <SECTNO>300.950</SECTNO> <SUBJECT>Submission of Proprietary Business Information (PBI).</SUBJECT> <SECTNO>300.955</SECTNO> <SUBJECT>Addition of a product to the NCP Product Schedule or Sorbent ProductLlist.</SUBJECT> <SECTNO>300.965</SECTNO> <SUBJECT>Mandatory Product Disclaimer.</SUBJECT> <SECTNO>300.970</SECTNO> <SUBJECT>Removal of a product from the NCP Product Schedule or Sorbent Product List.</SUBJECT> </SUBPART> <SUBPART> <RESERVED>Subpart K—Federal Facilities [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart L—National Oil and Hazardous Substances Pollution Contingency Plan; Involuntary Acquisition of Property by the Government</HD> <SECTNO>300.1105</SECTNO> <SUBJECT>Involuntary acquisition of property by the government.</SUBJECT> <APP>Appendix A to Part 300—The Hazard Ranking System</APP> <APP>Appendix B to Part 300—National Priorities List</APP> <APP>Appendix C to Part 300—Swirling Flask Dispersant Effectiveness Test, Revised Standard Dispersant Toxicity Test, and Bioremediation Agent Effectiveness Test</APP> <APP>Appendix D to Part 300—Appropriate Actions and Methods of Remedying Releases</APP> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P> 33 U.S.C. 1251 <E T="03">et seq.;</E> 42 U.S.C. 9601-9657; E.O. 13626, 77 FR 56749, 3 CFR, 2013 Comp., p. 306; E.O. 12777, 56 FR 54757, 3 CFR, 1991 Comp., p. 351; E.O. 12580, 52 FR 2923, 3 CFR, 1987 Comp., p. 193. </P> </AUTH> <SUBPART> <HD SOURCE="HED">Subpart A—Introduction</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47416, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.1</SECTNO> <SUBJECT>Purpose and objectives.</SUBJECT> <P>The purpose of the National Oil and Hazardous Substances Pollution Contingency Plan (NCP) is to provide the organizational structure and procedures for preparing for and responding to discharges of oil and releases of hazardous substances, pollutants, and contaminants.</P> </SECTION> <SECTION> <SECTNO>§ 300.2</SECTNO> <SUBJECT>Authority and applicability.</SUBJECT> <P>The NCP is required by section 105 of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, 42 U.S.C. 9605, as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), Pub. L. 99-499, (hereinafter CERCLA), and by section 311(d) of the Clean Water Act (CWA), 33 U.S.C. 1321(d), as amended by the Oil Pollution Act of 1990 (OPA), Pub. L. 101-380. In Executive Order (E.O.) 12777 (56 FR 54757, October 22, 1991), the President delegated to the Environmental Protection Agency (EPA) the responsibility for the amendment of the NCP. Amendments to the NCP are coordinated with members of the National Response Team (NRT) prior to publication for notice and comment. This includes coordination with the Federal Emergency Management Agency (FEMA) and the Nuclear Regulatory Commission in order to avoid inconsistent or duplicative requirements in the emergency planning responsibilities of those agencies. The NCP is applicable to response actions taken pursuant to the authorities under CERCLA and section 311 of the CWA, as amended.</P> </SECTION> <SECTION> <SECTNO>§ 300.3</SECTNO> <SUBJECT>Scope.</SUBJECT> <P>(a) The NCP applies to and is in effect for:</P> <P> (1) Discharges of oil into or on the navigable waters of the United States, on the adjoining shorelines, the waters of the contiguous zone, into waters of the exclusive economic zone, or that may affect natural resources belonging to, appertaining to, or under the exclusive management authority of the <PRTPAGE P="7"/> United States (See sections 311(c)(1) and 502(7) of the CWA). </P> <P>(2) Releases into the environment of hazardous substances, and pollutants or contaminants which may present an imminent and substantial danger to public health or welfare of the United States.</P> <P>(b) The NCP provides for efficient, coordinated, and effective response to discharges of oil and releases of hazardous substances, pollutants, and contaminants in accordance with the authorities of CERCLA and the CWA. It provides for:</P> <P>(1) The national response organization that may be activated in response actions. It specifies responsibilities among the federal, state, and local governments and describes resources that are available for response.</P> <P>(2) The establishment of requirements for federal, regional, and area contingency plans. It also summarizes state and local emergency planning requirements under SARA Title III.</P> <P>(3) Procedures for undertaking removal actions pursuant to section 311 of the CWA.</P> <P>(4) Procedures for undertaking response actions pursuant to CERCLA.</P> <P>(5) Procedures for involving state governments in the initiation, development, selection, and implementation of response actions, pursuant to CERCLA.</P> <P>(6) Listing of federal trustees for natural resources for purposes of CERCLA and the CWA.</P> <P>(7) Procedures for the participation of other persons in response actions.</P> <P>(8) Procedures for compiling and making available an administrative record for response actions.</P> <P>(9) National procedures for the use of dispersants and other chemicals in removals under the CWA and response actions under CERCLA.</P> <P>(c) In implementing the NCP, consideration shall be given to international assistance plans and agreements, security regulations and responsibilities based on international agreements, federal statutes, and executive orders. Actions taken pursuant to the provisions of any applicable international joint contingency plans shall be consistent with the NCP, to the greatest extent possible. The Department of State shall be consulted, as appropriate, prior to taking any action which may affect its activities.</P> <P>(d) Additionally, the NCP applies to and is in effect when the Federal Response Plan and some or all its Emergency Support Functions (ESFs) are activated.</P> </SECTION> <SECTION> <SECTNO>§ 300.4</SECTNO> <SUBJECT>Abbreviations.</SUBJECT> <P> (a) <E T="03">Department and Agency Title Abbreviations:</E> </P> <EXTRACT> <FP SOURCE="FP-1">ATSDR—Agency for Toxic Substances and Disease Registry</FP> <FP SOURCE="FP-1">CDC—Centers for Disease Control</FP> <FP SOURCE="FP-1">DOC—Department of Commerce</FP> <FP SOURCE="FP-1">DOD—Department of Defense</FP> <FP SOURCE="FP-1">DOE—Department of Energy</FP> <FP SOURCE="FP-1">DOI—Department of the Interior</FP> <FP SOURCE="FP-1">DOJ—Department of Justice</FP> <FP SOURCE="FP-1">DOL—Department of Labor</FP> <FP SOURCE="FP-1">DOS—Department of State</FP> <FP SOURCE="FP-1">DOT—Department of Transportation</FP> <FP SOURCE="FP-1">EPA—Environmental Protection Agency</FP> <FP SOURCE="FP-1">FEMA—Federal Emergency Management Agency</FP> <FP SOURCE="FP-1">GSA—General Services Administration</FP> <FP SOURCE="FP-1">HHS—Department of Health and Human Services</FP> <FP SOURCE="FP-1">NIOSH—National Institute for Occupational Safety and Health</FP> <FP SOURCE="FP-1">NOAA—National Oceanic and Atmospheric Administration</FP> <FP SOURCE="FP-1">OSHA—Occupational Health and Safety Administration</FP> <FP SOURCE="FP-1">RSPA—Research and Special Programs Administration</FP> <FP SOURCE="FP-1">USCG—United States Coast Guard</FP> <FP SOURCE="FP-1">USDA—United States Department of Agriculture</FP> </EXTRACT> <NOTE> <HD SOURCE="HED">Note:</HD> <P>Reference is made in the NCP to both the Nuclear Regulatory Commission and the National Response Center. In order to avoid confusion, the NCP will spell out Nuclear Regulatory Commission and use the abbreviation “NRC” only with respect to the National Response Center.</P> </NOTE> <P> (b) <E T="03">Operational Abbreviations:</E> </P> <EXTRACT> <FP SOURCE="FP-1">ACP—Area Contingency Plan</FP> <FP SOURCE="FP-1">ARARs—Applicable or Relevant and Appropriate Requirements</FP> <FP SOURCE="FP-1">CERCLIS—CERCLA Information System</FP> <FP SOURCE="FP-1">CRC—Community Relations Coordinator</FP> <FP SOURCE="FP-1">CRP—Community Relations Plan</FP> <FP SOURCE="FP-1">DRAT—District Response Advisory Team</FP> <FP SOURCE="FP-1">DRG—District Response Group</FP> <FP SOURCE="FP-1">ERT—Environmental Response Team</FP> <FP SOURCE="FP-1">ESF—Emergency Support Function</FP> <FP SOURCE="FP-1">FCO—Federal Coordinating Officer</FP> <FP SOURCE="FP-1">FRERP—Federal Radiological Emergency Response Plan</FP> <FP SOURCE="FP-1">FRP—Federal Response Plan</FP> <FP SOURCE="FP-1">FS—Feasibility Study</FP> <FP SOURCE="FP-1"> HRS—Hazard Ranking System <PRTPAGE P="8"/> </FP> <FP SOURCE="FP-1">LEPC—Local Emergency Planning Committee</FP> <FP SOURCE="FP-1">NCP—National Contingency Plan</FP> <FP SOURCE="FP-1">NPFC—National Pollution Funds Center</FP> <FP SOURCE="FP-1">NPL—National Priorities List</FP> <FP SOURCE="FP-1">NRC—National Response Center</FP> <FP SOURCE="FP-1">NRS—National Response System</FP> <FP SOURCE="FP-1">NRT—National Response Team</FP> <FP SOURCE="FP-1">NSF—National Strike Force</FP> <FP SOURCE="FP-1">NSFCC—National Strike Force Coordination Center</FP> <FP SOURCE="FP-1">O&M—Operation and Maintenance</FP> <FP SOURCE="FP-1">OSC—On-Scene Coordinator</FP> <FP SOURCE="FP-1">OSLTF—Oil Spill Liability Trust Fund</FP> <FP SOURCE="FP-1">PA—Preliminary Assessment</FP> <FP SOURCE="FP-1">PIAT—Public Information Assist Team</FP> <FP SOURCE="FP-1">RA—Remedial Action</FP> <FP SOURCE="FP-1">RCP—Regional Contingency Plan</FP> <FP SOURCE="FP-1">RD—Remedial Design</FP> <FP SOURCE="FP-1">RERT—Radiological Emergency Response Team</FP> <FP SOURCE="FP-1">RI—Remedial Investigation</FP> <FP SOURCE="FP-1">ROD—Record of Decision</FP> <FP SOURCE="FP-1">RPM—Remedial Project Manager</FP> <FP SOURCE="FP-1">RRC—Regional Response Center</FP> <FP SOURCE="FP-1">RRT—Regional Response Team</FP> <FP SOURCE="FP-1">SAC—Support Agency Coordinator</FP> <FP SOURCE="FP-1">SEMS—Superfund Enterprise Management System</FP> <FP SOURCE="FP-1">SERC—State Emergency Response Commission</FP> <FP SOURCE="FP-1">SI—Site Inspection</FP> <FP SOURCE="FP-1">SMOA—Superfund Memorandum of Agreement</FP> <FP SOURCE="FP-1">SONS—Spill of National Significance</FP> <FP SOURCE="FP-1">SSC—Scientific Support Coordinator</FP> <FP SOURCE="FP-1">SUPSALV—United States Navy Supervisor of Salvage</FP> <FP SOURCE="FP-1">USFWS—United States Fish and Wildlife Service</FP> </EXTRACT> <CITA>[59 FR 47416, Sept. 15, 1994, as amended at 79 FR 65592, Nov. 5, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.5</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>Terms not defined in this section have the meaning given by CERCLA, the OPA, or the CWA.</P> <P> <E T="03">Activation</E> means notification by telephone or other expeditious manner or, when required, the assembly of some or all appropriate members of the RRT or NRT. </P> <P> <E T="03">Alternative water supplies</E> as defined by section 101(34) of CERCLA, includes, but is not limited to, drinking water and household water supplies. </P> <P> <E T="03">Applicable requirements</E> means those cleanup standards, standards of control, and other substantive requirements, criteria, or limitations promulgated under federal environmental or state environmental or facility siting laws that specifically address a hazardous substance, pollutant, contaminant, remedial action, location, or other circumstance found at a CERCLA site. Only those state standards that are identified by a state in a timely manner and that are more stringent than federal requirements may be applicable. </P> <P> <E T="03">Area Committee</E> (AC) as provided for by CWA sections 311(a)(18) and (j)(4), means the entity appointed by the President consisting of members from qualified personnel of federal, state, and local agencies with responsibilities that include preparing an area contingency plan for an area designated by the President. </P> <P> <E T="03">Area contingency plan</E> (ACP) as provided for by CWA sections 311(a)(19) and (j)(4), means the plan prepared by an Area Committee that is developed to be implemented in conjunction with the NCP and RCP, in part to address removal of a worst case discharge and to mitigate or prevent a substantial threat of such a discharge from a vessel, offshore facility, or onshore facility operating in or near an area designated by the President. </P> <P> <E T="03">Bioaccumulation</E> is the process of accumulation of chemicals in the tissue of organisms through any route, including respiration, ingestion, or direct contact with the ambient or contaminated medium. </P> <P> <E T="03">Bioconcentration</E> is the accumulation of chemicals in the tissues of organisms from water alone. </P> <P> <E T="03">Biodegradation</E> is a process by which microorganisms metabolically decompose contaminants into biomass and smaller molecular compounds such as carbon dioxide, water, and end products. </P> <P> <E T="03">Biological agents</E> are microorganisms (typically bacteria, fungi, or algae) or biological catalysts, such as enzymes, that can enhance the biodegradation of a contaminated environment. </P> <P> <E T="03">Bioremediation</E> is the process of enhancing the ability of microorganisms to convert contaminants into biomass and smaller molecular end products by the addition of materials into a contaminated environment to accelerate the natural biodegradation process. </P> <P> <E T="03">Bioremediation agents</E> are biological agents and/or nutrient additives deliberately introduced into a contaminated environment to increase the rate of <PRTPAGE P="9"/> biodegradation and mitigate any deleterious effects caused by the contaminant constituents. Bioremediation agents include microorganisms, enzymes, and nutrient additives such as fertilizers containing bioavailable forms of nitrogen, phosphorus, and potassium. </P> <P> <E T="03">Burning agents</E> are additives that, through physical or chemical means, improve the combustibility of the materials to which they are applied. </P> <P> <E T="03">CERCLA</E> is the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986. </P> <P> <E T="03">CERCLIS</E> was the abbreviation for the CERCLA Information System. This system has been retired and has been replaced with SEMS, the Superfund Enterprise Management System. </P> <P> <E T="03">Chemical agents</E> are elements, compounds, or mixtures designed to facilitate the removal of oil from a contaminated environment and to mitigate any deleterious effects. Chemical agent categories include burning agents, dispersants, herding agents, solidifiers, surface washing agents, and bioremediation agents that consist of nutrient additives. </P> <P> <E T="03">Claim</E> for purposes of a release under CERCLA, means a demand in writing for a sum certain; for purposes of a discharge under CWA, it means a request, made in writing for a sum certain, for compensation for damages or removal costs resulting from an incident. </P> <P> <E T="03">Claimant</E> as defined by section 1001 of the OPA means any person or government who presents a claim for compensation under Title I of the OPA. </P> <P> <E T="03">Coastal waters</E> for the purposes of classifying the size of discharges, means the waters of the coastal zone except for the Great Lakes and specified ports and harbors on inland rivers. </P> <P> <E T="03">Coastal zone</E> as defined for the purpose of the NCP, means all United States waters subject to the tide, United States waters of the Great Lakes, specified ports and harbors on inland rivers, waters of the contiguous zone, other waters of the high seas subject to the NCP, and the land surface or land substrata, ground waters, and ambient air proximal to those waters. The term coastal zone delineates an area of federal responsibility for response action. Precise boundaries are determined by EPA/USCG agreements and identified in federal regional contingency plans. </P> <P> <E T="03">Coast Guard District Response Group</E> (DRG) as provided for by CWA sections 311(a)(20) and (j)(3), means the entity established by the Secretary of the department in which the USCG is operating, within each USCG district, and shall consist of: the combined USCG personnel and equipment, including marine firefighting equipment, of each port in the district; additional prepositioned response equipment; and a district response advisory team. </P> <P> <E T="03">Community relations</E> means EPA's program to inform and encourage public participation in the Superfund process and to respond to community concerns. The term “public” includes citizens directly affected by the site, other interested citizens or parties, organized groups, elected officials, and potentially responsible parties (PRPs). </P> <P> <E T="03">Community relations coordinator</E> means lead agency staff who work with the OSC/RPM to involve and inform the public about the Superfund process and response actions in accordance with the interactive community relations requirements set forth in the NCP. </P> <P> <E T="03">Contiguous zone</E> means the zone of the high seas, established by the United States under Article 24 of the Convention on the Territorial Sea and Contiguous Zone, which is contiguous to the territorial sea and which extends nine miles seaward from the outer limit of the territorial sea. </P> <P> <E T="03">Cooperative agreement</E> is a legal instrument EPA uses to transfer money, property, services, or anything of value to a recipient to accomplish a public purpose in which substantial EPA involvement is anticipated during the performance of the project. </P> <P> <E T="03">Damages</E> as defined by section 1001 of the OPA means damages specified in section 1002(b) of the Act, and includes the cost of assessing these damages. </P> <P> <E T="03">Discharge</E> as defined by section 311(a)(2) of the CWA, includes, but is not limited to, any spilling, leaking, pumping, pouring, emitting, emptying, or dumping of oil, but excludes discharges in compliance with a permit <PRTPAGE P="10"/> under section 402 of the CWA, discharges resulting from circumstances identified and reviewed and made a part of the public record with respect to a permit issued or modified under section 402 of the CWA, and subject to a condition in such permit, or continuous or anticipated intermittent discharges from a point source, identified in a permit or permit application under section 402 of the CWA, that are caused by events occurring within the scope of relevant operating or treatment systems. For purposes of the NCP, discharge also means substantial threat of discharge. </P> <P> <E T="03">Dispersants</E> are substances that emulsify, disperse, or solubilize oil by promoting the formation of small droplets or particles of oil in the water column. </P> <P> <E T="03">Drinking water supply</E> as defined by section 101(7) of CERCLA, means any raw or finished water source that is or may be used by a public water system (as defined in the Safe Drinking Water Act (42 U.S.C. 300 <E T="03">et seq.</E> ) or as drinking water by one or more individuals. </P> <P> <E T="03">Environment</E> as defined by section 101(8) of CERCLA, means the navigable waters, the waters of the contiguous zone, and the ocean waters of which the natural resources are under the exclusive management authority of the United States under the Magnuson Fishery Conservation and Management Act (16 U.S.C. 1801 <E T="03">et seq.</E> ); and any other surface water, ground water, drinking water supply, land surface or subsurface strata, or ambient air within the United States or under the jurisdiction of the United States. </P> <P> <E T="03">Exclusive economic zone,</E> as defined by OPA section 1001, means the zone established by Presidential Proclamation Numbered 5030, dated March 10, 1983, including the ocean waters of the areas referred to as “eastern special areas” in Article 3(1) of the Agreement between the United States of America and the Union of Soviet Socialist Republics on the Maritime Boundary, signed June 1, 1990. </P> <P> <E T="03">Facility</E> as defined by section 101(9) of CERCLA, means any building, structure, installation, equipment, pipe or pipeline (including any pipe into a sewer or publicly owned treatment works), well, pit, pond, lagoon, impoundment, ditch, landfill, storage container, motor vehicle, rolling stock, or aircraft, or any site or area, where a hazardous substance has been deposited, stored, disposed of, or placed, or otherwise come to be located; but does not include any consumer product in consumer use or any vessel. As defined by section 1001 of the OPA, it means any structure, group of structures, equipment, or device (other than a vessel) which is used for one or more of the following purposes: Exploring for, drilling for, producing, storing, handling, transferring, processing, or transporting oil. This term includes any motor vehicle, rolling stock, or pipeline used for one or more of these purposes. </P> <P> <E T="03">Feasibility study</E> (FS) means a study undertaken by the lead agency to develop and evaluate options for remedial action. The FS emphasizes data analysis and is generally performed concurrently and in an interactive fashion with the remedial investigation (RI), using data gathered during the RI. The RI data are used to define the objectives of the response action, to develop remedial action alternatives, and to undertake an initial screening and detailed analysis of the alternatives. The term also refers to a report that describes the results of the study. </P> <P> <E T="03">Federal Radiological Emergency Response Plan</E> (FRERP) means the inter-agency agreement for coordinating the response of various agencies, under a variety of statutes, to a large radiological accident. The Lead Federal Agency (LFA), defined by the FRERP, activates the FRERP for any peacetime radiological emergency which, based upon its professional judgment, is expected to have a significant radiological effect within the United States, its territories, possessions, or territorial waters and that could require a response by several federal agencies. </P> <P> <E T="03">Federal Response Plan</E> (FRP) means the agreement signed by 27 federal departments and agencies in April 1987 and developed under the authorities of the Earthquake Hazards Reduction Act of 1977 (42 U.S.C. 7701 <E T="03">et seq.</E> ) and the Disaster Relief Act of 1974 (42 U.S.C. 3231 <E T="03">et seq.</E> ), as amended by the Stafford Disaster Relief Act of 1988. <PRTPAGE P="11"/> </P> <P> <E T="03">First federal official</E> means the first federal representative of a participating agency of the National Response Team to arrive at the scene of a discharge or a release. This official coordinates activities under the NCP and may initiate, in consultation with the OSC, any necessary actions until the arrival of the predesignated OSC. A state with primary jurisdiction over a site covered by a cooperative agreement will act in the stead of the first federal official for any incident at the site. </P> <P> <E T="03">Fund</E> or <E T="03">Trust Fund</E> means the Hazardous Substance Superfund established by section 9507 of the Internal Revenue Code of 1986. </P> <P> <E T="03">Ground water</E> as defined by section 101(12) of CERCLA, means water in a saturated zone or stratum beneath the surface of land or water. </P> <P> <E T="03">Hazard Ranking System</E> (HRS) means the method used by EPA to evaluate the relative potential of hazardous substance releases to cause health or safety problems, or ecological or environmental damage. </P> <P> <E T="03">Hazardous substance</E> as defined by section 101(14) of CERCLA, means: Any substance designated pursuant to section 311(b)(2)(A) of the CWA; any element, compound, mixture, solution, or substance designated pursuant to section 102 of CERCLA; any hazardous waste having the characteristics identified under or listed pursuant to section 3001 of the Solid Waste Disposal Act (but not including any waste the regulation of which under the Solid Waste Disposal Act (42 U.S.C. 6901 <E T="03">et seq.</E> ) has been suspended by Act of Congress); any toxic pollutant listed under section 307(a) of the CWA; any hazardous air pollutant listed under section 112 of the Clean Air Act (42 U.S.C. 7521 <E T="03">et seq.</E> ); and any imminently hazardous chemical substance or mixture with respect to which the EPA Administrator has taken action pursuant to section 7 of the Toxic Substances Control Act (15 U.S.C. 2601 <E T="03">et seq.</E> ). The term does not include petroleum, including crude oil or any fraction thereof which is not otherwise specifically listed or designated as a hazardous substance in the first sentence of this paragraph, and the term does not include natural gas, natural gas liquids, liquified natural gas, or synthetic gas usable for fuel (or mixtures of natural gas and such synthetic gas). </P> <P> <E T="03">Herding agents</E> are substances that form a film on the water surface to control the spreading of the oil to allow for oil removal. </P> <P> <E T="03">Indian tribe</E> as defined by section 101(36) of CERCLA, means any Indian tribe, band, nation, or other organized group or community, including any Alaska Native village but not including any Alaska Native regional or village corporation, which is recognized as eligible for the special programs and services provided by the United States to Indians because of their status as Indians. “Indian tribe,” as defined by OPA section 1001, means any Indian tribe, band, nation, or other organized group or community, but not including any Alaska Native regional or village corporation, which is recognized as eligible for the special programs and services provided by the United States to Indians because of their status as Indians and has governmental authority over lands belonging to or controlled by the tribe. </P> <P> <E T="03">Inland waters,</E> for the purposes of classifying the size of discharges, means those waters of the United States in the inland zone, waters of the Great Lakes, and specified ports and harbors on inland rivers. </P> <P> <E T="03">Inland zone</E> means the environment inland of the coastal zone excluding the Great Lakes and specified ports and harbors on inland rivers. The term inland zone delineates an area of federal responsibility for response action. Precise boundaries are determined by EPA/USCG agreements and identified in federal regional contingency plans. </P> <P> <E T="03">Lead administrative trustee</E> means a natural resource trustee who is designated on an incident-by-incident basis for the purpose of preassessment and damage assessment and chosen by the other trustees whose natural resources are affected by the incident. The lead administrative trustee facilitates effective and efficient communication during response operations between the OSC and the other natural resource trustees conducting activities associated with damage assessment, and is responsible for applying to the OSC for access to response operations <PRTPAGE P="12"/> resources on behalf of all trustees for initiation of a damage assessment. </P> <P> <E T="03">Lead agency</E> means the agency that provides the OSC/RPM to plan and implement response actions under the NCP. EPA, the USCG, another federal agency, or a state (or political subdivision of a state) operating pursuant to a contract or cooperative agreement executed pursuant to section 104(d)(1) of CERCLA, or designated pursuant to a Superfund Memorandum of Agreement (SMOA) entered into pursuant to subpart F of the NCP or other agreements may be the lead agency for a response action. In the case of a release of a hazardous substance, pollutant, or contaminant, where the release is on, or the sole source of the release is from, any facility or vessel under the jurisdiction, custody, or control of Department of Defense (DOD) or Department of Energy (DOE), then DOD or DOE will be the lead agency. Where the release is on, or the sole source of the release is from, any facility or vessel under the jurisdiction, custody, or control of a federal agency other than EPA, the USCG, DOD, or DOE, then that agency will be the lead agency for remedial actions and removal actions other than emergencies. The federal agency maintains its lead agency responsibilities whether the remedy is selected by the federal agency for non-NPL sites or by EPA and the federal agency or by EPA alone under CERCLA section 120. The lead agency will consult with the support agency, if one exists, throughout the response process. </P> <P> <E T="03">Management of migration</E> means actions that are taken to minimize and mitigate the migration of hazardous substances or pollutants or contaminants and the effects of such migration. Measures may include, but are not limited to, management of a plume of contamination, restoration of a drinking water aquifer, or surface water restoration. </P> <P> <E T="03">National Pollution Funds Center</E> (NPFC) means the entity established by the Secretary of Transportation whose function is the administration of the Oil Spill Liability Trust Fund (OSLTF). Among the NPFC's duties are: providing appropriate access to the OSLTF for federal agencies and states for removal actions and for federal trustees to initiate the assessment of natural resource damages; providing appropriate access to the OSLTF for claims; and coordinating cost recovery efforts. </P> <P> <E T="03">National Priorities List</E> (NPL) means the list, compiled by EPA pursuant to CERCLA section 105, of uncontrolled hazardous substance releases in the United States that are priorities for long-term remedial evaluation and response. </P> <P> <E T="03">National response system</E> (NRS) is the mechanism for coordinating response actions by all levels of government in support of the OSC/RPM. The NRS is composed of the NRT, RRTs, OSC/RPM, Area Committees, and Special Teams and related support entities. The NRS is capable of expanding or contracting to accommodate the response effort required by the size or complexity of the discharge or release. </P> <P> <E T="03">National Strike Force</E> (NSF) is a special team established by the USCG, including the three USCG Strike Teams, the Public Information Assist Team (PIAT), and the National Strike Force Coordination Center. The NSF is available to assist OSCs/RPMs in their preparedness and response duties. </P> <P> <E T="03">National Strike Force Coordination Center</E> (NSFCC), authorized as the National Response Unit by CWA sections 311(a)(23) and (j)(2), means the entity established by the Secretary of the department in which the USCG is operating at Elizabeth City, North Carolina with responsibilities that include administration of the USCG Strike Teams, maintenance of response equipment inventories and logistic networks, and conducting a national exercise program. </P> <P> <E T="03">Natural resources</E> means land, fish, wildlife, biota, air, water, ground water, drinking water supplies, and other such resources belonging to, managed by, held in trust by, appertaining to, or otherwise controlled by the United States (including the resources of the exclusive economic zone defined by the Magnuson Fishery Conservation and Management Act of 1976), any state or local government, any foreign government, any Indian tribe, or, if such resources are subject to a trust <PRTPAGE P="13"/> restriction on alienation, any member of an Indian tribe. </P> <P> <E T="03">Navigable waters</E> means the waters of the United States, including the territorial seas, as defined in § 120.2 of this chapter. </P> <P> <E T="03">Offshore facility</E> as defined by section 101(17) of CERCLA and section 311(a)(11) of the CWA, means any facility of any kind located in, on, or under any of the navigable waters of the United States, and any facility of any kind which is subject to the jurisdiction of the United States and is located in, on, or under any other waters, other than a vessel or a public vessel. </P> <P> <E T="03">Oil</E> as defined by section 311(a)(1) of the CWA, means oil of any kind or in any form, including, but not limited to, petroleum, fuel oil, sludge, oil refuse, and oil mixed with wastes other than dredged spoil. Oil, as defined by section 1001 of the OPA means oil of any kind or in any form, including, but not limited to, petroleum, fuel oil, sludge, oil refuse, and oil mixed with wastes other than dredged spoil, but does not include petroleum, including crude oil or any fraction thereof, which is specifically listed or designated as a hazardous substance under subparagraphs (A) through (F) of section 101(14) of the Comprehensive Environmental Response, Compensation, and Liability Act (42 U.S.C. 9601) and which is subject to the provisions of that Act. </P> <P> <E T="03">Oil Spill Liability Trust Fund</E> (OSLTF) means the fund established under section 9509 of the Internal Revenue Code of 1986 (26 U.S.C. 9509). </P> <P> <E T="03">On-scene coordinator</E> (OSC) means the federal official predesignated by EPA or the USCG to coordinate and direct responses under subpart D, or the government official designated by the lead agency to coordinate and direct removal actions under subpart E of the NCP. </P> <P> <E T="03">Onshore facility</E> as defined by section 101(18) of CERCLA, means any facility (including, but not limited to, motor vehicles and rolling stock) of any kind located in, on, or under any land or non-navigable waters within the United States; and, as defined by section 311(a)(10) of the CWA, means any facility (including, but not limited to, motor vehicles and rolling stock) of any kind located in, on, or under any land within the United States other than submerged land. </P> <P> <E T="03">On-site</E> means the areal extent of contamination and all suitable areas in very close proximity to the contamination necessary for implementation of the response action. </P> <P> <E T="03">Operable unit</E> means a discrete action that comprises an incremental step toward comprehensively addressing site problems. This discrete portion of a remedial response manages migration, or eliminates or mitigates a release, threat of a release, or pathway of exposure. The cleanup of a site can be divided into a number of operable units, depending on the complexity of the problems associated with the site. Operable units may address geographical portions of a site, specific site problems, or initial phases of an action, or may consist of any set of actions performed over time or any actions that are concurrent but located in different parts of a site. </P> <P> <E T="03">Operation and maintenance</E> (O&M) means measures required to maintain the effectiveness of response actions. </P> <P> <E T="03">Person</E> as defined by section 101(21) of CERCLA, means an individual, firm, corporation, association, partnership, consortium, joint venture, commercial entity, United States government, state, municipality, commission, political subdivision of a state, or any interstate body. As defined by section 1001 of the OPA, “person” means an individual, corporation, partnership, association, state, municipality, commission, or political subdivision of a state, or any interstate body. </P> <P> <E T="03">Pollutant or contaminant</E> as defined by section 101(33) of CERCLA, shall include, but not be limited to, any element, substance, compound, or mixture, including disease-causing agents, which after release into the environment and upon exposure, ingestion, inhalation, or assimilation into any organism, either directly from the environment or indirectly by ingestion through food chains, will or may reasonably be anticipated to cause death, disease, behavioral abnormalities, cancer, genetic mutation, physiological malfunctions (including malfunctions <PRTPAGE P="14"/> in reproduction) or physical deformations, in such organisms or their offspring. The term does not include petroleum, including crude oil or any fraction thereof which is not otherwise specifically listed or designated as a hazardous substance under section 101(14) (A) through (F) of CERCLA, nor does it include natural gas, liquified natural gas, or synthetic gas of pipeline quality (or mixtures of natural gas and such synthetic gas). For purposes of the NCP, the term pollutant or contaminant means any pollutant or contaminant that may present an imminent and substantial danger to public health or welfare of the United States. </P> <P> <E T="03">Post-removal site control</E> means those activities that are necessary to sustain the integrity of a Fund-financed removal action following its conclusion. Post-removal site control may be a removal or remedial action under CERCLA. The term includes, without being limited to, activities such as relighting gas flares, replacing filters, and collecting leachate. </P> <P> <E T="03">Preliminary assessment</E> (PA) under CERCLA means review of existing information and an off-site reconnaissance, if appropriate, to determine if a release may require additional investigation or action. A PA may include an on-site reconnaissance, if appropriate. </P> <P> <E T="03">Products</E> are chemical or biological agents or other substances manufactured using a unique composition or formulation. </P> <P> <E T="03">Public participation,</E> see the definition for community relations. </P> <P> <E T="03">Public vessel</E> as defined by section 311(a)(4) of the CWA, means a vessel owned or bareboat-chartered and operated by the United States, or by a state or political subdivision thereof, or by a foreign nation, except when such vessel is engaged in commerce. </P> <P> <E T="03">Quality assurance project plan</E> (QAPP) is a written document, associated with all remedial site sampling activities, which presents in specific terms the organization (where applicable), objectives, functional activities, and specific quality assurance (QA) and quality control (QC) activities designed to achieve the data quality objectives of a specific project(s) or continuing operation(s). The QAPP is prepared for each specific project or continuing operation (or group of similar projects or continuing operations). The QAPP will be prepared by the responsible program office, regional office, laboratory, contractor, recipient of an assistance agreement, or other organization. For an enforcement action, potentially responsible parties may prepare a QAPP subject to lead agency approval. </P> <P> <E T="03">Release</E> as defined by section 101(22) of CERCLA, means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, or disposing into the environment (including the abandonment or discarding of barrels, containers, and other closed receptacles containing any hazardous substance or pollutant or contaminant), but excludes: Any release which results in exposure to persons solely within a workplace, with respect to a claim which such persons may assert against the employer of such persons; emissions from the engine exhaust of a motor vehicle, rolling stock, aircraft, vessel, or pipeline pumping station engine; release of source, byproduct, or special nuclear material from a nuclear incident, as those terms are defined in the Atomic Energy Act of 1954, if such release is subject to requirements with respect to financial protection established by the Nuclear Regulatory Commission under section 170 of such Act, or, for the purposes of section 104 of CERCLA or any other response action, any release of source, byproduct, or special nuclear material from any processing site designated under section 102(a)(1) or 302(a) of the Uranium Mill Tailings Radiation Control Act of 1978 (42 U.S.C. 7901 <E T="03">et seq.</E> ); and the normal application of fertilizer. For purposes of the NCP, release also means threat of release. </P> <P> <E T="03">Relevant and appropriate requirements</E> means those cleanup standards, standards of control, and other substantive requirements, criteria, or limitations promulgated under federal environmental or state environmental or facility siting laws that, while not “applicable” to a hazardous substance, pollutant, contaminant, remedial action, location, or other circumstance at a CERCLA site, address problems or situations sufficiently similar to those encountered at the CERCLA site that <PRTPAGE P="15"/> their use is well suited to the particular site. Only those state standards that are identified in a timely manner and are more stringent than federal requirements may be relevant and appropriate. </P> <P> <E T="03">Remedial design</E> (RD) means the technical analysis and procedures which follow the selection of remedy for a site and result in a detailed set of plans and specifications for implementation of the remedial action. </P> <P> <E T="03">Remedial investigation</E> (RI) is a process undertaken by the lead agency to determine the nature and extent of the problem presented by the release. The RI emphasizes data collection and site characterization, and is generally performed concurrently and in an interactive fashion with the feasibility study. The RI includes sampling and monitoring, as necessary, and includes the gathering of sufficient information to determine the necessity for remedial action and to support the evaluation of remedial alternatives. </P> <P> <E T="03">Remedial project manager</E> (RPM) means the official designated by the lead agency to coordinate, monitor, or direct remedial or other response actions under subpart E of the NCP. </P> <P> <E T="03">Remedy or remedial action</E> (RA) means those actions consistent with permanent remedy taken instead of, or in addition to, removal action in the event of a release or threatened release of a hazardous substance into the environment, to prevent or minimize the release of hazardous substances so that they do not migrate to cause substantial danger to present or future public health or welfare or the environment. The term includes, but is not limited to, such actions at the location of the release as storage, confinement, perimeter protection using dikes, trenches, or ditches, clay cover, neutralization, cleanup of released hazardous substances and associated contaminated materials, recycling or reuse, diversion, destruction, segregation of reactive wastes, dredging or excavations, repair or replacement of leaking containers, collection of leachate and runoff, on-site treatment or incineration, provision of alternative water supplies, any monitoring reasonably required to assure that such actions protect the public health and welfare and the environment and, where appropriate, post-removal site control activities. The term includes the costs of permanent relocation of residents and businesses and community facilities (including the cost of providing “alternative land of equivalent value” to an Indian tribe pursuant to CERCLA section 126(b)) where EPA determines that, alone or in combination with other measures, such relocation is more cost-effective than, and environmentally preferable to, the transportation, storage, treatment, destruction, or secure disposition off-site of such hazardous substances, or may otherwise be necessary to protect the public health or welfare; the term includes off-site transport and off-site storage, treatment, destruction, or secure disposition of hazardous substances and associated contaminated materials. For the purpose of the NCP, the term also includes enforcement activities related thereto. </P> <P> <E T="03">Remove or removal</E> as defined by section 311(a)(8) of the CWA, refers to containment and removal of oil or hazardous substances from the water and shorelines or the taking of such other actions as may be necessary to minimize or mitigate damage to the public health or welfare of the United States (including, but not limited to, fish, shellfish, wildlife, public and private property, and shorelines and beaches) or to the environment. For the purpose of the NCP, the term also includes monitoring of action to remove a discharge. As defined by section 101(23) of CERCLA, remove or removal means the cleanup or removal of released hazardous substances from the environment; such actions as may be necessary taken in the event of the threat of release of hazardous substances into the environment; such actions as may be necessary to monitor, assess, and evaluate the release or threat of release of hazardous substances; the disposal of removed material; or the taking of such other actions as may be necessary to prevent, minimize, or mitigate damage to the public health or welfare of the United States or to the environment, which may otherwise result from a release or threat of release. The term includes, in addition, without being limited to, security fencing or other measures to limit access, <PRTPAGE P="16"/> provision of alternative water supplies, temporary evacuation and housing of threatened individuals not otherwise provided for, action taken under section 104(b) of CERCLA, post-removal site control, where appropriate, and any emergency assistance which may be provided under the Disaster Relief Act of 1974. For the purpose of the NCP, the term also includes enforcement activities related thereto. </P> <P> <E T="03">Removal costs</E> as defined by section 1001 of the OPA means the costs of removal that are incurred after a discharge of oil has occurred, or in any case in which there is a substantial threat of a discharge of oil, the costs to prevent, minimize, or mitigate oil pollution from such an incident. </P> <P> <E T="03">Respond or response</E> as defined by section 101(25) of CERCLA, means remove, removal, remedy, or remedial action, including enforcement activities related thereto. </P> <P> <E T="03">Responsible party</E> as defined by section 1001 of the OPA, means the following: </P> <P>(1) Vessels—In the case of a vessel, any person owning, operating, or demise chartering the vessel.</P> <P>(2) Onshore Facilities—In the case of an onshore facility (other than a pipeline), any person owning or operating the facility, except a federal agency, state, municipality, commission, or political subdivision of a state, or any interstate body, that as the owner transfers possession and right to use the property to another person by lease, assignment, or permit.</P> <P> (3) Offshore Facilities—In the case of an offshore facility (other than a pipeline or a deepwater port licensed under the Deepwater Port Act of 1974 (33 U.S.C. 1501 <E T="03">et seq.</E> )), the lessee or permittee of the area in which the facility is located or the holder of a right of use and easement granted under applicable state law or the Outer Continental Shelf Lands Act (43 U.S.C. 1301-1356) for the area in which the facility is located (if the holder is a different person than the lessee or permittee), except a federal agency, state, municipality, commission, or political subdivision of a state, or any interstate body, that as owner transfers possession and right to use the property to another person by lease, assignment, or permit. </P> <P>(4) Deepwater Ports—In the case of a deepwater port licensed under the Deepwater Port Act of 1974 (33 U.S.C. 1501-1524), the licensee.</P> <P>(5) Pipelines—In the case of a pipeline, any person owning or operating the pipeline.</P> <P>(6) Abandonment—In the case of an abandoned vessel, onshore facility, deepwater port, pipeline, or offshore facility, the person who would have been responsible parties immediately prior to the abandonment of the vessel or facility.</P> <P> <E T="03">SARA</E> is the Superfund Amendments and Reauthorization Act of 1986. In addition to certain free-standing provisions of law, it includes amendments to CERCLA, the Solid Waste Disposal Act, and the Internal Revenue Code. Among the free-standing provisions of law is Title III of SARA, also known as the “Emergency Planning and Community Right-to-Know Act of 1986” and Title IV of SARA, also known as the “Radon Gas and Indoor Air Quality Research Act of 1986.” Title V of SARA amending the Internal Revenue Code is also known as the “Superfund Revenue Act of 1986.” </P> <P> <E T="03">SEMS</E> is the abbreviation for the Superfund Enterprise Management System. SEMS is EPA's comprehensive data management system that inventories and tracks information about releases addressed or needing to be addressed by the CERCLA Superfund program. SEMS consolidates legacy systems including CERCLIS into a single integrated platform. SEMS contains information for potential and confirmed hazardous waste sites addressed under the Superfund remedial and removal programs. SEMS includes sites in the active site inventory and archived sites. The active site inventory includes sites on the NPL, and sites not on the NPL where site assessment, removal, remedial, enforcement, cost recovery, or oversight activities are being planned or conducted. Archived sites include non-NPL sites that were formerly in the active site inventory which have no further site assessment, removal, remedial, enforcement, cost recovery or oversight needed under the Federal Superfund <PRTPAGE P="17"/> program based on available information. New information may warrant return of an archive site to the active inventory. Inclusion of a specific site or area in SEMS does not represent a determination of any party's liability, nor does it represent a finding that any response action is necessary.” </P> <P> <E T="03">Sinking agents</E> are substances introduced into an oil discharge for the purpose of submerging the oil to the bottom of a water body. </P> <P> <E T="03">Site inspection</E> (SI) means an on-site investigation to determine whether there is a release or potential release and the nature of the associated threats. The purpose is to augment the data collected in the preliminary assessment and to generate, if necessary, sampling and other field data to determine if further action or investigation is appropriate. </P> <P> <E T="03">Size classes</E> of discharges refers to the following size classes of oil discharges which are provided as guidance to the OSC and serve as the criteria for the actions delineated in subpart D. They are not meant to imply associated degrees of hazard to public health or welfare of the United States, nor are they a measure of environmental injury. Any oil discharge that poses a substantial threat to public health or welfare of the United States or the environment or results in significant public concern shall be classified as a major discharge regardless of the following quantitative measures: </P> <P>(1) Minor discharge means a discharge to the inland waters of less than 1,000 gallons of oil or a discharge to the coastal waters of less than 10,000 gallons of oil.</P> <P>(2) Medium discharge means a discharge of 1,000 to 10,000 gallons of oil to the inland waters or a discharge of 10,000 to 100,000 gallons of oil to the coastal waters.</P> <P>(3) Major discharge means a discharge of more than 10,000 gallons of oil to the inland waters or more than 100,000 gallons of oil to the coastal waters.</P> <P> <E T="03">Size classes</E> of releases refers to the following size classifications which are provided as guidance to the OSC for meeting pollution reporting requirements in subpart B. The final determination of the appropriate classification of a release will be made by the OSC based on consideration of the particular release (e.g., size, location, impact, etc.): </P> <P>(1) Minor release means a release of a quantity of hazardous substance(s), pollutant(s), or contaminant(s) that poses minimal threat to public health or welfare of the United States or the environment.</P> <P>(2) Medium release means a release not meeting the criteria for classification as a minor or major release.</P> <P>(3) Major release means a release of any quantity of hazardous substance(s), pollutant(s), or contaminant(s) that poses a substantial threat to public health or welfare of the United States or the environment or results in significant public concern.</P> <P> <E T="03">Solidifiers</E> are substances that through a chemical reaction cause oil to become a cohesive mass, preventing oil from dissolving or dispersing into the water column. Solidifiers are generally collected and recovered from the environment. </P> <P> <E T="03">Sorbents</E> are inert and insoluble substances that readily absorb and/or adsorb oil or hazardous substances, and that are not combined with or act as a chemical agent, biological agent, or sinking agent. Sorbents may be used in their natural bulk form or as manufactured products in particulate form, sheets, rolls, pillows, or booms. Sorbents are generally collected and recovered from the environment. Sorbents consist of: </P> <P> (1) Natural organic substances ( <E T="03">e.g.,</E> feathers, cork, peat moss, and cellulose fibers such as bagasse, corncobs, and straw); </P> <P> (2) Inorganic/mineral compounds ( <E T="03">e.g.,</E> volcanic ash, perlite, vermiculite, zeolite, clay); and </P> <P> (3) Synthetic compounds ( <E T="03">e.g.,</E> polypropylene, polyethylene, polyurethane, polyester). </P> <P> <E T="03">Source control</E> action is the construction or installation and start-up of those actions necessary to prevent the continued release of hazardous substances or pollutants or contaminants (primarily from a source on top of or within the ground, or in buildings or other structures) into the environment. <PRTPAGE P="18"/> </P> <P> <E T="03">Source control maintenance measures</E> are those measures intended to maintain the effectiveness of source control actions once such actions are operating and functioning properly, such as the maintenance of landfill caps and leachate collection systems. </P> <P> <E T="03">Specified ports and harbors</E> means those ports and harbor areas on inland rivers, and land areas immediately adjacent to those waters, where the USCG acts as predesignated on-scene coordinator. Precise locations are determined by EPA/USCG regional agreements and identified in federal Regional Contingency Plans and Area Contingency Plans. </P> <P> <E T="03">Spill of national significance</E> (SONS) means a spill that due to its severity, size, location, actual or potential impact on the public health and welfare or the environment, or the necessary response effort, is so complex that it requires extraordinary coordination of federal, state, local, and responsible party resources to contain and clean up the discharge. </P> <P> <E T="03">State</E> means the several states of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the U.S. Virgin Islands, the Commonwealth of the Northern Marianas, and any other territory or possession over which the United States has jurisdiction. For purposes of the NCP, the term includes Indian tribes as defined in the NCP except where specifically noted. Section 126 of CERCLA provides that the governing body of an Indian tribe shall be afforded substantially the same treatment as a state with respect to certain provisions of CERCLA. Section 300.515(b) of the NCP describes the requirements pertaining to Indian tribes that wish to be treated as states under CERCLA. </P> <P> <E T="03">Superfund Memorandum of Agreement</E> (SMOA) means a nonbinding, written document executed by an EPA Regional Administrator and the head of a state agency that may establish the nature and extent of EPA and state interaction during the removal, pre-remedial, remedial, and/or enforcement response process. The SMOA is not a site-specific document although attachments may address specific sites. The SMOA generally defines the role and responsibilities of both the lead and the support agencies. </P> <P> <E T="03">Superfund state contract</E> is a joint, legally binding agreement between EPA and a state to obtain the necessary assurances before a federal-lead remedial action can begin at a site. In the case of a political subdivision-lead remedial response, a three-party Superfund state contract among EPA, the state, and political subdivision thereof, is required before a political subdivision takes the lead for any phase of remedial response to ensure state involvement pursuant to section 121(f)(1) of CERCLA. The Superfund state contract may be amended to provide the state's CERCLA section 104 assurances before a political subdivision can take the lead for remedial action. </P> <P> <E T="03">Support agency</E> means the agency or agencies that provide the support agency coordinator to furnish necessary data to the lead agency, review response data and documents, and provide other assistance as requested by the OSC or RPM. EPA, the USCG, another federal agency, or a state may be support agencies for a response action if operating pursuant to a contract executed under section 104(d)(1) of CERCLA or designated pursuant to a Superfund Memorandum of Agreement entered into pursuant to subpart F of the NCP or other agreement. The support agency may also concur on decision documents. </P> <P> <E T="03">Support agency coordinator</E> (SAC) means the official designated by the support agency, as appropriate, to interact and coordinate with the lead agency in response actions under subpart E of this part. </P> <P> <E T="03">Surface washing agents</E> are substances that separate oil from solid surfaces, such as beaches, rocks, metals, or concrete, through a detergency mechanism that lifts and floats oil. Product and oil are generally to be collected and recovered from the environment with minimal dissolution, dispersion, or transfer into the water column. </P> <P> <E T="03">Tank vessel</E> as defined by section 1001 of the OPA means a vessel that is constructed or adapted to carry, or that carries oil or hazardous material in bulk as cargo or cargo residue, and that: </P> <P> (1) is a vessel of the United States; <PRTPAGE P="19"/> </P> <P>(2) operates on the navigable waters; or</P> <P>(3) transfers oil or hazardous material in a place subject to the jurisdiction of the United States.</P> <P> <E T="03">Threat of discharge or release,</E> see definitions for discharge and release. </P> <P> <E T="03">Threat of release,</E> see definition for release. </P> <P> <E T="03">Treatment technology</E> means any unit operation or series of unit operations that alters the composition of a hazardous substance or pollutant or contaminant through chemical, biological, or physical means so as to reduce toxicity, mobility, or volume of the contaminated materials being treated. Treatment technologies are an alternative to land disposal of hazardous wastes without treatment. </P> <P> <E T="03">Trustee</E> means an official of a federal natural resources management agency designated in subpart G of the NCP or a designated state official or Indian tribe or, in the case of discharges covered by the OPA, a foreign government official, who may pursue claims for damages under section 107(f) of CERCLA or section 1006 of the OPA. </P> <P> <E T="03">United States</E> when used in relation to section 311(a)(5) of the CWA, means the states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, Guam, American Samoa, the United States Virgin Islands, and the Pacific Island Governments. United States, when used in relation to section 101(27) of CERCLA and section 1001(36) of the OPA, includes the several states of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the United States Virgin Islands, the Commonwealth of the Northern Marianas, and any other territory or possession over which the United States has jurisdiction. </P> <P> <E T="03">Vessel</E> as defined by section 101(28) of CERCLA, means every description of watercraft or other artificial contrivance used, or capable of being used, as a means of transportation on water; and, as defined by section 311(a)(3) of the CWA, means every description of watercraft or other artificial contrivance used, or capable of being used, as a means of transportation on water other than a public vessel. </P> <P> <E T="03">Volunteer</E> means any individual accepted to perform services by the lead agency which has authority to accept volunteer services (examples: See 16 U.S.C. 742f(c)). A volunteer is subject to the provisions of the authorizing statute and the NCP. </P> <P> <E T="03">Worst case discharge</E> as defined by section 311(a)(24) of the CWA, means, in the case of a vessel, a discharge in adverse weather conditions of its entire cargo, and, in the case of an offshore facility or onshore facility, the largest foreseeable discharge in adverse weather conditions. </P> <FP>59 FR 47416, Sept. 15, 1994, as amended at 60 FR 16054, Mar. 29, 1995;79 FR 65592, Nov. 5, 2014; 80 FR 37119, June 29, 2015; 83 FR 5209, Feb. 6, 2018; 88 FR 38332, June 12, 2023]</FP> </SECTION> <SECTION> <SECTNO>§ 300.6</SECTNO> <SUBJECT>Use of number and gender.</SUBJECT> <P>As used in this regulation, words in the singular also include the plural and words in the masculine gender also include the feminine and vice versa, as the case may require.</P> </SECTION> <SECTION> <SECTNO>§ 300.7</SECTNO> <SUBJECT>Computation of time.</SUBJECT> <P>In computing any period of time prescribed or allowed in these rules of practice, except as otherwise provided, the day of the event from which the designated period begins to run shall not be included. Saturdays, Sundays, and federal legal holidays shall be included. When a stated time expires on a Saturday, Sunday, or legal holiday, the stated time period shall be extended to include the next business day.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Responsibility and Organization for Response</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47424, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.100</SECTNO> <SUBJECT>Duties of President delegated to federal agencies.</SUBJECT> <P>In Executive Orders 12580 and 12777, the President delegated certain functions and responsibilities vested in him by the CWA, CERCLA, and the OPA.</P> </SECTION> <SECTION> <SECTNO>§ 300.105</SECTNO> <SUBJECT>General organization concepts.</SUBJECT> <P> (a) Federal agencies should: <PRTPAGE P="20"/> </P> <P>(1) Plan for emergencies and develop procedures for addressing oil discharges and releases of hazardous substances, pollutants, or contaminants;</P> <P>(2) Coordinate their planning, preparedness, and response activities with one another;</P> <P>(3) Coordinate their planning, preparedness, and response activities with affected states, local governments, and private entities; and</P> <P>(4) Make available those facilities or resources that may be useful in a response situation, consistent with agency authorities and capabilities.</P> <P>(b) Three fundamental kinds of activities are performed pursuant to the NCP:</P> <P>(1) Preparedness planning and coordination for response to a discharge of oil or release of a hazardous substance, pollutant, or contaminant;</P> <P>(2) Notification and communications; and</P> <P>(3) Response operations at the scene of a discharge or release.</P> <P>(c) The organizational elements created to perform these activities are:</P> <P>(1) The NRT, responsible for national response and preparedness planning, for coordinating regional planning, and for providing policy guidance and support to the Regional Response Teams (RRTs). NRT membership consists of representatives from the agencies specified in § 300.175(b).</P> <P>(2) RRTs, responsible for regional planning and preparedness activities before response actions, and for providing advice and support to the OSC or RPM when activated during a response. RRT membership consists of designated representatives from each federal agency participating in the NRT together with state and (as agreed upon by the states) local government representatives.</P> <P>(3) The OSC and the RPM, primarily responsible for directing response efforts and coordinating all other efforts at the scene of a discharge or release. The other responsibilities of OSCs and RPMs are described in § 300.135.</P> <P>(4) Area Committees, responsible for developing, under direction of the OSC, ACPs for each area designated by the President. Responsibilities of Area Committees are described in § 300.205(c).</P> <P>(d) The basic framework for the response management structure is a system (e.g., a unified command system) that brings together the functions of the Federal Government, the state government, and the responsible party to achieve an effective and efficient response, where the OSC maintains authority.</P> <P>(e)(1) The organizational concepts of the national response system are depicted in the following Figures 1a and 1b:</P> <GPH SPAN="2" DEEP="425"> <PRTPAGE P="21"/> <GID>EC02AU92.000</GID> </GPH> <GPH SPAN="2" DEEP="394"> <PRTPAGE P="22"/> <GID>EC02AU92.001</GID> </GPH> <PRTPAGE P="23"/> <P>(2) The standard federal regional boundaries (which are also the geographic areas of responsibility for the RRTs) are shown in the following Figure 2:</P> <GPH SPAN="2" DEEP="470"> <GID>EC02AU92.002</GID> </GPH> <PRTPAGE P="24"/> <P>(3) The USCG District boundaries are shown in the following Figure 3:</P> <GPH SPAN="2" DEEP="430"> <GID>ER08JN07.004</GID> </GPH> <CITA>[59 FR 47424, Sept. 15, 1994, as amended at 72 FR 31753, June 8, 2007; 84 FR 56670, Oct. 22, 2019]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.110</SECTNO> <SUBJECT>National Response Team.</SUBJECT> <P> National planning and coordination is accomplished through the NRT. <PRTPAGE P="25"/> </P> <P>(a) The NRT consists of representatives from the agencies named in § 300.175(b). Each agency shall designate a member to the team and sufficient alternates to ensure representation, as agency resources permit. The NRT will consider requests for membership on the NRT from other agencies. Other agencies may request membership by forwarding such requests to the chair of the NRT.</P> <P>(b) The chair of the NRT shall be the representative of EPA and the vice chair shall be the representative of the USCG, with the exception of periods of activation because of response action. During activation, the chair shall be the member agency providing the OSC/RPM. The vice chair shall maintain records of NRT activities along with national, regional, and area plans for response actions.</P> <P>(c) While the NRT desires to achieve a consensus on all matters brought before it, certain matters may prove unresolvable by this means. In such cases, each agency serving as a participating agency on the NRT may be accorded one vote in NRT proceedings.</P> <P>(d) The NRT may establish such bylaws and committees as it deems appropriate to further the purposes for which it is established.</P> <P>(e) The NRT shall evaluate methods of responding to discharges or releases; shall recommend any changes needed in the response organization; and shall recommend to the Administrator of EPA changes to the NCP designed to improve the effectiveness of the national response system, including drafting of regulatory language.</P> <P>(f) The NRT shall provide policy and program direction to the RRTs.</P> <P>(g) The NRT may consider and make recommendations to appropriate agencies on the training, equipping, and protection of response teams and necessary research, development, demonstration, and evaluation to improve response capabilities.</P> <P>(h) Direct planning and preparedness responsibilities of the NRT include:</P> <P>(1) Maintaining national preparedness to respond to a major discharge of oil or release of a hazardous substance, pollutant, or contaminant that is beyond regional capabilities;</P> <P>(2) Publishing guidance documents for preparation and implementation of SARA Title III local emergency response plans;</P> <P>(3) Monitoring incoming reports from all RRTs and activating for a response action, when necessary;</P> <P>(4) Coordinating a national program to assist member agencies in preparedness planning and response, and enhancing coordination of member agency preparedness programs;</P> <P>(5) Developing procedures, in coordination with the NSFCC, as appropriate, to ensure the coordination of federal, state, and local governments, and private response to oil discharges and releases of hazardous substances, pollutants, or contaminants;</P> <P>(6) Monitoring response-related research and development, testing, and evaluation activities of NRT agencies to enhance coordination, avoid duplication of effort, and facilitate research in support of response activities;</P> <P>(7) Developing recommendations for response training and for enhancing the coordination of available resources among agencies with training responsibilities under the NCP;</P> <P>(8) Reviewing regional responses to oil discharges and hazardous substance, pollutant, or contaminant releases, including an evaluation of equipment readiness and coordination among responsible public agencies and private organizations; and</P> <P>(9) Assisting in developing a national exercise program, in coordination with the NSFCC, to ensure preparedness and coordination nationwide.</P> <P>(i) The NRT will consider matters referred to it for advice or resolution by an RRT.</P> <P>(j) The NRT should be activated as an emergency response team:</P> <P>(1) When an oil discharge or hazardous substance release:</P> <P>(i) Exceeds the response capability of the region in which it occurs;</P> <P>(ii) Transects regional boundaries; or</P> <P>(iii) Involves a substantial threat to the public health or welfare of the United States or the environment, substantial amounts of property, or substantial threats to natural resources;</P> <P> (2) If requested by any NRT member. <PRTPAGE P="26"/> </P> <P>(k) When activated for a response action, the NRT shall meet at the call of the chair and may:</P> <P>(1) Monitor and evaluate reports from the OSC/RPM and recommend to the OSC/RPM, through the RRT, actions to combat the discharge or release;</P> <P>(2) Request other federal, state, and local governments, or private agencies, to provide resources under their existing authorities to combat a discharge or release, or to monitor response operations; and</P> <P>(3) Coordinate the supply of equipment, personnel, or technical advice to the affected region from other regions or districts.</P> </SECTION> <SECTION> <SECTNO>§ 300.115</SECTNO> <SUBJECT>Regional Response Teams.</SUBJECT> <P>(a) Regional planning and coordination of preparedness and response actions is accomplished through the RRT. In the case of a discharge of oil, preparedness activities will be carried out in conjunction with Area Committees, as appropriate. The RRT agency membership parallels that of the NRT, as described in § 300.110, but also includes state and local representation. The RRT provides:</P> <P>(1) The appropriate regional mechanism for development and coordination of preparedness activities before a response action is taken and for coordination of assistance and advice to the OSC/RPM during such response actions; and</P> <P>(2) Guidance to Area Committees, as appropriate, to ensure inter-area consistency and consistency of individual ACPs with the RCP and NCP.</P> <P>(b) The two principal components of the RRT mechanism are a standing team, which consists of designated representatives from each participating federal agency, state governments, and local governments (as agreed upon by the states); and incident-specific teams formed from the standing team when the RRT is activated for a response. On incident-specific teams, participation by the RRT member agencies will relate to the technical nature of the incident and its geographic location.</P> <P>(1) The standing team's jurisdiction corresponds to the standard federal regions, except for Alaska, Oceania in the Pacific, and the Caribbean area, each of which has a separate standing RRT. The role of the standing RRT includes communications systems and procedures, planning, coordination, training, evaluation, preparedness, and related matters on a regionwide basis. It also includes coordination of Area Committees for these functions in areas within their respective regions, as appropriate.</P> <P>(2) The role of the incident-specific team is determined by the operational requirements of the response to a specific discharge or release. Appropriate levels of activation and/or notification of the incident-specific RRT, including participation by state and local governments, shall be determined by the designated RRT chair for the incident, based on the RCP. The incident-specific RRT supports the designated OSC/RPM. The designated OSC/RPM directs response efforts and coordinates all other efforts at the scene of a discharge or release.</P> <P>(c) The representatives of EPA and the USCG shall act as co-chairs of RRTs except when the RRT is activated. When the RRT is activated for response actions, the chair shall be the member agency providing the OSC/RPM.</P> <P>(d) Each participating agency should designate one member and at least one alternate member to the RRT. Agencies whose regional subdivisions do not correspond to the standard federal regions may designate additional representatives to the standing RRT to ensure appropriate coverage of the standard federal region. Participating states may also designate one member and at least one alternate member to the RRT. Indian tribal governments may arrange for representation with the RRT appropriate to their geographical location. All agencies and states may also provide additional representatives as observers to meetings of the RRT.</P> <P>(e) RRT members should designate representatives and alternates from their agencies as resource personnel for RRT activities, including RRT work planning, and membership on incident-specific teams in support of the OSCs/RPMs.</P> <P> (f) Federal RRT members or their representatives should provide OSCs/ <PRTPAGE P="27"/> RPMs with assistance from their respective federal agencies commensurate with agency responsibilities, resources, and capabilities within the region. During a response action, the members of the RRT should seek to make available the resources of their agencies to the OSC/RPM as specified in the RCP and ACP. </P> <P>(g) RRT members should nominate appropriately qualified representatives from their agencies to work with OSCs in developing and maintaining ACPs.</P> <P>(h) Affected states are encouraged to participate actively in all RRT activities. Each state governor is requested to assign an office or agency to represent the state on the appropriate RRT; to designate representatives to work with the RRT in developing RCPs; to plan for, make available, and coordinate state resources; and to serve as the contact point for coordination of response with local government agencies, whether or not represented on the RRT. The state's RRT representative should keep the State Emergency Response Commission (SERC), described in § 300.205(d), apprised of RRT activities and coordinate RRT activities with the SERC. Local governments are invited to participate in activities on the appropriate RRT as provided by state law or as arranged by the state's representative. Indian tribes are also invited to participate in such activities.</P> <P>(i) The standing RRT shall recommend changes in the regional response organization as needed, revise the RCP as needed, evaluate the preparedness of the participating agencies and the effectiveness of ACPs for the federal response to discharges and releases, and provide technical assistance for preparedness to the response community. The RRT should:</P> <P>(1) Review and comment, to the extent practicable, on local emergency response plans or other issues related to the preparation, implementation, or exercise of such plans upon request of a local emergency planning committee;</P> <P>(2) Evaluate regional and local responses to discharges or releases on a continuing basis, considering available legal remedies, equipment readiness, and coordination among responsible public agencies and private organizations, and recommend improvements;</P> <P>(3) Recommend revisions of the NCP to the NRT, based on observations of response operations;</P> <P>(4) Review OSC actions to ensure that RCPs and ACPs are effective;</P> <P>(5) Encourage the state and local response community to improve its preparedness for response;</P> <P>(6) In coordination with Area Committees and in accordance with any applicable laws, regulations, or requirements, conduct advance planning for use of dispersants, surface washing agents, surface collecting agents, burning agents, bioremediation agents, or other chemical agents in accordance with subpart J of this part;</P> <P>(7) Be prepared to provide response resources to major discharges or releases outside the region;</P> <P>(8) Conduct or participate in training and exercises as necessary to encourage preparedness activities of the response community within the region;</P> <P>(9) Meet at least semiannually to review response actions carried out during the preceding period, consider changes in RCPs, and recommend changes in ACPs;</P> <P>(10) Provide letter reports on RRT activities to the NRT twice a year, no later than January 31 and July 31. At a minimum, reports should summarize recent activities, organizational changes, operational concerns, and efforts to improve state and local coordination; and</P> <P>(11) Ensure maximum participation in the national exercise program for announced and unannounced exercises.</P> <P>(j)(1) The RRT may be activated by the chair as an incident-specific response team when a discharge or release:</P> <P>(i) Exceeds the response capability available to the OSC/RPM in the place where it occurs;</P> <P>(ii) Transects state boundaries;</P> <P>(iii) May pose a substantial threat to the public health or welfare of the United States or the environment, or to regionally significant amounts of property; or</P> <P> (iv) Is a worst case discharge, as described in § 300.324. RCPs shall specify detailed criteria for activation of RRTs. <PRTPAGE P="28"/> </P> <P>(2) The RRT will be activated during any discharge or release upon a request from the OSC/RPM, or from any RRT representative, to the chair of the RRT. Requests for RRT activation shall later be confirmed in writing. Each representative, or an appropriate alternate, should be notified immediately when the RRT is activated.</P> <P>(3) During prolonged removal or remedial action, the RRT may not need to be activated or may need to be activated only in a limited sense, or may need to have available only those member agencies of the RRT who are directly affected or who can provide direct response assistance.</P> <P>(4) When the RRT is activated for a discharge or release, agency representatives shall meet at the call of the chair and may:</P> <P>(i) Monitor and evaluate reports from the OSC/RPM, advise the OSC/RPM on the duration and extent of response, and recommend to the OSC/RPM specific actions to respond to the discharge or release;</P> <P>(ii) Request other federal, state, or local governments, or private agencies, to provide resources under their existing authorities to respond to a discharge or release or to monitor response operations;</P> <P>(iii) Help the OSC/RPM prepare information releases for the public and for communication with the NRT;</P> <P>(iv) If the circumstances warrant, make recommendations to the regional or district head of the agency providing the OSC/RPM that a different OSC/RPM should be designated; and</P> <P>(v) Submit pollution reports to the NRC as significant developments occur.</P> <P>(5) At the regional level, a Regional Response Center (RRC) may provide facilities and personnel for communications, information storage, and other requirements for coordinating response. The location of each RRC should be provided in the RCP.</P> <P>(6) When the RRT is activated, affected states may participate in all RRT deliberations. State government representatives participating in the RRT have the same status as any federal member of the RRT.</P> <P>(7) The RRT can be deactivated when the incident-specific RRT chair determines that the OSC/RPM no longer requires RRT assistance.</P> <P>(8) Notification of the RRT may be appropriate when full activation is not necessary, with systematic communication of pollution reports or other means to keep RRT members informed as to actions of potential concern to a particular agency, or to assist in later RRT evaluation of regionwide response effectiveness.</P> <P>(k) Whenever there is insufficient national policy guidance on a matter before the RRT, a technical matter requiring solution, a question concerning interpretation of the NCP, or a disagreement on discretionary actions among RRT members that cannot be resolved at the regional level, it may be referred to the NRT, described in § 300.110, for advice.</P> </SECTION> <SECTION> <SECTNO>§ 300.120</SECTNO> <SUBJECT>On-scene coordinators and remedial project managers: general responsibilities.</SUBJECT> <P>(a) The OSC/RPM directs response efforts and coordinates all other efforts at the scene of a discharge or release. As part of the planning and preparedness for response, OSCs shall be predesignated by the regional or district head of the lead agency. EPA and the USCG shall predesignate OSCs for all areas in each region, except as provided in paragraphs (c) and (d) of this section. RPMs shall be assigned by the lead agency to manage remedial or other response actions at NPL sites, except as provided in paragraphs (c) and (d) of this section.</P> <P> (1) The USCG shall provide OSCs for oil discharges, including discharges from facilities and vessels under the jurisdiction of another federal agency, within or threatening the coastal zone. The USCG shall also provide OSCs for the removal of releases of hazardous substances, pollutants, or contaminants into or threatening the coastal zone, except as provided in paragraph (b) of this section. The USCG shall not provide predesignated OSCs for discharges or releases from hazardous waste management facilities or in similarly chronic incidents. The USCG shall provide an initial response to discharges or releases from hazardous waste management facilities within <PRTPAGE P="29"/> the coastal zone in accordance with Department of Transportation (DOT)/EPA Instrument of Redelegation (May 27, 1988) except as provided by paragraph (b) of this section. The USCG OSC shall contact the cognizant RPM as soon as it is evident that a removal may require a follow-up remedial action, to ensure that the required planning can be initiated and an orderly transition to an EPA or state lead can occur. </P> <P>(2) EPA shall provide OSCs for discharges or releases into or threatening the inland zone and shall provide RPMs for federally funded remedial actions, except in the case of state-lead federally funded response and as provided in paragraph (b) of this section. EPA will also assume all remedial actions at NPL sites in the coastal zone, even where removals are initiated by the USCG, except as provided in paragraph (b) of this section.</P> <P>(b) In general, USCG Captains of the Port (COTP) shall serve as the designated OSCs for areas in the coastal zone for which an ACP is required under CWA section 311(j) and EPA Regional Administrators shall designate OSCs for areas in the inland zone for which an ACP is required under CWA section 311(j).</P> <P>(c) For releases of hazardous substances, pollutants, or contaminants, when the release is on, or the sole source of the release is from, any facility or vessel, including vessels bareboat-chartered and operated, under the jurisdiction, custody, or control of DOD, DOE, or other federal agency:</P> <P>(1) In the case of DOD or DOE, DOD or DOE shall provide OSCs/RPMs responsible for taking all response actions; and</P> <P>(2) In the case of a federal agency other than EPA, DOD, or DOE, such agency shall provide OSCs for all removal actions that are not emergencies and shall provide RPMs for all remedial actions.</P> <P>(d) DOD will be the removal response authority with respect to incidents involving DOD military weapons and munitions or weapons and munitions under the jurisdiction, custody, or control of DOD.</P> <P>(e) The OSC is responsible for overseeing development of the ACP in the area of the OSC's responsibility. ACPs shall, as appropriate, be accomplished in cooperation with the RRT, and designated state and local representatives. In contingency planning and removal, the OSC coordinates, directs, and reviews the work of other agencies, Area Committees, responsible parties, and contractors to assure compliance with the NCP, decision document, consent decree, administrative order, and lead agency-approved plans applicable to the response.</P> <P>(f) The RPM is the prime contact for remedial or other response actions being taken (or needed) at sites on the proposed or promulgated NPL, and for sites not on the NPL but under the jurisdiction, custody, or control of a federal agency. The RPM's responsibilities include:</P> <P>(1) Fund-financed response: The RPM coordinates, directs, and reviews the work of EPA, states and local governments, the U.S. Army Corps of Engineers, and all other agencies and contractors to assure compliance with the NCP. Based upon the reports of these parties, the RPM recommends action for decisions by lead agency officials. The RPM's period of responsibility begins prior to initiation of the remedial investigation/feasibility study (RI/FS), described in § 300.430, and continues through design, remedial action, deletion of the site from the NPL, and the CERCLA cost recovery activity. When a removal and remedial action occur at the same site, the OSC and RPM should coordinate to ensure an orderly transition of responsibility.</P> <P> (2) Federal-lead non-Fund-financed response: The RPM coordinates, directs, and reviews the work of other agencies, responsible parties, and contractors to assure compliance with the NCP, Record of Decision (ROD), consent decree, administrative order, and lead agency-approved plans applicable to the response. Based upon the reports of these parties, the RPM shall recommend action for decisions by lead agency officials. The RPM's period of responsibility begins prior to initiation of the RI/FS, described in § 300.430, and continues through design and remedial action and the CERCLA cost recovery activity. The OSC and RPM shall ensure orderly transition of responsibilities from one to the other. <PRTPAGE P="30"/> </P> <P>(3) The RPM shall participate in all decision-making processes necessary to ensure compliance with the NCP, including, as appropriate, agreements between EPA or other federal agencies and the state. The RPM may also review responses where EPA has preauthorized a person to file a claim for reimbursement to determine that the response was consistent with the terms of such preauthorization in cases where claims are filed for reimbursement.</P> <P>(g)(1) Where a support agency has been identified through a cooperative agreement, Superfund Memorandum of Agreement (SMOA), or other agreement, that agency may designate a support agency coordinator (SAC) to provide assistance, as requested, by the OSC/RPM. The SAC is the prime representative of the support agency for response actions.</P> <P>(2) The SAC's responsibilities may include:</P> <P>(i) Providing and reviewing data and documents as requested by the OSC/RPM during the planning, design, and cleanup activities of the response action; and</P> <P>(ii) Providing other assistance as requested.</P> <P>(h)(1) The lead agency should provide appropriate training for its OSCs, RPMs, and other response personnel to carry out their responsibilities under the NCP.</P> <P>(2) OSCs/RPMs should ensure that persons designated to act as their on-scene representatives are adequately trained and prepared to carry out actions under the NCP, to the extent practicable.</P> </SECTION> <SECTION> <SECTNO>§ 300.125</SECTNO> <SUBJECT>Notification and communications.</SUBJECT> <P>(a) The National Response Center (NRC), located at USCG Headquarters, is the national communications center, continuously manned for handling activities related to response actions. The NRC acts as the single point of contact for all pollution incident reporting, and as the NRT communications center. Notice of discharges and releases must be made telephonically through a toll free number or a special local number (Telecommunication Device for the Deaf (TDD) and collect calls accepted). (Notification details appear in §§ 300.300 and 300.405.) The NRC receives and immediately relays telephone notices of discharges or releases to the appropriate predesignated federal OSC. The telephone report is distributed to any interested NRT member agency or federal entity that has established a written agreement or understanding with the NRC. The NRC evaluates incoming information and immediately advises FEMA of a potential major disaster situation.</P> <P>(b) The Commandant, USCG, in conjunction with other NRT agencies, shall provide the necessary personnel, communications, plotting facilities, and equipment for the NRC.</P> <P>(c) Notice of an oil discharge or release of a hazardous substance in an amount equal to or greater than the reportable quantity must be made immediately in accordance with 33 CFR part 153, subpart B, and 40 CFR part 302, respectively. Notification shall be made to the NRC Duty Officer, HQ USCG, Washington, DC, telephone (800) 424-8802 or (202) 267-2675. All notices of discharges or releases received at the NRC will be relayed immediately by telephone to the OSC.</P> </SECTION> <SECTION> <SECTNO>§ 300.130</SECTNO> <SUBJECT>Determinations to initiate response and special conditions.</SUBJECT> <P>(a) In accordance with CWA and CERCLA, the Administrator of EPA or the Secretary of the department in which the USCG is operating, as appropriate, is authorized to act for the United States to take response measures deemed necessary to protect the public health or welfare or environment from discharges of oil or releases of hazardous substances, pollutants, or contaminants except with respect to such releases on or from vessels or facilities under the jurisdiction, custody, or control of other federal agencies.</P> <P> (b) The Administrator of EPA or the Secretary of the department in which the USCG is operating, as appropriate, is authorized to initiate and, in the case of a discharge posing a substantial threat to public health or welfare of the United States is required to initiate and direct, appropriate response activities when the Administrator or Secretary determines that any oil or CWA hazardous substance is discharged <PRTPAGE P="31"/> or there is a substantial threat of such discharge from any vessel or offshore or onshore facility into or on the navigable waters of the United States, on the adjoining shorelines to the navigable waters, into or on the waters of the exclusive economic zone, or that may affect natural resources belonging to, appertaining to, or under exclusive management authority of the United States; or </P> <P>(c) The Administrator of EPA or the Secretary of the department in which the USCG is operating, as appropriate, is authorized to initiate appropriate response activities when the Administrator or Secretary determines that any hazardous substance is released or there is a threat of such a release into the environment, or there is a release or threat of release into the environment of any pollutant or contaminant which may present an imminent and substantial danger to the public health or welfare of the United States.</P> <P>(d) In addition to any actions taken by a state or local government, the Administrator of EPA or the Secretary of the department in which the USCG is operating may request the U.S. Attorney General to secure the relief from any person, including the owner or operator of the vessel or facility necessary to abate a threat or, after notice to the affected state, take any other action authorized by section 311 of the CWA or section 106 of CERCLA as appropriate, including issuing administrative orders, that may be necessary to protect the public health or welfare, if the Administrator or Secretary determines:</P> <P>(1) That there may be an imminent and substantial threat to the public health or welfare of the United States or the environment of the United States, including fish, shellfish, and wildlife, public and private property, shorelines, beaches, habitats, and other living and nonliving natural resources under the jurisdiction or control of the United States, because of an actual or threatened discharge of oil or a CWA hazardous substance from any vessel or offshore or onshore facility into or upon the navigable waters of the United States; or</P> <P>(2) That there may be an imminent and substantial endangerment to the public health or welfare of the United States or the environment because of a release of a CERCLA hazardous substance from a facility.</P> <P>(e) Response actions to remove discharges originating from operations conducted subject to the Outer Continental Shelf Lands Act shall be in accordance with the NCP.</P> <P>(f) Where appropriate, when a discharge or release involves radioactive materials, the lead or support federal agency shall act consistent with the notification and assistance procedures described in the appropriate Federal Radiological Plan. For the purpose of the NCP, the FRERP (24 CFR part 2401) is the appropriate plan. Most radiological discharges and releases do not result in FRERP activation and should be handled in accordance with the NCP. However, releases from nuclear incidents subject to requirements for financial protection established by the Nuclear Regulatory Commission under the Price-Anderson amendments (section 170) of the Atomic Energy Act are specifically excluded from CERCLA and NCP requirements.</P> <P>(g) Removal actions involving nuclear weapons should be conducted in accordance with the joint Department of Defense, Department of Energy, and FEMA Agreement for Response to Nuclear Incidents and Nuclear Weapons Significant Incidents (January 8, 1981).</P> <P>(h) If the situation is beyond the capability of state and local governments and the statutory authority of federal agencies, the President may, under the Disaster Relief Act of 1974, act upon a request by the governor and declare a major disaster or emergency and appoint a Federal Coordinating Officer (FCO) to coordinate all federal disaster assistance activities. In such cases, the OSC/RPM would continue to carry out OSC/RPM responsibilities under the NCP, but would coordinate those activities with the FCO to ensure consistency with other federal disaster assistance activities.</P> <P> (i) In the event of a declaration of a major disaster by the President, the FEMA may activate the Federal Response Plan (FRP). A FCO, designated by the President, may implement the FRP and coordinate and direct emergency assistance and disaster relief of <PRTPAGE P="32"/> impacted individuals, business, and public services under the Robert T. Stafford Disaster Relief Act. Delivery of federal assistance is facilitated through twelve functional annexes to the FRP known as Emergency Support Functions (ESFs). EPA coordinates activities under ESF #10—Hazardous Materials, which addresses preparedness and response to hazardous materials and oil incidents caused by a natural disaster or other catastrophic event. In such cases, the OSC/RPM should coordinate response activities with the FCO, through the incident-specific ESF #10 Chair, to ensure consistency with federal disaster assistance activities. </P> </SECTION> <SECTION> <SECTNO>§ 300.135</SECTNO> <SUBJECT>Response operations.</SUBJECT> <P>(a) The OSC/RPM, consistent with §§ 300.120 and 300.125, shall direct response efforts and coordinate all other efforts at the scene of a discharge or release. As part of the planning and preparation for response, the OSCs/RPMs shall be predesignated by the regional or district head of the lead agency.</P> <P>(b) The first federal official affiliated with an NRT member agency to arrive at the scene of a discharge or release should coordinate activities under the NCP and is authorized to initiate, in consultation with the OSC, any necessary actions normally carried out by the OSC until the arrival of the predesignated OSC. This official may initiate federal fund-financed actions only as authorized by the OSC or, if the OSC is unavailable, the authorized representative of the lead agency.</P> <P>(c) The OSC/RPM shall, to the extent practicable, collect pertinent facts about the discharge or release, such as its source and cause; the identification of potentially responsible parties; the nature, amount, and location of discharged or released materials; the probable direction and time of travel of discharged or released materials; whether the discharge is a worst case discharge as discussed in § 300.324; the pathways to human and environmental exposure; the potential impact on human health, welfare, and safety and the environment; whether the discharge or release poses a substantial threat to the public health or welfare of the United States as discussed in § 300.322; the potential impact on natural resources and property which may be affected; priorities for protecting human health and welfare and the environment; and appropriate cost documentation.</P> <P>(d) The OSC's/RPM's efforts shall be coordinated with other appropriate federal, state, local, and private response agencies. OSCs/RPMs may designate capable persons from federal, state, or local agencies to act as their on-scene representatives. State and local governments, however, are not authorized to take actions under subparts D and E of the NCP that involve expenditures of the Oil Spill Liability Trust Fund or CERCLA funds unless an appropriate contract or cooperative agreement has been established. The basic framework for the response management structure is a system (e.g., a unified command system), that brings together the functions of the federal government, the state government, and the responsible party to achieve an effective and efficient response, where the OSC maintains authority.</P> <P>(e) The OSC/RPM should consult regularly with the RRT and NSFCC, as appropriate, in carrying out the NCP and keep the RRT and NSFCC, as appropriate, informed of activities under the NCP.</P> <P>(f) The OSC/RPM shall advise the support agency as promptly as possible of reported releases.</P> <P>(g) The OSC/RPM should evaluate incoming information and immediately advise FEMA of potential major disaster situations.</P> <P>(h) In those instances where a possible public health emergency exists, the OSC/RPM should notify the Department of Health and Human Services (HHS) representative to the RRT. Throughout response actions, the OSC/RPM may call upon the HHS representative for assistance in determining public health threats and call upon the Occupational Safety and Health Administration (OSHA) and HHS for assistance on worker health and safety issues.</P> <P> (i) All federal agencies should plan for emergencies and develop procedures for dealing with oil discharges and releases of hazardous substances, pollutants, or contaminants from vessels and <PRTPAGE P="33"/> facilities under their jurisdiction. All federal agencies, therefore, are responsible for designating the office that coordinates response to such incidents in accordance with the NCP and applicable federal regulations and guidelines. </P> <P>(j)(1) The OSC/RPM shall ensure that the trustees for natural resources are promptly notified of discharges or releases.</P> <P>(2) The OSC or RPM shall coordinate all response activities with the affected natural resource trustees and, for discharges of oil, the OSC shall consult with the affected trustees on the appropriate removal action to be taken.</P> <P>(k) Where the OSC/RPM becomes aware that a discharge or release may affect any endangered or threatened species or their habitat, the OSC/RPM shall consult with the Department of Interior (DOI), or the Department of Commerce (DOC) (NOAA) and, if appropriate, the cognizant federal land managing agency.</P> <P>(l) The OSC/RPM is responsible for addressing worker health and safety concerns at a response scene, in accordance with § 300.150.</P> <P>(m) The OSC shall submit pollution reports to the RRT and other appropriate agencies as significant developments occur during response actions, through communications networks or procedures agreed to by the RRT and covered in the RCP.</P> <P>(n) OSCs/RPMs should ensure that all appropriate public and private interests are kept informed and that their concerns are considered throughout a response, to the extent practicable, consistent with the requirements of § 300.155 of this part.</P> </SECTION> <SECTION> <SECTNO>§ 300.140</SECTNO> <SUBJECT>Multi-regional responses.</SUBJECT> <P>(a) If a discharge or release moves from the area covered by one ACP or RCP into another area, the authority for response actions should likewise shift. If a discharge or release affects areas covered by two or more ACPs or RCPs, the response mechanisms of each applicable plan may be activated. In this case, response actions of all regions concerned shall be fully coordinated as detailed in the RCPs and ACPs.</P> <P>(b) There shall be only one OSC and/or RPM at any time during the course of a response operation. Should a discharge or release affect two or more areas, EPA, the USCG, DOD, DOE, or other lead agency, as appropriate, shall give prime consideration to the area vulnerable to the greatest threat, in determining which agency should provide the OSC and/or RPM. The RRT shall designate the OSC and/or RPM if the RRT member agencies who have response authority within the affected areas are unable to agree on the designation. The NRT shall designate the OSC and/or RPM if members of one RRT or two adjacent RRTs are unable to agree on the designation.</P> <P>(c) Where the USCG has initially provided the OSC for response to a release from hazardous waste management facilities located in the coastal zone, responsibility for response action shall shift to EPA or another federal agency, as appropriate.</P> </SECTION> <SECTION> <SECTNO>§ 300.145</SECTNO> <SUBJECT>Special teams and other assistance available to OSCs/RPMs.</SUBJECT> <P>(a) The NSF is a special team established by the USCG, including the three USCG Strike Teams, the Public Information Assist Team (PIAT), and the NSFCC. The NSF is available to assist OSCs/RPMs in their preparedness and response duties.</P> <P>(1) The three Strike Teams (Atlantic, Gulf, and Pacific) provide trained personnel and specialized equipment to assist the OSC in training for spill response, stabilizing and containing the spill, and in monitoring or directing the response actions of the responsible parties and/or contractors. The OSC has a specific team designated for initial contact and may contact that team directly for any assistance.</P> <P>(2) The NSFCC can provide the following support to the OSC:</P> <P>(i) Technical assistance, equipment and other resources to augment the OSC staff during spill response.</P> <P>(ii) Assistance in coordinating the use of private and public resources in support of the OSC during a response to or a threat of a worst case discharge of oil.</P> <P> (iii) Review of the area contingency plan, including an evaluation of equipment readiness and coordination among responsible public agencies and private organizations. <PRTPAGE P="34"/> </P> <P>(iv) Assistance in locating spill response resources for both response and planning, using the NSFCC's national and international computerized inventory of spill response resources.</P> <P>(v) Coordination and evaluation of pollution response exercises.</P> <P>(vi) Inspection of district prepositioned pollution response equipment.</P> <P>(3) PIAT is an element of the NSFCC staff which is available to assist OSCs to meet the demands for public information during a response or exercise. Its use is encouraged any time the OSC requires outside public affairs support. Requests for PIAT assistance may be made through the NSFCC or NRC.</P> <P>(b)(1) The Environmental Response Team (ERT) is established by EPA in accordance with its disaster and emergency responsibilities. The ERT has expertise in treatment technology, biology, chemistry, hydrology, geology, and engineering.</P> <P>(2) The ERT can provide access to special decontamination equipment for chemical releases and advice to the OSC/RPM in hazard evaluation; risk assessment; multimedia sampling and analysis program; on-site safety, including development and implementation plans; cleanup techniques and priorities; water supply decontamination and protection; application of dispersants; environmental assessment; degree of cleanup required; and disposal of contaminated material.</P> <P>(3) The ERT also provides both introductory and intermediate level training courses to prepare response personnel.</P> <P>(4) OSC/RPM or RRT requests for ERT support should be made to the EPA representative on the RRT; EPA Headquarters, Director, Emergency Response Division; or the appropriate EPA regional emergency coordinator.</P> <P>(c) Scientific Support Coordinators (SSCs) may be designated by the OSC (and RPM in the case of EPA SSCs) as the principal advisors for scientific issues, communication with the scientific community, and coordination of requests for assistance from state and federal agencies regarding scientific studies. The SSC strives for a consensus on scientific issues affecting the response, but ensures that differing opinions within the community are communicated to the OSC/RPM.</P> <P>(1) Generally, SSCs are provided by NOAA in the coastal zones, and by EPA in the inland zone. OSC/RPM requests for SSC support can be made directly to the SSC assigned to the area or to the agency member of the RRT. NOAA SSCs can also be requested through NOAA's SSC program office in Seattle, WA. NOAA SSCs are assigned to USCG Districts and are supported by a scientific support team that includes expertise in environmental chemistry, oil slick tracking, pollutant transport modeling, natural resources at risk, environmental tradeoffs of countermeasures and cleanup, and information management.</P> <P>(2) During a response, the SSC serves on the federal OSC's/RPM's staff and may, at the request of the OSC/RPM, lead the scientific team and be responsible for providing scientific support for operational decisions and for coordinating on-scene scientific activity. Depending on the nature and location of the incident, the SSC integrates expertise from governmental agencies, universities, community representatives, and industry to assist the OSC/RPM in evaluating the hazards and potential effects of releases and in developing response strategies.</P> <P>(3) At the request of the OSC, the SSC may facilitate the OSC's work with the lead administrative trustee for natural resources to ensure coordination between damage assessment data collection efforts and data collected in support of response operations.</P> <P>(4) SSCs support the Regional Response Teams and the Area Committees in preparing regional and area contingency plans and in conducting spill training and exercises. For area plans, the SSC provides leadership for the synthesis and integration of environmental information required for spill response decisions in support of the OSC.</P> <P> (d)(1) SUPSALV has an extensive salvage/search and recovery equipment inventory with the requisite knowledge and expertise to support these operations, including specialized salvage, firefighting, and petroleum, oil and lubricants offloading capability. <PRTPAGE P="35"/> </P> <P>(2) When possible, SUPSALV will provide equipment for training exercises in support of national and regional contingency planning objectives.</P> <P>(3) The OSC/RPM may request assistance directly from SUPSALV. Formal requests are routed through the Chief of Naval Operations (N312).</P> <P>(e) For marine salvage operations, OSCs/RPMs with responsibility for monitoring, evaluating, or supervising these activities should request technical assistance from DOD, the Strike Teams, or commercial salvors as necessary to ensure that proper actions are taken. Marine salvage operations generally fall into five categories: afloat salvage; offshore salvage; river and harbor clearance; cargo salvage; and rescue towing. Each category requires different knowledge and specialized types of equipment. The complexity of such operations may be further compounded by local environmental and geographic conditions. The nature of marine salvage and the conditions under which it occurs combine to make such operations imprecise, difficult, hazardous, and expensive. Thus, responsible parties or other persons attempting to perform such operations without adequate knowledge, equipment, and experience could aggravate, rather than relieve, the situation.</P> <P>(f) Radiological Emergency Response Teams (RERTs) have been established by EPA's Office of Radiation Programs (ORP) to provide response and support for incidents or sites containing radiological hazards. Expertise is available in radiation monitoring, radionuclide analysis, radiation health physics, and risk assessment. RERTs can provide on-site support including mobile monitoring laboratories for field analyses of samples and fixed laboratories for radiochemical sampling and analyses. Requests for support may be made 24 hours a day via the NRC or directly to the EPA Radiological Response Coordinator in the Office of Radiation Programs. Assistance is also available from DOE and other federal agencies.</P> <P>(g)(1) DRGs assist the OSC by providing technical assistance, personnel, and equipment, including pre-positioned equipment. Each DRG consists of all Coast Guard personnel and equipment, including marine firefighting equipment, in its district, additional pre-positioned equipment, and a District Response Advisory Team (DRAT) that is available to provide support to the OSC in the event that a spill exceeds local response capabilities. Each DRG:</P> <P>(i) Shall provide technical assistance, equipment, and other resources, as available, when requested by an OSC through the USCG representative to the RRT;</P> <P>(ii) Shall ensure maintenance of all USCG response equipment within its district;</P> <P>(iii) May provide technical assistance in the preparation of the ACP; and</P> <P>(iv) Shall review each of those plans that affect its area of geographic responsibility.</P> <P>(2) In deciding where to locate personnel and pre-positioned equipment, the USCG shall give priority emphasis to:</P> <P>(i) The availability of facilities for loading and unloading heavy or bulky equipment by barge;</P> <P>(ii) The proximity to an airport capable of supporting large military transport aircraft;</P> <P>(iii) The flight time to provide response to oil spills in all areas of the Coast Guard district with the potential for marine casualties;</P> <P>(iv) The availability of trained local personnel capable of responding in an oil spill emergency; and</P> <P>(v) Areas where large quantities of petroleum products are transported.</P> <P>(h) The NPFC is responsible for implementing those portions of Title I of the OPA that have been delegated to the Secretary of the department in which the Coast Guard is operating. The NPFC is responsible for addressing funding issues arising from discharges and threats of discharges of oil. The NPFC:</P> <P>(1) Issues Certificates of Financial Responsibility to owners and operators of vessels to pay for costs and damages that are incurred by their vessels as a result of oil discharges;</P> <P> (2) Provides funding for various response organizations for timely abatement and removal actions related to oil discharges; <PRTPAGE P="36"/> </P> <P>(3) Provides equitable compensation to claimants who sustain costs and damages from oil discharges when the responsible party fails to do so;</P> <P>(4) Recovers monies from persons liable for costs and damages resulting from oil discharges to the full extent of liability under the law; and</P> <P>(5) Provides funds to initiate natural resource damage assessments.</P> </SECTION> <SECTION> <SECTNO>§ 300.150</SECTNO> <SUBJECT>Worker health and safety.</SUBJECT> <P>(a) Response actions under the NCP will comply with the provisions for response action worker safety and health in 29 CFR 1910.120. The NRS meets the requirements of 29 CFR 1910.120 concerning use of an incident command system.</P> <P>(b) In a response action taken by a responsible party, the responsible party must assure that an occupational safety and health program consistent with 29 CFR 1910.120 is made available for the protection of workers at the response site.</P> <P> (c) In a response taken under the NCP by a lead agency, an occupational safety and health program should be made available for the protection of workers at the response site, consistent with, and to the extent required by, 29 CFR 1910.120. Contracts relating to a response action under the NCP should contain assurances that the contractor at the response site will comply with this program and with any applicable provisions of the Occupational Safety and Health Act of 1970 (29 U.S.C. 651 <E T="03">et seq.</E> ) (OSH Act) and state laws with plans approved under section 18 of the OSH Act. </P> <P>(d) When a state, or political subdivision of a state, without an OSHA-approved state plan is the lead agency for response, the state or political subdivision must comply with standards in 40 CFR part 311, promulgated by EPA pursuant to section 126(f) of SARA.</P> <P>(e) Requirements, standards, and regulations of the OSH Act and of state OSH laws not directly referenced in paragraphs (a) through (d) of this section, must be complied with where applicable. Federal OSH Act requirements include, among other things, Construction Standards (29 CFR part 1926), General Industry Standards (29 CFR part 1910), and the general duty requirement of section 5(a)(1) of the OSH Act (29 U.S.C. 654(a)(1)). No action by the lead agency with respect to response activities under the NCP constitutes an exercise of statutory authority within the meaning of section 4(b)(1) of the OSH Act. All governmental agencies and private employers are directly responsible for the health and safety of their own employees.</P> </SECTION> <SECTION> <SECTNO>§ 300.155</SECTNO> <SUBJECT>Public information and community relations.</SUBJECT> <P>(a) When an incident occurs, it is imperative to give the public prompt, accurate information on the nature of the incident and the actions underway to mitigate the damage. OSCs/RPMs and community relations personnel should ensure that all appropriate public and private interests are kept informed and that their concerns are considered throughout a response. They should coordinate with available public affairs/community relations resources to carry out this responsibility by establishing, as appropriate, a Joint Information Center bringing together resources from federal and state agencies and the responsible party.</P> <P> (b) An on-scene news office may be established to coordinate media relations and to issue official federal information on an incident. Whenever possible, it will be headed by a representative of the lead agency. The OSC/RPM determines the location of the on-scene news office, but every effort should be made to locate it near the scene of the incident. If a participating agency believes public interest warrants the issuance of statements and an on-scene news office has not been established, the affected agency should recommend its establishment. All federal news releases or statements by participating agencies should be cleared through the OSC/RPM. Information dissemination relating to natural resource damage assessment activities shall be coordinated through the lead administrative trustee. The designated lead administrative trustee may assist the OSC/RPM by disseminating information on issues relating to damage assessment activities. Following termination of removal activity, information dissemination on damage assessment activities <PRTPAGE P="37"/> shall be through the lead administrative trustee. </P> <P>(c) The community relations requirements specified in §§ 300.415, 300.430, and 300.435 apply to removal, remedial, and enforcement actions and are intended to promote active communication between communities affected by discharges or releases and the lead agency responsible for response actions. Community Relations Plans (CRPs) are required by EPA for certain response actions. The OSC/RPM should ensure coordination with such plans which may be in effect at the scene of a discharge or release or which may need to be developed during follow-up activities.</P> </SECTION> <SECTION> <SECTNO>§ 300.160</SECTNO> <SUBJECT>Documentation and cost recovery.</SUBJECT> <P>(a) For releases of a hazardous substance, pollutant, or contaminant, the following provisions apply:</P> <P>(1) During all phases of response, the lead agency shall complete and maintain documentation to support all actions taken under the NCP and to form the basis for cost recovery. In general, documentation shall be sufficient to provide the source and circumstances of the release, the identity of responsible parties, the response action taken, accurate accounting of federal, state, or private party costs incurred for response actions, and impacts and potential impacts to the public health and welfare and the environment. Where applicable, documentation shall state when the NRC received notification of a release of a reportable quantity.</P> <P>(2) The information and reports obtained by the lead agency for Fund-financed response actions shall, as appropriate, be transmitted to the chair of the RRT. Copies can then be forwarded to the NRT, members of the RRT, and others as appropriate.</P> <P>(3) The lead agency shall make available to the trustees of affected natural resources information and documentation that can assist the trustees in the determination of actual or potential natural resource injuries.</P> <P>(b) For discharges of oil, documentation and cost recovery provisions are described in § 300.315.</P> <P>(c) Response actions undertaken by the participating agencies shall be carried out under existing programs and authorities when available. Federal agencies are to make resources available, expend funds, or participate in response to discharges and releases under their existing authority. Interagency agreements may be signed when necessary to ensure that the federal resources will be available for a timely response to a discharge or release. The ultimate decision as to the appropriateness of expending funds rests with the agency that is held accountable for such expenditures. Further funding provisions for discharges of oil are described in § 300.335.</P> <P>(d) The Administrator of EPA and the Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR) shall assure that the costs of health assessment or health effect studies conducted under the authority of CERCLA section 104(i) are documented in accordance with standard EPA procedures for cost recovery. Documentation shall include information on the nature of the hazardous substances addressed by the research, information concerning the locations where these substances have been found, and any available information on response actions taken concerning these substances at the location.</P> </SECTION> <SECTION> <SECTNO>§ 300.165</SECTNO> <SUBJECT>OSC reports.</SUBJECT> <P>(a) As requested by the NRT or RRT, the OSC/RPM shall submit to the NRT or RRT a complete report on the removal operation and the actions taken. The RRT shall review the OSC report and send to the NRT a copy of the OSC report with its comments or recommendations within 30 days after the RRT has received the OSC report.</P> <P>(b) The OSC report shall record the situation as it developed, the actions taken, the resources committed, and the problems encountered.</P> </SECTION> <SECTION> <SECTNO>§ 300.170</SECTNO> <SUBJECT>Federal agency participation.</SUBJECT> <P> Federal agencies listed in § 300.175 have duties established by statute, executive order, or Presidential directive which may apply to federal response actions following, or in prevention of, the discharge of oil or release of a hazardous substance, pollutant, or contaminant. Some of these agencies also have duties relating to the restoration, <PRTPAGE P="38"/> rehabilitation, replacement, or acquisition of equivalent natural resources injured or lost as a result of such discharge or release as described in subpart G of this part. The NRT, RRT, and Area Committee organizational structure, and the NCP, RCPs and ACPs, described in § 300.210, provide for agencies to coordinate with each other in carrying out these duties. </P> <P>(a) Federal agencies may be called upon by an OSC/RPM during response planning and implementation to provide assistance in their respective areas of expertise, as described in § 300.175, consistent with the agencies' capabilities and authorities.</P> <P>(b) In addition to their general responsibilities, federal agencies should:</P> <P>(1) Make necessary information available to the Secretary of the NRT, RRTs, Area Committees, and OSCs/RPMs.</P> <P>(2) Provide representatives to the NRT and RRTs and otherwise assist RRTs and OSCs, as necessary, in formulating RCPs and ACPs.</P> <P>(3) Inform the NRT, RRTs, and Area Committees, consistent with national security considerations, of changes in the availability of resources that would affect the operations implemented under the NCP.</P> <P>(c) All federal agencies are responsible for reporting releases of hazardous substances from facilities or vessels under their jurisdiction or control in accordance with section 103 of CERCLA.</P> <P>(d) All federal agencies are encouraged to report releases of pollutants or contaminants and must report discharges of oil, as required in 40 CFR part 110, from facilities or vessels under their jurisdiction or control to the NRC.</P> </SECTION> <SECTION> <SECTNO>§ 300.175</SECTNO> <SUBJECT>Federal agencies: additional responsibilities and assistance.</SUBJECT> <P>(a) During preparedness planning or in an actual response, various federal agencies may be called upon to provide assistance in their respective areas of expertise, as indicated in paragraph (b) of this section, consistent with agency legal authorities and capabilities.</P> <P>(b) The federal agencies include:</P> <P>(1) USCG, as provided in 14 U.S.C. 1-3, is an agency in DOT, except when operating as an agency in the United States Navy (USN) in time of war. The USCG provides the NRT vice chair, co-chairs for the standing RRTs, and predesignated OSCs for the coastal zone, as described in § 300.120(a)(1). The USCG maintains continuously manned facilities which can be used for command, control, and surveillance of oil discharges and hazardous substance releases occurring in the coastal zone. The USCG also offers expertise in domestic and international fields of port safety and security, maritime law enforcement, ship navigation and construction, and the manning, operation, and safety of vessels and marine facilities. The USCG may enter into a contract or cooperative agreement with the appropriate state in order to implement a response action.</P> <P> (2) EPA chairs the NRT and co-chairs, with the USCG, the standing RRTs; provides predesignated OSCs for all inland areas for which an ACP is required under CWA section 311(j) and for discharges and releases occurring in the inland zone and RPMs for remedial actions except as otherwise provided; and generally provides the SSC for responses in the inland zone. EPA provides expertise on human health and ecological effects of oil discharges or releases of hazardous substances, pollutants, or contaminants; ecological and human health risk assessment methods; and environmental pollution control techniques. Access to EPA's scientific expertise can be facilitated through the EPA representative to the Research and Development Committee of the National Response Team; the EPA Office of Research and Development's Superfund Technical Liaisons or Regional Scientists located in EPA Regional offices; or through EPA's Office of Science Planning and Regulatory Evaluation. EPA also provides legal expertise on the interpretation of CERCLA and other environmental statutes. EPA may enter into a contract or cooperative agreement with the appropriate state in order to implement a response action. <PRTPAGE P="39"/> </P> <P>(3) FEMA provides guidance, policy and program advice, and technical assistance in hazardous materials, chemical, and radiological emergency preparedness activities (including planning, training, and exercising). FEMA's primary point of contact for administering financial and technical assistance to state and local governments to support their efforts to develop and maintain an effective emergency management and response capability is the Preparedness, Training, and Exercises Directorate.</P> <P>(4) DOD has responsibility to take all action necessary with respect to releases where either the release is on, or the sole source of the release is from, any facility or vessel under the jurisdiction, custody, or control of DOD. In addition to those capabilities provided by SUPSALV, DOD may also, consistent with its operational requirements and upon request of the OSC, provide locally deployed USN oil spill equipment and provide assistance to other federal agencies on request. The following two branches of DOD have particularly relevant expertise:</P> <P>(i) The United States Army Corps of Engineers has specialized equipment and personnel for maintaining navigation channels, for removing navigation obstructions, for accomplishing structural repairs, and for performing maintenance to hydropower electric generating equipment. The Corps can also provide design services, perform construction, and provide contract writing and contract administrative services for other federal agencies.</P> <P>(ii) The U.S. Navy Supervisor of Salvage (SUPSALV) is the branch of service within DOD most knowledgeable and experienced in ship salvage, shipboard damage control, and diving. The USN has an extensive array of specialized equipment and personnel available for use in these areas as well as specialized containment, collection, and removal equipment specifically designed for salvage-related and open-sea pollution incidents.</P> <P>(5) DOE generally provides designated OSCs/RPMs that are responsible for taking all response actions with respect to releases where either the release is on, or the sole source of the release is from, any facility or vessel under its jurisdiction, custody, or control, including vessels bareboat-chartered and operated. In addition, under the FRERP, DOE provides advice and assistance to other OSCs/RPMs for emergency actions essential for the control of immediate radiological hazards. Incidents that qualify for DOE radiological advice and assistance are those believed to involve source, by-product, or special nuclear material or other ionizing radiation sources, including radium, and other naturally occurring radionuclides, as well as particle accelerators. Assistance is available through direct contact with the appropriate DOE Radiological Assistance Program Regional Office.</P> <P>(6) The Department of Agriculture (USDA) has scientific and technical capability to measure, evaluate, and monitor, either on the ground or by use of aircraft, situations where natural resources including soil, water, wildlife, and vegetation have been impacted by fire, insects and diseases, floods, hazardous substances, and other natural or man-caused emergencies. The USDA may be contacted through Forest Service emergency staff officers who are the designated members of the RRT. Agencies within USDA have relevant capabilities and expertise as follows:</P> <P>(i) The Forest Service has responsibility for protection and management of national forests and national grasslands. The Forest Service has personnel, laboratory, and field capability to measure, evaluate, monitor, and control as needed, releases of pesticides and other hazardous substances on lands under its jurisdiction.</P> <P> (ii) The Agriculture Research Service (ARS) administers an applied and developmental research program in animal and plant protection and production; the use and improvement of soil, water, and air; the processing, storage, and distribution of farm products; and human nutrition. The ARS has the capabilities to provide regulation of, and evaluation and training for, employees exposed to biological, chemical, radiological, and industrial hazards. In emergency situations, the ARS can identify, control, and abate pollution in the areas of air, soil, wastes, pesticides, radiation, and toxic substances for ARS facilities. <PRTPAGE P="40"/> </P> <P>(iii) The Soil Conservation Service (SCS) has personnel in nearly every county in the nation who are knowledgeable in soil, agronomy, engineering, and biology. These personnel can help to predict the effects of pollutants on soil and their movements over and through soils. Technical specialists can assist in identifying potential hazardous waste sites and provide review and advice on plans for remedial measures.</P> <P>(iv) The Animal and Plant Health Inspection Service (APHIS) can respond in an emergency to regulate movement of diseased or infected organisms to prevent the spread and contamination of nonaffected areas.</P> <P>(v) The Food Safety and Inspection Service (FSIS) has responsibility to prevent meat and poultry products contaminated with harmful substances from entering human food channels. In emergencies, the FSIS works with other federal and state agencies to establish acceptability for slaughter of exposed or potentially exposed animals and their products. In addition they are charged with managing the Federal Radiological Emergency Response Program for the USDA.</P> <P>(7) DOC, through NOAA, provides scientific support for response and contingency planning in coastal and marine areas, including assessments of the hazards that may be involved, predictions of movement and dispersion of oil and hazardous substances through trajectory modeling, and information on the sensitivity of coastal environments to oil and hazardous substances and associated clean-up and mitigation methods; provides expertise on living marine resources and their habitats, including endangered species, marine mammals and National Marine Sanctuary ecosystems; provides information on actual and predicted meteorological, hydrological, ice, and oceanographic conditions for marine, coastal, and inland waters, and tide and circulation data for coastal and territorial waters and for the Great Lakes.</P> <P>(8) HHS assists with the assessment, preservation, and protection of human health and helps ensure the availability of essential human services. HHS provides technical and nontechnical assistance in the form of advice, guidance, and resources to other federal agencies as well as state and local governments.</P> <P>(i) The principal HHS response comes from the U.S. Public Health Service and is coordinated from the Office of the Assistant Secretary for Health, and various Public Health Service regional offices. Within the Public Health Service, the primary response to a hazardous materials emergency comes from Agency for Toxic Substances and Disease Registry (ATSDR) and the Centers for Disease Control (CDC). Both ATSDR and CDC have a 24-hour emergency response capability wherein scientific and technical personnel are available to provide technical assistance to the lead federal agency and state and local response agencies on human health threat assessment and analysis, and exposure prevention and mitigation. Such assistance is used for situations requiring evacuation of affected areas, human exposure to hazardous materials, and technical advice on mitigation and prevention. CDC takes the lead during petroleum releases regulated under the CWA and OPA while ATSDR takes the lead during chemical releases under CERCLA. Both agencies are mutually supportive.</P> <P>(ii) Other Public Health Service agencies involved in support during hazardous materials incidents either directly or through ATSDR/CDC include the Food and Drug Administration, the Health Resources and Services Administration, the Indian Health Service, and the National Institutes of Health.</P> <P>(iii) Statutory authority for HHS/National Institutes for Environmental Health Sciences (NIEHS) involvement in hazardous materials accident prevention is non-regulatory in nature and focused on two primary areas for preventing community and worker exposure to hazardous materials releases: Worker safety training and basic research activities. Under section 126 of SARA, NIEHS is given statutory authority for supporting development of curricula and model training programs for waste workers and chemical emergency responders.</P> <P> Under section 118(b) of the Hazardous Materials Transportation and Uniform Safety Act (HMTUSA) (49 U.S.C. 1802 <E T="03"> et <PRTPAGE P="41"/> seq. </E> ), NIEHS also administers the Hazmat Employee Training Program to prepare curricula and training for hazardous materials transportation workers. In the basic research arena, NIEHS is authorized under section 311 of SARA to conduct a hazardous substance basic research and training program to evaluate toxic effects and assess human health risks from accidental releases of hazardous materials. Under Title IX, section 901(h) of the Clean Air Act Amendments, NIEHS also is authorized to conduct basic research on air pollutants, as well as train physicians in environmental health. Federal research and training in hazardous materials release prevention represents an important non-regulatory activity and supplements ongoing private sector programs. </P> <P>(9) DOI may be contacted through Regional Environmental Officers (REOs), who are the designated members of RRTs. Department land managers have jurisdiction over the national park system, national wildlife refuges and fish hatcheries, the public lands, and certain water projects in western states. In addition, bureaus and offices have relevant expertise as follows:</P> <P>(i) United States Fish and Wildlife Service (USFWS) and other Bureaus: Anadromous and certain other fishes and wildlife, including endangered and threatened species, migratory birds, and certain marine mammals; waters and wetlands; and effects on natural resources.</P> <P>(ii) The National Biological Survey performs research in support of biological resource management; inventories, monitors, and reports on the status and trends in the Nation's biotic resources; and transfers the information gained in research and monitoring to resource managers and others concerned with the care, use, and conservation of the Nation's natural resources. The National Biological Survey has laboratory/research facilities.</P> <P>(iii) Geological Survey: Geology, hydrology (ground water and surface water), and natural hazards.</P> <P>(iv) Bureau of Land Management: Minerals, soils, vegetation, wildlife, habitat, archaeology, and wilderness; and hazardous materials.</P> <P>(v) Minerals Management Service: Oversight of offshore oil and gas exploration and production facilities and associated pipelines and pipeline facilities under the Outer Continental Shelf Lands Act and the CWA; oil spill response technology research; and establishing oil discharge contingency planning requirements for offshore facilities.</P> <P>(vi) Bureau of Mines: Analysis and identification of inorganic hazardous substances and technical expertise in metals and metallurgy relevant to site cleanup.</P> <P>(vii) Office of Surface Mining: Coal mine wastes and land reclamation.</P> <P>(viii) National Park Service: General biological, natural, and cultural resource managers to evaluate, measure, monitor, and contain threats to park system lands and resources; archaeological and historical expertise in protection, preservation, evaluation, impact mitigation, and restoration of cultural resources; emergency personnel.</P> <P>(ix) Bureau of Reclamation: Operation and maintenance of water projects in the West; engineering and hydrology; and reservoirs.</P> <P>(x) Bureau of Indian Affairs: Coordination of activities affecting Indian lands; assistance in identifying Indian tribal government officials.</P> <P>(xi) Office of Territorial Affairs: Assistance in implementing the NCP in American Samoa, Guam, the Pacific Island Governments, the Northern Mariana Islands, and the Virgin Islands.</P> <P>(10) The Department of Justice (DOJ) can provide expert advice on complicated legal questions arising from discharges or releases, and federal agency responses. In addition, the DOJ represents the federal government, including its agencies, in litigation relating to such discharges or releases. Other legal issues or questions shall be directed to the federal agency counsel for the agency providing the OSC/RPM for the response.</P> <P> (11) The Department of Labor (DOL), through OSHA and the states operating plans approved under section 18 of the OSH Act, has authority to conduct <PRTPAGE P="42"/> safety and health inspections of hazardous waste sites to assure that employees are being protected and to determine if the site is in compliance with: </P> <P>(i) Safety and health standards and regulations promulgated by OSHA (or the states) in accordance with section 126 of SARA and all other applicable standards; and</P> <P>(ii) Regulations promulgated under the OSH Act and its general duty clause. OSHA inspections may be self-generated, consistent with its program operations and objectives, or may be conducted in response to requests from EPA or another lead agency, or in response to accidents or employee complaints. OSHA may also conduct inspections at hazardous waste sites in those states with approved plans that choose not to exercise their jurisdiction to inspect such sites. On request, OSHA will provide advice and consultation to EPA and other NRT/RRT agencies as well as to the OSC/RPM regarding hazards to persons engaged in response activities. OSHA may also take any other action necessary to assure that employees are properly protected at such response activities. Any questions about occupational safety and health at these sites may be referred to the OSHA Regional Office.</P> <P>(12) DOT provides response expertise pertaining to transportation of oil or hazardous substances by all modes of transportation. Through the Research and Special Programs Administration (RSPA), DOT offers expertise in the requirements for packaging, handling, and transporting regulated hazardous materials. DOT, through RSPA, establishes oil discharge contingency planning requirements for pipelines, transport by rail and containers or bulk transport of oil.</P> <P>(13) The Department of State (DOS) will lead in the development of international joint contingency plans. It will also help to coordinate an international response when discharges or releases cross international boundaries or involve foreign flag vessels. Additionally, DOS will coordinate requests for assistance from foreign governments and U.S. proposals for conducting research at incidents that occur in waters of other countries.</P> <P>(14) The Nuclear Regulatory Commission will respond, as appropriate, to releases of radioactive materials by its licensees, in accordance with the NRC Incident Response Plan (NUREG-0728) to monitor the actions of those licensees and assure that the public health and environment are protected and adequate recovery operations are instituted. The Nuclear Regulatory Commission will keep EPA informed of any significant actual or potential releases in accordance with procedural agreements. In addition, the Nuclear Regulatory Commission will provide advice to the OSC/RPM when assistance is required in identifying the source and character of other hazardous substance releases where the Nuclear Regulatory Commission has licensing authority for activities utilizing radioactive materials.</P> <P>(15) The General Services Administration (GSA) provides logistic and telecommunications support to federal agencies. During an emergency situation, GSA quickly responds to aid state and local governments as directed by other federal agencies. The type of support provided might include leasing and furnishing office space, setting up telecommunications and transportation services, and advisory assistance.</P> </SECTION> <SECTION> <SECTNO>§ 300.180</SECTNO> <SUBJECT>State and local participation in response.</SUBJECT> <P> (a) Each state governor is requested to designate one state office/representative to represent the state on the appropriate RRT. The state's office/representative may participate fully in all activities of the appropriate RRT. Each state governor is also requested to designate a lead state agency that will direct state-lead response operations. This agency is responsible for designating the lead state response official for federal and/or state-lead response actions, and coordinating/communicating with any other state agencies, as appropriate. Local governments are invited to participate in activities on the appropriate RRT as may be provided by state law or arranged by the state's representative. Indian tribes wishing to participate should assign one person or office to represent the <PRTPAGE P="43"/> tribal government on the appropriate RRT. </P> <P>(b) Appropriate local and state officials (including Indian tribes) will participate as part of the response structure as provided in the ACP.</P> <P>(c) In addition to meeting the requirements for local emergency plans under SARA section 303, state and local government agencies are encouraged to include contingency planning for responses, consistent with the NCP, RCP, and ACP in all emergency and disaster planning.</P> <P>(d) For facilities not addressed under CERCLA or the CWA, states are encouraged to undertake response actions themselves or to use their authorities to compel potentially responsible parties to undertake response actions.</P> <P>(e) States are encouraged to enter into cooperative agreements pursuant to sections 104 (c)(3) and (d) of CERCLA to enable them to undertake actions authorized under subpart E of the NCP. Requirements for entering into these agreements are included in subpart F of the NCP. A state agency that acts pursuant to such agreements is referred to as the lead agency. In the event there is no cooperative agreement, the lead agency can be designated in a SMOA or other agreement.</P> <P>(f) Because state and local public safety organizations would normally be the first government representatives at the scene of a discharge or release, they are expected to initiate public safety measures that are necessary to protect public health and welfare and that are consistent with containment and cleanup requirements in the NCP, and are responsible for directing evacuations pursuant to existing state or local procedures.</P> </SECTION> <SECTION> <SECTNO>§ 300.185</SECTNO> <SUBJECT>Nongovernmental participation.</SUBJECT> <P>(a) Industry groups, academic organizations, and others are encouraged to commit resources for response operations. Specific commitments should be listed in the RCP and ACP. Those entities required to develop tank vessel and facility response plans under CWA section 311(j) must be able to respond to a worst case discharge to the maximum extent practicable, and shall commit sufficient resources to implement other aspects of those plans in accordance with the requirements of 30 CFR part 254, 33 CFR parts 150, 154, and 155; 40 CFR parts 112 and 118; and 49 CFR parts 171 and 194.</P> <P>(b) The technical and scientific information generated by the local community, along with information from federal, state, and local governments, should be used to assist the OSC/RPM in devising response strategies where effective standard techniques are unavailable. Such information and strategies will be incorporated into the ACP, as appropriate. The SSC may act as liaison between the OSC/RPM and such interested organizations.</P> <P>(c) ACPs shall establish procedures to allow for well organized, worthwhile, and safe use of volunteers, including compliance with § 300.150 regarding worker health and safety. ACPs should provide for the direction of volunteers by the OSC/RPM or by other federal, state, or local officials knowledgeable in contingency operations and capable of providing leadership. ACPs also should identify specific areas in which volunteers can be used, such as beach surveillance, logistical support, and bird and wildlife treatment. Unless specifically requested by the OSC/RPM, volunteers generally should not be used for physical removal or remedial activities. If, in the judgment of the OSC/RPM, dangerous conditions exist, volunteers shall be restricted from on-scene operations.</P> <P>(d) Nongovernmental participation must be in compliance with the requirements of subpart H of this part if any recovery of costs will be sought.</P> <CITA>[59 FR 47424, Sept. 15, 1994, as amended at 89 FR 21966, Mar. 28, 2024]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Planning and Preparedness</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47440, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.200</SECTNO> <SUBJECT>General.</SUBJECT> <P> This subpart summarizes emergency preparedness activities relating to discharges of oil and releases of hazardous substances, pollutants, or contaminants; describes the three levels of contingency planning under the national <PRTPAGE P="44"/> response system; and cross-references state and local emergency preparedness activities under SARA Title III, also known as the “Emergency Planning and Community Right-to-Know Act of 1986” but referred to herein as “Title III.” Regulations implementing Title III are codified at 40 CFR subchapter J. </P> </SECTION> <SECTION> <SECTNO>§ 300.205</SECTNO> <SUBJECT>Planning and coordination structure.</SUBJECT> <P> (a) <E T="03">National.</E> As described in § 300.110, the NRT is responsible for national planning and coordination. </P> <P> (b) <E T="03">Regional.</E> As described in § 300.115, the RRTs are responsible for regional planning and coordination. </P> <P> (c) <E T="03">Area.</E> As required by section 311(j) of the CWA, under the direction of the federal OSC for its area, Area Committees comprising qualified personnel of federal, state, and local agencies shall be responsible for: </P> <P>(1) Preparing an ACP for their areas (as described in § 300.210(c));</P> <P>(2) Working with appropriate federal, state, and local officials to enhance the contingency planning of those officials and to assure pre-planning of joint response efforts, including appropriate procedures for mechanical recovery, dispersal, shoreline cleanup, protection of sensitive environmental areas, and protection, rescue, and rehabilitation of fisheries and wildlife; and</P> <P>(3) Working with appropriate federal, state, and local officials to expedite decisions for the use of dispersants and other mitigating substances and devices.</P> <P> (d) <E T="03">State.</E> As provided by sections 301 and 303 of Title III, the SERC of each state, appointed by the Governor, is to designate emergency planning districts, appoint Local Emergency Planning Committees (LEPCs), supervise and coordinate their activities, and review local emergency response plans, which are described in § 300.215. The SERC also is to establish procedures for receiving and processing requests from the public for information generated by Title III reporting requirements and to designate an official to serve as coordinator for information. </P> <P> (e) <E T="03">Local.</E> As provided by sections 301 and 303 of Title III, emergency planning districts are designated by the SERC in order to facilitate the preparation and implementation of emergency plans. Each LEPC is to prepare a local emergency response plan for the emergency planning district and establish procedures for receiving and processing requests from the public for information generated by Title III reporting requirements. The LEPC is to appoint a chair and establish rules for the LEPC. The LEPC is to designate an official to serve as coordinator for information and designate in its plan a community emergency coordinator. </P> <P>(f) As required by section 311(j)(5) of the CWA, a tank vessel, as defined under section 2101 of title 46, U.S. Code, an offshore facility, and an onshore facility that, because of its location, could reasonably be expected to cause substantial harm to the environment by discharging into or on the navigable waters, adjoining shorelines, or exclusive economic zone must prepare and submit a plan for responding, to the maximum extent practicable, to a worst case discharge, and to a substantial threat of such a discharge, of oil or a hazardous substance.</P> <P>(g) The relationship of these plans is described in Figure 4.</P> <GPH SPAN="2" DEEP="414"> <PRTPAGE P="45"/> <GID>EC02AU92.004</GID> </GPH> </SECTION> <SECTION> <SECTNO>§ 300.210</SECTNO> <SUBJECT>Federal contingency plans.</SUBJECT> <P>There are three levels of contingency plans under the national response system: The National Contingency Plan, RCPs, and ACPs. These plans are available for inspection at EPA regional offices or USCG district offices. Addresses and telephone numbers for these offices may be found in the United States Government Manual, issued annually, or in local telephone directories.</P> <P> (a) <E T="03">The National Contingency Plan.</E> The purpose and objectives, authority, and scope of the NCP are described in §§ 300.1 through 300.3. </P> <P> (b) <E T="03">Regional Contingency Plans.</E> The RRTs, working with the states, shall develop federal RCPs for each standard federal region, Alaska, Oceania in the <PRTPAGE P="46"/> Pacific, and the Caribbean to coordinate timely, effective response by various federal agencies and other organizations to discharges of oil or releases of hazardous substances, pollutants, or contaminants. RCPs shall, as appropriate, include information on all useful facilities and resources in the region, from government, commercial, academic, and other sources. To the greatest extent possible, RCPs shall follow the format of the NCP and be coordinated with state emergency response plans, ACPs, which are described in § 300.210(c), and Title III local emergency response plans, which are described in § 300.215. Such coordination should be accomplished by working with the SERCs in the region covered by the RCP. RCPs shall contain lines of demarcation between the inland and coastal zones, as mutually agreed upon by USCG and EPA. </P> <P> (c) <E T="03">Area Contingency Plans.</E> (1) Under the direction of an OSC and subject to approval by the lead agency, each Area Committee, in consultation with the appropriate RRTs, Coast Guard DRGs, the NSFCC, SSCs, LEPCs, and SERCs, shall develop an ACP for its designated area. This plan, when implemented in conjunction with other provisions of the NCP, shall be adequate to remove a worst case discharge under § 300.324, and to mitigate or prevent a substantial threat of such a discharge, from a vessel, offshore facility, or onshore facility operating in or near the area. </P> <P>(2) The areas of responsibility may include several Title III local planning districts, or parts of such districts. In developing the ACP, the OSC shall coordinate with affected SERCs and LEPCs. The ACP shall provide for a well coordinated response that is integrated and compatible, to the greatest extent possible, with all appropriate response plans of state, local, and non-federal entities, and especially with Title III local emergency response plans.</P> <P>(3) The ACP shall include the following:</P> <P>(i) A description of the area covered by the plan, including the areas of special economic or environmental importance that might be damaged by a discharge;</P> <P>(ii) A description in detail of the responsibilities of an owner or operator and of federal, state, and local agencies in removing a discharge, and in mitigating or preventing a substantial threat of a discharge;</P> <P>(iii) A list of equipment (including firefighting equipment), dispersants, or other mitigating substances and devices, and personnel available to an owner or operator and federal, state, and local agencies, to ensure an effective and immediate removal of a discharge, and to ensure mitigation or prevention of a substantial threat of a discharge (this may be provided in an appendix or by reference to other relevant emergency plans (e.g., state or LEPC plans), which may include such equipment lists);</P> <P>(iv) A description of procedures to be followed for obtaining an expedited decision regarding the use of dispersants; and</P> <P>(v) A detailed description of how the plan is integrated into other ACPs and tank vessel, offshore facility, and onshore facility response plans approved by the President, and into operating procedures of the NSFCC.</P> <P> (4)(i) In order to provide for coordinated, immediate and effective protection, rescue, and rehabilitation of, and minimization of risk of injury to, fish and wildlife resources and habitat, Area Committees shall incorporate into each ACP a detailed annex containing a Fish and Wildlife and Sensitive Environments Plan that is consistent with the RCP and NCP. The annex shall be prepared in consultation with the USFWS and NOAA and other interested natural resource management agencies and parties. It shall address fish and wildlife resources and their habitat, and shall include other areas considered sensitive environments in a separate section of the annex, based upon Area Committee recommendations. The annex will provide the necessary information and procedures to immediately and effectively respond to discharges that may adversely affect fish and wildlife and their habitat and sensitive environments, including provisions for a response to a worst case discharge. Such information shall include the identification of appropriate agencies and <PRTPAGE P="47"/> their responsibilities, procedures to notify these agencies following a discharge or threat of a discharge, protocols for obtaining required fish and wildlife permits and other necessary permits, and provisions to ensure compatibility of annex-related activities with removal operations. </P> <P>(ii) The annex shall:</P> <P>(A) Identify and establish priorities for fish and wildlife resources and their habitats and other important sensitive areas requiring protection from any direct or indirect effects from discharges that may occur. These effects include, but are not limited to, any seasonal or historical use, as well as all critical, special, significant, or otherwise designated protected areas.</P> <P>(B) Provide a mechanism to be used during a spill response for timely identification of protection priorities of those fish and wildlife resources and habitats and sensitive environmental areas that may be threatened or injured by a discharge. These include as appropriate, not only marine and freshwater species, habitats, and their food sources, but also terrestrial wildlife and their habitats that may be affected directly by onshore oil or indirectly by oil-related factors, such as loss or contamination of forage. The mechanism shall also provide for expeditious evaluation and appropriate consultations on the effects to fish and wildlife, their habitat, and other sensitive environments from the application of chemical countermeasures or other countermeasures not addressed under paragraph (e)(4)(iii).</P> <P>(C) Identify potential environmental effects on fish and wildlife, their habitat, and other sensitive environments resulting from removal actions or countermeasures, including the option of no removal. Based on this evaluation of potential environmental effects, the annex should establish priorities for application of countermeasure and removal actions to habitats within the geographic region of the ACP. The annex should establish methods to minimize the identified effects on fish and wildlife because of response activities, including, but not limited to: Disturbance of sensitive areas and habitats; illegal or inadvertent taking or disturbance of fish and wildlife or specimens by response personnel; and fish and wildlife, their habitat, and environmentally sensitive areas coming in contact with various cleaning or bioremediation agents. Furthermore, the annex should identify the areas where the movement of oiled debris may pose a risk to resident, transient, or migratory fish and wildlife, and other sensitive environments and should discuss measures to be considered for removing such oiled debris in a timely fashion to reduce such risk.</P> <P>(D) Provide for pre-approval of application of specific countermeasures or removal actions that, if expeditiously applied, will minimize adverse spill-induced impacts to fish and wildlife resources, their habitat, and other sensitive environments. Such pre-approval plans must be consistent with paragraphs (c)(4)(ii)(B) and (C) of this section and subpart J requirements, and must have the concurrence of the natural resource trustees.</P> <P>(E) Provide monitoring plan(s) to evaluate the effectiveness of different countermeasures or removal actions in protecting the environment. Monitoring should include “set-aside” or “control” areas, where no mitigative actions are taken.</P> <P>(F) Identify and plan for the acquisition and utilization of necessary response capabilities for protection, rescue, and rehabilitation of fish and wildlife resources and habitat. This may include appropriately permitted private organizations and individuals with appropriate expertise and experience. The suitable organizations should be identified in cooperation with natural resource law enforcement agencies. Such capabilities shall include, but not be limited to, identification of facilities and equipment necessary for deterring sensitive fish and wildlife from entering oiled areas, and for capturing, holding, cleaning, and releasing injured wildlife. Plans for the provision of such capabilities shall ensure that there is no interference with other OSC removal operations.</P> <P> (G) Identify appropriate federal and state agency contacts and alternates responsible for coordination of fish and wildlife rescue and rehabilitation and protection of sensitive environments; identify and provide for required fish <PRTPAGE P="48"/> and wildlife handling and rehabilitation permits necessary under federal and state laws; and provide guidance on the implementation of law enforcement requirements included under current federal and state laws and corresponding regulations. Requirements include, but are not limited to procedures regarding the capture, transport, rehabilitation, and release of wildlife exposed to or threatened by oil, and disposal of contaminated carcasses of wildlife. </P> <P>(H) Identify and secure the means for providing, if needed, the minimum required OSHA and EPA training for volunteers, including those who assist with injured wildlife.</P> <P>(I) Define the requirements for evaluating the compatibility between this annex and non-federal response plans (including those of vessels, facilities, and pipelines) on issues affecting fish and wildlife, their habitat, and sensitive environments.</P> </SECTION> <SECTION> <SECTNO>§ 300.211</SECTNO> <SUBJECT>OPA facility and vessel response plans.</SUBJECT> <P>This section describes and cross-references the regulations that implement section 311(j)(5) of the CWA. A tank vessel, as defined under section 2101 of title 46, U.S. Code, an offshore facility, and an onshore facility that, because of its location, could reasonably expect to cause substantial harm to the environment by discharging into or on the navigable waters, adjoining shorelines, or exclusive economic zone must prepare and submit a plan for responding, to the maximum extent practicable, to a worst case discharge, and to a substantial threat of such a discharge, of oil or a hazardous substance. These response plans are required to be consistent with applicable Area Contingency Plans. These regulations are codified as follows:</P> <P>(a) For tank vessels, these regulations are codified in 33 CFR part 155;</P> <P>(b) For offshore facilities, these regulations are codified in 30 CFR part 254;</P> <P>(c) For non-transportation-related onshore facilities, these regulations are codified in 40 CFR 112.20 and 40 CFR part 118;</P> <P>(d) For transportation-related onshore facilities, these regulations are codified in 33 CFR part 154;</P> <P>(e) For pipeline facilities, these regulations are codified in 49 CFR part 194; and</P> <P>(f) For rolling stock, these regulations are codified in 49 CFR part 106 et al.</P> <CITA>[59 FR 47424, Sept. 15, 1994, as amended at 89 FR 21966, Mar. 28, 2024]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.212</SECTNO> <SUBJECT>Area response drills.</SUBJECT> <P>The OSC periodically shall conduct drills of removal capability (including fish and wildlife response capability), without prior notice, in areas for which ACPs are required by § 300.210(c) and under relevant tank vessel and facility response plans.</P> </SECTION> <SECTION> <SECTNO>§ 300.215</SECTNO> <SUBJECT>Title III local emergency response plans.</SUBJECT> <P>This section describes and cross-references the regulations that implement Title III. These regulations are codified at 40 CFR part 355.</P> <P>(a) Each LEPC is to prepare an emergency response plan in accordance with section 303 of Title III and review the plan once a year, or more frequently as changed circumstances in the community or at any facility may require. Such Title III local emergency response plans should be closely coordinated with applicable federal ACPs and state emergency response plans.</P> <P>(b) [Reserved]</P> </SECTION> <SECTION> <SECTNO>§ 300.220</SECTNO> <SUBJECT>Related Title III issues.</SUBJECT> <P>Other related Title III requirements are found in 40 CFR part 355.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Operational Response Phases for Oil Removal</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47444, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.300</SECTNO> <SUBJECT>Phase I—Discovery or notification.</SUBJECT> <P>(a) A discharge of oil may be discovered through:</P> <P>(1) A report submitted by the person in charge of a vessel or facility, in accordance with statutory requirements;</P> <P>(2) Deliberate search by patrols;</P> <P>(3) Random or incidental observation by government agencies or the public; or</P> <P> (4) Other sources. <PRTPAGE P="49"/> </P> <P>(b) Any person in charge of a vessel or a facility shall, as soon as he or she has knowledge of any discharge from such vessel or facility in violation of section 311(b)(3) of the CWA, immediately notify the NRC. If direct reporting to the NRC is not practicable, reports may be made to the USCG or EPA predesignated OSC for the geographic area where the discharge occurs. The EPA predesignated OSC may also be contacted through the regional 24-hour emergency response telephone number. All such reports shall be promptly relayed to the NRC. If it is not possible to notify the NRC or predesignated OSC immediately, reports may be made immediately to the nearest Coast Guard unit. In any event such person in charge of the vessel or facility shall notify the NRC as soon as possible.</P> <P>(c) Any other person shall, as appropriate, notify the NRC of a discharge of oil.</P> <P>(d) Upon receipt of a notification of discharge, the NRC shall promptly notify the OSC. The OSC shall ensure notification of the appropriate state agency of any state which is, or may reasonably be expected to be, affected by the discharge. The OSC shall then proceed with the following phases as outlined in the RCP and ACP.</P> </SECTION> <SECTION> <SECTNO>§ 300.305</SECTNO> <SUBJECT>Phase II—Preliminary assessment and initiation of action.</SUBJECT> <P>(a) The OSC is responsible for promptly initiating a preliminary assessment.</P> <P>(b) The preliminary assessment shall be conducted using available information, supplemented where necessary and possible by an on-scene inspection. The OSC shall undertake actions to:</P> <P>(1) Evaluate the magnitude and severity of the discharge or threat to public health or welfare of the United States or the environment;</P> <P>(2) Assess the feasibility of removal; and</P> <P>(3) To the extent practicable, identify potentially responsible parties.</P> <P>(c) Where practicable, the framework for the response management structure is a system (e.g., a unified command system), that brings together the functions of the federal government, the state government, and the responsible party to achieve an effective and efficient response, where the OSC maintains authority.</P> <P>(d) Except in a case when the OSC is required to direct the response to a discharge that may pose a substantial threat to the public health or welfare of the United States (including but not limited to fish, shellfish, wildlife, other natural resources, and the public and private beaches and shorelines of the United States), the OSC may allow the responsible party to voluntarily and promptly perform removal actions, provided the OSC determines such actions will ensure an effective and immediate removal of the discharge or mitigation or prevention of a substantial threat of a discharge. If the responsible party does conduct the removal, the OSC shall ensure adequate surveillance over whatever actions are initiated. If effective actions are not being taken to eliminate the threat, or if removal is not being properly done, the OSC should, to the extent practicable under the circumstances, so advise the responsible party. If the responsible party does not respond properly the OSC shall take appropriate response actions and should notify the responsible party of the potential liability for federal response costs incurred by the OSC pursuant to the OPA and CWA. Where practicable, continuing efforts should be made to encourage response by responsible parties.</P> <P>(1) In carrying out a response under this section, the OSC may:</P> <P>(i) Remove or arrange for the removal of a discharge, and mitigate or prevent a substantial threat of a discharge, at any time;</P> <P>(ii) Direct or monitor all federal, state, and private actions to remove a discharge; and</P> <P>(iii) Remove and, if necessary, destroy a vessel discharging, or threatening to discharge, by whatever means are available.</P> <P> (2) If the discharge results in a substantial threat to the public health or welfare of the United States (including, but not limited to fish, shellfish, wildlife, other natural resources, and the public and private beaches and shorelines of the United States), the OSC must direct all response efforts, as provided in § 300.322(b) of this part. The <PRTPAGE P="50"/> OSC should declare as expeditiously as practicable to spill response participants that the federal government will direct the response. The OSC may act without regard to any other provision of the law governing contracting procedures or employment of personnel by the federal government in removing or arranging for the removal of such a discharge. </P> <P> (e) The OSC shall ensure that the natural resource trustees are promptly notified in the event of any discharge of oil, to the maximum extent practicable as provided in the Fish and Wildlife and Sensitive Environments Plan annex to the ACP for the area in which the discharge occurs. The OSC and the trustees shall coordinate assessments, evaluations, investigations, and planning with respect to appropriate removal actions. The OSC shall consult with the affected trustees on the appropriate removal action to be taken. The trustees will provide timely advice concerning recommended actions with regard to trustee resources potentially affected. The trustees also will assure that the OSC is informed of their activities in natural resource damage assessment that may affect response operations. The trustees shall assure, through the lead administrative trustee, that all data from the natural resource damage assessment activities that may support more effective operational decisions are provided in a timely manner to the OSC. When circumstances permit, the OSC shall share the use of non-monetary response resources ( <E T="03">i.e.</E> , personnel and equipment) with the trustees, provided trustee activities do not interfere with response actions. The lead administrative trustee facilitates effective and efficient communication between the OSC and the other trustees during response operations and is responsible for applying to the OSC for non-monetary federal response resources on behalf of all trustees. The lead administrative trustee is also responsible for applying to the NPFC for funding for initiation of damage assessment for injuries to natural resources. </P> </SECTION> <SECTION> <SECTNO>§ 300.310</SECTNO> <SUBJECT>Phase III—Containment, countermeasures, cleanup, and disposal.</SUBJECT> <P>(a) Defensive actions shall begin as soon as possible to prevent, minimize, or mitigate threat(s) to the public health or welfare of the United States or the environment. Actions may include but are not limited to: Analyzing water samples to determine the source and spread of the oil; controlling the source of discharge; measuring and sampling; source and spread control or salvage operations; placement of physical barriers to deter the spread of the oil and to protect natural resources and sensitive ecosystems; control of the water discharged from upstream impoundment; and the use of chemicals and other materials in accordance with subpart J of this part to restrain the spread of the oil and mitigate its effects. The ACP prepared under § 300.210(c) should be consulted for procedures to be followed for obtaining an expedited decision regarding the use of dispersants and other products listed on the NCP Product Schedule.</P> <P>(b) As appropriate, actions shall be taken to recover the oil or mitigate its effects. Of the numerous chemical or physical methods that may be used, the chosen methods shall be the most consistent with protecting public health and welfare and the environment. Sinking agents shall not be used.</P> <P> (c) Oil and contaminated materials recovered in cleanup operations shall be disposed of in accordance with the RCP, ACP, and any applicable laws, regulations, or requirements. RRT and Area Committee guidelines may identify the disposal options available during an oil spill response and may describe what disposal requirements are mandatory or may not be waived by the OSC. ACP guidelines should address: the sampling, testing, and classifying of recovered oil and oiled debris; the segregation, temporary storage, and stockpiling of recovered oil and oiled debris; prior state disposal approvals and permits; and the routes; methods (e.g. recycle/reuse, on-site burning, incineration, landfilling, etc.); and sites for the disposal of collected oil, oiled debris, and animal carcasses; and procedures for obtaining waivers, <PRTPAGE P="51"/> exemptions, or authorizations associated with handling or transporting waste materials. The ACPs may identify a hierarchy of preferences for disposal alternatives, with recycling (reprocessing) being the most preferred, and other alternatives preferred based on priorities for health or the environment. </P> </SECTION> <SECTION> <SECTNO>§ 300.315</SECTNO> <SUBJECT>Phase IV—Documentation and cost recovery.</SUBJECT> <P>(a) All OSLTF users need to collect and maintain documentation to support all actions taken under the CWA. In general, documentation shall be sufficient to support full cost recovery for resources utilized and shall identify the source and circumstances of the incident, the responsible party or parties, and impacts and potential impacts to public health and welfare and the environment. Documentation procedures are contained in 33 CFR part 136.</P> <P>(b) When appropriate, documentation shall also be collected for scientific understanding of the environment and for research and development of improved response methods and technology. Funding for these actions is restricted by section 6002 of the OPA.</P> <P>(c) OSCs shall submit OSC reports to the NRT or RRT, only if requested, as provided by § 300.165.</P> <P>(d) OSCs shall ensure the necessary collection and safeguarding of information, samples, and reports. Samples and information shall be gathered expeditiously during the response to ensure an accurate record of the impacts incurred. Documentation materials shall be made available to the trustees of affected natural resources. The OSC shall make available to trustees of the affected natural resources information and documentation in the OSC's possession that can assist the trustees in the determination of actual or potential natural resource injuries.</P> <P>(e) Information and reports obtained by the EPA or USCG OSC shall be transmitted to the appropriate offices responsible for follow-up actions.</P> </SECTION> <SECTION> <SECTNO>§ 300.317</SECTNO> <SUBJECT>National response priorities.</SUBJECT> <P>(a) Safety of human life must be given the top priority during every response action. This includes any search and rescue efforts in the general proximity of the discharge and the insurance of safety of response personnel.</P> <P>(b) Stabilizing the situation to preclude the event from worsening is the next priority. All efforts must be focused on saving a vessel that has been involved in a grounding, collision, fire, or explosion, so that it does not compound the problem. Comparable measures should be taken to stabilize a situation involving a facility, pipeline, or other source of pollution. Stabilizing the situation includes securing the source of the spill and/or removing the remaining oil from the container (vessel, tank, or pipeline) to prevent additional oil spillage, to reduce the need for follow-up response action, and to minimize adverse impact to the environment.</P> <P>(c) The response must use all necessary containment and removal tactics in a coordinated manner to ensure a timely, effective response that minimizes adverse impact to the environment.</P> <P>(d) All parts of this national response strategy should be addressed concurrently, but safety and stabilization are the highest priorities. The OSC should not delay containment and removal decisions unnecessarily and should take actions to minimize adverse impact to the environment that begins as soon as a discharge occurs, as well as actions to minimize further adverse environmental impact from additional discharges.</P> <P>(e) The priorities set forth in this section are broad in nature, and should not be interpreted to preclude the consideration of other priorities that may arise on a site-specific basis.</P> </SECTION> <SECTION> <SECTNO>§ 300.320</SECTNO> <SUBJECT>General pattern of response.</SUBJECT> <P>(a) When the OSC receives a report of a discharge, actions normally should be taken in the following sequence:</P> <P>(1) Investigate the report to determine pertinent information such as the threat posed to public health or welfare of the United States or the environment, the type and quantity of polluting material, and the source of the discharge.</P> <P> (2) Officially classify the size ( <E T="03">i.e.</E> , minor, medium, major) and type ( <E T="03">i.e.</E> , substantial threat to the public health or welfare of the United States, worst <PRTPAGE P="52"/> case discharge) of the discharge and determine the course of action to be followed to ensure effective and immediate removal, mitigation, or prevention of the discharge. Some discharges that are classified as a substantial threat to the public health or welfare of the United States may be further classified as a spill of national significance by the Administrator of EPA or the Commandant of the USCG. The appropriate course of action may be prescribed in §§ 300.322, 300.323, and 300.324. </P> <P>(i) When the reported discharge is an actual or potential major discharge, the OSC shall immediately notify the RRT and the NRC.</P> <P>(ii) When the investigation shows that an actual or potential medium discharge exists, the OSC shall recommend activation of the RRT, if appropriate.</P> <P>(iii) When the investigation shows that an actual or potential minor discharge exists, the OSC shall monitor the situation to ensure that proper removal action is being taken.</P> <P>(3) If the OSC determines that effective and immediate removal, mitigation, or prevention of a discharge can be achieved by private party efforts, and where the discharge does not pose a substantial threat to the public health or welfare of the United States, determine whether the responsible party or other person is properly carrying out removal. Removal is being done properly when:</P> <P>(i) The responsible party is applying the resources called for in its response plan to effectively and immediately remove, minimize, or mitigate threat(s) to public health and welfare and the environment; and</P> <P>(ii) The removal efforts are in accordance with applicable regulations, including the NCP. Even if the OSC supplements responsible party resources with government resources, the spill response will not be considered improper, unless specifically determined by the OSC.</P> <P>(4) Where appropriate, determine whether a state or political subdivision thereof has the capability to carry out any or all removal actions. If so, the OSC may arrange funding to support these actions.</P> <P>(5) Ensure prompt notification of the trustees of affected natural resources in accordance with the applicable RCP and ACP.</P> <P>(b) Removal shall be considered complete when so determined by the OSC in consultation with the Governor or Governors of the affected states. When the OSC considers removal complete, OSLTF removal funding shall end. This determination shall not preclude additional removal actions under applicable state law.</P> </SECTION> <SECTION> <SECTNO>§ 300.322</SECTNO> <SUBJECT>Response to substantial threats to public health or welfare of the United States.</SUBJECT> <P>(a) As part of the investigation described in § 300.320, the OSC shall determine whether a discharge results in a substantial threat to public health or welfare of the United States (including, but not limited to, fish, shellfish, wildlife, other natural resources, and the public and private beaches and shorelines of the United States). Factors to be considered by the OSC in making this determination include, but are not limited to, the size of the discharge, the character of the discharge, and the nature of the threat to public health or welfare of the United States. Upon obtaining such information, the OSC shall conduct an evaluation of the threat posed, based on the OSC's experience in assessing other discharges, and consultation with senior lead agency officials and readily available authorities on issues outside the OSC's technical expertise.</P> <P>(b) If the investigation by the OSC shows that the discharge poses or may present a substantial threat to public health or welfare of the United States, the OSC shall direct all federal, state, or private actions to remove the discharge or to mitigate or prevent the threat of such a discharge, as appropriate. In directing the response in such cases, the OSC may act without regard to any other provision of law governing contracting procedures or employment of personnel by the federal government to:</P> <P>(1) Remove or arrange for the removal of the discharge;</P> <P> (2) Mitigate or prevent the substantial threat of the discharge; and <PRTPAGE P="53"/> </P> <P>(3) Remove and, if necessary, destroy a vessel discharging, or threatening to discharge, by whatever means are available.</P> <P>(c) In the case of a substantial threat to public health or welfare of the United States, the OSC shall:</P> <P>(1) Assess opportunities for the use of various special teams and other assistance described in § 300.145, including the use of the services of the NSFCC, as appropriate;</P> <P>(2) Request immediate activation of the RRT; and</P> <P>(3) Take whatever additional response actions are deemed appropriate, including, but not limited to, implementation of the ACP as required by section 311(j)(4) of the CWA or relevant tank vessel or facility response plan required by section 311(j)(5) of the CWA. When requested by the OSC, the lead agency or RRT shall dispatch appropriate personnel to the scene of the discharge to assist the OSC. This assistance may include technical support in the agency's areas of expertise and disseminating information to the public. The lead agency shall ensure that a contracting officer is available on scene, at the request of the OSC.</P> </SECTION> <SECTION> <SECTNO>§ 300.323</SECTNO> <SUBJECT>Spills of national significance.</SUBJECT> <P>(a) A discharge may be classified as a spill of national significance (SONS) by the Administrator of EPA for discharges occurring in the inland zone and the Commandant of the USCG for discharges occurring in the coastal zone.</P> <P>(b) For a SONS in the inland zone, the EPA Administrator may name a senior Agency official to assist the OSC in communicating with affected parties and the public and coordinating federal, state, local, and international resources at the national level. This strategic coordination will involve, as appropriate, the NRT, RRT(s), the Governor(s) of affected state(s), and the mayor(s) or other chief executive(s) of local government(s).</P> <P>(c) For a SONS in the coastal zone, the USCG Commandant may name a National Incident Commander (NIC) who will assume the role of the OSC in communicating with affected parties and the public, and coordinating federal, state, local, and international resources at the national level. This strategic coordination will involve, as appropriate, the NRT, RRT(s), the Governor(s) of affected state(s), and the mayor(s) or other chief executive(s) of local government(s).</P> </SECTION> <SECTION> <SECTNO>§ 300.324</SECTNO> <SUBJECT>Response to worst case discharges.</SUBJECT> <P>(a) If the investigation by the OSC shows that a discharge is a worst case discharge as defined in the ACP, or there is a substantial threat of such a discharge, the OSC shall:</P> <P>(1) Notify the NSFCC;</P> <P>(2) Require, where applicable, implementation of the worst case portion of an approved tank vessel or facility response plan required by section 311(j)(5) of the CWA;</P> <P>(3) Implement the worst case portion of the ACP required by section 311(j)(4) of the CWA; and</P> <P>(4) Take whatever additional response actions are deemed appropriate.</P> <P>(b) Under the direction of the OSC, the NSFCC shall coordinate use of private and public personnel and equipment, including strike teams, to remove a worst case discharge and mitigate or prevent a substantial threat of such a discharge.</P> </SECTION> <SECTION> <SECTNO>§ 300.335</SECTNO> <SUBJECT>Funding.</SUBJECT> <P>(a) The OSLTF is available under certain circumstances to fund removal of oil performed under section 311 of the CWA. Those circumstances and the procedures for accessing the OSLTF are described in 33 CFR part 136. The responsible party is liable for costs of federal removal and damages in accordance with section 311(f) of the CWA, section 1002 of the OPA, and other federal laws.</P> <P>(b) Where the OSC requests assistance from a federal agency, that agency may be reimbursed in accordance with the provisions of 33 CFR part 136. Specific interagency reimbursement agreements may be used when necessary to ensure that the federal resources will be available for a timely response to a discharge of oil.</P> <P> (c) Procedures for funding the initiation of natural resource damage assessment are covered in 33 CFR part 136. <PRTPAGE P="54"/> </P> <P>(d) Response actions other than removal, such as scientific investigations not in support of removal actions or law enforcement, shall be provided by the agency with legal responsibility for those specific actions.</P> <P>(e) The funding of a response to a discharge from a federally owned, operated, or supervised facility or vessel is the responsibility of the owning, operating, or supervising agency if it is a responsible party.</P> <P>(f) The following agencies have funds available for certain discharge removal actions:</P> <P>(1) DOD has two specific sources of funds that may be applicable to an oil discharge under appropriate circumstances. This does not consider military resources that might be made available under specific conditions.</P> <P>(i) Funds required for removal of a sunken vessel or similar obstruction of navigation are available to the Corps of Engineers through Civil Works Appropriations, Operations and Maintenance, General.</P> <P>(ii) USN may conduct salvage operations contingent on defense operational commitments, when funded by the requesting agency. Such funding may be requested on a direct cite basis.</P> <P>(2) Pursuant to Title I of the OPA, the state or states affected by a discharge of oil may act where necessary to remove such discharge. Pursuant to 33 CFR part 136 states may be reimbursed from the OSLTF for the reasonable costs incurred in such a removal.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Hazardous Substance Response</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>55 FR 8839, Mar. 8, 1990, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.400</SECTNO> <SUBJECT>General.</SUBJECT> <P>(a) This subpart establishes methods and criteria for determining the appropriate extent of response authorized by CERCLA and CWA section 311(c):</P> <P>(1) When there is a release of a hazardous substance into the environment; or</P> <P>(2) When there is a release into the environment of any pollutant or contaminant that may present an imminent and substantial danger to the public health or welfare of the United States.</P> <P> (b) <E T="03">Limitations on response.</E> Unless the lead agency determines that a release constitutes a public health or environmental emergency and no other person with the authority and capability to respond will do so in a timely manner, a removal or remedial action under section 104 of CERCLA shall not be undertaken in response to a release: </P> <P>(1) Of a naturally occurring substance in its unaltered form, or altered solely through naturally occurring processes or phenomena, from a location where it is naturally found;</P> <P>(2) From products that are part of the structure of, and result in exposure within, residential buildings or business or community structures; or</P> <P>(3) Into public or private drinking water supplies due to deterioration of the system through ordinary use.</P> <P> (c) <E T="03">Fund-financed action.</E> In determining the need for and in planning or undertaking Fund-financed action, the lead agency shall, to the extent practicable: </P> <P>(1) Engage in prompt response;</P> <P>(2) Provide for state participation in response actions, as described in subpart F of this part;</P> <P>(3) Conserve Fund monies by encouraging private party response;</P> <P>(4) Be sensitive to local community concerns;</P> <P>(5) Consider using treatment technologies;</P> <P>(6) Involve the Regional Response Team (RRT) in both removal and remedial response actions at appropriate decision-making stages;</P> <P>(7) Encourage the involvement and sharing of technology by industry and other experts; and</P> <P>(8) Encourage the involvement of organizations to coordinate responsible party actions, foster site response, and provide technical advice to the public, federal and state governments, and industry.</P> <P> (d) <E T="03">Entry and access.</E> (1) For purposes of determining the need for response, or choosing or taking a response action, or otherwise enforcing the provisions of CERCLA, EPA, or the appropriate federal agency, and a state or <PRTPAGE P="55"/> political subdivision operating pursuant to a contract or cooperative agreement under CERCLA section 104(d)(1), has the authority to enter any vessel, facility, establishment or other place, property, or location described in paragraph (d)(2) of this section and conduct, complete, operate, and maintain any response actions authorized by CERCLA or these regulations. </P> <P>(2)(i) Under the authorities described in paragraph (d)(1) of this section, EPA, or the appropriate federal agency, and a state or political subdivision operating pursuant to a contract or cooperative agreement under CERCLA section 104(d)(1), may enter:</P> <P>(A) Any vessel, facility, establishment, or other place or property where any hazardous substance or pollutant or contaminant may be or has been generated, stored, treated, disposed of, or transported from;</P> <P>(B) Any vessel, facility, establishment, or other place or property from which, or to which, a hazardous substance or pollutant or contaminant has been, or may have been, released or where such release is or may be threatened;</P> <P>(C) Any vessel, facility, establishment, or other place or property where entry is necessary to determine the need for response or the appropriate response or to effectuate a response action; or</P> <P>(D) Any vessel, facility, establishment, or other place, property, or location adjacent to those vessels, facilities, establishments, places, or properties described in paragraphs (d)(2)(i)(A), (B), or (C) of this section.</P> <P>(ii) Once a determination has been made that there is a reasonable basis to believe that there has been or may be a release, EPA, or the appropriate federal agency, and a state or political subdivision operating pursuant to a contract or cooperative agreement under CERCLA section 104(d)(1), is authorized to enter all vessels, facilities, establishments, places, properties, or locations specified in paragraph (d)(2)(i) of this section, at which the release is believed to be, and all other vessels, facilities, establishments, places, properties, or locations identified in paragraph (d)(2)(i) of this section that are related to the response or are necessary to enter in responding to that release.</P> <P>(3) The lead agency may designate as its representative solely for the purpose of access, among others, one or more potentially responsible parties, including representatives, employees, agents, and contractors of such parties. EPA, or the appropriate federal agency, may exercise the authority contained in section 104(e) of CERCLA to obtain access for its designated representative. A potentially responsible party may only be designated as a representative of the lead agency where that potentially responsible party has agreed to conduct response activities pursuant to an administrative order or consent decree.</P> <P>(4)(i) If consent is not granted under the authorities described in paragraph (d)(1) of this section, or if consent is conditioned in any manner, EPA, or the appropriate federal agency, may issue an order pursuant to section 104(e)(5) of CERCLA directing compliance with the request for access made under § 300.400(d)(1). EPA or the appropriate federal agency may ask the Attorney General to commence a civil action to compel compliance with either a request for access or an order directing compliance.</P> <P>(ii) EPA reserves the right to proceed, where appropriate, under applicable authority other than CERCLA section 104(e).</P> <P>(iii) The administrative order may direct compliance with a request to enter or inspect any vessel, facility, establishment, place, property, or location described in paragraph (d)(2) of this section.</P> <P>(iv) Each order shall contain:</P> <P>(A) A determination by EPA, or the appropriate federal agency, that it is reasonable to believe that there may be or has been a release or threat of a release of a hazardous substance or pollutant or contaminant and a statement of the facts upon which the determination is based;</P> <P> (B) A description, in light of CERCLA response authorities, of the purpose and estimated scope and duration of the entry, including a description of the specific anticipated activities to be conducted pursuant to the order; <PRTPAGE P="56"/> </P> <P>(C) A provision advising the person who failed to consent that an officer or employee of the agency that issued the order will be available to confer with respondent prior to effective date of the order; and</P> <P>(D) A provision advising the person who failed to consent that a court may impose a penalty of up to $25,000 per day for unreasonable failure to comply with the order. The civil monetary penalty amount listed in this section may not reflect recent inflation adjustments EPA is required to make. The current maximum and minimum statutory civil penalty amounts are located in § 19.4.</P> <P>(v) Orders shall be served upon the person or responsible party who failed to consent prior to their effective date. Force shall not be used to compel compliance with an order.</P> <P>(vi) Orders may not be issued for any criminal investigations.</P> <P> (e) <E T="03">Permit requirements.</E> (1) No federal, state, or local permits are required for on-site response actions conducted pursuant to CERCLA sections 104, 106, 120, 121, or 122. The term <E T="03">on-site</E> means the areal extent of contamination and all suitable areas in very close proximity to the contamination necessary for implementation of the response action. </P> <P>(2) Permits, if required, shall be obtained for all response activities conducted off-site.</P> <P> (f) <E T="03">Health assessments.</E> Health assessments shall be performed by ATSDR at facilities on or proposed to be listed on the NPL and may be performed at other releases or facilities in response to petitions made to ATSDR. Where available, these health assessments may be used by the lead agency to assist in determining whether response actions should be taken and/or to identify the need for additional studies to assist in the assessment of potential human health effects associated with releases or potential releases of hazardous substances. </P> <P> (g) <E T="03">Identification of applicable or relevant and appropriate requirements.</E> (1) The lead and support agencies shall identify requirements applicable to the release or remedial action contemplated based upon an objective determination of whether the requirement specifically addresses a hazardous substance, pollutant, contaminant, remedial action, location, or other circumstance found at a CERCLA site. </P> <P>(2) If, based upon paragraph (g)(1) of this section, it is determined that a requirement is not applicable to a specific release, the requirement may still be relevant and appropriate to the circumstances of the release. In evaluating relevance and appropriateness, the factors in paragraphs (g)(2)(i) through (viii) of this section shall be examined, where pertinent, to determine whether a requirement addresses problems or situations sufficiently similar to the circumstances of the release or remedial action contemplated, and whether the requirement is well-suited to the site, and therefore is both relevant and appropriate. The pertinence of each of the following factors will depend, in part, on whether a requirement addresses a chemical, location, or action. The following comparisons shall be made, where pertinent, to determine relevance and appropriateness:</P> <P>(i) The purpose of the requirement and the purpose of the CERCLA action;</P> <P>(ii) The medium regulated or affected by the requirement and the medium contaminated or affected at the CERCLA site;</P> <P>(iii) The substances regulated by the requirement and the substances found at the CERCLA site;</P> <P>(iv) The actions or activities regulated by the requirement and the remedial action contemplated at the CERCLA site;</P> <P>(v) Any variances, waivers, or exemptions of the requirement and their availability for the circumstances at the CERCLA site;</P> <P>(vi) The type of place regulated and the type of place affected by the release or CERCLA action;</P> <P>(vii) The type and size of structure or facility regulated and the type and size of structure or facility affected by the release or contemplated by the CERCLA action;</P> <P> (viii) Any consideration of use or potential use of affected resources in the requirement and the use or potential use of the affected resource at the CERCLA site. <PRTPAGE P="57"/> </P> <P>(3) In addition to applicable or relevant and appropriate requirements, the lead and support agencies may, as appropriate, identify other advisories, criteria, or guidance to be considered for a particular release. The “to be considered” (TBC) category consists of advisories, criteria, or guidance that were developed by EPA, other federal agencies, or states that may be useful in developing CERCLA remedies.</P> <P> (4) Only those state standards that are promulgated, are identified by the state in a timely manner, and are more stringent than federal requirements may be applicable or relevant and appropriate. For purposes of identification and notification of promulgated state standards, the term <E T="03">promulgated</E> means that the standards are of general applicability and are legally enforceable. </P> <P>(5) The lead agency and support agency shall identify their specific requirements that are applicable or relevant and appropriate for a particular site. These agencies shall notify each other, in a timely manner as described in § 300.515(d), of the requirements they have determined to be applicable or relevant and appropriate. When identifying a requirement as an ARAR, the lead agency and support agency shall include a citation to the statute or regulation from which the requirement is derived.</P> <P>(6) Notification of ARARs shall be according to procedures and timeframes specified in § 300.515 (d)(2) and (h)(2).</P> <P> (h) <E T="03">Oversight.</E> The lead agency may provide oversight for actions taken by potentially responsible parties to ensure that a response is conducted consistent with this part. The lead agency may also monitor the actions of third parties preauthorized under subpart H of this part. EPA will provide oversight when the response is pursuant to an EPA order or federal consent decree. </P> <P> (i) <E T="03">Other.</E> (1) This subpart does not establish any preconditions to enforcement action by either the federal or state governments to compel response actions by potentially responsible parties. </P> <P>(2) While much of this subpart is oriented toward federally funded response actions, this subpart may be used as guidance concerning methods and criteria for response actions by other parties under other funding mechanisms. Except as provided in subpart H of this part, nothing in this part is intended to limit the rights of any person to seek recovery of response costs from responsible parties pursuant to CERCLA section 107.</P> <P>(3) Activities by the federal and state governments in implementing this subpart are discretionary governmental functions. This subpart does not create in any private party a right to federal response or enforcement action. This subpart does not create any duty of the federal government to take any response action at any particular time.</P> <CITA>[55 FR 8839, Mar. 8, 1990, as amended at 59 FR 47447, Sept. 15, 1994; 89 FR 88656, Nov. 8, 2024]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.405</SECTNO> <SUBJECT>Discovery or notification.</SUBJECT> <P>(a) A release may be discovered through:</P> <P> (1) A report submitted in accordance with section 103(a) of CERCLA, <E T="03">i.e.</E> , reportable quantities codified at 40 CFR part 302; </P> <P>(2) A report submitted to EPA in accordance with section 103(c) of CERCLA;</P> <P>(3) Investigation by government authorities conducted in accordance with section 104(e) of CERCLA or other statutory authority;</P> <P>(4) Notification of a release by a federal or state permit holder when required by its permit;</P> <P>(5) Inventory or survey efforts or random or incidental observation reported by government agencies or the public;</P> <P>(6) Submission of a citizen petition to EPA or the appropriate federal facility requesting a preliminary assessment, in accordance with section 105(d) of CERCLA;</P> <P>(7) A report submitted in accordance with section 311(b)(5) of the CWA; and</P> <P>(8) Other sources.</P> <P> (b) Any person in charge of a vessel or a facility shall report releases as described in paragraph (a)(1) of this section to the National Response Center (NRC). If direct reporting to the NRC is not practicable, reports may be made to the United States Coast Guard (USCG) on-scene coordinator (OSC) for the geographic area where the release occurs. The EPA predesignated OSC <PRTPAGE P="58"/> may also be contacted through the regional 24-hour emergency response telephone number. All such reports shall be promptly relayed to the NRC. If it is not possible to notify the NRC or predesignated OSC immediately, reports may be made immediately to the nearest USCG unit. In any event, such person in charge of the vessel or facility shall notify the NRC as soon as possible. </P> <P>(c) All other reports of releases described under paragraph (a) of this section, except releases reported under paragraphs (a)(2) and (6) of this section, shall, as appropriate, be made to the NRC.</P> <P>(d) The NRC will generally need information that will help to characterize the release. This will include, but not be limited to: Location of the release; type(s) of material(s) released; an estimate of the quantity of material released; possible source of the release; and date and time of the release. Reporting under paragraphs (b) and (c) of this section shall not be delayed due to incomplete notification information.</P> <P>(e) Upon receipt of a notification of a release, the NRC shall promptly notify the appropriate OSC. The OSC shall notify the Governor, or designee, of the state affected by the release.</P> <P>(f)(1) When the OSC is notified of a release that may require response pursuant to § 300.415(b), a removal site evaluation shall, as appropriate, be promptly undertaken pursuant to § 300.410.</P> <P>(2) When notification indicates that removal action pursuant to § 300.415(b) is not required, a remedial site evaluation shall, if appropriate, be undertaken by the lead agency pursuant to § 300.420, if one has not already been performed.</P> <P>(3) If radioactive substances are present in a release, the EPA Radiological Response Coordinator should be notified for evaluation and assistance either directly or via the NRC, consistent with §§ 300.130(e) and 300.145(f).</P> <P>(g) Release notification made to the NRC under this section does not relieve the owner/operator of a facility from any obligations to which it is subject under SARA Title III or state law. In particular, it does not relieve the owner/operator from the requirements of section 304 of SARA Title III and 40 CFR part 355 and § 300.215(f) of this part for notifying the community emergency coordinator for the appropriate local emergency planning committee of all affected areas and the state emergency response commission of any state affected that there has been a release. Federal agencies are not legally obligated to comply with the requirements of Title III of SARA.</P> <CITA>[55 FR 8839, Mar. 8, 1990, as amended at 59 FR 47447, Sept. 15, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.410</SECTNO> <SUBJECT>Removal site evaluation.</SUBJECT> <P>(a) A removal site evaluation includes a removal preliminary assessment and, if warranted, a removal site inspection.</P> <P>(b) A removal site evaluation of a release identified for possible CERCLA response pursuant to § 300.415 shall, as appropriate, be undertaken by the lead agency as promptly as possible. The lead agency may perform a removal preliminary assessment in response to petitions submitted by a person who is, or may be, affected by a release of a hazardous substance, pollutant, or contaminant pursuant to § 300.420(b)(5).</P> <P>(c)(1) The lead agency shall, as appropriate, base the removal preliminary assessment on readily available information. A removal preliminary assessment may include, but is not limited to:</P> <P>(i) Identification of the source and nature of the release or threat of release;</P> <P>(ii) Evaluation by ATSDR or by other sources, for example, state public health agencies, of the threat to public health;</P> <P>(iii) Evaluation of the magnitude of the threat;</P> <P>(iv) Evaluation of factors necessary to make the determination of whether a removal is necessary; and</P> <P>(v) Determination of whether a nonfederal party is undertaking proper response.</P> <P> (2) A removal preliminary assessment of releases from hazardous waste management facilities may include collection or review of data such as site management practices, information from generators, photographs, analysis of historical photographs, literature <PRTPAGE P="59"/> searches, and personal interviews conducted, as appropriate. </P> <P> (d) A removal site inspection may be performed if more information is needed. Such inspection may include a perimeter ( <E T="03">i.e.</E> , off-site) or on-site inspection, taking into consideration whether such inspection can be performed safely. </P> <P>(e)(1) As part of the evaluation under this section, the OSC shall determine whether a release governed by CWA section 311(c)(1), as amended by OPA section 4201(a), has occurred.</P> <P>(2) If such a release of a CWA hazardous substance has occurred, the OSC shall determine whether the release results in a substantial threat to the public health or welfare of the United States. Factors to be considered by the OSC in making this determination include, but are not limited to, the size of the release, the character of the release, and the nature of the threat to public health or welfare of the United States. Upon obtaining relevant elements of such information, the OSC shall conduct an evaluation of the threat posed, based on the OSC's experience in assessing other releases, and consultation with senior lead agency officials and readily available authorities on issues outside the OSC's technical expertise.</P> <P>(f) A removal site evaluation shall be terminated when the OSC or lead agency determines:</P> <P>(1) There is no release;</P> <P>(2) The source is neither a vessel nor a facility as defined in § 300.5 of the NCP;</P> <P>(3) The release involves neither a hazardous substance, nor a pollutant or contaminant that may present an imminent and substantial danger to public health or welfare of the United States;</P> <P>(4) The release consists of a situation specified in § 300.400(b)(1) through (3) subject to limitations on response;</P> <P>(5) The amount, quantity, or concentration released does not warrant federal response;</P> <P>(6) A party responsible for the release, or any other person, is providing appropriate response, and on-scene monitoring by the government is not required; or</P> <P>(7) The removal site evaluation is completed.</P> <P>(g) The results of the removal site evaluation shall be documented.</P> <P>(h) The OSC or lead agency shall ensure that natural resource trustees are promptly notified in order that they may initiate appropriate actions, including those identified in subpart G of this part. The OSC or lead agency shall coordinate all response activities with such affected trustees.</P> <P>(i) If the removal site evaluation indicates that removal action under § 300.415 is not required, but that remedial action under § 300.430 may be necessary, the lead agency shall, as appropriate, initiate a remedial site evaluation pursuant to § 300.420.</P> <CITA>[59 FR 47448, Sept. 15, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§  300.411</SECTNO> <SUBJECT>Response to CWA hazardous substance worst case discharges.</SUBJECT> <P>(a) If the investigation by the OSC shows that a discharge is a worst case discharge as defined in the ACP, or there is a substantial threat of such a discharge, the OSC shall:</P> <P>(1) Notify the NSFCC;</P> <P>(2) Require, where applicable, implementation of the worst case portion of an approved facility response plan required by CWA section 311(j)(5);</P> <P>(3) Implement the worst case portion of the ACP required by CWA section 311(j)(4); and</P> <P>(4) Take whatever additional response actions are deemed appropriate.</P> <P>(b) Under the direction of the OSC, the NSFCC shall coordinate use of private and public personnel and equipment, including strike teams, to respond to a worst case discharge and mitigate or prevent a substantial threat of such a discharge.</P> <CITA>[89 FR 21966, Mar. 28, 2024]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.415</SECTNO> <SUBJECT>Removal action.</SUBJECT> <P> (a)(1) In determining the appropriate extent of action to be taken in response to a given release, the lead agency shall first review the removal site evaluation, any information produced through a remedial site evaluation, if any has been done previously, and the current site conditions, to determine if removal action is appropriate. <PRTPAGE P="60"/> </P> <P>(2) Where the responsible parties are known, an effort initially shall be made, to the extent practicable, to determine whether they can and will perform the necessary removal action promptly and properly.</P> <P>(3) This section does not apply to removal actions taken pursuant to section 104(b) of CERCLA. The criteria for such actions are set forth in section 104(b) of CERCLA.</P> <P>(b)(1) At any release, regardless of whether the site is included on the National Priorities List (NPL), where the lead agency makes the determination, based on the factors in paragraph (b)(2) of this section, that there is a threat to public health or welfare of the United States or the environment, the lead agency may take any appropriate removal action to abate, prevent, minimize, stabilize, mitigate, or eliminate the release or the threat of release.</P> <P>(2) The following factors shall be considered in determining the appropriateness of a removal action pursuant to this section:</P> <P>(i) Actual or potential exposure to nearby human populations, animals, or the food chain from hazardous substances or pollutants or contaminants;</P> <P>(ii) Actual or potential contamination of drinking water supplies or sensitive ecosystems;</P> <P>(iii) Hazardous substances or pollutants or contaminants in drums, barrels, tanks, or other bulk storage containers, that may pose a threat of release;</P> <P>(iv) High levels of hazardous substances or pollutants or contaminants in soils largely at or near the surface, that may migrate;</P> <P>(v) Weather conditions that may cause hazardous substances or pollutants or contaminants to migrate or be released;</P> <P>(vi) Threat of fire or explosion;</P> <P>(vii) The availability of other appropriate federal or state response mechanisms to respond to the release; and</P> <P>(viii) Other situations or factors that may pose threats to public health or welfare of the United States or the environment.</P> <P>(3) If the lead agency determines that a removal action is appropriate, actions shall, as appropriate, begin as soon as possible to abate, prevent, minimize, stabilize, mitigate, or eliminate the threat to public health or welfare of the United States or the environment. The lead agency shall, at the earliest possible time, also make any necessary determinations pursuant to paragraph (b)(4) of this section.</P> <P>(4) Whenever a planning period of at least six months exists before on-site activities must be initiated, and the lead agency determines, based on a site evaluation, that a removal action is appropriate:</P> <P>(i) The lead agency shall conduct an engineering evaluation/cost analysis (EE/CA) or its equivalent. The EE/CA is an analysis of removal alternatives for a site.</P> <P>(ii) If environmental samples are to be collected, the lead agency shall develop sampling and analysis plans that shall provide a process for obtaining data of sufficient quality and quantity to satisfy data needs. Sampling and analysis plans shall be reviewed and approved by EPA. The sampling and analysis plans shall consist of two parts:</P> <P>(A) The field sampling plan, which describes the number, type, and location of samples and the type of analyses; and</P> <P>(B) The quality assurance project plan, which describes policy, organization, and functional activities and the data quality objectives and measures necessary to achieve adequate data for use in planning and documenting the removal action.</P> <P>(5) CERCLA fund-financed removal actions, other than those authorized under section 104(b) of CERCLA, shall be terminated after $2 million has been obligated for the action or 12 months have elapsed from the date that removal activities begin on-site, unless the lead agency determines that:</P> <P>(i) There is an immediate risk to public health or welfare of the United States or the environment; continued response actions are immediately required to prevent, limit, or mitigate an emergency; and such assistance will not otherwise be provided on a timely basis; or</P> <P> (ii) Continued response action is otherwise appropriate and consistent with the remedial action to be taken. <PRTPAGE P="61"/> </P> <P>(c)(1) In carrying out a response to a release of a CWA hazardous substance, as described in CWA section 311(c)(1), as amended by OPA section 4201(a), the OSC may:</P> <P>(i) Remove or arrange for the removal of a release, and mitigate or prevent a substantial threat of a release, at any time;</P> <P>(ii) Direct or monitor all federal, state, and private actions to remove a release; and</P> <P>(iii) Remove and, if necessary, destroy a vessel releasing or threatening to release CWA hazardous substances, by whatever means are available.</P> <P>(2) If the investigation by the OSC under § 300.410 shows that the release of a CWA hazardous substance results in a substantial threat to public health or welfare of the United States, the OSC shall direct all federal, state, or private actions to remove the release or to mitigate or prevent the threat of such a release, as appropriate. In directing the response, the OSC may act without regard to any other provision of law governing contracting procedures or employment of personnel by the federal government to:</P> <P>(i) Remove or arrange for the removal of the release;</P> <P>(ii) Mitigate or prevent the substantial threat of the release; and</P> <P>(iii) Remove and, if necessary, destroy a vessel releasing, or threatening to release, by whatever means are available.</P> <P>(3) In the case of a release of a CWA hazardous substance posing a substantial threat to public health or welfare of the United States, the OSC shall:</P> <P>(i) Assess opportunities for the use of various special teams and other assistance described in § 300.145, as appropriate;</P> <P>(ii) Request immediate activation of the RRT; and</P> <P>(iii) Take whatever additional response actions are deemed appropriate. When requested by the OSC, the lead agency or RRT shall dispatch appropriate personnel to the scene of the release to assist the OSC. This assistance may include technical support in the agency's areas of expertise and disseminating information to the public in accordance with § 300.155. The lead agency shall ensure that a contracting officer is available on-scene, at the request of the OSC.</P> <P>(d) Removal actions shall, to the extent practicable, contribute to the efficient performance of any anticipated long-term remedial action with respect to the release concerned.</P> <P>(e) The following removal actions are, as a general rule, appropriate in the types of situations shown; however, this list is not exhaustive and is not intended to prevent the lead agency from taking any other actions deemed necessary under CERCLA, CWA section 311, or other appropriate federal or state enforcement or response authorities, and the list does not create a duty on the lead agency to take action at any particular time:</P> <P>(1) Fences, warning signs, or other security or site control precautions—where humans or animals have access to the release;</P> <P>(2) Drainage controls, for example, run-off or run-on diversion—where needed to reduce migration of hazardous substances or pollutants or contaminants off-site or to prevent precipitation or run-off from other sources, for example, flooding, from entering the release area from other areas;</P> <P>(3) Stabilization of berms, dikes, or impoundments or drainage or closing of lagoons—where needed to maintain the integrity of the structures;</P> <P>(4) Capping of contaminated soils or sludges—where needed to reduce migration of hazardous substances or pollutants or contaminants into soil, ground or surface water, or air;</P> <P>(5) Using chemicals and other materials to retard the spread of the release or to mitigate its effects—where the use of such chemicals will reduce the spread of the release;</P> <P>(6) Excavation, consolidation, or removal of highly contaminated soils from drainage or other areas—where such actions will reduce the spread of, or direct contact with, the contamination;</P> <P> (7) Removal of drums, barrels, tanks, or other bulk containers that contain or may contain hazardous substances or pollutants or contaminants—where it will reduce the likelihood of spillage; leakage; exposure to humans, animals, or food chain; or fire or explosion; <PRTPAGE P="62"/> </P> <P>(8) Containment, treatment, disposal, or incineration of hazardous materials—where needed to reduce the likelihood of human, animal, or food chain exposure; or</P> <P>(9) Provision of alternative water supply—where necessary immediately to reduce exposure to contaminated household water and continuing until such time as local authorities can satisfy the need for a permanent remedy.</P> <P>(f) Where necessary to protect public health or welfare, the lead agency shall request that FEMA conduct a temporary relocation or that state/local officials conduct an evacuation.</P> <P>(g) If the lead agency determines that the removal action will not fully address the threat posed by the release and the release may require remedial action, the lead agency shall ensure an orderly transition from removal to remedial response activities.</P> <P>(h) CERCLA removal actions conducted by states under cooperative agreements, described in subpart F of this part, shall comply with all requirements of this section.</P> <P>(i) Facilities operated by a state or political subdivision at the time of disposal require a state cost share of at least 50 percent of Fund-financed response costs if a Fund-financed remedial action is conducted.</P> <P>(j) Fund-financed removal actions under CERCLA section 104 and removal actions pursuant to CERCLA section 106 shall, to the extent practicable considering the exigencies of the situation, attain applicable or relevant and appropriate requirements (ARARs) under federal environmental or state environmental or facility siting laws. Waivers described in § 300.430(f)(1)(ii)(C) may be used for removal actions. Other federal and state advisories, criteria, or guidance may, as appropriate, be considered in formulating the removal action (see § 300.400(g)(3)). In determining whether compliance with ARARs is practicable, the lead agency may consider appropriate factors, including:</P> <P>(1) The urgency of the situation; and</P> <P>(2) The scope of the removal action to be conducted.</P> <P>(k) Removal actions pursuant to section 106 or 122 of CERCLA are not subject to the following requirements of this section:</P> <P>(1) Section 300.415(a)(2) requirement to locate responsible parties and have them undertake the response;</P> <P>(2) Section 300.415(b)(2)(vii) requirement to consider the availability of other appropriate federal or state response and enforcement mechanisms to respond to the release;</P> <P>(3) Section 300.415(b)(5) requirement to terminate response after $2 million has been obligated or 12 months have elapsed from the date of the initial response; and</P> <P>(4) Section 300.415(g) requirement to assure an orderly transition from removal to remedial action.</P> <P>(l) To the extent practicable, provision for post-removal site control following a CERCLA Fund-financed removal action at both NPL and non-NPL sites is encouraged to be made prior to the initiation of the removal action. Such post-removal site control includes actions necessary to ensure the effectiveness and integrity of the removal action after the completion of the on-site removal action or after the $2 million or 12-month statutory limits are reached for sites that do not meet the exemption criteria in paragraph (b)(5) of this section. Post-removal site control may be conducted by:</P> <P>(1) The affected state or political subdivision thereof or local units of government for any removal;</P> <P>(2) Potentially responsible parties; or</P> <P>(3) EPA's remedial program for some federal-lead Fund-financed responses at NPL sites.</P> <P>(m) OSCs/RPMs conducting removal actions shall submit OSC reports to the RRT as required by § 300.165.</P> <P> (n) <E T="03">Community relations in removal actions.</E> (1) In the case of all CERCLA removal actions taken pursuant to § 300.415 or CERCLA enforcement actions to compel removal response, a spokesperson shall be designated by the lead agency. The spokesperson shall inform the community of actions taken, respond to inquiries, and provide information concerning the release. All news releases or statements made by participating agencies shall be coordinated with the OSC/RPM. The spokesperson shall notify, at a minimum, immediately affected citizens, <PRTPAGE P="63"/> state and local officials, and, when appropriate, civil defense or emergency management agencies. </P> <P>(2) For CERCLA actions where, based on the site evaluation, the lead agency determines that a removal is appropriate, and that less than six months exists before on-site removal activity must begin, the lead agency shall:</P> <P>(i) Publish a notice of availability of the administrative record file established pursuant to § 300.820 in a major local newspaper of general circulation or use one or more other mechanisms to give adequate notice to a community within 60 days of initiation of on-site removal activity;</P> <P>(ii) Provide a public comment period, as appropriate, of not less than 30 days from the time the administrative record file is made available for public inspection, pursuant to § 300.820(b)(2); and</P> <P>(iii) Prepare a written response to significant comments pursuant to § 300.820(b)(3).</P> <P>(3) For CERCLA removal actions where on-site action is expected to extend beyond 120 days from the initiation of on-site removal activities, the lead agency shall by the end of the 120-day period:</P> <P>(i) Conduct interviews with local officials, community residents, public interest groups, or other interested or affected parties, as appropriate, to solicit their concerns, information needs, and how or when citizens would like to be involved in the Superfund process;</P> <P>(ii) Prepare a formal community relations plan (CRP) based on the community interviews and other relevant information, specifying the community relations activities that the lead agency expects to undertake during the response; and</P> <P>(iii) Establish at least one local information repository at or near the location of the response action. The information repository should contain items made available for public information. Further, an administrative record file established pursuant to subpart I for all removal actions shall be available for public inspection in at least one of the repositories. The lead agency shall inform the public of the establishment of the information repository and provide notice of availability of the administrative record file for public review. All items in the repository shall be available for public inspection and copying.</P> <P>(4) Where, based on the site evaluation, the lead agency determines that a CERCLA removal action is appropriate and that a planning period of at least six months exists prior to initiation of the on-site removal activities, the lead agency shall at a minimum:</P> <P>(i) Comply with the requirements set forth in paragraphs (n)(3)(i), (ii), and (iii) of this section, prior to the completion of the EE/CA, or its equivalent, except that the information repository and the administrative record file will be established no later than when the EE/CA approval memorandum is signed;</P> <P>(ii) Publish a notice of availability and brief description of the EE/CA in a major local newspaper of general circulation or use one or more other mechanisms to give adequate notice to a community pursuant to § 300.820;</P> <P>(iii) Provide a reasonable opportunity, not less than 30 calendar days, for submission of written and oral comments after completion of the EE/CA pursuant to § 300.820(a). Upon timely request, the lead agency will extend the public comment period by a minimum of 15 days; and</P> <P>(iv) Prepare a written response to significant comments pursuant to § 300.820(a).</P> <CITA>[59 FR 47448, Sept. 15, 1994, as amended at 80 FR 17706, Apr. 2, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.420</SECTNO> <SUBJECT>Remedial site evaluation.</SUBJECT> <P> (a) <E T="03">General.</E> The purpose of this section is to describe the methods, procedures, and criteria the lead agency shall use to collect data, as required, and evaluate releases of hazardous substances, pollutants, or contaminants. The evaluation may consist of two steps: a remedial preliminary assessment (PA) and a remedial site inspection (SI). </P> <P> (b) <E T="03">Remedial preliminary assessment.</E> (1) The lead agency shall perform a remedial PA on all sites entered into the SEMS remedial assessment active inventory as defined in § 300.5 to: </P> <P> (i) Eliminate from further consideration those sites that pose no threat to public health or the environment; <PRTPAGE P="64"/> </P> <P>(ii) Determine if there is any potential need for removal action;</P> <P>(iii) Set priorities for site inspections; and</P> <P>(iv) Gather existing data to facilitate later evaluation of the release pursuant to the Hazard Ranking System (HRS) if warranted.</P> <P>(2) A remedial PA shall consist of a review of existing information about a release such as information on the pathways of exposure, exposure targets, and source and nature of release. A remedial PA shall also include an off-site reconnaissance as appropriate. A remedial PA may include an on-site reconnaissance where appropriate.</P> <P>(3) If the remedial PA indicates that a removal action may be warranted, the lead agency shall initiate removal evaluation pursuant to § 300.410.</P> <P>(4) In performing a remedial PA, the lead agency may complete the EPA Preliminary Assessment form, available from EPA regional offices, or its equivalent, and shall prepare a PA report, which shall include:</P> <P>(i) A description of the release;</P> <P>(ii) A description of the probable nature of the release; and</P> <P>(iii) A recommendation on whether further action is warranted, which lead agency should conduct further action, and whether an SI or removal action or both should be undertaken.</P> <P>(5) Any person may petition the lead federal agency (EPA or the appropriate federal agency in the case of a release or suspected release from a federal facility), to perform a PA of a release when such person is, or may be, affected by a release of a hazardous substance, pollutant, or contaminant. Such petitions shall be addressed to the EPA Regional Administrator for the region in which the release is located, except that petitions for PAs involving federal facilities should be addressed to the head of the appropriate federal agency.</P> <P>(i) Petitions shall be signed by the petitioner and shall contain the following:</P> <P>(A) The full name, address, and phone number of petitioner;</P> <P>(B) A description, as precisely as possible, of the location of the release; and</P> <P>(C) How the petitioner is or may be affected by the release.</P> <P>(ii) Petitions should also contain the following information to the extent available:</P> <P>(A) What type of substances were or may be released;</P> <P>(B) The nature of activities that have occurred where the release is located; and</P> <P>(C) Whether local and state authorities have been contacted about the release.</P> <P>(iii) The lead federal agency shall complete a remedial or removal PA within one year of the date of receipt of a complete petition pursuant to paragraph (b)(5) of this section, if one has not been performed previously, unless the lead federal agency determines that a PA is not appropriate. Where such a determination is made, the lead federal agency shall notify the petitioner and will provide a reason for the determination.</P> <P>(iv) When determining if performance of a PA is appropriate, the lead federal agency shall take into consideration:</P> <P>(A) Whether there is information indicating that a release has occurred or there is a threat of a release of a hazardous substance, pollutant, or contaminant; and</P> <P>(B) Whether the release is eligible for response under CERCLA.</P> <P> (c) <E T="03">Remedial site inspection.</E> (1) The lead agency shall perform a remedial SI as appropriate to: </P> <P>(i) Eliminate from further consideration those releases that pose no significant threat to public health or the environment;</P> <P>(ii) Determine the potential need for removal action;</P> <P>(iii) Collect or develop additional data, as appropriate, to evaluate the release pursuant to the HRS; and</P> <P>(iv) Collect data in addition to that required to score the release pursuant to the HRS, as appropriate, to better characterize the release for more effective and rapid initiation of the RI/FS or response under other authorities.</P> <P>(2) The remedial SI shall build upon the information collected in the remedial PA. The remedial SI shall involve, as appropriate, both on- and off-site field investigatory efforts, and sampling.</P> <P> (3) If the remedial SI indicates that removal action may be appropriate, the <PRTPAGE P="65"/> lead agency shall initiate removal site evaluation pursuant to § 300.410. </P> <P>(4) Prior to conducting field sampling as part of site inspections, the lead agency shall develop sampling and analysis plans that shall provide a process for obtaining data of sufficient quality and quantity to satisfy data needs. The sampling and analysis plans shall consist of two parts:</P> <P>(i) The field sampling plan, which describes the number, type, and location of samples, and the type of analyses, and</P> <P>(ii) The quality assurance project plan (QAPP), which describes policy, organization, and functional activities, and the data quality objectives and measures necessary to achieve adequate data for use in site evaluation and hazard ranking system activities.</P> <P>(5) Upon completion of a remedial SI, the lead agency shall prepare a report that includes the following:</P> <P>(i) A description/history/nature of waste handling;</P> <P>(ii) A description of known contaminants;</P> <P>(iii) A description of pathways of migration of contaminants;</P> <P>(iv) An identification and description of human and environmental targets; and</P> <P>(v) A recommendation on whether further action is warranted.</P> <CITA>[55 FR 8839, Mar. 8, 1990, as amended at 79 FR 65592, Nov. 5, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.425</SECTNO> <SUBJECT>Establishing remedial priorities.</SUBJECT> <P> (a) <E T="03">General.</E> The purpose of this section is to identify the criteria as well as the methods and procedures EPA uses to establish its priorities for remedial actions. </P> <P> (b) <E T="03">National Priorities List.</E> The NPL is the list of priority releases for long-term remedial evaluation and response. </P> <P>(1) Only those releases included on the NPL shall be considered eligible for Fund-financed remedial action. Removal actions (including remedial planning activities, RI/FSs, and other actions taken pursuant to CERCLA section 104(b)) are not limited to NPL sites.</P> <P>(2) Inclusion of a release on the NPL does not imply that monies will be expended, nor does the rank of a release on the NPL establish the precise priorities for the allocation of Fund resources. EPA may also pursue other appropriate authorities to remedy the release, including enforcement actions under CERCLA and other laws. A site's rank on the NPL serves, along with other factors, including enforcement actions, as a basis to guide the allocation of Fund resources among releases.</P> <P>(3) Federal facilities that meet the criteria identified in paragraph (c) of this section are eligible for inclusion on the NPL. Except as provided by CERCLA sections 111(e)(3) and 111(c), federal facilities are not eligible for Fund-financed remedial actions.</P> <P>(4) Inclusion on the NPL is not a precondition to action by the lead agency under CERCLA sections 106 or 122 or to action under CERCLA section 107 for recovery of non-Fund-financed costs or Fund-financed costs other than Fund-financed remedial construction costs.</P> <P> (c) <E T="03">Methods for determining eligibility for NPL.</E> A release may be included on the NPL if the release meets one of the following criteria: </P> <P>(1) The release scores sufficiently high pursuant to the Hazard Ranking System described in appendix A to this part.</P> <P>(2) A state (not including Indian tribes) has designated a release as its highest priority. States may make only one such designation; or</P> <P>(3) The release satisfies all of the following criteria:</P> <P>(i) The Agency for Toxic Substances and Disease Registry has issued a health advisory that recommends dissociation of individuals from the release;</P> <P>(ii) EPA determines that the release poses a significant threat to public health; and</P> <P>(iii) EPA anticipates that it will be more cost-effective to use its remedial authority than to use removal authority to respond to the release.</P> <P> (d) <E T="03">Procedures for placing sites on the NPL.</E> Lead agencies may submit candidates to EPA by scoring the release using the HRS and providing the appropriate backup documentation. </P> <P> (1) Lead agencies may submit HRS scoring packages to EPA anytime throughout the year. <PRTPAGE P="66"/> </P> <P>(2) EPA shall review lead agencies' HRS scoring packages and revise them as appropriate. EPA shall develop any additional HRS scoring packages on releases known to EPA.</P> <P>(3) EPA shall compile the NPL based on the methods identified in paragraph (c) of this section.</P> <P>(4) EPA shall update the NPL at least once a year.</P> <P>(5) To ensure public involvement during the proposal to add a release to the NPL, EPA shall:</P> <P> (i) Publish the proposed rule in the <E T="04">Federal Register</E> and solicit comments through a public comment period; and </P> <P> (ii) Publish the final rule in the <E T="04">Federal Register,</E> and make available a response to each significant comment and any significant new data submitted during the comment period. </P> <P>(6) Releases may be categorized on the NPL when deemed appropriate by EPA.</P> <P> (e) <E T="03">Deletion from the NPL.</E> Releases may be deleted from or recategorized on the NPL where no further response is appropriate. </P> <P>(1) EPA shall consult with the state on proposed deletions from the NPL prior to developing the notice of intent to delete. In making a determination to delete a release from the NPL, EPA shall consider, in consultation with the state, whether any of the following criteria has been met:</P> <P>(i) Responsible parties or other persons have implemented all appropriate response actions required;</P> <P>(ii) All appropriate Fund-financed response under CERCLA has been implemented, and no further response action by responsible parties is appropriate; or</P> <P>(iii) The remedial investigation has shown that the release poses no significant threat to public health or the environment and, therefore, taking of remedial measures is not appropriate.</P> <P> (2) Releases shall not be deleted from the NPL until the state in which the release was located has concurred on the proposed deletion. EPA shall provide the state 30 working days for review of the deletion notice prior to its publication in the <E T="04">Federal Register.</E> </P> <P>(3) All releases deleted from the NPL are eligible for further Fund-financed remedial actions should future conditions warrant such action. Whenever there is a significant release from a site deleted from the NPL, the site shall be restored to the NPL without application of the HRS.</P> <P>(4) To ensure public involvement during the proposal to delete a release from the NPL, EPA shall:</P> <P> (i) Publish a notice of intent to delete in the <E T="04">Federal Register</E> and solicit comment through a public comment period of a minimum of 30 calendar days; </P> <P>(ii) In a major local newspaper of general circulation at or near the release that is proposed for deletion, publish a notice of availability or use one or more other mechanisms to give adequate notice to a community of the intent to delete;</P> <P>(iii) Place copies of information supporting the proposed deletion in the information repository, described in § 300.430(c)(2)(iii), at or near the release proposed for deletion. These items shall be available for public inspection and copying; and</P> <P>(iv) Respond to each significant comment and any significant new data submitted during the comment period and include this response document in the final deletion package.</P> <P> (5) EPA shall place the final deletion package in the local information repository once the notice of final deletion has been published in the <E T="04">Federal Register.</E> </P> <CITA>[55 FR 8839, Mar. 8, 1990, as amended at 80 FR 17706, Apr. 2, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.430</SECTNO> <SUBJECT>Remedial investigation/feasibility study and selection of remedy.</SUBJECT> <P> (a) <E T="03">General</E> —(1) <E T="03">Introduction.</E> The purpose of the remedy selection process is to implement remedies that eliminate, reduce, or control risks to human health and the environment. Remedial actions are to be implemented as soon as site data and information make it possible to do so. Accordingly, EPA has established the following program goal, expectations, and program management principles to assist in the identification and implementation of appropriate remedial actions. <PRTPAGE P="67"/> </P> <P> (i) <E T="03">Program goal.</E> The national goal of the remedy selection process is to select remedies that are protective of human health and the environment, that maintain protection over time, and that minimize untreated waste. </P> <P> (ii) <E T="03">Program management principles.</E> EPA generally shall consider the following general principles of program management during the remedial process: </P> <P>(A) Sites should generally be remediated in operable units when early actions are necessary or appropriate to achieve significant risk reduction quickly, when phased analysis and response is necessary or appropriate given the size or complexity of the site, or to expedite the completion of total site cleanup.</P> <P>(B) Operable units, including interim action operable units, should not be inconsistent with nor preclude implementation of the expected final remedy.</P> <P>(C) Site-specific data needs, the evaluation of alternatives, and the documentation of the selected remedy should reflect the scope and complexity of the site problems being addressed.</P> <P> (iii) <E T="03">Expectations.</E> EPA generally shall consider the following expectations in developing appropriate remedial alternatives: </P> <P>(A) EPA expects to use treatment to address the principal threats posed by a site, wherever practicable. Principal threats for which treatment is most likely to be appropriate include liquids, areas contaminated with high concentrations of toxic compounds, and highly mobile materials.</P> <P>(B) EPA expects to use engineering controls, such as containment, for waste that poses a relatively low long-term threat or where treatment is impracticable.</P> <P>(C) EPA expects to use a combination of methods, as appropriate, to achieve protection of human health and the environment. In appropriate site situations, treatment of the principal threats posed by a site, with priority placed on treating waste that is liquid, highly toxic or highly mobile, will be combined with engineering controls (such as containment) and institutional controls, as appropriate, for treatment residuals and untreated waste.</P> <P>(D) EPA expects to use institutional controls such as water use and deed restrictions to supplement engineering controls as appropriate for short- and long-term management to prevent or limit exposure to hazardous substances, pollutants, or contaminants. Institutional controls may be used during the conduct of the remedial investigation/feasibility study (RI/FS) and implementation of the remedial action and, where necessary, as a component of the completed remedy. The use of institutional controls shall not substitute for active response measures (e.g., treatment and/or containment of source material, restoration of ground waters to their beneficial uses) as the sole remedy unless such active measures are determined not to be practicable, based on the balancing of trade-offs among alternatives that is conducted during the selection of remedy.</P> <P>(E) EPA expects to consider using innovative technology when such technology offers the potential for comparable or superior treatment performance or implementability, fewer or lesser adverse impacts than other available approaches, or lower costs for similar levels of performance than demonstrated technologies.</P> <P>(F) EPA expects to return usable ground waters to their beneficial uses wherever practicable, within a timeframe that is reasonable given the particular circumstances of the site. When restoration of ground water to beneficial uses is not practicable, EPA expects to prevent further migration of the plume, prevent exposure to the contaminated ground water, and evaluate further risk reduction.</P> <P> (2) <E T="03">Remedial investigation/feasibility study.</E> The purpose of the remedial investigation/feasibility study (RI/FS) is to assess site conditions and evaluate alternatives to the extent necessary to select a remedy. Developing and conducting an RI/FS generally includes the following activities: project scoping, data collection, risk assessment, treatability studies, and analysis of alternatives. The scope and timing of these activities should be tailored to <PRTPAGE P="68"/> the nature and complexity of the problem and the response alternatives being considered. </P> <P> (b) <E T="03">Scoping.</E> In implementing this section, the lead agency should consider the program goal, program management principles, and expectations contained in this rule. The investigative and analytical studies should be tailored to site circumstances so that the scope and detail of the analysis is appropriate to the complexity of site problems being addressed. During scoping, the lead and support agencies shall confer to identify the optimal set and sequence of actions necessary to address site problems. Specifically, the lead agency shall: </P> <P>(1) Assemble and evaluate existing data on the site, including the results of any removal actions, remedial preliminary assessment and site inspections, and the NPL listing process.</P> <P>(2) Develop a conceptual understanding of the site based on the evaluation of existing data described in paragraph (b)(1) of this section.</P> <P>(3) Identify likely response scenarios and potentially applicable technologies and operable units that may address site problems.</P> <P>(4) Undertake limited data collection efforts or studies where this information will assist in scoping the RI/FS or accelerate response actions, and begin to identify the need for treatability studies, as appropriate.</P> <P>(5) Identify the type, quality, and quantity of the data that will be collected during the RI/FS to support decisions regarding remedial response activities.</P> <P>(6) Prepare site-specific health and safety plans that shall specify, at a minimum, employee training and protective equipment, medical surveillance requirements, standard operating procedures, and a contingency plan that conforms with 29 CFR 1910.120 (l)(1) and (l)(2).</P> <P>(7) If natural resources are or may be injured by the release, ensure that state and federal trustees of the affected natural resources have been notified in order that the trustees may initiate appropriate actions, including those identified in subpart G of this part. The lead agency shall seek to coordinate necessary assessments, evaluations, investigations, and planning with such state and federal trustees.</P> <P>(8) Develop sampling and analysis plans that shall provide a process for obtaining data of sufficient quality and quantity to satisfy data needs. Sampling and analysis plans shall be reviewed and approved by EPA. The sampling and analysis plans shall consist of two parts:</P> <P>(i) The field sampling plan, which describes the number, type, and location of samples and the type of analyses; and</P> <P>(ii) The quality assurance project plan, which describes policy, organization, and functional activities and the data quality objectives and measures necessary to achieve adequate data for use in selecting the appropriate remedy.</P> <P>(9) Initiate the identification of potential federal and state ARARs and, as appropriate, other criteria, advisories, or guidance to be considered.</P> <P> (c) <E T="03">Community relations.</E> (1) The community relations requirements described in this section apply to all remedial activities undertaken pursuant to CERCLA section 104 and to section 106 or section 122 consent orders or decrees, or section 106 administrative orders. </P> <P>(2) The lead agency shall provide for the conduct of the following community relations activities, to the extent practicable, prior to commencing field work for the remedial investigation:</P> <P>(i) Conducting interviews with local officials, community residents, public interest groups, or other interested or affected parties, as appropriate, to solicit their concerns and information needs, and to learn how and when citizens would like to be involved in the Superfund process.</P> <P>(ii) Preparing a formal community relations plan (CRP), based on the community interviews and other relevant information, specifying the community relations activities that the lead agency expects to undertake during the remedial response. The purpose of the CRP is to:</P> <P> (A) Ensure the public appropriate opportunities for involvement in a wide <PRTPAGE P="69"/> variety of site-related decisions, including site analysis and characterization, alternatives analysis, and selection of remedy; </P> <P>(B) Determine, based on community interviews, appropriate activities to ensure such public involvement, and</P> <P>(C) Provide appropriate opportunities for the community to learn about the site.</P> <P>(iii) Establishing at least one local information repository at or near the location of the response action. Each information repository should contain a copy of items made available to the public, including information that describes the technical assistance grants application process. The lead agency shall inform interested parties of the establishment of the information repository.</P> <P>(iv) Informing the community of the availability of technical assistance grants.</P> <P>(3) For PRP actions, the lead agency shall plan and implement the community relations program at a site. PRPs may participate in aspects of the community relations program at the discretion of and with oversight by the lead agency.</P> <P>(4) The lead agency may conduct technical discussions involving PRPs and the public. These technical discussions may be held separately from, but contemporaneously with, the negotiations/settlement discussions.</P> <P>(5) In addition, the following provisions specifically apply to enforcement actions:</P> <P> (i) Lead agencies entering into an enforcement agreement with de minimis parties under CERCLA section 122(g) or cost recovery settlements under section 122(h) shall publish a notice of the proposed agreement in the <E T="04">Federal Register</E> at least 30 days before the agreement becomes final, as required by section 122(i). The notice must identify the name of the facility and the parties to the proposed agreement and must allow an opportunity for comment and consideration of comments; and </P> <P>(ii) Where the enforcement agreement is embodied in a consent decree, public notice and opportunity for public comment shall be provided in accordance with 28 CFR 50.7.</P> <P> (d) <E T="03">Remedial investigation.</E> (1) The purpose of the remedial investigation (RI) is to collect data necessary to adequately characterize the site for the purpose of developing and evaluating effective remedial alternatives. To characterize the site, the lead agency shall, as appropriate, conduct field investigations, including treatability studies, and conduct a baseline risk assessment. The RI provides information to assess the risks to human health and the environment and to support the development, evaluation, and selection of appropriate response alternatives. Site characterization may be conducted in one or more phases to focus sampling efforts and increase the efficiency of the investigation. Because estimates of actual or potential exposures and associated impacts on human and environmental receptors may be refined throughout the phases of the RI as new information is obtained, site characterization activities should be fully integrated with the development and evaluation of alternatives in the feasibility study. Bench- or pilot-scale treatability studies shall be conducted, when appropriate and practicable, to provide additional data for the detailed analysis and to support engineering design of remedial alternatives. </P> <P>(2) The lead agency shall characterize the nature of and threat posed by the hazardous substances and hazardous materials and gather data necessary to assess the extent to which the release poses a threat to human health or the environment or to support the analysis and design of potential response actions by conducting, as appropriate, field investigations to assess the following factors:</P> <P>(i) Physical characteristics of the site, including important surface features, soils, geology, hydrogeology, meteorology, and ecology;</P> <P>(ii) Characteristics or classifications of air, surface water, and ground water;</P> <P>(iii) The general characteristics of the waste, including quantities, state, concentration, toxicity, propensity to bioaccumulate, persistence, and mobility;</P> <P> (iv) The extent to which the source can be adequately identified and characterized; <PRTPAGE P="70"/> </P> <P>(v) Actual and potential exposure pathways through environmental media;</P> <P>(vi) Actual and potential exposure routes, for example, inhalation and ingestion; and</P> <P>(vii) Other factors, such as sensitive populations, that pertain to the characterization of the site or support the analysis of potential remedial action alternatives.</P> <P>(3) The lead and support agency shall identify their respective potential ARARs related to the location of and contaminants at the site in a timely manner. The lead and support agencies may also, as appropriate, identify other pertinent advisories, criteria, or guidance in a timely manner (see § 300.400(g)(3)).</P> <P>(4) Using the data developed under paragraphs (d)(1) and (2) of this section, the lead agency shall conduct a site-specific baseline risk assessment to characterize the current and potential threats to human health and the environment that may be posed by contaminants migrating to ground water or surface water, releasing to air, leaching through soil, remaining in the soil, and bioaccumulating in the food chain. The results of the baseline risk assessment will help establish acceptable exposure levels for use in developing remedial alternatives in the FS, as described in paragraph (e) of this section.</P> <P> (e) <E T="03">Feasibility study.</E> (1) The primary objective of the feasibility study (FS) is to ensure that appropriate remedial alternatives are developed and evaluated such that relevant information concerning the remedial action options can be presented to a decision-maker and an appropriate remedy selected. The lead agency may develop a feasibility study to address a specific site problem or the entire site. The development and evaluation of alternatives shall reflect the scope and complexity of the remedial action under consideration and the site problems being addressed. Development of alternatives shall be fully integrated with the site characterization activities of the remedial investigation described in paragraph (d) of this section. The lead agency shall include an alternatives screening step, when needed, to select a reasonable number of alternatives for detailed analysis. </P> <P>(2) Alternatives shall be developed that protect human health and the environment by recycling waste or by eliminating, reducing, and/or controlling risks posed through each pathway by a site. The number and type of alternatives to be analyzed shall be determined at each site, taking into account the scope, characteristics, and complexity of the site problem that is being addressed. In developing and, as appropriate, screening the alternatives, the lead agency shall:</P> <P>(i) Establish remedial action objectives specifying contaminants and media of concern, potential exposure pathways, and remediation goals. Initially, preliminary remediation goals are developed based on readily available information, such as chemical-specific ARARs or other reliable information. Preliminary remediation goals should be modified, as necessary, as more information becomes available during the RI/FS. Final remediation goals will be determined when the remedy is selected. Remediation goals shall establish acceptable exposure levels that are protective of human health and the environment and shall be developed by considering the following:</P> <P>(A) Applicable or relevant and appropriate requirements under federal environmental or state environmental or facility siting laws, if available, and the following factors:</P> <P> ( <E T="03">1</E> ) For systemic toxicants, acceptable exposure levels shall represent concentration levels to which the human population, including sensitive subgroups, may be exposed without adverse effect during a lifetime or part of a lifetime, incorporating an adequate margin of safety; </P> <P> ( <E T="03">2</E> ) For known or suspected carcinogens, acceptable exposure levels are generally concentration levels that represent an excess upper bound lifetime cancer risk to an individual of between 10 <E T="51">−4</E> and 10 <E T="51">−6</E> using information on the relationship between dose and response. The 10 <E T="51">−6</E> risk level shall be used as the point of departure for determining remediation goals for alternatives when ARARs are not available <PRTPAGE P="71"/> or are not sufficiently protective because of the presence of multiple contaminants at a site or multiple pathways of exposure; </P> <P> ( <E T="03">3</E> ) Factors related to technical limitations such as detection/quantification limits for contaminants; </P> <P> ( <E T="03">4</E> ) Factors related to uncertainty; and </P> <P> ( <E T="03">5</E> ) Other pertinent information. </P> <P>(B) Maximum contaminant level goals (MCLGs), established under the Safe Drinking Water Act, that are set at levels above zero, shall be attained by remedial actions for ground or surface waters that are current or potential sources of drinking water, where the MCLGs are relevant and appropriate under the circumstances of the release based on the factors in § 300.400(g)(2). If an MCLG is determined not to be relevant and appropriate, the corresponding maximum contaminant level (MCL) shall be attained where relevant and appropriate to the circumstances of the release.</P> <P>(C) Where the MCLG for a contaminant has been set at a level of zero, the MCL promulgated for that contaminant under the Safe Drinking Water Act shall be attained by remedial actions for ground or surface waters that are current or potential sources of drinking water, where the MCL is relevant and appropriate under the circumstances of the release based on the factors in § 300.400(g)(2).</P> <P> (D) In cases involving multiple contaminants or pathways where attainment of chemical-specific ARARs will result in cumulative risk in excess of 10 <E T="51">−4</E> , criteria in paragraph (e)(2)(i)(A) of this section may also be considered when determining the cleanup level to be attained. </P> <P>(E) Water quality criteria established under sections 303 or 304 of the Clean Water Act shall be attained where relevant and appropriate under the circumstances of the release.</P> <P>(F) An alternate concentration limit (ACL) may be established in accordance with CERCLA section 121(d)(2)(B)(ii).</P> <P>(G) Environmental evaluations shall be performed to assess threats to the environment, especially sensitive habitats and critical habitats of species protected under the Endangered Species Act.</P> <P>(ii) Identify and evaluate potentially suitable technologies, including innovative technologies;</P> <P>(iii) Assemble suitable technologies into alternative remedial actions.</P> <P>(3) For source control actions, the lead agency shall develop, as appropriate:</P> <P>(i) A range of alternatives in which treatment that reduces the toxicity, mobility, or volume of the hazardous substances, pollutants, or contaminants is a principal element. As appropriate, this range shall include an alternative that removes or destroys hazardous substances, pollutants, or contaminants to the maximum extent feasible, eliminating or minimizing, to the degree possible, the need for long-term management. The lead agency also shall develop, as appropriate, other alternatives which, at a minimum, treat the principal threats posed by the site but vary in the degree of treatment employed and the quantities and characteristics of the treatment residuals and untreated waste that must be managed; and</P> <P>(ii) One or more alternatives that involve little or no treatment, but provide protection of human health and the environment primarily by preventing or controlling exposure to hazardous substances, pollutants, or contaminants, through engineering controls, for example, containment, and, as necessary, institutional controls to protect human health and the environment and to assure continued effectiveness of the response action.</P> <P>(4) For ground-water response actions, the lead agency shall develop a limited number of remedial alternatives that attain site-specific remediation levels within different restoration time periods utilizing one or more different technologies.</P> <P> (5) The lead agency shall develop one or more innovative treatment technologies for further consideration if those technologies offer the potential for comparable or superior performance or implementability; fewer or lesser adverse impacts than other available approaches; or lower costs for similar levels of performance than demonstrated treatment technologies. <PRTPAGE P="72"/> </P> <P>(6) The no-action alternative, which may be no further action if some removal or remedial action has already occurred at the site, shall be developed.</P> <P>(7) As appropriate, and to the extent sufficient information is available, the short- and long-term aspects of the following three criteria shall be used to guide the development and screening of remedial alternatives:</P> <P> (i) <E T="03">Effectiveness.</E> This criterion focuses on the degree to which an alternative reduces toxicity, mobility, or volume through treatment, minimizes residual risks and affords long-term protection, complies with ARARs, minimizes short-term impacts, and how quickly it achieves protection. Alternatives providing significantly less effectiveness than other, more promising alternatives may be eliminated. Alternatives that do not provide adequate protection of human health and the environment shall be eliminated from further consideration. </P> <P> (ii) <E T="03">Implementability.</E> This criterion focuses on the technical feasibility and availability of the technologies each alternative would employ and the administrative feasibility of implementing the alternative. Alternatives that are technically or administratively infeasible or that would require equipment, specialists, or facilities that are not available within a reasonable period of time may be eliminated from further consideration. </P> <P> (iii) <E T="03">Cost.</E> The costs of construction and any long-term costs to operate and maintain the alternatives shall be considered. Costs that are grossly excessive compared to the overall effectiveness of alternatives may be considered as one of several factors used to eliminate alternatives. Alternatives providing effectiveness and implementability similar to that of another alternative by employing a similar method of treatment or engineering control, but at greater cost, may be eliminated. </P> <P>(8) The lead agency shall notify the support agency of the alternatives that will be evaluated in detail to facilitate the identification of ARARs and, as appropriate, pertinent advisories, criteria, or guidance to be considered.</P> <P> (9) <E T="03">Detailed analysis of alternatives.</E> (i) A detailed analysis shall be conducted on the limited number of alternatives that represent viable approaches to remedial action after evaluation in the screening stage. The lead and support agencies must identify their ARARs related to specific actions in a timely manner and no later than the early stages of the comparative analysis. The lead and support agencies may also, as appropriate, identify other pertinent advisories, criteria, or guidance in a timely manner. </P> <P>(ii) The detailed analysis consists of an assessment of individual alternatives against each of nine evaluation criteria and a comparative analysis that focuses upon the relative performance of each alternative against those criteria.</P> <P> (iii) <E T="03">Nine criteria for evaluation.</E> The analysis of alternatives under review shall reflect the scope and complexity of site problems and alternatives being evaluated and consider the relative significance of the factors within each criteria. The nine evaluation criteria are as follows: </P> <P> (A) <E T="03">Overall protection of human health and the environment.</E> Alternatives shall be assessed to determine whether they can adequately protect human health and the environment, in both the short- and long-term, from unacceptable risks posed by hazardous substances, pollutants, or contaminants present at the site by eliminating, reducing, or controlling exposures to levels established during development of remediation goals consistent with § 300.430(e)(2)(i). Overall protection of human health and the environment draws on the assessments of other evaluation criteria, especially long-term effectiveness and permanence, short-term effectiveness, and compliance with ARARs. </P> <P> (B) <E T="03">Compliance with ARARs.</E> The alternatives shall be assessed to determine whether they attain applicable or relevant and appropriate requirements under federal environmental laws and state environmental or facility siting laws or provide grounds for invoking one of the waivers under paragraph (f)(1)(ii)(C) of this section. </P> <P> (C) <E T="03">Long-term effectiveness and permanence.</E> Alternatives shall be assessed for the long-term effectiveness and permanence they afford, along with the <PRTPAGE P="73"/> degree of certainty that the alternative will prove successful. Factors that shall be considered, as appropriate, include the following: </P> <P> ( <E T="03">1</E> ) Magnitude of residual risk remaining from untreated waste or treatment residuals remaining at the conclusion of the remedial activities. The characteristics of the residuals should be considered to the degree that they remain hazardous, taking into account their volume, toxicity, mobility, and propensity to bioaccumulate. </P> <P> ( <E T="03">2</E> ) Adequacy and reliability of controls such as containment systems and institutional controls that are necessary to manage treatment residuals and untreated waste. This factor addresses in particular the uncertainties associated with land disposal for providing long-term protection from residuals; the assessment of the potential need to replace technical components of the alternative, such as a cap, a slurry wall, or a treatment system; and the potential exposure pathways and risks posed should the remedial action need replacement. </P> <P> (D) <E T="03">Reduction of toxicity, mobility, or volume through treatment.</E> The degree to which alternatives employ recycling or treatment that reduces toxicity, mobility, or volume shall be assessed, including how treatment is used to address the principal threats posed by the site. Factors that shall be considered, as appropriate, include the following: </P> <P> ( <E T="03">1</E> ) The treatment or recycling processes the alternatives employ and materials they will treat; </P> <P> ( <E T="03">2</E> ) The amount of hazardous substances, pollutants, or contaminants that will be destroyed, treated, or recycled; </P> <P> ( <E T="03">3</E> ) The degree of expected reduction in toxicity, mobility, or volume of the waste due to treatment or recycling and the specification of which reduction(s) are occurring; </P> <P> ( <E T="03">4</E> ) The degree to which the treatment is irreversible; </P> <P> ( <E T="03">5</E> ) The type and quantity of residuals that will remain following treatment, considering the persistence, toxicity, mobility, and propensity to bioaccumulate of such hazardous substances and their constituents; and </P> <P> ( <E T="03">6</E> ) The degree to which treatment reduces the inherent hazards posed by principal threats at the site. </P> <P> (E) <E T="03">Short-term effectiveness.</E> The short-term impacts of alternatives shall be assessed considering the following: </P> <P> ( <E T="03">1</E> ) Short-term risks that might be posed to the community during implementation of an alternative; </P> <P> ( <E T="03">2</E> ) Potential impacts on workers during remedial action and the effectiveness and reliability of protective measures; </P> <P> ( <E T="03">3</E> ) Potential environmental impacts of the remedial action and the effectiveness and reliability of mitigative measures during implementation; and </P> <P> ( <E T="03">4</E> ) Time until protection is achieved. </P> <P> (F) <E T="03">Implementability.</E> The ease or difficulty of implementing the alternatives shall be assessed by considering the following types of factors as appropriate: </P> <P> ( <E T="03">1</E> ) Technical feasibility, including technical difficulties and unknowns associated with the construction and operation of a technology, the reliability of the technology, ease of undertaking additional remedial actions, and the ability to monitor the effectiveness of the remedy. </P> <P> ( <E T="03">2</E> ) Administrative feasibility, including activities needed to coordinate with other offices and agencies and the ability and time required to obtain any necessary approvals and permits from other agencies (for off-site actions); </P> <P> ( <E T="03">3</E> ) Availability of services and materials, including the availability of adequate off-site treatment, storage capacity, and disposal capacity and services; the availability of necessary equipment and specialists, and provisions to ensure any necessary additional resources; the availability of services and materials; and availability of prospective technologies. </P> <P> (G) <E T="03">Cost.</E> The types of costs that shall be assessed include the following: </P> <P> ( <E T="03">1</E> ) Capital costs, including both direct and indirect costs; </P> <P> ( <E T="03">2</E> ) Annual operation and maintenance costs; and </P> <P> ( <E T="03">3</E> ) Net present value of capital and O&M costs. </P> <P> (H) <E T="03">State acceptance.</E> Assessment of state concerns may not be completed <PRTPAGE P="74"/> until comments on the RI/FS are received but may be discussed, to the extent possible, in the proposed plan issued for public comment. The state concerns that shall be assessed include the following: </P> <P> ( <E T="03">1</E> ) The state's position and key concerns related to the preferred alternative and other alternatives; and </P> <P> ( <E T="03">2</E> ) State comments on ARARs or the proposed use of waivers. </P> <P> (I) <E T="03">Community acceptance.</E> This assessment includes determining which components of the alternatives interested persons in the community support, have reservations about, or oppose. This assessment may not be completed until comments on the proposed plan are received. </P> <P> (f) <E T="03">Selection of remedy</E> —(1) Remedies selected shall reflect the scope and purpose of the actions being undertaken and how the action relates to long-term, comprehensive response at the site. </P> <P>(i) The criteria noted in paragraph (e)(9)(iii) of this section are used to select a remedy. These criteria are categorized into three groups.</P> <P> (A) <E T="03">Threshold criteria.</E> Overall protection of human health and the environment and compliance with ARARs (unless a specific ARAR is waived) are threshold requirements that each alternative must meet in order to be eligible for selection. </P> <P> (B) <E T="03">Primary balancing criteria.</E> The five primary balancing criteria are long-term effectiveness and permanence; reduction of toxicity, mobility, or volume through treatment; short-term effectiveness; implementability; and cost. </P> <P> (C) <E T="03">Modifying criteria.</E> State and community acceptance are modifying criteria that shall be considered in remedy selection. </P> <P>(ii) The selection of a remedial action is a two-step process and shall proceed in accordance with § 300.515(e). First, the lead agency, in conjunction with the support agency, identifies a preferred alternative and presents it to the public in a proposed plan, for review and comment. Second, the lead agency shall review the public comments and consult with the state (or support agency) in order to determine if the alternative remains the most appropriate remedial action for the site or site problem. The lead agency, as specified in § 300.515(e), makes the final remedy selection decision, which shall be documented in the ROD. Each remedial alternative selected as a Superfund remedy will employ the criteria as indicated in paragraph (f)(1)(i) of this section to make the following determination:</P> <P>(A) Each remedial action selected shall be protective of human health and the environment.</P> <P>(B) On-site remedial actions selected in a ROD must attain those ARARs that are identified at the time of ROD signature or provide grounds for invoking a waiver under § 300.430(f)(1)(ii)(C).</P> <P> ( <E T="03">1</E> ) Requirements that are promulgated or modified after ROD signature must be attained (or waived) only when determined to be applicable or relevant and appropriate and necessary to ensure that the remedy is protective of human health and the environment. </P> <P> ( <E T="03">2</E> ) Components of the remedy not described in the ROD must attain (or waive) requirements that are identified as applicable or relevant and appropriate at the time the amendment to the ROD or the explanation of significant difference describing the component is signed. </P> <P>(C) An alternative that does not meet an ARAR under federal environmental or state environmental or facility siting laws may be selected under the following circumstances:</P> <P> ( <E T="03">1</E> ) The alternative is an interim measure and will become part of a total remedial action that will attain the applicable or relevant and appropriate federal or state requirement; </P> <P> ( <E T="03">2</E> ) Compliance with the requirement will result in greater risk to human health and the environment than other alternatives; </P> <P> ( <E T="03">3</E> ) Compliance with the requirement is technically impracticable from an engineering perspective; </P> <P> ( <E T="03">4</E> ) The alternative will attain a standard of performance that is equivalent to that required under the otherwise applicable standard, requirement, or limitation through use of another method or approach; </P> <P> ( <E T="03">5</E> ) With respect to a state requirement, the state has not consistently applied, or demonstrated the intention <PRTPAGE P="75"/> to consistently apply, the promulgated requirement in similar circumstances at other remedial actions within the state; or </P> <P> ( <E T="03">6</E> ) For Fund-financed response actions only, an alternative that attains the ARAR will not provide a balance between the need for protection of human health and the environment at the site and the availability of Fund monies to respond to other sites that may present a threat to human health and the environment. </P> <P>(D) Each remedial action selected shall be cost-effective, provided that it first satisfies the threshold criteria set forth in § 300.430(f)(1)(ii)(A) and (B). Cost-effectiveness is determined by evaluating the following three of the five balancing criteria noted in § 300.430(f)(1)(i)(B) to determine overall effectiveness: long-term effectiveness and permanence, reduction of toxicity, mobility, or volume through treatment, and short-term effectiveness. Overall effectiveness is then compared to cost to ensure that the remedy is cost-effective. A remedy shall be cost-effective if its costs are proportional to its overall effectiveness.</P> <P>(E) Each remedial action shall utilize permanent solutions and alternative treatment technologies or resource recovery technologies to the maximum extent practicable. This requirement shall be fulfilled by selecting the alternative that satisfies paragraph (f)(1)(ii)(A) and (B) of this section and provides the best balance of trade-offs among alternatives in terms of the five primary balancing criteria noted in paragraph (f)(1)(i)(B) of this section. The balancing shall emphasize long-term effectiveness and reduction of toxicity, mobility, or volume through treatment. The balancing shall also consider the preference for treatment as a principal element and the bias against off-site land disposal of untreated waste. In making the determination under this paragraph, the modifying criteria of state acceptance and community acceptance described in paragraph (f)(1)(i)(C) of this section shall also be considered.</P> <P> (2) <E T="03">The proposed plan.</E> In the first step in the remedy selection process, the lead agency shall identify the alternative that best meets the requirements in § 300.430(f)(1), above, and shall present that alternative to the public in a proposed plan. The lead agency, in conjunction with the support agency and consistent with § 300.515(e), shall prepare a proposed plan that briefly describes the remedial alternatives analyzed by the lead agency, proposes a preferred remedial action alternative, and summarizes the information relied upon to select the preferred alternative. The selection of remedy process for an operable unit may be initiated at any time during the remedial action process. The purpose of the proposed plan is to supplement the RI/FS and provide the public with a reasonable opportunity to comment on the preferred alternative for remedial action, as well as alternative plans under consideration, and to participate in the selection of remedial action at a site. At a minimum, the proposed plan shall: </P> <P>(i) Provide a brief summary description of the remedial alternatives evaluated in the detailed analysis established under paragraph (e)(9) of this section;</P> <P>(ii) Identify and provide a discussion of the rationale that supports the preferred alternative;</P> <P>(iii) Provide a summary of any formal comments received from the support agency; and</P> <P>(iv) Provide a summary explanation of any proposed waiver identified under paragraph (f)(1)(ii)(C) of this section from an ARAR.</P> <P> (3) <E T="03">Community relations to support the selection of remedy.</E> (i) The lead agency, after preparation of the proposed plan and review by the support agency, shall conduct the following activities: </P> <P>(A) Publish a notice of availability and brief analysis of the proposed plan in a major local newspaper of general circulation;</P> <P>(B) Make the proposed plan and supporting analysis and information available in the administrative record required under subpart I of this part;</P> <P> (C) Provide a reasonable opportunity, not less than 30 calendar days, for submission of written and oral comments on the proposed plan and the supporting analysis and information located in the information repository, including the RI/FS. Upon timely request, the lead agency will extend the <PRTPAGE P="76"/> public comment period by a minimum of 30 additional days; </P> <P>(D) Provide the opportunity for a public meeting to be held during the public comment period at or near the site at issue regarding the proposed plan and the supporting analysis and information;</P> <P>(E) Keep a transcript of the public meeting held during the public comment period pursuant to CERCLA section 117(a) and make such transcript available to the public; and</P> <P>(F) Prepare a written summary of significant comments, criticisms, and new relevant information submitted during the public comment period and the lead agency response to each issue. This responsiveness summary shall be made available with the record of decision.</P> <P>(ii) After publication of the proposed plan and prior to adoption of the selected remedy in the record of decision, if new information is made available that significantly changes the basic features of the remedy with respect to scope, performance, or cost, such that the remedy significantly differs from the original proposal in the proposed plan and the supporting analysis and information, the lead agency shall:</P> <P>(A) Include a discussion in the record of decision of the significant changes and reasons for such changes, if the lead agency determines such changes could be reasonably anticipated by the public based on the alternatives and other information available in the proposed plan or the supporting analysis and information in the administrative record; or</P> <P>(B) Seek additional public comment on a revised proposed plan, when the lead agency determines the change could not have been reasonably anticipated by the public based on the information available in the proposed plan or the supporting analysis and information in the administrative record. The lead agency shall, prior to adoption of the selected remedy in the ROD, issue a revised proposed plan, which shall include a discussion of the significant changes and the reasons for such changes, in accordance with the public participation requirements described in paragraph (f)(3)(i) of this section.</P> <P> (4) <E T="03">Final remedy selection.</E> (i) In the second and final step in the remedy selection process, the lead agency shall reassess its initial determination that the preferred alternative provides the best balance of trade-offs, now factoring in any new information or points of view expressed by the state (or support agency) and community during the public comment period. The lead agency shall consider state (or support agency) and community comments regarding the lead agency's evaluation of alternatives with respect to the other criteria. These comments may prompt the lead agency to modify aspects of the preferred alternative or decide that another alternative provides a more appropriate balance. The lead agency, as specified in § 300.515(e), shall make the final remedy selection decision and document that decision in the ROD. </P> <P>(ii) If a remedial action is selected that results in hazardous substances, pollutants, or contaminants remaining at the site above levels that allow for unlimited use and unrestricted exposure, the lead agency shall review such action no less often than every five years after initiation of the selected remedial action.</P> <P>(iii) The process for selection of a remedial action at a federal facility on the NPL, pursuant to CERCLA section 120, shall entail:</P> <P>(A) Joint selection of remedial action by the head of the relevant department, agency, or instrumentality and EPA; or</P> <P>(B) If mutual agreement on the remedy is not reached, selection of the remedy is made by EPA.</P> <P> (5) <E T="03">Documenting the decision.</E> (i) To support the selection of a remedial action, all facts, analyses of facts, and site-specific policy determinations considered in the course of carrying out activities in this section shall be documented, as appropriate, in a record of decision, in a level of detail appropriate to the site situation, for inclusion in the administrative record required under subpart I of this part. Documentation shall explain how the evaluation criteria in paragraph (e)(9)(iii) of this section were used to select the remedy. <PRTPAGE P="77"/> </P> <P>(ii) The ROD shall describe the following statutory requirements as they relate to the scope and objectives of the action:</P> <P>(A) How the selected remedy is protective of human health and the environment, explaining how the remedy eliminates, reduces, or controls exposures to human and environmental receptors;</P> <P>(B) The federal and state requirements that are applicable or relevant and appropriate to the site that the remedy will attain;</P> <P>(C) The applicable or relevant and appropriate requirements of other federal and state laws that the remedy will not meet, the waiver invoked, and the justification for invoking the waiver;</P> <P> (D) How the remedy is cost-effective, <E T="03">i.e.</E> , explaining how the remedy provides overall effectiveness proportional to its costs; </P> <P>(E) How the remedy utilizes permanent solutions and alternative treatment technologies or resource recovery technologies to the maximum extent practicable; and</P> <P>(F) Whether the preference for remedies employing treatment which permanently and significantly reduces the toxicity, mobility, or volume of the hazardous substances, pollutants, or contaminants as a principal element is or is not satisfied by the selected remedy. If this preference is not satisfied, the record of decision must explain why a remedial action involving such reductions in toxicity, mobility, or volume was not selected.</P> <P>(iii) The ROD also shall:</P> <P>(A) Indicate, as appropriate, the remediation goals, discussed in paragraph (e)(2)(i) of this section, that the remedy is expected to achieve. Performance shall be measured at appropriate locations in the ground water, surface water, soils, air, and other affected environmental media. Measurement relating to the performance of the treatment processes and the engineering controls may also be identified, as appropriate;</P> <P>(B) Discuss significant changes and the response to comments described in paragraph (f)(3)(i)(F) of this section;</P> <P>(C) Describe whether hazardous substances, pollutants, or contaminants will remain at the site such that a review of the remedial action under paragraph (f)(4)(ii) of this section no less often than every five years shall be required; and</P> <P>(D) When appropriate, provide a commitment for further analysis and selection of long-term response measures within an appropriate time-frame.</P> <P> (6) <E T="03">Community relations when the record of decision is signed.</E> After the ROD is signed, the lead agency shall: </P> <P>(i) Publish a notice of the availability of the ROD in a major local newspaper of general circulation; and</P> <P>(ii) Make the record of decision available for public inspection and copying at or near the facility at issue prior to the commencement of any remedial action.</P> </SECTION> <SECTION> <SECTNO>§ 300.435</SECTNO> <SUBJECT>Remedial design/remedial action, operation and maintenance.</SUBJECT> <P> (a) <E T="03">General.</E> The remedial design/remedial action (RD/RA) stage includes the development of the actual design of the selected remedy and implementation of the remedy through construction. A period of operation and maintenance may follow the RA activities. </P> <P> (b) <E T="03">RD/RA activities.</E> (1) All RD/RA activities shall be in conformance with the remedy selected and set forth in the ROD or other decision document for that site. Those portions of RD/RA sampling and analysis plans describing the QA/QC requirements for chemical and analytical testing and sampling procedures of samples taken for the purpose of determining whether cleanup action levels specified in the ROD are achieved, generally will be consistent with the requirements of § 300.430(b)(8). </P> <P>(2) During the course of the RD/RA, the lead agency shall be responsible for ensuring that all federal and state requirements that are identified in the ROD as applicable or relevant and appropriate requirements for the action are met. If waivers from any ARARs are involved, the lead agency shall be responsible for ensuring that the conditions of the waivers are met.</P> <P> (c) <E T="03">Community relations.</E> (1) Prior to the initiation of RD, the lead agency shall review the CRP to determine whether it should be revised to describe further public involvement activities <PRTPAGE P="78"/> during RD/RA that are not already addressed or provided for in the CRP. </P> <P>(2) After the adoption of the ROD, if the remedial action or enforcement action taken, or the settlement or consent decree entered into, differs significantly from the remedy selected in the ROD with respect to scope, performance, or cost, the lead agency shall consult with the support agency, as appropriate, and shall either:</P> <P>(i) Publish an explanation of significant differences when the differences in the remedial or enforcement action, settlement, or consent decree significantly change but do not fundamentally alter the remedy selected in the ROD with respect to scope, performance, or cost. To issue an explanation of significant differences, the lead agency shall:</P> <P>(A) Make the explanation of significant differences and supporting information available to the public in the administrative record established under § 300.815 and the information repository; and</P> <P>(B) Publish a notice that briefly summarizes the explanation of significant differences, including the reasons for such differences, in a major local newspaper of general circulation; or</P> <P>(ii) Propose an amendment to the ROD if the differences in the remedial or enforcement action, settlement, or consent decree fundamentally alter the basic features of the selected remedy with respect to scope, performance, or cost. To amend the ROD, the lead agency, in conjunction with the support agency, as provided in § 300.515(e), shall:</P> <P>(A) Issue a notice of availability and brief description of the proposed amendment to the ROD in a major local newspaper of general circulation;</P> <P>(B) Make the proposed amendment to the ROD and information supporting the decision available for public comment;</P> <P>(C) Provide a reasonable opportunity, not less than 30 calendar days, for submission of written or oral comments on the amendment to the ROD. Upon timely request, the lead agency will extend the public comment period by a minimum of 30 additional days;</P> <P>(D) Provide the opportunity for a public meeting to be held during the public comment period at or near the facility at issue;</P> <P>(E) Keep a transcript of comments received at the public meeting held during the public comment period;</P> <P>(F) Include in the amended ROD a brief explanation of the amendment and the response to each of the significant comments, criticisms, and new relevant information submitted during the public comment period;</P> <P>(G) Publish a notice of the availability of the amended ROD in a major local newspaper of general circulation; and</P> <P>(H) Make the amended ROD and supporting information available to the public in the administrative record and information repository prior to the commencement of the remedial action affected by the amendment.</P> <P>(3) After the completion of the final engineering design, the lead agency shall issue a fact sheet and provide, as appropriate, a public briefing prior to the initiation of the remedial action.</P> <P> (d) <E T="03">Contractor conflict of interest.</E> (1) For Fund-financed RD/RA and O&M activities, the lead agency shall: </P> <P>(i) Include appropriate language in the solicitation requiring potential prime contractors to submit information on their status, as well as the status of their subcontractors, parent companies, and affiliates, as potentially responsible parties at the site.</P> <P>(ii) Require potential prime contractors to certify that, to the best of their knowledge, they and their potential subcontractors, parent companies, and affiliates have disclosed all information described in § 300.435(d)(1)(i) or that no such information exists, and that any such information discovered after submission of their bid or proposal or contract award will be disclosed immediately.</P> <P>(2) Prior to contract award, the lead agency shall evaluate the information provided by the potential prime contractors and:</P> <P>(i) Determine whether they have conflicts of interest that could significantly impact the performance of the contract or the liability of potential prime contractors or subcontractors.</P> <P> (ii) If a potential prime contractor or subcontractor has a conflict of interest <PRTPAGE P="79"/> that cannot be avoided or otherwise resolved, and using that potential prime contractor or subcontractor to conduct RD/RA or O&M work under a Fund-financed action would not be in the best interests of the state or federal government, an offeror or bidder contemplating use of that prime contractor or subcontractor may be declared nonresponsible or ineligible for award in accordance with appropriate acquisition regulations, and the contract may be awarded to the next eligible offeror or bidder. </P> <P> (e) <E T="03">Recontracting.</E> (1) If a Fund-financed contract must be terminated because additional work outside the scope of the contract is needed, EPA is authorized to take appropriate steps to continue interim RAs as necessary to reduce risks to public health and the environment. Appropriate steps may include extending an existing contract for a federal-lead RA or amending a cooperative agreement for a state-lead RA. Until the lead agency can reopen the bidding process and recontract to complete the RA, EPA may take such appropriate steps as described above to cover interim work to reduce such risks, where: </P> <P>(i) Additional work is found to be needed as a result of such unforeseen situations as newly discovered sources, types, or quantities of hazardous substances at a facility; and</P> <P>(ii) Performance of the complete RA requires the lead agency to rebid the contract because the existing contract does not encompass this newly discovered work.</P> <P>(2) The cost of such interim actions shall not exceed $2 million.</P> <P> (f) <E T="03">Operation and maintenance.</E> (1) Operation and maintenance (O&M) measures are initiated after the remedy has achieved the remedial action objectives and remediation goals in the ROD, and is determined to be operational and functional, except for ground- or surface-water restoration actions covered under § 300.435(f)(4). A state must provide its assurance to assume responsibility for O&M, including, where appropriate, requirements for maintaining institutional controls, under § 300.510(c). </P> <P>(2) A remedy becomes “operational and functional” either one year after construction is complete, or when the remedy is determined concurrently by EPA and the state to be functioning properly and is performing as designed, whichever is earlier. EPA may grant extensions to the one-year period, as appropriate.</P> <P>(3) For Fund-financed remedial actions involving treatment or other measures to restore ground- or surface-water quality to a level that assures protection of human health and the environment, the operation of such treatment or other measures for a period of up to 10 years after the remedy becomes operational and functional will be considered part of the remedial action. Activities required to maintain the effectiveness of such treatment or measures following the 10-year period, or after remedial action is complete, whichever is earlier, shall be considered O&M. For the purposes of federal funding provided under CERCLA section 104(c)(6), a restoration activity will be considered administratively “complete” when:</P> <P>(i) Measures restore ground- or surface-water quality to a level that assures protection of human health and the environment;</P> <P>(ii) Measures restore ground or surface water to such a point that reductions in contaminant concentrations are no longer significant; or</P> <P>(iii) Ten years have elapsed, whichever is earliest.</P> <P>(4) The following shall not be deemed to constitute treatment or other measures to restore contaminated ground or surface water under § 300.435(f)(3):</P> <P>(i) Source control maintenance measures; and</P> <P>(ii) Ground- or surface-water measures initiated for the primary purpose of providing a drinking-water supply, not for the purpose of restoring ground water.</P> </SECTION> <SECTION> <SECTNO>§ 300.440</SECTNO> <SUBJECT>Procedures for planning and implementing off-site response actions.</SUBJECT> <P> (a) <E T="03">Applicability.</E> (1) This section applies to any remedial or removal action involving the off-site transfer of any hazardous substance, pollutant, or contaminant as defined under CERCLA sections 101 (14) and (33) (“CERCLA waste”) that is conducted by EPA, <PRTPAGE P="80"/> States, private parties, or other Federal agencies, that is Fund-financed and/or is taken pursuant to any CERCLA authority, including cleanups at Federal facilities under section 120 of CERCLA, and cleanups under section 311 of the Clean Water Act (except for cleanup of petroleum exempt under CERCLA). Applicability extends to those actions taken jointly under CERCLA and another authority. </P> <P>(2) In cases of emergency removal actions under CERCLA, emergency actions taken during remedial actions, or response actions under section 311 of the Clean Water Act where the release poses an immediate and significant threat to human health and the environment, the On-Scene Coordinator (OSC) may determine that it is necessary to transfer CERCLA waste off-site without following the requirements of this section.</P> <P>(3) This section applies to CERCLA wastes from cleanup actions based on CERCLA decision documents signed or consent decrees lodged after October 17, 1986 (“post-SARA CERCLA wastes”) as well as those based on CERCLA decision documents signed and consent decrees lodged prior to October 17, 1986 (“pre-SARA CERCLA wastes”). Pre-SARA and post-SARA CERCLA wastes are subject to the same acceptability criteria in § 300.440(b)(1) and (2).</P> <P>(4) EPA (usually the EPA Regional Office) will determine the acceptability under this section of any facility selected for the treatment, storage, or disposal of CERCLA waste. EPA will determine if there are relevant releases or relevant violations at a facility prior to the facility's initial receipt of CERCLA waste. A facility which has previously been evaluated and found acceptable under this rule (or the preceding policy) is acceptable until the EPA Regional Office notifies the facility otherwise pursuant to § 300.440(d).</P> <P>(5) Off-site transfers of those laboratory samples and treatability study CERCLA wastes from CERCLA sites set out in paragraphs (a)(5)(i) through (iii) of this section, are not subject to the requirements of this section. However, those CERCLA wastes may not be transferred back to the CERCLA site unless the Remedial Project Manager or OSC assures the proper management of the CERCLA waste samples or residues and gives permission to the laboratory or treatment facility for the samples and/or residues to be returned to the site.</P> <P>(i) Samples of CERCLA wastes sent to a laboratory for characterization;</P> <P>(ii) RCRA hazardous wastes that are being transferred from a CERCLA site for treatability studies and that meet the requirements for an exemption for RCRA under 40 CFR 261.4(e); and</P> <P>(iii) Non-RCRA wastes that are being transferred from a CERCLA site for treatability studies and that are below the quantity threshold established at 40 CFR 261.4(e)(2).</P> <P> (b) <E T="03">Acceptability criteria</E> —(1) <E T="03">Facility compliance.</E> (i) A facility will be deemed in compliance for the purpose of this rule if there are no relevant violations at or affecting the unit or units receiving CERCLA waste: </P> <P>(A) For treatment to standards specified in 40 CFR part 268, subpart D, including any pre-treatment or storage units used prior to treatment;</P> <P>(B) For treatment to substantially reduce its mobility, toxicity or persistence in the absence of a defined treatment standard, including any pre-treatment or storage units used prior to treatment; or</P> <P>(C) For storage or ultimate disposal of CERCLA waste not treated to the previous criteria at the same facility.</P> <P>(ii) Relevant violations include significant deviations from regulations, compliance order provisions, or permit conditions designed to: ensure that CERCLA waste is destined for and delivered to authorized facilities; prevent releases of hazardous waste, hazardous constituents, or hazardous substances to the environment; ensure early detection of such releases; or compel corrective action for releases. Criminal violations which result in indictment are also relevant violations. In addition, violations of the following requirements may be considered relevant:</P> <P>(A) Applicable subsections of sections 3004 and 3005 of RCRA or, where applicable, other Federal laws (such as the Toxic Substances Control Act and subtitle D of RCRA);</P> <P> (B) Applicable sections of State environmental laws; and <PRTPAGE P="81"/> </P> <P>(C) In addition, land disposal units at RCRA subtitle C facilities receiving RCRA hazardous waste from response actions authorized or funded under CERCLA must be in compliance with RCRA section 3004(o) minimum technology requirements. Exceptions may be made only if the unit has been granted a waiver from these requirements under 40 CFR 264.301.</P> <P> (2) <E T="03">Releases.</E> (i) Release is defined in § 300.5 of this part. Releases under this section do not include: </P> <P> (A) <E T="03">De minimis</E> releases; </P> <P>(B) Releases permitted under Federal programs or under Federal programs delegated to the States (Federally permitted releases are defined in § 300.5), except to the extent that such releases are found to pose a threat to human health and the environment; or</P> <P>(C) Releases to the air that do not exceed standards promulgated pursuant to RCRA section 3004(n), or absent such standards, or where such standards do not apply, releases to the air that do not present a threat to human health or the environment.</P> <P>(ii) Releases from units at a facility designated for off-site transfer of CERCLA waste must be addressed as follows:</P> <P> (A) <E T="03">Receiving units at RCRA subtitle C facilities.</E> CERCLA wastes may be transferred to an off-site unit regulated under subtitle C of RCRA, including a facility regulated under the permit-by-rule provisions of 40 CFR 270.60 (a), (b) or (c), only if that unit is not releasing any hazardous waste, hazardous constituent, or hazardous substance into the ground water, surface water, soil or air. </P> <P> (B) <E T="03">Other units at RCRA subtitle C land disposal facilities.</E> CERCLA wastes may not be transferred to any unit at a RCRA subtitle C land disposal facility where a non-receiving unit is releasing any hazardous waste, hazardous constituent, or hazardous substance into the ground water, surface water, soil, or air, unless that release is controlled by an enforceable agreement for corrective action under subtitle C of RCRA or other applicable Federal or State authority. For purposes of this section, a RCRA “land disposal facility” is any RCRA facility at which a land disposal unit is located, regardless of whether a land disposal unit is the receiving unit. </P> <P> (C) <E T="03">Other units at RCRA subtitle C treatment, storage, and permit-by-rule facilities.</E> CERCLA wastes may not be transferred to any unit at a RCRA subtitle C treatment, storage or permit-by-rule facility, where a release of any hazardous waste, hazardous constituent, or hazardous substance from non-receiving units poses a significant threat to public health or the environment, unless that release is controlled by an enforceable agreement for corrective action under subtitle C of RCRA or other applicable Federal or State authority. </P> <P> (D) <E T="03">All other facilities.</E> CERCLA wastes should not be transferred to any unit at an other-than-RCRA subtitle C facility if the EPA Regional Office has information indicating that an environmentally significant release of hazardous substances has occurred at that facility, unless the release is controlled by an enforceable agreement for corrective action under an applicable Federal or State authority. </P> <P>(iii) Releases are considered to be “controlled” for the purpose of this section as provided in § 300.440 (f)(3)(iv) and (f)(3)(v). A release is not considered “controlled” for the purpose of this section during the pendency of administrative or judicial challenges to corrective action requirements, unless the facility has made the requisite showing under § 300.440(e).</P> <P> (c) <E T="03">Basis for determining acceptability.</E> (1) If a State finds that a facility within its jurisdiction is operating in non-compliance with state law requirements including the requirements of any Federal program for which the State has been authorized, EPA will determine, after consulting with the State as appropriate, if the violation is relevant under the rule and if so, issue an initial determination of unacceptability. </P> <P> (2) If a State finds that releases are occurring at a facility regulated under State law or a Federal program for which the State is authorized, EPA will determine, after consulting with the State as appropriate, if the release is relevant under the rule and if so, issue an initial determination of unacceptability. <PRTPAGE P="82"/> </P> <P>(3) EPA may also issue initial determinations of unacceptability based on its own findings. EPA can undertake any inspections, data collection and/or assessments necessary. EPA will then notify with the State about the results and issue a determination notice if a relevant violation or release is found.</P> <P> (d) <E T="03">Determination of unacceptability.</E> (1) Upon initial determination by the EPA Regional Office that a facility being considered for the off-site transfer of any CERCLA waste does not meet the criteria for acceptability stated in § 300.440(b), the EPA Region shall notify the owner/operator of such facility, and the responsible agency in the State in which the facility is located, of the unacceptability finding. The notice will be sent by certified and first-class mail, return receipt requested. The certified notice, if not acknowledged by the return receipt card, should be considered to have been received by the addressee if properly sent by regular mail to the last address known to the EPA Regional Office. </P> <P>(2) The notice shall generally: state that based on available information from a RCRA Facility Assessment (RFA), inspection, or other data sources, the facility has been found not to meet the requirements of § 300.440; cite the specific acts, omissions, or conditions which form the basis of these findings; and inform the owner/operator of the procedural recourse available under this regulation.</P> <P>(3) A facility which was previously evaluated and found acceptable under this rule (or the preceding policy) may continue to receive CERCLA waste for 60 calendar days after the date of issuance of the notice, unless otherwise determined in accordance with paragraphs (d)(8) or (d)(9) of this section.</P> <P>(4) If the owner or operator of the facility in question submits a written request for an informal conference with the EPA Regional Office within 10 calendar days from the issuance of the notice, the EPA Regional Office shall provide the opportunity for such conference no later than 30 calendar days after the date of the notice, if possible, to discuss the basis for the underlying violation or release determination, and its relevance to the facility's acceptability to receive CERCLA cleanup wastes. State representatives may attend the informal conference, submit written comments prior to the informal conference, and/or request additional meetings with the EPA Region, relating to the unacceptability issue during the determination process. If no State representative is present, EPA shall notify the State of the outcome of the conference. An owner/operator may submit written comments by the 30th day after issuance of the notice, in addition to or instead of requesting an informal conference.</P> <P>(5) If the owner or operator neither requests an informal conference nor submits written comments, the facility becomes unacceptable to receive CERCLA waste on the 60th day after the notice is issued (or on such other date designated under paragraph (d)(9) of this section). The facility will remain unacceptable until such time as the EPA Regional Office notifies the owner or operator otherwise.</P> <P>(6) If an informal conference is held or written comments are received, the EPA Region shall decide whether or not the information provided is sufficient to show that the facility is operating in physical compliance with respect to the relevant violations cited in the initial notice of unacceptability, and that all relevant releases have been eliminated or controlled, as required in paragraph (b)(2) of this section, such that a determination of acceptability would be appropriate. EPA will notify the owner/operator in writing whether or not the information provided is sufficient to support a determination of acceptability. Unless EPA determines that information provided by the owner/operator and the State is sufficient to support a determination of acceptability, the facility becomes unacceptable on the 60th calendar day after issuance of the original notice of unacceptability (or other date established pursuant to paragraphs (d)(8) or (d)(9) of this section).</P> <P> (7) Within 10 days of hearing from the EPA Regional Office after the informal conference or the submittal of written comments, the owner/operator or the State may request a reconsideration of the unacceptability determination by the EPA Regional Administrator (RA). Reconsideration may be by review of <PRTPAGE P="83"/> the record, by conference, or by other means deemed appropriate by the Regional Administrator; reconsideration does not automatically stay the determination beyond the 60-day period. The owner/operator will receive notice in writing of the decision of the RA. </P> <P>(8) The EPA Regional Administrator may decide to extend the 60-day period if more time is required to review a submission. The facility owner/operator shall be notified in writing if the Regional Administrator extends the 60 days.</P> <P>(9) The EPA Regional Office may decide that a facility's unacceptability is immediately effective (or effective in less than 60 days) in extraordinary situations such as, but not limited to, emergencies at the facility or egregious violations. The EPA Region shall notify the facility owner/operator of the date of unacceptability, and may modify timeframes for comments and other procedures accordingly.</P> <P> (e) <E T="03">Unacceptability during administrative and judicial challenges of corrective action decisions.</E> For a facility with releases that are subject to a corrective action permit, order, or decree, an administrative or judicial challenge to the corrective action (or a challenge to a permit modification calling for additional corrective action) shall not be considered to be part of a corrective action “program” controlling those releases and shall not act to stay a determination of unacceptability under this rule. However, such facility may remain acceptable to receive CERCLA waste during the pendency of the appeal or litigation if: </P> <P>(1) It satisfies the EPA Regional Office that adequate interim corrective action measures will continue at the facility; or</P> <P>(2) It demonstrates to the EPA Regional Office the absence of a need to take corrective action during the short-term, interim period.</P> <FP>Either demonstration may be made during the 60-day review period in the context of the informal conference and RA reconsideration.</FP> <P> (f) <E T="03">Re-evaluating unacceptability.</E> If, after notification of unacceptability and the opportunity to confer as described in § 300.440(d), the facility remains unacceptable, the facility can regain acceptability. A facility found to be unacceptable to receive CERCLA wastes based on relevant violations or releases may regain acceptability if the following conditions are met: </P> <P> (1) <E T="03">Judgment on the merits.</E> The facility has prevailed on the merits in an administrative or judicial challenge to the finding of noncompliance or uncontrolled releases upon which the unacceptability determination was based. </P> <P> (2) <E T="03">Relevant violations.</E> The facility has demonstrated to the EPA Region its return to physical compliance for the relevant violations cited in the notice. </P> <P> (3) <E T="03">Releases.</E> The facility has demonstrated to the EPA Region that: </P> <P>(i) All releases from receiving units at RCRA subtitle C facilities have been eliminated and prior contamination from such releases is controlled by a corrective action program approved under subtitle C of RCRA;</P> <P>(ii) All releases from other units at RCRA subtitle C land disposal facilities are controlled by a corrective action program approved under subtitle C of RCRA;</P> <P>(iii) All releases from other units at RCRA subtitle C treatment and storage facilities do not pose a significant threat to human health or the environment, or are controlled by a corrective action program approved under subtitle C of RCRA.</P> <P> (iv) A RCRA subtitle C corrective action program may be incorporated into a permit, order, or decree, including the following: a corrective action order under RCRA section 3008(h), section 7003 or section 3013, a RCRA permit under 40 CFR 264.100 or 264.101, or a permit under an equivalent authority in a State authorized for corrective action under RCRA section 3004(u). Releases will be deemed controlled upon issuance of the order, permit, or decree which initiates and requires completion of one or more of the following: a RCRA Facility Investigation, a RCRA Corrective Measures Study, and/or Corrective Measures Implementation. The release remains controlled as long as the facility is in compliance with the order, permit, or decree, and enters <PRTPAGE P="84"/> into subsequent agreements for implementation of additional corrective action measures when necessary, except during periods of administrative or judicial challenges, when the facility must make a demonstration under § 300.440(e) in order to remain acceptable. </P> <P>(v) Facilities with releases regulated under other applicable Federal laws, or State laws under a Federally-delegated program may regain acceptability under this section if the releases are deemed by the EPA Regional Office not to pose a threat to human health or the environment, or if the facility enters into an enforceable agreement under those laws to conduct corrective action activities to control releases. Releases will be deemed controlled upon the issuance of an order, permit, or decree which initiates and requires one or more of the following: a facility investigation, a corrective action study, and/or corrective measures implementation. The release remains controlled as long as the facility is in compliance with the order, permit, or decree, and enters into subsequent agreements for implementation of additional corrective measures when necessary, except during periods of administrative or judicial challenges, when the facility must make a demonstration under § 300.440(e) in order to remain acceptable.</P> <P>(4) Prior to the issuance of a determination that a facility has returned to acceptability, the EPA Region shall notify the State in which the facility is located, and provide an opportunity for the State to discuss the facility's acceptability status with EPA.</P> <P>(5) An unacceptable facility may be reconsidered for acceptability whenever the EPA Regional Office finds that the facility fulfills the criteria stated in § 300.440(b). Upon such a finding, the EPA Regional Office shall notify the facility and the State in writing.</P> <CITA>[58 FR 49215, Sept. 22, 1993]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart F—State Involvement in Hazardous Substance Response</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>55 FR 8853, Mar. 8, 1990, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.500</SECTNO> <SUBJECT>General.</SUBJECT> <P>(a) EPA shall ensure meaningful and substantial state involvement in hazardous substance response as specified in this subpart. EPA shall provide an opportunity for state participation in removal, pre-remedial, remedial, and enforcement response activities. EPA shall encourage states to enter into an EPA/state Superfund Memorandum of Agreement (SMOA) under § 300.505 to increase state involvement and strengthen the EPA/state partnership.</P> <P>(b) EPA shall encourage states to participate in Fund-financed response in two ways. Pursuant to § 300.515(a), states may either assume the lead through a cooperative agreement for the response action or may be the support agency in EPA-lead remedial response. Section 300.515 sets forth requirements for state involvement in EPA-lead remedial and enforcement response and also addresses comparable requirements for EPA involvement in state-lead remedial and enforcement response. Section 300.520 specifies requirements for state involvement in EPA-lead enforcement negotiations. Section 300.525 specifies requirements for state involvement in removal actions. In addition to the requirements set forth in this subpart, 40 CFR part 35, subpart O, “Cooperative Agreements and Superfund State Contracts for Superfund Response Actions,” contains further requirements for state participation during response.</P> </SECTION> <SECTION> <SECTNO>§ 300.505</SECTNO> <SUBJECT>EPA/State Superfund Memorandum of Agreement (SMOA).</SUBJECT> <P>(a) The SMOA may establish the nature and extent of EPA and state interaction during EPA-lead and state-lead response (Indian tribes meeting the requirements of § 300.515(b) may be treated as states for purposes of this section). EPA shall enter into SMOA discussions if requested by a state. The following may be addressed in a SMOA:</P> <P>(1) The EPA/state or Indian tribe relationship for removal, pre-remedial, remedial, and enforcement response, including a description of the roles and the responsibilities of each.</P> <P> (2) The general requirements for EPA oversight. Oversight requirements may be more specifically defined in cooperative agreements. <PRTPAGE P="85"/> </P> <P>(3) The general nature of lead and support agency interaction regarding the review of key documents and/or decision points in removal, pre-remedial, remedial, and enforcement response. The requirements for EPA and state review of each other's key documents when each is serving as the support agency shall be equivalent to the extent practicable. Review times agreed to in the SMOA must also be documented in site-specific cooperative agreements or Superfund state contracts in order to be binding.</P> <P>(4) Procedures for modification of the SMOA (e.g., if EPA and a state agree that the lead and support agency roles and responsibilities have changed, or if modifications are required to achieve desired goals).</P> <P>(b) The SMOA and any modifications thereto shall be executed by the EPA Regional Administrator and the head of the state agency designated as lead agency for state implementation of CERCLA.</P> <P>(c) Site-specific agreements entered into pursuant to section 104(d)(1) of CERCLA shall be developed in accordance with 40 CFR part 35, subpart O. The SMOA shall not supersede such agreements.</P> <P>(d)(1) EPA and the state shall consult annually to determine priorities and make lead and support agency designations for removal, pre-remedial, remedial, and enforcement response to be conducted during the next fiscal year and to discuss future priorities and long-term requirements for response. These consultations shall include the exchange of information on both Fund- and non-Fund-financed response activities. The SMOA may describe the timeframe and process for the EPA/state consultation.</P> <P>(2) The following activities shall be discussed in the EPA/state consultations established in the SMOA, or otherwise initiated and documented in writing in the absence of a SMOA, on a site-specific basis with EPA and the state identifying the lead agency for each response action discussed:</P> <P>(i) Pre-remedial response actions, including preliminary assessments and site inspections;</P> <P>(ii) Hazard Ranking System scoring and NPL listing and deletion activities;</P> <P>(iii) Remedial phase activities, including remedial investigation/feasibility study, identification of potential applicable or relevant and appropriate requirements (ARARs) under federal and state environmental laws and, as appropriate, other advisories, criteria, or guidance to be considered (TBCs), proposed plan, ROD, remedial design, remedial action, and operation and maintenance;</P> <P>(iv) Potentially responsible party (PRP) searches, notices to PRPs, response to information requests, PRP negotiations, oversight of PRPs, other enforcement actions pursuant to state law, and activities where the state provides support to EPA;</P> <P>(v) Compilation and maintenance of the administrative record for selection of a response action as required by subpart I of this part;</P> <P>(vi) Related site support activities;</P> <P>(vii) State ability to share in the cost and timing of payments; and</P> <P>(viii) General CERCLA implementation activities.</P> <P>(3) If a state is designated as the lead agency for a non-Fund-financed action at an NPL site, the SMOA shall be supplemented by site-specific enforcement agreements between EPA and the state which specify schedules and EPA involvement.</P> <P>(4) In the absence of a SMOA, EPA and the state shall comply with the requirements in § 300.515(h). If the SMOA does not address all of the requirements specified in § 300.515(h), EPA and the state shall comply with any unaddressed requirements in that section.</P> </SECTION> <SECTION> <SECTNO>§ 300.510</SECTNO> <SUBJECT>State assurances.</SUBJECT> <P> (a) A Fund-financed remedial action undertaken pursuant to CERCLA section 104(a) cannot proceed unless a state provides its applicable required assurances. The assurances must be provided by the state prior to the initiation of remedial action pursuant to a Superfund state contract for EPA-lead (or political subdivision-lead) remedial action or pursuant to a cooperative agreement for a state-lead remedial action. The SMOA may not be used for this purpose. Federally recognized Indian tribes are not required to provide CERCLA section 104(c)(3) assurances <PRTPAGE P="86"/> for Fund-financed response actions. Further requirements pertaining to state, political subdivision, and federally recognized Indian tribe involvement in CERCLA response are found in 40 CFR part 35, subpart O. </P> <P>(b)(1) The state is not required to share in the cost of state- or EPA-lead Fund-financed removal actions (including remedial planning activities associated with remedial actions) conducted pursuant to CERCLA section 104 unless the facility was operated by the state or a political subdivision thereof at the time of disposal of hazardous substances therein and a remedial action is ultimately undertaken at the site. Such remedial planning activities include, but are not limited to, remedial investigations (RIs), feasibility studies (FSs), and remedial design (RD). States shall be required to share 50 percent, or greater, in the cost of all Fund-financed response actions if the facility was publicly operated at the time of the disposal of hazardous substances. For other facilities, except federal facilities, the state shall be required to share 10 percent of the cost of the remedial action.</P> <P>(2) CERCLA section 104(c)(5) provides that EPA shall grant a state credit for reasonable, documented, direct, out-of-pocket, non-federal expenditures subject to the limitations specified in CERCLA section 104(c)(5). For a state to apply credit toward its cost share, it must enter into a cooperative agreement or Superfund state contract. The state must submit as soon as possible, but no later than at the time CERCLA section 104 assurances are provided for a remedial action, its accounting of eligible credit expenditures for EPA verification. Additional credit requirements are contained in 40 CFR part 35, subpart O.</P> <P>(3) Credit may be applied to a state's future cost share requirements at NPL sites for response expenditures or obligations incurred by the state or a political subdivision from January 1, 1978 to December 11, 1980, and for the remedial action expenditures incurred only by the state after October 17, 1986.</P> <P>(4) Credit that exceeds the required cost share at the site for which the credit is granted may be transferred to another site to offset a state's required remedial action cost share.</P> <P>(c)(1) Prior to a Fund-financed remedial action, the state must also provide its assurance in accordance with CERCLA section 104(c)(3)(A) to assume responsibility for operation and maintenance of implemented remedial actions for the expected life of such actions. In addition, when appropriate, as part of the O&M assurance, the state must assure that any institutional controls implemented as part of the remedial action at a site are in place, reliable, and will remain in place after the initiation of O&M. The state and EPA shall consult on a plan for operation and maintenance prior to the initiation of a remedial action.</P> <P>(2) After a joint EPA/State inspection of the implemented Fund-financed remedial action under § 300.515(g), EPA may share, for any extension period established in § 300.435(f)(2), in the cost of the operation of the remedy to ensure that the remedy is operational and functional. In the case of restoration of ground or surface water, EPA shall share in the cost of the State's operation of ground- or surface-water restoration remedial actions as specified in § 300.435(f)(3).</P> <P>(d) In accordance with CERCLA sections 104 (c)(3)(B) and 121(d)(3), if the remedial action requires off-site storage, destruction, treatment, or disposal, the state must provide its assurance before the remedial action begins on the availability of a hazardous waste disposal facility that is in compliance with CERCLA section 121(d)(3) and is acceptable to EPA.</P> <P>(e)(1) In accordance with CERCLA section 104(c)(9), EPA shall not provide any remedial action pursuant to CERCLA section 104 until the state in which the release occurs enters into a cooperative agreement or Superfund state contract with EPA providing assurances deemed adequate by EPA that the state will assure the availability of hazardous waste treatment or disposal facilities which:</P> <P> (i) Have adequate capacity for the destruction, treatment, or secure disposition of all hazardous wastes that are reasonably expected to be generated <PRTPAGE P="87"/> within the state during the 20-year period following the date of such cooperative agreement or Superfund state contract and to be destroyed, treated, or disposed; </P> <P>(ii) Are within the state, or outside the state in accordance with an interstate agreement or regional agreement or authority;</P> <P>(iii) Are acceptable to EPA; and</P> <P>(iv) Are in compliance with the requirements of Subtitle C of the Solid Waste Disposal Act.</P> <P>(2) This rule does not address whether or not Indian tribes are states for purposes of this paragraph (e).</P> <P>(f) EPA may determine that an interest in real property must be acquired in order to conduct a response action. However, as provided in CERCLA section 104(j)(2), EPA may acquire an interest in real estate in order to conduct a remedial action only if the State in which the interest to be acquired is located provides assurances, through a contract, cooperative agreement or otherwise, that the State will accept transfer of the interest upon completion of the remedial action. For purposes of this paragraph, “completion of the remedial action” is the point at which operation and maintenance (O&M) measures would be initiated pursuant to § 300.435(f). The State may accept a transfer of interest at an earlier point in time if agreed upon in writing by the State and EPA. Indian tribe assurances are to be provided as set out at 40 CFR part 35, subpart O, § 35.6110(b)(2).</P> <CITA>[55 FR 8853, Mar. 8, 1990, as amended at 59 FR 35854, July 14, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.515</SECTNO> <SUBJECT>Requirements for state involvement in remedial and enforcement response.</SUBJECT> <P> (a) <E T="03">General.</E> (1) States are encouraged to undertake actions authorized under subpart E. Section 104(d)(1) of CERCLA authorizes EPA to enter into cooperative agreements or contracts with a state, political subdivision, or a federally recognized Indian tribe to carry out Fund-financed response actions authorized under CERCLA, when EPA determines that the state, the political subdivision, or federally recognized Indian tribe has the capability to undertake such actions. EPA will use a cooperative agreement to transfer funds to those entities to undertake Fund-financed response activities. The requirements for states, political subdivisions, or Indian tribes to receive funds as a lead or support agency for response are addressed at 40 CFR part 35, subpart O. </P> <P>(2) For EPA-lead Fund-financed remedial planning activities, including, but not limited to, remedial investigations, feasibility studies, and remedial designs, the state agency acceptance of the support agency role during an EPA-lead response shall be documented in a letter, SMOA, or cooperative agreement. Superfund state contracts are unnecessary for this purpose.</P> <P>(3) Cooperative agreements and Superfund state contracts are only appropriate for non-Fund-financed response actions if a state intends to seek credit for remedial action expenses under § 300.510.</P> <P> (b) <E T="03">Indian tribe involvement during response.</E> To be afforded substantially the same treatment as states under section 104 of CERCLA, the governing body of the Indian tribe must: </P> <P>(1) Be federally recognized; and</P> <P>(2) Have a tribal governing body that is currently performing governmental functions to promote the health, safety, and welfare of the affected population or to protect the environment within a defined geographic area; and</P> <P>(3) Have jurisdiction over a site at which Fund-financed response, including pre-remedial activities, is contemplated.</P> <P> (c) <E T="03">State involvement in PA/SI and National Priorities List process.</E> EPA shall ensure state involvement in the listing and deletion process by providing states opportunities for review, consultation, or concurrence specified in this section. </P> <P>(1) EPA shall consult with states as appropriate on the information to be used in developing HRS scores for releases.</P> <P>(2) EPA shall, to the extent feasible, provide the state 30 working days to review releases which were scored by EPA and which will be considered for placement on the National Priorities List (NPL).</P> <P> (3) EPA shall provide the state 30 working days to review and concur on <PRTPAGE P="88"/> the Notice of Intent to Delete a release from the NPL. Section 300.425 describes the EPA/state consultation and concurrence process for deleting releases from the NPL. </P> <P> (d) <E T="03">State involvement in RI/FS process.</E> A key component of the EPA/state partnership shall be the communication of potential federal and state ARARs and, as appropriate, other pertinent advisories, criteria, or guidance to be considered (TBCs). </P> <P> (1) In accordance with §§ 300.400(g) and 300.430, the lead and support agencies shall identify their respective potential ARARs and communicate them to each other in a timely manner, <E T="03">i.e.</E> , no later than the early stages of the comparative analysis described in § 300.430(e)(9), such that sufficient time is available for the lead agency to consider and incorporate all potential ARARs without inordinate delays and duplication of effort. The lead and support agencies may also identify TBCs and communicate them in a timely manner. </P> <P>(2) When a state and EPA have entered into a SMOA, the SMOA may specify a consultation process which requires the lead agency to solicit potential ARARs at specified points in the remedial planning and remedy selection processes. At a minimum, the SMOA shall include the points specified in § 300.515(h)(2). The SMOA shall specify timeframes for support agency response to lead agency requests to ensure that potential ARARs are identified and communicated in a timely manner. Such timeframes must also be documented in site-specific agreements. The SMOA may also discuss identification and communication of TBCs.</P> <P>(3) If EPA in its statement of a proposed plan intends to waive any state-identified ARARs, or does not agree with the state that a certain state standard is an ARAR, it shall formally notify the state when it submits the RI/FS report for state review or responds to the state's submission of the RI/FS report.</P> <P>(4) EPA shall respond to state comments on waivers from or disagreements about state ARARs, as well as the preferred alternative when making the RI/FS report and proposed plan available for public comment.</P> <P> (e) <E T="03">State involvement in selection of remedy.</E> (1) Both EPA and the state shall be involved in preliminary discussions of the alternatives addressed in the FS prior to preparation of the proposed plan and ROD. At the conclusion of the RI/FS, the lead agency, in conjunction with the support agency, shall develop a proposed plan. The support agency shall have an opportunity to comment on the plan. The lead agency shall publish a notice of availability of the RI/FS report and a brief analysis of the proposed plan pursuant to § 300.430(e) and (f). Included in the proposed plan shall be a statement that the lead and support agencies have reached agreement or, where this is not the case, a statement explaining the concerns of the support agency with the lead agency's proposed plan. The state may not publish a proposed plan that EPA has not approved. EPA may assume the lead from the state if agreement cannot be reached. </P> <P> (2)(i) EPA and the state shall identify, at least annually, sites for which RODs will be prepared during the next fiscal year, in accordance with § 300.515(h)(1). For all EPA-lead sites, EPA shall prepare the ROD and provide the state an opportunity to concur with the recommended remedy. For Fund-financed state-lead sites, EPA and the state shall designate sites, in a site-specific agreement, for which the state shall prepare the ROD and seek EPA's concurrence and adoption of the remedy specified therein, and sites for which EPA shall prepare the ROD and seek the state's concurrence. EPA and the state may designate sites for which the state shall prepare the ROD for non-Fund-financed state-lead enforcement response actions ( <E T="03">i.e.</E> , actions taken under state law) at an NPL site. The state may seek EPA's concurrence in the remedy specified therein. Either EPA or the state may choose not to designate a site as state-lead. </P> <P> (ii) State concurrence on a ROD is not a prerequisite to EPA's selecting a remedy, <E T="03">i.e.</E> , signing a ROD, nor is EPA's concurrence a prerequisite to a state's selecting a remedy at a non-Fund-financed state-lead enforcement <PRTPAGE P="89"/> site under state law. Unless EPA's Assistant Administrator for Solid Waste and Emergency Response or Regional Administrator concurs in writing with a state-prepared ROD, EPA shall not be deemed to have approved the state decision. A state may not proceed with a Fund-financed response action unless EPA has first concurred in and adopted the ROD. Section 300.510(a) specifies limitations on EPA's proceeding with a remedial action without state assurances. </P> <P>(iii) The lead agency shall provide the support agency with a copy of the signed ROD for remedial actions to be conducted pursuant to CERCLA.</P> <P>(iv) On state-lead sites identified for EPA concurrence, the state generally shall be expected to maintain its lead agency status through the completion of the remedial action.</P> <P> (f) <E T="03">Enhancement of remedy.</E> (1) A state may ask EPA to make changes in or expansions of a remedial action selected under subpart E. </P> <P>(i) If EPA finds that the proposed change or expansion is necessary and appropriate to the EPA-selected remedial action, the remedy may be modified (consistent with § 300.435(c)(2)) and any additional costs paid as part of the remedial action.</P> <P>(ii) If EPA finds that the proposed change or expansion is not necessary to the selected remedial action, but would not conflict or be inconsistent with the EPA-selected remedy, EPA may agree to integrate the proposed change or expansion into the planned CERCLA remedial work if:</P> <P>(A) The state agrees to fund the entire additional cost associated with the change or expansion; and</P> <P>(B) The state agrees to assume the lead for supervising the state-funded component of the remedy or, if EPA determines that the state-funded component cannot be conducted as a separate phase or activity, for supervising the remedial design and construction of the entire remedy.</P> <P>(2) Where a state does not concur in a remedial action secured by EPA under CERCLA section 106, and the state desires to have the remedial action conform to an ARAR that has been waived under § 300.430(f)(1)(ii)(C), a state may seek to have that remedial action so conform, in accordance with the procedures set out in CERCLA section 121(f)(2) .</P> <P> (g) <E T="03">State involvement in remedial design/remedial action.</E> The extent and nature of state involvement during remedial design and remedial action shall be specified in site-specific cooperative agreements or Superfund state contracts, consistent with 40 CFR part 35, subpart O. For Fund-financed remedial actions, the lead and support agencies shall conduct a joint inspection at the conclusion of construction of the remedial action to determine that the remedy has been constructed in accordance with the ROD and with the remedial design. </P> <P> (h) <E T="03">Requirements for state involvement in absence of SMOA.</E> In the absence of a SMOA, EPA and the state shall comply with the requirements in § 300.515(h). If the SMOA does not address all of the requirements specified in § 300.515(h), EPA and the state shall comply with any unaddressed requirements in that section. </P> <P> (1) <E T="03">Annual consultations.</E> EPA shall conduct consultations with states at least annually to establish priorities and identify and document in writing the lead for remedial and enforcement response for each NPL site within the state for the upcoming fiscal year. States shall be given the opportunity to participate in long-term planning efforts for remedial and enforcement response during these annual consultations. </P> <P> (2) <E T="03">Identification of ARARs and TBCs.</E> The lead and support agencies shall discuss potential ARARs during the scoping of the RI/FS. The lead agency shall request potential ARARs from the support agency no later than the time that the site characterization data are available. The support agency shall communicate in writing those potential ARARs to the lead agency within 30 working days of receipt of the lead agency request for these ARARs. The lead and support agencies may also discuss and communicate other pertinent advisories, criteria, or guidance to be considered (TBCs). After the initial screening of alternatives has been completed but prior to initiation of the comparative analysis conducted during the detailed analysis phase of the FS, <PRTPAGE P="90"/> the lead agency shall request that the support agency communicate any additional requirements that are applicable or relevant and appropriate to the alternatives contemplated within 30 working days of receipt of this request. The lead agency shall thereafter consult the support agency to ensure that identified ARARs and TBCs are updated as appropriate. </P> <P> (3) <E T="03">Support agency review of lead agency documents.</E> The lead agency shall provide the support agency an opportunity to review and comment on the RI/FS, proposed plan, ROD, and remedial design, and any proposed determinations on potential ARARs and TBCs. The support agency shall have a minimum of 10 working days and a maximum of 15 working days to provide comments to the lead agency on the RI/FS, ROD, ARAR/TBC determinations, and remedial design. The support agency shall have a minimum of five working days and a maximum of 10 working days to comment on the proposed plan. </P> <P> (i) <E T="03">Administrative record requirements.</E> The state, where it is the lead agency for a Fund-financed site, shall compile and maintain the administrative record for selection of a response action under subpart I of this part unless specified otherwise in the SMOA. </P> </SECTION> <SECTION> <SECTNO>§ 300.520</SECTNO> <SUBJECT>State involvement in EPA-lead enforcement negotiations.</SUBJECT> <P>(a) EPA shall notify states of response action negotiations to be conducted by EPA with potentially responsible parties during each fiscal year.</P> <P>(b) The state must notify EPA of such negotiations in which it intends to participate.</P> <P>(c) The state is not foreclosed from signing a consent decree if it does not participate substantially in the negotiations.</P> </SECTION> <SECTION> <SECTNO>§ 300.525</SECTNO> <SUBJECT>State involvement in removal actions.</SUBJECT> <P>(a) States may undertake Fund-financed removal actions pursuant to a cooperative agreement with EPA. State-lead removal actions taken pursuant to cooperative agreements must be conducted in accordance with § 300.415 on removal actions, and 40 CFR part 35, subpart O.</P> <P>(b) States are not required under section 104(c)(3) of CERCLA to share in the cost of a Fund-financed removal action, unless the removal is conducted at an NPL site that was operated by a state or political subdivision at the time of disposal of hazardous substances therein and a Fund-financed remedial action is ultimately undertaken at the site. In this situation, states are required to share, 50 percent or greater, in the cost of all removal (including remedial planning) and remedial action costs at the time of the remedial action.</P> <P>(c) States are encouraged to provide for post-removal site control as discussed in § 300.415(k) for all Fund-financed removal actions.</P> <P>(d) States shall be responsible for identifying potential state ARARs for all Fund-financed removal actions and for providing such ARARs to EPA in a timely manner for all EPA-lead removal actions.</P> <P>(e) EPA shall consult with a state on all removal actions to be conducted in that state.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart G—Trustees for Natural Resources</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47450, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.600</SECTNO> <SUBJECT>Designation of federal trustees.</SUBJECT> <P>(a) The President is required to designate in the NCP those federal officials who are to act on behalf of the public as trustees for natural resources. Federal officials so designated will act pursuant to section 107(f) of CERCLA, section 311(f)(5) of the CWA, and section 1006 of the OPA. Natural resources means land, fish, wildlife, biota, air, water, ground water, drinking water supplies, and other such resources belonging to, managed by, held in trust by, appertaining to, or otherwise controlled (hereinafter referred to as “managed or controlled”) by the United States (including the resources of the exclusive economic zone).</P> <P> (b) The following individuals shall be the designated trustee(s) for general <PRTPAGE P="91"/> categories of natural resources, including their supporting ecosystems. They are authorized to act pursuant to section 107(f) of CERCLA, section 311(f)(5) of the CWA, or section 1006 of the OPA when there is injury to, destruction of, loss of, or threat to natural resources, including their supporting ecosystems, as a result of a release of a hazardous substance or a discharge of oil. Notwithstanding the other designations in this section, the Secretaries of Commerce and the Interior shall act as trustees of those resources subject to their respective management or control. </P> <P> (1) <E T="03">Secretary of Commerce.</E> The Secretary of Commerce shall act as trustee for natural resources managed or controlled by DOC and for natural resources managed or controlled by other federal agencies and that are found in, under, or using waters navigable by deep draft vessels, tidally influenced waters, or waters of the contiguous zone, the exclusive economic zone, and the outer continental shelf. However, before the Secretary takes an action with respect to an affected resource under the management or control of another federal agency, he shall, whenever practicable, seek to obtain the concurrence of that other federal agency. Examples of the Secretary's trusteeship include the following natural resources and their supporting ecosystems: marine fishery resources; anadromous fish; endangered species and marine mammals; and the resources of National Marine Sanctuaries and National Estuarine Research Reserves. </P> <P> (2) <E T="03">Secretary of the Interior.</E> The Secretary of the Interior shall act as trustee for natural resources managed or controlled by the DOI. Examples of the Secretary's trusteeship include the following natural resources and their supporting ecosystems: migratory birds; anadromous fish; endangered species and marine mammals; federally owned minerals; and certain federally managed water resources. The Secretary of the Interior shall also be trustee for those natural resources for which an Indian tribe would otherwise act as trustee in those cases where the United States acts on behalf of the Indian tribe. </P> <P> (3) <E T="03">Secretary for the land managing agency.</E> For natural resources located on, over, or under land administered by the United States, the trustee shall be the head of the department in which the land managing agency is found. The trustees for the principal federal land managing agencies are the Secretaries of DOI, USDA, DOD, and DOE. </P> <P> (4) <E T="03">Head of authorized agencies.</E> For natural resources located in the United States but not otherwise described in this section, the trustee shall be the head of the federal agency or agencies authorized to manage or control those resources. </P> <P> (5) <E T="03">Additional trustees for the Deepwater Horizon Oil Spill.</E> The Administrator of EPA and the Secretary of Agriculture shall act as trustees in connection with injury to, destruction of, loss of, or loss of use of natural resources, including their supporting ecosystems, resulting from the Deepwater Horizon Oil Spill. </P> <CITA>[59 FR 47450, Sept. 15, 1994, as amended at 79 FR 36431, June 27, 2014]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.605</SECTNO> <SUBJECT>State trustees.</SUBJECT> <P> State trustees shall act on behalf of the public as trustees for natural resources, including their supporting ecosystems, within the boundary of a state or belonging to, managed by, controlled by, or appertaining to such state. For the purposes of subpart G of this part, the definition of the term <E T="03">state</E> does not include Indian tribes. The governor of a state is encouraged to designate a state lead trustee to coordinate all state trustee responsibilities with other trustee agencies and with response activities of the RRT and OSC. The state's lead trustee would designate a representative to serve as contact with the OSC. This individual should have ready access to appropriate state officials with environmental protection, emergency response, and natural resource responsibilities. The EPA Administrator or USCG Commandant or their designees may appoint the state lead trustee as a member of the Area Committee. Response strategies should be coordinated between the state and other trustees and the OSC for specific natural resource locations in an inland or coastal zone and should be included in the Fish <PRTPAGE P="92"/> and Wildlife and Sensitive Environments Plan annex of the ACP. </P> </SECTION> <SECTION> <SECTNO>§ 300.610</SECTNO> <SUBJECT>Indian tribes.</SUBJECT> <P>The tribal chairmen (or heads of the governing bodies) of Indian tribes, as defined in § 300.5, or a person designated by the tribal officials, shall act on behalf of the Indian tribes as trustees for the natural resources, including their supporting ecosystems, belonging to, managed by, controlled by, or appertaining to such Indian tribe, or held in trust for the benefit of such Indian tribe, or belonging to a member of such Indian tribe, if such resources are subject to a trust restriction on alienation. When the tribal chairman or head of the tribal governing body designates another person as trustee, the tribal chairman or head of the tribal governing body shall notify the President of such designation. Such officials are authorized to act when there is injury to, destruction of, loss of, or threat to natural resources, including their supporting ecosystems as a result of a release of a hazardous substance.</P> </SECTION> <SECTION> <SECTNO>§ 300.612</SECTNO> <SUBJECT>Foreign trustees.</SUBJECT> <P>Pursuant to section 1006 of the OPA, foreign trustees shall act on behalf of the head of a foreign government as trustees for natural resources belonging to, managed by, controlled by, or appertaining to such foreign government.</P> </SECTION> <SECTION> <SECTNO>§ 300.615</SECTNO> <SUBJECT>Responsibilities of trustees.</SUBJECT> <P>(a) Where there are multiple trustees, because of coexisting or contiguous natural resources or concurrent jurisdictions, they should coordinate and cooperate in carrying out these responsibilities.</P> <P>(b) Trustees are responsible for designating to the RRTs and the Area Committees, for inclusion in the RCP and the ACP, appropriate contacts to receive notifications from the OSCs/RPMs of discharges or releases.</P> <P>(c)(1) Upon notification or discovery of injury to, destruction of, loss of, or threat to natural resources, trustees may, pursuant to section 107(f) of CERCLA, or section 311(f)(5) of the CWA, take the following or other actions as appropriate:</P> <P>(i) Conduct a preliminary survey of the area affected by the discharge or release to determine if trust resources under their jurisdiction are, or potentially may be, affected;</P> <P>(ii) Cooperate with the OSC/RPM in coordinating assessments, investigations, and planning;</P> <P>(iii) Carry out damage assessments; or</P> <P>(iv) Devise and carry out a plan for restoration, rehabilitation, replacement, or acquisition of equivalent natural resources. In assessing damages to natural resources, the federal, state, and Indian tribe trustees have the option of following the procedures for natural resource damage assessments located at 43 CFR part 11.</P> <P>(2) Upon notification or discovery of injury to, destruction of, loss of, or loss of use of, natural resources, or the potential for such, resulting from a discharge of oil occurring after August 18, 1990, the trustees, pursuant to section 1006 of the OPA, are to take the following actions:</P> <P>(i) In accordance with OPA section 1006(c), determine the need for assessment of natural resource damages, collect data necessary for a potential damage assessment, and, where appropriate, assess damages to natural resources under their trusteeship; and</P> <P>(ii) As appropriate, and subject to the public participation requirements of OPA section 1006(c), develop and implement a plan for the restoration, rehabilitation, replacement, or acquisition of the equivalent, of the natural resources under their trusteeship;</P> <P>(3)(i) The trustees, consistent with procedures specified in the Fish and Wildlife and Sensitive Environments Plan Annex to the Area Contingency Plan, shall provide timely advice on recommended actions concerning trustee resources that are potentially affected by a discharge of oil. This may include providing assistance to the OSC in identifying/recommending pre-approved response techniques and in predesignating shoreline types and areas in ACPs.</P> <P> (ii) The trustees shall assure, through the lead administrative trustee, that the OSC is informed of their activities regarding natural resource <PRTPAGE P="93"/> damage assessment that may affect response operations in order to assure coordination and minimize any interference with such operations. The trustees shall assure, through the lead administrative trustee, that all data from the natural resource damage assessment activities that may support more effective operational decisions are provided in a timely manner to the OSC. </P> <P>(iii) When circumstances permit, the OSC shall share the use of federal response resources (including but not limited to aircraft, vessels, and booms to contain and remove discharged oil) with the trustees, providing trustee activities do not interfere with response actions. The lead administrative trustee facilitates effective and efficient communication between the OSC and the other trustees during response operations and is responsible for applying to the OSC for non-monetary federal response resources on behalf of all trustees. The lead administrative trustee is also responsible for applying to the NPFC for funding for initiation of damage assessment for injuries to natural resources.</P> <P>(d) The authority of federal trustees includes, but is not limited to the following actions:</P> <P>(1) Requesting that the Attorney General seek compensation from the responsible parties for the damages assessed and for the costs of an assessment and of restoration planning; and</P> <P>(2) Participating in negotiations between the United States and potentially responsible parties to obtain PRP-financed or PRP-conducted assessments and restorations for injured resources or protection for threatened resources and to agree to covenants not to sue, where appropriate.</P> <P>(3) Requiring, in consultation with the lead agency, any person to comply with the requirements of CERCLA section 104(e) regarding information gathering and access.</P> <P>(4) Initiating damage assessments, as provided in OPA section 6002.</P> <P>(e) Actions which may be taken by any trustee pursuant to section 107(f) of CERCLA, section 311(f)(5) of the CWA, or section 1006 of the OPA include, but are not limited to, any of the following:</P> <P>(1) Requesting that an authorized agency issue an administrative order or pursue injunctive relief against the parties responsible for the discharge or release; or</P> <P>(2) Requesting that the lead agency remove, or arrange for the removal of, or provide for remedial action with respect to, any oil or hazardous substances from a contaminated medium pursuant to section 104 of CERCLA or section 311 of CWA.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart H—Participation by Other Persons</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47452, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.700</SECTNO> <SUBJECT>Activities by other persons.</SUBJECT> <P> (a) <E T="03">General.</E> Except as provided (e.g., in CWA section 311(c)), any person may undertake a response action to reduce or eliminate a release of a hazardous substance, pollutant, or contaminant. </P> <P> (b) <E T="03">Summary of CERCLA authorities.</E> The mechanisms available to recover the costs of response actions under CERCLA are, in summary: </P> <P>(1) Section 107(a), wherein any person may receive a court award of his or her response costs, plus interest, from the party or parties found to be liable;</P> <P>(2) Section 111(a)(2), wherein a private party, a PRP pursuant to a settlement agreement, or certain foreign entities may file a claim against the Fund for reimbursement of response costs;</P> <P>(3) Section 106(b), wherein any person who has complied with a section 106(a) order may petition the Fund for reimbursement of reasonable costs, plus interest; and</P> <P>(4) Section 123, wherein a general purpose unit of local government may apply to the Fund under 40 CFR part 310 for reimbursement of the costs of temporary emergency measures that are necessary to prevent or mitigate injury to human health or the environment associated with a release.</P> <P> (c) <E T="03">Section 107(a) cost recovery actions.</E> (1) Responsible parties shall be liable for all response costs incurred by the United States government or a state or an Indian tribe not inconsistent with the NCP. <PRTPAGE P="94"/> </P> <P>(2) Responsible parties shall be liable for necessary costs of response actions to releases of hazardous substances incurred by any other person consistent with the NCP.</P> <P>(3) For the purpose of cost recovery under section 107(a)(4)(B) of CERCLA:</P> <P>(i) A private party response action will be considered “consistent with the NCP” if the action, when evaluated as a whole, is in substantial compliance with the applicable requirements in paragraphs (5) and (6) of this section, and results in a CERCLA-quality cleanup; and</P> <P>(ii) Any response action carried out in compliance with the terms of an order issued by EPA pursuant to section 106 of CERCLA, or a consent decree entered into pursuant to section 122 of CERCLA, will be considered “consistent with the NCP.”</P> <P>(4) Actions under § 300.700(c)(1) will not be considered “inconsistent with the NCP,” and actions under § 300.700(c)(2) will not be considered not “consistent with the NCP,” based on immaterial or insubstantial deviations from the provisions of 40 CFR part 300.</P> <P>(5) The following provisions of this part are potentially applicable to private party response actions:</P> <P>(i) Section 300.150 (on worker health and safety);</P> <P>(ii) Section 300.160 (on documentation and cost recovery);</P> <P>(iii) Section 300.400(c)(1), (4), (5), and (7) (on determining the need for a Fund-financed action); (e) (on permit requirements) except that the permit waiver does not apply to private party response actions; and (g) (on identification of ARARs) except that applicable requirements of federal or state law may not be waived by a private party;</P> <P>(iv) Section 300.405(b), (c), and (d) (on reports of releases to the NRC);</P> <P>(v) Section 300.410 (on removal site evaluation) except paragraphs (f)(5) and (6);</P> <P>(vi) Section 300.415 (on removal actions) except paragraphs (a)(2), (b)(2)(vii), (b)(5), and (g); and including § 300.415(j) with regard to meeting ARARs where practicable except that private party removal actions must always comply with the requirements of applicable law;</P> <P>(vii) Section 300.420 (on remedial site evaluation);</P> <P>(viii) Section 300.430 (on RI/FS and selection of remedy) except paragraph (f)(1)(ii)(C)(6) and that applicable requirements of federal or state law may not be waived by a private party; and</P> <P>(ix) Section 300.435 (on RD/RA and operation and maintenance).</P> <P>(6) Private parties undertaking response actions should provide an opportunity for public comment concerning the selection of the response action based on the provisions set out below, or based on substantially equivalent state and local requirements. The following provisions of this part regarding public participation are potentially applicable to private party response actions, with the exception of administrative record and information repository requirements stated therein:</P> <P>(i) Section 300.155 (on public information and community relations);</P> <P>(ii) Section 300.415(n) (on community relations during removal actions);</P> <P>(iii) Section 300.430(c) (on community relations during RI/FS) except paragraph (c)(5);</P> <P>(iv) Section 300.430(f)(2), (3), and (6) (on community relations during selection of remedy); and</P> <P>(v) Section 300.435(c) (on community relations during RD/RA and operation and maintenance).</P> <P>(7) When selecting the appropriate remedial action, the methods of remedying releases listed in appendix D of this part may also be appropriate to a private party response action.</P> <P>(8) Except for actions taken pursuant to CERCLA sections 104 or 106 or response actions for which reimbursement from the Fund will be sought, any action to be taken by the lead agency listed in paragraphs (c)(5) through (c)(7) may be taken by the person carrying out the response action.</P> <P> (d) <E T="03">Section 111(a)(2) claims.</E> (1) Persons, other than those listed in paragraphs (d)(1)(i) through (iii) of this section, may be able to receive reimbursement of response costs by means of a claim against the Fund. The categories of persons excluded from pursuing this claims authority are: </P> <P> (i) Federal government; <PRTPAGE P="95"/> </P> <P>(ii) State governments, and their political subdivisions, unless they are potentially responsible parties covered by an order or consent decree pursuant to section 122 of CERCLA; and</P> <P>(iii) Persons operating under a procurement contract or an assistance agreement with the United States with respect to matters covered by that contract or assistance agreement, unless specifically provided therein.</P> <P> (2) In order to be reimbursed by the Fund, an eligible person must notify the Administrator of EPA or designee prior to taking a response action and receive prior approval, <E T="03">i.e.</E> , “preauthorization,” for such action. </P> <P>(3) Preauthorization is EPA's prior approval to submit a claim against the Fund for necessary response costs incurred as a result of carrying out the NCP. All applications for preauthorization will be reviewed to determine whether the request should receive priority for funding. EPA, in its discretion, may grant preauthorization of a claim. Preauthorization will be considered only for:</P> <P>(i) Removal actions pursuant to § 300.415;</P> <P>(ii) CERCLA section 104(b) activities; and</P> <P>(iii) Remedial actions at National Priorities List sites pursuant to § 300.435.</P> <P>(4) To receive EPA's prior approval, the eligible person must:</P> <P>(i) Demonstrate technical and other capabilities to respond safely and effectively to releases of hazardous substances, pollutants, or contaminants; and</P> <P>(ii) Establish that the action will be consistent with the NCP in accordance with the elements set forth in paragraphs (c)(5) through (8) of this section.</P> <P>(5) EPA will grant preauthorization to a claim by a party it determines to be potentially liable under section 107 of CERCLA only in accordance with an order issued pursuant to section 106 of CERCLA, or a settlement with the federal government in accordance with section 122 of CERCLA.</P> <P>(6) Preauthorization does not establish an enforceable contractual relationship between EPA and the claimant.</P> <P>(7) Preauthorization represents EPA's commitment that if funds are appropriated for response actions, the response action is conducted in accordance with the preauthorization decision document, and costs are reasonable and necessary, reimbursement will be made from the Superfund, up to the maximum amount provided in the preauthorization decision document.</P> <P>(8) For a claim to be awarded under section 111 of CERCLA, EPA must certify that the costs were necessary and consistent with the preauthorization decision document.</P> <P> (e) <E T="03">Section 106(b) petition.</E> Subject to conditions specified in CERCLA section 106(b), any person who has complied with an order issued after October 16, 1986 pursuant to section 106(a) of CERCLA, may seek reimbursement for response costs incurred in complying with that order unless the person has waived that right. </P> <P> (f) <E T="03">Section 123 reimbursement to local governments.</E> Any general purpose unit of local government for a political subdivision that is affected by a release may receive reimbursement for the costs of temporary emergency measures necessary to prevent or mitigate injury to human health or the environment subject to the conditions set forth in 40 CFR part 310. Such reimbursement may not exceed $25,000 for a single response. </P> <P> (g) <E T="03">Release From Liability.</E> Implementation of response measures by potentially responsible parties or by any other person does not release those parties from liability under section 107(a) of CERCLA, except as provided in a settlement under section 122 of CERCLA or a federal court judgment. </P> <P> (h) <E T="03">Oil Pollution Act Claims.</E> Claims are authorized to be presented to the OSLTF under section 1013 of the OPA, for certain uncompensated removal costs or uncompensated damages resulting from the discharge, or substantial threat of discharge, of oil from a vessel or facility into or upon the navigable waters, adjoining shorelines, or exclusive economic zone of the United States. Anyone desiring to file a claim against the OSLTF may obtain general information on the procedure for filing a claim from the Director, National Pollution Funds Center, Suite 1000, 4200 <PRTPAGE P="96"/> Wilson Boulevard, Arlington, Virginia 22203-1804, (703) 235-4756. </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart I—Administrative Record for Selection of Response Action</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>55 FR 8859, Mar. 8, 1990, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.800</SECTNO> <SUBJECT>Establishment of an administrative record.</SUBJECT> <P> (a) <E T="03">General requirement.</E> The lead agency shall establish an administrative record that contains the documents that form the basis for the selection of a response action. The lead agency shall compile and maintain the administrative record in accordance with this subpart. </P> <P> (b) <E T="03">Administrative records for federal facilities.</E> (1) If a federal agency other than EPA is the lead agency for a federal facility, the federal agency shall compile and maintain the administrative record for the selection of the response action for that facility in accordance with this subpart. EPA may furnish documents which the federal agency shall place in the administrative record file to ensure that the administrative record includes all documents that form the basis for the selection of the response action. </P> <P>(2) EPA or the U.S. Coast Guard shall compile and maintain the administrative record when it is the lead agency for a federal facility.</P> <P>(3) If EPA is involved in the selection of the response action at a federal facility on the NPL, the federal agency acting as the lead agency shall provide EPA with a copy of the index of documents included in the administrative record file, the RI/FS workplan, the RI/FS released for public comment, the proposed plan, any public comments received on the RI/FS and proposed plan, and any other documents EPA may request on a case-by-case basis.</P> <P> (c) <E T="03">Administrative record for state-lead sites.</E> If a state is the lead agency for a site, the state shall compile and maintain the administrative record for the selection of the response action for that site in accordance with this subpart. EPA may require the state to place additional documents in the administrative record file to ensure that the administrative record includes all documents which form the basis for the selection of the response action. The state shall provide EPA with a copy of the index of documents included in the administrative record file, the RI/FS workplan, the RI/FS released for public comment, the proposed plan, any public comments received on the RI/FS and proposed plan, and any other documents EPA may request on a case-by-case basis. </P> <P> (d) <E T="03">Applicability.</E> This subpart applies to all response actions taken under section 104 of CERCLA or sought, secured, or ordered administratively or judicially under section 106 of CERCLA, as follows: </P> <P>(1) Remedial actions where the remedial investigation commenced after the promulgation of these regulations; and</P> <P>(2) Removal actions where the action memorandum is signed after the promulgation of these regulations.</P> <P>(e) For those response actions not included in paragraph (d) of this section, the lead agency shall comply with this subpart to the extent practicable.</P> </SECTION> <SECTION> <SECTNO>§ 300.805</SECTNO> <SUBJECT>Location of the administrative record file.</SUBJECT> <P>(a) The lead agency shall establish a docket at an office of the lead agency or other central location at which documents included in the administrative record file shall be located and a copy of the documents included in the administrative record file shall also be made available for public inspection at or near the site at issue, except as provided below:</P> <P>(1) Sampling and testing data, quality control and quality assurance documentation, and chain of custody forms, need not be located at or near the site at issue or at the central location, provided that the index to the administrative record file indicates the location and availability of this information.</P> <P>(2) Guidance documents not generated specifically for the site at issue need not be located at or near the site at issue, provided that they are maintained at the central location and the index to the administrative record file indicates the location and availability of these guidance documents.</P> <P> (3) Publicly available technical literature not generated for the site at issue, such as engineering textbooks, <PRTPAGE P="97"/> articles from technical journals, and toxicological profiles, need not be located at or near the site at issue or at the central location, provided that the literature is listed in the index to the administrative record file or the literature is cited in a document in the record. </P> <P>(4) Documents included in the confidential portion of the administrative record file shall be located only in the central location.</P> <P>(5) The administrative record for a removal action where the release or threat of release requires that on-site removal activities be initiated within hours of the lead agency's determination that a removal is appropriate and on-site removal activities cease within 30 days of initiation, need be available for public inspection only at the central location.</P> <P>(b) Where documents are placed in the central location but not in the file located at or near the site, such documents shall be added to the file located at or near the site upon request, except for documents included in paragraph (a)(4) of this section.</P> <P>(c) The lead agency may make the administrative record file available to the public in microform, computer telecommunications, or other electronic means.</P> <CITA>[55 FR 8859, Mar. 8, 1990, as amended at 78 FR 16614, Mar. 18, 2013]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.810</SECTNO> <SUBJECT>Contents of the administrative record file.</SUBJECT> <P> (a) <E T="03">Contents.</E> The administrative record file for selection of a response action typically, but not in all cases, will contain the following types of documents: </P> <P>(1) Documents containing factual information, data and analysis of the factual information, and data that may form a basis for the selection of a response action. Such documents may include verified sampling data, quality control and quality assurance documentation, chain of custody forms, site inspection reports, preliminary assessment and site evaluation reports, ATSDR health assessments, documents supporting the lead agency's determination of imminent and substantial endangerment, public health evaluations, and technical and engineering evaluations. In addition, for remedial actions, such documents may include approved workplans for the remedial investigation/feasibility study, state documentation of applicable or relevant and appropriate requirements, and the RI/FS;</P> <P>(2) Guidance documents, technical literature, and site-specific policy memoranda that may form a basis for the selection of the response action. Such documents may include guidance on conducting remedial investigations and feasibility studies, guidance on determining applicable or relevant and appropriate requirements, guidance on risk/exposure assessments, engineering handbooks, articles from technical journals, memoranda on the application of a specific regulation to a site, and memoranda on off-site disposal capacity;</P> <P>(3) Documents received, published, or made available to the public under § 300.815 for remedial actions, or § 300.820 for removal actions. Such documents may include notice of availability of the administrative record file, community relations plan, proposed plan for remedial action, notices of public comment periods, public comments and information received by the lead agency, and responses to significant comments;</P> <P>(4) Decision documents. Such documents may include action memoranda and records of decision;</P> <P>(5) Enforcement orders. Such documents may include administrative orders and consent decrees; and</P> <P>(6) An index of the documents included in the administrative record file. If documents are customarily grouped together, as with sampling data chain of custody documents, they may be listed as a group in the index to the administrative record file.</P> <P> (b) <E T="03">Documents not included in the administrative record file.</E> The lead agency is not required to include documents in the administrative record file which do not form a basis for the selection of the response action. Such documents include but are not limited to draft documents, internal memoranda, and day-to-day notes of staff unless such documents contain information that forms the basis of selection of the response <PRTPAGE P="98"/> action and the information is not included in any other document in the administrative record file. </P> <P> (c) <E T="03">Privileged documents.</E> Privileged documents shall not be included in the record file except as provided in paragraph (d) of this section or where such privilege is waived. Privileged documents include but are not limited to documents subject to the attorney-client, attorney work product, deliberative process, or other applicable privilege. </P> <P> (d) <E T="03">Confidential file.</E> If information which forms the basis for the selection of a response action is included only in a document containing confidential or privileged information and is not otherwise available to the public, the information, to the extent feasible, shall be summarized in such a way as to make it disclosable and the summary shall be placed in the publicly available portion of the administrative record file. The confidential or privileged document itself shall be placed in the confidential portion of the administrative record file. If information, such as confidential business information, cannot be summarized in a disclosable manner, the information shall be placed only in the confidential portion of the administrative record file. All documents contained in the confidential portion of the administrative record file shall be listed in the index to the file. </P> </SECTION> <SECTION> <SECTNO>§ 300.815</SECTNO> <SUBJECT>Administrative record file for a remedial action.</SUBJECT> <P>(a) The administrative record file for the selection of a remedial action shall be made available for public inspection at the commencement of the remedial investigation phase. At such time, the lead agency shall publish in a major local newspaper of general circulation a notice or use one or more other mechanisms to give adequate notice to a community of the availability of the administrative record file.</P> <P>(b) The lead agency shall provide a public comment period as specified in § 300.430(f)(3) so that interested persons may submit comments on the selection of the remedial action for inclusion in the administrative record file. The lead agency is encouraged to consider and respond as appropriate to significant comments that were submitted prior to the public comment period. A written response to significant comments submitted during the public comment period shall be included in the administrative record file.</P> <P>(c) The lead agency shall comply with the public participation procedures required in § 300.430(f)(3) and shall document such compliance in the administrative record.</P> <P>(d) Documents generated or received after the record of decision is signed shall be added to the administrative record file only as provided in § 300.825.</P> <CITA>[55 FR 8859, Mar. 8, 1990, as amended at 80 FR 17706, Apr. 2, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.820</SECTNO> <SUBJECT>Administrative record file for a removal action.</SUBJECT> <P>(a) If, based on the site evaluation, the lead agency determines that a removal action is appropriate and that a planning period of at least six months exists before on-site removal activities must be initiated:</P> <P>(1) The administrative record file shall be made available for public inspection when the engineering evaluation/cost analysis (EE/CA) is made available for public comment. At such time, the lead agency shall publish in a major local newspaper of general circulation a notice or use one or more other mechanisms to give adequate notice to a community of the availability of the administrative record file.</P> <P>(2) The lead agency shall provide a public comment period as specified in § 300.415 so that interested persons may submit comments on the selection of the removal action for inclusion in the administrative record file. The lead agency is encouraged to consider and respond, as appropriate, to significant comments that were submitted prior to the public comment period. A written response to significant comments submitted during the public comment period shall be included in the administrative record file.</P> <P>(3) The lead agency shall comply with the public participation procedures of § 300.415(m) and shall document compliance with § 300.415(m)(3)(i) through (iii) in the administrative record file.</P> <P> (4) Documents generated or received after the decision document is signed <PRTPAGE P="99"/> shall be added to the administrative record file only as provided in § 300.825. </P> <P>(b) For all removal actions not included in paragraph (a) of this section:</P> <P>(1) Documents included in the administrative record file shall be made available for public inspection no later than 60 days after initiation of on-site removal activity. At such time, the lead agency shall publish in a major local newspaper of general circulation a notice or use one or more other mechanisms to give adequate notice to a community of the availability of the administrative record file.</P> <P>(2) The lead agency shall, as appropriate, provide a public comment period of not less than 30 days beginning at the time the administrative record file is made available to the public. The lead agency is encouraged to consider and respond, as appropriate, to significant comments that were submitted prior to the public comment period. A written response to significant comments submitted during the public comment period shall be included in the administrative record file.</P> <P>(3) Documents generated or received after the decision document is signed shall be added to the administrative record file only as provided in § 300.825.</P> <CITA>[55 FR 8859, Mar. 8, 1990, as amended at 80 FR 17706, Apr. 2, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.825</SECTNO> <SUBJECT>Record requirements after the decision document is signed.</SUBJECT> <P>(a) The lead agency may add documents to the administrative record file after the decision document selecting the response action has been signed if:</P> <P>(1) The documents concern a portion of a response action decision that the decision document does not address or reserves to be decided at a later date; or</P> <P>(2) An explanation of significant differences required by § 300.435(c), or an amended decision document is issued, in which case, the explanation of significant differences or amended decision document and all documents that form the basis for the decision to modify the response action shall be added to the administrative record file.</P> <P>(b) The lead agency may hold additional public comment periods or extend the time for the submission of public comment after a decision document has been signed on any issues concerning selection of the response action. Such comment shall be limited to the issues for which the lead agency has requested additional comment. All additional comments submitted during such comment periods that are responsive to the request, and any response to these comments, along with documents supporting the request and any final decision with respect to the issue, shall be placed in the administrative record file.</P> <P>(c) The lead agency is required to consider comments submitted by interested persons after the close of the public comment period only to the extent that the comments contain significant information not contained elsewhere in the administrative record file which could not have been submitted during the public comment period and which substantially support the need to significantly alter the response action. All such comments and any responses thereto shall be placed in the administrative record file.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart J—Use of Dispersants, and Other Chemical and Biological Agents</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>59 FR 47453, Sept. 15, 1994, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.900</SECTNO> <SUBJECT>General.</SUBJECT> <P>(a) Section 311(d)(2)(G) of the Clean Water Act (CWA) requires EPA to prepare a schedule identifying dispersants, other chemicals, other spill mitigating devices and substances, if any, that may be used in carrying out the NCP; and the waters and quantities in which they may be used safely. This subpart establishes a schedule that includes the NCP Product Schedule identifying chemical and biological agents, the Sorbents Product List, and the authorization of use procedures that, when taken together, identify the waters and quantities in which such dispersants, other chemicals, or other spill mitigating devices and substances may be used safely.</P> <P> (b) This subpart applies to the navigable waters of the United States and adjoining shorelines, the waters of the contiguous zone, and the high seas beyond the contiguous zone in connection <PRTPAGE P="100"/> with activities under the Outer Continental Shelf Lands Act, activities under the Deepwater Port Act of 1974, or activities that may affect natural resources belonging to, appertaining to, or under the exclusive management authority of the United States, including resources under the Magnuson Fishery Conservation and Management Act of 1976. </P> <P>(c) This subpart applies to the use of chemical and biological agents as defined in Subpart A of this part, or other substances that may be used to remove, control, or otherwise mitigate oil discharges.</P> <P>(d) [Reserved]</P> <CITA>[59 FR 47453, Sept. 15, 1994, as amended at 88 FR 38333, June 12, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.910</SECTNO> <SUBJECT>Authorization for agent use.</SUBJECT> <P>Use of chemical or biological agents in response to oil discharges must be authorized by the OSC in accordance with the provisions of this section.</P> <P> (a) <E T="03">Use of agents identified on the NCP Product Schedule or use of burning agents on oil discharges addressed by a preauthorization plan.</E> Area Committees and RRTs shall address, as part of their planning activities, whether preauthorization of the use of chemical and biological agents listed on the NCP Product Schedule or the use of burning agents on certain oil discharges is appropriate. Area Committees and RRTs shall, as appropriate, include applicable approved preauthorization plans in ACPs and RCPs. When a preauthorization plan is approved in advance for the use of certain agents under specified discharge situations, then the OSC may authorize the use of agents listed on the NCP Product Schedule, or the use of burning agents, for the purpose for which they were specifically listed without obtaining the incident-specific concurrences and without the natural resource trustees consultations described in paragraph (b) of this section. </P> <P> (1) <E T="03">Preauthorization plan development.</E> For discharge situations identified where such agents may be used, the preauthorization plan must, at a minimum, specify limits for the quantities and the duration of use, and use parameters for water depth, distance to shoreline, and proximity to populated areas. In meeting the provisions of this paragraph, preauthorization plans should document how regional factors are addressed including likely sources and types of oil that might be discharged, various potential discharge scenarios, the existence and location of environmentally sensitive resources or restricted areas that might be impacted by discharged oil, and logistical factors including inventory, storage locations and manufacturing capability of available agents, availability of equipment needed for agent use, availability of adequately trained operators, and means to monitor agent use in the environment. Preauthorization plans are to be developed by the Area Committees or the RRT in consultation with the Area Committee(s). </P> <P> (2) <E T="03">Preauthorization plan approval.</E> The EPA representative to the RRT, the Department of Commerce and the Department of the Interior natural resource trustees and, as appropriate the RRT representative from the state(s) with jurisdiction over waters and adjoining shorelines within the preauthorization plan area shall review and either approve, approve with modification, or disapprove the preauthorization plans. The Area Committees and RRTs shall address the withdrawal of approval from a preauthorization plan, and the RRT shall notify the NRT of the status of the preauthorization plan within 30 days from any such withdrawal. </P> <P> (3) <E T="03">Preauthorization plan reviews.</E> The RRT in consultation with the Area Committee(s) must review, and revise, as needed, approved preauthorization plans. These reviews must be conducted following a regular timeframe, established by the RRT and documented in the plan, to address changes that may impact the conditions under which the use of chemical and biological agents have been preauthorized. Reviews must also be conducted in any affected region, at a minimum, after a major discharge or after a Spill of National Significance (SONS) relevant to the preauthorization plan area; to address revisions of the NCP Product Schedule impacting chemical or biological agents that may be individually listed within a preauthorization plan; <PRTPAGE P="101"/> and to reflect new listings of threatened and/or endangered species applicable to the preauthorization plan area. The EPA RRT representative, the Department of Commerce and Department of the Interior natural resource trustees, and the RRT representative from the state(s) with jurisdiction over the waters of the area to which a preauthorization plan applies shall review and either approve, approve with modification, or disapprove any revisions to the preauthorization plans. </P> <P> (b) <E T="03">Use of agents identified on the NCP Product Schedule or use of burning agents on oil discharges not addressed by a preauthorization plan.</E> For discharge situations that are not addressed by a preauthorization plan developed pursuant to paragraph (a) of this section, the OSC may authorize the use of chemical or biological agents identified on the NCP Product Schedule on an oil discharge, or the use of burning agents, for the specific purpose for which they were listed with the concurrence of the EPA RRT representative and, as appropriate, the concurrence of the RRT representatives from the state(s) with jurisdiction over the waters and adjoining shorelines threatened by the release or discharge, and in consultation with the Department of Commerce and Department of the Interior natural resource trustees. In meeting the provisions of this paragraph, the OSC must consider and document for their authorization request to the RRT, at a minimum, the parameters for the use of agents including the quantities requested to be authorized, the duration of use, the depth of water, the distance to shoreline and proximity to populated areas, and should consider and document factors such as environmentally sensitive resources or restricted areas that might be impacted, agent inventory and storage locations, agent manufacturing capability, availability of equipment needed for agent use, availability of adequately trained operators and appropriate means to monitor agent use in the environment. </P> <P>(c) [Reserved]</P> <P> (d) <E T="03">Temporary exception.</E> In circumstances to prevent or substantially reduce an imminent threat to human life that cannot be immediately addressed by other procedures or provisions of the NCP, the OSC may authorize the provisional use of any chemical or biological agent, whether it is identified or not on the NCP Product Schedule, without obtaining the concurrence of the EPA RRT representative and, as appropriate, the RRT representatives from the state(s) with jurisdiction over the waters and adjoining shorelines threatened by the release or discharge, and without consultation with the Department of Commerce and the Department of the Interior natural resource trustees. This exception shall not be used as a substitute for compliance with § 300.150 of this part, including the use of personal protective equipment, or when there is sufficient time to seek authorization in accordance with paragraphs (a) or (b) of this section. If an agent is authorized for use pursuant to this paragraph, the OSC shall notify as soon as possible the EPA RRT representative and as appropriate, the RRT representatives from the affected state(s) and the Department of Commerce and Department of the Interior natural resource trustees. The OSC shall document the circumstances and the reasons for use of the agent authorized pursuant to this paragraph. Agent use for individual circumstances under this exception shall be in accordance with paragraphs (a) or (b) of this section no later than 24 hours after initial application. </P> <P> (e) <E T="03">Prohibited agents or substances.</E> The OSC may not authorize the use of the following: </P> <P>(1) Sinking agents, or any other chemical agent, biological agent, or any substance that is used to directly sink the oil to the bottom of a water body.</P> <P>(2) [Reserved]</P> <P> (f) <E T="03">Storage and use of agents listed on the NCP Product Schedule.</E> (1) The OSC may authorize for use only products listed on the NCP Product Schedule that are documented and certified by the responsible party or its representative to have been stored under the conditions provided by the submitter under § 300.915(a)(6), and whose date of use does not exceed the expiration date listed on the container's label unless otherwise specified for expired products as provided in § 300.910(f)(2), at the time of the incident. <PRTPAGE P="102"/> </P> <P>(2) The OSC may authorize for use products listed on the NCP Product Schedule that exceed their expiration date after the responsible party or its representative documents and certifies that the expired product has been stored under the conditions provided by the submitter under § 300.915(a)(6) and still meets the applicable efficacy and toxicity listing provisions under § 300.915, based on testing of representative samples within the previous 12 months.</P> <P> (g) <E T="03">Supplemental testing, monitoring, and information.</E> The RRT may require, for both planning and response, including authorization of use, supplemental toxicity and efficacy testing, or submission of available data and information that addresses site, area, and ecosystem-specific concerns relative to the use of any chemical or biological agent. The product manufacturer or responsible party shall provide, upon request of the RRT or OSC, additional monitoring or testing data and information to inform chemical or biological agent use decisions specific to a response. </P> <P> (h) <E T="03">Recovery of chemical agents and other substances from the environment.</E> The responsible party shall ensure that removal actions adequately contain, collect, store, and dispose of chemical agents and other substances that are to be recovered from the environment, unless otherwise directed by the OSC. Chemical agents and other substances to be recovered include solidifiers, surface washing agents, and sorbents. The OSC should, at a minimum, consider factors such as the safety of response personnel and harm to the environment in making determinations pursuant to this paragraph. </P> <P> (i) <E T="03">Reporting of agent use.</E> (1) The authorizing OSC shall provide the RRT the following information on chemical and biological agents used in response to an oil discharge: product name, product category, quantity and concentrations used, duration of use, location(s) of use, any available data collected, and any available analyses of efficacy and environmental effects. This information must be provided within 30 days of completion of agent use. This information may be submitted in accordance with the OSC reporting provisions under § 300.165 of this part, as applicable, subject to the 30-day timing requirement. </P> <P>(2) In support of sections 300.135(n) and 300.155(a) and (b) of this part, the authorizing OSC shall provide for notification to the public, updated during a response as appropriate, the following information on chemical and biological agents used in response to an oil discharge: product name, product category, quantity and concentrations used, duration of use, and location(s) of use.</P> <CITA>[88 FR 38333, June 12, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.913</SECTNO> <SUBJECT>Monitoring the use of dispersants.</SUBJECT> <P>The responsible party shall monitor any subsurface use of dispersant in response to an oil discharge, any surface use of dispersant for more than 96 hours after initial application in response to an oil discharge, and any surface use of dispersant in response to oil discharges of more than 100,000 U.S. gallons occurring within a 24-hour period, and shall submit a Dispersant Monitoring Quality Assurance Project Plan (DMQAPP) covering the collection of environmental data within this section to the OSC. When any dispersant is used subsurface in response to an oil discharge, the responsible party shall implement paragraphs (a) through (g) of this section for the entire duration of the subsurface dispersant use. When any dispersant is used on the surface in response to oil discharges of greater than 100,000 U.S. gallons occurring within a 24-hour period, the responsible party shall implement paragraphs (a) through (g) of this section as soon as possible for the entire or remaining duration of surface dispersant use, as applicable. When any dispersant is used on the surface in response to an oil discharge for more than 96 hours after initial application, the responsible party shall implement paragraphs (a) through (g) of this section for the remaining duration of surface dispersant use.</P> <P>(a) Document:</P> <P>(1) The characteristics of the source oil.</P> <P> (2) The best estimate of the oil discharge volume or flow rate, periodically reevaluated as conditions dictate, <PRTPAGE P="103"/> including a description of the method, associated uncertainties, and materials. </P> <P>(3) The dispersant used, rationale for dispersant choice(s) including the results of any efficacy and toxicity tests specific to area or site conditions, recommended dispersant-to-oil ratio (DOR).</P> <P>(4) The application method(s) and procedures, including a description of the equipment to be used, hourly application rates, capacities, and total amount of dispersant.</P> <P>(5) For subsurface discharges, the best estimate of the discharge flow rate of any associated volatile petroleum hydrocarbons, periodically reevaluated as conditions dictate, including a description of the method, associated uncertainties, and materials.</P> <P>(b) Collect a representative set of ambient background water column samples in areas not affected by the discharge of oil, at the closest safe distance from the discharge as determined by the OSC, and in all directions of likely oil transport considering surface and subsurface currents. Collect a representative set of baseline water column samples absent dispersant application at such depths and locations affected by the oil discharge, considering surface and subsurface currents, oil properties, and other relevant discharge conditions. On a daily basis, collect dispersed oil plume water column samples at such depths and locations where dispersed oil is likely to be present, considering surface and subsurface currents, oil properties, and other relevant discharge conditions. Collect these ambient background, baseline, and dispersed oil plume water column samples following standard operating and quality assurance procedures. Analyze the collected ambient background, baseline, and dispersed oil plume water column samples for:</P> <P>(1) In-situ oil droplet size distribution, including mass or volume mean diameter for droplet sizes ranging from 2.5 to 2,000 µm, with the majority of data collected between the 2.5 and 100 µm size.</P> <P>(2) In-situ fluorometry and fluorescence signatures targeted to the type of oil discharged and referenced against the source oil.</P> <P>(3) Dissolved oxygen (DO) (subsurface only).</P> <P>(4) Total petroleum hydrocarbons, individual resolvable constituents including volatile organic compounds, aliphatic hydrocarbons, monocyclic, polycyclic, and other aromatic hydrocarbons including alkylated homologs, and hopane and sterane biomarker compounds.</P> <P>(5) Methane, if present (subsurface only).</P> <P>(6) Heavy metals, including nickel and vanadium.</P> <P>(7) Turbidity.</P> <P>(8) Water temperature.</P> <P>(9) pH.</P> <P>(10) Conductivity.</P> <P>(c) Considering available technologies, characterize the dispersant effectiveness and oil distribution including trajectory, accounting for the condition of oil, dispersant, and dispersed oil components from the discharge location, and describing associated uncertainties.</P> <P> (d) Characterize the ecological receptors ( <E T="03">e.g.,</E> aquatic species, wildlife, and/or other biological resources) and their habitats that may be present in the discharge area and their exposure pathways. The characterization shall include, but is not limited to, those species that may be in sensitive life stages, transient or migratory species, breeding or breeding-related activities ( <E T="03">e.g.,</E> embryo and larvae development), and threatened and/or endangered species that may be exposed to the oil that is not dispersed, the dispersed oil, and the dispersant alone. The responsible party shall also estimate an acute toxicity level of concern for the dispersed oil using available dose-response information relevant to potentially exposed species following a species sensitivity distribution. </P> <P>(e) Immediately report to the OSC any:</P> <P>(1) Deviation of more than 10 percent from the mean hourly dispersant use rate for subsurface application, based on the dispersant volume authorized for 24 hours use, and the reason for the deviation.</P> <P> (2) Ecological receptors of environmental importance, and any other ecological receptors as identified by the OSC or the Natural Resource Trustees, <PRTPAGE P="104"/> including any threatened or endangered species that may be exposed based on dispersed plume trajectory modeling and level of concern information. </P> <P>(f) Report daily to the OSC water sampling and data analyses collected in paragraph (b) of this section and include:</P> <P>(1) For each application platform, the actual amount of dispersant used for each one-hour period and the total amount of dispersant used for the previous 24-hour reporting period.</P> <P> (2) All collected data and analyses of those data within a time frame necessary to make operational decisions ( <E T="03">e.g.,</E> within 24 hours of collection), including documented observations, photographs, video, and any other information related to dispersant use, unless an alternate time frame is authorized by the OSC. </P> <P>(3) For analyses that take more than 24 hours due to analytical methods, provide such data and results as available but no later than five days, unless an alternate time frame is authorized by the OSC.</P> <P>(4) Estimates of the daily transport of dispersed oil, non-dispersed oil, the associated volatile petroleum hydrocarbons, and dispersants, using available technology as described in paragraph (c) of this section.</P> <P>(g) Report all information provided to the OSC under paragraphs (e) and (f) of this section to the applicable RRT(s).</P> <CITA>[86 FR 40263, July 27, 2021]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.915</SECTNO> <SUBJECT>Data and information requirements for listing on the NCP Product Schedule or Sorbent Product List.</SUBJECT> <P>If you are submitting an application for listing a product to the NCP Product Schedule or Sorbent Product List, you must provide EPA the information required under § 300.955. Technical product data submissions are not required for burning agents. Your submission for each product must contain:</P> <P> (a) <E T="03">General information for any product category.</E> (1) Your name, physical address, email, and telephone number; </P> <P>(2) Your identity and documentation of that identity, as the manufacturer of the product, vendor, importer, distributor of the product, and/or a designated agent acting on behalf of the manufacturer.</P> <P>(3) All name(s), brand(s), and/or trademark(s) under which the product is to be sold;</P> <P> (4) Names, physical addresses, emails <E T="03">,</E> and telephone numbers of the primary distributors, vendors, importers and/or designated agent acting on behalf of the manufacturer; </P> <P>(5) The Safety Data Sheet (SDS) for the product;</P> <P>(6) The maximum, minimum, and optimum temperature, humidity, and other relevant conditions for product storage and a brief description of the consequences to performance if the product is not stored within these limits;</P> <P>(7) The anticipated shelf life of the product at the storage conditions noted in paragraph (a)(6) of this section and documentation for this determination;</P> <P>(8) A sample product label for all name(s), brand(s), and/or trademark(s) under which the product is to be sold that includes manufacture and expiration dates, and conditions for storage. You may use an existing label provided it already contains the required dates and storage information;</P> <P> (9) The chemical or biological agent category under which you want the product to be considered for listing on the NCP Product Schedule, including detailed information on the specific process(es) through which the product affects the oil, and the specific environment(s) on which it is intended to be used ( <E T="03">e.g.,</E> waters and/or adjoining shorelines). If your product meets the definition of more than one chemical or biological agent category, you must identify all applicable categories and provide the test data to meet the listing criteria appropriate to each; </P> <P> (10) Recommended product use procedures, including product concentrations, use ratios, types of application equipment, conditions for use, any application restrictions; and, as applicable, procedures for product and oil containment, collection, recovery, and disposal. These procedures must address, as appropriate, variables such as weather, water salinity, water temperature, types and weathering states <PRTPAGE P="105"/> of oils or other pollutants. The procedures must include supporting documentation and current applicable standard methods used to determine them; </P> <P>(11) Available information on environmental fate, including any known measured data, methodologies, and supporting documentation, on the persistence, bioconcentration factor, bioaccumulation factor, and biodegradability of the product and all of its components in the environment;</P> <P>(12) The physical and chemical properties of the product, as appropriate, and a citation for the current applicable standard methods used to determine them, including:</P> <P>(i) Physical state and appearance;</P> <P>(ii) Vapor pressure;</P> <P>(iii) Flash point;</P> <P>(iv) Pour point;</P> <P>(v) Viscosity;</P> <P>(vi) Specific gravity;</P> <P>(vii) Particle size for solid components; and</P> <P>(viii) pH;</P> <P> (13) The identity and concentration of all components in the product, including each specific component name; corresponding Chemical Abstract Service (CAS) Registry Number; the maximum, minimum, and average weight percent of each component in the product; and the intended function of each component ( <E T="03">e.g.,</E> solvent, surfactant); </P> <P>(14) For products that also contain microorganisms, enzymes, and/or nutrients, provide the following along with a citation or a description of the methodology used to determine:</P> <P>(i) The name of all microorganisms by current genus and species, including any reclassifications, and any physical, chemical, or biological manipulation of the genetic composition and the weight percent of each genus in the product;</P> <P>(ii) The name of all enzymes and their International Union of Biochemistry (I.U.B.) number(s); Enzyme Classification (EC) code numbers; the source of each enzyme; units; and specific oil-degrading activity;</P> <P>(iii) The name(s), maximum, minimum, and average weight percent of the nutrients contained in the product; and</P> <P> (iv) Data, methodology, and supporting documentation, for the levels of bacterial, fungal, or viral pathogens or opportunistic pathogens including, but not limited to: enteric bacteria such as <E T="03">Salmonella,</E> fecal coliforms, <E T="03">Shigella,</E> coagulase positive <E T="03">Staphylococci,</E> and beta hemolytic <E T="03">Streptococci</E> and enterococci; </P> <P>(15) Data, methodology, and supporting documentation for the levels of the following:</P> <P>(i) Arsenic, cadmium, chromium, copper, lead, mercury, nickel, vanadium, zinc, and any other heavy metal reasonably expected to be in the product;</P> <P>(ii) Cyanide;</P> <P>(iii) Chlorinated hydrocarbons;</P> <P>(iv) Pesticides;</P> <P>(v) Polychlorinated Biphenyls (PCBs); and</P> <P>(vi) Polycyclic aromatic hydrocarbons (PAHs).</P> <P>(16) Certification, including data, methodology, and supporting documentation, indicating that the product does not contain any of the prohibited agents or substances identified in § 300.910(e);</P> <P>(17) Information about the accredited laboratory that conducted the required tests, including:</P> <P>(i) Name of the laboratory, address, contact name, email, and phone number; and</P> <P>(ii) The national and/or international accreditations held by the laboratory that are applicable to the test(s) performed;</P> <P>(18) All test data and calculations, including:</P> <P>(i) Raw data and replicates, including positive controls;</P> <P>(ii) Notes and observations collected during tests;</P> <P>(iii) Calculated mean values and standard deviations;</P> <P>(iv) Reports, including a summary of stock solution preparation;</P> <P>(v) Source and preparation of test organisms;</P> <P>(vi) Test conditions; and</P> <P>(vii) Chain of custody forms;</P> <P> (19) An estimate of the annual product production volume, the average and maximum amount that could be produced per day, and the time frame needed to reach that maximum production rate in days; <PRTPAGE P="106"/> </P> <P>(20) Recognition received from EPA's Design for the Environment (DfE) or Safer Choice programs, as applicable; and</P> <P>(21) International product testing or use data or certifications, if available, informing the performance capabilities or environmental impacts of the product.</P> <P> (b) <E T="03">Dispersant testing and listing requirements</E> —(1) <E T="03">Dispersant efficacy test and listing criteria.</E> Test the dispersant product for efficacy using the Baffled Flask Test (BFT) method in Appendix C to part 300. To be listed on the NCP Product Schedule, the dispersant must demonstrate for each temperature a Dispersant Effectiveness (DE) at the 95% lower confidence level (LCL <E T="52">95</E> ) greater than or equal to: </P> <P>(i) ≥70% for Strategic Petroleum Reserve Bryan Mound at 5 °C;</P> <P>(ii) ≥75% for Strategic Petroleum Reserve Bryan Mound at 25 °C;</P> <P> (2) <E T="03">Dispersant toxicity tests and listing criteria.</E> Use the methods specified in Appendix C to part 300 to test the dispersant alone, and the dispersant mixed with Strategic Petroleum Reserve Bryan Mound for acute toxicity, using <E T="03">Americamysis bahia</E> and <E T="03">Menidia beryllina.</E> Use the methods specified in Appendix C to part 300 to test the dispersant alone for developmental toxicity using <E T="03">Strongylocentrotus purpuratus</E> or <E T="03">Arbacia punctulata</E> and for subchronic effects using <E T="03">Americamysis bahia</E> and <E T="03">Menidia beryllina.</E> To be listed on the NCP Product Schedule, the dispersant alone must demonstrate: </P> <P> (i) A median lethal concentration (LC <E T="52">50</E> ) at the lower 95% confidence interval greater than 10 ppm; </P> <P> (ii) An inhibition concentration for 50% of the test species (IC <E T="52">50</E> ) at the lower 95% confidence interval greater than 1 ppm; and </P> <P>(iii) A subchronic No Observed Effect Concentration (NOEC) greater than 1 ppm.</P> <P> (3) <E T="03">Limitations.</E> A dispersant may only be listed on the NCP Product Schedule for use in saltwater environments for which it meets the efficacy and toxicity listing criteria. </P> <P> (c) <E T="03">Surface washing agent testing and listing requirements</E> —(1) <E T="03">Surface washing agent efficacy test and listing criteria.</E> To be listed on the NCP Product Schedule, using an applicable standard methodology, the surface washing agent must meet an efficacy of greater than or equal to 30% in either freshwater or saltwater, or both, depending on the intended product use. </P> <P> (2) <E T="03">Surface washing agent toxicity test and listing criteria.</E> Using the toxicity test methodology in Appendix C to part 300, test the surface washing agent for acute toxicity against freshwater species <E T="03">Ceriodaphnia dubia</E> and <E T="03">Pimephales promelas,</E> or saltwater species <E T="03">Americamysis bahia</E> and <E T="03">Menidia beryllina,</E> or both, depending on the intended product use. To be listed on the NCP Product Schedule, the surface washing agent must demonstrate an LC <E T="52">50</E> at the lower 95% confidence interval greater than 10 ppm in either freshwater or saltwater for all tested species. </P> <P> (3) <E T="03">Limitations.</E> Surface washing agent listing would be for use only in freshwater and/or saltwater environments for which it was tested and for which it met the efficacy and toxicity listing criteria. </P> <P> (d) <E T="03">Bioremediation agent testing and listing requirements</E> —(1) <E T="03">Bioremediation agent efficacy test and listing criteria.</E> To be listed on the NCP Product Schedule, a bioremediation agent must successfully degrade both alkanes and aromatics as determined by gas chromatography/mass spectrometry (GC/MS) in freshwater or saltwater, or both, depending on the intended product use, following the test method specified in Appendix C to part 300. The percentage reduction of total alkanes (aliphatic fraction) from the GC/MS analysis must be greater than or equal to 85% at day 28, based on the ninety-fifth (95th) percentile Upper Confidence Limit (UCL <E T="52">95</E> ) for both freshwater and saltwater. The percentage reduction of total aromatics (aromatic fraction) must be greater than or equal to 35% at day 28 for both saltwater and freshwater based on the UCL95. </P> <P> (2) <E T="03">Bioremediation agent toxicity test and listing criteria.</E> The bioremediation agent must be tested for acute toxicity in freshwater or saltwater, or both, depending on the intended product use, following the method specified in Appendix C to part 300. To be listed on the <PRTPAGE P="107"/> NCP Product Schedule, the bioremediation agent must demonstrate an LC <E T="52">50</E> at the lower 95% confidence interval greater than 10 ppm in either freshwater or saltwater for all tested species. </P> <P> (3) <E T="03">Limitations.</E> Bioremediation agent listing would be for use only in the freshwater and/or saltwater environments for which it was tested and for which it met the efficacy and toxicity listing criteria. </P> <P> (4) <E T="03">Generic listing.</E> If the product consists solely of: ammonium nitrate, ammonium phosphate, ammonium sulfate, calcium ammonium nitrate, sodium nitrate, potassium nitrate, synthetically-derived urea, sodium triphosphate (or tripolyphosphate), sodium phosphate, potassium phosphate (mono- or dibasic), triple super phosphate, potassium sulphate, or any combination thereof, no technical product data are required. The product will be generically listed as non-proprietary nutrients on the NCP Product Schedule, and no further action is necessary. </P> <P> (e) <E T="03">Solidifier testing and listing requirements.</E> (1) Solidifiers must be tested for acute toxicity in freshwater or saltwater, or both, depending on the intended product use, following the method specified in Appendix C to part 300. To be listed on the NCP Product Schedule, the solidifier must demonstrate an LC <E T="52">50</E> at the lower 95% confidence interval greater than 10 ppm in either freshwater or saltwater for all tested species. </P> <P> (2) <E T="03">Limitations.</E> Solidifier listing would be for use only in the freshwater and/or saltwater environments for which it was tested and for which it met the toxicity listing criteria. </P> <P> (f) <E T="03">Herding agent testing and listing requirements.</E> (1) Herding agents must be tested for acute toxicity in freshwater or saltwater, or both, depending on the intended product use, following the method specified in Appendix C to part 300. To be listed on the NCP Product Schedule, the herding agent must demonstrate an LC <E T="52">50</E> at the lower 95% confidence interval greater than 10 ppm in either freshwater or saltwater for all tested species. </P> <P> (2) <E T="03">Limitations.</E> Herding agent listing would be for use only in freshwater and/or saltwater environments for which it was tested and for which it met the toxicity listing criteria. </P> <P> (g) <E T="03">Sorbent requirements.</E> Known sorbent materials and products will be identified on a publicly available Sorbent Product List for the use of such products when responding to an oil discharge as follows: </P> <P>(1) For sorbent products that consist solely of the following materials, or any combination thereof, no technical data are required to be submitted for listing on the Sorbent Product List, and no further action is necessary for use as a sorbent:</P> <P>(i) Feathers, cork, peat moss, and cellulose fibers such as bagasse, corncobs, and straw;</P> <P>(ii) Volcanic ash, perlite, vermiculite, zeolite, and clay; and</P> <P>(iii) Polypropylene, polyethylene, polyurethane, and polyester.</P> <P>(2) If the product consists of one or more natural organic substances, inorganic/mineral compounds, and/or synthetic compounds not specifically identified in paragraph (g)(1) of this section but you believe the product meets the definition of a sorbent then, as applicable under § 300.955(a) and (b), you must submit the following information for consideration for listing it as a sorbent on the Sorbent Product List:</P> <P>(i) The information required under paragraphs (a)(1) through (a)(8), and paragraph (a)(13) through (a)(15) of this section;</P> <P>(ii) The certification required under paragraph (a)(16) of this section; and</P> <P>(iii) Information, including data, to support the claim your product meets the sorbent definition under § 300.5.</P> <CITA>[88 FR 38334, June 12, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.950</SECTNO> <SUBJECT>Submission of Proprietary Business Information (PBI).</SUBJECT> <P>(a) Except as provided in paragraph (b) of this section, all product information submitted to EPA as required under § 300.915 and § 300.955 will be available for public disclosure upon submission, without further notice to the submitter.</P> <P> (b) You may only claim as PBI the concentration; the maximum, minimum, and average weight percent; and the units of each component as identified in § 300.915(a)(13) and (14) and as applicable. EPA will handle such claims <PRTPAGE P="108"/> in accordance with 40 CFR part 2, subpart B Confidentiality of Business Information. </P> <P>(1) You must make your PBI claim at the time you submit your information to EPA to be listed on the NCP Product Schedule or Sorbent Product List.</P> <P>(2) You must separate the PBI from all other submitted information. Include all PBI separately with your submission package, marking it as “Proprietary Business Information” and placing it in a separate inner envelope labeled with “PROPRIETARY BUSINESS INFORMATION—TO BE OPENED BY THE PRODUCT SCHEDULE MANAGER ONLY.”</P> <CITA>[88 FR 38336, June 12, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.955</SECTNO> <SUBJECT>Addition of a product to the NCP Product Schedule or Sorbent ProductLlist.</SUBJECT> <P> (a) <E T="03">Submission.</E> Submit your complete package to: U.S. Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Mail Code: 5104A, Room 1448, William J. Clinton North, Washington, DC 20460, Attention: Product Schedule Manager. </P> <P> (b) <E T="03">Package contents.</E> Your package shall include, as applicable, in this order: </P> <P>(1) A cover letter on company letterhead signed and dated by you certifying that:</P> <P>(i) All testing was conducted on representative product samples;</P> <P>(ii) Testing was conducted at a nationally or internationally accredited laboratory in accordance with the methods specified in Appendix C to part 300, and other applicable methods as appropriate; and</P> <P>(iii) All test results and product technical data and information are true and accurate.</P> <P>(2) A page numbered Table of Contents showing the information and data submitted under § 300.915(a) through (g), as applicable;</P> <P>(3) All required data and information arranged in the same order as specified in § 300.915(a) through (g); and</P> <P>(4) A separate envelope containing and labeled Proprietary Business Information as specified in § 300.950(b), if applicable.</P> <P> (c) <E T="03">EPA Review.</E> EPA shall, within 90 days of receiving a submission package: </P> <P>(1) Review the package for completeness and compliance with all data and information requirements in §§ 300.915, 300.950, and this section; verify information; and request clarification or additional information, including testing as necessary;</P> <P>(2) Make a product listing determination based on a technical evaluation of all data and information submitted in accordance with the requirements for each product category, relevant information on impacts or potential impacts of the product or any of its components on human health or the environment, and the intended use of the product; and</P> <P>(3) Notify you in writing of its decision to list the product on the NCP Product Schedule or the Sorbent Product List, or of its decision and supporting rationale to reject the submission. If your submission is rejected:</P> <P>(i) You may revise and resubmit a complete package to address test results, data, or information deficiencies.</P> <P>(ii) EPA's 90-day review will not start until a complete package is resubmitted.</P> <P> (d) <E T="03">Request for review of decision.</E> If your product is rejected for listing on the NCP Product Schedule or the Sorbent Product List, you may request that the EPA Administrator or designee review the determination. Your request must be in writing within 30 days of receipt of notification of EPA's decision not to list the product on the NCP Product Schedule or the Sorbent Product List. Your request must contain a clear and concise statement with supporting facts and technical analysis demonstrating why the product meets the listing requirements. </P> <P>(1) The EPA Administrator or designee may request additional information from you and may offer an opportunity for you to meet with EPA.</P> <P>(2) The EPA Administrator or designee will notify you in writing of the decision within 60 days of receipt of your request, or within 60 days of receipt of requested additional information.</P> <P> (e) <E T="03"> Changes to a product listing</E> —(1) <E T="03">Administrative change.</E> You must notify <PRTPAGE P="109"/> EPA in writing within 30 days of any changes to information submitted under § 300.915(a)(1) through (8) and § 300.915(a)(19) through (21) for a product on the NCP Product Schedule. In the notification, you must detail the specific changes, the reasons for such changes and supporting data and information. EPA may request additional information and clarification regarding these changes. </P> <P> (2) <E T="03">Reformulation.</E> If you change the components and/or concentrations, you must retest the reformulated product according to the requirements for the product category and submit a new complete package under a new, distinct name in accordance with § 300.955(b) for review and consideration for listing on the NCP Product Schedule or Sorbent Product List by EPA. </P> <P> (f) <E T="03">Transitioning Listed Products to the New NCP Product Schedule or Sorbent Product List.</E> All products on the current NCP Product Schedule as of December 11, 2023 will remain conditionally listed until December 12, 2025 at which time all products that have not been submitted and listed in the new NCP Product Schedule based on the amended test and listing criteria will be removed. Your product will be transitioned from the current NCP Product Schedule to the new NCP Product Schedule prior to December 12, 2025 after you submit a new complete package in accordance with § 300.955(b), and EPA makes a determination to list the product on the new NCP Product Schedule. All products previously identified as sorbents by EPA will remain available for use until December 12, 2025, at which time all sorbent products must have submitted information as applicable under § 300.955(a) and (b) and be listed in the new Sorbent Product List. </P> <CITA>[88 FR 38337, June 12, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.965</SECTNO> <SUBJECT>Mandatory Product Disclaimer.</SUBJECT> <P>The listing of a product on the NCP Product Schedule does not constitute approval or recommendation of the product. To avoid possible misinterpretation or misrepresentation, any label, advertisement, or technical literature for products listed on the NCP Product Schedule must display in its entirety the disclaimer shown below. The disclaimer must be conspicuous and must be fully reproduced on all product literatures, labels, and electronic media including website pages.</P> <HD SOURCE="HD3">Disclaimer</HD> <P>[PRODUCT NAME] is listed on the National Contingency Plan (NCP) Product Schedule. This listing does NOT mean that EPA approves, recommends, licenses, or certifies the use of [PRODUCT NAME] on an oil discharge. This listing means only that data have been submitted to EPA as required by Subpart J of the NCP. Only a Federal On-Scene Coordinator (OSC) may authorize use of this product in accordance with Subpart J of the NCP in response to an oil discharge.</P> <CITA>[88 FR 38337, June 12, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 300.970</SECTNO> <SUBJECT>Removal of a product from the NCP Product Schedule or Sorbent Product List.</SUBJECT> <P>(a) The EPA Administrator or designee may remove your product from the NCP Product Schedule or the Sorbent Product List for reasons including, but not limited to:</P> <P>(1) Statements or information that are misleading, inaccurate, outdated, or incorrect regarding the composition or use of the product to remove or control oil discharges made to any person, or private or public entity, including on labels, advertisements, technical literature, electronic media, or within the product submission to EPA; or</P> <P>(2) Alterations to the components, concentrations, or use conditions of the product without proper notification to EPA as required by § 300.955(e); or</P> <P>(3) Failure to print the disclaimer provided in § 300.965 on all labels, advertisements, technical literature, or electronic media for products listed on the NCP Product Schedule; or</P> <P>(4) New or relevant information not previously considered concerning the impacts or potential impacts of the product to human health or the environment.</P> <P> (b) EPA will notify you in writing, at your address of record, of its reasons for deciding to remove the product from the NCP Product Schedule. If EPA receives no appeal from you in 30 <PRTPAGE P="110"/> days, the product will be removed from the NCP Product Schedule without further notice to you. </P> <P>(c) You may appeal the decision to remove your product from the NCP Product Schedule within 30 days of receipt of EPA's notification. Your appeal must contain a clear and concise statement with supporting facts and technical analysis demonstrating why the product should not be removed. The EPA Administrator or designee will notify you in writing of the decision within 60 days of your appeal, or within 60 days of receipt of any requested additional information.</P> <CITA>[88 FR 38337, June 12, 2023]</CITA> </SECTION> </SUBPART> <SUBPART> <RESERVED>Subpart K—Federal Facilities [Reserved]</RESERVED> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart L—National Oil and Hazardous Substances Pollution Contingency Plan; Involuntary Acquisition of Property by the Government</HD> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>62 FR 34602, June 26, 1997, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 300.1105</SECTNO> <SUBJECT>Involuntary acquisition of property by the government.</SUBJECT> <P>(a) Governmental ownership or control of property by involuntary acquisitions or involuntary transfers within the meaning of CERCLA section 101(20)(D) or section 101(35)(A)(ii) includes, but is not limited to:</P> <P>(1) Acquisitions by or transfers to the government in its capacity as a sovereign, including transfers or acquisitions pursuant to abandonment proceedings, or as the result of tax delinquency, or escheat, or other circumstances in which the government involuntarily obtains ownership or control of property by virtue of its function as sovereign;</P> <P>(2) Acquisitions by or transfers to a government entity or its agent (including governmental lending and credit institutions, loan guarantors, loan insurers, and financial regulatory entities which acquire security interests or properties of failed private lending or depository institutions) acting as a conservator or receiver pursuant to a clear and direct statutory mandate or regulatory authority;</P> <P>(3) Acquisitions or transfers of assets through foreclosure and its equivalents (as defined in 40 CFR 300.1100(d)(1)) or other means by a Federal, state, or local government entity in the course of administering a governmental loan or loan guarantee or loan insurance program; and</P> <P>(4) Acquisitions by or transfers to a government entity pursuant to seizure or forfeiture authority.</P> <P>(b) Nothing in this section or in CERCLA section 101(20)(D) or section 101(35)(A)(ii) affects the applicability of 40 CFR 300.1100 to any security interest, property, or asset acquired pursuant to an involuntary acquisition or transfer, as described in this section.</P> <NOTE> <HD SOURCE="HED"> Note to paragraphs ( <E T="01">a</E> )(3) and ( <E T="01">b</E> of this section: </HD> <P> Reference to 40 CFR 300.1100 is a reference to the provisions regarding secured creditors in CERCLA sections 101(20)(E)-(G), 42 U.S.C. 9601(20)(E)-(G). <E T="03">See</E> Section 2504(a) of the Asset Conservation, Lender Liability, and Deposit Insurance Protection Act, Public Law, 104-208, 110 Stat. 3009-462, 3009-468 (1996). </P> </NOTE> </SECTION> <APPENDIX> <EAR>Pt. 300, App. A</EAR> <HD SOURCE="HED">Appendix A to Part 300—The Hazard Ranking System</HD> <HD SOURCE="HD2">Table of Contents</HD> <FP SOURCE="FP-2">List of Figures</FP> <FP SOURCE="FP-2">List of Tables</FP> <FP SOURCE="FP-2">1.0. Introduction.</FP> <FP SOURCE="FP-2">1.1 Definitions.</FP> <FP SOURCE="FP-2">2.0 Evaluations Common to Multiple Pathways.</FP> <FP SOURCE="FP-2">2.1 Overview.</FP> <FP SOURCE="FP-2">2.1.1 Calculation of HRS site score.</FP> <FP SOURCE="FP-2">2.1.2 Calculation of pathway score.</FP> <FP SOURCE="FP-2">2.1.3 Common evaluations.</FP> <FP SOURCE="FP-2">2.2 Characterize sources.</FP> <FP SOURCE="FP-2">2.2.1 Identify sources.</FP> <FP SOURCE="FP-2">2.2.2 Identify hazardous substances associated with a source.</FP> <FP SOURCE="FP-2">2.2.3 Identify hazardous substances available to a pathway.</FP> <FP SOURCE="FP-2">2.3 Likelihood of release.</FP> <FP SOURCE="FP-2">2.4 Waste characteristics.</FP> <FP SOURCE="FP-2">2.4.1 Selection of substance potentially posing greatest hazard.</FP> <FP SOURCE="FP1-2">2.4.1.1 Toxicity factor.</FP> <FP SOURCE="FP1-2">2.4.1.2 Hazardous substance selection.</FP> <FP SOURCE="FP-2">2.4.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">2.4.2.1 Source hazardous waste quantity.</FP> <FP SOURCE="FP1-2">2.4.2.1.1 Hazardous constituent quantity.</FP> <FP SOURCE="FP1-2">2.4.2.1.2 Hazardous wastestream quantity.</FP> <FP SOURCE="FP1-2">2.4.2.1.3 Volume.</FP> <FP SOURCE="FP1-2">2.4.2.1.4 Area.</FP> <FP SOURCE="FP1-2"> 2.4.2.1.5 Calculation of source hazardous waste quantity value. <PRTPAGE P="111"/> </FP> <FP SOURCE="FP1-2">2.4.2.2 Calculation of hazardous waste quantity factor value.</FP> <FP SOURCE="FP-2">2.4.3 Waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">2.4.3.1 Factor category value.</FP> <FP SOURCE="FP1-2">2.4.3.2 Factor category value, considering bioaccumulation potential.</FP> <FP SOURCE="FP-2">2.5 Targets.</FP> <FP SOURCE="FP-2">2.5.1 Determination of level of actual contamination at a sampling location.</FP> <FP SOURCE="FP-2">2.5.2 Comparison to benchmarks.</FP> <FP SOURCE="FP-2">3.0 Ground Water Migration Pathway.</FP> <FP SOURCE="FP-2">3.0.1 General considerations.</FP> <FP SOURCE="FP1-2">3.0.1.1 Ground water target distance limit.</FP> <FP SOURCE="FP1-2">3.0.1.2 Aquifer boundaries.</FP> <FP SOURCE="FP1-2">3.0.1.2.1 Aquifer interconnections.</FP> <FP SOURCE="FP1-2">3.0.1.2.2 Aquifer discontinuities.</FP> <FP SOURCE="FP1-2">3.0.1.3 Karst aquifer.</FP> <FP SOURCE="FP-2">3.1 Likelihood of release.</FP> <FP SOURCE="FP-2">3.1.1 Observed release.</FP> <FP SOURCE="FP-2">3.1.2 Potential to release.</FP> <FP SOURCE="FP1-2">3.1.2.1 Containment.</FP> <FP SOURCE="FP1-2">3.1.2.2 Net precipitation.</FP> <FP SOURCE="FP1-2">3.1.2.3 Depth to aquifer.</FP> <FP SOURCE="FP1-2">3.1.2.4 Travel time.</FP> <FP SOURCE="FP1-2">3.1.2.5 Calculation of potential to release factor value.</FP> <FP SOURCE="FP-2">3.1.3 Calculation of likelihood of release factor category value.</FP> <FP SOURCE="FP-2">3.2 Waste characteristics.</FP> <FP SOURCE="FP-2">3.2.1 Toxicity/mobility.</FP> <FP SOURCE="FP1-2">3.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">3.2.1.2 Mobility.</FP> <FP SOURCE="FP1-2">3.2.1.3 Calculation of toxicity/mobility factor value.</FP> <FP SOURCE="FP-2">3.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP-2">3.2.3 Calculation of waste characteristics factor category value.</FP> <FP SOURCE="FP-2">3.3 Targets.</FP> <FP SOURCE="FP-2">3.3.1 Nearest well.</FP> <FP SOURCE="FP-2">3.3.2 Population.</FP> <FP SOURCE="FP1-2">3.3.2.1 Level of contamination.</FP> <FP SOURCE="FP1-2">3.3.2.2 Level I concentrations.</FP> <FP SOURCE="FP1-2">3.3.2.3 Level II concentrations.</FP> <FP SOURCE="FP1-2">3.3.2.4 Potential contamination.</FP> <FP SOURCE="FP1-2">3.3.2.5 Calculation of population factor value.</FP> <FP SOURCE="FP-2">3.3.3 Resources.</FP> <FP SOURCE="FP-2">3.3.4 Wellhead Protection Area.</FP> <FP SOURCE="FP-2">3.3.5 Calculation of targets factor category value.</FP> <FP SOURCE="FP-2">3.4 Ground water migration score for an aquifer.</FP> <FP SOURCE="FP-2">3.5 Calculation of ground water migration pathway score.</FP> <FP SOURCE="FP-2">4.0 Surface Water Migration Pathway.</FP> <FP SOURCE="FP-2">4.0.1 Migration components.</FP> <FP SOURCE="FP-2">4.0.2 Surface water categories.</FP> <FP SOURCE="FP-2">4.1 Overland/flood migration component.</FP> <FP SOURCE="FP-2">4.1.1 General considerations.</FP> <FP SOURCE="FP1-2">4.1.1.1 Definition of hazardous substance migration path for overland/flood migration component.</FP> <FP SOURCE="FP1-2">4.1.1.2 Target distance limit.</FP> <FP SOURCE="FP1-2">4.1.1.3 Evaluation of overland/flood migration component.</FP> <FP SOURCE="FP-2">4.1.2 Drinking water threat.</FP> <FP SOURCE="FP1-2">4.1.2.1 Drinking water threat-likelihood of release.</FP> <FP SOURCE="FP1-2">4.1.2.1.1 Observed release.</FP> <FP SOURCE="FP1-2">4.1.2.1.2 Potential to release.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.1 Potential to release by overland flow.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.1.1 Containment.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.1.2 Runoff.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.1.3 Distance to surface water.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.1.4 Calculation of factor value for potential to release by overland flow.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.2 Potential to release by flood.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.2.1 Containment (flood).</FP> <FP SOURCE="FP1-2">4.1.2.1.2.2.2 Flood frequency.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.2.3 Calculation of factor value for potential to release by flood.</FP> <FP SOURCE="FP1-2">4.1.2.1.2.3 Calculation of potential to release factor value.</FP> <FP SOURCE="FP1-2">4.1.2.1.3 Calculation of drinking water threat-likelihood of release factor category value.</FP> <FP SOURCE="FP1-2">4.1.2.2 Drinking water threat-waste characteristics.</FP> <FP SOURCE="FP1-2">4.1.2.2.1 Toxicity/persistence.</FP> <FP SOURCE="FP1-2">4.1.2.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">4.1.2.2.1.2 Persistence.</FP> <FP SOURCE="FP1-2">4.1.2.2.1.3 Calculation of toxicity/persistence factor value.</FP> <FP SOURCE="FP1-2">4.1.2.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">4.1.2.2.3 Calculation of drinking water threat-waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">4.1.2.3 Drinking water threat-targets.</FP> <FP SOURCE="FP1-2">4.1.2.3.1 Nearest intake.</FP> <FP SOURCE="FP1-2">4.1.2.3.2 Population.</FP> <FP SOURCE="FP1-2">4.1.2.3.2.1 Level of contamination.</FP> <FP SOURCE="FP1-2">4.1.2.3.2.2 Level I concentrations.</FP> <FP SOURCE="FP1-2">4.1.2.3.2.3 Level II concentrations.</FP> <FP SOURCE="FP1-2">4.1.2.3.2.4 Potential contamination.</FP> <FP SOURCE="FP1-2">4.1.2.3.2.5 Calculation of population factor value.</FP> <FP SOURCE="FP1-2">4.1.2.3.3 Resources.</FP> <FP SOURCE="FP1-2">4.1.2.3.4 Calculation of drinking water threat-targets factor category value.</FP> <FP SOURCE="FP1-2">4.1.2.4 Calculation of the drinking water threat score for a watershed.</FP> <FP SOURCE="FP-2">4.1.3 Human food chain threat.</FP> <FP SOURCE="FP1-2">4.1.3.1 Human food chain threat-likelihood of release.</FP> <FP SOURCE="FP1-2">4.1.3.2 Human food chain threat-waste characteristics.</FP> <FP SOURCE="FP1-2">4.1.3.2.1 Toxicity/persistence/bioaccumulation.</FP> <FP SOURCE="FP1-2">4.1.3.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">4.1.3.2.1.2 Persistence.</FP> <FP SOURCE="FP1-2">4.1.3.2.1.3 Bioaccumulation potential.</FP> <FP SOURCE="FP1-2">4.1.3.2.1.4 Calculation of toxicity/persistence/bioaccumulation factor value.</FP> <FP SOURCE="FP1-2">4.1.3.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">4.1.3.2.3 Calculation of human food chain threat-waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">4.1.3.3 Human food chain threat-targets.</FP> <FP SOURCE="FP1-2">4.1.3.3.1 Food chain individual.</FP> <FP SOURCE="FP1-2">4.1.3.3.2 Population.</FP> <FP SOURCE="FP1-2">4.1.3.3.2.1 Level I concentrations.</FP> <FP SOURCE="FP1-2"> 4.1.3.3.2.2 Level II concentrations. <PRTPAGE P="112"/> </FP> <FP SOURCE="FP1-2">4.1.3.3.2.3 Potential human food chain contamination.</FP> <FP SOURCE="FP1-2">4.1.3.3.2.4 Calculation of population factor value.</FP> <FP SOURCE="FP1-2">4.1.3.3.3 Calculation of human food chain threat-targets factor category value.</FP> <FP SOURCE="FP1-2">4.1.3.4 Calculation of human food chain threat score for a watershed.</FP> <FP SOURCE="FP-2">4.1.4 Environmental threat.</FP> <FP SOURCE="FP1-2">4.1.4.1 Environmental threat-likelihood of release.</FP> <FP SOURCE="FP1-2">4.1.4.2 Environmental threat-waste characteristics.</FP> <FP SOURCE="FP1-2">4.1.4.2.1 Ecosystem toxicity/persistence/bioaccumulation.</FP> <FP SOURCE="FP1-2">4.1.4.2.1.1 Ecosystem toxicity.</FP> <FP SOURCE="FP1-2">4.1.4.2.1.2 Persistence.</FP> <FP SOURCE="FP1-2">4.1.4.2.1.3 Ecosystem bioaccumulation potential.</FP> <FP SOURCE="FP1-2">4.1.4.2.1.4 Calculation of ecosystem toxicity/persistence/bioaccumulation factor value.</FP> <FP SOURCE="FP1-2">4.1.4.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">4.1.4.2.3 Calculation of environmental threat-waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">4.1.4.3 Environmental threat-targets.</FP> <FP SOURCE="FP1-2">4.1.4.3.1 Sensitive environments.</FP> <FP SOURCE="FP1-2">4.1.4.3.1.1 Level I concentrations.</FP> <FP SOURCE="FP1-2">4.1.4.3.1.2 Level II concentrations.</FP> <FP SOURCE="FP1-2">4.1.4.3.1.3 Potential contamination.</FP> <FP SOURCE="FP1-2">4.1.4.3.1.4 Calculation of environmental threat-targets factor category value.</FP> <FP SOURCE="FP1-2">4.1.4.4 Calculation of environmental threat score for a watershed.</FP> <FP SOURCE="FP-2">4.1.5 Calculation of overland/flood migration component score for a watershed.</FP> <FP SOURCE="FP-2">4.1.6 Calculation of overland/flood migration component score.</FP> <FP SOURCE="FP-2">4.2 Ground water to surface water migration component.</FP> <FP SOURCE="FP-2">4.2.1 General Considerations.</FP> <FP SOURCE="FP1-2">4.2.1.1 Eligible surface waters.</FP> <FP SOURCE="FP1-2">4.2.1.2 Definition of hazardous substance migration path for ground water to surface water migration component.</FP> <FP SOURCE="FP1-2">4.2.1.3 Observed release of a specific hazardous substance to surface water in-water segment.</FP> <FP SOURCE="FP1-2">4.2.1.4 Target distance limit.</FP> <FP SOURCE="FP1-2">4.2.1.5 Evaluation of ground water to surface water migration component.</FP> <FP SOURCE="FP-2">4.2.2 Drinking water threat.</FP> <FP SOURCE="FP1-2">4.2.2.1 Drinking water threat-likelihood of release.</FP> <FP SOURCE="FP1-2">4.2.2.1.1 Observed release.</FP> <FP SOURCE="FP1-2">4.2.2.1.2 Potential to release.</FP> <FP SOURCE="FP1-2">4.2.2.1.3 Calculation of drinking water threat-likelihood of release factor category value.</FP> <FP SOURCE="FP1-2">4.2.2.2 Drinking water threat-waste characteristics.</FP> <FP SOURCE="FP1-2">4.2.2.2.1 Toxicity/mobility/persistence.</FP> <FP SOURCE="FP1-2">4.2.2.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">4.2.2.2.1.2 Mobility.</FP> <FP SOURCE="FP1-2">4.2.2.2.1.3 Persistence.</FP> <FP SOURCE="FP1-2">4.2.2.2.1.4 Calculation of toxicity/mobility/persistence factor value.</FP> <FP SOURCE="FP1-2">4.2.2.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">4.2.2.2.3 Calculation of drinking water threat-waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">4.2.2.3 Drinking water threat-targets.</FP> <FP SOURCE="FP1-2">4.2.2.3.1 Nearest intake.</FP> <FP SOURCE="FP1-2">4.2.2.3.2 Population.</FP> <FP SOURCE="FP1-2">4.2.2.3.2.1 Level I concentrations.</FP> <FP SOURCE="FP1-2">4.2.2.3.2.2 Level II concentrations.</FP> <FP SOURCE="FP1-2">4.2.2.3.2.3 Potential contamination.</FP> <FP SOURCE="FP1-2">4.2.2.3.2.4 Calculation of population factor value.</FP> <FP SOURCE="FP1-2">4.2.2.3.3 Resources.</FP> <FP SOURCE="FP1-2">4.2.2.3.4 Calculation of drinking water threat-targets factor category value.</FP> <FP SOURCE="FP1-2">4.2.2.4 Calculation of drinking water threat score for a watershed.</FP> <FP SOURCE="FP-2">4.2.3 Human food chain threat.</FP> <FP SOURCE="FP1-2">4.2.3.1 Human food chain threat-likelihood of release.</FP> <FP SOURCE="FP1-2">4.2.3.2 Human food chain threat-waste characteristics.</FP> <FP SOURCE="FP1-2">4.2.3.2.1 Toxicity/mobility/persistence/bioaccumulation.</FP> <FP SOURCE="FP1-2">4.2.3.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">4.2.3.2.1.2 Mobility.</FP> <FP SOURCE="FP1-2">4.2.3.2.1.3 Persistence.</FP> <FP SOURCE="FP1-2">4.2.3.2.1.4 Bioaccumulation potential.</FP> <FP SOURCE="FP1-2">4.2.3.2.1.5 Calculation of toxicity/mobility/persistence/bioaccumulation factor value.</FP> <FP SOURCE="FP1-2">4.2.3.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">4.2.3.2.3 Calculation of human food chain threat-waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">4.2.3.3 Human food chain threat-targets.</FP> <FP SOURCE="FP1-2">4.2.3.3.1 Food chain individual.</FP> <FP SOURCE="FP1-2">4.2.3.3.2 Population.</FP> <FP SOURCE="FP1-2">4.2.3.3.2.1 Level I concentrations.</FP> <FP SOURCE="FP1-2">4.2.3.3.2.2 Level II concentrations.</FP> <FP SOURCE="FP1-2">4.2.3.3.2.3 Potential human food chain contamination.</FP> <FP SOURCE="FP1-2">4.2.3.3.2.4 Calculation of population factor value.</FP> <FP SOURCE="FP1-2">4.2.3.3.3 Calculation of human food chain threat-targets factor category value.</FP> <FP SOURCE="FP1-2">4.2.3.4 Calculation of human food chain threat score for a watershed.</FP> <FP SOURCE="FP-2">4.2.4 Environmental threat.</FP> <FP SOURCE="FP1-2">4.2.4.1 Environmental threat-likelihood of release.</FP> <FP SOURCE="FP1-2">4.2.4.2 Environmental threat-waste characteristics.</FP> <FP SOURCE="FP1-2">4.2.4.2.1 Ecosystem toxicity/mobility/persistence/bioaccumulation.</FP> <FP SOURCE="FP1-2">4.2.4.2.1.1 Ecosystem toxicity.</FP> <FP SOURCE="FP1-2">4.2.4.2.1.2 Mobility.</FP> <FP SOURCE="FP1-2">4.2.4.2.1.3 Persistence.</FP> <FP SOURCE="FP1-2">4.2.4.2.1.4 Ecosystem bioaccumulation potential.</FP> <FP SOURCE="FP1-2">4.2.4.2.1.5 Calculation of ecosystem toxicity/mobility/persistence/bioaccumulation factor value.</FP> <FP SOURCE="FP1-2"> 4.2.4.2.2 Hazardous waste quantity. <PRTPAGE P="113"/> </FP> <FP SOURCE="FP1-2">4.2.4.2.3 Calculation of environmental threat-waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">4.2.4.3 Environmental threat-targets.</FP> <FP SOURCE="FP1-2">4.2.4.3.1 Sensitive environments.</FP> <FP SOURCE="FP1-2">4.2.4.3.1.1 Level I concentrations.</FP> <FP SOURCE="FP1-2">4.2.4.3.1.2 Level II concentrations.</FP> <FP SOURCE="FP1-2">4.2.4.3.1.3 Potential contamination.</FP> <FP SOURCE="FP1-2">4.2.4.3.1.4 Calculation of environmental threat-targets factor category value.</FP> <FP SOURCE="FP1-2">4.2.4.4 Calculation of environmental threat score for a watershed.</FP> <FP SOURCE="FP-2">4.2.5 Calculation of ground water to surface water migration component score for a watershed.</FP> <FP SOURCE="FP-2">4.2.6 Calculation of ground water to surface water migration component score.</FP> <FP SOURCE="FP-2">4.3 Calculation of surface water migration pathway score.</FP> <FP SOURCE="FP-2">5.0 Soil Exposure and Subsurface Intrusion Pathway.</FP> <FP SOURCE="FP-2">5.0.1 Exposure components.</FP> <FP SOURCE="FP-2">5.1 Soil exposure component.</FP> <FP SOURCE="FP-2">5.1.0 General considerations.</FP> <FP SOURCE="FP-2">5.1.1 Resident population threat.</FP> <FP SOURCE="FP1-2">5.1.1.1 Likelihood of exposure.</FP> <FP SOURCE="FP1-2">5.1.1.2 Waste characteristics.</FP> <FP SOURCE="FP1-2">5.1.1.2.1 Toxicity.</FP> <FP SOURCE="FP1-2">5.1.1.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">5.1.1.2.3 Calculation of waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">5.1.1.3 Targets.</FP> <FP SOURCE="FP1-2">5.1.1.3.1 Resident individual.</FP> <FP SOURCE="FP1-2">5.1.1.3.2 Resident population.</FP> <FP SOURCE="FP1-2">5.1.1.3.2.1 Level I concentrations.</FP> <FP SOURCE="FP1-2">5.1.1.3.2.2 Level II concentrations.</FP> <FP SOURCE="FP1-2">5.1.1.3.2.3 Calculation of resident population factor value.</FP> <FP SOURCE="FP1-2">5.1.1.3.3 Workers.</FP> <FP SOURCE="FP1-2">5.1.1.3.4 Resources.</FP> <FP SOURCE="FP1-2">5.1.1.3.5 Terrestrial sensitive environments.</FP> <FP SOURCE="FP1-2">5.1.1.3.6 Calculation of resident population targets factor category value.</FP> <FP SOURCE="FP1-2">5.1.1.4 Calculation of resident population threat score.</FP> <FP SOURCE="FP-2">5.1.2 Nearby population threat.</FP> <FP SOURCE="FP1-2">5.1.2.1 Likelihood of exposure.</FP> <FP SOURCE="FP1-2">5.1.2.1.1 Attractiveness/accessibility.</FP> <FP SOURCE="FP1-2">5.1.2.1.2 Area of contamination.</FP> <FP SOURCE="FP1-2">5.1.2.1.3 Likelihood of exposure factor category value.</FP> <FP SOURCE="FP1-2">5.1.2.2 Waste characteristics.</FP> <FP SOURCE="FP1-2">5.1.2.2.1 Toxicity.</FP> <FP SOURCE="FP1-2">5.1.2.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">5.1.2.2.3 Calculation of waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">5.1.2.3 Targets.</FP> <FP SOURCE="FP1-2">5.1.2.3.1 Nearby individual.</FP> <FP SOURCE="FP1-2">5.1.2.3.2 Population within 1 mile.</FP> <FP SOURCE="FP1-2">5.1.2.3.3 Calculation of nearby population targets factor category value.</FP> <FP SOURCE="FP1-2">5.1.2.4 Calculation of nearby population threat score.</FP> <FP SOURCE="FP1-2">5.1.3 Calculation of soil exposure component score.</FP> <FP SOURCE="FP-2">5.2 Subsurface intrusion component.</FP> <FP SOURCE="FP-2">5.2.0 General considerations.</FP> <FP SOURCE="FP-2">5.2.1 Subsurface intrusion component.</FP> <FP SOURCE="FP1-2">5.2.1.1 Likelihood of exposure.</FP> <FP SOURCE="FP1-2">5.2.1.1.1 Observed exposure.</FP> <FP SOURCE="FP1-2">5.2.1.1.2 Potential for exposure.</FP> <FP SOURCE="FP1-2">5.2.1.1.2.1 Structure containment.</FP> <FP SOURCE="FP1-2">5.2.1.1.2.2 Depth to contamination.</FP> <FP SOURCE="FP1-2">5.2.1.1.2.3 Vertical migration.</FP> <FP SOURCE="FP1-2">5.2.1.1.2.4 Vapor migration potential.</FP> <FP SOURCE="FP1-2">5.2.1.1.2.5 Calculation of potential for exposure factor value.</FP> <FP SOURCE="FP1-2">5.2.1.1.3 Calculation of likelihood of exposure factor category value.</FP> <FP SOURCE="FP1-2">5.2.1.2 Waste characteristics.</FP> <FP SOURCE="FP1-2">5.2.1.2.1 Toxicity/degradation.</FP> <FP SOURCE="FP1-2">5.2.1.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">5.2.1.2.1.2 Degradation.</FP> <FP SOURCE="FP1-2">5.2.1.2.1.3 Calculation of toxicity/degradation factor value.</FP> <FP SOURCE="FP1-2">5.2.1.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">5.2.1.2.3 Calculation of waste characteristics factor category value.</FP> <FP SOURCE="FP1-2">5.2.1.3 Targets.</FP> <FP SOURCE="FP1-2">5.2.1.3.1 Exposed individual.</FP> <FP SOURCE="FP1-2">5.2.1.3.2 Population.</FP> <FP SOURCE="FP1-2">5.2.1.3.2.1 Level I concentrations.</FP> <FP SOURCE="FP1-2">5.2.1.3.2.2 Level II concentrations.</FP> <FP SOURCE="FP1-2">5.2.1.3.2.3 Population within area(s) of subsurface contamination.</FP> <FP SOURCE="FP1-2">5.2.1.3.2.4 Calculation of population factor value.</FP> <FP SOURCE="FP1-2">5.2.1.3.3 Resources.</FP> <FP SOURCE="FP1-2">5.2.1.3.4 Calculation of targets factor category value.</FP> <FP SOURCE="FP1-2">5.2.2 Calculation of subsurface intrusion component score.</FP> <FP SOURCE="FP-2">5.3 Calculation of the soil exposure and subsurface intrusion pathway score.</FP> <FP SOURCE="FP-2">6.0 Air Migration Pathway.</FP> <FP SOURCE="FP-2">6.1 Likelihood of release.</FP> <FP SOURCE="FP-2">6.1.1 Observed release.</FP> <FP SOURCE="FP-2">6.1.2 Potential to release.</FP> <FP SOURCE="FP1-2">6.1.2.1 Gas potential to release.</FP> <FP SOURCE="FP1-2">6.1.2.1.1 Gas containment.</FP> <FP SOURCE="FP1-2">6.1.2.1.2 Gas source type.</FP> <FP SOURCE="FP1-2">6.1.2.1.3 Gas migration potential.</FP> <FP SOURCE="FP1-2">6.1.2.1.4 Calculation of gas potential to release value.</FP> <FP SOURCE="FP1-2">6.1.2.2 Particulate potential to release.</FP> <FP SOURCE="FP1-2">6.1.2.2.1 Particulate containment.</FP> <FP SOURCE="FP1-2">6.1.2.2.2 Pariculate source type.</FP> <FP SOURCE="FP1-2">6.1.2.2.3 Particulate migration potential.</FP> <FP SOURCE="FP1-2">6.1.2.2.4 Calculation of particulate potential to release value.</FP> <FP SOURCE="FP1-2">6.1.2.3 Calculation of potential to release factor value for the site.</FP> <FP SOURCE="FP-2">6.1.3 Calculation of likelihood of release factor category value.</FP> <FP SOURCE="FP-2">6.2 Waste characteristics.</FP> <FP SOURCE="FP-2">6.2.1 Toxicity/mobility.</FP> <FP SOURCE="FP1-2">6.2.1.1 Toxicity.</FP> <FP SOURCE="FP1-2">6.2.1.2 Mobility.</FP> <FP SOURCE="FP1-2">6.2.1.3 Calculation of toxicity/mobility factor value.</FP> <FP SOURCE="FP-2">6.2.2 Hazardous waste quantity.</FP> <FP SOURCE="FP-2"> 6.2.3 Calculation of waste characteristics factor category value. <PRTPAGE P="114"/> </FP> <FP SOURCE="FP-2">6.3 Targets.</FP> <FP SOURCE="FP-2">6.3.1 Nearest individual.</FP> <FP SOURCE="FP-2">6.3.2 Population.</FP> <FP SOURCE="FP1-2">6.3.2.1 Level of contamination.</FP> <FP SOURCE="FP1-2">6.3.2.2 Level I concentrations.</FP> <FP SOURCE="FP1-2">6.3.2.3 Level II concentrations.</FP> <FP SOURCE="FP1-2">6.3.2.4 Potential contamination.</FP> <FP SOURCE="FP1-2">6.3.2.5 Calculation of population factor value.</FP> <FP SOURCE="FP-2">6.3.3 Resources.</FP> <FP SOURCE="FP-2">6.3.4 Sensitive environments.</FP> <FP SOURCE="FP1-2">6.3.4.1 Actual contamination.</FP> <FP SOURCE="FP1-2">6.3.4.2 Potential contamination.</FP> <FP SOURCE="FP1-2">6.3.4.3 Calculation of sensitive environments factor value.</FP> <FP SOURCE="FP-2">6.3.5 Calculation of targets factor category value.</FP> <FP SOURCE="FP-2">6.4 Calculation of air migration pathway score.</FP> <FP SOURCE="FP-2">7.0 Sites Containing Radioactive Substances.</FP> <FP SOURCE="FP-2">7.1 Likelihood of release/likelihood of exposure.</FP> <FP SOURCE="FP-2">7.1.1 Observed release/observed contamination/observed exposure.</FP> <FP SOURCE="FP-2">7.1.2 Potential to release/potential for exposure.</FP> <FP SOURCE="FP-2">7.2 Waste characteristics.</FP> <FP SOURCE="FP-2">7.2.1 Human toxicity.</FP> <FP SOURCE="FP-2">7.2.2 Ecosystem toxicity.</FP> <FP SOURCE="FP-2">7.2.3 Persistence/degradation.</FP> <FP SOURCE="FP-2">7.2.4 Selection of substance potentially posing greatest hazard.</FP> <FP SOURCE="FP-2">7.2.5 Hazardous waste quantity.</FP> <FP SOURCE="FP1-2">7.2.5.1 Source hazardous waste quantity for radionuclides.</FP> <FP SOURCE="FP1-2">7.2.5.1.1 Radionuclide constituent quantity (Tier A).</FP> <FP SOURCE="FP1-2">7.2.5.1.2 Radionuclide wastestream quantity (Tier B).</FP> <FP SOURCE="FP1-2">7.2.5.1.3 Calculation of source hazardous waste quantity value for radionuclides.</FP> <FP SOURCE="FP1-2">7.2.5.2 Calculation of hazardous waste quantity factor value for radionuclides.</FP> <FP SOURCE="FP1-2">7.2.5.3 Calculation of hazardous waste quantity factor value for sites containing mixed radioactive and other hazardous substances.</FP> <FP SOURCE="FP-2">7.3 Targets.</FP> <FP SOURCE="FP-2">7.3.1 Level of contamination at a sampling location.</FP> <FP SOURCE="FP-2">7.3.2 Comparison to benchmarks.</FP> <FP SOURCE="FP-2">7.3.3 Weighting of targets within an area of subsurface contamination.</FP> <HD SOURCE="HD1">List of Figures</HD> <HD SOURCE="HD2">Figure number</HD> <FP SOURCE="FP-2">3-1 Overview of ground water migration pathway.</FP> <FP SOURCE="FP-2">3-2 Net precipitation factor values.</FP> <FP SOURCE="FP-2">4-1 Overview of surface water overland/flood migration component.</FP> <FP SOURCE="FP-2">4-2 Overview of ground water to surface water migration component.</FP> <FP SOURCE="FP-2">4-3 Sample determination of ground water to surface water angle.</FP> <FP SOURCE="FP-2">5-1 Overview of the soil exposure and subsurface intrusion pathway.</FP> <FP SOURCE="FP-2">6-1 Overview of air migration pathway.</FP> <FP SOURCE="FP-2">6-2 Particulate migration potential factor values.</FP> <FP SOURCE="FP-2">6-3 Particulate mobility factor values.</FP> <HD SOURCE="HD1">List of Tables</HD> <HD SOURCE="HD2">Table number</HD> <FP SOURCE="FP-2">2-1 Sample pathway scoresheet.</FP> <FP SOURCE="FP-2">2-2 Sample source characterization worksheet.</FP> <FP SOURCE="FP-2">2-3 Observed release criteria for chemical analysis.</FP> <FP SOURCE="FP-2">2-4 Toxicity factor evaluation.</FP> <FP SOURCE="FP-2">2-5 Hazardous waste quantity evaluation equations.</FP> <FP SOURCE="FP-2">2-6 Hazardous waste quantity factor values.</FP> <FP SOURCE="FP-2">2-7 Waste characteristics factor category values.</FP> <FP SOURCE="FP-2">3-1 Ground water migration pathway scoresheet.</FP> <FP SOURCE="FP-2">3-2 Containment factor values for ground water migration pathway.</FP> <FP SOURCE="FP-2">3-3 Monthly latitude adjusting values.</FP> <FP SOURCE="FP-2">3-4 Net precipitation factor values.</FP> <FP SOURCE="FP-2">3-5 Depth to aquifer factor values.</FP> <FP SOURCE="FP-2">3-6 Hydraulic conductivity of geologic materials.</FP> <FP SOURCE="FP-2">3-7 Travel time factor values.</FP> <FP SOURCE="FP-2">3-8 Ground water mobility factor values.</FP> <FP SOURCE="FP-2">3-9 Toxicity/mobility factor values.</FP> <FP SOURCE="FP-2">3-10 Health-based benchmarks for hazardous substances in drinking water.</FP> <FP SOURCE="FP-2">3-11 Nearest well factor values.</FP> <FP SOURCE="FP-2">3-12 Distance-weighted population values for potential contamination factor for ground water migration pathway.</FP> <FP SOURCE="FP-2">4-1 Surface water overland/flood migration component scoresheet.</FP> <FP SOURCE="FP-2">4-2 Containment factor values for surface water migration pathway.</FP> <FP SOURCE="FP-2">4-3 Drainage area values.</FP> <FP SOURCE="FP-2">4-4 Soil group designations.</FP> <FP SOURCE="FP-2">4-5 Rainfall/runoff values.</FP> <FP SOURCE="FP-2">4-6 Runoff factor values.</FP> <FP SOURCE="FP-2">4-7 Distance to surface water factor values.</FP> <FP SOURCE="FP-2">4-8 Containment (flood) factor values.</FP> <FP SOURCE="FP-2">4-9 Flood frequency factor values.</FP> <FP SOURCE="FP-2">4-10 Persistence factor values—half-life.</FP> <FP SOURCE="FP-2"> 4-11 Persistence factor values—log K <E T="52">ow</E> </FP> <FP SOURCE="FP-2">4-12 Toxicity/persistence factor values.</FP> <FP SOURCE="FP-2">4-13 Surface water dilution weights.</FP> <FP SOURCE="FP-2">4-14 Dilution-weighted population values for potential contamination factor for surface water migration pathway.</FP> <FP SOURCE="FP-2">4-15 Bioaccumulation potential factor values.</FP> <FP SOURCE="FP-2">4-16 Toxicity/persistence/bioaccumulation factor values.</FP> <FP SOURCE="FP-2">4-17 Health-based benchmarks for hazardous substances in human food chain.</FP> <FP SOURCE="FP-2">4-18 Human food chain population values.</FP> <FP SOURCE="FP-2">4-19 Ecosystem toxicity factor values.</FP> <FP SOURCE="FP-2"> 4-20 Ecosystem toxicity/persistence factor values. <PRTPAGE P="115"/> </FP> <FP SOURCE="FP-2">4-21 Ecosystem toxicity/persistence/bioaccumulation factor values.</FP> <FP SOURCE="FP-2">4-22 Ecological-based benchmarks for hazardous substances in surface water.</FP> <FP SOURCE="FP-2">4-23 Sensitive environments rating values.</FP> <FP SOURCE="FP-2">4-24 Wetlands rating values for surface water migration pathway.</FP> <FP SOURCE="FP-2">4-25 Ground water to surface water migration component scoresheet.</FP> <FP SOURCE="FP-2">4-26 Toxicity/mobility/persistence factor values.</FP> <FP SOURCE="FP-2">4-27 Dilution weight adjustments.</FP> <FP SOURCE="FP-2">4-28 Toxicity/mobility/persistence/bioaccumulation factor values.</FP> <FP SOURCE="FP-2">4-29 Ecosystem toxicity/mobility/persistence factor values.</FP> <FP SOURCE="FP-2">4-30 Ecosystem toxicity/mobility/persistence/bioaccumulation factor values.</FP> <FP SOURCE="FP-2">5-1 Soil exposure component scoresheet.</FP> <FP SOURCE="FP-2">5-2 Hazardous waste quantity evaluation equations for soil exposure component.</FP> <FP SOURCE="FP-2">5-3 Health-based benchmarks for hazardous substances in soils.</FP> <FP SOURCE="FP-2">5-4 Factor values for workers.</FP> <FP SOURCE="FP-2">5-5 Terrestrial sensitive environments rating values.</FP> <FP SOURCE="FP-2">5-6 Attractiveness/accessibility values.</FP> <FP SOURCE="FP-2">5-7 Area of contamination factor values.</FP> <FP SOURCE="FP-2">5-8 Nearby population likelihood of exposure factor values.</FP> <FP SOURCE="FP-2">5-9 Nearby individual factor values.</FP> <FP SOURCE="FP-2">5-10 Distance-weighted population values for nearby population threat.</FP> <FP SOURCE="FP-2">5-11 Subsurface intrusion component scoresheet.</FP> <FP SOURCE="FP-2">5-12 Structure containment.</FP> <FP SOURCE="FP-2">5-13 Depth to contamination.</FP> <FP SOURCE="FP-2">5-14 Effective porosity/permeability of geological materials.</FP> <FP SOURCE="FP-2">5-15 Vertical migration factor values.</FP> <FP SOURCE="FP-2">5-16 Values for vapor pressure and Henry's constant.</FP> <FP SOURCE="FP-2">5-17 Vapor migration potential factor values for a hazardous substance.</FP> <FP SOURCE="FP-2">5-18 Degradation factor value table.</FP> <FP SOURCE="FP-2">5-19 Hazardous waste quantity evaluation equations for subsurface intrusion component.</FP> <FP SOURCE="FP-2">5-20 Health-based benchmarks for hazardous substances in the subsurface intrusion component.</FP> <FP SOURCE="FP-2">5-21 Weighting factor values for populations within an area of subsurface contamination.</FP> <FP SOURCE="FP-2">6-1 Air migration pathway scoresheet.</FP> <FP SOURCE="FP-2">6-2 Gas potential to release evaluation.</FP> <FP SOURCE="FP-2">6-3 Gas containment factor values.</FP> <FP SOURCE="FP-2">6-4 Source type factor values.</FP> <FP SOURCE="FP-2">6-5 Values for vapor pressure and Henry's constant.</FP> <FP SOURCE="FP-2">6-6 Gas migration potential values for a hazardous substance.</FP> <FP SOURCE="FP-2">6-7 Gas migration potential values for the source.</FP> <FP SOURCE="FP-2">6-8 Particulate potential to release evaluation.</FP> <FP SOURCE="FP-2">6-9 Particulate containment factor values.</FP> <FP SOURCE="FP-2">6-10 Particulate migration potential values.</FP> <FP SOURCE="FP-2">6-11 Gas mobility factor values.</FP> <FP SOURCE="FP-2">6-12 Particulate mobility factor values.</FP> <FP SOURCE="FP-2">6-13 Toxicity/mobility factor values.</FP> <FP SOURCE="FP-2">6-14 Health-based benchmarks for hazardous substances in air.</FP> <FP SOURCE="FP-2">6-15 Air migration pathway distance weights.</FP> <FP SOURCE="FP-2">6-16 Nearest individual factor values.</FP> <FP SOURCE="FP-2">6-17 Distance-weighted population values for potential contamination factor for air pathway.</FP> <FP SOURCE="FP-2">6-18 Wetlands rating values for air migration pathway.</FP> <FP SOURCE="FP-2">7-1 HRS factors evaluated differently for radionuclides.</FP> <FP SOURCE="FP-2">7-2 Toxicity factor values for radionuclides.</FP> <HD SOURCE="HD2">1.0 Introduction</HD> <P>The Hazard Ranking System (HRS) is the principal mechanism the U.S. Environmental Protection Agency (EPA) uses to place sites on the National Priorities List (NPL). The HRS serves as a screening device to evaluate the potential for releases of uncontrolled hazardous substances to cause human health or environmental damage. The HRS provides a measure of relative rather than absolute risk. It is designed so that it can be consistently applied to a wide variety of sites.</P> <HD SOURCE="HD2">1.1 Definitions</HD> <P> <E T="03">Acute toxicity:</E> Measure of toxicological responses that result from a single exposure to a substance or from multiple exposures within a short period of time (typically several days or less). Specific measures of acute toxicity used within the HRS include lethal dose <E T="52">50</E> (LD <E T="52">50</E> ) and lethal concentration <E T="52">50</E> (LC <E T="52">50</E> ), typically measured within a 24-hour to 96-hour period. </P> <P> <E T="03">Ambient Aquatic Life Advisory Concentrations (AALACs):</E> EPA's advisory concentration limit for acute or chronic toxicity to aquatic organisms as established under section 304(a)(1) of the Clean Water Act, as amended. </P> <P> <E T="03">Ambient Water Quality Criteria (AWQC)/National Recommended Water Quality Criteria:</E> EPA's maximum acute (Criteria Maximum Concentration or CMC) or chronic (Criterion Continuous Concentration or CCC) toxicity concentrations for protection of aquatic life and its uses as established under section 304(a)(1) of the Clean Water Act, as amended. </P> <P> <E T="03">Bioconcentration factor (BCF):</E> Measure of the tendency for a substance to accumulate in the tissue of an aquatic organism. BCF is determined by the extent of partitioning of a substance, at equilibrium, between the tissue of an aquatic organism and water. As the ratio of concentration of a substance in the organism divided by the concentration in water, higher BCF values reflect a tendency <PRTPAGE P="116"/> for substances to accumulate in the tissue of aquatic organisms. [unitless]. </P> <P> <E T="03">Biodegradation:</E> Chemical reaction of a substance induced by enzymatic activity of microorganisms. </P> <P> <E T="03">CERCLA:</E> Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended (Pub. L. 96-510, as amended). </P> <P> <E T="03">Channelized flow:</E> Natural geological or manmade features such as karst, fractures, lava tubes, and utility conduits ( <E T="03">e.g.,</E> sewer lines), which allow ground water and/or soil gas to move through the subsurface environment more easily. </P> <P> <E T="03">Chronic toxicity:</E> Measure of toxicological responses that result from repeated exposure to a substance over an extended period of time (typically 3 months or longer). Such responses may persist beyond the exposure or may not appear until much later in time than the exposure. HRS measures of chronic toxicity include Reference Dose (RfD) and Reference Concentration (RfC) values. </P> <P> <E T="03">Contract Laboratory Program (CLP):</E> Analytical program developed for CERCLA waste site samples to fill the need for legally defensible analytical results supported by a high level of quality assurance and documentation. </P> <P> <E T="03">Contract-Required Detection Limit (CRDL):</E> Term equivalent to contract-required quantitation limit, but used primarily for inorganic substances. </P> <P> <E T="03">Contract-Required Quantitation Limit (CRQL):</E> Substance-specific level that a CLP laboratory must be able to routinely and reliably detect in specific sample matrices. It is not the lowest detectable level achievable, but rather the level that a CLP laboratory should reasonably quantify. The CRQL may or may not be equal to the quantitation limit of a given substance in a given sample. For HRS purposes, the term CRQL refers to both the contract-required quantitation limit and the contract-required detection limit. </P> <P> <E T="03">Crawl space:</E> The enclosed or semi-enclosed area between a regularly occupied structure's foundation ( <E T="03">e.g.,</E> pier and beam construction) and the ground surface. Crawl space samples are collected to determine the concentration of hazardous substances in the air beneath a regularly occupied structure. </P> <P> <E T="03">Curie (Ci):</E> Measure used to quantify the amount of radioactivity. One curie equals 37 billion nuclear transformations per second, and one picocurie (pCi) equals 10 <E T="51">−12</E> Ci. </P> <P> <E T="03">Decay product:</E> Isotope formed by the radioactive decay of some other isotope. This newly formed isotope possesses physical and chemical properties that are different from those of its parent isotope, and may also be radioactive. </P> <P> <E T="03">Detection Limit (DL):</E> Lowest amount that can be distinguished from the normal random “noise” of an analytical instrument or method. For HRS purposes, the detection limit used is the method detection limit (MDL) or, for real-time field instruments, the detection limit of the instrument as used in the field. </P> <P> <E T="03">Dilution weight:</E> Parameter in the HRS surface water migration pathway that reduces the point value assigned to targets as the flow or depth of the relevant surface water body increases. [unitless]. </P> <P> <E T="03">Distance weight:</E> Parameter in the HRS air migration pathway, ground water migration pathway, and the soil exposure component of the soil exposure and subsurface intrusion pathway that reduces the point value assigned to targets as their distance increases from the site. <E T="03">[unitless].</E> </P> <P> <E T="03">Distribution coefficient (K</E> <E T="54">d</E> <E T="03">):</E> Measure of the extent of partitioning of a substance between geologic materials (for example, soil, sediment, rock) and water (also called partition coefficient). The distribution coefficient is used in the HRS in evaluating the mobility of a substance for the ground water migration pathway. [ml/g]. </P> <P> <E T="03">ED</E> <E T="54">10</E> ( <E T="03">10 percent effective dose):</E> Estimated dose associated with a 10 percent increase in response over control groups. For HRS purposes, the response considered is cancer. [milligrams toxicant per kilogram body weight per day (mg/kg-day)]. </P> <P> <E T="03">Food and Drug Administration Action Level (FDAAL):</E> Under section 408 of the Federal Food, Drug and Cosmetic Act, as amended, concentration of a poisonous or deleterious substance in human food or animal feed at or above which FDA will take legal action to remove adulterated products from the market. Only FDAALs established for fish and shellfish apply in the HRS. </P> <P> <E T="03">Half-life:</E> Length of time required for an initial concentration of a substance to be halved as a result of loss through decay. The HRS considers five decay processes for assigning surface water persistence: Biodegradation, hydrolysis, photolysis, radioactive decay, and volatilization. The HRS considers two decay processes for assigning subsurface intrusion degradation: Biodegradation and hydrolysis. </P> <P> <E T="03">Hazardous substance:</E> CERCLA hazardous substances, pollutants, and contaminants as defined in CERCLA sections 101(14) and 101(33), except where otherwise specifically noted in the HRS. </P> <P> <E T="03">Hazardous wastestream:</E> Material containing CERCLA hazardous substances (as defined in CERCLA section 101[14]) that was deposited, stored, disposed, or placed in, or that otherwise migrated to, a source. </P> <P> HRS <E T="03">“factor”:</E> Primary rating elements internal to the HRS. </P> <P> HRS <E T="03">“factor category”:</E> Set of HRS factors (that is, likelihood of release [or exposure], waste characteristics, targets). <PRTPAGE P="117"/> </P> <P> HRS <E T="03">“migration pathways”:</E> HRS ground water, surface water, and air migration pathways. </P> <P> HRS <E T="03">“pathway”:</E> Set of HRS factor categories combined to produce a score to measure relative risks posed by a site in one of four environmental pathways (that is, ground water, surface water, soil exposure and subsurface intrusion, and air). </P> <P> HRS <E T="03">“site score”:</E> Composite of the four HRS pathway scores. </P> <P> <E T="03">Henry's law constant:</E> Measure of the volatility of a substance in a dilute solution of water at equilibrium. It is the ratio of the vapor pressure exerted by a substance in the gas phase over a dilute aqueous solution of that substance to its concentration in the solution at a given temperature. For HRS purposes, use the value reported at or near 25 °C. [atmosphere-cubic meters per mole (atm-m  <SU>3</SU> /mol)]. </P> <P> <E T="03">Hydrolysis:</E> Chemical reaction of a substance with water. </P> <P> <E T="03">Indoor air:</E> The air present within a structure. </P> <P> <E T="03">Inhalation Unit Risk (IUR):</E> The upper-bound excess lifetime cancer risk estimated to result from continuous exposure to an agent ( <E T="03">i.e.,</E> hazardous substance) at a concentration of 1µg/m <SU>3</SU> in air. </P> <P> <E T="03">Karst:</E> Terrain with characteristics of relief and drainage arising from a high degree of rock solubility in natural waters. The majority of karst occurs in limestones, but karst may also form in dolomite, gypsum, and salt deposits. Features associated with karst terrains typically include irregular topography, sinkholes, vertical shafts, abrupt ridges, caverns, abundant springs, and/or disappearing streams. Karst aquifers are associated with karst terrain. </P> <P> <E T="03">LC</E> <E T="54">50</E> ( <E T="03">lethal concentration, 50 percent</E> ): Concentration of a substance in air [typically micrograms per cubic meter (µg/m <SU>3</SU> )] or water [typically micrograms per liter (µg/l)] that kills 50 percent of a group of exposed organisms. The LC <E T="52">50</E> is used in the HRS in assessing acute toxicity. </P> <P> <E T="03">LD</E> <E T="54">50</E> ( <E T="03">lethal dose, 50 percent</E> ): Dose of a substance that kills 50 percent of a group of exposed organisms. The LD <E T="52">50</E> is used in the HRS in assessing acute toxicity [milligrams toxicant per kilogram body weight (mg/kg)]. </P> <P> <E T="03">Maximum Contaminant Level (MCL):</E> Under section 1412 of the Safe Drinking Water Act, as amended, the maximum permissible concentration of a substance in water that is delivered to any user of a public water supply. </P> <P> <E T="03">Maximum Contaminant Level Goal (MCLG):</E> Under section 1412 of the Safe Drinking Water Act, as amended, a nonenforceable concentration for a substance in drinking water that is protective of adverse human health effects and allows an adequate margin of safety. </P> <P> <E T="03">Method Detection Limit (MDL):</E> Lowest concentration of analyte that a method can detect reliably in either a sample or blank. </P> <P> <E T="03">Mixed radioactive and other hazardous substances:</E> Material containing both radioactive hazardous substances and nonradioactive hazardous substances, regardless of whether these types of substances are physically separated, combined chemically, or simply mixed together. </P> <P> <E T="03">National Ambient Air Quality Standards (NAAQS):</E> Primary standards for air quality established under sections 108 and 109 of the Clean Air Act, as amended. </P> <P> <E T="03">National Emission Standards for Hazardous Air Pollutants (NESHAPs):</E> Standards established for substances listed under section 112 of the Clean Air Act, as amended. Only those NESHAPs promulgated in ambient concentration units apply in the HRS. </P> <P> <E T="03">Non-Aqueous Phase Liquid (NAPL):</E> Contaminants and substances that are water-immiscible liquids composed of constituents with varying degrees of water solubility. </P> <P> <E T="03">Octanol-water partition coefficient (K</E> <E T="54">ow</E> [ <E T="03">or P</E> ]): Measure of the extent of partitioning of a substance between water and octanol at equilibrium. The K <E T="52">ow</E> is determined by the ratio between the concentration in octanol divided by the concentration in water at equilibrium. [unitless]. </P> <P> <E T="03">Organic carbon partition coefficient (K</E> <E T="54">oc</E> <E T="03">):</E> Measure of the extent of partitioning of a substance, at equilibrium, between organic carbon in geologic materials and water. The higher the K <E T="52">oc</E> , the more likely a substance is to bind to geologic materials than to remain in water. [ml/g]. </P> <P> <E T="03">Photolysis:</E> Chemical reaction of a substance caused by direct absorption of solar energy (direct photolysis) or caused by other substances that absorb solar energy (indirect photolysis). </P> <P> <E T="03">Preferential subsurface intrusion pathways:</E> Subsurface features such as animal burrows, cracks in walls, spaces around utility lines, or drains through which a hazardous substance moves more easily into a regularly occupied structure. </P> <P> <E T="03">Radiation:</E> Particles (alpha, beta, neutrons) or photons (x- and gamma-rays) emitted by radionuclides. </P> <P> <E T="03">Radioactive decay:</E> Process of spontaneous nuclear transformation, whereby an isotope of one element is transformed into an isotope of another element, releasing excess energy in the form of radiation. </P> <P> <E T="03">Radioactive half-life:</E> Time required for one-half the atoms in a given quantity of a specific radionuclide to undergo radioactive decay. </P> <P> <E T="03">Radioactive substance:</E> Solid, liquid, or gas containing atoms of a single radionuclide or multiple radionuclides. </P> <P> <E T="03">Radioactivity:</E> Property of those isotopes of elements that exhibit radioactive decay and emit radiation. <PRTPAGE P="118"/> </P> <P> <E T="03">Radionuclide/radioisotope:</E> Isotope of an element exhibiting radioactivity. For HRS purposes, “radionuclide” and “radioisotope” are used synonymously. </P> <P> <E T="03">Reference concentration (RfC):</E> An estimate of a continuous inhalation exposure to the human population that is likely to be without an appreciable risk of deleterious effects during a lifetime. </P> <P> <E T="03">Reference dose (RfD):</E> An estimate of a daily oral exposure to the human population that is likely to be without an appreciable risk of deleterious effects during a lifetime. </P> <P> <E T="03">Regularly occupied structures:</E> Structures with enclosed air space, where people either reside, attend school or day care, or work on a regular basis, or that were previously occupied but vacated due to a site-related hazardous substance(s). This also includes resource structures ( <E T="03">e.g.,</E> library, church, tribal structure). </P> <P> <E T="03">Removal action:</E> Action that removes hazardous substances from the site for proper disposal or destruction in a facility permitted under the Resource Conservation and Recovery Act or the Toxic Substances Control Act or by the Nuclear Regulatory Commission. </P> <P> <E T="03">Roentgen (R):</E> Measure of external exposures to ionizing radiation. One roentgen equals that amount of x-ray or gamma radiation required to produce ions carrying a charge of 1 electrostatic unit (esu) in 1 cubic centimeter of dry air under standard conditions. One microroentgen (µR) equals 10 <E T="51">−6</E> R. </P> <P> <E T="03">Sample quantitation limit (SQL):</E> Quantity of a substance that can be reasonably quantified given the limits of detection for the methods of analysis and sample characteristics that may affect quantitation (for example, dilution, concentration). </P> <P> <E T="03">Screening concentration:</E> Media-specific benchmark concentration for a hazardous substance that is used in the HRS for comparison with the concentration of that hazardous substance in a sample from that media. The screening concentration for a specific hazardous substance corresponds to its reference concentration for inhalation exposures or reference dose for oral exposures, as appropriate, and, if the substance is a human carcinogen with either a weight-of-evidence classification of A, B, or C, or a weight-of-evidence classification of carcinogenic to humans, likely to be carcinogenic to humans or suggestive evidence of carcinogenic potential, to that concentration that corresponds to its 10 <E T="51">−6</E> individual lifetime excess cancer risk for inhalation exposures or for oral exposures, as appropriate. </P> <P> <E T="03">Shallow ground water:</E> The uppermost saturated zone, typically unconfined. </P> <P> <E T="03">Site:</E> Area(s) where a hazardous substance has been deposited, stored, disposed, or placed, or has otherwise come to be located. Such areas may include multiple sources and may include the area between sources. </P> <P> <E T="03">Slope factor (also referred to as cancer potency factor):</E> Estimate of the probability of response (for example, cancer) per unit intake of a substance over a lifetime. The slope factor is typically used to estimate upper-bound probability of an individual developing cancer as a result of exposure to a particular level of a human carcinogen with either a weight-of-evidence classification of A, B, or C, or a weight-of-evidence classification of carcinogenic to humans, likely to be carcinogenic to humans or having suggestive evidence of carcinogenic potential. [(mg/kg-day) <E T="51">−1</E> for non-radioactive substances and (pCi) <E T="51">−1</E> for radioactive substances]. </P> <P> <E T="03">Soil gas:</E> The gaseous elements and compounds in the small spaces between particles of soil. </P> <P> <E T="03">Soil porosity:</E> The degree to which the total volume of soil is permeated with pores or cavities through which fluids (including air or gas) can move. It is typically calculated as the ratio of the pore spaces within the soil to the overall volume of the soil. </P> <P> <E T="03">Source:</E> Any area where a hazardous substance has been deposited, stored, disposed, or placed, plus those soils that have become contaminated from migration of a hazardous substance. Sources do not include those volumes of air, ground water, surface water, or surface water sediments that have become contaminated by migration, except: In the case of either a ground water plume with no identified source or contaminated surface water sediments with no identified source, the plume or contaminated sediments may be considered a source. </P> <P> <E T="03">Subslab:</E> The area immediately beneath a regularly occupied structure with a basement foundation or a slab-on-grade foundation. Subslab samples are collected to determine the concentration of hazardous substances in the soil gas beneath a home or building. </P> <P> <E T="03">Subsurface intrusion:</E> The migration of hazardous substances from the unsaturated zone and/or ground water into overlying structures. </P> <P> <E T="03">Target distance limit:</E> Maximum distance over which targets for the site are evaluated. The target distance limit varies by HRS pathway. </P> <P> <E T="03">Unit risk:</E> The upper-bound excess lifetime cancer risk estimated to result from continuous exposure to an agent ( <E T="03">i.e.,</E> hazardous substance) at a concentration of 1 µg/L in water, or 1 µg/m <SU>3</SU> in air. </P> <P> <E T="03">Unsaturated zone:</E> The portion of subsurface between the land surface and the zone of saturation. It extends from the ground surface to the top of the shallowest ground water table (excluding localized or perched water). </P> <P> <E T="03">Uranium Mill Tailings Radiation Control Act (UMTRCA) Standards:</E> Standards for radionuclides established under sections 102, 104, <PRTPAGE P="119"/> and 108 of the Uranium Mill Tailings Radiation Control Act, as amended. </P> <P> <E T="03">Vapor pressure:</E> Pressure exerted by the vapor of a substance when it is in equilibrium with its solid or liquid form at a given temperature. For HRS purposes, use the value reported at or near 25 °C. [atmosphere or torr]. </P> <P> <E T="03">Volatilization:</E> Physical transfer process through which a substance undergoes a change of state from a solid or liquid to a gas. </P> <P> <E T="03">Water solubility:</E> Maximum concentration of a substance in pure water at a given temperature. For HRS purposes, use the value reported at or near 25 °C. [milligrams per liter (mg/l)]. </P> <P> <E T="03">Weight-of-evidence:</E> EPA classification system for characterizing the evidence supporting the designation of a substance as a human carcinogen. The EPA weight-of-evidence, depending on the date EPA updated the profile, includes either the groupings: </P> <P>• Group A: Human carcinogen—sufficient evidence of carcinogenicity in humans.</P> <P>• Group B1: Probable human carcinogen—limited evidence of carcinogenicity in humans.</P> <P>• Group B2: Probable human carcinogen—sufficient evidence of carcinogenicity in animals.</P> <P>• Group C: Possible human carcinogen—limited evidence of carcinogenicity in animals.</P> <P>• Group D: Not classifiable as to human carcinogenicity—applicable when there is no animal evidence, or when human or animal evidence is inadequate.</P> <P>• Group E: Evidence of noncarcinogenicity for humans.</P> <P>Or the descriptors:</P> <P>• Carcinogenic to humans.</P> <P>• Likely to be carcinogenic to humans.</P> <P>• Suggestive evidence of carcinogenic potential.</P> <P>• Inadequate information to assess carcinogenic potential.</P> <P>• Not likely to be carcinogenic to humans.</P> <HD SOURCE="HD1">2.0 Evaluations Common to Multiple Pathways</HD> <P> 2.1 <E T="03">Overview.</E> The HRS site score (S) is the result of an evaluation of four pathways: </P> <P> • Ground Water Migration (S <E T="52">gw</E> ). </P> <P> • Surface Water Migration (S <E T="52">sw</E> ). </P> <P> • Soil Exposure and Subsurface Intrusion (S <E T="52">sessi</E> ). </P> <P> • Air Migration (S <E T="52">a</E> ). </P> <P>The ground water and air migration pathways use single threat evaluations, while the surface water migration and soil exposure and subsurface intrusion pathways use multiple threat evaluations. Three threats are evaluated for the surface water migration pathway: Drinking water, human food chain, and environmental. These threats are evaluated for two separate migration components—overland/flood migration and ground water to surface water migration. Two components are evaluated for the soil exposure and subsurface intrusion pathway: Soil exposure and subsurface intrusion. The soil exposure component evaluates two threats: Resident population and nearby population, and the subsurface intrusion component is a single threat evaluation.</P> <P>The HRS is structured to provide a parallel evaluation for each of these pathways, components, and threats. This section focuses on these parallel evaluations, starting with the calculation of the HRS site score and the individual pathway scores.</P> <P> 2.1.1  <E T="03">Calculation of HRS site score.</E> Scores are first calculated for the individual pathways as specified in sections 2 through 7 and then are combined for the site using the following root-mean-square equation to determine the overall HRS site score, which ranges from 0 to 100: </P> <GPH SPAN="2" DEEP="40"> <GID>ER09JA17.062</GID> </GPH> <P> 2.1.2  <E T="03">Calculation of pathway score.</E> Table 2-1, which is based on the air migration pathway, illustrates the basic parameters used to calculate a pathway score. As Table 2-1 shows, each pathway (component or threat) score is the product of three “factor categories”: Likelihood of release, waste characteristics, and targets. (The soil exposure and subsurface intrusion pathway uses likelihood of exposure rather than likelihood of release.) Each of the three factor categories contains a set of factors that are assigned numerical values and combined as specified in sections 2 through 7. The factor values are rounded to the nearest integer, except where otherwise noted. </P> <P> 2.1.3  <E T="03">Common evaluations.</E> Evaluations common to all four HRS pathways include: </P> <FP SOURCE="FP-2">• Characterizing sources.</FP> <FP SOURCE="FP1-2"> —Identifying sources (and, for the soil exposure and subsurface intrusion pathway, areas of observed contamination, <PRTPAGE P="120"/> areas of observed exposure and/or areas of subsurface contamination [see sections 5.1.0 and 5.2.0]). </FP> <FP SOURCE="FP1-2">—Identifying hazardous substances associated with each source (or area of observed contamination, or observed exposure, or subsurface contamination).</FP> <FP SOURCE="FP1-2">—Identifying hazardous substances available to a pathway.</FP> <GPOTABLE COLS="3" OPTS="L2" CDEF="s100,12,12"> <TTITLE>Table 2-1—Sample Pathway Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor category</CHED> <CHED H="1">Maximum value</CHED> <CHED H="1"> Value <LI>assigned</LI> </CHED> </BOXHD> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Likelihood of Release</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">1. Observed Release</ENT> <ENT>550</ENT> </ROW> <ROW> <ENT I="01">2. Potential to Release</ENT> <ENT>500</ENT> </ROW> <ROW RUL="s"> <ENT I="01">3. Likelihood of Release (higher of lines 1 and 2)</ENT> <ENT>550</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Waste Characteristics</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">4. Toxicity/Mobility</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="01">5. Hazardous Waste Quantity</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW RUL="s"> <ENT I="01">6. Waste Characteristics</ENT> <ENT>100</ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Targets</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">7. Nearest Individual</ENT> </ROW> <ROW> <ENT I="03">7a. Level I</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="03">7b. Level II</ENT> <ENT>45</ENT> </ROW> <ROW> <ENT I="03">7c. Potential Contamination</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="03">7d. Nearest Individual (higher of lines 7a, 7b, or 7c)</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">8. Population</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">8a. Level I</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">8b. Level II</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">8c. Potential Contamination</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">8d. Total Population (lines 8a+8b+8c)</ENT> </ROW> <ROW> <ENT I="01">9. Resources</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">10. Sensitive Environments</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">10a. Actual Contamination</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">10b. Potential Environments</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">10c. Sensitive Environments (lines 10a+10b)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="01">11. Targets (lines 7d+8d+9+10c)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="01">12. Pathway Score is the product of Likelihood of Release, Waste Characteristics, and Targets, divided by 82,500. Pathway scores are limited to a maximum of 100 points</ENT> </ROW> <TNOTE> <SU>a</SU>  Maximum value applies to waste characteristics category. The product of lines 4 and 5 is used in Table 2-7 to derive the value for the waste characteristics factor category. </TNOTE> <TNOTE> <SU>b</SU>  There is no limit to the human population or sensitive environments factor values. However, the pathway score based solely on sensitive environments is limited to a maximum of 60 points. </TNOTE> </GPOTABLE> <FP SOURCE="FP-2">• Scoring likelihood of release (or likelihood of exposure) factor category.</FP> <FP SOURCE="FP1-2">—Scoring observed release (or observed exposure or observed contamination).</FP> <FP SOURCE="FP1-2">—Scoring potential to release when there is no observed release.</FP> <FP SOURCE="FP-2">• Scoring waste characteristics factor category.</FP> <FP SOURCE="FP1-2">—Evaluating toxicity.</FP> <FP SOURCE="FP1-2">▪ Combining toxicity with mobility, persistence, degradation and/or bioaccumulation (or ecosystem bioaccumulation) potential, as appropriate to the pathway (component or threat).</FP> <FP SOURCE="FP1-2">▪ Evaluating hazardous waste quantity.</FP> <FP SOURCE="FP1-2">—Combining hazardous waste quantity with the other waste characteristics factors.</FP> <FP SOURCE="FP1-2">▪ Determining waste characteristics factor category value.</FP> <FP SOURCE="FP-2">• Scoring targets factor category.</FP> <FP SOURCE="FP1-2">—Determining level of contamination for targets.</FP> <P>These evaluations are essentially identical for the three migration pathways (ground water, surface water, and air). However, the evaluations differ in certain respects for the soil exposure and subsurface intrusion pathway.</P> <P>Section 7 specifies modifications that apply to each pathway when evaluating sites containing radioactive substances.</P> <P> Section 2 focuses on evaluations common at the pathway, component, and threat levels. Note that for the ground water and surface water migration pathways, separate scores are calculated for each aquifer (see section 3.0) and each watershed (see sections 4.1.1.3 and 4.2.1.5) when determining the pathway scores for a site. Although the evaluations in section 2 do not vary when different aquifers or watersheds are scored at a site, the specific factor values (for example, observed release, hazardous waste quantity, toxicity/mobility) that result from these <PRTPAGE P="121"/> evaluations can vary by aquifer and by watershed at the site. This can occur through differences both in the specific sources and targets eligible to be evaluated for each aquifer and watershed and in whether observed releases can be established for each aquifer and watershed. Such differences in scoring at the aquifer and watershed level are addressed in sections 3 and 4, not section 2. </P> <P> 2.2  <E T="03">Characterize sources.</E> Source characterization includes identification of the following: </P> <P>• Sources (and areas of observed contamination, areas of observed exposure, or areas of subsurface contamination) at the site.</P> <P>• Hazardous substances associated with these sources (or areas of observed contamination, areas of observed exposure, or areas of subsurface contamination).</P> <P>• Pathways potentially threatened by these hazardous substances.</P> <P>Table 2-2 presents a sample worksheet for source characterization.</P> <P> 2.2.1  <E T="03">Identify sources.</E> For the three migration pathways, identify the sources at the site that contain hazardous substances. Identify the migration pathway(s) to which each source applies. For the soil exposure and subsurface intrusion pathway, identify areas of observed contamination, areas of observed exposure, and/or areas of subsurface contamination at the site (see sections 5.1.0 and 5.2.0). </P> <HD SOURCE="HD1">Table 2-2—Sample Source Characterization Worksheet</HD> <FP SOURCE="FP-1">Source: ____</FP> <FP SOURCE="FP-1">A. Source dimensions and hazardous waste quantity.</FP> <FP SOURCE="FP-1">Hazardous constituent quantity: ____</FP> <FP SOURCE="FP-1">Hazardous wastestream quantity: ____</FP> <FP SOURCE="FP-1">Volume: ____</FP> <FP SOURCE="FP-1">Area: ____</FP> <FP SOURCE="FP-1">Area of observed contamination: ____</FP> <FP SOURCE="FP-1">Area of observed exposure: ____</FP> <FP SOURCE="FP-1">Area of subsurface contamination: ____</FP> <FP SOURCE="FP-1"> B. Hazardous substances associated with the source. <PRTPAGE P="122"/> </FP> <GPOTABLE COLS="10" OPTS="L2" CDEF="s25,10,10,10,10,10,10,10,12,13"> <BOXHD> <CHED H="1">Hazardous substance</CHED> <CHED H="1">Available to pathway</CHED> <CHED H="2">Air</CHED> <CHED H="3">Gas</CHED> <CHED H="3">Particulate</CHED> <CHED H="2"> Ground Water <LI>(GW)</LI> </CHED> <CHED H="2"> Surface Water <LI>(SW)</LI> </CHED> <CHED H="3">Overland/flood</CHED> <CHED H="3">GW to SW</CHED> <CHED H="2">Soil Exposure/Subsurface Intrusion (SESSI)</CHED> <CHED H="3"> Soil <LI>exposure</LI> </CHED> <CHED H="4">Resident</CHED> <CHED H="4">Nearby</CHED> <CHED H="3">Subsurface Intrusion</CHED> <CHED H="4"> Area of <LI>observed</LI> <LI>exposure</LI> </CHED> <CHED H="4"> Area of <LI>subsurface</LI> <LI>contamination</LI> </CHED> </BOXHD> <ROW RUL="s"> <ENT I="22"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> </ROW> <ROW RUL="s"> <ENT I="22"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> </ROW> <ROW RUL="s"> <ENT I="22"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> </ROW> <ROW RUL="s"> <ENT I="22"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> </ROW> <ROW> <ENT I="22"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> </ROW> </GPOTABLE> <PRTPAGE P="123"/> <P> 2.2.2  <E T="03">Identify hazardous substances associated with a source.</E> For each of the three migration pathways, consider those hazardous substances documented in a source (for example, by sampling, labels, manifests, oral or written statements) to be associated with that source when evaluating each pathway. In some instances, a hazardous substance can be documented as being present at a site (for example, by labels, manifests, oral or written statements), but the specific source(s) containing that hazardous substance cannot be documented. For the three migration pathways, in those instances when the specific source(s) cannot be documented for a hazardous substance, consider the hazardous substance to be present in each source at the site, except sources for which definitive information indicates that the hazardous substance was not or could not be present. </P> <P>For an area of observed contamination in the soil exposure component of the soil exposure and subsurface intrusion pathway, consider only those hazardous substances that meet the criteria for observed contamination for that area (see section 5.1.0) to be associated with that area when evaluating the pathway.</P> <P>For an area of observed exposure or area of subsurface contamination (see section 5.2.0) in the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, consider only those hazardous substances that:</P> <P>• Meet the criteria for observed exposure, or</P> <P> • Meet the criteria for observed release in an area of subsurface contamination and have a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol, or </P> <P> • Meet the criteria for an observed release in a structure within, or in a sample from below, an area of observed exposure and have a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol. </P> <P> 2.2.3  <E T="03">Identify hazardous substances available to a pathway.</E> In evaluating each migration pathway, consider the following hazardous substances available to migrate from the sources at the site to the pathway: </P> <FP SOURCE="FP-2">• Ground water migration.</FP> <FP SOURCE="FP1-2">—Hazardous substances that meet the criteria for an observed release (see section 2.3) to ground water.</FP> <FP SOURCE="FP1-2">—All hazardous substances associated with a source with a ground water containment factor value greater than 0 (see section 3.1.2.1).</FP> <FP SOURCE="FP-2">• Surface water migration—overland/flood component.</FP> <FP SOURCE="FP1-2">—Hazardous substances that meet the criteria for an observed release to surface water in the watershed being evaluated.</FP> <FP SOURCE="FP1-2">—All hazardous substances associated with a source with a surface water containment factor value greater than 0 for the watershed (see sections 4.1.2.1.2.1.1 and 4.1.2.1.2.2.1).</FP> <FP SOURCE="FP-2">• Surface water migration—ground water to surface water component.</FP> <FP SOURCE="FP1-2">—Hazardous substances that meet the criteria for an observed release to ground water.</FP> <FP SOURCE="FP1-2">—All hazardous substances associated with a source with a ground water containment factor value greater than 0 (see sections 4.2.2.1.2 and 3.1.2.1).</FP> <FP SOURCE="FP-2">• Air migration.</FP> <FP SOURCE="FP1-2">—Hazardous substances that meet the criteria for an observed release to the atmosphere.</FP> <FP SOURCE="FP1-2">—All gaseous hazardous substances associated with a source with a gas containment factor value greater than 0 (see section 6.1.2.1.1).</FP> <FP SOURCE="FP1-2">—All particulate hazardous substances associated with a source with a particulate containment factor value greater than 0 (see section 6.1.2.2.1).</FP> <FP SOURCE="FP-2">• For each migration pathway, in those instances when the specific source(s) containing the hazardous substance cannot be documented, consider that hazardous substance to be available to migrate to the pathway when it can be associated (see section 2.2.2) with at least one source having a containment factor value greater than 0 for that pathway.</FP> <P>In evaluating the soil exposure and subsurface intrusion pathway, consider the following hazardous substances available to the pathway:</P> <FP SOURCE="FP-2">• Soil exposure component—resident population threat.</FP> <FP SOURCE="FP1-2">—All hazardous substances that meet the criteria for observed contamination at the site (see section 5.1.0).</FP> <FP SOURCE="FP-2">• Soil exposure component—nearby population threat.</FP> <FP SOURCE="FP1-2">—All hazardous substances that meet the criteria for observed contamination at areas with an attractiveness/accessibility factor value greater than 0 (see section 5.1.2.1.1).</FP> <FP SOURCE="FP-2">• Subsurface intrusion component.</FP> <FP SOURCE="FP1-2">—All hazardous substances that meet the criteria for observed exposure at the site (see section 5.2.0).</FP> <FP SOURCE="FP1-2"> —All hazardous substances with a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol that meet the criteria for an observed release in an area of subsurface contamination (see section 5.2.0). </FP> <FP SOURCE="FP1-2"> —All hazardous substances that meet the criteria for an observed release in a structure within, or in a sample from <PRTPAGE P="124"/> below, an area of observed exposure (see section 5.2.0). </FP> <P> 2.3  <E T="03">Likelihood of release.</E> Likelihood of release is a measure of the likelihood that a waste has been or will be released to the environment. The likelihood of release factor category is assigned the maximum value of 550 for a migration pathway whenever the criteria for an observed release are met for that pathway. If the criteria for an observed release are met, do not evaluate potential to release for that pathway. When the criteria for an observed release are not met, evaluate potential to release for that pathway, with a maximum value of 500. The evaluation of potential to release varies by migration pathway (see sections 3, 4 and 6). </P> <P>Establish an observed release either by direct observation of the release of a hazardous substance into the media being evaluated (for example, surface water) or by chemical analysis of samples appropriate to the pathway being evaluated (see sections 3, 4 and 6). The minimum standard to establish an observed release by chemical analysis is analytical evidence of a hazardous substance in the media significantly above the background level. Further, some portion of the release must be attributable to the site. Use the criteria in Table 2-3 as the standard for determining analytical significance. (The criteria in Table 2-3 are also used in establishing observed contamination for the soil exposure component and for establishing areas of observed exposure and areas of subsurface contamination in the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, see section 5.1.0 and section 5.2.0). Separate criteria apply to radionuclides (see section 7.1.1).</P> <GPOTABLE COLS="1" OPTS="L1" CDEF="s200"> <TTITLE>Table 2-3—Observed Release Criteria for Chemical Analysis</TTITLE> <BOXHD> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01"> Sample Measurement < Sample Quantitation Limit. <SU>a</SU> </ENT> </ROW> <ROW> <ENT I="01">No observed release is established.</ENT> </ROW> <ROW> <ENT I="01"> Sample Measurement ≥ Sample Quantitation Limit. <SU>a</SU> </ENT> </ROW> <ROW> <ENT I="01">An observed release is established as follows:</ENT> </ROW> <ROW> <ENT I="03"> • If the background concentration is not detected (or is less than the detection limit), an observed release is established when the sample measurement equals or exceeds the sample quantitation limit. <SU>a</SU> </ENT> </ROW> <ROW> <ENT I="03">• If the background concentration equals or exceeds the detection limit, an observed release is established when the sample measurement is 3 times or more above the background concentration.</ENT> </ROW> <TNOTE> <SU>a</SU>  If the sample quantitation limit (SQL) cannot be established, determine if there is an observed release as follows: </TNOTE> <TNOTE>—If the sample analysis was performed under the EPA Contract Laboratory Program, use the EPA contract-required quantitation limit (CRQL) in place of the SQL.</TNOTE> <TNOTE>—If the sample analysis is not performed under the EPA Contract Laboratory Program, use the detection limit (DL) in place of the SQL.</TNOTE> </GPOTABLE> <P> 2.4  <E T="03">Waste characteristics.</E> The waste characteristics factor category includes the following factors: Hazardous waste quantity, toxicity, and as appropriate to the pathway or threat being evaluated, mobility, persistence, degradation, and/or bioaccumulation (or ecosystem bioaccumulation) potential. </P> <P> 2.4.1  <E T="03">Selection of substance potentially posing greatest hazard.</E> For all pathways (components and threats), select the hazardous substance potentially posing the greatest hazard for the pathway (component or threat) and use that substance in evaluating the waste characteristics category of the pathway (component or threat). For the three migration pathways (and threats), base the selection of this hazardous substance on the toxicity factor value for the substance, combined with its mobility, persistence, and/or bioaccumulation (or ecosystem bioaccumulation) potential factor values, as applicable to the migration pathway (or threat). For the soil exposure component of the soil exposure and subsurface intrusion pathway, base the selection on the toxicity factor alone. For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, base the selection on the toxicity factor value for the substance, combined with its degradation factor value. Evaluation of the toxicity factor is specified in section 2.4.1.1. Use and evaluation of the mobility, persistence, degradation, and/or bioaccumulation (or ecosystem bioaccumulation) potential factors vary by pathway (component or threat) and are specified under the appropriate pathway (component or threat) section. Section 2.4.1.2 identifies the specific factors that are combined with toxicity in evaluating each pathway (component or threat). </P> <P> 2.4.1.1  <E T="03">Toxicity factor.</E> Evaluate toxicity for those hazardous substances at the site that are available to the pathway being scored. For all pathways and threats, except the surface water environmental threat, evaluate human toxicity as specified below. For the surface water environmental threat, evaluate ecosystem toxicity as specified in section 4.1.4.2.1.1. </P> <P>Establish human toxicity factor values based on quantitative dose-response parameters for the following three types of toxicity:</P> <P> • Cancer—Use slope factors (also referred to as cancer potency factors) combined with <PRTPAGE P="125"/> weight-of-evidence ratings for carcinogenicity for all exposure routes except inhalation. Use inhalation unit risk (IUR) for inhalation exposure. If an inhalation unit risk or a slope factor is not available for a substance, use its ED <E T="52">10</E> value to estimate a slope factor as follows: </P> <GPH SPAN="2" DEEP="28"> <GID>ER09JA17.063</GID> </GPH> <P>• Noncancer toxicological responses of chronic exposure—use reference dose (RfD) or reference concentration (RfC) values as applicable.</P> <P> • Noncancer toxicological responses of acute exposure—use acute toxicity parameters, such as the LD <E T="52">50</E> . </P> <P>Assign human toxicity factor values to a hazardous substance using Table 2-4, as follows:</P> <P>• If RfD/RfC and slope factor/inhalation unit risk values are available for the hazardous substance, assign the substance a value from Table 2-4 for each. Select the higher of the two values assigned and use it as the overall toxicity factor value for the hazardous substance.</P> <P>• If either an RfD/RfC or slope factor/inhalation unit risk value is available, but not both, assign the hazardous substance an overall toxicity factor value from Table 2-4 based solely on the available value (RfD/RfC or slope factor/inhalation unit risk).</P> <P>• If neither an RfD/RfC nor slope factor/inhalation unit risk value is available, assign the hazardous substance an overall toxicity factor value from Table 2-4 based solely on acute toxicity. That is, consider acute toxicity in Table 2-4 only when both RfD/RfC and slope factor/IUR values are not available.</P> <P>• If neither an RfD/RfC, nor slope factor/inhalation unit risk, nor acute toxicity value is available, assign the hazardous substance an overall toxicity factor value of 0 and use other hazardous substances for which information is available in evaluating the pathway.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,12"> <TTITLE>Table 2-4—Toxicity Factor Evaluation</TTITLE> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Chronic Toxicity (Human)</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="22">Reference dose (RfD) (mg/kg-day):</ENT> </ROW> <ROW> <ENT I="02">RfD < 0.0005</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="02">0.0005 ≤ RfD < 0.005</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="02">0.005 ≤ RfD < 0.05</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="02">0.05 ≤ RfD < 0.5</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">0.5 ≤ RfD</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="02">RfD not available</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="22"> Reference concentration (RfC) (mg/m <SU>3</SU> ): </ENT> </ROW> <ROW> <ENT I="02">RfC < 0.0001</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="02">0.0001 ≤ RfC < 0.006</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="02">0.006 ≤ RfC < 0.2</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="02">0.2 ≤ RfC < 2.0</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">2.0 ≤ RfC</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="02">RfC not available</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="4" OPTS="L2" CDEF="s50,r50,r50,12"> <BOXHD> <CHED H="1">Carcinogenicity (human)</CHED> <CHED H="2">A or Carcinogenic to humans</CHED> <CHED H="2"> B or Likely to be carcinogenic <LI>to humans</LI> </CHED> <CHED H="2"> C or Suggestive evidence of <LI>carcinogenic potential</LI> </CHED> <CHED H="2"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Weight-of-evidence</E> <SU>a</SU> <E T="02">/Slope factor (mg/kg-day)</E> <E T="51">−1</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01"> 0.5 ≤ SF  <SU>b</SU> </ENT> <ENT>5 ≤ SF</ENT> <ENT>50 ≤ SF</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">0.05 ≤ SF < 0.5</ENT> <ENT>0.5 ≤ SF < 5</ENT> <ENT>5 ≤ SF < 50</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">SF < 0.05</ENT> <ENT>0.05 ≤ SF < 0.5</ENT> <ENT>0.5 ≤ SF < 5</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>SF < 0.05</ENT> <ENT>SF < 0.5</ENT> <ENT>10</ENT> </ROW> <ROW RUL="s"> <ENT I="01">Slope factor not available</ENT> <ENT>Slope factor not available</ENT> <ENT>Slope factor not available</ENT> <ENT>0</ENT> </ROW> <ROW EXPSTB="03" RUL="s"> <ENT I="21"> <E T="02">Weight-of-evidence </E> <SU>a</SU> <E T="02">/Inhalation unit risk (µg/m</E> <SU>3</SU> <E T="02">)</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01"> 0.00004 ≤ IUR  <SU>c</SU> </ENT> <ENT>0.0004 ≤ IUR</ENT> <ENT>0.004 ≤ IUR</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">0.00001 ≤ IUR < 0.00004</ENT> <ENT>0.0001 ≤ IUR < 0.0004</ENT> <ENT>0.001 ≤ IUR < 0.004</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">IUR < 0.00001</ENT> <ENT>0.00001 ≤ IUR < 0.0001</ENT> <ENT>0.0001 ≤ IUR < 0.001</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>< 0.00001</ENT> <ENT>IUR < 0.0001</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Inhalation unit risk not available</ENT> <ENT>Inhalation unit risk not available</ENT> <ENT>Inhalation unit risk not available</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  A, B, and C, as well as Carcinogenic to humans, Likely to be carcinogenic to humans, and Suggestive evidence of carcinogenic potential refer to weight-of-evidence categories. Assign substances with a weight-of-evidence category of D (inadequate evidence of carcinogenicity) or E (evidence of lack of carcinogenicity), as well as inadequate information to assess carcinogenic potential and not likely to be carcinogenic to humans a value of 0 for carcinogenicity. </TNOTE> <TNOTE> <SU>b</SU>  SF = Slope factor. </TNOTE> <TNOTE> <SU>c</SU>  IUR = Inhalation Unit Risk. </TNOTE> </GPOTABLE> <PRTPAGE P="126"/> <GPOTABLE COLS="5" OPTS="L2" CDEF="s50,r50,r50,r50,12"> <BOXHD> <CHED H="1">Acute Toxicity (human)</CHED> <CHED H="2"> Oral LD <E T="0732">50</E> <LI>(mg/kg)</LI> </CHED> <CHED H="2"> Dermal LD <E T="0732">50</E> <LI>(mg/kg)</LI> </CHED> <CHED H="2"> Dust or mist LC <E T="0732">50</E> <LI>(mg/l)</LI> </CHED> <CHED H="2"> Gas or vapor LC <E T="0732">50</E> <LI>(ppm)</LI> </CHED> <CHED H="2">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> LD <E T="0732">50</E> < 5 </ENT> <ENT> LD <E T="0732">50</E> < 2 </ENT> <ENT> LC <E T="0732">50</E> < 0.2 </ENT> <ENT> LC <E T="0732">50</E> < 20 </ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01"> 5 ≤ LD <E T="0732">50</E> < 50 </ENT> <ENT> 2 ≤ LD <E T="0732">50</E> < 20 </ENT> <ENT> 0.2 ≤ LC <E T="0732">50</E> < 2 </ENT> <ENT> 20 ≤ LC <E T="0732">50</E> <200 </ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01"> 50 ≤ LD <E T="0732">50</E> < 500 </ENT> <ENT> 20 ≤ LD <E T="0732">50</E> < 200 </ENT> <ENT> 2 ≤ LC <E T="0732">50</E> <20 </ENT> <ENT> 200 ≤ LC <E T="0732">50</E> <2,000 </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01"> 500 ≤ LD <E T="0732">50</E> </ENT> <ENT> 200 ≤ LD <E T="0732">50</E> </ENT> <ENT> 20 ≤ LC <E T="0732">50</E> </ENT> <ENT> 2,000 ≤ LC <E T="0732">50</E> </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01"> LD <E T="0732">50</E> not available </ENT> <ENT> LD <E T="0732">50</E> not available </ENT> <ENT> LC <E T="0732">50</E> not available </ENT> <ENT> LC <E T="0732">50</E> not available </ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <P>If a toxicity factor value of 0 is assigned to all hazardous substances available to a particular pathway (that is, insufficient toxicity data are available for evaluating all the substances), use a default value of 100 as the overall human toxicity factor value for all hazardous substances available to the pathway. For hazardous substances having usable toxicity data for multiple exposure routes (for example, inhalation and ingestion), consider all exposure routes and use the highest assigned value, regardless of exposure route, as the toxicity factor value. For HRS purposes, assign both asbestos and lead (and its compounds) a human toxicity factor value of 10,000.</P> <P>Separate criteria apply for assigning factor values for human toxicity and ecosystem toxicity for radionuclides (see sections 7.2.1 and 7.2.2).</P> <P> 2.4.1.2  <E T="03">Hazardous substance selection.</E> For each hazardous substance evaluated for a migration pathway (or threat), combine the human toxicity factor value (or ecosystem toxicity factor value) for the hazardous substance with a mobility, persistence, and/or bioaccumulation (or ecosystem bioaccumulation) potential factor value as follows: </P> <FP SOURCE="FP-2">• Ground water migration.</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/mobility factor value for the hazardous substance (see section 3.2.1).</FP> <FP SOURCE="FP-2">• Surface water migration—overland/flood migration component.</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/persistence factor value for the hazardous substance for the drinking water threat (see section 4.1.2.2.1).</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/persistence/bioaccumulation factor value for the hazardous substance for the human food chain threat (see section 4.1.3.2.1).</FP> <FP SOURCE="FP1-2">—Determine a combined ecosystem toxicity/persistence/bioaccumulation factor value for the hazardous substance for the environmental threat (see section 4.1.4.2.1).</FP> <FP SOURCE="FP-2">• Surface water migration—ground water to surface water migration component.</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/mobility/persistence factor value for the hazardous substance for the drinking water threat (see section 4.2.2.2.1).</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/mobility/persistence/bioaccumulation factor value for the hazardous substance for the human food chain threat (see section 4.2.3.2.1).</FP> <FP SOURCE="FP1-2">—Determine a combined ecosystem toxicity/mobility/persistence/bioaccumulation factor value for the hazardous substance for the environmental threat (see section 4.2.4.2.1).</FP> <FP SOURCE="FP-2">• Air migration.</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/mobility factor value for the hazardous substance (see section 6.2.1).</FP> <P>Determine each combined factor value for a hazardous substance by multiplying the individual factor values appropriate to the pathway (or threat). For each migration pathway (or threat) being evaluated, select the hazardous substance with the highest combined factor value and use that substance in evaluating the waste characteristics factor category of the pathway (or threat).</P> <P>For the soil exposure and subsurface intrusion pathway, determine toxicity and toxicity/degradation factor values as follows:</P> <FP SOURCE="FP-2">• Soil exposure and subsurface intrusion—soil exposure component.</FP> <FP SOURCE="FP1-2">—Select the hazardous substance with the highest human toxicity factor value from among the substances that meet the criteria for observed contamination for the threat evaluated and use that substance in evaluating the waste characteristics factor category (see section 5.1.1.2.1).</FP> <FP SOURCE="FP-2">• Soil exposure and subsurface intrusion—subsurface intrusion component.</FP> <FP SOURCE="FP1-2">—Determine a combined human toxicity/degradation factor value for each hazardous substance being evaluated that:</FP> <FP SOURCE="FP1-2">▪ Meets the criteria for observed exposure, or</FP> <FP SOURCE="FP1-2"> ▪ Meets the criteria for observed release in an area of subsurface contamination and has a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−5</E> atm-m <SU>3</SU> /mol, or </FP> <FP SOURCE="FP1-2"> ▪ Meets the criteria for an observed release in a structure within, or in a sample from below, an area of observed exposure and has a vapor pressure greater than or equal to one torr or a Henry's <PRTPAGE P="127"/> constant greater than or equal to 10 <E T="51">−5</E> atm-m <SU>3</SU> /mol. </FP> <FP SOURCE="FP1-2">—Select the hazardous substance with the highest combined factor value and use that substance in evaluating the waste characteristics factor category (see sections 5.2.1.2.1 and 5.2.1.2).</FP> <P> 2.4.2  <E T="03">Hazardous waste quantity.</E> Evaluate the hazardous waste quantity factor by first assigning each source (or area of observed contamination, area of observed exposure, or area of subsurface contamination) a source hazardous waste quantity value as specified below. Sum these values to obtain the hazardous waste quantity factor value for the pathway being evaluated. </P> <P>In evaluating the hazardous waste quantity factor for the three migration pathways, allocate hazardous substances and hazardous wastestreams to specific sources in the manner specified in section 2.2.2, except: Consider hazardous substances and hazardous wastestreams that cannot be allocated to any specific source to constitute a separate “unallocated source” for purposes of evaluating only this factor for the three migration pathways. Do not, however, include a hazardous substance or hazardous wastestream in the unallocated source for a migration pathway if there is definitive information indicating that the substance or wastestream could only have been placed in sources with a containment factor value of 0 for that migration pathway.</P> <P>In evaluating the hazardous waste quantity factor for the soil exposure component of the soil exposure and subsurface intrusion pathway, allocate to each area of observed contamination only those hazardous substances that meet the criteria for observed contamination for that area of observed contamination and only those hazardous wastestreams that contain hazardous substances that meet the criteria for observed contamination for that area of observed contamination. Do not consider other hazardous substances or hazardous wastestreams at the site in evaluating this factor for the soil exposure component of the soil exposure and subsurface intrusion pathway.</P> <P>In evaluating the hazardous waste quantity factor for the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, allocate to each area of observed exposure or area of subsurface contamination only those hazardous substances and hazardous wastestreams that contain hazardous substances that:</P> <FP SOURCE="FP-1">• Meet the criteria for observed exposure, or</FP> <FP SOURCE="FP-1"> • Meet the criteria for observed release in an area of subsurface contamination and have a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−5</E> atm-m <SU>3</SU> /mol, or </FP> <FP SOURCE="FP-1"> • Meet the criteria for an observed release in a structure within, or in a sample from below, an area of observed exposure and have a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−5</E> atm-m <SU>3</SU> /mol. </FP> <P>Do not consider other hazardous substances or hazardous wastestreams at the site in evaluating this factor for the subsurface intrusion component of the soil exposure and subsurface intrusion pathway. When determining the hazardous waste quantity for multi-subunit structures, use the procedures identified in section 5.2.1.2.2.</P> <P> 2.4.2.1  <E T="03">Source hazardous waste quantity.</E> For each of the three migration pathways, assign a source hazardous waste quantity value to each source (including the unallocated source) having a containment factor value greater than 0 for the pathway being evaluated. Consider the unallocated source to have a containment factor value greater than 0 for each migration pathway. </P> <P>For the soil exposure component of the soil exposure and subsurface intrusion pathway, assign a source hazardous waste quantity value to each area of observed contamination, as applicable to the threat being evaluated.</P> <P>For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, assign a source hazardous waste quantity value to each regularly occupied structure within an area of observed exposure or an area of subsurface contamination that has a structure containment factor value greater than 0. If sufficient data is available and state of the science shows there is no unacceptable risk due to subsurface intrusion into a regularly occupied structure located within an area of subsurface contamination, that structure can be excluded from the area of subsurface contamination.</P> <P>For determining all hazardous waste quantity calculations except for an unallocated source or an area of subsurface contamination, evaluate using the following four measures in the following hierarchy:</P> <P>• Hazardous constituent quantity.</P> <P>• Hazardous wastestream quantity.</P> <P>• Volume.</P> <P>• Area.</P> <P>For the unallocated source, use only the first two measures. For an area of subsurface contamination, evaluate non-radioactive hazardous substances using only the last two measures and evaluate radioactive hazardous substances using hazardous wastestream quantity only. See also section 7.0 regarding the evaluation of radioactive substances.</P> <P>Separate criteria apply for assigning a source hazardous waste quantity value for radionuclides (see section 7.2.5).</P> <P> 2.4.2.1.1  <E T="03">Hazardous constituent quantity.</E> Evaluate hazardous constituent quantity for the source (or area of observed contamination) based solely on the mass of CERCLA hazardous substances (as defined in CERCLA <PRTPAGE P="128"/> section 101(14), as amended) allocated to the source (or area of observed contamination), except: </P> <P> • For a hazardous waste listed pursuant to section 3001 of the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976 (RCRA), 42 U.S.C. 6901 <E T="03">et seq.,</E> determine its mass for the evaluation of this measure as follows: </P> <FP SOURCE="FP-1">—If the hazardous waste is listed solely for Hazard Code T (toxic waste), include only the mass of constituents in the hazardous waste that are CERCLA hazardous substances and not the mass of the entire hazardous waste.</FP> <FP SOURCE="FP-1">—If the hazardous waste is listed for any other Hazard Code (including T plus any other Hazard Code), include the mass of the entire hazardous waste.</FP> <P>• For a RCRA hazardous waste that exhibits the characteristics identified under section 3001 of RCRA, as amended, determine its mass for the evaluation of this measure as follows:</P> <FP SOURCE="FP-1">—If the hazardous waste exhibits only the characteristic of toxicity (or only the characteristic of EP toxicity), include only the mass of constituents in the hazardous waste that are CERCLA hazardous substances and not the mass of the entire hazardous waste.</FP> <FP SOURCE="FP-1">—If the hazardous waste exhibits any other characteristic identified under section 3001 (including any other characteristic plus the characteristic of toxicity [or the characteristic of EP toxicity]), include the mass of the entire hazardous waste.</FP> <P>Based on this mass, designated as C, assign a value for hazardous constituent quantity as follows:</P> <P>• For the migration pathways, assign the source a value for hazardous constituent quantity using the Tier A equation of Table 2-5.</P> <P>• For the soil exposure and subsurface intrusion pathway—soil exposure component, assign the area of observed contamination a value using the Tier A equation of Table 5-2 (section 5.1.1.2.2).</P> <P>• For the soil exposure and subsurface intrusion pathway—subsurface intrusion component, assign the area of observed exposure a value using the Tier A equation of Table 5-19 (section 5.2.1.2.2).</P> <P>If the hazardous constituent quantity for the source (or area of observed contamination or area of observed exposure) is adequately determined (that is, the total mass of all CERCLA hazardous substances in the source and releases from the source [or in the area of observed contamination or area of observed exposure] is known or is estimated with reasonable confidence), do not evaluate the other three measures discussed below. Instead assign these other three measures a value of 0 for the source (or area of observed contamination or area of observed exposure) and proceed to section 2.4.2.1.5.</P> <P>If the hazardous constituent quantity is not adequately determined, assign the source (or area of observed contamination or area of observed exposure) a value for hazardous constituent quantity based on the available data and proceed to section 2.4.2.1.2.</P> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs60,r50,xs60,xs60"> <TTITLE>Table 2-5—Hazardous Waste Quantity Evaluation Equations</TTITLE> <BOXHD> <CHED H="1">Tier</CHED> <CHED H="1">Measure</CHED> <CHED H="1">Units</CHED> <CHED H="1"> Equation <LI>for assigning</LI> <LI> value  <SU>a</SU> </LI> </CHED> </BOXHD> <ROW> <ENT I="01">A</ENT> <ENT>Hazardous constituent quantity (C)</ENT> <ENT>lb</ENT> <ENT>C.</ENT> </ROW> <ROW> <ENT I="01"> B  <SU>b</SU> </ENT> <ENT>Hazardous wastestream quantity (W)</ENT> <ENT>lb</ENT> <ENT>W/5,000.</ENT> </ROW> <ROW> <ENT I="01"> C  <SU>b</SU> </ENT> <ENT>Volume (V)</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Landfill</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2,500.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Surface impoundment</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Surface impoundment (buried/backfilled)</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Drums  <SU>c</SU> </ENT> <ENT>gallon</ENT> <ENT>V/500.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tanks and containers other than drums</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Contaminated soil</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2,500.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pile</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Other</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <ENT I="01"> D  <SU>b</SU> </ENT> <ENT>Area (A)</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Landfill</ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/3,400.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Surface impoundment</ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/13.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Surface impoundment (buried/backfilled)</ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/13.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Land treatment</ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/270.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Pile <SU>d</SU> </ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/13.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Contaminated soil</ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/34,000.</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  Convert volume to mass when necessary: 1 ton = 2,000 pounds = 1 cubic yard = 4 drums = 200 gallons. </TNOTE> <TNOTE> <SU>c</SU>  If actual volume of drums is unavailable, assume 1 drum=50 gallons. </TNOTE> <TNOTE> <SU>d</SU>  Use land surface area under pile, not surface area of pile. </TNOTE> </GPOTABLE> <PRTPAGE P="129"/> <P> 2.4.2.1.2  <E T="03">Hazardous wastestream quantity.</E> Evaluate hazardous wastestream quantity for the source (or area of observed contamination or area of observed exposure) based on the mass of hazardous wastestreams plus the mass of any additional CERCLA pollutants and contaminants (as defined in CERCLA section 101[33], as amended) that are allocated to the source (or area of observed contamination or area of observed exposure). For a wastestream that consists solely of a hazardous waste listed pursuant to section 3001 of RCRA, as amended or that consists solely of a RCRA hazardous waste that exhibits the characteristics identified under section 3001 of RCRA, as amended, include the mass of that entire hazardous waste in the evaluation of this measure. </P> <P>Based on this mass, designated as W, assign a value for hazardous wastestream quantity as follows:</P> <P>• For the migration pathways, assign the source a value for hazardous wastestream quantity using the Tier B equation of Table 2-5.</P> <P>• For the soil exposure and subsurface intrusion pathway—soil exposure component, assign the area of observed contamination a value using the Tier B equation of Table 5-2 (section 5.1.1.2.2).</P> <P>• For the soil exposure and subsurface intrusion pathway—subsurface intrusion component, assign the area of observed exposure a value using the Tier B equation of Table 5-19 (section 5.2.1.2.2).</P> <P>Do not evaluate the volume and area measures described below if the source is the unallocated source or if the following condition applies:</P> <P>• The hazardous wastestream quantity for the source (or area of observed contamination or area of observed exposure) is adequately determined—that is, total mass of all hazardous wastestreams and CERCLA pollutants and contaminants for the source and releases from the source (or for the area of observed contamination) is known or is estimated with reasonable confidence.</P> <P>If the source is the unallocated source or if this condition applies, assign the volume and area measures a value of 0 for the source (or area of observed contamination) and proceed to section 2.4.2.1.5. Otherwise, assign the source (or area of observed contamination) a value for hazardous wastestream quantity based on the available data and proceed to section 2.4.2.1.3.</P> <P> 2.4.2.1.3  <E T="03">Volume.</E> Evaluate the volume measure using the volume of the source (or the volume of the area of observed contamination, area of observed exposure, or area of subsurface contamination). For the soil exposure and subsurface intrusion pathway, restrict the use of the volume measure to those areas of observed contamination, areas of observed exposure, or areas of subsurface contamination as specified in sections 5.1.1.2.2 and 5.2.1.2.2. </P> <P>Based on the volume, designated as V, assign a value to the volume measure as follows:</P> <P>• For the migration pathways, assign the source a value for volume using the appropriate Tier C equation of Table 2-5.</P> <P>• For the soil exposure and subsurface intrusion pathway—soil exposure component, assign the area of observed contamination a value for volume using the appropriate Tier C equation of Table 5-2 (section 5.1.1.2.2).</P> <P>• For the soil exposure and subsurface intrusion pathway—subsurface intrusion component, assign the value based on the volume of the regularly occupied structures within the area of observed exposure or area of subsurface contamination using the Tier C equation of Table 5-19 (section 5.2.1.2.2).</P> <P>If the volume of the source (or volume of the area of observed contamination, area of observed exposure, or area of subsurface contamination, if applicable) can be determined, do not evaluate the area measure. Instead, assign the area measure a value of 0 and proceed to section 2.4.2.1.5. If the volume cannot be determined (or is not applicable for the soil exposure and subsurface intrusion pathway), assign the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination) a value of 0 for the volume measure and proceed to section 2.4.2.1.4.</P> <P> 2.4.2.1.4  <E T="03">Area.</E> Evaluate the area measure using the area of the source (or the area of the area of observed contamination, area of observed exposure, or area of subsurface contamination). Based on this area, designated as A, assign a value to the area measure as follows: </P> <P>• For the migration pathways, assign the source a value for area using the appropriate Tier D equation of Table 2-5.</P> <P>• For the soil exposure and subsurface intrusion pathway—soil exposure component, assign the area of observed contamination a value for area using the appropriate Tier D equation of Table 5-2 (section 5.1.1.2.2).</P> <P>• For the soil exposure and subsurface intrusion pathway—subsurface intrusion component, assign a value based on the area of regularly occupied structures within the area of observed exposure or area of subsurface contamination using the Tier D equation of Table 5-19 (section 5.2.1.2.2).</P> <P> 2.4.2.1.5  <E T="03">Calculation of source hazardous waste quantity value.</E> Select the highest of the values assigned to the source (or areas of observed contamination, areas of observed exposure, or areas of subsurface contamination) for the hazardous constituent quantity, hazardous wastestream quantity, volume, and area measures. Assign this value as the source hazardous waste quantity value. Do not round to the nearest integer. <PRTPAGE P="130"/> </P> <P> 2.4.2.2  <E T="03">Calculation of hazardous waste quantity factor value.</E> Sum the source hazardous waste quantity values assigned to all sources (including the unallocated source) or areas of observed contamination, areas of observed exposure, or areas of subsurface contamination for the pathway being evaluated and round this sum to the nearest integer, except: If the sum is greater than 0, but less than 1, round it to 1. Based on this value, select a hazardous waste quantity factor value for the pathway from Table 2-6. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,12"> <TTITLE>Table 2-6—Hazardous Waste Quantity Factor Values</TTITLE> <BOXHD> <CHED H="1">Hazardous waste quantity value</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01"> 1  <SU>a</SU> to 100 </ENT> <ENT> <SU>b</SU>  1 </ENT> </ROW> <ROW> <ENT I="01">Greater than 100 to 10,000</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Greater than 10,000 to 1,000,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000,000</ENT> <ENT>1,000,000</ENT> </ROW> <TNOTE> <SU>a</SU>  If the hazardous waste quantity value is greater than 0, but less than 1, round it to 1 as specified in text. </TNOTE> <TNOTE> <SU>b</SU>  For the pathway, if hazardous constituent quantity is not adequately determined, assign a value as specified in the text; do not assign the value of 1. </TNOTE> </GPOTABLE> <P>For a migration pathway, if the hazardous constituent quantity is adequately determined (see section 2.4.2.1.1) for all sources (or all portions of sources and releases remaining after a removal action), assign the value from Table 2-6 as the hazardous waste quantity factor value for the pathway. If the hazardous constituent quantity is not adequately determined for one or more sources (or one or more portions of sources or releases remaining after a removal action) assign a factor value as follows:</P> <P>• If any target for that migration pathway is subject to Level I or Level II concentrations (see section 2.5), assign either the value from Table 2-6 or a value of 100, whichever is greater, as the hazardous waste quantity factor value for that pathway.</P> <P>• If none of the targets for that pathway is subject to Level I or Level II concentrations, assign a factor value as follows:</P> <FP SOURCE="FP-1">—If there has been no removal action, assign either the value from Table 2-6 or a value of 10, whichever is greater, as the hazardous waste quantity factor value for that pathway.</FP> <FP SOURCE="FP-1">—If there has been a removal action:</FP> <FP SOURCE="FP1-2">▪ Determine values from Table 2-6 with and without consideration of the removal action.</FP> <FP SOURCE="FP1-2">▪ If the value that would be assigned from Table 2-6 without consideration of the removal action would be 100 or greater, assign either the value from Table 2-6 with consideration of the removal action or a value of 100, whichever is greater, as the hazardous waste quantity factor value for the pathway.</FP> <FP SOURCE="FP1-2">▪ If the value that would be assigned from Table 2-6 without consideration of the removal action would be less than 100, assign a value of 10 as the hazardous waste quantity factor value for the pathway.</FP> <P>For the soil exposure component of the soil exposure and subsurface intrusion pathway, if the hazardous constituent quantity is adequately determined for all areas of observed contamination, assign the value from Table 2-6 as the hazardous waste quantity factor value. If the hazardous constituent quantity is not adequately determined for one or more areas of observed contamination, assign either the value from Table 2-6 or a value of 10, whichever is greater, as the hazardous waste quantity factor value.</P> <P>For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, if the hazardous constituent quantity is adequately determined for all areas of observed exposure, assign the value from Table 2-6 as the hazardous waste quantity factor value. If the hazardous constituent quantity is not adequately determined for one or more areas of observed exposure, assign either the value from Table 2-6 or assign a factor value as follows:</P> <P>• If any target for the subsurface intrusion component is subject to Level I or Level II concentrations (see section 2.5), assign either the value from Table 2-6 or a value of 100, whichever is greater, as the hazardous waste quantity factor value for this component.</P> <P>• If none of the targets for the subsurface intrusion component is subject to Level I or Level II concentrations and if there has been a removal or other temporary response action that does not permanently interrupt target exposure form subsurface intrusion, assign a factor value as follows:</P> <FP SOURCE="FP-1">—Determine the values from Table 2-6 with and without consideration of the removal or other temporary response action.</FP> <FP SOURCE="FP-1">—If the value that would be assigned from Table 2-6 without consideration of the removal or other temporary response action would be 100 or greater, assign either the value from Table 2-6 with consideration of the removal action or a value of 100, whichever is greater, as the hazardous waste quantity factor value for the component.</FP> <FP SOURCE="FP-1">—If the value that would be assigned from Table 2-6 without consideration of the removal or other temporary response action would be less than 100, assign a value of 10 as the hazardous waste quantity factor value for the component.</FP> <P> • Otherwise, if none of the targets for the subsurface intrusion component is subject to Level I or Level II concentrations and there has not been a removal action, assign a value from Table 2-6 or a value of 10, whichever is greater. <PRTPAGE P="131"/> </P> <P> 2.4.3  <E T="03">Waste characteristics factor category value.</E> Determine the waste characteristics factor category value as specified in section 2.4.3.1 for all pathways and threats, except the surface water-human food chain threat and the surface water-environmental threat. Determine the waste characteristics factor category value for these latter two threats as specified in section 2.4.3.2. </P> <P> 2.4.3.1  <E T="03">Factor category value.</E> For the pathway (component or threat) being evaluated, multiply the toxicity or combined factor value, as appropriate, from section 2.4.1.2 and the hazardous waste quantity factor value from section 2.4.2.2, subject to a maximum product of 1x10 <SU>8</SU> . Based on this waste characteristics product, assign a waste characteristics factor category value to the pathway (component or threat) from Table 2-7. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,12"> <TTITLE>Table 2-7—Waste Characteristics Factor Category Values</TTITLE> <BOXHD> <CHED H="1">Waste characteristics product</CHED> <CHED H="1"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Greater than 0 to less than 10</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01"> 10 to less than 1x10 <SU>2</SU> </ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>2</SU> to less than 1x10 <SU>3</SU> </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>3</SU> to less than 1x10 <SU>4</SU> </ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>4</SU> to less than 1x10 <SU>5</SU> </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>5</SU> to less than 1x10 <SU>6</SU> </ENT> <ENT>18</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>6</SU> to less than 1x10 <SU>7</SU> </ENT> <ENT>32</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>7</SU> to less than 1x10 <SU>8</SU> </ENT> <ENT>56</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>8</SU> to less than 1x10 <SU>9</SU> </ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>9</SU> to less than 1x10 <SU>10</SU> </ENT> <ENT>180</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>10</SU> to less than 1x10 <SU>11</SU> </ENT> <ENT>320</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>11</SU> to less than 1x10 <SU>12</SU> </ENT> <ENT>560</ENT> </ROW> <ROW> <ENT I="01"> 1x10 <SU>12</SU> </ENT> <ENT>1,000</ENT> </ROW> </GPOTABLE> <P> 2.4.3.2  <E T="03">Factor category value, considering bioaccumulation potential.</E> For the surface water-human food chain threat and the surface water-environmental threat, multiply the toxicity or combined factor value, as appropriate, from section 2.4.1.2 and the hazardous waste quantity factor value from section 2.4.2.2, subject to: </P> <P> • A maximum product of 1x10 <SU>12</SU> , <E T="03">and</E> </P> <P> • A maximum product exclusive of the bioaccumulation (or ecosystem bioaccumulation) potential factor of 1x10 <SU>8</SU> . </P> <P>Based on the total waste characteristics product, assign a waste characteristics factor category value to these threats from Table 2-7.</P> <P> 2.5  <E T="03">Targets.</E> The types of targets evaluated include the following: </P> <P>• Individual (factor name varies by pathway, component, and threat).</P> <P>• Human population.</P> <P>• Resources (these vary by pathway, component, and threat).</P> <P>• Sensitive environments (included for the surface water migration pathway, air migration pathway, and soil exposure component of the soil exposure and subsurface intrusion pathway).</P> <P>The factor values that may be assigned to each type of target have the same range for each pathway for which that type of target is evaluated. The factor value for most types of targets depends on whether the target is subject to actual or potential contamination for the pathway and whether the actual contamination is Level I or Level II:</P> <P>• Actual contamination: Target is associated either with a sampling location that meets the criteria for an observed release (or observed contamination or observed exposure) for the pathway or with an observed release based on direct observation for the pathway (additional criteria apply for establishing actual contamination for the human food chain threat in the surface water migration pathway, see sections 4.1.3.3 and 4.2.3.3). Sections 3 through 6 specify how to determine the targets associated with a sampling location or with an observed release based on direct observation. Determine whether the actual contamination is Level I or Level II as follows:</P> <FP SOURCE="FP-1">—Level I:</FP> <FP SOURCE="FP1-2">▪ Media-specific concentrations for the target meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway and are at or above media-specific benchmark values. These benchmark values (see section 2.5.2) include both screening concentrations and concentrations specified in regulatory limits (such as Maximum Contaminant Level (MCL) values), or</FP> <FP SOURCE="FP1-2">▪ For the human food chain threat in the surface water migration pathway, concentrations in tissue samples from aquatic human food chain organisms are at or above benchmark values. Such tissue samples may be used in addition to media-specific concentrations only as specified in sections 4.1.3.3 and 4.2.3.3.</FP> <FP SOURCE="FP-1">—Level II:</FP> <FP SOURCE="FP1-2">▪ Media-specific concentrations for the target meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway, but are less than media-specific benchmarks. If none of the hazardous substances eligible to be evaluated for the sampling location has an applicable benchmark, assign Level II to the actual contamination at the sampling location, or</FP> <FP SOURCE="FP1-2">▪ For observed releases or observed exposures based on direct observation, assign Level II to targets as specified in sections 3, 4, 5, and 6, or</FP> <FP SOURCE="FP1-2">▪ For the human food chain threat in the surface water migration pathway, concentrations in tissue samples from aquatic human food chain organisms, when applicable, are below benchmark values.</FP> <FP SOURCE="FP-2"> —If a target is subject to both Level I and Level II concentrations for a pathway <PRTPAGE P="132"/> (component or threat), evaluate the target using Level I concentrations for that pathway (component or threat). </FP> <P>• Potential contamination: Target is subject to a potential release (that is, target is not associated with actual contamination for that pathway or threat).</P> <P>Assign a factor value for individual risk as follows (select the highest value that applies to the pathway, component or threat):</P> <P>• 50 points if any individual is exposed to Level I concentrations.</P> <P>• 45 points if any individual is exposed to Level II concentrations.</P> <P>• Maximum of 20 points if any individual is subject to potential contamination. The value assigned is 20 unless reduced by a distance or dilution weight appropriate to the pathway. Assign factor values for population and sensitive environments as follows:</P> <P>• Sum Level I targets and multiply by 10. (Level I is not used for sensitive environments in the soil exposure component of the soil exposure and subsurface intrusion and air migration pathways.)</P> <P>• Sum Level II targets.</P> <P>• Multiply potential targets in all but the soil exposure and subsurface intrusion pathway by distance or dilution weights appropriate to the pathway, sum, and divide by 10. Distance or dilution weighting accounts for diminishing exposure with increasing distance or dilution within the different pathways. For targets within an area of subsurface contamination in the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, multiply by a weighting factor as directed in section 5.2.1.3.2.3.</P> <P>• Sum the values for the three levels.</P> <P>In addition, resource value points are assigned within all pathways for welfare-related impacts (for example, impacts to agricultural land), but do not depend on whether there is actual or potential contamination.</P> <P> 2.5.1  <E T="03">Determination of level of actual contamination at a sampling location.</E> Determine whether Level I concentrations or Level II concentrations apply at a sampling location (and thus to the associated targets) as follows: </P> <P>• Select the benchmarks applicable to the pathway (component or threat) being evaluated.</P> <P>• Compare the concentrations of hazardous substances in the sample (or comparable samples) to their benchmark concentrations for the pathway (component or threat), as specified in section 2.5.2.</P> <P>• Determine which level applies based on this comparison.</P> <P>• If none of the hazardous substances eligible to be evaluated for the sampling location has an applicable benchmark, assign Level II to the actual contamination at that sampling location for the pathway (component or threat).</P> <P>In making the comparison, consider only those samples, and only those hazardous substances in the sample, that meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway, except: Tissue samples from aquatic human food chain organisms may also be used as specified in sections 4.1.3.3 and 4.2.3.3 of the surface water-human food chain threat. If any hazardous substance is present in more than one comparable sample for the sampling location, use the highest concentration of that hazardous substance from any of the comparable samples in making the comparisons.</P> <P>Treat sets of samples that are not comparable separately and make a separate comparison for each such set.</P> <P> 2.5.2  <E T="03">Comparison to benchmarks.</E> Use the following media-specific benchmarks for making the comparisons for the indicated pathway (or threat): </P> <P>• Maximum Contaminant Level Goals (MCLGs)—ground water migration pathway and drinking water threat in surface water migration pathway. Use only MCLG values greater than 0.</P> <P>• Maximum Contaminant Levels (MCLs)—ground water migration pathway and drinking water threat in surface water migration pathway.</P> <P>• Food and Drug Administration Action Level (FDAAL) for fish or shellfish—human food chain threat in surface water migration pathway.</P> <P>• EPA Ambient Water Quality Criteria (AWQC/National Recommended Water Quality Criteria) for protection of aquatic life—environmental threat in surface water migration pathway.</P> <P>• EPA Ambient Aquatic Life Advisory Concentrations (AALAC)—environmental threat in surface water migration pathway.</P> <P>• National Ambient Air Quality Standards (NAAQS)—air migration pathway.</P> <P>• National Emission Standards for Hazardous Air Pollutants (NESHAPs)—air migration pathway. Use only those NESHAPs promulgated in ambient concentration units.</P> <P> • Screening concentration for cancer corresponding to that concentration that corresponds to the 10 <E T="51">−6</E> individual cancer risk for inhalation exposures (air migration pathway or subsurface intrusion component of the soil exposure and subsurface intrusion pathway) or for oral exposures (ground water migration pathway; drinking water and human food chain threats in surface water migration pathway; and soil exposure and subsurface intrusion pathway). </P> <P> • Screening concentration for noncancer toxicological responses corresponding to the RfC for inhalation exposures (air migration pathway and subsurface intrusion component of the soil exposure and subsurface intrusion pathway) or RfD for oral exposures (ground water migration pathway; drinking <PRTPAGE P="133"/> water and human food chain threats in surface water migration pathway; and soil exposure and subsurface intrusion pathway). </P> <P>Select the benchmark(s) applicable to the pathway (component or threat) being evaluated as specified in sections 3 through 6. Compare the concentration of each hazardous substance from the sampling location to its benchmark concentration(s) for that pathway (component or threat). Use only those samples and only those hazardous substances in the sample that meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway, except: Tissue samples from aquatic human food chain organisms may be used as specified in sections 4.1.3.3 and 4.2.3.3. If the concentration of any applicable hazardous substance from any sample equals or exceeds its benchmark concentration, consider the sampling location to be subject to Level I concentrations for that pathway (or threat). If more than one benchmark applies to the hazardous substance, assign Level I if the concentration of the hazardous substance equals or exceeds the lowest applicable benchmark concentration.</P> <P>If no hazardous substance individually equals or exceeds its benchmark concentration, but more than one hazardous substance either meets the criteria for an observed release (or observed contamination or observed exposure) for the sample (or comparable samples) or is eligible to be evaluated for a tissue sample (see sections 4.1.3.3 and 4.2.3.3), calculate the indices I and J specified below based on these hazardous substances.</P> <P>For those hazardous substances that are carcinogens (that is, those having either a carcinogen weight-of-evidence classification of A, B, or C or a weight-of-evidence classification of carcinogenic to humans, likely to be carcinogenic to humans, or suggestive evidence of carcinogenic potential), calculate an index I for the sample location as follows:</P> <GPH SPAN="2" DEEP="37"> <GID>ER09JA17.064</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> C <E T="52">i</E> = Concentration of hazardous substance i in sample (or highest concentration of hazardous substance i from among comparable samples). </FP> <FP SOURCE="FP-2"> SC <E T="52">i</E> = Screening concentration for cancer corresponding to that concentration that corresponds to its 10 <E T="51">−6</E> individual cancer risk for applicable exposure (inhalation or oral) for hazardous substance i. </FP> <FP SOURCE="FP-2"> n = Number of applicable hazardous substances in sample (or comparable samples) that are carcinogens and for which an SC <E T="52">i</E> is available. </FP> <P>For those hazardous substances for which an RfD or RfC is available, calculate an index J for the sample location as follows:</P> <GPH SPAN="2" DEEP="39"> <GID>ER09JA17.065</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> C <E T="52">j</E> = Concentration of hazardous substance j in sample (or highest concentration of hazardous substance j from among comparable samples). </FP> <FP SOURCE="FP-2"> CR <E T="52">j</E> = Screening concentration for noncancer toxicological responses corresponding to RfD or RfC for applicable exposure (inhalation or oral) for hazardous substance j. </FP> <FP SOURCE="FP-2"> m = Number of applicable hazardous substances in sample (or comparable samples) for which a CR <E T="52">j</E> is available. </FP> <P>If either I or J equals or exceeds 1, consider the sampling location to be subject to Level I concentrations for that pathway (component or threat). If both I and J are less than 1, consider the sampling location to be subject to Level II concentrations for that pathway (component or threat). If, for the sampling location, there are sets of samples that are not comparable, calculate I and J separately for each such set, and use the highest calculated values of I and J to assign Level I and Level II.</P> <P> See sections 7.3.1 and 7.3.2 for criteria for determining the level of contamination for radioactive substances. <PRTPAGE P="134"/> </P> <HD SOURCE="HD2">3.0 Ground Water Migration Pathway</HD> <P>Evaluate the ground water migration pathway based on three factor categories: likelihood of release, waste characteristics, and targets. Figure 3-1 indicates the factors included within each factor category.</P> <P> Determine the ground water migration pathway score (S <E T="52">gw</E> ) in terms of the factor category values as follows: </P> <MATH SPAN="1" DEEP="24"> <MID>EC15NO91.145</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">LR = Likelihood of release factor category value.</FP> <FP SOURCE="FP-2">WC = Waste characteristics factor category value.</FP> <FP SOURCE="FP-2">T = Targets factor category value.</FP> <FP SOURCE="FP-2">SF = Scaling factor.</FP> <P>Table 3-1 outlines the specific calculation procedure.</P> <P>Calculate a separate ground water migration pathway score for each aquifer, using the factor category values for that aquifer for likelihood of release, waste characteristics, and targets. In doing so, include both the targets using water from that aquifer and the targets using water from all overlying aquifers through which the hazardous substances would migrate to reach the aquifer being evaluated. Assign the highest ground water migration pathway score that results for any aquifer as the ground water migration pathway score for the site.</P> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="135"/> <GID>EC02AU92.005</GID> </GPH> <PRTPAGE P="136"/> <GPOTABLE COLS="3" OPTS="L2" CDEF="s200,12,12"> <TTITLE>Table 3-1—Ground Water Migration Pathway Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor categories and factors</CHED> <CHED H="1">Maximum value</CHED> <CHED H="1">Value assigned</CHED> </BOXHD> <ROW> <ENT I="11"> <E T="02">Likelihood of Release to an Aquifer:</E> </ENT> </ROW> <ROW> <ENT I="02"> 1. Observed Release</ENT> <ENT>550</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="12"> 2. Potential to Release:</ENT> </ROW> <ROW> <ENT I="05">2a. Containment</ENT> <ENT>10</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2b. Net Precipitation</ENT> <ENT>10</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2c. Depth to Aquifer</ENT> <ENT>5</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2d. Travel Time</ENT> <ENT>35</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2e. Potential to Release [lines 2a(2b + 2c + 2d)]</ENT> <ENT>500</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="02"> 3. Likelihood of Release (higher of lines 1 and 2e)</ENT> <ENT>550</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="02"> 4. Toxicity/Mobility</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="02"> 5. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="02"> 6. Waste Characteristics</ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="02"> 7. Nearest Well</ENT> <ENT>50</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="12"> 8. Population:</ENT> </ROW> <ROW> <ENT I="05">8a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">8b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">8c. Potential Contamination</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">8d. Population (lines 8a + 8b + 8c)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="02"> 9. Resources</ENT> <ENT>5</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="02">10. Wellhead Protection Area</ENT> <ENT>20</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="02">11. Targets (lines 7 + 8d + 9 + 10)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Ground Water Migration Score for an Aquifer:</E> </ENT> </ROW> <ROW> <ENT I="02"> 12. Aquifer Score [(lines 3 × 6 × 11) / 82,500]  <SU>c</SU> </ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Ground Water Migration Pathway Score:</E> </ENT> </ROW> <ROW> <ENT I="02"> 13. Pathway Score (S <E T="52">gw</E> ), (highest value from line 12 for all aquifers evaluated)  <SU>c</SU> </ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <TNOTE> <SU>a</SU>  Maximum value applies to waste characteristics category. </TNOTE> <TNOTE> <SU>b</SU>  Maximum value not applicable. </TNOTE> <TNOTE> <SU>c</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 3.0.1  <E T="03">General considerations</E> </P> <P> 3.0.1.1  <E T="03">Ground water target distance limit.</E> The target distance limit defines the maximum distance from the sources at the site over which targets are evaluated. Use a target distance limit of 4 miles for the ground water migration pathway, except when aquifer discontinuities apply (see section 3.0.1.2.2). Furthermore, consider any well with an observed release from a source at the site (see section 3.1.1) to lie within the target distance limit of the site, regardless of the well's distance from the sources at the site. </P> <P>For sites that consist solely of a contaminated ground water plume with no identified source, begin measuring the 4-mile target distance limit at the center of the area of observed ground water contamination. Determine the area of observed ground water contamination based on available samples that meet the criteria for an observed release.</P> <P> 3.0.1.2 <E T="03"> Aquifer boundaries.</E> Combine multiple aquifers into a single hydrologic unit for scoring purposes if aquifer interconnections can be established for these aquifers. In contrast, restrict aquifer boundaries if aquifer discontinuities can be established. </P> <P> 3.0.1.2.1 <E T="03"> Aquifer interconnections.</E> Evaluate whether aquifer interconnections occur within 2 miles of the sources at the site. If they occur within this 2-mile distance, combine the aquifers having interconnections in scoring the site. In addition, if observed ground water contamination attributable to the sources at the site extends beyond 2 miles from the sources, use any locations within the limits of this observed ground water contamination in evaluating aquifer interconnections. If data are not adequate to establish aquifer interconnections, evaluate the aquifers as separate aquifers. </P> <P> 3.0.1.2.2  <E T="03">Aquifer discontinuities.</E> Evaluate whether aquifer discontinuities occur within the 4-mile target distance limit. An aquifer discontinuity occurs for scoring purposes only when a geologic, topographic, or other structure or feature entirely transects an aquifer within the 4-mile target distance limit, thereby creating a continuous boundary to ground water flow within this limit. If two or more aquifers can be combined into a single hydrologic unit for scoring purposes, an aquifer discontinuity occurs only when the structure or feature entirely transects the boundaries of this single hydrologic unit. </P> <P>When an aquifer discontinuity is established within the 4-mile target distance limit, exclude that portion of the aquifer beyond the discontinuity in evaluating the ground water migration pathway. However, if hazardous substances have migrated across an apparent discontinuity within the 4-mile target distance limit, do not consider this to be a discontinuity in scoring the site.</P> <P> 3.0.1.3 <E T="03"> Karst aquifer.</E> Give a karst aquifer that underlies any portion of the sources at <PRTPAGE P="137"/> the site special consideration in the evaluation of two potential to release factors (depth to aquifer in section 3.1.2.3 and travel time in section 3.1.2.4), one waste characteristics factor (mobility in section 3.2.1.2), and two targets factors (nearest well in section 3.3.1 and potential contamination in section 3.3.2.4). </P> <P> 3.1  <E T="03">Likelihood of release.</E> For an aquifer, evaluate the likelihood of release factor category in terms of an observed release factor or a potential to release factor. </P> <P> 3.1.1  <E T="03">Observed release.</E> Establish an observed release to an aquifer by demonstrating that the site has released a hazardous substance to the aquifer. Base this demonstration on either: </P> <P>• Direct observation—a material that contains one or more hazardous substances has been deposited into or has been observed entering the aquifer.</P> <P>• Chemical analysis—an analysis of ground water samples from the aquifer indicates that the concentration of hazardous substance(s) has increased significantly above the background concentration for the site (see section 2.3). Some portion of the significant increase must be attributable to the site to establish the observed release, except: when the source itself consists of a ground water plume with no identified source, no separate attribution is required.</P> <P>If an observed release can be established for the aquifer, assign the aquifer an observed release factor value of 550, enter this value in table 3-1, and proceed to section 3.1.3. If an observed release cannot be established for the aquifer, assign an observed release factor value of 0, enter this value in table 3-1, and proceed to section 3.1.2.</P> <P> 3.1.2  <E T="03">Potential to release.</E> Evaluate potential to release only if an observed release cannot be established for the aquifer. Evaluate potential to release based on four factors: containment, net precipitation, depth to aquifer, and travel time. For sources overlying karst terrain, give any karst aquifer that underlies any portion of the sources at the site special consideration in evaluating depth to aquifer and travel time, as specified in sections 3.1.2.3 and 3.1.2.4. </P> <P> 3.1.2.1  <E T="03">Containment.</E> Assign a containment factor value from table 3-2 to each source at the site. Select the highest containment factor value assigned to those sources with a source hazardous waste quantity value of 0.5 or more (see section 2.4.2.1.5). (Do not include this minimum size requirement in evaluating any other factor of this pathway.) Assign this highest value as the containment factor value for the aquifer being evaluated. Enter this value in Table ­3-1. </P> <P>If no source at the site meets the minimum size requirement, then select the highest value assigned to the sources at the site and assign it as the containment factor value for the aquifer being evaluated. Enter this value in table 3-1.</P> <P> 3.1.2.2  <E T="03">Net precipitation.</E> Assign a net precipitation factor value to the site. Figure 3-2 provides computed net precipitation factor values, based on site location. Where necessary, determine the net precipitation factor value as follows: </P> <P>• Determine monthly precipitation and monthly evapotranspiration:</P> <P SOURCE="P-1">-Use local measured monthly averages.</P> <P SOURCE="P-1">-When local data are not available, use monthly averages from the nearest National Oceanographic and Atmospheric Administration weather station that is in a similar geographic setting.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s150,xs48"> <TTITLE>Table 3-2—Containment Factor Values for Ground Water Migration Pathway</TTITLE> <BOXHD> <CHED H="1">Source</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="21"> <E T="02">All Sources (Except Surface Impoundments, Land Treatment, Containers, and Tanks)</E> </ENT> </ROW> <ROW> <ENT I="01"> Evidence of hazardous substance migration from source area ( <E T="03">i.e.</E> , source area includes source and any associated containment structures) </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">No liner</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from source area, a liner, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="02">(a) None of the following present: (1) maintained engineered cover, or (2) functioning and maintained run-on control system and runoff management system, or (3) functioning leachate collection and removal system immediately above liner</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">(b) Any one of the three items in (a) present</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="02">(c) Any two of the items in (a) present</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">(d) All three items in (a) present plus a functioning ground water monitoring system</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(e) All items in (d) present, plus no bulk or non-containerized liquids nor materials containing free liquids deposited in source area</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from source area, double liner with functioning leachate collection and removal system above and between liners, functioning ground water monitoring system, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="02">(f) Only one of the following deficiencies present in containment: (1) bulk or noncontainerized liquids or materials containing free liquids deposited in source area, or (2) no or nonfunctioning or nonmaintained run-on control system and runoff management system, or (3) no or nonmaintained engineered cover</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">(g) None of the deficiencies in (f) present</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Source area inside or under maintained intact structure that provides protection from precipitation so that neither runoff nor leachate is generated, liquids or materials containing free liquids not deposited in source area, and functioning and maintained run-on control present</ENT> <ENT>0</ENT> </ROW> <ROW> <PRTPAGE P="138"/> <ENT I="21"> <E T="02">Surface Impoundment</E> </ENT> </ROW> <ROW> <ENT I="01">Evidence of hazardous substance migration from surface impoundment</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">No liner</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Free liquids present with either no diking, unsound diking, or diking that is not regularly inspected and maintained</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from surface impoundment, free liquids present, sound diking that is regularly inspected and maintained, adequate freeboard, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="02">(a) Liner</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="02">(b) Liner with functioning leachate collection and removal system below liner, and functioning ground water monitoring system</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(c) Double liner with functioning leachate collection and removal system between liners, and functioning ground water monitoring system</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">No evidence of hazardous substance migration from surface impoundment and all free liquids eliminated at closure (either by removal of liquids or solidification of remaining wastes and waste residues)</ENT> <ENT> Evaluate using <E T="02">All sources</E> criteria (with no bulk or free liquid deposited). </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Land Treatment</E> </ENT> </ROW> <ROW> <ENT I="01">Evidence of hazardous substance migration from land treatment zone</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">No functioning, maintained, run-on control and runoff management system</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from land treatment zone <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="02">(a) Functioning and maintained run-on control and runoff management system</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">(b) Functioning and maintained run-on control and runoff management system, and vegetative cover established over entire land treatment area</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(c) Land treatment area maintained in compliance with 40 CFR 264.280</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Containers</E> </ENT> </ROW> <ROW> <ENT I="01">All containers buried</ENT> <ENT> Evaluate using <E T="02">All sources</E> criteria. </ENT> </ROW> <ROW> <ENT I="01"> Evidence of hazardous substance migration from container area ( <E T="03">i.e.</E> , container area includes containers and any associated containment structures) </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">No liner (or no essentially impervious base) under container area.</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">No diking (or no similar structure) surrounding container area</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Diking surrounding container area unsound or not regularly inspected and maintained</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from container area, container area surrounded by sound diking that is regularly inspected and maintained, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="02">(a) Liner (or essentially impervious base) under container area</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="02">(b) Essentially impervious base under container area with liquids collection and removal system</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">(c) Containment system includes essentially impervious base, liquids collection system, sufficient capacity to contain 10 percent of volume of all containers, and functioning and maintained run-on control; plus functioning ground water monitoring system, and spilled or leaked hazardous substances and accumulated precipitation removed in timely manner to prevent overflow of collection system, at least weekly inspection of containers, hazardous substances in leaking or deteriorating containers transferred to containers in good condition, and containers sealed except when waste is added or removed</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(d) Free liquids present, containment system has sufficient capacity to hold total volume of all containers and to provide adequate freeboard, single liner under container area with functioning leachate collection and removal system below liner, and functioning ground water monitoring system</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(e) Same as (d) except: double liner under container area with functioning leachate collection and removal system between liners</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Containers inside or under maintained intact structure that provides protection from precipitation so that neither runoff nor leachate would be generated from any unsealed or ruptured containers, liquids or materials containing free liquids not deposited in any container, and functioning and maintained run-off control present</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">No evidence of hazardous substance migration from container area, containers leaking, and all free liquids eliminated at closure (either by removal of liquid or solidification of remaining wastes and waste residues)</ENT> <ENT> Evaluate using <E T="02">All sources</E> criteria (with no bulk or free liquid deposited). </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Tank</E> </ENT> </ROW> <ROW> <ENT I="01">Below-ground tank</ENT> <ENT> Evaluate using <E T="02">All sources</E> criteria. </ENT> </ROW> <ROW> <ENT I="01"> Evidence of hazardous substance migration from tank area ( <E T="03">i.e.</E> , tank area includes tank, ancillary equipment such as piping, and any associated containment structures) </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Tank and ancillary equipment not provided with secondary containment (e.g., liner under tank area, vault system, double wall)</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">No diking (or no similar structure) surrounding tank and ancillary equipment</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Diking surrounding tank and ancillary equipment unsound or not regularly inspected and maintained</ENT> <ENT>10</ENT> </ROW> <ROW> <PRTPAGE P="139"/> <ENT I="11"> No evidence of hazardous substance migration from tank area, tank and ancillary equipment surrounded by sound diking that is regularly inspected and maintained, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="02">(a) Tank and ancillary equipment provided with secondary containment</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="02">(b) Tank and ancillary equipment provided with secondary containment with leak detection and collection system</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">(c) Tank and ancillary equipment provided with secondary containment system that detects and collects spilled or leaked hazardous substances and accumulated precipitation and has sufficient capacity to contain 110 percent of volume of largest tank within containment area, spilled or leaked hazardous substances and accumulated precipitation removed in timely manner, at least weekly inspection of tank and secondary containment system, all leaking or unfit-for-use tank systems promptly responded to, and functioning ground water monitoring system</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(d) Containment system has sufficient capacity to hold volume of all tanks within tank containment area and to provide adequate freeboard, single liner under that containment area with functioning leachate collection and removal system below liner, and functioning ground water monitoring system</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="02">(e) Same as (d) except: double liner under tank containment area with functioning leachate collection and removal system between liners</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Tank is above ground, and inside or under maintained intact structure that provides protection from precipitation so that neither runoff nor leachate would be generated from any material released from tank, liquids or materials containing free liquids not deposited in any tank, and functioning and maintained run-on control present</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="450"> <PRTPAGE P="140"/> <GID>EC02AU92.006</GID> </GPH> <GPH SPAN="2" DEEP="448"> <PRTPAGE P="141"/> <GID>EC02AU92.007</GID> </GPH> <P SOURCE="P-1"> -When measured monthly evapotranspiration is not available, calculate monthly potential evapotranspiration (E <E T="52">i</E> ) as follows: </P> <FP SOURCE="FP1-2">  E <E T="52">i</E> = 0.6 F <E T="52">i</E> (10 T <E T="52">i</E> /I)  <SU>a</SU> </FP> <FP SOURCE="FP1-2"> where:</FP> <FP SOURCE="FP1-2">  E <E T="52">i</E> = Monthly potential evapotranspiration (inches) for month i. </FP> <FP SOURCE="FP1-2">  F <E T="52">i</E> = Monthly latitude adjusting value for month i. </FP> <FP SOURCE="FP1-2">  T <E T="52">i</E> = Mean monthly temperature (°C) for month i. </FP> <MATH SPAN="1" DEEP="29"> <PRTPAGE P="142"/> <MID>EC15NO91.146</MID> </MATH> <FP SOURCE="FP1-2">  a = 6.75 × 10 <E T="51">−7</E> I <SU>3</SU> −7.71 × 10 <E T="51">−5</E> I <SU>2</SU> + </FP> <FP SOURCE="FP1-2">  1.79 × 10 <E T="51">−2</E> I + 0.49239 </FP> <P>Select the latitude adjusting value for each month from table 3-3. For latitudes lower than 50° North or 20° South, determine the monthly latitude adjusting value by interpolation.</P> <P>• Calculate monthly net precipitation by subtracting monthly evapotranspiration (or monthly potential evapotranspiration) from monthly precipitation. If evapotranspiration (or potential evapotranspiration) exceeds precipitation for a month, assign that month a net precipitation value of 0.</P> <P>• Calculate the annual net precipitation by summing the monthly net precipitation values.</P> <P>• Based on the annual net precipitation, assign a net precipitation factor value from table 3-4.</P> <P>Enter the value assigned from Figure 3-2 or from table 3-4, as appropriate, in table 3-1.</P> <GPOTABLE COLS="13" OPTS="L2" CDEF="8,5,5,5,5,5,5,5,5,5,5,5,5"> <TTITLE> Table 3-3—Monthly Latitude Adjusting Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1"> Latitude  <SU>b</SU> (degrees) </CHED> <CHED H="1">Month</CHED> <CHED H="2">Jan.</CHED> <CHED H="2">Feb.</CHED> <CHED H="2">March</CHED> <CHED H="2">April</CHED> <CHED H="2">May</CHED> <CHED H="2">June</CHED> <CHED H="2">July</CHED> <CHED H="2">August</CHED> <CHED H="2">Sept.</CHED> <CHED H="2">Oct.</CHED> <CHED H="2">Nov.</CHED> <CHED H="2">Dec.</CHED> </BOXHD> <ROW> <ENT I="01">≥50 N</ENT> <ENT>0.74</ENT> <ENT>0.78</ENT> <ENT>1.02</ENT> <ENT>1.15</ENT> <ENT>1.33</ENT> <ENT>1.36</ENT> <ENT>1.37</ENT> <ENT>1.25</ENT> <ENT>1.06</ENT> <ENT>0.92</ENT> <ENT>0.76</ENT> <ENT>0.70</ENT> </ROW> <ROW> <ENT I="01">45 N</ENT> <ENT>0.80</ENT> <ENT>0.81</ENT> <ENT>1.02</ENT> <ENT>1.13</ENT> <ENT>1.28</ENT> <ENT>1.29</ENT> <ENT>1.31</ENT> <ENT>1.21</ENT> <ENT>1.04</ENT> <ENT>0.94</ENT> <ENT>0.79</ENT> <ENT>0.75</ENT> </ROW> <ROW> <ENT I="01">40 N</ENT> <ENT>0.84</ENT> <ENT>0.83</ENT> <ENT>1.03</ENT> <ENT>1.11</ENT> <ENT>1.24</ENT> <ENT>1.25</ENT> <ENT>1.27</ENT> <ENT>1.18</ENT> <ENT>1.04</ENT> <ENT>0.96</ENT> <ENT>0.83</ENT> <ENT>0.81</ENT> </ROW> <ROW> <ENT I="01">35 N</ENT> <ENT>0.87</ENT> <ENT>0.85</ENT> <ENT>1.03</ENT> <ENT>1.09</ENT> <ENT>1.21</ENT> <ENT>1.21</ENT> <ENT>1.23</ENT> <ENT>1.16</ENT> <ENT>1.03</ENT> <ENT>0.97</ENT> <ENT>0.89</ENT> <ENT>0.85</ENT> </ROW> <ROW> <ENT I="01">30 N</ENT> <ENT>0.90</ENT> <ENT>0.87</ENT> <ENT>1.03</ENT> <ENT>1.08</ENT> <ENT>1.18</ENT> <ENT>1.17</ENT> <ENT>1.20</ENT> <ENT>1.14</ENT> <ENT>1.03</ENT> <ENT>0.98</ENT> <ENT>0.89</ENT> <ENT>0.88</ENT> </ROW> <ROW> <ENT I="01">20 N</ENT> <ENT>0.95</ENT> <ENT>0.90</ENT> <ENT>1.03</ENT> <ENT>1.05</ENT> <ENT>1.13</ENT> <ENT>1.11</ENT> <ENT>1.14</ENT> <ENT>1.11</ENT> <ENT>1.02</ENT> <ENT>1.00</ENT> <ENT>0.93</ENT> <ENT>0.94</ENT> </ROW> <ROW> <ENT I="01">10 N</ENT> <ENT>1.00</ENT> <ENT>0.91</ENT> <ENT>1.03</ENT> <ENT>1.03</ENT> <ENT>1.08</ENT> <ENT>1.06</ENT> <ENT>1.08</ENT> <ENT>1.07</ENT> <ENT>1.02</ENT> <ENT>1.02</ENT> <ENT>0.98</ENT> <ENT>0.99</ENT> </ROW> <ROW> <ENT I="01">0 </ENT> <ENT>1.04</ENT> <ENT>0.94</ENT> <ENT>1.04</ENT> <ENT>1.01</ENT> <ENT>1.04</ENT> <ENT>1.01</ENT> <ENT>1.04</ENT> <ENT>1.04</ENT> <ENT>1.01</ENT> <ENT>1.04</ENT> <ENT>1.01</ENT> <ENT>1.04</ENT> </ROW> <ROW> <ENT I="01">10 S</ENT> <ENT>1.08</ENT> <ENT>0.97</ENT> <ENT>1.05</ENT> <ENT>0.99</ENT> <ENT>1.00</ENT> <ENT>0.96</ENT> <ENT>1.00</ENT> <ENT>1.02</ENT> <ENT>1.00</ENT> <ENT>1.06</ENT> <ENT>1.05</ENT> <ENT>1.09</ENT> </ROW> <ROW> <ENT I="01">20 S</ENT> <ENT>1.14</ENT> <ENT>0.99</ENT> <ENT>1.05</ENT> <ENT>0.97</ENT> <ENT>0.96</ENT> <ENT>0.91</ENT> <ENT>0.95</ENT> <ENT>0.99</ENT> <ENT>1.00</ENT> <ENT>1.08</ENT> <ENT>1.09</ENT> <ENT>1.15</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  For unlisted latitudes lower than 50° North or 20° South, determine the latitude adjusting value by interpolation. </TNOTE> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE>Table 3-4—Net Precipitation Factor Values</TTITLE> <BOXHD> <CHED H="1">Net precipitation (inches)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Greater than 0 to 5</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">Greater than 5 to 15</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Greater than 15 to 30</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">Greater than 30</ENT> <ENT>10</ENT> </ROW> </GPOTABLE> <P> 3.1.2.3  <E T="03">Depth to aquifer.</E> Evaluate depth to aquifer by determining the depth from the lowest known point of hazardous substances at a site to the top of the aquifer being evaluated, considering all layers in that interval. Measure the depth to an aquifer as the distance from the surface to the top of the aquifer minus the distance from the surface to the lowest known point of hazardous substances eligible to be evaluated for that aquifer. In evaluating depth to aquifer in karst terrain, assign a thickness of 0 feet to a karst aquifer that underlies any portion of the sources at the site. Based on the calculated depth, assign a value from table 3-5 to the depth to aquifer factor. </P> <P>Determine the depth to aquifer only at locations within 2 miles of the sources at the site, except: if observed ground water contamination attributable to sources at the site extends more than 2 miles beyond these sources, use any location within the limits of this observed ground water contamination when evaluating the depth to aquifer factor for any aquifer that does not have an observed release. If the necessary geologic information is available at multiple locations, calculate the depth to aquifer at each location. Use the location having the smallest depth to assign the factor value. Enter this value in table 3-1.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE>Table 3-5—Depth to Aquifer Factor Values</TTITLE> <BOXHD> <CHED H="1"> Depth to aquifer  <SU>a</SU> (feet) </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than or equal to 25</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">Greater than 25 to 250</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Greater than 250</ENT> <ENT>1</ENT> </ROW> <TNOTE> <SU>a</SU>  Use depth of all layers between the hazardous substances and aquifer. Assign a thickness of 0 feet to any karst aquifer that underlies any portion of the sources at the site. </TNOTE> </GPOTABLE> <P> 3.1.2.4  <E T="03">Travel time.</E> Evaluate the travel time factor based on the geologic materials in the interval between the lowest known point of hazardous substances at the site and the top of the aquifer being evaluated. Assign a value to the travel time factor as follows: </P> <P>• If the depth to aquifer (see section 3.1.2.3) is 10 feet or less, assign a value of 35.</P> <P>• If, for the interval being evaluated, all layers that underlie a portion of the sources at the site are karst, assign a value of 35.</P> <P>• Otherwise:</P> <P SOURCE="P-1"> -Select the lowest hydraulic conductivity layer(s) from within the above interval. <PRTPAGE P="143"/> Consider only layers at least 3 feet thick. However, do not consider layers or portions of layers within the first 10 feet of the depth to the aquifer. </P> <P SOURCE="P-1">-Determine hydraulic conductivities for individual layers from table 3-6 or from in-situ or laboratory tests. Use representative, measured, hydraulic conductivity values whenever available.</P> <P SOURCE="P-1">-If more than one layer has the same lowest hydraulic conductivity, include all such layers and sum their thicknesses. Assign a thickness of 0 feet to a karst layer that underlies any portion of the sources at the site.</P> <P SOURCE="P-1">-Assign a value from table 3-7 to the travel time factor, based on the thickness and hydraulic conductivity of the lowest hydraulic conductivity layer(s).</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,14"> <TTITLE>Table 3-6—Hydraulic Conductivity of Geologic Materials</TTITLE> <BOXHD> <CHED H="1">Type of material</CHED> <CHED H="1"> Assigned hydraulic conductivity  <SU>a</SU> (cm/sec) </CHED> </BOXHD> <ROW> <ENT I="01">Clay; low permeability till (compact unfractured till); shale; unfractured metamorphic and igneous rocks</ENT> <ENT> 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01">Silt; loesses; silty clays; sediments that are predominantly silts; moderately permeable till (fine-grained, unconsolidated till, or compact till with some fractures); low permeability limestones and dolomites (no karst); low permeability sandstone; low permeability fractured igneous and metamorphic rocks</ENT> <ENT> 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01">Sands; sandy silts; sediments that are predominantly sand; highly permeable till (coarse-grained, unconsolidated or compact and highly fractured); peat; moderately permeable limestones and dolomites (no karst); moderately permeable sandstone; moderately permeable fractured igneous and metamorphic rocks</ENT> <ENT> 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">Gravel; clean sand; highly permeable fractured igneous and metamorphic rocks; permeable basalt; karst limestones and dolomites</ENT> <ENT> 10 <E T="51">−2</E> </ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <GPOTABLE COLS="5" OPTS="L2" CDEF="s100,8,8,8,8"> <TTITLE> Table 3-7—Travel Time Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Hydraulic conductivity (cm/sec)</CHED> <CHED H="1"> Thickness of lowest hydraulic conductivity layer(s)  <SU>b</SU> (feet) </CHED> <CHED H="2">Greater than 3 to 5</CHED> <CHED H="2">Greater than 5 to 100</CHED> <CHED H="2">Greater than 100 to 500</CHED> <CHED H="2">Greater than 500</CHED> </BOXHD> <ROW> <ENT I="01"> Greater than or equal to 10 <E T="51">−3</E> </ENT> <ENT>35</ENT> <ENT>35</ENT> <ENT>35</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="01"> Less than 10 <E T="51">−3</E> to 10 <E T="51">−5</E> </ENT> <ENT>35</ENT> <ENT>25</ENT> <ENT>15</ENT> <ENT>15</ENT> </ROW> <ROW> <ENT I="01"> Less than 10 <E T="51">−5</E> to 10 <E T="51">−7</E> </ENT> <ENT>15</ENT> <ENT>15</ENT> <ENT>5</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01"> Less than 10 <E T="51">−7</E> </ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>1</ENT> <ENT>1</ENT> </ROW> <TNOTE> <SU>a</SU>  If depth to aquifer is 10 feet or less or if, for the interval being evaluated, all layers that underlie a portion of the sources at the site are karst, assign a value of 35. </TNOTE> <TNOTE> <SU>b</SU>  Consider only layers at least 3 feet thick. Do not consider layers or portions of layers within the first 10 feet of the depth to the aquifer. </TNOTE> </GPOTABLE> <P>Determine travel time only at locations within 2 miles of the sources at the site, except: if observed ground water contamination attributable to sources at the site extends more than 2 miles beyond these sources, use any location within the limits of this observed ground water contamination when evaluating the travel time factor for any aquifer that does not have an observed release. If the necessary subsurface geologic information is available at multiple locations, evaluate the travel time factor at each location. Use the location having the highest travel time factor value to assign the factor value for the aquifer. Enter this value in table 3-1.</P> <P> 3.1.2.5  <E T="03">Calculation of potential to release factor value.</E> Sum the factor values for net precipitation, depth to aquifer, and travel time, and multiply this sum by the factor value for containment. Assign this product as the potential to release factor value for the aquifer. Enter this value in table 3-1. </P> <P> 3.1.3  <E T="03">Calculation of likelihood of release factor category value.</E> If an observed release is established for an aquifer, assign the observed release factor value of 550 as the likelihood of release factor category value for that aquifer. Otherwise, assign the potential to release factor value for that aquifer as the likelihood of release value. Enter the value assigned in table 3-1. </P> <P> 3.2  <E T="03">Waste characteristics.</E> Evaluate the waste characteristics factor category for an aquifer based on two factors: toxicity/mobility and hazardous waste quantity. Evaluate only those hazardous substances available to migrate from the sources at the site to ground water. Such hazardous substances include: </P> <P>• Hazardous substances that meet the criteria for an observed release to ground water.</P> <P> • All hazardous substances associated with a source that has a ground water containment factor value greater than 0 (see sections 2.2.2, 2.2.3, and 3.1.2.1). <PRTPAGE P="144"/> </P> <P> 3.2.1  <E T="03">Toxicity/mobility.</E> For each hazardous substance, assign a toxicity factor value, a mobility factor value, and a combined toxicity/mobility factor value as specified in the following sections. Select the toxicity/mobility factor value for the aquifer being evaluated as specified in section 3.2.1.3. </P> <P> 3.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in Section 2.4.1.1. </P> <P> 3.2.1.2  <E T="03">Mobility.</E> Assign a mobility factor value to each hazardous substance for the aquifer being evaluated as follows: </P> <P>• For any hazardous substance that meets the criteria for an observed release by chemical analysis to one or more aquifers underlying the sources at the site, regardless of the aquifer being evaluated, assign a mobility factor value of 1.</P> <P> • For any hazardous substance that does not meet the criteria for an observed release by chemical analysis to at least one of the aquifers, assign that hazardous substance a mobility factor value from table 3-8 for the aquifer being evaluated, based on its water solubility and distribution coefficient (K <E T="52">d</E> ). </P> <P>• If the hazardous substance cannot be assigned a mobility factor value because data on its water solubility or distribution coefficient are not available, use other hazardous substances for which information is available in evaluating the pathway.</P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s100,8,8,8,8"> <TTITLE> Table 3-8—Ground Water Mobility Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Water solubility (mg/l)</CHED> <CHED H="1"> Distribution coefficient (K <E T="52">d</E> ) (ml/g) </CHED> <CHED H="2"> Karst  <SU>c</SU> </CHED> <CHED H="2">≤10</CHED> <CHED H="2">>10 to 1,000</CHED> <CHED H="2">>1,000</CHED> </BOXHD> <ROW> <ENT I="01"> Present as liquid  <SU>b</SU> </ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>0.01</ENT> <ENT>0.0001</ENT> </ROW> <ROW> <ENT I="01">Greater than 100</ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>0.01</ENT> <ENT>0.0001</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 100</ENT> <ENT>0.2</ENT> <ENT>0.2</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01">Greater than 0.01 to 1</ENT> <ENT>0.002</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01">Less than or equal to 0.01</ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−7</E> </ENT> <ENT> 2 × 10 <E T="51">−9</E> </ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  Use if the hazardous substance is present or deposited as a liquid. </TNOTE> <TNOTE> <SU>c</SU>  Use if the entire interval from the source to the aquifer being evaluated is karst. </TNOTE> </GPOTABLE> <P>• If none of the hazardous substances eligible to be evaluated can be assigned a mobility factor value, use a default value of 0.002 as the mobility factor value for all these hazardous substances.</P> <P>Determine the water solubility to be used in table 3-8 for the hazardous substance as follows (use this same water solubility for all aquifers):</P> <P>• For any hazardous substance that does not meet the criteria for an observed release by chemical analysis, if the hazardous substance is present or deposited as a liquid, use the water solubility category “Present as Liquid” in table 3-8 to assign the mobility factor value to that hazardous substance.</P> <P>• Otherwise:</P> <P SOURCE="P-1">-For any hazardous substance that is a metal (or metalloid) and that does not meet the criteria for an observed release by chemical analysis, establish a water solubility for the hazardous substance as follows:</P> <FP SOURCE="FP1-2"> -Determine the overall range of water solubilities for compounds of this hazardous substance (consider all compounds for which adequate water solubility information is available, not just compounds identified as present at the site).</FP> <FP SOURCE="FP1-2"> -Calculate the geometric mean of the highest and the lowest water solubility in this range.</FP> <FP SOURCE="FP1-2"> -Use this geometric mean as the water solubility in assigning the hazardous substance a mobility factor value from table 3-8.</FP> <P SOURCE="P-1">-For any other hazardous substance (either organic or inorganic) that does not meet the criteria for an observed release by chemical analysis, use the water solubility of that hazardous substance to assign a mobility factor value from table 3-8 to the hazardous substance.</P> <P>For the aquifer being evaluated, determine the distribution coefficient to be used in table 3-8 for the hazardous substance as follows:</P> <P>• For any hazardous substance that does not meet the criteria for an observed release by chemical analysis, if the entire interval from a source at the site to the aquifer being evaluated is karst, use the distribution coefficient category “Karst” in table 3-8 in assigning the mobility factor value for that hazardous substance for that aquifer.</P> <P>• Otherwise:</P> <P SOURCE="P-1">-For any hazardous substance that is a metal (or metalloid) and that does not meet the criteria for an observed release by chemical analysis, use the distribution coefficient for the metal or (metalloid) to assign a mobility factor value from table 3-8 for that hazardous substance.</P> <P SOURCE="P-1"> -For any other inorganic hazardous substance that does not meet the criteria for an observed release by chemical analysis, <PRTPAGE P="145"/> use the distribution coefficient for that inorganic hazardous substance, if available, to assign a mobility factor value from table 3-8. If the distribution coefficient is not available, use a default value of “less than 10” as the distribution coefficient, except: for asbestos use a default value of “greater than 1,000” as the distribution coefficient. </P> <P SOURCE="P-1">-For any hazardous substance that is organic and that does not meet the criteria for an observed release by chemical analysis, establish a distribution coefficient for that hazardous substance as follows:</P> <FP SOURCE="FP1-2">  -Estimate the K <E T="52">d</E> range for the hazardous substance using the following equation: </FP> <FP SOURCE="FP-2"> K <E T="52">d</E> = (K <E T="52">oc</E> )(f <E T="52">s</E> ) </FP> <FP>where:</FP> <FP SOURCE="FP-2"> K <E T="52">oc</E> = Soil-water partition coefficient for organic carbon for the hazardous substance. </FP> <FP SOURCE="FP-2"> f <E T="52">s</E> = Sorbent content (fraction of clays plus organic carbon) in the subsurface. </FP> <FP SOURCE="FP-2">  -Use f <E T="52">s</E> values of 0.03 and 0.77 in the above equation to establish the upper and lower values of the K <E T="52">d</E> range for the hazardous substance. </FP> <FP SOURCE="FP-2">  -Calculate the geometric mean of the upper and lower K <E T="52">d</E> range values. Use this geometric mean as the distribution coefficient in assigning the hazardous substance a mobility factor value from table 3-8. </FP> <P> 3.2.1.3  <E T="03">Calculation of toxicity/mobility factor value.</E> Assign each hazardous substance a toxicity/mobility factor value from table 3-9, based on the values assigned to the hazardous substance for the toxicity and mobility factors. Use the hazardous substance with the highest toxicity/mobility factor value for the aquifer being evaluated to assign the value to the toxicity/mobility factor for that aquifer. Enter this value in table 3-1. </P> <GPOTABLE COLS="7" OPTS="L2" CDEF="8,6,6,6,6,6,2"> <TTITLE> Table 3-9—Toxicity/Mobility Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Mobility factor value</CHED> <CHED H="1">Toxicity factor value</CHED> <CHED H="2">10,000</CHED> <CHED H="2">1,000</CHED> <CHED H="2">100</CHED> <CHED H="2">10</CHED> <CHED H="2">1</CHED> <CHED H="2">0</CHED> </BOXHD> <ROW> <ENT I="01">1.0</ENT> <ENT>10,000</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.01</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.002</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.0001</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−5</E> </ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−7</E> </ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−6</E> </ENT> <ENT> 2 × 10 <E T="51">−7</E> </ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−6</E> </ENT> <ENT> 2 × 10 <E T="51">−7</E> </ENT> <ENT> 2 × 10 <E T="51">−8</E> </ENT> <ENT> 2 × 10 <E T="51">−9</E> </ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 3.2.2  <E T="03">Hazardous waste quantity.</E> Assign a hazardous waste quantity factor value for the ground water pathway (or aquifer) as specified in section 2.4.2. Enter this value in table 3-1. </P> <P> 3.2.3  <E T="03">Calculation of waste characteristics factor category value.</E> Multiply the toxicity/mobility and hazardous waste quantity factor values, subject to a maximum product of 1 × 10 <SU>8</SU> . Based on this product, assign a value from table 2-7 (section 2.4.3.1) to the waste characteristics factor category. Enter this value in table 3-1. </P> <P> 3.3  <E T="03">Targets.</E> Evaluate the targets factor category for an aquifer based on four factors: nearest well, population, resources, and Wellhead Protection Area. Evaluate these four factors based on targets within the target distance limit specified in section 3.0.1.1 and the aquifer boundaries specified in section 3.0.1.2. Determine the targets to be included in evaluating these factors for an aquifer as specified in section 3.0. </P> <P> 3.3.1  <E T="03">Nearest well.</E> In evaluating the nearest well factor, include both the drinking water wells drawing from the aquifer being evaluated and those drawing from overlying aquifers as specified in section 3.0. Include standby wells in evaluating this factor only if they are used for drinking water supply at least once every year. </P> <P>If there is an observed release by direct observation for a drinking water well within the target distance limit, assign Level II concentrations to that well. However, if one or more samples meet the criteria for an observed release for that well, determine if that well is subject to Level I or Level II concentrations as specified in sections 2.5.1 and 2.5.2. Use the health-based benchmarks from table 3-10 in determining the level of contamination.</P> <P>Assign a value for the nearest well factor as follows:</P> <P>• If one or more drinking water wells is subject to Level I concentrations, assign a value of 50.</P> <P>• If not, but if one or more drinking water wells is subject to Level II concentrations, assign a value of 45.</P> <P> • If none of the drinking water wells is subject to Level I or Level II concentrations, assign a value as follows: <PRTPAGE P="146"/> </P> <P SOURCE="P-1">-If one of the target aquifers is a karst aquifer that underlies any portion of the sources at the site and any well draws drinking water from this karst aquifer within the target distance limit, assign a value of 20.</P> <P SOURCE="P-1">-If not, determine the shortest distance to any drinking water well, as measured from any source at the site with a ground water containment factor value greater than 0. Select a value from table 3-11 based on this distance. Assign it as the value for the nearest well factor.</P> <P>Enter the value assigned to the nearest well factor in table 3-1.</P> <GPOTABLE COLS="1" OPTS="L1(,0,),p1,7/8" CDEF="s10"> <TTITLE>Table 3-10—Health-Based Benchmarks for Hazardous Substances in Drinking Water</TTITLE> <ROW> <ENT I="11">• Concentration corresponding to Maximum Contaminant Level (MCL).</ENT> </ROW> <ROW> <ENT I="11">• Concentration corresponding to a nonzero Maximum Contaminant Level Goal (MCLG).</ENT> </ROW> <ROW> <ENT I="11"> • Screening concentration for cancer corresponding to that concentration that corresponds to the 10 <E T="51">−6</E> individual cancer risk for oral exposures. </ENT> </ROW> <ROW> <ENT I="11">• Screening concentration for noncancer toxicological responses corresponding to the Reference Dose (RfD) for oral exposures.</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE>Table 3-11—Nearest Well Factor Values</TTITLE> <BOXHD> <CHED H="1">Distance from source (miles)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> Level I concentrations  <SU>a</SU> </ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01"> Level II concentrations  <SU>a</SU> </ENT> <ENT>45</ENT> </ROW> <ROW> <ENT I="01"> 0 to <FR>1/4</FR> </ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to <FR>1/2</FR> </ENT> <ENT>18</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 2</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">Greater than 2 to 3</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Greater than 3 to 4</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">Greater than 4</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU> Distance does not apply. </TNOTE> </GPOTABLE> <P> 3.3.2  <E T="03">Population.</E> In evaluating the population factor, include those persons served by drinking water wells within the target distance limit specified in section 3.0.1.1. For the aquifer being evaluated, count those persons served by wells in that aquifer and those persons served by wells in overlying aquifers as specified in section 3.0. Include residents, students, and workers who regularly use the water. Exclude transient populations such as customers and travelers passing through the area. Evaluate the population based on the location of the water supply wells, not on the location of residences, work places, etc. When a standby well is maintained on a regular basis so that water can be withdrawn, include it in evaluating the population factor. </P> <P>In estimating residential population, when the estimate is based on the number of residences, multiply each residence by the average number of persons per residence for the county in which the residence is located.</P> <P>In determining the population served by a well, if the water from the well is blended with other water (for example, water from other ground water wells or surface water intakes), apportion the total population regularly served by the blended system to the well based on the well's relative contribution to the total blended system. In estimating the well's relative contribution, assume each well and intake contributes equally and apportion the population accordingly, except: if the relative contribution of any one well or intake exceeds 40 percent based on average annual pumpage or capacity, estimate the relative contribution of the wells and intakes considering the following data, if available:</P> <P>• Average annual pumpage from the ground water wells and surface water intakes in the blended system.</P> <P>• Capacities of the wells and intakes in the blended system.</P> <P>For systems with standby ground water wells or standby surface water intakes, apportion the total population regularly served by the blended system as described above, except:</P> <P>• Exclude standby surface water intakes in apportioning the population.</P> <P>• When using pumpage data for a standby ground water well, use average pumpage for the period during which the standby well is used rather than average annual pumpage.</P> <P>• For that portion of the total population that could be apportioned to a standby ground water well, assign that portion of the population either to that standby well or to the other ground water well(s) and surface water intake(s) that serve that population; do not assign that portion of the population both to the standby well and to the other well(s) and intake(s) in the blended system. Use the apportioning that results in the highest population factor value. (Either include all standby well(s) or exclude some or all of the standby well(s) as appropriate to obtain this highest value.) Note that the specific standby well(s) included or excluded and, thus, the specific apportioning may vary in evaluating different aquifers and in evaluating the surface water pathway.</P> <P> 3.3.2.1  <E T="03">Level of contamination.</E> Evaluate the population served by water from a point of withdrawal based on the level of contamination for that point of withdrawal. Use the applicable factor: Level I concentrations, Level II concentrations, or potential contamination. </P> <P> If no samples meet the criteria for an observed release for a point of withdrawal and there is no observed release by direct observation for that point of withdrawal, evaluate that point of withdrawal using the potential contamination factor in section 3.3.2.4. If <PRTPAGE P="147"/> there is an observed release by direct observation, use Level II concentrations for that point of withdrawal. However, if one or more samples meet the criteria for an observed release for the point of withdrawal, determine which factor (Level I or Level II concentrations) applies to that point of withdrawal as specified in sections 2.5.1 and 2.5.2. Use the health-based benchmarks from table 3-10 in determining the level of contamination. Evaluate the point of withdrawal using the Level I concentrations factor in section 3.3.2.2 or the Level II concentrations factor in section 3.3.2.3, as appropriate. </P> <P>For the potential contamination factor, use population ranges in evaluating the factor as specified in section 3.3.2.4. For the Level I and Level II concentrations factors, use the population estimate, not population ranges, in evaluating both factors.</P> <P> 3.3.2.2  <E T="03">Level I concentrations.</E> Sum the number of people served by drinking water from points of withdrawal subject to Level I concentrations. Multiply this sum by 10. Assign this product as the value for this factor. Enter this value in table 3-1. </P> <P> 3.3.2.3  <E T="03">Level II concentrations.</E> Sum the number of people served by drinking water from points of withdrawal subject to Level II concentrations. Do not include those people already counted under the Level I concentrations factor. Assign this sum as the value for this factor. Enter this value in table 3-1. </P> <P> 3.3.2.4  <E T="03">Potential contamination.</E> Determine the number of people served by drinking water from points of withdrawal subject to potential contamination. Do not include those people already counted under the Level I and Level II concentrations factors. </P> <P>Assign distance-weighted population values from table 3-12 to this population as follows:</P> <P>• Use the “Karst” portion of table 3-12 to assign values only for that portion of the population served by points of withdrawal that draw drinking water from a karst aquifer that underlies any portion of the sources at the site.</P> <P SOURCE="P-1">-For this portion of the population, determine the number of people included within each “Karst” distance category in table 3-12.</P> <GPOTABLE COLS="14" OPTS="L2" CDEF="s25,1,3,2,3,3,5,5,6,6,7,7,7,7"> <TTITLE> Table 3-12—Distance-Weighted Population Values for Potential Contamination Factor for Ground Water Migration Pathway  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Distance category (miles)</CHED> <CHED H="1">Number of people within the distance category</CHED> <CHED H="2">0</CHED> <CHED H="2">1 to 10</CHED> <CHED H="2">11 to 30</CHED> <CHED H="2">31 to 100</CHED> <CHED H="2">101 to 300</CHED> <CHED H="2">301 to 1,000</CHED> <CHED H="2">1,001 to 3,000</CHED> <CHED H="2">3,001 to 10,000</CHED> <CHED H="2">10,001 to 30,000</CHED> <CHED H="2">30,001 to 100,000</CHED> <CHED H="2">100,001 to 300,000</CHED> <CHED H="2">300,001 to 1,000,000</CHED> <CHED H="2">1,000,001 to 3,000,000</CHED> </BOXHD> <ROW> <ENT I="11"> <E T="02">Other Than Karst</E>   <SU>b</SU> : </ENT> </ROW> <ROW> <ENT I="01"> 0 to <FR>1/4</FR> </ENT> <ENT>0</ENT> <ENT>4</ENT> <ENT>17</ENT> <ENT>53</ENT> <ENT>164</ENT> <ENT>522</ENT> <ENT>1,633</ENT> <ENT>5,214</ENT> <ENT>16,325</ENT> <ENT>52,137</ENT> <ENT>163,246</ENT> <ENT>521,360</ENT> <ENT>1,632,455</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to <FR>1/2</FR> </ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>11</ENT> <ENT>33</ENT> <ENT>102</ENT> <ENT>324</ENT> <ENT>1,013</ENT> <ENT>3,233</ENT> <ENT>10,122</ENT> <ENT>32,325</ENT> <ENT>101,213</ENT> <ENT>323,243</ENT> <ENT>1,012,122</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>5</ENT> <ENT>17</ENT> <ENT>52</ENT> <ENT>167</ENT> <ENT>523</ENT> <ENT>1,669</ENT> <ENT>5,224</ENT> <ENT>16,684</ENT> <ENT>52,239</ENT> <ENT>166,835</ENT> <ENT>522,385</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 2</ENT> <ENT>0</ENT> <ENT>0.7</ENT> <ENT>3</ENT> <ENT>10</ENT> <ENT>30</ENT> <ENT>94</ENT> <ENT>294</ENT> <ENT>939</ENT> <ENT>2,939</ENT> <ENT>9,385</ENT> <ENT>29,384</ENT> <ENT>93,845</ENT> <ENT>293,842</ENT> </ROW> <ROW> <ENT I="01">Greater than 2 to 3</ENT> <ENT>0</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>7</ENT> <ENT>21</ENT> <ENT>68</ENT> <ENT>212</ENT> <ENT>678</ENT> <ENT>2,122</ENT> <ENT>6,778</ENT> <ENT>21,222</ENT> <ENT>67,777</ENT> <ENT>212,219</ENT> </ROW> <ROW RUL="s"> <ENT I="01">Greater than 3 to 4</ENT> <ENT>0</ENT> <ENT>0.3</ENT> <ENT>1</ENT> <ENT>4</ENT> <ENT>13</ENT> <ENT>42</ENT> <ENT>131</ENT> <ENT>417</ENT> <ENT>1,306</ENT> <ENT>4,171</ENT> <ENT>13,060</ENT> <ENT>41,709</ENT> <ENT>130,596</ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Karst</E>   <SU>c</SU> : </ENT> </ROW> <ROW> <ENT I="01"> 0 to <FR>1/4</FR> </ENT> <ENT>0</ENT> <ENT>4</ENT> <ENT>17</ENT> <ENT>53</ENT> <ENT>164</ENT> <ENT>522</ENT> <ENT>1,633</ENT> <ENT>5,214</ENT> <ENT>16,325</ENT> <ENT>52,137</ENT> <ENT>163,246</ENT> <ENT>521,360</ENT> <ENT>1,632,455</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to <FR>1/2</FR> </ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>11</ENT> <ENT>33</ENT> <ENT>102</ENT> <ENT>324</ENT> <ENT>1,013</ENT> <ENT>3,233</ENT> <ENT>10,122</ENT> <ENT>32,325</ENT> <ENT>101,213</ENT> <ENT>323,243</ENT> <ENT>1,012,122</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>9</ENT> <ENT>26</ENT> <ENT>82</ENT> <ENT>261</ENT> <ENT>817</ENT> <ENT>2,607</ENT> <ENT>8,163</ENT> <ENT>26,068</ENT> <ENT>81,623</ENT> <ENT>260,680</ENT> <ENT>816,227</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 2</ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>9</ENT> <ENT>26</ENT> <ENT>82</ENT> <ENT>261</ENT> <ENT>817</ENT> <ENT>2,607</ENT> <ENT>8,163</ENT> <ENT>26,068</ENT> <ENT>81,623</ENT> <ENT>260,680</ENT> <ENT>816,227</ENT> </ROW> <ROW> <ENT I="01">Greater than 2 to 3</ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>9</ENT> <ENT>26</ENT> <ENT>82</ENT> <ENT>261</ENT> <ENT>817</ENT> <ENT>2,607</ENT> <ENT>8,163</ENT> <ENT>26,068</ENT> <ENT>81,623</ENT> <ENT>260,680</ENT> <ENT>816,227</ENT> </ROW> <ROW> <ENT I="01">Greater than 3 to 4</ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>9</ENT> <ENT>26</ENT> <ENT>82</ENT> <ENT>261</ENT> <ENT>817</ENT> <ENT>2,607</ENT> <ENT>8,163</ENT> <ENT>26,068</ENT> <ENT>81,623</ENT> <ENT>260,680</ENT> <ENT>816,227</ENT> </ROW> <TNOTE> <SU>a</SU>  Round the number of people present within a distance category to nearest integer. Do not round the assigned distance-weighted population value to nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  Use for all aquifers, except karst aquifers underlying any portion of the sources at the site. </TNOTE> <TNOTE> <SU>c</SU>  Use only for karst aquifers underlying any portion of the sources at the site. </TNOTE> </GPOTABLE> <P SOURCE="P-1"> -Assign a distance-weighted population value for each distance category based on the number of people included within the distance category. <PRTPAGE P="148"/> </P> <P>• Use the “Other Than Karst” portion of table 3-12 for the remainder of the population served by points of withdrawal subject to potential contamination.</P> <P SOURCE="P-1">-For this portion of the population, determine the number of people included within each “Other Than Karst” distance category in table 3-12.</P> <P SOURCE="P-1">-Assign a distance-weighted population value for each distance category based on the number of people included within the distance category.</P> <P>Calculate the value for the potential contamination factor (PC) as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.147</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2"> W <E T="52">i</E> = Distance-weighted population from “Other Than Karst” portion of table 3-12 for distance category i. </FP> <FP SOURCE="FP-2"> K <E T="52">i</E> = Distance-weighted population from “Karst” portion of table 3-12 for distance category i. </FP> <FP SOURCE="FP-2">n = Number of distance categories.</FP> <P>If PC is less than 1, do not round it to the nearest integer; if PC is 1 or more, round to the nearest integer. Enter this value in table 3-1.</P> <P> 3.3.2.5  <E T="03">Calculation of population factor value.</E> Sum the factor values for Level I concentrations, Level II concentrations, and potential contamination. Do not round this sum to the nearest integer. Assign this sum as the population factor value for the aquifer. Enter this value in table 3-1. </P> <P> 3.3.3  <E T="03">Resources.</E> To evaluate the resources factor, select the highest value specified below that applies for the aquifer being evaluated. Assign this value as the resources factor value for the aquifer. Enter this value in table 3-1. </P> <P>Assign a resources value of 5 if water drawn from any target well for the aquifer being evaluated or overlying aquifers (as specified in section 3.0) is used for one or more of the following purposes:</P> <P>• Irrigation (5-acre minimum) of commercial food crops or commercial forage crops.</P> <P>• Watering of commercial livestock.</P> <P>• Ingredient in commercial food preparation.</P> <P>• Supply for commercial aquaculture.</P> <P>• Supply for a major or designated water recreation area, excluding drinking water use.</P> <P>Assign a resources value of 5 if no drinking water wells are within the target distance limit, but the water in the aquifer being evaluated or any overlying aquifers (as specified in section 3.0) is usable for drinking water purposes.</P> <P>Assign a resources value of 0 if none of the above applies.</P> <P> 3.3.4  <E T="03">Wellhead Protection Area.</E> Evaluate the Wellhead Protection Area factor based on Wellhead Protection Areas designated according to section 1428 of the Safe Drinking Water Act, as amended. Consider only those Wellhead Protection Areas applicable to the aquifer being evaluated or overlying aquifers (as specified in section 3.0). Select the highest value below that applies. Assign it as the value for the Wellhead Protection Area factor for the aquifer being evaluated. Enter this value in table 3-1. </P> <P>Assign a value of 20 if either of the following criteria applies for the aquifer being evaluated or overlying aquifers:</P> <P>• A source with a ground water containment factor value greater than 0 lies, either partially or fully, within or above the designated Wellhead Protection Area.</P> <P>• Observed ground water contamination attributable to the sources at the site lies, either partially or fully, within the designated Wellhead Protection Area.</P> <P>If neither criterion applies, assign a value of 5, if, within the target distance limit, there is a designated Wellhead Protection Area applicable to the aquifer being evaluated or overlying aquifers.</P> <P>Assign a value of 0 if none of the above applies.</P> <P> 3.3.5  <E T="03">Calculation of targets factor category value.</E> Sum the factor values for nearest well, population, resources, and Wellhead Protection Area. Do not round this sum to the nearest integer. Use this sum as the targets factor category value for the aquifer. Enter this value in table 3-1. </P> <P> 3.4  <E T="03">Ground water migration score for an aquifer.</E> For the aquifer being evaluated, multiply the factor category values for likelihood of release, waste characteristics, and targets, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum value of 100, as the ground water migration pathway score for the aquifer. Enter this score in table 3-1. </P> <P> 3.5  <E T="03">Calculation of ground water migration pathway score.</E> Calculate a ground water migration score for each aquifer underlying the sources at the site, as appropriate. Assign the highest ground water migration score for an aquifer as the ground water migration pathway score (S <E T="52">gw</E> ) for the site. Enter this score in table 3-1. </P> <HD SOURCE="HD2">4.0 Surface Water Migration Pathway</HD> <P> 4.0.1  <E T="03">Migration components.</E> Evaluate the surface water migration pathway based on two migration components: </P> <P>• Overland/flood migration to surface water (see section 4.1).</P> <P> • Ground water to surface water migration (see section 4.2). <PRTPAGE P="149"/> </P> <FP>Evaluate each component based on the same three threats: drinking water threat, human food chain threat, and environmental threat.</FP> <P>Score one or both components, considering their relative importance. If only one component is scored, assign its score as the surface water migration pathway score. If both components are scored, select the higher of the two scores and assign it as the surface water migration pathway score.</P> <P> 4.0.2  <E T="03">Surface water categories.</E> For HRS purposes, classify surface water into four categories: rivers, lakes, oceans, and coastal tidal waters. </P> <P>Rivers include:</P> <P>• Perennially flowing waters from point of origin to the ocean or to coastal tidal waters, whichever comes first, and wetlands contiguous to these flowing waters.</P> <P>• Aboveground portions of disappearing rivers.</P> <P>• Man-made ditches only insofar as they perennially flow into other surface water.</P> <P>• Intermittently flowing waters and contiguous intermittently flowing ditches only in arid or semiarid areas with less than 20 inches of mean annual precipitation.</P> <P>Lakes include:</P> <P>• Natural and man-made lakes (including impoundments) that lie along rivers, but excluding the Great Lakes.</P> <P>• Isolated, but perennial, lakes, ponds, and wetlands.</P> <P>• Static water channels or oxbow lakes contiguous to rivers.</P> <P>• Small rivers, without diking, that merge into surrounding perennially inundated wetlands.</P> <P>• Wetlands contiguous to water bodies defined here as lakes.</P> <P>Ocean and ocean-like water bodies include:</P> <P>• Ocean areas seaward from the baseline of the Territorial Sea. (This baseline represents the generalized coastline of the United States. It is parallel to the seaward limit of the Territorial Sea and other maritime limits such as the inner boundary of Federal fisheries jurisdiction and the limit of States jurisdiction under the Submerged Lands Act, as amended.)</P> <P>• The Great Lakes.</P> <P>• Wetlands contiguous to the Great Lakes.</P> <P>Coastal tidal waters include:</P> <P>• Embayments, harbors, sounds, estuaries, back bays, lagoons, wetlands, etc. seaward from mouths of rivers and landward from the baseline of the Territorial Sea.</P> <P> 4.1  <E T="03">Overland/flood migration component.</E> Use the overland/flood migration component to evaluate surface water threats that result from overland migration of hazardous substances from a source at the site to surface water. Evaluate three types of threats for this component: drinking water threat, human food chain threat, and environmental threat. </P> <P> 4.1.1  <E T="03">General considerations.</E> </P> <P> 4.1.1.1  <E T="03">Definition of hazardous substance migration path for overland/flood migration component.</E> The hazardous substance migration path includes both the overland segment and the in-water segment that hazardous substances would take as they migrate away from sources at the site: </P> <P>• Begin the overland segment at a source and proceed downgradient to the probable point of entry to surface water.</P> <P>• Begin the in-water segment at this probable point of entry.</P> <P SOURCE="P-1">-For rivers, continue the in-water segment in the direction of flow (including any tidal flows) for the distance established by the target distance limit (see section 4.1.1.2).</P> <P SOURCE="P-1">-For lakes, oceans, coastal tidal waters, or Great Lakes, do not consider flow direction. Instead apply the target distance limit as an arc.</P> <P SOURCE="P-1">-If the in-water segment includes both rivers and lakes (or oceans, coastal tidal waters, or Great Lakes), apply the target distance limit to their combined in-water segments.</P> <P>For sites that consist of contaminated sediments with no identified source, the hazardous substance migration path consists solely of the in-water segment specified in section 4.1.1.2.</P> <P>Consider a site to be in two or more watersheds for this component if two or more hazardous substance migration paths from the sources at the site do not reach a common point within the target distance limit. If the site is in more than one watershed, define a separate hazardous substance migration path for each watershed. Evaluate the overland/flood migration component for each watershed separately as specified in section 4.1.1.3.</P> <P> 4.1.1.2  <E T="03">Target distance limit.</E> The target distance limit defines the maximum distance over which targets are considered in evaluating the site. Determine a separate target distance limit for each watershed as follows: </P> <P>• If there is no observed release to surface water in the watershed or if there is an observed release only by direct observation (see section 4.1.2.1.1), begin measuring the target distance limit for the watershed at the probable point of entry to surface water and extend it for 15 miles along the surface water from that point.</P> <P> • If there is an observed release from the site to the surface water in the watershed that is based on sampling, begin measuring the target distance limit for the watershed at the probable point of entry; extend the target distance limit either for 15 miles along the surface water or to the most distant sample point that meets the criteria for an observed release to that watershed, whichever is greater. <PRTPAGE P="150"/> </P> <P>In evaluating the site, include only surface water targets (for example, intakes, fisheries, sensitive environments) that are within or contiguous to the hazardous substance migration path and located, partially or wholly, at or between the probable point of entry and the target distance limit applicable to the watershed:</P> <P>• If flow within the hazardous substance migration path is reversed by tides, evaluate upstream targets only if there is documentation that the tidal run could carry substances from the site as far as those upstream targets.</P> <P>• Determine whether targets within or contiguous to the hazardous substance migration path are subject to actual or potential contamination as follows:</P> <P SOURCE="P-1">-If a target is located, partially or wholly, either at or between the probable point of entry and any sampling point that meets the criteria for an observed release to the watershed or at a point that meets the criteria for an observed release by direct observation, evaluate that target as subject to actual contamination, except as otherwise specified for fisheries in section 4.1.3.3 and for wetlands in section 4.1.4.3.1.1. If the actual contamination is based on direct observation, assign Level II to the actual contamination. However, if the actual contamination is based on samples, determine whether the actual contamination is at Level I or Level II concentrations as specified in sections 4.1.2.3, 4.1.3.3, and 4.1.4.3.1.</P> <P SOURCE="P-1">-If a target is located, partially or wholly, within the target distance limit for the watershed, but not at or between the probable point of entry and any sampling point that meets the criteria for an observed release to the watershed, nor at a point that meets the criteria for an observed release by direct observation, evaluate it as subject to potential contamination.</P> <P>For sites consisting solely of contaminated sediments with no identified source, determine the target distance limit as follows:</P> <P>• If there is a clearly defined direction of flow for the surface water body (or bodies) containing the contaminated sediments, begin measuring the target distance limit at the point of observed sediment contamination that is farthest upstream (that is, at the location of the farthest available upstream sediment sample that meets the criteria for an observed release); extend the target distance limit either for 15 miles along the surface water or to the most distant downstream sample point that meets the criteria for an observed release to that watershed, whichever is greater.</P> <P>• If there is no clearly defined direction of flow, begin measuring the target distance limit at the center of the area of observed sediment contamination. Extend the target distance limit as an arc either for 15 miles along the surface water or to the most distant sample point that meets the criteria for an observed release to that watershed, whichever is greater. Determine the area of observed sediment contamination based on available samples that meet the criteria for an observed release.</P> <FP>Note that the hazardous substance migration path for these contaminated sediment sites consists solely of the in-water segment defined by the target distance limit; there is no overland segment.</FP> <P>For these contaminated sediment sites, include only those targets (for example, intakes, fisheries, sensitive environments) that are within or contiguous to the hazardous substance migration path and located, wholly or partially, within the target distance limit for the site. Determine whether these targets are subject to actual or potential contamination as follows:</P> <P>• If a target is located, partially or wholly, within the area of observed sediment contamination, evaluate it as subject to actual contamination, except as otherwise specified for fisheries in section 4.1.3.3 and wetlands in section 4.1.4.3.1.1.</P> <P SOURCE="P-1">-If a drinking water target is subject to actual contamination, evaluate it using Level II concentrations.</P> <P SOURCE="P-1">-If a human food chain target or environmental target is subject to actual contamination, evaluate it using Level I or Level II concentrations, as appropriate (see sections 4.1.3.3 and 4.1.4.3.1).</P> <P>• If a target is located, partially or wholly, within the target distance limit for the watershed, but not within the area of observed sediment contamination, evaluate it as subject to potential contamination.</P> <P> 4.1.1.3 <E T="03">Evaluation of overland/flood migration component.</E> Evaluate the drinking water threat, human food chain threat, and environmental threat for each watershed for this component based on three factor categories: likelihood of release, waste characteristics, and targets. Figure 4-1 indicates the factors included within each factor category for each type of threat. </P> <P> Determine the overland/flood migration component score (S <E T="52">of</E> ) for a watershed in terms of the factor category values as follows: </P> <MATH SPAN="1" DEEP="30"> <MID>EC15NO91.148</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2"> LR <E T="52">i</E> = Likelihood of release factor category value for threat i (that is, drinking water, human food chain, or environmental threat). </FP> <FP SOURCE="FP-2"> WC <E T="52">i</E> = Waste characteristics factor category value for threat i. </FP> <FP SOURCE="FP-2"> T <E T="52">i</E> = Targets factor category value for threat i. <PRTPAGE P="151"/> </FP> <FP SOURCE="FP-2">SF = Scaling factor.</FP> <FP SOURCE="FP-2">Table 4-1 outlines the specific calculation procedure.</FP> <P>If the site is in only one watershed, assign the overland/flood migration score for that watershed as the overland/flood migration component score for the site.</P> <GPH SPAN="2" DEEP="465"> <GID>EC02AU92.008</GID> </GPH> <PRTPAGE P="152"/> <GPOTABLE COLS="3" OPTS="L2" CDEF="s200,12,14"> <TTITLE>Table 4-1—Surface Water Overland/Flood Migration Component Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor categories and factors</CHED> <CHED H="1">Maximum value</CHED> <CHED H="1">Value assigned</CHED> </BOXHD> <ROW> <ENT I="21"> <E T="02">Drinking Water Threat</E> </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Likelihood of Release:</E> </ENT> </ROW> <ROW> <ENT I="03"> 1. Observed Release</ENT> <ENT>550</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="13"> 2. Potential to Release by Overland Flow:</ENT> </ROW> <ROW> <ENT I="05">2a. Containment</ENT> <ENT>10</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">2b. Runoff</ENT> <ENT>25</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">2c. Distance to Surface Water</ENT> <ENT>25</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">2d. Potential to Release by Overland Flow (lines 2a[2b + 2c])</ENT> <ENT>500</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="13"> 3. Potential to Release by Flood:</ENT> </ROW> <ROW> <ENT I="05">3a. Containment (Flood)</ENT> <ENT>10</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">3b. Flood Frequency</ENT> <ENT>50</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">3c. Potential to Release by Flood (lines 3a × 3b)</ENT> <ENT>500</ENT> <ENT> ______  </ENT> </ROW> <ROW> <ENT I="03"> 4. Potential to Release (lines 2d + 3c, subject to a maximum of 500)</ENT> <ENT>500</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03"> 5. Likelihood of Release (higher of lines 1 and 4)</ENT> <ENT>550</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="03"> 6. Toxicity/Persistence</ENT> <ENT>(a)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03"> 7. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03"> 8. Waste Characteristics</ENT> <ENT>100</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="03"> 9. Nearest Intake</ENT> <ENT>50</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">10. Population</ENT> <ENT> </ENT> <ENT> </ENT> </ROW> <ROW> <ENT I="05">10a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">10b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">10c. Potential Contamination</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">10d. Population (lines 10a + 10b + 10c)</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">11. Resources</ENT> <ENT>5</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">12. Targets (lines 9 + 10d + 11)</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Drinking Water Threat Score:</E> </ENT> </ROW> <ROW> <ENT I="03">13. Drinking Water Threat Score ([lines 5 × 8 × 12]/82,500, subject to a maximum of 100)</ENT> <ENT>100</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Human Food Chain Threat</E> </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Likelihood of Release:</E> </ENT> </ROW> <ROW> <ENT I="03">14. Likelihood of Release (same value as line 5)</ENT> <ENT>550</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="03">15. Toxicity/Persistence/Bioaccumulation</ENT> <ENT>(a)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">16. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">17. Waste Characteristics</ENT> <ENT>1,000</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="03">18. Food Chain Individual</ENT> <ENT>50</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">19. Population</ENT> <ENT> </ENT> <ENT> </ENT> </ROW> <ROW> <ENT I="05">19a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">19b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">19c. Potential Human Food Chain Contamination</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">19d. Population (lines 19a + 19b + 19c)</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">20. Targets (lines 18 + 19d)</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Human Food Chain Threat Score:</E> </ENT> </ROW> <ROW> <ENT I="03">21. Human Food Chain Threat Score ([lines 14 × 17 × 20]/82,500, subject to a maximum of 100)</ENT> <ENT>100</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Environmental Threat</E> </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Likelihood of Release:</E> </ENT> </ROW> <ROW> <ENT I="03">22. Likelihood of Release (same value as line 5)</ENT> <ENT>550</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="03">23. Ecosystem Toxicity/Persistence/Bioaccumulation</ENT> <ENT>(a)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">24. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="03">25. Waste Characteristics</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="03">26. Sensitive Environments</ENT> </ROW> <ROW> <ENT I="05">26a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">26b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">26c. Potential Contamination</ENT> <ENT>(b)</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="05">26d. Sensitive Environments (lines 26a + 26b + 26c)</ENT> <ENT>(b)</ENT> </ROW> <ROW> <ENT I="03">27. Targets (value from line 26d)</ENT> <ENT>(b)</ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Environmental Threat Score:</E> </ENT> </ROW> <ROW> <ENT I="03">28. Environmental Threat Score ([lines 22 × 25 × 27]/82,500, subject to a maximum of 60)</ENT> <ENT>60</ENT> <ENT>______  </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Surface Water Overland/Flood Migration Component Score for a Watershed</E> </ENT> </ROW> <ROW> <ENT I="03"> 29. Watershed Score  <SU>c</SU> (lines 13 + 21 + 28, subject to a maximum of 100) </ENT> <ENT>100</ENT> <ENT>______  </ENT> </ROW> <ROW> <PRTPAGE P="153"/> <ENT I="21"> <E T="02">Surface Water Overland/Flood Migration Component Score</E> </ENT> </ROW> <ROW> <ENT I="03"> 30. Component Score (S <E T="52">of</E> )  <SU>c</SU> (highest score from line 29 for all watersheds evaluated, subject to a maximum of 100) </ENT> <ENT>100</ENT> <ENT>______  </ENT> </ROW> <TNOTE> <SU>a</SU>  Maximum value applies to waste characteristics category. </TNOTE> <TNOTE> <SU>b</SU>  Maximum value not applicable. </TNOTE> <TNOTE> <SU>c</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P>If the site is in more than one watershed:</P> <P>• Calculate a separate overland/flood migration component score for each watershed, using likelihood of release, waste characteristics, and targets applicable to each watershed.</P> <P>• Select the highest overland/flood migration component score from the watersheds evaluated and assign it as the overland/flood migration component score for the site.</P> <P> 4.1.2  <E T="03">Drinking water threat.</E> Evaluate the drinking water threat for each watershed based on three factor categories: likelihood of release, waste characteristics, and targets. </P> <P> 4.1.2.1  <E T="03">Drinking water threat—likelihood of release.</E> Evaluate the likelihood of release factor category for each watershed in terms of an observed release factor or a potential to release factor. </P> <P> 4.1.2.1.1  <E T="03">Observed release.</E> Establish an observed release to surface water for a watershed by demonstrating that the site has released a hazardous substance to the surface water in the watershed. Base this demonstration on either: </P> <P>• Direct observation:</P> <P SOURCE="P-1">-A material that contains one or more hazardous substances has been seen entering surface water through migration or is known to have entered surface water through direct deposition, or</P> <P SOURCE="P-1">-A source area has been flooded at a time that hazardous substances were present, and one or more hazardous substances were in contact with the flood waters, or</P> <P SOURCE="P-1">-When evidence supports the inference of a release of a material that contains one or more hazardous substances by the site to surface water, demonstrated adverse effects associated with that release may also be used to establish an observed release.</P> <P>• Chemical analysis:</P> <P SOURCE="P-1">-Analysis of surface water, benthic, or sediment samples indicates that the concentration of hazardous substance(s) has increased significantly above the background concentration for the site for that type of sample (see section 2.3).</P> <FP SOURCE="FP1-2">-Limit comparisons to similar types of samples and background concentrations—for example, compare surface water samples to surface water background concentrations.</FP> <FP SOURCE="FP1-2">-For benthic samples, limit comparisons to essentially sessile organisms.</FP> <P SOURCE="P-1">-Some portion of the significant increase must be attributable to the site to establish the observed release, except: when the site itself consists of contaminated sediments with no identified source, no separate attribution is required.</P> <P>If an observed release can be established for a watershed, assign an observed release factor value of 550 to that watershed, enter this value in table 4-1, and proceed to section 4.1.2.1.3. If no observed release can be established for the watershed, assign an observed release factor value of 0 to that watershed, enter this value in table 4-1, and proceed to section 4.1.2.1.2.</P> <P> 4.1.2.1.2  <E T="03">Potential to release.</E> Evaluate potential to release only if an observed release cannot be established for the watershed. Evaluate potential to release based on two components: potential to release by overland flow (see section 4.1.2.1.2.1) and potential to release by flood (see section 4.1.2.1.2.2). Sum the values for these two components to obtain the potential to release factor value for the watershed, subject to a maximum value of 500. </P> <P> 4.1.2.1.2.1  <E T="03">Potential to release by overland flow.</E> Evaluate potential to release by overland flow for the watershed based on three factors: containment, runoff, and distance to surface water. </P> <P>Assign potential to release by overland flow a value of 0 for the watershed if:</P> <P>• No overland segment of the hazardous substance migration path can be defined for the watershed, or</P> <P>• The overland segment of the hazardous substance migration path for the watershed exceeds 2 miles before surface water is encountered.</P> <FP>If either condition applies, enter a value of 0 in table 4-1 and proceed to section 4.1.2.1.2.2 to evaluate potential to release by flood. If neither applies, proceed to section 4.1.2.1.2.1.1 to evaluate potential to release by overland flow.</FP> <P> 4.1.2.1.2.1.1  <E T="03">Containment.</E> Determine the containment factor value for the watershed as follows: </P> <P> • If one or more sources is located in surface water in the watershed (for example, intact sealed drums in surface water), assign <PRTPAGE P="154"/> the containment factor a value of 10 for the watershed. Enter this value in table 4-1. </P> <P>• If none of the sources is located in surface water in the watershed, assign a containment factor value from table 4-2 to each source at the site that can potentially release hazardous substances to the hazardous substance migration path for this watershed. Assign the containment factor value for the watershed as follows:</P> <P SOURCE="P-1">-Select the highest containment factor value assigned to those sources that meet the minimum size requirement described below. Assign this highest value as the containment factor value for the watershed. Enter this value in table 4-1.</P> <P SOURCE="P-1">-If, for this watershed, no source at the site meets the minimum size requirement, then select the highest containment factor value assigned to the sources at the site eligible to be evaluated for this watershed and assign it as the containment factor value for the watershed. Enter this value in table 4-1.</P> <P>A source meets the minimum size requirement if its source hazardous waste quantity value (see section 2.4.2.1.5) is 0.5 or more. Do not include the minimum size requirement in evaluating any other factor of this surface water migration component, except potential to release by flood as specified in section 4.1.2.1.2.2.3.</P> <P> 4.1.2.1.2.1.2  <E T="03">Runoff.</E> Evaluate runoff based on three components: rainfall, drainage area, and soil group. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,xs48"> <TTITLE>Table 4-2—Containment Factor Values for Surface Water Migration Pathway</TTITLE> <BOXHD> <CHED H="1">Source</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="21"> <E T="02">All Sources (Except Surface Impoundments, Land Treatment, Containers, and Tanks)</E> </ENT> </ROW> <ROW> <ENT I="01"> Evidence of hazardous substance migration from source area ( <E T="03">i.e.</E> , source area includes source and any associated containment structures). </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from source area <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="03">(a) Neither of the following present: (1) maintained engineered cover, or (2) functioning and maintained run-on control system and runoff management system</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="03">(b) Any one of the two items in (a) present</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="03">(c) Any two of the following present: (1) maintained engineered cover, or (2) functioning and maintained run-on control system and runoff management system, or (3) liner with functioning leachate collection and removal system immediately above liner</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="03">(d) All items in (c) present</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">(e) All items in (c) present, plus no bulk or non-containerized liquids nor materials containing free liquids deposited in source area.</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="11"> No evidence of hazardous substance migration from source area, double liner with functioning leachate collection and removal system above and between liners, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="03">(f) Only one of the following deficiencies present in containment: (1) bulk or noncontainerized liquids or materials containing free liquids deposited in source area, or (2) no or nonfunctioning or nonmaintained run-on control system and runoff management system, or (3) no or nonmaintained engineered cover</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="03">(g) None of the deficiencies in (f) present.</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Source area inside or under maintained intact structure that provides protection from precipitation so that neither runoff nor leachate is generated, liquids or materials containing free liquids not deposited in source area, and functioning and maintained run-on control present</ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Surface Impoundment</E> </ENT> </ROW> <ROW> <ENT I="02">Evidence of hazardous substance migration from surface impoundment</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">Free liquids present with either no diking, unsound diking, or diking that is not regularly inspected and maintained</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="12"> No evidence of hazardous substance migration from surface impoundment, free liquids present, sound diking that is regularly inspected and maintained, adequate freeboard, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="03">(a) No liner</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="03">(b) Liner</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="03">(c) Liner with functioning leachate collection and removal system below liner</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">(d) Double liner with functioning leachate collection and removal system between liners</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">No evidence of hazardous substance migration from surface impoundment and all free liquids eliminated at closure (either by removal of liquids or solidification of remaining wastes and waste residues)</ENT> <ENT> Evaluate using <E T="02">All Sources</E> criteria (with no bulk or free liquids deposited). </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Land Treatment</E> </ENT> </ROW> <ROW> <ENT I="02">Evidence of hazardous substance migration from land treatment zone</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="12">No functioning and maintained run-on control and runoff management system</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="12"> No evidence of hazardous substance migration from land treatment zone <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="03">(a) Functioning and maintained run-on control and runoff management system</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="03">(b) Functioning and maintained run-on control and runoff management system, and vegetative cover established over entire land treatment area</ENT> <ENT>5</ENT> </ROW> <ROW> <PRTPAGE P="155"/> <ENT I="03">(c) Land treatment area maintained in compliance with 40 CFR 264.280</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Containers</E> </ENT> </ROW> <ROW> <ENT I="02">All containers buried</ENT> <ENT> Evaluate using <E T="02">All Sources</E> criteria. </ENT> </ROW> <ROW> <ENT I="02"> Evidence of hazardous substance migration from container area ( <E T="03">i.e.</E> , container area includes containers and any associated containment structures) </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">No diking (or no similar structure) surrounding container area</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">Diking surrounding container area unsound or not regularly inspected and maintained</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">No evidence of hazardous substance migration from container area and container area surrounded by sound diking that is regularly inspected and maintained</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="02" O="xl"> No evidence of hazardous substance migration from container area, container area surrounded by sound diking that is regularly inspected and maintained, <E T="03">and:</E> </ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="03">(a) Essentially impervious base under container area with liquids collection and removal system</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="03">(b) Containment system includes essentially impervious base, liquids collection system, sufficient capacity to contain 10 percent of volume of all containers, and functioning and maintained run-on control; and spilled or leaked hazardous substances and accumulated precipitation removed in timely manner to prevent overflow of collection system, at least weekly inspection of containers, hazardous substances in leaking or deteriorating containers transferred to containers in good condition, and containers sealed except when waste is added or removed</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">(c) Free liquids present, containment system has sufficient capacity to hold total volume of all containers and to provide adequate freeboard, and single liner under container area with functioning leachate collection and removal system below liner</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">(d) Same as (c) except: double liner under container area with functioning leachate collection and removal system between liners</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">Containers inside or under maintained intact structure that provides protection from precipitation so that neither runoff nor leachate would be generated from any unsealed or ruptured containers, liquids or materials containing free liquids not deposited in any container, and functioning and maintained run-on control present</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">No evidence of hazardous substance migration from container area, containers leaking, and all free liquids eliminated at closure (either by removal of liquids or solidification of remaining wastes and waste residues)</ENT> <ENT>Evaluate using All Sources criteria (with no bulk or free liquids deposited).</ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Tank</E> </ENT> </ROW> <ROW> <ENT I="01">Below-ground tank</ENT> <ENT>Evaluate using All Sources criteria</ENT> </ROW> <ROW> <ENT I="02"> Evidence of hazardous substance migration from tank area ( <E T="03">i.e.</E> , tank area includes tank, ancillary equipment such as piping, and any associated containment structures) </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">No diking (or no similar structure) surrounding tank and ancillary equipment</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">Diking surrounding tank and ancillary equipment unsound or not regularly inspected and maintained</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="02">No evidence of hazardous substance migration from tank area and tank and ancillary equipment surrounded by sound diking that is regularly inspected and maintained</ENT> <ENT> 9</ENT> </ROW> <ROW> <ENT I="12"> No evidence of hazardous substance migration from tank area, tank and ancillary equipment surrounded by sound diking that is regularly inspected and maintained, <E T="03">and:</E> </ENT> </ROW> <ROW> <ENT I="03">(a) Tank and ancillary equipment provided with secondary containment (e.g., liner under tank area, vault system, double-wall) with leak detection and collection system</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="03">(b) Tank and ancillary equipment provided with secondary containment system that detects and collects spilled or leaked hazardous substances and accumulated precipitation and has sufficient capacity to contain 110 percent of volume of largest tank within containment area, spilled or leaked hazardous substances and accumulated precipitation removed in a timely manner, at least weekly inspection of tank and secondary containment system, and all leaking or unfit-for-use tank systems promptly responded to</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">(c) Containment system has sufficient capacity to hold total volume of all tanks within the tank containment area and to provide adequate freeboard, and single liner under tank containment area with functioning leachate collection and removal system below liner</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">(d) Same as (c) except: double liner under tank containment area with functioning leachate collection and removal system between liners</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">Tank is above ground, and inside or under maintained intact structure that provides protection from precipitation so that neither runoff nor leachate would be generated from any material released from tank, liquids or materials containing free liquids not deposited in any tank, and functioning and maintained run-on control present</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <P> Rainfall. Determine the 2-year, 24-hour rainfall for the site. Use site-specific, 2-year, 24-hour rainfall data if records are available for at least 20 years. If such site-specific data are not available, estimate the 2-year, 24-hour rainfall for the site from a rainfall-frequency map. Do not round the rainfall value to the nearest integer. <PRTPAGE P="156"/> </P> <P>Drainage area. Determine the drainage area for the sources at the site. Include in this drainage area both the source areas and the area upgradient of the sources, but exclude any portion of this drainage area for which runoff is diverted from entering the sources by storm sewers or run-on control and/or runoff management systems. Assign a drainage area value for the watershed from table 4-3.</P> <P>Soil group. Based on the predominant soil group within the drainage area described above, assign a soil group designation for the watershed from table 4-4 as follows:</P> <P>• Select the predominant soil group as that type which comprises the largest total area within the applicable drainage area.</P> <P>• If a predominant soil group cannot be delineated, select that soil group in the drainage area that yields the highest value for the runoff factor.</P> <P>Calculation of runoff factor value. Assign a combined rainfall/runoff value for the watershed from table 4-5, based on the 2-year, 24-hour rainfall and the soil group designation. Determine the runoff factor value for the watershed from table 4-6, based on the rainfall/runoff and drainage area values. Enter the runoff factor value in table 4-1.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,10"> <TTITLE>Table 4-3—Drainage Area Values</TTITLE> <BOXHD> <CHED H="1">Drainage area (acres)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 50</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">50 to 250</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">Greater than 250 to 1,000</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000</ENT> <ENT>4</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s80,xs42"> <TTITLE>Table 4-4—Soil Group Designations</TTITLE> <BOXHD> <CHED H="1">Surface soil description</CHED> <CHED H="1">Soil group designation</CHED> </BOXHD> <ROW> <ENT I="01">Coarse-textured soils with high infiltration rates (for example, sands, loamy sands)</ENT> <ENT>A</ENT> </ROW> <ROW> <ENT I="01">Medium-textured soils with moderate infiltration rates (for example, sandy loams, loams)</ENT> <ENT>B</ENT> </ROW> <ROW> <ENT I="01">Moderately fine-textured soils with low infiltration rates (for example, silty loams, silts, sandy clay loams)</ENT> <ENT>C</ENT> </ROW> <ROW> <ENT I="01">Fine-textured soils with very low infiltration rates (for example, clays, sandy clays, silty clay loams, clay loams, silty clays); or impermeable surfaces (for example, pavement)</ENT> <ENT>D</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="5" OPTS="L2" CDEF="s50,4,4,4,4"> <TTITLE>Table 4-5—Rainfall/Runoff Values</TTITLE> <BOXHD> <CHED H="1">2-Year, 24-hour rainfall (inches)</CHED> <CHED H="1">Soil group designation</CHED> <CHED H="2">A</CHED> <CHED H="2">B</CHED> <CHED H="2">C</CHED> <CHED H="2">D</CHED> </BOXHD> <ROW> <ENT I="01">Less than 1.0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">1.0 to less than 1.5</ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>2</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">1.5 to less than 2.0</ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>3</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">2.0 to less than 2.5</ENT> <ENT>1</ENT> <ENT>2</ENT> <ENT>3</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">2.5 to less than 3.0</ENT> <ENT>2</ENT> <ENT>3</ENT> <ENT>4</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">3.0 to less than 3.5</ENT> <ENT>2</ENT> <ENT>3</ENT> <ENT>4</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">3.5 or greater</ENT> <ENT>3</ENT> <ENT>4</ENT> <ENT>5</ENT> <ENT>6</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="8" OPTS="L2" CDEF="s20,3,3,3,3,3,3,3"> <TTITLE>Table 4-6—Runoff Factor Values</TTITLE> <BOXHD> <CHED H="1">Drainage area value</CHED> <CHED H="1">Rainfall/runoff value</CHED> <CHED H="2">0</CHED> <CHED H="2">1</CHED> <CHED H="2">2</CHED> <CHED H="2">3</CHED> <CHED H="2">4</CHED> <CHED H="2">5</CHED> <CHED H="2">6</CHED> </BOXHD> <ROW> <ENT I="01">1</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>2</ENT> <ENT>3</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">3</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>3</ENT> <ENT>7</ENT> <ENT>11</ENT> <ENT>15</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>2</ENT> <ENT>7</ENT> <ENT>17</ENT> <ENT>25</ENT> <ENT>25</ENT> </ROW> </GPOTABLE> <P> 4.1.2.1.2.1.3  <E T="03">Distance to surface water.</E> Evaluate the distance to surface water as the shortest distance, along the overland segment, from any source with a surface water containment factor value greater than 0 to either the mean high water level for tidal waters or the mean water level for other surface waters. Based on this distance, assign a value from table 4-7 to the distance to surface water factor for the watershed. Enter this value in table 4-1. </P> <P> 4.1.2.1.2.1.4  <E T="03">Calculation of factor value for potential to release by overland flow.</E> Sum the factor values for runoff and distance to surface water for the watershed and multiply this sum by the factor value for containment. Assign the resulting product as the factor value for potential to release by overland flow for the watershed. Enter this value in table 4-1. </P> <P> 4.1.2.1.2.2  <E T="03">Potential to release by flood.</E> Evaluate potential to release by flood for each watershed as the product of two factors: containment (flood) and flood frequency. Evaluate potential to release by flood separately for each source that is within the watershed. Furthermore, for each source, evaluate potential to release by flood separately for each category of floodplain in which the source lies. (See section 4.1.2.1.2.2.2 for the applicable floodplain categories.) Calculate the value for the potential to release by flood factor as specified in 4.1.2.1.2.2.3. </P> <P> 4.1.2.1.2.2.1  <E T="03">Containment (flood).</E> For each source within the watershed, separately evaluate the containment (flood) factor for each category of floodplain in which the source is partially or wholly located. Assign a containment (flood) factor value from table 4-8 to each floodplain category applicable to that source. Assign a containment (flood) factor value of 0 to each floodplain category in which the source does not lie. </P> <P> 4.1.2.1.2.2.2  <E T="03">Flood frequency.</E> For each source within the watershed, separately evaluate the flood frequency factor for each category of floodplain in which the source is partially or wholly located. Assign a flood <PRTPAGE P="157"/> frequency factor value from table 4-9 to each floodplain category in which the source is located. </P> <P> 4.1.2.1.2.2.3  <E T="03">Calculation of factor value for potential to release by flood.</E> For each source within the watershed and for each category of floodplain in which the source is partially or wholly located, calculate a separate potential to release by flood factor value. Calculate this value as the product of the containment (flood) value and the flood frequency value applicable to the source for the floodplain category. Select the highest value calculated for those sources that meet the minimum size requirement specified in section 4.1.2.1.2.1.1 and assign it as the value for the potential to release by flood factor for the watershed. However, if, for this watershed, no source at the site meets the minimum size requirement, select the highest value calculated for the sources at the site eligible to be evaluated for this watershed and assign it as the value for this factor. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,10"> <TTITLE>Table 4-7—Distance to Surface Water Factor Values</TTITLE> <BOXHD> <CHED H="1">Distance</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 100 feet</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="01">100 feet to 500 feet</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01">Greater than 500 feet to 1,000 feet</ENT> <ENT>16</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000 feet to 2,500 feet</ENT> <ENT>9</ENT> </ROW> <ROW> <ENT I="01">Greater than 2,500 feet to 1.5 miles</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">Greater than 1.5 miles to 2 miles</ENT> <ENT>3</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,10"> <TTITLE>Table 4-8—Containment (Flood) Factor Values</TTITLE> <BOXHD> <CHED H="1">Containment criteria</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Documentation that containment at the source is designed, constructed, operated, and maintained to prevent a washout of hazardous substances by the flood being evaluated</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Other</ENT> <ENT>10</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,10"> <TTITLE>Table 4-9—Flood Frequency Factor Values</TTITLE> <BOXHD> <CHED H="1">Floodplain category</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Source floods annually</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">Source in 10-year floodplain</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">Source in 100-year floodplain</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="01">Source in 500-year floodplain</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">None of above</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <P>Enter this highest potential to release by flood factor value for the watershed in table 4-1, as well as the values for containment (flood) and flood frequency that yield this highest value.</P> <P> 4.1.2.1.2.3  <E T="03">Calculation of potential to release factor value.</E> Sum the factor values assigned to the watershed for potential to release by overland flow and potential to release by flood. Assign this sum as the potential to release factor value for the watershed, subject to a maximum value of 500. Enter this value in table 4-1. </P> <P> 4.1.2.1.3  <E T="03">Calculation of drinking water threat-likelihood of release factor category value.</E> If an observed release is established for the watershed, assign the observed release factor value of 550 as the likelihood of release factor category value for that watershed. Otherwise, assign the potential to release factor value for that watershed as the likelihood of release factor category value for that watershed. Enter the value assigned in table 4-1. </P> <P> 4.1.2.2  <E T="03">Drinking water threat-waste characteristics.</E> Evaluate the waste characteristics factor category for each watershed based on two factors: toxicity/persistence and hazardous waste quantity. Evaluate only those hazardous substances that are available to migrate from the sources at the site to surface water in the watershed via the overland/flood hazardous substance migration path for the watershed (see section 4.1.1.1). Such hazardous substances include: </P> <P>• Hazardous substances that meet the criteria for an observed release to surface water in the watershed.</P> <P>• All hazardous substances associated with a source that has a surface water containment factor value greater than 0 for the watershed (see sections 2.2.2, 2.2.3, 4.1.2.1.2.1.1, and 4.1.2.1.2.2.1).</P> <P> 4.1.2.2.1  <E T="03">Toxicity/persistence.</E> For each hazardous substance, assign a toxicity factor value, a persistence factor value, and a combined toxicity/persistence factor value as specified in sections 4.1.2.2.1.1 through 4.1.2.2.1.3. Select the toxicity/persistence factor value for the watershed as specified in section 4.1.2.2.1.3. </P> <P> 4.1.2.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in section 2.4.1.1. </P> <P> 4.1.2.2.1.2  <E T="03">Persistence.</E> Assign a persistence factor value to each hazardous substance. In assigning this value, evaluate persistence based primarily on the half-life of the hazardous substance in surface water and secondarily on the sorption of the hazardous substance to sediments. The half-life in surface water is defined for HRS purposes as the time required to reduce the initial concentration in surface water by one-half as a result of the combined decay processes of biodegradation, hydrolysis, photolysis, and volatilization. Sorption to sediments is evaluated for the HRS based on the logarithm of the n-octanol-water partition coefficient (log K <E T="52">ow</E> ) of the hazardous substance. </P> <P> Estimate the half-life (t <E T="52">1/2</E> ) of a hazardous substance as follows: </P> <MATH SPAN="1" DEEP="26"> <PRTPAGE P="158"/> <MID>EC15NO91.149</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">h = Hydrolysis half-life.</FP> <FP SOURCE="FP-2">b = Biodegradation half-life.</FP> <FP SOURCE="FP-2">p = Photolysis half-life.</FP> <FP SOURCE="FP-2">v = Volatilization half-life.</FP> <P>If one or more of these four component half-lives cannot be estimated for the hazardous substance from available data, delete that component half-life from the above equation. If none of these four component half-lives can be estimated for the hazardous substance from available data, use the default procedure indicated below. Estimate a half-life for the hazardous substance for lakes or for rivers, oceans, coastal tidal waters, and Great Lakes, as appropriate.</P> <P>If a half-life can be estimated for a hazardous substance:</P> <P>• Assign that hazardous substance a persistence factor value from the appropriate portion of table 4-10 (that is lakes; or rivers, oceans, coastal tidal waters, and Great Lakes).</P> <P>• Select the appropriate portion of table 4-10 as follows:</P> <P SOURCE="P-1">-If there is one or more drinking water intakes along the hazardous substance migration path for the watershed, select the nearest drinking water intake as measured from the probable point of entry. If the in-water segment between the probable point of entry and this selected intake includes both lakes and other water bodies, use the lakes portion of table 4-10 only if more than half the distance to this selected intake lies in lake(s). Otherwise, use the rivers, oceans, coastal tidal waters, and Great Lakes portion of table 4-10. For contaminated sediments with no identified source, use the point where measurement begins (see section 4.1.1.2) rather than the probable point of entry.</P> <P SOURCE="P-1">-If there are no drinking water intakes but there are intakes or points of use for any of the resource types listed in section 4.1.2.3.3, select the nearest such intake or point of use. Select the portion of table 4-10 based on this intake or point of use in the manner specified for drinking water intakes.</P> <P SOURCE="P-1">-If there are no drinking water intakes and no specified resource intakes and points of use, but there is another type of resource listed in section 4.1.2.3.3 (for example, the water is usable for drinking water purposes even though not used), select the portion of table 4-10 based on the nearest point of this resource in the manner specified for drinking water intakes.</P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s100,r150,9"> <TTITLE>Table 4-10—Persistence Factor Values—Half-Life</TTITLE> <BOXHD> <CHED H="1">Surface water category</CHED> <CHED H="1">Substance half-life (days)</CHED> <CHED H="1"> Assigned value  <SU>a</SU> </CHED> </BOXHD> <ROW RUL="s"> <ENT I="11">Rivers, oceans, coastal tidal waters, and Great Lakes</ENT> <ENT> Less than or equal to 0.2 <LI>Greater than 0.2 to 0.5</LI> <LI>Greater than 0.5 to 1.5</LI> <LI>Greater than 1.5</LI> </ENT> <ENT> 0.0007 <LI>0.07</LI> <LI>0.4</LI> <LI>1</LI> </ENT> </ROW> <ROW> <ENT I="11">Lakes</ENT> <ENT> Less than or equal to 0.02 <LI>Greater than 0.02 to 2</LI> <LI>Greater than 2 to 20</LI> <LI>Greater than 20</LI> </ENT> <ENT> 0.0007 <LI>0.07</LI> <LI>0.4</LI> <LI>1</LI> </ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P>If a half-life cannot be estimated for a hazardous substance from available data, use the following default procedure to assign a persistence factor value to that hazardous substance:</P> <P>• For those hazardous substances that are metals (or metalloids), assign a persistence factor value of 1 as a default for all surface water bodies.</P> <P>• For other hazardous substances (both organic and inorganic), assign a persistence factor value of 0.4 as a default for rivers, oceans, coastal tidal waters, and Great Lakes, and a persistence factor value of 0.07 as a default for lakes. Select the appropriate value in the same manner specified for using table 4-10.</P> <P> Use the persistence factor value assigned based on half-life or the default procedure unless the hazardous substance can be assigned a higher factor value from Table ­4-11, based on its Log K <E T="52">ow</E> . If a higher value can be assigned from table 4-11, assign this higher value as the persistence factor value for the hazardous substance. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,8"> <TTITLE> Table 4-11—Persistence Factor Values—Log K <E T="52">ow</E> </TTITLE> <BOXHD> <CHED H="1"> Log K <E T="52">ow</E> </CHED> <CHED H="1"> Assigned value  <SU>a</SU> </CHED> </BOXHD> <ROW> <ENT I="01">Less than 3.5</ENT> <ENT>0.0007</ENT> </ROW> <ROW> <ENT I="01">3.5 to less than 4.0</ENT> <ENT>0.07</ENT> </ROW> <ROW> <ENT I="01">4.0 to 4.5</ENT> <ENT>0.4</ENT> </ROW> <ROW> <PRTPAGE P="159"/> <ENT I="01">Greater than 4.5</ENT> <ENT>1</ENT> </ROW> <TNOTE> <SU>a</SU>  Use for lakes, rivers, oceans, coastal tidal waters, and Great Lakes. Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.1.2.2.1.3  <E T="03">Calculation of toxicity/persistence factor value.</E> Assign each hazardous substance a toxicity/persistence factor value from table 4-12, based on the values assigned to the hazardous substance for the toxicity and persistence factors. Use the hazardous substance with the highest toxicity/persistence factor value for the watershed to assign the toxicity/persistence factor value for the drinking water threat for the watershed. Enter this value in table 4-1. </P> <P> 4.1.2.2.2  <E T="03">Hazardous waste quantity.</E> Assign a hazardous waste quantity factor value for the watershed as specified in section 2.4.2. Enter this value in table 4-1. </P> <P> 4.1.2.2.3  <E T="03">Calculation of drinking water threat-waste characteristics factor category value.</E> Multiply the toxicity/persistence and hazardous waste quantity factor values for the watershed, subject to a maximum product of 1 × 10 <SU>8</SU> . Based on this product, assign a value from table 2-7 (section 2.4.3.1) to the drinking water threat-waste characteristics factor category for the watershed. Enter this value in table 4-1. </P> <GPOTABLE COLS="7" OPTS="L2" CDEF="s50,8,8,7,7,7,2"> <TTITLE> Table 4-12—Toxicity/Persistence Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Persistence factor value</CHED> <CHED H="1">Toxicity factor value</CHED> <CHED H="2">10,000</CHED> <CHED H="2">1,000</CHED> <CHED H="2">100</CHED> <CHED H="2">10</CHED> <CHED H="2">1</CHED> <CHED H="2">0</CHED> </BOXHD> <ROW> <ENT I="01">1.0</ENT> <ENT>10,000</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.4</ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.07</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.0007</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT>0.0007</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.1.2.3  <E T="03">Drinking water threat-targets.</E> Evaluate the targets factor category for each watershed based on three factors: nearest intake, population, and resources. </P> <P>To evaluate the nearest intake and population factors, determine whether the target surface water intakes are subject to actual or potential contamination as specified in section 4.1.1.2. Use either an observed release based on direct observation at the intake or the exposure concentrations from samples (or comparable samples) taken at or beyond the intake to make this determination (see section 4.1.2.1.1). The exposure concentrations for a sample (that is, surface water, benthic, or sediment sample) consist of the concentrations of those hazardous substances present that are significantly above background levels and attributable at least in part to the site (that is, those hazardous substance concentrations that meet the criteria for an observed release).</P> <P>When an intake is subject to actual contamination, evaluate it using Level I concentrations or Level II concentrations. If the actual contamination is based on an observed release by direct observation, use Level II concentrations for that intake. However, if the actual contamination is based on an observed release from samples, determine which level applies for the intake by comparing the exposure concentrations from samples (or comparable samples) to health-based benchmarks as specified in sections 2.5.1 and 2.5.2. Use the health-based benchmarks from table 3-10 (section 3.3.1) in determining the level of contamination from samples. For contaminated sediments with no identified source, evaluate the actual contamination using Level II concentrations (see section 4.1.1.2).</P> <P> 4.1.2.3.1  <E T="03">Nearest intake.</E> Evaluate the nearest intake factor based on the drinking water intakes along the overland/flood hazardous substance migration path for the watershed. Include standby intakes in evaluating this factor only if they are used for supply at least once a year. </P> <P>Assign the nearest intake factor a value as follows and enter the value in table 4-1:</P> <P>• If one or more of these drinking water intakes is subject to Level I concentrations as specified in section 4.1.2.3, assign a factor value of 50.</P> <P>• If not, but if one or more of these drinking water intakes is subject to Level II concentrations, assign a factor value of 45.</P> <P>• If none of these drinking water intakes is subject to Level I or Level II concentrations, determine the nearest of these drinking water intakes, as measured from the probable point of entry (or from the point where measurement begins for contaminated sediments with no identified source). Assign a dilution weight from table 4-13 to this intake, based on the type of surface water body in which it is located. Multiply this dilution weight by 20, round the product to the nearest integer, and assign it as the factor value.</P> <P> Assign the dilution weight from table 4-13 as follows: <PRTPAGE P="160"/> </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="xs144,r50,10"> <TTITLE>Table 4-13—Surface Water Dilution Weights</TTITLE> <BOXHD> <CHED H="1"> Type of surface water body  <SU>a</SU> </CHED> <CHED H="2">Descriptor</CHED> <CHED H="2">Flow characteristics</CHED> <CHED H="1"> Assigned dilution weight  <SU>b</SU> </CHED> </BOXHD> <ROW> <ENT I="01">Minimal stream</ENT> <ENT> Less than 10 cfs  <SU>c</SU> </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">Small to moderate stream</ENT> <ENT>10 to 100 cfs</ENT> <ENT>0.1</ENT> </ROW> <ROW> <ENT I="01">Moderate to large stream</ENT> <ENT>Greater than 100 to 1,000 cfs</ENT> <ENT>0.01</ENT> </ROW> <ROW> <ENT I="01">Large stream to river</ENT> <ENT>Greater than 1,000 to 10,000 cfs</ENT> <ENT>0.001</ENT> </ROW> <ROW> <ENT I="01">Large river</ENT> <ENT>Greater than 10,000 to 100,000 cfs</ENT> <ENT>0.0001</ENT> </ROW> <ROW> <ENT I="01">Very large river</ENT> <ENT>Greater than 100,000 cfs</ENT> <ENT>0.00001</ENT> </ROW> <ROW> <ENT I="01"> Coastal tidal waters  <SU>d</SU> </ENT> <ENT>Flow not applicable, depth not applicable</ENT> <ENT>0.0001</ENT> </ROW> <ROW> <ENT I="01"> Shallow ocean zone  <SU>e</SU> or Great Lake </ENT> <ENT>Flow not applicable, depth less than 20 feet</ENT> <ENT>0.0001</ENT> </ROW> <ROW> <ENT I="01"> Moderate depth ocean zone  <SU>e</SU> or Great Lake </ENT> <ENT>Flow not applicable, depth 20 to 200 feet</ENT> <ENT>0.00001</ENT> </ROW> <ROW> <ENT I="01"> Deep ocean zone  <SU>e</SU> or Great Lake </ENT> <ENT>Flow not applicable, depth greater than 200 feet</ENT> <ENT>0.000005</ENT> </ROW> <ROW> <ENT I="01">3-mile mixing zone in quiet flowing river</ENT> <ENT>10 cfs or greater</ENT> <ENT>0.5</ENT> </ROW> <TNOTE> <SU>a</SU>  Treat each lake as a separate type of water body and assign a dilution weight as specified in text. </TNOTE> <TNOTE> <SU>b</SU>  Do not round to nearest integer. </TNOTE> <TNOTE> <SU>c</SU>  cfs = cubic feet per second. </TNOTE> <TNOTE> <SU>d</SU>  Embayments, harbors, sounds, estuaries, back bays, lagoons, wetlands, etc., seaward from mouths of rivers and landward from baseline of Territorial Sea. </TNOTE> <TNOTE> <SU>e</SU>  Seaward from baseline of Territorial Sea. This baseline represents the generalized U.S. coastline. It is parallel to the seaward limit of the Territorial Sea and other maritime limits such as the inner boundary of the Federal fisheries jurisdiction and the limit of States jurisdiction under the Submerged Lands Act, as amended. </TNOTE> </GPOTABLE> <P>• For a river (that is, surface water body types specified in table 4-13 as minimal stream through very large river), assign a dilution weight based on the average annual flow in the river at the intake. If available, use the average annual discharge as defined in the U.S. Geological Survey Water Resources Data Annual Report. Otherwise, estimate the average annual flow.</P> <P>• For a lake, assign a dilution weight as follows:</P> <P SOURCE="P-1">-For a lake that has surface water flow entering the lake, assign a dilution weight based on the sum of the average annual flows for the surface water bodies entering the lake up to the point of the intake.</P> <P SOURCE="P-1">-For a lake that has no surface water flow entering, but that does have surface water flow leaving, assign a dilution weight based on the sum of the average annual flows for the surface water bodies leaving the lake.</P> <P SOURCE="P-1">-For a closed lake (that is, a lake without surface water flow entering or leaving), assign a dilution weight based on the average annual ground water flow into the lake, if available, using the dilution weight for the corresponding river flow rate in table 4-13. If not available, assign a default dilution weight of 1.</P> <P>• For the ocean and the Great Lakes, assign a dilution weight based on depth.</P> <P>• For coastal tidal waters, assign a dilution weight of 0.0001; do not consider depth or flow.</P> <P>• For a quiet-flowing river that has average annual flow of 10 cubic feet per second (cfs) or greater and that contains the probable point of entry to surface water, apply a zone of mixing in assigning the dilution weight:</P> <P SOURCE="P-1">-Start the zone of mixing at the probable point of entry and extend it for 3 miles from the probable point of entry, except: if the surface water characteristics change to turbulent within this 3-mile distance, extend the zone of mixing only to the point at which the change occurs.</P> <P SOURCE="P-1">-Assign a dilution weight of 0.5 to any intake that lies within this zone of mixing.</P> <P SOURCE="P-1">-Beyond this zone of mixing, assign a dilution weight the same as for any other river (that is, assign the dilution weight based on average annual flow).</P> <P SOURCE="P-1">-Treat a quiet-flowing river with an average annual flow of less than 10 cfs the same as any other river (that is, assign it a dilution weight of 1).</P> <FP>In those cases where water flows from a surface water body with a lower assigned dilution weight (from table 4-13) to a surface water body with a higher assigned dilution weight (that is, water flows from a surface water body with more dilution to one with less dilution), use the lower assigned dilution weight as the dilution weight for the latter surface water body.</FP> <P> 4.1.2.3.2  <E T="03">Population.</E> In evaluating the population factor, include only persons served by drinking water drawn from intakes that are along the overland/flood hazardous substance migration path for the watershed and that are within the target distance limit specified in section 4.1.1.2. Include residents, students, and workers who regularly use the water. Exclude transient populations such as customers and travelers passing through the area. When a standby intake is maintained on a regular basis so that water can be withdrawn, include it in evaluating the population factor. <PRTPAGE P="161"/> </P> <P>In estimating residential population, when the estimate is based on the number of residences, multiply each residence by the average number of persons per residence for the county in which the residence is located.</P> <P>In estimating the population served by an intake, if the water from the intake is blended with other water (for example, water from other surface water intakes or ground water wells), apportion the total population regularly served by the blended system to the intake based on the intake's relative contribution to the total blended system. In estimating the intake's relative contribution, assume each well or intake contributes equally and apportion the population accordingly, except: if the relative contribution of any one intake or well exceeds 40 percent based on average annual pumpage or capacity, estimate the relative contribution of the wells and intakes considering the following data, if available:</P> <P>• Average annual pumpage from the ground water wells and surface water intakes in the blended system.</P> <P>• Capacities of the wells and intakes in the blended system.</P> <P>For systems with standby surface water intakes or standby ground water wells, apportion the total population regularly served by the blended system as described above, except:</P> <P>• Exclude standby ground water wells in apportioning the population.</P> <P>• When using pumpage data for a standby surface water intake, use average pumpage for the period during which the standby intake is used rather than average annual pumpage.</P> <P>• For that portion of the total population that could be apportioned to a standby surface water intake, assign that portion of the population either to that standby intake or to the other surface water intake(s) and ground water well(s) that serve that population; do not assign that portion of the population both to the standby intake and to the other intake(s) and well(s) in the blended system. Use the apportioning that results in the highest population factor value. (Either include all standby intake(s) or exclude some or all of the standby intake(s) as appropriate to obtain this highest value.) Note that the specific standby intake(s) included or excluded and, thus, the specific apportioning may vary in evaluating different watersheds and in evaluating the ground water pathway.</P> <P> 4.1.2.3.2.1  <E T="03">Level of contamination.</E> Evaluate the population factor based on three factors: Level I concentrations, Level II concentrations, and potential contamination. Determine which factor applies for an intake as specified in section 4.1.2.3. Evaluate intakes subject to Level I concentration as specified in section 4.1.2.3.2.2, intakes subject to Level II concentration as specified in section 4.1.2.3.2.3, and intakes subject to potential contamination as specified in section 4.1.2.3.2.4. </P> <P>For the potential contamination factor, use population ranges in evaluating the factor as specified in section 4.1.2.3.2.4. For the Level I and Level II concentrations factors, use the population estimate, not population ranges, in evaluating both factors.</P> <P> 4.1.2.3.2.2  <E T="03">Level I concentrations.</E> Sum the number of people served by drinking water from intakes subject to Level I concentrations. Multiply this sum by 10. Assign this product as the value for this factor. Enter this value in table 4-1. </P> <P> 4.1.2.3.2.3  <E T="03">Level II concentrations.</E> Sum the number of people served by drinking water from intakes subject to Level II concentrations. Do not include people already counted under the Level I concentrations factor. Assign this sum as the value for this factor. Enter this value in table 4-1. </P> <P> 4.1.2.3.2.4  <E T="03">Potential contamination.</E> For each applicable type of surface water body in table 4-14, first determine the number of people served by drinking water from intakes subject to potential contamination in that type of surface water body. Do not include those people already counted under the Level I and Level II concentrations factors. <PRTPAGE P="162"/> </P> <GPOTABLE COLS="15" OPTS="L2" CDEF="s10,7,7,7,7,7,7,7,7,7,7,7,7,7,8"> <TTITLE> Table 4-14—Dilution-Weighted Population Values for Potential Contamination Factor For Surface Water Migration Pathway  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1"> Type of surface water body  <SU>b</SU> </CHED> <CHED H="1">Number of people</CHED> <CHED H="2">0</CHED> <CHED H="2">1 to 10</CHED> <CHED H="2">11 to 30</CHED> <CHED H="2">31 to 100</CHED> <CHED H="2">101 to 300</CHED> <CHED H="2">301 to 1,000</CHED> <CHED H="2">1,001 to 3,000</CHED> <CHED H="2">3,001 to 10,000</CHED> <CHED H="2">10,001 to 30,000</CHED> <CHED H="2">30,001 to 100,000</CHED> <CHED H="2">100,001 to 300,000</CHED> <CHED H="2">300,001 to 1,000,000</CHED> <CHED H="2">1,000,001 to 3,000,000</CHED> <CHED H="2">3,000,001 to 10,000,000</CHED> </BOXHD> <ROW> <ENT I="01">Minimal stream (<10 cfs)</ENT> <ENT>0</ENT> <ENT>4</ENT> <ENT>17</ENT> <ENT>53</ENT> <ENT>164</ENT> <ENT>522</ENT> <ENT>1,633</ENT> <ENT>5,214</ENT> <ENT>16,325</ENT> <ENT>52,137</ENT> <ENT>163,246</ENT> <ENT>521,360</ENT> <ENT>1,632,455</ENT> <ENT>5,213,590</ENT> </ROW> <ROW> <ENT I="01">Small to moderate stream (10 to 100 cfs)</ENT> <ENT>0</ENT> <ENT>0.4</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> <ENT>163</ENT> <ENT>521</ENT> <ENT>1,633</ENT> <ENT>5,214</ENT> <ENT>16,325</ENT> <ENT>52,136</ENT> <ENT>163,245</ENT> <ENT>521,359</ENT> </ROW> <ROW> <ENT I="01">Moderate to large stream (>100 to 1,000 cfs)</ENT> <ENT>0</ENT> <ENT>0.04</ENT> <ENT>0.2</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> <ENT>163</ENT> <ENT>521</ENT> <ENT>1,633</ENT> <ENT>5,214</ENT> <ENT>16,325</ENT> <ENT>52,136</ENT> </ROW> <ROW> <ENT I="01">Large stream to river (>1,000 to 10,000 cfs)</ENT> <ENT>0</ENT> <ENT>0.004</ENT> <ENT>0.02</ENT> <ENT>0.05</ENT> <ENT>0.2</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> <ENT>163</ENT> <ENT>521</ENT> <ENT>1,632</ENT> <ENT>5,214</ENT> </ROW> <ROW> <ENT I="01">Large river (>10,000 to 100,000 cfs)</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0.002</ENT> <ENT>0.005</ENT> <ENT>0.02</ENT> <ENT>0.05</ENT> <ENT>0.2</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> <ENT>163</ENT> <ENT>521</ENT> </ROW> <ROW> <ENT I="01">Very large river (>100,000 cfs)</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0.001</ENT> <ENT>0.002</ENT> <ENT>0.005</ENT> <ENT>0.02</ENT> <ENT>0.05</ENT> <ENT>0.2</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> </ROW> <ROW> <ENT I="01">Shallow ocean zone or Great Lake (depth <20 feet)</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0.002</ENT> <ENT>0.005</ENT> <ENT>0.02</ENT> <ENT>0.05</ENT> <ENT>0.2</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> <ENT>163</ENT> <ENT>521</ENT> </ROW> <ROW> <ENT I="01">Moderate ocean zone or Great Lake (depth 20 to 200 feet)</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0.001</ENT> <ENT>0.002</ENT> <ENT>0.005</ENT> <ENT>0.02</ENT> <ENT>0.05</ENT> <ENT>0.2</ENT> <ENT>0.5</ENT> <ENT>2</ENT> <ENT>5</ENT> <ENT>16</ENT> <ENT>52</ENT> </ROW> <ROW> <ENT I="01">Deep ocean zone or Great Lakes (depth >200 feet)</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0.001</ENT> <ENT>0.003</ENT> <ENT>0.008</ENT> <ENT>0.03</ENT> <ENT>0.08</ENT> <ENT>0.3</ENT> <ENT>1</ENT> <ENT>3</ENT> <ENT>8</ENT> <ENT>26</ENT> </ROW> <ROW> <ENT I="01">3-mile mixing zone in quiet flowing river (≥10 cfs)</ENT> <ENT>0</ENT> <ENT>2</ENT> <ENT>9</ENT> <ENT>26</ENT> <ENT>82</ENT> <ENT>261</ENT> <ENT>817</ENT> <ENT>2,607</ENT> <ENT>8,163</ENT> <ENT>26,068</ENT> <ENT>81,623</ENT> <ENT>260,680</ENT> <ENT>816,227</ENT> <ENT>2,606,795</ENT> </ROW> <TNOTE> <SU>a</SU>  Round the number of people to nearest integer. Do not round the assigned dilution-weighted population value to nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  Treat each lake as a separate type of water body and assign it a dilution-weighted population value using the surface water body type with the same dilution-weighted from table 4-13 as the lake. If drinking water is withdrawn from coastal tidal water or the ocean, assign a dilution-weighted population value to it using the surface water body type with the same dilution weight from table 4-13 as the coastal tidal water or the ocean zone. </TNOTE> </GPOTABLE> <PRTPAGE P="163"/> <P>For each type of surface water body, assign a dilution-weighted population value from table 4-14, based on the number of people included for that type of surface water body. (Note that the dilution-weighted population values in table 4-14 incorporate the dilution weights from table 4-13. Do not multiply the values from table 4-14 by these dilution weights.)</P> <P>Calculate the value for the potential contamination factor (PC) for the watershed as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.150</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2"> W <E T="52">i</E> = Dilution-weighted population from table 4-14 for surface water body type i. </FP> <FP SOURCE="FP-2">n = Number of different surface water body types in the watershed.</FP> <P>If PC is less than 1, do not round it to the nearest integer; if PC is 1 or more, round to the nearest integer. Enter this value for the potential contamination factor in table 4-1.</P> <P> 4.1.2.3.2.5  <E T="03">Calculation of population factor value.</E> Sum the factor values for Level I concentrations, Level II concentrations, and potential contamination. Do not round this sum to the nearest integer. Assign this sum as the population factor value for the watershed. Enter this value in table 4-1. </P> <P> 4.1.2.3.3  <E T="03">Resources.</E> To evaluate the resources factor for the watershed, select the highest value below that applies to the watershed. Assign this value as the resources factor value for the watershed. Enter this value in table 4-1. </P> <P>Assign a value of 5 if, within the in-water segment of the hazardous substance migration path for the watershed, the surface water is used for one or more of the following purposes:</P> <P>• Irrigation (5 acre minimum) of commercial food crops or commercial forage crops.</P> <P>• Watering of commercial livestock.</P> <P>• Ingredient in commercial food preparation.</P> <P>• Major or designated water recreation area, excluding drinking water use.</P> <P>Assign a value of 5 if, within the in-water segment of the hazardous substance migration path for the watershed, the surface water is not used for drinking water, but either of the following applies:</P> <P>• Any portion of the surface water is designated by a State for drinking water use under section 305(a) of the Clean Water Act, as amended.</P> <P>• Any portion of the surface water is usable for drinking water purposes.</P> <P>Assign a value of 0 if none of the above applies.</P> <P> 4.1.2.3.4  <E T="03">Calculation of drinking water threat-targets factor category value.</E> Sum the nearest intake, population, and resources factor values for the watershed. Do not round this sum to the nearest integer. Assign this sum as the drinking water threat-targets factor category value for the watershed. Enter this value in table 4-1. </P> <P> 4.1.2.4  <E T="03">Calculation of the drinking water threat score for a watershed.</E> Multiply the drinking water threat factor category values for likelihood of release, waste char- </P> <FP>acteristics, and targets for the watershed, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum of 100, as the drinking water threat score for the watershed. Enter this value in table 4-1.</FP> <P> 4.1.3  <E T="03">Human food chain threat.</E> Evaluate the human food chain threat for each watershed based on three factor categories: likelihood of release, waste characteristics, and targets. </P> <P> 4.1.3.1  <E T="03">Human food chain threat-likelihood of release.</E> Assign the same likelihood of release factor category value for the human food chain threat for the watershed as would be assigned in section 4.1.2.1.3 for the drinking water threat. Enter this value in table 4-1. </P> <P> 4.1.3.2  <E T="03">Human food chain threat-waste characteristics.</E> Evaluate the waste characteristics factor category for each watershed based on two factors: toxicity/persistence/bioaccumulation and hazardous waste quantity. </P> <P> 4.1.3.2.1  <E T="03">Toxicity/persistence/bioaccumulation.</E> Evaluate all those hazardous substances eligible to be evaluated for toxicity/persistence in the drinking water threat for the watershed (see section 4.1.2.2). </P> <P> 4.1.3.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in section 2.4.1.1. </P> <P> 4.1.3.2.1.2  <E T="03">Persistence.</E> Assign a persistence factor value to each hazardous substance as specified for the drinking water threat (see section 4.1.2.2.1.2), except: use the predominant water category (that is, lakes; or rivers, oceans, coastal tidal waters, or Great Lakes) between the probable point of entry and the nearest fishery (not the nearest drinking water or resources intake) along the hazardous substance migration path for the watershed to determine which portion of table 4-10 to use. Determine the predominant water category based on distance as specified in section 4.1.2.2.1.2. For contaminated sediments with no identified source, use the point where measurement begins rather than the probable point of entry. </P> <P> 4.1.3.2.1.3  <E T="03">Bioaccumulation potential.</E> Use the following data hierarchy to assign a bioaccumulation potential factor value to each hazardous substance: </P> <P>• Bioconcentration factor (BCF) data.</P> <P> • Logarithm of the n-octanol-water partition coefficient (log K <E T="52">ow</E> ) data. </P> <P> • Water solubility data. <PRTPAGE P="164"/> </P> <FP>Assign a bioaccumulation potential factor value to each hazardous substance from table 4-15.</FP> <P>If BCF data are available for any aquatic human food chain organism for the substance being evaluated, assign the bioaccumulation potential factor value to the hazardous substance as follows:</P> <P>• If BCF data are available for both fresh water and salt water for the hazardous substance, use the BCF data that correspond to the type of water body (that is, fresh water or salt water) in which the fisheries are located to assign the bioaccumulation potential factor value to the hazardous substance.</P> <P>• If, however, some of the fisheries being evaluated are in fresh water and some are in salt water, or if any are in brackish water, use the BCF data that yield the higher factor value to assign the bioaccumulation potential factor value to the hazardous substance.</P> <P>• If BCF data are available for either fresh water or salt water, but not for both, use the available BCF data to assign the bioaccumulation potential factor value to the hazardous substance.</P> <P> If BCF data are not available for the hazardous substance, use log K <E T="52">ow</E> data to assign a bioaccumulation potential factor value to organic substances, but not to inorganic substances. If BCF data are not available, and if either log K <E T="52">ow</E> data are not available, the log K <E T="52">ow</E> is available but exceeds 6.0, or the substance is an inorganic substance, use water solubility data to assign a bioaccumulation potential factor value. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s80,8"> <TTITLE> Table 4-15—Bioaccumulation Potential Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <TDESC> If bioconcentration factor (BCF) data are available for any aquatic human food chain organism, assign a value as follows:  <SU>b</SU> </TDESC> <BOXHD> <CHED H="1">BCF</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Greater than or equal to 10,000</ENT> <ENT>50,000</ENT> </ROW> <ROW> <ENT I="01">1,000 to less than 10,000</ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">100 to less than 1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10 to less than 100</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">1 to less than 10</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">Less than 1</ENT> <ENT>0.5</ENT> </ROW> </GPOTABLE> <FP> If BCF data are not available, and log K <E T="52">ow</E> data are available and do not exceed 6.0, assign a value to an organic hazardous substance as follows (for inorganic hazardous substances, skip this step and proceed to the next): </FP> <GPOTABLE COLS="2" OPTS="L2" CDEF="s80,8"> <BOXHD> <CHED H="1"> Log K <E T="52">ow</E> </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">5.5 to 6.0</ENT> <ENT>50,000</ENT> </ROW> <ROW> <ENT I="01">4.5 to less than 5.5</ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">3.2 to less than 4.5</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2.0 to less than 3.2</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">0.8 to less than 2.0</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">Less than 0.8</ENT> <ENT>0.5</ENT> </ROW> </GPOTABLE> <FP> If BCF data are not available, and if either Log K <E T="52">ow</E> data are not available, a log K <E T="52">ow</E> is available but exceeds 6.0, or the substance is an inorganic substance, assign a value as follows: </FP> <GPOTABLE COLS="2" OPTS="L2" CDEF="s80,8"> <TTITLE> Table 4-15—Bioaccumulation Potential Factor Values  <E T="01"> <SU>a</SU> </E> —Concluded </TTITLE> <BOXHD> <CHED H="1">Water solubility (mg/l)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 25</ENT> <ENT>50,000</ENT> </ROW> <ROW> <ENT I="01">25 to 500</ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">Greater than 500 to 1,500</ENT> <ENT>500</ENT> </ROW> <ROW RUL="s"> <ENT I="01">Greater than 1,500</ENT> <ENT>0.5</ENT> </ROW> <ROW EXPSTB="01"> <ENT I="22"> <E T="02">If none of these data are available, assign a value of 0.5.</E> </ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  See text for use of freshwater and saltwater BCF data. </TNOTE> <TNOTE> </TNOTE> </GPOTABLE> <FP> Do not distinguish between fresh water and salt water in assigning the bioaccumulation potential factor value based on log K <E T="52">ow</E> or water solubility data. </FP> <P>If none of these data are available, assign the hazardous substance a bioaccumulation potential factor value of 0.5.</P> <P> 4.1.3.2.1.4  <E T="03">Calculation of toxicity/persistence/bioaccumulation factor value.</E> Assign each hazardous substance a toxicity/persistence factor value from table 4-12, based on the values assigned to the hazardous substance for the toxicity and persistence factors. Then assign each hazardous substance a toxicity/persistence/bioaccumulation factor value from table 4-16, based on the values assigned for the toxicity/persistence and bioaccumulation potential factors. Use the hazardous substance with the highest toxicity/persistence/bioaccumulation factor value for the watershed to assign the value to this factor. Enter this value in table 4-1. </P> <GPOTABLE COLS="7" OPTS="L2" CDEF="s10,8,8,8,8,8,8"> <TTITLE> Table 4-16—Toxicity/Persistence/Bioaccumulation Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Toxicity persistence factor value</CHED> <CHED H="1">Bioaccumulation potential factor value</CHED> <CHED H="2">50,000</CHED> <CHED H="2">5,000</CHED> <CHED H="2">500</CHED> <CHED H="2">50</CHED> <CHED H="2">5</CHED> <CHED H="2">0.5</CHED> </BOXHD> <ROW EXPSTB="00"> <ENT I="01">10,000</ENT> <ENT> 5 × 10 <SU>8</SU> </ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">4,000</ENT> <ENT> 2 × 10 <SU>8</SU> </ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> </ROW> <ROW> <ENT I="01">1,000</ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">700</ENT> <ENT> 3.5 × 10 <SU>7</SU> </ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> </ROW> <ROW> <ENT I="01">400</ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> </ROW> <ROW> <PRTPAGE P="165"/> <ENT I="01">70</ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> </ROW> <ROW> <ENT I="01">40</ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">7</ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">1</ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> </ROW> <ROW> <ENT I="01">0.7</ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> </ROW> <ROW> <ENT I="01">0.4</ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01">0.07</ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> </ROW> <ROW> <ENT I="01">0.007</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> </ROW> <ROW> <ENT I="01">0.0007</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT>0.00035</ENT> </ROW> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.1.3.2.2  <E T="03">Hazardous waste quantity.</E> Assign the same factor value for hazardous waste quantity for the watershed as would be assigned in section 4.1.2.2.2 for the drinking water threat. Enter this value in table 4-1. </P> <P> 4.1.3.2.3  <E T="03">Calculation of human food chain threat-waste characteristics factor category value.</E> For the hazardous substance selected for the watershed in section 4.1.3.2.1.4, use its toxicity/persistence factor value and bioaccumulation potential factor value as follows to assign a value to the waste characteristics factor category. First, multiply the toxicity/persistence factor value and the hazardous waste quantity factor value for the watershed, subject to a maximum product of 1 × 10 <SU>8</SU> . Then multiply this product by the bioaccumulation potential factor value for this hazardous substance, subject to a maximum product of 1 × 10 <SU>12</SU> . Based on this second product, assign a value from Table ­2-7 (section 2.4.3.1) to the human food chain threat-waste characteristics factor category for the watershed. Enter this value in table 4-1. </P> <P> 4.1.3.3  <E T="03">Human food chain threat-targets.</E> Evaluate two target factors for each watershed: food chain individual and population. For both factors, determine whether the target fisheries are subject to actual or potential human food chain contamination. </P> <P>Consider a fishery (or portion of a fishery) within the target distance limit of the watershed to be subject to actual human food chain contamination if any of the following apply:</P> <P>• A hazardous substance having a bioaccumulation potential factor value of 500 or greater is present either in an observed release by direct observation to the watershed or in a surface water or sediment sample from the watershed at a level that meets the criteria for an observed release to the watershed from the site, and at least a portion of the fishery is within the boundaries of the observed release (that is, it is located either at the point of direct observation or at or between the probable point of entry and the most distant sampling point establishing the observed release).</P> <P>• The fishery is closed, and a hazardous substance for which the fishery has been closed has been documented in an observed release to the watershed from the site, and at least a portion of the fishery is within the boundaries of the observed release.</P> <P>• A hazardous substance is present in a tissue sample from an essentially sessile, benthic, human food chain organism from the watershed at a level that meets the criteria for an observed release to the watershed from the site, and at least a portion of the fishery is within the boundaries of the observed release.</P> <P>For a fishery that meets any of these three criteria, but that is not wholly within the boundaries of the observed release, consider only the portion of the fishery that is within the boundaries of the observed release to be subject to actual human food chain contamination. Consider the remainder of the fishery within the target distance limit to be subject to potential food chain contamination.</P> <P>In addition, consider all other fisheries that are partially or wholly within the target distance limit for the watershed, including fisheries partially or wholly within the boundaries of an observed release for the watershed that do not meet any of the three criteria listed above, to be subject to potential human food chain contamination. If only a portion of the fishery is within the target distance limit for the watershed, include only that portion in evaluating the targets factor category.</P> <P> When a fishery (or portion of a fishery) is subject to actual food chain contamination, determine the part of the fishery subject to Level I concentrations and the part subject to Level II concentrations. If the actual food chain contamination is based on direct observation, evaluate it using Level II concentrations. However, if the actual food chain contamination is based on samples <PRTPAGE P="166"/> from the watershed, use these samples and, if available, additional tissue samples from aquatic human food chain organisms as specified below, to determine the part subject to Level I concentrations and the part subject to Level II concentrations: </P> <P>• Determine the level of actual contamination from samples (including tissue samples from essentially sessile, benthic organisms) that meet the criteria for actual food chain contamination by comparing the exposure concentrations (see section 4.1.2.3) from these samples (or comparable samples) to the health-based benchmarks from table 4-17, as described in section 2.5.1 and 2.5.2. Use only the exposure concentrations for those hazardous substances in the sample (or comparable samples) that meet the criteria for actual contamination of the fishery.</P> <P>• In addition, determine the level of actual contamination from other tissue samples by comparing the concentrations of hazardous substances in the tissue samples (or comparable tissue samples) to the health-based benchmarks from table 4-17, as described in sections 2.5.1 and 2.5.2. Use only those additional tissue samples and only those hazardous substances in the tissue samples that meet all the following criteria:</P> <P SOURCE="P-1">-The tissue sample is from a location that is within the boundaries of the actual food chain contamination for the site (that is, either at the point of direct observation or at or between the probable point of entry and the most distant sample point meeting the criteria for actual food chain contamination).</P> <P SOURCE="P-1">-The tissue sample is from a species of aquatic human food chain organism that spends extended periods of time within the boundaries of the actual food chain contamination for the site and that is not an essentially sessile, benthic organism.</P> <P SOURCE="P-1">-The hazardous substance is a substance that is also present in a surface water, benthic, or sediment sample from within the target distance limit for the watershed and, for such a sample, meets the criteria for actual food chain contamination.</P> <HD SOURCE="HD1">Table 4-17—Health-Based Benchmarks for Hazardous Substances in Human Food Chain</HD> <P>• Concentration corresponding to Food and Drug Administration Action Level (FDAAL) for fish or shellfish.</P> <P> • Screening concentration for cancer corresponding to that concentration that corresponds to the 10 <E T="51">−6</E> individual cancer risk for oral exposures. </P> <P>• Screening concentration for noncancer toxicological responses corresponding to the Reference Dose (RfD) for oral exposures.</P> <P> 4.1.3.3.1  <E T="03">Food chain individual.</E> Evaluate the food chain individual factor based on the fisheries (or portions of fisheries) within the target distance limit for the watershed. Assign this factor a value as follows: </P> <P>• If any fishery (or portion of a fishery) is subject to Level I concentrations, assign a value of 50.</P> <P>• If not, but if any fishery (or portion of a fishery) is subject to Level II concentrations, assign a value of 45.</P> <P>• If not, but if there is an observed release of a hazardous substance having a bioaccumulation potential factor value of 500 or greater to surface water in the watershed and there is a fishery (or portion of a fishery) present anywhere within the target distance limit, assign a value of 20.</P> <P>• If there is no observed release to surface water in the watershed or there is no observed release of a hazardous substance having a bioaccumulation potential factor value of 500 or greater, but there is a fishery (or portion of a fishery) present anywhere within the target distance limit, assign a value as follows:</P> <P SOURCE="P-1">-Using table 4-13, determine the highest dilution weight (that is, lowest amount of dilution) applicable to the fisheries (or portions of fisheries) within the target distance limit. Multiply this dilution weight by 20 and round to the nearest integer.</P> <P SOURCE="P-1">-Assign this calculated value as the factor value.</P> <P>• If there are no fisheries (or portions of fisheries) within the target distance limit of the watershed, assign a value of 0.</P> <P>Enter the value assigned in table 4-1.</P> <P> 4.1.3.3.2  <E T="03">Population.</E> Evaluate the population factor for the watershed based on three factors: Level I concentrations, Level II concentrations, and potential human food chain contamination. Determine which factor applies for a fishery (or portion of a fishery) as specified in section 4.1.3.3. </P> <P> 4.1.3.3.2.1  <E T="03">Level I concentrations.</E> Determine those fisheries (or portions of fisheries) within the watershed that are subject to Level I concentrations. </P> <P>Estimate the human food chain population value for each fishery (or portion of a fishery) as follows:</P> <P>• Estimate human food chain production for the fishery based on the estimated annual production (in pounds) of human food chain organisms (for example, fish, shellfish) for that fishery, except: if the fishery is closed and a hazardous substance for which the fishery has been closed has been documented in an observed release to the fishery from a source at the site, use the estimated annual production for the period prior to closure of the fishery or use the estimated annual production from comparable fisheries that are not closed.</P> <P> • Assign the fishery a value for human food chain population from table 4-18, based on the estimated human food production for the fishery. <PRTPAGE P="167"/> </P> <P>• Set boundaries between fisheries at those points where human food chain production changes or where the surface water dilution weight changes.</P> <P>Sum the human food chain population value for each fishery (and portion of a fishery). Multiply this sum by 10. If the product is less than 1, do not round it to the nearest integer; if 1 or more, round to the nearest integer. Assign the resulting value as the Level I concentrations factor value. Enter this value in table 4-1.</P> <P> 4.1.3.3.2.2  <E T="03">Level II concentrations.</E> Determine those fisheries (or portions of fisheries) within the watershed that are subject to Level II concentrations. Do not include any fisheries (or portions of fisheries) already counted under the Level I concentrations factor. </P> <P>Assign each fishery (or portion of a fishery) a value for human food chain population from table 4-18, based on the estimated human food production for the fishery. Estimate the human food chain production for the fishery as specified in section 4.1.3.3.2.1.</P> <P>Sum the human food chain population value for each fishery (and portion of a fishery). If this sum is less than 1, do not round it to the nearest integer; if 1 or more, round to the nearest integer. Assign the resulting value as the Level II concentrations factor value. Enter this value in table 4-1.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s90,10"> <TTITLE> Table 4-18—Human Food Chain Population Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Human food chain production (pounds per year)</CHED> <CHED H="1">Assigned human food chain population value</CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Greater than 0 to 100</ENT> <ENT>0.03</ENT> </ROW> <ROW> <ENT I="01">Greater than 100 to 1,000</ENT> <ENT>0.3</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000 to 10,000</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Greater than 10,000 to 100,000</ENT> <ENT>31</ENT> </ROW> <ROW> <ENT I="01">Greater than 100,000 to 1,000,000</ENT> <ENT>310</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <SU>6</SU> to 10 <SU>7</SU> </ENT> <ENT>3,100</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <SU>7</SU> to 10 <SU>8</SU> </ENT> <ENT>31,000</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <SU>8</SU> to 10 <SU>9</SU> </ENT> <ENT>310,000</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <SU>9</SU> </ENT> <ENT>3,100,000</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.1.3.3.2.3  <E T="03">Potential human food chain contamination.</E> Determine those fisheries (or portions of fisheries) within the watershed that are subject to potential human food chain contamination. Do not include those fisheries (or portion of fisheries) already counted under the Level I or Level II concentrations factors. </P> <P>Calculate the value for the potential human food chain contamination factor (PF) for the watershed as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.151</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2"> P <E T="52">i</E> = Human food chain population value for fishery i. </FP> <FP SOURCE="FP-2"> D <E T="52">i</E> = Dilution weight from table 4-13 for fishery i. </FP> <FP SOURCE="FP-2">n = Number of fisheries subject to potential human food chain contamination.</FP> <P>In calculating PF:</P> <P> • Estimate the human food chain population value (P <E T="52">i</E> ) for a fishery (or portion of a fishery) as specified in section 4.1.3.3.2.1. </P> <P>• Assign the fishery (or portion of a fishery) a dilution weight as indicated in table 4-13 (section 4.1.2.3.1), except: do not assign a dilution weight of 0.5 for a “3-mile mixing zone in quiet flowing river”; instead assign a dilution weight based on the average annual flow.</P> <P>If PF is less than 1, do not round it to the nearest integer; if PF is 1 or more, round to the nearest integer. Enter the value assigned in table 4-1.</P> <P> 4.1.3.3.2.4  <E T="03">Calculation of population factor value.</E> Sum the values for the Level I concentrations, Level II concentrations, and potential human food chain contamination factors for the watershed. Do not round this sum to the nearest integer. Assign it as the population factor value for the watershed. Enter this value in table 4-1. </P> <P> 4.1.3.3.3  <E T="03">Calculation of human food chain threat-targets factor category value.</E> Sum the food chain individual and population factor values for the watershed. Do not round this sum to the nearest integer. Assign it as the human food chain threat-targets factor category value for the watershed. Enter this value in table 4-1. </P> <P> 4.1.3.4  <E T="03">Calculation of human food chain threat score for a watershed.</E> Multiply the human food chain threat factor category values for likelihood of release, waste characteristics, and targets for the watershed, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum of 100, as the human food chain threat score for the watershed. Enter this score in table 4-1. </P> <P> 4.1.4  <E T="03">Environmental threat.</E> Evaluate the environmental threat for the watershed based on three factor categories: likelihood of release, waste characteristics, and targets. </P> <P> 4.1.4.1  <E T="03">Environmental threat-likelihood of release.</E> Assign the same likelihood of release factor category value for the environmental threat for the watershed as would be assigned in section 4.1.2.1.3 for the drinking water threat. Enter this value in table 4-1. </P> <P> 4.1.4.2  <E T="03">Environmental threat-waste characteristics.</E> Evaluate the waste characteristics factor category for each watershed based on two factors: ecosystem toxicity/persistence/bioaccumulation and hazardous waste quantity. </P> <P> 4.1.4.2.1  <E T="03">Ecosystem toxicity/persistence/bioaccumulation.</E> Evaluate all those hazardous <PRTPAGE P="168"/> substances eligible to be evaluated for toxicity/persistence in the drinking water threat for the watershed (see section 4.1.2.2). </P> <P> 4.1.4.2.1.1  <E T="03">Ecosystem toxicity.</E> Assign an ecosystem toxicity factor value from Table 4-19 to each hazardous substance on the basis of the following data hierarchy: </P> <P>• EPA chronic Ambient Water Quality Criterion (AWQC) for the substance.</P> <P>• EPA chronic Ambient Aquatic Life Advisory Concentrations (AALAC) for the substance.</P> <P>• EPA acute AWQC for the substance.</P> <P>• EPA acute AALAC for the substance.</P> <P> • Lowest LC <E T="52">50</E> value for the substance. </P> <P>In assigning the ecosystem toxicity factor value to the hazardous substance:</P> <P>• If either an EPA chronic AWQC or AALAC is available for the hazardous substance, use it to assign the ecosystem toxicity factor value. Use the chronic AWQC in preference to the chronic AALAC when both are available.</P> <P>• If neither is available, use the EPA acute AWQC or AALAC to assign the ecosystem toxicity factor value. Use the acute AWQC in preference to the acute AALAC.</P> <P> • If none of the chronic and acute AWQCs and AALACs is available, use the lowest LC <E T="52">50</E> value to assign the ecosystem toxicity factor value. </P> <P> • If an LC <E T="52">50</E> value is also not available, assign an ecosystem toxicity factor value of 0 to the hazardous substance and use other hazardous substances for which data are available in evaluating the pathway. </P> <P>If an ecosystem toxicity factor value of 0 is assigned to all hazardous substances eligible to be evaluated for the watershed (that is, insufficient data are available for evaluating all the substances), use a default value of 100 as the ecosystem toxicity factor value for all these hazardous substances.</P> <P> With regard to the AWQC, AALAC, or LC <E T="52">50</E> selected for assigning the ecosystem toxicity factor value to the hazardous substance: </P> <P> • If values for the selected AWQC, AALAC, or LC <E T="52">50</E> are available for both fresh water and marine water for the hazardous substance, use the value that corresponds to the type of water body (that is, fresh water or salt water) in which the sensitive environments are located to assign the ecosystem toxicity factor value to the hazardous substance. </P> <P>• If, however, some of the sensitive environments being evaluated are in fresh water and some are in salt water, or if any are in brackish water, use the value (fresh water or marine) that yields the higher factor value to assign the ecosystem toxicity factor value to the hazardous substance.</P> <P> • If a value for the selected AWQC, AALAC, or LC <E T="52">50</E> is available for either fresh water or marine water, but not for both, use the available one to assign an ecosystem toxicity factor value to the hazardous substance. </P> <GPOTABLE COLS="2" OPTS="L2(,,0)" CDEF="s80,8"> <TTITLE>Table 4-19—Ecosystem Toxicity Factor Values</TTITLE> <TDESC> If an EPA chronic AWQC  <SU>a</SU> or AALAC  <SU>b</SU> is available, assign a value as follows:  <SU>c</SU> </TDESC> <BOXHD> <CHED H="1">EPA chronic AWQC or AALAC</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 1 µg/l</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">1 to 10 µg/l</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">Greater than 10 to 100 µg/l</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Greater than 100 to 1,000 µg/l</ENT> <ENT>10</ENT> </ROW> <ROW RUL="s"> <ENT I="01">Greater than 1,000 µg/l</ENT> <ENT>1</ENT> </ROW> <ROW EXPSTB="01"> <ENT I="11"> <E T="02">If neither an EPA chronic AWQC nor EPA chronic AALAC is available, assign a value based on the EPA acute AWQC or AALAC as follows:</E>   <SU>c</SU> </ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2(,,0)" CDEF="s80,8"> <BOXHD> <CHED H="1">EPA acute AWQC or AALAC</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 100 µg/l</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">100 to 1,000 µg/l</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000 to 10,000 µg/l</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Greater than 10,000 to 100,000 µg/l</ENT> <ENT>10</ENT> </ROW> <ROW RUL="s"> <ENT I="01">Greater than 100,000 µg/l</ENT> <ENT>1</ENT> </ROW> <ROW EXPSTB="01"> <ENT I="11"> <E T="02">If neither an EPA chronic or acute AWQC nor EPA chronic or acute AALAC is available, assign a value from the LC</E> <E T="52">50</E> <E T="02">as follows:</E> </ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s80,8"> <BOXHD> <CHED H="1"> LC <E T="52">50</E> </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 100 µg/l</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">100 to 1,000 µg/l</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000 to 10,000 µg/l</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Greater than 10,000 to 100,000 µg/l</ENT> <ENT>10</ENT> </ROW> <ROW RUL="s"> <ENT I="01">Greater than 100,000 µg/l</ENT> <ENT>1</ENT> </ROW> <ROW EXPSTB="01"> <ENT I="11"> <E T="02">If none of the AWQCs and AALACs nor the LC</E> <E T="52">50</E> <E T="02">is available, assign a value of 0.</E> </ENT> </ROW> <TNOTE> <SU>a</SU>  AWQC—Ambient Water Quality Criteria. </TNOTE> <TNOTE> <SU>b</SU>  AALAC—Ambient Aquatic Life Advisory Concentrations. </TNOTE> <TNOTE> <SU>c</SU>  Use the AWQC value in preference to the AALAC when both are available. See text for use of fresh water and marine values. </TNOTE> </GPOTABLE> <P> 4.1.4.2.1.2  <E T="03">Persistence.</E> Assign a persistence factor value to each hazardous substance as specified in section 4.1.2.2.1.2, except: use the predominant water category (that is lakes; or rivers, oceans, coastal tidal waters, or Great Lakes) between the probable point of entry and the nearest sensitive environment (not the nearest drinking water or resources intake) along the hazardous substance migration path for the watershed to determine which portion of table 4-10 to use. Determine the predominant water category based on distance as specified in section 4.1.2.2.1.2. For contaminated sediments with no identified source, use the point where measurement begins rather than the probable point of entry. </P> <P> 4.1.4.2.1.3  <E T="03">Ecosystem bioaccumulation potential.</E> Assign an ecosystem bioaccumulation potential factor value to each hazardous substance in the same manner specified for the bioaccumulation potential factor in section 4.1.3.2.1.3, except: </P> <P> • Use BCF data for all aquatic organisms, not just for aquatic human food chain organisms. <PRTPAGE P="169"/> </P> <P>• Use the BCF data that corresponds to the type of water body (that is, fresh water or salt water) in which the sensitive environments (not fisheries) are located.</P> <P> 4.1.4.2.1.4  <E T="03">Calculation of ecosystem toxicity/persistence/bioaccumulation factor value.</E> Assign each hazardous substance an ecosystem toxicity/persistence factor value from table 4-20, based on the values assigned to the hazardous substance for the ecosystem toxicity and persistence factors. Then assign each hazardous substance an ecosystem toxicity/persistence/bioaccumulation factor value from table ­4-21, based on the values assigned for the ecosystem toxicity/persistence and ecosystem bioaccumulation potential factors. Select the hazardous substance with the highest ecosystem toxicity/persistence/bioaccumulation factor value for the watershed and use it to assign the value to this factor. Enter this value in table 4-1. </P> <GPOTABLE COLS="7" OPTS="L2" CDEF="s50,8,8,7,7,7,2"> <TTITLE> Table 4-20—Ecosystem Toxicity/Persistence Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Persistence factor value</CHED> <CHED H="1">Ecosystem toxicity factor value</CHED> <CHED H="2">10,000</CHED> <CHED H="2">1,000</CHED> <CHED H="2">100</CHED> <CHED H="2">10</CHED> <CHED H="2">1</CHED> <CHED H="2">0</CHED> </BOXHD> <ROW> <ENT I="01">1.0</ENT> <ENT>10,000</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.4</ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.07</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.0007</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT>0.0007</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <GPOTABLE COLS="7" OPTS="L2" CDEF="s10,8,8,8,8,8,8"> <TTITLE> Table 4-21—Ecosystem Toxicity/Persistence/Bioaccumulation Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Ecosystem toxicity persistence factor value</CHED> <CHED H="1">Ecosystem bioaccumulation potential factor value</CHED> <CHED H="2">50,000</CHED> <CHED H="2">5,000</CHED> <CHED H="2">500</CHED> <CHED H="2">50</CHED> <CHED H="2">5</CHED> <CHED H="2">0.5</CHED> </BOXHD> <ROW> <ENT I="01">10,000</ENT> <ENT> 5 × 10 <SU>8</SU> </ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">4,000</ENT> <ENT> 2 × 10 <SU>8</SU> </ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> </ROW> <ROW> <ENT I="01">1,000</ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">700</ENT> <ENT> 3.5 × 10 <SU>7</SU> </ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> </ROW> <ROW> <ENT I="01">400</ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">70</ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> </ROW> <ROW> <ENT I="01">40</ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">7</ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">1</ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> </ROW> <ROW> <ENT I="01">0.7</ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> </ROW> <ROW> <ENT I="01">0.4</ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01">0.07</ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> </ROW> <ROW> <ENT I="01">0.007</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> </ROW> <ROW> <ENT I="01">0.0007</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT>0.00035</ENT> </ROW> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.1.4.2.2  <E T="03">Hazardous waste quantity.</E> Assign the same factor value for hazardous waste quantity for the watershed as would be assigned in section 4.1.2.2.2 for the drinking water threat. Enter this value in table 4-1. </P> <P> 4.1.4.2.3  <E T="03">Calculation of environmental threat-waste characteristics factor category value.</E> For the hazardous substance selected for the watershed in section 4.1.4.2.1.4, use its ecosystem toxicity/persistence factor value and ecosystem bioaccumulation potential factor value as follows to assign a value to the waste characteristics factor category. First, multiply the ecosystem toxicity/persistence factor value and the hazardous waste quantity factor value for the watershed, subject to a maximum product of 1 × 10 <SU>8</SU> . Then multiply this product by the ecosystem bioaccumulation potential factor value for this hazardous substance, subject to a maximum product of 1 × 10 <SU>12</SU> . Based on this second product, assign a value from Table ­2-7 (section 2.4.3.1) to the environmental threat-waste characteristics factor category for the watershed. Enter this value in table 4-1. </P> <HD SOURCE="HD1">Table 4-22—Ecological-Based Benchmarks for Hazardous Substances in Surface Water</HD> <P>• Concentration corresponding to EPA Ambient Water Quality Criteria (AWQC) for protection of aquatic life (fresh water or marine).</P> <P> • Concentration corresponding to EPA Ambient Aquatic Life Advisory Concentrations (AALAC). <PRTPAGE P="170"/> </P> <P>• Select the appropriate AWQC and AALAC as follows:</P> <P SOURCE="P-1">-Use chronic value, if available; otherwise use acute value.</P> <P SOURCE="P-1">-If the sensitive environment being evaluated is in fresh water, use fresh water value, except: if no fresh water value is available, use marine value if available.</P> <P SOURCE="P-1">-If the sensitive environment being evaluated is in salt water, use marine value, except: if no marine value is available, use fresh water value if available.</P> <P SOURCE="P-1">-If the sensitive environment being evaluated is in both fresh water and salt water, or is in brackish water, use lower of fresh water or marine values.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,8"> <TTITLE>Table 4-23—Sensitive Environments Rating Values</TTITLE> <BOXHD> <CHED H="1">Sensitive environment</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> Critical habitat  <SU>a</SU> for Federal designated endangered or threatened species </ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="11">Marine Sanctuary</ENT> </ROW> <ROW> <ENT I="11">National Park</ENT> </ROW> <ROW> <ENT I="11">Designated Federal Wilderness Area</ENT> </ROW> <ROW> <ENT I="11"> Areas identified under Coastal Zone Management Act  <SU>b</SU> </ENT> </ROW> <ROW> <ENT I="11"> Sensitive areas identified under National Estuary Program  <SU>c</SU> or Near Coastal Waters Program  <SU>d</SU> </ENT> </ROW> <ROW> <ENT I="11"> Critical areas identified under the Clean Lakes Program  <SU>e</SU> </ENT> </ROW> <ROW> <ENT I="11"> National Monument  <SU>f</SU> </ENT> </ROW> <ROW> <ENT I="11">National Seashore Recreational Area</ENT> </ROW> <ROW RUL="s,s"> <ENT I="11">National Lakeshore Recreational Area</ENT> </ROW> <ROW> <ENT I="01">Habitat known to be used by Federal designated or proposed endangered or threatened species</ENT> <ENT>75</ENT> </ROW> <ROW> <ENT I="11">National Preserve</ENT> </ROW> <ROW> <ENT I="11">National or State Wildlife Refuge</ENT> </ROW> <ROW> <ENT I="11">Unit of Coastal Barrier Resources System</ENT> </ROW> <ROW> <ENT I="11">Coastal Barrier (undeveloped)</ENT> </ROW> <ROW> <ENT I="11">Federal land designated for protection of natural ecosystems</ENT> </ROW> <ROW> <ENT I="11">Administratively Proposed Federal Wilderness Area</ENT> </ROW> <ROW> <ENT I="11"> Spawning areas critical  <SU>g</SU> for the maintenance of fish/shellfish species within river, lake, or coastal tidal waters </ENT> </ROW> <ROW> <ENT I="11">Migratory pathways and feeding areas critical for maintenance of anadromous fish species within river reaches or areas in lakes or coastal tidal waters in which the fish spend extended periods of time</ENT> </ROW> <ROW> <ENT I="11"> Terrestrial areas utilized for breeding by large or dense aggregations of animals  <SU>h</SU> </ENT> </ROW> <ROW RUL="s,s"> <ENT I="11">National river reach designated as Recreational</ENT> </ROW> <ROW> <ENT I="01">Habitat known to be used by State designated endangered or threatened species</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="11">Habitat known to be used by species under review as to its Federal endangered or threatened status</ENT> </ROW> <ROW> <ENT I="11">Coastal Barrier (partially developed)</ENT> </ROW> <ROW RUL="s,s"> <ENT I="11">Federal designated Scenic or Wild River</ENT> </ROW> <ROW> <ENT I="01">State land designated for wildlife or game management</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="11">State designated Scenic or Wild River</ENT> </ROW> <ROW> <ENT I="11">State designated Natural Areas</ENT> </ROW> <ROW RUL="s,s"> <ENT I="11">Particular areas, relatively small in size, important to maintenance of unique biotic communities</ENT> </ROW> <ROW> <ENT I="01"> State designated areas for protection or maintenance of aquatic life  <SU>i</SU> </ENT> <ENT>5</ENT> </ROW> <TNOTE> <SU>a</SU>  Critical habitat as defined in 50 CFR 424.02. </TNOTE> <TNOTE> <SU>b</SU>  Areas identified in State Coastal Zone Management plans as requiring protection because of ecological value. </TNOTE> <TNOTE> <SU>c</SU>  National Estuary Program study areas (subareas within estuaries) identified in Comprehensive Conservation and Management Plans as requiring protection because they support critical life stages of key estuarine species (Section 320 of Clean Water Act, as amended). </TNOTE> <TNOTE> <SU>d</SU>  Near Coastal Waters as defined in Sections 104(b)(3), 304(1), 319, and 320 of Clean Water Act, as amended. </TNOTE> <TNOTE> <SU>e</SU>  Clean Lakes Program critical areas (subareas within lakes, or in some cases entire small lakes) identified by State Clean Lake Plans as critical habitat (Section 314 of Clean Water Act, as amended). </TNOTE> <TNOTE> <SU>f</SU>  Use only for air migration pathway. </TNOTE> <TNOTE> <SU>g</SU>  Limit to areas described as being used for intense or concentrated spawning by a given species. </TNOTE> <TNOTE> <SU>h</SU>  For the air migration pathway, limit to terrestrial vertebrate species. For the surface water migration pathway, limit to terrestrial vertebrate species with aquatic or semiaquatic foraging habits. </TNOTE> <TNOTE> <SU>i</SU>  Areas designated under Section 305(a) of Clean Water Act, as amended. </TNOTE> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,8"> <TTITLE>Table 4-24—Wetlands Rating Values for Surface Water Migration Pathway</TTITLE> <BOXHD> <CHED H="1"> Total length of wetlands  <SU>a</SU> (miles) </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 0.1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.1 to 1</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 2</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">Greater than 2 to 3</ENT> <ENT>75</ENT> </ROW> <ROW> <ENT I="01">Greater than 3 to 4</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Greater than 4 to 8</ENT> <ENT>150</ENT> </ROW> <ROW> <ENT I="01">Greater than 8 to 12</ENT> <ENT>250</ENT> </ROW> <ROW> <ENT I="01">Greater than 12 to 16</ENT> <ENT>350</ENT> </ROW> <ROW> <ENT I="01">Greater than 16 to 20</ENT> <ENT>450</ENT> </ROW> <ROW> <ENT I="01">Greater than 20</ENT> <ENT>500</ENT> </ROW> <TNOTE> <SU>a</SU>  Wetlands as defined in 40 CFR section 230.3. </TNOTE> </GPOTABLE> <PRTPAGE P="171"/> <P> 4.1.4.3  <E T="03">Environmental threat-targets.</E> Evaluate the environmental threat-targets factor category for a watershed using one factor: sensitive environments. </P> <P> 4.1.4.3.1  <E T="03">Sensitive environments.</E> Evaluate sensitive environments along the hazardous substance migration path for the watershed based on three factors: Level I concentrations, Level II concentrations, and potential contamination. </P> <P>Determine which factor applies to each sensitive environment as specified in section 4.1.2.3, except: use ecological-based benchmarks (Table 4-22) rather than health-based benchmarks (Table 3-10) in determining the level of contamination from samples. In determining the level of actual contamination, use a point of direct observation anywhere within the sensitive environment or samples (that is, surface water, benthic, or sediment samples) taken anywhere within or beyond the sensitive environment (or anywhere adjacent to or beyond the sensitive environment if it is contiguous to the migration path).</P> <P> 4.1.4.3.1.1  <E T="03">Level I concentrations.</E> Assign value(s) from table 4-23 to each sensitive environment subject to Level I concentrations. </P> <P>For those sensitive environments that are wetlands, assign an additional value from table 4-24. In assigning a value from table 4-24, include only those portions of wetlands located along the hazardous substance migration path in the area of Level I concentrations. If a wetland is located partially along the area of Level I concentrations and partially along the area of Level II concentrations and/or potential contamination, then solely for purposes of table 4-24, count the portion(s) along the areas of Level II concentrations or potential contamination under the Level II concentrations factor (section 4.1.4.3.1.2) or potential contamination factor (section 4.1.4.3.1.3), as appropriate.</P> <P>Estimate the total length of wetlands along the hazardous substance migration path (that is, wetland frontage) in the area of Level I concentrations and assign a value from table 4-24 based on this total length. Estimate this length as follows:</P> <P>• For an isolated wetland or for a wetland where the probable point of entry to surface water is in the wetland, use the perimeter of that portion of the wetland subject to Level I concentrations as the length.</P> <P>• For rivers, use the length of the wetlands contiguous to the in-water segment of the hazardous substance migration path (that is, wetland frontage).</P> <P>• For lakes, oceans, coastal tidal waters, and Great Lakes, use the length of the wetlands along the shoreline within the target distance limit (that is, wetland frontage along the shoreline).</P> <P>Calculate the Level I concentrations factor value (SH) for the watershed as follows:</P> <MATH SPAN="1" DEEP="32"> <MID>EC15NO91.152</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">WH = Value assigned from table 4-24 to wetlands along the area of Level I concentrations.</FP> <FP SOURCE="FP-2"> S <E T="52">i</E> = Value(s) assigned from table 4-23 to sensitive environment i. </FP> <FP SOURCE="FP-2">n = Number of sensitive environments from table 4-23 subject to Level I concentrations.</FP> <P>Enter the value assigned in table 4-1.</P> <P> 4.1.4.3.1.2  <E T="03">Level II concentrations.</E> Assign value(s) from table 4-23 to each sensitive environment subject to Level II concentrations. Do not include sensitive environments already counted for table 4-23 under the Level I concentrations factor for this watershed. </P> <P>For those sensitive environments that are wetlands, assign an additional value from table 4-24. In assigning a value from table 4-24, include only those portions of wetlands located along the hazardous substance migration path in the area of Level II concentrations, as specified in section 4.1.4.3.1.1.</P> <P>Estimate the total length of wetlands along the hazardous substance migration path (that is, wetland frontage) in the area of Level II concentrations and assign a value from table 4-24 based on this total length. Estimate this length as specified in section 4.1.4.3.1.1, except: for an isolated wetland or for a wetland where the probable point of entry to surface water is in the wetland, use the perimeter of that portion of the wetland subject to Level II (not Level I) concentrations as the length.</P> <P>Calculate the Level II concentrations value (SL) for the watershed as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.153</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">WL = Value assigned from table 4-24 to wetlands along the area of Level II concentrations.</FP> <FP SOURCE="FP-2"> S <E T="52">i</E> = Value(s) assigned from table 4-23 to sensitive environment i. </FP> <FP SOURCE="FP-2">n = Number of sensitive environments from table 4-23 subject to Level II concentrations.</FP> <P>Enter the value assigned in table 4-1.</P> <P> 4.1.4.3.1.3  <E T="03">Potential contamination.</E> Assign value(s) from table 4-23 to each sensitive environment subject to potential contamination. Do not include sensitive environments already counted for table 4-23 under the Level I or Level II concentrations factors. </P> <P> For each type of surface water body in table 4-13 (section 4.1.2.3.1), sum the value(s) <PRTPAGE P="172"/> assigned from table 4-23 to the sensitive environments along that type of surface water body, except: do not use the surface water body type “3-mile mixing zone in quiet flowing river.” If a sensitive environment is along two or more types of surface water bodies (for example, Wildlife Refuge contiguous to both a moderate stream and a large river), assign the sensitive environment only to that surface water body type having the highest dilution weight value from table 4-13. </P> <P>For those sensitive environments that are wetlands, assign an additional value from table 4-24. In assigning a value from table 4-24, include only those portions of wetlands located along the hazardous substance migration path in the area of potential contamination, as specified in section 4.1.4.3.1.1. Aggregate these wetlands by type of surface water body, except: do not use the surface water body type “3-mile mixing zone in quiet flowing river.” Treat the wetlands aggregated within each type of surface water body as separate sensitive environments solely for purposes of applying table 4-24. Estimate the total length of the wetlands within each surface water body type as specified in section 4.1.4.3.1.1, except: for an isolated wetland or for a wetland where the probable point of entry to surface water is in the wetland, use the perimeter of that portion of the wetland subject to potential contamination (or the portion of that perimeter that is within the target distance limit) as the length. Assign a separate value from table 4-24 for each type of surface water body in the watershed.</P> <P>Calculate the potential contamination factor value (SP) for the watershed as follows:</P> <MATH SPAN="1" DEEP="31"> <MID>EC15NO91.154</MID> </MATH> <FP>where:</FP> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.155</MID> </MATH> <FP SOURCE="FP-2"> S <E T="52">ij</E> = Value(s) assigned from table 4-23 to sensitive environment i in surface water body type j. </FP> <FP SOURCE="FP-2">n = Number of sensitive environments from table 4-23 subject to potential contamination.</FP> <FP SOURCE="FP-2"> W <E T="52">j</E> = Value assigned from table 4-24 for wetlands along the area of potential contamination in surface water body type j. </FP> <FP SOURCE="FP-2"> D <E T="52">j</E> = Dilution weight from table 4-13 for surface water body type j. </FP> <FP SOURCE="FP-2">m = Number of different surface water body types from table 4-13 in the watershed.</FP> <P>If SP is less than 1, do not round it to the nearest integer; if SP is 1 or more, round to the nearest integer. Enter this value for the potential contamination factor in table 4-1.</P> <P> 4.1.4.3.1.4  <E T="03">Calculation of environmental threat-targets factor category value.</E> Sum the values for the Level I concentrations, Level II concentrations, and potential contamination factors for the watershed. Do not round this sum to the nearest integer. Assign this sum as the environmental threat-targets factor category value for the watershed. Enter this value in table 4-1. </P> <P> 4.1.4.4  <E T="03">Calculation of environmental threat score for a watershed.</E> Multiply the environmental threat factor category values for likelihood of release, waste characteristics, and targets for the watershed, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum of 60, as the environmental threat score for the watershed. Enter this score in table 4-1. </P> <P> 4.1.5  <E T="03">Calculation of overland/flood migration component score for a watershed.</E> Sum the scores for the three threats for the watershed (that is, drinking water, human food chain, and environmental threats). Assign the resulting score, subject to a maximum value of 100, as the surface water overland/flood migration component score for the watershed. Enter this score in table 4-1. </P> <P> 4.1.6  <E T="03">Calculation of overland/flood migration component score.</E> Select the highest surface water overland/flood migration component score from the watersheds evaluated. Assign this score as the surface water overland/flood migration component score for the site, subject to a maximum score of 100. Enter this score in table 4-1. </P> <P> 4.2  <E T="03">Ground water to surface water migration component.</E> Use the ground water to surface water migration component to evaluate surface water threats that result from migration of hazardous substances from a source at the site to surface water via ground water. Evaluate three types of threats for this component: drinking water threat, human food chain threat, and environmental threat. </P> <P> 4.2.1  <E T="03">General considerations.</E> </P> <P> 4.2.1.1  <E T="03">Eligible surface waters.</E> Calculate ground water to surface water migration component scores only for surface waters (see section 4.0.2) for which all the following conditions are met: </P> <P>• A portion of the surface water is within 1 mile of one or more sources at the site having a containment factor value greater than 0 (see section 4.2.2.1.2).</P> <P>• No aquifer discontinuity is established between the source and the portion of the surface water within 1 mile of the source (see section 3.0.1.2.2). However, if hazardous substances have migrated across an apparent discontinuity within this 1 mile distance, do not consider a discontinuity present in scoring the site.</P> <P> • The top of the uppermost aquifer is at or above the bottom of the surface water. <PRTPAGE P="173"/> </P> <P>Do not evaluate this component for sites consisting solely of contaminated sediments with no identified source.</P> <P> 4.2.1.2  <E T="03">Definition of hazardous substance migration path for ground water to surface water migration component.</E> The hazardous substance migration path includes both the ground water segment and the surface water in-water segment that hazardous substances would take as they migrate away from sources at the site: </P> <P>• Restrict the ground water segment to migration via the uppermost aquifer between a source and the surface water.</P> <P>• Begin the surface water in-water segment at the probable point of entry from the uppermost aquifer to the surface water. Identify the probable point of entry as that point of the surface water that yields the shortest straight-line distance, within the aquifer boundary (see section 3.0.1.2), from the sources at the site with a containment factor value greater than 0 to the surface water.</P> <P SOURCE="P-1">-For rivers, continue the in-water segment in the direction of flow (including any tidal flows) for the distance established by the target distance limit (see section 4.2.1.4).</P> <P SOURCE="P-1">-For lakes, oceans, coastal tidal waters, or Great Lakes, do not consider flow direction. Instead apply the target distance limit as an arc.</P> <P SOURCE="P-1">-If the in-water segment includes both rivers and lakes (or oceans, coastal tidal waters, or Great Lakes), apply the target distance limit to their combined in-water segments.</P> <P>Consider a site to be in two or more watersheds for this component if two or more hazardous substance migration paths from the sources at the site do not reach a common point within the target distance limit. If the site is in more than one watershed, define a separate hazardous substance migration path for each watershed. Evaluate the ground water to surface water migration component for each watershed separately as specified in section 4.2.1.5.</P> <P> 4.2.1.3  <E T="03">Observed release of a specific hazardous substance to surface water in-water segment.</E> Section 4.2.2.1.1 specifies the criteria for assigning values to the observed release factor for the ground water to surface water migration component. With regard to an individual hazardous substance, consider an observed release of that hazardous substance to be established for the surface water in-water segment of the ground water to surface water migration component only when the hazardous substance meets the criteria both for an observed release both to ground water (see section 4.2.2.1.1) and for an observed release by chemical analysis to surface water (see section 4.1.2.1.1). </P> <P>If the hazardous substance meets the section 4.1.2.1.1 criteria for an observed release by chemical analysis to surface water but does not also meet the criteria for an observed release to ground water, do not use any samples of that hazardous substance from the surface water in-water segment in evaluating the factors of this component (for example, do not use the hazardous substance in establishing targets subject to actual contamination or in determining the level of actual contamination for a target).</P> <P> 4.2.1.4  <E T="03">Target distance limit.</E> Determine the target distance limit for each watershed as specified in section 4.1.1.2, except: do not extend the target distance limit to a sample location beyond 15 miles unless at least one hazardous substance in a sample from that location meets the criteria in section 4.2.1.3 for an observed release to the surface water in-water segment. </P> <P>Determine the targets eligible to be evaluated for each watershed and establish whether these targets are subject to actual or potential contamination as specified in section 4.1.1.2, except: do not establish actual contamination based on a sample location unless at least one hazardous substance in a sample from that location meets the criteria in section 4.2.1.3 for an observed release to the surface water in-water segment.</P> <P> 4.2.1.5  <E T="03">Evaluation of ground water to surface water migration component.</E> Evaluate the drinking water threat, human food chain threat, and environmental threat for each watershed for this component based on three factor categories: likelihood of release, waste characteristics, and targets. Figure 4-2 indicates the factors included within each factor category for each type of threat. </P> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="174"/> <GID>EC02AU92.009</GID> </GPH> <PRTPAGE P="175"/> <P> Determine the ground water to surface water migration component score (S <E T="52">gs</E> ) for a watershed in terms of the factor category values as follows: </P> <MATH SPAN="1" DEEP="41"> <MID>EC15NO91.156</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2"> LR <E T="52">i</E> = Likelihood of release factor category value for threat i (that is, drinking water, human food chain, or environmental threat). </FP> <FP SOURCE="FP-2"> WC <E T="52">i</E> = Waste characteristics factor category value for threat i. </FP> <FP SOURCE="FP-2"> T <E T="52">i</E> = Targets factor category value for threat i. </FP> <FP SOURCE="FP-2">SF = Scaling factor.</FP> <FP SOURCE="FP-1">Table 4-25 outlines the specific calculation procedure.</FP> <P>If the site is in only one watershed, assign the ground water to surface water migration component score for that watershed as the ground water to surface water migration component score for the site.</P> <P>If the site is in more than one watershed:</P> <P>• Calculate a separate ground water to surface water migration component score for each watershed, using likelihood of release, waste characteristics, and targets applicable to each watershed.</P> <P>• Select the highest ground water to surface water migration component score from the watersheds evaluated and assign it as the ground water to surface water migration component score for the site.</P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s200,8,16"> <TTITLE>Table 4-25—Ground Water to Surface Water Migration Component Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor categories and factors</CHED> <CHED H="1">Maximum value</CHED> <CHED H="1">Value assigned</CHED> </BOXHD> <ROW> <ENT I="21"> <E T="02">Drinking Water Threat</E> </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Likelihood of Release to Aquifer:</E> </ENT> </ROW> <ROW> <ENT I="03"> 1. Observed Release</ENT> <ENT>550</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="13"> 2. Potential to Release:</ENT> </ROW> <ROW> <ENT I="05">2a. Containment</ENT> <ENT>10</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2b. Net Precipitation</ENT> <ENT>10</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2c. Depth to Aquifer</ENT> <ENT>5</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2d. Travel Time</ENT> <ENT>35</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">2e. Potential to Release (lines 2a[2b + 2c + 2d])</ENT> <ENT>500</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03"> 3. Likelihood of Release (higher of lines 1 and 2e)</ENT> <ENT>550</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="03"> 4. Toxicity/Mobility/Persistence</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03"> 5. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03"> 6. Waste Characteristics</ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="03"> 7. Nearest Intake</ENT> <ENT>50</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="13"> 8. Population</ENT> </ROW> <ROW> <ENT I="05">8a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">8b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">8c. Potential Contamination</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">8d. Population (lines 8a + 8b + 8c)</ENT> <ENT/> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03"> 9. Resources</ENT> <ENT>5</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03">10. Targets (lines 7 + 8d + 9)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Drinking Water Threat Score:</E> </ENT> </ROW> <ROW> <ENT I="03">11. Drinking Water Threat Score ([lines 3 × 6 × 10]/82,500, subject to a maximum of 100)</ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Human Food Chain Threat</E> </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Likelihood of Release:</E> </ENT> </ROW> <ROW> <ENT I="03">12. Likelihood of Release (same value as line 3)</ENT> <ENT>550</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="03">13. Toxicity/Mobility/Persistence/Bioaccumulation</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03">14. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03">15. Waste Characteristics</ENT> <ENT>1,000</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="03">16. Food Chain Individual</ENT> <ENT>50</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="13">17. Population:</ENT> </ROW> <ROW> <ENT I="05">17a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">17b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">17c. Potential Human Food Chain Contamination</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">17d. Population (lines 17a + 17b + 17c)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03">18. Targets (Lines 16 + 17d)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Human Food Chain Threat Score:</E> </ENT> </ROW> <ROW> <ENT I="03">19. Human Food Chain Threat Score ([lines 12 × 15 × 18]/82,500, subject to a maximum of 100)</ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="21"> <E T="02">Environmental Threat</E> </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Likelihood of Release:</E> </ENT> </ROW> <ROW> <ENT I="03">20. Likelihood of Release (same value as line 3)</ENT> <ENT>550</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics:</E> </ENT> </ROW> <ROW> <ENT I="03">21. Ecosystem Toxicity/Mobility/Persistence/Bioaccumulation</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <PRTPAGE P="176"/> <ENT I="03">22. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03">23. Waste Characteristics</ENT> <ENT>1,000</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets:</E> </ENT> </ROW> <ROW> <ENT I="13">24. Sensitive Environments:</ENT> </ROW> <ROW> <ENT I="05">24a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">24b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">24c. Potential Contamination</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="05">24d. Sensitive Environments (lines 24a + 24b + 24c)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03">25. Targets (value from line 24d)</ENT> <ENT>(b)</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Environmental Threat Score:</E> </ENT> </ROW> <ROW> <ENT I="03">26. Environmental Threat Score ([lines 20 × 23 × 25]/82,500, subject to a maximum of 60)</ENT> <ENT>60</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Ground Water to Surface Water Migration Component Score for a Watershed</E> </ENT> </ROW> <ROW> <ENT I="03"> 27. Watershed Score  <SU>c</SU> (lines 11 + 19 + 26, subject to a maximum of 100) </ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <ROW> <ENT I="03"> 28. Component Score (S <E T="52">gs</E> )  <SU>c</SU> (highest score from Line 27 for all watersheds evaluated, subject to a maximum of 100) </ENT> <ENT>100</ENT> <ENT>______   </ENT> </ROW> <TNOTE> <SU>a</SU>  Maximum value applies to waste characteristics category. </TNOTE> <TNOTE> <SU>b</SU>  Maximum value not applicable. </TNOTE> <TNOTE> <SU>c</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.2.2  <E T="03">Drinking water threat.</E> Evaluate the drinking water threat for each watershed based on three factor categories: likelihood of release, waste characteristics, and targets. </P> <P> 4.2.2.1  <E T="03">Drinking water threat-likelihood of release.</E> Evaluate the likelihood of release factor category for each watershed in terms of an observed release factor or a potential to release factor. </P> <P> 4.2.2.1.1  <E T="03">Observed release.</E> Establish an observed release to the uppermost aquifer as specified in section 3.1.1. If an observed release can be established for the uppermost aquifer, assign an observed release factor value of 550 to that watershed, enter this value in table 4-25, and proceed to section 4.2.2.1.3. If no observed release can be established, assign an observed release factor value of 0, enter this value in table 4-25, and proceed to section 4.2.2.1.2. </P> <P> 4.2.2.1.2  <E T="03">Potential to release.</E> Evaluate potential to release only if an observed release cannot be established for the uppermost aquifer. Calculate a potential to release value for the uppermost aquifer as specified in section 3.1.2 and sections 3.1.2.1 through 3.1.2.5. Assign the potential to release value for the uppermost aquifer as the potential to release factor value for the watershed. Enter this value in table 4-25. </P> <P> 4.2.2.1.3  <E T="03">Calculation of drinking water threat-likelihood of release factor category value.</E> If an observed release is established for the uppermost aquifer, assign the observed release factor value of 550 as the likelihood of release factor category value for the watershed. Otherwise, assign the potential to release factor value as the likelihood of release factor category value for the watershed. Enter the value assigned in table 4-25. </P> <P> 4.2.2.2  <E T="03">Drinking water threat-waste characteristics.</E> Evaluate the waste characteristics factor category for each watershed based on two factors: toxicity/mobility/persistence and hazardous waste quantity. Evaluate only those hazardous substances available to migrate from the sources at the site to the uppermost aquifer (see section 3.2). Such hazardous substances include: </P> <P>• Hazardous substances that meet the criteria for an observed release to ground water.</P> <P>• All hazardous substances associated with a source that has a ground water containment factor value greater than 0 (see sections 2.2.2, 2.2.3, and 3.1.2.1).</P> <P> 4.2.2.2.1  <E T="03">Toxicity/mobility/persistence.</E> For each hazardous substance, assign a toxicity factor value, a mobility factor value, a persistence factor value, and a combined toxicity/mobility/persistence factor value as specified in sections 4.2.2.2.1.1 through 4.2.2.2.1.4. </P> <P> 4.2.2.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in section 2.4.1.1. </P> <P> 4.2.2.2.1.2  <E T="03">Mobility.</E> Assign a ground water mobility factor value to each hazardous substance as specified in section 3.2.1.2. </P> <P> 4.2.2.2.1.3  <E T="03">Persistence.</E> Assign a surface water persistence factor value to each hazardous substance as specified in section 4.1.2.2.1.2. </P> <P> 4.2.2.2.1.4  <E T="03">Calculation of toxicity/mobility/persistence factor value.</E> First, assign each hazardous substance a toxicity/mobility factor value from table 3-9 (section 3.2.1.3), based on the values assigned to the hazardous substance for the toxicity and mobility factors. Then assign each hazardous substance a toxicity/mobility/persistence factor <PRTPAGE P="177"/> value from table 4-26, based on the values assigned for the toxicity/mobility and persistence factors. Use the substance with the highest toxicity/mobility/ persistence factor value for the watershed to assign the value to this factor. Enter this value in table 4-25. </P> <P> 4.2.2.2.2  <E T="03">Hazardous waste quantity.</E> Assign the same factor value for hazardous waste quantity for the watershed as would be assigned for the uppermost aquifer in section 3.2.2. Enter this value in table 4-25. </P> <P> 4.2.2.2.3  <E T="03">Calculation of drinking water threat-waste characteristics factor category value.</E> Multiply the toxicity/mobility/persistence and hazardous waste quantity factor values for the watershed, subject to a maximum product of 1 × 10 <SU>8</SU> . Based on this product, assign a value from table 2-7 (section 2.4.3.1) to the drinking water threat-waste characteristics factor category for the watershed. Enter this value in table 4-25. </P> <P> 4.2.2.3  <E T="03">Drinking water threat-targets.</E> Evaluate the targets factor category for each watershed based on three factors: nearest intake, population, and resources. </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,8,8,10,10"> <TTITLE> Table 4-26—Toxicity/Mobility/Persistence Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Toxicity/mobility factor value</CHED> <CHED H="1">Persistence factor value</CHED> <CHED H="2">1.0</CHED> <CHED H="2">0.4</CHED> <CHED H="2">0.07</CHED> <CHED H="2">0.0007</CHED> </BOXHD> <ROW> <ENT I="01">10,000</ENT> <ENT>10,000</ENT> <ENT>4,000</ENT> <ENT>700</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">2,000</ENT> <ENT>2,000</ENT> <ENT>800</ENT> <ENT>140</ENT> <ENT>1.4</ENT> </ROW> <ROW> <ENT I="01">1,000</ENT> <ENT>1,000</ENT> <ENT>400</ENT> <ENT>70</ENT> <ENT>0.7</ENT> </ROW> <ROW> <ENT I="01">200</ENT> <ENT>200</ENT> <ENT>80</ENT> <ENT>14</ENT> <ENT>0.14</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT>100</ENT> <ENT>40</ENT> <ENT>7</ENT> <ENT>0.07</ENT> </ROW> <ROW> <ENT I="01">20</ENT> <ENT>20</ENT> <ENT>8</ENT> <ENT>1.4</ENT> <ENT>0.014</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT>10</ENT> <ENT>4</ENT> <ENT>0.7</ENT> <ENT>0.007</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>2</ENT> <ENT>0.8</ENT> <ENT>0.14</ENT> <ENT>0.0014</ENT> </ROW> <ROW> <ENT I="01">1</ENT> <ENT>1</ENT> <ENT>0.4</ENT> <ENT>0.07</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT>0.2</ENT> <ENT>0.08</ENT> <ENT>0.014</ENT> <ENT> 1.4 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">0.1</ENT> <ENT>0.1</ENT> <ENT>0.04</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01">0.02</ENT> <ENT>0.02</ENT> <ENT>0.008</ENT> <ENT>0.0014</ENT> <ENT> 1.4 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01">0.01</ENT> <ENT>0.01</ENT> <ENT>0.004</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01">0.002</ENT> <ENT>0.002</ENT> <ENT> 8 × 10 <E T="51">−4</E> </ENT> <ENT> 1.4 × 10 <E T="51">−4</E> </ENT> <ENT> 1.4 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01">0.001</ENT> <ENT>0.001</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 8 × 10 <E T="51">−5</E> </ENT> <ENT> 1.4 × 10 <E T="51">−5</E> </ENT> <ENT> 1.4 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 8 × 10 <E T="51">−6</E> </ENT> <ENT> 1.4 × 10 <E T="51">−6</E> </ENT> <ENT> 1.4 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−6</E> </ENT> <ENT> 2 × 10 <E T="51">−6</E> </ENT> <ENT> 8 × 10 <E T="51">−7</E> </ENT> <ENT> 1.4 × 10 <E T="51">−7</E> </ENT> <ENT> 1.4 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−7</E> </ENT> <ENT> 2 × 10 <E T="51">−7</E> </ENT> <ENT> 8 × 10 <E T="51">−8</E> </ENT> <ENT> 1.4 × 10 <E T="51">−8</E> </ENT> <ENT> 1.4 × 10 <E T="51">−10</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−8</E> </ENT> <ENT> 2 × 10 <E T="51">−8</E> </ENT> <ENT> 8 × 10 <E T="51">−9</E> </ENT> <ENT> 1.4 × 10 <E T="51">−9</E> </ENT> <ENT> 1.4 × 10 <E T="51">−11</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 8 × 10 <E T="51">−10</E> </ENT> <ENT> 1.4 × 10 <E T="51">−10</E> </ENT> <ENT> 1.4 × 10 <E T="51">−12</E> </ENT> </ROW> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P>For the nearest intake and population factors, determine whether the target surface water intakes are subject to actual or potential contamination as specified in section 4.1.1.2, subject to the restrictions specified in sections 4.2.1.3 and 4.2.1.4.</P> <P>When the intake is subject to actual contamination, evaluate it using Level I concentrations or Level II concentrations. Determine which level applies for the intake by comparing the exposure concentrations from a sample (or comparable samples) to health-based benchmarks as specified in section 4.1.2.3, except use only those samples from the surface water in-water segment and only those hazardous substances in such samples that meet the conditions in sections 4.2.1.3 and 4.2.1.4.</P> <P> 4.2.2.3.1  <E T="03">Nearest intake.</E> Assign a value to the nearest intake factor as specified in section 4.1.2.3.1 with the following modification. For the intake being evaluated, multiply its dilution weight from table 4-13 (section 4.1.2.3.1) by a value selected from table 4-27. Use the resulting product, not the value from table 4-13, as the dilution weight for the intake for the ground water to surface water component. Do not round this product to the nearest integer. </P> <P> Select the value from table 4-27 based on the angle Θ, the angle defined by the sources at the site and either the two points at the intersection of the surface water body and the 1-mile distance ring of any two other points of the surface water body within the 1-mile distance ring, whichever results in the largest angle. (See Figure 4-3 for an example of how to determine Θ.) If the surface water body does not extend to the 1-mile ring at one or both ends, define Θ using the surface water endpoint(s) within the 1-mile ring or any two other points of the surface water body within the 1-mile distance ring, whichever results in the largest angle. <PRTPAGE P="178"/> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,1.2"> <TTITLE>Table 4-27—Dilution Weight Adjustments</TTITLE> <BOXHD> <CHED H="1">Angle Θ (degrees)</CHED> <CHED H="1"> Assigned value  <SU>a</SU> </CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Greater than 0 to 18</ENT> <ENT>0.05</ENT> </ROW> <ROW> <ENT I="01">Greater than 18 to 54</ENT> <ENT>0.1</ENT> </ROW> <ROW> <ENT I="01">Greater than 54 to 90</ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01">Greater than 90 to 126</ENT> <ENT>0.3</ENT> </ROW> <ROW> <ENT I="01">Greater than 126 to 162</ENT> <ENT>0.4</ENT> </ROW> <ROW> <ENT I="01">Greater than 162 to 198</ENT> <ENT>0.5</ENT> </ROW> <ROW> <ENT I="01">Greater than 198 to 234</ENT> <ENT>0.6</ENT> </ROW> <ROW> <ENT I="01">Greater than 234 to 270</ENT> <ENT>0.7</ENT> </ROW> <ROW> <ENT I="01">Greater than 270 to 306</ENT> <ENT>0.8</ENT> </ROW> <ROW> <ENT I="01">Greater than 306 to 342</ENT> <ENT>0.9</ENT> </ROW> <ROW> <ENT I="01">Greater than 342 to 360</ENT> <ENT>1.0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <GPH SPAN="2" DEEP="449"> <PRTPAGE P="179"/> <GID>EC02AU92.010</GID> </GPH> <GPOTABLE COLS="7" OPTS="L2" CDEF="s10,8,8,8,8,8,8"> <TTITLE> Table 4-28—Toxicity/Mobility/Persistence/Bioaccumulation Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Toxicity/mobility/persistence factor value</CHED> <CHED H="1">Bioaccumlation potential factor value</CHED> <CHED H="2">50,000</CHED> <CHED H="2">5,000</CHED> <CHED H="2">500</CHED> <CHED H="2">50</CHED> <CHED H="2">5</CHED> <CHED H="2">0.5</CHED> </BOXHD> <ROW> <ENT I="01">10,000</ENT> <ENT> 5 × 10 <SU>8</SU> </ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">4,000</ENT> <ENT> 2 × 10 <SU>8</SU> </ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> </ROW> <ROW> <ENT I="01">2,000</ENT> <ENT> 1 × 10 <SU>8</SU> </ENT> <ENT> 1 × 10 <SU>7</SU> </ENT> <ENT> 1 × 10 <SU>6</SU> </ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> </ROW> <ROW> <PRTPAGE P="180"/> <ENT I="01">1,000</ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">800</ENT> <ENT> 4 × 10 <SU>7</SU> </ENT> <ENT> 4 × 10 <SU>6</SU> </ENT> <ENT> 4 × 10 <SU>5</SU> </ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> </ROW> <ROW> <ENT I="01">700</ENT> <ENT> 3.5 × 10 <SU>7</SU> </ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> </ROW> <ROW> <ENT I="01">400</ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01">200</ENT> <ENT> 1 × 10 <SU>7</SU> </ENT> <ENT> 1 × 10 <SU>6</SU> </ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">140</ENT> <ENT> 7 × 10 <SU>6</SU> </ENT> <ENT> 7 × 10 <SU>5</SU> </ENT> <ENT> 7 × 10 <SU>4</SU> </ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">80</ENT> <ENT> 4 × 10 <SU>6</SU> </ENT> <ENT> 4 × 10 <SU>5</SU> </ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> </ROW> <ROW> <ENT I="01">70</ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> </ROW> <ROW> <ENT I="01">40</ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01">20</ENT> <ENT> 1 × 10 <SU>6</SU> </ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">14</ENT> <ENT> 7 × 10 <SU>5</SU> </ENT> <ENT> 7 × 10 <SU>4</SU> </ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">8</ENT> <ENT> 4 × 10 <SU>5</SU> </ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">7</ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">1.4</ENT> <ENT> 7 × 10 <SU>4</SU> </ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> </ROW> <ROW> <ENT I="01">1.0</ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> </ROW> <ROW> <ENT I="01">0.8</ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> </ROW> <ROW> <ENT I="01">0.7</ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> </ROW> <ROW> <ENT I="01">0.4</ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> </ROW> <ROW> <ENT I="01">0.14</ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> </ROW> <ROW> <ENT I="01">0.1</ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> </ROW> <ROW> <ENT I="01">0.08</ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> </ROW> <ROW> <ENT I="01">0.07</ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> </ROW> <ROW> <ENT I="01">0.04</ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> </ROW> <ROW> <ENT I="01">0.02</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> </ROW> <ROW> <ENT I="01">0.014</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> </ROW> <ROW> <ENT I="01">0.01</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> <ENT>0.005</ENT> </ROW> <ROW> <ENT I="01">0.008</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> </ROW> <ROW> <ENT I="01">0.007</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> </ROW> <ROW> <ENT I="01">0.004</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> </ROW> <ROW> <ENT I="01">0.002</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> </ROW> <ROW> <ENT I="01">0.0014</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">0.001</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> <ENT>0.005</ENT> <ENT> 5 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−4</E> </ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−4</E> </ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.035</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 4 × 10 <E T="51">−4</E> </ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−4</E> </ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−4</E> </ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 1 × 10 <E T="51">−4</E> </ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> <ENT>0.005</ENT> <ENT> 5 × 10 <E T="51">−4</E> </ENT> <ENT> 5 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−5</E> </ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−5</E> </ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 4 × 10 <E T="51">−5</E> </ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−5</E> </ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−5</E> </ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−6</E> </ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−6</E> </ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> <ENT> 3.5 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−6</E> </ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−6</E> </ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−7</E> </ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−7</E> </ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> <ENT> 3.5 × 10 <E T="51">−6</E> </ENT> <ENT> 3.5 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−7</E> </ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> <ENT> 1 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−7</E> </ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−8</E> </ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> <ENT> 4 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−8</E> </ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> <ENT> 3.5 × 10 <E T="51">−6</E> </ENT> <ENT> 3.5 × 10 <E T="51">−7</E> </ENT> <ENT> 3.5 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−8</E> </ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> <ENT> 1 × 10 <E T="51">−7</E> </ENT> <ENT> 1 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−9</E> </ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> <ENT> 4 × 10 <E T="51">−8</E> </ENT> <ENT> 4 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> <ENT> 1 × 10 <E T="51">−7</E> </ENT> <ENT> 1 × 10 <E T="51">−8</E> </ENT> <ENT> 1 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−10</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> <ENT> 4 × 10 <E T="51">−8</E> </ENT> <ENT> 4 × 10 <E T="51">−9</E> </ENT> <ENT> 4 × 10 <E T="51">−10</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> <ENT> 4 × 10 <E T="51">−11</E> </ENT> </ROW> <ROW> <PRTPAGE P="181"/> <ENT I="01"> 1.4 × 10 <E T="51">−11</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−11</E> </ENT> <ENT> 7 × 10 <E T="51">−12</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−12</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−11</E> </ENT> <ENT> 7 × 10 <E T="51">−12</E> </ENT> <ENT> 7 × 10 <E T="51">−13</E> </ENT> </ROW> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU> Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.2.2.3.2  <E T="03">Population.</E> Evaluate the population factor for the watershed based on three factors: Level I concentrations, Level II concentrations, and potential contamination. Determine which factor applies to an intake as specified in section 4.2.2.3. Determine the population to be counted for that intake as specified in section 4.1.2.3.2, using the target distance limits in section 4.2.1.4 and the hazardous substance migration path in section 4.2.1.2. </P> <P> 4.2.2.3.2.1  <E T="03">Level I concentrations.</E> Assign a value to this factor as specified in section 4.1.2.3.2.2. </P> <P> 4.2.2.3.2.2  <E T="03">Level II concentrations.</E> Assign a value to this factor as specified in section 4.1.2.3.2.3. </P> <P> 4.2.2.3.2.3  <E T="03">Potential contamination.</E> For each applicable type of surface water body in table 4-14, determine the dilution-weighted population value as specified in section 4.1.2.3.2.4. Select the appropriate dilution weight adjustment value from table 4-27 as specified in section 4.2.2.3.1. </P> <P>Calculate the value for the potential contamination factor (PC) for the watershed as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.157</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">A = Dilution weight adjustment value from table 4-27.</FP> <FP SOURCE="FP-2"> W <E T="52">i</E> = Dilution-weighted population from table 4-14 for surface water body type i. </FP> <FP SOURCE="FP-2">n = Number of different surface water body types in the watershed.</FP> <P>If PC is less than 1, do not round it to the nearest integer; if PC is 1 or more, round to the nearest integer. Enter the value in table 4-25.</P> <P> 4.2.2.3.2.4  <E T="03">Calculation of population factor value.</E> Sum the factor values for Level I concentrations, Level II concentrations, and potential contamination. Do not round this sum to the nearest integer. Assign this sum as the population factor value for the watershed. Enter this value in table 4-25. </P> <P> 4.2.2.3.3  <E T="03">Resources.</E> Assign a value to the resources factor as specified in section 4.1.2.3.3. </P> <P> 4.2.2.3.4  <E T="03">Calculation of drinking water threat-targets factor category value.</E> Sum the nearest intake, population, and resources factor values for the watershed. Do not round this sum to the nearest integer. Assign this sum as the drinking water threat-targets factor category value for the watershed. Enter this value in table 4-25. </P> <P> 4.2.2.4  <E T="03">Calculation of drinking water threat score for a watershed.</E> Multiply the drinking water threat factor category values for likelihood of release, waste characteristics, and targets for the watershed, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum of 100, as the drinking water threat score for the watershed. Enter this score in table 4-25. </P> <P> 4.2.3  <E T="03">Human food chain threat.</E> Evaluate the human food chain threat for a watershed based on three factor categories: likelihood of release, waste characteristics, and targets. </P> <P> 4.2.3.1  <E T="03">Human food chain threat-likelihood of release.</E> Assign the same likelihood of release factor category value for the human food chain threat for the watershed as would be assigned in section 4.2.2.1.3 for the drinking water threat. Enter this value in table 4-25. </P> <P> 4.2.3.2  <E T="03">Human food chain threat-waste characteristics.</E> Evaluate the waste characteristics factor category for each watershed based on two factors: toxicity/mobility/persistence/bioaccumulation and hazardous waste quantity. </P> <P> 4.2.3.2.1  <E T="03">Toxicity/mobility/persistence/bioaccumulation.</E> Evaluate all those hazardous substances eligible to be evaluated for toxicity/mobility/persistence in the drinking water threat for the watershed (see section 4.2.2.2.1). </P> <P> 4.2.3.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in section 2.4.1.1. </P> <P> 4.2.3.2.1.2  <E T="03">Mobility.</E> Assign a ground water mobility factor value to each hazardous substance as specified for the drinking water threat (see section 4.2.2.2.1.2). </P> <P> 4.2.3.2.1.3  <E T="03">Persistence.</E> Assign a surface water persistence factor value to each hazardous substance as specified for the drinking water threat (see section 4.2.2.2.1.3), except: use the predominant water category (that is, lakes; or rivers, oceans, coastal tidal waters, or Great Lakes) between the <PRTPAGE P="182"/> probable point of entry and the nearest fishery (not the nearest drinking water or resources intake) along the hazardous substance migration path for the watershed to determine which portion of table 4-10 to use. Determine the predominant water category based on distance as specified in section 4.1.2.2.1.2. </P> <P> 4.2.3.2.1.4  <E T="03">Bioaccumulation potential.</E> Assign a bioaccumulation potential factor value to each hazardous substance as specified in section 4.1.3.2.1.3. </P> <P> 4.2.3.2.1.5  <E T="03">Calculation of toxicity/mobility/persistence/ bioaccumulation factor value.</E> Assign each hazardous substance a toxicity/mobility factor value from table 3-9 (section 3.2.1.3), based on the values assigned to the hazardous substance for the toxicity and mobility factors. Then assign each hazardous substance a toxicity/mobility/persistence factor value from table 4-26, based on the values assigned for the toxicity/mobility and persistence factors. Then assign each hazardous substance a toxicity/mobility/persistence/bioaccumulation factor value from table 4-28. Use the substance with the highest toxicity/mobility/persistence/bioaccumulation factor value for the watershed to assign the value to this factor for the watershed. Enter this value in table 4-25. </P> <P> 4.2.3.2.2  <E T="03">Hazardous waste quantity.</E> Assign the same factor value for hazardous waste quantity for the watershed as would be assigned in section 4.2.2.2.2 for the drinking water threat. Enter this value in table 4-25. </P> <P> 4.2.3.2.3  <E T="03">Calculation of human food chain threat-waste characteristics factor category value.</E> For the hazardous substance selected for the watershed in section 4.2.3.2.1.5, use its toxicity/mobility/ persistence factor value and bioaccumulation potential factor value as follows to assign a value to the waste characteristics factor category. First, multiply the toxicity/mobility/persistence factor value and the hazardous waste quantity factor value for the watershed, subject to a maximum product of 1 × 10 <SU>8</SU> . Then multiply this product by the bioaccumulation potential factor value for this hazardous substance, subject to a maximum product of 1 × 10 <SU>12</SU> . Based on this second product, assign a value from table 2-7 (section 2.4.3.1) to the human food chain threat-waste characteristics factor category for the watershed. Enter this value in table 4-25. </P> <P> 4.2.3.3  <E T="03">Human food chain threat-targets.</E> Evaluate two target factors for the watershed: food chain individual and population. </P> <P>For both factors, determine whether the target fisheries are subject to Level I concentrations, Level II concentrations, or potential human food chain contamination. Determine which applies to each fishery (or portion of a fishery) as specified in section 4.1.3.3, subject to the restrictions specified in sections 4.2.1.3 and 4.2.1.4.</P> <P> 4.2.3.3.1  <E T="03">Food chain individual.</E> Assign a value to the food chain individual factor as specified in section 4.1.3.3.1 with the following modification. When a dilution weight is used, multiply the appropriate dilution weight from table 4-13 by the adjustment value selected from table 4-27, as specified in section 4.2.2.3.1. Use the resulting product, not the value from table 4-13, as the dilution weight in assigning the factor value. Do not round this product to the nearest integer. Enter the value assigned in table 4-25. </P> <P> 4.2.3.3.2  <E T="03">Population.</E> Evaluate the population factor for the watershed based on three factors: Level I concentrations, Level II concentrations, and potential human food chain contamination. Determine which of these factors is to be applied to each fishery as specified in section 4.2.3.3. </P> <P> 4.2.3.3.2.1  <E T="03">Level I concentrations.</E> Assign a value to this factor as specified in section 4.1.3.3.2.1. Enter this value in table 4-25. </P> <P> 4.2.3.3.2.2  <E T="03">Level II concentrations.</E> Assign a value to this factor as specified in section 4.1.3.3.2.2. Enter this value in table 4-25. </P> <P> 4.2.3.3.2.3  <E T="03">Potential human food chain contamination.</E> Assign a value to this factor as specified in section 4.1.3.3.2.3 with the following modification. For each fishery being evaluated, multiply the appropriate dilution weight for that fishery from table 4-13 by the adjustment value selected from table 4-27, as specified in section 4.2.2.3.1. Use the resulting product, not the value from table 4-13, as the dilution weight for the fishery. Do not round this product to the nearest integer. Enter the value assigned in table 4-25. </P> <P> 4.2.3.3.2.4  <E T="03">Calculation of population factor value.</E> Sum the factor values for Level I concentrations, Level II concentrations, and potential human food chain contamination for the watershed. Do not round this sum to the nearest integer. Assign this sum as the population factor value for the watershed. Enter this value in table 4-25. </P> <P> 4.2.3.3.3  <E T="03">Calculation of human food chain threat-targets factor category value.</E> Sum the food chain individual and population factor values for the watershed. Do not round this sum to the nearest integer. Assign this sum as the human food chain threat-targets factor category value for the watershed. Enter this value in table 4-25. </P> <P> 4.2.3.4  <E T="03">Calculation of human food chain threat score for a watershed.</E> Multiply the human food chain threat factor category values for likelihood of release, waste characteristics, and targets for the watershed, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum of 100, as the human food chain threat score for the watershed. Enter this score in table 4-25. </P> <P> 4.2.4  <E T="03">Environmental threat.</E> Evaluate the environmental threat for the watershed based on three factor categories: likelihood of release, waste characteristics, and targets. <PRTPAGE P="183"/> </P> <P> 4.2.4.1  <E T="03">Environmental threat-likelihood of release.</E> Assign the same likelihood of release factor category value for the environmental threat for the watershed as would be assigned in section 4.2.2.1.3 for the drinking water threat. Enter this value in table 4-25. </P> <P> 4.2.4.2  <E T="03">Environmental threat-waste characteristics.</E> Evaluate the waste characteristics factor category for each watershed based on two factors: ecosystem toxicity/mobility/persistence/bioaccumulation and hazardous waste quantity. </P> <P> 4.2.4.2.1  <E T="03">Ecosystem toxicity/mobility/persistence/bioaccumulation.</E> Evaluate all those hazardous substances eligible to be evaluated for toxicity/mobility/persistence in the drinking water threat for the watershed (see section 4.2.2.2.1). </P> <P> 4.2.4.2.1.1  <E T="03">Ecosystem toxicity.</E> Assign an ecosystem toxicity factor value to each hazardous substance as specified in section 4.1.4.2.1.1. </P> <P> 4.2.4.2.1.2  <E T="03">Mobility.</E> Assign a ground water mobility factor value to each hazardous substance as specified in section 4.2.2.2.1.2 for the drinking water threat. </P> <P> 4.2.4.2.1.3  <E T="03">Persistence.</E> Assign a surface water persistence factor value to each hazardous substance as specified in section 4.2.2.2.1.3 for the drinking water threat, except: use the predominant water category (that is, lakes; or rivers, oceans, coastal tidal waters, or Great Lakes) between the probable point of entry and the nearest sensitive environment (not the nearest drinking water or resources intake) along the hazardous substance migration path for the watershed to determine which portion of table 4-10 to use. Determine the predominant water category based on distance as specified in section 4.1.2.2.1.2. </P> <P> 4.2.4.2.1.4  <E T="03">Ecosystem bioaccumulation potential.</E> Assign an ecosystem bioaccumulation potential factor value to each hazardous substance as specified in section 4.1.4.2.1.3. </P> <P> 4.2.4.2.1.5  <E T="03">Calculation of ecosystem toxicity/mobility/persistence/ bioaccumulation factor value.</E> Assign each hazardous substance an ecosystem toxicity/mobility factor value from table 3-9 (section 3.2.1.3), based on the values assigned to the hazardous substance for the ecosystem toxicity and mobility factors. Then assign each hazardous substance an ecosystem toxicity/mobility/persistence factor value from table 4-29, based on the values assigned for the ecosystem toxicity/mobility and persistence factors. Then assign each hazardous substance an ecosystem toxicity/mobility/persistence/bioaccumulation factor value from table 4-30, based on the values assigned for the ecosystem toxicity/mobility/persistence and ecosystem bioaccumulation potential factors. Select the substance with the highest ecosystem toxicity/mobility/persistence/bioaccumulation factor value for the watershed and use it to assign the value to this factor for the watershed. Enter this value in table 4-25. </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s30,8,8,10,10"> <TTITLE> Table 4-29—Ecosystem Toxicity/Mobility/Persistence Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Ecosystem toxicity/mobility factor value</CHED> <CHED H="1">Persistence factor value</CHED> <CHED H="2">1.0</CHED> <CHED H="2">0.4</CHED> <CHED H="2">0.07</CHED> <CHED H="2">0.0007</CHED> </BOXHD> <ROW> <ENT I="01">10,000</ENT> <ENT>10,000</ENT> <ENT>4,000</ENT> <ENT>700</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">2,000</ENT> <ENT>2,000</ENT> <ENT>800</ENT> <ENT>140</ENT> <ENT>1.41,000</ENT> </ROW> <ROW> <ENT I="01">1,000</ENT> <ENT>1,000</ENT> <ENT>400</ENT> <ENT>70</ENT> <ENT>0.7</ENT> </ROW> <ROW> <ENT I="01">200</ENT> <ENT>200</ENT> <ENT>80</ENT> <ENT>14</ENT> <ENT>0.14</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT>100</ENT> <ENT>40</ENT> <ENT>7</ENT> <ENT>0.07</ENT> </ROW> <ROW> <ENT I="01">20</ENT> <ENT>20</ENT> <ENT>8</ENT> <ENT>1.4</ENT> <ENT>0.014</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT>10</ENT> <ENT>4</ENT> <ENT>0.7</ENT> <ENT>0.007</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>2</ENT> <ENT>0.8</ENT> <ENT>0.14</ENT> <ENT>0.0014</ENT> </ROW> <ROW> <ENT I="01">1</ENT> <ENT>1</ENT> <ENT>0.4</ENT> <ENT>0.07</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT>0.2</ENT> <ENT>0.08</ENT> <ENT>0.014</ENT> <ENT> 1.4 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">0.1</ENT> <ENT>0.1</ENT> <ENT>0.04</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT>0.2</ENT> <ENT>0.008</ENT> <ENT>0.0014</ENT> <ENT> 1.4 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01">0.01</ENT> <ENT>0.01</ENT> <ENT>0.004</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01">0.002</ENT> <ENT>0.002</ENT> <ENT> 8 × 10 <E T="51">−4</E> </ENT> <ENT> 1.4 × 10 <E T="51">−4</E> </ENT> <ENT> 1.4 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01">0.001</ENT> <ENT>0.001</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 8 × 10 <E T="51">−5</E> </ENT> <ENT> 1.4 × 10 <E T="51">−5</E> </ENT> <ENT> 1.4 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> <ENT> 8 × 10 <E T="51">−6</E> </ENT> <ENT> 1.4 × 10 <E T="51">−6</E> </ENT> <ENT> 1.4 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−6</E> </ENT> <ENT> 2 × 10 <E T="51">−6</E> </ENT> <ENT> 8 × 10 <E T="51">−7</E> </ENT> <ENT> 1.4 × 10 <E T="51">−7</E> </ENT> <ENT> 1.4 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−7</E> </ENT> <ENT> 2 × 10 <E T="51">−7</E> </ENT> <ENT> 8 × 10 <E T="51">−8</E> </ENT> <ENT> 1.4 × 10 <E T="51">−8</E> </ENT> <ENT> 1.4 × 10 <E T="51">−10</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−8</E> </ENT> <ENT> 2 × 10 <E T="51">−8</E> </ENT> <ENT> 8 × 10 <E T="51">−9</E> </ENT> <ENT> 1.4 × 10 <E T="51">−9</E> </ENT> <ENT> 1.4 × 10 <E T="51">−11</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 8 × 10 <E T="51">−10</E> </ENT> <ENT> 1.4 × 10 <E T="51">−10</E> </ENT> <ENT> 1.4 × 10 <E T="51">−12</E> </ENT> </ROW> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU> Do not round to nearest integer. </TNOTE> </GPOTABLE> <PRTPAGE P="184"/> <GPOTABLE COLS="7" OPTS="L2" CDEF="s10,8,8,8,8,8,8"> <TTITLE> Table 4-30—Ecosystem Toxicity/Mobility/Persistence/Bioaccumulation Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Ecosystem toxicity/mobility/persistence factor value</CHED> <CHED H="1">Ecosystem bioaccumulation potential factor value</CHED> <CHED H="2">50,000</CHED> <CHED H="2">5,000</CHED> <CHED H="2">500</CHED> <CHED H="2">50</CHED> <CHED H="2">5</CHED> <CHED H="2">0.5</CHED> </BOXHD> <ROW> <ENT I="01">10,000</ENT> <ENT> 5 × 10 <SU>8</SU> </ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> </ROW> <ROW> <ENT I="01">4,000</ENT> <ENT> 2 × 10 <SU>8</SU> </ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> </ROW> <ROW> <ENT I="01">2,000</ENT> <ENT> 1, × 10 <SU>8</SU> </ENT> <ENT> 1 × 10 <SU>7</SU> </ENT> <ENT> 1 × 10 <SU>6</SU> </ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">1,000</ENT> <ENT> 5 × 10 <SU>7</SU> </ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">800</ENT> <ENT> 4 × 10 <SU>7</SU> </ENT> <ENT> 4 × 10 <SU>6</SU> </ENT> <ENT> 4 × 10 <SU>5</SU> </ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> </ROW> <ROW> <ENT I="01">700</ENT> <ENT> 3.5 × 10 <SU>7</SU> </ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> </ROW> <ROW> <ENT I="01">400</ENT> <ENT> 2 × 10 <SU>7</SU> </ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01">200</ENT> <ENT> 1 × 10 <SU>7</SU> </ENT> <ENT> 1 × 10 <SU>6</SU> </ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">140</ENT> <ENT> 7 × 10 <SU>6</SU> </ENT> <ENT> 7 × 10 <SU>5</SU> </ENT> <ENT> 7 × 10 <SU>4</SU> </ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT> 5 × 10 <SU>6</SU> </ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">80</ENT> <ENT> 4 × 10 <SU>6</SU> </ENT> <ENT> 4 × 10 <SU>5</SU> </ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> </ROW> <ROW> <ENT I="01">70</ENT> <ENT> 3.5 × 10 <SU>6</SU> </ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> </ROW> <ROW> <ENT I="01">40</ENT> <ENT> 2 × 10 <SU>6</SU> </ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01">20</ENT> <ENT> 1 × 10 <SU>6</SU> </ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">14</ENT> <ENT> 7 × 10 <SU>5</SU> </ENT> <ENT> 7 × 10 <SU>4</SU> </ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT> 5 × 10 <SU>5</SU> </ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">8</ENT> <ENT> 4 × 10 <SU>5</SU> </ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">7</ENT> <ENT> 3.5 × 10 <SU>5</SU> </ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT> 2 × 10 <SU>5</SU> </ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT> 1 × 10 <SU>5</SU> </ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">1.4</ENT> <ENT> 7 × 10 <SU>4</SU> </ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> </ROW> <ROW> <ENT I="01">1.0</ENT> <ENT> 5 × 10 <SU>4</SU> </ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> </ROW> <ROW> <ENT I="01">0.8</ENT> <ENT> 4 × 10 <SU>4</SU> </ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> </ROW> <ROW> <ENT I="01">0.7</ENT> <ENT> 3.5 × 10 <SU>4</SU> </ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> </ROW> <ROW> <ENT I="01">0.4</ENT> <ENT> 2 × 10 <SU>4</SU> </ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT> 1 × 10 <SU>4</SU> </ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> </ROW> <ROW> <ENT I="01">0.14</ENT> <ENT>7,000</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> </ROW> <ROW> <ENT I="01">0.1</ENT> <ENT>5,000</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> </ROW> <ROW> <ENT I="01">0.08</ENT> <ENT>4,000</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> </ROW> <ROW> <ENT I="01">0.07</ENT> <ENT>3,500</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> </ROW> <ROW> <ENT I="01">0.04</ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> </ROW> <ROW> <ENT I="01">0.02</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> </ROW> <ROW> <ENT I="01">0.014</ENT> <ENT>700</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> </ROW> <ROW> <ENT I="01">0.01</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> <ENT>0.005</ENT> </ROW> <ROW> <ENT I="01">0.008</ENT> <ENT>400</ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> </ROW> <ROW> <ENT I="01">0.007</ENT> <ENT>350</ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> </ROW> <ROW> <ENT I="01">0.004</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> </ROW> <ROW> <ENT I="01">0.002</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> </ROW> <ROW> <ENT I="01">0.0014</ENT> <ENT>70</ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01">0.001</ENT> <ENT>50</ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> <ENT>0.005</ENT> <ENT> 5 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−4</E> </ENT> <ENT>40</ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−4</E> </ENT> <ENT>35</ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 4 × 10 <E T="51">−4</E> </ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−4</E> </ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−4</E> </ENT> <ENT>7</ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 1 × 10 <E T="51">−4</E> </ENT> <ENT>5</ENT> <ENT>0.5</ENT> <ENT>0.05</ENT> <ENT>0.005</ENT> <ENT> 5 × 10 <E T="51">−4</E> </ENT> <ENT> 5 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−5</E> </ENT> <ENT>4</ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−5</E> </ENT> <ENT>3.5</ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 4 × 10 <E T="51">−5</E> </ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT> 2 × 10 <E T="51">−4</E> </ENT> <ENT> 2 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−5</E> </ENT> <ENT>1</ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−5</E> </ENT> <ENT>0.7</ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−6</E> </ENT> <ENT>0.4</ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−6</E> </ENT> <ENT>0.35</ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> <ENT> 3.5 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−6</E> </ENT> <ENT>0.1</ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−6</E> </ENT> <ENT>0.07</ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−7</E> </ENT> <ENT>0.04</ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−7</E> </ENT> <ENT>0.035</ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> <ENT> 3.5 × 10 <E T="51">−6</E> </ENT> <ENT> 3.5 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−7</E> </ENT> <ENT>0.01</ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> <ENT> 1 × 10 <E T="51">−7</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−7</E> </ENT> <ENT>0.007</ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−8</E> </ENT> <ENT>0.004</ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> <ENT> 4 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 7 × 10 <E T="51">−8</E> </ENT> <ENT>0.0035</ENT> <ENT> 3.5 × 10 <E T="51">−4</E> </ENT> <ENT> 3.5 × 10 <E T="51">−5</E> </ENT> <ENT> 3.5 × 10 <E T="51">−6</E> </ENT> <ENT> 3.5 × 10 <E T="51">−7</E> </ENT> <ENT> 3.5 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−8</E> </ENT> <ENT>0.001</ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> <ENT> 1 × 10 <E T="51">−7</E> </ENT> <ENT> 1 × 10 <E T="51">−8</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−4</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−9</E> </ENT> <ENT> 4 × 10 <E T="51">−4</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> <ENT> 4 × 10 <E T="51">−8</E> </ENT> <ENT> 4 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <ENT I="01"> 2 × 10 <E T="51">−9</E> </ENT> <ENT> 1 × 10 <E T="51">−4</E> </ENT> <ENT> 1 × 10 <E T="51">−5</E> </ENT> <ENT> 1 × 10 <E T="51">−6</E> </ENT> <ENT> 1 × 10 <E T="51">−7</E> </ENT> <ENT> 1 × 10 <E T="51">−8</E> </ENT> <ENT> 1 × 10 <E T="51">−9</E> </ENT> </ROW> <ROW> <PRTPAGE P="185"/> <ENT I="01"> 1.4 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−5</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> </ROW> <ROW> <ENT I="01"> 8 × 10 <E T="51">−10</E> </ENT> <ENT> 4 × 10 <E T="51">−5</E> </ENT> <ENT> 4 × 10 <E T="51">−6</E> </ENT> <ENT> 4 × 10 <E T="51">−7</E> </ENT> <ENT> 4 × 10 <E T="51">−8</E> </ENT> <ENT> 4 × 10 <E T="51">−9</E> </ENT> <ENT> 4 × 10 <E T="51">−10</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−6</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−11</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−11</E> </ENT> <ENT> 7 × 10 <E T="51">−7</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−11</E> </ENT> <ENT> 7 × 10 <E T="51">−12</E> </ENT> </ROW> <ROW> <ENT I="01"> 1.4 × 10 <E T="51">−12</E> </ENT> <ENT> 7 × 10 <E T="51">−8</E> </ENT> <ENT> 7 × 10 <E T="51">−9</E> </ENT> <ENT> 7 × 10 <E T="51">−10</E> </ENT> <ENT> 7 × 10 <E T="51">−11</E> </ENT> <ENT> 7 × 10 <E T="51">−12</E> </ENT> <ENT> 7 × 10 <E T="51">−13</E> </ENT> </ROW> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU> Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 4.2.4.2.2  <E T="03">Hazardous waste quantity.</E> Assign the same factor value for hazardous waste quantity for the watershed as would be assigned in section 4.2.2.2.2 for the drinking water threat. Enter this value in table 4-25. </P> <P> 4.2.4.2.3  <E T="03">Calculation of environmental threat-waste characteristics factor category value.</E> For the hazardous substance selected for the watershed in section 4.2.4.2.1.5, use its ecosystem toxicity/mobility/persistence factor value and ecosystem bioaccumulation potential factor value as follows to assign a value to the waste characteristics factor category. First, multiply the ecosystem toxicity/mobility/persistence factor value and the hazardous waste quantity factor value for the watershed, subject to a maximum product of 1 × 10 <SU>8</SU> . Then multiply this product by the ecosystem bioaccumulation potential factor value for this hazardous substance, subject to a maximum product of 1 × 10 <SU>12</SU> . Based on this product, assign a value from table 2-7 (section 2.4.3.1) to the environmental threat-waste characteristics category for the watershed. Enter the value in table 4-25. </P> <P> 4.2.4.3  <E T="03">Environmental threat-targets.</E> Evaluate the environmental threat-targets factor category for a watershed using one factor: sensitive environments. </P> <P> 4.2.4.3.1  <E T="03">Sensitive environments.</E> Evaluate sensitive environments for the watershed based on three factors: Level I concentrations, Level II concentrations, and potential contamination. Determine which applies to each sensitive environment as specified in section 4.1.4.3.1, except: use only those samples from the surface water in-water segment and only those hazardous substances in such samples that meet the conditions in sections 4.2.1.3 and 4.2.1.4. </P> <P> 4.2.4.3.1.1  <E T="03">Level I concentrations.</E> Assign a value to this factor as specified in section 4.1.4.3.1.1. Enter this value in table 4-25. </P> <P> 4.2.4.3.1.2  <E T="03">Level II concentrations.</E> Assign a value to this factor as specified in section 4.1.4.3.1.2. Enter this value in table 4-25. </P> <P> 4.2.4.3.1.3  <E T="03">Potential contamination.</E> Assign a value to this factor as specified in section 4.1.4.3.1.3 with the following modification. Multiply the appropriate dilution weight from table 4-13 for the sensitive environments in each type of surface water body by the adjustment value selected from table 4-27, as specified in section 4.2.2.3.1. Use the resulting product, not the value from table 4-13, as the dilution weight for the sensitive environments in that type of surface water body. Do not round this product to the nearest integer. Enter the value assigned in table 4-25. </P> <P> 4.2.4.3.1.4  <E T="03">Calculation of environmental threat-targets factor category value.</E> Sum the values for Level I concentrations, Level II concentrations, and potential contamination for the watershed. Do not round this sum to the nearest integer. Assign this sum as the environmental threat targets factor category value for the watershed. Enter this value in table 4-25. </P> <P> 4.2.4.4  <E T="03">Calculation of environmental threat score for a watershed.</E> Multiply the environmental threat factor category values for likelihood of release, waste characteristics, and targets for the watershed, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum of 60, as the environmental threat score for the watershed. Enter this score in table 4-25. </P> <P> 4.2.5  <E T="03">Calculation of ground water to surface water migration component score for a watershed.</E> Sum the scores for the three threats for the watershed (that is, drinking water, human food chain, and environmental threats). Assign the resulting score, subject to a maximum value of 100, as the ground water to surface water migration component score for the watershed. Enter this score in table 4-25. </P> <P> 4.2.6  <E T="03">Calculation of ground water to surface water migration component score.</E> Select the highest ground water to surface water migration component score from the watersheds evaluated. Assign this score as the ground water to surface water migration component score for the site, subject to a maximum score of 100. Enter this score in table 4-25. </P> <P> 4.3  <E T="03">Calculation of surface water migration pathway score.</E> Determine the surface water migration pathway score as follows: <PRTPAGE P="186"/> </P> <P>• If only one of the two surface water migration components (overland/flood or ground water to surface water) is scored, assign the score of that component as the surface water migration pathway score.</P> <P>• If both components are scored, select the higher of the two component scores from sections 4.1.6 and 4.2.6. Assign that score as the surface water migration pathway score.</P> <HD SOURCE="HD1">5.0 Soil Exposure and Subsurface Intrusion Pathway</HD> <P> 5.0.1  <E T="03">Exposure components.</E> Evaluate the soil exposure and subsurface intrusion pathway based on two exposure components: </P> <P>• Soil exposure component (see section 5.1).</P> <P>• Subsurface intrusion component (see section 5.2).</P> <P>Score one or both components considering their relative importance. If only one component is scored, assign its score as the soil exposure and subsurface intrusion pathway score. If both components are scored, sum the two scores and assign it as the soil exposure and subsurface intrusion pathway score, subject to a maximum of 100.</P> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="187"/> <GID>ER09JA17.066</GID> </GPH> <P> 5.1  <E T="03">Soil exposure component.</E> Evaluate the soil exposure component based on two threats: Resident population threat and nearby population threat. Evaluate both threats based on three factor categories: Likelihood of exposure, waste characteristics, and targets. Figure 5-1 indicates the <PRTPAGE P="188"/> factors included within each factor category for each type of threat. </P> <P> Determine the soil exposure component score (S <E T="52">se</E> ) in terms of the factor category values as follows: </P> <GPH SPAN="2" DEEP="32"> <GID>ER09JA17.067</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> LE <E T="52">i</E> = Likelihood of exposure factor category value for threat i (that is, resident population threat or nearby population threat). </FP> <FP SOURCE="FP-2"> WC <E T="52">i</E> = Waste characteristics factor category value for threat i. </FP> <FP SOURCE="FP-2"> T <E T="52">i</E> = Targets factor category value for threat i. </FP> <FP SOURCE="FP-2">SF = Scaling factor.</FP> <P>Table 5-1 outlines the specific calculation procedure.</P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s100,12,12"> <TTITLE>Table 5-1—Soil Exposure Component Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor categories and factors</CHED> <CHED H="1">Maximum value</CHED> <CHED H="1"> Value <LI>assigned</LI> </CHED> </BOXHD> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Resident Population Threat</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="22">Likelihood of Exposure:</ENT> </ROW> <ROW> <ENT I="03">1. Likelihood of Exposure</ENT> <ENT>550</ENT> </ROW> <ROW> <ENT I="22">Waste Characteristics:</ENT> </ROW> <ROW> <ENT I="03">2. Toxicity</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="03">3. Hazardous Waste Quantity</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="03">4. Waste Characteristics</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="22">Targets:</ENT> </ROW> <ROW> <ENT I="03">5. Resident Individual</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="03">6. Resident Population:</ENT> </ROW> <ROW> <ENT I="05">6a. Level I Concentrations</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="05">6b. Level II Concentrations</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="05">6c. Resident Population (lines 6a + 6b)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">7. Workers</ENT> <ENT>15</ENT> </ROW> <ROW> <ENT I="03">8. Resources</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">9. Terrestrial Sensitive Environments</ENT> <ENT> ( <SU>c</SU> ) </ENT> </ROW> <ROW> <ENT I="03">10. Targets (lines 5 + 6c + 7 + 8 + 9)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="22">Resident Population Threat Score:</ENT> </ROW> <ROW RUL="s"> <ENT I="03">11. Resident Population Threat (lines 1 × 4 × 10)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW EXPSTB="02" RUL="s"> <ENT I="21"> <E T="02">Nearby Population Threat</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="22">Likelihood of Exposure:</ENT> </ROW> <ROW> <ENT I="03">12. Attractiveness/Accessibility</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="03">13. Area of Contamination</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="03">14. Likelihood of Exposure</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="22">Waste Characteristics:</ENT> </ROW> <ROW> <ENT I="03">15. Toxicity</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="03">16. Hazardous Waste Quantity</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="03">17. Waste Characteristics</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="22">Targets:</ENT> </ROW> <ROW> <ENT I="03">18. Nearby Individual</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="03">19. Population Within 1 Mile</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">20. Targets (lines 18 + 19)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="22">Nearby Population Threat Score:</ENT> </ROW> <ROW> <ENT I="03">21. Nearby Population Threat (lines 14 × 17 × 20)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="22">Soil Exposure Component Score:</ENT> </ROW> <ROW> <ENT I="03"> 22. Soil Exposure Component Score  <SU>d</SU> (S <E T="52">se</E> ), (lines [11 + 21]/82,500, subject to a maximum of 100) </ENT> <ENT>100</ENT> </ROW> <TNOTE> <SU>a</SU>   Maximum value applies to waste characteristics category. </TNOTE> <TNOTE> <SU>b</SU>  Maximum value not applicable. </TNOTE> <TNOTE> <SU>c</SU>  No specific maximum value applies to factor. However, pathway score based solely on terrestrial sensitive environments is limited to maximum of 60. </TNOTE> <TNOTE> <SU>d</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <PRTPAGE P="189"/> <P> 5.1.0  <E T="03">General considerations.</E> Evaluate the soil exposure component based on areas of observed contamination: </P> <P>• Consider observed contamination to be present at sampling locations where analytic evidence indicates that:</P> <FP SOURCE="FP-1"> —A hazardous substance attributable to the site is present at a concentration significantly above background levels for the site (see Table 2-3 in section 2.3 for the criteria for determining analytical significance), <E T="03">and</E> </FP> <FP SOURCE="FP-1">—This hazardous substance, if not present at the surface, is covered by 2 feet or less of cover material (for example, soil).</FP> <P>• Establish areas of observed contamination based on sampling locations at which there is observed contamination as follows:</P> <FP SOURCE="FP-1">—For all sources except contaminated soil, if observed contamination from the site is present at any sampling location within the source, consider that entire source to be an area of observed contamination.</FP> <FP SOURCE="FP-1">—For contaminated soil, consider both the sampling location(s) with observed contamination from the site and the area lying between such locations to be an area of observed contamination, unless available information indicates otherwise.</FP> <P>• If an area of observed contamination (or portion of such an area) is covered by a permanent, or otherwise maintained, essentially impenetrable material (for example, asphalt) that is not more than 2 feet thick, exclude that area (or portion of the area) in evaluating the soil exposure component.</P> <P>• For an area of observed contamination, consider only those hazardous substances that meet the criteria for observed contamination for that area to be associated with that area in evaluating the soil exposure component (see section 2.2.2).</P> <P>If there is observed contamination, assign scores for the resident population threat and the nearby population threat, as specified in sections 5.1.1 and 5.1.2. If there is no observed contamination, assign the soil exposure component of the soil exposure and subsurface intrusion pathway a score of 0.</P> <P> 5.1.1  <E T="03">Resident population threat.</E> Evaluate the resident population threat only if there is an area of observed contamination in one or more of the following locations: </P> <P> • Within the property boundary of a residence, school, or day care center <E T="03">and</E> within 200 feet of the respective residence, school, or day care center, or </P> <P> • Within a workplace property boundary <E T="03">and</E> within 200 feet of a workplace area, or </P> <P>• Within the boundaries of a resource specified in section 5.1.1.3.4, or</P> <P>• Within the boundaries of a terrestrial sensitive environment specified in section 5.1.1.3.5.</P> <P>If not, assign the resident population threat a value of 0, enter this value in Table 5-1, and proceed to the nearby population threat (section 5.1.2).</P> <P> 5.1.1.1  <E T="03">Likelihood of exposure.</E> Assign a value of 550 to the likelihood of exposure factor category for the resident population threat if there is an area of observed contamination in one or more locations listed in section 5.1.1. Enter this value in Table 5-1. </P> <P> 5.1.1.2  <E T="03">Waste characteristics.</E> Evaluate waste characteristics based on two factors: toxicity and hazardous waste quantity. Evaluate only those hazardous substances that meet the criteria for observed contamination at the site (see section 5.1.0). </P> <P> 5.1.1.2.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in section 2.4.1.1. Use the hazardous substance with the highest toxicity factor value to assign the value to the toxicity factor for the resident population threat. Enter this value in Table 5-1. </P> <P> 5.1.1.2.2  <E T="03">Hazardous waste quantity.</E> Assign a hazardous waste quantity factor value as specified in section 2.4.2. In estimating the hazardous waste quantity, use Table 5-2 and: </P> <P>• Consider only the first 2 feet of depth of an area of observed contamination, except as specified for the volume measure.</P> <P>• Use the volume measure (see section 2.4.2.1.3) only for those types of areas of observed contamination listed in Tier C of Table 5-2. In evaluating the volume measure for these listed areas of observed contamination, use the full volume, not just the volume within the top 2 feet.</P> <P>• Use the area measure (see section 2.4.2.1.4), not the volume measure, for all other types of areas of observed contamination, even if their volume is known.</P> <P>Enter the value assigned in Table 5-1.</P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s25,r100,r25,xs60"> <TTITLE>Table 5-2—Hazardous Waste Quantity Evaluation Equations for Soil Exposure Component</TTITLE> <BOXHD> <CHED H="1">Tier</CHED> <CHED H="1">Measure</CHED> <CHED H="1">Units</CHED> <CHED H="1"> Equation for <LI>assigning</LI> <LI> value  <SU>a</SU> </LI> </CHED> </BOXHD> <ROW> <ENT I="01">A</ENT> <ENT>Hazardous Constituent Quantity (C)</ENT> <ENT>lb</ENT> <ENT>C.</ENT> </ROW> <ROW> <ENT I="01">  B <SU>b</SU> </ENT> <ENT>Hazardous Wastestream Quantity (W)</ENT> <ENT>lb</ENT> <ENT>W/5,000.</ENT> </ROW> <ROW> <ENT I="01"> C  <SU>b</SU> </ENT> <ENT>Volume (V)</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Surface Impoundment  <SU>c</SU> </ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Drums  <SU>d</SU> </ENT> <ENT>gallon</ENT> <ENT>V/500.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tanks and Containers Other Than Drums</ENT> <ENT> yd  <SU>3</SU> </ENT> <ENT>V/2.5.</ENT> </ROW> <ROW> <PRTPAGE P="190"/> <ENT I="01"> D  <SU>b</SU> </ENT> <ENT>Area (A)</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Landfill</ENT> <ENT> ft  <SU>2</SU> </ENT> <ENT>A/34,000.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Surface Impoundment</ENT> <ENT> ft  <SU>2</SU> </ENT> <ENT>A/13.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Surface Impoundment (Buried/backfilled)</ENT> <ENT> ft  <SU>2</SU> </ENT> <ENT>A/13.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Land treatment</ENT> <ENT> ft  <SU>2</SU> </ENT> <ENT>A/270.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Pile  <SU>e</SU> </ENT> <ENT> ft  <SU>2</SU> </ENT> <ENT>A/34.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Contaminated Soil</ENT> <ENT> ft  <SU>2</SU> </ENT> <ENT>A/34,000.</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  Convert volume to mass when necessary: 1 ton = 2,000 pounds = 1 cubic yard = 4 drums = 200 gallons. </TNOTE> <TNOTE> <SU>c</SU>  Use volume measure only for surface impoundments containing hazardous substances present as liquids. Use area measures in Tier D for dry surface impoundments and for buried/backfilled surface impoundments. </TNOTE> <TNOTE> <SU>d</SU>  If actual volume of drums is unavailable, assume 1 drum = 50 gallons. </TNOTE> <TNOTE> <SU>e</SU>  Use land surface area under pile, not surface area of pile. </TNOTE> </GPOTABLE> <P> 5.1.1.2.3  <E T="03">Calculation of waste characteristics factor category value.</E> Multiply the toxicity and hazardous waste quantity factor values, subject to a maximum product of 1 × 10  <SU>8</SU> . Based on this product, assign a value from Table 2-7 (section 2.4.3.1) to the waste characteristics factor category. Enter this value in Table 5-1. </P> <P> 5.1.1.3  <E T="03">Targets.</E> Evaluate the targets factor category for the resident population threat based on five factors: Resident individual, resident population, workers, resources, and terrestrial sensitive environments. </P> <P>In evaluating the targets factor category for the resident population threat, count only the following as targets:</P> <P> • Resident individual—a person living or attending school or day care on a property with an area of observed contamination <E T="03">and</E> whose residence, school, or day care center, respectively, is on or within 200 feet of the area of observed contamination. </P> <P> • Worker—a person working on a property with an area of observed contamination <E T="03">and</E> whose workplace area is on or within 200 feet of the area of observed contamination. </P> <P>• Resources located on an area of observed contamination, as specified in section 5.1.1.</P> <P>• Terrestrial sensitive environments located on an area of observed contamination, as specified in section 5.1.1.</P> <P> 5.1.1.3.1  <E T="03">Resident individual.</E> Evaluate this factor based on whether there is a resident individual, as specified in section 5.1.1.3, who is subject to Level I or Level II concentrations. </P> <P>First, determine those areas of observed contamination subject to Level I concentrations and those subject to Level II concentrations as specified in sections 2.5.1 and 2.5.2. Use the health-based benchmarks from Table 5-3 in determining the level of contamination. Then assign a value to the resident individual factor as follows:</P> <P>• Assign a value of 50 if there is at least one resident individual for one or more areas subject to Level I concentrations.</P> <P>• Assign a value of 45 if there is no such resident individuals, but there is at least one resident individual for one or more areas subject to Level II concentrations.</P> <P>• Assign a value of 0 if there is no resident individual.</P> <FP>Enter the value assigned in Table 5-1.</FP> <P> 5.1.1.3.2  <E T="03">Resident population.</E> Evaluate resident population based on two factors: Level I concentrations and Level II concentrations. Determine which factor applies as specified in sections 2.5.1 and 2.5.2, using the health-based benchmarks from Table 5-3. Evaluate populations subject to Level I concentrations as specified in section 5.1.1.3.2.1 and populations subject to Level II concentrations as specified in section 5.1.1.3.2.2. </P> <GPOTABLE COLS="1" OPTS="L1" CDEF="s200"> <TTITLE>Table 5-3—Health-Based Benchmarks for Hazardous Substances in Soils</TTITLE> <BOXHD> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01"> Screening concentration for cancer corresponding to that concentration that corresponds to the 10  <E T="51">−6</E> individual cancer risk for oral exposures. </ENT> </ROW> <ROW> <ENT I="01">Screening concentration for noncancer toxicological responses corresponding to the Reference Dose (RfD) for oral exposures.</ENT> </ROW> </GPOTABLE> <P> Count only those persons meeting the criteria for resident individual as specified in section 5.1.1.3. In estimating the number of people living on property with an area of observed contamination, when the estimate is based on the number of residences, multiply <PRTPAGE P="191"/> each residence by the average number of persons per residence for the county in which the residence is located. </P> <P> 5.1.1.3.2.1  <E T="03">Level I concentrations.</E> Sum the number of resident individuals subject to Level I concentrations and multiply this sum by 10. Assign the resulting product as the value for this factor. Enter this value in Table 5-1. </P> <P> 5.1.1.3.2.2  <E T="03">Level II concentrations.</E> Sum the number of resident individuals subject to Level II concentrations. Do not include those people already counted under the Level I concentrations factor. Assign this sum as the value for this factor. Enter this value in Table 5-1. </P> <P> 5.1.1.3.2.3  <E T="03">Calculation of resident population factor value.</E> Sum the factor values for Level I concentrations and Level II concentrations. Assign this sum as the resident population factor value. Enter this value in Table 5-1. </P> <P> 5.1.1.3.3  <E T="03">Workers.</E> Evaluate this factor based on the number of workers that meet the section 5.1.1.3 criteria. Assign a value for these workers using Table 5-4. Enter this value in Table 5-1. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s25,10"> <TTITLE>Table 5-4—Factor Values for Workers</TTITLE> <BOXHD> <CHED H="1">Number of workers</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">1 to 100</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">101 to 1,000</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Greater than 1,000</ENT> <ENT>15</ENT> </ROW> </GPOTABLE> <P> 5.1.1.3.4  <E T="03">Resources.</E> Evaluate the resources factor as follows: </P> <P>• Assign a value of 5 to the resources factor if one or more of the following is present on an area of observed contamination at the site:</P> <FP SOURCE="FP-1">—Commercial agriculture.</FP> <FP SOURCE="FP-1">—Commercial silviculture.</FP> <FP SOURCE="FP-1">—Commercial livestock production or commercial livestock grazing.</FP> <P>• Assign a value of 0 if none of the above are present.</P> <P>Enter the value assigned in Table 5-1.</P> <P> 5.1.1.3.5  <E T="03">Terrestrial sensitive environments.</E> Assign value(s) from Table 5-5 to each terrestrial sensitive environment that meets the eligibility criteria of section 5.1.1.3. </P> <P>Calculate a value (ES) for terrestrial sensitive environments as follows:</P> <GPH SPAN="2" DEEP="37"> <GID>ER09JA17.068</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> S <E T="52">i</E> = Value(s) assigned from Table 5-5 to terrestrial sensitive environment i. </FP> <FP SOURCE="FP-2">n = Number of terrestrial sensitive environments meeting section 5.1.1.3 criteria.</FP> <P>Because the pathway score based solely on terrestrial sensitive environments is limited to a maximum of 60, determine the value for the terrestrial sensitive environments factor as follows:</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,12"> <TTITLE>Table 5-5—Terrestrial Sensitive Environments Rating Values</TTITLE> <BOXHD> <CHED H="1">Terrestrial sensitive environments</CHED> <CHED H="1"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="01"> Terrestrial critical habitat  <SU>a</SU> for Federal designated endangered or threatened species </ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="03" O="xl"> National Park <LI>Designated Federal Wilderness Area</LI> <LI>National Monument</LI> </ENT> </ROW> <ROW> <ENT I="01">Terrestrial habitat known to be used by Federal designated or proposed threatened or endangered species</ENT> <ENT>75</ENT> </ROW> <ROW> <ENT I="03" O="xl"> National Preserve (terrestrial) <LI> National or State Terrestrial Wildlife Refuge</LI> <LI>Federal land designated for protection of natural ecosystems</LI> <LI> Administratively proposed Federal Wilderness Area</LI> <LI> Terrestrial areas utilized for breeding by large or dense aggregations of animals  <SU>b</SU> </LI> </ENT> </ROW> <ROW> <ENT I="01">Terrestrial habitat known to be used by State designated endangered or threatened species</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="03" O="xl">Terrestrial habitat known to be used by species under review as to its Federal designated endangered or threatened status</ENT> </ROW> <ROW> <ENT I="01">State lands designated for wildlife or game management</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="03" O="xl"> State designated Natural Areas <LI>Particular areas, relatively small in size, important to maintenance of unique biotic communities</LI> </ENT> </ROW> <TNOTE> <SU>a</SU>  Critical habitat as defined in 50 CFR 424.02. </TNOTE> <TNOTE> <SU>b</SU>  Limit to vertebrate species. </TNOTE> </GPOTABLE> <PRTPAGE P="192"/> <P>• Multiply the values assigned to the resident population threat for likelihood of exposure (LE), waste characteristics (WC), and ES. Divide the product by 82,500.</P> <FP SOURCE="FP-1">—If the result is 60 or less, assign the value ES as the terrestrial sensitive environments factor value.</FP> <FP SOURCE="FP-1">—If the result exceeds 60, calculate a value EC as follows:</FP> <GPH SPAN="2" DEEP="29"> <GID>ER09JA17.069</GID> </GPH> <P>Assign the value EC as the terrestrial sensitive environments factor value. Do not round this value to the nearest integer.</P> <P>Enter the value assigned for the terrestrial sensitive environments factor in Table 5-1.</P> <P> 5.1.1.3.6  <E T="03">Calculation of resident population targets factor category value.</E> Sum the values for the resident individual, resident population, workers, resources, and terrestrial sensitive environments factors. Do not round to the nearest integer. Assign this sum as the targets factor category value for the resident population threat. Enter this value in Table 5-1. </P> <P> 5.1.1.4  <E T="03">Calculation of resident population threat score.</E> Multiply the values for likelihood of exposure, waste characteristics, and targets for the resident population threat, and round the product to the nearest integer. Assign this product as the resident population threat score. Enter this score in Table 5-1. </P> <P> 5.1.2  <E T="03">Nearby population threat.</E> Include in the nearby population only those individuals who live or attend school within a 1-mile travel distance of an area of observed contamination at the site and who do not meet the criteria for resident individual as specified in section 5.1.1.3. </P> <P>Do not consider areas of observed contamination that have an attractiveness/accessibility factor value of 0 (see section 5.1.2.1.1) in evaluating the nearby population threat.</P> <P> 5.1.2.1  <E T="03">Likelihood of exposure.</E> Evaluate two factors for the likelihood of exposure factor category for the nearby population threat: attractiveness/accessibility and area of contamination. </P> <P> 5.1.2.1.1  <E T="03">Attractiveness/accessibility.</E> Assign a value for attractiveness/accessibility from Table 5-6 to each area of observed contamination, excluding any land used for residences. Select the highest value assigned to the areas evaluated and use it as the value for the attractiveness/accessibility factor. Enter this value in Table 5-1. </P> <P> 5.1.2.1.2  <E T="03">Area of contamination.</E> Evaluate area of contamination based on the total area of the areas of observed contamination at the site. Count only the area(s) that meet the criteria in section 5.1.0 and that receive an attractiveness/accessibility value greater than 0. Assign a value to this factor from Table5-7. Enter this value in Table 5-1. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s150,12"> <TTITLE>Table 5-6—Attractiveness/Accessibility Values</TTITLE> <BOXHD> <CHED H="1">Area of observed contamination</CHED> <CHED H="1"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Designated recreational area</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Regularly used for public recreation (for example, fishing, hiking, softball)</ENT> <ENT>75</ENT> </ROW> <ROW> <ENT I="01">Accessible and unique recreational area (for example, vacant lots in urban area)</ENT> <ENT>75</ENT> </ROW> <ROW> <ENT I="01">Moderately accessible (may have some access improvements, for example, gravel road), with some public recreation use</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01">Slightly accessible (for example, extremely rural area with no road improvement), with some public recreation use</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="01">Accessible, with no public recreation use</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Surrounded by maintained fence or combination of maintained fence and natural barriers</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">Physically inaccessible to public, with no evidence of public recreation use</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,12"> <TTITLE>Table 5-7—Area of Contamination Factor Values</TTITLE> <BOXHD> <CHED H="1">Total area of the areas of observed contamination (square feet)</CHED> <CHED H="1"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Less than or equal to 5,000</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">Greater than 5,000 to 125,000</ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01">Greater than 125,000 to 250,000</ENT> <ENT>40</ENT> </ROW> <ROW> <ENT I="01">Greater than 250,000 to 375,000</ENT> <ENT>60</ENT> </ROW> <ROW> <ENT I="01">Greater than 375,000 to 500,000</ENT> <ENT>80</ENT> </ROW> <ROW> <ENT I="01">Greater than 500,000</ENT> <ENT>100</ENT> </ROW> </GPOTABLE> <PRTPAGE P="193"/> <P> 5.1.2.1.3  <E T="03">Likelihood of exposure factor category value.</E> Assign a value from Table 5-8 to the likelihood of exposure factor category, based on the values assigned to the attractiveness/accessibility and area of contamination factors. Enter this value in Table 5-1. </P> <GPOTABLE COLS="8" OPTS="L2" CDEF="s25,9,9,9,9,9,9,9"> <TTITLE>Table 5-8—Nearby Population Likelihood of Exposure Factor Values</TTITLE> <BOXHD> <CHED H="1">Area of contamination factor value</CHED> <CHED H="1">Attractiveness/accessibility factor value</CHED> <CHED H="2">100</CHED> <CHED H="2">75</CHED> <CHED H="2">50</CHED> <CHED H="2">25</CHED> <CHED H="2">10</CHED> <CHED H="2">5</CHED> <CHED H="2">0</CHED> </BOXHD> <ROW> <ENT I="01">100</ENT> <ENT>500</ENT> <ENT>500</ENT> <ENT>375</ENT> <ENT>250</ENT> <ENT>125</ENT> <ENT>50</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">80</ENT> <ENT>500</ENT> <ENT>375</ENT> <ENT>250</ENT> <ENT>125</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">60</ENT> <ENT>375</ENT> <ENT>250</ENT> <ENT>125</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>5</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">40</ENT> <ENT>250</ENT> <ENT>125</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">20</ENT> <ENT>125</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">5</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>5</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <P> 5.1.2.2  <E T="03">Waste characteristics.</E> Evaluate waste characteristics based on two factors: toxicity and hazardous waste quantity. Evaluate only those hazardous substances that meet the criteria for observed contamination (see section 5.1.0) at areas that can be assigned an attractiveness/accessibility factor value greater than 0. </P> <P> 5.1.2.2.1  <E T="03">Toxicity.</E> Assign a toxicity factor value as specified in section 2.4.1.1 to each hazardous substance meeting the criteria in section 5.1.2.2. Use the hazardous substance with the highest toxicity factor value to assign the value to the toxicity factor for the nearby population threat. Enter this value in Table 5-1. </P> <P> 5.1.2.2.2  <E T="03">Hazardous waste quantity.</E> Assign a value to the hazardous waste quantity factor as specified in section 5.1.1.2.2, except: consider only those areas of observed contamination that can be assigned an attractiveness/accessibility factor value greater than 0. Enter the value assigned in Table 5-1. </P> <P> 5.1.2.2.3  <E T="03">Calculation of waste characteristics factor category value.</E> Multiply the toxicity and hazardous waste quantity factor values, subject to a maximum product of 1 × 10 <SU>8</SU> . Based on this product, assign a value from Table 2-7 (section 2.4.3.1) to the waste characteristics factor category. Enter this value in Table 5-1. </P> <P> 5.1.2.3  <E T="03">Targets.</E> Evaluate the targets factory category for the nearby population threat based on two factors: nearby individual and population within a 1-mile travel distance from the site. </P> <P> 5.1.2.3.1  <E T="03">Nearby individual.</E> If one or more persons meet the section 5.1.1.3 criteria for a resident individual, assign this factor a value of 0. Enter this value in Table 5-1. </P> <P>If no person meets the criteria for a resident individual, determine the shortest travel distance from the site to any residence or school. In determining the travel distance, measure the shortest overland distance an individual would travel from a residence or school to the nearest area of observed contamination for the site with an attractiveness/accessibility factor value greater than 0. If there are no natural barriers to travel, measure the travel distance as the shortest straight-line distance from the residence or school to the area of observed contamination. If natural barriers exist (for example, a river), measure the travel distance as the shortest straight-line distance from the residence or school to the nearest crossing point and from there as the shortest straight-line distance to the area of observed contamination. Based on the shortest travel distance, assign a value from Table 5-9 to the nearest individual factor. Enter this value in Table 5-1.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s25,8"> <TTITLE>Table 5-9—Nearby Individual Factor Values</TTITLE> <BOXHD> <CHED H="1"> Travel distance for nearby <LI>individual (miles)</LI> </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> Greater than 0 to <FR>1/4</FR> </ENT> <ENT> <SU>a</SU>  1 </ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to 1 </ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Assign a value of 0 if one or more persons meet the section 5.1.1.3 criteria for resident individual. </TNOTE> </GPOTABLE> <P> 5.1.2.3.2  <E T="03">Population within 1 mile.</E> Determine the population within each travel distance category of Table 5-10. Count residents and students who attend school within this travel distance. Do not include those people already counted in the resident population threat. Determine travel distances as specified in section 5.1.2.3.1. </P> <P>In estimating residential population, when the estimate is based on the number of residences, multiply each residence by the average number of persons per residence for the county in which the residence is located.</P> <P>Based on the number of people included within a travel distance category, assign a distance-weighted population value for that travel distance from Table 5-10.</P> <P>Calculate the value for the population within 1 mile factor (PN) as follows:</P> <GPH SPAN="2" DEEP="39"> <PRTPAGE P="194"/> <GID>ER09JA17.070</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2"> W <E T="52">i</E> =Distance-weighted population value from Table 5-10 for travel distance category i. </FP> <P>If PN is less than 1, do not round it to the nearest integer; if PN is 1 or more, round to the nearest integer. Enter this value in Table 5-1.</P> <P> 5.1.2.3.3  <E T="03">Calculation of nearby population targets factor category value.</E> Sum the values for the nearby individual factor and the population within 1 mile factor. Do not round this sum to the nearest integer. Assign this sum as the targets factor category value for the nearby population threat. Enter this value in Table 5-1. </P> <GPOTABLE COLS="13" OPTS="L2" CDEF="s25,5,5,5,5,5,5,5,6,6,7,7,9"> <TTITLE> Table 5-10—Distance Weighted Population Values for Nearby Population Threat  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Travel distance category (miles)</CHED> <CHED H="1">Number of people within the travel distance category</CHED> <CHED H="2">0</CHED> <CHED H="2">1 to 10</CHED> <CHED H="2">11 to 30</CHED> <CHED H="2">31 to 100</CHED> <CHED H="2">101 to 300</CHED> <CHED H="2">301 to 1,000</CHED> <CHED H="2">1,001 to 3,000</CHED> <CHED H="2">3,001 to 10,000</CHED> <CHED H="2">10,001 to 30,000</CHED> <CHED H="2">30,001 to 100,000</CHED> <CHED H="2">100,001 to 300,000</CHED> <CHED H="2">300,001 to 1,000,000</CHED> </BOXHD> <ROW> <ENT I="01"> Greater than 0 to <FR>1/4</FR> </ENT> <ENT>0</ENT> <ENT>0.1</ENT> <ENT>0.4</ENT> <ENT>1.0</ENT> <ENT>4</ENT> <ENT>13</ENT> <ENT>41</ENT> <ENT>130</ENT> <ENT>408</ENT> <ENT>1,303</ENT> <ENT>4,081</ENT> <ENT>13,034</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to <FR>1/2</FR> </ENT> <ENT>0</ENT> <ENT>0.05</ENT> <ENT>0.2</ENT> <ENT>0.7</ENT> <ENT>2</ENT> <ENT>7</ENT> <ENT>20</ENT> <ENT>65</ENT> <ENT>204</ENT> <ENT>652</ENT> <ENT>2,041</ENT> <ENT>6,517</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>0</ENT> <ENT>0.02</ENT> <ENT>0.1</ENT> <ENT>0.3</ENT> <ENT>1</ENT> <ENT>3</ENT> <ENT>10</ENT> <ENT>33</ENT> <ENT>102</ENT> <ENT>326</ENT> <ENT>1,020</ENT> <ENT>3,258</ENT> </ROW> <TNOTE> <SU>a</SU>  Round the number of people present within a travel distance category to nearest integer. Do not round the assigned distance-weighted population value to nearest integer. </TNOTE> </GPOTABLE> <P> 5.1.2.4  <E T="03">Calculation of nearby population threat score.</E> Multiply the values for likelihood of exposure, waste characteristics, and targets for the nearby population threat, and round the product to the nearest integer. Assign this product as the nearby population threat score. Enter this score in Table 5-1. </P> <P> 5.1.3  <E T="03">Calculation of soil exposure component score.</E> Sum the resident population threat score and the nearby population threat score, and divide the sum by 82,500. Assign the resulting value, subject to a maximum of 100, as the soil exposure component score (S <E T="52">se</E> ). Enter this score in Table 5-1. </P> <P> 5.2  <E T="03">Subsurface intrusion component.</E> Evaluate the subsurface intrusion component based on three factor categories: likelihood of exposure, waste characteristics, and targets. Figure 5-1 indicates the factors included within each factor category for the subsurface intrusion component. </P> <P> Determine the component score (S <E T="52">ssi</E> ) in terms of the factor category values as follows: </P> <GPH SPAN="2" DEEP="30"> <GID>ER09JA17.071</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">LE=Likelihood of exposure factor category value.</FP> <FP SOURCE="FP-2">WC=Waste characteristics factor category value.</FP> <FP SOURCE="FP-2">T=Targets factor category value.</FP> <FP SOURCE="FP-2">SF=Scaling factor.</FP> <P> Table 5-11 outlines the specific calculation procedure. <PRTPAGE P="195"/> </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s100,12,12"> <TTITLE>Table 5-11—Subsurface Intrusion Component Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor categories and factors</CHED> <CHED H="1"> Maximum <LI>value</LI> </CHED> <CHED H="1"> Value <LI>assigned</LI> </CHED> </BOXHD> <ROW> <ENT I="01" O="xl">Subsurface Intrusion Component:</ENT> </ROW> <ROW> <ENT I="22">Likelihood of Exposure:</ENT> </ROW> <ROW> <ENT I="03">1. Observed Exposure</ENT> <ENT>550</ENT> </ROW> <ROW> <ENT I="03">2. Potential for Exposure</ENT> </ROW> <ROW> <ENT I="05">2a. Structure Containment</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="05">2b. Depth to contamination</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="05">2c. Vertical Migration</ENT> <ENT>15</ENT> </ROW> <ROW> <ENT I="05">2d. Vapor Migration Potential</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="03">3. Potential for Exposure (lines 2a * (2b + 2c + 2d), subject to a maximum of 500)</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="03">4. Likelihood of Exposure (higher of lines 1 or 3)</ENT> <ENT>550</ENT> </ROW> <ROW> <ENT I="22">Waste Characteristics:</ENT> </ROW> <ROW> <ENT I="03">5. Toxicity/Degradation</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="03">6. Hazardous Waste Quantity</ENT> <ENT> ( <SU>a</SU> ) </ENT> </ROW> <ROW> <ENT I="03">7. Waste Characteristics (subject to a maximum of 100)</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="22">Targets:</ENT> </ROW> <ROW> <ENT I="03">8. Exposed Individual</ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="03">9. Population:</ENT> </ROW> <ROW> <ENT I="05">9a. Level I Concentrations</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="05">9b. Level II Concentrations</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="05">9c. Population within an Area of Subsurface Contamination</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="05">9d. Total Population (lines 9a + 9b + 9c)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="03">10. Resources</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="03">11. Targets (lines 8 + 9d + 10)</ENT> <ENT> ( <SU>b</SU> ) </ENT> </ROW> <ROW> <ENT I="22">Subsurface Intrusion Component Score:</ENT> </ROW> <ROW> <ENT I="03"> 12. Subsurface Intrusion Component (lines 4 × 7 × 11)/82,500  <SU>c</SU> (subject to a maximum of 100) </ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="22">Soil Exposure and Subsurface Intrusion Pathway Score:</ENT> </ROW> <ROW> <ENT I="03">13. Soil Exposure Component + Subsurface Intrusion Component (subject to a maximum of 100)</ENT> <ENT>100</ENT> </ROW> <TNOTE> <SU>a</SU>  Maximum value applies to waste characteristics category. </TNOTE> <TNOTE> <SU>b</SU>  Maximum value not applicable. </TNOTE> <TNOTE> <SU>c</SU>  Do not round to the nearest integer. </TNOTE> </GPOTABLE> <P> 5.2.0  <E T="03">General considerations.</E> The subsurface intrusion component evaluates the threats from hazardous substances that have or could intrude into regularly occupied structures from the subsurface. Evaluate the subsurface intrusion component based on the actual or potential intrusion of hazardous substances into all regularly occupied structures that have structure containment values greater than zero and meet the criteria identified in the section below as being either in an area of observed exposure or in an area of subsurface contamination. These structures may or may not have subunits. Subunits are partitioned areas within a structure with separate heating, ventilating, and air conditioning (HVAC) systems or distinctly different air exchange rates. Subunits include regularly occupied partitioned tenant spaces such as office suites, apartments, condos, common or shared areas, and portions of residential, commercial or industrial structures with separate heating, ventilating, and air conditioning (HVAC) systems. </P> <P>In evaluating the subsurface intrusion component, consider the following:</P> <P> • Area(s) of observed exposure: An area of observed exposure is delineated by regularly occupied structures with documented contamination meeting observed exposure criteria; an area of observed exposure includes regularly occupied structures with samples meeting observed exposure criteria or inferred to be within an area of observed exposure based on samples meeting observed exposure criteria (see section 5.2.1.1.1 <E T="03">Observed exposure</E> ). Establish areas of observed exposure as follows: </P> <FP SOURCE="FP-1"> —For regularly occupied structures that have no subunits, consider both the regularly occupied structures containing sampling location(s) meeting observed exposure criteria for the site and the regularly occupied structure(s) in the area lying between such locations to be an area of observed exposure ( <E T="03">i.e.,</E> inferred to be in an area of observed exposure), unless available information indicates otherwise. </FP> <FP SOURCE="FP-1">—In multi-story, multi-subunit, regularly occupied structures, consider all subunits on a level with sampling locations meeting observed exposure criteria from the site and all levels below, if any, to be within an area of observed exposure, unless available information indicates otherwise.</FP> <FP SOURCE="FP-1"> —In multi-tenant structures, that do not have a documented observed exposure, but are located in an area lying between locations where observed exposures have been documented, consider only those regularly occupied subunits, if any, on the lowest <PRTPAGE P="196"/> level of the structure, to be within an area of observed exposure ( <E T="03">i.e.,</E> inferred to be in an area of observed exposure, unless available information indicates otherwise. </FP> <P>• Area(s) of subsurface contamination: An area of subsurface contamination is delineated by sampling locations meeting observed release criteria for subsurface intrusion, excluding areas of observed exposure (see Table 2-3 in section 2.3). The area within an area of subsurface contamination includes potentially exposed populations. If the significant increase in hazardous substance levels cannot be attributed at least in part to the site, and cannot be attributed to other sites, attribution can be established based on the presence of hazardous substances in the area of subsurface contamination. Establish areas of subsurface contamination as follows:</P> <FP SOURCE="FP-1">—Exclude those areas that contain structures meeting the criteria defined as an area of observed exposure.</FP> <FP SOURCE="FP-1"> —Consider both the sampling location(s) with subsurface contamination meeting observed release criteria from the site and the area lying between such locations to be an area of subsurface contamination ( <E T="03">i.e.,</E> inferred to be in an area of subsurface contamination). If sufficient data is available and state of the science shows there is no unacceptable risk due to subsurface intrusion into a regularly occupied structure located within an area of subsurface contamination, that structure can be excluded from the area of subsurface contamination. </FP> <FP SOURCE="FP-1">—Evaluate an area of subsurface contamination based on hazardous substances that:</FP> <FP SOURCE="FP1-2"> ▪ Meet the criteria for observed exposure of a chemical that has a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol, or </FP> <FP SOURCE="FP1-2"> ▪ Meet the criteria for observed release in an area of subsurface contamination and have a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol, or </FP> <FP SOURCE="FP1-2"> ▪ Meet the criteria for an observed release in a structure within, or in a sample from below, an area of observed exposure and have a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol. </FP> <FP SOURCE="FP1-2">—Evaluate all structures with no subunits that have containment factor values greater than zero, and not documented to meet observed exposure criteria to be in an area of subsurface contamination if they are lying between locations of subsurface intrusion samples meeting observed release criteria.</FP> <FP SOURCE="FP1-2">—Evaluate multi-subunit structures as follows:</FP> <FP SOURCE="FP1-2">▪ If an observed exposure has been documented based on a gaseous indoor air sample, consider all regularly occupied subunit(s), if any, on the level immediately above the level where an observed exposure has been documented (or has been inferred to be within an area of observed exposure), to be within an area of subsurface contamination. If sufficient data is available and state of the science shows there is no unacceptable risk due to subsurface intrusion on the level immediately above the level where an observed exposure has been documented (or has been inferred to be within an area of observed exposure) that level can be excluded from the area of subsurface contamination.</FP> <FP SOURCE="FP1-2">▪ If observed release criteria have been met based on a gaseous indoor air sample collected from a level not regularly occupied, consider all regularly occupied subunit(s), if any, on the level immediately above the level where the observed release criteria has been documented, to be within an area of subsurface contamination. If sufficient data is available and state of the science shows there is no unacceptable risk due to subsurface intrusion on the level immediately above the level where the observed release criteria has been documented that level can be excluded from the area of subsurface contamination.</FP> <FP SOURCE="FP1-2">▪ If any regularly occupied multi-subunit structure is inferred to be in an area of subsurface contamination, consider only those regularly occupied subunit(s), if any, on the lowest level, to be within an area of subsurface contamination. If sufficient data is available and state of the science shows there is no unacceptable risk due to subsurface intrusion on the lowest level, that structure can be excluded from the area of subsurface contamination.</FP> <P>See Section 7.0 for establishing an area of subsurface contamination based on the presence of radioactive hazardous substances.</P> <P>If there is no area of observed exposure and no area of subsurface contamination, assign a score of 0 for the subsurface intrusion component.</P> <P> 5.2.1  <E T="03">Subsurface intrusion component.</E> Evaluate this component only if there is an area of observed exposure or area of subsurface contamination: </P> <P>• Within or underlying a residence, school, day care center, workplace, or</P> <P>• Within or underlying a resource specified in section 5.2.1.3.3.</P> <P> 5.2.1.1  <E T="03">Likelihood of exposure.</E> Assign a value of 550 to the likelihood of exposure factor category for the subsurface intrusion component if there is an area of observed exposure in one or more locations listed in section 5.2.1. Enter this value in Table 5-11. <PRTPAGE P="197"/> </P> <P> 5.2.1.1.1  <E T="03">Observed exposure.</E> Establish observed exposure in a regularly occupied structure by demonstrating that a hazardous substance has been released into a regularly occupied structure via the subsurface. Base this demonstration on either of the following criteria: </P> <P>• Direct observation:</P> <FP SOURCE="FP-1">—A solid, liquid, or gaseous material that contains one or more hazardous substances attributable to the site has been observed entering a regularly occupied structure through migration via the subsurface or is known to have entered a regularly occupied structure via the subsurface, or</FP> <FP SOURCE="FP-1">—When evidence supports the inference of subsurface intrusion of a material that contains one or more hazardous substances associated with the site into a regularly occupied structure, demonstrated adverse effects associated with that release may be used to establish observed exposure.</FP> <P>• Chemical analysis:</P> <FP SOURCE="FP-1">—Analysis of indoor samples indicates that the concentration of hazardous substance(s) is significantly above the background concentration for the site for that type of sample (see section 2.3).</FP> <FP SOURCE="FP-1">—Some portion of the significant increase above background must be attributable to the site to establish the observed exposure. Documentation of this attribution should account for possible concentrations of the hazardous substance(s) in outdoor air or from materials found in the regularly occupied structure, and should provide a rationale for the increase being from subsurface intrusion.</FP> <P>If observed exposure can be established in a regularly occupied structure, assign an observed exposure factor value of 550, enter this value in Table 5-11, and proceed to section 5.2.1.1.3. If no observed exposure can be established, assign an observed exposure factor value of 0, enter this value in Table 5-11, and proceed to section 5.2.1.1.2.</P> <P> 5.2.1.1.2  <E T="03">Potential for exposure.</E> Evaluate potential for exposure only if an observed exposure cannot be established, but an area of subsurface contamination has been delineated. Evaluate potential for exposure based only on the presence of hazardous substances with a vapor pressure greater than or equal to one torr or a Henry's constant greater than or equal to 10 <E T="51">−</E> <SU>5</SU> atm-m <SU>3</SU> /mol. Evaluate potential for exposure for each area of subsurface contamination based on four factors: Structure containment (see section 5.2.1.1.2.1), depth to contamination (see section 5.2.1.1.2.2), vertical migration (see section 5.2.1.1.2.3) and vapor migration potential (see section 5.2.1.1.2.4). For each area of subsurface contamination, assign the highest value for each factor. If information is insufficient to calculate any single factor value used to calculate the potential for exposure factor values at an identified area of subsurface contamination, information collected for another area of subsurface contamination at the site may be used when evaluating potential for exposure. Calculate the potential for exposure value for the site as specified in section 5.2.1.1.2.5. </P> <P> 5.2.1.1.2.1  <E T="03">Structure containment.</E> Calculate containment for eligible hazardous substances within this component as directed in Table 5-12 and enter this value into Table 5-11. Assign each regularly occupied structure within an area of subsurface contamination the highest appropriate structure containment value from Table 5-12 and use the regularly occupied structure at the site with the highest structure containment value in performing the potential for exposure calculation. For all regularly occupied structures with unknown containment features assign a structure containment value of greater than zero for the purposes of evaluating targets (see section 5.2.1.3). </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="xs54,r100,12"> <TTITLE>Table 5-12—Structure Containment</TTITLE> <BOXHD> <CHED H="1">No.</CHED> <CHED H="1">Evidence of structure containment</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">1.</ENT> <ENT>Regularly occupied structure with evidence of subsurface intrusion, including documented observed exposure or sampling of bio or inert gases, such as methane and radon</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">2.</ENT> <ENT> Regularly occupied structure with open preferential subsurface intrusion pathways ( <E T="03">e.g.,</E> sumps, foundation cracks, unsealed utility lines) </ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">3.</ENT> <ENT>Regularly occupied structure with an engineered vapor migration barrier system that does not address all preferential subsurface intrusion pathways</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">4.</ENT> <ENT> Regularly occupied structure with an engineered passive vapor mitigation system <E T="03">without</E> documented institutional controls ( <E T="03">e.g.,</E> deed restrictions) or evidence of regular maintenance and inspection </ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">5.</ENT> <ENT> Regularly occupied structure with no visible open preferential subsurface intrusion pathways from the subsurface ( <E T="03">e.g.,</E> sumps, foundation cracks, unsealed utility lines) </ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">6.</ENT> <ENT> Regularly occupied structure with an engineered passive vapor mitigation system ( <E T="03">e.g.,</E> passive venting) <E T="03">with</E> documented institutional controls ( <E T="03">e.g.,</E> deed restrictions) or evidence of regular maintenance and inspection </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">7.</ENT> <ENT> Regularly occupied structure with an engineered, active vapor mitigation system ( <E T="03">e.g.,</E> active venting) <E T="03">without</E> documented institutional controls ( <E T="03">e.g.,</E> deed restrictions) and funding in place for on-going operation, inspection and maintenance </ENT> <ENT>2</ENT> </ROW> <ROW> <PRTPAGE P="198"/> <ENT I="01">8.</ENT> <ENT> Regularly occupied structure with a permanent engineered, active vapor mitigation system ( <E T="03">e.g.,</E> active venting) <E T="03">with</E> documented institutional controls ( <E T="03">e.g.,</E> deed restrictions) and funding in place for on-going operation, inspection and maintenance </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">9.</ENT> <ENT> Regularly occupied structure with a foundation raised greater than 6 feet above ground surface ( <E T="03">e.g.,</E> structure on stilts) or structure that has been built, and maintained, in a manner to prevent subsurface intrusion </ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <P> 5.2.1.1.2.2  <E T="03">Depth to contamination.</E> Assign each area of subsurface contamination a depth to contamination based on the least depth to either contaminated crawl space or subsurface media underlying a regularly occupied structure. Measure this depth to contamination based on the distance between the lowest point of a regularly occupied structure to the highest known point of hazardous substances eligible to be evaluated. Use any regularly occupied structure within an area of subsurface contamination with a structure containment factor value greater than zero. Subtract from the depth to contamination the thickness of any subsurface layer composed of features that would allow channelized flow ( <E T="03">e.g.,</E> karst, lava tubes, open fractures, as well as manmade preferential pathways such as utility conduits or drainage systems). </P> <P> Based on this calculated depth, assign a factor value from Table 5-13. If the necessary information is available at multiple locations, calculate the depth to contamination at each location. Use the location having the least depth to contamination to assign the factor value. Enter this value in Table 5-11. <SU/> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,12"> <TTITLE>Table 5-13—Depth to Contamination</TTITLE> <BOXHD> <CHED H="1"> Depth range  <SU>1 2</SU> </CHED> <CHED H="1"> Depth to <LI>contamination</LI> <LI>assigned</LI> <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="01">0 to <10 ft (Including subslab and semi-enclosed or enclosed crawl space contamination)</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">>10 to 20 ft</ENT> <ENT>8</ENT> </ROW> <ROW> <ENT I="01">>20 to 50 ft</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">>50 to 100 ft</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">>100 to 150 ft</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">>150 ft</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>1</SU>  If any part of the subsurface profile has channelized flow features, assign that portion of the subsurface profile a depth of 0. </TNOTE> <TNOTE> <SU>2</SU>  Measure elevation below any regularly occupied structure within an area of subsurface contamination at a site. Select the regularly occupied structure with the least depth to contamination below a structure. </TNOTE> </GPOTABLE> <P> 5.2.1.1.2.3  <E T="03">Vertical migration.</E> Evaluate the vertical migration factor for each area of subsurface contamination based on the geologic materials in the interval between the lowest point of a regularly occupied structure and the highest known point of hazardous substances in the subsurface. Use any regularly occupied structure either within an area of subsurface contamination or overlying subsurface soil gas or ground water contamination. Assign a value to the vertical migration factor as follows: </P> <P>• If the depth to contamination (see section 5.2.1.1.2.2) is 10 feet or less, assign a value of 15.</P> <P>• If the depth to contamination is greater than 10 feet, do not consider layers or portions of layers within the first 10 feet of the depth to contamination (as assigned in section 5.2.1.1.2.2).</P> <P>• If, for the interval between the lowest point of a regularly occupied structure and the highest point of hazardous substances in the subsurface, all layers that underlie a portion of a regularly occupied structure at the site are karst or otherwise allow channelized flow, assign a value of 15.</P> <P>• Otherwise:</P> <FP SOURCE="FP-1">—Select the lowest effective porosity/permeability layer(s) from within the interval identified above. Consider only layers at least 1 foot thick.—Assign a value for individual layers from Table 5-14 using the hydraulic conductivity of the layer, if available. If the hydraulic conductivity is not available, assign a value based on the type of material in the selected layer.</FP> <FP SOURCE="FP-1">—If more than one layer has the same assigned porosity/permeability value, include all such layers and sum their thicknesses. Assign a thickness of 0 feet to a layer with channelized flow features found within any area of subsurface contamination at the site.</FP> <FP SOURCE="FP-1">—Assign a value from Table 5-15 to the vertical migration factor, based on the thickness and assigned porosity/permeability value of the lowest effective porosity/permeability layer(s).</FP> <P> Determine vertical migration only at locations within an area of subsurface contamination at the site. If the necessary subsurface geologic information is available at multiple locations, evaluate the vertical migration factor at each location. Use the location having the highest vertical migration factor value to assign the factor value. Enter this value in Table 5-11. <PRTPAGE P="199"/> </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s100,r25,12"> <TTITLE>Table 5-14—Effective Porosity/Permeability of Geologic Materials</TTITLE> <BOXHD> <CHED H="1">Type of material</CHED> <CHED H="1"> Hydraulic conductivity <LI>(cm/sec)</LI> </CHED> <CHED H="1"> Assigned <LI>porosity/</LI> <LI>permeability</LI> <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Gravel; clean sand; highly permeable fractured igneous and metamorphic rocks; permeable basalt; karst limestones and dolomites</ENT> <ENT> Greater than or equal to 1 × 10 <E T="51">−</E> <SU>3</SU> </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">Sand; sandy clays; sandy loams; loamy sands; sandy silts; sediments that are predominantly sand; highly permeable till (coarse-grained, unconsolidated or compact and highly fractured); peat; moderately permeable limestones and dolomites (no karst); moderately permeable sandstone; moderately permeable fractured igneous and metamorphic rocks</ENT> <ENT> Less than 1 × 10 <E T="51">−</E> <SU>3</SU> </ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">Silt; loams; silty loams; loesses; silty clays; sediments that are predominantly silts; moderately permeable till (fine-grained, unconsolidated till, or compact till with some fractures); low permeability limestones and dolomites (no karst); low permeability sandstone; low permeability fractured igneous and metamorphic rocks</ENT> <ENT> Less than 1 × 10 <E T="51">−</E> <SU>5</SU> </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01">Clay; low permeability till (compact unfractured till); shale; unfractured metamorphic and igneous rocks</ENT> <ENT> Less than 1 × 10 <E T="51">−</E> <SU>7</SU> </ENT> <ENT>4</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="7" OPTS="L2" CDEF="s12,12,12,12,12,12,12"> <TTITLE> Table 5-15—Vertical Migration Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Assigned porosity/permeability value</CHED> <CHED H="1"> Thickness of lowest porosity layer(s)  <SU>b</SU> (feet) </CHED> <CHED H="2">0 to 5</CHED> <CHED H="2"> Greater than <LI>5 to 10</LI> </CHED> <CHED H="2">Greater than 10 to 20</CHED> <CHED H="2">Greater than 20 to 50</CHED> <CHED H="2">Greater than 50 to 100</CHED> <CHED H="2">Greater than 100 to 150</CHED> </BOXHD> <ROW> <ENT I="01">1</ENT> <ENT>15</ENT> <ENT>15</ENT> <ENT>14</ENT> <ENT>11</ENT> <ENT>8</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>15</ENT> <ENT>14</ENT> <ENT>12</ENT> <ENT>9</ENT> <ENT>6</ENT> <ENT>4</ENT> </ROW> <ROW> <ENT I="01">3</ENT> <ENT>15</ENT> <ENT>13</ENT> <ENT>10</ENT> <ENT>7</ENT> <ENT>5</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT>15</ENT> <ENT>12</ENT> <ENT>9</ENT> <ENT>6</ENT> <ENT>3</ENT> <ENT>1</ENT> </ROW> <TNOTE> <SU>a</SU>  If depth to contamination is 10 feet or less or if, for the interval being evaluated, all layers that underlie a portion of the structure at the site are karst or have other channelized flow features, assign a value of 15. </TNOTE> <TNOTE> <SU>b</SU>  Consider only layers at least 1 foot thick. </TNOTE> </GPOTABLE> <P> 5.2.1.1.2.4  <E T="03">Vapor migration potential.</E> Evaluate this factor for each area of subsurface contamination as follows: </P> <P>• If the depth to contamination (see section 5.2.1.1.2.2) is 10 feet or less, assign a value of 25.</P> <P>• Assign a value for vapor migration potential to each of the gaseous hazardous substances associated with the area of subsurface contamination (see section 2.2.2) as follows:</P> <FP SOURCE="FP-1">—Assign values from Table 5-16 for both vapor pressure and Henry's constant to each hazardous substance. If Henry's constant cannot be determined for a hazardous substance, assign that hazardous substance a value of 2 for the Henry's constant component.</FP> <FP SOURCE="FP-1">—Sum the two values assigned to each hazardous substance.</FP> <FP SOURCE="FP-1">—Based on this sum, assign each hazardous substance a value from Table 5-17 for vapor migration potential.</FP> <P>• Assign a value for vapor migration potential to each area of subsurface contamination as follows:</P> <FP SOURCE="FP-1">—Select the hazardous substance associated with the area of subsurface contamination with the highest vapor migration potential value and assign this value as the vapor migration potential factor value for the area of subsurface contamination.</FP> <P>Enter this value in Table 5-11.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,15"> <TTITLE>Table 5-16—Values for Vapor Pressure and Henry's Constant</TTITLE> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> Assigned <LI>value</LI> </CHED> </BOXHD> <ROW> <ENT I="22">Vapor Pressure (Torr):</ENT> </ROW> <ROW> <ENT I="03">Greater than 10</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="03">1 to 10</ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="03">Less than 1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="22"> Henry's Constant (atm-m <SU>3</SU> /mol): </ENT> </ROW> <ROW> <ENT I="03"> Greater than 10  <E T="51">−</E> <SU>3</SU> </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="03"> Greater than 10  <E T="51">−</E> <SU>4</SU> to 10  <E T="51">−</E> <SU>3</SU> </ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="03"> 10  <E T="51">−</E> <SU>5</SU> to 10  <E T="51">−</E> <SU>4</SU> </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="03"> Less than 10  <E T="51">−</E> <SU>5</SU> </ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <PRTPAGE P="200"/> <GPOTABLE COLS="2" OPTS="L2" CDEF="s12,12"> <TTITLE>Table 5-17—Vapor Migration Potential Factor Values for a Hazardous Substance</TTITLE> <BOXHD> <CHED H="1">Sum of values for vapor pressure and Henry's constant</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">1 or 2</ENT> <ENT>5</ENT> </ROW> <ROW> <ENT I="01">3 or 4</ENT> <ENT>15</ENT> </ROW> <ROW> <ENT I="01">5 or 6</ENT> <ENT>25</ENT> </ROW> </GPOTABLE> <P> 5.2.1.1.2.5  <E T="03">Calculation of potential for exposure factor value.</E> For each identified area of subsurface contamination, sum the factor values for depth to contamination, vertical migration, and vapor migration potential, and multiply this sum by the factor value for structure containment. Select the highest product for any area of subsurface contamination and assign this value as the potential for exposure factor value for the component. Enter this value in Table 5-11. </P> <P> 5.2.1.1.3  <E T="03">Calculation of likelihood of exposure factor category value.</E> If observed exposure is established for the site, assign the observed exposure factor value of 550 as the likelihood of exposure factor category value for the site. Otherwise, assign the potential for exposure factor value for the component as the likelihood of exposure value. Enter the value assigned in Table 5-11. </P> <P> 5.2.1.2  <E T="03">Waste characteristics.</E> Evaluate waste characteristics based on two factors: toxicity/degradation and hazardous waste quantity. </P> <P> 5.2.1.2.1  <E T="03">Toxicity/degradation.</E> For each hazardous substance, assign a toxicity factor value, a degradation factor value and a combined toxicity/degradation factor value as specified in sections 2.2.3, 2.4.1.2 and 5.2.1.2.1.1 through 5.2.1.2.1.3. </P> <P> 5.2.1.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in sections 2.2.2 and 2.4.1.1. </P> <P> 5.2.1.2.1.2  <E T="03">Degradation.</E> Assign a degradation factor value to each hazardous substance as follows: </P> <P>• For any hazardous substance that meets the criteria for an observed exposure, or if a NAPL is present in the subsurface below an area of observed exposure or area of subsurface contamination at a depth less than or equal to 30 feet, assign that substance a degradation factor value of 1.</P> <P>• For all other situations, assign a degradation factor value using Table 5-18. Assign the depth to contamination as directed in section 5.2.1.1.2.2, except if evidence indicates that biologically active soil is not present throughout the depth beneath any regularly occupied structure. In this situation, subtract any thickness of non-biologically active soil from the estimated depth to contamination.</P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s25,15,15,15"> <TTITLE>Table 5-18—Degradation Factor Value Table</TTITLE> <BOXHD> <CHED H="1"> Depth to contamination (feet)  <SU>a</SU> </CHED> <CHED H="1">Half-life</CHED> <CHED H="2">>100 Days</CHED> <CHED H="2">>30 days and ≤100 days</CHED> <CHED H="2">≤30 days</CHED> </BOXHD> <ROW> <ENT I="01"><10</ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">10 to ≤30</ENT> <ENT>1</ENT> <ENT>1</ENT> <ENT>0.1</ENT> </ROW> <ROW> <ENT I="01">>30</ENT> <ENT>1</ENT> <ENT>0.5</ENT> <ENT>0.1</ENT> </ROW> <TNOTE> <SU>a</SU>  When determining the depth to contamination do not include layers of non-biologically-active soil, nor subsurface intervals with channelized flow ( <E T="03">e.g.,</E> karst, lava tubes, open fractures, and manmade preferential pathways as directed in section 5.2.1.1.2.2). </TNOTE> </GPOTABLE> <FP>Calculate the half-life for each hazardous substance that meets subsurface intrusion observed release criteria as follows:</FP> <P>The half-life of a substance in the subsurface is defined for HRS purposes as the time required to reduce the initial concentration of the substance in the subsurface by one-half as a result of the combined decay processes of two components: Biodegradation and hydrolysis.</P> <P> Estimate the half-life (t <E T="52">1/2</E> ) of a hazardous substance as follows: </P> <GPH SPAN="2" DEEP="33"> <GID>ER09JA17.072</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">h=Hydrolysis half-life.</FP> <FP SOURCE="FP-2">b=Biodegradation half-life.</FP> <P> If either of these component half-lives cannot be estimated for the hazardous substance from available data, delete that component half-life from the above equation. <PRTPAGE P="201"/> </P> <P>If no half-life information is available for a hazardous substance and the substance is not already assigned a value of 1, unless information indicates otherwise, assign a value of 1.</P> <P> 5.2.1.2.1.3  <E T="03">Calculation of toxicity/degradation factor value.</E> Assign each substance a toxicity/degradation value by multiplying the toxicity factor value by the degradation factor value. Use the hazardous substance with the highest combined toxicity/degradation value to assign the factor value to the toxicity/degradation factor for the subsurface intrusion threat. Enter this value in Table 5-11. </P> <P> 5.2.1.2.2  <E T="03">Hazardous waste quantity.</E> Assign a hazardous waste quantity factor value as specified in section 2.4.2. Consider only those regularly occupied structures or subunits with a non-zero structure containment value. Also include all regularly occupied structures or subunits that have had mitigation systems installed as part of a removal or other temporary response action. If sufficient structure-specific concentration data is available and state of the science shows there is no unacceptable risk of exposure to populations in a regularly occupied structure or subunit in an area of subsurface contamination, that structure or subunit is not included in the hazardous waste quantity evaluation. In estimating the hazardous waste quantity, use Tables 2-5 and 5-19 and: </P> <P>• For Tier A, hazardous constituent quantity, use the mass of constituents found in the regularly occupied structure(s) where the observed exposure has been identified.</P> <FP SOURCE="FP-1">—For multi-subunit structures, when calculating Tier A, use the mass of constituents found in the regularly occupied subunit space(s) where the observed exposure has been identified.</FP> <P>• For Tier B, hazardous wastestream quantity, use the flow-through volume of the regularly occupied structures where the observed exposure has been identified.</P> <FP SOURCE="FP-1">—For multi-subunit structures, when calculating Tier B, use the flow-through volume of the regularly occupied subunit spaces where the observed exposure has been identified.</FP> <P>• For Tier C, volume, use the volume divisor listed in Tier C of Table 5-19. Volume is calculated for those regularly occupied structures located within areas of observed exposure with observed or inferred intrusion and within areas of subsurface contamination.</P> <FP SOURCE="FP-1">—In evaluating the volume measure for these listed areas of observed exposure and areas of subsurface contamination based on a gaseous/vapor intrusion or the potential for gaseous/vapor intrusion, consider the following:</FP> <FP SOURCE="FP1-2">▪ Calculate the volume of each regularly occupied structure based on actual data. If unknown, use a ceiling height of 8 feet.</FP> <FP SOURCE="FP1-2">▪ For multi-subunit structures, when calculating Tier C, calculate volume for those subunit spaces with observed or inferred exposure and all other regularly occupied subunit spaces on that level, unless available information indicates otherwise. If the structure has multiple stories, also include the volume of all regularly occupied subunit spaces below the floor with an observed exposure and one story above, unless evidence indicates otherwise.</FP> <FP SOURCE="FP1-2">▪ For multi-subunit structures within an area of subsurface contamination and no observed or inferred exposure, consider only the volume of the regularly occupied subunit spaces on the lowest story, unless available information indicates otherwise.</FP> <P>• For Tier D, area, if volume is unknown, use the area divisor listed in Tier D of Table 5-19 for those regularly occupied structures within areas of observed exposure with observed or inferred intrusion and within areas of subsurface contamination.</P> <FP SOURCE="FP-1">—In evaluating the area measure for these listed areas of observed exposure and areas of subsurface contamination, calculate the area of each regularly occupied structure (including multi-subunit structures) or subunit based on actual footprint area data.</FP> <FP SOURCE="FP1-2">▪ If the actual footprint area of the structure(s) is unknown, use an area of 1,740 square feet for each structure (or subunit space).</FP> <FP SOURCE="FP1-2">▪ For multi-subunit structures, when calculating Tier D, calculate area for those subunit spaces with observed or inferred exposure and all other regularly occupied subunit spaces on that level, unless available information indicates otherwise. If the structure has multiple stories, also include the area of all regularly occupied subunit spaces below the floor with an observed exposure and one story above, unless evidence indicates otherwise.</FP> <FP SOURCE="FP1-2"> ▪ For multi-subunit structures within an area of subsurface contamination and no observed or inferred exposure, consider only the area of the regularly occupied subunit spaces on the lowest story, unless available information indicates otherwise. <PRTPAGE P="202"/> </FP> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs54,r100,xs54,xs54"> <TTITLE>Table 5-19—Hazardous Waste Quantity Evaluation Equations for Subsurface Intrusion Component</TTITLE> <BOXHD> <CHED H="1">Tier</CHED> <CHED H="1">Measure</CHED> <CHED H="1">Units</CHED> <CHED H="1"> Equation for assigning value  <SU>a</SU> </CHED> </BOXHD> <ROW> <ENT I="01">A</ENT> <ENT>Hazardous Constituent Quantity (C)</ENT> <ENT>Lb</ENT> <ENT>C</ENT> </ROW> <ROW> <ENT I="01"> B <SU>b</SU> </ENT> <ENT>Hazardous Wastestream Quantity (W)</ENT> <ENT>Lb</ENT> <ENT>W/5,000</ENT> </ROW> <ROW> <ENT I="01"> C <SU>b,c</SU> </ENT> <ENT>Volume (V)</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Regularly occupied structure(s) in areas of observed exposure or subsurface contamination</ENT> <ENT> yd <SU>3</SU> </ENT> <ENT>V/2.5</ENT> </ROW> <ROW> <ENT I="01"> D <SU>b,d</SU> </ENT> <ENT>Area (A)</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Regularly occupied structure(s) in areas of observed exposure or subsurface contamination</ENT> <ENT> ft <SU>2</SU> </ENT> <ENT>A/13</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to the nearest integer. </TNOTE> <TNOTE> <SU>b</SU>  Convert volume to mass when necessary: 1 ton=2,000 pounds=1 cubic yard=4 drums=200 gallons. </TNOTE> <TNOTE> <SU>c</SU>  Calculate volume of each regularly occupied structure or subunit space in areas of observed exposure and areas of subsurface contamination—Assume 8-foot ceiling height unless actual value is known. </TNOTE> <TNOTE> <SU>d</SU>  Calculate area of the footprint of each regularly occupied structure in areas of observed exposure and areas of subsurface contamination. If the footprint area of a regularly occupied structure is unknown, use 1,740 square feet as the footprint area of the structure or subunit space. </TNOTE> </GPOTABLE> <P>For the subsurface intrusion component, if the hazardous constituent quantity is adequately determined for all areas of observed exposure, assign the value from Table 2-6 as the hazardous waste quantity factor value. If the hazardous constituent quantity is not adequately determined for one or more areas of observed exposure or if one or more areas of subsurface contamination are present, assign either the value from Table 2-6 or assign a factor value as follows:</P> <P>• If any target for the subsurface intrusion component is subject to Level I or Level II concentrations (see section 2.5), assign either the value from Table 2-6 or a value of 100, whichever is greater, as the hazardous waste quantity factor value for this component.</P> <P>• If none of the targets for the subsurface intrusion component is subject to Level I or Level II concentrations and if there has been a removal action that does not permanently interrupt target exposure from subsurface intrusion, and if an area of subsurface contamination exists, assign a factor value as follows:</P> <FP SOURCE="FP-1">—Determine the values from Table 2-6 with and without consideration of the removal action.</FP> <FP SOURCE="FP-1">—If the value that would be assigned from Table 2-6 without consideration of the removal action would be 100 or greater, assign either the value from Table 2-6 with consideration of the removal action or a value of 100, whichever is greater, as the hazardous waste quantity factor value for the component.</FP> <FP SOURCE="FP-1">—If the value that would be assigned from Table 2-6 without consideration of the removal action would be less than 100, assign a value of 10 as the hazardous waste quantity factor value for the component.</FP> <P>• Otherwise, if none of the targets for the subsurface intrusion component is subject to Level I or Level II concentrations and there has not been a removal action, assign a value from Table 2-6 or a value of 10, whichever is greater.</P> <P>Enter the value assigned in Table 5-11.</P> <P> 5.2.1.2.3  <E T="03">Calculation of waste characteristics factor category value.</E> Multiply the toxicity/degradation and hazardous waste quantity factor values, subject to a maximum product of 1 × 10 <SU>8</SU> . Based on this product, assign a value from Table 2-7 (section 2.4.3.1) to the waste characteristics factor category. Enter this value in Table 5-11. </P> <P> 5.2.1.3  <E T="03">Targets.</E> Evaluate the targets factor category for the subsurface intrusion threat based on three factors: Exposed individual, population, and resources in regularly occupied structures with structure containment factors greater than 0. Evaluate only those targets within areas of observed exposure and areas of subsurface contamination (see section 5.2.0). </P> <P>In evaluating the targets factor category for the subsurface intrusion threat, count only the following as targets:</P> <P>• Exposed individual—a person living, attending school or day care, or working in a regularly occupied structure with observed exposure or in a structure within an area of observed exposure or within an area of subsurface contamination.</P> <P>• Population—exposed individuals in a regularly occupied structure within an area of observed exposure or within an area of subsurface contamination.</P> <P>• Resources—located within an area of observed exposure or within an area of subsurface contamination as specified in section 5.2.1.3.3.</P> <P> If a formerly occupied structure has been vacated due to subsurface intrusion attributable to the site, count the initial targets as if they were still residing in the structure. In addition, if a removal or temporary response action has occurred that has not completely mitigated the release, count the initial targets as if the removal or temporary <PRTPAGE P="203"/> response action has not permanently interrupted target exposure from subsurface intrusion. Evaluate those targets based on conditions at the time of removal of temporary response action. </P> <P>For populations residing in or working in a multi-subunit structure with multiple stories in an area of observed exposure or area of subsurface contamination, count these targets as follows:</P> <P>• If there is no observed exposure within the structure, include in the evaluation only those targets, if any, in the lowest occupied level. If sufficient structure-specific concentration data is available and state of the science shows there is no unacceptable risk of exposure to targets in the lowest level, those targets are not included in the evaluation.</P> <P>• If there is an observed exposure in any level, include in the evaluation those targets in that level, the level above and all levels below. (The weighting of these targets is specified in Section 5.2.1.3.2.) If sufficient structure-specific concentration data is available and state of the science shows there is no unacceptable risk of exposure to targets in the level above where the observed exposure has been documented, those targets are not included in the evaluation.</P> <P> 5.2.1.3.1  <E T="03">Exposed individual.</E> Evaluate this factor based on whether there is an exposed individual, as specified in sections 2.5.1, 2.5.2 and 5.2.1.3, who is subject to Level I or Level II concentrations. </P> <P>First, determine those regularly occupied structures or partitioned subunit(s) within structures in an area of observed exposure subject to Level I concentrations and those subject to Level II concentrations as specified as follows (see section 5.2.0):</P> <P>• Level I Concentrations: For contamination resulting from subsurface intrusion, compare the hazardous substance concentrations in any sample meeting the observed exposure by chemical analysis criteria to the appropriate benchmark. Use the health-based benchmarks from Table 5-20 to determine the level of contamination.</P> <FP SOURCE="FP-1">—If the sample is from a structure with no subunits and the concentration equals or exceeds the appropriate benchmark, assign Level I concentrations to the entire structure.</FP> <FP SOURCE="FP-1">—If the sample is from a subunit within a structure and the concentration from that subunit equals or exceeds the appropriate benchmark, assign Level I concentrations to that subunit.</FP> <P>• Level II Concentrations: Structures, or subunits within structures, with one or more samples that meet observed exposure by chemical analysis criteria but do not equal or exceed the appropriate benchmark; structures, or subunits, that have an observed exposure by direct observation; and structures inferred to be in an area of observed exposure based on samples meeting observed exposure, are assigned Level II concentrations.</P> <FP SOURCE="FP-1">—For all regularly occupied structures, or subunits in such structures, in an area of observed exposure that are not assigned Level I concentrations, assign Level II concentrations.</FP> <P>Then assign a value to the exposed individual factor as follows:</P> <P>• Assign a value of 50 if there is at least one exposed individual in one or more regularly occupied structures subject to Level I concentrations.</P> <P>• Assign a value of 45 if there are no Level I exposed individuals, but there is at least one exposed individual in one or more regularly occupied structures subject to Level II concentrations.</P> <P>• Assign a value of 20 if there is no Level I or Level II exposed individual but there is at least one individual in a regularly occupied structure within an area of subsurface contamination. Enter the value assigned in Table 5-11.</P> <P> 5.2.1.3.2  <E T="03">Population.</E> Evaluate population based on three factors: Level I concentrations, Level II concentrations, and population within an area of subsurface contamination. Determine which factors apply as specified in section 5.2.1.3.1, using the health-based benchmarks from Table 5-20. Evaluate populations subject to Level I and Level II concentrations as specified in section 2.5. </P> <GPOTABLE COLS="1" OPTS="L2,p1,7/8" CDEF="s100"> <TTITLE>Table 5-20—Health-Based Benchmarks for Hazardous Substances in the Subsurface Intrusion Component</TTITLE> <ROW> <ENT I="01"> Screening concentration for cancer corresponding to that concentration that corresponds to the 10 <E T="51">−6</E> individual cancer risk using the inhalation unit risk. For oral exposures use the oral cancer slope factor. </ENT> </ROW> <ROW> <ENT I="01">Screening concentration for noncancer toxicological responses corresponding to the reference dose (RfD) for oral exposure and the reference concentration (RfC) for inhalation exposures.</ENT> </ROW> </GPOTABLE> <P>Count only those persons meeting the criteria for population as specified in section 5.2.1.3. In estimating the number of individuals in structures in an area of observed exposure or area of subsurface contamination if the actual number of residents is not known, multiply each residence by the average number of persons per residence for the county in which the residence is located.</P> <P> 5.2.1.3.2.1  <E T="03">Level I concentrations.</E> Assign the population subject to Level I concentrations as follows: </P> <P> 1. Identify all exposed individuals regularly present in an eligible structure with a structure containment value greater than zero, or if the structure has subunits, identify those regularly present in each subunit, <PRTPAGE P="204"/> located in an area of observed exposure subject to Level I concentrations as described in sections 5.2.0 and 5.2.1.3.1. Identify only once per structure those exposed individuals that are using more than one eligible subunit of the same structure ( <E T="03">e.g.,</E> using a common or shared area and other parts of the same structure). </P> <P>2. For each structure or subunit count the number of individuals residing in or attending school or day care in the structure or subunit.</P> <P>3. Count the number of full-time and part-time workers in the structure or subunit(s) subject to Level I concentrations. If information is unavailable to classify a worker as full- or part-time, evaluate that worker as being full-time. Divide the number of full-time workers by 3 and the number of part-time workers by 6, and then sum these products with the number of other individuals for each structure or subunit.</P> <P>4. Sum this combined value for all structures, or subunits, within areas of observed exposure and multiply this sum by 10.</P> <P>Assign the resulting product as the combined population factor value subject to Level I concentrations for the site. Enter this value in line 9a of Table 5-11.</P> <P> 5.2.1.3.2.2  <E T="03">Level II concentrations.</E> Assign the population subject to Level II concentrations as follows: </P> <P> 1. Identify all exposed individuals regularly present in an eligible structure with a structure containment value greater than zero, or if the structure has subunits, identify those regularly present in each subunit, located in an area of observed exposure subject to Level II concentrations as described in sections 5.2.0 and 5.2.1.3.1. Identify only once per structure those exposed individuals that are using more than one eligible subunit of the same structure ( <E T="03">e.g.,</E> using a common or shared area and other parts of the same structure). </P> <P>2. Do not include exposed individuals already counted under the Level I concentrations factor.</P> <P>3. For each structure or subunit(s), count the number of individuals residing in or attending school or day care in the structure, or subunit, subject to Level II concentrations.</P> <P>4. Count the number of full-time and part-time workers in the structure or subunit(s) subject to Level II concentrations. If information is unavailable to classify a worker as full- or part-time, evaluate that worker as being full-time. Divide the number of full-time workers by 3 and the number of part-time workers by 6, and then sum these products with the number of other individuals for each structure or subunit.</P> <P>5. Sum the combined population value for all structures within the areas of observed exposure for the site.</P> <P>Assign this sum as the combined population factor value subject to Level II concentrations for this site. Enter this value in line 9b of Table 5-11.</P> <P> 5.2.1.3.2.3  <E T="03">Population within area(s) of subsurface contamination.</E> Assign the population in area(s) of subsurface contamination factor value as follows. If sufficient structure-specific concentration data is available and state of the science shows there is no unacceptable risk of exposure to populations in a regularly occupied structure in an area of subsurface contamination, those populations are not included in the evaluation. (see sections 5.2.0 and 5.2.1.3.1): </P> <P>1. Identify the regularly occupied structures with a structure containment value greater than zero and the eligible population associated with the structures or portions of structures in each area of subsurface contamination:</P> <P>• For each regularly occupied structure or portion of a structure in an area of subsurface contamination, sum the number of all individuals residing in or attending school or day care, in the structure or portion of the structure in the area of subsurface contamination.</P> <P>• Count the number of full-time and part-time workers regularly present in each structure or portion of a structure in an area of subsurface contamination. If information is unavailable to classify a worker as full- or part-time, evaluate that worker as being full-time. Divide the number of full-time workers by 3 and the number of part-time workers by 6. Sum these products with the number of individuals residing in or attending school or day care in the structure.</P> <P>• Use this sum as the population for the structure.</P> <P>2. Estimate the depth or distance to contamination at each regularly occupied structure within an area of subsurface contamination based on available sampling data, and categorize each eligible structure based on the depth or distance to contamination and sample media as presented in Table 5-21. Weight the population in each structure using the appropriate weighting factors in Table 5-21. If samples from multiple media are available, use the sample that results in the highest weighting factor.</P> <P> 3. Sum the weighted population in all structures within the area(s) of subsurface contamination and assign this sum as the population within an area of subsurface contamination factor value. Enter this value in line 9c of Table 5-11. <PRTPAGE P="205"/> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,12"> <TTITLE>Table 5-21—Weighting Factor Values for Populations Within an Area of Subsurface Contamination</TTITLE> <BOXHD> <CHED H="1"> Eligible populations  <SU>a</SU> in structures  <SU>b</SU> within an area of subsurface contamination </CHED> <CHED H="1"> Population weighting <LI>factor</LI> </CHED> </BOXHD> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Samples From Within Structures or in Crawl Spaces</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="22">1. Population in a structure with levels of contamination in a semi-enclosed or enclosed crawl space sample meeting observed release criteria or</ENT> <ENT>0.9</ENT> </ROW> <ROW> <ENT I="01" O="xl">Population in a subunit of a multi-story structure within an area of subsurface contamination located directly above a level in an area of observed exposure or a gaseous indoor air sample meeting observed release criteria or</ENT> </ROW> <ROW> <ENT I="22" O="xl">Population within a structure where a mitigation system has been installed as part of a removal or other temporary response action.</ENT> </ROW> <ROW> <ENT I="01">2. Population in a structure where levels of contaminants meeting observed release criteria are inferred based on semi-enclosed or enclosed crawl space samples in surrounding structures, and a NAPL is present in those samples</ENT> <ENT>0.8</ENT> </ROW> <ROW RUL="s"> <ENT I="01">3. Population in a structure where levels of contaminants meeting observed release criteria are inferred based on semi-enclosed or enclosed crawl space samples in surrounding structures, but no NAPL is present</ENT> <ENT>0.4</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Subsurface Samples From Less Than or Equal to 5 Feet From a Foundation</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">4. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on any sampling media at or within five feet horizontally or vertically of the structure foundation, and a NAPL is present within that depth</ENT> <ENT>0.8</ENT> </ROW> <ROW RUL="s"> <ENT I="01">5. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on any sampling media at or within five feet horizontally or vertically of the structure foundation, but no NAPL is present within that depth</ENT> <ENT>0.4</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Subsurface Samples From Greater Than 5 Feet But Less Than or Equal to 30 Feet Depth</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">6. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on any underlying non-ground water subsurface sample at a depth greater than 5 feet but less than or equal to 30 feet from a structure foundation and a NAPL is present within that depth</ENT> <ENT>0.4</ENT> </ROW> <ROW> <ENT I="01">7. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on any underlying non-ground water subsurface sample at a depth greater than 5 feet but less than or equal to 30 feet, but no NAPL is present within that depth</ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01">8. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on underlying ground water samples greater than 5 feet from the structure foundation but less than or equal to 30 feet, and a NAPL is present in those samples</ENT> <ENT>0.2</ENT> </ROW> <ROW RUL="s"> <ENT I="01">9. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on underlying ground water samples greater than 5 feet from the structure foundation but less than or equal to 30 feet, but no NAPL is present in those samples</ENT> <ENT>0.1</ENT> </ROW> <ROW EXPSTB="01" RUL="s"> <ENT I="21"> <E T="02">Subsurface Samples From Greater Than 30 Feet Depth</E> </ENT> </ROW> <ROW EXPSTB="00"> <ENT I="01">10. Population in a structure where levels of contaminants meeting observed release criteria are found or inferred based on any underlying sample at depths greater than 30 feet</ENT> <ENT>0.1</ENT> </ROW> <TNOTE> <SU>a</SU>  Eligible populations include residents (including individuals living in, or attending school or day care in the structure), and workers in regularly occupied structures (see HRS Section 5.2.1.3). </TNOTE> <TNOTE> <SU>b</SU>  Eligible structures may include single- or multi-tenant structures where eligible populations reside, attend school or day care, or work. These structures may also be mixed use structures. </TNOTE> </GPOTABLE> <P> 5.2.1.3.2.4  <E T="03">Calculation of population factor value.</E> Sum the factor values for Level I concentrations, Level II concentrations, and population within the area(s) of subsurface contamination. Assign this sum as the population factor value. Enter this value in line 9d of Table 5-11. </P> <P> 5.2.1.3.3  <E T="03">Resources.</E> Evaluate the resources factor as follows: </P> <P> • Assign a value of 5 if a resource structure ( <E T="03">e.g.,</E> library, church, tribal facility) is present and regularly occupied within either an area of observed exposure or area of subsurface contamination. </P> <P>• Assign a value of 0 if there is no resource structure within an area of observed exposure or area of subsurface contamination.</P> <P>Enter the value assigned in Table 5-11.</P> <P> 5.2.1.3.4  <E T="03">Calculation of targets factor category value.</E> Sum the values for the exposed individual, population, and resources factors. Do not round to the nearest integer. Assign this sum as the targets factor category value for the subsurface intrusion component. Enter this value in Table 5-11. </P> <P> 5.2.2  <E T="03">Calculation of subsurface intrusion component score.</E> Multiply the factor category values for likelihood of exposure, waste characteristics, and targets and round the product to the nearest integer. Divide the product by 82,500. Assign the resulting value, subject to a maximum of 100, as the subsurface intrusion component score and enter this score in Table 5-11. <PRTPAGE P="206"/> </P> <P> 5.3  <E T="03">Calculation of the soil exposure and subsurface intrusion pathway score.</E> Sum the soil exposure component score and subsurface intrusion component score. Assign the resulting value, subject to a maximum of 100, as the soil exposure and subsurface intrusion pathway score (S <E T="52">sessi</E> ). Enter this score in Table 5-11. </P> <HD SOURCE="HD2">6.0 Air Migration Pathway</HD> <P>Evaluate the air migration pathway based on three factor categories: likelihood of release, waste characteristics, and targets. Figure 6-1 indicates the factors included within each factor category.</P> <P> Determine the air migration pathway score (S <E T="52">a</E> ) in terms of the factor category values as follows: </P> <MATH SPAN="1" DEEP="24"> <MID>EC15NO91.162</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">LR = Likelihood of release factor category value.</FP> <FP SOURCE="FP-2">WC = Waste characteristics factor category value.</FP> <FP SOURCE="FP-2">T = Targets factor category value.</FP> <FP SOURCE="FP-2">SF = Scaling factor.</FP> <P>Table 6-1 outlines the specific calculation procedure.</P> <GPH SPAN="2" DEEP="438"> <PRTPAGE P="207"/> <GID>EC02AU92.012</GID> </GPH> <GPOTABLE COLS="3" OPTS="L2" CDEF="s250,10,10"> <TTITLE>Table 6-1—Air Migration Pathway Scoresheet</TTITLE> <BOXHD> <CHED H="1">Factor categories and factors</CHED> <CHED H="1">Maximum value</CHED> <CHED H="1">Value assigned</CHED> </BOXHD> <ROW> <ENT I="11"> <E T="02">Likelihood of Release</E> </ENT> </ROW> <ROW> <ENT I="03"> 1. Observed Release</ENT> <ENT>550</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="13"> 2. Potential to Release:</ENT> </ROW> <ROW> <ENT I="05">2a. Gas Potential to Release</ENT> <ENT>500</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">2b. Particulate Potential to Release</ENT> <ENT>500</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">2c. Potential to Release (higher of lines 2a and 2b)</ENT> <ENT>500</ENT> <ENT>____  </ENT> </ROW> <ROW> <PRTPAGE P="208"/> <ENT I="03"> 3. Likelihood of Release (higher of lines 1 and 2c)</ENT> <ENT>550</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Waste Characteristics</E> </ENT> </ROW> <ROW> <ENT I="03"> 4. Toxicity/Mobility</ENT> <ENT>(a)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="03"> 5. Hazardous Waste Quantity</ENT> <ENT>(a)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="03"> 6. Waste Characteristics</ENT> <ENT>100</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Targets</E> </ENT> </ROW> <ROW> <ENT I="03"> 7. Nearest Individual</ENT> <ENT>50</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="13"> 8. Population:</ENT> </ROW> <ROW> <ENT I="05">8a. Level I Concentrations</ENT> <ENT>(b)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">8b. Level II Concentrations</ENT> <ENT>(b)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">8c. Potential Contamination</ENT> <ENT>(b)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">8d. Population (lines 8a + 8b + 8c)</ENT> <ENT>(b)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="03"> 9. Resources</ENT> <ENT>5</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="13">10. Sensitive Environments</ENT> </ROW> <ROW> <ENT I="05">10a. Actual Contamination</ENT> <ENT>(c)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">10b. Potential Contamination</ENT> <ENT>(c)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="05">10c. Sensitive Environments (lines 10a + 10b)</ENT> <ENT>(c)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="03">11. Targets (lines 7 + 8d + 9 + 10c)</ENT> <ENT>(b)</ENT> <ENT>____  </ENT> </ROW> <ROW> <ENT I="11"> <E T="02">Air Migration Pathway Score</E> </ENT> </ROW> <ROW> <ENT I="03"> 12. Pathway Score (S <E T="52">a</E> ) [(lines 3 × 6 × 11)/82,500]  <SU>d</SU> </ENT> <ENT>100</ENT> <ENT>____  </ENT> </ROW> <TNOTE> <SU>a</SU>  Maximum value applies to waste characteristics category. </TNOTE> <TNOTE> <SU>b</SU>  Maximum value not applicable. </TNOTE> <TNOTE> <SU>c</SU>  No specific maximum value applies to factor. However, pathway score based solely on sensitive environments is limited to maximum of 60. </TNOTE> <TNOTE> <SU>d</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 6.1 <E T="03">Likelihood of Release.</E> Evaluate the likelihood of release factor category in terms of an observed release factor or a potential to release factor. </P> <P> 6.1.1  <E T="03">Observed release.</E> Establish an observed release to the atmosphere by demonstrating that the site has released a hazardous substance to the atmosphere. Base this demonstration on either: </P> <P>• Direct observation—a material (for example, particulate matter) that contains one or more hazardous substances has been seen entering the atmosphere directly. When evidence supports the inference of a release of a material that contains one or more hazardous substances by the site to the atmosphere, demonstrated adverse effects accumulated with that release may be used to establish an observed release.</P> <P>• Chemical analysis—an analysis of air samples indicates that the concentration of ambient hazardous substance(s) has increased significantly above the background concentration for the site (see section 2.3). Some portion of the significant increase must be attributable to the site to establish the observed release.</P> <P>If an observed release can be established, assign an observed release factor value of 550, enter this value in table 6-1, and proceed to section 6.1.3. If an observed release cannot be established, assign an observed release factor value of 0, enter this value in table 6-1, and proceed to section 6.1.2.</P> <P> 6.1.2  <E T="03">Potential to release.</E> Evaluate potential to release only if an observed release cannot be established. Determine the potential to release factor value for the site by separately evaluating the gas potential to release and the particulate potential to release for each source at the site. Select the highest potential to release value (either gas or particulate) calculated for the sources evaluated and assign that value as the site potential to release factor value as specified below. </P> <P> 6.1.2.1  <E T="03">Gas potential to release.</E> Evaluate gas potential to release for those sources that contain gaseous hazardous substances—that is, those hazardous substances with a vapor pressure greater than or equal to 10 <E T="51">−9</E> torr. </P> <P> Evaluate gas potential to release for each source based on three factors: gas containment, gas source type, and gas migration potential. Calculate the gas potential to release value as illustrated in table 6-2. Combine sources with similar characteristics into a single source in evaluating the gas potential to release factors. <PRTPAGE P="209"/> </P> <GPOTABLE COLS="7" OPTS="L2" CDEF="s100,10,10,10,10,10,10"> <TTITLE>Table 6-2—Gas Potential to Release Evaluation</TTITLE> <BOXHD> <CHED H="1">Source</CHED> <CHED H="1"> Source type  <SU>a</SU> </CHED> <CHED H="1"> Gas containment factor value  <SU>b</SU> </CHED> <CHED H="1"> Gas source type factor value  <SU>c</SU> </CHED> <CHED H="1"> Gas migration potential factor value  <SU>d</SU> </CHED> <CHED H="1">Sum</CHED> <CHED H="1">Gas source value</CHED> </BOXHD> <ROW> <ENT I="11"> </ENT> <ENT> </ENT> <ENT>A</ENT> <ENT>B</ENT> <ENT>C</ENT> <ENT>(B + C)</ENT> <ENT>A(B + C)</ENT> </ROW> <ROW> <ENT I="01">1.</ENT> </ROW> <ROW> <ENT I="01">2.</ENT> </ROW> <ROW> <ENT I="01">3.</ENT> </ROW> <ROW> <ENT I="01">4.</ENT> </ROW> <ROW> <ENT I="01">5.</ENT> </ROW> <ROW> <ENT I="01">6.</ENT> </ROW> <ROW> <ENT I="01">7.</ENT> </ROW> <ROW> <ENT I="01">8.</ENT> </ROW> <ROW EXPSTB="06" RUL="n,n,n,n,n,n,s"> <ENT I="21">Gas Potential to Release Factor (Select the Highest Gas Source Value)</ENT> </ROW> <TNOTE> <SU>a</SU>  Enter a Source Type listed in table 6-4. </TNOTE> <TNOTE> <SU>b</SU>  Enter Gas Containment Factor Value from section 6.1.2.1.1. </TNOTE> <TNOTE> <SU>c</SU>  Enter Gas Source Type Factor Value from section 6.1.2.1.2. </TNOTE> <TNOTE> <SU>d</SU>  Enter Gas Migration Potential Factor Value from section 6.1.2.1.3. </TNOTE> </GPOTABLE> <P> 6.1.2.1.1  <E T="03">Gas containment.</E> Assign each source a value from table 6-3 for gas containment. Use the lowest value from table 6-3 that applies to the source, except: assign a value of 10 if there is evidence of biogas release or if there is an active fire within the source. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,9"> <TTITLE>Table 6-3—Gas Containment Factor Values</TTITLE> <BOXHD> <CHED H="1">Gas containment description</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW EXPSTB="00"> <ENT I="01">All situations except those specifically listed below</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Evidence of biogas release</ENT> <ENT> 10  <SU>a</SU> </ENT> </ROW> <ROW> <ENT I="01">Active fire within source</ENT> <ENT> 10  <SU>a</SU> </ENT> </ROW> <ROW> <ENT I="01">Gas collection/treatment system functioning, regularly inspected, maintained, and completely covering source</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Source substantially surrounded by engineering windbreak and no other containment specifically described in this table applies</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">Source covered with essentially impermeable, regularly inspected, maintained cover</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="11">Uncontaminated soil cover >3 feet:</ENT> </ROW> <ROW> <ENT I="02">• Source substantially vegetated with little exposed soil</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">• Source lightly vegetated with much exposed soil</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">• Source substantially devoid of vegetation</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="11">Uncontaminated soil cover ≥1 foot and ≥3 feet:</ENT> </ROW> <ROW> <ENT I="02">• Source heavily vegetated with essentially no exposed soil</ENT> </ROW> <ROW> <ENT I="03"> —Cover soil type resistant to gas migration  <SU>b</SU> </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="03"> —Cover soil type not resistant to gas migration  <SU>b</SU> or unknown </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02"> • Source substantially vegetated with little exposed soil and cover soil type resistant to gas migration  <SU>b</SU> </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11">Uncontaminated soil cover <1 foot:</ENT> </ROW> <ROW> <ENT I="02"> • Source heavily vegetated with essentially no exposed soil and cover soil type resistant to gas migration  <SU>b</SU> </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Totally or partially enclosed within structurally intact building and no other containment specifically described in this table applies</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="11">Source consists solely of intact, sealed containers:</ENT> </ROW> <ROW> <ENT I="02">• Totally protected from weather by regularly inspected, maintained cover</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>3</ENT> </ROW> <TNOTE> <SU>a</SU>  This value must be used if applicable. </TNOTE> <TNOTE> <SU>b</SU>  Consider moist fine-grained and saturated coarse-grained soils resistant to gas migration. Consider all other soils nonresistant. </TNOTE> </GPOTABLE> <P> 6.1.2.1.2  <E T="03">Gas source type.</E> Assign a value for gas source type to each source as follows: </P> <P>• Determine if the source meets the minimum size requirement based on the source hazardous waste quantity value (see section 2.4.2.1.5). If the source receives a source hazardous waste quantity value of 0.5 or more, consider the source to meet the minimum size requirement.</P> <P>• If the source meets the minimum size requirement, assign it a value from table 6-4 for gas source type.</P> <P>• If the source does not meet the minimum size requirement, assign it a value of 0 for gas source type.</P> <P> If no source at the site meets the minimum size requirement, assign each source at the <PRTPAGE P="210"/> site a value from table 6-4 for gas source type. </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s50,4,5"> <TTITLE>Table 6-4—Source Type Factor Values</TTITLE> <BOXHD> <CHED H="1">Source type</CHED> <CHED H="1">Assigned value</CHED> <CHED H="2">Gas</CHED> <CHED H="2">Particulate</CHED> </BOXHD> <ROW> <ENT I="01">Active fire area</ENT> <ENT>14</ENT> <ENT>30</ENT> </ROW> <ROW> <ENT I="01">Burn pit</ENT> <ENT>19</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="11">Containers or tanks (buried/below-ground):</ENT> </ROW> <ROW> <ENT I="02">• Evidence of biogas release</ENT> <ENT>33</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="02">• No evidence of biogas release</ENT> <ENT>11</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="01">Containers or tanks, not elsewhere specified</ENT> <ENT>28</ENT> <ENT>14</ENT> </ROW> <ROW> <ENT I="01">Contaminated soil (excluding land treatment)</ENT> <ENT>19</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="01">Landfarm/land treatment</ENT> <ENT>28</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="11">Landfill:</ENT> </ROW> <ROW> <ENT I="02">• Evidence of biogas release</ENT> <ENT>33</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="02">• No evidence of biogas release</ENT> <ENT>11</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="11">Pile:</ENT> </ROW> <ROW> <ENT I="02">• Tailings pile</ENT> <ENT>6</ENT> <ENT>28</ENT> </ROW> <ROW> <ENT I="02">• Scrap metal or junk pile</ENT> <ENT>6</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">• Trash pile</ENT> <ENT>6</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">• Chemical waste pile</ENT> <ENT>11</ENT> <ENT>28</ENT> </ROW> <ROW> <ENT I="02">• Other waste piles</ENT> <ENT>17</ENT> <ENT>28</ENT> </ROW> <ROW> <ENT I="11">Surface impoundments (buried/backfilled):</ENT> </ROW> <ROW> <ENT I="02">• Evidence of biogas release</ENT> <ENT>33</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="02">• No evidence of biogas release</ENT> <ENT>11</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="11">Surface impoundment (not buried/backfilled):</ENT> </ROW> <ROW> <ENT I="02">• Dry</ENT> <ENT>19</ENT> <ENT>22</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>28</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Other types of sources, not elsewhere specified</ENT> <ENT>0</ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <P> 6.1.2.1.3  <E T="03">Gas migration potential.</E> Evaluate this factor for each source as follows: </P> <P>• Assign a value for gas migration potential to each of the gaseous hazardous substances associated with the source (see section 2.2.2) as follows:</P> <P SOURCE="P-1">-Assign values from table 6-5 for vapor pressure and Henry's constant to each hazardous substance. If Henry's constant cannot be determined for a hazardous substance, assign that hazardous substance a value of 2 for the Henry's constant component.</P> <P SOURCE="P-1">-Sum the two values assigned to the hazardous substance.</P> <P SOURCE="P-1">-Based on this sum, assign the hazardous substance a value from table 6-6 for gas migration potential.</P> <P>• Assign a value for gas migration potential to each source as follows:</P> <P SOURCE="P-1">-Select three hazardous substances associated with the source:</P> <FP SOURCE="FP1-2"> -If more than three gaseous hazardous substances can be associated with the source, select three that have the highest gas migration potential values.</FP> <FP SOURCE="FP1-2"> -If fewer than three gaseous hazardous substances can be associated with a source, select all of them.</FP> <P SOURCE="P-1">-Average the gas migration potential values assigned to the selected hazardous substances.</P> <P SOURCE="P-1">-Based on this average value, assign the source a gas migration potential value from table 6-7.</P> <GPOTABLE COLS="2" OPTS="L2(,,0)" CDEF="s50,9"> <TTITLE>Table 6-5—Values for Vapor Pressure and Henry's Constant</TTITLE> <BOXHD> <CHED H="1">Vapor pressure (Torr)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Greater than 10</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <E T="51">−3</E> to 10 </ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01"> 10 <E T="51">−5</E> to 10 <E T="51">−3</E> </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01"> Less than 10 <E T="51">−5</E> </ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <BOXHD> <CHED H="1"> Henry's constant (atm-m <SU>3</SU> /mol) </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> Greater than 10 <E T="51">−3</E> </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <E T="51">−5</E> to 10 <E T="51">−3</E> </ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01"> 10 <E T="51">−7</E> to 10 <E T="51">−5</E> </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01"> Less than 10 <E T="51">−7</E> </ENT> <ENT>0</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE>Table 6-6—Gas Migration Potential Values for a Hazardous Substance</TTITLE> <BOXHD> <CHED H="1">Sum of values for vapor pressure and Henry's constant</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">1 or 2</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">3 or 4</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="01">5 or 6</ENT> <ENT>17</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE>Table 6-7—Gas Migration Potential Values for the Source</TTITLE> <BOXHD> <CHED H="1"> Average of gas migration potential values for three hazardous substances  <SU>a</SU> </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">0 to <3</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">3 to <8</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">8 to <14</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="01">14 to 17</ENT> <ENT>17</ENT> </ROW> <TNOTE> <SU>a</SU>  If fewer than three hazardous substances can be associated with the source, compute the average based only on those hazardous substances that can be associated. </TNOTE> </GPOTABLE> <P> 6.1.2.1.4  <E T="03">Calculation of gas potential to release value.</E> Determine the gas potential to release value for each source as illustrated in table 6-2. For each source, sum the gas source type factor value and gas migration potential factor value and multiply this sum by the gas containment factor value. Select the highest product calculated for the sources evaluated and assign it as the gas potential to release value for the site. Enter this value in table 6-1. </P> <P> 6.1.2.2  <E T="03">Particulate potential to release.</E> Evaluate particulate potential to release for those sources that contain particulate hazardous substances—that is, those hazardous substances with a vapor pressure less than or equal to 10 <E T="51">−1</E> torr. </P> <P> Evaluate particulate potential to release for each source based on three factors: particulate containment, particulate source type, and particulate migration potential. <PRTPAGE P="211"/> Calculate the particulate potential to release value as illustrated in table 6-8. Combine sources with similar characteristics into a single source in evaluating the particulate potential to release factors. </P> <P> 6.1.2.2.1  <E T="03">Particulate containment.</E> Assign each source a value from table 6-9 for particulate containment. Use the lowest value from table 6-9 that applies to the source. </P> <P> 6.1.2.2.2  <E T="03">Particulate source type.</E> Assign a value for particulate source type to each source in the same manner as specified for gas sources in section 6.1.2.1.2. </P> <P> 6.1.2.2.3  <E T="03">Particulate migration potential.</E> Based on the site location, assign a value from Figure 6-2 for particulate migration potential. Assign this same value to each source at the site. </P> <GPOTABLE COLS="7" OPTS="L2" CDEF="s10,10,10,10,10,10,10"> <TTITLE>Table 6-8—Particulate Potential to Release Evaluation</TTITLE> <BOXHD> <CHED H="1">Source</CHED> <CHED H="1"> Source type  <SU>a</SU> </CHED> <CHED H="1"> Particulate containment factor value  <SU>b</SU> </CHED> <CHED H="1"> Particulate type factor value  <SU>c</SU> </CHED> <CHED H="1"> Particulate migration potential factor value  <SU>d</SU> </CHED> <CHED H="1">Sum</CHED> <CHED H="1">Particulate source value</CHED> </BOXHD> <ROW> <ENT I="11"> </ENT> <ENT> </ENT> <ENT>A</ENT> <ENT>B</ENT> <ENT>C</ENT> <ENT>(B + C)</ENT> <ENT>A (B + C)</ENT> </ROW> <ROW> <ENT I="01">1.</ENT> </ROW> <ROW> <ENT I="01">2.</ENT> </ROW> <ROW> <ENT I="01">3.</ENT> </ROW> <ROW> <ENT I="01">4.</ENT> </ROW> <ROW> <ENT I="01">5.</ENT> </ROW> <ROW> <ENT I="01">6.</ENT> </ROW> <ROW> <ENT I="01">7.</ENT> </ROW> <ROW> <ENT I="01">8.</ENT> </ROW> <ROW EXPSTB="06" RUL="n,n,n,n,n,n,s"> <ENT I="21">Particulate Potential to Release Factor Value (Select Highest Particulate Source Value)</ENT> </ROW> <TNOTE> <SU>a</SU>  Enter a Source Type listed in table 6-4. </TNOTE> <TNOTE> <SU>b</SU>  Enter Particulate Containment Factor Value from section 6.1.2.2.1. </TNOTE> <TNOTE> <SU>c</SU>  Enter Particulate Source Type Factor Value from section 6.1.2.2.2. </TNOTE> <TNOTE> <SU>d</SU>  Enter Particulate Migration Potential Factor Value from section 6.1.2.2.3. </TNOTE> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,9"> <TTITLE>Table 6-9—Particulate Containment Factor Values</TTITLE> <BOXHD> <CHED H="1">Particulate containment description</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW EXPSTB="00"> <ENT I="01">All situations except those specifically listed below</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Source contains only particulate hazardous substances totally covered by liquids</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">Source substantially surrounded by engineered windbreak and no other containment specifically described in this table applies</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01">Source covered with essentially impermeable, regularly inspected, maintained cover</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="11">Uncontaminated soil cover >3 feet:</ENT> </ROW> <ROW> <ENT I="02">• Source substantially vegetated with little or no exposed soil</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">• Source lightly vegetated with much exposed soil</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">• Source substantially devoid of vegetation</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="11">Uncontaminated soil cover ≥1 foot and ≤3 feet:</ENT> </ROW> <ROW> <ENT I="02" O="xl">• Source heavily vegetated with essentially no exposed soil:</ENT> </ROW> <ROW> <ENT I="03"> —Cover soil type resistant to gas migration  <SU>a</SU> </ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="03"> —Cover soil type not resistant to gas migration  <SU>a</SU> or unknown </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02"> • Source substantially vegetated with little exposed soil and cover soil type resistant to gas migration  <SU>a</SU> </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="11">Uncontaminated soil cover <1 foot:</ENT> </ROW> <ROW> <ENT I="02"> • Source heavily vegetated with essentially no exposed soil and cover soil type resistant to gas migration  <SU>a</SU> </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Totally or partially enclosed within structurally intact building and no other containment specifically described in this table applies</ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="11">Source consists solely of containers:</ENT> </ROW> <ROW> <ENT I="02">• All containers contain only liquids</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">• All containers intact, sealed, and totally protected from weather by regularly inspected, maintained cover</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">• All containers intact and sealed</ENT> <ENT>3</ENT> </ROW> <ROW> <ENT I="02">• Other</ENT> <ENT>10</ENT> </ROW> <TNOTE> <SU>a</SU>  Consider moist fine-grained and saturated coarse-grained soils resistant to gas migration. Consider all other soils nonresistant. </TNOTE> </GPOTABLE> <GPH SPAN="2" DEEP="445"> <PRTPAGE P="212"/> <GID>EC02AU92.013</GID> </GPH> <PRTPAGE P="213"/> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,10"> <TTITLE>Figure 6-2—Particulate Migration Potential Factor Values—Concluded</TTITLE> <BOXHD> <CHED H="1">Location</CHED> <CHED H="1">Particulate migration potential assigned value</CHED> </BOXHD> <ROW> <ENT I="11">Hawaiian Islands</ENT> </ROW> <ROW> <ENT I="02">Hilo, Hawaii</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Honolulu, Oahu</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Kahului, Maui</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Lanai</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Lihue, Kauai</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">Molokai</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="11">Pacific Islands</ENT> </ROW> <ROW> <ENT I="02">Guam</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Johnston Island</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Koror Island</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Kwajalein Island</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Mujuro, Marshall Islands</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Pago Pago, American Samoa</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Ponape Island</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Truk, Caroline Islands</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Wake Island</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Yap Island</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="11">Alaska</ENT> </ROW> <ROW> <ENT I="02">Anchorage</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Annette</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Barrow</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Barter Island</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Bethel</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Bettles</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Big Delta</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Cold Bay</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Fairbanks</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Gulkana</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Homer</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">Juneau</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">King Salmon</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">Kodiak</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Kutzebue</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">McGrath</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Nome</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">St. Paul Island</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">Talkeetna</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Unalakleet</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">Valdez</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="02">Yakutat</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="11">American Virgin Islands</ENT> </ROW> <ROW> <ENT I="02">St. Croix</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">St. John</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">St. Thomas</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="11">Puerto Rico</ENT> </ROW> <ROW> <ENT I="02">Arecibo</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Coloso</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Fajardo</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">Humacao</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="02">Isabela Station</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="02">Ponce</ENT> <ENT>17</ENT> </ROW> <ROW> <ENT I="02">San Juan</ENT> <ENT>11</ENT> </ROW> </GPOTABLE> <P>For site locations not on Figure 6-2, and for site locations near the boundary points on Figure 6-2, assign a value as follows. First, calculate a Thornthwaite P-E index using the following equation:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.163</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">PE = Thornthwaite P-E index.</FP> <FP SOURCE="FP-2"> P <E T="52">i</E> = Mean monthly precipitation for month i, in inches. </FP> <FP SOURCE="FP-2"> T <E T="52">i</E> = Mean monthly temperature for month i, in degrees Fahrenheit; for any month having a mean monthly temperature less than 28.4 °F, use 28.4 °F. </FP> <FP>Based on the calculated Thornthwaite P-E index, assign a source particulate migration potential value to the site from table 6-10. Assign this same value to each source at the site.</FP> <GPOTABLE COLS="2" OPTS="L2" CDEF="s25,8"> <TTITLE>Table 6-10—Particulate Migration Potential Values</TTITLE> <BOXHD> <CHED H="1">Thornthwaite P-E Index</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Greater than 150</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">85 to 150</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">50 to less than 85</ENT> <ENT>11</ENT> </ROW> <ROW> <ENT I="01">Less than 50</ENT> <ENT>17</ENT> </ROW> </GPOTABLE> <P> 6.1.2.2.4  <E T="03">Calculation of particulate potential to release value.</E> Determine the particulate potential to release value for each source as illustrated in table 6-8. For each source, sum its particulate source type factor value and particulate migration potential factor value and multiply this sum by its particulate containment factor value. Select the highest product calculated for the sources evaluated and assign it as the particulate potential to release value for the site. Enter the value in table 6-1. </P> <P> 6.1.2.3  <E T="03">Calculation of potential to release factor value for the site.</E> Select the higher of the gas potential to release value assigned in section 6.1.2.1.4 and the particulate potential to release value assigned in section 6.1.2.2.4. Assign the value selected as the site potential to release factor value. Enter this value in table 6-1. </P> <P> 6.1.3  <E T="03">Calculation of likelihood of release factor category value.</E> If an observed release is established, assign the observed release factor value of 550 as the likelihood of release factor category value. Otherwise, assign the site potential to release factor value as the likelihood of release factor category value. Enter the value in table 6-1. </P> <P> 6.2  <E T="03">Waste characteristics.</E> Evaluate the waste characteristics factor category based on two factors: toxicity/mobility and hazardous waste quantity. Evaluate only those hazardous substances available to migrate from the sources at the site to the atmosphere. Such hazardous substances include: </P> <P>• Hazardous substances that meet the criteria for an observed release to the atmosphere.</P> <P>• All gaseous hazardous substances associated with a source that has a gas containment factor value greater than 0 (see section 2.2.2, 2.2.3, and 6.1.2.1.1).</P> <P> • All particulate hazardous substances associated with a source that has a particulate <PRTPAGE P="214"/> containment factor value greater than 0 (see section 2.2.2, 2.2.3, and 6.1.2.2.1). </P> <P> 6.2.1  <E T="03">Toxicity/mobility.</E> For each hazardous substance, assign a toxicity factor value, a mobility factor value, and a combined toxicity/mobility factor value as specified below. Select the toxicity/mobility factor value for the air migration pathway as specified in section 6.2.1.3. </P> <P> 6.2.1.1  <E T="03">Toxicity.</E> Assign a toxicity factor value to each hazardous substance as specified in section 2.4.1.1. </P> <P> 6.2.1.2  <E T="03">Mobility.</E> Assign a mobility factor value to each hazardous substance as follows: </P> <P>• Gaseous hazardous substance.</P> <P SOURCE="P-1">-Assign a mobility factor value of 1 to each gaseous hazardous substance that meets the criteria for an observed release to the atmosphere.</P> <P SOURCE="P-1">-Assign a mobility factor value from table 6-11, based on vapor pressure, to each gaseous hazardous substance that does not meet the criteria for an observed release.</P> <P>• Particulate hazardous substance.</P> <P SOURCE="P-1">-Assign a mobility factor value of 0.02 to each particulate hazardous substance that meets the criteria for an observed release to the atmosphere.</P> <P SOURCE="P-1">-Assign a mobility factor value from Figure 6-3, based on the site's location, to each particulate hazardous substance that does not meet the criteria for an observed release. (Assign all such particulate hazardous substances this same value.)</P> <P SOURCE="P-1">-For site locations not on Figure 6-3 and for site locations near the boundary points on Figure 6-3, assign a mobility factor value to each particulate hazardous substance that does not meet the criteria for an observed release as follows:</P> <FP SOURCE="FP1-2"> -Calculate a value M:</FP> <FP SOURCE="FP-2"> M = 0.0182 (U <SU>3</SU> /[PE] <SU>2</SU> ) </FP> <FP>where:</FP> <FP SOURCE="FP-2">U = Mean average annual wind speed (meters per second).</FP> <FP SOURCE="FP-2">PE = Thornthwaite P-E index from section 6.1.2.2.3.</FP> <FP SOURCE="FP1-2"> -Based on the value M, assign a mobility factor value from table 6-12 to each particulate hazardous substance.</FP> <P>• Gaseous and particulate hazardous substances.</P> <P SOURCE="P-1">-For a hazardous substance potentially present in both gaseous and particulate forms, select the higher of the factor values for gas mobility and particulate mobility for that substance and assign that value as the mobility factor value for the hazardous substance.</P> <P> 6.2.1.3  <E T="03">Calculation of toxicity/mobility factor value.</E> Assign each hazardous substance a toxicity/mobility factor value from table 6-13, based on the values assigned to the hazardous substance for the toxicity and mobility factors. Use the hazardous substance with the highest toxicity/mobility factor value to assign the value to the toxicity/mobility factor for the air migration pathway. Enter this value in table 6-1. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s25,10"> <TTITLE>Table 6-11—Gas Mobility Factor Values</TTITLE> <BOXHD> <CHED H="1">Vapor pressure (Torr)</CHED> <CHED H="1"> Assigned value  <E T="0731">a</E> </CHED> </BOXHD> <ROW> <ENT I="01"> Greater than 10 <E T="51">−1</E> </ENT> <ENT>1.0</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <E T="51">−3</E> to 10 <E T="51">−1</E> </ENT> <ENT>0.2</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <E T="51">−5</E> to 10 <E T="51">−3</E> </ENT> <ENT>0.02</ENT> </ROW> <ROW> <ENT I="01"> Greater than 10 <E T="51">−7</E> to 10 <E T="51">−5</E> </ENT> <ENT>0.002</ENT> </ROW> <ROW> <ENT I="01"> Less than or equal to 10 <E T="51">−7</E> </ENT> <ENT>0.0002</ENT> </ROW> <TNOTE> <E T="0731">a</E>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <GPH SPAN="2" DEEP="441"> <PRTPAGE P="215"/> <GID>EC02AU92.014</GID> </GPH> <GPH SPAN="2" DEEP="423"> <PRTPAGE P="216"/> <GID>EC02AU92.015</GID> </GPH> <GPH SPAN="2" DEEP="452"> <PRTPAGE P="217"/> <GID>EC02AU92.016</GID> </GPH> <PRTPAGE P="218"/> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE>Figure 6-3—Particulate Mobility Factor Values—Concluded</TTITLE> <BOXHD> <CHED H="1">Location</CHED> <CHED H="1">Particulated mobility assigned value</CHED> </BOXHD> <ROW> <ENT I="11">Pacific Islands</ENT> </ROW> <ROW> <ENT I="02">Guam</ENT> <ENT>0.0002</ENT> </ROW> <ROW> <ENT I="02">Johnston Island</ENT> <ENT>0.002</ENT> </ROW> <ROW> <ENT I="02">Koror Island</ENT> <ENT>0.00008</ENT> </ROW> <ROW> <ENT I="02">Kwajalein Island</ENT> <ENT>0.0002</ENT> </ROW> <ROW> <ENT I="02">Mujuro, Marshall Islands</ENT> <ENT>0.00008</ENT> </ROW> <ROW> <ENT I="02">Pago Pago, American Samoa</ENT> <ENT>0.00008</ENT> </ROW> <ROW> <ENT I="02">Ponape Island</ENT> <ENT>0.00002</ENT> </ROW> <ROW> <ENT I="02">Truk, Caroline Islands</ENT> <ENT>0.00008</ENT> </ROW> <ROW> <ENT I="02">Wake Island</ENT> <ENT>0.002</ENT> </ROW> <ROW> <ENT I="02">Yap Island</ENT> <ENT>0.00008</ENT> </ROW> <ROW> <ENT I="11">American Virgin Islands</ENT> </ROW> <ROW> <ENT I="02">St. Croix</ENT> <ENT>0.0008</ENT> </ROW> <ROW> <ENT I="02">St. John</ENT> <ENT>0.0002</ENT> </ROW> <ROW> <ENT I="02">St. Thomas</ENT> <ENT>0.0002</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s75,9"> <TTITLE>Table 6-12—Particulate Mobility Factor Values</TTITLE> <BOXHD> <CHED H="1">M</CHED> <CHED H="1"> Assigned value  <E T="0731">a</E> </CHED> </BOXHD> <ROW> <ENT I="01"> Greater than 1.4 × 10 <E T="51">−2</E> </ENT> <ENT>0.02</ENT> </ROW> <ROW> <ENT I="01"> Greater than 4.4 × 10 <E T="51">−3</E> to 1.4 × 10 <E T="51">−2</E> </ENT> <ENT>0.008</ENT> </ROW> <ROW> <ENT I="01"> Greater than 1.4 × 10 <E T="51">−3</E> to 4.4 × 10 <E T="51">−3</E> </ENT> <ENT>0.002</ENT> </ROW> <ROW> <ENT I="01"> Greater than 4.4 × 10 <E T="51">−4</E> to 1.4 × 10 <E T="51">−3</E> </ENT> <ENT>0.0008</ENT> </ROW> <ROW> <ENT I="01"> Greater than 1.4 × 10 <E T="51">−4</E> to 4.4 × 10 <E T="51">−4</E> </ENT> <ENT>0.0002</ENT> </ROW> <ROW> <ENT I="01"> Greater than 4.4 × 10 <E T="51">−5</E> to 1.4 × 10 <E T="51">−4</E> </ENT> <ENT>0.00008</ENT> </ROW> <ROW> <ENT I="01"> Less than or equal to 4.4 × 10 <E T="51">−5</E> </ENT> <ENT>0.00002</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <GPOTABLE COLS="7" OPTS="L2" CDEF="s100,7,7,6,6,7,3"> <TTITLE> Table 6-13—Toxicity/Mobility Factor Values  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Mobility factor value</CHED> <CHED H="1">Toxicity factor value</CHED> <CHED H="2">10,000</CHED> <CHED H="2">1,000</CHED> <CHED H="2">100</CHED> <CHED H="2">10</CHED> <CHED H="2">1</CHED> <CHED H="2">0</CHED> </BOXHD> <ROW> <ENT I="01">1.0</ENT> <ENT>10,000</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.2</ENT> <ENT>2,000</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.02</ENT> <ENT>200</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.008</ENT> <ENT>80</ENT> <ENT>8</ENT> <ENT>0.8</ENT> <ENT>0.08</ENT> <ENT>0.008</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.002</ENT> <ENT>20</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.0008</ENT> <ENT>8</ENT> <ENT>0.8</ENT> <ENT>0.08</ENT> <ENT>0.008</ENT> <ENT>0.0008</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.0002</ENT> <ENT>2</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT>0.0002</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.00008</ENT> <ENT>0.8</ENT> <ENT>0.08</ENT> <ENT>0.008</ENT> <ENT>0.0008</ENT> <ENT>0.00008</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">0.00002</ENT> <ENT>0.2</ENT> <ENT>0.02</ENT> <ENT>0.002</ENT> <ENT>0.0002</ENT> <ENT>0.00002</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 6.2.2  <E T="03">Hazardous waste quantity.</E> Assign a hazardous waste quantity factor value for the air migration pathway as specified in section 2.4.2. Enter this value in table 6-1. </P> <P> 6.2.3  <E T="03">Calculation of waste characteristics factor category value.</E> Multiply the toxicity/mobility factor value and the hazardous waste quantity factor value, subject to a maximum product of 1 × 10 <SU>8</SU> . Based on this product, assign a value from table 2-7 (section 2.4.3.1) to the waste characteristics factor category. Enter this value in table 6-1. </P> <P> 6.3  <E T="03">Targets.</E> </P> <P>Evaluate the targets factor category based on four factors: nearest individual, population, resources, and sensitive environments. Include only those targets (for example, individuals, sensitive environments) located within the 4-mile target distance limit, except: if an observed release is established beyond the 4-mile target distance limit, include those additional targets that are specified below in this section and in section 6.3.4.</P> <P>Evaluate the nearest individual and population factors based on whether the target populations are subject to Level I concentrations, Level II concentrations, or potential contamination. Determine which applies to a target population as follows.</P> <P>If no samples meet the criteria for an observed release to air and if there is no observed release by direct observation, consider the entire population within the 4-mile target distance limit to be subject to potential contamination.</P> <P>If one or more samples meet the criteria for an observed release to air or if there is an observed release by direct observation, evaluate the population as follows:</P> <P>• Determine the most distant sample location that meets the criteria for Level I concentrations as specified in sections 2.5.1 and 2.5.2 and the most distant location (that is, sample location or direct observation location) that meets the criteria for Level II concentrations. Use the health-based benchmarks from table 6-14 in determining the level of contamination for sample locations. If the most distant Level II location is closer to a source than the most distant Level I sample location, do not consider the Level II location.</P> <P> • Determine the single most distant location (sample location or direct observation location) that meets the criteria for Level I or Level II concentrations. <PRTPAGE P="219"/> </P> <P>• If this single most distant location is within the 4-mile target distance limit, identify the distance categories from table ­6-15 in which the selected Level I concentrations sample and Level II concentrations sample (or direct observation location) are located:</P> <P SOURCE="P-1">-Consider the target population anywhere within this furthest Level I distance category, or anywhere within a distance category closer to a source at the site, as subject to Level I concentrations.</P> <P SOURCE="P-1">-Consider the target population located beyond any Level I distance categories, up to and including the population anywhere within the furthest Level II distance category, as subject to Level II concentrations.</P> <P SOURCE="P-1">-Consider the remainder of the target population within the 4-mile target distance limit as subject to potential contamination.</P> <P>• If the single most distant location is beyond the 4-mile target distance limit, identify the distance at which the selected Level I concentrations sample and Level II concentrations sample (or direct observation location) are located:</P> <P SOURCE="P-1">-If the Level I sample location is within the 4-mile target distance limit, identify the target population subject to Level I concentrations as specified above.</P> <P SOURCE="P-1">-If the Level I sample location is beyond the 4-mile target distance limit, consider the target population located anywhere within a distance from the sources at the site equal to the distance to this sample location to be subject to Level I concentrations and include them in the evaluation.</P> <P SOURCE="P-1">-Consider the target population located beyond the Level I target population, but located anywhere within a distance from the sources at the site equal to the distance to the selected Level II location, to be subject to Level II concentrations and include them in the evaluation.</P> <P SOURCE="P-1">-Do not include any target population as subject to potential contamination.</P> <GPOTABLE COLS="1" OPTS="L2,p1,8/9" CDEF="xl200"> <TTITLE>Table 6-14—Health-based Benchmarks for Hazardous Substances in Air</TTITLE> <BOXHD> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01">• Concentration corresponding to National Ambient Air Quality Standard (NAAQS).</ENT> </ROW> <ROW> <ENT I="01">• Concentration corresponding to National Emission Standards for Hazardous Air Pollutants (NESHAPs).</ENT> </ROW> <ROW> <ENT I="01"> • Screening concentration for cancer corresponding to that concentration that corresponds to the 10 <E T="51">−</E> <SU>6</SU> individual cancer risk for inhalation exposures. </ENT> </ROW> <ROW> <ENT I="01">• Screening concentration for noncancer toxicological responses corresponding to the Reference Concentration (RfC) for inhalation exposures.</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,10"> <TTITLE>Table 6-15—Air Migration Pathway Distance Weights</TTITLE> <BOXHD> <CHED H="1">Distance category (miles)</CHED> <CHED H="1"> Assigned distance weight  <SU>a</SU> </CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>1.0</ENT> </ROW> <ROW> <ENT I="01"> Greater than 0 to <FR>1/4</FR> </ENT> <ENT>0.25</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to <FR>1/2</FR> </ENT> <ENT>0.054</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>0.016</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 2</ENT> <ENT>0.0051</ENT> </ROW> <ROW> <ENT I="01">Greater than 2 to 3</ENT> <ENT>0.0023</ENT> </ROW> <ROW> <ENT I="01">Greater than 3 to 4</ENT> <ENT>0.0014</ENT> </ROW> <ROW> <ENT I="01">Greater than 4</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Do not round to nearest integer. </TNOTE> </GPOTABLE> <P> 6.3.1  <E T="03">Nearest individual.</E> Assign the nearest individual factor a value as follows: </P> <P>• If one or more residences or regularly occupied buildings or areas is subject to Level I concentrations as specified in section 6.3, assign a value of 50.</P> <P>• If not, but if one or more a residences or regularly occupied buildings or areas is subject to Level II concentrations, assign a value of 45.</P> <P>• If none of the residences and regularly occupied buildings and areas is subject to Level I or Level II concentrations, assign a value to this factor based on the shortest distance to any residence or regularly occupied building or area, as measured from any source at the site with an air migration containment factor value greater than 0. Based on this shortest distance, assign a value from table 6-16 to the nearest individual factor.</P> <P>Enter the value assigned in table 6-1.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,10"> <TTITLE>Table 6-16—Nearest Individual Factor Values</TTITLE> <BOXHD> <CHED H="1">Distance to nearest individual (miles)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> Level I concentrations  <SU>a</SU> </ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01"> Level II concentrations  <SU>a</SU> </ENT> <ENT>45</ENT> </ROW> <ROW> <ENT I="01"> 0 to <FR>1/8</FR> </ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/8</FR> to <FR>1/4</FR> </ENT> <ENT>7</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to 1/2 </ENT> <ENT>2</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">Greater than 1</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Distance does not apply. </TNOTE> </GPOTABLE> <P> 6.3.2  <E T="03">Population.</E> In evaluating the population factor, count residents, students, and workers regularly present within the target distance limit. Do not count transient populations such as customers and travelers passing through the area. <PRTPAGE P="220"/> </P> <P>In estimating residential population, when the estimate is based on the number of residences, multiply each residence by the average number of persons per residence for the county in which the residence is located.</P> <P> 6.3.2.1  <E T="03">Level of contamination.</E> Evaluate the population factor based on three factors: Level I concentrations, Level II concentrations, and potential contamination. </P> <P>Evaluate the population subject to Level I concentrations (see section 6.3) as specified in section 6.3.2.2, the population subject to Level II concentrations as specified in section 6.3.2.3, and the population subject to potential contamination as specified in section 6.3.2.4.</P> <P>For the potential contamination factor, use population ranges in evaluating the factor as specified in section 6.3.2.4. For the Level I and Level II concentrations factors, use the population estimate, not population ranges, in evaluating both factors.</P> <P> 6.3.2.2  <E T="03">Level I concentrations.</E> Sum the number of people subject to Level I concentrations. Multiply this sum by 10. Assign the product as the value for this factor. Enter this value in table 6-1. </P> <P> 6.3.2.3  <E T="03">Level II concentrations.</E> Sum the number of people subject to Level II concentrations. Do not include those people already counted under the Level I concentrations factor. Assign this sum as the value for this factor. Enter this value in table 6-1. </P> <P> 6.3.2.4  <E T="03">Potential contamination.</E> Determine the number of people within each distance category of the target distance limit (see table 6-15) who are subject to potential contamination. Do not include those people already counted under the Level I and Level II concentrations factors. </P> <P>Based on the number of people present within a distance category, assign a distance-weighted population value for that distance category from table 6-17. (Note that the distance-weighted population values in table 6-17 incorporate the distance weights from table 6-15. Do not multiply the values from table 6-17 by these distance weights.)</P> <P>Calculate the potential contamination factor value (PI) as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.164</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2"> W <E T="52">i</E> = Distance-weighted population from table 6-17 for distance category i. </FP> <FP SOURCE="FP-2">n = Number of distance categories.</FP> <P>If PI is less than 1, do not round it to the nearest integer; if PI is 1 or more, round to the nearest integer. Enter this value in table 6-1.</P> <P> 6.3.2.5  <E T="03">Calculation of population factor value.</E> Sum the factor values for Level I concentrations, Level II concentrations, and potential contamination. Do not round this sum to the nearest integer. Assign this sum as the population factor value. Enter this value in table 6-1. <PRTPAGE P="221"/> </P> <GPOTABLE COLS="14" OPTS="L2" CDEF="s40,3,5,5,5,5,5,6,7,7,8,8,8,8"> <TTITLE> Table 6-17—Distance-Weighted Population Values For Potential Contamination Factor for Air Pathway  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Distance category (miles)</CHED> <CHED H="1">Number of people within the distance category</CHED> <CHED H="2">0</CHED> <CHED H="2">1 to 10</CHED> <CHED H="2">11 to 30</CHED> <CHED H="2">31 to 100</CHED> <CHED H="2">101 to 300</CHED> <CHED H="2">301 to 1,000</CHED> <CHED H="2">1,001 to 3,000</CHED> <CHED H="2">3,001 to 10,000</CHED> <CHED H="2">10,001 to 30,000</CHED> <CHED H="2">30,001 to 100,000</CHED> <CHED H="2">100,001 to 300,000</CHED> <CHED H="2">300,001 to 1,000,000</CHED> <CHED H="2">1,000,001 to 3,000,000</CHED> </BOXHD> <ROW> <ENT I="01">On a source</ENT> <ENT>0</ENT> <ENT>4</ENT> <ENT>17</ENT> <ENT>53</ENT> <ENT>164</ENT> <ENT>522</ENT> <ENT>1,633</ENT> <ENT>5,214</ENT> <ENT>16,325</ENT> <ENT>52,137</ENT> <ENT>163,246</ENT> <ENT>521,360</ENT> <ENT>1,632,455</ENT> </ROW> <ROW> <ENT I="01"> Greater than 0 to <FR>1/4</FR> </ENT> <ENT>0</ENT> <ENT>1</ENT> <ENT>4</ENT> <ENT>13</ENT> <ENT>41</ENT> <ENT>131</ENT> <ENT>408</ENT> <ENT>1,304</ENT> <ENT>4,081</ENT> <ENT>13,034</ENT> <ENT>40,812</ENT> <ENT>130,340</ENT> <ENT>408,114</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/4</FR> to <FR>1/2</FR> </ENT> <ENT>0</ENT> <ENT>0.2</ENT> <ENT>0.9</ENT> <ENT>3</ENT> <ENT>9</ENT> <ENT>28</ENT> <ENT>88</ENT> <ENT>282</ENT> <ENT>882</ENT> <ENT>2,815</ENT> <ENT>8,815</ENT> <ENT>28,153</ENT> <ENT>88,153</ENT> </ROW> <ROW> <ENT I="01"> Greater than <FR>1/2</FR> to 1 </ENT> <ENT>0</ENT> <ENT>0.06</ENT> <ENT>0.3</ENT> <ENT>0.9</ENT> <ENT>3</ENT> <ENT>8</ENT> <ENT>26</ENT> <ENT>83</ENT> <ENT>261</ENT> <ENT>834</ENT> <ENT>2,612</ENT> <ENT>8,342</ENT> <ENT>26,119</ENT> </ROW> <ROW> <ENT I="01">Greater than 1 to 2</ENT> <ENT>0</ENT> <ENT>0.02</ENT> <ENT>0.09</ENT> <ENT>0.3</ENT> <ENT>0.8</ENT> <ENT>3</ENT> <ENT>8</ENT> <ENT>27</ENT> <ENT>83</ENT> <ENT>266</ENT> <ENT>833</ENT> <ENT>2,659</ENT> <ENT>8,326</ENT> </ROW> <ROW> <ENT I="01">Greater than 2 to 3</ENT> <ENT>0</ENT> <ENT>0.009</ENT> <ENT>0.04</ENT> <ENT>0.1</ENT> <ENT>0.4</ENT> <ENT>1</ENT> <ENT>4</ENT> <ENT>12</ENT> <ENT>38</ENT> <ENT>120</ENT> <ENT>375</ENT> <ENT>1,199</ENT> <ENT>3,755</ENT> </ROW> <ROW> <ENT I="01">Greater than 3 to 4</ENT> <ENT>0</ENT> <ENT>0.005</ENT> <ENT>0.02</ENT> <ENT>0.07</ENT> <ENT>0.2</ENT> <ENT>0.7</ENT> <ENT>2</ENT> <ENT>7</ENT> <ENT>23</ENT> <ENT>73</ENT> <ENT>229</ENT> <ENT>730</ENT> <ENT>2,285</ENT> </ROW> <TNOTE> <SU>a</SU>  Round the number of people present within a distance category to nearest integer. Do not round the assigned distance-weighted population value to nearest integer. </TNOTE> </GPOTABLE> <PRTPAGE P="222"/> <P> 6.3.3  <E T="03">Resources.</E> Evaluate the resources factor as follows: </P> <P>• Assign a value of 5 if one or more of the following resources are present within one-half mile of a source at the site having an air migration containment factor value greater than 0:</P> <P SOURCE="P-1">-Commercial agriculture.</P> <P SOURCE="P-1">-Commercial silviculture.</P> <P SOURCE="P-1">-Major or designated recreation area.</P> <P>• Assign a value of 0 if none of these resources is present.</P> <P>Enter the value assigned in table 6-1.</P> <P> 6.3.4  <E T="03">Sensitive environments.</E> Evaluate sensitive environments based on two factors: actual contamination and potential contamination. Determine which factor applies as follows. </P> <P>If no samples meet the criteria for an observed release to air and if there is no observed release by direct observation, consider all sensitive environments located, partially or wholly, within the target distance limit to be subject to potential contamination.</P> <P>If one or more samples meet the criteria for an observed release to air or if there is an observed release by direct observation, determine the most distant location (that is, sample location or direct observation location) that meets the criteria for an observed release:</P> <P>• If the most distant location meeting the criteria for an observed release is within the 4-mile target distance limit, identify the distance category from table 6-15 in which it is located:</P> <P SOURCE="P-1">-Consider sensitive environments located, partially or wholly, anywhere within this distance category or anywhere within a distance category closer to a source at the site as subject to actual contamination.</P> <P SOURCE="P-1">-Consider all other sensitive environments located, partially or wholly, within the target distance limit as subject to potential contamination.</P> <P>• If the most distant location meeting the criteria for an observed release is beyond the 4-mile target distance limit, identify the distance at which it is located:</P> <P SOURCE="P-1">-Consider sensitive environments located, partially or wholly, anywhere within a distance from the sources at the site equal to the distance to this location to be subject to actual contamination and include all such sensitive environments in the evaluation.</P> <P SOURCE="P-1">-Do not include any sensitive environments as subject to potential contamination.</P> <P> 6.3.4.1 <E T="03">Actual contamination.</E> Determine those sensitive environments subject to actual contamination ( <E T="03">i.e.</E> , those located partially or wholly within a distance category subject to actual contamination). Assign value(s) from table 4-23 (section 4.1.4.3.1.1) to each sensitive environment subject to actual contamination. </P> <P>For those sensitive environments that are wetlands, assign an additional value from table 6-18. In assigning a value from table 6-18, include only those portions of wetlands located within distance categories subject to actual contamination. If a wetland is located partially in a distance category subject to actual contamination and partially in one subject to potential contamination, then solely for purposes of table 6-18, count the portion in the distance category subject to potential contamination under the potential contamination factor in section 6.3.4.2. Determine the total acreage of wetlands within those distance categories subject to actual contamination and assign a value from table 6-18 based on this total acreage.</P> <P>Calculate the actual contamination factor value (EA) as follows:</P> <MATH SPAN="1" DEEP="29"> <MID>EC15NO91.165</MID> </MATH> <FP>where:</FP> <FP SOURCE="FP-2">WA = Value assigned from table 6-18 for wetlands in distance categories subject to actual contamination.</FP> <FP SOURCE="FP-2"> S <E T="52">i</E> = Value(s) assigned from table 4-23 to sensitive environment i. </FP> <FP SOURCE="FP-2">n = Number of sensitive environments subject to actual contamination.</FP> <P>Enter the value assigned in table 6-1.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,9"> <TTITLE> Table 6-18—Wetlands Rating Values for Air Migration Pathway  <E T="01"> <SU>a</SU> </E> </TTITLE> <BOXHD> <CHED H="1">Wetland area (acres)</CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01">Less than 1</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">1 to 50</ENT> <ENT>25</ENT> </ROW> <ROW> <ENT I="01">Greater than 50 to 100</ENT> <ENT>75</ENT> </ROW> <ROW> <ENT I="01">Greater than 100 to 150</ENT> <ENT>125</ENT> </ROW> <ROW> <ENT I="01">Greater than 150 to 200</ENT> <ENT>175</ENT> </ROW> <ROW> <ENT I="01">Greater than 200 to 300</ENT> <ENT>250</ENT> </ROW> <ROW> <ENT I="01">Greater than 300 to 400</ENT> <ENT>350</ENT> </ROW> <ROW> <ENT I="01">Greater than 400 to 500</ENT> <ENT>450</ENT> </ROW> <ROW> <ENT I="01">Greater than 500</ENT> <ENT>500</ENT> </ROW> <TNOTE> <SU>a</SU>  Wetlands as defined in 40 CFR section 230.3. </TNOTE> </GPOTABLE> <P> 6.3.4.2  <E T="03">Potential contamination.</E> Determine those sensitive environments located, partially or wholly, within the target distance limit that are subject to potential contamination. Assign value(s) from table 4-23 to each sensitive environment subject to potential contamination. Do not include those sensitive environments already counted for table 4-23 under the actual contamination factor. </P> <P> For each distance category subject to potential contamination, sum the value(s) assigned from table 4-23 to the sensitive environments in that distance category. If a sensitive environment is located in more than one distance category, assign the sensitive <PRTPAGE P="223"/> environment only to that distance category having the highest distance weighting value from table 6-15. </P> <P>For those sensitive environments that are wetlands, assign an additional value from table 6-18. In assigning a value from table 6-18, include only those portions of wetlands located within distance categories subject to potential contamination, as specified in section 6.3.4.1. Treat the wetlands in each separate distance category as separate sensitive environments solely for purposes of applying table 6-18. Determine the total acreage of wetlands within each of these distance categories and assign a separate value from table 6-18 for each distance category.</P> <P>Calculate the potential contamination factor value (EP) as follows:</P> <MATH SPAN="1" DEEP="63"> <MID>EC15NO91.166</MID> </MATH> <FP SOURCE="FP-2"> S <E T="52">ij</E> = Value(s) assigned from table 4-23 to sensitive environment in distance category j. </FP> <FP SOURCE="FP-2">n = Number of sensitive environments subject to potential contamination.</FP> <FP SOURCE="FP-2"> W <E T="52">j</E> = Value assigned from table 6-18 for wetland area in distance category j. </FP> <FP SOURCE="FP-2"> D <E T="52">j</E> = Distance weight from table 6-15 for distance category j. </FP> <FP SOURCE="FP-2">m = Number of distance categories subject to potential contamination.</FP> <P>If EP is less than 1, do not round it to the nearest integer; if EP is 1 or more, round to the nearest integer. Enter the value assigned in table 6-1.</P> <P> 6.3.4.3  <E T="03">Calculation of sensitive environments factor value.</E> Sum the factor values for actual contamination and potential contamination. Do not round this sum, designated as EB, to the nearest integer. </P> <P>Because the pathway score based solely on sensitive environments is limited to a maximum of 60, use the value EB to determine the value for the sensitive environments factor as follows:</P> <P>• Multiply the values assigned to likelihood of release (LR), waste characteristics (WC), and EB. Divide the product by 82,500.</P> <P SOURCE="P-1">-If the result is 60 or less, assign the value EB as the sensitive environments factor value.</P> <P SOURCE="P-1">-If the result exceeds 60, calculate a value EC as follows:</P> <MATH SPAN="1" DEEP="26"> <MID>EC15NO91.167</MID> </MATH> <FP SOURCE="FP1-2">Assign the value EC as the sensitive environments factor value. Do not round this value to the nearest integer.</FP> <P>Enter the value assigned for the sensitive environments factor in table 6-1.</P> <P> 6.3.5  <E T="03">Calculation of targets factor category value.</E> Sum the nearest individual, population, resources, and sensitive environments factor values. Do not round this sum to the nearest integer. Assign this sum as the targets factor category value. Enter this value in table 6-1. </P> <P> 6.4  <E T="03">Calculation of air migration pathway score.</E> Multiply the values for likelihood of release, waste characteristics, and targets, and round the product to the nearest integer. Then divide by 82,500. Assign the resulting value, subject to a maximum value of 100, as the air migration pathway score (S <E T="52">a</E> ). Enter this score in table 6-1. </P> <HD SOURCE="HD2">7.0 Sites Containing Radioactive Substances.</HD> <P>In general, radioactive substances are hazardous substances under CERCLA and should be considered in HRS scoring. Releases of certain radioactive substances are, however, excluded from the definition of “release” in section 101(22) of CERCLA, as amended, and should not be considered in HRS scoring.</P> <P> Evaluate sites containing radioactive substances using the instructions specified in sections 2 through 6, supplemented by the instructions in this section. Those factors denoted with a “yes” in table 7-1 are evaluated differently for sites containing radioactive substances than for sites containing only nonradioactive hazardous substances, while those denoted with a “no” are not evaluated differently and are not addressed in this section. <PRTPAGE P="224"/> </P> <GPOTABLE COLS="10" OPTS="L2" CDEF="s70,r20,r35,r20,r35,r20,r35,r20,r35,r20"> <TTITLE>Table 7-1—HRS Factors Evaluated Differently for Radionuclides</TTITLE> <BOXHD> <CHED H="1"> Ground water <LI>pathway</LI> </CHED> <CHED H="1"> Status  <SU>a</SU> </CHED> <CHED H="1">Surface water pathway</CHED> <CHED H="1"> Status  <SU>a</SU> </CHED> <CHED H="1"> Soil exposure <LI>component of</LI> <LI>SESSI pathway</LI> </CHED> <CHED H="1"> Status  <SU>a</SU> </CHED> <CHED H="1"> Subsurface <LI>intrusion</LI> <LI>component of</LI> <LI>SESSI pathway</LI> </CHED> <CHED H="1"> Status  <SU>a</SU> </CHED> <CHED H="1">Air pathway</CHED> <CHED H="1"> Status  <SU>a</SU> </CHED> </BOXHD> <ROW RUL="s"> <ENT I="25"> Likelihood of <LI>Release</LI> </ENT> <ENT O="xl"/> <ENT> Likelihood of <LI>Release</LI> </ENT> <ENT O="xl"/> <ENT O="oi0"> Likelihood of <LI>Exposure</LI> </ENT> <ENT O="xl"/> <ENT O="oi0"> Likelihood of <LI>Exposure</LI> </ENT> <ENT O="xl"/> <ENT> Likelihood of <LI>Release</LI> </ENT> </ROW> <ROW> <ENT I="01">Observed Release</ENT> <ENT>Yes</ENT> <ENT>Observed Release</ENT> <ENT>Yes</ENT> <ENT>Observed Contamination</ENT> <ENT>Yes</ENT> <ENT>Observed Exposure</ENT> <ENT>Yes</ENT> <ENT>Observed Release</ENT> <ENT>Yes.</ENT> </ROW> <ROW> <ENT I="01">Potential to Release</ENT> <ENT>No</ENT> <ENT>Potential to Release</ENT> <ENT>No</ENT> <ENT>Attractiveness/Accessibility to Nearby Residents</ENT> <ENT>No</ENT> <ENT>Potential for Exposure</ENT> <ENT>Yes</ENT> <ENT>Gas Potential to Release</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="01">Containment</ENT> <ENT>No</ENT> <ENT>Overland Flow Containment</ENT> <ENT>No</ENT> <ENT>Area of Contamination</ENT> <ENT>No</ENT> <ENT>Structure Containment</ENT> <ENT>No</ENT> <ENT>Gas Containment</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="01">Net Precipitation</ENT> <ENT>No</ENT> <ENT>Runoff</ENT> <ENT>No</ENT> <ENT/> <ENT/> <ENT>Depth to Contamination</ENT> <ENT>Yes</ENT> <ENT>Gas Source Type</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="01">Depth to Aquifer</ENT> <ENT>No</ENT> <ENT>Distance to Surface water</ENT> <ENT>No</ENT> <ENT/> <ENT/> <ENT>Vertical migration</ENT> <ENT>No</ENT> <ENT>Gas Migration Potential</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="01">Travel Time</ENT> <ENT>No</ENT> <ENT>Flood Frequency</ENT> <ENT>No</ENT> <ENT/> <ENT/> <ENT>Vapor Migration Potential</ENT> <ENT>No</ENT> <ENT>Particulate Potential to Release</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT>Flood Containment</ENT> <ENT>No</ENT> <ENT/> <ENT/> <ENT>Area of Observed Exposure</ENT> <ENT>No</ENT> <ENT>Particulate Containment</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT>Area of Subsurface Contamination</ENT> <ENT>No</ENT> <ENT>Particulate Source Type</ENT> <ENT>No.</ENT> </ROW> <ROW RUL="s"> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT O="xl"/> <ENT>Particulate Migration Potential</ENT> <ENT>No.</ENT> </ROW> <ROW RUL="s"> <ENT I="25"> Waste <LI>Characteristics</LI> </ENT> <ENT O="xl"/> <ENT> Waste <LI>Characteristics</LI> </ENT> <ENT O="xl"/> <ENT> Waste <LI>Characteristics</LI> </ENT> <ENT O="xl"/> <ENT> Waste <LI>Characteristics</LI> </ENT> <ENT O="xl"/> <ENT> Waste <LI>Characteristics</LI> </ENT> </ROW> <ROW> <ENT I="01">Toxicity</ENT> <ENT>Yes</ENT> <ENT>Toxicity/Ecotoxicity</ENT> <ENT>Yes/Yes</ENT> <ENT>Toxicity</ENT> <ENT>Yes</ENT> <ENT>Toxicity/Degradation</ENT> <ENT>Yes/Yes</ENT> <ENT>Toxicity</ENT> <ENT>Yes.</ENT> </ROW> <ROW> <ENT I="01">Mobility</ENT> <ENT>No</ENT> <ENT>Persistence/Mobility</ENT> <ENT>Yes/No</ENT> <ENT>Hazardous Waste Quantity</ENT> <ENT>Yes</ENT> <ENT>Hazardous Waste Quantity</ENT> <ENT>Yes</ENT> <ENT>Mobility</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="01">Hazardous Waste Quantity</ENT> <ENT>Yes</ENT> <ENT>Bioaccumulation Potential</ENT> <ENT>No</ENT> <ENT/> <ENT/> <ENT/> <ENT/> <ENT>Hazardous Waste Quantity</ENT> <ENT>Yes.</ENT> </ROW> <ROW RUL="s"> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT>Hazardous Waste Quantity</ENT> <ENT>Yes</ENT> </ROW> <ROW RUL="s"> <ENT I="25">Targets</ENT> <ENT O="xl"/> <ENT>Targets</ENT> <ENT O="xl"/> <ENT>Targets</ENT> <ENT O="xl"/> <ENT>Targets</ENT> <ENT O="xl"/> <ENT>Targets</ENT> </ROW> <ROW> <ENT I="01">Nearest Well</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Nearest Intake</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Resident Individual</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Exposed Individual</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Nearest Individual</ENT> <ENT> Yes. <SU>b</SU> </ENT> </ROW> <ROW> <ENT I="01">Population</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Drinking Water Population</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Resident Population</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Population</ENT> <ENT> Yes <SU>b</SU> </ENT> <ENT>Population</ENT> <ENT> Yes. <SU>b</SU> </ENT> </ROW> <ROW> <ENT I="01">Resources</ENT> <ENT>No</ENT> <ENT>Resources</ENT> <ENT>No</ENT> <ENT>Workers</ENT> <ENT>No</ENT> <ENT>Resources</ENT> <ENT>No</ENT> <ENT>Resources</ENT> <ENT>No.</ENT> </ROW> <ROW> <PRTPAGE P="225"/> <ENT I="01">Wellhead Protection Area</ENT> <ENT>No</ENT> <ENT>Sensitive Environments</ENT> <ENT> Yes  <SU>b</SU> </ENT> <ENT>Resources</ENT> <ENT>No</ENT> <ENT/> <ENT/> <ENT>Sensitive Environments</ENT> <ENT>No.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT>Human Food Chain Individual</ENT> <ENT> Yes  <SU>b</SU> </ENT> <ENT>Terrestrial Sensitive Environments</ENT> <ENT>No</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT>Human Food Chain Population</ENT> <ENT> Yes  <SU>b</SU> </ENT> <ENT> Nearby Individual <LI>Population Within 1 Mile</LI> </ENT> <ENT> No <LI>No</LI> </ENT> </ROW> <TNOTE>a—Factors evaluated differently are denoted by “yes”; factors not evaluated differently are denoted by “no”.</TNOTE> <TNOTE>b—Difference is in the determination of Level I and Level II concentrations.</TNOTE> </GPOTABLE> <PRTPAGE P="226"/> <P>In general, sites containing mixed radioactive and other hazardous substances involve more evaluation than sites containing only radionuclides. For sites containing mixed radioactive and other hazardous substances, HRS factors are evaluated based on considerations of both the radioactive substances and the other hazardous substances in order to derive a single set of factor values for each factor category in each of the four pathways. Thus, the HRS score for these sites reflects the combined potential hazards posed by both the radioactive and other hazardous substances.</P> <P>Section 7 is organized by factor category, similar to sections 3 through 6. Pathway-specific differences in evaluation criteria are specified under each factor category, as appropriate. These differences apply largely to the soil exposure and subsurface intrusion pathway and to sites containing mixed radioactive and other hazardous substances. All evaluation criteria specified in sections 2 through 6 must be met, except where modified in section 7.</P> <P> 7.1  <E T="03">Likelihood of release/likelihood of exposure.</E> Evaluate likelihood of release for the three migration pathways and likelihood of exposure for the soil exposure and subsurface intrusion pathway as specified in sections 2 through 6, except: establish an observed release, observed contamination, and/or observed exposure as specified in section 7.1.1. When an observed release or exposure cannot be established for a migration pathway or the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, evaluate potential to release as specified in section 7.1.2. When observed contamination cannot be established, do not evaluate the soil exposure component of the soil exposure and subsurface intrusion pathway. </P> <P> 7.1.1  <E T="03">Observed release/observed contamination/observed exposure.</E> For radioactive substances, establish an observed release for each migration pathway by demonstrating that the site has released a radioactive substance to the pathway (or watershed or aquifer, as appropriate); establish observed contamination or observed exposure for the soil exposure and subsurface intrusion pathway as indicated below. Base these demonstrations on one or more of the following, as appropriate to the pathway being evaluated: </P> <P>• Direct observation:</P> <FP SOURCE="FP-1">—For each migration pathway, a material that contains one or more radionuclides has been seen entering the atmosphere, surface water, or ground water, as appropriate, or is known to have entered ground water or surface water through direct deposition, or</FP> <FP SOURCE="FP-1">—For the surface water migration pathway, a source area containing radioactive substances has been flooded at a time that radioactive substances were present and one or more radioactive substances were in contact with the flood waters.</FP> <FP SOURCE="FP-1">—For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, a material that contains one or more radionuclides has been observed entering a regularly occupied structure via the subsurface or is known to have entered a regularly occupied structure via the subsurface. Also, when evidence supports the inference of subsurface intrusion of a material that contains one or more radionuclides by the site into a regularly occupied structure, demonstrated adverse effects associated with that release may also be used to establish observed exposure by direct observation.</FP> <P>• Analysis of radionuclide concentrations in samples appropriate to the pathway (that is, ground water, soil, air, indoor air, soil gas, surface water, benthic, or sediment samples):</P> <FP SOURCE="FP-1">—For radionuclides that occur naturally and for radionuclides that are ubiquitous in the environment:</FP> <FP SOURCE="FP1-2">▪ Measured concentration (in units of activity, for example, pCi per kilogram [pCi/kg], pCi per liter [pCi/L], pCi per cubic meter [pCi/m3]) of a given radionuclide in the sample are at a level that:</FP> <FP SOURCE="FP1-2">○ Equals or exceeds a value 2 standard deviations above the mean site-specific background concentration for that radionuclide in that type of sample, or</FP> <FP SOURCE="FP1-2">○ Exceeds the upper-limit value of the range of regional background concentration values for that specific radionuclide in that type of sample.</FP> <FP SOURCE="FP1-2">▪ Some portion of the increase must be attributable to the site to establish the observed release (or observed contamination or observed exposure), and</FP> <FP SOURCE="FP1-2">▪ For the soil exposure component of the soil exposure and subsurface intrusion pathway only, the radionuclide must also be present at the surface or covered by 2 feet or less of cover material (for example, soil) to establish observed contamination.</FP> <FP SOURCE="FP-1">—For man-made radionuclides without ubiquitous background concentrations in the environment:</FP> <FP SOURCE="FP1-2">▪ Measured concentration (in units of activity) of a given radionuclide in a sample equals or exceeds the sample quantitation limit for that specific radionuclide in that type of media and is attributable to the site.</FP> <FP SOURCE="FP1-2"> ▪ However, if the radionuclide concentration equals or exceeds its sample quantitation limit, but its release can also be attributed to one or more neighboring sites, then the measured concentration of that radionuclide must also equal or exceed a value either 2 standard deviations above the mean concentration of <PRTPAGE P="227"/> that radionuclide contributed by those neighboring sites or 3 times its background concentration, whichever is lower. </FP> <FP SOURCE="FP1-2">▪ If the sample quantitation limit cannot be established:</FP> <FP SOURCE="FP1-2">○ If the sample analysis was performed under the EPA Contract Laboratory Program, use the EPA contract-required quantitation limit (CRQL) in place of the sample quantitation limit in establishing an observed release (or observed contamination or observed exposure).</FP> <FP SOURCE="FP1-2">○ If the sample analysis is not performed under the EPA Contract Laboratory Program, use the detection limit in place of the sample quantitation limit.</FP> <FP SOURCE="FP1-2">▪ For the soil exposure component of the soil exposure and subsurface intrusion pathway only, the radionuclide must also be present at the surface or covered by 2 feet or less of cover material (for example, soil) to establish observed contamination.</FP> <P>• Gamma radiation measurements (applies only to observed contamination or observed exposure in the soil exposure and subsurface intrusion pathway):</P> <FP SOURCE="FP-1">—The gamma radiation exposure rate, as measured in microroentgens per hour (µR/hr) using a survey instrument held 1 meter above the ground surface or floor or walls of a structure (or 1 meter away from an aboveground source for the soil exposure component), equals or exceeds 2 times the site-specific background gamma radiation exposure rate.</FP> <FP SOURCE="FP-1">—Some portion of the increase must be attributable to the site to establish observed contamination or observed exposure. The gamma-emitting radionuclides do not have to be within 2 feet of the surface of the source.</FP> <P>For the three migration pathways and for the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, if an observed release or observed exposure can be established for the pathway (or component, threat, aquifer, or watershed, as appropriate), assign the pathway (or component, threat, aquifer, or watershed) an observed release or observed exposure factor value of 550 and proceed to section 7.2. If an observed release or observed exposure cannot be established, assign an observed release or observed exposure factor value of 0 and proceed to section 7.1.2.</P> <P>For the soil exposure component of the soil exposure and subsurface intrusion pathway, if observed contamination can be established, assign the likelihood of exposure factor for resident population a value of 550 if there is an area of observed contamination in one or more locations listed in section 5.1.1; evaluate the likelihood of exposure factor for nearby population as specified in section 5.1.2.1; and proceed to section 7.2. If observed contamination cannot be established, do not evaluate the soil exposure component of the soil exposure and subsurface intrusion pathway.</P> <P>At sites containing mixed radioactive and other hazardous substances, evaluate observed release (or component, observed contamination or observed exposure) separately for radionuclides as described in this section and for other hazardous substances as described in sections 2 through 6.</P> <P>For the three migration pathways and the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, if an observed release or observed exposure can be established based on either radionuclides or other hazardous substances, or both, assign the pathway (or threat, aquifer, or watershed) an observed release or observed exposure factor value of 550 and proceed to section 7.2. If an observed release or observed exposure cannot be established based on either radionuclides or other hazardous substances, assign an observed release or observed exposure factor value of 0 and proceed to section 7.1.2.</P> <P>For the soil exposure component of the soil exposure and subsurface intrusion pathway, if observed contamination can be established based on either radionuclides or other hazardous substances, or both, assign the likelihood of exposure factor for resident population a value of 550 if there is an area of observed contamination in one or more locations listed in section 5.1.1; evaluate the likelihood of exposure factor for nearby population as specified in section 5.1.2.1; and proceed to section 7.2. If observed contamination cannot be established based on either radionuclides or other hazardous substances, do not evaluate the soil exposure component of the soil exposure and subsurface intrusion pathway.</P> <P>7.1.2 Potential to release/potential for exposure. For the three migration pathways and the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, evaluate potential to release or potential for exposure for sites containing radionuclides in the same manner as specified for sites containing other hazardous substances. Base the evaluation on the physical and chemical properties of the radionuclides, not on their level of radioactivity. For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, if the potential for exposure is based on the presence of gamma emitting radioactive substances, assign a potential for exposure factor value of 500 only if the contamination is found within 2 feet beneath a regularly occupied structure, otherwise assign a potential for exposure factor value of 0.</P> <P> For sites containing mixed radioactive and other hazardous substances, evaluate potential to release or potential for exposure considering radionuclides and other hazardous <PRTPAGE P="228"/> substances together. Evaluate potential to release for each migration pathway and the potential for exposure for the subsurface intrusion component of the soil exposure and subsurface intrusion pathway as specified in sections 3 through 6, as appropriate. </P> <P> 7.2  <E T="03">Waste characteristics.</E> For radioactive substances, evaluate the human toxicity factor, the ecosystem toxicity factor, the surface water persistence factor, and the hazardous waste quantity factor as specified in the following sections. Evaluate all other waste characteristic factors as specified in sections 2 through 6. </P> <P>7.2.1 Human Toxicity. For radioactive substances, evaluate the human toxicity factor as specified below, not as specified in section 2.4.1.1.</P> <P>Assign human toxicity factor values to those radionuclides available to the pathway based on quantitative dose-response parameters for cancer risks as follows:</P> <P>• Evaluate radionuclides only on the basis of carcinogenicity and assign all radionuclides to weight-of-evidence category A, or weight-of-evidence category “Carcinogenic to Humans”.</P> <P>• Assign a human toxicity factor value from Table 7-2 to each radionuclide based on its slope factor (also referred to as a cancer potency factor).</P> <FP SOURCE="FP-1">—For each radionuclide, use the higher of the slope factors for inhalation and ingestion to assign the factor value.</FP> <FP SOURCE="FP-1">—If only one slope factor is available for the radionuclide use it to assign the toxicity factor value.</FP> <FP SOURCE="FP-1">—If no slope factor is available for the radionuclide, assign that radionuclide a toxicity factor value of 0 and use other radionuclides for which a slope factor is available to evaluate the pathway.</FP> <P>• If all radionuclides available to a particular pathway are assigned a human toxicity factor value of 0 (that is, no slope factor is available for all the radionuclides), use a default human toxicity factor value of 1,000 as the human toxicity factor value for all radionuclides available to the pathway.</P> <P>At sites containing mixed radioactive and other hazardous substances, evaluate the toxicity factor separately for the radioactive and other hazardous substances and assign each a separate toxicity factor value. This applies regardless of whether the radioactive and other hazardous substances are physically separated, combined chemically, or simply mixed together. Assign toxicity factor values to the radionuclides as specified above and to the other hazardous substances as specified in section 2.4.1.1.</P> <P>At sites containing mixed radioactive and other hazardous substances, if all radionuclides available to a particular pathway are assigned a human toxicity factor value of 0, use a default human toxicity factor value of 1,000 for all those radionuclides even if nonradioactive hazardous substances available to the pathway are assigned human toxicity factor values greater than 0. Similarly, if all nonradioactive hazardous substances available to the pathway are assigned a human toxicity factor value of 0, use a default human toxicity factor value of 100 for all these nonradioactive hazardous substances even if radionuclides available to the pathway are assigned human toxicity factor values greater than 0.</P> <P> <E T="03">7.2.2 Ecosystem toxicity.</E> For the surface water environmental threat (see sections 4.1.4 and 4.2.4). assign an ecosystem toxicity factor value to radionuclides (alone or combined chemically or mixed with other hazardous substances) using the same slope factors and procedures specified for the human toxicity factor in section 7.2.1, except: use a default of 100, not 1,000, if all radionuclides eligible to be evaluated for ecosystem toxicity receive an ecosystem toxicity factor value of 0. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s100,8"> <TTITLE>Table 7-2—Toxicity Factor Values for Radionuclides</TTITLE> <BOXHD> <CHED H="1"> Cancer slope factor  <SU>a</SU> (SF) (pCi) <E T="51">−1</E> </CHED> <CHED H="1">Assigned value</CHED> </BOXHD> <ROW> <ENT I="01"> 3 × 10 <E T="51">−11</E> ≤SF </ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01"> 3 × 10 <E T="51">−12</E> ≤SF<3 × 10 <E T="51">−11</E> </ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="06"> SF<3 × 10 <E T="51">−12</E> </ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">SF not available for the radionuclide</ENT> <ENT>0</ENT> </ROW> <TNOTE> <SU>a</SU>  Radionuclide slope factors are estimates of age-averaged, individual lifetime total excess cancer risk per picocurie of radionuclide inhaled or ingested. </TNOTE> </GPOTABLE> <P> At sites containing mixed radioactive and other hazardous substances, evaluate the ecosystem toxicity factor separately for the radioactive and other hazardous substances and assign each a separate ecosystem toxicity factor value. This applies regardless of whether the radioactive and other hazardous substances are physically separated, combined chemically, or simply mixed together. Assign ecosystem toxicity factor values to the radionuclides as specified above and to the other hazardous substances as specified in sections 4.1.4.2.1.1 and 4.2.4.2.1.1. If all radionuclides available to a particular pathway are assigned an ecosystem toxicity factor value of 0, use a default ecosystem toxicity factor value of 100 for all these radionuclides even if nonradioactive hazardous substances available to the pathway are assigned ecosystem toxicity factor values greater than 0. Similarly, if all nonradioactive hazardous substances available to the pathway are assigned an ecosystem toxicity factor value of 0, use a default ecosystem toxicity factor value of 100 for all these nonradioactive hazardous substances even if radionuclides available to the pathway are assigned ecosystem toxicity factor values greater than 0. <PRTPAGE P="229"/> </P> <P> 7.2.3  <E T="03">Persistence/Degradation.</E> In determining the surface water persistence factor for radionuclides, evaluate this factor based solely on half-life; do not include sorption to sediments in the evaluation as is done for nonradioactive hazardous substances. Assign a persistence factor value from Table 4-10 (section 4.1.2.2.1.2) to each radionuclide based on half-life (t <E T="52">1/2</E> ) calculated as follows: </P> <GPH SPAN="2" DEEP="30"> <GID>ER09JA17.073</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">r = Radioactive half-life.</FP> <FP SOURCE="FP-2">V = Volatilization half-life.</FP> <P>If the volatilization half-life cannot be estimated for a radionuclide from available data, delete it from the equation. Select the portion of Table 4-10 to use in assigning the persistence factor value as specified in section 4.1.2.2.1.2.</P> <P>At sites containing mixed radioactive and other hazardous substances, evaluate the persistence factor separately for each radionuclide and for each nonradioactive hazardous substance, even if the available data indicate that they are combined chemically. Assign a persistence factor value to each radionuclide as specified in this section and to each nonradioactive hazardous substance as specified in section 4.1.2.2.1.2. When combined chemically, assign a single persistence factor value based on the higher of the two values assigned (individually) to the radioactive and nonradioactive components.</P> <P> In determining the subsurface intrusion degradation factor for radionuclides, when evaluating this factor based solely on half-life, assign a degradation factor value from section 5.2.1.2.1.2 to each radionuclide based on half-life (t <E T="52">1/2</E> ) calculated as follows: </P> <GPH SPAN="2" DEEP="33"> <GID>ER09JA17.074</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">r = Radioactive half-life.</FP> <P>If no radioactive half-life information is available for a radionuclide and the substance is not already assigned a value of 1, unless information indicates otherwise, assign a value of 1.</P> <P>At sites containing mixed radioactive and other hazardous substances, evaluate the degradation factor separately for each radionuclide and for each nonradioactive hazardous substance, even if the available data indicate that they are combined chemically. Assign a degradation factor value to each radionuclide as specified in this section and to each nonradioactive hazardous substance as specified in section 5.2.1.2.1.2. If no radioactive half-life information is available for a radionuclide and the substance is not already assigned a value of 1, unless information indicates otherwise, assign a value of 1. Similarly, if no half-life information is available for a nonradioactive substance, and the substance is not already assigned a value of 1, unless information indicates otherwise, assign a value of 1. When combined chemically, assign a single persistence or degradation factor value based on the higher of the two values assigned (individually) to the radioactive and nonradioactive components.</P> <P> 7.2.4  <E T="03"> Selection of substance potentially posing greatest hazard.</E> For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway and each migration pathway (or threat, aquifer, or watershed, as appropriate), select the radioactive substance or nonradioactive hazardous substance that potentially poses the greatest hazard based on its toxicity factor value, combined with the applicable mobility, persistence, degradation and/or bioaccumulation (or ecosystem bioaccumulation) potential factor values. Combine these factor values as specified in sections 2 through 6. For the soil exposure component of the soil exposure and subsurface intrusion pathway, base the selection on the toxicity factor alone (see sections 2 and 5). </P> <P> 7.2.5 <E T="03"> Hazardous waste quantity.</E> To calculate the hazardous waste quantity factor value for sites containing radioactive substances, evaluate source hazardous waste quantity (see section 2.4.2.1) using only the following two measures in the following hierarchy (these measures are consistent with <PRTPAGE P="230"/> Tiers A and B for nonradioactive hazardous substances in sections 2.4.2.1.1 and 2.4.2.1.2): </P> <P>• Radionuclide constituent quantity (Tier A).</P> <P>• Radionuclide wastestream quantity (Tier B).</P> <P> 7.2.5.1  <E T="03">Source hazardous waste quantity for radionuclides.</E> For each migration pathway, assign a source hazardous waste quantity value to each source having a containment factor value greater than 0 for the pathway being evaluated. For the soil exposure component of the soil exposure and subsurface intrusion pathway, assign a source hazardous waste quantity value to each area of observed contamination, as applicable to the threat being evaluated. For the subsurface intrusion component, assign a source hazardous waste quantity value to each regularly occupied structure located within areas of observed exposure or areas of subsurface contamination. Allocate hazardous substances and hazardous wastestreams to specific sources (or areas of observed contamination, areas of observed exposure or areas of subsurface contamination) as specified in sections 2.4.2 and 5.2.0. </P> <P> 7.2.5.1.1  <E T="03">Radionuclide constituent quantity (Tier A).</E> Evaluate radionuclide constituent quantity for each source (or area of observed contamination or area of observed exposure) based on the activity content of the radionuclides allocated to the source (or area of observed contamination or area of observed exposure) as follows: </P> <P>• Estimate the net activity content (in curies) for the source (or area of observed contamination or area of observed exposure) based on:</P> <FP SOURCE="FP-1">—Manifests, or</FP> <FP SOURCE="FP-1">—Either of the following equations, as applicable:</FP> <GPH SPAN="2" DEEP="37"> <GID>ER09JA17.075</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">N = Estimated net activity content (in curies) for the source (or area of observed contamination or area of observed exposure).</FP> <FP SOURCE="FP-2">V = Total volume of material (in cubic yards) in a source (or area of observed contamination or area of observed exposure) containing radionuclides.</FP> <FP SOURCE="FP-2"> AC <E T="52">i</E> = Activity concentration above the respective background concentration (in pCi/g) for each radionuclide i allocated to the source (or area of observed contamination or area of observed exposure). </FP> <FP SOURCE="FP-2">n = Number of radionuclides allocated to the source (or area of observed contamination or area of observed exposure) above the respective background concentrations.</FP> <FP SOURCE="FP-2">or,</FP> <GPH SPAN="2" DEEP="37"> <GID>ER09JA17.076</GID> </GPH> <FP SOURCE="FP-2">Where:</FP> <FP SOURCE="FP-2">N = Estimated net activity content (in curies) for the source (or area of observed contamination or area of observed exposure).</FP> <FP SOURCE="FP-2">V = Total volume of material (in gallons) in a source (or area of observed contamination or area of observed exposure) containing radionuclides.</FP> <FP SOURCE="FP-2"> AC <E T="52">i</E> = Activity concentration above the respective background concentration (in pCi/1) for each radionuclide i allocated to the source (or area of observed contamination or area of observed exposure). </FP> <FP SOURCE="FP-2">n = Number of radionuclides allocated to the source (or area of observed contamination or area of observed exposure) above the respective background concentrations.</FP> <FP SOURCE="FP-1">—Estimate volume for the source (or volume for the area of observed contamination or area of observed exposure) based on records or measurements.</FP> <FP SOURCE="FP-1"> —For the soil exposure component of the soil exposure and subsurface intrusion pathway, in estimating the volume for areas of observed contamination, do not include more than the first 2 feet of depth, except: <PRTPAGE P="231"/> for those types of areas of observed contamination listed in Tier C of Table 5-2 (section 5.1.1.2.2), include the entire depth, not just that within 2 feet of the surface. </FP> <FP SOURCE="FP-1">—For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, in estimating the volume for areas of observed exposure, only use the volume of air in the regularly occupied structures where observed exposure has been documented.</FP> <P>• Convert from curies of radionuclides to equivalent pounds of nonradioactive hazardous substances by multiplying the activity estimate for the source (or area of observed contamination or area of observed exposure) by 1,000.</P> <P>• Assign this resulting product as the radionuclide constituent quantity value for the source (or area of observed contamination or area of observed exposure).</P> <P>If the radionuclide constituent quantity for the source (or area of observed contamination or area of observed exposure) is adequately determined (that is, the total activity of all radionuclides in the source and releases from the source [or in the area of observed contamination or area of observed exposure] is known or is estimated with reasonable confidence), do not evaluate the radionuclide wastestream quantity measure in section 7.2.5.1.2. Instead, assign radionuclide wastestream quantity a value of 0 and proceed to section 7.2.5.1.3. If the radionuclide constituent quantity is not adequately determined, assign the source (or area of observed contamination or area of observed exposure) a value for radionuclide constituent quantity based on the available data and proceed to section 7.2.5.1.2.</P> <P>7.2.5.1.2 Radionuclide wastestream quantity (Tier B). Evaluate radionuclide wastestream quantity for the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination) based on the activity content of radionuclide wastestreams allocated to the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination) as follows:</P> <P>• Estimate the total volume (in cubic yards or in gallons) of wastestreams containing radionuclides allocated to the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination).</P> <P>• Divide the volume in cubic yards by 0.55 (or the volume in gallons by 110) to convert to the activity content expressed in terms of equivalent pounds of nonradioactive hazardous substances.</P> <P>• Assign the resulting value as the radionuclide wastestream quantity value for the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination).</P> <P>• For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, estimate the total wastestream volume for all regularly occupied structures that have a containment value >0 and that are located within areas of observed exposure with observed or inferred intrusion, and within areas of subsurface contamination. Calculate the volume of each regularly occupied structure based on actual data. If unknown, use a ceiling height of 8 feet.</P> <P>7.2.5.1.3 Calculation of source hazardous waste quantity value for radionuclides. Select the higher of the values assigned to the source (or area of observed contamination, area of observed exposure, and/or area of subsurface contamination) for radionuclide constituent quantity and radionuclide wastestream quantity. Assign this value as the source hazardous waste quantity value for the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination). Do not round to the nearest integer.</P> <P>7.2.5.2 Calculation of hazardous waste quantity factor value for radionuclides. Sum the source hazardous waste quantity values assigned to all sources (or areas of observed contamination, areas of observed exposure, or areas of subsurface contamination) for the pathway being evaluated and round this sum to the nearest integer, except: if the sum is greater than 0, but less than 1, round it to 1. Based on this value, select a hazardous waste quantity factor value for this pathway from Table 2-6 (section 2.4.2.2).</P> <P>For a migration pathway, if the radionuclide constituent quantity is adequately determined (see section 7.2.5.1.1) for all sources (or all portions of sources and releases remaining after a removal action), assign the value from Table 2-6 as the hazardous waste quantity factor value for the pathway. If the radionuclide constituent quantity is not adequately determined for one or more sources (or one or more portions of sources or releases remaining after a removal action), assign a factor value as follows:</P> <P>• If any target for that migration pathway is subject to Level I or Level II concentrations (see section 7.3), assign either the value from Table 2-6 or a value of 100, whichever is greater, as the hazardous waste quantity factor value for that pathway.</P> <P>• If none of the targets for that pathway is subject to Level I or Level II concentrations, assign a factor value as follows:</P> <FP SOURCE="FP-1">—If there has been no removal action, assign either the value from Table 2-6 or a value of 10, whichever is greater, as the hazardous waste quantity factor value for that pathway.</FP> <FP SOURCE="FP-1">—If there has been a removal action:</FP> <FP SOURCE="FP1-2"> ▪ Determine values from Table 2-6 with and without consideration of the removal action. <PRTPAGE P="232"/> </FP> <FP SOURCE="FP1-2">▪ If the value that would be assigned from Table 2-6 without consideration of the removal action would be 100 or greater, assign either the value from Table 2-6 with consideration of the removal action or a value of 100, whichever is greater, as the hazardous waste quantity factor value for the pathway.</FP> <FP SOURCE="FP1-2">▪ If the value that would be assigned from Table 2-6 without consideration of the removal action would be less than 100, assign a value of 10 as the hazardous waste quantity factor value for the pathway.</FP> <P>For the soil exposure component of the soil exposure and subsurface intrusion pathway, if the radionuclide constituent quantity is adequately determined for all areas of observed contamination, assign the value from Table 2-6 as the hazardous waste quantity factor value. If the radionuclide constituent quantity is not adequately determined for one or more areas of observed contamination, assign either the value from Table 2-6 or a value of 10, whichever is greater, as the hazardous waste quantity factor value.</P> <P>For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, if the radionuclide constituent quantity is adequately determined for all areas of observed exposure, assign the value from Table 2-6 as the hazardous waste quantity factor value. If the radionuclide constituent quantity is not adequately determined for one or more areas of observed exposure, assign either the value from Table 2-6 or a value of 10, whichever is greater, as the hazardous waste quantity factor value.</P> <P>7.2.5.3 Calculation of hazardous waste quantity factor value for sites containing mixed radioactive and other hazardous substances. For each source (or area of observed contamination, area of observed exposure, or area of subsurface contamination) containing mixed radioactive and other hazardous substances, calculate two source hazardous waste quantity values—one based on radionuclides as specified in sections 7.2.5.1 through 7.2.5.1.3 and the other based on the nonradioactive hazardous substances as specified in sections 2.4.2.1 through 2.4.2.1.5, and sections 5.1.1.2.2, 5.1.2.2.2 and 5.2.1.2.2 (that is, determine each value as if the other type of substance was not present). Sum the two values to determine a combined source hazardous waste quantity value for the source (or area of observed contamination, area of observed exposure, or area of subsurface contamination). Do not round this value to the nearest integer.</P> <P>Use this combined source hazardous waste quantity value to calculate the hazardous waste quantity factor value for the pathway as specified in section 2.4.2.2, except: if either the hazardous constituent quantity or the radionuclide constituent quantity, or both, are not adequately determined for one or more sources (or one or more portions of sources or releases remaining after a removal action) or for one or more areas of observed contamination or areas of observed exposure, as applicable, assign the value from Table 2-6 or the default value applicable for the pathway, whichever is greater, as the hazardous waste quantity factor value for the pathway.</P> <P>7.3 Targets. For radioactive substances, evaluate the targets factor category as specified in section 2.5 and sections 3 through 6, except: Establish Level I and Level II concentrations at sampling locations as specified in sections 7.3.1 and 7.3.2 and establish weighting factors for populations associated with an area of subsurface contamination in the subsurface intrusion component of the soil exposure and subsurface intrusion pathway as specified in section 7.3.3.</P> <P>For all pathways (components and threats), use the same target distance limits for sites containing radioactive substances as is specified in sections 3 through 6 for sites containing nonradioactive hazardous substances. At sites containing mixed radioactive and other hazardous substances, include all sources (or areas of observed contamination, areas of observed exposure, or areas of subsurface contamination) at the site in identifying the applicable targets for the pathway.</P> <P> 7.3.1  <E T="03"> Level of contamination at a sampling location.</E> Determine whether Level I or Level II concentrations apply at a sampling location (and thus to the associated targets) as follows: </P> <P>• Select the benchmarks from section 7.3.2 applicable to the pathway (or component or threat) being evaluated.</P> <P>• Compare the concentrations of radionuclides in the sample (or comparable samples) to their benchmark concentrations for the pathway (or component or threat) as specified in section 7.3.2. Treat comparable samples as specified in section 2.5.1.</P> <P>• Determine which level applies based on this comparison.</P> <P>• If none of the radionuclides eligible to be evaluated for the sampling location have an applicable benchmark, assign Level II to the actual contamination at that sampling location for the pathway (or component or threat).</P> <P>• In making the comparison, consider only those samples, and only those radionuclides in the sample, that meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway, except: Tissue samples from aquatic human food chain organisms may also be used for the human food chain threat of the surface water pathway as specified in sections 4.1.3.3 and 4.2.3.3.</P> <P> 7.3.2  <E T="03"> Comparison to benchmarks.</E> Use the following media specific benchmarks (expressed in activity units, for example,pCi/l <PRTPAGE P="233"/> for water, pCi/kg for soil and for aquatic human food chain organisms, and pCi/m3 for air) for making the comparisons for the indicated pathway (or threat): </P> <P>• Maximum Contaminant Levels (MCLs)—ground water migration pathway and drinking water threat in surface water migration pathway.</P> <P>• Uranium Mill Tailings Radiation Control Act (UMTRCA) standards—soil exposure component of the soil exposure and subsurface intrusion pathway only.</P> <P> • Screening concentration for cancer corresponding to that concentration that corresponds to the 10 <E T="51">−6</E> individual cancer risk for inhalation exposures (air migration pathway and subsurface intrusion component of the soil exposure and subsurface intrusion pathway) or for oral exposures (ground water migration pathway; drinking water or human food chain threats in surface water migration pathway; and soil exposure and subsurface intrusion pathway). </P> <FP SOURCE="FP-1">—For the soil exposure component of the soil exposure and subsurface intrusion pathway, include two screening concentrations for cancer—one for ingestion of surface materials and one for external radiation exposures from gamma-emitting radionuclides in surface materials.</FP> <P>Select the benchmark(s) applicable to the pathway (component or threat) being evaluated. Compare the concentration of each radionuclide from the sampling location to its benchmark concentration(s) for that pathway (component or threat). Use only those samples and only those radionuclides in the sample that meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway, except: Tissue samples from aquatic human food chain organisms may be used as specified in sections 4.1.3.3 and 4.2.3.3. If the concentration of any applicable radionuclide from any sample equals or exceeds its benchmark concentration, consider the sampling location to be subject to Level I concentrations for that pathway (component or threat). If more than one benchmark applies to the radionuclide, assign Level I if the radionuclide concentration equals or exceeds the lowest applicable benchmark concentration. In addition, for the soil exposure and subsurface intrusion pathway, assign Level I concentrations at the sampling location if measured gamma radiation exposure rates equal or exceed 2 times the background level (see section 7.1.1).</P> <P>If no radionuclide individually equals or exceeds its benchmark concentration, but more than one radionuclide either meets the criteria for an observed release (or observed contamination or observed exposure) for the sample or is eligible to be evaluated for a tissue sample (see sections 4.1.3.3 and 4.2.3.3), calculate a value for index I for these radionuclides as specified in section 2.5.2. If I equals or exceeds 1, assign Level I to the sampling location. If I is less than 1, assign Level II.</P> <P>At sites containing mixed radioactive and other hazardous substances, establish the level of contamination for each sampling location considering radioactive substances and nonradioactive hazardous substances separately. Compare the concentration of each radionuclide and each nonradioactive hazardous substance from the sampling location to its respective benchmark concentration(s). Use only those samples and only those substances in the sample that meet the criteria for an observed release (or observed contamination or observed exposure) for the pathway except: Tissue samples from aquatic human food chain organisms may be used as specified in sections 4.1.3.3 and 4.2.3.3. If the concentration of one or more applicable radionuclides or other hazardous substances from any sample equals or exceeds its benchmark concentration, consider the sampling location to be subject to Level I concentrations. If more than one benchmark applies to a radionuclide or other hazardous substance, assign Level I if the concentration of the radionuclide or other hazardous substance equals or exceeds its lowest applicable benchmark concentration.</P> <P>If no radionuclide or other hazardous substance individually exceed a benchmark concentration, but more than one radionuclide or other hazardous substance either meets the criteria for an observed release (or observed contamination or observed exposure) for the sample or is eligible to be evaluated for a tissue sample, calculate an index I for both types of substances as specified in section 2.5.2. Sum the index I values for the two types of substances. If the value, individually or combined, equals or exceeds 1, assign Level I to the sample location. If it is less than 1, calculate an index J for the nonradioactive hazardous substances as specified in section 2.5.2. If J equals or exceeds 1, assign Level I to the sampling location. If J is less than 1, assign Level II.</P> <P> 7.3.3 Weighting of targets within an area of subsurface contamination. For the subsurface intrusion component of the soil exposure and subsurface intrusion pathway, assign a weighting factor as specified in section 5.2.1.3.2.3 except when a structure in an area of subsurface contamination is delineated or inferred to be delineated by gamma radiation exposure rates meeting observed release criteria with a depth to contamination of 2 feet or less. For those populations residing, working, or attending school or day care in a structure delineated or inferred to be delineated by gamma radiation exposure rates meeting observed release criteria with <PRTPAGE P="234"/> a depth to contamination of 2 feet or less, assign a weighting factor of 0.9. </P> <CITA>[55 FR 51583, Dec. 14, 1990, as amended at 82 FR 2779, Jan. 9, 2017; 83 FR 38037, Aug. 3, 2018]</CITA> </APPENDIX> <APPENDIX> <EAR>Pt. 300, App. B</EAR> <HD SOURCE="HED">Appendix B to Part 300—National Priorities List</HD> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs48,r120,r60,xs36"> <TTITLE>Table 1—General Superfund Section</TTITLE> <BOXHD> <CHED H="1">State</CHED> <CHED H="1">Site name</CHED> <CHED H="1">City/County</CHED> <CHED H="1">Notes(a)</CHED> </BOXHD> <ROW> <ENT I="01">AK</ENT> <ENT>Salt Chuck Mine</ENT> <ENT>Outer Ketchikan County</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Alabama Plating Company, Inc.</ENT> <ENT>Vincent</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>American Brass</ENT> <ENT>Headland</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Ciba-Geigy Corp. (McIntosh Plant)</ENT> <ENT>McIntosh</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Interstate Lead Co. (ILCO)</ENT> <ENT>Leeds</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Olin Corp. (McIntosh Plant)</ENT> <ENT>McIntosh</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Stauffer Chemical Co. (Cold Creek Plant)</ENT> <ENT>Bucks</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Stauffer Chemical Co. (LeMoyne Plant)</ENT> <ENT>Axis</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>T.H. Agriculture & Nutrition (Montgomery)</ENT> <ENT>Montgomery</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Triana/Tennessee River</ENT> <ENT>Limestone/Morgan</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Arkwood, Inc</ENT> <ENT>Omaha</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Cedar Chemical Corporation</ENT> <ENT>West Helena</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>MacMillan Ring Free Oil</ENT> <ENT>Norphlet</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Mid-South Wood Products</ENT> <ENT>Mena</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Midland Products</ENT> <ENT>Ola/Birta</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Mountain Pine Pressure Treating, Inc</ENT> <ENT>Plainview</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Ouachita Nevada Wood Treater</ENT> <ENT>Reader.</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Popile, Inc</ENT> <ENT>El Dorado</ENT> </ROW> <ROW> <ENT I="01">AR</ENT> <ENT>Vertac, Inc.</ENT> <ENT>Jacksonville</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Apache Powder Co.</ENT> <ENT>St. David</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Hassayampa Landfill</ENT> <ENT>Hassayampa</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Indian Bend Wash Area</ENT> <ENT>Scottsdale/Tempe/Phoenix</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Iron King Mine—Humboldt Smelter</ENT> <ENT>Dewey-Humboldt</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Litchfield Airport Area</ENT> <ENT>Goodyear/Avondale</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Lukachukai Mountains Mining District</ENT> <ENT>Cove, Navajo Nation</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Motorola, Inc. (52nd Street Plant)</ENT> <ENT>Phoenix</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Tucson International Airport Area</ENT> <ENT>Tucson</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Advanced Micro Devices, Inc</ENT> <ENT>Sunnyvale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Advanced Micro Devices, Inc. (Bldg. 915)</ENT> <ENT>Sunnyvale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Aerojet General Corp</ENT> <ENT>Rancho Cordova</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Afterthought Mine</ENT> <ENT O="xl">Bella Vista</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Alark Hard Chrome</ENT> <ENT>Riverside</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>AMCO Chemical</ENT> <ENT>Oakland</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Applied Materials</ENT> <ENT>Santa Clara</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Argonaut Mine</ENT> <ENT>Jackson</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Atlas Asbestos Mine</ENT> <ENT>Fresno County</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Blue Ledge Mine</ENT> <ENT>Rogue River—Siskiyou National Forest</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Brown & Bryant, Inc (Arvin Plant)</ENT> <ENT>Arvin</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>CTS Printex, Inc.</ENT> <ENT>Mountain View</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Casmalia Resources</ENT> <ENT>Casmalia</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Coast Wood Preserving</ENT> <ENT>Ukiah</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Copper Bluff Mine</ENT> <ENT>Hoopa</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Cooper Drum Company</ENT> <ENT>South Gate.</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Crazy Horse Sanitary Landfill</ENT> <ENT>Salinas</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Del Amo</ENT> <ENT>Los Angeles</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Fairchild Semiconductor Corp. (Mt View)</ENT> <ENT>Mountain View</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Fairchild Semiconductor Corp. (S San Jose)</ENT> <ENT>South San Jose</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Fresno Municipal Sanitary Landfill</ENT> <ENT>Fresno</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Frontier Fertilizer</ENT> <ENT>Davis</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Halaco Engineering Company</ENT> <ENT>Oxnard</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Hewlett-Packard (620-640 Page Mill Road)</ENT> <ENT>Palo Alto</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Industrial Waste Processing</ENT> <ENT>Fresno</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Intel Corp. (Mountain View Plant)</ENT> <ENT>Mountain View</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Intel Magnetics</ENT> <ENT>Santa Clara</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Intersil Inc./Siemens Components</ENT> <ENT>Cupertino</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Iron Mountain Mine</ENT> <ENT>Redding</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>J.H. Baxter & Co</ENT> <ENT>Weed</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Jervis B. Webb</ENT> <ENT>South Gate</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Klau/Buena Vista Mine</ENT> <ENT>San Luis Obispo County</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Koppers Co., Inc. (Oroville Plant)</ENT> <ENT>Oroville</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Lava Cap Mine</ENT> <ENT>Nevada City</ENT> </ROW> <ROW> <PRTPAGE P="235"/> <ENT I="01">CA</ENT> <ENT>Leviathan Mine</ENT> <ENT>Alpine County.</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Lorentz Barrel & Drum Co</ENT> <ENT>San Jose</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>McColl</ENT> <ENT>Fullerton</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>McCormick & Baxter Creosoting Co</ENT> <ENT>Stockton</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Modesto Ground Water Contamination</ENT> <ENT>Modesto</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Monolithic Memories</ENT> <ENT>Sunnyvale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Montrose Chemical Corp</ENT> <ENT>Torrance</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>National Semiconductor Corp</ENT> <ENT>Santa Clara</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>New Idria Mercury Mine</ENT> <ENT>Idria</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Newmark Ground Water Contamination</ENT> <ENT>San Bernardino</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Omega Chemical Corporation</ENT> <ENT>Whittier</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Operating Industries, Inc., Landfill</ENT> <ENT>Monterey Park</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Orange County North Basin</ENT> <ENT>Orange County</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Pacific Coast Pipe Lines</ENT> <ENT>Fillmore</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Pemaco Maywood</ENT> <ENT>Maywood</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Purity Oil Sales, Inc</ENT> <ENT>Malaga</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Raytheon Corp</ENT> <ENT>Mountain View</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Rockets, Fireworks, and Flares (RFF)</ENT> <ENT>Rialto</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Fernando Valley (Area 1)</ENT> <ENT>Los Angeles</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Fernando Valley (Area 2)</ENT> <ENT>Los Angeles/Glendale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Fernando Valley (Area 3)</ENT> <ENT>Glendale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Fernando Valley (Area 4)</ENT> <ENT>Los Angeles</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Gabriel Valley (Area 1)</ENT> <ENT>El Monte</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Gabriel Valley (Area 2)</ENT> <ENT>Baldwin Park Area</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Gabriel Valley (Area 3)</ENT> <ENT>Alhambra</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>San Gabriel Valley (Area 4)</ENT> <ENT>La Puente</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Selma Treating Co</ENT> <ENT>Selma</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>South Bay Asbestos Area</ENT> <ENT>Alviso</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Southern Avenue Industrial Area</ENT> <ENT>South Gate</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Spectra-Physics, Inc</ENT> <ENT>Mountain View</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Stringfellow</ENT> <ENT>Glen Avon Heights</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Sulphur Bank Mercury Mine</ENT> <ENT>Clear Lake</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Synertek, Inc. (Building 1)</ENT> <ENT>Santa Clara</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>TRW Microwave, Inc (Building 825)</ENT> <ENT>Sunnyvale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Teledyne Semiconductor</ENT> <ENT>Mountain View</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>United Heckathorn Co</ENT> <ENT>Richmond</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Valley Wood Preserving, Inc</ENT> <ENT>Turlock</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Waste Disposal, Inc</ENT> <ENT>Santa Fe Springs</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Watkins-Johnson Co. (Stewart Division)</ENT> <ENT>Scotts Valley</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Westinghouse Elecetric Corp. (Sunnyvale)</ENT> <ENT>Sunnyvale</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Bonita Peak Mining District</ENT> <ENT>San Juan County</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Broderick Wood Products</ENT> <ENT>Denver</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>California Gulch</ENT> <ENT>Leadville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Captain Jack Mill</ENT> <ENT>Ward</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Central City-Clear Creek</ENT> <ENT>Idaho Springs</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Chemical Sales Co</ENT> <ENT>Denver</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Colorado Smelter</ENT> <ENT>Pueblo</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Denver Radium Site</ENT> <ENT>Denver</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Eagle Mine</ENT> <ENT>Minturn/Redcliff</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Lincoln Park</ENT> <ENT>Canon City</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Lowry Landfill</ENT> <ENT>Arapahoe County</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Marshall Landfill</ENT> <ENT>Boulder County</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Nelson Tunnel/Commodore Waste Rock</ENT> <ENT>Creede</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Standard Mine</ENT> <ENT>Gunnison National Forest</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Summitville Mine</ENT> <ENT>Rio Grande County</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Uravan Uranium Project (Union Carbide)</ENT> <ENT>(former town of) Uravan</ENT> <ENT>P*</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Vasquez Boulevard and I-70</ENT> <ENT>Denver</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Barkhamsted-New Hartford Landfill</ENT> <ENT>Barkhamsted</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Beacon Heights Landfill</ENT> <ENT>Beacon Falls</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Durham Meadows</ENT> <ENT>Durham</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Gallup's Quarry</ENT> <ENT>Plainfield</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Kellogg-Deering Well Field</ENT> <ENT>Norwalk</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Laurel Park, Inc</ENT> <ENT>Naugatuck Borough</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Linemaster Switch Corp</ENT> <ENT>Woodstock</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Precision Plating Corp</ENT> <ENT>Vernon</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Raymark Industries, Inc</ENT> <ENT>Stratford</ENT> <ENT>A</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Scovill Industrial Landfill</ENT> <ENT>Waterbury</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Solvents Recovery Service New England</ENT> <ENT>Southington</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>Yaworski Waste Lagoon</ENT> <ENT>Canterbury</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Army Creek Landfill</ENT> <ENT>New Castle County</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Blades Groundwater</ENT> <ENT>Blades</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Delaware City PVC Plant</ENT> <ENT>Delaware City</ENT> </ROW> <ROW> <PRTPAGE P="236"/> <ENT I="01">DE</ENT> <ENT>Delaware Sand & Gravel Landfill</ENT> <ENT>New Castle County</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Dover Gas Light Co</ENT> <ENT>Dover</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>East Basin Road Groundwater</ENT> <ENT>New Castle</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>E.I.Du Pont de Nemours (Newport Landfill)</ENT> <ENT>Newport</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Georgetown North Groundwater</ENT> <ENT>Georgetown</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Halby Chemical Co</ENT> <ENT>New Castle</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Harvey & Knott Drum, Inc</ENT> <ENT>Kirkwood</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Hockessin Groundwater</ENT> <ENT>Hockessin</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Koppers Co., Inc. (Newport Plant)</ENT> <ENT>Newport</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>NCR Corp. (Millsboro Plant)</ENT> <ENT>Millsboro</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Newark South Ground Water Plume</ENT> <ENT>Newark</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Standard Chlorine of Delaware, Inc</ENT> <ENT>Delaware City</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Tybouts Corner Landfill</ENT> <ENT>New Castle County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Agrico Chemical Co</ENT> <ENT>Pensacola</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Airco Plating Co</ENT> <ENT>Miami</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Alaric Area Ground Water Plume</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>American Creosote Works (Pensacola Plt)</ENT> <ENT>Pensacola</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Anodyne, Inc</ENT> <ENT>North Miami Beach</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Arkla Terra Property</ENT> <ENT>Thonotosassa.</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Cabot/Koppers</ENT> <ENT>Gainesville</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Chevron Chemical Co. (Ortho Division)</ENT> <ENT>Orlando</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>City Industries, Inc</ENT> <ENT>Orlando</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Continental Cleaners</ENT> <ENT>Miami</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Escambia Wood—Pensacola</ENT> <ENT>Pensacola</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Flash Cleaners</ENT> <ENT>Pompano Beach</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Florida Petroleum Reprocessors</ENT> <ENT>Fort Lauderdale</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Florida Steel Corp</ENT> <ENT>Indiantown</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>General Dynamics Longwood</ENT> <ENT>Longwood.</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Harris Corp. (Palm Bay Plant)</ENT> <ENT>Palm Bay</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Helena Chemical Co. (Tampa Plant)</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Hollingsworth Solderless Terminal</ENT> <ENT>Fort Lauderdale</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>JJ Seifert Machine</ENT> <ENT>Ruskin</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Kerr-McGee Chemical Corp-Jacksonville</ENT> <ENT>Jacksonville</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Landia Chemical Company</ENT> <ENT>Lakeland</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>MRI Corp (Tampa)</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Madison County Sanitary Landfill</ENT> <ENT>Madison</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Miami Drum Services</ENT> <ENT>Miami</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Peak Oil Co./Bay Drum Co</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Pepper Steel & Alloys, Inc</ENT> <ENT>Medley</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Petroleum Products Corp</ENT> <ENT>Pembroke Park</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Pickettville Road Landfill</ENT> <ENT>Jacksonville</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Piper Aircraft/Vero Beach Water & Sewer</ENT> <ENT>Vero Beach</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Post and Lumber Preserving Co. Inc</ENT> <ENT>Quincy</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Raleigh Street Dump</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Reeves Southeast Galvanizing Corp</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Sanford Dry Cleaners</ENT> <ENT>Sanford</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Sapp Battery Salvage</ENT> <ENT>Cottondale</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Sherwood Medical Industries</ENT> <ENT>Deland</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Solitron Microwave</ENT> <ENT>Port Salerno</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Southern Solvents, Inc</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Stauffer Chemical Co. (Tampa)</ENT> <ENT>Tampa</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Stauffer Chemical Co. (Tarpon Springs)</ENT> <ENT>Tarpon Springs</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Sydney Mine Sludge Ponds</ENT> <ENT>Brandon</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Taylor Road Landfill</ENT> <ENT>Seffner</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Tower Chemical Co</ENT> <ENT>Clermont</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Trans Circuit, Inc.</ENT> <ENT>Lake Park</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>United Metals, Inc</ENT> <ENT>Marianna</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Wingate Road Municipal Incinerator Dump</ENT> <ENT>Fort Lauderdale</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Zellwood Ground Water Contamination</ENT> <ENT>Zellwood</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Alternate Energy Resources</ENT> <ENT>Augusta</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Armstrong World Industries</ENT> <ENT>Macon</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Brunswick Wood Preserving</ENT> <ENT>Brunswick</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Camilla Wood Preserving Company</ENT> <ENT>Camilla</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Diamond Shamrock Corp. Landfill</ENT> <ENT>Cedartown</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Firestone Tire & Rubber Co. (Albany Plant)</ENT> <ENT>Albany</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Hercules 009 Landfill</ENT> <ENT>Brunswick</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>LCP Chemicals Georgia</ENT> <ENT>Brunswick</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Macon Naval Ordnance Plant</ENT> <ENT>Macon</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Marzone Inc./Chevron Chemical Co</ENT> <ENT>Tifton</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Mathis Brothers Landfill</ENT> <ENT>Kensington</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Peach Orchard Road PCE Ground Water Plume</ENT> <ENT>Augusta</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>T.H. Agriculture & Nutrition (Albany)</ENT> <ENT>Albany</ENT> </ROW> <ROW> <PRTPAGE P="237"/> <ENT I="01">GA</ENT> <ENT>Westside Lead</ENT> <ENT>Atlanta</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Woolfolk Chemical Works, Inc</ENT> <ENT>Fort Valley</ENT> </ROW> <ROW> <ENT I="01">GU</ENT> <ENT>Ordot Landfill</ENT> <ENT>Guam</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">HI</ENT> <ENT>Del Monte Corp. (Oahu Plantation)</ENT> <ENT>Honolulu County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Des Moines TCE</ENT> <ENT>Des Moines</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Fairfield Coal Gasification Plant</ENT> <ENT>Fairfield</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Highway 3 PCE</ENT> <ENT>Le Mars</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Lawrence Todtz Farm</ENT> <ENT>Camanche</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Lot 46 Valley Gardens TCE</ENT> <ENT>Des Moines</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Mason City Coal Gasification Plant</ENT> <ENT>Mason City</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Midwest Manufacturing/North Farm</ENT> <ENT>Kellogg</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>PCE Former Dry Cleaner</ENT> <ENT>Atlantic</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Peoples Natural Gas Co</ENT> <ENT>Dubuque</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Railroad Avenue Groundwater Contamination</ENT> <ENT>Des Moines</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Shaw Avenue Dump</ENT> <ENT>Charles City</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Vogel Paint & Wax Co</ENT> <ENT>Orange City</ENT> </ROW> <ROW> <ENT I="01">ID</ENT> <ENT>Bunker Hill Mining & Metallurgical</ENT> <ENT>Smelterville</ENT> </ROW> <ROW> <ENT I="01">ID</ENT> <ENT>Eastern Michaud Flats Contamination</ENT> <ENT>Pocatello</ENT> </ROW> <ROW> <ENT I="01">ID</ENT> <ENT>Kerr-McGee Chemical Corp. (Soda Springs)</ENT> <ENT>Soda Springs</ENT> </ROW> <ROW> <ENT I="01">ID</ENT> <ENT>Monsanto Chemical Co. (Soda Springs)</ENT> <ENT>Soda Springs</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Acme Solvent Reclaiming (Morristown Plant)</ENT> <ENT>Morristown</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Acme Steel Coke Plant</ENT> <ENT>Chicago</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Adams County Quincy Landfills 2&3</ENT> <ENT>Quincy</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Amoco Chemicals (Joliet Landfill)</ENT> <ENT>Joliet</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>ASARCO Taylor Springs</ENT> <ENT>Taylor Springs</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Bautsch-Gray Mine</ENT> <ENT>Galena</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Beloit Corp</ENT> <ENT>Rockton</ENT> <ENT>* P</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Byron Salvage Yard</ENT> <ENT>Byron</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Central Illinois Public Service Co</ENT> <ENT>Taylorville</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Chemetco</ENT> <ENT>Madison County</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Cross Brothers Pail Recycling (Pembroke)</ENT> <ENT>Pembroke Township</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>DePue/New Jersey Zinc/Mobil ChemCorp</ENT> <ENT>DePue</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Eagle Zinc Co Div T L Diamond</ENT> <ENT>Hillsboro</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Estech General Chemical Company</ENT> <ENT>Calumet City</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Galesburg/Koppers Co</ENT> <ENT>Galesburg</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>H.O.D. Landfill</ENT> <ENT>Antioch</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Hegeler Zinc</ENT> <ENT>Danville</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Indian Refinery—Texaco Lawrenceville</ENT> <ENT>Lawrenceville</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Interstate Pollution Control, Inc</ENT> <ENT>Rockford</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Jennison-Wright Corporation</ENT> <ENT>Granite City</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Johns-Manville Corp</ENT> <ENT>Waukegan</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Kerr-McGee (Kress Creek/W Branch DuPage)</ENT> <ENT>DuPage County</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Kerr-McGee (Residential Areas)</ENT> <ENT>West Chicago/DuPage County</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Lake Calumet Cluster</ENT> <ENT>Chicago</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>LaSalle Electric Utilities</ENT> <ENT>LaSalle</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Lenz Oil Service, Inc</ENT> <ENT>Lemont</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Matthiessen and Hegeler Zinc Company</ENT> <ENT>LaSalle</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>MIG/Dewane Landfill</ENT> <ENT>Belvidere</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>NL Industries/Taracorp Lead Smelter</ENT> <ENT>Granite City</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Old American Zinc Plant</ENT> <ENT>Fairmont City</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Ottawa Radiation Areas</ENT> <ENT>Ottawa</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Outboard Marine Corp</ENT> <ENT>Waukegan</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Pagel's Pit</ENT> <ENT>Rockford</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Parsons Casket Hardware Co</ENT> <ENT>Belvidere</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Sandoval Zinc Company</ENT> <ENT>Sandoval</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Schroud Property</ENT> <ENT O="xl">Chicago</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Southeast Rockford Gd Wtr Contamination</ENT> <ENT>Rockford</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Tri-County Landfill/Waste Mgmt Illinois</ENT> <ENT>South Elgin</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Velsicol Chemical Corp. (Illinois)</ENT> <ENT>Marshall</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Wauconda Sand & Gravel</ENT> <ENT>Wauconda</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Woodstock Municipal Landfill</ENT> <ENT>Woodstock</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Yeoman Creek Landfill</ENT> <ENT>Waukegan</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>American Chemical Service, Inc</ENT> <ENT>Griffith</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Beck's Lake</ENT> <ENT>South Bend</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Broadway Street Corridor Groundwater Contamination</ENT> <ENT>Anderson</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Cam-Or Inc</ENT> <ENT>Westville.</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Cliff Drive Groundwater Contamination</ENT> <ENT>Logansport</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Conrail Rail Yard (Elkhart)</ENT> <ENT>Elkhart</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Continental Steel Corp</ENT> <ENT>Kokomo</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Douglas Road/Uniroyal, Inc., Landfill</ENT> <ENT>Mishawaka</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Elm Street Ground Water Contamination</ENT> <ENT>Terre Haute</ENT> </ROW> <ROW> <PRTPAGE P="238"/> <ENT I="01">IN</ENT> <ENT>Envirochem Corp</ENT> <ENT>Zionsville</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Federated Metals Corp Whiting</ENT> <ENT>Hammond</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Fisher-Calo</ENT> <ENT>LaPorte</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Fort Wayne Reduction Dump</ENT> <ENT>Fort Wayne</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Franklin Street Groundwater Contamination</ENT> <ENT>Spencer</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Galen Myers Dump/Drum Salvage</ENT> <ENT>Osceola</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Garden City Ground Water Plume</ENT> <ENT>Garden City</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Gary Development Company</ENT> <ENT>Gary</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Himco Dump</ENT> <ENT>Elkhart</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Jacobsville Neighborhood Soil Contamination</ENT> <ENT>Evansville</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Keystone Corridor Ground Water Contamination</ENT> <ENT>Indianapolis</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Kokomo Contaminated Ground Water Plume</ENT> <ENT>Kokomo</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Lake Sandy Jo (M&M Landfill)</ENT> <ENT>Gary</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Lakeland Disposal Service, Inc</ENT> <ENT>Claypool</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Lane Street Ground Water Contamination</ENT> <ENT>Elkhart.</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Lusher Street Ground Water Contamination</ENT> <ENT>Elkhart</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>MIDCO I</ENT> <ENT>Gary</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>MIDCO II</ENT> <ENT>Gary</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Main Street Well Field</ENT> <ENT>Elkhart</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Marion (Bragg) Dump</ENT> <ENT>Marion</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Ninth Avenue Dump</ENT> <ENT>Gary</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>North 5th Street Groundwater Contamination</ENT> <ENT>Goshen</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>North Shore Drive</ENT> <ENT>Elkhart</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Northside Sanitary Landfill, Inc</ENT> <ENT>Zionsville</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Pike and Mulberry Streets PCE Plume</ENT> <ENT>Martinsville</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Prestolite Battery Division</ENT> <ENT>Vincennes</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Reilly Tar & Chemical (Indianapolis Plant)</ENT> <ENT>Indianapolis</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Seymour Recycling Corp</ENT> <ENT>Seymour</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Tippecanoe Sanitary Landfill, Inc</ENT> <ENT>Lafayette</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>U.S. Smelter & Lead Refining Inc</ENT> <ENT>East Chicago</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">IN</ENT> <ENT>Wayne Waste Oil</ENT> <ENT>Columbia City</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>57th and North Broadway Streets Site</ENT> <ENT>Wichita Heights</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Ace Services</ENT> <ENT>Colby</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Caney Residential Yards</ENT> <ENT>Caney</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Chemical Commodities, Inc</ENT> <ENT>Olathe</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Cherokee County</ENT> <ENT>Cherokee County</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Cherokee Zinc—Weir Smelter</ENT> <ENT>Weir</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Doepke Disposal (Holliday)</ENT> <ENT>Johnson County</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Former United Zinc & Associated Smelters</ENT> <ENT>Iola</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Obee Road</ENT> <ENT>Hutchinson</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Pester Refinery Co</ENT> <ENT>El Dorado</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Plating, Inc</ENT> <ENT>Great Bend</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Strother Field Industrial Park</ENT> <ENT>Cowley County</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Wright Ground Water Contamination</ENT> <ENT>Wright</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>B.F. Goodrich</ENT> <ENT>Calvert City</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Caldwell Lace Leather Co., Inc</ENT> <ENT>Auburn</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Distler Brickyard</ENT> <ENT>West Point</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Distler Farm</ENT> <ENT>Jefferson County</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Green River Disposal, Inc</ENT> <ENT>Maceo</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Maxey Flats Nuclear Disposal</ENT> <ENT>Hillsboro</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>National Electric Coil/Cooper Industries</ENT> <ENT>Dayhoit</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Smith's Farm</ENT> <ENT>Brooks</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Tri-City Disposal Co</ENT> <ENT>Shepherdsville</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Agriculture Street Landfill</ENT> <ENT>New Orleans</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>American Creosote DeRidder</ENT> <ENT>DeRidder</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>American Creosote Works, Inc (Winnfield)</ENT> <ENT>Winnfield</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Bayou Bonfouca</ENT> <ENT>Slidell</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Capitol Lakes</ENT> <ENT>Baton Rouge</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Colonial Creosote</ENT> <ENT>Bogalusa</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Combustion, Inc</ENT> <ENT>Denham Springs</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Delta Shipyard</ENT> <ENT>Houma</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>EVR-Wood Treating/Evangeline Refining Company</ENT> <ENT>Jennings</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Exide Baton Rouge</ENT> <ENT>Baton Rouge</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Madisonville Creosote Works</ENT> <ENT>Madisonville</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Marion Pressure Treating</ENT> <ENT>Marion</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Petro-Processors of Louisiana Inc</ENT> <ENT>Scotlandville</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>SBA Shipyard</ENT> <ENT>Jennings</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Atlas Tack Corp</ENT> <ENT>Fairhaven</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Baird & McGuire</ENT> <ENT>Holbrook</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>BJAT LLC</ENT> <ENT>Franklin</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Blackburn & Union Privileges</ENT> <ENT>Walpole</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Charles-George Reclamation Landfill</ENT> <ENT>Tyngsborough</ENT> </ROW> <ROW> <PRTPAGE P="239"/> <ENT I="01">MA</ENT> <ENT>Creese &Cook Tannery (Former)</ENT> <ENT>Danvers</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Groveland Wells</ENT> <ENT>Groveland</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Haverhill Municipal Landfill</ENT> <ENT>Haverhill</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Hocomonco Pond</ENT> <ENT>Westborough</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Industri-Plex</ENT> <ENT>Woburn</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Iron Horse Park</ENT> <ENT>Billerica</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Lower Neponset River</ENT> <ENT>Boston/Milton</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Microfab, Inc. (Former)</ENT> <ENT>Amesbury</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>New Bedford Site</ENT> <ENT>New Bedford</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Nuclear Metals, Inc</ENT> <ENT>Concord.</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Nyanza Chemical Waste Dump</ENT> <ENT>Ashland</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Olin Chemical</ENT> <ENT>Wilmington</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>PSC Resources</ENT> <ENT>Palmer</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Re-Solve, Inc</ENT> <ENT>Dartmouth</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Rose Disposal Pit</ENT> <ENT>Lanesboro</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Silresim Chemical Corp</ENT> <ENT>Lowell</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Sullivan's Ledge</ENT> <ENT>New Bedford</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Sutton Brook Disposal Area</ENT> <ENT>Tewksbury.</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>W.R. Grace & Co Inc (Acton Plant)</ENT> <ENT>Acton</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Walton &Lonsbury Inc.</ENT> <ENT>Attleboro</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Wells G&H</ENT> <ENT>Woburn</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Bear Creek Sediments</ENT> <ENT>Baltimore County</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Bush Valley Landfill</ENT> <ENT>Abingdon</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Central Chemical</ENT> <ENT>Hagerstown</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Dwyer Property Ground Water Plume</ENT> <ENT>Elkton</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Kane & Lombard Street Drums</ENT> <ENT>Baltimore</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Limestone Road</ENT> <ENT>Cumberland</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Ordnance Products, Inc.</ENT> <ENT>Cecil County</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Sand, Gravel & Stone</ENT> <ENT>Elkton</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Sauer Dump</ENT> <ENT>Dundalk</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Spectron, Inc</ENT> <ENT>Elkton</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Woodlawn County Landfill</ENT> <ENT>Woodlawn</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Callahan Mine</ENT> <ENT>Brooksville</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Eastern Surplus</ENT> <ENT>Meddybemps</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Eastland Woolen Mill</ENT> <ENT>Corinna</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Keddy Mill</ENT> <ENT>Windham</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Leeds Metal</ENT> <ENT>Leeds</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Saco Municipal Landfill</ENT> <ENT>Saco</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>West Site/Hows Corners</ENT> <ENT>Plymouth</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Winthrop Landfill</ENT> <ENT>Winthrop</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Adam's Plating</ENT> <ENT>Lansing</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Aircraft Components (D & L Sales)</ENT> <ENT>Benton Harbor</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Albion-Sheridan Township Landfill</ENT> <ENT>Albion</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Allied Paper/Portage Ck/Kalamazoo River</ENT> <ENT>Kalamazoo</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>American Anodco, Inc</ENT> <ENT>Ionia</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Auto Ion Chemicals, Inc</ENT> <ENT>Kalamazoo</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Bendix Corp./Allied Automotive</ENT> <ENT>St. Joseph</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Bofors Nobel, Inc</ENT> <ENT>Muskegon</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Butterworth #2 Landfill</ENT> <ENT>Grand Rapids</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Cannelton Industries, Inc</ENT> <ENT>Saulte Saint Marie</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Chem Central</ENT> <ENT>Wyoming Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Clare Water Supply</ENT> <ENT>Clare</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>DSC McLouth Steel Gibraltar Plant</ENT> <ENT>Gibraltar</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Electrovoice</ENT> <ENT>Buchanan</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Forest Waste Products</ENT> <ENT>Otisville</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>G&H Landfill</ENT> <ENT>Utica</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Grand Traverse Overall Supply Co</ENT> <ENT>Greilickville</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Gratiot County Golf Course</ENT> <ENT>St. Louis</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Gratiot County Landfill</ENT> <ENT>St. Louis</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>H. Brown Co., Inc</ENT> <ENT>Grand Rapids</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Hedblum Industries</ENT> <ENT>Oscoda</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Hi-Mill Manufacturing Co</ENT> <ENT>Highlan</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Ionia City Landfill</ENT> <ENT>Ionia</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>J & L Landfill</ENT> <ENT>Rochester Hills</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>K&L Avenue Landfill</ENT> <ENT>Oshtemo Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Kaydon Corp</ENT> <ENT>Muskegon</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Kentwood Landfill</ENT> <ENT>Kentwood</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Kysor Industrial Corp</ENT> <ENT>Cadillac</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Liquid Disposal, Inc</ENT> <ENT>Utica</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>McGraw Edison Corp</ENT> <ENT>Albion</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>McLouth Steel Corp</ENT> <ENT>Trenton</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Metamora Landfill</ENT> <ENT>Metamora</ENT> </ROW> <ROW> <PRTPAGE P="240"/> <ENT I="01">MI</ENT> <ENT>Michigan Disposal (Cork Street Landfill)</ENT> <ENT>Kalamazoo</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Michner Plating—Mechanic Street</ENT> <ENT>Jackson</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Motor Wheel</ENT> <ENT>Lansing</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Muskegon Chemical Co</ENT> <ENT>Whitehall</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>North Bronson Industrial Area</ENT> <ENT>Bronson</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Northernaire Plating</ENT> <ENT>Cadillac</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Organic Chemicals, Inc</ENT> <ENT>Grandville</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Ott/Story/Cordova Chemical Co</ENT> <ENT>Dalton Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Packaging Corp. of America</ENT> <ENT>Filer City</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Parsons Chemical Works, Inc</ENT> <ENT>Grand Ledge</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Peerless Plating Co</ENT> <ENT>Muskegon</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Petoskey Municipal Well Field</ENT> <ENT>Petoskey</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Rasmussen's Dump</ENT> <ENT>Green Oak Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Rockwell International Corp. (Allegan)</ENT> <ENT>Allegan</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Rose Township Dump</ENT> <ENT>Rose Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Roto-Finish Co., Inc</ENT> <ENT>Kalamazoo</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>SCA Independent Landfill</ENT> <ENT>Muskegon Heights</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Shiawassee River</ENT> <ENT>Howell</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>South Macomb Disposal (Landfills 9 & 9A)</ENT> <ENT>Macomb Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Southwest Ottawa County Landfill</ENT> <ENT>Park Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Sparta Landfill</ENT> <ENT>Sparta Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Spartan Chemical Co</ENT> <ENT>Wyoming</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Springfield Township Dump</ENT> <ENT>Davisburg</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>State Disposal Landfill, Inc</ENT> <ENT>Grand Rapids</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Sturgis Municipal Wells</ENT> <ENT>Sturgis</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Tar Lake</ENT> <ENT>Antrim</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Ten-Mile Drain</ENT> <ENT>St. Clair Shores.</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Thermo-Chem, Inc</ENT> <ENT>Muskegon</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Torch Lake</ENT> <ENT>Houghton</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>U.S. Aviex</ENT> <ENT>Howard Township</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Velsicol Chemical Corp. (Michigan)</ENT> <ENT>St. Louis</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Verona Well Field</ENT> <ENT>Battle Creek</ENT> </ROW> <ROW> <ENT I="01">MI</ENT> <ENT>Wash King Laundry</ENT> <ENT>Pleasant Plains Twp</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Baytown Township Ground Water Plume</ENT> <ENT>Baytown Township</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Burlington Northern (Brainerd/Baxter)</ENT> <ENT>Brainerd/Baxter</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>FMC Corp. (Fridley Plant)</ENT> <ENT>Fridley</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Freeway Sanitary Landfill</ENT> <ENT>Burnsville</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>General Mills/Henkel Corp</ENT> <ENT>Minneapolis</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Highway 100 and County Road 3 Groundwater Plume</ENT> <ENT>St. Louis Park and Edina</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Joslyn Manufacturing and Supply Co</ENT> <ENT>Brooklyn Center</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Koppers Coke</ENT> <ENT>St. Paul</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Kurt Manufacturing Co</ENT> <ENT>Fridley</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Lehillier/Mankato Site</ENT> <ENT>Lehillier/Mankato</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Long Prairie Ground Water Contamination</ENT> <ENT>Long Prairie</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>MacGillis & Gibbs/Bell Lumber & Pole C</ENT> <ENT>New Brighton</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Oakdale Dump</ENT> <ENT>Oakdale</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Perham Arsenic Site</ENT> <ENT>Perham</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Reilly Tar&Chem (St. Louis Park Plant)</ENT> <ENT>St. Louis Park</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Ritari Post & Pole</ENT> <ENT>Sebeka</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>South Andover Site</ENT> <ENT>Andover</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Southeast Hennepin Area Groundwater and Vapor</ENT> <ENT>Minneapolis</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>South Minneapolis Residential Soil Contamination</ENT> <ENT>Minneapolis</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Spring Park Municipal Well Field</ENT> <ENT>Spring Park</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>St. Louis River Site</ENT> <ENT>St. Louis County</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>St. Regis Paper Co</ENT> <ENT>Cass Lake</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Waite Park Wells</ENT> <ENT>Waite Park</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Armour Road</ENT> <ENT>North Kansas City</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Bee Cee Manufacturing Co</ENT> <ENT>Malden</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Big River Mine Tailings/St. Joe Minerals</ENT> <ENT>Desloge</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Compass Plaza Well TCE</ENT> <ENT>Rogersville</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Conservation Chemical Co</ENT> <ENT>Kansas City</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Ellisville Site</ENT> <ENT>Ellisville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Fulbright Landfill</ENT> <ENT>Springfield</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Lee Chemical</ENT> <ENT>Libert</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Madison County Mines</ENT> <ENT>Fredericktown</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Minker/Stout/Romaine Creek</ENT> <ENT>Imperial</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Missouri Electric Works</ENT> <ENT>Cape Girardeau</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Newton County Mine Tailings</ENT> <ENT>Newton County</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Newton County Wells</ENT> <ENT>Newton County</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Oak Grove Village Well</ENT> <ENT>Oak Grove Village</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Oronogo-Duenweg Mining Belt</ENT> <ENT>Jasper County</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Pools Prairie</ENT> <ENT>Neosho</ENT> </ROW> <ROW> <PRTPAGE P="241"/> <ENT I="01">MO</ENT> <ENT>Quality Plating</ENT> <ENT>Sikeston</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Riverfront</ENT> <ENT>New Haven</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Solid State Circuits, Inc</ENT> <ENT>Republic</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Southwest Jefferson County Mining</ENT> <ENT>Jefferson County.</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Sporlan Valve Plant #1</ENT> <ENT>Washington</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>St. Louis Airport/HIS/Futura Coatings Co</ENT> <ENT>St. Louis County</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Syntex Facility</ENT> <ENT>Verona</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Valley Park TCE</ENT> <ENT>Valley Park</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Vienna Wells</ENT> <ENT>Vienna.</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Washington County Lead District—Furnace Creek</ENT> <ENT>Caledonia</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Washington County Lead District—Old Mines</ENT> <ENT>Old Mines</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Washington County Lead District—Potosi</ENT> <ENT>Potosi</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Washington County Lead District—Richwoods</ENT> <ENT>Richwoods</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Westlake Landfill</ENT> <ENT>Bridgeton</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>American Creosote Works, Inc</ENT> <ENT>Louisville</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Chemfax, Inc</ENT> <ENT>Gulfport</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Hercules Inc</ENT> <ENT>Hattiesburg</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Kerr-McGee Chemical Corp—Columbus</ENT> <ENT>Columbus</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Mississippi Phosphates Corporation</ENT> <ENT>Pascagoula</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Picayune Wood Treating</ENT> <ENT>Picayune</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Rockwell International Wheel & Trim</ENT> <ENT>Grenada</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Sonford Products</ENT> <ENT>Flowood</ENT> </ROW> <ROW> <ENT I="01">MS</ENT> <ENT>Southeastern Wood Preserving</ENT> <ENT>Canton</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>ACM Smelter and Refinery</ENT> <ENT>Cascade County</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Anaconda Aluminum Co Columbia Falls Reduction Plant</ENT> <ENT>Columbia Falls</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Anaconda Co. Smelter</ENT> <ENT>Anaconda</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Barker Hughesville Mining District</ENT> <ENT>Barker</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Basin Mining Area</ENT> <ENT>Basin</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Billings PCE</ENT> <ENT>Billings</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Carpenter Snow Creek Mining District</ENT> <ENT>Neihart</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>East Helena Site</ENT> <ENT>East Helena</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Flat Creek IMM</ENT> <ENT>Superior.</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Idaho Pole Co</ENT> <ENT>Bozeman</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Libby Asbestos</ENT> <ENT>Libby</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Libby Ground Water Contamination</ENT> <ENT>Libby</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Lockwood Solvent Ground Water Plume</ENT> <ENT>Billings</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Milltown Reservoir Sediments</ENT> <ENT>Milltown</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Montana Pole and Treating</ENT> <ENT>Butte</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Mouat Industries</ENT> <ENT>Columbus</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Silver Bow Creek/Butte Area</ENT> <ENT>Sil Bow/Deer Lodge</ENT> </ROW> <ROW> <ENT I="01">MT</ENT> <ENT>Upper Tenmile Creek Mining Area</ENT> <ENT>Lewis and Clark</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>ABC One Hour Cleaners</ENT> <ENT>Jacksonville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Aberdeen Contaminated Ground Water</ENT> <ENT>Aberdeen</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Aberdeen Pesticide Dumps</ENT> <ENT>Aberdeen</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Barber Orchard</ENT> <ENT>Waynesville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Benfield Industries, Inc.</ENT> <ENT>Hazelwood</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Blue Ridge Plating</ENT> <ENT>Arden</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Bypass 601 Ground Water Contamination</ENT> <ENT>Concord</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Cape Fear Wood Preserving</ENT> <ENT>Fayetteville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Carolina Transformer Co</ENT> <ENT>Fayetteville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Celanese Corp. (Shelby Fiber Operations)</ENT> <ENT>Shelby/Cleveland</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Charles Macon Lagoon & Drum Storage</ENT> <ENT>Cordova</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Chemtronics, Inc</ENT> <ENT>Swannanoa</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Cristex Drum</ENT> <ENT>Oxford</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>CTS of Asheville, Inc.</ENT> <ENT>Asheville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Davis Park Road TCE</ENT> <ENT>Gastonia</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>FCX, Inc. (Statesville Plant)</ENT> <ENT>Statesville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>FCX, Inc. (Washington Plant)</ENT> <ENT>Washington</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>GMH Electronics</ENT> <ENT>Roxboro.</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Geigy Chemical Corp. (Aberdeen Plant)</ENT> <ENT>Aberdeen</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>General Electric Co/Shepherd Farm</ENT> <ENT>East Flat Rock</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Hemphill Road TCE</ENT> <ENT>Gastonia</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Holcomb Creosote Co</ENT> <ENT>Yadkinville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Horton Iron and Metal</ENT> <ENT>Wilmington</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>JFD Electronics/Channel Master</ENT> <ENT>Oxford</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Jadco-Hughes Facility</ENT> <ENT>Belmont</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Kerr-McGee Chemical Corp-Navassa</ENT> <ENT>Navassa</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Koppers Co., Inc. (Morrisville Plant)</ENT> <ENT>Morrisville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>NC State University (Lot 86,Farm Unit #1)</ENT> <ENT>Raleigh</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>National Starch & Chemical Corp</ENT> <ENT>Salisbury</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>North Belmont PCE</ENT> <ENT>North Belmont</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Ore Knob Mine</ENT> <ENT>Ashe County.</ENT> </ROW> <ROW> <PRTPAGE P="242"/> <ENT I="01">NC</ENT> <ENT>Potter's Septic Tank Service Pits</ENT> <ENT>Maco</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Ram Leather Care</ENT> <ENT>Charlotte</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Sigmon's Septic Tank</ENT> <ENT>Statesville</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Ward Transformer</ENT> <ENT>Raleigh.</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Wright Chemical Corporation</ENT> <ENT>Riegelwood</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>10th Street Site</ENT> <ENT>Columbus</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Bruno Co-op Association/Associated Prop</ENT> <ENT>Bruno</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Cleburn Street Well</ENT> <ENT>Grand Island</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Garvey Elevator</ENT> <ENT>Hastings</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Hastings Ground Water Contamination</ENT> <ENT>Hastings</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Iowa-Nebraska Light & Power Co</ENT> <ENT>Norfolk</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Lindsay Manufacturing Co</ENT> <ENT>Lindsay</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Nebraska Ordnance Plant (Former)</ENT> <ENT>Mead</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Ogallala Ground Water Contamination</ENT> <ENT>Ogallala</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Old HWY 275 and N 288th Street</ENT> <ENT>Valley</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Omaha Lead</ENT> <ENT>Omaha/Douglas</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Parkview Well</ENT> <ENT>Grand Island</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>PCE—Carriage Cleaners</ENT> <ENT>Bellevue</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>PCE Southeast Contamination</ENT> <ENT>York</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>PCE/TCE Northeast Contamination</ENT> <ENT>York</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Sherwood Medical Co</ENT> <ENT>Norfolk</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>West Highway 6 & Highway 281</ENT> <ENT>Hastings</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Auburn Road Landfill</ENT> <ENT>Londonderry</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Beede Waste Oil</ENT> <ENT>Plaistow</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Chlor-Alkali Facility (Former)</ENT> <ENT>Berlin</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Coakley Landfill</ENT> <ENT>North Hampton</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Collins & Aikman Plant (Former)</ENT> <ENT>Farmington</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Dover Municipal Landfill</ENT> <ENT>Dover</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Fletcher's Paint Works & Storage</ENT> <ENT>Milford</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Kearsarge Metallurgical Corp</ENT> <ENT>Conway</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Keefe Environmental Services</ENT> <ENT>Epping</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Mottolo Pig Farm</ENT> <ENT>Raymond</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>New Hampshire Plating Co</ENT> <ENT>Merrimack</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Ottati & Goss/Kingston Steel Drum</ENT> <ENT>Kingston</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Savage Municipal Water Supply</ENT> <ENT>Milford</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Somersworth Sanitary Landfill</ENT> <ENT>Somersworth</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>South Municipal Water Supply Well</ENT> <ENT>Peterborough</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Sylvester</ENT> <ENT>NashuaS</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Tibbetts Road</ENT> <ENT>Barrington</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Tinkham Garage</ENT> <ENT>Londonderry</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Troy Mills Landfill</ENT> <ENT>Troy</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>A. O. Polymer</ENT> <ENT>Sparta/Sussex</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>American Cyanamid Co.</ENT> <ENT>Bound Brook</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Asbestos Dump</ENT> <ENT>Millington</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Atlantic Resources Corporation</ENT> <ENT>Sayreville</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Bog Creek Farm</ENT> <ENT>Howell Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Brick Township Landfill</ENT> <ENT>Brick Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Bridgeport Rental & Oil Services</ENT> <ENT>Bridgeport</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Brook Industrial Park</ENT> <ENT>Bound Brook</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Burnt Fly Bog</ENT> <ENT>Marlboro Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>CPS/Madison Industries</ENT> <ENT>Old Bridge Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Caldwell Trucking Co</ENT> <ENT>Fairfield</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Chemical Control</ENT> <ENT>Elizabeth</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Chemical Insecticide Corp</ENT> <ENT>Edison Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Chemical Leaman Tank Lines, Inc</ENT> <ENT>Bridgeport</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Chemsol, Inc</ENT> <ENT>Piscataway</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Ciba-Geigy Corp</ENT> <ENT>Toms River</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Cinnaminson Ground Water Contamination</ENT> <ENT>Cinnaminson Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Combe Fill South Landfill</ENT> <ENT>Chester Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Cornell Dubilier Electronics Inc</ENT> <ENT>South Plainfield</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Cosden Chemical Coatings Corp</ENT> <ENT>Beverly</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Curcio Scrap Metal, Inc</ENT> <ENT>Saddle Brook Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Curtis Specialty Papers, Inc</ENT> <ENT>Milford.</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>D'Imperio Property</ENT> <ENT>Hamilton Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Dayco Corp./L.E Carpenter Co</ENT> <ENT>Wharton Borough</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>De Rewal Chemical Co</ENT> <ENT>Kingwood Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Diamond Alkali Co</ENT> <ENT>Newark</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Diamond Head Oil Refinery Div</ENT> <ENT>Kearny</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Dover Municipal Well 4</ENT> <ENT>Dover Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Ellis Property</ENT> <ENT>Evesham Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Emmell's Septic Landfill</ENT> <ENT>Galloway Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Evor Phillips Leasing</ENT> <ENT>Old Bridge Township</ENT> </ROW> <ROW> <PRTPAGE P="243"/> <ENT I="01">NJ</ENT> <ENT>Ewan Property</ENT> <ENT>Shamong Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Fair Lawn Well Field</ENT> <ENT>Fair Lawn</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Former Kil-Tone Company</ENT> <ENT>Vineland</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Franklin Burn</ENT> <ENT>Franklin Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Fried Industries</ENT> <ENT>East Brunswick Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Garfield Ground Water Contamination</ENT> <ENT>Garfield</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>GEMS Landfill</ENT> <ENT>Gloucester Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Garden State Cleaners Co</ENT> <ENT>Minotola</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Global Sanitary Landfill</ENT> <ENT>Old Bridge Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Goose Farm</ENT> <ENT>Plumstead Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Helen Kramer Landfill</ENT> <ENT>Mantua Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Hercules, Inc. (Gibbstown Plant)</ENT> <ENT>Gibbstown</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Higgins Disposal</ENT> <ENT>Kingston</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Higgins Farm</ENT> <ENT>Franklin Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Horseshoe Road</ENT> <ENT>Sayreville</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Iceland Coin Laundry Area Ground Water Plume</ENT> <ENT>Vineland</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Imperial Oil Co., Inc./Champion Chemicals</ENT> <ENT>Morganville</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>JIS Landfill</ENT> <ENT>Jamesburg/S. Brnswck</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Kauffman & Minteer, Inc</ENT> <ENT>Jobstown</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Kin-Buc Landfill</ENT> <ENT>Edison Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>King of Prussia</ENT> <ENT>Winslow Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>LCP Chemicals Inc</ENT> <ENT>Linden</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Landfill & Development Co</ENT> <ENT>Mount Holly</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Lang Property</ENT> <ENT>Pemberton Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Lightman Drum Company</ENT> <ENT>Winslow Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Lone Pine Landfill</ENT> <ENT>Freehold Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Lower Hackensack River</ENT> <ENT>Bergen and Hudson Counties</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Mansfield Trail Dump</ENT> <ENT>Byram Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Martin Aaron, Inc</ENT> <ENT>Camden</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Matlack, Inc.</ENT> <ENT>Woolwich Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Maywood Chemical Co</ENT> <ENT>Maywood/Rochelle Park</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Matteo & Sons, Inc.</ENT> <ENT>Thorofare</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Metaltec/Aerosystems</ENT> <ENT>Franklin Borough</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Monitor Devices/Intercircuits Inc</ENT> <ENT>Wall Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Montgomery Township Housing Development</ENT> <ENT>Montgomery Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Myers Property</ENT> <ENT>Franklin Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>NL Industries</ENT> <ENT>Pedricktown</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Nascolite Corp</ENT> <ENT>Millville</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Orange Valley Regional Ground Water Contamination</ENT> <ENT>West Orange/Orange</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Pierson's Creek</ENT> <ENT>Newark</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Pioneer Metal Finishing Inc</ENT> <ENT>Franklinville</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>PJP Landfill</ENT> <ENT>Jersey City</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Pohatcong Valley Ground Water Contaminat</ENT> <ENT>Warren County</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Price Landfill</ENT> <ENT>Pleasantville</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Puchack Well Field</ENT> <ENT>Pennsauken Township.</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Quanta Resources</ENT> <ENT>Edgewater</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Radiation Technology, Inc</ENT> <ENT>Rockaway Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Raritan Bay Slag</ENT> <ENT>Old Bridge Township/Sayreville.</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Ringwood Mines/Landfill</ENT> <ENT>Ringwood</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Riverside Industrial Park</ENT> <ENT>Newark</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Rockaway Borough Well Field</ENT> <ENT>Rockaway Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Rockaway Township Wells</ENT> <ENT>Rockaway</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Rocky Hill Municipal Well</ENT> <ENT>Rocky Hill Borough</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Roebling Steel Co</ENT> <ENT>Florence</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Rolling Knolls Landfill</ENT> <ENT>Chatham Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Scientific Chemical Processing</ENT> <ENT>Carlstadt</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Sharkey Landfill</ENT> <ENT>Parsippany/Troy Hls</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Sherwin-Williams/Hilliards Creek</ENT> <ENT>Gibbsboro</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Shieldalloy Corp</ENT> <ENT>Newfield Borough</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>South Jersey Clothing Co</ENT> <ENT>Minotola</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Standard Chlorine</ENT> <ENT>Kearny</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Swope Oil & Chemical Co</ENT> <ENT>Pennsauken</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Syncon Resins</ENT> <ENT>South Kearny</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>U.S. Radium Corp</ENT> <ENT>Orange</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Unimatic Manufacturing Corporation</ENT> <ENT>Fairfield</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>United States Avenue Burn</ENT> <ENT>Gibbsboro</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Universal Oil Products (Chemical Division)</ENT> <ENT>East Rutherford</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Ventron/Velsicol</ENT> <ENT>Wood Ridge Borough</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Vineland Chemical Co., Inc</ENT> <ENT>Vineland</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Waldick Aerospace Devices, Inc</ENT> <ENT>Wall Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Welsbach & General Gas Mantle (Camden)</ENT> <ENT>Camden and Gloucester City</ENT> </ROW> <ROW> <PRTPAGE P="244"/> <ENT I="01">NJ</ENT> <ENT>White Chemical Corp</ENT> <ENT>Newark</ENT> <ENT>A</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>White Swan Cleaners/Sun Cleaners Area Ground Water Contamination</ENT> <ENT>Wall Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Williams Property</ENT> <ENT>Swainton</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Woodbrook Road Dump</ENT> <ENT>South Plainfield.</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Woodland Route 532 Dump</ENT> <ENT>Woodland Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Woodland Route 72 Dump</ENT> <ENT>Woodland Township</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Zschiegner Refining</ENT> <ENT>Howell Township.</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>AT&SF Albuquerque</ENT> <ENT>Albuquerque</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Chevron Questa Mine</ENT> <ENT>Questa</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Eagle Picher Carefree Battery</ENT> <ENT>Socorro</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Fruit Avenue Plume</ENT> <ENT>Albuquerque</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Grants Chlorinated Solvents Plume</ENT> <ENT>Grants</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Griggs & Walnut Ground Water Plume</ENT> <ENT>Las Cruces.</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Homestake Mining Co</ENT> <ENT>Milan</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Jackpile-Paguate Uranium Mine</ENT> <ENT>Laguna Pueblo</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Lea and West Second Street</ENT> <ENT>Roswell</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>McGaffey and Main Groundwater Plume</ENT> <ENT>Roswell</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>North Railroad Avenue Plume</ENT> <ENT>Espanola</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Prewitt Abandoned Refinery</ENT> <ENT>Prewitt</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>South Valley</ENT> <ENT>Albuquerque</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>United Nuclear Corp</ENT> <ENT>Church Rock</ENT> </ROW> <ROW> <ENT I="01">NV</ENT> <ENT>Carson River Mercury Site</ENT> <ENT>Lyon/Churchill Cnty</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>American Thermostat Co</ENT> <ENT>South Cairo</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Applied Environmental Services</ENT> <ENT>Glenwood Landing</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Arsenic Mine</ENT> <ENT>Kent</ENT> <ENT>A</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Black River PCBs</ENT> <ENT>Jefferson County</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Brewster Well Field</ENT> <ENT>Putnam County</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Brillo Landfill</ENT> <ENT>Victory</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Byron Barrel & Drum</ENT> <ENT>Byron</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Carroll & Dubies Sewage Disposal</ENT> <ENT>Port Jervis</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Cayuga County Ground Water Contamination</ENT> <ENT>Cayuga County</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Circuitron Corp</ENT> <ENT>East Farmingdale</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Claremont Polychemical</ENT> <ENT>Old Bethpage</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Colesville Municipal Landfill</ENT> <ENT>Town of Colesville</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Computer Circuits</ENT> <ENT>Hauppauge</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Cortese Landfill</ENT> <ENT>Village of Narrowsburg</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Crown Cleaners of Watertown, Inc</ENT> <ENT>Carthage</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Dewey Loeffel Landfill</ENT> <ENT>Nassau</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Diaz Chemical Corporation</ENT> <ENT>Holley</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Eighteenmile Creek</ENT> <ENT>Niagara County</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Endicott Village Well Field</ENT> <ENT>Village of Endicott</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Facet Enterprises, Inc</ENT> <ENT>Elmira</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Forest Glen Mobile Home Subdivision</ENT> <ENT>Niagara Falls</ENT> <ENT>A</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Fulton Avenue</ENT> <ENT>North Hempstead.</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>GCL Tie & Treating Inc</ENT> <ENT>Village of Sidney</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>GE Moreau</ENT> <ENT>South Glen Falls</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>General Motors (Central Foundry Division)</ENT> <ENT>Massena</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Genzale Plating Co</ENT> <ENT>Franklin Square</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Goldisc Recordings, Inc</ENT> <ENT>Holbrook</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Gowanus Canal</ENT> <ENT>Brooklyn</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Hertel Landfill</ENT> <ENT>Plattekill</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Hooker (S Area)</ENT> <ENT>Niagara Falls</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Hooker Chemical/Ruco Polymer Corp</ENT> <ENT>Hicksville</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Hopewell Precision Area Contamination</ENT> <ENT>Hopewell Junction</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Hudson River PCBs</ENT> <ENT>Hudson River</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Islip Municipal Sanitary Landfill</ENT> <ENT>Islip</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Johnstown City Landfill</ENT> <ENT>Town of Johnstown</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Jones Chemicals, Inc</ENT> <ENT>Caledonia</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Kentucky Avenue Well Field</ENT> <ENT>Horseheads</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Lawrence Aviation, Inc</ENT> <ENT>Port Jefferson Station</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Lehigh Valley Railroad</ENT> <ENT>Le Roy</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Li Tungsten Corp</ENT> <ENT>Glen Cove</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Liberty Industrial Finishing</ENT> <ENT>Farmingdale</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Little Valley</ENT> <ENT>Little Valley</ENT> <ENT>A</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>MacKenzie Chemical Works, Inc</ENT> <ENT>Central Islip</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Magna Metals</ENT> <ENT>Cortlandt Manor</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Malta Rocket Fuel Area</ENT> <ENT>Malta</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Mattiace Petrochemical Co., Inc</ENT> <ENT>Glen Cove</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Meeker Avenue Plume</ENT> <ENT>Brooklyn</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Mohonk Road Industrial Plant</ENT> <ENT>High Falls</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Nepera Chemical Co., Inc</ENT> <ENT>Maybrook</ENT> </ROW> <ROW> <PRTPAGE P="245"/> <ENT I="01">NY</ENT> <ENT>New Cassel/Hicksville Ground Water Contamination</ENT> <ENT>New Cassel/Hicksville</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Newtown Creek</ENT> <ENT>Brooklyn/Queens</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Niagara Mohawk Power Co (Saratoga Spings)</ENT> <ENT>Saratoga Springs</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Old Bethpage Landfill</ENT> <ENT>Oyster Bay</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Old Roosevelt Field Contaminated Ground Water Area</ENT> <ENT>Garden City.</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Olean Well Field</ENT> <ENT>Olean</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Onondaga Lake</ENT> <ENT>Syracuse</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Peninsula Boulevard Ground Water Plume</ENT> <ENT>Hewlett</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Pollution Abatement Services</ENT> <ENT>Oswego</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Port Washington Landfill</ENT> <ENT>Port Washington</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Preferred Plating Corp</ENT> <ENT>Farmingdale</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Ramapo Landfill</ENT> <ENT>Ramapo</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Richardson Hill Road Landfill/Pond</ENT> <ENT>Sidney Center</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Robintech, Inc./National Pipe Co.</ENT> <ENT>Town of Vestal</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Rosen Brothers Scrap Yard/Dump</ENT> <ENT>Cortland</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Rowe Industries Gnd Water Contamination</ENT> <ENT>Noyack/Sag Harbor</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Saint-Gobain Performance Plastics</ENT> <ENT>Village of Hoosick Falls</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Sarney Farm</ENT> <ENT>Amenia</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Sealand Restoration, Inc</ENT> <ENT>Lisbon</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Shenandoah Road Ground Water Contamination</ENT> <ENT>East Fishkill.</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Sidney Landfill</ENT> <ENT>Sidney</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Sinclair Refinery</ENT> <ENT>Wellsville</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Solvent Savers</ENT> <ENT>Lincklaen</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Stanton Cleaners Area Ground Water Contamination</ENT> <ENT>Great Neck</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Tri-Cities Barrel Co., Inc</ENT> <ENT>Port Crane</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Vestal Water Supply Well 1-1</ENT> <ENT>Vestal</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Volney Municipal Landfill</ENT> <ENT>Town of Volney</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Wappinger Creek</ENT> <ENT>Dutchess County</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Wolff-Alport Chemical Company</ENT> <ENT>Ridgewood</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>York Oil Co</ENT> <ENT>Moira</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Allied Chemical & Ironton Coke</ENT> <ENT>Ironton</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Behr Dayton Thermal System VOC Plume</ENT> <ENT>Dayton.</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Big D Campground</ENT> <ENT>Kingsville</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Chem-Dyne</ENT> <ENT>Hamilton</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Copley Square Plaza</ENT> <ENT>Copley</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Donnelsville Contaminated Aquifer</ENT> <ENT>Donnelsville</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>E.H. Schilling Landfill</ENT> <ENT>Hamilton Township</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>East Troy Contaminated Aquifer</ENT> <ENT>Troy</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Fields Brook</ENT> <ENT>Ashtabula</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Fultz Landfill</ENT> <ENT>Jackson Township</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Industrial Excess Landfill</ENT> <ENT>Uniontown</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Lammers Barrel</ENT> <ENT>Beavercreek</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Little Scioto River</ENT> <ENT>Marion County.</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Miami County Incinerator</ENT> <ENT>Troy</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Milford Contaminated Aquifer</ENT> <ENT>Milford</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Nease Chemical</ENT> <ENT>Salem</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>New Carlisle Landfill</ENT> <ENT>New Carlisle.</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>New Lyme Landfill</ENT> <ENT>New Lyme</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>North Sanitary Landfill</ENT> <ENT>Dayton</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Old Mill</ENT> <ENT>Rock Creek</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Ormet Corp</ENT> <ENT>Hannibal</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Peters Cartridge Factory</ENT> <ENT>Kings Mills</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Powell Road Landfill</ENT> <ENT>Dayton</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Pristine, Inc</ENT> <ENT>Reading</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Reilly Tar & Chemical (Dover Plant)</ENT> <ENT>Dover</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Sanitary Landfill Co. (Industrial Waste)</ENT> <ENT>Dayton</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Skinner Landfill</ENT> <ENT>West Chester</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>South Point Plant</ENT> <ENT>South Point</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Summit National</ENT> <ENT>Deerfield Township</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>TRW, Inc. (Minerva Plant)</ENT> <ENT>Minerva</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Valley Pike VOCs</ENT> <ENT>Riverside</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Van Dale Junkyard</ENT> <ENT>Marietta</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>West Troy Contaminated Aquifer</ENT> <ENT>Troy</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Zanesville Well Field</ENT> <ENT>Zanesville</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Double Eagle Refinery Co.</ENT> <ENT>Oklahoma City</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Eagle Industries</ENT> <ENT>Midwest City</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Fansteel Metals/FMRI</ENT> <ENT>Muskogee</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Fourth Street Abandoned Refinery</ENT> <ENT>Okalahoma City</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Hardage/Criner</ENT> <ENT>Criner</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Henryetta Iron and Metal</ENT> <ENT>Henryetta</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Hudson Refinery</ENT> <ENT>Cushing</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Oklahoma Refining Co</ENT> <ENT>Cyril</ENT> </ROW> <ROW> <PRTPAGE P="246"/> <ENT I="01">OK</ENT> <ENT>Tar Creek (Ottawa County)</ENT> <ENT>Ottawa County</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Wilcox Oil Company</ENT> <ENT>Creek County</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Black Butte Mine</ENT> <ENT>Cottage Grove</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Formosa Mine</ENT> <ENT>Douglas County</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>McCormick & Baxter Creos. Co (Portland)</ENT> <ENT>Portland</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>North Ridge Estates</ENT> <ENT>Klamath Falls</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Northwest Pipe & Casing/Hall Process Company</ENT> <ENT>Clackamas</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Portland Harbor</ENT> <ENT>Portland</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Reynolds Metals Company</ENT> <ENT>Troutdale</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Taylor Lumber and Treating</ENT> <ENT>Sheridan.</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Teledyne Wah Chang</ENT> <ENT>Albany</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Union Pacific Railroad Tie Treatment</ENT> <ENT>The Dalles</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>United Chrome Products, Inc</ENT> <ENT>Corvallis</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>A.I.W. Frank/Mid-County Mustang</ENT> <ENT>Exton</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Avco Lycoming (Williamsport Division)</ENT> <ENT>Williamsport</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Baghurst Drive</ENT> <ENT>Harleysville</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Bally Ground Water Contamination</ENT> <ENT>Bally Borough</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Bell Landfill</ENT> <ENT>Terry Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Bendix Flight Systems Division</ENT> <ENT>Bridgewater Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Berks Sand Pit</ENT> <ENT>Longswamp Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Blosenski Landfill</ENT> <ENT>West Caln Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Boarhead Farms</ENT> <ENT>Bridgeton Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>BoRit Asbetos</ENT> <ENT>Ambler.</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Breslube-Penn, Inc</ENT> <ENT>Coraopolis</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Brown's Battery Breaking</ENT> <ENT>Shoemakersville</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Butz Landfill</ENT> <ENT>Stroudsburg</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Centre County Kepone</ENT> <ENT>State College Borough</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Chem-Fab</ENT> <ENT>Doylestown</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Commodore Semiconductor Group</ENT> <ENT>Lower Providence Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Crater Resources/Keystone Coke/Alan Wood</ENT> <ENT>Upper Merion Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Crossley Farm</ENT> <ENT>Hereford Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Croydon TCE</ENT> <ENT>Croydon</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>CryoChem, Inc</ENT> <ENT>Worman</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Delta Quarries & Disp./Stotler Landfill</ENT> <ENT>Antis/Logan Twps</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Douglassville Disposal</ENT> <ENT>Douglassville</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Drake Chemical</ENT> <ENT>Lock Haven</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Dublin TCE Site</ENT> <ENT>Dublin Borough</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>East Mount Zion</ENT> <ENT>Springettsbury Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Eastern Diversified Metals</ENT> <ENT>Hometown</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Elizabethtown Landfill</ENT> <ENT>Elizabethtown</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Fischer & Porter Co</ENT> <ENT>Warminster</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Foote Mineral Co</ENT> <ENT>East Whiteland Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Former Exide Technologies Laureldale</ENT> <ENT>Laureldale</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Franklin Slag Pile (MDC)</ENT> <ENT>Philadelphia</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Havertown PCP</ENT> <ENT>Haverford</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Heleva Landfill</ENT> <ENT>North Whitehall Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Hellertown Manufacturing Co</ENT> <ENT>Hellertown</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Henderson Road</ENT> <ENT>Upper Merion Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Hunterstown Road</ENT> <ENT>Straban Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Industrial Lane</ENT> <ENT>Williams Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Jacks Creek/Sitkin Smelting and Refinery</ENT> <ENT>Maitland</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Jackson Ceramix</ENT> <ENT>Falls Creek</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Keystone Sanitation Landfill</ENT> <ENT>Union Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Kimberton Site</ENT> <ENT>Kimberton Borough</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Lindane Dump</ENT> <ENT>Harrison Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Lord-Shope Landfill</ENT> <ENT>Girard Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Lower Darby Creek Area</ENT> <ENT>Delaware/Philadelphia Counties.</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>MW Manufacturing</ENT> <ENT>Valley Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Malvern TCE</ENT> <ENT>Malvern</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Metal Banks</ENT> <ENT>Philadelphia</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Metro Container Corporation</ENT> <ENT>Trainer</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Mill Creek Dump</ENT> <ENT>Erie</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Modern Sanitation Landfill</ENT> <ENT>Lower Windsor Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>North Penn—Area 1</ENT> <ENT>Souderton</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>North Penn—Area 12</ENT> <ENT>Worcester</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>North Penn—Area 2</ENT> <ENT>Hatfield</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>North Penn—Area 5</ENT> <ENT>Montgomery Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>North Penn Area 6</ENT> <ENT>Lansdale</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>North Penn—Area 7</ENT> <ENT>North Wales</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Novak Sanitary Landfill</ENT> <ENT>South Whitehall Township</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Occidental Chemical Corp./Firestone Tire</ENT> <ENT>Lower Pottsgrove Township</ENT> </ROW> <ROW> <PRTPAGE P="247"/> <ENT I="01">PA</ENT> <ENT>Ohio River Park</ENT> <ENT>Neville Island</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Old City of York Landfill</ENT> <ENT>Seven Valleys</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Old Wilmington Road Ground Water Contamination</ENT> <ENT>Sadsburyville</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Osborne Landfill</ENT> <ENT>Grove City</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Palmerton Zinc Pile</ENT> <ENT>Palmerton</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Paoli Rail Yard</ENT> <ENT>Paoli</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Price Battery</ENT> <ENT>Hamburg</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Raymark</ENT> <ENT>Hatboro</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Revere Chemical Co</ENT> <ENT>Nockamixon Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Rodale Manufacturing Co., Inc</ENT> <ENT>Emmaus Borough</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Ryeland Road Arsenic</ENT> <ENT>Heidelberg Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Saegertown Industrial Area</ENT> <ENT>Saegertown.</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Safety Light Corporation</ENT> <ENT>Bloomsburg</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Salford Quarry</ENT> <ENT>Lower Salford Township.</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Sharon Steel Corp. (Farrell Wks Disp Area)</ENT> <ENT>Hickory Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Shriver's Corner</ENT> <ENT>Straban Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Stanley Kessler</ENT> <ENT>King of Prussia</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Tobyhanna Army Depot</ENT> <ENT>Tobyhanna</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Tonolli Corp</ENT> <ENT>Nesquehoning</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Tysons Dump</ENT> <ENT>Upper Merion Twp</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>UGI Columbia Gas Plant</ENT> <ENT>Columbia</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Valmont TCE</ENT> <ENT>Hazle Township and West Hazleton</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Walsh Landfill</ENT> <ENT>Honeybrook Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Watson Johnson Landfill</ENT> <ENT>Richland Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Westinghouse Electronic (Sharon Plant)</ENT> <ENT>Sharon</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Westinghouse Elevator Co. Plant</ENT> <ENT>Gettysburg</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Whitmoyer Laboratories</ENT> <ENT>Jackson Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>William Dick Lagoons</ENT> <ENT>West Caln Township</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Cabo Rojo Ground Water Contamination</ENT> <ENT>Cabo Rojo</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Cidra Ground Water Contamination</ENT> <ENT>Cidra</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Corozal Well</ENT> <ENT>Corozal</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Dorado Ground Water Contamination</ENT> <ENT>Dorado</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Fibers Public Supply Wells</ENT> <ENT>Jobos</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Juncos Landfill</ENT> <ENT>Juncos</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Maunabo Area Ground Water Contamination</ENT> <ENT>Maunabo</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Ochoa Fertilizer Co</ENT> <ENT>Guánica</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Papelera Puertorriquena, Inc</ENT> <ENT>Utuado.</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Pesticide Warehouse I</ENT> <ENT>Arecibo</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Pesticide Warehouse III</ENT> <ENT>Manati.</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>PROTECO</ENT> <ENT>Peñuelas</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>San German Ground Water Contamination</ENT> <ENT>San German</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Scorpio Recycling, Inc.</ENT> <ENT>Candeleria Ward</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>The Battery Recycling Company</ENT> <ENT>Bo. Cambalache</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Upjohn Facility</ENT> <ENT>Barceloneta</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Vega Alta Public Supply Wells</ENT> <ENT>Vega Alta</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Vega Baja Solid Waste Disposal</ENT> <ENT>Vega Baja</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Central Landfill</ENT> <ENT>Johnston</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Centredale Manor Restoration Project</ENT> <ENT>North Providence</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Davis Liquid Waste</ENT> <ENT>Smithfield</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Landfill & Resource Recovery, Inc. (L&RR)</ENT> <ENT>North Smithfield</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Peterson/Puritan, Inc</ENT> <ENT>Lincoln/Cumberland</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Picillo Farm</ENT> <ENT>Coventry</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Rose Hill Regional Landfill</ENT> <ENT>South Kingston</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Stamina Mills, Inc</ENT> <ENT>North Smithfield</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>West Kingston Town Dump/URI Disposal</ENT> <ENT>South Kingston</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Western Sand & Gravel</ENT> <ENT>Burrillville</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Aqua-Tech Environmental Inc (Groce Labs)</ENT> <ENT>Greer</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Barite Hill/Nevada Goldfields</ENT> <ENT>McCormick.</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Beaunit Corp. (Circular Knit & Dye)</ENT> <ENT>Fountain Inn</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Brewer Gold Mine</ENT> <ENT>Jefferson</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Burlington Industries Cheraw</ENT> <ENT>Cheraw</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Carolawn, Inc</ENT> <ENT>Fort Lawn</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Clearwater Finishing</ENT> <ENT>Clearwater</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Elmore Waste Disposal</ENT> <ENT>Greer</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Galey and Lord Plant</ENT> <ENT>Society Hill</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Helena Chemical Co Landfill</ENT> <ENT>Fairfax</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Kalama Specialty Chemicals</ENT> <ENT>Beaufort</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Koppers Co., Inc (Charleston Plant)</ENT> <ENT>Charleston</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Leonard Chemical Co., Inc</ENT> <ENT>Rock Hill</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Lexington County Landfill Area</ENT> <ENT>Cayce</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Macalloy Corporation</ENT> <ENT>North Charleston</ENT> <ENT>P</ENT> </ROW> <ROW> <PRTPAGE P="248"/> <ENT I="01">SC</ENT> <ENT>Medley Farm Drum Dump</ENT> <ENT>Gaffney</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Palmetto Wood Preserving</ENT> <ENT>Dixiana</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Para-Chem Southern, Inc</ENT> <ENT>Simpsonville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Rock Hill Chemical Co</ENT> <ENT>Rock Hill</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>SCRDI Bluff Road</ENT> <ENT>Columbia</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>SCRDI Dixiana</ENT> <ENT>Cayce</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Sangamo Weston</ENT> <ENT>Pickens</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Shuron Inc</ENT> <ENT>Barnwell</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Townsend Saw Chain Co. Superfund Site</ENT> <ENT>Pontiac</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>US Finishing/Cone Mills</ENT> <ENT>Greenville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Wamchem, Inc</ENT> <ENT>Burton</ENT> </ROW> <ROW> <ENT I="01">SD</ENT> <ENT>Gilt Edge Mine</ENT> <ENT>Lead</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Alamo Contaminated Ground Water</ENT> <ENT>Alamo</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>American Creosote Works, (Jackson Plant)</ENT> <ENT>Jackson</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Arlington Blending & Packaging</ENT> <ENT>Arlington</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Carrier Air Conditioning Co</ENT> <ENT>Collierville</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Clinch River Corporation</ENT> <ENT>Harriman</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Former Custom Cleaners</ENT> <ENT>Memphis</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Mallory Capacitor Co</ENT> <ENT>Waynesboro</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Murray-Ohio Dump</ENT> <ENT>Lawrenceburg</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>National Fireworks</ENT> <ENT>Cordova</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Ross Metals Inc</ENT> <ENT>Rossville</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Smalley-Piper</ENT> <ENT>Collierville</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Smokey Mountain Smelters</ENT> <ENT>Knox County.</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Southside Chattanooga Lead</ENT> <ENT>Chattanooga</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Velsicol Chemical Corp (Hardeman County)</ENT> <ENT>Toone</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Walker Machine Products, Inc.</ENT> <ENT>Collierville</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Wrigley Charcoal Plant</ENT> <ENT>Wrigley</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>ALCOA (Point Comfort)/Lavaca Bay</ENT> <ENT>Point Comfort</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Attebury Grain Storage Facility</ENT> <ENT>Happy.</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Bandera Road Ground Water Plume</ENT> <ENT>Leon Valley</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Brine Service Company</ENT> <ENT>Corpus Christi</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Circle Court Ground Water Plume</ENT> <ENT>Willow Park</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>City of Perryton Well No. 2</ENT> <ENT>Perryton</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Conroe Creosoting Company</ENT> <ENT>Conroe</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Crystal Chemical Co</ENT> <ENT>Houston</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Delfasco Forge</ENT> <ENT>Grand Prairie</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Donna Reservoir and Canal System</ENT> <ENT>Donna</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>East 67th Street Ground Water Plume</ENT> <ENT>Odessa</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Eldorado Chemical Co., Inc.</ENT> <ENT>Live Oak</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Falcon Refinery</ENT> <ENT>Ingleside</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>French, Ltd</ENT> <ENT>Crosby</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Garland Creosoting</ENT> <ENT>Longview</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Geneva Industries/Fuhrmann Energy</ENT> <ENT>Houston</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Gulfco Marine Maintenance</ENT> <ENT>Freeport.</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Hart Creosoting Company</ENT> <ENT>Jasper</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Highlands Acid Pit</ENT> <ENT>Highlands</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Highway 18 Ground Water</ENT> <ENT>Kermit</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Jasper Creosoting Company Inc</ENT> <ENT>Jasper County</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Jones Road Ground Water Plume</ENT> <ENT>Harris County</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Koppers Co Inc (Texarkana Plant)</ENT> <ENT>Texarkana</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Lane Plating Works, Inc</ENT> <ENT>Dallas</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Main Street Ground Water Plume</ENT> <ENT>Burnet</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Malone Service Company, Inc</ENT> <ENT>Texas City.</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Many Diversified Interests, Inc</ENT> <ENT>Houston</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Midessa Ground Water Plume</ENT> <ENT>Odessa</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Motco, Inc</ENT> <ENT>La Marque</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>North Cavalcade Street</ENT> <ENT>Houston</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Northwest Odessa Groundwater</ENT> <ENT>Odessa</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Odessa Chromium #1</ENT> <ENT>Odessa</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Patrick Bayou</ENT> <ENT>Deer Park</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Petro-Chemical Systems, (Turtle Bayou)</ENT> <ENT>Liberty County</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>RSR Corp</ENT> <ENT>Dallas</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Rockwool Industries Inc</ENT> <ENT>Bell County</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Sandy Beach Road Ground Water Plume</ENT> <ENT>Azle</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>San Jacinto River Waste Pits</ENT> <ENT>Harris County</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Sheridan Disposal Services</ENT> <ENT>Hempstead</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Sikes Disposal Pits</ENT> <ENT>Crosby</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Sol Lynn/Industrial Transformers</ENT> <ENT>Houston</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>South Cavalcade Street</ENT> <ENT>Houston</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Sprague Road Ground Water Plume</ENT> <ENT>Odessa</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Star Lake Canal</ENT> <ENT>Port Neches</ENT> </ROW> <ROW> <PRTPAGE P="249"/> <ENT I="01">TX</ENT> <ENT>State Road 114 Ground Water Plume</ENT> <ENT>Levelland</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Texarkana Wood Preserving Co</ENT> <ENT>Texarkana</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Tex-Tin Superfund</ENT> <ENT>Texas City, Galveston</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>United Creosoting Co</ENT> <ENT>Conroe</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>US Oil Recovery</ENT> <ENT>Pasadena</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Van der Horst USA Corporation</ENT> <ENT>Terrell</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>West County Road 112 Ground Water</ENT> <ENT>Midland</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Bountiful/Woods Cross 5th South PCE Plume</ENT> <ENT>Bountiful/Woods Cross</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Five Points PCE Plume</ENT> <ENT>Woods Cross/Bountiful</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Jacobs Smelters</ENT> <ENT>Tooele County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Portland Cement (Kiln Dust 2 & 3)</ENT> <ENT>Salt Lake City</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>U.S. Magnesium</ENT> <ENT>Tooele County.</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Utah Power & Light/American Barrel Co</ENT> <ENT>Salt Lake City</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Wasatch Chemical Co. (Lot 6)</ENT> <ENT>Salt Lake City</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Abex Corp</ENT> <ENT>Portsmouth</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Arrowhead Associates/Scovill Corp</ENT> <ENT>Montross</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Atlantic Wood Industries, Inc</ENT> <ENT>Portsmouth</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Avtex Fibers, Inc</ENT> <ENT>Front Royal</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Buckingham County Landfill</ENT> <ENT>Buckingham</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Chisman Creek</ENT> <ENT>York County</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Culpeper Wood Preservers, Inc</ENT> <ENT>Culpeper</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Former Nansemond Ordnance Depot</ENT> <ENT>Suffolk</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Greenwood Chemical Co</ENT> <ENT>Newtown</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>H & H Inc., Burn Pit</ENT> <ENT>Farrington</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Hidden Lane Landfill</ENT> <ENT>Sterling</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Kim-Stan Landfill</ENT> <ENT>Selma</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>L.A. Clarke & Son</ENT> <ENT>Spotsylvania County</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Peck Iron and Metal</ENT> <ENT>Portsmouth.</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Rentokil, Inc. (Virginia Wood Preserving Division)</ENT> <ENT>Richmond</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Saltville Waste Disposal Ponds</ENT> <ENT>Saltville</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Saunders Supply Co</ENT> <ENT>Chuckatuck</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>U.S. Titanium</ENT> <ENT>Piney River</ENT> </ROW> <ROW> <ENT I="01">VI</ENT> <ENT>Tutu Wellfield</ENT> <ENT>Tutu</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>BFI Sanitary Landfill (Rockingham)</ENT> <ENT>Rockingham</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Bennington Municipal Sanitary Landfill</ENT> <ENT>Bennington</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Burgess Brothers Landfill</ENT> <ENT>Woodford</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Commerce Street Plume</ENT> <ENT>Williston</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Elizabeth Mine</ENT> <ENT>Strafford.</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Ely Copper Mine</ENT> <ENT>Vershire</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Jard Company, Inc.</ENT> <ENT>Bennington</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Old Springfield Landfill</ENT> <ENT>Springfield</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Parker Sanitary Landfill</ENT> <ENT>Lyndon</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Pike Hill Copper Mine</ENT> <ENT>Corinth</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Pine Street Canal</ENT> <ENT>Burlington</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">VT</ENT> <ENT>Pownal Tannery</ENT> <ENT>Pownal</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Boomsnub/Airco</ENT> <ENT>Vancouver</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Bremerton Gasworks</ENT> <ENT>Bremerton</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Centralia Municipal Landfill</ENT> <ENT>Centralia</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Colbert Landfill</ENT> <ENT>Colbert</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Commencement Bay, Near Shore/Tide Flats</ENT> <ENT>Pierce County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Commencement Bay, South Tacoma Channel</ENT> <ENT>Tacoma</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>FMC Corp. (Yakima Pit)</ENT> <ENT>Yakima</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>General Electric Co. (Spokane Shop)</ENT> <ENT>Spokane</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Grain Handling Facility at Freeman</ENT> <ENT>Freeman</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Greenacres Landfill</ENT> <ENT>Spokane County</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Hamilton/Labree Roads Ground Water Contamination</ENT> <ENT>Chehalis</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Harbor Island (Lead)</ENT> <ENT>Seattle</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Hidden Valley Landfill (Thun Field)</ENT> <ENT>Pierce County</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Kaiser Aluminum Mead Works</ENT> <ENT>Mead</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Lakewood Site</ENT> <ENT>Lakewood</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Lockheed West Seattle</ENT> <ENT>Seattle</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Lower Duwamish Waterway</ENT> <ENT>Seattle</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Makah Reservation Warmhouse Beach Dump</ENT> <ENT>Neah Bay</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Mica Landfill</ENT> <ENT>Mica</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Midnite Mine</ENT> <ENT>Wellpinit.</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Midway Landfill</ENT> <ENT>Kent</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Moses Lake Wellfield Contamination</ENT> <ENT>Moses Lake</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>North Market Street</ENT> <ENT>Spokane</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Oeser Co.</ENT> <ENT>Bellingham</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Pacific Car & Foundry Co</ENT> <ENT>Renton</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Pacific Sound Resources</ENT> <ENT>Seattle</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Palermo Well Field Ground Water Contam</ENT> <ENT>Tumwater</ENT> </ROW> <ROW> <PRTPAGE P="250"/> <ENT I="01">WA</ENT> <ENT>Pasco Sanitary Landfill</ENT> <ENT>Pasco</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Queen City Farms</ENT> <ENT>Maple Valley</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Quendall Terminals</ENT> <ENT>Renton</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Seattle Municipal Landfill (Kent Hghlnds)</ENT> <ENT>Kent</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Upper Columbia River</ENT> <ENT>Upper Columbia River</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Western Processing Co., Inc</ENT> <ENT>Kent</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Wyckoff Co./Eagle Harbor</ENT> <ENT>Bainbridge Island</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Algoma Municipal Landfill</ENT> <ENT>Algoma</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Amcast Industrial Corporation</ENT> <ENT>Cedarburg</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Ashland/Northern States Power Lakefront</ENT> <ENT>Ashland</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Better Brite Plating Chrome & Zinc Shops</ENT> <ENT>DePere</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>City Disposal Corp. Landfill</ENT> <ENT>Dunn</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Delavan Municipal Well #4</ENT> <ENT>Delavan</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Hagen Farm</ENT> <ENT>Stoughton</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Hechimovich Sanitary Landfill</ENT> <ENT>Williamstown</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Hunts Disposal Landfill</ENT> <ENT>Caledonia</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Janesville Ash Beds</ENT> <ENT>Janesville</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Janesville Old Landfill</ENT> <ENT>Janesville</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Kohler Co. Landfill</ENT> <ENT>Kohler</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Lauer I Sanitary Landfill</ENT> <ENT>Menomonee Falls</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Lemberger Landfill, Inc</ENT> <ENT>Whitelaw</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Lemberger Transport & Recycling</ENT> <ENT>Franklin Township</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Madison Metropolitan Sewerage District</ENT> <ENT>Blooming Grove</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Master Disposal Service Landfill</ENT> <ENT>Brookfield</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Mid-State Disposal, Inc. Landfill</ENT> <ENT>Cleveland Township</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Moss-American(Kerr-McGee Oil Co.)</ENT> <ENT>Milwaukee</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Muskego Sanitary Landfill</ENT> <ENT>Muskego</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>N.W. Mauthe Co., Inc</ENT> <ENT>Appleton</ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>National Presto Industries, Inc</ENT> <ENT>Eau Claire</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Oconomowoc Electroplating Co. Inc</ENT> <ENT>Ashippin</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Onalaska Municipal Landfill</ENT> <ENT>Onalaska</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Penta Wood Products</ENT> <ENT>Daniels</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Refuse Hideaway Landfill</ENT> <ENT>Middleton</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Ripon City Landfill</ENT> <ENT>Ripon</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Sauk County Landfill</ENT> <ENT>Excelsior</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Schmalz Dump</ENT> <ENT>Harrison</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Sheboygan Harbor & River</ENT> <ENT>Sheboygan</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Spickler Landfill</ENT> <ENT>Spencer</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Stoughton City Landfill</ENT> <ENT>Stoughton</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Tomah Municipal Sanitary Landfill</ENT> <ENT>Tomah</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Unity Auto Mart</ENT> <ENT>Unity</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Waste Mgmt of WI (Brookfield Sanit LF)</ENT> <ENT>Brookfield</ENT> </ROW> <ROW> <ENT I="01">WI</ENT> <ENT>Wausau Ground Water Contamination</ENT> <ENT>Wausau</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Big John Salvage—Hoult Road</ENT> <ENT>Fairmont</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Fike Chemical, Inc</ENT> <ENT>Nitro</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Hanlin-Allied-Olin</ENT> <ENT>Moundsville</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>North 25th Street Glass and Zinc</ENT> <ENT>Clarksburg</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Paden City Groundwater</ENT> <ENT>Paden City</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Ravenswood PCE Ground Water Plume</ENT> <ENT>Ravenswood</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Shaffer Equipment/Arbuckle Creek Area</ENT> <ENT>Minden</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Sharon Steel Corp (Fairmont Coke Works)</ENT> <ENT>Fairmont</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Vienna Tetrachloroethene</ENT> <ENT>Vienna</ENT> </ROW> <TNOTE> <SU>a</SU>  A = Based on issuance of health advisory by Agency for Toxic Substances and Disease Registry (if scored, HRS score need not be greater than or equal to 28.50). </TNOTE> <TNOTE>S = State top priority (included among the 100 top priority sites regardless of score).</TNOTE> <TNOTE>P = Sites with partial deletion(s).</TNOTE> </GPOTABLE> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs48,r120,r60,xs36"> <TTITLE>Table 2—Federal Facilities Section</TTITLE> <BOXHD> <CHED H="1">St</CHED> <CHED H="1">Site name</CHED> <CHED H="1">City/County</CHED> <CHED H="1">Notes(a)</CHED> </BOXHD> <ROW> <ENT I="01">AK</ENT> <ENT>Adak Naval Air Station</ENT> <ENT>Adak</ENT> </ROW> <ROW> <ENT I="01">AK</ENT> <ENT>Eielson Air Force Base</ENT> <ENT>Fairbanks N Star Borough</ENT> </ROW> <ROW> <ENT I="01">AK</ENT> <ENT>Elmendorf Air Force Base</ENT> <ENT>Greater Anchorage Borough</ENT> </ROW> <ROW> <ENT I="01">AK</ENT> <ENT>Fort Richardson (USARMY)</ENT> <ENT>Anchorage</ENT> </ROW> <ROW> <ENT I="01">AK</ENT> <ENT>Fort Wainwright</ENT> <ENT>Fairbanks N Star Borough</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Alabama Army Ammunition Plant</ENT> <ENT>Childersburg</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Anniston Army Depot (SE Industrial Area)</ENT> <ENT>Anniston</ENT> </ROW> <ROW> <ENT I="01">AL</ENT> <ENT>Redstone Arsenal (USARMY/NASA)</ENT> <ENT>Huntsville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Williams Air Force Base</ENT> <ENT>Chandler</ENT> </ROW> <ROW> <ENT I="01">AZ</ENT> <ENT>Yuma Marine Corps Air Station</ENT> <ENT>Yuma</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Alameda Naval Air Station</ENT> <ENT>Alameda</ENT> </ROW> <ROW> <PRTPAGE P="251"/> <ENT I="01">CA</ENT> <ENT>Barstow Marine Corps Logistics Base</ENT> <ENT>Barstow</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Camp Pendleton Marine Corps Base</ENT> <ENT>San Diego County</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Castle Air Force Base</ENT> <ENT>Merced</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Concord Naval Weapons Station</ENT> <ENT>Concord</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Edwards Air Force Base</ENT> <ENT>Kern County</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>El Toro Marine Corps Air Station</ENT> <ENT>El Toro</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Fort Ord</ENT> <ENT>Marina</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>George Air Force Base</ENT> <ENT>Victorville</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Hunters Point Naval Shipyard</ENT> <ENT>San Francisco</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Jet Propulsion Laboratory (NASA)</ENT> <ENT>Pasadena</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>LEHR/Old Campus Landfill (USDOE)</ENT> <ENT>Davis</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Lawrence Livermore Lab Site 300 (USDOE)</ENT> <ENT>Livermore</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Lawrence Livermore Laboratory (USDOE)</ENT> <ENT>Livermore</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>March Air Force Base</ENT> <ENT>Riverside</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Mather Air Force Base</ENT> <ENT>Sacramento</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>McClellan Air Force Base (GW Contam)</ENT> <ENT>Sacramento</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Moffett Naval Air Station</ENT> <ENT>Sunnyvale</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Norton Air Force Base</ENT> <ENT>San Bernardino</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Riverbank Army Ammunition Plant</ENT> <ENT>Riverbank</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Sacramento Army Depot</ENT> <ENT>Sacramento</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Sharpe Army Depot</ENT> <ENT>Lathrop</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Tracy Defense Depot (USARMY)</ENT> <ENT>Tracy</ENT> </ROW> <ROW> <ENT I="01">CA</ENT> <ENT>Travis Air Force Base</ENT> <ENT>Solano County</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Air Force Plant PJKS</ENT> <ENT>Waterton</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Rocky Flats Plant (USDOE)</ENT> <ENT>Jefferson and Boulder Counties</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CO</ENT> <ENT>Rocky Mountain Arsenal (USARMY)</ENT> <ENT>Adams County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">CT</ENT> <ENT>New London Submarine Base</ENT> <ENT>New London</ENT> </ROW> <ROW> <ENT I="01">DC</ENT> <ENT>Washington Navy Yard</ENT> <ENT>Washington DC</ENT> </ROW> <ROW> <ENT I="01">DE</ENT> <ENT>Dover Air Force Base</ENT> <ENT>Dover</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Cecil Field Naval Air Station</ENT> <ENT>Jacksonville</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Homestead Air Force Base</ENT> <ENT>Homestead</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Jacksonville Naval Air Station</ENT> <ENT>Jacksonville</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Pensacola Naval Air Station</ENT> <ENT>Pensacola</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Tyndall Air Force Base</ENT> <ENT>Panama City</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">FL</ENT> <ENT>Whiting Field Naval Air Station</ENT> <ENT>Milton</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Marine Corps Logistics Base</ENT> <ENT>Albany</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">GA</ENT> <ENT>Robins Air Force Base(Lf#4/Sludge Lagoon</ENT> <ENT>Houston County</ENT> </ROW> <ROW> <ENT I="01">GU</ENT> <ENT>Andersen Air Force Base</ENT> <ENT>Yigo</ENT> </ROW> <ROW> <ENT I="01">HI</ENT> <ENT>Naval Computer & Telecommunications Area</ENT> <ENT>Oahu</ENT> </ROW> <ROW> <ENT I="01">HI</ENT> <ENT>Pearl Harbor Naval Complex</ENT> <ENT>Pearl Harbor</ENT> </ROW> <ROW> <ENT I="01">IA</ENT> <ENT>Iowa Army Ammunition Plant</ENT> <ENT>Middletown</ENT> </ROW> <ROW> <ENT I="01">ID</ENT> <ENT>Idaho National Engineering Lab (USDOE)</ENT> <ENT>Idaho Falls</ENT> </ROW> <ROW> <ENT I="01">ID</ENT> <ENT>Mountain Home Air Force Base</ENT> <ENT>Mountain Home</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Joliet Army Ammunition Plant (LAP Area)</ENT> <ENT>Joliet</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Joliet Army Ammunition Plant (Mfg Area)</ENT> <ENT>Joliet</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Sangamo Electric/Crab Orchard NWR (USDOI)</ENT> <ENT>Carterville</ENT> </ROW> <ROW> <ENT I="01">IL</ENT> <ENT>Savanna Army Depot Activity</ENT> <ENT>Savanna</ENT> </ROW> <ROW> <ENT I="01">KS</ENT> <ENT>Fort Riley</ENT> <ENT>Junction City</ENT> </ROW> <ROW> <ENT I="01">KY</ENT> <ENT>Paducah Gaseous Diffusion Plant (USDOE)</ENT> <ENT>Paducah</ENT> </ROW> <ROW> <ENT I="01">LA</ENT> <ENT>Louisiana Army Ammunition Plant</ENT> <ENT>Doyline</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Fort Devens</ENT> <ENT>Fort Devens</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Hanscom Field/Hanscom Air Force Base</ENT> <ENT>Bedford</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Natick Laboratory Army Research, D&E Cntr</ENT> <ENT>Natick</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Naval Weapons Industrial Reserve Plant</ENT> <ENT>Bedford</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>Otis Air National Guard Base/Camp Edwards</ENT> <ENT>Sandwich, Falmouth, Bourne, Mashpee</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MA</ENT> <ENT>South Weymouth Naval Air Station</ENT> <ENT>Weymouth</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Aberdeen Proving Ground (Edgewood Area)</ENT> <ENT>Edgewood</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Aberdeen Proving Ground (Michaelsville LF)</ENT> <ENT>Aberdeen</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Andrews Air Force Base</ENT> <ENT>Camp Springs</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Beltsville Agricultural Research (USDA)</ENT> <ENT>Beltsville</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Brandywine DRMO</ENT> <ENT>Brandywine</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Curtis Bay Coast Guard Yard</ENT> <ENT>Anne Arundel County</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Fort Detrick Area B Ground Water</ENT> <ENT>Frederick</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Fort George G. Meade</ENT> <ENT>Odenton</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Indian Head Naval Surface Warfare Center</ENT> <ENT>Indian Head</ENT> </ROW> <ROW> <ENT I="01">MD</ENT> <ENT>Patuxent River Naval Air Station</ENT> <ENT>St. Mary's County</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Brunswick Naval Air Station</ENT> <ENT>Brunswick</ENT> </ROW> <ROW> <ENT I="01">ME</ENT> <ENT>Loring Air Force Base</ENT> <ENT>Limestone</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>Naval Industrial Reserve Ordnance Plant</ENT> <ENT>Fridley</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">MN</ENT> <ENT>New Brighton/Arden Hills/TCAAP (USARMY)</ENT> <ENT>New Brighton</ENT> <ENT>P</ENT> </ROW> <ROW> <PRTPAGE P="252"/> <ENT I="01">MO</ENT> <ENT>Lake City Army Ammu. Plant (NW Lagoon)</ENT> <ENT>Independence</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Weldon Spring Former Army Ordnance Works</ENT> <ENT>St. Charles County</ENT> </ROW> <ROW> <ENT I="01">MO</ENT> <ENT>Weldon Spring Quarry/Plant/Pitts (USDOE)</ENT> <ENT>St. Charles County</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Camp Lejeune Military Res. (USNAVY)</ENT> <ENT>Onslow County</ENT> </ROW> <ROW> <ENT I="01">NC</ENT> <ENT>Cherry Point Marine Corps Air Station</ENT> <ENT>Havelock</ENT> </ROW> <ROW> <ENT I="01">NE</ENT> <ENT>Cornhusker Army Ammunition Plant</ENT> <ENT>Hall County</ENT> </ROW> <ROW> <ENT I="01">NH</ENT> <ENT>Pease Air Force Base</ENT> <ENT>Portsmouth/Newington</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Federal Aviation Admin. Tech. Center</ENT> <ENT>Atlantic County</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>McGuire Air Force Base #1</ENT> <ENT>Wrightstown</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Middlesex Sampling Plant (USDOE)</ENT> <ENT>Middlesex</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Naval Air Engineering Center</ENT> <ENT>Lakehurst</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Naval Weapons Station Earle (Site A)</ENT> <ENT>Colts Neck</ENT> </ROW> <ROW> <ENT I="01">NJ</ENT> <ENT>Picatinny Arsenal (USARMY)</ENT> <ENT>Rockaway Township</ENT> </ROW> <ROW> <ENT I="01">NM</ENT> <ENT>Lee Acres Landfill (USDOI)</ENT> <ENT>Farmington</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Brookhaven National Laboratory (USDOE)</ENT> <ENT>Upton</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Griffiss Air Force Base</ENT> <ENT>Rome</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Plattsburgh Air Force Base</ENT> <ENT>Plattsburgh</ENT> </ROW> <ROW> <ENT I="01">NY</ENT> <ENT>Seneca Army Depot</ENT> <ENT>Romulus</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Feed Materials Production Center (USDOE)</ENT> <ENT>Fernald</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Mound Plant (USDOE)</ENT> <ENT>Miamisburg</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">OH</ENT> <ENT>Wright-Patterson Air Force Base</ENT> <ENT>Dayton</ENT> </ROW> <ROW> <ENT I="01">OK</ENT> <ENT>Tinker Air Force (Soldier Cr/Bldg 300)</ENT> <ENT>Oklahoma City</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Bradford Island</ENT> <ENT>Cascade Locks</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Fremont Nat. Forest Uranium Mines (USDA)</ENT> <ENT>Lakeview</ENT> </ROW> <ROW> <ENT I="01">OR</ENT> <ENT>Umatilla Army Depot (Lagoons)</ENT> <ENT>Hermiston</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Letterkenny Army Depot (SE Area)</ENT> <ENT>Chambersburg</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Letterkenny Army Depot (PDO Area)</ENT> <ENT>Franklin County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Naval Air Development Center (8 Areas)</ENT> <ENT>Warminster Township</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Navy Ships Parts Control Center</ENT> <ENT>Mechanicsburg</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Tobyhanna Army Depot</ENT> <ENT>Tobyhanna</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">PA</ENT> <ENT>Willow Grove Naval Air & Air Res. Stn.</ENT> <ENT>Willow Grove</ENT> </ROW> <ROW> <ENT I="01">PR</ENT> <ENT>Atlantic Fleet Weapons Training Area—Vieques</ENT> <ENT> Island of Vieques <SU>1</SU> </ENT> <ENT>S</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Davisville Naval Construction Batt Cent</ENT> <ENT>North Kingston</ENT> </ROW> <ROW> <ENT I="01">RI</ENT> <ENT>Newport Naval Education/Training Center</ENT> <ENT>Newport</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Parris Island Marine Corps Recruit Depot</ENT> <ENT>Parris Island</ENT> </ROW> <ROW> <ENT I="01">SC</ENT> <ENT>Savannah River Site (USDOE)</ENT> <ENT>Aiken</ENT> </ROW> <ROW> <ENT I="01">SD</ENT> <ENT>Ellsworth Air Force Base</ENT> <ENT>Rapid City</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Memphis Defense Depot (DLA)</ENT> <ENT>Memphis</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Milan Army Ammunition Plant</ENT> <ENT>Milan</ENT> </ROW> <ROW> <ENT I="01">TN</ENT> <ENT>Oak Ridge Reservation (USDOE)</ENT> <ENT>Oak Ridge</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Air Force Plant #4 (General Dynamics)</ENT> <ENT>Fort Worth</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Lone Star Army Ammunition Plant</ENT> <ENT>Texarkana</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Longhorn Army Ammunition Plant</ENT> <ENT>Karnack</ENT> </ROW> <ROW> <ENT I="01">TX</ENT> <ENT>Pantex Plant (USDOE)</ENT> <ENT>Pantex Village</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>700 South 1600 East PCE Plume</ENT> <ENT>Salt Lake City</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Hill Air Force Base</ENT> <ENT>Ogden</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Monticello Mill Tailings (USDOE)</ENT> <ENT>Monticello</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Ogden Defense Depot (DLA)</ENT> <ENT>Ogden</ENT> </ROW> <ROW> <ENT I="01">UT</ENT> <ENT>Tooele Army Depot (North Area)</ENT> <ENT>Tooele</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Defense General Supply Center (DLA)</ENT> <ENT>Chesterfield County</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Fort Eustis (US Army)</ENT> <ENT>Newport News</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Langley Air Force Base/NASA Langley Cntr</ENT> <ENT>Hampton</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Marine Corps Combat Development Command</ENT> <ENT>Quantico</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Naval Amphibious Base Little Creek</ENT> <ENT>Virginia Beach</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Naval Surface Warfare—Dahlgren</ENT> <ENT>Dahlgren</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Naval Weapons Station—Yorktown</ENT> <ENT>Yorktown</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Naval Weapons Station Yorktown—Cheatham Annex</ENT> <ENT>Williamsburg</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Norfolk Naval Base (Sewells Pt Nvl Cmpx)</ENT> <ENT>Norfolk</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>Norfolk Naval Shipyard</ENT> <ENT>Portsmouth</ENT> </ROW> <ROW> <ENT I="01">VA</ENT> <ENT>St. Juliens Creek Annex (U.S. Navy)</ENT> <ENT>Chesapeake</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>American Lake Gardens/McChord AFB</ENT> <ENT>Tacoma</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Bangor Naval Submarine Base</ENT> <ENT>Silverdale</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Bangor Ordnance Disposal (USNAVY)</ENT> <ENT>Bremerton</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Fairchild Air Force Base (4 Waste Areas)</ENT> <ENT>Spokane County</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Fort Lewis Logistics Center</ENT> <ENT>Tillicum</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Hanford 100-Area (USDOE)</ENT> <ENT>Benton County</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Hanford 200-Area (USDOE)</ENT> <ENT>Benton County</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Hanford 300-Area (USDOE)</ENT> <ENT>Benton County</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Jackson Park Housing Complex (USNAVY)</ENT> <ENT>Kitsap County</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Naval Air Station, Whidbey Island (Ault)</ENT> <ENT>Whidbey Island</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Naval Undersea Warfare Station (4 Areas)</ENT> <ENT>Keyport</ENT> </ROW> <ROW> <ENT I="01">WA</ENT> <ENT>Old Navy Dump/Manchester Lab (USEPA/NOAA)</ENT> <ENT>Manchester</ENT> </ROW> <ROW> <PRTPAGE P="253"/> <ENT I="01">WA</ENT> <ENT>Puget Sound Naval Shipyard Complex</ENT> <ENT>Bremerton</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>Allegany Ballistics Laboratory (USNAVY)</ENT> <ENT>Mineral</ENT> </ROW> <ROW> <ENT I="01">WV</ENT> <ENT>West Virginia Ordnance (USARMY)</ENT> <ENT>Point Pleasant</ENT> <ENT>P</ENT> </ROW> <ROW> <ENT I="01">WY</ENT> <ENT>F.E. Warren Air Force Base</ENT> <ENT>Cheyenne</ENT> </ROW> <TNOTE> <SU>1</SU>  Only the Vieques portions of the AFWTA are included in appendix B to Part 300, the National Priorities List. The Culebra portions of the AFWTA (that were included in the NPL proposal AFWTA on August 13, 2004) are not included at this time due to ongoing negotiations between the Commonwealth of Puerto Rico and the Department of the Army. </TNOTE> <TNOTE> <E T="03">Notes:</E> </TNOTE> <TNOTE> <SU>(a)</SU>  A = Based on issuance of health advisory by Agency for Toxic Substances and Disease Registry (if scored, HRS score need not be greater than or equal to 28.50). </TNOTE> <TNOTE>S = State top priority (included among the 100 top priority sites regardless of score).</TNOTE> <TNOTE>P = Sites with partial deletion(s).</TNOTE> </GPOTABLE> <CITA>[62 FR 15576, Apr. 1, 1997]</CITA> <EDNOTE> <HD SOURCE="HED">Editorial Note:</HD> <P> For <E T="04">Federal Register</E> citations affecting part 300, appendix B, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at <E T="03">www.govinfo.gov.</E> </P> </EDNOTE> </APPENDIX> <APPENDIX> <EAR>Pt. 300, App. C</EAR> <HD SOURCE="HED">Appendix C to Part 300—Requirements for Product Testing Protocols and Summary Test Data: Dispersant Baffled Flask Efficacy and Toxicity Tests; Standard Acute Toxicity Test for Bioremediation Agents, Surface Washing Agents, Herding Agents, and Solidifiers; and Bioremediation Agent Efficacy Test</HD> <HD SOURCE="HD1">Table of Contents</HD> <FP SOURCE="FP-2">1.0 Applicability and Scope</FP> <FP SOURCE="FP-2">2.0 Baffled Flask Dispersant Efficacy Test (BFT)</FP> <FP SOURCE="FP-2">3.0 Dispersant Toxicity Testing</FP> <FP SOURCE="FP-2">4.0 Standard Acute Toxicity Testing for Surface Washing Agents, Bioremediation Agents, Herding Agents, and Solidifiers</FP> <FP SOURCE="FP-2">5.0 Bioremediation Agent Efficacy Test Protocol</FP> <HD SOURCE="HD1">Illustrations</HD> <HD SOURCE="HD2">Figure Number</HD> <FP SOURCE="FP-2">1. A Baffled Trypsinizing Flask</FP> <HD SOURCE="HD1">Tables</HD> <HD SOURCE="HD2">Table Number</HD> <FP SOURCE="FP-2">1. Constituent Concentrations for GP2 Artificial Seawater</FP> <FP SOURCE="FP-2">2. Test Oil Characteristics</FP> <FP SOURCE="FP-2">3. Stock Standard Solution Preparation</FP> <FP SOURCE="FP-2">4. Dispersant Calibration Example for Test Oil</FP> <FP SOURCE="FP-2">5. Sample Calculation With ANS</FP> <FP SOURCE="FP-2">6. Toxicity Testing Requirements for Dispersants</FP> <FP SOURCE="FP-2">7. Summary of Test Conditions—Dispersant Toxicity</FP> <FP SOURCE="FP-2">8. Toxicity Testing Requirements for Surface Washing Agents, Herding Agents, Bioremediation Agents and Solidifiers</FP> <FP SOURCE="FP-2">9. Summary of Test Conditions—Surface Washing Agents, Herding Agents, Bioremediation Agents and Solidifiers Toxicity</FP> <FP SOURCE="FP-2">10. Artificial Seawater Nutrient Concentrations</FP> <FP SOURCE="FP-2">11. Artificial Seawater Nutrient Concentrations for Bioremediation Agents Having No Nutrients Included</FP> <FP SOURCE="FP-2">12. Constituent Concentrations for Artificial Freshwater (Bushnell-Haas)</FP> <FP SOURCE="FP-2">13. Freshwater Nutrient Concentrations</FP> <FP SOURCE="FP-2">14. Artificial Freshwater Nutrient Concentration for Bioremediation Agents Having No Nutrients Included</FP> <FP SOURCE="FP-2">15. Bioremediation Efficacy Test—Summary of Experimental Setup</FP> <FP SOURCE="FP-2">16. Bioremediation Efficacy—Summary of Analytical Procedures</FP> <FP SOURCE="FP-2">17. QA/QC Checks</FP> <HD SOURCE="HD1">Standard Operating Procedures Tables</HD> <FP SOURCE="FP-1">SOP 3-1 Amount of Stock Solutions Required To Make the Working Standards</FP> <FP SOURCE="FP-1">SOP 4-1 Ions Associated With Retention Time Groups</FP> <FP SOURCE="FP-1">SOP 4-2 Instrumental Conditions for Crude Oil Analysis</FP> <FP SOURCE="FP-1">SOP 4-3 Ion Abundance Criteria for DFTPP</FP> <FP SOURCE="FP-1">SOP 4-4 Target Compound List</FP> <P> 1.0  <E T="03">Applicability and Scope.</E> This Appendix establishes laboratory protocols required under Subpart J (Use of Dispersants and Other Chemical and Biological Agents) of 40 CFR part 300 (National Oil and Hazardous Substances Pollution Contingency Plan) to make listing determinations for the Product Schedule. The protocols apply, based on product type, to dispersants, bioremediation agents, surface washing agents, herding agents, and solidifiers as defined in Subpart A (Introduction) of 40 CFR part 300. </P> <P> 2.0  <E T="03">Baffled Flask Dispersant Efficacy Test (BFT)</E> <PRTPAGE P="254"/> </P> <P> 2.1  <E T="03">Summary.</E> This laboratory protocol establishes procedures to evaluate the degree to which a product effectively disperses oil spilled on the surface of seawater, using a modified 150-mL screw-cap trypsinizing flask (an Erlenmeyer flask with baffles) with a glass and Teflon® stopcock near the bottom to allow removal of subsurface water samples without disturbing the surface oil layer. The efficacy of a dispersant is measured using one reference oil, Strategic Petroleum Oil Reserve Bryan Mound at two temperatures (5 °C and 25 °C). Six replicates and one method blank are required at each temperature. A layer of oil is placed on the surface of artificial seawater, and the dispersant is added to the slick at a dispersant:oil ratio (DOR) of 1:25 (4%) by volume. A standard orbital shaker table provides turbulent mixing at a speed of 250 revolutions per minute (rpm) for 10 minutes, immediately after which it is maintained stationary for 10 minutes to allow non-dispersed oil to rise to the water's surface. An undisturbed water sample is removed from the bottom of the flask through the stopcock, extracted with dichloromethane (DCM), and analyzed for oil content by UV-visible absorption spectrophotometry at wavelengths ranging between 340 and 400 nm. </P> <P> 2.2  <E T="03">Apparatus.</E> All equipment must be maintained and calibrated per standard laboratory procedures. </P> <P> 2.2.1  <E T="03">Modified Trypsinizing Flask.</E> A modified 150 mL glass screw-capped Erlenmeyer flasks with baffles ( <E T="03">e.g.,</E> Wheaton No. 355394 or equivalent) fitted with a 2 mm bore Teflon® stopcock and glass tubing, the center of which is no more than 1.3 cm from the bottom, as shown in Figure 1. </P> <GPH SPAN="2" DEEP="406"> <PRTPAGE P="255"/> <GID>ER12JN23.078</GID> </GPH> <HD SOURCE="HD1">Figure 1. A Baffled Trypsinizing Flask</HD> <P> 2.2.2  <E T="03">Orbital Shaker Table.</E> An orbital shaker table with a variable speed control unit capable of maintaining 250 rpm. The orbital diameter must be approximately 1.0 inch (2.5 cm) ±0.1 inch (0.25 cm). </P> <P> 2.2.3  <E T="03">Spectrophotometer.</E> A UV-visible spectrophotometer capable of measuring absorbance between 340 and 400 nm ( <E T="03">e.g.,</E> Shimadzu UV-1800, Agilent 8453, or equivalent). Use standard transmission-matched quartz 10-mm path length rectangular cells with PTFE cover for absorbance measurements. </P> <P> 2.2.4  <E T="03">Glassware.</E> Including: 25-ml graduated mixing cylinders (a graduated cylinder with a ground glass stopper); 50- and 100-ml graduated cylinders; 125-mL separatory funnels with Teflon stopcocks; 10-ml volumetric flasks; 30-ml crimp style glass serum bottles; 1-, 2-, 5-mL pipettes; other miscellaneous laboratory items. </P> <P> 2.2.5  <E T="03">Micropipettor.</E> Use a micropipettor capable of dispensing 4 µL of dispersant and 100 <PRTPAGE P="256"/> µL of oil ( <E T="03">e.g.,</E> Brinkmann Eppendorf repeater pipettor with 100 µL and 5 mL syringe tip attachments or equivalent). </P> <P> 2.2.6  <E T="03">Syringes.</E> 25-, 100-, 250-, 1,000-, 2,500-, 5,000-µl gas-tight syringes. </P> <P> 2.2.7  <E T="03">Constant temperature rooms or incubators to hold the shaker at</E> 5 °C and 25 °C. </P> <P> 2.2.8  <E T="03">Analytical Balance.</E> </P> <P> 2.2.9  <E T="03">Chemical fume hood.</E> </P> <P> 2.3  <E T="03">Reagents.</E> </P> <P> 2.3.1  <E T="03">Artificial seawater.</E> Use the artificial seawater GP2 formulation shown in Table 1 of this Appendix. </P> <P> 2.3.2  <E T="03">Test oil.</E> Use the EPA standard reference oil Strategic Petroleum Reserve Bryan Mound. To obtain this oil at no charge (except for a minimal shipping fee), see the instructions at <E T="03">http://www.epa.gov/emergencies/content/ncp/index.htm.</E> Selected properties are summarized in Table 2 of this Appendix. </P> <P> 2.3.3  <E T="03">Dichloromethane (DCM) (also known as methylene chloride), pesticide quality.</E> </P> <P> 2.4  <E T="03">Container Handling and Storage.</E> </P> <P> 2.4.1  <E T="03">Glassware.</E> If the glassware has been used with oil before, rinse with DCM to remove as much of the oil adhering to the sides of the flask as possible; waste DCM may be used. Soak in warm water with detergent and individually wash with bristled brushes. First rinse with tap water, then follow with two de-ionized water rinses. Dry either on a rack or in a 110 °C drying oven. After drying, rinse with fresh DCM (use sparingly). </P> <P> 2.4.2  <E T="03">Serum bottles and other non-volumetric glassware.</E> Bake for at least 4 hours in a muffle furnace at 450 °C. </P> <P> 2.5  <E T="03">Calibration Curve for the UV-visible spectrophotometer.</E> </P> <P> 2.5.1  <E T="03">Stock Standard Solution Preparation.</E> Stock standard solution concentrations are based on the mass measurements after each addition and density determinations of the oil/dispersant/DCM solution using a density bottle or a 1-mL gas tight syringe. An example calculation is given in Table 3 of this Appendix according to the following equation: </P> <GPH SPAN="2" DEEP="17"> <GID>ER28JN23.004</GID> </GPH> <P>Use the reference oil and the specific dispersant being tested for a particular set of experimental test runs. Prepare the stock standard solution of dispersant-oil mixture in DCM, starting with 2 ml of the oil, then adding 80 µl of the dispersant followed by 18 ml of DCM.</P> <P> 2.5.2 Six <E T="03">-point Calibration Curve.</E> For the reference oil, add specific volumes of its stock standard solution (given in Table 4 of this Appendix) to 30 ml of artificial seawater in a 125 ml separatory funnel. Extract the oil/dispersant water mixture with triplicate 5 ml volumes of DCM. Follow each DCM addition by 15 seconds of vigorous shaking, carefully releasing the initial pressure inside the separatory funnel by partially removing the glass stopper inside a fume hood after the first few shakes. Then, allow a 2-minute stationary period for phase separation for each extraction. Drain the extracts into a 25-mL graduated mixing cylinder. Release any entrained bubbles of DCM from the water layer by sideways shaking of the funnel. Use precaution not to drain water into the DCM extract as it can affect the absorbance readings. Adjust the final volume of the collected extracts to 25 mL in the mixing cylinder using DCM. Determine specific masses for oil concentrations in the standards as volumes of oil/dispersant solution multiplied by the concentration of the stock solution. An example calculation is given in Table 4 of this Appendix. One calibration curve is needed for the reference oil and dispersant combination. </P> <P> 2.6  <E T="03">Sample Preparation and Testing.</E> See section 2.7 of this Appendix for a detailed description of the spectrophotometer's linear calibration procedure. </P> <P>2.6.1 Six replicates of the oil and test dispersant are required at each temperature plus two additional tests of method blanks (artificial seawater without oil and dispersant), one at each temperature. A completed test consists of 14 baffled flask tests (a total of six replicates for the reference oil/test dispersant combination at two temperatures (5 °C and 25 °C), plus two method blanks).</P> <P>2.6.2 Attach a 3-inch length of Teflon tubing to the stopcock of each of the 150-mL baffled flasks. Add 120 mL of artificial seawater to each flask. Put screw cap on flasks and place them at the appropriate temperature (either 5 °C or 25 °C) for equilibration.</P> <P>2.6.3 Calibrate and adjust the shaker table to 250 ± 10 rpm.</P> <P> 2.6.4 Prepare and time separately each baffled flask. Sequentially add 100 µL of oil and 4 µL of dispersant to the flask layering them onto the center of the seawater to give a dispersant-to-oil ratio (DOR) of 1:25. Avoid any oil or dispersant splashing on the flask walls, as it may reduce efficacy or cause errors in the calculated results. Discard the sample and repeat the setup if: (1) any oil or dispersant splashing occurs during the additions, or (2) the dispersant contacts the <PRTPAGE P="257"/> water first rather than the oil. This is especially important for 5 °C work because of increased oil viscosity. </P> <P>2.6.5 For the oil, fill the tip of the pipettor, using a wipe to remove any oil from the sides of the tip. Holding the pipettor vertically, dispense several times back into the reservoir to ensure that the oil flows smoothly. Insert the syringe tip vertically into the baffled flask and let the bottom of the pipettor rest on the neck of the flask. Slowly and carefully dispense the oil one time onto the center of the water's surface. The remainder of the oil can either be returned to the oil bottle or set aside for use in the next test flask.</P> <P> <E T="04">Note to 2.6.5:</E> If a Brinkmann Eppendorf repeater pipettor is used for dispensing the oil, attach a 5-mL syringe tip, and set the dial to 1. </P> <P>2.6.6 For the dispersant, use the same procedure as for the oil to dispense onto the center of the oil slick surface. As the dispersant first contacts the oil, it will usually push the oil to the sides of the flask. Replace the screw cap onto the flask.</P> <P> <E T="04">Note to 2.6.6:</E> If a Brinkmann Eppendorf repeater pipettor is used for dispensing the dispersant, attach a 100-µL syringe tip, and set the dial to 2. </P> <P>2.6.7 Carefully place flask securely onto the shaker and agitate for 10 ± 0.25 minutes at 250 ± 10 rpm.</P> <P>2.6.8 Remove the flask from the shaker table and allow a stationary, quiescent period of 10 ± 0.25 minutes to allow undispersed and/or recoalesced oil droplets to refloat to the surface.</P> <P>2.6.9 Carefully open the screw cap, then the stopcock at the bottom, and discard the first several mL of seawater into a waste beaker to remove non-mixed water-oil initially trapped in the stopcock tubing. Collect a volume slightly greater than 30-mL into a 50-mL graduated cylinder. Adjust the collected volume to the 30-mL mark by removing excess with a disposable glass Pasteur pipette. A web-like emulsion may form at the solvent/water interface during the water sample extraction. Avoid pulling any emulsion phase into the DCM extract as it may cloud the DCM-extract, leading to error.</P> <P>2.6.10 Transfer the water-oil sample from the graduated cylinder into a 125-mL glass separatory funnel fitted with a Teflon stopcock.</P> <P>2.6.11 Add 5 mL DCM to the separatory funnel. Start shaking, releasing pressure into the fume hood by loosening the glass stopper. Shake vigorously at least 20 times for 15 seconds.</P> <P>2.6.12 Allow the funnel to remain in a stationary position for 2 minutes to allow phase separation of the water and DCM.</P> <P>2.6.13 Drain the DCM layer from the separatory funnel into a 25 mL mixing cylinder. Avoid pulling any emulsion phase into the DCM extract as it may cloud the DCM extract.</P> <P>2.6.14 Repeat the DCM-extraction process two or three additional times until the DCM is clear. Collect each extract in the graduated cylinder. After the final extraction, lightly shake the separatory funnel sideways once or twice to dislodge entrained bubbles of DCM and drain.</P> <P>2.6.15 Adjust the final volume to a known quantity, 25 mL, in the mixing cylinder. Using a syringe, dispense 2.5 mL or 5.0 mL of a reference oil sample into a 10-mL volumetric flask, and fill with DCM to make either a 1:4 or 1:2 dilution, respectively.</P> <P>2.6.16 If analysis cannot be conducted immediately, store the extracted DCM samples at 4 ± 2 °C until time of analysis. Glass-stoppered mixing cylinders may be used for short-term storage or prior to bringing the extracts up to volume. After bringing to volume, transfer the DCM extracts to 25-30 ml crimp-style serum vials with aluminum/Teflon seals.</P> <P>2.6.17 Complete all analysis within 10 consecutive days from when the sample was collected.</P> <P> 2.7  <E T="03">UV-Visible Spectrophotometer Linear Stability Calibration</E> </P> <P>2.7.1 A six-point calibration of the UV-visible spectrophotometer is required at least once per day for each oil. The stability calibration criterion is determined with the six oil standards identified in Table 4 of this Appendix.</P> <P>2.7.2 Turn on spectrophotometer and allow it to warm up for at least 30 minutes before beginning analysis. Blank the instrument for the wavelengths between 340 and 400 nm with DCM.</P> <P>2.7.3 If refrigerated, allow all extracts, standards, and samples to warm to room temperature.</P> <P>2.7.4 Determine the absorbance of the six standards between the wavelengths of 340 and 400 nm. This can be done by either one of the following methods:</P> <P> 2.7.4.1  <E T="03">Trapezoidal Rule.</E> Program the spectrophotometer to take readings every 5λ or 10λ and calculate the area under the curve using the Trapezoidal rule: </P> <GPH SPAN="2" DEEP="17"> <GID>ER28JN23.005</GID> </GPH> <PRTPAGE P="258"/> <FP>where N + 1 = number of absorbance measurements to delineate N equally spaced sections of the curve, and H = the distance (λ) between each reading. For H = 5, N + 1 = 13 measurements, for H = 10, N + 1 = 7. The following formula illustrates readings taken every 10λ.</FP> <GPH SPAN="2" DEEP="15"> <GID>ER28JN23.006</GID> </GPH> <P>When using readings taken every 5λ, each absorbance sum is multiplied by 5.</P> <P> 2.7.4.2 Automatic <E T="03">Integration.</E> Program the spectrophotometer to automatically integrate the area under the curve between 340 nm and 400 nm. </P> <P>2.7.4.3 If the wavelengths must be manually set on the spectrophotometer, the older method of only measuring at 340λ, 370λ, and 400λ may be used. Then calculate using the trapezoidal rule for N + 1 = 3, H = 30. While the resulting area count with the older method is less accurate, the final results are similar since the inaccuracy is systematic.</P> <P>2.7.5 After determining the area count for each standard, determine the response factor (RF) for the oil at each concentration using the following equation:</P> <GPH SPAN="2" DEEP="24"> <GID>ER28JN23.007</GID> </GPH> <P>2.7.6 Spectrophotometer stability for the initial calibration is acceptable when the RFs of the six standard extracts are less than 10% different from the overall mean value for the six standards, as calculated in Equation 5 of this Appendix and depicted in the example in Table 4 of this Appendix.</P> <GPH SPAN="2" DEEP="19"> <GID>ER28JN23.008</GID> </GPH> <P> 2.7.7 If this criterion is satisfied, begin analysis of sample extracts. Absorbances greater than or equal to 3.5 are not included because absorbance saturation occurs at and above this value. If any of the standard oil extracts fails to satisfy the initial-stability criterion, the source of the problem ( <E T="03">e.g.,</E> preparation protocol for the oil standards, spectrophotometer stability, etc.) must be corrected before analysis of the sample extracts begins. </P> <P>2.7.8 Determine the slope of the calibration points by using linear regression forced zero intercept:</P> <GPH SPAN="2" DEEP="09"> <GID>ER28JN23.009</GID> </GPH> <P> 2.8 Spectrophotometric <E T="03">Analysis and Calculations</E> </P> <P>2.8.1 Once a successful calibration curve for the reference oil has been created and verified, measure experimental replicates for the reference oil at each temperature followed by a standard check sample.</P> <P>2.8.2 Determine the area for the absorbance values obtained for the experimental samples by using Equation 2 of this Appendix and illustrated by Equation 3 of this Appendix.</P> <P>2.8.3 Calculate the Total Oil dispersed and the percentage of oil dispersed (%OD) based on the ratio of oil dispersed in the test system to the total oil added to the system, as follows:</P> <GPH SPAN="2" DEEP="17"> <PRTPAGE P="259"/> <GID>ER28JN23.010</GID> </GPH> <FP SOURCE="FP-2">where:</FP> <FP SOURCE="FP-2"> V <E T="52">DCM</E> = final volume of the DCM extract (mL) </FP> <FP SOURCE="FP-2"> V <E T="52">tw</E> = total seawater in Baffled Flask (120 mL) </FP> <FP SOURCE="FP-2"> V <E T="52">ew</E> = volume seawater extracted (30 mL) </FP> <GPH SPAN="2" DEEP="20"> <GID>ER28JN23.011</GID> </GPH> <FP SOURCE="FP-2">where:</FP> <FP SOURCE="FP-2"> r <E T="52">Oil</E> = density of the specific test oil, mg/mL and </FP> <FP SOURCE="FP-2"> V <E T="52">Oil</E> = Volume (mL of oil added to test flask (100 µL = 0.1 mL)) </FP> <P> 2.8.4 The %ODs for the six replicates within a particular treatment are then subjected to an outlier test, the Grubb's Test or Maximum Normal Residual test (6). A convenient internet-based calculator of a Grubbs outlier may be found at: <E T="03">http://www.graphpad.com/quickcalcs/Grubbs1.cfm.</E> If an outlier is detected (p < 0.05), analyze an additional replicate to obtain the required six replicates. </P> <P> 2.8.5 Report the Dispersion Efficacy value for each oil and each temperature, which is the lower 95% confidence level of the 6 independent replicates (DE <E T="52">LCL95</E> ) for each oil/temperature combination. Error bars are not needed as reporting the lower confidence level computationally takes the variability of the replicates into account as shown in Equation 9 of this Appendix. </P> <GPH SPAN="2" DEEP="19"> <GID>ER28JN23.012</GID> </GPH> <FP>where (%OD)</FP> > <P> (%OD) = mean percentage oil dispersed for the n = 6 replicates, S = standard deviation, and t <E T="52">(n-1,1-</E> <E T="7334">α</E> <E T="52">)</E> = 100 * (1-α)th percentile from the t-distribution with n-1 degrees of freedom. For 6 replicates, t <E T="52">n-1,1-</E> <E T="7334">α</E> = 2.015, where α = 0.05. An example of the calculations is given in Table 5 of this Appendix. </P> <P> 2.9  <E T="03">Performance Criterion</E> </P> <P> The dispersant product tested will remain in consideration for listing on the NCP Product Schedule if the dispersant efficacy (DE <E T="52">LCL95</E> ), as calculated in section 2.8.6 of this Appendix, is: </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s50,5,7"> <BOXHD> <CHED H="1">Oil</CHED> <CHED H="1"> Temp <LI>( °C)</LI> </CHED> <CHED H="1"> DE <E T="0732">LCL95</E> <LI>(%)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Bryan Mound</ENT> <ENT>5</ENT> <ENT>≥70</ENT> </ROW> <ROW> <ENT I="01">Bryan Mound</ENT> <ENT>25</ENT> <ENT>≥75</ENT> </ROW> </GPOTABLE> <P> 2.10  <E T="03">Quality Control (QC) Procedures for Oil Concentration Measurements</E> </P> <P> 2.10.1  <E T="03">Absorbance readings.</E> Perform at least 5% of all UV-visible spectrophotometric measurements in duplicate as a QC check on the analytical measurement method. The absorbance values for the duplicates must agree within ±5% of their mean value. </P> <P> 2.10.2  <E T="03">Method blanks.</E> Analytical method blanks involve an analysis of artificial seawater blanks (artificial seawater without oil or dispersant in a baffled flask) through testing and analytical procedures. Analyze method blanks with a frequency of at least two per completed test. Oil concentrations in method blanks must be less than detectable limits. </P> <P> 2.10.3  <E T="03">Accuracy.</E> Determine accuracy by using a mid-point standard calibration check after each set of replicate samples analyzed. The acceptance criterion is based on a percent recovery of 90-110% using the following equation: </P> <GPH SPAN="2" DEEP="19"> <GID>ER28JN23.013</GID> </GPH> <PRTPAGE P="260"/> <P> 2.10.4 Calibration <E T="03">QC checks.</E> Before analyzing samples, the spectrophotometer must meet an instrument stability calibration criterion using the oil standards. The instrument stability for initial calibration is acceptable when the RFs (Equation 5 of this Appendix) for each of the six standard concentration levels are less than 10% different from the overall mean value. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,15"> <TTITLE>Table 1—Constituent Concentrations for GP2 Artificial Seawater</TTITLE> <TDESC>[Based on Spotte et al., 1984]</TDESC> <BOXHD> <CHED H="1">Constituent</CHED> <CHED H="1"> Concentration <LI>(g/L)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">NaCl</ENT> <ENT>21.03</ENT> </ROW> <ROW> <ENT I="01"> Na <E T="0732">2</E> SO <E T="0732">4</E> </ENT> <ENT>3.52</ENT> </ROW> <ROW> <ENT I="01">KCl</ENT> <ENT>0.61</ENT> </ROW> <ROW> <ENT I="01">KBr *</ENT> <ENT>0.088</ENT> </ROW> <ROW> <ENT I="01"> Na <E T="0732">2</E> B <E T="0732">4</E> O <E T="0732">7</E> × 10H <E T="0732">2</E> O * </ENT> <ENT>0.034</ENT> </ROW> <ROW> <ENT I="01"> MgCl <E T="0732">2</E> × 6H <E T="0732">2</E> O </ENT> <ENT>9.50</ENT> </ROW> <ROW> <ENT I="01"> CaCl <E T="0732">2</E> × 2H <E T="0732">2</E> O </ENT> <ENT>1.32</ENT> </ROW> <ROW> <ENT I="01"> SrCl <E T="0732">2</E> × 6H <E T="0732">2</E> O * </ENT> <ENT>0.02</ENT> </ROW> <ROW> <ENT I="01"> NaHCO <E T="0732">2</E>  * </ENT> <ENT>0.17</ENT> </ROW> <TNOTE>* Use Stock Solution, 1 mL/L GP2 for 100X stock solution for Bromide, Borate, and Strontium. 10 mL/L GP2 for bicarbonate—10X stock solution as it is not soluble in a 100X solution. Adjust to pH 8.0 prior to autoclaving.</TNOTE> </GPOTABLE> <GPOTABLE COLS="5" OPTS="L2" CDEF="s50,14,14,14,xs60"> <TTITLE>Table 2—Test Oil Characteristics</TTITLE> <TDESC>[April 2023 oil assay]</TDESC> <BOXHD> <CHED H="1">Oil</CHED> <CHED H="1"> Density, mg/mL <LI>@15 °C</LI> </CHED> <CHED H="1"> API gravity <LI>@15 °C</LI> </CHED> <CHED H="1"> Viscosity <LI>@25 °C, (cSt)</LI> </CHED> <CHED H="1"> Category by <LI>API gravity</LI> </CHED> </BOXHD> <ROW> <ENT I="01">SPR Bryan Mound</ENT> <ENT>0.8320</ENT> <ENT>38.6</ENT> <ENT>4.721</ENT> <ENT>Light Oil.</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="3" OPTS="L2" CDEF="s100,15C,12"> <TTITLE>Table 3—Sample Calculation for Preparation of Oil + Dispersant Stock Standard Solution</TTITLE> <BOXHD> <CHED H="1">Item</CHED> <CHED H="1">Identifier</CHED> <CHED H="1">Amount</CHED> </BOXHD> <ROW> <ENT I="01">Mass of Bottle, g</ENT> <ENT>A</ENT> <ENT>29.498</ENT> </ROW> <ROW> <ENT I="01">Mass of Bottle + oil, g</ENT> <ENT>B</ENT> <ENT>31.225</ENT> </ROW> <ROW> <ENT I="01">Mass of bottle + disp + oil + DCM, g</ENT> <ENT>C</ENT> <ENT>54.380</ENT> </ROW> <ROW> <ENT I="01"> Mass of oil, g ( <E T="03">derived</E> ) </ENT> <ENT>F = B−A</ENT> <ENT>1.727</ENT> </ROW> <ROW> <ENT I="01"> Mass of disp + oil + DCM, g ( <E T="03">derived</E> ) </ENT> <ENT>G = C−A</ENT> <ENT>24.882</ENT> </ROW> <ROW> <ENT I="01">Mass of 1 mL syringe, g</ENT> <ENT>D</ENT> <ENT>14.556</ENT> </ROW> <ROW> <ENT I="01">Mass of 1 mL syringe + solution, g</ENT> <ENT>E</ENT> <ENT>15.820</ENT> </ROW> <ROW> <ENT I="01"> Density of solution, g/mL ( <E T="03">derived</E> ) </ENT> <ENT>H = E−D</ENT> <ENT>1.264</ENT> </ROW> <ROW> <ENT I="01"> Volume of solution, mL ( <E T="03">derived</E> ) </ENT> <ENT>I = G/H</ENT> <ENT>19.687</ENT> </ROW> <ROW> <ENT I="01"> Conc. of stock solution, mg/mL ( <E T="03">derived</E> ) </ENT> <ENT>J = F*1000/I</ENT> <ENT>87.704</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="7" OPTS="L2" CDEF="s50,12,12,9,9,9,9"> <TTITLE>Table 4—Sample Calculations for Oil + Dispersant Six Point Calibration</TTITLE> <BOXHD> <CHED H="1"> Oil + Dispersant Stock Standard Solution Concentration = 87.7 mg/mL ( <E T="03">Table 3</E> ) </CHED> <CHED H="2">Standard—stock vol. (uL)</CHED> <CHED H="2">Theoretical conc., mg/mL</CHED> <CHED H="2"> Area <LI> <E T="03">(340-400 nm)</E> </LI> </CHED> <CHED H="2">RF</CHED> <CHED H="2">Avg. RF</CHED> <CHED H="2"> Dev. from <LI>avg. RF</LI> </CHED> <CHED H="2">Slope</CHED> </BOXHD> <ROW> <ENT I="01">25</ENT> <ENT>0.088</ENT> <ENT>4.126</ENT> <ENT>0.021</ENT> <ENT>0.021</ENT> <ENT>2.931</ENT> <ENT>48.759</ENT> </ROW> <ROW> <ENT I="01">50</ENT> <ENT>0.175</ENT> <ENT>8.757</ENT> <ENT>0.020</ENT> <ENT/> <ENT>3.017</ENT> </ROW> <ROW> <ENT I="01">100</ENT> <ENT>0.351</ENT> <ENT>16.559</ENT> <ENT>0.021</ENT> <ENT/> <ENT>2.577</ENT> </ROW> <ROW> <ENT I="01">150</ENT> <ENT>0.526</ENT> <ENT>25.666</ENT> <ENT>0.021</ENT> <ENT/> <ENT>0.731</ENT> </ROW> <ROW> <ENT I="01">200</ENT> <ENT>0.702</ENT> <ENT>34.142</ENT> <ENT>0.021</ENT> <ENT/> <ENT>0.500</ENT> </ROW> <ROW> <ENT I="01">250</ENT> <ENT>0.877</ENT> <ENT>43.006</ENT> <ENT>0.020</ENT> <ENT/> <ENT>1.260</ENT> <ENT/> </ROW> </GPOTABLE> <PRTPAGE P="261"/> <GPOTABLE COLS="13" OPTS="L2,p7,7/8" CDEF="s25,8,8,7,7,7,9,10,7,7,8,8,7"> <TTITLE>Table 5—LCL95 Sample Calculation With Test Oil and Example Dispersant `A'</TTITLE> <BOXHD> <CHED H="1">Rep</CHED> <CHED H="1"> Area <LI>(340-400</LI> <LI>nm)</LI> </CHED> <CHED H="1">Dilution factor</CHED> <CHED H="1"> Extract <LI>volume</LI> <LI>(ml) *</LI> </CHED> <CHED H="1"> Conc, <LI>mg/mL.</LI> </CHED> <CHED H="1"> Mass in <LI>30 mL,</LI> <LI>mg</LI> </CHED> <CHED H="1"> Total oil dispersed, <LI>mg</LI> </CHED> <CHED H="1"> Efficiency, <LI>%</LI> </CHED> <CHED H="1">Average</CHED> <CHED H="1"> Std. <LI>dev.</LI> </CHED> <CHED H="1">Variance</CHED> <CHED H="1"> Coef. of <LI>variation</LI> </CHED> <CHED H="1">LCL95</CHED> </BOXHD> <ROW> <ENT I="01">1</ENT> <ENT>32.197</ENT> <ENT>1</ENT> <ENT>25</ENT> <ENT>0.66</ENT> <ENT>16.51</ENT> <ENT>66.03</ENT> <ENT>79.76</ENT> <ENT>81.30</ENT> <ENT>4.46</ENT> <ENT>19.85</ENT> <ENT>5.48</ENT> <ENT>81.30</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>35.470</ENT> <ENT>1</ENT> <ENT>25</ENT> <ENT>0.73</ENT> <ENT>18.19</ENT> <ENT>72.75</ENT> <ENT>87.87</ENT> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="01">3</ENT> <ENT>30.260</ENT> <ENT>1</ENT> <ENT>25</ENT> <ENT>0.62</ENT> <ENT>15.52</ENT> <ENT>62.06</ENT> <ENT>74.96</ENT> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="01">4</ENT> <ENT>31.831</ENT> <ENT>1</ENT> <ENT>25</ENT> <ENT>0.65</ENT> <ENT>16.32</ENT> <ENT>65.28</ENT> <ENT>78.85</ENT> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="01">5</ENT> <ENT>33.355</ENT> <ENT>1</ENT> <ENT>25</ENT> <ENT>0.68</ENT> <ENT>17.10</ENT> <ENT>68.41</ENT> <ENT>82.63</ENT> <ENT/> <ENT/> <ENT/> </ROW> <ROW> <ENT I="01">6</ENT> <ENT>33.791</ENT> <ENT>1</ENT> <ENT>25</ENT> <ENT>0.69</ENT> <ENT>17.33</ENT> <ENT>69.30</ENT> <ENT>83.71</ENT> <ENT/> <ENT/> <ENT/> <ENT/> </ROW> <TNOTE>* = 25 ml of DCM extract captured oil from 30 ml of aqueous DE test.</TNOTE> </GPOTABLE> <PRTPAGE P="262"/> <P>2.11 References for Section 2.0</P> <FP SOURCE="FP-2"> (1) U.S. Environmental Protection Agency (1994), “Swirling Flask Dispersant Effectiveness Test,” <E T="03">Title 40 Code of Federal Regulations,</E> Pt. 300, Appendix C, pp 47458-47461. </FP> <FP SOURCE="FP-2">(2) Sorial, G.A., A.D. Venosa, K.M, Koran, E. Holder, and D.W. King. 2004. “Oil spill dispersant effectiveness protocol: I. Impact of operational variables.” ASCE J. Env. Eng. 130(10):1073-1084.</FP> <FP SOURCE="FP-2">(3) Sorial, G.A., A.D. Venosa, K.M, Koran, E. Holder, and D.W. King. 2004. “Oil spill dispersant effectiveness protocol: II. Performance of revised protocol.” ASCE J. Env. Eng. 130(10):1085-1093.</FP> <FP SOURCE="FP-2">(4) Venosa, A.D., D.W. King, and G.A. Sorial. 2002. “The baffled flask test for dispersant effectiveness: a round robin evaluation of reproducibility and repeatability.” Spill Sci. & Technol. Bulletin 7(5-6):299-308.</FP> <FP SOURCE="FP-2">(5) Spotte, S., G. Adams, and P.M. Bubucis. 1984. “GP2 medium is an synthetic seawater for culture or maintenance of marine organisms,” Zoo Biol, 3:229-240.</FP> <FP SOURCE="FP-2">(6) Grubbs, F. 1969. “Sample Criteria for Testing Outlying Observations,” Annals of Mathematical Statistics, pp. 27-58.</FP> <P>3.0 Dispersant Toxicity Testing</P> <P> 3.1  <E T="03">Summary.</E> This laboratory protocol includes testing for: (1) dispersant standard static acute toxicity tests for the mysid shrimp, <E T="03">Americamysis bahia</E> (48-hr duration) and the inland silverside, <E T="03">Menidia beryllina</E> (96-hr duration); (2) dispersant-oil mixture static acute toxicity tests for <E T="03">Americamysis bahia</E> and <E T="03">Menidia beryllina</E> (48-hr and 96-hr duration, respectively); (3) dispersant developmental assay for <E T="03">Strongylocentrotus purpuratus</E> or <E T="03">Arbacia punctulata,</E> (72-hr duration); and (4) dispersant 7-day static subchronic tests with <E T="03">Americamysis bahia</E> and <E T="03">Menidia beryllina</E> (Table 6 of this Appendix). <PRTPAGE P="263"/> </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s50,xs80,xs80,xs72,xs72"> <TTITLE>Table 6—Toxicity Testing Requirements for Dispersants</TTITLE> <BOXHD> <CHED H="1">Test procedure</CHED> <CHED H="2"> Test <LI>substance</LI> </CHED> <CHED H="2"> 96-Hr static acute: <LI> <E T="03">Menidia beryllina</E> </LI> </CHED> <CHED H="2"> 48-Hr static acute: <LI> <E T="03"> Americamysis</E> </LI> <LI> <E T="03">Bahia</E> </LI> </CHED> <CHED H="2"> 72-Hr sea urchin <LI> <E T="03"> developmental</E> </LI> <LI> <E T="03">assay</E> </LI> </CHED> <CHED H="2"> 7-Day subchronic: <LI> <E T="03">M. beryllina &</E> </LI> <LI> <E T="03">A. bahia</E> </LI> </CHED> </BOXHD> <ROW> <ENT I="01"> <E T="03">Dispersant only</E> </ENT> <ENT> <E T="03">yes</E> </ENT> <ENT> <E T="03">yes</E> </ENT> <ENT> <E T="03">yes</E> </ENT> <ENT> <E T="03">yes</E> . </ENT> </ROW> <ROW> <ENT I="01"> <E T="03">Dispersant—Reference Oil Mixture</E> </ENT> <ENT> <E T="03">yes</E> </ENT> <ENT> <E T="03">yes</E> </ENT> <ENT> <E T="03">no</E> </ENT> <ENT> <E T="03">no</E> . </ENT> </ROW> </GPOTABLE> <PRTPAGE P="264"/> <P> 3.2  <E T="03">Preparation of Stock Solutions</E> </P> <P> 3.2.1  <E T="03">Dispersant.</E> Prepare a 1000 µL/L primary stock solution prior to test initiation by adding 1.1 mL of dispersant to 1100 mL of dilution water consisting of salinity adjusted uncontaminated natural or artificial seawater, in a glass vessel. Using a laboratory top stirrer equipped with a stainless-steel blade, center the stirrer blade in the mixing vessel one inch off the bottom. Initially mix the resulting stock solution for approximately five seconds at speeds of <10,000 rpm to avoid foaming. Thereafter, set the speed to provide a 70% vortex. Using a glass pipette, remove appropriate aliquots of stock solution from between the mixing vessel wall and edge of the vortex and place directly into the dilution water within an exposure vessel. Suspend mixing of the stock solution after the removal of each aliquot. Base the preparation of exposure solutions on the nominal concentration of the stock solution and follow procedures outlined in sections 3.5 and 3.6 of this Appendix. </P> <P> 3.2.2  <E T="03">Dispersant-Reference Oil(s) Mixtures.</E> Use Strategic Petroleum Reserve Bryan Mound reference oil. To obtain this oil at no charge (except for a minimal shipping fee) see <E T="03">https://www.epa.gov/emergency-response/national-contingency-plan-subpart-j#howto.</E> Assessment of dispersant-reference oil mixture (DOM) toxicity is determined for each reference oil using the aqueous phase of a chemically enhanced-water accommodated fraction (CE-WAF). Fit a glass aspirator bottle (approximately 23 L) equipped with a hose bib at the base with a length of silicon tubing containing a hose clamp. Fill the bottle with 19L of seawater leaving a 20% headspace above the liquid, place on a magnetic stir plate then add and center a stir bar. Add the reference oil at 25 g/L using a silicon tube attached to a glass funnel that reaches just below the water surface. Using this method reduces the production of air bubbles on the oil surface slick. Adjust the stir plate to obtain an oil vortex of 25% of the total volume of the seawater, then add the dispersant to be tested at a ratio of 1:10 dispersant:oil (2.5 g/L). Securely seal the bottle to reduce the loss of volatiles using a silicon stopper and wraps of Parafilm and stir for 18 hours, then allow the solution to settle for 6 hours. Maintain the temperature at 25 °C during stirring and settling. Purge the hose at the base of the bottle of any material followed by removal of the CE-WAF (aqueous phase) into a clean glass container without disturbing the surface oil slick. The CE-WAF should be remixed and 1 to 2 L removed for chemical analysis of total petroleum hydrocarbons (TPH) following the procedures outlined in section 3.4 of this Appendix. The remaining volume will be used for the preparation of exposure solutions following procedures outlined in section 3.3 of this Appendix. To reduce time and cost, mix sufficient amounts of dispersant product-reference oil mixture CE-WAF to allow preparation of exposure solutions for conducting simultaneous acute tests with both <E T="03">Americamysis bahia</E> and <E T="03">Menidia beryllina.</E> </P> <P> 3.3  <E T="03">Preparation of Exposure Concentrations.</E> </P> <P> 3.3.1  <E T="03">Concentration Selection.</E> Preliminary rangefinder tests may be necessary using a series of logarithmic concentrations ( <E T="03">e.g.</E> 0.1, 1, 10, 100 µl dispersant product/L or mg TPH/L) to determine the appropriate exposure concentration range necessary to determine LC <E T="52">50</E> values and 95% confidence intervals. For definitive tests, conduct a minimum of five test concentrations using a geometric ratio between 1.5 and 2.0 ( <E T="03">e.g.</E> 2, 4, 8, 16, and 32). Note that when testing only the dispersant product, the highest test concentration must not exceed the dispersant's self-dispersibility limit. </P> <P> 3.3.2  <E T="03">Exposure Concentrations.</E> Exposure solutions are prepared by adding the appropriate amount of stock solution directly to dilution water in each test chamber. Mix each exposure solution using five rotations in one direction followed by five rotations in the opposite direction using a solid glass stir rod. </P> <P> 3.3.3  <E T="03">Reference Toxicants.</E> Separate toxicity tests must be performed with a reference toxicant for each species tested. Conduct additional reference toxicity tests any time a change in the population or source of a test species occurs. Use sodium dodecyl sulfate (SDS), also known as dodecyl sodium sulfate (DSS), and sodium lauryl sulfate (SLS) as the reference toxicant for exposures conducted with <E T="03">Menidia beryllina</E> and <E T="03">Americamysis bahia.</E> Use copper chloride as the reference toxicant for exposures conducted with the sea urchin developmental test. Use reagent grade quality SDS and copper chloride for tests. Information on procedures for conducting reference toxicant tests with these species can be found in the specific EPA methods documents cited in sections 3.5.1, 3.6.1, and 3.7.1 of this Appendix. </P> <P> 3.4  <E T="03">Chemical Analysis of Stock Solutions.</E> Add the 1 L sample of CE-WAF (Section 3.2.2 of this Appendix) solutions directly to amber glass bottles with Teflon®-lined cap. Collect a replicate sample in the event of accidental loss or if reanalysis of the stock solution becomes necessary. Adjust sample to a pH=2 using 50% hydrochloric acid, immediately refrigerate and analyze within 48 hours of collection. Analyze samples for C9-C32 TPH by gas chromatography-flame ionization detection (GC-FID) following EPA SW-846, Method 8015B-DRO (4). Report TPH concentration of stock solutions as milligrams TPH/L and use in the calculation of exposure concentrations for all toxicity tests conducted with CE-WAF. </P> <P> 3.5  <E T="03">Static Acute Tests with M. beryllina and A. bahia</E> <PRTPAGE P="265"/> </P> <P> 3.5.1  <E T="03">General.</E> Use EPA's <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms</E> (EPA-821-R-02-012) (1) for testing each species separately with dispersant product or a mixture of dispersant product and reference oil (DOM). </P> <P> 3.5.2  <E T="03">Test Solutions.</E> Modify procedures in EPA-821-R-02-012 specifically dealing with the handling and toxicity testing of effluents or receiving water samples as follows: Prepare stock solutions following section 3.2 of this Appendix and exposure concentrations following section 3.3 of this Appendix. </P> <P> 3.5.3  <E T="03">Number of Treatments, Replicates and Organisms.</E> Conduct a minimum of three replicates of at least five exposure treatments plus a minimum of three replicate dilution water controls. Expose ten organisms per replicate treatment. </P> <P> 3.5.4  <E T="03">Exposure Period.</E> Test duration is 48-hr for <E T="03">Americamysis bahia</E> and 96-hr for <E T="03">Menidia beryllina.</E> Mortality must be recorded at each 24-hour period of each test. </P> <P> 3.5.5  <E T="03">Test Acceptability.</E> For each test performed, survival of control animals must be >90% and test results must allow determination of statistically valid LC <E T="52">50</E> and 95% confidence interval values except in cases where the LC <E T="52">50</E> is >1000 µl/L or is determined to be greater than the limits of water solubility of dispersibility. </P> <P> 3.5.6  <E T="03">Static Acute Test Summary.</E> A summary of required test conditions is provided in Table 7 of this Appendix. </P> <P> 3.6  <E T="03">Sea Urchin Developmental Test with Dispersant Product</E> </P> <P> 3.6.1  <E T="03">General.</E> Use Section 15, “Purple Urchin, <E T="03">Strongylocentrotus purpuratus</E> and Sand Dollar, <E T="03">Dendraster excentricus</E> Larval Development Test Method” of EPA's <E T="03">Short-Term Methods for Estimating the Chronic Toxicity of Effluents and Receiving Waters to West Coast Marine and Estuarine Organisms</E> (EPA/600/R-95-136) (2). Alternatively, the development of the urchin <E T="03">Arbacia punctulata</E> may be tested (see Table 7). </P> <P> 3.6.2  <E T="03">Test Organism.</E> Tests of dispersant products are to follow methods for the purple urchin only. Tests with the sand dollar are not required. </P> <P> 3.6.3  <E T="03">Test Solutions.</E> Modify procedures in EPA/600/R-95-136, Section 15 specifically dealing with the handling and toxicity testing of effluents or receiving water samples as follows: Prepare stock solutions following section 3.2.1 of this Appendix and exposure concentrations following section 3.3 of this Appendix. </P> <P> 3.6.4  <E T="03">Number of Treatments and Replicates.</E> Conduct a minimum of four replicates of five exposure treatments plus a minimum of four replicate dilution water controls. </P> <P> 3.6.5  <E T="03">Exposure Duration and Test Endpoint.</E> Examine the effects of the dispersant product on normal development of sea urchin embryos over a period of 72 hours. An IC <E T="52">50</E> (the exposure concentration at which normal development is inhibited in 50% of the embryos) with 95% confidence intervals are to be determined in place of an IC <E T="52">25.</E> The concentration of dispersant causing inhibition of development in 50% of exposed embryos (IC <E T="52">50</E> ) with the lower and upper 95% confidence intervals (LCI <E T="52">95</E> and ULCI <E T="52">95</E> ) must be calculated at the end of the exposure period. Mortality determinations are not required. </P> <P> 3.6.6  <E T="03">Test Acceptability.</E> Requirements of the assay are: (i) ≥80% normal larval development in the control treatment, (ii) the minimum significant difference (MSD) that can be statically detected relative to the control is ≤25%, iii) test results which support the determination of a statistically valid IC <E T="52">50</E> and 95% confidence interval unless the LC <E T="52">50</E> is >1000 µl/L or is greater than the limits of water solubility of dispersibility. </P> <P> 3.6.7  <E T="03">Urchin Developmental Test Summary.</E> A summary of required test conditions is provided in Table 7 of this Appendix. </P> <P> 3.7  <E T="03">Seven-day Subchronic Tests with M. beryllina and A. bahia</E> </P> <P> 3.7.1  <E T="03">General.</E> Use Section 13, Method 1006.0, “Inland Silverside ( <E T="03">Menidia beryllina</E> ) Larval Survival and Growth Method,” and Section 14, Method 1007.0, “Mysid ( <E T="03">Mysidopsis</E> [renamed <E T="03">Americamysis</E> ] <E T="03">bahia</E> ) Survival, Growth, and Fecundity Method” of EPA's <E T="03">Short-Term Methods for Estimating the Chronic Toxicity of Effluents and Receiving Waters to Marine and Estuarine Organisms</E> (EPA-821-R-02-014) (3) for testing of dispersant product. </P> <P> 3.7.2  <E T="03">Test Solutions.</E> Modify procedures in EPA-821-R-02-014, sections 13 and 14 specifically dealing with the handling and toxicity testing of effluents or receiving water samples as follows: Prepare stock solutions following section 3.2.1 of this Appendix and exposure concentrations following section 3.3 of this Appendix. Exposure solutions should be renewed every 24 hours for the duration of the test. </P> <P> 3.7.3  <E T="03">Number of Treatments, Replicates and Organisms.</E> (i) <E T="03">Menidia beryllina:</E> Conduct a minimum of four replicates of at least five exposure treatments plus a minimum of four replicate dilution water controls. Expose ten <E T="03">M. beryllina</E> per replicate treatment. (ii) <E T="03">Americamysis bahia:</E> Conduct a minimum of eight replicates of at least five exposure treatments plus a minimum of eight replicate dilution water controls. Expose five <E T="03">A. bahia</E> per replicate treatment. </P> <P> 3.7.4  <E T="03">Exposure Duration and Test Endpoint.</E> The test duration is seven days for both species. Test endpoints for <E T="03">Menidia beryllina</E> are survival and growth (dry weight) and for <E T="03">Americamysis bahia</E> is survival, growth (dry weight) and fecundity. Calculate an LC <E T="52">50</E> and 95% confidence interval for survival and IC <E T="52">25</E> and IC <E T="52">50</E> with 95% confidence intervals for growth (and fecundity for <E T="03">A. bahia</E> only). Report the lowest observed effect concentration <PRTPAGE P="266"/> (LOEC) and no observed effect concentration (NOEC) for each endpoint. </P> <P> 3.7.5  <E T="03">Test Acceptability.</E> Requirements of the assay are: (i) ≥80% survival in the control treatment for each species, (ii) dry weights must meet the specific requirements as stipulated in Method 1006.0 for <E T="03">Menidia beryllina</E> and Method 1007.0 for <E T="03">Americamysis bahia.</E> </P> <P> 3.7.6  <E T="03">Subchronic Test Summary.</E> A summary of required test conditions for each species is provided in Table 7 of this Appendix. </P> <P> 3.8  <E T="03">Laboratory Report.</E> The laboratory must include, for each toxicity test report, all applicable information, data and analyses as follows: </P> <P> 3.8.1  <E T="03">Test Objective:</E> protocol title and source, endpoint(s); </P> <P> 3.8.2  <E T="03">Product Information:</E> product name, manufacturer contact information, lot number, production date, date received/chain of custody; </P> <P> 3.8.3  <E T="03">Contract Facility:</E> contact information; </P> <P> 3.8.4  <E T="03">Dilution Water:</E> source, pretreatment, physical and chemical characteristics (pH, salinity); </P> <P> 3.8.5  <E T="03">Test Conditions:</E> date and time of test (start and end), test chambers type and volume, volume of solution per chamber, number of organisms per chamber, number of replicate chambers per treatment, feeding frequency, amount and type of food, test concentrations, test temperature (mean and range), test salinity (mean and range); </P> <P> 3.8.6  <E T="03">Test Organisms:</E> common and scientific name, source contact information, age and date purchased, acclimation conditions ( <E T="03">e.g.,</E> temperature, salinity, both mean and range), age at test start; </P> <P> 3.8.7  <E T="03">Reference toxicant:</E> date received, lot number, date of most recent test, results and current Cumulative Sum Chart, dilution water used, physical and chemical methods used; </P> <P> 3.8.8  <E T="03">Quality Assurance:</E> verification of laboratory accreditation, including subcontractor facilities; </P> <P> 3.8.9  <E T="03">Test Results:</E> raw data in tabular and graphical form, daily records of affected organisms in each concentration replicate and controls, table of required endpoints ( <E T="03">i.e.,</E> LC <E T="52">50</E> with 95% confidence interval (CI), IC <E T="52">25</E> and IC <E T="52">50</E> with 95% CI, LOEC and NOEC), statistical methods used to calculate endpoints, summary tables of test conditions and QA data; </P> <P> 3.8.10  <E T="03">Analytical Results:</E> method summary including Limit of Detection (LOD)/Limit of Quantitation (LOQ), deviations and reasons if any, sample summary, results including chromatograms and data qualifiers, QA summary including calibration curves, method blank and surrogate recovery, analytical results summary; and </P> <P> 3.8.11  <E T="03">Conclusions:</E> Relationship between test endpoints and threshold limit. <PRTPAGE P="267"/> </P> <GPOTABLE COLS="6" OPTS="L2,p7,7/8" CDEF="s100,r30,r30,r75,r50,r50"> <TTITLE>Table 7—Summary of Test Conditions—Dispersant Toxicity</TTITLE> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> Acute <E T="03">M. beryllina</E> </CHED> <CHED H="1"> Acute <E T="03">A. bahia</E> </CHED> <CHED H="1"> Subchronic <E T="03">M. beryllina</E> </CHED> <CHED H="1"> Subchronic <E T="03">A. bahia</E> </CHED> <CHED H="1"> Development <LI> <E T="03">S. purpuratus/A. punctulata</E> </LI> </CHED> </BOXHD> <ROW> <ENT I="01">Test type</ENT> <ENT>Static non-renewal</ENT> <ENT>Static non-renewal</ENT> <ENT>Static renewal (daily)</ENT> <ENT>Static renewal (daily)</ENT> <ENT>Static non-renewal.</ENT> </ROW> <ROW> <ENT I="01">Test duration</ENT> <ENT>96 hours</ENT> <ENT>48 hours</ENT> <ENT>7 days</ENT> <ENT>7 days</ENT> <ENT>72 ± 2 hours.</ENT> </ROW> <ROW RUL="n,s,s,s,s,n"> <ENT I="01">Salinity</ENT> <ENT>20 ± 2‰</ENT> <ENT>20 ± 2‰</ENT> <ENT>20 ± 2‰</ENT> <ENT>20 ± 2‰</ENT> <ENT>34 ± 2‰.</ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Temperature</ENT> <ENT A="03">25 ± 1 °C. Test temperatures must not deviate (maximum minus minimum temperature) by for than 3 °C during the test.</ENT> <ENT>15 ± 1 °C.</ENT> </ROW> <ROW> <ENT I="01">Light quality</ENT> <ENT A="04">Ambient laboratory illumination.</ENT> </ROW> <ROW> <ENT I="01">Light intensity</ENT> <ENT A="04"> 10-20 µE/m <SU>2</SU> /s. </ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Photoperiod</ENT> <ENT A="04">16 h light, 8 h darkness, with phase in/out period recommended.</ENT> </ROW> <ROW> <ENT I="01"> Test chamber size  <SU>1</SU> </ENT> <ENT>250 mL</ENT> <ENT>250 mL</ENT> <ENT>600 mL-1 L</ENT> <ENT>400 mL</ENT> <ENT>30 mL.</ENT> </ROW> <ROW> <ENT I="01"> Test solution volume  <SU>1</SU> </ENT> <ENT>200 mL</ENT> <ENT>200 mL</ENT> <ENT>500-750 mL</ENT> <ENT>150 mL</ENT> <ENT>10 mL.</ENT> </ROW> <ROW> <ENT I="01"> Age of test organism  <SU>2</SU> </ENT> <ENT>9-14 days</ENT> <ENT>1-5 days</ENT> <ENT>7-11 days</ENT> <ENT>7 days</ENT> <ENT>1 hr old fertilized eggs.</ENT> </ROW> <ROW> <ENT I="01">No. organisms per test chamber</ENT> <ENT>10</ENT> <ENT>10</ENT> <ENT>10</ENT> <ENT>5</ENT> <ENT>25 embryos per mL.</ENT> </ROW> <ROW RUL="n,s,s,s,s,n"> <ENT I="01">No. of replicate chambers per concentration</ENT> <ENT>3</ENT> <ENT>3</ENT> <ENT>4</ENT> <ENT>8</ENT> <ENT>4.</ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Feeding regime</ENT> <ENT A="03">Refer to specific feeding procedures provided in each test method.</ENT> <ENT>None.</ENT> </ROW> <ROW> <ENT I="01">Aeration</ENT> <ENT A="04">None, unless DO falls below 4.0 mg/L, then aerate all chambers. Rate: <100 bubbles/minute.</ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Test concentrations</ENT> <ENT A="04">5 exposure concentrations and a control (minimum required).</ENT> </ROW> <ROW> <ENT I="01">Test acceptability (required)</ENT> <ENT>≥90% survival in controls</ENT> <ENT>≥90% survival in controls</ENT> <ENT>For controls: ≥80% survival; average dry weight ≥0.5mg where test starts with 7 day old larvae, or ≥0.43 mg for larvae preserved for ≤7days</ENT> <ENT>For controls: ≥80% survival; average dry weight ≥0.20 mg</ENT> <ENT>≥80% normal shell development in controls.</ENT> </ROW> <TNOTE> <SU>1</SU>  Recommended minimum value. </TNOTE> <TNOTE> <SU>2</SU>  Less than or equal to 24-hr range in age. </TNOTE> </GPOTABLE> <PRTPAGE P="268"/> <P> 3.9  <E T="03">References for Section 3.0</E> </P> <FP SOURCE="FP-2"> (1) U.S. EPA. 2002. <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms.</E> Fifth Edition. U.S. Environmental Protection Agency, Washington, DC (EPA-821-R-02-012). </FP> <FP SOURCE="FP-2"> (2) U.S. EPA. 1995. <E T="03">Short-Term Methods for Estimating the Chronic Toxicity of Effluents and Receiving Waters to West Coast Marine and Estuarine Organisms.</E> First Edition. U.S. Environmental Protection Agency, Washington, DC (EPA/600/R-95-136) </FP> <FP SOURCE="FP-2"> (3) U.S. EPA. 2002. <E T="03">Short-Term Methods for Estimating the Chronic Toxicity of Effluents and Receiving Waters to Marine and Estuarine Organisms.</E> Third Edition. U.S. Environmental Protection Agency, Washington, DC (EPA-821-R-02-014). </FP> <FP SOURCE="FP-2"> (4) U.S. EPA. 2008. <E T="03">Test Methods for Evaluating Solid Waste, Physical/Chemical Methods</E> U.S. Environmental Protection Agency, Washington, DC (SW-846) <E T="03">http://www.epa.gov/osw/hazard/testmethods/sw846/online/index.htm</E> . </FP> <P> 4.0  <E T="03">Standard Acute Toxicity Testing of Surface Washing Agents, Bioremediation Agents, Herding Agents, and Solidifiers.</E> </P> <P> 4.1  <E T="03">Summary.</E> This laboratory protocol includes testing for: (1) saltwater standard static acute toxicity tests for test products with the mysid shrimp, <E T="03">Americamysis bahia</E> (48-hr duration) and the inland silverside, <E T="03">Menidia beryllina</E> (96-hr duration); and (2) freshwater standard static acute toxicity tests for test products with the daphnid, <E T="03">Ceriodaphnia dubia</E> (48-hr duration) and the fathead minnow, <E T="03">Pimephales promelas</E> (96-hr duration) (see Table 8 of this Appendix). </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s50,r50,r50,r50,r50"> <TTITLE>Table 8—Toxicity Testing Requirements for Surface Washing Agents, Herding Agents, Bioremediation Agents and Solidifiers</TTITLE> <BOXHD> <CHED H="1">Application environment</CHED> <CHED H="1">Test procedure</CHED> <CHED H="2"> 96-hr Static acute: <LI> <E T="03">Menidia beryllina</E> </LI> </CHED> <CHED H="2"> 48-hr Static acute: <LI> <E T="03">Americamysis bahia</E> </LI> </CHED> <CHED H="2"> 96-hr Static acute: <LI> <E T="03">Pimephales promelas</E> </LI> </CHED> <CHED H="2"> 48-hr Static acute: <LI> <E T="03">Ceriodaphnia dubia</E> </LI> </CHED> </BOXHD> <ROW> <ENT I="01">Saltwater only</ENT> <ENT>yes</ENT> <ENT>yes</ENT> <ENT>no</ENT> <ENT>no.</ENT> </ROW> <ROW> <ENT I="01">Freshwater only</ENT> <ENT>no</ENT> <ENT>no</ENT> <ENT>yes</ENT> <ENT>yes.</ENT> </ROW> <ROW> <ENT I="01">Freshwater and saltwater use</ENT> <ENT>yes</ENT> <ENT>yes</ENT> <ENT>yes</ENT> <ENT>yes.</ENT> </ROW> </GPOTABLE> <P> 4.2  <E T="03">Dilution Water.</E> Use Section 7 of EPA's <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms</E> (EPA-821-R-02-012) [1] for preparation of the appropriate dilution water for each species tested. Use of clean natural or synthetic seawater for tests conducted with saltwater species is acceptable. </P> <P> 4.3  <E T="03">Preparation of Stock Solutions.</E> </P> <P> 4.3.1 Liquid <E T="03">Surface Washing Agents and/or Herding Agents.</E> Prepare a 1000 µL/L stock solution prior to test initiation by adding 1.1 mL of test product to 1100 mL of dilution water in a glass vessel. Place on a magnetic stir plate then add and center a stir bar and adjust the stir plate to obtain a vortex of 25% of the total volume of the liquid. Mix the resulting stock solution for approximately five minutes at room temperature. Using a glass pipette, remove appropriate aliquots of stock solution from between the mixing vessel wall and edge of the vortex and place directly into the dilution water within an exposure vessel. Base the preparation of exposure solutions on the nominal concentration of the stock solution and follow procedures outlined in sections 4.6 and/or 4.7 of this Appendix, as appropriate. </P> <P> 4.3.2  <E T="03">Bioremediation Agents.</E> For products consisting of two or more liquid and/or solid components, prepare the product following the manufacturers recommended procedure and ensure the test product mixture is completely blended. Prepare a 1000 µL/L stock solution prior to test initiation by adding 1.1 mL of the test product mixture to 1100 mL of dilution water in a glass vessel. Place on a magnetic stir plate then add and center a stir bar and adjust the stir plate to obtain a vortex of 25% of the total volume of the liquid. Mix the resulting stock solution for approximately five minutes at room temperature. Using a glass pipette, remove appropriate aliquots of stock solution from between the mixing vessel wall and edge of the vortex and place directly into the dilution water within an exposure vessel. Base the preparation of exposure solutions on the nominal concentration of the stock solution and follow procedures outlined in sections 4.5 and/or 4.6 of this Appendix, as appropriate. </P> <P> 4.3.3  <E T="03">Solid Phase Products.</E> Assessment of the toxicity of solidifiers and other solid phase products are determined using the aqueous phase of water-accommodated fractions (WAFs) of the test product. Fit a glass aspirator bottle (approximately 23L) equipped with a hose bib at the base with a length of silicon tubing containing a hose clamp. Fill the bottle with 19L of dilution water leaving a 20% headspace above the liquid, place on a magnetic stir plate then add and center a stir bar. Add the test product at 25 g/L and securely seal the bottle using a <PRTPAGE P="269"/> silicon stopper and wraps of parafilm. Adjust the stir plate to obtain a vortex of 25% of the total fluid volume, stir for 18 hours then settle for 6 hours. Maintain the temperature at 25 °C during stirring and settling. Purge the hose at the base of the bottle of any material followed by removal of the WAF (aqueous phase) into a clean glass container without disturbing the product on the surface. The WAF should be remixed and used for the preparation of exposure solutions following procedures outlined in section 4.4 of this Appendix. </P> <P> 4.4  <E T="03">Preparation of Exposure Concentrations.</E> </P> <P> 4.4.1  <E T="03">Concentration Selection.</E> Preliminary rangefinder tests may be necessary using a series of logarithmic concentrations ( <E T="03">e.g.</E> 0.1, 1, 10, 100 µl test product/L) to determine the appropriate exposure concentration range necessary to determine LC <E T="52">50</E> values and 95% confidence intervals. For definitive tests, conduct a minimum of five test concentrations using a geometric ratio between 1.5 and 2.0 ( <E T="03">e.g.</E> 2, 4, 8, 16, and 32). Note that when testing the product, the highest test concentration should not exceed the test product's self-dispersibility limit. </P> <P> 4.4.2  <E T="03">Exposure Concentrations.</E> Exposure solutions are prepared by adding the appropriate amount of stock solution directly to dilution water in each test chamber. Mix each exposure solution using five rotations in one direction followed by five rotations in the opposite direction using a solid glass stir rod. </P> <P> 4.4.3  <E T="03">Reference Toxicants.</E> Separate toxicity tests must be performed with a reference toxicant for each species tested. Conduct additional reference toxicity tests any time a change in the culture population or source of a test species occurs. Use reagent grade quality sodium dodecyl sulfate (SDS), also known as dodecyl sodium sulfate (DSS), and sodium lauryl sulfate (SLS) as the reference toxicant. Information on procedures for conducting reference toxicant tests with these species can be found in section 4 of EPA's <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms</E> (EPA-821-R-02-012) (3). </P> <P> 4.5  <E T="03">Saltwater Static Acute Tests with Menidia beryllina and Americamysis bahia</E> </P> <P> 4.5.1  <E T="03">General.</E> Use EPA's <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms</E> (EPA-821-R-02-012) (1) for testing each species separately with the test product. </P> <P> 4.5.2  <E T="03">Test Solutions.</E> Modify procedures in EPA-821-R-02-012 specifically dealing with the handling and toxicity testing of effluents or receiving water samples as follows: Prepare stock solutions following the appropriate sections (4.3.1, 4.3.2, or 4.3.3) of this Appendix and exposure concentrations following section 4.4 of this Appendix. </P> <P> 4.5.3  <E T="03">Number of Treatments, Replicates and Organisms.</E> Conduct a minimum of three replicates of at least five exposure treatments plus a minimum of three replicate dilution water controls. Expose ten organisms per replicate treatment. </P> <P> 4.5.4  <E T="03">Exposure Period.</E> Test duration is 48-hr for <E T="03">A. bahia</E> and 96-hr for <E T="03">M. beryllina.</E> Mortality must be recorded at each 24 hour period of each test. </P> <P> 4.5.5  <E T="03">Test Acceptability.</E> For each test performed, survival of control animals must be >90% and test results must allow determination of statistically valid LC <E T="52">50</E> and 95% confidence interval values except in cases where the LC <E T="52">50</E> is >1000 µl/L or is determined to be greater than the limits of water solubility or dispersibility. </P> <P> 4.5.6  <E T="03">Static Acute Test Summary.</E> A summary of required test conditions is provided in Table 9 of this Appendix. </P> <P> 4.6  <E T="03">Freshwater Static Acute Tests with Pimephales promelas and Ceriodaphnia dubia</E> </P> <P> 4.6.1  <E T="03">General.</E> Use EPA's <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms</E> (EPA-821-R-02-012) (1) for testing each species separately with the test product. </P> <P> 4.6.2  <E T="03">Test Solutions.</E> Modify procedures in EPA-821-R-02-012 specifically dealing with the handling and toxicity testing of effluents or receiving water samples as follows: Prepare stock solutions following the appropriate sections (4.3.1, 4.3.2, or 4.3.3) of this Appendix and exposure concentrations following section 4.4 of this Appendix. </P> <P> 4.6.3  <E T="03">Number of Treatments, Replicates and Organisms. P. promelas:</E> Conduct a minimum of three replicates of at least five exposure treatments plus a minimum of three replicate dilution water controls. Expose ten organisms per replicate treatment. <E T="03">C. dubia:</E> Conduct a minimum of four replicates of at least five exposure treatments plus a minimum of four replicate dilution water controls. Expose five organisms per replicate treatment. </P> <P> 4.6.4  <E T="03">Exposure Period.</E> Test duration is 48-hr for <E T="03">C. dubia</E> and 96-hr for <E T="03">P. promelas.</E> Mortality must be recorded at each 24 hour period of each test. </P> <P> 4.6.5  <E T="03">Test Acceptability.</E> For each test performed, survival of control animals must be >90% and test results must allow determination of statistically valid LC <E T="52">50</E> and 95% confidence interval values except in cases where the LC <E T="52">50</E> is >1000 µl/L or is determined to be greater than the limits of water solubility of dispersibility. </P> <P> 4.6.6  <E T="03">Static Acute Test Summary.</E> A summary of required test conditions is provided in Table 9 of this Appendix. </P> <P> 4.7  <E T="03">Laboratory Report.</E> The laboratory must include, for each toxicity test report, all applicable information, data and analyses as follows: <PRTPAGE P="270"/> </P> <P> 4.7.1  <E T="03">Test Objective:</E> protocol title and source, endpoint(s); </P> <P> 4.7.2  <E T="03">Product Information:</E> product name, manufacturer contact information, lot number, production date, date received/chain of custody; </P> <P> 4.7.3  <E T="03">Contract Facility:</E> contact information; </P> <P> 4.7.4  <E T="03">Dilution Water:</E> source, pretreatment, physical and chemical characteristics (pH, salinity); </P> <P> 4.7.5  <E T="03">Test Conditions:</E> date and time of test (start and end), test chambers type and volume, volume of solution per chamber, number of organisms per chamber, number of replicate chambers per treatment, feeding frequency, amount and type of food, test concentrations, test temperature (mean and range), test salinity (mean and range); </P> <P> 4.7.6  <E T="03">Test Organisms:</E> common and scientific name, source contact information, age and date purchased, acclimation conditions ( <E T="03">e.g.,</E> temperature, salinity, both mean and range), age at test start; </P> <P> 4.7.7  <E T="03">Reference toxicant:</E> date received, lot number, date of most recent test, results and current Cumulative Sum Chart, dilution water used, physical and chemical methods used; </P> <P> 4.7.8  <E T="03">Quality Assurance:</E> verification of laboratory accreditation, including subcontractor facilities; </P> <P> 4.7.9  <E T="03">Test Results:</E> raw data in tabular and graphical form, daily records of affected organisms in each concentration replicate and controls, table of required endpoints ( <E T="03">i.e.,</E> LC <E T="52">50</E> , 95% CI, inhibited concentration for 50% of the species (IC <E T="52">50</E> ), lower observed effect concentration (LOEC) and no observed effect concentration (NOEC)), statistical methods used to calculate endpoints, summary tables of test conditions and QA data; and </P> <P> 4.7.10  <E T="03">Conclusions:</E> Relationship between test endpoints and threshold limit. </P> <GPOTABLE COLS="5" OPTS="L2" CDEF="s50,r50,r50,r50,r50"> <TTITLE>Table 9—Summary of Test Conditions—Surface Washing Agents, Herding Agents, Bioremediation Agents and Solidifiers Toxicity</TTITLE> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> Saltwater acute <LI> <E T="03">M. beryllina</E> </LI> </CHED> <CHED H="1"> Saltwater acute <E T="03">A. bahia</E> </CHED> <CHED H="1"> Freshwater acute <LI> <E T="03">P. promelas</E> </LI> </CHED> <CHED H="1"> Freshwater acute <E T="03">C. dubia</E> </CHED> </BOXHD> <ROW> <ENT I="01">Test type</ENT> <ENT>Static non-renewal</ENT> <ENT>Static non-renewal</ENT> <ENT>Static non-renewal</ENT> <ENT>Static non-renewal.</ENT> </ROW> <ROW> <ENT I="01">Test duration</ENT> <ENT>96 hours</ENT> <ENT>48 hours</ENT> <ENT>96 hours</ENT> <ENT>48 hours.</ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Salinity</ENT> <ENT>20 ± 2‰</ENT> <ENT>20 ± 2‰</ENT> <ENT>NA</ENT> <ENT>NA.</ENT> </ROW> <ROW> <ENT I="01">Temperature</ENT> <ENT A="03">25 ± 1 °C. Test temperatures must not deviate (maximum minus minimum temperature) by more than 3 °C during the test.</ENT> </ROW> <ROW> <ENT I="01">Light quality</ENT> <ENT A="03">Ambient laboratory illumination.</ENT> </ROW> <ROW> <ENT I="01">Light intensity</ENT> <ENT A="03"> 10-20 µE/m <SU>2</SU> /s. </ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">Photoperiod</ENT> <ENT A="03">16 h light, 8 h darkness, with phase in/out period recommended.</ENT> </ROW> <ROW> <ENT I="01"> Test chamber size  <SU>1</SU> </ENT> <ENT>250 mL</ENT> <ENT>250 mL</ENT> <ENT>250 mL</ENT> <ENT>30 mL.</ENT> </ROW> <ROW> <ENT I="01"> Test solution volume  <SU>1</SU> </ENT> <ENT>200 mL</ENT> <ENT>200 mL</ENT> <ENT>200 mL</ENT> <ENT>15 mL.</ENT> </ROW> <ROW> <ENT I="01"> Age of test organism  <SU>2</SU> </ENT> <ENT>9-14 days</ENT> <ENT>1-5 days</ENT> <ENT>1-14 days</ENT> <ENT><24 hours.</ENT> </ROW> <ROW> <ENT I="01">No. organisms per test chamber</ENT> <ENT>10</ENT> <ENT>10</ENT> <ENT>10</ENT> <ENT>5.</ENT> </ROW> <ROW RUL="n,s"> <ENT I="01">No. of replicate chambers per concentration (minimum)</ENT> <ENT>3</ENT> <ENT>3</ENT> <ENT>3</ENT> <ENT>4.</ENT> </ROW> <ROW> <ENT I="01">Feeding regime</ENT> <ENT A="03">Refer to specific feeding procedures provided in each test method.</ENT> </ROW> <ROW> <ENT I="01">Aeration</ENT> <ENT A="03">None, unless DO falls below 4.0 mg/L, then aerate all chambers. Rate: <100 bubbles/minute.</ENT> </ROW> <ROW> <ENT I="01">Test concentrations</ENT> <ENT A="03">5 exposure concentrations and a control (minimum required).</ENT> </ROW> <ROW> <ENT I="01">Test acceptability (required)</ENT> <ENT A="03">≥90% survival in controls.</ENT> </ROW> <TNOTE> <SU>1</SU>  Recommended minimum value. </TNOTE> <TNOTE> <SU>2</SU>  Less than or equal to 24-hr range in age. </TNOTE> </GPOTABLE> <P> 4.8  <E T="03">References for Section 4</E> </P> <FP SOURCE="FP-2"> (1) U.S. EPA. 2002. <E T="03">Methods for Measuring the Acute Toxicity of Effluents and Receiving Waters to Freshwater and Marine Organisms.</E> Fifth Edition. U.S. Environmental Protection Agency, Washington, DC (EPA-821-R-02-012). </FP> <P> 5.0  <E T="03">Bioremediation Agent Efficacy Test Protocol</E> </P> <P> 5.1  <E T="03">Summary.</E> This protocol quantifies changes in weathered Alaska North Slope (ANS) crude oil composition of alkanes and aromatics resulting from the use of a bioremediation agent in either artificial seawater or freshwater. The manufacturer may test either one or both freshwater or saltwater, depending on the product's intended use. Biodegradation of the alkanes and aromatics is monitored for 28 days at 20-23 °C. Product flasks at Day 28 are compared to Day 0 flasks to determine reductions in alkanes and aromatics. A positive control of a known oil-degrading bacterial consortium supplied by EPA is tested. A negative, sterile control is also set up containing exposure <PRTPAGE P="271"/> water, weathered crude oil, product, and a sterilant, sodium azide. The purpose of the negative, killed control is to make sure the disappearance of the oil constituents at day 28 is due to biodegradation and not some physical loss such as volatilization. The day 28 GC/MS results from the killed control must not be less than 90% of the day 0 results. The sample preparation procedure extracts the oil phase into the solvent dichloromethane (DCM) (also known as methylene chloride) with a subsequent solvent exchange into hexane. The hexane extracts are analyzed by a high-resolution gas chromatograph/mass spectrometer (GC/MS) operated in the selected ion monitoring mode (SIM) at a scan rate of >5 scans per second. </P> <P> <E T="03">Note to 5.1:</E> Alaska North Slope (ANS) crude oil is artificially weathered by distillation at 521 °F (272 °C) to remove the low molecular weight hydrocarbons to approximate natural weathering processes that occur after a spill. </P> <P> 5.2  <E T="03">Apparatus.</E> All equipment must be maintained and calibrated per standard laboratory procedures. </P> <P>5.2.1 Assorted flasks and other glassware;</P> <P>5.2.2 Graduated cylinders (100 mL);</P> <P>5.2.3 Deionized water;</P> <P>5.2.4 250 mL borosilicate glass Erlenmeyer flasks;</P> <P>5.2.5 250 mL separatory funnels with stopcocks</P> <P>5.2.6 Pasteur pipettes;</P> <P>5.2.7 Multichannel pipettor (5-50 mL and 50-200 mL);</P> <P>5.2.8 Autoclave; environmental room or incubator;</P> <P>5.2.9 Balance accurate to 0.1 mg;</P> <P>5.2.10 Orbital shaker table with clamps sized to hold flasks securely;</P> <P>5.2.11 GC/MS instrument equipped with a DB-5 capillary column (30 m, 0.25 mm ID, and 0.25 mm film thickness) or equivalent, and a split/splitless injection port operating in the splitless mode, such as an Agilent 6890 GC/5973 MS (or equivalent) equipped with an auto-sampler for testing multiple samples; and</P> <P>5.2.12 Fixed Rotor Centrifuge.</P> <P> 5.3  <E T="03">Reagents and consortium medium.</E> </P> <P> 5.3.1  <E T="03">Stock Seawater Preparation.</E> Prepare the artificial seawater GP2 (modified from Spotte <E T="03">et al.,</E> 1984) following the procedures in section 2.3 of this Appendix, to obtain the final concentration of the salts listed in Table 1 of this Appendix, except for the sodium bicarbonate (NaHCO <E T="52">3</E> ) which is prepared separately. Autoclave the artificial seawater. Filter sterilize the concentrated solution of sodium bicarbonate through a 0.45 µm membrane filter and add to the autoclaved and cooled artificial seawater GP2 to obtain the final concentration listed in Table 1 of this Appendix. </P> <P> 5.3.2  <E T="03">Seawater for the positive control flasks.</E> Prepare sodium triphosphate (a.k.a., sodium tripolyphosphate) (Na <E T="52">5</E> P <E T="52">3</E> O <E T="52">10</E> ), potassium nitrate (KNO <E T="52">3</E> ), and ferric chloride hexahydrate (FeCl <E T="52">3</E> · 6H <E T="52">2</E> O) as a concentrated solution. Filter sterilize through a 0.45 µm membrane filter and add to autoclaved artificial seawater to obtain the final nutrient concentrations listed in Table 10 of this Appendix. Calibrate the pH meter at room temperature (approximately 20-23 °C) using commercial buffers of pH 4.0, 7.0, and 10.0, as appropriate, prior to use. Adjust the pH of the artificial seawater with concentrated hydrochloric acid (HCl) or 10 normality sodium hydroxide (10 N NaOH), as appropriate. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s25,14"> <TTITLE>Table 10—Artificial Seawater Nutrient Concentrations</TTITLE> <BOXHD> <CHED H="1">Constituent</CHED> <CHED H="1"> Final <LI>concentration,</LI> <LI>g/L</LI> </CHED> </BOXHD> <ROW> <ENT I="01"> * FeCl <E T="0732">3</E> · 6H <E T="0732">2</E> O </ENT> <ENT>0.050</ENT> </ROW> <ROW> <ENT I="01"> KNO <E T="0732">3</E> </ENT> <ENT>2.890</ENT> </ROW> <ROW> <ENT I="01"> * Na <E T="0732">5</E> P <E T="0732">3</E> O <E T="0732">10</E> </ENT> <ENT>0.297</ENT> </ROW> <TNOTE>* Added aseptically after the GP2 has been autoclaved to limit phosphorus and iron precipitation.</TNOTE> </GPOTABLE> <P>5.3.3 Seawater for bioremediation agents that do not include nutrients. If a bioremediation agent contains living microorganisms but not nutrients (or limiting concentrations of nutrients), then nutrients may be added by the manufacturer. However, the total concentration of the nutrients added to the bioremediation agent must not exceed the final concentrations listed in Table 11 of this Appendix.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,r50"> <TTITLE>Table 11—Artificial Seawater Nutrient Concentrations for BioRemediation Agents Having No Nutrients Included</TTITLE> <BOXHD> <CHED H="1">Constituent</CHED> <CHED H="1"> Final <LI>concentration,</LI> <LI>g/L</LI> </CHED> </BOXHD> <ROW> <ENT I="01">as Iron (Fe)</ENT> <ENT>0.010</ENT> </ROW> <ROW> <ENT I="01">as Nitrogen (N)</ENT> <ENT>0.400</ENT> </ROW> <ROW> <ENT I="01">as Phosphorus (P)</ENT> <ENT>0.075</ENT> </ROW> </GPOTABLE> <FP>If nutrients are supplied by the product manufacturer, the specific composition and concentration used in the efficacy testing must be submitted.</FP> <P> 5.3.4  <E T="03">Freshwater Preparation.</E> The artificial freshwater, which is a modification of Bushnell-Haas medium (Haines <E T="03">et al.,</E> 2005), is prepared following the concentrations listed in Table 12 of this Appendix and then autoclaved. The pH is adjusted to 7.4 before autoclaving. Constituents removed from the original formulation are KNO <E T="52">3</E> , K <E T="52">2</E> HPO4 and KH <E T="52">2</E> PO <E T="52">4</E> . <PRTPAGE P="272"/> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,14"> <TTITLE>Table 12—Constituent Concentrations for Artificial Freshwater</TTITLE> <TDESC>[Bushnell-Haas]</TDESC> <BOXHD> <CHED H="1">Constituent</CHED> <CHED H="1"> Final <LI>concentration</LI> <LI>(mg/L)</LI> </CHED> </BOXHD> <ROW> <ENT I="01"> MgSO <E T="0732">4</E> · 7H <E T="0732">2</E> O </ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01"> CaCl <E T="0732">2</E> · 2H <E T="0732">2</E> O </ENT> <ENT>20</ENT> </ROW> <ROW> <ENT I="01"> FeCl <E T="0732">3</E> · 6H <E T="0732">2</E> O </ENT> <ENT>50</ENT> </ROW> <ROW> <ENT I="01"> MnSO <E T="0732">4</E> × H <E T="0732">2</E> O </ENT> <ENT>0.0302</ENT> </ROW> <ROW> <ENT I="01"> H <E T="0732">3</E> BO <E T="52">3</E> </ENT> <ENT>0.0572</ENT> </ROW> <ROW> <ENT I="01"> ZnSO <E T="52">4</E> × 7H <E T="0732">2</E> O </ENT> <ENT>0.0428</ENT> </ROW> <ROW> <ENT I="01"> (NH <E T="0732">4</E> ) <E T="52">6</E> Mo <E T="0732">7</E> O <E T="0732">2</E> </ENT> <ENT>0.0347</ENT> </ROW> </GPOTABLE> <P> 5.3.5  <E T="03">Freshwater for the positive control.</E> To prepare the freshwater for the positive controls, prepare the nutrients potassium phosphate monobasic (KH2PO4), potassium phosphate dibasic (K2HPO4) and potassium nitrate (KNO3) as a concentrated solution. Filter sterilize and add to autoclaved artificial freshwater to obtain the final concentrations given in Table 13 of this Appendix. Calibrate the pH meter at room temperature (approximately 20-23 °C) using commercial buffers of pH 4.0, 7.0, and 10.0, as appropriate, prior to use. Adjust the pH of the artificial freshwater to 7.4 with 1 N HCl or 1 N NaOH, as appropriate. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,14"> <TTITLE>Table 13—Freshwater Nutrient Concentrations</TTITLE> <BOXHD> <CHED H="1">Constituent</CHED> <CHED H="1"> Final <LI>concentration</LI> <LI> (g/L)  <SU>1</SU> </LI> </CHED> </BOXHD> <ROW> <ENT I="01"> KNO <E T="0732">3</E> </ENT> <ENT>2.89</ENT> </ROW> <ROW> <ENT I="01"> KH <E T="0732">2</E> PO <E T="0732">4</E> </ENT> <ENT>1.00</ENT> </ROW> <ROW> <ENT I="01"> K <E T="0732">2</E> HPO <E T="0732">4</E> </ENT> <ENT>1.00</ENT> </ROW> <TNOTE> <SU>1</SU>  Adjust pH to 7.4 prior to autoclaving. </TNOTE> </GPOTABLE> <P> 5.3.6  <E T="03">Freshwater for bioremediation agents that contain living microorganisms but not nutrients or limiting concentrations of nutrients.</E> If a bioremediation agent does not include nutrients, then nutrients may be added. However, the total concentration of the nutrients added to the bioremediation agent must not exceed the final concentrations provided in Table 14 of this Appendix. </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,r75"> <TTITLE>Table 14—Artificial Freshwater Nutrient Concentrations for Bioremediation Agents Having No Nutrients Included</TTITLE> <BOXHD> <CHED H="1">Constituent</CHED> <CHED H="1"> Final <LI>concentration,</LI> <LI> g/L  <SU>1</SU> </LI> </CHED> </BOXHD> <ROW> <ENT I="01">as Iron (Fe)</ENT> <ENT>not added since iron is already in the freshwater solution.</ENT> </ROW> <ROW> <ENT I="01">as Nitrogen (N)</ENT> <ENT>0.400.</ENT> </ROW> <ROW> <ENT I="01">as Phosphorus (P)</ENT> <ENT>0.400.</ENT> </ROW> <TNOTE> <SU>1</SU>  Adjust to pH 7.4 prior to autoclaving. </TNOTE> </GPOTABLE> <FP>If nutrients are supplied by the product vendor, the specific composition and concentration used in the efficacy testing must be submitted.</FP> <P> 5.3.7  <E T="03">Oil Preparation.</E> The test oil, weathered ANS521 crude oil, can be obtained from EPA at no charge (except for a minimal shipping fee). See <E T="03">https://www.epa.gov/emergency-response/national-contingency-plan-subpart-j#howto</E> for more information. </P> <P> 5.3.8  <E T="03">Sodium azide sterilant.</E> Prepare a stock solution of NaN <E T="52">3</E> for addition to the negative killed control. The final concentration in the killed controls will be 0.5 g/L. </P> <P> 5.4  <E T="03">Experimental Setup and Procedure</E> </P> <P>5.4.1 Autoclave clean borosilicate glass Erlenmeyer flasks (250 mL) for 20 minutes at 121 °C at 15 psig.</P> <P>5.4.2 Label flasks with the appropriate code (negative control, positive control, or product; day to be sampled (0 or 28); letter indicating replicate number) to reflect the following treatment design in Table 15 of this Appendix:</P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s100,6,6,10"> <TTITLE>Table 15—Bioremediation Efficacy Test—Summary of Experimental Setup</TTITLE> <BOXHD> <CHED H="1">Treatment</CHED> <CHED H="1"> Number of <LI>replicates at</LI> <LI>sampling times</LI> </CHED> <CHED H="2">Day 0</CHED> <CHED H="2">Day 28</CHED> <CHED H="1">Analysis</CHED> </BOXHD> <ROW> <ENT I="01"> Negative (killed) Control (oil + exposure water + product + EPA consortium + NaN <E T="52">3</E> sterilant) </ENT> <ENT>0</ENT> <ENT>3</ENT> <ENT>GC/MS</ENT> </ROW> <ROW> <ENT I="01">* Positive control (oil + exposure water + nutrients + EPA consortium)</ENT> <ENT>6</ENT> <ENT>6</ENT> <ENT>GC/MS</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">Test Type 1:</E> Product containing living microorganisms (oil + exposure water + living product + supplemented nutrients (if necessary)) </ENT> <ENT>6</ENT> <ENT>6</ENT> <ENT>GC/MS</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">Test Type 2:</E> Product containing proprietary nutrients but no live microorganisms (oil + exposure water + product + EPA consortium) </ENT> <ENT>6</ENT> <ENT>6</ENT> <ENT>GC/MS</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">Test Type</E> 3: Product (such as an enzyme) containing no live microorganisms and no nutrients (oil + exposure water + product) </ENT> <ENT>6</ENT> <ENT>6</ENT> <ENT>GC/MS</ENT> </ROW> <TNOTE>* The laboratory must report positive control test results conducted within the year of any test results for bioremediation products, for one or both types of water as applicable.</TNOTE> </GPOTABLE> <P> 5.4.3 Aseptically dispense 100 mL of pre-sterilized artificial exposure water (seawater or freshwater) into each sterile flask. For the positive control flasks, use exposure water containing nutrients. <PRTPAGE P="273"/> </P> <P>5.4.4 Tare the labeled flasks containing exposure water and other additions, as necessary, on the balance with a minimum accuracy of 0.01 g. Add drop-wise 0.50 g oil (this results in a final oil concentration of 5 g/L) using a sterile Pasteur pipette to the center of the flask taking care to avoid splashing the oil onto the sides of the flasks. Record the precise weight. ANS521 may be previously warmed in a hot water bath at 60 °C for 40-60 minutes to facilitate its flow. Take precautions when handling and charging the flasks to minimize the likelihood of contamination by exogenous microbes, including using a new sterile pipette for each series of flasks.</P> <P> 5.4.5 Preparation of the EPA consortium for both the positive control flasks and the flasks containing non-living bio-stimulation products. Use the supplied vials containing approximately 5 mL of the known EPA consortium frozen in glycerol. Thaw the supplied vials at room temperature ( <E T="03">do not allow cultures preserved in glycerol to sit at room temperature past thawing</E> ), transfer the contents of the thawed vials to a single sterile centrifuge tube, rinse tubes with two volumes each of sterile exposure water, centrifuge at between 6,000- and 7,000-times gravity (6,000-7,000 × <E T="03">g</E> ) for 15 minutes using a fixed rotor to fully pellet the cells. Carefully resuspend the cell pellet in sterile exposure water using the appropriate volume to achieve the desired seeding density, which will be provided by EPA upon shipment of the consortium. </P> <P>5.4.6 Positive control flasks contain exposure water, oil, nutrients, and the EPA consortium.</P> <P>5.4.7 Negative killed control flasks for all products shall contain exposure water, oil, product, the EPA consortium for products not containing a living culture, and the sodium azide sterilant at a final concentration of 0.5 g/L. Add the sodium azide sterilant prior to adding any product or EPA consortium. For the negative killed control flasks and product flasks, prepare and add the product to the flasks in a concentration specified by the manufacturer or vendor.</P> <P>5.4.8 For non-living products that contain nutrient only, use the EPA consortium as the inoculum.</P> <P> 5.4.9 For other non-living products ( <E T="03">e.g.,</E> enzymes), do not add nutrients or the EPA consortium as the inoculum as they are not needed. </P> <P>5.4.10 For products containing living microorganisms, prepare 6 flasks the same way as in Steps a-d, but without the EPA consortium. A product that contains its own nutrients must not be amended with nutrients, unless the product contains insufficient nutrients. Since this is a closed flask test, nutrients could be limiting if they are at the same concentration as used in the field. This could cause the product to fail the test. Thus, the manufacturer has the option to supplement its product with a higher concentration of nutrients than that contained in the product. Any nutrient supplements to a product must be reported and must not exceed the concentration limits in Table 10 (for seawater) and 13 (for freshwater) of this Appendix, as applicable.</P> <P>5.4.11 Cap all flasks either with sterile cotton stoppers or loosely applied aluminum foil to allow gas exchange with the atmosphere. Set aside the T = 0 flasks for immediate extraction and analysis. Place the rest of the flasks onto the orbital shaker table. Do not tip the flasks excessively to avoid stranding oil above the mixing area of the flask. Set the orbital shaker to 200 rpm and shake the flasks for 28 days at 20-23 °C in the dark.</P> <P>5.4.12 Submit all information on added microorganisms and nutrients for testing in the data report.</P> <P> 5.5  <E T="03">Sampling and Chemical Analysis.</E> </P> <P> 5.5.1  <E T="03">Summary.</E> At each sampling event (Days 0 and 28), product and control flasks are sacrificed for analysis of residual oil concentrations (SOP 4 of this Appendix). Record all physical observations for each flask (such as degree of emulsification, whether the oil has congealed into tar balls, wall growth, color, etc.) at each sampling. The analytical procedure is summarized in Table 16 of this Appendix. Dichloromethane (DCM) is the solvent used for the initial extraction. Solvent-exchange the extract into hexane prior to injection into the gas chromatograph. The solvent exchange is done to prevent asphaltenes from contaminating the column. </P> <GPOTABLE COLS="7" OPTS="L2,nj,p7,7/8" CDEF="xs36,r40,r40,xs36,r40,12,9"> <TTITLE>Table 16—Bioremediation Efficacy—Summary of Analytical Procedures</TTITLE> <BOXHD> <CHED H="1">Matrix</CHED> <CHED H="1">Measurement</CHED> <CHED H="1"> Sampling/ <LI>measurement method</LI> </CHED> <CHED H="1"> Analysis <LI>method</LI> </CHED> <CHED H="1">Sample container/quantity of sample</CHED> <CHED H="1"> Preservation/ <LI>storage</LI> <LI>( °C)</LI> </CHED> <CHED H="1"> Holding <LI>times</LI> <LI>(months)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">DCM</ENT> <ENT>N/A</ENT> <ENT>Solvent Exchange to Hexane</ENT> <ENT>N/A</ENT> <ENT>Capped Vial with Teflon septa, 30  mL</ENT> <ENT>4</ENT> <ENT>6</ENT> </ROW> <ROW> <ENT I="01">Hexane</ENT> <ENT>Hydrocarbon Concentration</ENT> <ENT>SOP 4</ENT> <ENT>GC/MS</ENT> <ENT>Capped Vial with Teflon septa, 10  mL</ENT> <ENT>4</ENT> <ENT>6</ENT> </ROW> </GPOTABLE> <PRTPAGE P="274"/> <P> 5.5.2  <E T="03">Hydrocarbon Extraction.</E> To measure extraction efficiency, 200 µL of the 400 mg/L surrogate recovery standard (compounds and concentrations described in SOP 1 in this Appendix) is added to each flask. Add 50 mL DCM to each flask. Transfer the contents to a 250 mL separatory funnel and shake for 2 minutes; allow the phases to separate for 2 minutes. If an emulsion remains after 2 minutes, centrifuge the emulsion in Teflon® centrifuge tubes for at least ten minutes in a low-speed centrifuge at 3,000 times gravity (3,000 × <E T="03">g</E> ) to break the emulsion and recover the DCM phase. Pass the DCM extract through a funnel plugged with glass wool and containing approximately 20 g anhydrous, granular sodium sulfate (Na <E T="52">2</E> SO <E T="52">4</E> ) to remove water. Repeat the steps above two more times with 25 mL DCM each (100 mL DCM used in total). Add 10 mL DCM on to the sodium sulfate after the third extraction to rinse off any oil residue. Collect the extract in 125 mL serum vials, capped with Teflon lined septa and aluminum crimp seals, and store at 4 °C for up to 6 months. </P> <P> 5.5.3  <E T="03">Solvent Exchange.</E> Perform a solvent exchange (DCM to hexane) prior to GC/MS analysis to prevent injection of asphaltenes into the GC/MS column. Transfer the DCM extract to concentration tubes. Place the tubes in a 29 °C water bath under a stream of dry nitrogen gas. Reduce the sample to 1 mL and transfer the extract to a 10 mL volumetric flask. Rinse the concentration tube with hexane and add it to the volumetric flask 2 times. Adjust the final volume with hexane to 10 mL. </P> <P> 5.5.4  <E T="03">Hydrocarbon Analysis.</E> Quantify the concentrations of 25 alkanes, 32 aromatics and hopane (SOP 4, Table SOP 4.4 of this Appendix) using an Agilent 6890 GC/5973 MS or equivalent equipped with a 30-m × 0.25-mm ID × 0.25-µm film thickness DB-5 or equivalent fused silica column. To prepare the samples, transfer 1.0 mL of the hexane extract into a 2 mL autosampler vial with Teflon lined cap. Add 20 µL of internal standard solution to each vial with a syringe or positive displacement pipettor. SOP 2 of this Appendix outlines the procedure for preparing the internal standard solution. Load vials onto the autosampler tray and analyze in selected ion monitoring mode (SIM). Sum the individual alkane concentrations for the total alkane concentration and the individual aromatic concentrations for total aromatic concentrations in each flask. </P> <P> 5.6  <E T="03">Quality Assurance/Quality Control (QA/QC).</E> </P> <P> 5.6.1  <E T="03">Objectives.</E> The critical variables to be analyzed for each set of experimental conditions are the individual petroleum hydrocarbons, <E T="03">i.e.,</E> the alkanes ranging in carbon number from nC-14 to nC-35, plus pristane and phytane, and the 2- to 4-ring polycyclic aromatic hydrocarbons (PAHs) and their alkylated homologs as listed in SOP 4 of this Appendix. The quality assurance objectives for precision, accuracy, and detection limits are ±20%, 75-125% recovery, and 22.5 µg/L on average for the 58 compounds, respectively. For more details, refer to the SOPs of this Appendix. </P> <P> 5.6.2  <E T="03">Precision Objectives.</E> Precision is presented as relative percent difference (RPD) for duplicate measurements and as relative standard deviation (RSD, or coefficient of variance) for triplicate measurements, applicable to replication of treatments as separate samples. </P> <P> 5.6.3  <E T="03">Accuracy Objectives.</E> These are based on the check standards and standard oil samples run concurrently with the sample analyses for GC/MS analysis of critical compounds. Critical compounds in the check standards and in the oil standards must fall within 75-125% of expected values for the analysis to be valid. Six surrogate compounds (SOP 1 of this Appendix) added to each sample before extraction can also serve as a surrogate for determining accuracy. The measured surrogate concentrations must fall within 75-125% of expected values. </P> <P> 5.6.4  <E T="03">Calibration Range.</E> Conduct all measurements within the linear calibration range of the instrument. The calibrated concentration range for GC/MS analysis is 0.1 mg/L to 30 mg/L. If the measured concentration of any critical compound is above the calibration range, dilute the sample and re-analyze to quantify that particular compound within the linear calibration range. </P> <P> 5.6.5  <E T="03">Quality Control.</E> Table 17 of this Appendix summarizes the QC checks for each measurement. See the corresponding SOP in this Appendix for detailed descriptions of QC checks, frequency, acceptance criteria, and corrective actions. </P> <GPOTABLE COLS="6" OPTS="L2,p7,7/8" CDEF="xs36,r30,r30,r30,r50,r50"> <TTITLE>Table 17—QA/QC Checks</TTITLE> <BOXHD> <CHED H="1"> Sample <LI>matrix</LI> </CHED> <CHED H="1">Measurement</CHED> <CHED H="1">QA/QC check</CHED> <CHED H="1">Frequency</CHED> <CHED H="1">Acceptance criteria</CHED> <CHED H="1">Corrective action</CHED> </BOXHD> <ROW> <ENT I="01">DCM</ENT> <ENT>GC/MS hydrocarbon analysis</ENT> <ENT>Blanks</ENT> <ENT>Once per calibrated run</ENT> <ENT>Peak area of interfering peaks <10% of lowest standard peak area</ENT> <ENT>Flush with solvent, clean injection port, and/or bake column.</ENT> </ROW> <ROW> <PRTPAGE P="275"/> <ENT I="01">DCM</ENT> <ENT>GC/MS hydrocarbon analysis</ENT> <ENT>DFTPP Check Standard</ENT> <ENT>Once per calibrated run</ENT> <ENT>Must pass all DFTPP criteria</ENT> <ENT>If any criteria fail, retune and rerun DFTPP check standard.</ENT> </ROW> <ROW> <ENT I="01">DCM</ENT> <ENT>GC/MS hydrocarbon analysis</ENT> <ENT>Initial Calibration Samples</ENT> <ENT>Once per calibrated run</ENT> <ENT>Response Factor RSD ≤25% or R2 >0.99</ENT> <ENT>If RSD for any one compound >25%, recalibrate.</ENT> </ROW> <ROW> <ENT I="01">DCM</ENT> <ENT>GC/MS hydrocarbon analysis</ENT> <ENT>Calibration Check Standards</ENT> <ENT>Every 10-15 samples</ENT> <ENT>±25% of expected values</ENT> <ENT>If >5 compounds are out of range, recalibrate and rerun samples.</ENT> </ROW> <ROW> <ENT I="01">Hexane</ENT> <ENT>GC/MS hydrocarbon analysis</ENT> <ENT>Surrogates</ENT> <ENT>Every Sample</ENT> <ENT>±30% of expected values</ENT> <ENT>Re-inject.</ENT> </ROW> <ROW> <ENT I="01">Hexane</ENT> <ENT>GC/MS hydrocarbon analysis</ENT> <ENT>Biomarker Concentration</ENT> <ENT>Every Sample</ENT> <ENT>±25% of average values</ENT> <ENT>Re-inject.</ENT> </ROW> </GPOTABLE> <P> 5.7  <E T="03">Pass/Fail Criteria.</E> </P> <P>5.7.1 Calculate the mean and standard deviation of the hopane-normalized total aromatics (sum of all resolved aromatics) and hopane-normalized total alkane concentrations (sum of all resolved alkanes) from the 6 independent replicates at days 0 and 28. To normalize, divide the sum of the alkane analytes and the sum of the aromatic analytes in each replicate by the hopane concentration in the corresponding replicate.</P> <P>5.7.2 From those data, calculate the 95% Upper Confidence Level (UCL95) at days 0 and 28 using the following formula (Equation 11 of this Appendix):</P> <GPH SPAN="2" DEEP="28"> <GID>ER12JN23.089</GID> </GPH> <FP SOURCE="FP-2">where:</FP> <FP SOURCE="FP-2"> <E T="03"> x <AC T="8"/> </E> <E T="54">t</E> <E T="52">(0</E> <E T="54">and</E> <E T="52">28)</E> = total hopane-normalized alkane or total hopane-normalized aromatic mean of 6 replicates at days 0 and 28, </FP> <FP SOURCE="FP-2"> <E T="03">t</E> <E T="52">95, 5 df</E> = the 95% one-tailed t-value with 5 degrees of freedom (2.015), </FP> <FP SOURCE="FP-2">s = the standard deviation of the 6 replicates at day 0 and 28, and</FP> <FP SOURCE="FP-2">n = no. of replicates = 6.</FP> <P> 5.7.3 Using Equation 12 of this Appendix, calculate the % reduction of each oil fraction from day 0 to day 28, using the day 0 and 28 UCL <E T="52">95</E> hopane-normalized values for each fraction: </P> <GPH SPAN="2" DEEP="32"> <GID>ER12JN23.090</GID> </GPH> <FP SOURCE="FP-2">where:</FP> <FP SOURCE="FP-2"> <E T="03">t</E> <E T="52">28(</E> <E T="54">UCL</E> <E T="52">95)</E> = UCL <E T="52">95</E> of the hopane-normalized total alkane or total aromatic mean of 6 replicates on day 28, and </FP> <FP SOURCE="FP-2"> <E T="03">t</E> <E T="52">0(</E> <E T="54">UCL95)</E> = UCL <E T="52">95</E> of the hopane-normalized total alkane or total aromatic mean of 6 replicates on day 0. </FP> <P> 5.7.4 A product is successful in saltwater or freshwater if the % reduction of total alkanes (aliphatic fraction) from the GC/MS analysis is greater than or equal to 85% and the % reduction of total aromatics (aromatic fraction) is greater than or equal to 35% at day 28 based on the UCL <E T="52">95</E> (Equation 12 of <PRTPAGE P="276"/> this Appendix). The benchmark reduction ranges in aliphatic and aromatic fractions for the positive control are the same as for the products specified above. The average concentration of the biomarker hopane at day 28 must not differ from the average concentration at day 0 by more than 12% in the positive control. If the conditions for the positive control are not met, the entire procedure must be repeated. </P> <P> 5.8  <E T="03">Data Verification and Reporting.</E> GC/MS data files are generated by MS ChemStation software (the Agilent standard software for GC/MS) or equivalent for each injection. Data files contain summed ion chromatograms and selected ion chromatograms. Calibration curves are generated within MS ChemStation software, and all data files are calculated against the calibration curve by MS ChemStation. Data verification would be done by crosschecking between analysts for 10% of the raw data and its reduction process. </P> <P> 5.9  <E T="03">Laboratory Report.</E> The summary of findings from a product test must include the data listings for each analyte that was analyzed ( <E T="03">i.e.,</E> all individual alkanes and aromatics in the list of required analytes), along with QA/QC checks (see Table 17) and instrument detection/reporting limits for each analyte. Express all concentrations as mg analyte/L exposure water. </P> <P> 5.10  <E T="03">Standard Operating Procedures (SOPs) 1-4</E> </P> <P> 5.10.1  <E T="03">SOP 1. Preparation of Surrogate Recovery Standards</E> </P> <P> 5.10.1.1  <E T="03">Preparation:</E> </P> <P> 5.10.1.1.1  <E T="03">Solvents:</E> Dichloromethane (DCM), Optima grade or equivalent. </P> <P> 5.10.1.1.2  <E T="03">Reagents:</E> </P> <FP SOURCE="FP-1">D36-Heptadecane (C17)</FP> <FP SOURCE="FP-1">D50-Tetracosane (C24)</FP> <FP SOURCE="FP-1">D66-Dotriacontane (C32)</FP> <FP SOURCE="FP-1">D10-1-Methylnaphthalene</FP> <FP SOURCE="FP-1">D10-Phenanthrene</FP> <FP SOURCE="FP-1">D10-Pyrene</FP> <FP SOURCE="FP-1">5-beta-cholestane (coprostane)</FP> <FP SOURCE="FP-1"> <E T="03">Note:</E> Deuterated reagents are available from Cambridge Isotope Laboratories, Andover, MA. </FP> <P> 5.10.1.1.3  <E T="03">Equipment:</E> </P> <FP SOURCE="FP-1">Micro-spatula</FP> <FP SOURCE="FP-1">Small beakers</FP> <FP SOURCE="FP-1">Glass funnel</FP> <FP SOURCE="FP-1">Analytical balance (0.0001g)</FP> <FP SOURCE="FP-1">Vials with Teflon-lined caps</FP> <FP SOURCE="FP-1">Teflon wash bottle with Optima grade DCM</FP> <FP SOURCE="FP-1">Volumetric flask (250 mL), class A</FP> <FP SOURCE="FP-1">Pasteur pipettes</FP> <P> 5.10.1.2  <E T="03">Procedure:</E> </P> <P>5.10.1.2.1 Using a calibrated analytical balance, weigh 100 mg (0.100 g) of each reagent into separate 10-25 mL beakers.</P> <P>5.10.1.2.2 Dissolve the reagents in their beakers by adding 10 mL DCM. Use a Pasteur pipette to transfer the solutions to a single 250 mL volumetric flask.</P> <P>5.10.1.2.3 Wash the beakers 3 or 4 times with DCM. Use a Pasteur pipette to transfer each of the washings to the 250 mL volumetric flask.</P> <P>5.10.1.2.4 Dilute the solution to the 250 mL volume mark on the volumetric flask with DCM.</P> <P>5.10.1.2.5 Use a glass stopper to seal the flask and homogenize the solution by inverting the flask 5 or more times. The final concentration of this solution is 400 mg/L for each of the reagents.</P> <P>5.10.1.2.6 Transfer the solution into 40 mL storage vials and cap with Teflon-lined caps and label each with the date of preparation, operator, sample names, and concentrations.</P> <P>5.10.1.2.7 Weigh each vial and record its weight on the label. This weight is used to monitor possible evaporation during storage.</P> <P>5.10.1.2.8 Store these vials at 0 °C or lower.</P> <P>5.10.1.2.9 Before using, allow the solution to come to room temperature, and then shake it well.</P> <P>5.10.1.2.10 Weigh the vial before using it and compare the weight with the last weight recorded on the vial.</P> <P>5.10.1.2.11 If the weights are consistent, the integrity of the solution can be assumed. If not, investigate and resolve the cause. Prepare a new solution if the integrity has been compromised.</P> <P> 5.10.1.3  <E T="03">Quality Control:</E> Inject 20 µL of the surrogate stock solution into 1 mL DCM. Add 20 µL of the internal standard solution (SOP 2 of this Appendix). Analyze this solution by GC/MS using a calibrated method (SOPs 3 and 4 of this Appendix). The expected concentration of each of the corresponding surrogate compounds is 8 ± 2 mg/L. If the measured value does not fall within this range, prepare and measure another independent surrogate solution. If the measured concentration of the second surrogate solution is within the allowable tolerance range, the calibration and instrument conditions are acceptable; properly discard the first surrogate solution. If the concentration of the second surrogate solution is also out of range, then clean and recalibrate the instrument until the problem is resolved. </P> <P> 5.10.2  <E T="03">SOP 2. Preparation of Internal Standard Solution</E> </P> <P> 5.10.2.1  <E T="03">Preparation:</E> </P> <P> 5.10.2.1.1  <E T="03">Solvents:</E> Dichloromethane (DCM), Optima grade or equivalent </P> <P> 5.10.2.1.2  <E T="03">Reagents:</E> </P> <FP SOURCE="FP-1">D34 n-Hexadecane (C16)</FP> <FP SOURCE="FP-1">D42 n-Eicosane (C20)</FP> <FP SOURCE="FP-1">D62 n-Triacontane (C30)</FP> <FP SOURCE="FP-1">D8-Naphthalene</FP> <FP SOURCE="FP-1">D10-Anthracene</FP> <FP SOURCE="FP-1">D12-Chrysene</FP> <FP SOURCE="FP-1">5-alpha-Androstane</FP> <PRTPAGE P="277"/> <P> <E T="03">Note:</E> Deuterated reagents are available from Cambridge Isotope Laboratories, Andover, MA. </P> <P> 5.10.2.1.3  <E T="03">Equipment:</E> </P> <FP SOURCE="FP-1"> Micro-spatula</FP> <FP SOURCE="FP-1">Small beakers</FP> <FP SOURCE="FP-1">Glass funnel</FP> <FP SOURCE="FP-1">Analytical balance (0.0001g), calibrated and checked for accuracy</FP> <FP SOURCE="FP-1">Amber vials with Teflon-lined caps, labeled</FP> <FP SOURCE="FP-1">Teflon wash bottle with DCM</FP> <FP SOURCE="FP-1">Volumetric flask (200 mL), class A</FP> <FP SOURCE="FP-1">Pasteur pipettes</FP> <P> 5.10.2.2  <E T="03">Procedure:</E> </P> <P>5.10.2.2.1 Using a calibrated analytical balance, weigh 100 mg (0.100 g) of each of the reagents into separate small beakers.</P> <P>5.10.2.2.2 Dissolve the reagents in their beakers by adding 10 mL DCM; using a Pasteur pipette, transfer the solutions to a single 200 mL volumetric flask.</P> <P>5.10.2.2.3 Wash the beakers 3 or 4 times with DCM; use a Pasteur pipette to transfer each of the washings to the 200 mL volume mark on the volumetric flask.</P> <P>5.10.2.2.4 Dilute the solution with DCM to the 200 mL volume.</P> <P>5.10.2.2.5 Seal the flask with a glass stopper and homogenize the solution by inverting the flask a minimum of 5 times. The final concentration of this solution is 500 mg/L of each reagent.</P> <P>5.10.2.2.6 Transfer the solution into 40 mL storage vials and cap with Teflon-lined caps. Label each vial with the date of preparation, operator, sample names, and concentrations.</P> <P>5.10.2.2.7 Weigh each vial, and record its weight on the label. This weight is used to monitor possible evaporation during storage.</P> <P>5.10.2.2.8 Store this solution at 0 °C or lower.</P> <P>5.10.2.2.9 Before using, allow the solution to come to room temperature, and then shake it well.</P> <P>5.10.2.2.10 Weigh the vial before using it, and compare the weight with the last weight recorded on the vial.</P> <P>5.10.2.2.11 If the weights are consistent, the integrity of the solution can be assumed. If not, investigate and resolve the cause. Prepare a new solution if the integrity has been compromised.</P> <P> 5.10.2.3  <E T="03">Quality Control:</E> Inject 20 µL of the internal standard solution into 1 mL DCM. Analyze this solution by GC/MS. The only peaks corresponding to the internal standards must appear. If other peaks appear, particularly close to the internal standard peaks, discard the internal standard solution and prepare a new solution. </P> <P> 5.10.3  <E T="03">SOP 3. Preparation of Working Standards, Check Standards, and Oil Standards for GC/MS Consistency.</E> </P> <P> 5.10.3.1  <E T="03">Preparation:</E> </P> <P> 5.10.3.1.1  <E T="03">Solvent:</E> Dichloromethane (DCM), Optima grade or equivalent </P> <P> 5.10.3.1.2  <E T="03">Stock solutions:</E> </P> <P> 5.10.3.1.2.1  <E T="03">Oil analysis standard:</E> 44 compounds, 100 mg/L in hexane/DCM (9:1), four, 1-mL vials required. Available from Absolute Standards, Inc., Hamden, CT, Part #90311. </P> <P> 5.10.3.1.2.2  <E T="03">Nine compound PAH standard:</E> 1,000 mg/L in DCM, one vial. Available from Absolute Standards, Inc., Hamden, CT, Part #90822. </P> <P>5.10.3.1.2.3 1,2-Benzodiphenylene sulfide, (synonym for naphthobenzothiophene). Prepare a 2 mg/mL stock solution. Available from Sigma-Aldrich Co., Part # 255122, purity 99%.</P> <P>5.10.3.1.2.4 Hopane solution (17 α (H), 21β (H), 0.1 mg/mL in isooctane. Available from Sigma-Aldrich Co. Part #90656.</P> <P> 5.10.3.1.2.5  <E T="03">Surrogate solution:</E> 400 mg/L of each reagent in DCM (see SOP 1 of this Appendix). </P> <P>5.10.3.1.2.6 Internal standard solution, 500 mg/L in DCM (see SOP 2 of this Appendix).</P> <P>5.10.3.1.3 Alaska North Slope Crude Oil 521 (ANS521).</P> <P> 5.10.3.1.4  <E T="03">Equipment:</E> </P> <P>5.10.3.1.4.1 Glass storage vials with Teflon-lined caps (2 mL and 40 mL capacity);</P> <P>5.10.3.1.4.2 Volumetric flasks, Class A, 5 mL, 10 mL, and 100 mL</P> <P>5.10.3.1.4.3 Glass syringes capable of dispensing 25-500 µL with an accuracy and precision of ± 1%, or equivalent</P> <P>5.10.3.1.4.4 Wheaton repetitive dispenser, Model 411 STEP-PETTE or equivalent</P> <P>5.10.3.1.4.5 Teflon wash bottle filled with Optima grade DCM or equivalent grade DCM</P> <P>5.10.3.1.4.6 Pasteur pipettes</P> <P> The volumes of stock solutions required to make the working standards are listed in Table SOP 3.1 of this Appendix. <PRTPAGE P="278"/> </P> <GPOTABLE COLS="8" OPTS="L2,p7,7/8" CDEF="s50,13,13,10,10,10,r50,10"> <TTITLE>Table SOP 3.1—Amount of Stock Solutions Required To Make the Working Standards</TTITLE> <BOXHD> <CHED H="1">Stock standards</CHED> <CHED H="2">Working standards concentration, mg/L</CHED> <CHED H="1">A</CHED> <CHED H="2"> Oil <LI>analysis mix</LI> <LI>(44 compounds,</LI> <LI>100 mg/L)</LI> <LI>µL</LI> </CHED> <CHED H="1">B</CHED> <CHED H="2"> Aromatics <LI>mix</LI> <LI>(9 compounds,</LI> <LI>1,000 mg/L)</LI> <LI>µL</LI> </CHED> <CHED H="1">C</CHED> <CHED H="2"> 1,2-Benzo- <LI>diphenylene</LI> <LI>sulfide</LI> <LI>(NBT)</LI> <LI>(2 mg/mL)</LI> <LI>µL</LI> </CHED> <CHED H="1">D</CHED> <CHED H="2"> Surrogate <LI>solution</LI> <LI>(100 mg/L)</LI> <LI>µL</LI> </CHED> <CHED H="1">E</CHED> <CHED H="2"> Hopane <LI>solution</LI> <LI>(100 mg/L)</LI> <LI>µL</LI> </CHED> <CHED H="1"> </CHED> <CHED H="2"> Volumetric flask volume <LI>mL</LI> </CHED> <CHED H="1">F</CHED> <CHED H="2"> ISTD <LI>(500 mg/L)</LI> <LI>µL</LI> </CHED> </BOXHD> <ROW> <ENT I="01">STD 30 (no hopane)</ENT> <ENT>1,500</ENT> <ENT>150</ENT> <ENT>75</ENT> <ENT>375</ENT> <ENT>0</ENT> <ENT>5</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">STD 20 (5 mg/L hopane)</ENT> <ENT>1,000</ENT> <ENT>100</ENT> <ENT>50</ENT> <ENT>250</ENT> <ENT>250</ENT> <ENT>5</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">STD 10 (2.5 mg/L hopane)</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>125</ENT> <ENT>125</ENT> <ENT>5</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">STD 5 * (1 mg/L hopane)</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>125</ENT> <ENT>100</ENT> <ENT>10</ENT> <ENT>200</ENT> </ROW> <ROW RUL="n,s,s,s,s,s,s,n"> <ENT I="01">STD 5-Utility (1 mg/L hopane)</ENT> <ENT>500</ENT> <ENT>50</ENT> <ENT>25</ENT> <ENT>125</ENT> <ENT>100</ENT> <ENT>10 (used for preparation of STD 2.5 & STD 1)</ENT> <ENT>0</ENT> </ROW> <ROW> <ENT I="01">STD 2.5 (0.5 mg/L hopane)</ENT> <ENT A="05">Use 5 mL of STD 5-Utility and dilute to 10 mL.</ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01">STD 1 (0.2 mg/L hopane)</ENT> <ENT A="05">Use 2 mL of STD 5-Utility and dilute to 10 mL.</ENT> <ENT>200</ENT> </ROW> <ROW> <ENT I="01">STD 0.1 (0.2 mg/L hopane)</ENT> <ENT A="05">Use 0.2 mL of STD 5-Utility and dilute to 10 mL.</ENT> <ENT>200</ENT> </ROW> <TNOTE>* Make extra STD 5 for use as check standard.</TNOTE> </GPOTABLE> <PRTPAGE P="279"/> <P> 5.10.3.2  <E T="03">Procedure for Working Standards and Check Standards:</E> </P> <P>5.10.3.2.1 Label three 5 mL volumetric flasks as STD30, STD20, STD10, and two 10 mL volumetric flasks as STD5, and STD5-utility.</P> <P>5.10.3.2.2 Add 1-2 mL of DCM to each volumetric flask.</P> <P>5.10.3.2.3 Using glass syringes, add the appropriate volume of stock solution A (as listed in Table SOP 3.1 of this Appendix) to the flasks labeled STD30, STD20, STD10, STD5, and STD5-utility.</P> <P>5.10.3.2.4 Wash the walls of the inner neck of the flasks with several drops of DCM to rinse off the residue of the stock solution into the flasks.</P> <P>5.10.3.2.5 Repeat Step 3 and Step 4 to dispense stock solutions B-E (do not add stock solution F, internal standard solution, at this step).</P> <P>5.10.3.2.6 Dilute to volume with DCM for all the above flasks, seal with glass stoppers, and invert several times to homogenize the solutions.</P> <P>5.10.3.2.7 Label three additional 10 mL volumetric flasks as STD2.5, STD1, and STD0.1. Wet with 1-2 mL DCM.</P> <P>5.10.3.2.8 Dispense 5 mL of STD5-utility solution into flask STD2.5, 2 mL of STD5-utility solution into flask STD1, and 0.2 mL of STD5-utility solution into flask STD0.1.</P> <P>5.10.3.2.9 Dilute to volume with DCM, seal with glass stoppers, and invert several times to homogenize the solutions.</P> <P>5.10.3.2.10 Using a 100 µL glass syringe, dispense 100 µL of internal standard solution into flasks STD30, STD20, and STD10. Dispense 200 µL into flasks STD5, STD2.5, STD1, and STD0.1 to give a final concentration of 10 mg/L internal standard.</P> <P>5.10.3.2.11 Seal with glass stoppers, and invert the flasks several times to homogenize the solutions.</P> <P>5.10.3.2.12 Transfer the solutions into 2 mL storage vials, and cap with Teflon-lined caps.</P> <P>5.10.3.1.13 Label each vial with date of preparation, analyst, sample names, and concentrations.</P> <P>5.10.3.2.14 Weigh each storage vial and record its weight on the label. This weight is used to monitor possible evaporation during storage.</P> <P>5.10.3.2.15 Store this solution at 0 °C or below.</P> <P>5.10.3.2.16 Before using, allow the solution to come to room temperature, and shake it well.</P> <P>5.10.3.2.17 Weigh the vial before opening, and compare the weight with the last weight recorded on the vial. If the weights are consistent, the integrity of the solution can be assumed. If not, investigate and resolve the cause. Do not use the solution if the integrity has been compromised.</P> <P> 5.10.3.3  <E T="03">Procedure for Oil Standard.</E> In a 100 mL volumetric flask, weigh 0.500 g of the standard ANS521 crude oil, add 2 mL of surrogate solution (see SOP 1 of this Appendix), and bring to volume with DCM. Add 2 mL of internal standard solution (see SOP 2 of this Appendix). Follow steps 5.10.3.2.11 through 5.10.3.2.17 of this SOP, substituting 40 mL storage vials for the 2 mL vials. </P> <P> 5.10.3.4  <E T="03">Quality Control/Quality Assurance:</E> </P> <P>5.10.3.4.1 Run the seven standard solutions using the GC/MS method (SOP 4) on a tuned GC/MS. Use the EnviroQuant software or equivalent to calculate the average Relative Response Factor (RRF) and the relative standard deviation (RSD) of the RRFs for each analyte over the six concentrations. The RRF is defined as:</P> <GPH SPAN="2" DEEP="22"> <GID>ER12JN23.091</GID> </GPH> <P>5.10.3.4.2 The RSD of the RRFs for all analytes must be 25% or less. Alternatively, the coefficients of determination (R2) for the calibration curve for each target compounds and surrogate should be over 0.99.</P> <P> 5.10.4  <E T="03">SOP 4. GC/MS Method for the Analysis of Crude Oil Samples.</E> </P> <P> 5.10.4.1  <E T="03">Instrument Specifications:</E> </P> <P> 5.10.4.1.1 Use an Agilent 6890 GC coupled with an Agilent 5973 mass selective detector (MSD) and an Agilent 6890 series auto sampler or equivalent, equipped with a DB-5 capillary column (30 m, 0.25 mm I.D., and 0.25 µm film thickness) or equivalent, and a split/splitless injection port operating in the splitless mode. Data acquisition occurs in the SIM (selected ion monitoring) mode for quantitative analysis. In SIM mode, the dwell time of each ion is set to be 10 milliseconds and the ions are split up into groups by retention time. One way to divide the ions is by retention time grouping as shown in Table SOP 4.1 of this Appendix. The number of ions in each ion group must be constant, yielding the same scan rate for each group. <PRTPAGE P="280"/> </P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s75,r200"> <TTITLE>Table SOP 4.1—Ions Associated With Retention Time Groups</TTITLE> <BOXHD> <CHED H="1">Group</CHED> <CHED H="1">Ions</CHED> </BOXHD> <ROW> <ENT I="01">1</ENT> <ENT>57, 66, 128, 136, 142, 152, 156, 166, 170, 184.</ENT> </ROW> <ROW> <ENT I="01">2</ENT> <ENT>57, 66, 166, 170, 178, 180, 184, 188, 192, 194, 198, 208.</ENT> </ROW> <ROW> <ENT I="01">3</ENT> <ENT>57, 66, 178, 184, 188, 192, 194, 198, 202, 206, 208, 212, 220, 226.</ENT> </ROW> <ROW> <ENT I="01">4</ENT> <ENT>57, 66, 192, 198, 202, 206, 208, 212, 216, 220, 226, 230, 234, 245.</ENT> </ROW> <ROW> <ENT I="01">5</ENT> <ENT>57, 66, 191, 217, 228, 240, 242, 248, 256, 262, 264, 270, 276, 284.</ENT> </ROW> </GPOTABLE> <P>5.10.4.1.2 Table SOP 4.2 of this Appendix summarizes the instrumental conditions for crude oil analysis. Use only ultra-high purity helium (99.999% pure) as the carrier gas. In series, connect a moisture trap, an oxygen trap, and an organic trap to the carrier gas line before it enters the column.</P> <GPOTABLE COLS="2" OPTS="L2,p1,8/9" CDEF="s75,r150"> <TTITLE>Table SOP 4.2—Instrumental Conditions for Crude Oil Analysis</TTITLE> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01">Instrument</ENT> <ENT>Agilent 6890 Series II Gas Chromatograph (GC) with an Agilent 5973MSD and an Agilent 6890 auto sampler, or equivalent.</ENT> </ROW> <ROW> <ENT I="01">Column</ENT> <ENT>DB-5 capillary column (30 m, 0.25 mm I.D., and 0.25-mm film thickness) or equivalent.</ENT> </ROW> <ROW> <ENT I="01">Carrier Gas</ENT> <ENT>Helium, ultra-high purity grade (99.999%).</ENT> </ROW> <ROW> <ENT I="01">Inlet Temperature</ENT> <ENT>300 °C.</ENT> </ROW> <ROW> <ENT I="01">Transfer Line (detector) Temperature</ENT> <ENT>310 °C.</ENT> </ROW> <ROW> <ENT I="01">Oven Temperature Program</ENT> <ENT>50 °C for 4 minutes, then 7 °C/min to 310 °C, hold for 18 minutes.</ENT> </ROW> <ROW> <ENT I="01">Flow Rate</ENT> <ENT>Constant flow at 1mL/min. Linear velocity: 36.2 cm/sec.</ENT> </ROW> <ROW> <ENT I="01">Injection Volume</ENT> <ENT>1 µL.</ENT> </ROW> <ROW> <ENT I="01">Split/Splitless Mode</ENT> <ENT>Splitless.</ENT> </ROW> <ROW> <ENT I="01">Total Run Time</ENT> <ENT>59.18 minutes.</ENT> </ROW> </GPOTABLE> <P> 5.10.4.2  <E T="03">Procedure for preparing the instrument:</E> </P> <P>5.10.4.2.1 Lower the injection port temperature and the oven temperature to 50 °C or less to avoid oxidation of the column.</P> <P>5.10.4.2.2 Replace the liner with a clean, silanized liner. Do not touch the liner with bare fingers. A small piece of muffled glass wool may be inserted to protect the column.</P> <P>5.10.4.2.3 Return the injection port and oven to the appropriate temperatures.</P> <P>5.10.4.2.4 Wait five minutes after the temperature equilibrates before using the instrument.</P> <P> 5.10.4.3  <E T="03">Procedure for tuning the MSD:</E> </P> <P>5.10.4.3.1 Perform an air/water check. The value reported for the relative abundance of water (m/z 18), nitrogen (m/z 28), oxygen (m/z 32), or carbon dioxide (m/z 44) shall be less than 5% of the base peak for the system to be considered leak free and are expected to be closed to 1% for a stable system.</P> <P>5.10.4.3.2 Tune the MSD using the Standard Autotune program and the decafluorotriphenylphosphine (DFTPP) Tune program to reduce instrument variability. The Autotune report file is referenced by the instrument when performing an air/water check and thus must be run at least once per month. Run standards and samples using DFTPP Tune parameters, and retune the instrument using DFTPP Tune at least once per week. The tune programs use three fragment ions of perfluorotributylamine (PFTBA) as a standard for tuning: m/z 69, 219, and 502. Tune reports must meet the following criteria:</P> <P>5.10.4.3.2.1 Symmetrical peaks;</P> <P>5.10.4.3.2.2 Mass assignments within ±0.2 amu's from 69, 219, and 502;</P> <P>5.10.4.3.2.3 Peak widths within 0.5 ± 0.1 amu's;</P> <P>5.10.4.3.2.4 Relative abundance is 100% for ion 69, at least 35% for ion 219, and at least 1% for ion 502;</P> <P>5.10.4.3.2.5 Relative abundances for isotope masses 70, 220, and 503 ± 0.2 amu's are 0.5-1.5%, 2-8%, and 5-15%, respectively; and</P> <P>5.10.4.3.2.6 Air and water peaks at m/z = 18, 28, 32, and 44 amu's must be very small and consistent with historical values.</P> <P> 5.10.4.4  <E T="03">Maintaining a log book.</E> Maintain an instrument log book, and make entries for each use. Include the following information in the logbook: operator name, helium cylinder tank pressure and outlet pressure, vacuum gauge reading, any maintenance performed on the instrument (such as changing <PRTPAGE P="281"/> the injection port liner, gold seal, guard column, source cleaning), sequence name, data path, samples in order of injection, method information, GC column number, and the Standard Auto Tune report and DFTPP Tune report. </P> <P> 5.10.4.5  <E T="03">Running a Solvent Blank:</E> Following a liner change or at the start of a new run, run an injection of a pure solvent to confirm that the system is free of excessive or interfering contamination. Analyze the solvent in SCAN mode using the same temperature program used for sample analysis. If contamination is present, analyze additional samples of fresh solvent until the interfering contamination is removed. </P> <P> 5.10.4.6  <E T="03">Checking the DFTPP Tune:</E> Prior to running the first calibration standard, verify the instrument tune conditions by running a 10 ng/µL DFTPP check standard to check the mass measuring accuracy of the MS, the resolution sensitivity, the baseline threshold, and the ion abundance ranges. Run the standard using the DFTPP method provided with the instrument. Each of the criteria identified in Table SOP 4.2 of this Appendix must be met before using the instrument for analysis: </P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s25,12,r50,r50"> <TTITLE>Table SOP 4.3—Ion Abundance Criteria for DFTPP</TTITLE> <BOXHD> <CHED H="1"> Mass, <LI>M/z</LI> </CHED> <CHED H="1">Relative to mass</CHED> <CHED H="1">Relative abundance criteria</CHED> <CHED H="1">Purpose of checkpoint</CHED> </BOXHD> <ROW> <ENT I="01">51</ENT> <ENT>442</ENT> <ENT>10-80% of the base peak</ENT> <ENT>Low mass sensitivity.</ENT> </ROW> <ROW> <ENT I="01">68</ENT> <ENT>69</ENT> <ENT><2% of mass 69</ENT> <ENT>Low mass resolution.</ENT> </ROW> <ROW> <ENT I="01">70</ENT> <ENT>69</ENT> <ENT><2% of mass 69</ENT> <ENT>Low mass resolution.</ENT> </ROW> <ROW> <ENT I="01">127</ENT> <ENT>442</ENT> <ENT>10-80% of the base peak</ENT> <ENT>Low-mid mass sensitivity.</ENT> </ROW> <ROW> <ENT I="01">197</ENT> <ENT>198</ENT> <ENT><2% of mass 198</ENT> <ENT>Mid mass resolution.</ENT> </ROW> <ROW> <ENT I="01">198</ENT> <ENT>442</ENT> <ENT>Base peak or >50% of 442</ENT> <ENT>Mid mass resolution and sensitivity.</ENT> </ROW> <ROW> <ENT I="01">199</ENT> <ENT>198</ENT> <ENT>5-9% of mass 198</ENT> <ENT>Mid mass resolution and isotope ratio.</ENT> </ROW> <ROW> <ENT I="01">275</ENT> <ENT>442</ENT> <ENT>10-60% of the base peak</ENT> <ENT>Mid-high mass sensitivity.</ENT> </ROW> <ROW> <ENT I="01">365</ENT> <ENT>442</ENT> <ENT>>1% of the base peak</ENT> <ENT>Baseline threshold.</ENT> </ROW> <ROW> <ENT I="01">441</ENT> <ENT>443</ENT> <ENT>Present and < mass 443</ENT> <ENT>High mass resolution.</ENT> </ROW> <ROW> <ENT I="01">442</ENT> <ENT>442</ENT> <ENT>Base peak or >50% of 198</ENT> <ENT>High mass resolution and sensitivity.</ENT> </ROW> <ROW> <ENT I="01">443</ENT> <ENT>442</ENT> <ENT>15-24% of mass 442</ENT> <ENT>High mass resolution and isotopic ratio.</ENT> </ROW> </GPOTABLE> <P> 5.10.4.7 Calibrating <E T="03">with a Multiple-Point Calibration Curve.</E> A 5- or 6-point calibration curve is obtained by running 5 or 6 working standards (see SOP 3) on the tuned GC/MS instrument. Calculate the relative response factor (RRF) for each compound relative to its corresponding deuterated internal standard as indicated in Table SOP 4.3 of this Appendix. The relative standard deviation (RSD) of the RRFs for each compound must be less than 25%. Run an independently prepared check standard immediately after the calibration standards to validate the accuracy of the calibration curve. </P> <P> 5.10.4.8  <E T="03">Running Samples.</E> Once the calibration curve has been validated, samples can be analyzed. Dispense 1,000 µL of sample extract into labeled auto-sampler vials. Add 20 µL of the internal standard solution (see SOP 2 of this Appendix) to the extract using a syringe or a positive displacement pipettor. Run a check standard every 10 samples to ensure the consistency of the instrument. The RRF for each compound in the check standard must be within 25% of the average RRF obtained in the initial calibration. </P> <P> 5.10.4.9  <E T="03">Quantification:</E> Once a calibration table has been generated, quantify each data file using the “Calculate and Generate” function in the MS ChemStation software, or equivalent software. Review individual peak integration manually to ensure proper baseline integration. The quantification of a compound is based on the peak area of the primary ion (Q Ion) indicated in Table SOP 4.4 of this Appendix. </P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s50,12,r50,r60"> <TTITLE>Table SOP 4.4—Target Compound List</TTITLE> <BOXHD> <CHED H="1">Compound name</CHED> <CHED H="1">Quantitation ion</CHED> <CHED H="1">Reference compound for response factor</CHED> <CHED H="1">Internal standard for quantitation</CHED> </BOXHD> <ROW> <ENT I="01">N D34 C16</ENT> <ENT>66</ENT> <ENT>N D34 C16</ENT> <ENT>D34 n C16 Q Ion 66.</ENT> </ROW> <ROW> <ENT I="01">n-C14</ENT> <ENT>57</ENT> <ENT>n C14</ENT> </ROW> <ROW> <ENT I="01">n-C15</ENT> <ENT>57</ENT> <ENT>n C15</ENT> </ROW> <ROW> <ENT I="01">n-C16</ENT> <ENT>57</ENT> <ENT>n C16</ENT> </ROW> <ROW> <ENT I="01">N D34 C17</ENT> <ENT>66</ENT> <ENT>N D34 C17</ENT> </ROW> <ROW> <ENT I="01">n-C17</ENT> <ENT>57</ENT> <ENT>n C17</ENT> </ROW> <ROW> <ENT I="01">Pristane</ENT> <ENT>57</ENT> <ENT>Pristane</ENT> </ROW> <ROW> <ENT I="01">n-C18</ENT> <ENT>57</ENT> <ENT>n C18</ENT> </ROW> <ROW> <ENT I="01">Phytane</ENT> <ENT>57</ENT> <ENT>Phytane</ENT> </ROW> <ROW> <ENT I="01">n C19</ENT> <ENT>57</ENT> <ENT>n C19</ENT> </ROW> <ROW> <ENT I="01">N D42 C20</ENT> <ENT>66</ENT> <ENT>N D42 C20</ENT> <ENT>D42 n C20 Q Ion 66.</ENT> </ROW> <ROW> <ENT I="01">n C20</ENT> <ENT>57</ENT> <ENT>n C20</ENT> </ROW> <ROW> <ENT I="01">n C21</ENT> <ENT>57</ENT> <ENT>n C21</ENT> </ROW> <ROW> <PRTPAGE P="282"/> <ENT I="01">n C22</ENT> <ENT>57</ENT> <ENT>n C22</ENT> </ROW> <ROW> <ENT I="01">n C23</ENT> <ENT>57</ENT> <ENT>n C23</ENT> </ROW> <ROW> <ENT I="01">N D50 C 24</ENT> <ENT>66</ENT> <ENT>N D50 C 24</ENT> </ROW> <ROW> <ENT I="01">n C24</ENT> <ENT>57</ENT> <ENT>n C24</ENT> </ROW> <ROW> <ENT I="01">n C25</ENT> <ENT>57</ENT> <ENT>n C25</ENT> </ROW> <ROW> <ENT I="01">n C26</ENT> <ENT>57</ENT> <ENT>n C26</ENT> </ROW> <ROW> <ENT I="01">n C27</ENT> <ENT>57</ENT> <ENT>n C27</ENT> </ROW> <ROW> <ENT I="01">n C28</ENT> <ENT>57</ENT> <ENT>n C28</ENT> </ROW> <ROW> <ENT I="01">n C29</ENT> <ENT>57</ENT> <ENT>n C29</ENT> </ROW> <ROW> <ENT I="01">N D62 C30</ENT> <ENT>66</ENT> <ENT>N D62 C30</ENT> <ENT>D62 n C30Q Ion 66.</ENT> </ROW> <ROW> <ENT I="01">n C30</ENT> <ENT>57</ENT> <ENT>n C30</ENT> </ROW> <ROW> <ENT I="01">n C31</ENT> <ENT>57</ENT> <ENT>n C31</ENT> </ROW> <ROW> <ENT I="01">N D66 C32</ENT> <ENT>57</ENT> <ENT>N D66 C32</ENT> </ROW> <ROW> <ENT I="01">n C32</ENT> <ENT>57</ENT> <ENT>n C32</ENT> </ROW> <ROW> <ENT I="01">n C33</ENT> <ENT>57</ENT> <ENT>n C33</ENT> </ROW> <ROW> <ENT I="01">n C34</ENT> <ENT>57</ENT> <ENT>n C34</ENT> </ROW> <ROW> <ENT I="01">n C35</ENT> <ENT>57</ENT> <ENT>n C35</ENT> </ROW> <ROW> <ENT I="01">D8 Naphthalene</ENT> <ENT>136</ENT> <ENT>D8 Naphthalene</ENT> <ENT>D8 Naphthalene Q Ion 136.</ENT> </ROW> <ROW> <ENT I="01">Naphthalene</ENT> <ENT>128</ENT> <ENT>Naphthalene</ENT> </ROW> <ROW> <ENT I="01">D10 1-Methylnaphthalene</ENT> <ENT>152</ENT> <ENT>D10 1-Methylnaphthalene</ENT> </ROW> <ROW> <ENT I="01">C1 Naphthalene *</ENT> <ENT>142</ENT> <ENT>C1 Naphthalene</ENT> </ROW> <ROW> <ENT I="01">C2 Naphthalene *</ENT> <ENT>156</ENT> <ENT>C2 Naphthalene</ENT> </ROW> <ROW> <ENT I="01">C3 Naphthalene *</ENT> <ENT>170</ENT> <ENT>C3 Naphthalene</ENT> </ROW> <ROW> <ENT I="01">C4 Naphthalene *</ENT> <ENT>184</ENT> <ENT>C3 Naphthalene</ENT> </ROW> <ROW> <ENT I="01">D10 Anthracene</ENT> <ENT>188</ENT> <ENT>D10 Anthracene</ENT> <ENT>D10 Anthracene Q Ion 188.</ENT> </ROW> <ROW> <ENT I="01">D10 Phenanthrene</ENT> <ENT>188</ENT> <ENT>D10 Phenanthrene</ENT> </ROW> <ROW> <ENT I="01">Phenanthrene</ENT> <ENT>178</ENT> <ENT>Phenanthrene</ENT> </ROW> <ROW> <ENT I="01">C1 Phenanthrene *</ENT> <ENT>192</ENT> <ENT>C1 Phenanthrene</ENT> </ROW> <ROW> <ENT I="01">C2 Phenanthrene *</ENT> <ENT>206</ENT> <ENT>C2 Phenanthrene</ENT> </ROW> <ROW> <ENT I="01">C3 Phenanthrene *</ENT> <ENT>220</ENT> <ENT>C2 Phenanthrene</ENT> </ROW> <ROW> <ENT I="01">C4 Phenanthrene *</ENT> <ENT>234</ENT> <ENT>C2 Phenanthrene</ENT> </ROW> <ROW> <ENT I="01">Fluorene</ENT> <ENT>166</ENT> <ENT>Fluorene</ENT> </ROW> <ROW> <ENT I="01">C1 Fluorene *</ENT> <ENT>180</ENT> <ENT>Fluorene</ENT> </ROW> <ROW> <ENT I="01">C2 Fluorene *</ENT> <ENT>194</ENT> <ENT>Fluorene</ENT> </ROW> <ROW> <ENT I="01">C3 Fluorene *</ENT> <ENT>208</ENT> <ENT>Fluorene</ENT> </ROW> <ROW> <ENT I="01">Dibenzothiophene</ENT> <ENT>184</ENT> <ENT>Dibenzothiophene</ENT> </ROW> <ROW> <ENT I="01">C1 Dibenzothiophene *</ENT> <ENT>198</ENT> <ENT>Dibenzothiophene</ENT> </ROW> <ROW> <ENT I="01">C2 Dibenzothiophene *</ENT> <ENT>212</ENT> <ENT>Dibenzothiophene</ENT> </ROW> <ROW> <ENT I="01">C3 Dibenzothiophene *</ENT> <ENT>226</ENT> <ENT>Dibenzothiophene</ENT> </ROW> <ROW> <ENT I="01">Naphthobenzothiophene (NBT)</ENT> <ENT>234</ENT> <ENT>Naphthobenzothiophene</ENT> </ROW> <ROW> <ENT I="01">C1 NBT *</ENT> <ENT>248</ENT> <ENT>Naphthobenzothiophene</ENT> </ROW> <ROW> <ENT I="01">C2 NBT *</ENT> <ENT>262</ENT> <ENT>Naphthobenzothiophene</ENT> </ROW> <ROW> <ENT I="01">C3 NBT *</ENT> <ENT>276</ENT> <ENT>Naphthobenzothiophene</ENT> </ROW> <ROW> <ENT I="01">Fluoranthene</ENT> <ENT>202</ENT> <ENT>Fluoranthene</ENT> </ROW> <ROW> <ENT I="01">D10 Pyrene</ENT> <ENT>212</ENT> <ENT>D10 Pyrene</ENT> </ROW> <ROW> <ENT I="01">Pyrene</ENT> <ENT>202</ENT> <ENT>Pyrene</ENT> </ROW> <ROW> <ENT I="01">C1 Pyrene *</ENT> <ENT>216</ENT> <ENT>Pyrene</ENT> </ROW> <ROW> <ENT I="01">C2 Pyrene *</ENT> <ENT>230</ENT> <ENT>Pyrene</ENT> </ROW> <ROW> <ENT I="01">D12 Chrysene</ENT> <ENT>240</ENT> <ENT>D12 Chrysene</ENT> <ENT>D12 Chrysene Q Ion 240.</ENT> </ROW> <ROW> <ENT I="01">Benzo(a)anthracene/Chrysene *</ENT> <ENT>228</ENT> <ENT>Chrysene</ENT> </ROW> <ROW> <ENT I="01">C1 Chrysene *</ENT> <ENT>242</ENT> <ENT>Chrysene</ENT> </ROW> <ROW> <ENT I="01">C2 Chrysene *</ENT> <ENT>256</ENT> <ENT>Chrysene</ENT> </ROW> <ROW> <ENT I="01">C3 Chrysene *</ENT> <ENT>270</ENT> <ENT>Chrysene</ENT> </ROW> <ROW> <ENT I="01">C4 Chrysene *</ENT> <ENT>284</ENT> <ENT>Chrysene</ENT> </ROW> <ROW> <ENT I="01">5α-androstane</ENT> <ENT>245</ENT> <ENT>5α-androstane</ENT> <ENT>5α-androstane Q Ion 245.</ENT> </ROW> <ROW> <ENT I="01">Coprostane</ENT> <ENT>219</ENT> <ENT>Coprostane</ENT> </ROW> <ROW> <ENT I="01">Hopane</ENT> <ENT>191</ENT> <ENT>Hopane</ENT> </ROW> <TNOTE>* Summed compounds; draw an integration line underneath all peaks with selected ion.</TNOTE> </GPOTABLE> <P>5.10.4.10 Equation 14 of this Appendix is used to calculate the concentration of analytes in units of µg/g oil added:</P> <GPH SPAN="2" DEEP="25"> <PRTPAGE P="283"/> <GID>ER12JN23.092</GID> </GPH> <FP SOURCE="FP-2">where:</FP> <FP SOURCE="FP-2"> A <E T="52">analyte</E> = the peak area of the analyte, </FP> <FP SOURCE="FP-2"> C <E T="52">istd</E> = the concentration of the internal standard, </FP> <FP SOURCE="FP-2"> A <E T="52">istd</E> = the area of the internal standard, </FP> <FP SOURCE="FP-2">RRF = the relative response factor, and</FP> <FP SOURCE="FP-2">100 is the conversion factor to convert mg/L DCM to µg/g oil added.</FP> <P>5.10.4.11 If some analytes are not commercially available, the RRFs of other compounds (usually the parent compound) are used to quantify those analytes. For example, the RRF of C3-naphthalene may be used to calculate the concentrations of C3- and C4-naphthalenes. See Table SOP 4.4 of this Appendix for details. The quantification of these alkylated PAHs is relative because it is assumed that the molecular ions of the alkylated PAHs have the same RRFs as the parent compound ions. Nevertheless, these relative concentrations are useful for monitoring the fate of these compounds during the course of any analysis, as long as their concentrations are measured in a consistent way throughout the analysis.</P> <P>5.10.4.12 Concentration calculations for all target compounds are performed using EnviroQuant software or equivalent. Data for each sample can be printed directly using a customized report template. Data can also be automatically entered into a spreadsheet within the EnviroQuant software.</P> <P> 5.10.5  <E T="03">Quality Assurance/Quality Control.</E> The following criteria must be met before any samples are analyzed: </P> <P>5.10.5.1 Air/water check to verify the system is leak free.</P> <P>5.10.5.2 AutoTune and DFTPP Tune pass all criteria.</P> <P>5.10.5.3 DFTPP check standard passes all criteria.</P> <P>5.10.5.4 Solvent blank scan indicates the GC/MS system is free of interfering contamination.</P> <P>5.10.5.5 Prepare and monitor a control chart of a standard oil analysis. Concentrations of the analytes in the control chart must be no more than 25% different from their historical averages.</P> <P>5.10.5.6 Relative response factors for analytes in the check standards inserted between every 10 samples must be no more than 25 percent different from the average RRF of those same analytes in the calibration curve. Peak shapes must be symmetrical.</P> <P> 5.11  <E T="03">References for Section 5</E> </P> <FP SOURCE="FP-2">(1) Haines, J.R., E.J. Kleiner, K.A. McClellan, K.M. Koran, E.L. Holder, D.W. King, and A.D. Venosa. 2005. “Laboratory evaluation of oil spill bioremediation products in salt and freshwater systems.” J. Ind. Microbiol. Biotech 32: 171-185.</FP> <CITA>[88 FR 38338, June 12, 2023, as amended at 88 FR 41834, June 28, 2023]</CITA> </APPENDIX> <APPENDIX> <EAR>Pt. 300, App. D</EAR> <HD SOURCE="HED">Appendix D to Part 300—Appropriate Actions and Methods of Remedying Releases</HD> <P>(a) This appendix D to part 300 describes types of remedial actions generally appropriate for specific situations commonly found at remedial sites and lists methods for remedying releases that may be considered by the lead agency to accomplish a particular response action. This list shall not be considered inclusive of all possible methods of remedying releases and does not limit the lead agency from selecting any other actions deemed necessary in response to any situation.</P> <P>(b) In response to contaminated soil, sediment, or waste, the following types of response actions shall generally be considered: removal, treatment, or containment of the soil, sediment, or waste to reduce or eliminate the potential for hazardous substances or pollutants or contaminants to contaminate other media (ground water, surface water, or air) and to reduce or eliminate the potential for such substances to be inhaled, absorbed, or ingested.</P> <P>(1) Techniques for removing contaminated soil, sediment, or waste include the following:</P> <P>(i) Excavation.</P> <P>(ii) Hydraulic dredging.</P> <P>(iii) Mechanical dredging.</P> <P>(2) Techniques for treating contaminated soil, sediment, or waste include the following:</P> <P>(i) Biological methods, including the following:</P> <P>(A) Treatment via modified conventional wastewater treatment techniques.</P> <P>(B) Anaerobic, aerated, and facultative lagoons.</P> <P>(C) Supported growth biological reactors.</P> <P>(D) Microbial biodegradation.</P> <P>(ii) Chemical methods, including the following:</P> <P>(A) Chlorination.</P> <P>(B) Precipitation, flocculation, sedimentation.</P> <P>(C) Neutralization.</P> <P>(D) Equalization.</P> <P>(E) Chemical oxidation.</P> <P> (iii) Physical methods, including the following: <PRTPAGE P="284"/> </P> <P>(A) Air stripping.</P> <P>(B) Carbon absorption.</P> <P>(C) Ion exchange.</P> <P>(D) Reverse osmosis.</P> <P>(E) Permeable bed treatment.</P> <P>(F) Wet air oxidation.</P> <P>(G) Solidification.</P> <P>(H) Encapsulation.</P> <P>(I) Soil washing or flushing.</P> <P>(J) Incineration.</P> <P>(c) In response to contaminated ground water, the following types of response actions will generally be considered: Elimination or containment of the contamination to prevent further contamination, treatment and/or removal of such ground water to reduce or eliminate the contamination, physical containment of such ground water to reduce or eliminate potential exposure to such contamination, and/or restrictions on use of the ground water to eliminate potential exposure to the contamination.</P> <P>(1) Techniques that can be used to contain or restore contaminated ground water include the following:</P> <P>(i) Impermeable barriers, including the following:</P> <P>(A) Slurry walls.</P> <P>(B) Grout curtains.</P> <P>(C) Sheet pilings.</P> <P>(ii) Permeable treatment beds.</P> <P>(iii) Ground-water pumping, including the following:</P> <P>(A) Water table adjustment.</P> <P>(B) Plume containment.</P> <P>(iv) Leachate control, including the following:</P> <P>(A) Subsurface drains.</P> <P>(B) Drainage ditches.</P> <P>(C) Liners.</P> <P>(2) Techniques suitable for the control of contamination of water and sewer lines include the following:</P> <P>(i) Grouting.</P> <P>(ii) Pipe relining and sleeving.</P> <P>(iii) Sewer relocation.</P> <P>(d)(1) In response to contaminated surface water, the following types of response actions shall generally be considered: Elimination or containment of the contamination to prevent further pollution, and/or treatment of the contaminated water to reduce or eliminate its hazard potential.</P> <P>(2) Techniques that can be used to control or remediate surface water include the following:</P> <P>(i) Surface seals.</P> <P>(ii) Surface water diversions and collection systems, including the following:</P> <P>(A) Dikes and berms.</P> <P>(B) Ditches, diversions, waterways.</P> <P>(C) Chutes and downpipes.</P> <P>(D) Levees.</P> <P>(E) Seepage basins and ditches.</P> <P>(F) Sedimentation basins and ditches.</P> <P>(G) Terraces and benches.</P> <P>(iii) Grading.</P> <P>(iv) Revegetation.</P> <P>(e) In response to air emissions, the following techniques will be considered:</P> <P>(1) Pipe vents.</P> <P>(2) Trench vents.</P> <P>(3) Gas barriers.</P> <P>(4) Gas collection.</P> <P>(5) Overpacking.</P> <P>(6) Treatment for gaseous emissions, including the following:</P> <P>(i) Vapor phase adsorption.</P> <P>(ii) Thermal oxidation.</P> <P>(f) Alternative water supplies can be provided in several ways, including the following:</P> <P>(i) Individual treatment units.</P> <P>(ii) Water distribution system.</P> <P>(iii) New wells in a new location or deeper wells.</P> <P>(iv) Cisterns.</P> <P>(v) Bottled or treated water.</P> <P>(vi) Upgraded treatment for existing distribution systems.</P> <P>(g) Temporary or permanent relocation of residents, businesses, and community facilities may be provided where it is determined necessary to protect human health and the environment.</P> <CITA>[55 FR 8865, Mar. 8, 1990]</CITA> </APPENDIX> </SUBPART> </PART> <PART> <EAR>Pt. 302</EAR> <HD SOURCE="HED">PART 302—DESIGNATION, REPORTABLE QUANTITIES, AND NOTIFICATION</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>302.1</SECTNO> <SUBJECT>Applicability.</SUBJECT> <SECTNO>302.2</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>302.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>302.4</SECTNO> <SUBJECT>Hazardous substances and reportable quantities.</SUBJECT> <SECTNO>302.5</SECTNO> <SUBJECT>Determination of reportable quantities.</SUBJECT> <SECTNO>302.6</SECTNO> <SUBJECT>Notification requirements.</SUBJECT> <SECTNO>302.7</SECTNO> <SUBJECT>Penalties.</SUBJECT> <SECTNO>302.8</SECTNO> <SUBJECT>Continuous releases.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P> 33 U.S.C. 1251 <E T="03">et. seq.,</E> 42 U.S.C. 9601 <E T="03">et. seq.</E> , 42 U.S.C. 9602, 42 U.S.C. 9603. </P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>50 FR 13474, Apr. 4, 1985, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 302.1</SECTNO> <SUBJECT>Applicability.</SUBJECT> <P> This regulation designates under section 102(a) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“the Act”) those substances in the statutes referred to in section 101(14) of the Act, identifies reportable quantities for these substances, and sets forth the notification requirements for releases of these substances. This regulation also <PRTPAGE P="285"/> sets forth reportable quantities for hazardous substances designated under section 311(b)(2)(A) of the Clean Water Act. </P> </SECTION> <SECTION> <SECTNO>§ 302.2</SECTNO> <RESERVED>[Reserved]</RESERVED> </SECTION> <SECTION> <SECTNO>§ 302.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>As used in this part, all terms shall have the meaning set forth below:</P> <P> <E T="03">The Act,</E> <E T="03">CERCLA,</E> or <E T="03">Superfund</E> means the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (Pub. L. 96-510); </P> <P> <E T="03">Administrator</E> means the Administrator of the United States Environmental Protection Agency (“EPA”); </P> <P> <E T="03">Animal waste</E> means feces, urine, or other excrement, digestive emission, urea, or similar substances emitted by animals (including any form of livestock, poultry, or fish). The term “animal waste” includes animal waste that is mixed or commingled with bedding, compost, feed, soil, or any other material typically found with such waste. </P> <P> <E T="03">Consumer product</E> shall have the meaning stated in 15 U.S.C. 2052; </P> <P> <E T="03">Environment</E> means (1) the navigable waters, the waters of the contiguous zone, and the ocean waters of which the natural resources are under the exclusive management authority of the United States under the Fishery Conservation and Management Act of 1976, and (2) any other surface water, ground water, drinking water supply, land surface or subsurface strata, or ambient air within the United States or under the jurisdiction of the United States; </P> <P> <E T="03">Facility</E> means (1) any building, structure, installation, equipment, pipe or pipeline (including any pipe into a sewer or publicly owned treatment works), well, pit, pond, lagoon, impoundment, ditch, landfill, storage container, motor vehicle, rolling stock, or aircraft, or (2) any site or area where a hazardous substance has been deposited, stored, disposed of, or placed, or otherwise come to be located; but does not include any consumer product in consumer use or any vessel; </P> <P> <E T="03">Farm</E> means a site or area (including associated structures) that— </P> <P>(1) Is used for—</P> <P>(i) The production of a crop; or</P> <P>(ii) The raising or selling of animals (including any form of livestock, poultry, or fish); and</P> <P>(2) Under normal conditions, produces during a farm year any agricultural products with a total value equal to not less than $1,000.</P> <P> <E T="03">Hazardous substance</E> means any substance designated pursuant to 40 CFR part 302; </P> <P> <E T="03">Hazardous waste</E> shall have the meaning provided in 40 CFR 261.3; </P> <P> <E T="03">Navigable waters</E> means the waters of the United States, including the territorial seas, as defined in § 120.2 of this chapter. </P> <P> <E T="03">Offshore facility</E> means any facility of any kind located in, on, or under, any of the navigable waters of the United States, and any facility of any kind which is subject to the jurisdiction of the United States and is located in, on, or under any other waters, other than a vessel or a public vessel; </P> <P> <E T="03">Onshore facility</E> means any facility (including, but not limited to, motor vehicles and rolling stock) of any kind located in, on, or under, any land or non-navigable waters within the United States; </P> <P> <E T="03">Person</E> means an individual, firm, corporation, association, partnership, consortium, joint venture, commercial entity, United States Government, State, municipality, commission, political subdivision of a State, or any interstate body; </P> <P> <E T="03">Release</E> means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, or disposing into the environment (including the abandonment or discarding of barrels, containers, and other closed receptacles containing any hazardous substance or pollutant or contaminant), but excludes: </P> <P>(1) Any release which results in exposure to persons solely within a workplace, with respect to a claim which such persons may assert against the employer of such persons;</P> <P>(2) Emissions from the engine exhaust of a motor vehicle, rolling stock, aircraft, vessel, or pipeline pumping station engine;</P> <P> (3) Release of source, byproduct, or special nuclear material from a nuclear incident, as those terms are defined in the Atomic Energy Act of 1954, if such <PRTPAGE P="286"/> release is subject to requirements with respect to financial protection established by the Nuclear Regulatory Commission under section 170 of such Act, or for the purposes of section 104 of the Comprehensive Environmental Response, Compensation, and Liability Act or any other response action, any release of source, byproduct, or special nuclear material from any processing site designated under section 102(a)(1) or 302(a) of the Uranium Mill Tailings Radiation Control Act of 1978; and </P> <P>(4) The normal application of fertilizer;</P> <P> <E T="03">Reportable quantity</E> (“RQ”) means that quantity, as set forth in this part, the release of which requires notification pursuant to this part; </P> <P> <E T="03">United States</E> include the several States of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the United States Virgin Islands, the Commonwealth of the Northern Marianas, and any other territory or possession over which the United States has jurisdiction; and </P> <P> <E T="03">Vessel</E> means every description of watercraft or other artificial contrivance used, or capable of being used, as a means of transportation on water. </P> <CITA>[50 FR 13474, Apr. 4, 1985, as amended at 67 FR 45321, July 9, 2002; 73 FR 76959, Dec. 18, 2008; 80 FR 37123, June 29, 2015; 83 FR 5209, Feb. 6, 2018; 83 FR 37446, Aug. 1, 2018; 84 FR 56671, Oct. 22, 2019; 85 FR 22342, Apr. 21, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 302.4</SECTNO> <SUBJECT>Hazardous substances and reportable quantities.</SUBJECT> <P> (a) <E T="03">Listed hazardous substances.</E> The elements and compounds and hazardous wastes appearing in table 302.4 are designated as hazardous substances under section 102(a) of the Act. </P> <P> (b) <E T="03">Unlisted hazardous substances.</E> A solid waste, as defined in 40 CFR 261.2, which is not excluded from regulation as a hazardous waste under 40 CFR 261.4(b), is a hazardous substance under section 101(14) of the Act if it exhibits any of the characteristics identified in 40 CFR 261.20 through 261.24. </P> <NOTE> <HD SOURCE="HED">Note I to Table 302.4</HD> <P>The numbers under the column headed “CASRN” are the Chemical Abstracts Service Registry Numbers for each hazardous substance. CASRNs are unique numeric identifiers for specific substances. CASRNs are updated by the Chemical Abstract Service and are sometimes deleted or replaced. This list of CERCLA hazardous substances relies on information provided in the statutory lists that comprise the table. CASRNs are provided for convenience only to aid in the identification of the designated hazardous substance. Some CASRNs are given only for parent compounds. In some cases, a chemical name may have more than one CASRN associated with it due to the chemical's various forms; however, each CAS Registry Number is a unique numeric identifier and designates only one substance. That is, two substances, or two forms of a substance, do not have the same CAS Registry Number. If there is a discrepancy between the hazardous substance name and the listed CAS Registry Number, the hazardous substance names appearing in Table 302.4 should be used as the official means to determine if a given chemical or substance is reportable.</P> </NOTE> <NOTE> <HD SOURCE="HED">Note II to Table 302.4</HD> <P>Hazardous substances are given a Statutory Code based on their statutory source. The “Statutory Code” column indicates the statutory source for designating each substance as a CERCLA hazardous substance. Statutory Code “1” indicates a Clean Water Act (CWA) Hazardous Substance [40 CFR 116.4; 33 U.S.C. 1321(b)(2)(A)]. Statutory Code “2” indicates a CWA Toxic Pollutant [40 CFR 401.15, 40 CFR part 423 Appendix A, and/or 40 CFR 131.36; 33 U.S.C. 1317(a)]. Statutory Code “3” indicates a CAA HAP [42 U.S.C. 7412(b); Pub. L. 101-549 November 15, 1990; 70 FR 75047 December 19, 2005; 69 FR 69320 November 29, 2004; 61 FR 30816 June 18, 1996; 65 FR 47342 August 2, 2000; 87 FR 393 January 5, 2022]. Statutory Code “4” indicates Resource Conservation and Recovery Act (RCRA) Hazardous Wastes [40 CFR part 261 Subpart D—Lists of Hazardous Wastes; 42 U.S.C. 6921]. (Note: The “RCRA waste No.” column provides the waste identification numbers assigned by RCRA regulations). Statutory Code “5” indicates a hazardous substance designated under section 102(a) of CERCLA. The “Final RQ [pounds (kg)]” column provides the reportable quantity for each hazardous substance in pounds and kilograms.</P> </NOTE> <GPOTABLE COLS="5" OPTS="L2" CDEF="s80,11,9,r40,12"> <TTITLE>Table 302.4—List of Hazardous Substances and Reportable Quantities</TTITLE> <TDESC>[All comments/notes are located at the end of the table.]</TDESC> <BOXHD> <CHED H="1">Hazardous substance</CHED> <CHED H="1"> CASRN  <SU>I</SU> </CHED> <CHED H="1"> Statutory <LI> code  <SU>II</SU> </LI> </CHED> <CHED H="1"> RCRA <LI>waste No.</LI> </CHED> <CHED H="1"> Final RQ <LI>[pounds (kg)]</LI> </CHED> </BOXHD> <ROW> <ENT I="01">A2213</ENT> <ENT>30558-43-1</ENT> <ENT>4</ENT> <ENT>U394</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <PRTPAGE P="287"/> <ENT I="01">Acenaphthene</ENT> <ENT>83-32-9</ENT> <ENT>2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Acenaphthylene</ENT> <ENT>208-96-8</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetaldehyde</ENT> <ENT>75-07-0</ENT> <ENT>1,3,4</ENT> <ENT>U001</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Acetaldehyde, chloro-</ENT> <ENT>107-20-0</ENT> <ENT>4</ENT> <ENT>P023</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Acetaldehyde, trichloro-</ENT> <ENT>75-87-6</ENT> <ENT>4</ENT> <ENT>U034</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetamide</ENT> <ENT>60-35-5</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Acetamide, N-(aminothioxomethyl)-</ENT> <ENT>591-08-2</ENT> <ENT>4</ENT> <ENT>P002</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Acetamide, N-(4-ethoxyphenyl)-</ENT> <ENT>62-44-2</ENT> <ENT>4</ENT> <ENT>U187</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Acetamide, N-9H-fluoren-2-yl-</ENT> <ENT>53-96-3</ENT> <ENT>3,4</ENT> <ENT>U005</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Acetamide, 2-fluoro-</ENT> <ENT>640-19-7</ENT> <ENT>4</ENT> <ENT>P057</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid</ENT> <ENT>64-19-7</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, (2,4-dichlorophenoxy)-, salts & esters</ENT> <ENT>94-75-7</ENT> <ENT>1,3,4</ENT> <ENT>U240</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, ethyl ester</ENT> <ENT>141-78-6</ENT> <ENT>4</ENT> <ENT>U112</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, fluoro-, sodium salt</ENT> <ENT>62-74-8</ENT> <ENT>4</ENT> <ENT>P058</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, lead(2 +) salt</ENT> <ENT>301-04-2</ENT> <ENT>1,4</ENT> <ENT>U144</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, thallium(1 +) salt</ENT> <ENT>563-68-8</ENT> <ENT>4</ENT> <ENT>U214</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, (2,4,5-trichlorophenoxy)-</ENT> <ENT>93-76-5</ENT> <ENT>1,4</ENT> <ENT>See F027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Acetic anhydride</ENT> <ENT>108-24-7</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetone</ENT> <ENT>67-64-1</ENT> <ENT>4</ENT> <ENT>U002</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetone cyanohydrin</ENT> <ENT>75-86-5</ENT> <ENT>1,4</ENT> <ENT>P069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Acetonitrile</ENT> <ENT>75-05-8</ENT> <ENT>3,4</ENT> <ENT>U003</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetophenone</ENT> <ENT>98-86-2</ENT> <ENT>3,4</ENT> <ENT>U004</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Acetylaminofluorene</ENT> <ENT>53-96-3</ENT> <ENT>3,4</ENT> <ENT>U005</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Acetyl bromide</ENT> <ENT>506-96-7</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acetyl chloride</ENT> <ENT>75-36-5</ENT> <ENT>1,4</ENT> <ENT>U006</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1-Acetyl-2-thiourea</ENT> <ENT>591-08-2</ENT> <ENT>4</ENT> <ENT>P002</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Acrolein</ENT> <ENT>107-02-8</ENT> <ENT>1,2,3,4</ENT> <ENT>P003</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Acrylamide</ENT> <ENT>79-06-1</ENT> <ENT>3,4</ENT> <ENT>U007</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acrylic acid</ENT> <ENT>79-10-7</ENT> <ENT>3,4</ENT> <ENT>U008</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Acrylonitrile</ENT> <ENT>107-13-1</ENT> <ENT>1,2,3,4</ENT> <ENT>U009</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Adipic acid</ENT> <ENT>124-04-9</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Aldicarb</ENT> <ENT>116-06-3</ENT> <ENT>4</ENT> <ENT>P070</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Aldicarb sulfone</ENT> <ENT>1646-88-4</ENT> <ENT>4</ENT> <ENT>P203</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Aldrin</ENT> <ENT>309-00-2</ENT> <ENT>1,2,4</ENT> <ENT>P004</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Allyl alcohol</ENT> <ENT>107-18-6</ENT> <ENT>1,4</ENT> <ENT>P005</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Allyl chloride</ENT> <ENT>107-05-1</ENT> <ENT>1,3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Aluminum phosphide</ENT> <ENT>20859-73-8</ENT> <ENT>4</ENT> <ENT>P006</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Aluminum sulfate</ENT> <ENT>10043-01-3</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">4-Aminobiphenyl</ENT> <ENT>92-67-1</ENT> <ENT>3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">5-(Aminomethyl)-3-isoxazolol</ENT> <ENT>2763-96-4</ENT> <ENT>4</ENT> <ENT>P007</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">4-Aminopyridine</ENT> <ENT>504-24-5</ENT> <ENT>4</ENT> <ENT>P008</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Amitrole</ENT> <ENT>61-82-5</ENT> <ENT>4</ENT> <ENT>U011</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ammonia</ENT> <ENT>7664-41-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ammonium acetate</ENT> <ENT>631-61-8</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium benzoate</ENT> <ENT>1863-63-4</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium bicarbonate</ENT> <ENT>1066-33-7</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium bichromate</ENT> <ENT>7789-09-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ammonium bifluoride</ENT> <ENT>1341-49-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ammonium bisulfilte</ENT> <ENT>10192-30-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium carbamate</ENT> <ENT>1111-78-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium carbonate</ENT> <ENT>506-87-6</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium chloride</ENT> <ENT>12125-02-9</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium chromate</ENT> <ENT>7788-98-9</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ammonium citrate, dibasic</ENT> <ENT>3012-65-5</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium fluoborate</ENT> <ENT>13826-83-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium fluoride</ENT> <ENT>12125-01-8</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ammonium hydroxide</ENT> <ENT>1336-21-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ammonium oxalate</ENT> <ENT> 6009-70-7 <LI>5972-73-6</LI> <LI>14258-49-2</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium picrate</ENT> <ENT>131-74-8</ENT> <ENT>4</ENT> <ENT>P009</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ammonium silicofluoride</ENT> <ENT>16919-19-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ammonium sulfamate</ENT> <ENT>7773-06-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium sulfide</ENT> <ENT>12135-76-1</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ammonium sulfite</ENT> <ENT>10196-04-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium tartrate</ENT> <ENT> 14307-43-8 <LI>3164-29-2</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium thiocyanate</ENT> <ENT>1762-95-4</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ammonium vanadate</ENT> <ENT>7803-55-6</ENT> <ENT>4</ENT> <ENT>P119</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Amyl acetate</ENT> <ENT>628-63-7</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <PRTPAGE P="288"/> <ENT I="03">iso-Amyl acetate</ENT> <ENT>123-92-2</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">sec-Amyl acetate</ENT> <ENT>626-38-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">tert-Amyl acetate</ENT> <ENT>625-16-1</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Aniline</ENT> <ENT>62-53-3</ENT> <ENT>1,3,4</ENT> <ENT>U012</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">o-Anisidine</ENT> <ENT>90-04-0</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Anthracene</ENT> <ENT>120-12-7</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">ANTIMONY AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Antimony Compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Antimony  <SU>III</SU> </ENT> <ENT>7440-36-0</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Antimony pentachloride</ENT> <ENT>7647-18-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Antimony potassium tartrate</ENT> <ENT>28300-74-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Antimony tribromide</ENT> <ENT>7789-61-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Antimony trichloride</ENT> <ENT>10025-91-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Antimony trifluoride</ENT> <ENT>7783-56-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Antimony trioxide</ENT> <ENT>1309-64-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Argentate(1-), bis(cyano-C)-, potassium</ENT> <ENT>506-61-6</ENT> <ENT>4</ENT> <ENT>P099</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Aroclors</ENT> <ENT>1336-36-3</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1016</ENT> <ENT>12674-11-2</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1221</ENT> <ENT>11104-28-2</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1232</ENT> <ENT>11141-16-5</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1242</ENT> <ENT>53469-21-9</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1248</ENT> <ENT>12672-29-6</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1254</ENT> <ENT>11097-69-1</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Aroclor 1260</ENT> <ENT>11096-82-5</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">ARSENIC AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Arsenic Compounds (inorganic including arsine)</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Arsenic  <SU>III</SU> </ENT> <ENT>7440-38-2</ENT> <ENT>2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic acid H3AsO4</ENT> <ENT>7778-39-4</ENT> <ENT>4</ENT> <ENT>P010</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic disulfide</ENT> <ENT>12044-79-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic oxide As2O3</ENT> <ENT>1327-53-3</ENT> <ENT>1,4</ENT> <ENT>P012</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic oxide As2O5</ENT> <ENT>1303-28-2</ENT> <ENT>1,4</ENT> <ENT>P011</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic pentoxide</ENT> <ENT>1303-28-2</ENT> <ENT>1,4</ENT> <ENT>P011</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic trichloride</ENT> <ENT>7784-34-1</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic trioxide</ENT> <ENT>1327-53-3</ENT> <ENT>1,4</ENT> <ENT>P012</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsenic trisulfide</ENT> <ENT>1303-33-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsine, diethyl-</ENT> <ENT>692-42-2</ENT> <ENT>4</ENT> <ENT>P038</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsinic acid, dimethyl-</ENT> <ENT>75-60-5</ENT> <ENT>4</ENT> <ENT>U136</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Arsonous dichloride, phenyl-</ENT> <ENT>696-28-6</ENT> <ENT>4</ENT> <ENT>P036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> Asbestos  <SU>IV</SU> </ENT> <ENT>1332-21-4</ENT> <ENT>2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Auramine</ENT> <ENT>492-80-8</ENT> <ENT>4</ENT> <ENT>U014</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Azaserine</ENT> <ENT>115-02-6</ENT> <ENT>4</ENT> <ENT>U015</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Aziridine</ENT> <ENT>151-56-4</ENT> <ENT>3,4</ENT> <ENT>P054</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Aziridine, 2-methyl-</ENT> <ENT>75-55-8</ENT> <ENT>3,4</ENT> <ENT>P067</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Azirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- hexahydro-8a-methoxy-5- methyl-,[1aS- (1aalpha,8beta,8aalpha, 8balpha)]-</ENT> <ENT>50-07-7</ENT> <ENT>4</ENT> <ENT>U010</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Barban</ENT> <ENT>101-27-9</ENT> <ENT>4</ENT> <ENT>U280</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Barium cyanide</ENT> <ENT>542-62-1</ENT> <ENT>1,4</ENT> <ENT>P013</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Bendiocarb</ENT> <ENT>22781-23-3</ENT> <ENT>4</ENT> <ENT>U278</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Bendiocarb phenol</ENT> <ENT>22961-82-6</ENT> <ENT>4</ENT> <ENT>U364</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benomyl</ENT> <ENT>17804-35-2</ENT> <ENT>4</ENT> <ENT>U271</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benz[j]aceanthrylene, 1,2-dihydro-3-methyl-</ENT> <ENT>56-49-5</ENT> <ENT>4</ENT> <ENT>U157</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benz[c]acridine</ENT> <ENT>225-51-4</ENT> <ENT>4</ENT> <ENT>U016</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzal chloride</ENT> <ENT>98-87-3</ENT> <ENT>4</ENT> <ENT>U017</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzamide, 3,5-dichloro-N-(1,1-dimethyl-2propynyl)-</ENT> <ENT>23950-58-5</ENT> <ENT>4</ENT> <ENT>U192</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benz[a]anthracene</ENT> <ENT>56-55-3</ENT> <ENT>2,4</ENT> <ENT>U018</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzanthracene</ENT> <ENT>56-55-3</ENT> <ENT>2,4</ENT> <ENT>U018</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benz[a]anthracene, 7,12-dimethyl-</ENT> <ENT>57-97-6</ENT> <ENT>4</ENT> <ENT>U094</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine</ENT> <ENT>62-53-3</ENT> <ENT>1,3,4</ENT> <ENT>U012</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 4,4′-carbonimidoylbis (N,N dimethyl-</ENT> <ENT>492-80-8</ENT> <ENT>4</ENT> <ENT>U014</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 4-chloro-</ENT> <ENT>106-47-8</ENT> <ENT>4</ENT> <ENT>P024</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 4-chloro-2-methyl-, hydrochloride</ENT> <ENT>3165-93-3</ENT> <ENT>4</ENT> <ENT>U049</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, N,N-dimethyl-4-(phenylazo)-</ENT> <ENT>60-11-7</ENT> <ENT>3,4</ENT> <ENT>U093</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 2-methyl-</ENT> <ENT>95-53-4</ENT> <ENT>3,4</ENT> <ENT>U328</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 4-methyl-</ENT> <ENT>106-49-0</ENT> <ENT>4</ENT> <ENT>U353</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 4,4′-methylenebis [2-chloro-</ENT> <ENT>101-14-4</ENT> <ENT>3,4</ENT> <ENT>U158</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 2-methyl-,hydrochloride</ENT> <ENT>636-21-5</ENT> <ENT>4</ENT> <ENT>U222</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 2-methyl-5-nitro-</ENT> <ENT>99-55-8</ENT> <ENT>4</ENT> <ENT>U181</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenamine, 4-nitro-</ENT> <ENT>100-01-6</ENT> <ENT>4</ENT> <ENT>P077</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <PRTPAGE P="289"/> <ENT I="01"> Benzene  <SU>a</SU> </ENT> <ENT>71-43-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U019</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzeneacetic acid, 4-chloro-α-(4-chlorophenyl)-α-hydroxy-, ethyl ester</ENT> <ENT>510-15-6</ENT> <ENT>3,4</ENT> <ENT>U038</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1-bromo-4-phenoxy-</ENT> <ENT>101-55-3</ENT> <ENT>2,4</ENT> <ENT>U030</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenebutanoic acid, 4-[bis(2- chloroethyl)amino]-</ENT> <ENT>305-03-3</ENT> <ENT>4</ENT> <ENT>U035</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzene, chloro-</ENT> <ENT>108-90-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U037</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene, (chloromethyl)-</ENT> <ENT>100-44-7</ENT> <ENT>1,3,4</ENT> <ENT>P028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenediamine, ar-methyl-</ENT> <ENT> 95-80-7 <LI>496-72-0</LI> <LI>823-40-5</LI> <LI>25376-45-8</LI> </ENT> <ENT>3,4</ENT> <ENT>U221</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester</ENT> <ENT>117-81-7</ENT> <ENT>2,3,4</ENT> <ENT>U028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzenedicarboxylic acid, dibutyl ester</ENT> <ENT>84-74-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzenedicarboxylic acid, diethyl ester</ENT> <ENT>84-66-2</ENT> <ENT>2,4</ENT> <ENT>U088</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzenedicarboxylic acid, dimethyl ester</ENT> <ENT>131-11-3</ENT> <ENT>2,3,4</ENT> <ENT>U102</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzenedicarboxylic acid, dioctyl ester</ENT> <ENT>117-84-0</ENT> <ENT>2,4</ENT> <ENT>U107</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1,2-dichloro-</ENT> <ENT>95-50-1</ENT> <ENT>1,2,4</ENT> <ENT>U070</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1,3-dichloro-</ENT> <ENT>541-73-1</ENT> <ENT>2,4</ENT> <ENT>U071</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1,4-dichloro-</ENT> <ENT>106-46-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U072</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1,1′-(2,2-dichloroethylidene) bis[4-chloro-</ENT> <ENT>72-54-8</ENT> <ENT>1,2,4</ENT> <ENT>U060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Benzene, (dichloromethyl)-</ENT> <ENT>98-87-3</ENT> <ENT>4</ENT> <ENT>U017</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1,3-diisocyanatomethyl-</ENT> <ENT> 91-08-7 <LI>584-84-9</LI> <LI>26471-62-5</LI> </ENT> <ENT>3,4</ENT> <ENT>U223</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene, dimethyl-</ENT> <ENT>1330-20-7</ENT> <ENT>1,3,4</ENT> <ENT>U239</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,3-Benzenediol</ENT> <ENT>108-46-3</ENT> <ENT>1,4</ENT> <ENT>U201</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1,2-Benzenediol,4-[1-hydroxy-2-(methyl amino)ethyl]-</ENT> <ENT>51-43-4</ENT> <ENT>4</ENT> <ENT>P042</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benzeneethanamine, alpha,alpha-dimethyl-</ENT> <ENT>122-09-8</ENT> <ENT>4</ENT> <ENT>P046</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzene, hexachloro-</ENT> <ENT>118-74-1</ENT> <ENT>2,3,4</ENT> <ENT>U127</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzene, hexahydro-</ENT> <ENT>110-82-7</ENT> <ENT>1,4</ENT> <ENT>U056</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benzene, methyl-</ENT> <ENT>108-88-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U220</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1-methyl-2,4-dinitro-</ENT> <ENT>121-14-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U105</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 2-methyl-1,3-dinitro-</ENT> <ENT>606-20-2</ENT> <ENT>1,2,4</ENT> <ENT>U106</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene, (1-methylethyl)-</ENT> <ENT>98-82-8</ENT> <ENT>3,4</ENT> <ENT>U055</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzene, nitro-</ENT> <ENT>98-95-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U169</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benzene, pentachloro-</ENT> <ENT>608-93-5</ENT> <ENT>4</ENT> <ENT>U183</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzene, pentachloronitro-</ENT> <ENT>82-68-8</ENT> <ENT>3,4</ENT> <ENT>U185</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenesulfonic acid chloride</ENT> <ENT>98-09-9</ENT> <ENT>4</ENT> <ENT>U020</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzenesulfonyl chloride</ENT> <ENT>98-09-9</ENT> <ENT>4</ENT> <ENT>U020</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene,1,2,4,5-tetrachloro-</ENT> <ENT>95-94-3</ENT> <ENT>4</ENT> <ENT>U207</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzenethiol</ENT> <ENT>108-98-5</ENT> <ENT>4</ENT> <ENT>P014</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzene,1,1′-(2,2,2-trichloroethylidene) bis[4-chloro-</ENT> <ENT>50-29-3</ENT> <ENT>1,2,4</ENT> <ENT>U061</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Benzene,1,1′-(2,2,2-trichloroethylidene) bis[4-methoxy-</ENT> <ENT>72-43-5</ENT> <ENT>1,3,4</ENT> <ENT>U247</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Benzene, (trichloromethyl)-</ENT> <ENT>98-07-7</ENT> <ENT>3,4</ENT> <ENT>U023</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzene, 1,3,5-trinitro-</ENT> <ENT>99-35-4</ENT> <ENT>4</ENT> <ENT>U234</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzidine</ENT> <ENT>92-87-5</ENT> <ENT>2,3,4</ENT> <ENT>U021</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Benzo[a]anthracene</ENT> <ENT>56-55-3</ENT> <ENT>2,4</ENT> <ENT>U018</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,3-Benzodioxole, 5-(1-propenyl)-1</ENT> <ENT>120-58-1</ENT> <ENT>4</ENT> <ENT>U141</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,3-Benzodioxole, 5-(2-propenyl)-</ENT> <ENT>94-59-7</ENT> <ENT>4</ENT> <ENT>U203</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,3-Benzodioxole, 5-propyl-</ENT> <ENT>94-58-6</ENT> <ENT>4</ENT> <ENT>U090</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,3-Benzodioxol-4-ol, 2,2-dimethyl-</ENT> <ENT>22961-82-6</ENT> <ENT>4</ENT> <ENT>U364</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,3-Benzodioxol-4-ol, 2,2-dimethyl-, methyl carbamate</ENT> <ENT>22781-23-3</ENT> <ENT>4</ENT> <ENT>U278</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzo[b]fluoranthene</ENT> <ENT>205-99-2</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Benzo(k)fluoranthene</ENT> <ENT>207-08-9</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-</ENT> <ENT>1563-38-8</ENT> <ENT>4</ENT> <ENT>U367</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">7-Benzofuranol, 2,3-dihydro-2,2- dimethyl-, methylcarbamate</ENT> <ENT>1563-66-2</ENT> <ENT>1,4</ENT> <ENT>P127</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzoic acid</ENT> <ENT>65-85-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate ester (1:1)</ENT> <ENT>57-64-7</ENT> <ENT>4</ENT> <ENT>P188</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzonitrile</ENT> <ENT>100-47-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Benzo[rst]pentaphene</ENT> <ENT>189-55-9</ENT> <ENT>4</ENT> <ENT>U064</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzo[ghi]perylene</ENT> <ENT>191-24-2</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, & salts</ENT> <ENT>81-81-2</ENT> <ENT>4</ENT> <ENT> P001 <LI>U248</LI> </ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Benzo[a]pyrene</ENT> <ENT>50-32-8</ENT> <ENT>2,4</ENT> <ENT>U022</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="290"/> <ENT I="01">3,4-Benzopyrene</ENT> <ENT>50-32-8</ENT> <ENT>2,4</ENT> <ENT>U022</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">ρ-Benzoquinone</ENT> <ENT>106-51-4</ENT> <ENT>3,4</ENT> <ENT>U197</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzotrichloride</ENT> <ENT>98-07-7</ENT> <ENT>3,4</ENT> <ENT>U023</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Benzoyl chloride</ENT> <ENT>98-88-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Benzyl chloride</ENT> <ENT>100-44-7</ENT> <ENT>1,3,4</ENT> <ENT>P028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">BERYLLIUM AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Beryllium  <SU>III</SU> </ENT> <ENT>7440-41-7</ENT> <ENT>2,3,4</ENT> <ENT>P015</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Beryllium chloride</ENT> <ENT>7787-47-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Beryllium compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Beryllium fluoride</ENT> <ENT>7787-49-7</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Beryllium nitrate</ENT> <ENT> 13597-99-4 <LI>7787-55-5</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> Beryllium powder  <SU>III</SU> </ENT> <ENT>7440-41-7</ENT> <ENT>2,3,4</ENT> <ENT>P015</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">alpha-BHC</ENT> <ENT>319-84-6</ENT> <ENT>2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">beta-BHC</ENT> <ENT>319-85-7</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">delta-BHC</ENT> <ENT>319-86-8</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">gamma-BHC</ENT> <ENT>58-89-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U129</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2,2′-Bioxirane</ENT> <ENT>1464-53-5</ENT> <ENT>4</ENT> <ENT>U085</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Biphenyl</ENT> <ENT>92-52-4</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">[1,1′-Biphenyl]-4,4′-diamine</ENT> <ENT>92-87-5</ENT> <ENT>2,3,4</ENT> <ENT>U021</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">[1,1′-Biphenyl]-4,4′-diamine,3,3′-dichloro-</ENT> <ENT>91-94-1</ENT> <ENT>2,3,4</ENT> <ENT>U073</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">[1,1′-Biphenyl]-4,4′-diamine,3,3′-dimethoxy-</ENT> <ENT>119-90-4</ENT> <ENT>3,4</ENT> <ENT>U091</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">[1,1′-Biphenyl]-4,4′-diamine,3,3′-dimethyl-</ENT> <ENT>119-93-7</ENT> <ENT>3,4</ENT> <ENT>U095</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Bis(2-chloroethoxy) methane</ENT> <ENT>111-91-1</ENT> <ENT>2,4</ENT> <ENT>U024</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Bis(2-chloroethyl) ether</ENT> <ENT>111-44-4</ENT> <ENT>2,3,4</ENT> <ENT>U025</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Bis(chloromethyl) ether</ENT> <ENT>542-88-1</ENT> <ENT>3,4</ENT> <ENT>P016</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Bis(2-ethylhexyl) phthalate</ENT> <ENT>117-81-7</ENT> <ENT>3,4</ENT> <ENT>U028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Bromoacetone</ENT> <ENT>598-31-2</ENT> <ENT>4</ENT> <ENT>P017</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1-Bromopropane (1-BP)</ENT> <ENT>106-94-5</ENT> <ENT>3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Bromoform</ENT> <ENT>75-25-2</ENT> <ENT>2,3,4</ENT> <ENT>U225</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Bromomethane</ENT> <ENT>74-83-9</ENT> <ENT>2,3,4</ENT> <ENT>U029</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">4-Bromophenyl phenyl ether</ENT> <ENT>101-55-3</ENT> <ENT>2,4</ENT> <ENT>U030</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Brucine</ENT> <ENT>357-57-3</ENT> <ENT>4</ENT> <ENT>P018</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,3-Butadiene</ENT> <ENT>106-99-0</ENT> <ENT>3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,3-Butadiene, 1,1,2,3,4,4-hexachloro-</ENT> <ENT>87-68-3</ENT> <ENT>2,3,4</ENT> <ENT>U128</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1-Butanamine, N-butyl-N-nitroso-</ENT> <ENT>924-16-3</ENT> <ENT>4</ENT> <ENT>U172</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1-Butanol</ENT> <ENT>71-36-3</ENT> <ENT>4</ENT> <ENT>U031</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Butanone</ENT> <ENT>78-93-3</ENT> <ENT>4</ENT> <ENT>U159</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Butanone, 3,3-dimethyl-1(methylthio)-, O-[(methylamino)carbonyl] oxime</ENT> <ENT>39196-18-4</ENT> <ENT>4</ENT> <ENT>P045</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Butanone peroxide</ENT> <ENT>1338-23-4</ENT> <ENT>4</ENT> <ENT>U160</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2-Butenal</ENT> <ENT> 123-73-9 <LI>4170-30-3</LI> </ENT> <ENT>1,4</ENT> <ENT>U053</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Butene, 1,4-dichloro-</ENT> <ENT>764-41-0</ENT> <ENT>4</ENT> <ENT>U074</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2-Butenoic acid, 2-methyl-, 7-[[2,3-dihydroxy-2-(1-methoxyethyl)-3- methyl-1-oxobutoxy] methyl]-2,3, 5,7a-tetrahydro- 1H-pyrrolizin-1-yl ester, [1S-[1alpha(Z), 7(2S*,3R*),7aalpha]]-</ENT> <ENT>303-34-4</ENT> <ENT>4</ENT> <ENT>U143</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Butyl acetate</ENT> <ENT>123-86-4</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">iso-Butyl acetate</ENT> <ENT>110-19-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">sec-Butyl acetate</ENT> <ENT>105-46-4</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">tert-Butyl acetate</ENT> <ENT>540-88-5</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">n-Butyl alcohol</ENT> <ENT>71-36-3</ENT> <ENT>4</ENT> <ENT>U031</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Butylamine</ENT> <ENT>109-73-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">iso-Butylamine</ENT> <ENT>78-81-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">sec-Butylamine</ENT> <ENT> 513-49-5 <LI>13952-84-6</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">tert-Butylamine</ENT> <ENT>75-64-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Butyl benzyl phthalate</ENT> <ENT>85-68-7</ENT> <ENT>2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">n-Butyl phthalate</ENT> <ENT>84-74-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Butyric acid</ENT> <ENT>107-92-6</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">iso-Butyric acid</ENT> <ENT>79-31-2</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Cacodylic acid</ENT> <ENT>75-60-5</ENT> <ENT>4</ENT> <ENT>U136</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">CADMIUM AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Cadmium  <SU>III</SU> </ENT> <ENT>7440-43-9</ENT> <ENT>2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cadmium acetate</ENT> <ENT>543-90-8</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cadmium bromide</ENT> <ENT>7789-42-6</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cadmium chloride</ENT> <ENT>10108-64-2</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cadmium compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Calcium arsenate</ENT> <ENT>7778-44-1</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="291"/> <ENT I="01">Calcium arsenite</ENT> <ENT>52740-16-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Calcium carbide</ENT> <ENT>75-20-7</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Calcium chromate</ENT> <ENT>13765-19-0</ENT> <ENT>1,4</ENT> <ENT>U032</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Calcium cyanamide</ENT> <ENT>156-62-7</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01"> Calcium cyanide Ca(CN) <E T="0732">2</E> </ENT> <ENT>592-01-8</ENT> <ENT>1,4</ENT> <ENT>P021</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Calcium dodecylbenzenesulfonate</ENT> <ENT>26264-06-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Calcium hypochlorite</ENT> <ENT>7778-54-3</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Captan</ENT> <ENT>133-06-2</ENT> <ENT>1,3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, 1H-benzimidazol-2-yl, methyl ester</ENT> <ENT>10605-21-7</ENT> <ENT>4</ENT> <ENT>U372</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, [1-[(butylamino)carbonyl]-1H-benzimidazol-2-yl]-,methyl ester</ENT> <ENT>17804-35-2</ENT> <ENT>4</ENT> <ENT>U271</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, (3-chlorophenyl)-, 4-chloro-2-butynyl ester</ENT> <ENT>101-27-9</ENT> <ENT>4</ENT> <ENT>U280</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, [(dibutylamino)-thio]methyl-, 2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester</ENT> <ENT>55285-14-8</ENT> <ENT>4</ENT> <ENT>P189</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, dimethyl-,1-[(dimethyl-amino)carbonyl]-5-methyl-1H-pyrazol-3-yl ester</ENT> <ENT>644-64-4</ENT> <ENT>4</ENT> <ENT>P191</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, dimethyl-, 3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl ester</ENT> <ENT>119-38-0</ENT> <ENT>4</ENT> <ENT>P192</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, ethyl ester</ENT> <ENT>51-79-6</ENT> <ENT>3,4</ENT> <ENT>U238</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, methyl-, 3-methylphenyl ester</ENT> <ENT>1129-41-5</ENT> <ENT>4</ENT> <ENT>P190</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, methylnitroso-, ethyl ester</ENT> <ENT>615-53-2</ENT> <ENT>4</ENT> <ENT>U178</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, [1,2-phenylenebis(iminocarbonothioyl)]bis-, dimethyl ester</ENT> <ENT>23564-05-8</ENT> <ENT>4</ENT> <ENT>U409</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbamic acid, phenyl-, 1-methylethyl ester</ENT> <ENT>122-42-9</ENT> <ENT>4</ENT> <ENT>U373</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Carbamic chloride, dimethyl-</ENT> <ENT>79-44-7</ENT> <ENT>3,4</ENT> <ENT>U097</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Carbamodithioic acid, 1,2-ethanediylbis-, salts & esters</ENT> <ENT>111-54-6</ENT> <ENT>4</ENT> <ENT>U114</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Carbamothioic acid, bis(1-methylethyl)-, S-(2,3-dichloro-2- propenyl) ester</ENT> <ENT>2303-16-4</ENT> <ENT>4</ENT> <ENT>U062</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbamothioic acid, bis(1-methylethyl)-, S-(2,3,3-trichloro-2-propenyl) ester</ENT> <ENT>2303-17-5</ENT> <ENT>4</ENT> <ENT>U389</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbamothioic acid, dipropyl-, S-(phenylmethyl) ester</ENT> <ENT>52888-80-9</ENT> <ENT>4</ENT> <ENT>U387</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Carbaryl</ENT> <ENT>63-25-2</ENT> <ENT>1,3,4</ENT> <ENT>U279</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbendazim</ENT> <ENT>10605-21-7</ENT> <ENT>4</ENT> <ENT>U372</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbofuran</ENT> <ENT>1563-66-2</ENT> <ENT>1,4</ENT> <ENT>P127</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbofuran phenol</ENT> <ENT>1563-38-8</ENT> <ENT>4</ENT> <ENT>U367</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbon disulfide</ENT> <ENT>75-15-0</ENT> <ENT>1,3,4</ENT> <ENT>P022</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbonic acid, dithallium(1 +) salt</ENT> <ENT>6533-73-9</ENT> <ENT>4</ENT> <ENT>U215</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbonic dichloride</ENT> <ENT>75-44-5</ENT> <ENT>1,3,4</ENT> <ENT>P095</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbonic difluoride</ENT> <ENT>353-50-4</ENT> <ENT>4</ENT> <ENT>U033</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Carbonochloridic acid, methyl ester</ENT> <ENT>79-22-1</ENT> <ENT>4</ENT> <ENT>U156</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Carbon oxyfluoride</ENT> <ENT>353-50-4</ENT> <ENT>4</ENT> <ENT>U033</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Carbon tetrachloride</ENT> <ENT>56-23-5</ENT> <ENT>1,2,3,4</ENT> <ENT>U211</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Carbonyl sulfide</ENT> <ENT>463-58-1</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Carbosulfan</ENT> <ENT>55285-14-8</ENT> <ENT>4</ENT> <ENT>P189</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Catechol</ENT> <ENT>120-80-9</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chloral</ENT> <ENT>75-87-6</ENT> <ENT>4</ENT> <ENT>U034</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Chloramben</ENT> <ENT>133-90-4</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chlorambucil</ENT> <ENT>305-03-3</ENT> <ENT>4</ENT> <ENT>U035</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">CHLORDANE (TECHNICAL MIXTURE AND METABOLITES)</ENT> <ENT>57-74-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Chlordane</ENT> <ENT>57-74-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Chlordane, alpha & gamma isomers</ENT> <ENT> 57-74-9 <LI>5103-71-9</LI> <LI>5103-74-2</LI> </ENT> <ENT>1,2,3,4</ENT> <ENT>U036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">CHLORINATED BENZENES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Chlorinated camphene</ENT> <ENT>8001-35-2</ENT> <ENT>1,2,3,4</ENT> <ENT>P123</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">CHLORINATED ETHANES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">CHLORINATED NAPHTHALENE</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">CHLORINATED PHENOLS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Chlorine</ENT> <ENT>7782-50-5</ENT> <ENT>1,3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Chlornaphazine</ENT> <ENT>494-03-1</ENT> <ENT>4</ENT> <ENT>U026</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chloroacetaldehyde</ENT> <ENT>107-20-0</ENT> <ENT>4</ENT> <ENT>P023</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Chloroacetic acid</ENT> <ENT>79-11-8</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Chloroacetophenone</ENT> <ENT>532-27-4</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">CHLOROALKYL ETHERS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">p-Chloroaniline</ENT> <ENT>106-47-8</ENT> <ENT>4</ENT> <ENT>P024</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Chlorobenzene</ENT> <ENT>108-90-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U037</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="292"/> <ENT I="01">Chlorobenzilate</ENT> <ENT>510-15-6</ENT> <ENT>3,4</ENT> <ENT>U038</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">p-Chloro-m-cresol</ENT> <ENT>59-50-7</ENT> <ENT>2,4</ENT> <ENT>U039</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Chlorodibromomethane</ENT> <ENT>124-48-1</ENT> <ENT>2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1-Chloro-2,3-epoxypropane</ENT> <ENT>106-89-8</ENT> <ENT>1,3,4</ENT> <ENT>U041</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chloroethane</ENT> <ENT>75-00-3</ENT> <ENT>2,3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Chloroethyl vinyl ether</ENT> <ENT>110-75-8</ENT> <ENT>2,4</ENT> <ENT>U042</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Chloroform</ENT> <ENT>67-66-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U044</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Chloromethane</ENT> <ENT>74-87-3</ENT> <ENT>2,3,4</ENT> <ENT>U045</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chloromethyl methyl ether</ENT> <ENT>107-30-2</ENT> <ENT>3,4</ENT> <ENT>U046</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">beta-Chloronaphthalene</ENT> <ENT>91-58-7</ENT> <ENT>2,4</ENT> <ENT>U047</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Chloronaphthalene</ENT> <ENT>91-58-7</ENT> <ENT>2,4</ENT> <ENT>U047</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Chlorophenol</ENT> <ENT>95-57-8</ENT> <ENT>2,4</ENT> <ENT>U048</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">o-Chlorophenol</ENT> <ENT>95-57-8</ENT> <ENT>2,4</ENT> <ENT>U048</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">4-Chlorophenyl phenyl ether</ENT> <ENT>7005-72-3</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1-(o-Chlorophenyl)thiourea</ENT> <ENT>5344-82-1</ENT> <ENT>4</ENT> <ENT>P026</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chloroprene</ENT> <ENT>126-99-8</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">3-Chloropropionitrile</ENT> <ENT>542-76-7</ENT> <ENT>4</ENT> <ENT>P027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Chlorosulfonic acid</ENT> <ENT>7790-94-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">4-Chloro-o-toluidine, hydrochloride</ENT> <ENT>3165-93-3</ENT> <ENT>4</ENT> <ENT>U049</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Chlorpyrifos</ENT> <ENT>2921-88-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Chromic acetate</ENT> <ENT>1066-30-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Chromic acid</ENT> <ENT>7738-94-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01"> Chromic acid H <E T="0732">2</E> CrO <E T="0732">4</E> , calcium salt </ENT> <ENT>13765-19-0</ENT> <ENT>1,4</ENT> <ENT>U032</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Chromic sulfate</ENT> <ENT>10101-53-8</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">CHROMIUM AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Chromium Compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Chromium  <SU>III</SU> </ENT> <ENT>7440-47-3</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Chromous chloride</ENT> <ENT>10049-05-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Chrysene</ENT> <ENT>218-01-9</ENT> <ENT>2,4</ENT> <ENT>U050</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cobalt Compounds</ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Cobaltous bromide</ENT> <ENT>7789-43-7</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Cobaltous formate</ENT> <ENT>544-18-3</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Cobaltous sulfamate</ENT> <ENT>14017-41-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Coke Oven Emissions</ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">COPPER AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Copper  <SU>III</SU> </ENT> <ENT>7440-50-8</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Copper cyanide Cu(CN)</ENT> <ENT>544-92-3</ENT> <ENT>4</ENT> <ENT>P029</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Coumaphos</ENT> <ENT>56-72-4</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Creosote</ENT> <ENT>N.A</ENT> <ENT>4</ENT> <ENT>U051</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Cresol (cresylic acid)</ENT> <ENT>1319-77-3</ENT> <ENT>1,3,4</ENT> <ENT>U052</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">m-Cresol</ENT> <ENT>108-39-4</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">o-Cresol</ENT> <ENT>95-48-7</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">p-Cresol</ENT> <ENT>106-44-5</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cresols (isomers and mixture)</ENT> <ENT>1319-77-3</ENT> <ENT>1,3,4</ENT> <ENT>U052</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cresylic acid (isomers and mixture)</ENT> <ENT>1319-77-3</ENT> <ENT>1,3,4</ENT> <ENT>U052</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Crotonaldehyde</ENT> <ENT> 123-73-9 <LI>4170-30-3</LI> </ENT> <ENT>1,4</ENT> <ENT>U053</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cumene</ENT> <ENT>98-82-8</ENT> <ENT>3,4</ENT> <ENT>U055</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">m-Cumenyl methylcarbamate</ENT> <ENT>64-00-6</ENT> <ENT>4</ENT> <ENT>P202</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cupric acetate</ENT> <ENT>142-71-2</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cupric acetoarsenite</ENT> <ENT>12002-03-8</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Cupric chloride</ENT> <ENT>7447-39-4</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cupric nitrate</ENT> <ENT>3251-23-8</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cupric oxalate</ENT> <ENT>55671-32-4</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cupric sulfate</ENT> <ENT>7758-98-7</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cupric sulfate, ammoniated</ENT> <ENT>10380-29-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cupric tartrate</ENT> <ENT>815-82-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">CYANIDES</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Cyanide Compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Cyanides (soluble salts and complexes) not otherwise specified</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>P030</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cyanogen</ENT> <ENT>460-19-5</ENT> <ENT>4</ENT> <ENT>P031</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Cyanogen bromide (CN)Br</ENT> <ENT>506-68-3</ENT> <ENT>4</ENT> <ENT>U246</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Cyanogen chloride (CN)Cl</ENT> <ENT>506-77-4</ENT> <ENT>1,4</ENT> <ENT>P033</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2,5-Cyclohexadiene-1,4-dione</ENT> <ENT>106-51-4</ENT> <ENT>3,4</ENT> <ENT>U197</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cyclohexane</ENT> <ENT>110-82-7</ENT> <ENT>1,4</ENT> <ENT>U056</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Cyclohexane, 1,2,3,4,5,6-hexachloro-, (1α, 2α, 3β-, 4α, 5α, 6β)</ENT> <ENT>58-89-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U129</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Cyclohexanone</ENT> <ENT>108-94-1</ENT> <ENT>4</ENT> <ENT>U057</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Cyclohexyl-4,6-dinitrophenol</ENT> <ENT>131-89-5</ENT> <ENT>4</ENT> <ENT>P034</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="293"/> <ENT I="01">1,3-Cyclopentadiene, 1,2,3,4,5,5-hexachloro-</ENT> <ENT>77-47-4</ENT> <ENT>1,2,3,4</ENT> <ENT>U130</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Cyclophosphamide</ENT> <ENT>50-18-0</ENT> <ENT>4</ENT> <ENT>U058</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2,4-D Acid</ENT> <ENT>94-75-7</ENT> <ENT>1,3,4</ENT> <ENT>U240</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,4-D Ester</ENT> <ENT> 94-11-1 <LI>94-79-1</LI> <LI>94-80-4</LI> <LI>1320-18-9</LI> <LI>1928-38-7</LI> <LI>1928-61-6</LI> <LI>1929-73-3</LI> <LI>2971-38-2</LI> <LI>25168-26-7</LI> <LI>53467-11-1</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,4-D, salts and esters</ENT> <ENT>94-75-7</ENT> <ENT>1,3,4</ENT> <ENT>U240</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Daunomycin</ENT> <ENT>20830-81-3</ENT> <ENT>4</ENT> <ENT>U059</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">DDD</ENT> <ENT>72-54-8</ENT> <ENT>1,2,4</ENT> <ENT>U060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">4,4′-DDD</ENT> <ENT>72-54-8</ENT> <ENT>1,2,4</ENT> <ENT>U060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> DDE  <SU>b</SU> </ENT> <ENT>72-55-9</ENT> <ENT>2,4</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> DDE  <SU>b</SU> </ENT> <ENT>3547-04-4</ENT> <ENT>3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">4,4′-DDE</ENT> <ENT>72-55-9</ENT> <ENT>2,4</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">DDT</ENT> <ENT>50-29-3</ENT> <ENT>1,2,4</ENT> <ENT>U061</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">4,4′-DDT</ENT> <ENT>50-29-3</ENT> <ENT>1,2,4</ENT> <ENT>U061</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">DDT AND METABOLITES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">DEHP</ENT> <ENT>117-81-7</ENT> <ENT>2,3,4</ENT> <ENT>U028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diallate</ENT> <ENT>2303-16-4</ENT> <ENT>4</ENT> <ENT>U062</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diazinon</ENT> <ENT>333-41-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Diazomethane</ENT> <ENT>334-88-3</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dibenz[a,h]anthracene</ENT> <ENT>53-70-3</ENT> <ENT>2,4</ENT> <ENT>U063</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,2:5,6-Dibenzanthracene</ENT> <ENT>53-70-3</ENT> <ENT>2,4</ENT> <ENT>U063</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dibenzo[a,h]anthracene</ENT> <ENT>53-70-3</ENT> <ENT>2,4</ENT> <ENT>U063</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dibenzofuran</ENT> <ENT>132-64-9</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dibenzo[a,i]pyrene</ENT> <ENT>189-55-9</ENT> <ENT>4</ENT> <ENT>U064</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,2-Dibromo-3-chloropropane</ENT> <ENT>96-12-8</ENT> <ENT>3,4</ENT> <ENT>U066</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dibromoethane</ENT> <ENT>106-93-4</ENT> <ENT>1,3,4</ENT> <ENT>U067</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dibutyl phthalate</ENT> <ENT>84-74-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Di-n-butyl phthalate</ENT> <ENT>84-74-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dicamba</ENT> <ENT>1918-00-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dichlobenil</ENT> <ENT>1194-65-6</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dichlone</ENT> <ENT>117-80-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dichlorobenzene</ENT> <ENT>25321-22-6</ENT> <ENT>1,2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,2-Dichlorobenzene</ENT> <ENT>95-50-1</ENT> <ENT>1,2,4</ENT> <ENT>U070</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,3-Dichlorobenzene</ENT> <ENT>541-73-1</ENT> <ENT>2,4</ENT> <ENT>U071</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,4-Dichlorobenzene</ENT> <ENT>106-46-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U072</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">m-Dichlorobenzene</ENT> <ENT>541-73-1</ENT> <ENT>2,4</ENT> <ENT>U071</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">o-Dichlorobenzene</ENT> <ENT>95-50-1</ENT> <ENT>1,2,4</ENT> <ENT>U070</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">p-Dichlorobenzene</ENT> <ENT>106-46-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U072</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">DICHLOROBENZIDINE</ENT> <ENT>1331-47-1</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="03">3,3′-Dichlorobenzidine</ENT> <ENT>91-94-1</ENT> <ENT>2,3,4</ENT> <ENT>U073</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dichlorobromomethane</ENT> <ENT>75-27-4</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1,4-Dichloro-2-butene</ENT> <ENT>764-41-0</ENT> <ENT>4</ENT> <ENT>U074</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dichlorodifluoromethane</ENT> <ENT>75-71-8</ENT> <ENT>4</ENT> <ENT>U075</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1,1-Dichloroethane</ENT> <ENT>75-34-3</ENT> <ENT>2,3,4</ENT> <ENT>U076</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloroethane</ENT> <ENT>107-06-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U077</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,1-Dichloroethylene</ENT> <ENT>75-35-4</ENT> <ENT>1,2,3,4</ENT> <ENT>U078</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloroethylene</ENT> <ENT>156-60-5</ENT> <ENT>2,4</ENT> <ENT>U079</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dichloroethyl ether</ENT> <ENT>111-44-4</ENT> <ENT>2,3,4</ENT> <ENT>U025</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dichloroisopropyl ether</ENT> <ENT>108-60-1</ENT> <ENT>2,4</ENT> <ENT>U027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dichloromethane</ENT> <ENT>75-09-2</ENT> <ENT>2,3,4</ENT> <ENT>U080</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dichloromethoxy ethane</ENT> <ENT>111-91-1</ENT> <ENT>2,4</ENT> <ENT>U024</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dichloromethyl ether</ENT> <ENT>542-88-1</ENT> <ENT>3,4</ENT> <ENT>P016</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2,4-Dichlorophenol</ENT> <ENT>120-83-2</ENT> <ENT>2,4</ENT> <ENT>U081</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,6-Dichlorophenol</ENT> <ENT>87-65-0</ENT> <ENT>4</ENT> <ENT>U082</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dichlorophenylarsine</ENT> <ENT>696-28-6</ENT> <ENT>4</ENT> <ENT>P036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dichloropropane</ENT> <ENT>26638-19-7</ENT> <ENT>1,2</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">1,1-Dichloropropane</ENT> <ENT>78-99-9</ENT> <ENT>1,2</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">1,2-Dichloropropane</ENT> <ENT>78-87-5</ENT> <ENT>1,2,3,4</ENT> <ENT>U083</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">1,3-Dichloropropane</ENT> <ENT>142-28-9</ENT> <ENT>1,2</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dichloropropane—Dichloropropene (mixture)</ENT> <ENT>8003-19-8</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dichloropropene</ENT> <ENT>26952-23-8</ENT> <ENT>1,2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,3-Dichloropropene</ENT> <ENT>542-75-6</ENT> <ENT>1,2,3,4</ENT> <ENT>U084</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="294"/> <ENT I="03">2,3-Dichloropropene</ENT> <ENT>78-88-6</ENT> <ENT>1,2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,2-Dichloropropionic acid</ENT> <ENT>75-99-0</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Dichlorvos</ENT> <ENT>62-73-7</ENT> <ENT>1,3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dicofol</ENT> <ENT>115-32-2</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dieldrin</ENT> <ENT>60-57-1</ENT> <ENT>1,2,4</ENT> <ENT>P037</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,2:3,4-Diepoxybutane</ENT> <ENT>1464-53-5</ENT> <ENT>4</ENT> <ENT>U085</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Diethanolamine</ENT> <ENT>111-42-2</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diethylamine</ENT> <ENT>109-89-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">N,N-Diethylaniline</ENT> <ENT>91-66-7</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Diethylarsine</ENT> <ENT>692-42-2</ENT> <ENT>4</ENT> <ENT>P038</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,4-Diethyleneoxide</ENT> <ENT>123-91-1</ENT> <ENT>3,4</ENT> <ENT>U108</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diethylene glycol, dicarbamate</ENT> <ENT>5952-26-1</ENT> <ENT>4</ENT> <ENT>U395</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Diethylhexyl phthalate</ENT> <ENT>117-81-7</ENT> <ENT>2,3,4</ENT> <ENT>U028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">N,N′-Diethylhydrazine</ENT> <ENT>1615-80-1</ENT> <ENT>4</ENT> <ENT>U086</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">O,O-Diethyl S-methyl dithiophosphate</ENT> <ENT>3288-58-2</ENT> <ENT>4</ENT> <ENT>U087</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Diethyl-p-nitrophenyl phosphate</ENT> <ENT>311-45-5</ENT> <ENT>4</ENT> <ENT>P041</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diethyl phthalate</ENT> <ENT>84-66-2</ENT> <ENT>2,4</ENT> <ENT>U088</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">O,O-Diethyl O-pyrazinyl phosphorothioate</ENT> <ENT>297-97-2</ENT> <ENT>4</ENT> <ENT>P040</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diethylstilbestrol</ENT> <ENT>56-53-1</ENT> <ENT>4</ENT> <ENT>U089</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Diethyl sulfate</ENT> <ENT>64-67-5</ENT> <ENT>3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dihydrosafrole</ENT> <ENT>94-58-6</ENT> <ENT>4</ENT> <ENT>U090</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Diisopropylfluorophosphate (DFP)</ENT> <ENT>55-91-4</ENT> <ENT>4</ENT> <ENT>P043</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5alpha, 8alpha,8abeta)-</ENT> <ENT>309-00-2</ENT> <ENT>1,2,4</ENT> <ENT>P004</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro- 1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta, 5beta,8beta,8abeta)-</ENT> <ENT>465-73-6</ENT> <ENT>4</ENT> <ENT>P060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2,7:3,6-Dimethanonaphth[2,3- b]oxirene,3,4,5,6,9,9- hexachloro-1a,2,2a,3,6,6a,7,7a- octahydro-,(1aalpha,2beta, 2aalpha,3beta,6beta,6aalpha, 7beta,7aalpha)-</ENT> <ENT>60-57-1</ENT> <ENT>1,2,4</ENT> <ENT>P037</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2,7:3,6-Dimethanonaphth[2, 3-b]oxirene,3,4,5,6,9,9- hexachloro-1a,2,2a,3,6,6a,7,7a- octahydro-,(1aalpha,2beta, 2abeta,3alpha,6alpha, 6abeta,7beta,7aalpha)-, & metabolites</ENT> <ENT>72-20-8</ENT> <ENT>1,2,4</ENT> <ENT>P051</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dimethoate</ENT> <ENT>60-51-5</ENT> <ENT>4</ENT> <ENT>P044</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethoxybenzidine</ENT> <ENT>119-90-4</ENT> <ENT>3,4</ENT> <ENT>U091</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dimethylamine</ENT> <ENT>124-40-3</ENT> <ENT>1,4</ENT> <ENT>U092</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Dimethyl aminoazobenzene</ENT> <ENT>60-11-7</ENT> <ENT>3,4</ENT> <ENT>U093</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">p-Dimethylaminoazobenzene</ENT> <ENT>60-11-7</ENT> <ENT>3,4</ENT> <ENT>U093</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">N,N-Dimethylaniline</ENT> <ENT>121-69-7</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">7,12-Dimethylbenz[a]anthracene</ENT> <ENT>57-97-6</ENT> <ENT>4</ENT> <ENT>U094</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethylbenzidine</ENT> <ENT>119-93-7</ENT> <ENT>3,4</ENT> <ENT>U095</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">alpha,alpha-Dimethylbenzylhydroperoxide</ENT> <ENT>80-15-9</ENT> <ENT>4</ENT> <ENT>U096</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dimethylcarbamoyl chloride</ENT> <ENT>79-44-7</ENT> <ENT>3,4</ENT> <ENT>U097</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dimethylformamide</ENT> <ENT>68-12-2</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,1-Dimethylhydrazine</ENT> <ENT>57-14-7</ENT> <ENT>3,4</ENT> <ENT>U098</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,2-Dimethylhydrazine</ENT> <ENT>540-73-8</ENT> <ENT>4</ENT> <ENT>U099</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">alpha,alpha-Dimethylphenethylamine</ENT> <ENT>122-09-8</ENT> <ENT>4</ENT> <ENT>P046</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2,4-Dimethylphenol</ENT> <ENT>105-67-9</ENT> <ENT>2,4</ENT> <ENT>U101</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dimethyl phthalate</ENT> <ENT>131-11-3</ENT> <ENT>2,3,4</ENT> <ENT>U102</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Dimethyl sulfate</ENT> <ENT>77-78-1</ENT> <ENT>3,4</ENT> <ENT>U103</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dimetilan</ENT> <ENT>644-64-4</ENT> <ENT>4</ENT> <ENT>P191</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dinitrobenzene (mixed)</ENT> <ENT>25154-54-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">m-Dinitrobenzene</ENT> <ENT>99-65-0</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">o-Dinitrobenzene</ENT> <ENT>528-29-0</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">p-Dinitrobenzene</ENT> <ENT>100-25-4</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">4,6-Dinitro-o-cresol</ENT> <ENT>534-52-1</ENT> <ENT>2,3,4</ENT> <ENT>P047</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">4,6-Dinitro-o-cresol, and salts</ENT> <ENT>534-52-1</ENT> <ENT>3,4</ENT> <ENT>P047</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dinitrophenol</ENT> <ENT>25550-58-7</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,4-Dinitrophenol</ENT> <ENT>51-28-5</ENT> <ENT>1,2,3,4</ENT> <ENT>P048</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,5-Dinitrophenol</ENT> <ENT>329-71-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,6-Dinitrophenol</ENT> <ENT>573-56-8</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dinitrotoluene</ENT> <ENT>25321-14-6</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,4-Dinitrotoluene</ENT> <ENT>121-14-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U105</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,6-Dinitrotoluene</ENT> <ENT>606-20-2</ENT> <ENT>1,2,4</ENT> <ENT>U106</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">3,4-Dinitrotoluene</ENT> <ENT>610-39-9</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dinoseb</ENT> <ENT>88-85-7</ENT> <ENT>4</ENT> <ENT>P020</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Di-n-octyl phthalate</ENT> <ENT>117-84-0</ENT> <ENT>2,4</ENT> <ENT>U107</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <PRTPAGE P="295"/> <ENT I="01">1,4-Dioxane</ENT> <ENT>123-91-1</ENT> <ENT>3,4</ENT> <ENT>U108</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">DIPHENYLHYDRAZINE</ENT> <ENT>38622-18-3</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">1,2-Diphenylhydrazine</ENT> <ENT>122-66-7</ENT> <ENT>2,3,4</ENT> <ENT>U109</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Diphosphoramide, octamethyl-</ENT> <ENT>152-16-9</ENT> <ENT>4</ENT> <ENT>P085</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diphosphoric acid, tetraethyl ester</ENT> <ENT>107-49-3</ENT> <ENT>1,4</ENT> <ENT>P111</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Dipropylamine</ENT> <ENT>142-84-7</ENT> <ENT>4</ENT> <ENT>U110</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Di-n-propylnitrosamine</ENT> <ENT>621-64-7</ENT> <ENT>2,4</ENT> <ENT>U111</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Diquat</ENT> <ENT> 85-00-7 <LI>2764-72-9</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Disulfoton</ENT> <ENT>298-04-4</ENT> <ENT>1,4</ENT> <ENT>P039</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Dithiobiuret</ENT> <ENT>541-53-7</ENT> <ENT>4</ENT> <ENT>P049</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O-[(methylamino)-carbonyl]oxime</ENT> <ENT>26419-73-8</ENT> <ENT>4</ENT> <ENT>P185</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Diuron</ENT> <ENT>330-54-1</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Dodecylbenzenesulfonic acid</ENT> <ENT>27176-87-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">ENDOSULFAN AND METABOLITES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Endosulfan</ENT> <ENT>115-29-7</ENT> <ENT>1,2,4</ENT> <ENT>P050</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">alpha-Endosulfan</ENT> <ENT>959-98-8</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">beta-Endosulfan</ENT> <ENT>33213-65-9</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Endosulfan sulfate</ENT> <ENT>1031-07-8</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Endothall</ENT> <ENT>145-73-3</ENT> <ENT>4</ENT> <ENT>P088</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">ENDRIN AND METABOLITES</ENT> <ENT>N.A.</ENT> <ENT>2,4</ENT> <ENT>P051</ENT> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Endrin, & metabolites</ENT> <ENT>72-20-8</ENT> <ENT>1,2,4</ENT> <ENT>P051</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Endrin</ENT> <ENT>72-20-8</ENT> <ENT>1,2,4</ENT> <ENT>P051</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Endrin aldehyde</ENT> <ENT>7421-93-4</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Epichlorohydrin</ENT> <ENT>106-89-8</ENT> <ENT>1,3,4</ENT> <ENT>U041</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Epinephrine</ENT> <ENT>51-43-4</ENT> <ENT>4</ENT> <ENT>P042</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,2-Epoxybutane</ENT> <ENT>106-88-7</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanal</ENT> <ENT>75-07-0</ENT> <ENT>1,3,4</ENT> <ENT>U001</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethanamine, N,N-diethyl-</ENT> <ENT>121-44-8</ENT> <ENT>1,3,4</ENT> <ENT>U404</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethanamine, N-ethyl-N-nitroso-</ENT> <ENT>55-18-5</ENT> <ENT>4</ENT> <ENT>U174</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,2-Ethanediamine, N,N-dimethyl-N′-2- pyridinyl-N′-(2- thienylmethyl)-</ENT> <ENT>91-80-5</ENT> <ENT>4</ENT> <ENT>U155</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,2-dibromo-</ENT> <ENT>106-93-4</ENT> <ENT>1,3,4</ENT> <ENT>U067</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1-dichloro-</ENT> <ENT>75-34-3</ENT> <ENT>2,3,4</ENT> <ENT>U076</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,2-dichloro-</ENT> <ENT>107-06-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U077</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanedinitrile</ENT> <ENT>460-19-5</ENT> <ENT>4</ENT> <ENT>P031</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethane, hexachloro-</ENT> <ENT>67-72-1</ENT> <ENT>2,3,4</ENT> <ENT>U131</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1′-[methylenebis(oxy)]bis[2- chloro-</ENT> <ENT>111-91-1</ENT> <ENT>2,4</ENT> <ENT>U024</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1′-oxybis-</ENT> <ENT>60-29-7</ENT> <ENT>4</ENT> <ENT>U117</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1′-oxybis[2-chloro-</ENT> <ENT>111-44-4</ENT> <ENT>2,3,4</ENT> <ENT>U025</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethane, pentachloro-</ENT> <ENT>76-01-7</ENT> <ENT>4</ENT> <ENT>U184</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1,1,2-tetrachloro-</ENT> <ENT>630-20-6</ENT> <ENT>4</ENT> <ENT>U208</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1,2,2-tetrachloro-</ENT> <ENT>79-34-5</ENT> <ENT>2,3,4</ENT> <ENT>U209</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanethioamide</ENT> <ENT>62-55-5</ENT> <ENT>4</ENT> <ENT>U218</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1,1-trichloro-</ENT> <ENT>71-55-6</ENT> <ENT>2,3,4</ENT> <ENT>U226</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethane, 1,1,2-trichloro-</ENT> <ENT>79-00-5</ENT> <ENT>2,3,4</ENT> <ENT>U227</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanimidothioic acid, 2-(dimethylamino)-N-hydroxy-2-oxo-, methyl ester</ENT> <ENT>30558-43-1</ENT> <ENT>4</ENT> <ENT>U394</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethanimidothioic acid, 2-(dimethylamino)-N-[[(methylamino)carbonyl]oxy]-2-oxo-, methyl ester</ENT> <ENT>23135-22-0</ENT> <ENT>4</ENT> <ENT>P194</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanimidothioic acid, N-[[(methylamino) carbonyl]oxy]-, methyl ester</ENT> <ENT>16752-77-5</ENT> <ENT>4</ENT> <ENT>P066</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanimidothioic acid, N,N′- [thiobis[(methylimino) carbonyloxy]]bis-, dimethyl ester</ENT> <ENT>59669-26-0</ENT> <ENT>4</ENT> <ENT>U410</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethanol, 2-ethoxy-</ENT> <ENT>110-80-5</ENT> <ENT>4</ENT> <ENT>U359</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethanol, 2,2′-(nitrosoimino)bis-</ENT> <ENT>1116-54-7</ENT> <ENT>4</ENT> <ENT>U173</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Ethanol, 2,2′-oxybis-, dicarbamate</ENT> <ENT>5952-26-1</ENT> <ENT>4</ENT> <ENT>U395</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethanone, 1-phenyl-</ENT> <ENT>98-86-2</ENT> <ENT>3,4</ENT> <ENT>U004</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethene, chloro-</ENT> <ENT>75-01-4</ENT> <ENT>2,3,4</ENT> <ENT>U043</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Ethene, (2-chloroethoxy)-</ENT> <ENT>110-75-8</ENT> <ENT>2,4</ENT> <ENT>U042</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethene, 1,1-dichloro-</ENT> <ENT>75-35-4</ENT> <ENT>1,2,3,4</ENT> <ENT>U078</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethene, 1,2-dichloro-(E)</ENT> <ENT>156-60-5</ENT> <ENT>2,4</ENT> <ENT>U079</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethene, tetrachloro-</ENT> <ENT>127-18-4</ENT> <ENT>2,3,4</ENT> <ENT>U210</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethene, trichloro-</ENT> <ENT>79-01-6</ENT> <ENT>1,2,3,4</ENT> <ENT>U228</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethion</ENT> <ENT>563-12-2</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethyl acetate</ENT> <ENT>141-78-6</ENT> <ENT>4</ENT> <ENT>U112</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethyl acrylate</ENT> <ENT>140-88-5</ENT> <ENT>3,4</ENT> <ENT>U113</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethylbenzene</ENT> <ENT>100-41-4</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethyl carbamate</ENT> <ENT>51-79-6</ENT> <ENT>3,4</ENT> <ENT>U238</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="296"/> <ENT I="01">Ethyl chloride</ENT> <ENT>75-00-3</ENT> <ENT>2,3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethyl cyanide</ENT> <ENT>107-12-0</ENT> <ENT>4</ENT> <ENT>P101</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethylenebisdithiocarbamic acid, salts & esters</ENT> <ENT>111-54-6</ENT> <ENT>4</ENT> <ENT>U114</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethylenediamine</ENT> <ENT>107-15-3</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethylenediamine-tetraacetic acid (EDTA)</ENT> <ENT>60-00-4</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethylene dibromide</ENT> <ENT>106-93-4</ENT> <ENT>1,3,4</ENT> <ENT>U067</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Ethylene dichloride</ENT> <ENT>107-06-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U077</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethylene glycol</ENT> <ENT>107-21-1</ENT> <ENT>3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Ethylene glycol monoethyl ether</ENT> <ENT>110-80-5</ENT> <ENT>4</ENT> <ENT>U359</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethylene oxide</ENT> <ENT>75-21-8</ENT> <ENT>3,4</ENT> <ENT>U115</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethylenethiourea</ENT> <ENT>96-45-7</ENT> <ENT>3,4</ENT> <ENT>U116</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Ethylenimine</ENT> <ENT>151-56-4</ENT> <ENT>3,4</ENT> <ENT>P054</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Ethyl ether</ENT> <ENT>60-29-7</ENT> <ENT>4</ENT> <ENT>U117</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ethylidene dichloride</ENT> <ENT>75-34-3</ENT> <ENT>2,3,4</ENT> <ENT>U076</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethyl methacrylate</ENT> <ENT>97-63-2</ENT> <ENT>4</ENT> <ENT>U118</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ethyl methanesulfonate</ENT> <ENT>62-50-0</ENT> <ENT>4</ENT> <ENT>U119</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Famphur</ENT> <ENT>52-85-7</ENT> <ENT>4</ENT> <ENT>P097</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferric ammonium citrate</ENT> <ENT>1185-57-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferric ammonium oxalate</ENT> <ENT> 2944-67-4 <LI>55488-87-4</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferric chloride</ENT> <ENT>7705-08-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferric fluoride</ENT> <ENT>7783-50-8</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ferric nitrate</ENT> <ENT>10421-48-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferric sulfate</ENT> <ENT>10028-22-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferrous ammonium sulfate</ENT> <ENT>10045-89-3</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ferrous chloride</ENT> <ENT>7758-94-3</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Ferrous sulfate</ENT> <ENT> 7720-78-7 <LI>7782-63-0</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01"> Fine mineral fibers  <SU>c</SU> </ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Fluoranthene</ENT> <ENT>206-44-0</ENT> <ENT>2,4</ENT> <ENT>U120</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Fluorene</ENT> <ENT>86-73-7</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Fluorine</ENT> <ENT>7782-41-4</ENT> <ENT>4</ENT> <ENT>P056</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Fluoroacetamide</ENT> <ENT>640-19-7</ENT> <ENT>4</ENT> <ENT>P057</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Fluoroacetic acid, sodium salt</ENT> <ENT>62-74-8</ENT> <ENT>4</ENT> <ENT>P058</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Formaldehyde</ENT> <ENT>50-00-0</ENT> <ENT>1,3,4</ENT> <ENT>U122</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Formetanate hydrochloride</ENT> <ENT>23422-53-9</ENT> <ENT>4</ENT> <ENT>P198</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Formic acid</ENT> <ENT>64-18-6</ENT> <ENT>1,4</ENT> <ENT>U123</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Formparanate</ENT> <ENT>17702-57-7</ENT> <ENT>4</ENT> <ENT>P197</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Fulminic acid, mercury(2 +)salt</ENT> <ENT>628-86-4</ENT> <ENT>4</ENT> <ENT>P065</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Fumaric acid</ENT> <ENT>110-17-8</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Furan</ENT> <ENT>110-00-9</ENT> <ENT>4</ENT> <ENT>U124</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Furancarboxaldehyde</ENT> <ENT>98-01-1</ENT> <ENT>1,4</ENT> <ENT>U125</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2,5-Furandione</ENT> <ENT>108-31-6</ENT> <ENT>1,3,4</ENT> <ENT>U147</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Furan, tetrahydro-</ENT> <ENT>109-99-9</ENT> <ENT>4</ENT> <ENT>U213</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Furfural</ENT> <ENT>98-01-1</ENT> <ENT>1,4</ENT> <ENT>U125</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Furfuran</ENT> <ENT>110-00-9</ENT> <ENT>4</ENT> <ENT>U124</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Glucopyranose, 2-deoxy-2-(3-methyl-3-nitrosoureido)-,D-</ENT> <ENT>18883-66-4</ENT> <ENT>4</ENT> <ENT>U206</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">D-Glucose, 2-deoxy-2-[[(methylnitrosoamino)-carbonyl]amino]-</ENT> <ENT>18883-66-4</ENT> <ENT>4</ENT> <ENT>U206</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Glycidylaldehyde</ENT> <ENT>765-34-4</ENT> <ENT>4</ENT> <ENT>U126</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01"> Glycol ethers  <SU>d</SU> </ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Guanidine, N-methyl-N′-nitro-N-nitroso-</ENT> <ENT>70-25-7</ENT> <ENT>4</ENT> <ENT>U163</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Guthion</ENT> <ENT>86-50-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">HALOETHERS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">HALOMETHANES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">HEPTACHLOR AND METABOLITES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Heptachlor</ENT> <ENT>76-44-8</ENT> <ENT>1,2,3,4</ENT> <ENT>P059</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Heptachlor epoxide</ENT> <ENT>1024-57-3</ENT> <ENT>2</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Hexachlorobenzene</ENT> <ENT>118-74-1</ENT> <ENT>2,3,4</ENT> <ENT>U127</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hexachlorobutadiene</ENT> <ENT>87-68-3</ENT> <ENT>2,3,4</ENT> <ENT>U128</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">HEXACHLOROCYCLOHEXANE (all isomers)</ENT> <ENT>608-73-1</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Hexachlorocyclopentadiene</ENT> <ENT>77-47-4</ENT> <ENT>1,2,3,4</ENT> <ENT>U130</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hexachloroethane</ENT> <ENT>67-72-1</ENT> <ENT>2,3,4</ENT> <ENT>U131</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hexachlorophene</ENT> <ENT>70-30-4</ENT> <ENT>4</ENT> <ENT>U132</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hexachloropropene</ENT> <ENT>1888-71-7</ENT> <ENT>4</ENT> <ENT>U243</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Hexaethyl tetraphosphate</ENT> <ENT>757-58-4</ENT> <ENT>4</ENT> <ENT>P062</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hexamethylene-1,6-diisocyanate</ENT> <ENT>822-06-0</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hexamethylphosphoramide</ENT> <ENT>680-31-9</ENT> <ENT>3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Hexane</ENT> <ENT>110-54-3</ENT> <ENT>3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <PRTPAGE P="297"/> <ENT I="01">Hexone</ENT> <ENT>108-10-1</ENT> <ENT>3,4</ENT> <ENT>U161</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Hydrazine</ENT> <ENT>302-01-2</ENT> <ENT>3,4</ENT> <ENT>U133</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Hydrazinecarbothioamide</ENT> <ENT>79-19-6</ENT> <ENT>4</ENT> <ENT>P116</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hydrazine, 1,2-diethyl-</ENT> <ENT>1615-80-1</ENT> <ENT>4</ENT> <ENT>U086</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydrazine, 1,1-dimethyl-</ENT> <ENT>57-14-7</ENT> <ENT>3,4</ENT> <ENT>U098</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydrazine, 1,2-dimethyl-</ENT> <ENT>540-73-8</ENT> <ENT>4</ENT> <ENT>U099</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Hydrazine, 1,2-diphenyl-</ENT> <ENT>122-66-7</ENT> <ENT>2,3,4</ENT> <ENT>U109</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydrazine, methyl-</ENT> <ENT>60-34-4</ENT> <ENT>3,4</ENT> <ENT>P068</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydrochloric acid</ENT> <ENT>7647-01-0</ENT> <ENT>1,3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Hydrocyanic acid</ENT> <ENT>74-90-8</ENT> <ENT>1,4</ENT> <ENT>P063</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydrofluoric acid</ENT> <ENT>7664-39-3</ENT> <ENT>1,3,4</ENT> <ENT>U134</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hydrogen chloride</ENT> <ENT>7647-01-0</ENT> <ENT>1,3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Hydrogen cyanide</ENT> <ENT>74-90-8</ENT> <ENT>1,4</ENT> <ENT>P063</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydrogen fluoride</ENT> <ENT>7664-39-3</ENT> <ENT>1,3,4</ENT> <ENT>U134</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hydrogen phosphide</ENT> <ENT>7803-51-2</ENT> <ENT>3,4</ENT> <ENT>P096</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hydrogen sulfide H2S</ENT> <ENT>7783-06-4</ENT> <ENT>1,4</ENT> <ENT>U135</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Hydroperoxide, 1-methyl-1-phenylethyl-</ENT> <ENT>80-15-9</ENT> <ENT>4</ENT> <ENT>U096</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Hydroquinone</ENT> <ENT>123-31-9</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Imidazolidinethione</ENT> <ENT>96-45-7</ENT> <ENT>3,4</ENT> <ENT>U116</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Indeno(1,2,3-cd)pyrene</ENT> <ENT>193-39-5</ENT> <ENT>2,4</ENT> <ENT>U137</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Iodomethane</ENT> <ENT>74-88-4</ENT> <ENT>3,4</ENT> <ENT>U138</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,3-Isobenzofurandione</ENT> <ENT>85-44-9</ENT> <ENT>3,4</ENT> <ENT>U190</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Isobutyl alcohol</ENT> <ENT>78-83-1</ENT> <ENT>4</ENT> <ENT>U140</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Isodrin</ENT> <ENT>465-73-6</ENT> <ENT>4</ENT> <ENT>P060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Isolan</ENT> <ENT>119-38-0</ENT> <ENT>4</ENT> <ENT>P192</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Isophorone</ENT> <ENT>78-59-1</ENT> <ENT>2,3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Isoprene</ENT> <ENT>78-79-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Isopropanolamine dodecylbenzenesulfonate</ENT> <ENT>42504-46-1</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">3-Isopropylphenyl N-methylcarbamate</ENT> <ENT>64-00-6</ENT> <ENT>4</ENT> <ENT>P202</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Isosafrole</ENT> <ENT>120-58-1</ENT> <ENT>4</ENT> <ENT>U141</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">3(2H)-Isoxazolone, 5-(aminomethyl)-</ENT> <ENT>2763-96-4</ENT> <ENT>4</ENT> <ENT>P007</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Kepone</ENT> <ENT>143-50-0</ENT> <ENT>1,4</ENT> <ENT>U142</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Lasiocarpine</ENT> <ENT>303-34-4</ENT> <ENT>4</ENT> <ENT>U143</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">LEAD AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Lead  <SU>III</SU> </ENT> <ENT>7439-92-1</ENT> <ENT>2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead acetate</ENT> <ENT>301-04-2</ENT> <ENT>1,4</ENT> <ENT>U144</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead arsenate</ENT> <ENT> 7784-40-9 <LI>7645-25-2</LI> <LI>10102-48-4</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Lead, bis(acetato-O)tetrahydroxytri-</ENT> <ENT>1335-32-6</ENT> <ENT>4</ENT> <ENT>U146</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead chloride</ENT> <ENT>7758-95-4</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Lead fluoborate</ENT> <ENT>13814-96-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead fluoride</ENT> <ENT>7783-46-2</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead iodide</ENT> <ENT>10101-63-0</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead nitrate</ENT> <ENT>10099-74-8</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead phosphate</ENT> <ENT>7446-27-7</ENT> <ENT>4</ENT> <ENT>U145</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead stearate</ENT> <ENT> 1072-35-1 <LI>7428-48-0</LI> <LI>56189-09-4</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead subacetate</ENT> <ENT>1335-32-6</ENT> <ENT>4</ENT> <ENT>U146</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead sulfate</ENT> <ENT> 7446-14-2 <LI>15739-80-7</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead sulfide</ENT> <ENT>1314-87-0</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lead thiocyanate</ENT> <ENT>592-87-0</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Lindane</ENT> <ENT>58-89-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U129</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Lindane (all isomers)</ENT> <ENT>58-89-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U129</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Lithium chromate</ENT> <ENT>14307-35-8</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Malathion</ENT> <ENT>121-75-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Maleic acid</ENT> <ENT>110-16-7</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Maleic anhydride</ENT> <ENT>108-31-6</ENT> <ENT>1,3,4</ENT> <ENT>U147</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Maleic hydrazide</ENT> <ENT>123-33-1</ENT> <ENT>4</ENT> <ENT>U148</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Malononitrile</ENT> <ENT>109-77-3</ENT> <ENT>4</ENT> <ENT>U149</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Manganese, bis (dimethylcarbamodithioato-S,S′)-</ENT> <ENT>15339-36-3</ENT> <ENT>4</ENT> <ENT>P196</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Manganese Compounds</ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Manganese dimethyldithiocarbamate</ENT> <ENT>15339-36-3</ENT> <ENT>4</ENT> <ENT>P196</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">MDI</ENT> <ENT>101-68-8</ENT> <ENT>3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">MEK</ENT> <ENT>78-93-3</ENT> <ENT>4</ENT> <ENT>U159</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Melphalan</ENT> <ENT>148-82-3</ENT> <ENT>4</ENT> <ENT>U150</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Mercaptodimethur</ENT> <ENT>2032-65-7</ENT> <ENT>1,4</ENT> <ENT>P199</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <PRTPAGE P="298"/> <ENT I="01">MERCURY AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Mercury Compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Mercuric cyanide</ENT> <ENT>592-04-1</ENT> <ENT>1</ENT> <ENT/> <ENT>1(0.454)</ENT> </ROW> <ROW> <ENT I="01">Mercuric nitrate</ENT> <ENT>10045-94-0</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Mercuric sulfate</ENT> <ENT>7783-35-9</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Mercuric thiocyanate</ENT> <ENT>592-85-8</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Mercurous nitrate</ENT> <ENT>10415-75-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Mercury</ENT> <ENT> 7782-86-7 <LI>7439-97-6</LI> </ENT> <ENT>2,3,4</ENT> <ENT>U151</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Mercury, (acetato-O)phenyl-</ENT> <ENT>62-38-4</ENT> <ENT>4</ENT> <ENT>P092</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Mercury fulminate</ENT> <ENT>628-86-4</ENT> <ENT>4</ENT> <ENT>P065</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methacrylonitrile</ENT> <ENT>126-98-7</ENT> <ENT>4</ENT> <ENT>U152</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methanamine, N-methyl-</ENT> <ENT>124-40-3</ENT> <ENT>1,4</ENT> <ENT>U092</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methanamine, N-methyl-N-nitroso-</ENT> <ENT>62-75-9</ENT> <ENT>2,3,4</ENT> <ENT>P082</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methane, bromo-</ENT> <ENT>74-83-9</ENT> <ENT>2,3,4</ENT> <ENT>U029</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methane, chloro-</ENT> <ENT>74-87-3</ENT> <ENT>2,3,4</ENT> <ENT>U045</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methane, chloromethoxy-</ENT> <ENT>107-30-2</ENT> <ENT>3,4</ENT> <ENT>U046</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methane, dibromo-</ENT> <ENT>74-95-3</ENT> <ENT>4</ENT> <ENT>U068</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methane, dichloro-</ENT> <ENT>75-09-2</ENT> <ENT>2,3,4</ENT> <ENT>U080</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methane, dichlorodifluoro-</ENT> <ENT>75-71-8</ENT> <ENT>4</ENT> <ENT>U075</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methane, iodo-</ENT> <ENT>74-88-4</ENT> <ENT>3,4</ENT> <ENT>U138</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methane, isocyanato-</ENT> <ENT>624-83-9</ENT> <ENT>3,4</ENT> <ENT>P064</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methane, oxybis(chloro-</ENT> <ENT>542-88-1</ENT> <ENT>3,4</ENT> <ENT>P016</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methanesulfenyl chloride, trichloro-</ENT> <ENT>594-42-3</ENT> <ENT>4</ENT> <ENT>P118</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methanesulfonic acid, ethyl ester</ENT> <ENT>62-50-0</ENT> <ENT>4</ENT> <ENT>U119</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Methane, tetrachloro-</ENT> <ENT>56-23-5</ENT> <ENT>1,2,3,4</ENT> <ENT>U211</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methane, tetranitro-</ENT> <ENT>509-14-8</ENT> <ENT>4</ENT> <ENT>P112</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methanethiol</ENT> <ENT>74-93-1</ENT> <ENT>1,4</ENT> <ENT>U153</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methane, tribromo-</ENT> <ENT>75-25-2</ENT> <ENT>2,3,4</ENT> <ENT>U225</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methane, trichloro-</ENT> <ENT>67-66-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U044</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methane, trichlorofluoro-</ENT> <ENT>75-69-4</ENT> <ENT>4</ENT> <ENT>U121</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methanimidamide, N,N-dimethyl-N′-[3-[[(methylamino)-carbonyl]oxy]phenyl]-, monohydrochloride</ENT> <ENT>23422-53-9</ENT> <ENT>4</ENT> <ENT>P198</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methanimidamide, N,N-dimethyl-N′-[2-methyl-4- [[(methylamino) carbonyl]oxy]phenyl]-</ENT> <ENT>17702-57-7</ENT> <ENT>4</ENT> <ENT>P197</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10-hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide</ENT> <ENT>115-29-7</ENT> <ENT>1,2,4</ENT> <ENT>P050</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-</ENT> <ENT>76-44-8</ENT> <ENT>1,2,3,4</ENT> <ENT>P059</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">4,7-Methano-1H-indene, 1,2,4,5,6,7,8,8-octachloro-2,3,3a,4,7,7a-hexahydro-</ENT> <ENT>57-74-9</ENT> <ENT>1,2,3,4</ENT> <ENT>U036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Methanol</ENT> <ENT>67-56-1</ENT> <ENT>3,4</ENT> <ENT>U154</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methapyrilene</ENT> <ENT>91-80-5</ENT> <ENT>4</ENT> <ENT>U155</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1,3,4-Metheno-2H-cyclobuta[cd]pentalen-2-one, 1,1a,3,3a,4,5,5,5a,5b,6-decachlorooctahydro-</ENT> <ENT>143-50-0</ENT> <ENT>1,4</ENT> <ENT>U142</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Methiocarb</ENT> <ENT>2032-65-7</ENT> <ENT>1,4</ENT> <ENT>P199</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methomyl</ENT> <ENT>16752-77-5</ENT> <ENT>4</ENT> <ENT>P066</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methoxychlor</ENT> <ENT>72-43-5</ENT> <ENT>1,3,4</ENT> <ENT>U247</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Methyl alcohol</ENT> <ENT>67-56-1</ENT> <ENT>3,4</ENT> <ENT>U154</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Methyl aziridine</ENT> <ENT>75-55-8</ENT> <ENT>3,4</ENT> <ENT>P067</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Methyl bromide</ENT> <ENT>74-83-9</ENT> <ENT>2,3,4</ENT> <ENT>U029</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1-Methylbutadiene</ENT> <ENT>504-60-9</ENT> <ENT>4</ENT> <ENT>U186</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methyl chloride</ENT> <ENT>74-87-3</ENT> <ENT>2,3,4</ENT> <ENT>U045</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methyl chlorocarbonate</ENT> <ENT>79-22-1</ENT> <ENT>4</ENT> <ENT>U156</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methyl chloroform</ENT> <ENT>71-55-6</ENT> <ENT>2,3,4</ENT> <ENT>U226</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">3-Methylcholanthrene</ENT> <ENT>56-49-5</ENT> <ENT>4</ENT> <ENT>U157</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">4,4′-Methylenebis(2-chloroaniline)</ENT> <ENT>101-14-4</ENT> <ENT>3,4</ENT> <ENT>U158</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methylene bromide</ENT> <ENT>74-95-3</ENT> <ENT>4</ENT> <ENT>U068</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methylene chloride</ENT> <ENT>75-09-2</ENT> <ENT>2,3,4</ENT> <ENT>U080</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">4,4′-Methylenedianiline</ENT> <ENT>101-77-9</ENT> <ENT>3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methylene diphenyl diisocyanate</ENT> <ENT>101-68-8</ENT> <ENT>3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methyl ethyl ketone</ENT> <ENT>78-93-3</ENT> <ENT>4</ENT> <ENT>U159</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methyl ethyl ketone peroxide</ENT> <ENT>1338-23-4</ENT> <ENT>4</ENT> <ENT>U160</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methyl hydrazine</ENT> <ENT>60-34-4</ENT> <ENT>3,4</ENT> <ENT>P068</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methyl iodide</ENT> <ENT>74-88-4</ENT> <ENT>3,4</ENT> <ENT>U138</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Methyl isobutyl ketone</ENT> <ENT>108-10-1</ENT> <ENT>3,4</ENT> <ENT>U161</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methyl isocyanate</ENT> <ENT>624-83-9</ENT> <ENT>3,4</ENT> <ENT>P064</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2-Methyllactonitrile</ENT> <ENT>75-86-5</ENT> <ENT>1,4</ENT> <ENT>P069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Methyl mercaptan</ENT> <ENT>74-93-1</ENT> <ENT>1,4</ENT> <ENT>U153</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="299"/> <ENT I="01">Methyl methacrylate</ENT> <ENT>80-62-6</ENT> <ENT>1,3,4</ENT> <ENT>U162</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methyl parathion</ENT> <ENT>298-00-0</ENT> <ENT>1,4</ENT> <ENT>P071</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">4-Methyl-2-pentanone</ENT> <ENT>108-10-1</ENT> <ENT>3,4</ENT> <ENT>U161</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Methyl tert-butyl ether</ENT> <ENT>1634-04-4</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Methylthiouracil</ENT> <ENT>56-04-2</ENT> <ENT>4</ENT> <ENT>U164</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Metolcarb</ENT> <ENT>1129-41-5</ENT> <ENT>4</ENT> <ENT>P190</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Mevinphos</ENT> <ENT>7786-34-7</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Mexacarbate</ENT> <ENT>315-18-4</ENT> <ENT>1,4</ENT> <ENT>P128</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Mitomycin C</ENT> <ENT>50-07-7</ENT> <ENT>4</ENT> <ENT>U010</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">MNNG</ENT> <ENT>70-25-7</ENT> <ENT>4</ENT> <ENT>U163</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Monoethylamine</ENT> <ENT>75-04-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Monomethylamine</ENT> <ENT>74-89-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Naled</ENT> <ENT>300-76-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-</ENT> <ENT>20830-81-3</ENT> <ENT>4</ENT> <ENT>U059</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1-Naphthalenamine</ENT> <ENT>134-32-7</ENT> <ENT>4</ENT> <ENT>U167</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Naphthalenamine</ENT> <ENT>91-59-8</ENT> <ENT>4</ENT> <ENT>U168</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Naphthalenamine, N,N′-bis(2-chloroethyl)-</ENT> <ENT>494-03-1</ENT> <ENT>4</ENT> <ENT>U026</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Naphthalene</ENT> <ENT>91-20-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U165</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Naphthalene, 2-chloro-</ENT> <ENT>91-58-7</ENT> <ENT>2,4</ENT> <ENT>U047</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1,4-Naphthalenedione</ENT> <ENT>130-15-4</ENT> <ENT>4</ENT> <ENT>U166</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethyl-(1,1′-biphenyl)-4,4′-diyl)-bis(azo)]bis(5-amino-4-hydroxy)-tetrasodium salt</ENT> <ENT>72-57-1</ENT> <ENT>4</ENT> <ENT>U236</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1-Naphthalenol, methylcarbamate</ENT> <ENT>63-25-2</ENT> <ENT>1,3,4</ENT> <ENT>U279</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Naphthenic acid</ENT> <ENT>1338-24-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,4-Naphthoquinone</ENT> <ENT>130-15-4</ENT> <ENT>4</ENT> <ENT>U166</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">alpha-Naphthylamine</ENT> <ENT>134-32-7</ENT> <ENT>4</ENT> <ENT>U167</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">beta-Naphthylamine</ENT> <ENT>91-59-8</ENT> <ENT>4</ENT> <ENT>U168</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">alpha-Naphthylthiourea</ENT> <ENT>86-88-4</ENT> <ENT>4</ENT> <ENT>P072</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">NICKEL AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Nickel  <SU>III</SU> </ENT> <ENT>7440-02-0</ENT> <ENT>2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nickel ammonium sulfate</ENT> <ENT>15699-18-0</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nickel carbonyl Ni(CO)4, (T-4)-</ENT> <ENT>13463-39-3</ENT> <ENT>4</ENT> <ENT>P073</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Nickel chloride</ENT> <ENT> 7718-54-9 <LI>37211-05-5</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nickel compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Nickel cyanide Ni(CN)2</ENT> <ENT>557-19-7</ENT> <ENT>4</ENT> <ENT>P074</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Nickel hydroxide</ENT> <ENT>12054-48-7</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Nickel nitrate</ENT> <ENT>14216-75-2</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nickel sulfate</ENT> <ENT>7786-81-4</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nicotine, & salts</ENT> <ENT>54-11-5</ENT> <ENT>4</ENT> <ENT>P075</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nitric acid</ENT> <ENT>7697-37-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Nitric acid, thallium (1 +) salt</ENT> <ENT>10102-45-1</ENT> <ENT>4</ENT> <ENT>U217</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Nitric oxide</ENT> <ENT>10102-43-9</ENT> <ENT>4</ENT> <ENT>P076</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">p-Nitroaniline</ENT> <ENT>100-01-6</ENT> <ENT>4</ENT> <ENT>P077</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Nitrobenzene</ENT> <ENT>98-95-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U169</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">4-Nitrobiphenyl</ENT> <ENT>92-93-3</ENT> <ENT>3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Nitrogen dioxide</ENT> <ENT>10102-44-0 10544-72-6</ENT> <ENT>1,4</ENT> <ENT>P078</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Nitrogen oxide NO</ENT> <ENT>10102-43-9</ENT> <ENT>4</ENT> <ENT>P076</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01"> Nitrogen oxide NO <E T="0732">2</E> </ENT> <ENT>10102-44-0 10544-72-6</ENT> <ENT>1,4</ENT> <ENT>P078</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Nitroglycerine</ENT> <ENT>55-63-0</ENT> <ENT>4</ENT> <ENT>P081</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">NITROPHENOLS</ENT> <ENT>25154-55-6</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Nitrophenol (mixed)</ENT> <ENT>25154-55-6</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">m-Nitrophenol</ENT> <ENT>554-84-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">o-Nitrophenol</ENT> <ENT>88-75-5</ENT> <ENT>1,2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">p-Nitrophenol</ENT> <ENT>100-02-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U170</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">2-Nitrophenol</ENT> <ENT>88-75-5</ENT> <ENT>1,2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">4-Nitrophenol</ENT> <ENT>100-02-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U170</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Nitropropane</ENT> <ENT>79-46-9</ENT> <ENT>3,4</ENT> <ENT>U171</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">NITROSAMINES</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosodi-n-butylamine</ENT> <ENT>924-16-3</ENT> <ENT>4</ENT> <ENT>U172</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosodiethanolamine</ENT> <ENT>1116-54-7</ENT> <ENT>4</ENT> <ENT>U173</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosodiethylamine</ENT> <ENT>55-18-5</ENT> <ENT>4</ENT> <ENT>U174</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosodimethylamine</ENT> <ENT>62-75-9</ENT> <ENT>2,3,4</ENT> <ENT>P082</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosodiphenylamine</ENT> <ENT>86-30-6</ENT> <ENT>2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">N-Nitroso-N-ethylurea</ENT> <ENT>759-73-9</ENT> <ENT>4</ENT> <ENT>U176</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="300"/> <ENT I="01">N-Nitroso-N-methylurea</ENT> <ENT>684-93-5</ENT> <ENT>3,4</ENT> <ENT>U177</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">N-Nitroso-N-methylurethane</ENT> <ENT>615-53-2</ENT> <ENT>4</ENT> <ENT>U178</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosomethylvinylamine</ENT> <ENT>4549-40-0</ENT> <ENT>4</ENT> <ENT>P084</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosomorpholine</ENT> <ENT>59-89-2</ENT> <ENT>3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosopiperidine</ENT> <ENT>100-75-4</ENT> <ENT>4</ENT> <ENT>U179</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">N-Nitrosopyrrolidine</ENT> <ENT>930-55-2</ENT> <ENT>4</ENT> <ENT>U180</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Nitrotoluene</ENT> <ENT>1321-12-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">m-Nitrotoluene</ENT> <ENT>99-08-1</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">o-Nitrotoluene</ENT> <ENT>88-72-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">p-Nitrotoluene</ENT> <ENT>99-99-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">5-Nitro-o-toluidine</ENT> <ENT>99-55-8</ENT> <ENT>4</ENT> <ENT>U181</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Octamethylpyrophosphoramide</ENT> <ENT>152-16-9</ENT> <ENT>4</ENT> <ENT>P085</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Osmium oxide OsO4, (T-4)-</ENT> <ENT>20816-12-0</ENT> <ENT>4</ENT> <ENT>P087</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Osmium tetroxide</ENT> <ENT>20816-12-0</ENT> <ENT>4</ENT> <ENT>P087</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">7-Oxabicyclo[221]heptane-2,3-dicarboxylic acid</ENT> <ENT>145-73-3</ENT> <ENT>4</ENT> <ENT>P088</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Oxamyl</ENT> <ENT>23135-22-0</ENT> <ENT>4</ENT> <ENT>P194</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,2-Oxathiolane, 2,2-dioxide</ENT> <ENT>1120-71-4</ENT> <ENT>3,4</ENT> <ENT>U193</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2H-1,3,2-Oxazaphosphorin-2-amine, N,N- bis(2-chloroethyl)tetrahydro-, 2-oxide</ENT> <ENT>50-18-0</ENT> <ENT>4</ENT> <ENT>U058</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Oxirane</ENT> <ENT>75-21-8</ENT> <ENT>3,4</ENT> <ENT>U115</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Oxiranecarboxyaldehyde</ENT> <ENT>765-34-4</ENT> <ENT>4</ENT> <ENT>U126</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Oxirane, (chloromethyl)-</ENT> <ENT>106-89-8</ENT> <ENT>1,3,4</ENT> <ENT>U041</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Paraformaldehyde</ENT> <ENT>30525-89-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Paraldehyde</ENT> <ENT>123-63-7</ENT> <ENT>4</ENT> <ENT>U182</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Parathion</ENT> <ENT>56-38-2</ENT> <ENT>1,3,4</ENT> <ENT>P089</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">PCBs</ENT> <ENT>1336-36-3</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">PCNB</ENT> <ENT>82-68-8</ENT> <ENT>3,4</ENT> <ENT>U185</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Pentachlorobenzene</ENT> <ENT>608-93-5</ENT> <ENT>4</ENT> <ENT>U183</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Pentachloroethane</ENT> <ENT>76-01-7</ENT> <ENT>4</ENT> <ENT>U184</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Pentachloronitrobenzene</ENT> <ENT>82-68-8</ENT> <ENT>3,4</ENT> <ENT>U185</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Pentachlorophenol</ENT> <ENT>87-86-5</ENT> <ENT>1,2,3,4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,3-Pentadiene</ENT> <ENT>504-60-9</ENT> <ENT>4</ENT> <ENT>U186</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Perchloroethylene</ENT> <ENT>127-18-4</ENT> <ENT>2,3,4</ENT> <ENT>U210</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01"> Perfluorooctanesulfonic acid, salts, & structural isomers  <SU>v</SU> </ENT> <ENT>N.A.</ENT> <ENT>5</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> Perfluorooctanesulfonic acid  <SU>v</SU> </ENT> <ENT>1763-23-1</ENT> <ENT>5</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> Perfluorooctanoic acid, salts, & structural isomers  <SU>v</SU> </ENT> <ENT>N.A.</ENT> <ENT>5</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> Perfluorooctanoic acid  <SU>v</SU> </ENT> <ENT>335-67-1</ENT> <ENT>5</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Phenacetin</ENT> <ENT>62-44-2</ENT> <ENT>4</ENT> <ENT>U187</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenanthrene</ENT> <ENT>85-01-8</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Phenol</ENT> <ENT>108-95-2</ENT> <ENT>1,2,3,4</ENT> <ENT>U188</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2-chloro-</ENT> <ENT>95-57-8</ENT> <ENT>2,4</ENT> <ENT>U048</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 4-chloro-3-methyl-</ENT> <ENT>59-50-7</ENT> <ENT>2,4</ENT> <ENT>U039</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2-cyclohexyl-4,6-dinitro-</ENT> <ENT>131-89-5</ENT> <ENT>4</ENT> <ENT>P034</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,4-dichloro-</ENT> <ENT>120-83-2</ENT> <ENT>2,4</ENT> <ENT>U081</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,6-dichloro-</ENT> <ENT>87-65-0</ENT> <ENT>4</ENT> <ENT>U082</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 4,4′-(1,2-diethyl-1,2-ethenediyl)bis-, (E)</ENT> <ENT>56-53-1</ENT> <ENT>4</ENT> <ENT>U089</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,4-dimethyl-</ENT> <ENT>105-67-9</ENT> <ENT>2,4</ENT> <ENT>U101</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 4-(dimethylamino)-3,5-dimethyl-, 4 methylcarbamate (ester)</ENT> <ENT>315-18-4</ENT> <ENT>1,4</ENT> <ENT>P128</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Phenol, (3,5-dimethyl-4-(methylthio)-, methylcarbamate</ENT> <ENT>2032-65-7</ENT> <ENT>1,4</ENT> <ENT>P199</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,4-dinitro-</ENT> <ENT>51-28-5</ENT> <ENT>1,2,3,4</ENT> <ENT>P048</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, methyl-</ENT> <ENT>1319-77-3</ENT> <ENT>1,3,4</ENT> <ENT>U052</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2-methyl-4,6-dinitro-</ENT> <ENT>534-52-1</ENT> <ENT>2,3,4</ENT> <ENT>P047</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2-methyl-4,6-dinitro-, & salts</ENT> <ENT>534-52-1</ENT> <ENT>3,4</ENT> <ENT>P047</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,2′-methylenebis[3,4,6- trichloro-</ENT> <ENT>70-30-4</ENT> <ENT>4</ENT> <ENT>U132</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2-(1-methylethoxy)-, methylcarbamate</ENT> <ENT>114-26-1</ENT> <ENT>3,4</ENT> <ENT>U411</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 3-(1-methylethyl)-, methyl carbamate</ENT> <ENT>64-00-6</ENT> <ENT>4</ENT> <ENT>P202</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 3-methyl-5-(1-methylethyl)-, methyl carbamate</ENT> <ENT>2631-37-0</ENT> <ENT>4</ENT> <ENT>P201</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2-(1-methylpropyl)-4,6-dinitro-</ENT> <ENT>88-85-7</ENT> <ENT>4</ENT> <ENT>P020</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 4-nitro-</ENT> <ENT>100-02-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U170</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenol, pentachloro-</ENT> <ENT>87-86-5</ENT> <ENT>1,2,3,4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,3,4,6-tetrachloro-</ENT> <ENT>58-90-2</ENT> <ENT>4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,4,5-trichloro-</ENT> <ENT>95-95-4</ENT> <ENT>1,3,4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,4,6-trichloro-</ENT> <ENT>88-06-2</ENT> <ENT>1,2,3,4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phenol, 2,4,6-trinitro-, ammonium salt</ENT> <ENT>131-74-8</ENT> <ENT>4</ENT> <ENT>P009</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">L-Phenylalanine, 4-[bis(2-chloroethyl)amino]-</ENT> <ENT>148-82-3</ENT> <ENT>4</ENT> <ENT>U150</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">p-Phenylenediamine</ENT> <ENT>106-50-3</ENT> <ENT>3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <PRTPAGE P="301"/> <ENT I="01">Phenylmercury acetate</ENT> <ENT>62-38-4</ENT> <ENT>4</ENT> <ENT>P092</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phenylthiourea</ENT> <ENT>103-85-5</ENT> <ENT>4</ENT> <ENT>P093</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phorate</ENT> <ENT>298-02-2</ENT> <ENT>4</ENT> <ENT>P094</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phosgene</ENT> <ENT>75-44-5</ENT> <ENT>1,3,4</ENT> <ENT>P095</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phosphine</ENT> <ENT>7803-51-2</ENT> <ENT>3,4</ENT> <ENT>P096</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphoric acid</ENT> <ENT>7664-38-2</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Phosphoric acid, diethyl 4-nitrophenyl ester</ENT> <ENT>311-45-5</ENT> <ENT>4</ENT> <ENT>P041</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphoric acid, lead(2 +) salt (2:3)</ENT> <ENT>7446-27-7</ENT> <ENT>4</ENT> <ENT>U145</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phosphorodithioic acid, O,O-diethyl S-[2-(ethylthio)ethyl] ester</ENT> <ENT>298-04-4</ENT> <ENT>1,4</ENT> <ENT>P039</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Phosphorodithioic acid, O,O-diethyl S-[(ethylthio)methyl] ester</ENT> <ENT>298-02-2</ENT> <ENT>4</ENT> <ENT>P094</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phosphorodithioic acid, O,O-diethyl S-methyl ester</ENT> <ENT>3288-58-2</ENT> <ENT>4</ENT> <ENT>U087</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Phosphorodithioic acid, O,O-dimethyl S-[2(methylamino)-2-oxoethyl] ester</ENT> <ENT>60-51-5</ENT> <ENT>4</ENT> <ENT>P044</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phosphorofluoridic acid, bis(1-methylethyl) ester</ENT> <ENT>55-91-4</ENT> <ENT>4</ENT> <ENT>P043</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphorothioic acid, O,O-diethyl O-(4-nitrophenyl) ester</ENT> <ENT>56-38-2</ENT> <ENT>1,3,4</ENT> <ENT>P089</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Phosphorothioic acid, O,O-diethyl O-pyrazinyl ester</ENT> <ENT>297-97-2</ENT> <ENT>4</ENT> <ENT>P040</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphorothioic acid, O-[4-[(dimethylamino) sulfonyl]phenyl] O,O-dimethyl ester</ENT> <ENT>52-85-7</ENT> <ENT>4</ENT> <ENT>P097</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Phosphorothioic acid, O,O-dimethyl O-(4-nitrophenyl) ester</ENT> <ENT>298-00-0</ENT> <ENT>1,4</ENT> <ENT>P071</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus</ENT> <ENT>7723-14-0</ENT> <ENT>1,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus oxychloride</ENT> <ENT>10025-87-3</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus pentasulfide</ENT> <ENT>1314-80-3</ENT> <ENT>1,4</ENT> <ENT>U189</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus sulfide</ENT> <ENT>1314-80-3</ENT> <ENT>1,4</ENT> <ENT>U189</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus trichloride</ENT> <ENT>7719-12-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Physostigmine</ENT> <ENT>57-47-6</ENT> <ENT>4</ENT> <ENT>P204</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Physostigmine salicylate</ENT> <ENT>57-64-7</ENT> <ENT>4</ENT> <ENT>P188</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">PHTHALATE ESTERS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Phthalic anhydride</ENT> <ENT>85-44-9</ENT> <ENT>3,4</ENT> <ENT>U190</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Picoline</ENT> <ENT>109-06-8</ENT> <ENT>4</ENT> <ENT>U191</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Piperidine, 1-nitroso-</ENT> <ENT>100-75-4</ENT> <ENT>4</ENT> <ENT>U179</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Plumbane, tetraethyl-</ENT> <ENT>78-00-2</ENT> <ENT>1,4</ENT> <ENT>P110</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">POLYCHLORINATED BIPHENYLS</ENT> <ENT>1336-36-3</ENT> <ENT>1,2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> Polycyclic Organic Matter  <SU>e</SU> </ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">POLYNUCLEAR AROMATIC HYDROCARBONS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Potassium arsenate</ENT> <ENT>7784-41-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Potassium arsenite</ENT> <ENT>10124-50-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Potassium bichromate</ENT> <ENT>7778-50-9</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Potassium chromate</ENT> <ENT>7789-00-6</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Potassium cyanide K(CN)</ENT> <ENT>151-50-8</ENT> <ENT>1,4</ENT> <ENT>P098</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Potassium hydroxide</ENT> <ENT>1310-58-3</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Potassium permanganate</ENT> <ENT>7722-64-7</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Potassium silver cyanide</ENT> <ENT>506-61-6</ENT> <ENT>4</ENT> <ENT>P099</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Promecarb</ENT> <ENT>2631-37-0</ENT> <ENT>4</ENT> <ENT>P201</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Pronamide</ENT> <ENT>23950-58-5</ENT> <ENT>4</ENT> <ENT>U192</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Propanal, 2-methyl-2-(methyl- sulfonyl)-, O-[(methylamino)carbonyl] oxime</ENT> <ENT>1646-88-4</ENT> <ENT>4</ENT> <ENT>P203</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino)carbonyl]oxime</ENT> <ENT>116-06-3</ENT> <ENT>4</ENT> <ENT>P070</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1-Propanamine</ENT> <ENT>107-10-8</ENT> <ENT>4</ENT> <ENT>U194</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1-Propanamine, N-propyl-</ENT> <ENT>142-84-7</ENT> <ENT>4</ENT> <ENT>U110</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1-Propanamine, N-nitroso-N-propyl-</ENT> <ENT>621-64-7</ENT> <ENT>2,4</ENT> <ENT>U111</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propane, 1,2-dibromo-3-chloro-</ENT> <ENT>96-12-8</ENT> <ENT>3,4</ENT> <ENT>U066</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Propane, 1,2-dichloro-</ENT> <ENT>78-87-5</ENT> <ENT>1,2,3,4</ENT> <ENT>U083</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Propanedinitrile</ENT> <ENT>109-77-3</ENT> <ENT>4</ENT> <ENT>U149</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Propanenitrile</ENT> <ENT>107-12-0</ENT> <ENT>4</ENT> <ENT>P101</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propanenitrile, 3-chloro-</ENT> <ENT>542-76-7</ENT> <ENT>4</ENT> <ENT>P027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Propanenitrile, 2-hydroxy-2-methyl-</ENT> <ENT>75-86-5</ENT> <ENT>1,4</ENT> <ENT>P069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propane, 2-nitro-</ENT> <ENT>79-46-9</ENT> <ENT>3,4</ENT> <ENT>U171</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propane, 2,2′-oxybis[2-chloro-</ENT> <ENT>108-60-1</ENT> <ENT>2,4</ENT> <ENT>U027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,3-Propane sultone</ENT> <ENT>1120-71-4</ENT> <ENT>3,4</ENT> <ENT>U193</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,2,3-Propanetriol, trinitrate</ENT> <ENT>55-63-0</ENT> <ENT>4</ENT> <ENT>P081</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propanoic acid, 2-(2,4,5-trichlorophenoxy)-</ENT> <ENT>93-72-1</ENT> <ENT>1,4</ENT> <ENT>See F027</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1-Propanol, 2,3-dibromo-, phosphate (3:1)</ENT> <ENT>126-72-7</ENT> <ENT>4</ENT> <ENT>U235</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1-Propanol, 2-methyl-</ENT> <ENT>78-83-1</ENT> <ENT>4</ENT> <ENT>U140</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Propanone</ENT> <ENT>67-64-1</ENT> <ENT>4</ENT> <ENT>U002</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Propanone, 1-bromo-</ENT> <ENT>598-31-2</ENT> <ENT>4</ENT> <ENT>P017</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <PRTPAGE P="302"/> <ENT I="01">Propargite</ENT> <ENT>2312-35-8</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propargyl alcohol</ENT> <ENT>107-19-7</ENT> <ENT>4</ENT> <ENT>P102</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2-Propenal</ENT> <ENT>107-02-8</ENT> <ENT>1,2,3,4</ENT> <ENT>P003</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2-Propenamide</ENT> <ENT>79-06-1</ENT> <ENT>3,4</ENT> <ENT>U007</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">1-Propene, 1,3-dichloro-</ENT> <ENT>542-75-6</ENT> <ENT>1,2,3,4</ENT> <ENT>U084</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1-Propene, 1,1,2,3,3,3-hexachloro-</ENT> <ENT>1888-71-7</ENT> <ENT>4</ENT> <ENT>U243</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2-Propenenitrile</ENT> <ENT>107-13-1</ENT> <ENT>1,2,3,4</ENT> <ENT>U009</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2-Propenenitrile, 2-methyl-</ENT> <ENT>126-98-7</ENT> <ENT>4</ENT> <ENT>U152</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid</ENT> <ENT>79-10-7</ENT> <ENT>3,4</ENT> <ENT>U008</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, ethyl ester</ENT> <ENT>140-88-5</ENT> <ENT>3,4</ENT> <ENT>U113</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, ethyl ester</ENT> <ENT>97-63-2</ENT> <ENT>4</ENT> <ENT>U118</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, methyl ester</ENT> <ENT>80-62-6</ENT> <ENT>1,3,4</ENT> <ENT>U162</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2-Propen-1-ol</ENT> <ENT>107-18-6</ENT> <ENT>1,4</ENT> <ENT>P005</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Propham</ENT> <ENT>122-42-9</ENT> <ENT>4</ENT> <ENT>U373</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">beta-Propiolactone</ENT> <ENT>57-57-8</ENT> <ENT>3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Propionaldehyde</ENT> <ENT>123-38-6</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Propionic acid</ENT> <ENT>79-09-4</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Propionic anhydride</ENT> <ENT>123-62-6</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Propoxur (Baygon)</ENT> <ENT>114-26-1</ENT> <ENT>3,4</ENT> <ENT>U411</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">n-Propylamine</ENT> <ENT>107-10-8</ENT> <ENT>4</ENT> <ENT>U194</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">n-Propyl bromide (nPB)</ENT> <ENT>106-94-5</ENT> <ENT>3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Propylene dichloride</ENT> <ENT>78-87-5</ENT> <ENT>1,2,3,4</ENT> <ENT>U083</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Propylene oxide</ENT> <ENT>75-56-9</ENT> <ENT>1,3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,2-Propylenimine</ENT> <ENT>75-55-8</ENT> <ENT>3,4</ENT> <ENT>P067</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2-Propyn-1-ol</ENT> <ENT>107-19-7</ENT> <ENT>4</ENT> <ENT>P102</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Prosulfocarb</ENT> <ENT>52888-80-9</ENT> <ENT>4</ENT> <ENT>U387</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Pyrene</ENT> <ENT>129-00-0</ENT> <ENT>2</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Pyrethrins</ENT> <ENT> 121-29-9 <LI>121-21-1</LI> <LI>8003-34-7</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">3,6-Pyridazinedione, 1,2-dihydro-</ENT> <ENT>123-33-1</ENT> <ENT>4</ENT> <ENT>U148</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">4-Pyridinamine</ENT> <ENT>504-24-5</ENT> <ENT>4</ENT> <ENT>P008</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Pyridine</ENT> <ENT>110-86-1</ENT> <ENT>4</ENT> <ENT>U196</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Pyridine, 2-methyl-</ENT> <ENT>109-06-8</ENT> <ENT>4</ENT> <ENT>U191</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-, & salts</ENT> <ENT>54-11-5</ENT> <ENT>4</ENT> <ENT>P075</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,4-(1H,3H)-Pyrimidinedione, 5-[bis(2- chloroethyl)amino]-</ENT> <ENT>66-75-1</ENT> <ENT>4</ENT> <ENT>U237</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">4(1H)-Pyrimidinone, 2,3-dihydro-6-methyl-2-thioxo-</ENT> <ENT>56-04-2</ENT> <ENT>4</ENT> <ENT>U164</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Pyrrolidine, 1-nitroso-</ENT> <ENT>930-55-2</ENT> <ENT>4</ENT> <ENT>U180</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a- hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-</ENT> <ENT>57-47-6</ENT> <ENT>4</ENT> <ENT>P204</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Quinoline</ENT> <ENT>91-22-5</ENT> <ENT>1,3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Quinone</ENT> <ENT>106-51-4</ENT> <ENT>3,4</ENT> <ENT>U197</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Quintobenzene</ENT> <ENT>82-68-8</ENT> <ENT>3,4</ENT> <ENT>U185</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Radionuclides (including radon)</ENT> <ENT>N.A.</ENT> <ENT>3</ENT> <ENT/> <ENT>§ </ENT> </ROW> <ROW> <ENT I="01">Reserpine</ENT> <ENT>50-55-5</ENT> <ENT>4</ENT> <ENT>U200</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Resorcinol</ENT> <ENT>108-46-3</ENT> <ENT>1,4</ENT> <ENT>U201</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Safrole</ENT> <ENT>94-59-7</ENT> <ENT>4</ENT> <ENT>U203</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">SELENIUM AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Selenium Compounds</ENT> <ENT>N.A.</ENT> <ENT>2,3</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Selenious acid</ENT> <ENT>7783-00-8</ENT> <ENT>4</ENT> <ENT>U204</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Selenious acid, dithallium (1 +) salt</ENT> <ENT>12039-52-0</ENT> <ENT>4</ENT> <ENT>P114</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01"> Selenium  <SU>III</SU> </ENT> <ENT>7782-49-2</ENT> <ENT>2</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Selenium dioxide</ENT> <ENT>7746-08-4</ENT> <ENT>1,4</ENT> <ENT>U204</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Selenium oxide</ENT> <ENT>7746-08-4</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Selenium sulfide SeS2</ENT> <ENT>7488-56-4</ENT> <ENT>4</ENT> <ENT>U205</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Selenourea</ENT> <ENT>630-10-4</ENT> <ENT>4</ENT> <ENT>P103</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">L-Serine, diazoacetate (ester)</ENT> <ENT>115-02-6</ENT> <ENT>4</ENT> <ENT>U015</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">SILVER AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01"> Silver  <SU>III</SU> </ENT> <ENT>7440-22-4</ENT> <ENT>2</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Silver cyanide Ag(CN)</ENT> <ENT>506-64-9</ENT> <ENT>4</ENT> <ENT>P104</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Silver nitrate</ENT> <ENT>7761-88-8</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Silvex (2,4,5-TP)</ENT> <ENT>93-72-1</ENT> <ENT>1,4</ENT> <ENT>See F027</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Sodium</ENT> <ENT>7440-23-5</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Sodium arsenate</ENT> <ENT>7631-89-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Sodium arsenite</ENT> <ENT>7784-46-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Sodium azide</ENT> <ENT>26628-22-8</ENT> <ENT>4</ENT> <ENT>P105</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sodium bichromate</ENT> <ENT>10588-01-9</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Sodium bifluoride</ENT> <ENT>1333-83-1</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="303"/> <ENT I="01">Sodium bisulfite</ENT> <ENT>7631-90-5</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Sodium chromate</ENT> <ENT>7775-11-3</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Sodium cyanide Na(CN)</ENT> <ENT>143-33-9</ENT> <ENT>1,4</ENT> <ENT>P106</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Sodium dodecylbenzenesulfonate</ENT> <ENT>25155-30-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sodium fluoride</ENT> <ENT>7681-49-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sodium hydrosulfide</ENT> <ENT>16721-80-5</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Sodium hydroxide</ENT> <ENT>1310-73-2</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sodium hypochlorite</ENT> <ENT> 7681-52-9 <LI>10022-70-5</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Sodium methylate</ENT> <ENT>124-41-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sodium nitrite</ENT> <ENT>7632-00-0</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Sodium phosphate, dibasic</ENT> <ENT> 7558-79-4 <LI>10039-32-4</LI> <LI>10140-65-5</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Sodium phosphate, tribasic</ENT> <ENT> 7601-54-9 <LI>10101-89-0</LI> <LI>10361-89-4</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Sodium selenite</ENT> <ENT> 7782-82-3 <LI>10102-18-8</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Streptozotocin</ENT> <ENT>18883-66-4</ENT> <ENT>4</ENT> <ENT>U206</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Strontium chromate</ENT> <ENT>7789-06-2</ENT> <ENT>1</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Strychnidin-10-one, & salts</ENT> <ENT>57-24-9</ENT> <ENT>1,4</ENT> <ENT>P108</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Strychnidin-10-one, 2,3-dimethoxy-</ENT> <ENT>357-57-3</ENT> <ENT>4</ENT> <ENT>P018</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Strychnine, & salts</ENT> <ENT>57-24-9</ENT> <ENT>1,4</ENT> <ENT>P108</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Styrene</ENT> <ENT>100-42-5</ENT> <ENT>1,3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Styrene oxide</ENT> <ENT>96-09-3</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Sulfuric acid</ENT> <ENT> 7664-93-9 <LI>8014-95-7</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sulfuric acid, dimethyl ester</ENT> <ENT>77-78-1</ENT> <ENT>3,4</ENT> <ENT>U103</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Sulfuric acid, dithallium (1 +) salt</ENT> <ENT> 7446-18-6 <LI>10031-59-1</LI> </ENT> <ENT>1,4</ENT> <ENT>P115</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Sulfur monochloride</ENT> <ENT>12771-08-3</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Sulfur phosphide</ENT> <ENT>1314-80-3</ENT> <ENT>1,4</ENT> <ENT>U189</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-T</ENT> <ENT>93-76-5</ENT> <ENT>1,4</ENT> <ENT>See F027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-T acid</ENT> <ENT>93-76-5</ENT> <ENT>1,4</ENT> <ENT>See F027</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-T amines</ENT> <ENT> 2008-46-0 <LI>1319-72-8</LI> <LI>3813-14-7</LI> <LI>6369-96-6</LI> <LI>6369-97-7</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-T esters</ENT> <ENT> 93-79-8 <LI>1928-47-8</LI> <LI>2545-59-7</LI> <LI>25168-15-4</LI> <LI>61792-07-2</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-T salts</ENT> <ENT>13560-99-1</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">TCDD</ENT> <ENT>1746-01-6</ENT> <ENT>2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">TDE</ENT> <ENT>72-54-8</ENT> <ENT>1,2,4</ENT> <ENT>U060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,2,4,5-Tetrachlorobenzene</ENT> <ENT>95-94-3</ENT> <ENT>4</ENT> <ENT>U207</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">2,3,7,8-Tetrachlorodibenzo-p-dioxin</ENT> <ENT>1746-01-6</ENT> <ENT>2,3</ENT> <ENT/> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">1,1,1,2-Tetrachloroethane</ENT> <ENT>630-20-6</ENT> <ENT>4</ENT> <ENT>U208</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrachloroethane</ENT> <ENT>79-34-5</ENT> <ENT>2,3,4</ENT> <ENT>U209</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Tetrachloroethylene</ENT> <ENT>127-18-4</ENT> <ENT>2,3,4</ENT> <ENT>U210</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,3,4,6-Tetrachlorophenol</ENT> <ENT>58-90-2</ENT> <ENT>4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Tetraethyl pyrophosphate</ENT> <ENT>107-49-3</ENT> <ENT>1,4</ENT> <ENT>P111</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Tetraethyl lead</ENT> <ENT>78-00-2</ENT> <ENT>1,4</ENT> <ENT>P110</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Tetraethyldithiopyrophosphate</ENT> <ENT>3689-24-5</ENT> <ENT>4</ENT> <ENT>P109</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Tetrahydrofuran</ENT> <ENT>109-99-9</ENT> <ENT>4</ENT> <ENT>U213</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Tetranitromethane</ENT> <ENT>509-14-8</ENT> <ENT>4</ENT> <ENT>P112</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Tetraphosphoric acid, hexaethyl ester</ENT> <ENT>757-58-4</ENT> <ENT>4</ENT> <ENT>P062</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">THALLIUM AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <ENT I="01">Thallic oxide</ENT> <ENT>1314-32-5</ENT> <ENT>4</ENT> <ENT>P113</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01"> Thallium  <SU>III</SU> </ENT> <ENT>7440-28-0</ENT> <ENT>2</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Thallium (I) acetate</ENT> <ENT>563-68-8</ENT> <ENT>4</ENT> <ENT>U214</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thallium (I) carbonate</ENT> <ENT>6533-73-9</ENT> <ENT>4</ENT> <ENT>U215</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thallium chloride TlCl</ENT> <ENT>7791-12-0</ENT> <ENT>4</ENT> <ENT>U216</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thallium (I) nitrate</ENT> <ENT>10102-45-1</ENT> <ENT>4</ENT> <ENT>U217</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thallium oxide Tl2O3</ENT> <ENT>1314-32-5</ENT> <ENT>4</ENT> <ENT>P113</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thallium (l) selenite</ENT> <ENT>12039-52-0</ENT> <ENT>4</ENT> <ENT>P114</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Thallium (I) sulfate</ENT> <ENT> 7446-18-6 <LI>10031-59-1</LI> </ENT> <ENT>1,4</ENT> <ENT>P115</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="304"/> <ENT I="01">Thioacetamide</ENT> <ENT>62-55-5</ENT> <ENT>4</ENT> <ENT>U218</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Thiodicarb</ENT> <ENT>59669-26-0</ENT> <ENT>4</ENT> <ENT>U410</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiodiphosphoric acid, tetraethyl ester</ENT> <ENT>3689-24-5</ENT> <ENT>4</ENT> <ENT>P109</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiofanox</ENT> <ENT>39196-18-4</ENT> <ENT>4</ENT> <ENT>P045</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thioimidodicarbonic diamide [(H2N)C(S)] 2NH</ENT> <ENT>541-53-7</ENT> <ENT>4</ENT> <ENT>P049</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiomethanol</ENT> <ENT>74-93-1</ENT> <ENT>1,4</ENT> <ENT>U153</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thioperoxydicarbonic diamide [(H2N)C(S)] 2S2, tetramethyl-</ENT> <ENT>137-26-8</ENT> <ENT>4</ENT> <ENT>U244</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Thiophanate-methyl</ENT> <ENT>23564-05-8</ENT> <ENT>4</ENT> <ENT>U409</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Thiophenol</ENT> <ENT>108-98-5</ENT> <ENT>4</ENT> <ENT>P014</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiosemicarbazide</ENT> <ENT>79-19-6</ENT> <ENT>4</ENT> <ENT>P116</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiourea</ENT> <ENT>62-56-6</ENT> <ENT>4</ENT> <ENT>U219</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Thiourea, (2-chlorophenyl)-</ENT> <ENT>5344-82-1</ENT> <ENT>4</ENT> <ENT>P026</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiourea, 1-naphthalenyl-</ENT> <ENT>86-88-4</ENT> <ENT>4</ENT> <ENT>P072</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiourea, phenyl-</ENT> <ENT>103-85-5</ENT> <ENT>4</ENT> <ENT>P093</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Thiram</ENT> <ENT>137-26-8</ENT> <ENT>4</ENT> <ENT>U244</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Tirpate</ENT> <ENT>26419-73-8</ENT> <ENT>4</ENT> <ENT>P185</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Titanium tetrachloride</ENT> <ENT>7550-45-0</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Toluene</ENT> <ENT>108-88-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U220</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Toluenediamine</ENT> <ENT> 95-80-7 <LI>496-72-0</LI> <LI>823-40-5</LI> <LI>25376-45-8</LI> </ENT> <ENT>3,4</ENT> <ENT>U221</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">2,4-Toluene diamine</ENT> <ENT> 95-80-7 <LI>496-72-0</LI> <LI>823-40-5</LI> <LI>25376-45-8</LI> </ENT> <ENT>3,4</ENT> <ENT>U221</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Toluene diisocyanate</ENT> <ENT> 91-08-7 <LI>584-84-9</LI> <LI>26471-62-5</LI> </ENT> <ENT>3,4</ENT> <ENT>U223</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,4-Toluene diisocyanate</ENT> <ENT> 91-08-7 <LI>584-84-9</LI> <LI>26471-62-5</LI> </ENT> <ENT>3,4</ENT> <ENT>U223</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">o-Toluidine</ENT> <ENT>95-53-4</ENT> <ENT>3,4</ENT> <ENT>U328</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">p-Toluidine</ENT> <ENT>106-49-0</ENT> <ENT>4</ENT> <ENT>U353</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">o-Toluidine hydrochloride</ENT> <ENT>636-21-5</ENT> <ENT>4</ENT> <ENT>U222</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Toxaphene</ENT> <ENT>8001-35-2</ENT> <ENT>1,2,3,4</ENT> <ENT>P123</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-TP acid</ENT> <ENT>93-72-1</ENT> <ENT>1,4</ENT> <ENT>See F027</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,4,5-TP esters</ENT> <ENT>32534-95-5</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Triallate</ENT> <ENT>2303-17-5</ENT> <ENT>4</ENT> <ENT>U389</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1H-1,2,4-Triazol-3-amine</ENT> <ENT>61-82-5</ENT> <ENT>4</ENT> <ENT>U011</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Trichlorfon</ENT> <ENT>52-68-6</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,2,4-Trichlorobenzene</ENT> <ENT>120-82-1</ENT> <ENT>2,3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">1,1,1-Trichloroethane</ENT> <ENT>71-55-6</ENT> <ENT>2,3,4</ENT> <ENT>U226</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,1,2-Trichloroethane</ENT> <ENT>79-00-5</ENT> <ENT>2,3,4</ENT> <ENT>U227</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Trichloroethylene</ENT> <ENT>79-01-6</ENT> <ENT>1,2,3,4</ENT> <ENT>U228</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Trichloromethanesulfenyl chloride</ENT> <ENT>594-42-3</ENT> <ENT>4</ENT> <ENT>P118</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Trichloromonofluoromethane</ENT> <ENT>75-69-4</ENT> <ENT>4</ENT> <ENT>U121</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Trichlorophenol</ENT> <ENT>25167-82-2</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,3,4-Trichlorophenol</ENT> <ENT>15950-66-0</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,3,5-Trichlorophenol</ENT> <ENT>933-78-8</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,3,6-Trichlorophenol</ENT> <ENT>933-75-5</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,4,5-Trichlorophenol</ENT> <ENT>95-95-4</ENT> <ENT>1,2,3,4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,4,6-Trichlorophenol</ENT> <ENT>88-06-2</ENT> <ENT>1,2,3,4</ENT> <ENT>See F027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">3,4,5-Trichlorophenol</ENT> <ENT>609-19-8</ENT> <ENT>1,2</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Triethanolamine dodecylbenzenesulfonate</ENT> <ENT>27323-41-7</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Triethylamine</ENT> <ENT>121-44-8</ENT> <ENT>1,3,4</ENT> <ENT>U404</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Trifluralin</ENT> <ENT>1582-09-8</ENT> <ENT>3</ENT> <ENT/> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Trimethylamine</ENT> <ENT>75-50-3</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">2,2,4-Trimethylpentane</ENT> <ENT>540-84-1</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">1,3,5-Trinitrobenzene</ENT> <ENT>99-35-4</ENT> <ENT>4</ENT> <ENT>U234</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">1,3,5-Trioxane, 2,4,6-trimethyl-</ENT> <ENT>123-63-7</ENT> <ENT>4</ENT> <ENT>U182</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Tris(2,3-dibromopropyl) phosphate</ENT> <ENT>126-72-7</ENT> <ENT>4</ENT> <ENT>U235</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Trypan blue</ENT> <ENT>72-57-1</ENT> <ENT>4</ENT> <ENT>U236</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Unlisted Hazardous Wastes Characteristic of Corrosivity</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D002</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Unlisted Hazardous Wastes Characteristic of Ignitability</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D001</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Unlisted Hazardous Wastes Characteristic of Reactivity</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D003</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="305"/> <ENT I="01">Unlisted Hazardous Wastes Characteristic of Toxicity</ENT> <ENT/> <ENT/> </ROW> <ROW> <ENT I="03">Arsenic (D004)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D004</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Barium (D005)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D005</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">Benzene (D018)</ENT> <ENT>N.A.</ENT> <ENT>1,2,3,4</ENT> <ENT>D018</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Cadmium (D006)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D006</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Carbon tetrachloride (D019)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D019</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Chlordane (D020)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D020</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Chlorobenzene (D021)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D021</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">Chloroform (D022)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D022</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Chromium (D007)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D007</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">o-Cresol (D023)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D023</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">m-Cresol (D024)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D024</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">p-Cresol (D025)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D025</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">Cresol (D026)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D026</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">2,4-D (D016)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D016</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,4-Dichlorobenzene (D027)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D027</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,2-Dichloroethane (D028)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D028</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">1,1-Dichloroethylene (D029)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D029</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">2,4-Dinitrotoluene (D030)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D030</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Endrin (D012)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D012</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Heptachlor (and epoxide) (D031)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D031</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Hexachlorobenzene (D032)</ENT> <ENT>N.A.</ENT> <ENT>2,4</ENT> <ENT>D032</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Hexachlorobutadiene (D033)</ENT> <ENT>N.A.</ENT> <ENT>2,4</ENT> <ENT>D033</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Hexachloroethane (D034)</ENT> <ENT>N.A.</ENT> <ENT>2,4</ENT> <ENT>D034</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">Lead (D008)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D008</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Lindane (D013)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D013</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Mercury (D009)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D009</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Methoxychlor (D014)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D014</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Methyl ethyl ketone (D035)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D035</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">Nitrobenzene (D036)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D036</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">Pentachlorophenol (D037)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D037</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Pyridine (D038)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D038</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">Selenium (D010)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D010</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">Silver (D011)</ENT> <ENT>N.A.</ENT> <ENT>4</ENT> <ENT>D011</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Tetrachloroethylene (D039)</ENT> <ENT>N.A.</ENT> <ENT>2,4</ENT> <ENT>D039</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">Toxaphene (D015)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D015</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="03">Trichloroethylene (D040)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D040</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">2,4,5-Trichlorophenol (D041)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D041</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,4,6-Trichlorophenol (D042)</ENT> <ENT>N.A.</ENT> <ENT>1,2,4</ENT> <ENT>D042</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">2,4,5-TP (D017)</ENT> <ENT>N.A.</ENT> <ENT>1,4</ENT> <ENT>D017</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">Vinyl chloride (D043)</ENT> <ENT>N.A.</ENT> <ENT>2,3,4</ENT> <ENT>D043</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Uracil mustard</ENT> <ENT>66-75-1</ENT> <ENT>4</ENT> <ENT>U237</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Uranyl acetate</ENT> <ENT>541-09-3</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Uranyl nitrate</ENT> <ENT>10102-06-4 36478-76-9</ENT> <ENT>1</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Urea, N-ethyl-N-nitroso-</ENT> <ENT>759-73-9</ENT> <ENT>4</ENT> <ENT>U176</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Urea, N-methyl-N-nitroso-</ENT> <ENT>684-93-5</ENT> <ENT>3,4</ENT> <ENT>U177</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Urethane</ENT> <ENT>51-79-6</ENT> <ENT>3,4</ENT> <ENT>U238</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Vanadic acid, ammonium salt</ENT> <ENT>7803-55-6</ENT> <ENT>4</ENT> <ENT>P119</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Vanadium oxide V2O5</ENT> <ENT>1314-62-1</ENT> <ENT>1,4</ENT> <ENT>P120</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Vanadium pentoxide</ENT> <ENT>1314-62-1</ENT> <ENT>1,4</ENT> <ENT>P120</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Vanadyl sulfate</ENT> <ENT>27774-13-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Vinyl acetate</ENT> <ENT>108-05-4</ENT> <ENT>1,3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Vinyl acetate monomer</ENT> <ENT>108-05-4</ENT> <ENT>1,3</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Vinylamine, N-methyl-N-nitroso-</ENT> <ENT>4549-40-0</ENT> <ENT>4</ENT> <ENT>P084</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Vinyl bromide</ENT> <ENT>593-60-2</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Vinyl chloride</ENT> <ENT>75-01-4</ENT> <ENT>2,3,4</ENT> <ENT>U043</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">Vinylidene chloride</ENT> <ENT>75-35-4</ENT> <ENT>1,2,3,4</ENT> <ENT>U078</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Warfarin, & salts</ENT> <ENT>81-81-2</ENT> <ENT>4</ENT> <ENT>P001, U248</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Xylene (mixed)</ENT> <ENT>1330-20-7</ENT> <ENT>1,3,4</ENT> <ENT>U239</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Xylenes (isomers and mixture)</ENT> <ENT>1330-20-7</ENT> <ENT>1,3,4</ENT> <ENT>U239</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Xylene</ENT> <ENT>1330-20-7</ENT> <ENT>1,3,4</ENT> <ENT>U239</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">m-Xylene</ENT> <ENT>108-38-3</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">o-Xylene</ENT> <ENT>95-47-6</ENT> <ENT>3</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">p-Xylene</ENT> <ENT>106-42-3</ENT> <ENT>3</ENT> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Xylenol</ENT> <ENT>1300-71-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester (3beta,16beta,17alpha, 18beta,20alpha)</ENT> <ENT>50-55-54</ENT> <ENT>4</ENT> <ENT>U200</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">ZINC AND COMPOUNDS</ENT> <ENT>N.A.</ENT> <ENT>2</ENT> <ENT/> <ENT>**</ENT> </ROW> <ROW> <PRTPAGE P="306"/> <ENT I="01"> Zinc  <SU>III</SU> </ENT> <ENT>7440-66-6</ENT> <ENT>2</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc acetate</ENT> <ENT>557-34-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc ammonium chloride</ENT> <ENT> 52628-25-8 <LI>14639-97-5</LI> <LI>14639-98-6</LI> </ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc, bis(dimethylcarbamodithioato-S,S′)-</ENT> <ENT>137-30-4</ENT> <ENT>4</ENT> <ENT>P205</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Zinc borate</ENT> <ENT>1332-07-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc bromide</ENT> <ENT>7699-45-8</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc carbonate</ENT> <ENT>3486-35-9</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc chloride</ENT> <ENT>7646-85-7</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc cyanide Zn(CN)2</ENT> <ENT>557-21-1</ENT> <ENT>1,4</ENT> <ENT>P121</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Zinc fluoride</ENT> <ENT>7783-49-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc formate</ENT> <ENT>557-41-5</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc hydrosulfite</ENT> <ENT>7779-86-4</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc nitrate</ENT> <ENT>7779-88-6</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zinc phenolsulfonate</ENT> <ENT>127-82-2</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Zinc phosphide Zn3P2</ENT> <ENT>1314-84-7</ENT> <ENT>1,4</ENT> <ENT>P122, U249</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">Zinc silicofluoride</ENT> <ENT>16871-71-9</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Zinc sulfate</ENT> <ENT>7733-02-0</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Ziram</ENT> <ENT>137-30-4</ENT> <ENT>4</ENT> <ENT>P205</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">Zirconium nitrate</ENT> <ENT>13746-89-9</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Zirconium potassium fluoride</ENT> <ENT>16923-95-8</ENT> <ENT>1</ENT> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">Zirconium sulfate</ENT> <ENT>14644-61-2</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">Zirconium tetrachloride</ENT> <ENT>10026-11-6</ENT> <ENT>1</ENT> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">F001—The following spent halogenated solvents used in degreasing; all spent solvent mixtures/blends used in degreasing containing, before use, a total of ten percent or more (by volume) of one or more of the halogenated solvents listed below or those solvents listed in F002, F004, and F005; and still bottoms from the recovery of these spent solvents and spent solvent mixtures</ENT> <ENT/> <ENT>4</ENT> <ENT>F001</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">(a) Tetrachloroethylene</ENT> <ENT>127-18-4</ENT> <ENT>2,3,4</ENT> <ENT>U210</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(b) Trichloroethylene</ENT> <ENT>79-01-6</ENT> <ENT>1,2,3,4</ENT> <ENT>U228</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(c) Methylene chloride</ENT> <ENT>75-09-2</ENT> <ENT>2,3,4</ENT> <ENT>U080</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(d) 1,1,1-Trichloroethane</ENT> <ENT>71-55-6</ENT> <ENT>2,3,4</ENT> <ENT>U226</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(e) Carbon tetrachloride</ENT> <ENT>56-23-5</ENT> <ENT>1,2,3,4</ENT> <ENT>U211</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">(f) Chlorinated fluorocarbons</ENT> <ENT>N.A.</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">F002—The following spent halogenated solvents; all spent solvent mixtures/blends containing, before use, a total of ten percent or more (by volume) of one or more of the halogenated solvents listed below or those solvents listed in F001, F004, or F005; and still bottoms from the recovery of these spent solvents and spent solvent mixtures</ENT> <ENT/> <ENT>4</ENT> <ENT>F002</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="03">(a) Tetrachloroethylene</ENT> <ENT>127-18-4</ENT> <ENT>2,3,4</ENT> <ENT>U210</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(b) Methylene chloride</ENT> <ENT>75-09-2</ENT> <ENT>2,3,4</ENT> <ENT>U080</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(c) Trichloroethylene</ENT> <ENT>79-01-6</ENT> <ENT>1,2,3,4</ENT> <ENT>U228</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(d) 1,1,1-Trichloroethane</ENT> <ENT>71-55-6</ENT> <ENT>2,3,4</ENT> <ENT>U226</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(e) Chlorobenzene</ENT> <ENT>108-90-7</ENT> <ENT>1,2,3,4</ENT> <ENT>U037</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(f) 1,1,2-Trichloro-1,2,2-trifluoroethane</ENT> <ENT>76-13-1</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(g) o-Dichlorobenzene</ENT> <ENT>95-50-1</ENT> <ENT>1,2,4</ENT> <ENT>U070</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(h) Trichlorofluoromethane</ENT> <ENT>75-69-4</ENT> <ENT>4</ENT> <ENT>U121</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(i) 1,1,2-Trichloroethane</ENT> <ENT>79-00-5</ENT> <ENT>2,3,4</ENT> <ENT>U227</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">F003—The following spent non-halogenated solvents and the still bottoms from the recovery of these solvents</ENT> <ENT/> <ENT>4</ENT> <ENT>F003</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(a) Xylene</ENT> <ENT>1330-20-7</ENT> <ENT/> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(b) Acetone</ENT> <ENT>67-64-1</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(c) Ethyl acetate</ENT> <ENT>141-78-6</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(d) Ethylbenzene</ENT> <ENT>100-41-4</ENT> <ENT/> <ENT/> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(e) Ethyl ether</ENT> <ENT>60-29-7</ENT> <ENT/> <ENT/> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(f) Methyl isobutyl ketone</ENT> <ENT>108-10-1</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(g) n-Butyl alcohol</ENT> <ENT>71-36-3</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(h) Cyclohexanone</ENT> <ENT>108-94-1</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(i) Methanol</ENT> <ENT>67-56-1</ENT> <ENT/> <ENT/> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">F004—The following spent non-halogenated solvents and the still bottoms from the recovery of these solvents</ENT> <ENT/> <ENT>4</ENT> <ENT>F004</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(a) Cresols/Cresylic acid</ENT> <ENT>1319-77-3</ENT> <ENT>1,3,4</ENT> <ENT>U052</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <PRTPAGE P="307"/> <ENT I="03">(b) Nitrobenzene</ENT> <ENT>98-95-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U169</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">F005—The following spent non-halogenated solvents and the still bottoms from the recovery of these solvents</ENT> <ENT/> <ENT>4</ENT> <ENT>F005</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(a) Toluene</ENT> <ENT>108-88-3</ENT> <ENT>1,2,3,4</ENT> <ENT>U220</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="03">(b) Methyl ethyl ketone</ENT> <ENT>78-93-3</ENT> <ENT>4</ENT> <ENT>U159</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(c) Carbon disulfide</ENT> <ENT>75-15-0</ENT> <ENT>1,3,4</ENT> <ENT>P022</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="03">(d) Isobutanol</ENT> <ENT>78-83-1</ENT> <ENT>4</ENT> <ENT>U140</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="03">(e) Pyridine</ENT> <ENT>110-86-1</ENT> <ENT>4</ENT> <ENT>U196</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">F006—Wastewater treatment sludges from electroplating operations except from the following processes: (1) Sulfuric acid anodizing of aluminum, (2) tin plating on carbon steel, (3) zinc plating (segregated basis) on carbon steel, (4) aluminum or zinc-aluminum plating on carbon steel, (5) cleaning/stripping associated with tin, zinc and aluminum plating on carbon steel, and (6) chemical etching and milling of aluminum</ENT> <ENT/> <ENT>4</ENT> <ENT>F006</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F007—Spent cyanide plating bath solutions from electroplating operations.</ENT> <ENT/> <ENT>4</ENT> <ENT>F007</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F008—Plating bath residues from the bottom of plating baths from electroplating operations where cyanides are used in the process</ENT> <ENT/> <ENT>4</ENT> <ENT>F008</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F009—Spent stripping and cleaning bath solutions from electroplating operations where cyanides are used in the process</ENT> <ENT/> <ENT>4</ENT> <ENT>F009</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F010—Quenching bath residues from oil baths from metal heat treating operations where cyanides are used in the process</ENT> <ENT/> <ENT>4</ENT> <ENT>F010</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F011—Spent cyanide solutions from salt bath pot cleaning from metal heat treating operations</ENT> <ENT/> <ENT>4</ENT> <ENT>F011</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F012—Quenching wastewater treatment sludges from metal heat treating operations where cyanides are used in the process</ENT> <ENT/> <ENT>4</ENT> <ENT>F012</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F019—Wastewater treatment sludges from the chemical conversion coating of aluminum except from zirconium phosphating in aluminum can washing when such phosphating is an exclusive conversion coating process . . . Wastewater treatment sludges from the manufacturing of motor vehicles using a zinc phosphating process will not be subject to this listing at the point of generation if the wastes are not placed outside on the land prior to shipment to a landfill for disposal and are either: Disposed in a Subtitle D municipal or industrial landfill unit that is equipped with a single clay liner and is permitted, licensed or otherwise authorized by the state; or disposed in a landfill unit subject to, or otherwise meeting, the landfill requirements in § 258.40, § 264.301 or § 265.301. For the purposes of this listing, motor vehicle manufacturing is defined in § 261.31(b)(4)(i) and § 261.31(b)(4)(ii) describes the recordkeeping requirements for motor vehicle manufacturing facilities</ENT> <ENT/> <ENT>4</ENT> <ENT>F019</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">F020—Wastes (except wastewater and spent carbon from hydrogen chloride purification) from the production or manufacturing use (as a reactant, chemical intermediate, or component in a formulating process) of tri- or tetrachlorophenol or of intermediates used to produce their pesticide derivatives. (This listing does not include wastes from the production of hexachlorophene from highly purified 2,4,5-trichlorophenol)</ENT> <ENT/> <ENT>4</ENT> <ENT>F020</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F021—Wastes (except wastewater and spent carbon from hydrogen chloride purification) from the production or manufacturing use (as a reactant, chemical intermediate, or component in a formulating process) of pentachlorophenol or of intermediates used to produce its derivatives</ENT> <ENT/> <ENT>4</ENT> <ENT>F021</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="308"/> <ENT I="01">F022—Wastes (except wastewater and spent carbon from hydrogen chloride purification) from the manufacturing use (as a reactant, chemical intermediate, or component in a formulating process) of tetra-, penta-, or hexachlorobenzenes under alkaline conditions</ENT> <ENT/> <ENT>4</ENT> <ENT>F022</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F023—Wastes (except wastewater and spent carbon from hydrogen chloride purification) from the production of materials on equipment previously used for the production or manufacturing use (as a reactant, chemical intermediate, or a component in a formulating process) of tri- and tetrachlorophenols. (This listing does not include wastes from equipment used only for the production or use of hexachlorophene from highly purified 2,4,5-trichlorophenol)</ENT> <ENT/> <ENT>4</ENT> <ENT>F023</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F024—Process wastes, including but not limited to, distillation residues, heavy ends, tars, and reactor clean-out wastes, from the production of certain chlorinated aliphatic hydrocarbons by free radical catalyzed processes. These chlorinated aliphatic hydrocarbons are those having carbon chain lengths ranging from one to and including five, with varying amounts and positions of chlorine substitution. (This listing does not include wastewaters, wastewater treatment sludges, spent catalysts, and wastes listed in 40 CFR 261.31 or 261.32)</ENT> <ENT/> <ENT>4</ENT> <ENT>F024</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F025—Condensed light ends, spent filters and filter aids, and spent desiccant wastes from the production of certain chlorinated aliphatic hydrocarbons, by free radical catalyzed processes. These chlorinated aliphatic hydrocarbons are those having carbon chain lengths ranging from one to and including five, with varying amounts and positions of chlorine substitution</ENT> <ENT/> <ENT>4</ENT> <ENT>F025</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F026—Wastes (except wastewater and spent carbon from hydrogen chloride purification) from the production of materials on equipment previously used for the manufacturing use (as a reactant, chemical intermediate, or component in a formulating process) of tetra-, penta-, or hexachlorobenzene under alkaline conditions</ENT> <ENT/> <ENT>4</ENT> <ENT>F026</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F027—Discarded unused formulations containing tri-, tetra-, or pentachlorophenol or discarded unused formulations containing compounds derived from these chlorophenols. (This listing does not include formulations containing hexachlorophene synthesized from prepurified 2,4,5- trichlorophenol as the sole component)</ENT> <ENT/> <ENT>4</ENT> <ENT>F027</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F028—Residues resulting from the incineration or thermal treatment of soil contaminated with EPA Hazardous Waste Nos. F020, F021, F022, F023, F026, and F027</ENT> <ENT/> <ENT>4</ENT> <ENT>F028</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="309"/> <ENT I="01">F032—Wastewaters (except those that have not come into contact with process contaminants), process residuals, preservative drippage, and spent formulations from wood preserving processes generated at plants that currently use or have previously used chlorophenolic formulations (except potentially cross-contaminated wastes that have had the F032 waste code deleted in accordance with § 261.35 of this chapter or potentially cross-contaminated wastes that are otherwise currently regulated as hazardous wastes (i.e., F034 or F035), and where the generator does not resume or initiate use of chlorophenolic formulations). This listing does not include K001 bottom sediment sludge from the treatment of wastewater from wood preserving processes that use creosote and/or pentachlorophenol</ENT> <ENT/> <ENT>4</ENT> <ENT>F032</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F034—Wastewaters (except those that have not come into contact with process contaminants), process residuals, preservative drippage, and spent formulations from wood preserving processes generated at plants that use creosote formulations. This listing does not include K001 bottom sediment sludge from the treatment of wastewater from wood preserving processes that use creosote and/or pentachlorophenol</ENT> <ENT/> <ENT>4</ENT> <ENT>F034</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F035—Wastewaters (except those that have not come into contact with process contaminants), process residuals, preservative drippage, and spent formulations from wood preserving processes generated at plants that use inorganic preservatives containing arsenic or chromium. This listing does not include K001 bottom sediment sludge from the treatment of wastewater from wood preserving processes that use creosote and/or pentachlorophenol</ENT> <ENT/> <ENT>4</ENT> <ENT>F035</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F037—Petroleum refinery primary oil/water/solids separation sludge-Any sludge generated from the gravitational separation of oil/water/solids during the storage or treatment of process wastewaters and oily cooling wastewaters from petroleum refineries. Such sludges include, but are not limited to those generated in oil/water/solids separators; tanks and impoundments; ditches and other conveyances; sumps; and stormwater units receiving dry weather flow. Sludges generated in stormwater units that do not receive dry weather flow, sludges generated from non-contact once-through cooling waters segregated for treatment from other process or oily cooling waters, sludges generated in aggressive biological treatment units as defined in § 261.31(b)(2) (including sludges generated in one or more additional units after wastewaters have been treated in aggressive biological treatment units) and K051 wastes are not included in this listing. This listing does include residuals generated from processing or recycling oil-bearing hazardous secondary materials excluded under § 261.4(a)(12)(i), if those residuals are to be disposed of</ENT> <ENT/> <ENT>4</ENT> <ENT>F037</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="310"/> <ENT I="01">F038—Petroleum refinery secondary (emulsified) oil/water/solids separation sludge-Any sludge and/or float generated from the physical and/or chemical separation of oil/water/solids in process wastewaters and oily cooling wastewaters from petroleum refineries. Such wastes include, but are not limited to, all sludges and floats generated in: Induced air flotation (IAF) units, tanks and impoundments, and all sludges generated in DAF units. Sludges generated in stormwater units that do not receive dry weather flow, sludges generated from non-contact once-through cooling waters segregated for treatment from other process or oily cooling waters, sludges and floats generated in aggressive biological treatment units as defined in § 261.31(b)(2) (including sludges and floats generated in one or more additional units after wastewaters have been treated in aggressive biological treatment units) and F037, K048, and K051 wastes are not included in this listing</ENT> <ENT/> <ENT>4</ENT> <ENT>F038</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">F039—Leachate (liquids that have percolated through land disposed wastes) resulting from the disposal of more than one restricted waste classified as hazardous under subpart D of 40 CFR part 261. (Leachate resulting from the disposal of one or more of the following EPA Hazardous Wastes and no other hazardous wastes retains its EPA Hazardous Waste Number(s): F020, F021, F022, F026, F027, and/or F028)</ENT> <ENT/> <ENT>4</ENT> <ENT>F039</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K001—Bottom sediment sludge from the treatment of wastewaters from wood preserving processes that use creosote and/or pentachlorophenol</ENT> <ENT/> <ENT>4</ENT> <ENT>K001</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K002—Wastewater treatment sludge from the production of chrome yellow and orange pigments</ENT> <ENT/> <ENT>4</ENT> <ENT>K002</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K003—Wastewater treatment sludge from the production of molybdate orange pigments</ENT> <ENT/> <ENT>4</ENT> <ENT>K003</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K004—Wastewater treatment sludge from the production of zinc yellow pigments</ENT> <ENT/> <ENT>4</ENT> <ENT>K004</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K005—Wastewater treatment sludge from the production of chrome green pigments</ENT> <ENT/> <ENT>4</ENT> <ENT>K005</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K006—Wastewater treatment sludge from the production of chrome oxide green pigments (anhydrous and hydrated)</ENT> <ENT/> <ENT>4</ENT> <ENT>K006</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K007—Wastewater treatment sludge from the production of iron blue pigments</ENT> <ENT/> <ENT>4</ENT> <ENT>K007</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K008—Oven residue from the production of chrome oxide green pigments</ENT> <ENT/> <ENT>4</ENT> <ENT>K008</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K009—Distillation bottoms from the production of acetaldehyde from ethylene</ENT> <ENT/> <ENT>4</ENT> <ENT>K009</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K010—Distillation side cuts from the production of acetaldehyde from ethylene</ENT> <ENT/> <ENT>4</ENT> <ENT>K010</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K011—Bottom stream from the wastewater stripper in the production of acrylonitrile</ENT> <ENT/> <ENT>4</ENT> <ENT>K011</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K013—Bottom stream from the acetonitrile column in the production of acrylonitrile</ENT> <ENT/> <ENT>4</ENT> <ENT>K013</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K014—Bottoms from the acetonitrile purification column in the production of acrylonitrile</ENT> <ENT/> <ENT>4</ENT> <ENT>K014</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">K015—Still bottoms from the distillation of benzyl chloride</ENT> <ENT/> <ENT>4</ENT> <ENT>K015</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K016—Heavy ends or distillation residues from the production of carbon tetrachloride</ENT> <ENT/> <ENT>4</ENT> <ENT>K016</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K017—Heavy ends (still bottoms) from the purification column in the production of epichlorohydrin</ENT> <ENT/> <ENT>4</ENT> <ENT>K017</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K018—Heavy ends from the fractionation column in ethyl chloride production</ENT> <ENT/> <ENT>4</ENT> <ENT>K018</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K019—Heavy ends from the distillation of ethylene dichloride in ethylene dichloride production</ENT> <ENT/> <ENT>4</ENT> <ENT>K019</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K020—Heavy ends from the distillation of vinyl chloride in vinyl chloride monomer production</ENT> <ENT/> <ENT>4</ENT> <ENT>K020</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="311"/> <ENT I="01">K021—Aqueous spent antimony catalyst waste from fluoromethanes production</ENT> <ENT/> <ENT>4</ENT> <ENT>K021</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K022—Distillation bottom tars from the production of phenol/acetone from cumene</ENT> <ENT/> <ENT>4</ENT> <ENT>K022</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K023—Distillation light ends from the production of phthalic anhydride from naphthalene</ENT> <ENT/> <ENT>4</ENT> <ENT>K023</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">K024—Distillation bottoms from the production of phthalic anhydride from naphthalene</ENT> <ENT/> <ENT>4</ENT> <ENT>K024</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">K025—Distillation bottoms from the production of nitrobenzene by the nitration of benzene</ENT> <ENT/> <ENT>4</ENT> <ENT>K025</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K026—Stripping still tails from the production of methyl ethyl pyridines</ENT> <ENT/> <ENT>4</ENT> <ENT>K026</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">K027—Centrifuge and distillation residues from toluene diisocyanate production</ENT> <ENT/> <ENT>4</ENT> <ENT>K027</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K028—Spent catalyst from the hydrochlorinator reactor in the production of 1,1,1-trichloroethane</ENT> <ENT/> <ENT>4</ENT> <ENT>K028</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K029—Waste from the product steam stripper in the production of 1,1,1- trichloroethane</ENT> <ENT/> <ENT>4</ENT> <ENT>K029</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K030—Column bottoms or heavy ends from the combined production of trichloroethylene and perchloroethylene</ENT> <ENT/> <ENT>4</ENT> <ENT>K030</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K031—By-product salts generated in the production of MSMA and cacodylic acid</ENT> <ENT/> <ENT>4</ENT> <ENT>K031</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K032—Wastewater treatment sludge from the production of chlordane</ENT> <ENT/> <ENT>4</ENT> <ENT>K032</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K033—Wastewater and scrub water from the chlorination of cyclopentadiene in the production of chlordane</ENT> <ENT/> <ENT>4</ENT> <ENT>K033</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K034—Filter solids from the filtration of hexachlorocyclopentadiene in the production of chlordane</ENT> <ENT/> <ENT>4</ENT> <ENT>K034</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K035—Wastewater treatment sludges generated in the production of creosote</ENT> <ENT/> <ENT>4</ENT> <ENT>K035</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K036—Still bottoms from toluene reclamation distillation in the production of disulfoton</ENT> <ENT/> <ENT>4</ENT> <ENT>K036</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K037—Wastewater treatment sludges from the production of disulfoton</ENT> <ENT/> <ENT>4</ENT> <ENT>K037</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K038—Wastewater from the washing and stripping of phorate production</ENT> <ENT/> <ENT>4</ENT> <ENT>K038</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K039—Filter cake from the filtration of diethylphosphorodithioic acid in the production of phorate</ENT> <ENT/> <ENT>4</ENT> <ENT>K039</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K040—Wastewater treatment sludge from the production of phorate</ENT> <ENT/> <ENT>4</ENT> <ENT>K040</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K041—Wastewater treatment sludge from the production of toxaphene</ENT> <ENT/> <ENT>4</ENT> <ENT>K041</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K042—Heavy ends or distillation residues from the distillation of tetrachlorobenzene in the production of 2,4,5-T</ENT> <ENT/> <ENT>4</ENT> <ENT>K042</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K043—2,6-Dichlorophenol waste from the production of 2,4-D</ENT> <ENT/> <ENT>4</ENT> <ENT>K043</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K044—Wastewater treatment sludges from the manufacturing and processing of explosives</ENT> <ENT/> <ENT>4</ENT> <ENT>K044</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K045—Spent carbon from the treatment of wastewater containing explosives</ENT> <ENT/> <ENT>4</ENT> <ENT>K045</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K046—Wastewater treatment sludges from the manufacturing, formulation and loading of lead-based initiating compounds</ENT> <ENT/> <ENT>4</ENT> <ENT>K046</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K047—Pink/red water from TNT operations</ENT> <ENT/> <ENT>4</ENT> <ENT>K047</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K048—Dissolved air flotation (DAF) float from the petroleum refining industry</ENT> <ENT/> <ENT>4</ENT> <ENT>K048</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K049—Slop oil emulsion solids from the petroleum refining industry</ENT> <ENT/> <ENT>4</ENT> <ENT>K049</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K050—Heat exchanger bundle cleaning sludge from the petroleum refining industry</ENT> <ENT/> <ENT>4</ENT> <ENT>K050</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K051—API separator sludge from the petroleum refining industry</ENT> <ENT/> <ENT>4</ENT> <ENT>K051</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K052—Tank bottoms (leaded) from the petroleum refining industry</ENT> <ENT/> <ENT>4</ENT> <ENT>K052</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <PRTPAGE P="312"/> <ENT I="01">K060—Ammonia still lime sludge from coking operations</ENT> <ENT/> <ENT>4</ENT> <ENT>K060</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K061—Emission control dust/sludge from the primary production of steel in electric furnaces</ENT> <ENT/> <ENT>4</ENT> <ENT>K061</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K062—Spent pickle liquor generated by steel finishing operations of facilities within the iron and steel industry (SIC Codes 331 and 332)</ENT> <ENT/> <ENT>4</ENT> <ENT>K062</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01"> K069—Emission control dust/sludge from secondary lead smelting. (Note: This listing is stayed administratively for sludge generated from secondary acid scrubber systems. The stay will remain in effect until further administrative action is taken. If EPA takes further action effecting the stay, EPA will publish a notice of the action in the <E T="02">Federal Register</E> ) </ENT> <ENT/> <ENT>4</ENT> <ENT>K069</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K071—Brine purification muds from the mercury cell process in chlorine production, where separately prepurified brine is not used</ENT> <ENT/> <ENT>4</ENT> <ENT>K071</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K073—Chlorinated hydrocarbon waste from the purification step of the diaphragm cellprocess using graphite anodes in chlorine production</ENT> <ENT/> <ENT>4</ENT> <ENT>K073</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K083—Distillation bottoms from aniline production</ENT> <ENT/> <ENT>4</ENT> <ENT>K083</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">K084—Wastewater treatment sludges generated during the production of veterinary pharmaceuticals from arsenic or organo-arsenic compounds</ENT> <ENT/> <ENT>4</ENT> <ENT>K084</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K085—Distillation or fractionation column bottoms from the production of chlorobenzenes</ENT> <ENT/> <ENT>4</ENT> <ENT>K085</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K086—Solvent washes and sludges, caustic washes and sludges, or water washes and sludges from cleaning tubs and equipment used in the formulation of ink from pigments, driers, soaps, and stabilizers containing chromium and lead</ENT> <ENT/> <ENT>4</ENT> <ENT>K086</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K087—Decanter tank tar sludge from coking operations</ENT> <ENT/> <ENT>4</ENT> <ENT>K087</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">K088—Spent potliners from primary aluminum reduction</ENT> <ENT/> <ENT>4</ENT> <ENT>K088</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K093—Distillation light ends from the production of phthalic anhydride from ortho-xylene</ENT> <ENT/> <ENT>4</ENT> <ENT>K093</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">K094—Distillation bottoms from the production of phthalic anhydride from ortho-xylene</ENT> <ENT/> <ENT>4</ENT> <ENT>K094</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">K095—Distillation bottoms from the production of 1,1,1-trichloroethane</ENT> <ENT/> <ENT>4</ENT> <ENT>K095</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">K096—Heavy ends from the heavy ends column from the production of 1,1,1-trichloroethane</ENT> <ENT/> <ENT>4</ENT> <ENT>K096</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">K097—Vacuum stripper discharge from the chlordane chlorinator in the production of chlordane</ENT> <ENT/> <ENT>4</ENT> <ENT>K097</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K098—Untreated process wastewater from the production of toxaphene</ENT> <ENT/> <ENT>4</ENT> <ENT>K098</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K099—Untreated wastewater from the production of 2,4-D</ENT> <ENT/> <ENT>4</ENT> <ENT>K099</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K100—Waste leaching solution from acid leaching of emission control dust/sludge from secondary lead smelting</ENT> <ENT/> <ENT>4</ENT> <ENT>K100</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K101—Distillation tar residues from the distillation of aniline-based compounds in the production of veterinary pharmaceuticals from arsenic or organo-arsenic compounds</ENT> <ENT/> <ENT>4</ENT> <ENT>K101</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K102—Residue from the use of activated carbon for decolorization in the production of veterinary pharmaceuticals from arsenic or organo-arsenic compounds</ENT> <ENT/> <ENT>4</ENT> <ENT>K102</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K103—Process residues from aniline extraction from the production of aniline</ENT> <ENT/> <ENT>4</ENT> <ENT>K103</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">K104—Combined wastewater streams generated from nitrobenzene/aniline production</ENT> <ENT/> <ENT>4</ENT> <ENT>K104</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K105—Separated aqueous stream from the reactor product washing step in the production of chlorobenzenes</ENT> <ENT/> <ENT>4</ENT> <ENT>K105</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <PRTPAGE P="313"/> <ENT I="01">K106—Wastewater treatment sludge from the mercury cell process in chlorine production</ENT> <ENT/> <ENT>4</ENT> <ENT>K106</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K107—Column bottoms from product separation from the production of 1,1- dimethylhydrazine (UDMH) from carboxylic acid hydrazines</ENT> <ENT/> <ENT>4</ENT> <ENT>K107</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K108—Condensed column overheads from product separation and condensed reactor vent gases from the production of 1,1- dimethylhydrazine (UDMH) from carboxylic acid hydrazides</ENT> <ENT/> <ENT>4</ENT> <ENT>K108</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K109—Spent filter cartridges from product purification from the production of 1,1-dimethylhydrazine (UDMH) from carboxylic acid hydrazides</ENT> <ENT/> <ENT>4</ENT> <ENT>K109</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K110—Condensed column overheads from intermediate separation from the production of 1,1-dimethylhydrazine (UDMH) from carboxylic acid hydrazides</ENT> <ENT/> <ENT>4</ENT> <ENT>K110</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K111—Product washwaters from the production of dinitrotoluene via nitration of toluene</ENT> <ENT/> <ENT>4</ENT> <ENT>K111</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K112—Reaction by-product water from the drying column in the production of toluenediamine via hydrogenation of dinitrotoluene</ENT> <ENT/> <ENT>4</ENT> <ENT>K112</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K113—Condensed liquid light ends from the purification of toluenediamine in the production of toluenediamine via hydrogenation of dinitrotoluene</ENT> <ENT/> <ENT>4</ENT> <ENT>K113</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K114—Vicinals from the purification of toluenediamine in the production of toluenediamine via hydrogenation of dinitrotoluene</ENT> <ENT/> <ENT>4</ENT> <ENT>K114</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K115—Heavy ends from the purification of toluenediamine in the production of toluenediamine via hydrogenation of dinitrotoluene</ENT> <ENT/> <ENT>4</ENT> <ENT>K115</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K116—Organic condensate from the solvent recovery column in the production of toluene diisocyanate via phosgenation of toluenediamine</ENT> <ENT/> <ENT>4</ENT> <ENT>K116</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K117—Wastewater from the reactor vent gas scrubber in the production of ethylene dibromide via bromination of ethene</ENT> <ENT/> <ENT>4</ENT> <ENT>K117</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K118—Spent adsorbent solids from purification of ethylene dibromide in the production of ethylene dibromide via bromination of ethene</ENT> <ENT/> <ENT>4</ENT> <ENT>K118</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K123—Process wastewater (including supernates, filtrates, and washwaters) from the production of ethylenebisdithiocarbamic acid and its salts</ENT> <ENT/> <ENT>4</ENT> <ENT>K123</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K124—Reactor vent scrubber water from the production of ethylenebisdithiocarbamic acid and its salts</ENT> <ENT/> <ENT>4</ENT> <ENT>K124</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K125—Filtration, evaporation, and centrifugation solids from the production of ethylenebisdithiocarbamic acid and its salts</ENT> <ENT/> <ENT>4</ENT> <ENT>K125</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K126—Baghouse dust and floor sweepings in milling and packaging operations from the production or formulation of ethylenebisdithiocarbamic acid and its salts</ENT> <ENT/> <ENT>4</ENT> <ENT>K126</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K131—Wastewater from the reactor and spent sulfuric acid from the acid dryer from the production of methyl bromide</ENT> <ENT/> <ENT>4</ENT> <ENT>K131</ENT> <ENT>100 (45.4)</ENT> </ROW> <ROW> <ENT I="01">K132—Spent absorbent and wastewater separator solids from the production of methyl bromide</ENT> <ENT/> <ENT>4</ENT> <ENT>K132</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">K136—Still bottoms from the purification of ethylene dibromide in the production of ethylene dibromide via bromination of ethene</ENT> <ENT/> <ENT>4</ENT> <ENT>K136</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K141—Process residues from the recovery of coal tar, including, but not limited to, collecting sump residues from the production of coke from coal or the recovery of coke by-products produced from coal This listing does not include K087 (decanter tank tar sludges from coking operations)</ENT> <ENT/> <ENT>4</ENT> <ENT>K141</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K142—Tar storage tank residues from the production of coke from coal or from the recovery of coke by-products produced from coal</ENT> <ENT/> <ENT>4</ENT> <ENT>K142</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="314"/> <ENT I="01">K143—Process residues from the recovery of light oil, including, but not limited to, those generated in stills, decanters, and wash oil recovery units from the recovery of coke by- products produced from coal</ENT> <ENT/> <ENT>4</ENT> <ENT>K143</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K144—Wastewater sump residues from light oil refining, including, but not limited to, intercepting or contamination sump sludges from the recovery of coke by-products produced from coal</ENT> <ENT/> <ENT>4</ENT> <ENT>K144</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K145—Residues from naphthalene collection and recovery operations from the recovery of coke by-products produced from coal</ENT> <ENT/> <ENT>4</ENT> <ENT>K145</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K147—Tar storage tank residues from coal tar refining</ENT> <ENT/> <ENT>4</ENT> <ENT>K147</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K148—Residues from coal tar distillation, including, but not limited to, still bottoms</ENT> <ENT/> <ENT>4</ENT> <ENT>K148</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K149—Distillation bottoms from the production of alpha-(or methyl-) chlorinated toluenes, ring-chlorinated toluenes, benzoyl chlorides, and compounds with mixtures of these functional groups. [This waste does not include still bottoms from the distillation of benzyl chloride]</ENT> <ENT/> <ENT>4</ENT> <ENT>K149</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K150—Organic residuals, excluding spent carbon adsorbent, from the spent chlorine gas and hydrochloric acid recovery processes associated with the production of alpha- (or methyl-) chlorinated toluenes, ring-chlorinated toluenes, benzoyl chlorides, and compounds with mixtures of these functional groups</ENT> <ENT/> <ENT>4</ENT> <ENT>K150</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K151—Wastewater treatment sludges, excluding neutralization and biological sludges, generated during the treatment of waste-waters from the production of alpha- (or methyl-) chlorinated toluenes, ring-chlorinated toluenes, benzoyl chlorides, and compounds with mixtures of these functional groups</ENT> <ENT/> <ENT>4</ENT> <ENT>K151</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K156—Organic waste (including heavy ends, still bottoms, light ends, spent solvents, filtrates, and decantates) from the production of carbamates and carbamoyl oximes. (This listing does not apply to wastes generated from the manufacture of 3-iodo-2-propynyl n-butylcarbamate)</ENT> <ENT/> <ENT>4</ENT> <ENT>K156</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K157—Wastewaters (including scrubber waters, condenser waters, washwaters, and separation waters) from the production of carbamates and carbamoyl oximes. (This listing does not apply to wastes generated from the manufacture of 3-iodo-2-propynyl n-butylcarbamate)</ENT> <ENT/> <ENT>4</ENT> <ENT>K157</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K158—Bag house dusts and filter/separation solids from the production of carbamates and carbamoyl oximes. (This listing does not apply to wastes generated from the manufacture of 3-iodo-2-propynyl n-butylcarbamate)</ENT> <ENT/> <ENT>4</ENT> <ENT>K158</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K159—Organics from the treatment of thiocarbamate wastes</ENT> <ENT/> <ENT>4</ENT> <ENT>K159</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01">K161—Purification solids (including filtration, evaporation, and centrifugation solids), bag-house dust and floor sweepings from the production of dithiocarbamate acids and their salts. (This listing does not include K125 or K126)</ENT> <ENT/> <ENT>4</ENT> <ENT>K161</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> K169  <SU>f</SU> —Crude oil storage tank sediment from petroleum refining operations </ENT> <ENT/> <ENT>4</ENT> <ENT>K169</ENT> <ENT>10 (4.54)</ENT> </ROW> <ROW> <ENT I="01"> K170  <SU>f</SU> —Clarified slurry oil tank sediment and/or in-line filter/separation solids from petroleum refining operations </ENT> <ENT/> <ENT>4</ENT> <ENT>K170</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> K171  <SU>f</SU> —Spent hydrotreating catalyst from petroleum refining operations. (This listing does not include inert support media) </ENT> <ENT/> <ENT>4</ENT> <ENT>K171</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <PRTPAGE P="315"/> <ENT I="01"> K172  <SU>f</SU> —Spent hydrorefining catalyst from petroleum refining operations. (This listing does not include inert support media) </ENT> <ENT/> <ENT>4</ENT> <ENT>K172</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> K174  <SU>f</SU> </ENT> <ENT/> <ENT>4</ENT> <ENT>K174</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> K175  <SU>f</SU> </ENT> <ENT/> <ENT>4</ENT> <ENT>K175</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01">K176—Baghouse filters from the production of antimony oxide, including filters from the production of intermediates (e.g., antimony metal or crude antimony oxide)</ENT> <ENT/> <ENT>4</ENT> <ENT>K176</ENT> <ENT>1 (0.454)</ENT> </ROW> <ROW> <ENT I="01"> K177—Slag from the production of antimony oxide that is speculatively accumulated or disposed, including slag from the production of intermediates ( <E T="03">e.g.,</E> antimony metal or crude antimony oxide) </ENT> <ENT/> <ENT>4</ENT> <ENT>K177</ENT> <ENT>5000 (2270)</ENT> </ROW> <ROW> <ENT I="01">K178—Residues from manufacturing and manufacturing-site storage of ferric chloride from acids formed during the production of titanium dioxide using the chloride-ilmenite process</ENT> <ENT/> <ENT>4</ENT> <ENT>K178</ENT> <ENT>1000 (454)</ENT> </ROW> <ROW> <ENT I="01">K181—Nonwastewaters from the production of dyes and/or pigments (including nonwastewaters commingled at the point of generation with nonwastewaters from other processes) that, at the point of generation, contain mass loadings of any of the constituents identified in paragraph (c) of section 261.32 that are equal to or greater than the corresponding paragraph (c) levels, as determined on a calendar year basis</ENT> <ENT/> <ENT>4</ENT> <ENT>K181</ENT> <ENT>(##)</ENT> </ROW> <TNOTE> <SU>I</SU>  Provides reference to Note I to Table 302.4 to discuss the applicability of CASRNs. </TNOTE> <TNOTE> <SU>II</SU>  Indicates the statutory source defined by 1, 2, 3, and 4, as described in the Note II to Table 302.4. </TNOTE> <TNOTE> <SU>III</SU>  No reporting of releases of this hazardous substance is required if the diameter of the pieces of the solid metal released is larger than 100 micrometers (0.004 inches). </TNOTE> <TNOTE> <SU>IV</SU>  The RQ for asbestos is limited to friable forms only. </TNOTE> <TNOTE> <SU>v</SU>  The Agency may adjust the statutory RQ for this hazardous substance in a future rulemaking; until then the statutory one-pound RQ applies. </TNOTE> <TNOTE>## The Agency may adjust the statutory RQ for this hazardous substance in a future rulemaking; until then the statutory one-pound RQ applies.</TNOTE> <TNOTE>§ The adjusted RQs for radionuclides may be found in appendix B to this table.</TNOTE> <TNOTE>** Indicates that no RQ is being assigned to the generic or broad class.</TNOTE> <TNOTE> <SU>a</SU>  Benzene was already a CERCLA hazardous substance prior to the CAA Amendments of 1990 and received an adjusted 10-pound RQ based on potential carcinogenicity in an August 14, 1989, final rule (54 FR 33418). The CAA Amendments specify that “benzene (including benzene from gasoline)” is a hazardous air pollutant and, thus, a CERCLA hazardous substance. </TNOTE> <TNOTE> <SU>b</SU>  The CAA Amendments of 1990 list DDE (3547-04-4) as a CAA hazardous air pollutant. The CAS number, 3547-04-4, is for the chemical, p,p′dichlorodiphenylethane. DDE or p,p′-dichlorodiphenyldichloroethylene, CAS number 72-55-9, is already listed in Table 302.4 with a final RQ of 1 pound. The substance identified by the CAS number 3547-04-4 has been evaluated and listed as DDE to be consistent with the CAA section 112 listing, as amended. </TNOTE> <TNOTE> <SU>c</SU>  Includes mineral fiber emissions from facilities manufacturing or processing glass, rock, or slag fibers (or other mineral derived fibers) of average diameter 1 micrometer or less. </TNOTE> <TNOTE> <SU>d</SU>  Includes mono- and di-ethers of ethylene glycol, diethylene glycol, and triethylene glycol R-(OCH2CH2)n-OR′ where: </TNOTE> <TNOTE>  n = 1, 2, or 3;</TNOTE> <TNOTE>  R = alkyl C7 or less; or</TNOTE> <TNOTE>  R = phenyl or alkyl substituted phenyl;</TNOTE> <TNOTE>  R′= H or alkyl C7 or less; or</TNOTE> <TNOTE>  OR′ consisting of carboxylic acid ester, sulfate, phosphate, nitrate, or sulfonate.</TNOTE> <TNOTE> <SU>e</SU>  Includes organic compounds with more than one benzene ring, and which have a boiling point greater than or equal to 100 °C. </TNOTE> <TNOTE> <SU>f</SU>  See 40 CFR 302.6(b)(1) for application of the mixture rule to this hazardous waste. </TNOTE> </GPOTABLE> <HD SOURCE="HD1">Appendix A to § 302.4—Sequential CAS Registry Number List of CERCLA Hazardous Substances</HD> <P> Appendix A to § 302.4 lists CERCLA hazardous substances in sequential order by CASRN and provides a per-substance grouping of regulatory synonyms ( <E T="03">i.e.,</E> names by which each hazardous substance is identified in other statutes and their implementing regulations). </P> <GPOTABLE COLS="2" OPTS="L2,nj,tp0,p7,7/8" CDEF="xs60,r200"> <BOXHD> <CHED H="1">CASRN</CHED> <CHED H="1">Hazardous substance</CHED> </BOXHD> <ROW> <ENT I="01">50-00-0</ENT> <ENT>Formaldehyde.</ENT> </ROW> <ROW> <PRTPAGE P="316"/> <ENT I="01">50-07-7</ENT> <ENT>Azirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione,6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a, 8b-hexahydro-8a-methoxy-5-methyl-, [1aS-(1aalpha, 8beta,8aalpha,8balpha)]-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Mitomycin C.</ENT> </ROW> <ROW> <ENT I="01">50-18-0</ENT> <ENT>Cyclophosphamide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide.</ENT> </ROW> <ROW> <ENT I="01">50-29-3</ENT> <ENT>Benzene, 1,1′-(2,2,2- trichloroethylidene)bis[4-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>DDT.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4,4′-DDT.</ENT> </ROW> <ROW> <ENT I="01">50-32-8</ENT> <ENT>Benzo[a]pyrene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3,4-Benzopyrene.</ENT> </ROW> <ROW> <ENT I="01">50-55-5</ENT> <ENT>Reserpine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3 ,4,5-trimethoxybenzoyl)oxy]-, methyl ester (3beta, 16beta,17alpha,18beta,20alpha)-.</ENT> </ROW> <ROW> <ENT I="01">51-28-5</ENT> <ENT>Phenol, 2,4-dinitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Dinitrophenol.</ENT> </ROW> <ROW> <ENT I="01">51-43-4</ENT> <ENT>Epinephrine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Benzenediol,4-[1-hydroxy-2-(methylamino) ethyl]-.</ENT> </ROW> <ROW> <ENT I="01">51-79-6</ENT> <ENT>Carbamic acid, ethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethyl carbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Urethane.</ENT> </ROW> <ROW> <ENT I="01">52-68-6</ENT> <ENT>Trichlorfon.</ENT> </ROW> <ROW> <ENT I="01">52-85-7</ENT> <ENT>Famphur.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorothioic acid, O-[4-[(dimethylamino) sulfonyl]phenyl] O,O-dimethyl ester.</ENT> </ROW> <ROW> <ENT I="01">53-70-3</ENT> <ENT>Dibenz[a,h]anthracene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dibenzo[a,h]anthracene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2:5,6-Dibenzanthracene.</ENT> </ROW> <ROW> <ENT I="01">53-96-3</ENT> <ENT>Acetamide, N-9H-fluoren-2-yl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Acetylaminofluorene.</ENT> </ROW> <ROW> <ENT I="01">54-11-5</ENT> <ENT>Nicotine, & salts.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-, & salts.</ENT> </ROW> <ROW> <ENT I="01">55-18-5</ENT> <ENT>Ethanamine, N-ethyl-N-nitroso-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>N-Nitrosodiethylamine.</ENT> </ROW> <ROW> <ENT I="01">55-63-0</ENT> <ENT>Nitroglycerine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3-Propanetriol, trinitrate.</ENT> </ROW> <ROW> <ENT I="01">55-91-4</ENT> <ENT>Diisopropylfluorophosphate (DFP).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorofluororidic acid, bis(1-methylethyl) ester.</ENT> </ROW> <ROW> <ENT I="01">56-04-2</ENT> <ENT>Methylthiouracil.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4(1H)-Pyrimidinone, 2,3-dihydro-6-methyl-2-thioxo-.</ENT> </ROW> <ROW> <ENT I="01">56-23-5</ENT> <ENT>Carbon tetrachloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, tetrachloro-.</ENT> </ROW> <ROW> <ENT I="01">56-38-2</ENT> <ENT>Parathion.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorothioic acid, O,O-diethyl O-(4-nitrophenyl) ester.</ENT> </ROW> <ROW> <ENT I="01">56-49-5</ENT> <ENT>Benz[j]aceanthrylene, 1,2-dihydro-3-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3-Methylcholanthrene.</ENT> </ROW> <ROW> <ENT I="01">56-53-1</ENT> <ENT>Diethylstilbestrol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 4,4′-(1,2-diethyl-1,2-ethenediyl)bis-, (E).</ENT> </ROW> <ROW> <ENT I="01">56-55-3</ENT> <ENT>Benz[a]anthracene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzo[a]anthracene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Benzanthracene.</ENT> </ROW> <ROW> <ENT I="01">56-72-4</ENT> <ENT>Coumaphos.</ENT> </ROW> <ROW> <ENT I="01">57-14-7</ENT> <ENT>Hydrazine, 1,1-dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,1-Dimethylhydrazine.</ENT> </ROW> <ROW> <ENT I="01">57-24-9</ENT> <ENT>Strychnidin-10-one, & salts.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Strychnine, & salts.</ENT> </ROW> <ROW> <ENT I="01">57-47-6</ENT> <ENT>Physostigmine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-.</ENT> </ROW> <ROW> <ENT I="01">57-57-8</ENT> <ENT>beta-Propiolactone.</ENT> </ROW> <ROW> <ENT I="01">57-64-7</ENT> <ENT>Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate ester (1:1).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Physostigmine salicylate.</ENT> </ROW> <ROW> <ENT I="01">57-74-9</ENT> <ENT>Chlordane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Chlordane, alpha & gamma isomers.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>CHLORDANE (TECHNICAL MIXTURE AND METABOLITES).</ENT> </ROW> <ROW> <PRTPAGE P="317"/> <ENT I="22"> </ENT> <ENT>4,7-Methano-1H-indene, 1,2,4,5,6,7,8,8- octachloro-2,3,3a,4,7,7a-hexahydro-.</ENT> </ROW> <ROW> <ENT I="01">57-97-6</ENT> <ENT>Benz[a]anthracene, 7,12-dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>7,12-Dimethylbenz[a]anthracene.</ENT> </ROW> <ROW> <ENT I="01">58-89-9</ENT> <ENT>γ-BHC.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Cyclohexane, 1,2,3,4,5,6-hexachloro-(1α,2α,3β,4α,5α,6β)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Lindane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Lindane (all isomers).</ENT> </ROW> <ROW> <ENT I="01">58-90-2</ENT> <ENT>Phenol, 2,3,4,6-tetrachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,3,4,6-Tetrachlorophenol.</ENT> </ROW> <ROW> <ENT I="01">59-50-7</ENT> <ENT>p-Chloro-m-cresol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 4-chloro-3-methyl-.</ENT> </ROW> <ROW> <ENT I="01">59-89-2</ENT> <ENT>N-Nitrosomorpholine.</ENT> </ROW> <ROW> <ENT I="01">60-00-4</ENT> <ENT>Ethylenediamine-tetraacetic acid (EDTA).</ENT> </ROW> <ROW> <ENT I="01">60-11-7</ENT> <ENT>Benzenamine, N,N-dimethyl-4-(phenylazo)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dimethyl aminoazobenzene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>p-Dimethylaminoazobenzene.</ENT> </ROW> <ROW> <ENT I="01">60-29-7</ENT> <ENT>Ethane, 1,1′-oxybis-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethyl ether.</ENT> </ROW> <ROW> <ENT I="01">60-34-4</ENT> <ENT>Hydrazine, methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl hydrazine.</ENT> </ROW> <ROW> <ENT I="01">60-35-5</ENT> <ENT>Acetamide.</ENT> </ROW> <ROW> <ENT I="01">60-51-5</ENT> <ENT>Dimethoate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorodithioic acid, O,O-dimethyl S-[2(methylamino)-2-oxoethyl] ester.</ENT> </ROW> <ROW> <ENT I="01">60-57-1</ENT> <ENT>Dieldrin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-1a,2, 2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2aalpha,3beta,6beta, 6aalpha,7beta, 7aalpha)-.</ENT> </ROW> <ROW> <ENT I="01">61-82-5</ENT> <ENT>Amitrole.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1H-1,2,4-Triazol-3-amine.</ENT> </ROW> <ROW> <ENT I="01">62-38-4</ENT> <ENT>Mercury, (acetato-O)phenyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenylmercury acetate.</ENT> </ROW> <ROW> <ENT I="01">62-44-2</ENT> <ENT>Acetamide, N-(4-ethoxyphenyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenacetin.</ENT> </ROW> <ROW> <ENT I="01">62-50-0</ENT> <ENT>Ethyl methanesulfonate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methanesulfonic acid, ethyl ester.</ENT> </ROW> <ROW> <ENT I="01">62-53-3</ENT> <ENT>Aniline.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzenamine.</ENT> </ROW> <ROW> <ENT I="01">62-55-5</ENT> <ENT>Ethanethioamide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thioacetamide.</ENT> </ROW> <ROW> <ENT I="01">62-56-6</ENT> <ENT>Thiourea.</ENT> </ROW> <ROW> <ENT I="01">62-73-7</ENT> <ENT>Dichlorvos.</ENT> </ROW> <ROW> <ENT I="01">62-74-8</ENT> <ENT>Acetic acid, fluoro-, sodium salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Fluoroacetic acid, sodium salt.</ENT> </ROW> <ROW> <ENT I="01">62-75-9</ENT> <ENT>Methanamine, N-methyl-N-nitroso-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>N-Nitrosodimethylamine.</ENT> </ROW> <ROW> <ENT I="01">63-25-2</ENT> <ENT>Carbaryl.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Naphthalenol, methylcarbamate.</ENT> </ROW> <ROW> <ENT I="01">64-00-6</ENT> <ENT>m-Cumenyl methylcarbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3-Isopropylphenyl N-methylcarbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 3-(1-methylethyl)-, methyl carbamate.</ENT> </ROW> <ROW> <ENT I="01">64-18-6</ENT> <ENT>Formic acid.</ENT> </ROW> <ROW> <ENT I="01">64-19-7</ENT> <ENT>Acetic acid.</ENT> </ROW> <ROW> <ENT I="01">64-67-5</ENT> <ENT>Diethyl sulfate.</ENT> </ROW> <ROW> <ENT I="01">65-85-0</ENT> <ENT>Benzoic acid.</ENT> </ROW> <ROW> <ENT I="01">66-75-1</ENT> <ENT>Uracil mustard.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-(1H,3H)-Pyrimidinedione, 5-[bis(2-chloroethyl) amino]-.</ENT> </ROW> <ROW> <ENT I="01">67-56-1</ENT> <ENT>Methanol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl alcohol.</ENT> </ROW> <ROW> <ENT I="01">67-64-1</ENT> <ENT>Acetone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propanone.</ENT> </ROW> <ROW> <ENT I="01">67-66-3</ENT> <ENT>Chloroform.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, trichloro-.</ENT> </ROW> <ROW> <ENT I="01">67-72-1</ENT> <ENT>Ethane, hexachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Hexachloroethane.</ENT> </ROW> <ROW> <ENT I="01">68-12-2</ENT> <ENT>Dimethylformamide.</ENT> </ROW> <ROW> <ENT I="01">70-25-7</ENT> <ENT>Guanidine, N-methyl-N′-nitro-N-nitroso-.</ENT> </ROW> <ROW> <PRTPAGE P="318"/> <ENT I="22"> </ENT> <ENT>MNNG.</ENT> </ROW> <ROW> <ENT I="01">70-30-4</ENT> <ENT>Hexachlorophene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 2,2′-methylenebis[3,4,6-tri- chloro-.</ENT> </ROW> <ROW> <ENT I="01">71-36-3</ENT> <ENT>n-Butyl alcohol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Butanol.</ENT> </ROW> <ROW> <ENT I="01">71-43-2</ENT> <ENT>Benzene.</ENT> </ROW> <ROW> <ENT I="01">71-55-6</ENT> <ENT>Ethane, 1,1,1-trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl chloroform.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,1,1-Trichloroethane.</ENT> </ROW> <ROW> <ENT I="01">72-20-8</ENT> <ENT>Endrin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Endrin, & metabolites.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,7:3.6-Dimethanonaphth[2,3-b]oxirene,3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2abeta,3alpha, 6alpha,6abeta,7beta,7aalpha)-, & metabolites.</ENT> </ROW> <ROW> <ENT I="01">72-43-5</ENT> <ENT>Benzene, 1,1′-(2,2,2-trichloroethylidene)bis[4- methoxy-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methoxychlor.</ENT> </ROW> <ROW> <ENT I="01">72-54-8</ENT> <ENT>Benzene, 1,1′-(2,2-dichloroethylidene)bis[4-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>DDD.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>TDE.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4,4′-DDD.</ENT> </ROW> <ROW> <ENT I="01">72-55-9</ENT> <ENT>DDE.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4,4′-DDE.</ENT> </ROW> <ROW> <ENT I="01">72-57-1</ENT> <ENT>Trypan blue.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′-dimethyl-(l,1′-biphenyl)-4,4′-diyl)-bis(azo)]bis(5-amino-4-hydroxy)-tetrasodium salt.</ENT> </ROW> <ROW> <ENT I="01">74-83-9</ENT> <ENT>Bromomethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, bromo-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl bromide.</ENT> </ROW> <ROW> <ENT I="01">74-87-3</ENT> <ENT>Chloromethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl chloride.</ENT> </ROW> <ROW> <ENT I="01">74-88-4</ENT> <ENT>Iodomethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, iodo-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl iodide.</ENT> </ROW> <ROW> <ENT I="01">74-89-5</ENT> <ENT>Monomethylamine.</ENT> </ROW> <ROW> <ENT I="01">74-90-8</ENT> <ENT>Hydrocyanic acid.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Hydrogen cyanide.</ENT> </ROW> <ROW> <ENT I="01">74-93-1</ENT> <ENT>Methanethiol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl mercaptan.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiomethanol.</ENT> </ROW> <ROW> <ENT I="01">74-95-3</ENT> <ENT>Methane, dibromo-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methylene bromide.</ENT> </ROW> <ROW> <ENT I="01">75-00-3</ENT> <ENT>Chloroethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethyl chloride.</ENT> </ROW> <ROW> <ENT I="01">75-01-4</ENT> <ENT>Ethene, chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Vinyl chloride.</ENT> </ROW> <ROW> <ENT I="01">75-04-7</ENT> <ENT>Monoethylamine.</ENT> </ROW> <ROW> <ENT I="01">75-05-8</ENT> <ENT>Acetonitrile.</ENT> </ROW> <ROW> <ENT I="01">75-07-0</ENT> <ENT>Acetaldehyde.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethanal.</ENT> </ROW> <ROW> <ENT I="01">75-09-2</ENT> <ENT>Dichloromethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methylene chloride.</ENT> </ROW> <ROW> <ENT I="01">75-15-0</ENT> <ENT>Carbon disulfide.</ENT> </ROW> <ROW> <ENT I="01">75-20-7</ENT> <ENT>Calcium carbide.</ENT> </ROW> <ROW> <ENT I="01">75-21-8</ENT> <ENT>Ethylene oxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Oxirane.</ENT> </ROW> <ROW> <ENT I="01">75-25-2</ENT> <ENT>Bromoform.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, tribromo-.</ENT> </ROW> <ROW> <ENT I="01">75-27-4</ENT> <ENT>Dichlorobromomethane.</ENT> </ROW> <ROW> <ENT I="01">75-34-3</ENT> <ENT>Ethane, 1,1-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethylidene dichloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,1-Dichloroethane.</ENT> </ROW> <ROW> <ENT I="01">75-35-4</ENT> <ENT>Ethene, 1,1-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Vinylidene chloride.</ENT> </ROW> <ROW> <PRTPAGE P="319"/> <ENT I="22"> </ENT> <ENT>1,1-Dichloroethylene.</ENT> </ROW> <ROW> <ENT I="01">75-36-5</ENT> <ENT>Acetyl chloride.</ENT> </ROW> <ROW> <ENT I="01">75-44-5</ENT> <ENT>Carbonic dichloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosgene.</ENT> </ROW> <ROW> <ENT I="01">75-50-3</ENT> <ENT>Trimethylamine.</ENT> </ROW> <ROW> <ENT I="01">75-55-8</ENT> <ENT>Aziridine, 2-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Methyl aziridine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Propylenimine.</ENT> </ROW> <ROW> <ENT I="01">75-56-9</ENT> <ENT>Propylene oxide.</ENT> </ROW> <ROW> <ENT I="01">75-60-5</ENT> <ENT>Arsinic acid, dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Cacodylic acid.</ENT> </ROW> <ROW> <ENT I="01">75-64-9</ENT> <ENT>tert-Butylamine.</ENT> </ROW> <ROW> <ENT I="01">75-69-4</ENT> <ENT>Methane, trichlorofluoro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Trichloromonofluoromethane.</ENT> </ROW> <ROW> <ENT I="01">75-71-8</ENT> <ENT>Dichlorodifluoromethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, dichlorodifluoro-.</ENT> </ROW> <ROW> <ENT I="01">75-86-5</ENT> <ENT>Acetone cyanohydrin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propanenitrile, 2-hydroxy-2-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Methyllactonitrile.</ENT> </ROW> <ROW> <ENT I="01">75-87-6</ENT> <ENT>Acetaldehyde, trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Chloral.</ENT> </ROW> <ROW> <ENT I="01">75-99-0</ENT> <ENT>2,2-Dichloropropionic acid.</ENT> </ROW> <ROW> <ENT I="01">76-01-7</ENT> <ENT>Ethane, pentachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pentachloroethane.</ENT> </ROW> <ROW> <ENT I="01">76-44-8</ENT> <ENT>Heptachlor.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-.</ENT> </ROW> <ROW> <ENT I="01">77-47-4</ENT> <ENT>Hexachlorocyclopentadiene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Cyclopentadiene, 1,2,3,4,5,5-hexa- chloro-.</ENT> </ROW> <ROW> <ENT I="01">77-78-1</ENT> <ENT>Dimethyl sulfate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Sulfuric acid, dimethyl ester.</ENT> </ROW> <ROW> <ENT I="01">78-00-2</ENT> <ENT>Plumbane, tetraethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tetraethyl lead.</ENT> </ROW> <ROW> <ENT I="01">78-59-1</ENT> <ENT>Isophorone.</ENT> </ROW> <ROW> <ENT I="01">78-79-5</ENT> <ENT>Isoprene.</ENT> </ROW> <ROW> <ENT I="01">78-81-9</ENT> <ENT>iso-Butylamine.</ENT> </ROW> <ROW> <ENT I="01">78-83-1</ENT> <ENT>Isobutyl alcohol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Propanol, 2-methyl-.</ENT> </ROW> <ROW> <ENT I="01">78-87-5</ENT> <ENT>Propane, 1,2-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propylene dichloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Dichloropropane.</ENT> </ROW> <ROW> <ENT I="01">78-88-6</ENT> <ENT>2,3-Dichloropropene.</ENT> </ROW> <ROW> <ENT I="01">78-93-3</ENT> <ENT>2-Butanone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>MEK.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl ethyl ketone.</ENT> </ROW> <ROW> <ENT I="01">78-99-9</ENT> <ENT>1,1-Dichloropropane.</ENT> </ROW> <ROW> <ENT I="01">79-00-5</ENT> <ENT>Ethane, 1,1,2-trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,1,2-Trichloroethane.</ENT> </ROW> <ROW> <ENT I="01">79-01-6</ENT> <ENT>Ethene, trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Trichloroethylene.</ENT> </ROW> <ROW> <ENT I="01">79-06-1</ENT> <ENT>Acrylamide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenamide.</ENT> </ROW> <ROW> <ENT I="01">79-09-4</ENT> <ENT>Propionic acid.</ENT> </ROW> <ROW> <ENT I="01">79-10-7</ENT> <ENT>Acrylic acid.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenoic acid.</ENT> </ROW> <ROW> <ENT I="01">79-11-8</ENT> <ENT>Chloroacetic acid.</ENT> </ROW> <ROW> <ENT I="01">79-19-6</ENT> <ENT>Hydrazinecarbothioamide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiosemicarbazide.</ENT> </ROW> <ROW> <ENT I="01">79-22-1</ENT> <ENT>Carbonochloridic acid, methyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl chlorocarbonate.</ENT> </ROW> <ROW> <ENT I="01">79-31-2</ENT> <ENT>iso-Butyric acid.</ENT> </ROW> <ROW> <ENT I="01">79-34-5</ENT> <ENT>Ethane, 1,1,2,2-tetrachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,1,2,2-Tetrachloroethane.</ENT> </ROW> <ROW> <ENT I="01">79-44-7</ENT> <ENT>Carbamic chloride, dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dimethylcarbamoyl chloride.</ENT> </ROW> <ROW> <ENT I="01">79-46-9</ENT> <ENT>Propane, 2-nitro-.</ENT> </ROW> <ROW> <PRTPAGE P="320"/> <ENT I="22"> </ENT> <ENT>2-Nitropropane.</ENT> </ROW> <ROW> <ENT I="01">80-15-9</ENT> <ENT>alpha,alpha-Dimethylbenzylhydroperoxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Hydroperoxide, 1-methyl-1-phenylethyl-.</ENT> </ROW> <ROW> <ENT I="01">80-62-6</ENT> <ENT>Methyl methacrylate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenoic acid, 2-methyl-, methyl ester.</ENT> </ROW> <ROW> <ENT I="01">81-81-2</ENT> <ENT>Warfarin, & salts.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, & salts.</ENT> </ROW> <ROW> <ENT I="01">82-68-8</ENT> <ENT>Benzene, pentachloronitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>PCNB.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pentachloronitrobenzene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Quintobenzene.</ENT> </ROW> <ROW> <ENT I="01">83-32-9</ENT> <ENT>Acenaphthene.</ENT> </ROW> <ROW> <ENT I="01">84-66-2</ENT> <ENT>Diethyl phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Benzenedicarboxylic acid, diethyl ester.</ENT> </ROW> <ROW> <ENT I="01">84-74-2</ENT> <ENT>Di-n-butyl phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dibutyl phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>n-Butyl phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Benzenedicarboxylic acid, dibutyl ester.</ENT> </ROW> <ROW> <ENT I="01">85-00-7</ENT> <ENT>Diquat.</ENT> </ROW> <ROW> <ENT I="01">85-01-8</ENT> <ENT>Phenanthrene.</ENT> </ROW> <ROW> <ENT I="01">85-44-9</ENT> <ENT>Phthalic anhydride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Isobenzofurandione.</ENT> </ROW> <ROW> <ENT I="01">85-68-7</ENT> <ENT>Butyl benzyl phthalate.</ENT> </ROW> <ROW> <ENT I="01">86-30-6</ENT> <ENT>N-Nitrosodiphenylamine.</ENT> </ROW> <ROW> <ENT I="01">86-50-0</ENT> <ENT>Guthion.</ENT> </ROW> <ROW> <ENT I="01">86-73-7</ENT> <ENT>Fluorene.</ENT> </ROW> <ROW> <ENT I="01">86-88-4</ENT> <ENT>alpha-Naphthylthiourea.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiourea, 1-naphthalenyl-.</ENT> </ROW> <ROW> <ENT I="01">87-65-0</ENT> <ENT>Phenol, 2,6-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,6-Dichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">87-68-3</ENT> <ENT>Hexachlorobutadiene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Butadiene, 1,1,2,3,4,4-hexachloro-.</ENT> </ROW> <ROW> <ENT I="01">87-86-5</ENT> <ENT>Pentachlorophenol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, pentachloro-.</ENT> </ROW> <ROW> <ENT I="01">88-06-2</ENT> <ENT>Phenol, 2,4,6-trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4,6-Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">88-72-2</ENT> <ENT>o-Nitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">88-75-5</ENT> <ENT>o-Nitrophenol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Nitrophenol.</ENT> </ROW> <ROW> <ENT I="01">88-85-7</ENT> <ENT>Dinoseb.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 2-(1-methylpropyl)-4,6-dinitro-.</ENT> </ROW> <ROW> <ENT I="01">90-04-0</ENT> <ENT>o-Anisidine.</ENT> </ROW> <ROW> <ENT I="01">91-08-7</ENT> <ENT>Benzene, 1,3-diisocyanatomethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluene diisocyanate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diisocyanate.</ENT> </ROW> <ROW> <ENT I="01">91-20-3</ENT> <ENT>Naphthalene.</ENT> </ROW> <ROW> <ENT I="01">91-22-5</ENT> <ENT>Quinoline.</ENT> </ROW> <ROW> <ENT I="01">91-58-7</ENT> <ENT>beta-Chloronaphthalene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Naphthalene, 2-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Chloronaphthalene.</ENT> </ROW> <ROW> <ENT I="01">91-59-8</ENT> <ENT>beta-Naphthylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Naphthalenamine.</ENT> </ROW> <ROW> <ENT I="01">91-66-7</ENT> <ENT>N,N-Diethylaniline.</ENT> </ROW> <ROW> <ENT I="01">91-80-5</ENT> <ENT>Methapyrilene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Ethanediamine, N,N-dimethyl-N′-2-pyridinyl-N′- (2-thienylmethyl)-.</ENT> </ROW> <ROW> <ENT I="01">91-94-1</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine,3,3′-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3,3′-Dichlorobenzidine.</ENT> </ROW> <ROW> <ENT I="01">92-52-4</ENT> <ENT>Biphenyl.</ENT> </ROW> <ROW> <ENT I="01">92-67-1</ENT> <ENT>4-Aminobiphenyl.</ENT> </ROW> <ROW> <ENT I="01">92-87-5</ENT> <ENT>Benzidine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine.</ENT> </ROW> <ROW> <ENT I="01">92-93-3</ENT> <ENT>4-Nitrobiphenyl.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propanoic acid, 2-(2,4,5-trichlorophenoxy)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Silvex (2,4,5-TP).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4,5-TP acid.</ENT> </ROW> <ROW> <PRTPAGE P="321"/> <ENT I="01">93-76-5</ENT> <ENT>Acetic acid, (2,4,5-trichlorophenoxy)-.</ENT> </ROW> <ROW> <ENT I="01">93-72-1</ENT> <ENT>2,4,5-T.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4,5-T acid.</ENT> </ROW> <ROW> <ENT I="01">93-79-8</ENT> <ENT>2,4,5-T esters.</ENT> </ROW> <ROW> <ENT I="01">94-11-1</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">94-58-6</ENT> <ENT>Dihydrosafrole.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Benzodioxole, 5-propyl-.</ENT> </ROW> <ROW> <ENT I="01">94-59-7</ENT> <ENT>Safrole.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Benzodioxole, 5-(2-propenyl)-.</ENT> </ROW> <ROW> <ENT I="01">94-79-1</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">94-80-4</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">95-47-6</ENT> <ENT>o-Xylene.</ENT> </ROW> <ROW> <ENT I="01">95-48-7</ENT> <ENT>o-Cresol.</ENT> </ROW> <ROW> <ENT I="01">95-50-1</ENT> <ENT>Benzene, 1,2-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>o-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">95-53-4</ENT> <ENT>Benzenamine, 2-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>o-Toluidine.</ENT> </ROW> <ROW> <ENT I="01">95-57-8</ENT> <ENT>o-Chlorophenol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 2-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Chlorophenol.</ENT> </ROW> <ROW> <ENT I="01">95-80-7</ENT> <ENT>Benzenediamine, ar-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluenediamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diamine.</ENT> </ROW> <ROW> <ENT I="01">95-94-3</ENT> <ENT>Benzene, 1,2,4,5-tetrachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,4,5-Tetrachlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">95-95-4</ENT> <ENT>Phenol, 2,4,5-trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4,5-Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">96-09-3</ENT> <ENT>Styrene oxide.</ENT> </ROW> <ROW> <ENT I="01">96-12-8</ENT> <ENT>Propane, 1,2-dibromo-3-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Dibromo-3-chloropropane.</ENT> </ROW> <ROW> <ENT I="01">96-45-7</ENT> <ENT>Ethylenethiourea.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Imidazolidinethione.</ENT> </ROW> <ROW> <ENT I="01">97-63-2</ENT> <ENT>Ethyl methacrylate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenoic acid, 2-methyl-, ethyl ester.</ENT> </ROW> <ROW> <ENT I="01">98-01-1</ENT> <ENT>Furfural.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Furancarboxaldehyde.</ENT> </ROW> <ROW> <ENT I="01">98-07-7</ENT> <ENT>Benzene, (trichloromethyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzotrichloride.</ENT> </ROW> <ROW> <ENT I="01">98-09-9</ENT> <ENT>Benzenesulfonic acid chloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzenesulfonyl chloride.</ENT> </ROW> <ROW> <ENT I="01">98-82-8</ENT> <ENT>Benzene, (1-methylethyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Cumene.</ENT> </ROW> <ROW> <ENT I="01">98-86-2</ENT> <ENT>Acetophenone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethanone, 1-phenyl-.</ENT> </ROW> <ROW> <ENT I="01">98-87-3</ENT> <ENT>Benzal chloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzene, (dichloromethyl)-.</ENT> </ROW> <ROW> <ENT I="01">98-88-4</ENT> <ENT>Benzoyl chloride.</ENT> </ROW> <ROW> <ENT I="01">98-95-3</ENT> <ENT>Benzene, nitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Nitrobenzene.</ENT> </ROW> <ROW> <ENT I="01">99-08-1</ENT> <ENT>m-Nitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">99-35-4</ENT> <ENT>Benzene, 1,3,5-trinitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3,5-Trinitrobenzene.</ENT> </ROW> <ROW> <ENT I="01">99-55-8</ENT> <ENT>Benzenamine, 2-methyl-5-nitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>5-Nitro-o-toluidine.</ENT> </ROW> <ROW> <ENT I="01">99-65-0</ENT> <ENT>m-Dinitrobenzene.</ENT> </ROW> <ROW> <ENT I="01">99-99-0</ENT> <ENT>p-Nitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">100-01-6</ENT> <ENT>Benzenamine, 4-nitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>p-Nitroaniline.</ENT> </ROW> <ROW> <ENT I="01">100-02-7</ENT> <ENT>p-Nitrophenol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 4-nitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4-Nitrophenol.</ENT> </ROW> <ROW> <ENT I="01">100-25-4</ENT> <ENT>p-Dinitrobenzene.</ENT> </ROW> <ROW> <ENT I="01">100-41-4</ENT> <ENT>Ethylbenzene.</ENT> </ROW> <ROW> <ENT I="01">100-42-5</ENT> <ENT>Styrene.</ENT> </ROW> <ROW> <PRTPAGE P="322"/> <ENT I="01">100-44-7</ENT> <ENT>Benzene, (chloromethyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzyl chloride.</ENT> </ROW> <ROW> <ENT I="01">100-47-0</ENT> <ENT>Benzonitrile.</ENT> </ROW> <ROW> <ENT I="01">100-75-4</ENT> <ENT>N-Nitrosopiperidine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Piperidine, 1-nitroso-.</ENT> </ROW> <ROW> <ENT I="01">101-14-4</ENT> <ENT> Benzenamine, 4,4′-methylenebis[2-chloro-. <LI>4,4′-Methylenebis(2-chloroaniline).</LI> </ENT> </ROW> <ROW> <ENT I="01">101-27-9</ENT> <ENT>Barban.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbamic acid, (3-chlorophenyl)-, 4-chloro-2-butynyl ester.</ENT> </ROW> <ROW> <ENT I="01">101-55-3</ENT> <ENT>Benzene, 1-bromo-4-phenoxy-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4-Bromophenyl phenyl ether.</ENT> </ROW> <ROW> <ENT I="01">101-68-8</ENT> <ENT>MDI.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methylene diphenyl diisocyanate.</ENT> </ROW> <ROW> <ENT I="01">101-77-9</ENT> <ENT>4,4′-Methylenedianiline.</ENT> </ROW> <ROW> <ENT I="01">103-85-5</ENT> <ENT>Phenylthiourea.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiourea, phenyl-.</ENT> </ROW> <ROW> <ENT I="01">105-46-4</ENT> <ENT>sec-Butyl acetate.</ENT> </ROW> <ROW> <ENT I="01">105-67-9</ENT> <ENT>Phenol, 2,4-dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Dimethylphenol.</ENT> </ROW> <ROW> <ENT I="01">106-42-3</ENT> <ENT>p-Xylene.</ENT> </ROW> <ROW> <ENT I="01">106-44-5</ENT> <ENT>p-Cresol.</ENT> </ROW> <ROW> <ENT I="01">106-46-7</ENT> <ENT>Benzene, 1,4-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>p-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,4-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">106-47-8</ENT> <ENT>Benzenamine, 4-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>p-Chloroaniline.</ENT> </ROW> <ROW> <ENT I="01">106-49-0</ENT> <ENT>Benzenamine, 4-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>p-Toluidine.</ENT> </ROW> <ROW> <ENT I="01">106-50-3</ENT> <ENT>p-Phenylenediamine.</ENT> </ROW> <ROW> <ENT I="01">106-51-4</ENT> <ENT>p-Benzoquinone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,5-Cyclohexadiene-1,4-dione.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Quinone.</ENT> </ROW> <ROW> <ENT I="01">106-88-7</ENT> <ENT>1,2-Epoxybutane.</ENT> </ROW> <ROW> <ENT I="01">106-89-8</ENT> <ENT>1-Chloro-2,3-epoxypropane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Epichlorohydrin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Oxirane, (chloromethyl)-.</ENT> </ROW> <ROW> <ENT I="01">106-93-4</ENT> <ENT>Dibromoethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethane, 1,2-dibromo-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethylene dibromide.</ENT> </ROW> <ROW> <ENT I="01">106-94-5</ENT> <ENT>1-Bromopropane (BP).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>n-Propyl bromide (nPB).</ENT> </ROW> <ROW> <ENT I="01">106-99-0</ENT> <ENT>1,3-Butadiene.</ENT> </ROW> <ROW> <ENT I="01">107-02-8</ENT> <ENT>Acrolein.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenal.</ENT> </ROW> <ROW> <ENT I="01">107-05-1</ENT> <ENT>Allyl chloride.</ENT> </ROW> <ROW> <ENT I="01">107-06-2</ENT> <ENT>Ethane, 1,2-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethylene dichloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Dichloroethane.</ENT> </ROW> <ROW> <ENT I="01">107-10-8</ENT> <ENT>n-Propylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Propanamine.</ENT> </ROW> <ROW> <ENT I="01">107-12-0</ENT> <ENT>Ethyl cyanide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propanenitrile.</ENT> </ROW> <ROW> <ENT I="01">107-13-1</ENT> <ENT>Acrylonitrile.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenenitrile.</ENT> </ROW> <ROW> <ENT I="01">107-15-3</ENT> <ENT>Ethylenediamine.</ENT> </ROW> <ROW> <ENT I="01">107-18-6</ENT> <ENT>Allyl alcohol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propen-1-ol.</ENT> </ROW> <ROW> <ENT I="01">107-19-7</ENT> <ENT>Propargyl alcohol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propyn-1-ol.</ENT> </ROW> <ROW> <ENT I="01">107-20-0</ENT> <ENT>Acetaldehyde, chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Chloroacetaldehyde.</ENT> </ROW> <ROW> <ENT I="01">107-21-1</ENT> <ENT>Ethylene glycol.</ENT> </ROW> <ROW> <ENT I="01">107-30-2</ENT> <ENT>Chloromethyl methyl ether.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, chloromethoxy-.</ENT> </ROW> <ROW> <ENT I="01">107-49-3</ENT> <ENT>Diphosphoric acid, tetraethyl ester.</ENT> </ROW> <ROW> <PRTPAGE P="323"/> <ENT I="22"> </ENT> <ENT>Tetraethyl pyrophosphate.</ENT> </ROW> <ROW> <ENT I="01">107-92-6</ENT> <ENT>Butyric acid.</ENT> </ROW> <ROW> <ENT I="01">108-05-4</ENT> <ENT>Vinyl acetate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Vinyl acetate monomer.</ENT> </ROW> <ROW> <ENT I="01">108-10-1</ENT> <ENT>Hexone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl isobutyl ketone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4-Methyl-2-pentanone.</ENT> </ROW> <ROW> <ENT I="01">108-24-7</ENT> <ENT>Acetic anhydride.</ENT> </ROW> <ROW> <ENT I="01">108-31-6</ENT> <ENT>Maleic anhydride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,5-Furandione.</ENT> </ROW> <ROW> <ENT I="01">108-38-3</ENT> <ENT>m-Xylene.</ENT> </ROW> <ROW> <ENT I="01">108-39-4</ENT> <ENT>m-Cresol.</ENT> </ROW> <ROW> <ENT I="01">108-46-3</ENT> <ENT>Resorcinol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Benzenediol.</ENT> </ROW> <ROW> <ENT I="01">108-60-1</ENT> <ENT> Dichloroisopropyl ether. <LI>Propane, 2,2″-oxybis[2-chloro-.</LI> </ENT> </ROW> <ROW> <ENT I="01">108-88-3</ENT> <ENT>Benzene, methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluene.</ENT> </ROW> <ROW> <ENT I="01">108-90-7</ENT> <ENT>Benzene, chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Chlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">108-94-1</ENT> <ENT>Cyclohexanone.</ENT> </ROW> <ROW> <ENT I="01">108-95-2</ENT> <ENT>Phenol.</ENT> </ROW> <ROW> <ENT I="01">108-98-5</ENT> <ENT>Benzenethiol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiophenol.</ENT> </ROW> <ROW> <ENT I="01">109-06-8</ENT> <ENT>Pyridine, 2-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Picoline.</ENT> </ROW> <ROW> <ENT I="01">109-73-9</ENT> <ENT>Butylamine.</ENT> </ROW> <ROW> <ENT I="01">109-77-3</ENT> <ENT>Malononitrile.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propanedinitrile.</ENT> </ROW> <ROW> <ENT I="01">109-89-7</ENT> <ENT>Diethylamine.</ENT> </ROW> <ROW> <ENT I="01">109-99-9</ENT> <ENT>Furan, tetrahydro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tetrahydrofuran.</ENT> </ROW> <ROW> <ENT I="01">110-00-9</ENT> <ENT>Furan.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Furfuran.</ENT> </ROW> <ROW> <ENT I="01">110-16-7</ENT> <ENT>Maleic acid.</ENT> </ROW> <ROW> <ENT I="01">110-17-8</ENT> <ENT>Fumaric acid.</ENT> </ROW> <ROW> <ENT I="01">110-19-0</ENT> <ENT>iso-Butyl acetate.</ENT> </ROW> <ROW> <ENT I="01">110-54-3</ENT> <ENT>Hexane.</ENT> </ROW> <ROW> <ENT I="01">110-75-8</ENT> <ENT> Ethene, (2-chloroethoxy)-. <LI>2-Chloroethyl vinyl ether.</LI> </ENT> </ROW> <ROW> <ENT I="01">110-80-5</ENT> <ENT> Ethanol, 2-ethoxy-. <LI>Ethylene glycol monoethyl ether.</LI> </ENT> </ROW> <ROW> <ENT I="01">110-82-7</ENT> <ENT>Benzene, hexahydro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Cyclohexane.</ENT> </ROW> <ROW> <ENT I="01">110-86-1</ENT> <ENT>Pyridine.</ENT> </ROW> <ROW> <ENT I="01">111-42-2</ENT> <ENT>Diethanolamine.</ENT> </ROW> <ROW> <ENT I="01">111-44-4</ENT> <ENT>Bis(2-chloroethyl) ether.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dichloroethyl ether.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethane, 1,1′-oxybis[2-chloro-.</ENT> </ROW> <ROW> <ENT I="01">111-54-6</ENT> <ENT>Carbamodithioic acid, 1,2-ethanediylbis-, salts & esters.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethylenebisdithiocarbamic acid, salts & esters.</ENT> </ROW> <ROW> <ENT I="01">111-91-1</ENT> <ENT>Bis(2-chloroethoxy) methane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dichloromethoxy ethane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethane, 1,1′-[methylenebis(oxy)]bis(2-chloro-.</ENT> </ROW> <ROW> <ENT I="01">114-26-1</ENT> <ENT>Phenol, 2-(1-methylethoxy)-, methylcarbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propoxur (Baygon).</ENT> </ROW> <ROW> <ENT I="01">115-02-6</ENT> <ENT>Azaserine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>L-Serine, diazoacetate (ester).</ENT> </ROW> <ROW> <ENT I="01">115-29-7</ENT> <ENT>Endosulfan.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10-hexachloro-1,5,5a,6,9,9a- hexahydro-, 3-oxide.</ENT> </ROW> <ROW> <ENT I="01">115-32-2</ENT> <ENT>Dicofol.</ENT> </ROW> <ROW> <ENT I="01">116-06-3</ENT> <ENT>Aldicarb.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propanal, 2-methyl-2-(methylthio)-, O-[(methylamino)carbonyl]oxime.</ENT> </ROW> <ROW> <ENT I="01">117-80-6</ENT> <ENT>Dichlone.</ENT> </ROW> <ROW> <PRTPAGE P="324"/> <ENT I="01">117-81-7</ENT> <ENT>1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Bis(2-ethylhexyl)phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>DEHP.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Diethylhexyl phthalate.</ENT> </ROW> <ROW> <ENT I="01">117-84-0</ENT> <ENT>Di-n-octyl phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Benzenedicarboxylic acid, dioctyl ester.</ENT> </ROW> <ROW> <ENT I="01">118-74-1</ENT> <ENT>Benzene, hexachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Hexachlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">119-38-0</ENT> <ENT>Carbamic acid, dimethyl-, 3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Isolan.</ENT> </ROW> <ROW> <ENT I="01">119-90-4</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine,3,3′-dimethoxy-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3,3′-Dimethoxybenzidine.</ENT> </ROW> <ROW> <ENT I="01">119-93-7</ENT> <ENT>[1,1′-Biphenyl]-4,4′-diamine,3,3′- dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3,3′-Dimethylbenzidine.</ENT> </ROW> <ROW> <ENT I="01">120-12-7</ENT> <ENT>Anthracene.</ENT> </ROW> <ROW> <ENT I="01">120-58-1</ENT> <ENT>Isosafrole.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Benzodioxole, 5-(1-propenyl)-.</ENT> </ROW> <ROW> <ENT I="01">120-80-9</ENT> <ENT>Catechol.</ENT> </ROW> <ROW> <ENT I="01">120-82-1</ENT> <ENT>1,2,4-Trichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">120-83-2</ENT> <ENT>Phenol, 2,4-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Dichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">121-14-2</ENT> <ENT>Benzene, 1-methyl-2,4-dinitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Dinitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">121-21-1</ENT> <ENT>Pyrethrins.</ENT> </ROW> <ROW> <ENT I="01">121-29-9</ENT> <ENT>Pyrethrins.</ENT> </ROW> <ROW> <ENT I="01">121-44-8</ENT> <ENT>Ethanamine, N,N-diethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Triethylamine.</ENT> </ROW> <ROW> <ENT I="01">121-69-7</ENT> <ENT>N,N-Dimethylaniline.</ENT> </ROW> <ROW> <ENT I="01">121-75-5</ENT> <ENT>Malathion.</ENT> </ROW> <ROW> <ENT I="01">122-09-8</ENT> <ENT>alpha,alpha-Dimethylphenethylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzeneethanamine, alpha,alpha-dimethyl-.</ENT> </ROW> <ROW> <ENT I="01">122-42-9</ENT> <ENT>Carbamic acid, phenyl-, 1-methylethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propham.</ENT> </ROW> <ROW> <ENT I="01">122-66-7</ENT> <ENT> Hydrazine, 1,2-diphenyl-. <LI>1,2-Diphenylhydrazine.</LI> </ENT> </ROW> <ROW> <ENT I="01">123-31-9</ENT> <ENT>Hydroquinone.</ENT> </ROW> <ROW> <ENT I="01">123-33-1</ENT> <ENT>Maleic hydrazide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3,6-Pyridazinedione, 1,2-dihydro-.</ENT> </ROW> <ROW> <ENT I="01">123-38-6</ENT> <ENT>Propionaldehyde.</ENT> </ROW> <ROW> <ENT I="01">123-62-6</ENT> <ENT>Propionic anhydride.</ENT> </ROW> <ROW> <ENT I="01">123-63-7</ENT> <ENT>Paraldehyde.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3,5-Trioxane, 2,4,6-trimethyl-.</ENT> </ROW> <ROW> <ENT I="01">123-73-9</ENT> <ENT>Crotonaldehyde.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Butenal.</ENT> </ROW> <ROW> <ENT I="01">123-86-4</ENT> <ENT>Butyl acetate.</ENT> </ROW> <ROW> <ENT I="01">123-91-1</ENT> <ENT>1,4-Diethyleneoxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,4-Dioxane.</ENT> </ROW> <ROW> <ENT I="01">123-92-2</ENT> <ENT>iso-Amyl acetate.</ENT> </ROW> <ROW> <ENT I="01">124-04-9</ENT> <ENT>Adipic acid.</ENT> </ROW> <ROW> <ENT I="01">124-40-3</ENT> <ENT>Dimethylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methanamine, N-methyl-.</ENT> </ROW> <ROW> <ENT I="01">124-41-4</ENT> <ENT>Sodium methylate.</ENT> </ROW> <ROW> <ENT I="01">124-48-1</ENT> <ENT>Chlorodibromomethane.</ENT> </ROW> <ROW> <ENT I="01">126-72-7</ENT> <ENT>Tris(2,3-dibromopropyl) phosphate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Propanol, 2,3-dibromo-, phosphate (3:1).</ENT> </ROW> <ROW> <ENT I="01">126-98-7</ENT> <ENT>Methacrylonitrile.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenenitrile, 2-methyl-.</ENT> </ROW> <ROW> <ENT I="01">126-99-8</ENT> <ENT>Chloroprene.</ENT> </ROW> <ROW> <ENT I="01">127-18-4</ENT> <ENT>Ethene, tetrachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Perchloroethylene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tetrachloroethylene.</ENT> </ROW> <ROW> <ENT I="01">127-82-2</ENT> <ENT>Zinc phenolsulfonate.</ENT> </ROW> <ROW> <ENT I="01">129-00-0</ENT> <ENT>Pyrene.</ENT> </ROW> <ROW> <ENT I="01">130-15-4</ENT> <ENT> 1,4-Naphthalenedione. <LI>1,4-Naphthoquinone.</LI> </ENT> </ROW> <ROW> <PRTPAGE P="325"/> <ENT I="01">131-11-3</ENT> <ENT>Dimethyl phthalate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Benzenedicarboxylic acid, dimethyl ester.</ENT> </ROW> <ROW> <ENT I="01">131-74-8</ENT> <ENT>Ammonium picrate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 2,4,6-trinitro-, ammonium salt.</ENT> </ROW> <ROW> <ENT I="01">131-89-5</ENT> <ENT>Phenol, 2-cyclohexyl-4,6-dinitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Cyclohexyl-4,6-dinitrophenol.</ENT> </ROW> <ROW> <ENT I="01">132-64-9</ENT> <ENT>Dibenzofuran.</ENT> </ROW> <ROW> <ENT I="01">133-06-2</ENT> <ENT>Captan.</ENT> </ROW> <ROW> <ENT I="01">133-90-4</ENT> <ENT>Chloramben.</ENT> </ROW> <ROW> <ENT I="01">134-32-7</ENT> <ENT>alpha-Naphthylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Naphthalenamine.</ENT> </ROW> <ROW> <ENT I="01">137-26-8</ENT> <ENT>Thioperoxydicarbonic diamide ([H2N)C(S)]2S2, tetramethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiram.</ENT> </ROW> <ROW> <ENT I="01">137-30-4</ENT> <ENT>Zinc, bis(dimethylcarbamodithioato-S,S')-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ziram.</ENT> </ROW> <ROW> <ENT I="01">140-88-5</ENT> <ENT>Ethyl acrylate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propenoic acid, ethyl ester.</ENT> </ROW> <ROW> <ENT I="01">141-78-6</ENT> <ENT>Acetic acid, ethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethyl acetate.</ENT> </ROW> <ROW> <ENT I="01">142-28-9</ENT> <ENT>1,3-Dichloropropane.</ENT> </ROW> <ROW> <ENT I="01">142-71-2</ENT> <ENT>Cupric acetate.</ENT> </ROW> <ROW> <ENT I="01">142-84-7</ENT> <ENT>Dipropylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Propanamine, N-propyl-.</ENT> </ROW> <ROW> <ENT I="01">143-33-9</ENT> <ENT>Sodium cyanide Na(CN).</ENT> </ROW> <ROW> <ENT I="01">143-50-0</ENT> <ENT>Kepone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3,4-Metheno-2H-cyclobuta[cd]pentalen-2-one,1,1a,3,3a,4,5,5,5a,5b,6-decachlorooctahydro-.</ENT> </ROW> <ROW> <ENT I="01">145-73-3</ENT> <ENT>Endothall.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>7-Oxabicyclo[221]heptane-2,3-dicarboxylic acid.</ENT> </ROW> <ROW> <ENT I="01">148-82-3</ENT> <ENT>L-Phenylalanine, 4-[bis(2-chloroethyl)amino]-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Melphalan.</ENT> </ROW> <ROW> <ENT I="01">151-50-8</ENT> <ENT>Potassium cyanide K(CN).</ENT> </ROW> <ROW> <ENT I="01">151-56-4</ENT> <ENT>Aziridine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethylenimine.</ENT> </ROW> <ROW> <ENT I="01">152-16-9</ENT> <ENT>Diphosphoramide, octamethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Octamethylpyrophosphoramide.</ENT> </ROW> <ROW> <ENT I="01">156-60-5</ENT> <ENT>Ethene, 1,2-dichloro- (E).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Dichloroethylene.</ENT> </ROW> <ROW> <ENT I="01">156-62-7</ENT> <ENT>Calcium cyanamide.</ENT> </ROW> <ROW> <ENT I="01">189-55-9</ENT> <ENT>Benzo[rst]pentaphene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dibenzo[a,i]pyrene.</ENT> </ROW> <ROW> <ENT I="01">191-24-2</ENT> <ENT>Benzo[ghi]perylene.</ENT> </ROW> <ROW> <ENT I="01">193-39-5</ENT> <ENT>Indeno(1,2,3-cd)pyrene.</ENT> </ROW> <ROW> <ENT I="01">205-99-2</ENT> <ENT>Benzo[b]fluoranthene.</ENT> </ROW> <ROW> <ENT I="01">206-44-0</ENT> <ENT>Fluoranthene.</ENT> </ROW> <ROW> <ENT I="01">207-08-9</ENT> <ENT>Benzo(k)fluoranthene.</ENT> </ROW> <ROW> <ENT I="01">208-96-8</ENT> <ENT>Acenaphthylene.</ENT> </ROW> <ROW> <ENT I="01">218-01-9</ENT> <ENT>Chrysene.</ENT> </ROW> <ROW> <ENT I="01">225-51-4</ENT> <ENT>Benz[c]acridine.</ENT> </ROW> <ROW> <ENT I="01">297-97-2</ENT> <ENT> O,O-Diethyl O-pyrazinyl phosphorothioate. <LI>Phosphorothioic acid, O,O-diethyl O-pyrazinyl ester.</LI> </ENT> </ROW> <ROW> <ENT I="01">298-00-0</ENT> <ENT>Methyl parathion.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorothioic acid, O,O-dimethyl O-(4-nitrophenyl) ester.</ENT> </ROW> <ROW> <ENT I="01">298-02-2</ENT> <ENT>Phorate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorodithioic acid, O,O-diethyl S-[(ethylthio) methyl] ester.</ENT> </ROW> <ROW> <ENT I="01">298-04-4</ENT> <ENT>Disulfoton.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorodithioic acid, O,O-diethyl S-[2-(ethylthio)ethyl] ester.</ENT> </ROW> <ROW> <ENT I="01">300-76-5</ENT> <ENT>Naled.</ENT> </ROW> <ROW> <ENT I="01">301-04-2</ENT> <ENT>Acetic acid, lead(2 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Lead acetate.</ENT> </ROW> <ROW> <ENT I="01">302-01-2</ENT> <ENT>Hydrazine.</ENT> </ROW> <ROW> <ENT I="01">303-34-4</ENT> <ENT>Lasiocarpine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Butenoic acid, 2-methyl-, 7-[[2,3-dihydroxy-2-(1-methoxyethyl)-3-methyl-1-oxobutoxy]methyl]-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yl ester, [1S-[1alpha(Z),7(2S*,3R*), 7aalpha]]-.</ENT> </ROW> <ROW> <PRTPAGE P="326"/> <ENT I="01">305-03-3</ENT> <ENT>Benzenebutanoic acid, 4-[bis(2-chloroethyl)amino]-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Chlorambucil.</ENT> </ROW> <ROW> <ENT I="01">309-00-2</ENT> <ENT>Aldrin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5alpha,8alpha, 8abeta)-.</ENT> </ROW> <ROW> <ENT I="01">311-45-5</ENT> <ENT>Diethyl-p-nitrophenyl phosphate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphoric acid, diethyl 4-nitrophenyl ester.</ENT> </ROW> <ROW> <ENT I="01">315-18-4</ENT> <ENT>Mexacarbate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 4-(dimethylamino)-3,5-dimethyl-, methylcarbamate (ester).</ENT> </ROW> <ROW> <ENT I="01">319-84-6</ENT> <ENT>alpha—BHC.</ENT> </ROW> <ROW> <ENT I="01">319-85-7</ENT> <ENT>beta—BHC.</ENT> </ROW> <ROW> <ENT I="01">319-86-8</ENT> <ENT>delta—BHC.</ENT> </ROW> <ROW> <ENT I="01">329-71-5</ENT> <ENT>2,5-Dinitrophenol.</ENT> </ROW> <ROW> <ENT I="01">330-54-1</ENT> <ENT>Diuron.</ENT> </ROW> <ROW> <ENT I="01">333-41-5</ENT> <ENT>Diazinon.</ENT> </ROW> <ROW> <ENT I="01">334-88-3</ENT> <ENT>Diazomethane.</ENT> </ROW> <ROW> <ENT I="01">335-67-1</ENT> <ENT>Perfluorooctanoic acid</ENT> </ROW> <ROW> <ENT I="01">353-50-4</ENT> <ENT>Carbon oxyfluoride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbonic difluoride.</ENT> </ROW> <ROW> <ENT I="01">357-57-3</ENT> <ENT>Brucine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Strychnidin-10-one, 2,3-dimethoxy-.</ENT> </ROW> <ROW> <ENT I="01">460-19-5</ENT> <ENT>Cyanogen.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Ethanedinitrile.</ENT> </ROW> <ROW> <ENT I="01">463-58-1</ENT> <ENT>Carbonyl sulfide.</ENT> </ROW> <ROW> <ENT I="01">465-73-6</ENT> <ENT>Isodrin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,4:5,8-Dimethanonaphthalene,1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5beta,8beta, 8abeta)-.</ENT> </ROW> <ROW> <ENT I="01">492-80-8</ENT> <ENT>Auramine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzenamine, 4,4′-carbonimidoylbis[N,N-dimethyl-.</ENT> </ROW> <ROW> <ENT I="01">494-03-1</ENT> <ENT>Chlornaphazine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Naphthalenamine, N,N′-bis(2-chloroethyl)-.</ENT> </ROW> <ROW> <ENT I="01">496-72-0</ENT> <ENT>Benzenediamine, ar-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluenediamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diamine.</ENT> </ROW> <ROW> <ENT I="01">504-24-5</ENT> <ENT>4-Aminopyridine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4-Pyridinamine.</ENT> </ROW> <ROW> <ENT I="01">504-60-9</ENT> <ENT>1-Methylbutadiene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Pentadiene.</ENT> </ROW> <ROW> <ENT I="01">506-61-6</ENT> <ENT>Argentate(1-), bis(cyano-C)-, potassium.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Potassium silver cyanide.</ENT> </ROW> <ROW> <ENT I="01">506-64-9</ENT> <ENT>Silver cyanide Ag(CN).</ENT> </ROW> <ROW> <ENT I="01">506-68-3</ENT> <ENT>Cyanogen bromide (CN)Br.</ENT> </ROW> <ROW> <ENT I="01">506-77-4</ENT> <ENT>Cyanogen chloride (CN)Cl.</ENT> </ROW> <ROW> <ENT I="01">506-87-6</ENT> <ENT>Ammonium carbonate.</ENT> </ROW> <ROW> <ENT I="01">506-96-7</ENT> <ENT>Acetyl bromide.</ENT> </ROW> <ROW> <ENT I="01">509-14-8</ENT> <ENT>Methane, tetranitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tetranitromethane.</ENT> </ROW> <ROW> <ENT I="01">510-15-6</ENT> <ENT>Benzeneacetic acid, 4-chloro-α- (4-chlorophenyl)-α-hydroxy-, ethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Chlorobenzilate.</ENT> </ROW> <ROW> <ENT I="01">513-49-5</ENT> <ENT>sec-Butylamine.</ENT> </ROW> <ROW> <ENT I="01">528-29-0</ENT> <ENT>o-Dinitrobenzene.</ENT> </ROW> <ROW> <ENT I="01">532-27-4</ENT> <ENT>2-Chloroacetophenone.</ENT> </ROW> <ROW> <ENT I="01">534-52-1</ENT> <ENT>4,6-Dinitro-o-cresol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4,6-Dinitro-o-cresol, and salts.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 2-methyl-4,6-dinitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, 2-methyl-4,6-dinitro-, & salts.</ENT> </ROW> <ROW> <ENT I="01">540-73-8</ENT> <ENT>Hydrazine, 1,2-dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2-Dimethylhydrazine.</ENT> </ROW> <ROW> <ENT I="01">540-84-1</ENT> <ENT>2,2,4-Trimethylpentane.</ENT> </ROW> <ROW> <ENT I="01">540-88-5</ENT> <ENT>tert-Butyl acetate.</ENT> </ROW> <ROW> <ENT I="01">541-09-3</ENT> <ENT>Uranyl acetate.</ENT> </ROW> <ROW> <ENT I="01">541-53-7</ENT> <ENT>Dithiobiuret.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Thioimidodicarbonic diamide [(H <E T="0732">2</E> N)C(S)] <E T="0732">2</E> NH. </ENT> </ROW> <ROW> <ENT I="01">541-73-1</ENT> <ENT>Benzene, 1,3-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>m-Dichlorobenzene.</ENT> </ROW> <ROW> <PRTPAGE P="327"/> <ENT I="22"> </ENT> <ENT>1,3-Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">542-62-1</ENT> <ENT>Barium cyanide.</ENT> </ROW> <ROW> <ENT I="01">542-75-6</ENT> <ENT>1-Propene, 1,3-dichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Dichloropropene.</ENT> </ROW> <ROW> <ENT I="01">542-76-7</ENT> <ENT>Propanenitrile, 3-chloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3-Chloropropionitrile.</ENT> </ROW> <ROW> <ENT I="01">542-88-1</ENT> <ENT>Bis(chloromethyl)ether.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dichloromethyl ether.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methane, oxybis(chloro-.</ENT> </ROW> <ROW> <ENT I="01">543-90-8</ENT> <ENT>Cadmium acetate.</ENT> </ROW> <ROW> <ENT I="01">544-18-3</ENT> <ENT>Cobaltous formate.</ENT> </ROW> <ROW> <ENT I="01">544-92-3</ENT> <ENT>Copper cyanide Cu(CN).</ENT> </ROW> <ROW> <ENT I="01">554-84-7</ENT> <ENT>m-Nitrophenol.</ENT> </ROW> <ROW> <ENT I="01">557-19-7</ENT> <ENT> Nickel cyanide Ni(CN) <E T="0732">2</E> . </ENT> </ROW> <ROW> <ENT I="01">557-21-1</ENT> <ENT> Zinc cyanide Zn(CN) <E T="0732">2</E> . </ENT> </ROW> <ROW> <ENT I="01">557-34-6</ENT> <ENT>Zinc acetate.</ENT> </ROW> <ROW> <ENT I="01">557-41-5</ENT> <ENT>Zinc formate.</ENT> </ROW> <ROW> <ENT I="01">563-12-2</ENT> <ENT>Ethion.</ENT> </ROW> <ROW> <ENT I="01">563-68-8</ENT> <ENT>Acetic acid, thallium(1 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thallium(I) acetate.</ENT> </ROW> <ROW> <ENT I="01">573-56-8</ENT> <ENT>2,6-Dinitrophenol.</ENT> </ROW> <ROW> <ENT I="01">584-84-9</ENT> <ENT>Benzene, 1,3-diisocyanatomethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluene diisocyanate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diisocyanate.</ENT> </ROW> <ROW> <ENT I="01">591-08-2</ENT> <ENT>Acetamide, N-(aminothioxomethyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Acetyl-2-thiourea.</ENT> </ROW> <ROW> <ENT I="01">592-01-8</ENT> <ENT> Calcium cyanide Ca(CN) <E T="0732">2</E> . </ENT> </ROW> <ROW> <ENT I="01">592-04-1</ENT> <ENT>Mercuric cyanide.</ENT> </ROW> <ROW> <ENT I="01">592-85-8</ENT> <ENT>Mercuric thiocyanate.</ENT> </ROW> <ROW> <ENT I="01">592-87-0</ENT> <ENT>Lead thiocyanate.</ENT> </ROW> <ROW> <ENT I="01">593-60-2</ENT> <ENT>Vinyl bromide.</ENT> </ROW> <ROW> <ENT I="01">594-42-3</ENT> <ENT>Methanesulfenyl chloride, trichloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Trichloromethanesulfenyl chloride.</ENT> </ROW> <ROW> <ENT I="01">598-31-2</ENT> <ENT>Bromoacetone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Propanone, 1-bromo-.</ENT> </ROW> <ROW> <ENT I="01">606-20-2</ENT> <ENT>Benzene, 2-methyl-1,3-dinitro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,6-Dinitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">608-73-1</ENT> <ENT>HEXACHLOROCYCLOHEXANE (all isomers).</ENT> </ROW> <ROW> <ENT I="01">608-93-5</ENT> <ENT>Benzene, pentachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pentachlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">609-19-8</ENT> <ENT>3,4,5-Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">610-39-9</ENT> <ENT>3,4-Dinitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">615-53-2</ENT> <ENT>Carbamic acid, methylnitroso-, ethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>N-Nitroso-N-methylurethane.</ENT> </ROW> <ROW> <ENT I="01">621-64-7</ENT> <ENT>Di-n-propylnitrosamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Propanamine, N-nitroso-N-propyl-.</ENT> </ROW> <ROW> <ENT I="01">624-83-9</ENT> <ENT>Methane, isocyanato-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methyl isocyanate.</ENT> </ROW> <ROW> <ENT I="01">625-16-1</ENT> <ENT>tert-Amyl acetate.</ENT> </ROW> <ROW> <ENT I="01">626-38-0</ENT> <ENT>sec-Amyl acetate.</ENT> </ROW> <ROW> <ENT I="01">628-63-7</ENT> <ENT>Amyl acetate.</ENT> </ROW> <ROW> <ENT I="01">628-86-4</ENT> <ENT>Fulminic acid, mercury(2 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Mercury fulminate.</ENT> </ROW> <ROW> <ENT I="01">630-10-4</ENT> <ENT>Selenourea.</ENT> </ROW> <ROW> <ENT I="01">630-20-6</ENT> <ENT>Ethane, 1,1,1,2-tetrachloro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,1,1,2-Tetrachloroethane.</ENT> </ROW> <ROW> <ENT I="01">631-61-8</ENT> <ENT>Ammonium acetate.</ENT> </ROW> <ROW> <ENT I="01">636-21-5</ENT> <ENT>Benzenamine, 2-methyl-, hydrochloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>o-Toluidine hydrochloride.</ENT> </ROW> <ROW> <ENT I="01">640-19-7</ENT> <ENT>Acetamide, 2-fluoro-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Fluoroacetamide.</ENT> </ROW> <ROW> <ENT I="01">644-64-4</ENT> <ENT>Carbamic acid, dimethyl-,1-[(dimethyl-amino)carbonyl]-5-methyl-1H-pyrazol-3-yl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dimetilan.</ENT> </ROW> <ROW> <ENT I="01">680-31-9</ENT> <ENT>Hexamethylphosphoramide.</ENT> </ROW> <ROW> <ENT I="01">684-93-5</ENT> <ENT>N-Nitroso-N-methylurea.</ENT> </ROW> <ROW> <PRTPAGE P="328"/> <ENT I="22"> </ENT> <ENT>Urea, N-methyl-N-nitroso-.</ENT> </ROW> <ROW> <ENT I="01">692-42-2</ENT> <ENT>Arsine, diethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Diethylarsine.</ENT> </ROW> <ROW> <ENT I="01">696-28-6</ENT> <ENT>Arsonous dichloride, phenyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dichlorophenylarsine.</ENT> </ROW> <ROW> <ENT I="01">757-58-4</ENT> <ENT>Hexaethyl tetraphosphate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tetraphosphoric acid, hexaethyl ester.</ENT> </ROW> <ROW> <ENT I="01">759-73-9</ENT> <ENT>N-Nitroso-N-ethylurea.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Urea, N-ethyl-N-nitroso-.</ENT> </ROW> <ROW> <ENT I="01">764-41-0</ENT> <ENT>1,4-Dichloro-2-butene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Butene, 1,4-dichloro-.</ENT> </ROW> <ROW> <ENT I="01">765-34-4</ENT> <ENT>Glycidylaldehyde.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Oxiranecarboxyaldehyde.</ENT> </ROW> <ROW> <ENT I="01">815-82-7</ENT> <ENT>Cupric tartrate.</ENT> </ROW> <ROW> <ENT I="01">822-06-0</ENT> <ENT>Hexamethylene-1,6-diisocyanate.</ENT> </ROW> <ROW> <ENT I="01">823-40-5</ENT> <ENT>Benzenediamine, ar-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluenediamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diamine.</ENT> </ROW> <ROW> <ENT I="01">924-16-3</ENT> <ENT>N-Nitrosodi-n-butylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Butanamine, N-butyl-N-nitroso-.</ENT> </ROW> <ROW> <ENT I="01">930-55-2</ENT> <ENT>N-Nitrosopyrrolidine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pyrrolidine, 1-nitroso-.</ENT> </ROW> <ROW> <ENT I="01">933-75-5</ENT> <ENT>2,3,6-Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">933-78-8</ENT> <ENT>2,3,5-Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">959-98-8</ENT> <ENT>alpha-Endosulfan.</ENT> </ROW> <ROW> <ENT I="01">1024-57-3</ENT> <ENT>Heptachlor epoxide.</ENT> </ROW> <ROW> <ENT I="01">1031-07-8</ENT> <ENT>Endosulfan sulfate.</ENT> </ROW> <ROW> <ENT I="01">1066-30-4</ENT> <ENT>Chromic acetate.</ENT> </ROW> <ROW> <ENT I="01">1066-33-7</ENT> <ENT>Ammonium bicarbonate.</ENT> </ROW> <ROW> <ENT I="01">1072-35-1</ENT> <ENT>Lead stearate.</ENT> </ROW> <ROW> <ENT I="01">1111-78-0</ENT> <ENT>Ammonium carbamate.</ENT> </ROW> <ROW> <ENT I="01">1116-54-7</ENT> <ENT>Ethanol, 2,2′-(nitrosoimino)bis-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>N-Nitrosodiethanolamine.</ENT> </ROW> <ROW> <ENT I="01">1120-71-4</ENT> <ENT>1,2-Oxathiolane, 2,2-dioxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Propane sultone.</ENT> </ROW> <ROW> <ENT I="01">1129-41-5</ENT> <ENT>Carbamic acid, methyl-, 3-methylphenyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Metolcarb.</ENT> </ROW> <ROW> <ENT I="01">1185-57-5</ENT> <ENT>Ferric ammonium citrate.</ENT> </ROW> <ROW> <ENT I="01">1194-65-6</ENT> <ENT>Dichlobenil.</ENT> </ROW> <ROW> <ENT I="01">1300-71-6</ENT> <ENT>Xylenol.</ENT> </ROW> <ROW> <ENT I="01">1303-28-2</ENT> <ENT> Arsenic oxide As <E T="0732">2</E> O <E T="0732">5</E> . </ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Arsenic pentoxide.</ENT> </ROW> <ROW> <ENT I="01">1303-33-9</ENT> <ENT>Arsenic trisulfide.</ENT> </ROW> <ROW> <ENT I="01">1309-64-4</ENT> <ENT>Antimony trioxide.</ENT> </ROW> <ROW> <ENT I="01">1310-58-3</ENT> <ENT>Potassium hydroxide.</ENT> </ROW> <ROW> <ENT I="01">1310-73-2</ENT> <ENT>Sodium hydroxide.</ENT> </ROW> <ROW> <ENT I="01">1314-32-5</ENT> <ENT>Thallic oxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Thallium oxide Tl <E T="0732">2</E> O <E T="0732">3</E> . </ENT> </ROW> <ROW> <ENT I="01">1314-62-1</ENT> <ENT> Vanadium oxide V <E T="0732">2</E> O <E T="0732">5</E> . </ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Vanadium pentoxide.</ENT> </ROW> <ROW> <ENT I="01">1314-80-3</ENT> <ENT>Phosphorus pentasulfide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphorus sulfide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Sulfur phosphide.</ENT> </ROW> <ROW> <ENT I="01">1314-84-7</ENT> <ENT> Zinc phosphide Zn <E T="0732">3</E> P <E T="0732">2</E> . </ENT> </ROW> <ROW> <ENT I="01">1314-87-0</ENT> <ENT>Lead sulfide.</ENT> </ROW> <ROW> <ENT I="01">1319-72-8</ENT> <ENT>2,4,5-T amines.</ENT> </ROW> <ROW> <ENT I="01">1319-77-3</ENT> <ENT>Cresol (cresylic acid).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Cresols (isomers and mixture).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Cresylic acid (isomers and mixture).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, methyl-.</ENT> </ROW> <ROW> <ENT I="01">1320-18-9</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">1321-12-6</ENT> <ENT>Nitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">1327-53-3</ENT> <ENT> Arsenic oxide As <E T="0732">2</E> O <E T="0732">3</E> . </ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Arsenic trioxide.</ENT> </ROW> <ROW> <ENT I="01">1330-20-7</ENT> <ENT>Benzene, dimethyl-.</ENT> </ROW> <ROW> <PRTPAGE P="329"/> <ENT I="22"> </ENT> <ENT>Xylene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Xylene (mixed).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Xylenes (isomers and mixture).</ENT> </ROW> <ROW> <ENT I="01">1331-47-1</ENT> <ENT>Dichlorobenzidine.</ENT> </ROW> <ROW> <ENT I="01">1332-07-6</ENT> <ENT>Zinc borate.</ENT> </ROW> <ROW> <ENT I="01">1332-21-4</ENT> <ENT>Asbestos.</ENT> </ROW> <ROW> <ENT I="01">1333-83-1</ENT> <ENT>Sodium bifluoride.</ENT> </ROW> <ROW> <ENT I="01">1335-32-6</ENT> <ENT>Lead subacetate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Lead, bis(acetato-O)tetrahydroxytri.</ENT> </ROW> <ROW> <ENT I="01">1336-21-6</ENT> <ENT>Ammonium hydroxide.</ENT> </ROW> <ROW> <ENT I="01">1336-36-3</ENT> <ENT>Aroclors.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>PCBs.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>POLYCHLORINATED BIPHENYLS.</ENT> </ROW> <ROW> <ENT I="01">1338-23-4</ENT> <ENT>Methyl ethyl ketone peroxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Butanone peroxide.</ENT> </ROW> <ROW> <ENT I="01">1338-24-5</ENT> <ENT>Naphthenic acid.</ENT> </ROW> <ROW> <ENT I="01">1341-49-7</ENT> <ENT>Ammonium bifluoride.</ENT> </ROW> <ROW> <ENT I="01">1464-53-5</ENT> <ENT>1,2:3,4-Diepoxybutane.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,2′-Bioxirane.</ENT> </ROW> <ROW> <ENT I="01">1563-38-8</ENT> <ENT>7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbofuran phenol.</ENT> </ROW> <ROW> <ENT I="01">1563-66-2</ENT> <ENT>7-Benzofuranol, 2,3-dihydro-2,2-dimethyl-, methylcarbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbofuran.</ENT> </ROW> <ROW> <ENT I="01">1582-09-8</ENT> <ENT>Trifluralin.</ENT> </ROW> <ROW> <ENT I="01">1615-80-1</ENT> <ENT>Hydrazine, 1,2-diethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>N,N′-Diethylhydrazine.</ENT> </ROW> <ROW> <ENT I="01">1634-04-4</ENT> <ENT>Methyl tert-butyl ether.</ENT> </ROW> <ROW> <ENT I="01">1646-88-4</ENT> <ENT>Aldicarb sulfone.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Propanal, 2-methyl-2-(methyl-sulfonyl)-, O-[(methylamino)carbonyl] oxime.</ENT> </ROW> <ROW> <ENT I="01">1746-01-6</ENT> <ENT>TCDD.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,3,7,8-Tetrachlorodibenzo-p-dioxin.</ENT> </ROW> <ROW> <ENT I="01">1762-95-4</ENT> <ENT>Ammonium thiocyanate.</ENT> </ROW> <ROW> <ENT I="01">1763-23-1</ENT> <ENT>Perfluorooctanesulfonic acid</ENT> </ROW> <ROW> <ENT I="01">1863-63-4</ENT> <ENT>Ammonium benzoate.</ENT> </ROW> <ROW> <ENT I="01">1888-71-7</ENT> <ENT>Hexachloropropene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-Propene, 1,1,2,3,3,3-hexachloro-.</ENT> </ROW> <ROW> <ENT I="01">1918-00-9</ENT> <ENT>Dicamba.</ENT> </ROW> <ROW> <ENT I="01">1928-38-7</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">1928-47-8</ENT> <ENT>2,4,5-T Esters.</ENT> </ROW> <ROW> <ENT I="01">1928-61-6</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">1929-73-3</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">2008-46-0</ENT> <ENT>2,4,5-T amines.</ENT> </ROW> <ROW> <ENT I="01">2032-65-7</ENT> <ENT>Mercaptodimethur.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methiocarb.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phenol, (3,5-dimethyl-4-(methylthio)-, methylcarbamate.</ENT> </ROW> <ROW> <ENT I="01">2303-16-4</ENT> <ENT>Carbamothioic acid, bis(1-methylethyl)-, S-(2,3-dichloro-2-propenyl) ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Diallate.</ENT> </ROW> <ROW> <ENT I="01">2303-17-5</ENT> <ENT>Carbamothioic acid, bis(1-methylethyl)-, S-(2,3,3-trichloro-2-propenyl) ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Triallate.</ENT> </ROW> <ROW> <ENT I="01">2312-35-8</ENT> <ENT>Propargite.</ENT> </ROW> <ROW> <ENT I="01">2545-59-7</ENT> <ENT>2,4,5-T esters.</ENT> </ROW> <ROW> <ENT I="01">2631-37-0</ENT> <ENT>Phenol, 3-methyl-5-(1-methylethyl)-, methyl carbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Promecarb.</ENT> </ROW> <ROW> <ENT I="01">2763-96-4</ENT> <ENT>3(2H)-Isoxazolone, 5-(aminomethyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>5-(Aminomethyl)-3-isoxazolol.</ENT> </ROW> <ROW> <ENT I="01">2764-72-9</ENT> <ENT>Diquat.</ENT> </ROW> <ROW> <ENT I="01">2921-88-2</ENT> <ENT>Chlorpyrifos.</ENT> </ROW> <ROW> <ENT I="01">2944-67-4</ENT> <ENT>Ferric ammonium oxalate.</ENT> </ROW> <ROW> <ENT I="01">2971-38-2</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">3012-65-5</ENT> <ENT>Ammonium citrate, dibasic.</ENT> </ROW> <ROW> <ENT I="01">3164-29-2</ENT> <ENT>Ammonium tartrate.</ENT> </ROW> <ROW> <ENT I="01">3165-93-3</ENT> <ENT>Benzenamine, 4-chloro-2-methyl-, hydrochloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>4-Chloro-o-toluidine, hydrochloride.</ENT> </ROW> <ROW> <ENT I="01">3251-23-8</ENT> <ENT>Cupric nitrate.</ENT> </ROW> <ROW> <ENT I="01">3288-58-2</ENT> <ENT>O,O-Diethyl S-methyl dithiophosphate.</ENT> </ROW> <ROW> <PRTPAGE P="330"/> <ENT I="22"> </ENT> <ENT>Phosphorodithioic acid, O,O-diethyl S-methyl ester.</ENT> </ROW> <ROW> <ENT I="01">3486-35-9</ENT> <ENT>Zinc carbonate.</ENT> </ROW> <ROW> <ENT I="01">3547-04-4</ENT> <ENT>DDE.</ENT> </ROW> <ROW> <ENT I="01">3689-24-5</ENT> <ENT>Tetraethyldithiopyrophosphate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiodiphosphoric acid, tetraethyl ester.</ENT> </ROW> <ROW> <ENT I="01">3813-14-7</ENT> <ENT>2,4,5-T amines.</ENT> </ROW> <ROW> <ENT I="01">4170-30-3</ENT> <ENT>Crotonaldehyde.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Butenal.</ENT> </ROW> <ROW> <ENT I="01">4549-40-0</ENT> <ENT>N-Nitrosomethylvinylamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Vinylamine, N-methyl-N-nitroso-.</ENT> </ROW> <ROW> <ENT I="01">5103-71-9</ENT> <ENT>Chlordane, alpha isomer.</ENT> </ROW> <ROW> <ENT I="01">5103-74-2</ENT> <ENT>Chlordane, gamma isomer.</ENT> </ROW> <ROW> <ENT I="01">5344-82-1</ENT> <ENT>Thiourea, (2-chlorophenyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1-(o-Chlorophenyl)thiourea.</ENT> </ROW> <ROW> <ENT I="01">5952-26-1</ENT> <ENT>Ethanol, 2,2'-oxybis-, dicarbamate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Diethylene glycol, dicarbamate.</ENT> </ROW> <ROW> <ENT I="01">5972-73-6</ENT> <ENT>Ammonium oxalate.</ENT> </ROW> <ROW> <ENT I="01">6009-70-7</ENT> <ENT>Ammonium oxalate.</ENT> </ROW> <ROW> <ENT I="01">6369-96-6</ENT> <ENT>2,4,5-T amines.</ENT> </ROW> <ROW> <ENT I="01">6369-97-7</ENT> <ENT>2,4,5-T amines.</ENT> </ROW> <ROW> <ENT I="01">6533-73-9</ENT> <ENT>Carbonic acid, dithallium(1 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thallium(I) carbonate.</ENT> </ROW> <ROW> <ENT I="01">7005-72-3</ENT> <ENT>4-Chlorophenyl phenyl ether.</ENT> </ROW> <ROW> <ENT I="01">7421-93-4</ENT> <ENT>Endrin aldehyde.</ENT> </ROW> <ROW> <ENT I="01">7428-48-0</ENT> <ENT>Lead stearate.</ENT> </ROW> <ROW> <ENT I="01">7439-92-1</ENT> <ENT>Lead.</ENT> </ROW> <ROW> <ENT I="01">7439-97-6</ENT> <ENT>Mercury.</ENT> </ROW> <ROW> <ENT I="01">7440-02-0</ENT> <ENT>Nickel.</ENT> </ROW> <ROW> <ENT I="01">7440-22-4</ENT> <ENT>Silver.</ENT> </ROW> <ROW> <ENT I="01">7440-23-5</ENT> <ENT>Sodium.</ENT> </ROW> <ROW> <ENT I="01">7440-28-0</ENT> <ENT>Thallium.</ENT> </ROW> <ROW> <ENT I="01">7440-36-0</ENT> <ENT>Antimony.</ENT> </ROW> <ROW> <ENT I="01">7440-38-2</ENT> <ENT>Arsenic.</ENT> </ROW> <ROW> <ENT I="01">7440-41-7</ENT> <ENT>Beryllium.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Beryllium powder.</ENT> </ROW> <ROW> <ENT I="01">7440-43-9</ENT> <ENT>Cadmium.</ENT> </ROW> <ROW> <ENT I="01">7440-47-3</ENT> <ENT>Chromium.</ENT> </ROW> <ROW> <ENT I="01">7440-50-8</ENT> <ENT>Copper.</ENT> </ROW> <ROW> <ENT I="01">7440-66-6</ENT> <ENT>Zinc.</ENT> </ROW> <ROW> <ENT I="01">7446-08-4</ENT> <ENT>Selenium dioxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Selenium oxide.</ENT> </ROW> <ROW> <ENT I="01">7446-14-2</ENT> <ENT>Lead sulfate.</ENT> </ROW> <ROW> <ENT I="01">7446-18-6</ENT> <ENT>Sulfuric acid, dithallium(1 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thallium(I) sulfate.</ENT> </ROW> <ROW> <ENT I="01">7446-27-7</ENT> <ENT>Lead phosphate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphoric acid, lead(2 +) salt (2:3).</ENT> </ROW> <ROW> <ENT I="01">7447-39-4</ENT> <ENT>Cupric chloride.</ENT> </ROW> <ROW> <ENT I="01">7488-56-4</ENT> <ENT>Selenium sulfide SeS2.</ENT> </ROW> <ROW> <ENT I="01">7550-45-0</ENT> <ENT>Titanium tetrachloride.</ENT> </ROW> <ROW> <ENT I="01">7558-79-4</ENT> <ENT>Sodium phosphate, dibasic.</ENT> </ROW> <ROW> <ENT I="01">7601-54-9</ENT> <ENT>Sodium phosphate, tribasic.</ENT> </ROW> <ROW> <ENT I="01">7631-89-2</ENT> <ENT>Sodium arsenate.</ENT> </ROW> <ROW> <ENT I="01">7631-90-5</ENT> <ENT>Sodium bisulfite.</ENT> </ROW> <ROW> <ENT I="01">7632-00-0</ENT> <ENT>Sodium nitrite.</ENT> </ROW> <ROW> <ENT I="01">7645-25-2</ENT> <ENT>Lead arsenate.</ENT> </ROW> <ROW> <ENT I="01">7646-85-7</ENT> <ENT>Zinc chloride.</ENT> </ROW> <ROW> <ENT I="01">7647-01-0</ENT> <ENT>Hydrochloric acid.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Hydrogen chloride.</ENT> </ROW> <ROW> <ENT I="01">7647-18-9</ENT> <ENT>Antimony pentachloride.</ENT> </ROW> <ROW> <ENT I="01">7664-38-2</ENT> <ENT>Phosphoric acid.</ENT> </ROW> <ROW> <ENT I="01">7664-39-3</ENT> <ENT>Hydrofluoric acid.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Hydrogen fluoride.</ENT> </ROW> <ROW> <ENT I="01">7664-41-7</ENT> <ENT>Ammonia.</ENT> </ROW> <ROW> <ENT I="01">7664-93-9</ENT> <ENT>Sulfuric acid.</ENT> </ROW> <ROW> <ENT I="01">7681-49-4</ENT> <ENT>Sodium fluoride.</ENT> </ROW> <ROW> <PRTPAGE P="331"/> <ENT I="01">7681-52-9</ENT> <ENT>Sodium hypochlorite.</ENT> </ROW> <ROW> <ENT I="01">7697-37-2</ENT> <ENT>Nitric acid.</ENT> </ROW> <ROW> <ENT I="01">7699-45-8</ENT> <ENT>Zinc bromide.</ENT> </ROW> <ROW> <ENT I="01">7705-08-0</ENT> <ENT>Ferric chloride.</ENT> </ROW> <ROW> <ENT I="01">7718-54-9</ENT> <ENT>Nickel chloride.</ENT> </ROW> <ROW> <ENT I="01">7719-12-2</ENT> <ENT>Phosphorus trichloride.</ENT> </ROW> <ROW> <ENT I="01">7720-78-7</ENT> <ENT>Ferrous sulfate.</ENT> </ROW> <ROW> <ENT I="01">7722-64-7</ENT> <ENT>Potassium permanganate.</ENT> </ROW> <ROW> <ENT I="01">7723-14-0</ENT> <ENT>Phosphorus.</ENT> </ROW> <ROW> <ENT I="01">7733-02-0</ENT> <ENT>Zinc sulfate.</ENT> </ROW> <ROW> <ENT I="01">7738-94-5</ENT> <ENT>Chromic acid.</ENT> </ROW> <ROW> <ENT I="01">7758-94-3</ENT> <ENT>Ferrous chloride.</ENT> </ROW> <ROW> <ENT I="01">7758-95-4</ENT> <ENT>Lead chloride.</ENT> </ROW> <ROW> <ENT I="01">7758-98-7</ENT> <ENT>Cupric sulfate.</ENT> </ROW> <ROW> <ENT I="01">7761-88-8</ENT> <ENT>Silver nitrate.</ENT> </ROW> <ROW> <ENT I="01">7773-06-0</ENT> <ENT>Ammonium sulfamate.</ENT> </ROW> <ROW> <ENT I="01">7775-11-3</ENT> <ENT>Sodium chromate.</ENT> </ROW> <ROW> <ENT I="01">7778-39-4</ENT> <ENT> Arsenic acid H <E T="0732">3</E> AsO <E T="0732">4</E> . </ENT> </ROW> <ROW> <ENT I="01">7778-44-1</ENT> <ENT>Calcium arsenate.</ENT> </ROW> <ROW> <ENT I="01">7778-50-9</ENT> <ENT>Potassium bichromate.</ENT> </ROW> <ROW> <ENT I="01">7778-54-3</ENT> <ENT>Calcium hypochlorite.</ENT> </ROW> <ROW> <ENT I="01">7779-86-4</ENT> <ENT>Zinc hydrosulfite.</ENT> </ROW> <ROW> <ENT I="01">7779-88-6</ENT> <ENT>Zinc nitrate.</ENT> </ROW> <ROW> <ENT I="01">7782-41-4</ENT> <ENT>Fluorine.</ENT> </ROW> <ROW> <ENT I="01">7782-49-2</ENT> <ENT>Selenium.</ENT> </ROW> <ROW> <ENT I="01">7782-50-5</ENT> <ENT>Chlorine.</ENT> </ROW> <ROW> <ENT I="01">7782-63-0</ENT> <ENT>Ferrous sulfate.</ENT> </ROW> <ROW> <ENT I="01">7782-82-3</ENT> <ENT>Sodium selenite.</ENT> </ROW> <ROW> <ENT I="01">7782-86-7</ENT> <ENT>Mercurous nitrate.</ENT> </ROW> <ROW> <ENT I="01">7783-00-8</ENT> <ENT>Selenious acid.</ENT> </ROW> <ROW> <ENT I="01">7783-06-4</ENT> <ENT> Hydrogen sulfide H <E T="0732">2</E> S. </ENT> </ROW> <ROW> <ENT I="01">7783-35-9</ENT> <ENT>Mercuric sulfate.</ENT> </ROW> <ROW> <ENT I="01">7783-46-2</ENT> <ENT>Lead fluoride.</ENT> </ROW> <ROW> <ENT I="01">7783-49-5</ENT> <ENT>Zinc fluoride.</ENT> </ROW> <ROW> <ENT I="01">7783-50-8</ENT> <ENT>Ferric fluoride.</ENT> </ROW> <ROW> <ENT I="01">7783-56-4</ENT> <ENT>Antimony trifluoride.</ENT> </ROW> <ROW> <ENT I="01">7784-34-1</ENT> <ENT>Arsenic trichloride.</ENT> </ROW> <ROW> <ENT I="01">7784-40-9</ENT> <ENT>Lead arsenate.</ENT> </ROW> <ROW> <ENT I="01">7784-41-0</ENT> <ENT>Potassium arsenate.</ENT> </ROW> <ROW> <ENT I="01">7784-46-5</ENT> <ENT>Sodium arsenite.</ENT> </ROW> <ROW> <ENT I="01">7786-34-7</ENT> <ENT>Mevinphos.</ENT> </ROW> <ROW> <ENT I="01">7786-81-4</ENT> <ENT>Nickel sulfate.</ENT> </ROW> <ROW> <ENT I="01">7787-47-5</ENT> <ENT>Beryllium chloride.</ENT> </ROW> <ROW> <ENT I="01">7787-49-7</ENT> <ENT>Beryllium fluoride.</ENT> </ROW> <ROW> <ENT I="01">7787-55-5</ENT> <ENT>Beryllium nitrate.</ENT> </ROW> <ROW> <ENT I="01">7788-98-9</ENT> <ENT>Ammonium chromate.</ENT> </ROW> <ROW> <ENT I="01">7789-00-6</ENT> <ENT>Potassium chromate.</ENT> </ROW> <ROW> <ENT I="01">7789-06-2</ENT> <ENT>Strontium chromate.</ENT> </ROW> <ROW> <ENT I="01">7789-09-5</ENT> <ENT>Ammonium bichromate.</ENT> </ROW> <ROW> <ENT I="01">7789-42-6</ENT> <ENT>Cadmium bromide.</ENT> </ROW> <ROW> <ENT I="01">7789-43-7</ENT> <ENT>Cobaltous bromide.</ENT> </ROW> <ROW> <ENT I="01">7789-61-9</ENT> <ENT>Antimony tribromide.</ENT> </ROW> <ROW> <ENT I="01">7790-94-5</ENT> <ENT>Chlorosulfonic acid.</ENT> </ROW> <ROW> <ENT I="01">7791-12-0</ENT> <ENT>Thallium chloride TlCl.</ENT> </ROW> <ROW> <ENT I="01">7803-51-2</ENT> <ENT>Hydrogen phosphide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Phosphine.</ENT> </ROW> <ROW> <ENT I="01">7803-55-6</ENT> <ENT>Ammonium vanadate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Vanadic acid, ammonium salt.</ENT> </ROW> <ROW> <ENT I="01">8001-35-2</ENT> <ENT>Chlorinated camphene.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toxaphene.</ENT> </ROW> <ROW> <ENT I="01">8003-19-8</ENT> <ENT>Dichloropropane—Dichloropropene (mixture).</ENT> </ROW> <ROW> <ENT I="01">8003-34-7</ENT> <ENT>Pyrethrins.</ENT> </ROW> <ROW> <ENT I="01">8014-95-7</ENT> <ENT>Sulfuric acid.</ENT> </ROW> <ROW> <ENT I="01">10022-70-5</ENT> <ENT>Sodium hypochlorite.</ENT> </ROW> <ROW> <ENT I="01">10025-87-3</ENT> <ENT>Phosphorus oxychloride.</ENT> </ROW> <ROW> <PRTPAGE P="332"/> <ENT I="01">10025-91-9</ENT> <ENT>Antimony trichloride.</ENT> </ROW> <ROW> <ENT I="01">10026-11-6</ENT> <ENT>Zirconium tetrachloride.</ENT> </ROW> <ROW> <ENT I="01">10028-22-5</ENT> <ENT>Ferric sulfate.</ENT> </ROW> <ROW> <ENT I="01">10031-59-1</ENT> <ENT>Sulfuric acid, dithallium(1 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thallium(I) sulfate.</ENT> </ROW> <ROW> <ENT I="01">10039-32-4</ENT> <ENT>Sodium phosphate, dibasic.</ENT> </ROW> <ROW> <ENT I="01">10043-01-3</ENT> <ENT>Aluminum sulfate.</ENT> </ROW> <ROW> <ENT I="01">10045-89-3</ENT> <ENT>Ferrous ammonium sulfate.</ENT> </ROW> <ROW> <ENT I="01">10045-94-0</ENT> <ENT>Mercuric nitrate.</ENT> </ROW> <ROW> <ENT I="01">10049-05-5</ENT> <ENT>Chromous chloride.</ENT> </ROW> <ROW> <ENT I="01">10099-74-8</ENT> <ENT>Lead nitrate.</ENT> </ROW> <ROW> <ENT I="01">10101-53-8</ENT> <ENT>Chromic sulfate.</ENT> </ROW> <ROW> <ENT I="01">10101-63-0</ENT> <ENT>Lead iodide.</ENT> </ROW> <ROW> <ENT I="01">10101-89-0</ENT> <ENT>Sodium phosphate, tribasic.</ENT> </ROW> <ROW> <ENT I="01">10102-06-4</ENT> <ENT>Uranyl nitrate.</ENT> </ROW> <ROW> <ENT I="01">10102-18-8</ENT> <ENT>Sodium selenite.</ENT> </ROW> <ROW> <ENT I="01">10102-43-9</ENT> <ENT>Nitric oxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Nitrogen oxide NO.</ENT> </ROW> <ROW> <ENT I="01">10102-44-0</ENT> <ENT>Nitrogen dioxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Nitrogen oxide NO <E T="0732">2</E> . </ENT> </ROW> <ROW> <ENT I="01">10102-45-1</ENT> <ENT>Nitric acid, thallium(1 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thallium(I) nitrate.</ENT> </ROW> <ROW> <ENT I="01">10102-48-4</ENT> <ENT>Lead arsenate.</ENT> </ROW> <ROW> <ENT I="01">10108-64-2</ENT> <ENT>Cadmium chloride.</ENT> </ROW> <ROW> <ENT I="01">10124-50-2</ENT> <ENT>Potassium arsenite.</ENT> </ROW> <ROW> <ENT I="01">10140-65-5</ENT> <ENT>Sodium phosphate, dibasic.</ENT> </ROW> <ROW> <ENT I="01">10192-30-0</ENT> <ENT>Ammonium bisulfite.</ENT> </ROW> <ROW> <ENT I="01">10196-04-0</ENT> <ENT>Ammonium sulfite.</ENT> </ROW> <ROW> <ENT I="01">10361-89-4</ENT> <ENT>Sodium phosphate, tribasic.</ENT> </ROW> <ROW> <ENT I="01">10380-29-7</ENT> <ENT>Cupric sulfate, ammoniated.</ENT> </ROW> <ROW> <ENT I="01">10415-75-5</ENT> <ENT>Mercurous nitrate.</ENT> </ROW> <ROW> <ENT I="01">10421-48-4</ENT> <ENT>Ferric nitrate.</ENT> </ROW> <ROW> <ENT I="01">10544-72-6</ENT> <ENT>Nitrogen dioxide.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Nitrogen oxide NO2.</ENT> </ROW> <ROW> <ENT I="01">10588-01-9</ENT> <ENT>Sodium bichromate.</ENT> </ROW> <ROW> <ENT I="01">10605-21-7</ENT> <ENT>Carbamic acid, 1H-benzimidazol-2-yl, methyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbendazim.</ENT> </ROW> <ROW> <ENT I="01">11096-82-5</ENT> <ENT>Aroclor 1260.</ENT> </ROW> <ROW> <ENT I="01">11097-69-1</ENT> <ENT>Aroclor 1254.</ENT> </ROW> <ROW> <ENT I="01">11104-28-2</ENT> <ENT>Aroclor 1221.</ENT> </ROW> <ROW> <ENT I="01">11141-16-5</ENT> <ENT>Aroclor 1232.</ENT> </ROW> <ROW> <ENT I="01">12002-03-8</ENT> <ENT>Cupric acetoarsenite.</ENT> </ROW> <ROW> <ENT I="01">12039-52-0</ENT> <ENT>Selenious acid, dithallium(1 +) salt.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thallium (I) selenite.</ENT> </ROW> <ROW> <ENT I="01">12044-79-0</ENT> <ENT>Arsenic disulfide.</ENT> </ROW> <ROW> <ENT I="01">12054-48-7</ENT> <ENT>Nickel hydroxide.</ENT> </ROW> <ROW> <ENT I="01">12125-01-8</ENT> <ENT>Ammonium fluoride.</ENT> </ROW> <ROW> <ENT I="01">12125-02-9</ENT> <ENT>Ammonium chloride.</ENT> </ROW> <ROW> <ENT I="01">12135-76-1</ENT> <ENT>Ammonium sulfide.</ENT> </ROW> <ROW> <ENT I="01">12672-29-6</ENT> <ENT>Aroclor 1248.</ENT> </ROW> <ROW> <ENT I="01">12674-11-2</ENT> <ENT>Aroclor 1016.</ENT> </ROW> <ROW> <ENT I="01">12771-08-3</ENT> <ENT>Sulfur monochloride.</ENT> </ROW> <ROW> <ENT I="01">13463-39-3</ENT> <ENT> Nickel carbonyl Ni(CO) <E T="0732">4</E> , (T-4)-. </ENT> </ROW> <ROW> <ENT I="01">13560-99-1</ENT> <ENT>2,4,5-T salts.</ENT> </ROW> <ROW> <ENT I="01">13597-99-4</ENT> <ENT>Beryllium nitrate.</ENT> </ROW> <ROW> <ENT I="01">13746-89-9</ENT> <ENT>Zirconium nitrate.</ENT> </ROW> <ROW> <ENT I="01">13765-19-0</ENT> <ENT>Calcium chromate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT> Chromic acid H <E T="0732">2</E> CrO <E T="0732">4</E> , calcium salt. </ENT> </ROW> <ROW> <ENT I="01">13814-96-5</ENT> <ENT>Lead fluoborate.</ENT> </ROW> <ROW> <ENT I="01">13826-83-0</ENT> <ENT>Ammonium fluoborate.</ENT> </ROW> <ROW> <ENT I="01">13952-84-6</ENT> <ENT>sec-Butylamine.</ENT> </ROW> <ROW> <ENT I="01">14017-41-5</ENT> <ENT>Cobaltous sulfamate.</ENT> </ROW> <ROW> <ENT I="01">14216-75-2</ENT> <ENT>Nickel nitrate.</ENT> </ROW> <ROW> <ENT I="01">14258-49-2</ENT> <ENT>Ammonium oxalate.</ENT> </ROW> <ROW> <ENT I="01">14307-35-8</ENT> <ENT>Lithium chromate.</ENT> </ROW> <ROW> <PRTPAGE P="333"/> <ENT I="01">14307-43-8</ENT> <ENT>Ammonium tartrate.</ENT> </ROW> <ROW> <ENT I="01">14639-97-5</ENT> <ENT>Zinc ammonium chloride.</ENT> </ROW> <ROW> <ENT I="01">14639-98-6</ENT> <ENT>Zinc ammonium chloride.</ENT> </ROW> <ROW> <ENT I="01">14644-61-2</ENT> <ENT>Zirconium sulfate.</ENT> </ROW> <ROW> <ENT I="01">15339-36-3</ENT> <ENT>Manganese, bis(dimethylcarbamodithioato-S,S')-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Manganese dimethyldithiocarbamate.</ENT> </ROW> <ROW> <ENT I="01">15699-18-0</ENT> <ENT>Nickel ammonium sulfate.</ENT> </ROW> <ROW> <ENT I="01">15739-80-7</ENT> <ENT>Lead sulfate.</ENT> </ROW> <ROW> <ENT I="01">15950-66-0</ENT> <ENT>2,3,4-Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">16721-80-5</ENT> <ENT>Sodium hydrosulfide.</ENT> </ROW> <ROW> <ENT I="01">16752-77-5</ENT> <ENT>Ethanimidothioic acid, N-[[(methylamino)carbonyl] oxy]-, methyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methomyl.</ENT> </ROW> <ROW> <ENT I="01">16871-71-9</ENT> <ENT>Zinc silicofluoride.</ENT> </ROW> <ROW> <ENT I="01">16919-19-0</ENT> <ENT>Ammonium silicofluoride.</ENT> </ROW> <ROW> <ENT I="01">16923-95-8</ENT> <ENT>Zirconium potassium fluoride.</ENT> </ROW> <ROW> <ENT I="01">17702-57-7</ENT> <ENT>Formparanate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]-.</ENT> </ROW> <ROW> <ENT I="01">17804-35-2</ENT> <ENT>Benomyl.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbamic acid, [1-[(butylamino)carbonyl]-1H-benzimidazol-2-yl]-, methyl ester.</ENT> </ROW> <ROW> <ENT I="01">18883-66-4</ENT> <ENT>D-Glucose, 2-deoxy-2[[(methylnitrosoamino)-carbonyl]amino]-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Glucopyranose, 2-deoxy-2-(3-methyl-3-nitrosoureido)-, D-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Streptozotocin.</ENT> </ROW> <ROW> <ENT I="01">20816-12-0</ENT> <ENT> Osmium oxide OsO <E T="0732">4</E> , (T-4)-. </ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Osmium tetroxide.</ENT> </ROW> <ROW> <ENT I="01">20830-81-3</ENT> <ENT>Daunomycin.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-.</ENT> </ROW> <ROW> <ENT I="01">20859-73-8</ENT> <ENT>Aluminum phosphide.</ENT> </ROW> <ROW> <ENT I="01">22781-23-3</ENT> <ENT>Bendiocarb.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Benzodioxol-4-ol, 2,2-dimethyl-, methyl carbamate.</ENT> </ROW> <ROW> <ENT I="01">22961-82-6</ENT> <ENT>Bendiocarb phenol.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,3-Benzodioxol-4-ol, 2,2-dimethyl-.</ENT> </ROW> <ROW> <ENT I="01">23135-22-0</ENT> <ENT>Ethanimidothioic acid, 2-(dimethylamino)-N-[[(methylamino)carbonyl]oxy]-2-oxo-, methyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Oxamyl.</ENT> </ROW> <ROW> <ENT I="01">23422-53-9</ENT> <ENT>Methanimidamide, N,N-dimethyl-N'-[3-[[(methylamino)-carbonyl]oxy]phenyl]-, monohydrochloride.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Formetanate hydrochloride.</ENT> </ROW> <ROW> <ENT I="01">23564-05-8</ENT> <ENT>Carbamic acid, [1,2-phenylenebis(iminocarbonothioyl)]bis-, dimethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiophanate-methyl.</ENT> </ROW> <ROW> <ENT I="01">23950-58-5</ENT> <ENT>Benzamide, 3,5-dichloro-N-(1,1- dimethyl-2-propynyl)-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Pronamide.</ENT> </ROW> <ROW> <ENT I="01">25154-54-5</ENT> <ENT>Dinitrobenzene (mixed).</ENT> </ROW> <ROW> <ENT I="01">25154-55-6</ENT> <ENT>Nitrophenol (mixed).</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Nitrophenols.</ENT> </ROW> <ROW> <ENT I="01">25155-30-0</ENT> <ENT>Sodium dodecylbenzenesulfonate.</ENT> </ROW> <ROW> <ENT I="01">25167-82-2</ENT> <ENT>Trichlorophenol.</ENT> </ROW> <ROW> <ENT I="01">25168-15-4</ENT> <ENT>2,4,5-T esters.</ENT> </ROW> <ROW> <ENT I="01">25168-26-7</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">25321-14-6</ENT> <ENT>Dinitrotoluene.</ENT> </ROW> <ROW> <ENT I="01">25321-22-6</ENT> <ENT>Dichlorobenzene.</ENT> </ROW> <ROW> <ENT I="01">25376-45-8</ENT> <ENT>Benzenediamine, ar-methyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluenediamine.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diamine.</ENT> </ROW> <ROW> <ENT I="01">25550-58-7</ENT> <ENT>Dinitrophenol.</ENT> </ROW> <ROW> <ENT I="01">26264-06-2</ENT> <ENT>Calcium dodecylbenzenesulfonate.</ENT> </ROW> <ROW> <ENT I="01">26419-73-8</ENT> <ENT>1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O-[(methylamino)-carbonyl]oxime.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Tirpate.</ENT> </ROW> <ROW> <ENT I="01">26471-62-5</ENT> <ENT>Benzene, 1,3-diisocyanatomethyl-.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Toluene diisocyanate.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,4-Toluene diisocyanate.</ENT> </ROW> <ROW> <ENT I="01">26628-22-8</ENT> <ENT>Sodium azide.</ENT> </ROW> <ROW> <ENT I="01">26638-19-7</ENT> <ENT>Dichloropropane.</ENT> </ROW> <ROW> <ENT I="01">26952-23-8</ENT> <ENT>Dichloropropene.</ENT> </ROW> <ROW> <ENT I="01">27176-87-0</ENT> <ENT>Dodecylbenzenesulfonic acid.</ENT> </ROW> <ROW> <PRTPAGE P="334"/> <ENT I="01">27323-41-7</ENT> <ENT>Triethanolamine dodecylbenzene sulfonate.</ENT> </ROW> <ROW> <ENT I="01">27774-13-6</ENT> <ENT>Vanadyl sulfate.</ENT> </ROW> <ROW> <ENT I="01">28300-74-5</ENT> <ENT>Antimony potassium tartrate.</ENT> </ROW> <ROW> <ENT I="01">30525-89-4</ENT> <ENT>Paraformaldehyde.</ENT> </ROW> <ROW> <ENT I="01">30558-43-1</ENT> <ENT>Ethanimidothioic acid, 2-(dimethylamino)-N-hydroxy-2-oxo-, methyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>A2213.</ENT> </ROW> <ROW> <ENT I="01">32534-95-5</ENT> <ENT>2,4,5-TP esters.</ENT> </ROW> <ROW> <ENT I="01">33213-65-9</ENT> <ENT>beta—Endosulfan.</ENT> </ROW> <ROW> <ENT I="01">36478-76-9</ENT> <ENT>Uranyl nitrate.</ENT> </ROW> <ROW> <ENT I="01">37211-05-5</ENT> <ENT>Nickel chloride.</ENT> </ROW> <ROW> <ENT I="01">38622-18-3</ENT> <ENT>Diphenylhydrazine.</ENT> </ROW> <ROW> <ENT I="01">39196-18-4</ENT> <ENT>Thiofanox.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2-Butanone, 3,3-dimethyl-1-(methylthio)-,O-[(methylamino)carbonyl] oxime.</ENT> </ROW> <ROW> <ENT I="01">42504-46-1</ENT> <ENT>Isopropanolamine dodecylbenzenesulfonate.</ENT> </ROW> <ROW> <ENT I="01">52628-25-8</ENT> <ENT>Zinc ammonium chloride.</ENT> </ROW> <ROW> <ENT I="01">52740-16-6</ENT> <ENT>Calcium arsenite.</ENT> </ROW> <ROW> <ENT I="01">52888-80-9</ENT> <ENT>Carbamothioic acid, dipropyl-, S-(phenylmethyl) ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Prosulfocarb.</ENT> </ROW> <ROW> <ENT I="01">53467-11-1</ENT> <ENT>2,4-D Ester.</ENT> </ROW> <ROW> <ENT I="01">53469-21-9</ENT> <ENT>Aroclor 1242.</ENT> </ROW> <ROW> <ENT I="01">55285-14-8</ENT> <ENT>Carbamic acid, [(dibutylamino)-thio]methyl-, 2,3-dihydro-2,2-dimethyl-7-benzofuranyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Carbosulfan.</ENT> </ROW> <ROW> <ENT I="01">55488-87-4</ENT> <ENT>Ferric ammonium oxalate.</ENT> </ROW> <ROW> <ENT I="01">55671-32-4</ENT> <ENT>Cupric oxalate.</ENT> </ROW> <ROW> <ENT I="01">56189-09-4</ENT> <ENT>Lead stearate.</ENT> </ROW> <ROW> <ENT I="01">59669-26-0</ENT> <ENT>Ethanimidothioic acid, N,N'-[thiobis[(methylimino)carbonyloxy]]bis-, dimethyl ester.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Thiodicarb.</ENT> </ROW> <ROW> <ENT I="01">61792-07-2</ENT> <ENT>2,4,5-T esters.</ENT> </ROW> </GPOTABLE> <GPOTABLE COLS="3" OPTS="L2,nj" CDEF="s10,7,14"> <TTITLE>Appendix B to § 302.4—Radionuclides</TTITLE> <BOXHD> <CHED H="1">Radionuclide</CHED> <CHED H="1">Atomic Number</CHED> <CHED H="1">Final RQ Ci (Bq)</CHED> </BOXHD> <ROW> <ENT I="01">Radionuclides@</ENT> <ENT/> <ENT>1&(3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Actinium-224</ENT> <ENT>89</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Actinium-225</ENT> <ENT>89</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Actinium-226</ENT> <ENT>89</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Actinium-227</ENT> <ENT>89</ENT> <ENT>0.001 (3.7E 7)</ENT> </ROW> <ROW> <ENT I="01">Actinium-228</ENT> <ENT>89</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Aluminum-26</ENT> <ENT>13</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Americium-237</ENT> <ENT>95</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Americium-238</ENT> <ENT>95</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Americium-239</ENT> <ENT>95</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Americium-240</ENT> <ENT>95</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Americium-241</ENT> <ENT>95</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Americium-242m</ENT> <ENT>95</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Americium-242</ENT> <ENT>95</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Americium-243</ENT> <ENT>95</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Americium-244m</ENT> <ENT>95</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Americium-244</ENT> <ENT>95</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Americium-245</ENT> <ENT>95</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Americium-246m</ENT> <ENT>95</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Americium-246</ENT> <ENT>95</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-115</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-116m</ENT> <ENT>51</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Antimony-116</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-117</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-118m</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-119</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-120 (16 min)</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-120 (5.76 day)</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-122</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-124m</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-124</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-125</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-126m</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-126</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-127</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-128 (10.4 min)</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Antimony-128 (9.01 hr)</ENT> <ENT>51</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Antimony-129</ENT> <ENT>51</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Antimony-130</ENT> <ENT>51</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Antimony-131</ENT> <ENT>51</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Argon-39</ENT> <ENT>18</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Argon-41</ENT> <ENT>18</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-69</ENT> <ENT>33</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-70</ENT> <ENT>33</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-71</ENT> <ENT>33</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-72</ENT> <ENT>33</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-73</ENT> <ENT>33</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-74</ENT> <ENT>33</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-76</ENT> <ENT>33</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-77</ENT> <ENT>33</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Arsenic-78</ENT> <ENT>33</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Astatine-207</ENT> <ENT>85</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Astatine-211</ENT> <ENT>85</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Barium-126</ENT> <ENT>56</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Barium-128</ENT> <ENT>56</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Barium-131m</ENT> <ENT>56</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Barium-131</ENT> <ENT>56</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Barium-133m</ENT> <ENT>56</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Barium-133</ENT> <ENT>56</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Barium-135m</ENT> <ENT>56</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Barium-139</ENT> <ENT>56</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Barium-140</ENT> <ENT>56</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Barium-141</ENT> <ENT>56</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Barium-142</ENT> <ENT>56</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Berkelium-245</ENT> <ENT>97</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Berkelium-246</ENT> <ENT>97</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Berkelium-247</ENT> <ENT>97</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <PRTPAGE P="335"/> <ENT I="01">Berkelium-249</ENT> <ENT>97</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Berkelium-250</ENT> <ENT>97</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Beryllium-7</ENT> <ENT>4</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Beryllium-10</ENT> <ENT>4</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-200</ENT> <ENT>83</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-201</ENT> <ENT>83</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-202</ENT> <ENT>83</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-203</ENT> <ENT>83</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-205</ENT> <ENT>83</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-206</ENT> <ENT>83</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-207</ENT> <ENT>83</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-210m</ENT> <ENT>83</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-210</ENT> <ENT>83</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-212</ENT> <ENT>83</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-213</ENT> <ENT>83</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bismuth-214</ENT> <ENT>83</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bromine-74m</ENT> <ENT>35</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bromine-74</ENT> <ENT>35</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bromine-75</ENT> <ENT>35</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bromine-76</ENT> <ENT>35</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bromine-77</ENT> <ENT>35</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Bromine-80m</ENT> <ENT>35</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Bromine-80</ENT> <ENT>35</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Bromine-82</ENT> <ENT>35</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Bromine-83</ENT> <ENT>35</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Bromine-84</ENT> <ENT>35</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-104</ENT> <ENT>48</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-107</ENT> <ENT>48</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-109</ENT> <ENT>48</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-113m</ENT> <ENT>48</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-113</ENT> <ENT>48</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-115m</ENT> <ENT>48</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-115</ENT> <ENT>48</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-117m</ENT> <ENT>48</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cadmium-117</ENT> <ENT>48</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Calcium-41</ENT> <ENT>20</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Calcium-45</ENT> <ENT>20</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Calcium-47</ENT> <ENT>20</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Californium-244</ENT> <ENT>98</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Californium-246</ENT> <ENT>98</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Californium-248</ENT> <ENT>98</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Californium-249</ENT> <ENT>98</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Californium-250</ENT> <ENT>98</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Californium-251</ENT> <ENT>98</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Californium-252</ENT> <ENT>98</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Californium-253</ENT> <ENT>98</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Californium-254</ENT> <ENT>98</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Carbon-11</ENT> <ENT>6</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Carbon-14</ENT> <ENT>6</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cerium-134</ENT> <ENT>58</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cerium-135</ENT> <ENT>58</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cerium-137m</ENT> <ENT>58</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cerium-137</ENT> <ENT>58</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cerium-139</ENT> <ENT>58</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cerium-141</ENT> <ENT>58</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cerium-143</ENT> <ENT>58</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cerium-144</ENT> <ENT>58</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Cesium-125</ENT> <ENT>55</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cesium-127</ENT> <ENT>55</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cesium-129</ENT> <ENT>55</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cesium-130</ENT> <ENT>55</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cesium-131</ENT> <ENT>55</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cesium-132</ENT> <ENT>55</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cesium-134m</ENT> <ENT>55</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cesium-134</ENT> <ENT>55</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Cesium-135m</ENT> <ENT>55</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cesium-135</ENT> <ENT>55</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cesium-136</ENT> <ENT>55</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cesium-137</ENT> <ENT>55</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Cesium-138</ENT> <ENT>55</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Chlorine-36</ENT> <ENT>17</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Chlorine-38</ENT> <ENT>17</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Chlorine-39</ENT> <ENT>17</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Chromium-48</ENT> <ENT>24</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Chromium-49</ENT> <ENT>24</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Chromium-51</ENT> <ENT>24</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-55</ENT> <ENT>27</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-56</ENT> <ENT>27</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-57</ENT> <ENT>27</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-58m</ENT> <ENT>27</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-58</ENT> <ENT>27</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-60m</ENT> <ENT>27</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-60</ENT> <ENT>27</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-61</ENT> <ENT>27</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Cobalt-62m</ENT> <ENT>27</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Copper-60</ENT> <ENT>29</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Copper-61</ENT> <ENT>29</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Copper-64</ENT> <ENT>29</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Copper-67</ENT> <ENT>29</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Curium-238</ENT> <ENT>96</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Curium-240</ENT> <ENT>96</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Curium-241</ENT> <ENT>96</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Curium-242</ENT> <ENT>96</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Curium-243</ENT> <ENT>96</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Curium-244</ENT> <ENT>96</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Curium-245</ENT> <ENT>96</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Curium-246</ENT> <ENT>96</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Curium-247</ENT> <ENT>96</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Curium-248</ENT> <ENT>96</ENT> <ENT>0.001 (3.7E 7)</ENT> </ROW> <ROW> <ENT I="01">Curium-249</ENT> <ENT>96</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Dysprosium-155</ENT> <ENT>66</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Dysprosium-157</ENT> <ENT>66</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Dysprosium-159</ENT> <ENT>66</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Dysprosium-165</ENT> <ENT>66</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Dysprosium-166</ENT> <ENT>66</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Einsteinium-250</ENT> <ENT>99</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Einsteinium-251</ENT> <ENT>99</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Einsteinium-253</ENT> <ENT>99</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Einsteinium-254m</ENT> <ENT>99</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Einsteinium-254</ENT> <ENT>99</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Erbium-161</ENT> <ENT>68</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Erbium-165</ENT> <ENT>68</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Erbium-169</ENT> <ENT>68</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Erbium-171</ENT> <ENT>68</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Erbium-172</ENT> <ENT>68</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-145</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-146</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-147</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-148</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-149</ENT> <ENT>63</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Europium-150 (12.6 hr)</ENT> <ENT>63</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Europium-150 (34.2 yr)</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-152m</ENT> <ENT>63</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Europium-152</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-154</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-155</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-156</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-157</ENT> <ENT>63</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Europium-158</ENT> <ENT>63</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Fermium-252</ENT> <ENT>100</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Fermium-253</ENT> <ENT>100</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Fermium-254</ENT> <ENT>100</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Fermium-255</ENT> <ENT>100</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Fermium-257</ENT> <ENT>100</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Fluorine-18</ENT> <ENT>9</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Francium-222</ENT> <ENT>87</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Francium-223</ENT> <ENT>87</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-145</ENT> <ENT>64</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-146</ENT> <ENT>64</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-147</ENT> <ENT>64</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <PRTPAGE P="336"/> <ENT I="01">Gadolinium-148</ENT> <ENT>64</ENT> <ENT>0.001 (3.7E7)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-149</ENT> <ENT>64</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-151</ENT> <ENT>64</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-152</ENT> <ENT>64</ENT> <ENT>0.001 (3.7E 7)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-153</ENT> <ENT>64</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gadolinium-159</ENT> <ENT>64</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Gallium-65</ENT> <ENT>31</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Gallium-66</ENT> <ENT>31</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gallium-67</ENT> <ENT>31</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gallium-68</ENT> <ENT>31</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Gallium-70</ENT> <ENT>31</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Gallium-72</ENT> <ENT>31</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gallium-73</ENT> <ENT>31</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Germanium-66</ENT> <ENT>32</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Germanium-67</ENT> <ENT>32</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Germanium-68</ENT> <ENT>32</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Germanium-69</ENT> <ENT>32</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Germanium-71</ENT> <ENT>32</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Germanium-75</ENT> <ENT>32</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Germanium-77</ENT> <ENT>32</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Germanium-78</ENT> <ENT>32</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Gold-193</ENT> <ENT>79</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gold-194</ENT> <ENT>79</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gold-195</ENT> <ENT>79</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gold-198m</ENT> <ENT>79</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gold-198</ENT> <ENT>79</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gold-199</ENT> <ENT>79</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Gold-200m</ENT> <ENT>79</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Gold-200</ENT> <ENT>79</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Gold-201</ENT> <ENT>79</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-170</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-172</ENT> <ENT>72</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-173</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-175</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-177m</ENT> <ENT>72</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-178m</ENT> <ENT>72</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-179m</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-180m</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-181</ENT> <ENT>72</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-182m</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-182</ENT> <ENT>72</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-183</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hafnium-184</ENT> <ENT>72</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Holmium-155</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-157</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-159</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-161</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-162m</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-162</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-164m</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-164</ENT> <ENT>67</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Holmium-166m</ENT> <ENT>67</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Holmium-166</ENT> <ENT>67</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Holmium-167</ENT> <ENT>67</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Hydrogen-3</ENT> <ENT>1</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-109</ENT> <ENT>49</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-110 (69.1 min)</ENT> <ENT>49</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-110 (4.9 hr)</ENT> <ENT>49</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Indium-111</ENT> <ENT>49</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-112</ENT> <ENT>49</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Indium-113m</ENT> <ENT>49</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Indium-114m</ENT> <ENT>49</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Indium-115m</ENT> <ENT>49</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-115</ENT> <ENT>49</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Indium-116m</ENT> <ENT>49</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-117m</ENT> <ENT>49</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Indium-117</ENT> <ENT>49</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Indium-119m</ENT> <ENT>49</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Iodine-120m</ENT> <ENT>53</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iodine-120</ENT> <ENT>53</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iodine-121</ENT> <ENT>53</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iodine-123</ENT> <ENT>53</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iodine-124</ENT> <ENT>53</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Iodine-125</ENT> <ENT>53</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Iodine-126</ENT> <ENT>53</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Iodine-128</ENT> <ENT>53</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Iodine-129</ENT> <ENT>53</ENT> <ENT>0.001 (3.7E 7)</ENT> </ROW> <ROW> <ENT I="01">Iodine-130</ENT> <ENT>53</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Iodine-131</ENT> <ENT>53</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Iodine-132m</ENT> <ENT>53</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iodine-132</ENT> <ENT>53</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iodine-133</ENT> <ENT>53</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Iodine-134</ENT> <ENT>53</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iodine-135</ENT> <ENT>53</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iridium-182</ENT> <ENT>77</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Iridium-184</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-185</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-186</ENT> <ENT>77</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iridium-187</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-188</ENT> <ENT>77</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iridium-189</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-190m</ENT> <ENT>77</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Iridium-190</ENT> <ENT>77</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iridium-192m</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-192</ENT> <ENT>77</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iridium-194m</ENT> <ENT>77</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iridium-194</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-195m</ENT> <ENT>77</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iridium-195</ENT> <ENT>77</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Iron-52</ENT> <ENT>26</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iron-55</ENT> <ENT>26</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Iron-59</ENT> <ENT>26</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Iron-60</ENT> <ENT>26</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Krypton-74</ENT> <ENT>36</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Krypton-76</ENT> <ENT>36</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Krypton-77</ENT> <ENT>36</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Krypton-79</ENT> <ENT>36</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Krypton-81</ENT> <ENT>36</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Krypton-83m</ENT> <ENT>36</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Krypton-85m</ENT> <ENT>36</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Krypton-85</ENT> <ENT>36</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Krypton-87</ENT> <ENT>36</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Krypton-88</ENT> <ENT>36</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-131</ENT> <ENT>57</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-132</ENT> <ENT>57</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-135</ENT> <ENT>57</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-137</ENT> <ENT>57</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-138</ENT> <ENT>57</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-140</ENT> <ENT>57</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-141</ENT> <ENT>57</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-142</ENT> <ENT>57</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lanthanum-143</ENT> <ENT>57</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lead-195m</ENT> <ENT>82</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lead-198</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-199</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-200</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-201</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-202m</ENT> <ENT>82</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lead-202</ENT> <ENT>82</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Lead-203</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-205</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-209</ENT> <ENT>82</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lead-210</ENT> <ENT>82</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Lead-211</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lead-212</ENT> <ENT>82</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lead-214</ENT> <ENT>82</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-169</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-170</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-171</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-172</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <PRTPAGE P="337"/> <ENT I="01">Lutetium-173</ENT> <ENT>71</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-174m</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-174</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-176m</ENT> <ENT>71</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-176</ENT> <ENT>71</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-177m</ENT> <ENT>71</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-177</ENT> <ENT>71</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-178m</ENT> <ENT>71</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-178</ENT> <ENT>71</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Lutetium-179</ENT> <ENT>71</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Magnesium-28</ENT> <ENT>12</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Manganese-51</ENT> <ENT>25</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Manganese-52m</ENT> <ENT>25</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Manganese-52</ENT> <ENT>25</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Manganese-53</ENT> <ENT>25</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Manganese-54</ENT> <ENT>25</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Manganese-56</ENT> <ENT>25</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Mendelevium-257</ENT> <ENT>101</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Mendelevium-258</ENT> <ENT>101</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Mercury-193m</ENT> <ENT>80</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Mercury-193</ENT> <ENT>80</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Mercury-194</ENT> <ENT>80</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Mercury-195m</ENT> <ENT>80</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Mercury-195</ENT> <ENT>80</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Mercury-197m</ENT> <ENT>80</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Mercury-197</ENT> <ENT>80</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Mercury-199m</ENT> <ENT>80</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Mercury-203</ENT> <ENT>80</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Molybdenum-90</ENT> <ENT>42</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Molybdenum-93m</ENT> <ENT>42</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Molybdenum-93</ENT> <ENT>42</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Molybdenum-99</ENT> <ENT>42</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Molybdenum-101</ENT> <ENT>42</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-136</ENT> <ENT>60</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-138</ENT> <ENT>60</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-139m</ENT> <ENT>60</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-139</ENT> <ENT>60</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-141</ENT> <ENT>60</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-147</ENT> <ENT>60</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-149</ENT> <ENT>60</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Neodymium-151</ENT> <ENT>60</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-232</ENT> <ENT>93</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-233</ENT> <ENT>93</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-234</ENT> <ENT>93</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-235</ENT> <ENT>93</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-236 (1.2 E 5 yr)</ENT> <ENT>93</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-236 (22.5 hr)</ENT> <ENT>93</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-237</ENT> <ENT>93</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-238</ENT> <ENT>93</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-239</ENT> <ENT>93</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Neptunium-240</ENT> <ENT>93</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Nickel-56</ENT> <ENT>28</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Nickel-57</ENT> <ENT>28</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Nickel-59</ENT> <ENT>28</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Nickel-63</ENT> <ENT>28</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Nickel-65</ENT> <ENT>28</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Nickel-66</ENT> <ENT>28</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Niobium-88</ENT> <ENT>41</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Niobium-89 (66 min)</ENT> <ENT>41</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Niobium-89 (122 min)</ENT> <ENT>41</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Niobium-90</ENT> <ENT>41</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Niobium-93m</ENT> <ENT>41</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Niobium-94</ENT> <ENT>41</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Niobium-95m</ENT> <ENT>41</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Niobium-95</ENT> <ENT>41</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Niobium-96</ENT> <ENT>41</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Niobium-97</ENT> <ENT>41</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Niobium-98</ENT> <ENT>41</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Osmium-180</ENT> <ENT>76</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Osmium-181</ENT> <ENT>76</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Osmium-182</ENT> <ENT>76</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Osmium-185</ENT> <ENT>76</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Osmium-189m</ENT> <ENT>76</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Osmium-191m</ENT> <ENT>76</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Osmium-191</ENT> <ENT>76</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Osmium-193</ENT> <ENT>76</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Osmium-194</ENT> <ENT>76</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Palladium-100</ENT> <ENT>46</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Palladium-101</ENT> <ENT>46</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Palladium-103</ENT> <ENT>46</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Palladium-107</ENT> <ENT>46</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Palladium-109</ENT> <ENT>46</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus-32</ENT> <ENT>15</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Phosphorus-33</ENT> <ENT>15</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Platinum-186</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Platinum-188</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Platinum-189</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Platinum-191</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Platinum-193m</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Platinum-193</ENT> <ENT>78</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Platinum-195m</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Platinum-197m</ENT> <ENT>78</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Platinum-197</ENT> <ENT>78</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Platinum-199</ENT> <ENT>78</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Platinum-200</ENT> <ENT>78</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-234</ENT> <ENT>94</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-235</ENT> <ENT>94</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-236</ENT> <ENT>94</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-237</ENT> <ENT>94</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-238</ENT> <ENT>94</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-239</ENT> <ENT>94</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-240</ENT> <ENT>94</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-241</ENT> <ENT>94</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-242</ENT> <ENT>94</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-243</ENT> <ENT>94</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-244</ENT> <ENT>94</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Plutonium-245</ENT> <ENT>94</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Polonium-203</ENT> <ENT>84</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Polonium-205</ENT> <ENT>84</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Polonium-207</ENT> <ENT>84</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Polonium-210</ENT> <ENT>84</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Potassium-40</ENT> <ENT>19</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Potassium-42</ENT> <ENT>19</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Potassium-43</ENT> <ENT>19</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Potassium-44</ENT> <ENT>19</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Potassium-45</ENT> <ENT>19</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-136</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-137</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-138m</ENT> <ENT>59</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-139</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-142m</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-142</ENT> <ENT>59</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-143</ENT> <ENT>59</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-144</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-145</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Praseodymium-147</ENT> <ENT>59</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Promethium-141</ENT> <ENT>61</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Promethium-143</ENT> <ENT>61</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Promethium-144</ENT> <ENT>61</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Promethium-145</ENT> <ENT>61</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Promethium-146</ENT> <ENT>61</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Promethium-147</ENT> <ENT>61</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Promethium-148m</ENT> <ENT>61</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Promethium-148</ENT> <ENT>61</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Promethium-149</ENT> <ENT>61</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Promethium-150</ENT> <ENT>61</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Promethium-151</ENT> <ENT>61</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Protactinium-227</ENT> <ENT>91</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Protactinium-228</ENT> <ENT>91</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Protactinium-230</ENT> <ENT>91</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <PRTPAGE P="338"/> <ENT I="01">Protactinium-231</ENT> <ENT>91</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Protactinium-232</ENT> <ENT>91</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Protactinium-233</ENT> <ENT>91</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Protactinium-234</ENT> <ENT>91</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Radium-223</ENT> <ENT>88</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Radium-224</ENT> <ENT>88</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Radium-225</ENT> <ENT>88</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Radium-226Φ</ENT> <ENT>88</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Radium-227</ENT> <ENT>88</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Radium-228</ENT> <ENT>88</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Radon-220</ENT> <ENT>86</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Radon-222</ENT> <ENT>86</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-177</ENT> <ENT>75</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-178</ENT> <ENT>75</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-181</ENT> <ENT>75</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-182 (12.7 hr)</ENT> <ENT>75</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-182 (64.0 hr)</ENT> <ENT>75</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-184m</ENT> <ENT>75</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-184</ENT> <ENT>75</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-186m</ENT> <ENT>75</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-186</ENT> <ENT>75</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-187</ENT> <ENT>75</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-188m</ENT> <ENT>75</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-188</ENT> <ENT>75</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhenium-189</ENT> <ENT>75</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-99m</ENT> <ENT>45</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-99</ENT> <ENT>45</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-100</ENT> <ENT>45</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-101m</ENT> <ENT>45</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-101</ENT> <ENT>45</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-102m</ENT> <ENT>45</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-102</ENT> <ENT>45</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-103m</ENT> <ENT>45</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-105</ENT> <ENT>45</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-106m</ENT> <ENT>45</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rhodium-107</ENT> <ENT>45</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-79</ENT> <ENT>37</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-81m</ENT> <ENT>37</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-81</ENT> <ENT>37</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-82m</ENT> <ENT>37</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-83</ENT> <ENT>37</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-84</ENT> <ENT>37</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-86</ENT> <ENT>37</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-88</ENT> <ENT>37</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-89</ENT> <ENT>37</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Rubidium-87</ENT> <ENT>37</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Ruthenium-94</ENT> <ENT>44</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Ruthenium-97</ENT> <ENT>44</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Ruthenium-103</ENT> <ENT>44</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Ruthenium-105</ENT> <ENT>44</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Ruthenium-106</ENT> <ENT>44</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Samarium-141m</ENT> <ENT>62</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Samarium-141</ENT> <ENT>62</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Samarium-142</ENT> <ENT>62</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Samarium-145</ENT> <ENT>62</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Samarium-146</ENT> <ENT>62</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Samarium-147</ENT> <ENT>62</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Samarium-151</ENT> <ENT>62</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Samarium-153</ENT> <ENT>62</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Samarium-155</ENT> <ENT>62</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Samarium-156</ENT> <ENT>62</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Scandium-43</ENT> <ENT>21</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Scandium-44m</ENT> <ENT>21</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Scandium-44</ENT> <ENT>21</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Scandium-46</ENT> <ENT>21</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Scandium-47</ENT> <ENT>21</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Scandium-48</ENT> <ENT>21</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Scandium-49</ENT> <ENT>21</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Selenium-70</ENT> <ENT>34</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Selenium-73m</ENT> <ENT>34</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Selenium-73</ENT> <ENT>34</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Selenium-75</ENT> <ENT>34</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Selenium-79</ENT> <ENT>34</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Selenium-81m</ENT> <ENT>34</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Selenium-81</ENT> <ENT>34</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Selenium-83</ENT> <ENT>34</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Silicon-31</ENT> <ENT>14</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Silicon-32</ENT> <ENT>14</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Silver-102</ENT> <ENT>47</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Silver-103</ENT> <ENT>47</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Silver-104m</ENT> <ENT>47</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Silver-104</ENT> <ENT>47</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Silver-105</ENT> <ENT>47</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Silver-106m</ENT> <ENT>47</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Silver-106</ENT> <ENT>47</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Silver-108m</ENT> <ENT>47</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Silver-110m</ENT> <ENT>47</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Silver-111</ENT> <ENT>47</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Silver-112</ENT> <ENT>47</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Silver-115</ENT> <ENT>47</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Sodium-22</ENT> <ENT>11</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Sodium-24</ENT> <ENT>11</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Strontium-80</ENT> <ENT>38</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Strontium-81</ENT> <ENT>38</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Strontium-83</ENT> <ENT>38</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Strontium-85m</ENT> <ENT>38</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Strontium-85</ENT> <ENT>38</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Strontium-87m</ENT> <ENT>38</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Strontium-89</ENT> <ENT>38</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Strontium-90</ENT> <ENT>38</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Strontium-91</ENT> <ENT>38</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Strontium-92</ENT> <ENT>38</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Sulfur-35</ENT> <ENT>16</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-172</ENT> <ENT>73</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-173</ENT> <ENT>73</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-174</ENT> <ENT>73</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-175</ENT> <ENT>73</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-176</ENT> <ENT>73</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-177</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-178</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-179</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-180m</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-180</ENT> <ENT>73</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-182m</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-182</ENT> <ENT>73</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-183</ENT> <ENT>73</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-184</ENT> <ENT>73</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-185</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tantalum-186</ENT> <ENT>73</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Technetium-93m</ENT> <ENT>43</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Technetium-93</ENT> <ENT>43</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Technetium-94m</ENT> <ENT>43</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Technetium-94</ENT> <ENT>43</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Technetium-96m</ENT> <ENT>43</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Technetium-96</ENT> <ENT>43</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Technetium-97m</ENT> <ENT>43</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Technetium-97</ENT> <ENT>43</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Technetium-98</ENT> <ENT>43</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Technetium-99m</ENT> <ENT>43</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Technetium-99</ENT> <ENT>43</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Technetium-101</ENT> <ENT>43</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Technetium-104</ENT> <ENT>43</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-116</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-121m</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-121</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-123m</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-123</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-125m</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-127m</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-127</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <PRTPAGE P="339"/> <ENT I="01">Tellurium-129m</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-129</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-131m</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-131</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-132</ENT> <ENT>52</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-133m</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-133</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tellurium-134</ENT> <ENT>52</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Terbium-147</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Terbium-149</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Terbium-150</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Terbium-151</ENT> <ENT>65</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Terbium-153</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Terbium-154</ENT> <ENT>65</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Terbium-155</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Terbium-156m (5.0 hr)</ENT> <ENT>65</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Terbium-156m (24.4 hr)</ENT> <ENT>65</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Terbium-156</ENT> <ENT>65</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Terbium-157</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Terbium-158</ENT> <ENT>65</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Terbium-160</ENT> <ENT>65</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Terbium-161</ENT> <ENT>65</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thallium-194m</ENT> <ENT>81</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thallium-194</ENT> <ENT>81</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Thallium-195</ENT> <ENT>81</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thallium-197</ENT> <ENT>81</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thallium-198m</ENT> <ENT>81</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thallium-198</ENT> <ENT>81</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Thallium-199</ENT> <ENT>81</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thallium-200</ENT> <ENT>81</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Thallium-201</ENT> <ENT>81</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Thallium-202</ENT> <ENT>81</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Thallium-204</ENT> <ENT>81</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Thorium-226</ENT> <ENT>90</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thorium-227</ENT> <ENT>90</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Thorium-228</ENT> <ENT>90</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Thorium-229</ENT> <ENT>90</ENT> <ENT>0.001 (3.7E 7)</ENT> </ROW> <ROW> <ENT I="01">Thorium-230</ENT> <ENT>90</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Thorium-231</ENT> <ENT>90</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thorium-232Φ</ENT> <ENT>90</ENT> <ENT>0.001 (3.7E 7)</ENT> </ROW> <ROW> <ENT I="01">Thorium-234</ENT> <ENT>90</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thulium-162</ENT> <ENT>69</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Thulium-166</ENT> <ENT>69</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Thulium-167</ENT> <ENT>69</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thulium-170</ENT> <ENT>69</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Thulium-171</ENT> <ENT>69</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thulium-172</ENT> <ENT>69</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thulium-173</ENT> <ENT>69</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Thulium-175</ENT> <ENT>69</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tin-110</ENT> <ENT>50</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tin-111</ENT> <ENT>50</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tin-113</ENT> <ENT>50</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tin-117m</ENT> <ENT>50</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tin-119m</ENT> <ENT>50</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tin-121m</ENT> <ENT>50</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tin-121</ENT> <ENT>50</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tin-123m</ENT> <ENT>50</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tin-123</ENT> <ENT>50</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tin-125</ENT> <ENT>50</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tin-126</ENT> <ENT>50</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Tin-127</ENT> <ENT>50</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tin-128</ENT> <ENT>50</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Titanium-44</ENT> <ENT>22</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Titanium-45</ENT> <ENT>22</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-176</ENT> <ENT>74</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-177</ENT> <ENT>74</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-178</ENT> <ENT>74</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-179</ENT> <ENT>74</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-181</ENT> <ENT>74</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-185</ENT> <ENT>74</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-187</ENT> <ENT>74</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Tungsten-188</ENT> <ENT>74</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Uranium-230</ENT> <ENT>92</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Uranium-231</ENT> <ENT>92</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Uranium-232</ENT> <ENT>92</ENT> <ENT>0.01 (3.7E 8)</ENT> </ROW> <ROW> <ENT I="01">Uranium-233</ENT> <ENT>92</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Uranium-234φ</ENT> <ENT>92</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Uranium-235φ</ENT> <ENT>92</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Uranium-236</ENT> <ENT>92</ENT> <ENT>0.1 (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Uranium-237</ENT> <ENT>92</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Uranium-238φ</ENT> <ENT>92</ENT> <ENT>0.1& (3.7E 9)</ENT> </ROW> <ROW> <ENT I="01">Uranium-239</ENT> <ENT>92</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Uranium-240</ENT> <ENT>92</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Vanadium-47</ENT> <ENT>23</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Vanadium-48</ENT> <ENT>23</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Vanadium-49</ENT> <ENT>23</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Xenon-120</ENT> <ENT>54</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Xenon-121</ENT> <ENT>54</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Xenon-122</ENT> <ENT>54</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Xenon-123</ENT> <ENT>54</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Xenon-125</ENT> <ENT>54</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Xenon-127</ENT> <ENT>54</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Xenon-129m</ENT> <ENT>54</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Xenon-131m</ENT> <ENT>54</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Xenon-133m</ENT> <ENT>54</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Xenon-133</ENT> <ENT>54</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Xenon-135m</ENT> <ENT>54</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Xenon-135</ENT> <ENT>54</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Xenon-138</ENT> <ENT>54</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-162</ENT> <ENT>70</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-166</ENT> <ENT>70</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-167</ENT> <ENT>70</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-169</ENT> <ENT>70</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-175</ENT> <ENT>70</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-177</ENT> <ENT>70</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Ytterbium-178</ENT> <ENT>70</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-86m</ENT> <ENT>39</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-86</ENT> <ENT>39</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-87</ENT> <ENT>39</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-88</ENT> <ENT>39</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-90m</ENT> <ENT>39</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-90</ENT> <ENT>39</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-91m</ENT> <ENT>39</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-91</ENT> <ENT>39</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-92</ENT> <ENT>39</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-93</ENT> <ENT>39</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-94</ENT> <ENT>39</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Yttrium-95</ENT> <ENT>39</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Zinc-62</ENT> <ENT>30</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Zinc-63</ENT> <ENT>30</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Zinc-65</ENT> <ENT>30</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Zinc-69m</ENT> <ENT>30</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Zinc-69</ENT> <ENT>30</ENT> <ENT>1000 (3.7E 13)</ENT> </ROW> <ROW> <ENT I="01">Zinc-71m</ENT> <ENT>30</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Zinc-72</ENT> <ENT>30</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Zirconium-86</ENT> <ENT>40</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Zirconium-88</ENT> <ENT>40</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Zirconium-89</ENT> <ENT>40</ENT> <ENT>100 (3.7E 12)</ENT> </ROW> <ROW> <ENT I="01">Zirconium-93</ENT> <ENT>40</ENT> <ENT>1 (3.7E 10)</ENT> </ROW> <ROW> <ENT I="01">Zirconium-95</ENT> <ENT>40</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <ROW> <ENT I="01">Zirconium-97</ENT> <ENT>40</ENT> <ENT>10 (3.7E 11)</ENT> </ROW> <TNOTE>Ci—Curie. The curie represents a rate of radioactive decay. One curie is the quantity of any radioactive nuclide which undergoes 3.7E 10 disintegrations per second.</TNOTE> <TNOTE>Bq—Becquerel. The becquerel represents a rate of radioactive decay. One becquerel is the quantity of any radioactive nuclide which undergoes one disintegration per second. One curie is equal to 3.7E 10 becquerel.</TNOTE> <TNOTE> @—Final RQs for all radionuclides apply to chemical compounds containing the radionuclides and elemental forms regardless of the diameter of pieces of solid material. <PRTPAGE P="340"/> </TNOTE> <TNOTE>&—The adjusted RQ of one curie applies to all radionuclides not otherwise listed. Whenever the RQs in table 302.4 and this appendix to the table are in conflict, the lowest RQ shall apply. For example, uranyl acetate and uranyl nitrate have adjusted RQs shown in table 302.4 of 100 pounds, equivalent to about one-tenth the RQ level for uranium-238 listed in this appendix.</TNOTE> <TNOTE>E—Exponent to the base 10. For example, 1.3E 2 is equal to 130 while 1.3E 3 is equal to 1300.</TNOTE> <TNOTE>m—Signifies a nuclear isomer which is a radionuclide in a higher energy metastable state relative to the parent isotope.</TNOTE> <TNOTE>φ—Notification requirements for releases of mixtures or solutions of radionuclides can be found in § 302.6(b) of this rule. Final RQs for the following four common radionuclide mixtures are provided: radium-226 in secular equilibrium with its daughters (0.053 curie); natural uranium (0.1 curie); natural uranium in secular equilibrium with its daughters (0.052 curie); and natural thorium in secular equilibrium with its daughters (0.011 curie).</TNOTE> </GPOTABLE> <EDNOTE> <HD SOURCE="HED">Editorial Note:</HD> <P> For <E T="04">Federal Register</E> citations affecting § 302.4, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at <E T="03">www.govinfo.gov.</E> </P> </EDNOTE> </SECTION> <SECTION> <SECTNO>§ 302.5</SECTNO> <SUBJECT>Determination of reportable quantities.</SUBJECT> <P> (a) <E T="03">Listed hazardous substances.</E> The quantity listed in the column “Final RQ” for each substance in table 302.4, or in appendix B to table 302.4, is the reportable quantity (RQ) for that substance. The RQs in table 302.4 are in units of pounds based on chemical toxicity, while the RQs in appendix B to table 302.4 are in units of curies based on radiation hazard. Whenever the RQs in table 302.4 and appendix B to the table are in conflict, the lowest RQ shall apply. </P> <P> (b) <E T="03">Unlisted hazardous substances.</E> Unlisted hazardous substances designated by 40 CFR 302.4(b) have the reportable quantity of 100 pounds, except for those unlisted hazardous wastes which exhibit toxicity identified in 40 CFR 261.24. Unlisted hazardous wastes which exhibit toxicity have the reportable quantities listed in Table 302.4 for the contaminant on which the characteristic of toxicity is based. The reportable quantity applies to the waste itself, not merely to the toxic contaminant. If an unlisted hazardous waste exhibits toxicity on the basis of more than one contaminant, the reportable quantity for that waste shall be the lowest of the reportable quantities listed in Table 302.4 for those contaminants. If an unlisted hazardous waste exhibits the characteristic of toxicity and one or more of the other characteristics referenced in 40 CFR 302.4(b), the reportable quantity for that waste shall be the lowest of the applicable reportable quantities. </P> <CITA>[51 FR 34547, Sept. 29, 1986, as amended at 54 FR 22538, May 24, 1989; 67 FR 45356, July 9, 2002]</CITA> </SECTION> <SECTION> <SECTNO>§ 302.6</SECTNO> <SUBJECT>Notification requirements.</SUBJECT> <P>(a) Any person in charge of a vessel or an offshore or an onshore facility shall, as soon as he or she has knowledge of any release (other than a federally permitted release or application of a pesticide) of a hazardous substance from such vessel or facility in a quantity equal to or exceeding the reportable quantity determined by this part in any 24-hour period, immediately notify the National Response Center (1-800-424-8802; in Washington, DC 202-267-2675; the facsimile number is 202-267-1322).</P> <P>(b) Releases of mixtures or solutions (including hazardous waste streams) of</P> <P>(1) Hazardous substances, except for radionuclides, are subject to the following notification requirements:</P> <P>(i) If the quantity of all of the hazardous constituent(s) of the mixture or solution is known, notification is required where an RQ or more of any hazardous constituent is released;</P> <P>(ii) If the quantity of one or more of the hazardous constituent(s) of the mixture or solution is unknown, notification is required where the total amount of the mixture or solution released equals or exceeds the RQ for the hazardous constituent with the lowest RQ; or</P> <P>(iii) For waste streams K169, K170, K171, K172, K174, and K175, knowledge of the quantity of all of the hazardous constituent(s) may be assumed, based on the following maximum observed constituent concentrations identified by EPA:</P> <GPOTABLE COLS="3" OPTS="L2" CDEF="xs36,r50,4.7"> <BOXHD> <CHED H="1">Waste</CHED> <CHED H="1">Constituent</CHED> <CHED H="1">max ppm</CHED> </BOXHD> <ROW> <ENT I="01">K169</ENT> <ENT>Benzene</ENT> <ENT>220.0</ENT> </ROW> <ROW> <ENT I="01">K170</ENT> <ENT>Benzene</ENT> <ENT>1.2</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzo (a) pyrene</ENT> <ENT>230.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Dibenz (a,h) anthracene</ENT> <ENT>49.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzo (a) anthracene</ENT> <ENT>390.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzo (b) fluoranthene</ENT> <ENT>110.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Benzo (k) fluoranthese</ENT> <ENT>110.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>3-Methylcholanthrene</ENT> <ENT>27.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>7, 12-Dimethylbenz (a) anthracene</ENT> <ENT>1,200.0</ENT> </ROW> <ROW> <ENT I="01">K171</ENT> <ENT>Benzene</ENT> <ENT>500.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Arsenic</ENT> <ENT>1,600.0</ENT> </ROW> <ROW> <ENT I="01">K172</ENT> <ENT>Benzene</ENT> <ENT>100.0</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Arsenic</ENT> <ENT>730.0</ENT> </ROW> <ROW> <PRTPAGE P="341"/> <ENT I="01">K174</ENT> <ENT>2,3,7,8-TCDD</ENT> <ENT>0.000039</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,7,8-PeCDD</ENT> <ENT>0.0000108</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,4,7,8,-HxCDD</ENT> <ENT>0.0000241</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,6,7,8,-HxCDD</ENT> <ENT>0.000083</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,7,8,9,-HxCDD</ENT> <ENT>0.000062</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,4,6,7,8-HpCDD</ENT> <ENT>0.00123</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>OCDD</ENT> <ENT>0.0129</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,3,7,8-TCDF</ENT> <ENT>0.000145</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,7,8-PeCDF</ENT> <ENT>0.0000777</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,3,4,7,8-PeCDF</ENT> <ENT>0.000127</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,4,7,8-HxCDF</ENT> <ENT>0.001425</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,6,7,8-HxCDF</ENT> <ENT>0.000281</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,7,8,9-HxCDF</ENT> <ENT>0.00014</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>2,3,4,6,7,8-HxCDF</ENT> <ENT>0.000648</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,4,6,7,8-HpCDF</ENT> <ENT>0.0207</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>1,2,3,4,7,8,9-HpCDF</ENT> <ENT>0.0135</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>OCDF</ENT> <ENT>0.212</ENT> </ROW> <ROW> <ENT I="01">K175</ENT> <ENT>Mercury</ENT> <ENT>9200</ENT> </ROW> </GPOTABLE> <P>(2) Radionuclides are subject to this section's notification requirements only in the following circumstances:</P> <P>(i) If the identity and quantity (in curies) of each radionuclide in a released mixture or solution is known, the ratio between the quantity released (in curies) and the RQ for the radionuclide must be determined for each radionuclide. The only such releases subject to this section's notification requirements are those in which the sum of the ratios for the radionuclides in the mixture or solution released is equal to or greater than one.</P> <P>(ii) If the identity of each radionuclide in a released mixture or solution is known but the quantity released (in curies) of one or more of the radionuclides is unknown, the only such releases subject to this section's notification requirements are those in which the total quantity (in curies) of the mixture or solution released is equal to or greater than the lowest RQ of any individual radionuclide in the mixture or solution.</P> <P>(iii) If the identity of one or more radionuclides in a released mixture or solution is unknown (or if the identity of a radionuclide released by itself is unknown), the only such releases subject to this section's notification requirements are those in which the total quantity (in curies) released is equal to or greater than either one curie or the lowest RQ of any known individual radionuclide in the mixture or solution, whichever is lower.</P> <P>(c) The following categories of releases are exempt from the notification requirements of this section:</P> <P>(1) Releases of those radionuclides that occur naturally in the soil from land holdings such as parks, golf courses, or other large tracts of land.</P> <P>(2) Releases of naturally occurring radionuclides from land disturbance activities, including farming, construction, and land disturbance incidental to extraction during mining activities, except that which occurs at uranium, phosphate, tin, zircon, hafnium, vanadium, monazite, and rare earth mines. Land disturbance incidental to extraction includes: land clearing; overburden removal and stockpiling; excavating, handling, transporting, and storing ores and other raw (not beneficiated or processed) materials; and replacing in mined-out areas coal ash, earthen materials from farming or construction, or overburden or other raw materials generated from the exempted mining activities.</P> <P>(3) Releases of radionuclides from the dumping and transportation of coal and coal ash (including fly ash, bottom ash, and boiler slags), including the dumping and land spreading operations that occur during coal ash uses.</P> <P>(4) Releases of radionuclides from piles of coal and coal ash, including fly ash, bottom ash, and boiler slags.</P> <P>(d) Except for releases of radionuclides, notification of the release of an RQ of solid particles of antimony, arsenic, beryllium, cadmium, chromium, copper, lead, nickel, selenium, silver, thallium, or zinc is not required if the mean diameter of the particles released is larger than 100 micrometers (0.004 inches).</P> <P>(e) The following releases are exempt from the notification requirements of this section:</P> <P>(1) Releases in amounts less than 1,000 pounds per 24 hours of nitrogen oxide to the air which are the result of combustion and combustion-related activities.</P> <P> (2) Releases in amounts less than 1,000 pounds per 24 hours of nitrogen dioxide to the air which are the result of combustion and combustion-related activities. <PRTPAGE P="342"/> </P> <P>(3) Air emissions from animal waste (including decomposing animal waste) at a farm.</P> <CITA>[50 FR 13474, Apr. 4, 1985, as amended at 54 FR 22538, May 24, 1989; 54 FR 33481, Aug. 14, 1989; 63 FR 13475, Mar. 19, 1998; 63 FR 42189, Aug. 6, 1998; 64 FR 13114, Mar. 17, 1999; 65 FR 67132, Nov. 8, 2000; 67 FR 45356, July 9, 2002; 71 FR 58533, Oct. 4, 2006; 73 FR 76959, Dec. 18, 2008; 76 FR 9666, Feb. 22, 2011; 77 FR 10390, Feb. 22, 2012; 83 FR 37446, Aug. 1, 2018]</CITA> </SECTION> <SECTION> <SECTNO>§ 302.7</SECTNO> <SUBJECT>Penalties.</SUBJECT> <P>(a) Any person—</P> <P>(1) In charge of a vessel from which a hazardous substance is released, other than a federally permitted release, into or upon the navigable waters of the United States, adjoining shorelines, or into or upon the waters of the contiguous zone,</P> <P>(2) In charge of a vessel from which a hazardous substance is released, other than a federally permitted release, which may affect natural resources belonging to, appertaining to, or under the exclusive management authority of the United States (including resources under the Fishery Conservation and Management Act of 1976), and who is otherwise subject to the jurisdiction of the United States at the time of the release, or</P> <P>(3) In charge of a facility from which a hazardous substance is released, other than a federally permitted release, in a quantity equal to or greater than that reportable quantity determined under this part who fails to notify immediately the National Response Center as soon as he or she has knowledge of such release or who submits in such a notification any information which he knows to be false or misleading shall be subject to all of the sanctions, including criminal penalties, set forth in section 103(b) of the Act.</P> <P>(b) Notification received pursuant to this section or information obtained by the exploitation of such notification shall not be used against any such person in any criminal case, except a prosecution for perjury or for giving a false statement.</P> <P>(c) This section shall not apply to the application of a pesticide product registered under the Federal Insecticide, Fungicide, and Rodenticide Act or to the handling and storage of such a pesticide product by an agricultural producer.</P> <CITA>[50 FR 13474, Apr. 4, 1985, as amended at 67 FR 45356, July 9, 2002]</CITA> </SECTION> <SECTION> <SECTNO>§ 302.8</SECTNO> <SUBJECT>Continuous releases.</SUBJECT> <P>(a) Except as provided in paragraph (c) of this section, no notification is required for any release of a hazardous substance that is, pursuant to the definitions in paragraph (b) of this section, continuous and stable in quantity and rate.</P> <P> (b) <E T="03">Definitions.</E> The following definitions apply to notification of continuous releases: </P> <P> <E T="03">Continuous.</E> A continuous release is a release that occurs without interruption or abatement or that is routine, anticipated, and intermittent and incidental to normal operations or treatment processes. </P> <P> <E T="03">Normal range.</E> The normal range of a release is all releases (in pounds or kilograms) of a hazardous substance reported or occurring over any 24-hour period under normal operating conditions during the preceding year. Only releases that are both continuous and stable in quantity and rate may be included in the normal range. </P> <P> <E T="03">Routine.</E> A routine release is a release that occurs during normal operating procedures or processes. </P> <P> <E T="03">Stable in quantity and rate.</E> A release that is stable in quantity and rate is a release that is predictable and regular in amount and rate of emission. </P> <P> <E T="03">Statistically significant increase.</E> A statistically significant increase in a release is an increase in the quantity of the hazardous substance released above the upper bound of the reported normal range of the release. </P> <P> (c) <E T="03">Notification.</E> The following notifications shall be given for any release qualifying for reduced reporting under this section: </P> <P>(1) Initial telephone notification;</P> <P>(2) Initial written notification within 30 days of the initial telephone notification;</P> <P>(3) Follow-up notification within 30 days of the first anniversary date of the initial written notification;</P> <P> (4) Notification of a change in the composition or source(s) of the release or in the other information submitted <PRTPAGE P="343"/> in the initial written notification of the release under paragraph (c)(2) of this section or the follow-up notification under paragraph (c)(3) of this section; and </P> <P>(5) Notification at such times as an increase in the quantity of the hazardous substance being released during any 24-hour period represents a statistically significant increase as defined in paragraph (b) of this section.</P> <P> (d) <E T="03">Initial telephone notification.</E> Prior to making an initial telephone notification of a continuous release, the person in charge of a facility or vessel must establish a sound basis for qualifying the release for reporting under CERCLA section 103(f)(2) by: </P> <P>(1) Using release data, engineering estimates, knowledge of operating procedures, or best professional judgment to establish the continuity and stability of the release;</P> <P>(2) Reporting the release to the National Response Center for a period sufficient to establish the continuity and stability of the release; or</P> <P>(3) When a person in charge of the facility or vessel believes that a basis has been established to qualify the release for reduced reporting under this section, initial notification to the National Response Center shall be made by telephone. The person in charge must identify the notification as an initial continuous release notification report and provide the following information:</P> <P>(i) The name and location of the facility or vessel; and</P> <P>(ii) The name(s) and identity(ies) of the hazardous substance(s) being released.</P> <P> (e) <E T="03">Initial written notification.</E> Initial written notification of a continuous release shall be made to the appropriate EPA HQ office. (Note: In addition to the requirements of this part, releases of CERCLA hazardous substances are also subject to the provisions of SARA Title III, also known as the Emergency Planning and Community Right-to-Know Act (EPCRA), section 304, and EPA's implementing regulations codified at 40 CFR part 355, which require initial telephone and written notifications of continuous releases to be submitted to the appropriate State emergency response commission and local emergency planning committee.) </P> <P>(1) Initial written notification to the appropriate EPA HQ office shall occur within 30 days of the initial telephone notification to the National Response Center, and shall include, for each release for which reduced reporting as a continuous release is claimed, the following information:</P> <P>(i) The name of the facility or vessel; the location, including the latitude and longitude; the case number assigned by the National Response Center or the Environmental Protection Agency; the Dun and Bradstreet number of the facility, if available; the port of registration of the vessel; the name and telephone number of the person in charge of the facility or vessel.</P> <P>(ii) The population density within a one-mile radius of the facility or vessel, described in terms of the following ranges: 0-50 persons, 51-100 persons, 101-500 persons, 501-1,000 persons, more than 1,000 persons.</P> <P>(iii) The identity and location of sensitive populations and ecosystems within a one-mile radius of the facility or vessel (e.g., elementary schools, hospitals, retirement communities, or wetlands).</P> <P>(iv) For each hazardous substance release claimed to qualify for reporting under CERCLA section 103(f)(2), the following information must be supplied:</P> <P>(A) The name/identity of the hazardous substance; the Chemical Abstracts Service Registry Number for the substance (if available); and if the substance being released is a mixture, the components of the mixture and their approximate concentrations and quantities, by weight.</P> <P>(B) The upper and lower bounds of the normal range of the release (in pounds or kilograms) over the previous year.</P> <P>(C) The source(s) of the release (e.g., valves, pump seals, storage tank vents, stacks). If the release is from a stack, the stack height (in feet or meters).</P> <P>(D) The frequency of the release and the fraction of the release from each release source and the specific period over which it occurs.</P> <P> (E) A brief statement describing the basis for stating that the release is <PRTPAGE P="344"/> continuous and stable in quantity and rate. </P> <P>(F) An estimate of the total annual amount that was released in the previous year (in pounds or kilograms).</P> <P>(G) The environmental medium(a) affected by the release:</P> <P> ( <E T="03">1</E> ) If surface water, the name of the surface water body; </P> <P> ( <E T="03">2</E> ) If a stream, the stream order or average flowrate (in cubic feet/second) and designated use; </P> <P> ( <E T="03">3</E> ) If a lake, the surface area (in acres) and average depth (in feet or meters); </P> <P> ( <E T="03">4</E> ) If on or under ground, the location of public water supply wells within two miles. </P> <P>(H) A signed statement that the hazardous substance release(s) described is(are) continuous and stable in quantity and rate under the definitions in paragraph (b) of this section and that all reported information is accurate and current to the best knowledge of the person in charge.</P> <P> (f) <E T="03">Follow-up notification.</E> Within 30 days of the first anniversary date of the initial written notification, the person in charge of the facility or vessel shall evaluate each hazardous substance release reported to verify and update the information submitted in the initial written notification. The follow-up written notification shall be submitted to the appropriate EPA HQ office. The follow-up notification shall include the following information: </P> <P>(1) The name of the facility or vessel; the location, including the latitude and longitude; the case number assigned by the National Response Center or the Environmental Protection Agency; the Dun and Bradstreet number of the facility, if available; the port of registration of the vessel; the name and telephone number of the person in charge of the facility or vessel.</P> <P>(2) The population density within a one-mile radius of the facility or vessel, described in terms of the following ranges: 0-50 persons, 51-100 persons, 101-500 persons, 501-1,000 persons, more than 1,000 persons.</P> <P>(3) The identity and location of sensitive populations and ecosystems within a one-mile radius of the facility or vessel (e.g., elementary schools, hospitals, retirement communities, or wetlands).</P> <P>(4) For each hazardous substance release claimed to qualify for reporting under CERCLA section 103(f)(2), the following information shall be supplied:</P> <P>(i) The name/identity of the hazardous substance; the Chemical Abstracts Service Registry Number for the substance (if available); and if the substance being released is a mixture, the components of the mixture and their approximate concentrations and quantities, by weight.</P> <P>(ii) The upper and lower bounds of the normal range of the release (in pounds or kilograms) over the previous year.</P> <P>(iii) The source(s) of the release (e.g., valves, pump seals, storage tank vents, stacks). If the release is from a stack, the stack height (in feet or meters).</P> <P>(iv) The frequency of the release and the fraction of the release from each release source and the specific period over which it occurs.</P> <P>(v) A brief statement describing the basis for stating that the release is continuous and stable in quantity and rate.</P> <P>(vi) An estimate of the total annual amount that was released in the previous year (in pounds or kilograms).</P> <P>(vii) The environmental medium(a) affected by the release:</P> <P>(A) If surface water, the name of the surface water body;</P> <P>(B) If a stream, the stream order or average flowrate (in cubic feet/second) and designated use;</P> <P>(C) If a lake, the surface area (in acres) and average depth (in feet or meters);</P> <P>(D) If on or under ground, the location of public water supply wells within two miles.</P> <P>(viii) A signed statement that the hazardous substance release(s) is(are) continuous and stable in quantity and rate under the definitions in paragraph (b) of this section and that all reported information is accurate and current to the best knowledge of the person in charge.</P> <P> (g) <E T="03">Notification of changes in the release.</E> If there is a change in the release, notification of the change, not otherwise reported, shall be provided in the following manner: <PRTPAGE P="345"/> </P> <P> (1) <E T="03">Change in source or composition.</E> If there is any change in the composition or source(s) of the release, the release is a new release and must be qualified for reporting under this section by the submission of initial telephone notification and initial written notification in accordance with paragraphs (c) (1) and (2) of this section as soon as there is a sufficient basis for asserting that the release is continuous and stable in quantity and rate; </P> <P> (2) <E T="03">Change in the normal range.</E> If there is a change in the release such that the quantity of the release exceeds the upper bound of the reported normal range, the release must be reported as a statistically significant increase in the release. If a change will result in a number of releases that exceed the upper bound of the normal range, the person in charge of a facility or vessel may modify the normal range by: </P> <P>(i) Reporting at least one statistically significant increase report as required under paragraph (h) of this section and, at the same time, informing the National Response Center of the change in the normal range; and</P> <P>(ii) Submitting, within 30 days of the telephone notification, written notification to the appropriate EPA Headquarters office describing the new normal range, the reason for the change, and the basis for stating that the release in the increased amount is continuous and stable in quantity and rate under the definitions in paragraph (b) of this section.</P> <P> (3) <E T="03">Changes in other reported information.</E> If there is a change in any information submitted in the initial written notification or the follow-up notification other than a change in the source, composition, or quantity of the release, the person in charge of the facility or vessel shall provide written notification of the change to the appropriate EPA HQ office, within 30 days of determining that the information submitted previously is no longer valid. Notification shall include the reason for the change, and the basis for stating that the release is continuous and stable under the changed conditions. </P> <P> (4) <E T="03">Certificate of changes.</E> Notification of changes shall include the case number assigned by the National Response Center or the Environmental Protection Agency and also the signed certification statement required at (e)(1)(iv)(H) of this section. </P> <P> (h) <E T="03">Notification of a statistically significant increase in a release.</E> Notification of a statistically significant increase in a release shall be made to the National Response Center as soon as the person in charge of the facility or vessel has knowledge of the increase. The release must be identified as a statistically significant increase in a continuous release. A determination of whether an increase is a “statistically significant increase” shall be made based upon calculations or estimation procedures that will identify releases that exceed the upper bound of the reported normal range. </P> <P> (i) <E T="03">Annual evaluation of releases.</E> Each hazardous substance release shall be evaluated annually to determine if changes have occurred in the information submitted in the initial written notification, the followup notification, and/or in a previous change notification. </P> <P> (j) <E T="03">Use of the SARA Title III (EPCRA) section 313 form.</E> In lieu of an initial written report or a follow-up report, owners or operators of facilities subject to the requirements of SARA Title III (EPCRA) section 313 may submit to the appropriate EPA HQ office, a copy of the Toxic Release Inventory form submitted under SARA Title III (EPCRA) section 313 the previous July 1, provided that the following information is added: </P> <P>(1) The population density within a one-mile radius of the facility or vessel, described in terms of the following ranges: 0-50 persons, 51-100 persons, 101-500 persons, 501-1,000 persons, more than 1,000 persons.</P> <P>(2) The identity and location of sensitive populations and ecosystems within a one-mile radius of the facility or vessel (e.g., elementary schools, hospitals, retirement communities, or wetlands).</P> <P>(3) For each hazardous substance release claimed to qualify for reporting under CERCLA section 103(f)(2), the following information must be supplied:</P> <P> (i) The upper and lower bounds of the normal range of the release (in pounds or kilograms) over the previous year. <PRTPAGE P="346"/> </P> <P>(ii) The frequency of the release and the fraction of the release from each release source and the specific period over which it occurs.</P> <P>(iii) A brief statement describing the basis for stating that the release is continuous and stable in quantity and rate.</P> <P>(iv) A signed statement that the hazardous substance release(s) is(are) continuous and stable in quantity and rate under the definitions in paragraph (b) of this section and that all reported information is accurate and current to the best knowledge of the person in charge.</P> <P> (k) <E T="03">Documentation supporting notification.</E> Where necessary to satisfy the requirements of this section, the person in charge may rely on recent release data, engineering estimates, the operating history of the facility or vessel, or other relevant information to support notification. All supporting documents, materials, and other information shall be kept on file at the facility, or in the case of a vessel, at an office within the United States in either a port of call, a place of regular berthing, or the headquarters of the business operating the vessel. Supporting materials shall be kept on file for a period of one year and shall substantiate the reported normal range of releases, the basis for stating that the release is continuous and stable in quantity and rate, and the other information in the initial written report, the followup report, and the annual evaluations required under paragraphs (e), (f), and (i), respectively. Such information shall be made available to EPA upon request as necessary to enforce the requirements of this section. </P> <P> (l) <E T="03">Multiple concurrent releases.</E> Multiple concurrent releases of the same substance occurring at various locations with respect to contiguous plants or installations upon contiguous grounds that are under common ownership or control may be considered separately or added together in determining whether such releases constitute a continuous release or a statistically significant increase under the definitions in paragraph (b) of this section; whichever approach is elected for purposes of determining whether a release is continuous also must be used to determine a statistically significant increase in the release. </P> <P> (m) <E T="03">Penalties for failure to comply.</E> The reduced reporting requirements provided for under this section shall apply only so long as the person in charge complies fully with all requirements of paragraph (c) of this section. Failure to comply with respect to any release from the facility or vessel shall subject the person in charge to all of the reporting requirements of § 302.6 for each such release, to the penalties under § 302.7, and to any other applicable penalties provided for by law. </P> <CITA>[55 FR 30185, July 24, 1990, as amended at 67 FR 45357, July 9, 2002; 86 FR 62737, Nov. 12, 2021]</CITA> </SECTION> </PART> <PART> <EAR>Pt. 303</EAR> <HD SOURCE="HED">PART 303—CITIZEN AWARDS FOR INFORMATION ON CRIMINAL VIOLATIONS UNDER SUPERFUND</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECHD>Sec.</SECHD> <SECTNO>303.10</SECTNO> <SUBJECT>Purpose.</SUBJECT> <SECTNO>303.11</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>303.12</SECTNO> <SUBJECT>Criminal violations covered by this award authority.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Eligibility To File a Claim for Award and Determination of Eligibility and Amount of Award</HD> <SECTNO>303.20</SECTNO> <SUBJECT>Eligibility to file a claim for award.</SUBJECT> <SECTNO>303.21</SECTNO> <SUBJECT>Determination of eligibility and amount of award.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Criteria for Payment of Award</HD> <SECTNO>303.30</SECTNO> <SUBJECT>Criteria for payment of award.</SUBJECT> <SECTNO>303.31</SECTNO> <SUBJECT>Assurance of claimant confidentiality.</SUBJECT> <SECTNO>303.32</SECTNO> <SUBJECT>Pre-payment offers.</SUBJECT> <SECTNO>303.33</SECTNO> <SUBJECT>Filing a claim.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 9609(d), Executive Order No. 12580.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>54 FR 26143, June 21, 1989, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECTION> <SECTNO>§ 303.10</SECTNO> <SUBJECT>Purpose.</SUBJECT> <P> This regulation implements the “citizen award” authority granted by Congress to the President in the 1986 Amendments to the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), section 109(d). As authorized in the Superfund <PRTPAGE P="347"/> Amendments and Reauthorization Act of 1986 (SARA) section 109(c) and Executive Order No. 12580 (issued by the President on January 23, 1987), the Environmental Protection Agency is empowered to pay up to $10,000.00 from the Superfund to any individual who provides information leading to the arrest and conviction of any person for a violation subject to a criminal penalty under CERCLA as amended. </P> </SECTION> <SECTION> <SECTNO>§ 303.11</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>(a) Arrest. Restraint of an arrestee's liberty or the equivalent through the service of judicial process compelling such a person to respond to a criminal accusation.</P> <P> (b) Conviction. A judgment of guilt entered in U.S. District Court, upon a verdict rendered by the court or petit jury or by a plea of guilty, including a plea of <E T="03">nolo contendere.</E> </P> <P>(c) Individual. A natural person, not a corporation or other legal entity nor an association of persons.</P> </SECTION> <SECTION> <SECTNO>§ 303.12</SECTNO> <SUBJECT>Criminal violations covered by this award authority.</SUBJECT> <P>(a) Failure to Give Required Notice of a Release of a Reportable Quantity of a Hazardous Substance, 42 U.S.C. 9603(a);</P> <P>(b) Destruction or Concealment of Records Required under CERCLA to have been Retained, 42 U.S.C. 9603(d).</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Eligibility To File a Claim for Award and Determination of Eligibility and Amount of Award</HD> <SECTION> <SECTNO>§ 303.20</SECTNO> <SUBJECT>Eligibility to file a claim for award.</SUBJECT> <P>(a) Any individual, except law enforcement officers and persons convicted in the case giving rise to the award claim and any persons identified in § 303.20(b) shall be eligible to file a claim for an award as provided for in § 303.33 of this subpart.</P> <P>(b) No person who was an employee of or contractor for the United States Environmental Protection Agency at the time he or she came into possession of the information disclosed to other Agency officials (or is so employed at the time of disclosure), which information constitutes in whole or part the basis for an award claim, shall be eligible to file a claim for an award.</P> <P>(c) To be eligible for an award, the informant must disclose the identity of person(s) [or other pertinent information that leads to the expeditious disclosure of the identity of said person(s)] criminally culpable for the violations set forth in § 303.12 of subpart A. Disclosure of such pertinent information must be made to an employee, agent or representative of the United States Environmental Protection Agency.</P> </SECTION> <SECTION> <SECTNO>§ 303.21</SECTNO> <SUBJECT>Determination of eligibility and amount of award.</SUBJECT> <P>The Agency's determinations as to eligibility and award amount shall constitute final Agency action as to either amount or eligibility. These determinations, consistent with the need to preserve from disclosure the identity of confidential informants (as noted in § 303.31) as well as to preserve from disclosure methods of Agency investigation, shall not be subject to administrative challenge by any person not making a claim to that award.</P> <NOTE> <HD SOURCE="HED">Note:</HD> <P>It is the Environmental Protection Agency's view that such determinations also would not be subject to judicial challenge by such person.</P> </NOTE> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Criteria for Payment of Award</HD> <SECTION> <SECTNO>§ 303.30</SECTNO> <SUBJECT>Criteria for payment of award.</SUBJECT> <P>Upon the filing of an eligible claim in accordance with the procedures as set forth in § 303.33, the Agency's Assistant Administrator for Enforcement and Compliance Monitoring, or his Deputy for Criminal Enforcement, in making the decision to grant an award, and if so, in what amount, shall consider all relevant criteria, giving such weight and importance to each separate criterion as appears warranted in his judgment alone. Relevant criteria include one or more of the following:</P> <P>(a) Whether the claimant's information constituted the initial, unsolicited notice to the Government of the violation;</P> <P> (b) Whether the Government would readily have obtained knowledge of the violation in a timely manner absent claimant's information; <PRTPAGE P="348"/> </P> <P>(c) Importance of the case, egregiousness of the violation, potential for or existence of environmental harm;</P> <P>(d) Concealment of a person criminally culpable or existence of an organized criminal conspiracy to conceal the offense(s) committed by the named defendant(s);</P> <P>(e) Willingness of the claimant to assist the Government's prosecution of the offense(s), which assistance includes providing further information and grand jury testimony, participating in trial preparation, and trial testimony if consistent with the limits on claimant identity disclosure as set forth in § 303.31.</P> <P>(f) Value of the claimant's assistance in comparison to that given by all other sources of information and evidence which led to arrest and conviction.</P> </SECTION> <SECTION> <SECTNO>§ 303.31</SECTNO> <SUBJECT>Assurance of claimant confidentiality.</SUBJECT> <P>No person, except as authorized by the Agency's Office of Enforcement and Compliance Monitoring to have this knowledge, shall be given access to the identity of, or information that would lead to the identity of, a claimant who has requested anonymity prior to disclosing information to the Agency.</P> </SECTION> <SECTION> <SECTNO>§ 303.32</SECTNO> <SUBJECT>Pre-payment offers.</SUBJECT> <P>Prior to the actual payment of an award, no employee of the United States Government, including any person purporting to act on behalf of the United States Environmental Protection Agency, is authorized by these regulations to make any promise, offer, or representation with respect to the Agency's grant of an award in exchange for information.</P> </SECTION> <SECTION> <SECTNO>§ 303.33</SECTNO> <SUBJECT>Filing a claim.</SUBJECT> <P>(a) Any individual seeking an award under this regulation is required to file a claim for such an award with the Deputy Assistant Administrator for Criminal Enforcement not later than 45 days after the conviction of the person(s) involved in the prosecution in which the information was provided.</P> <P>(b) The claim submission must provide, at a minimum, a summary of the information provided, the date the information was provided, and the name and title of the person to whom the information was provided.</P> <P>(c) All claim submissions must be submitted to the Office of Criminal Enforcement Counsel (LE-134X), United States Environmental Protection Agency, 1200 Pennsylvania Ave., NW,Washington, DC 20460. The claim envelope should also specify whether the information was submitted under a request for anonymity and whether such request is still in effect. All such externally identified claims shall be handled in accordance with the Agency procedures for maintaining informant confidentiality, as referenced in § 303.31 of this subpart.</P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 304</EAR> <HD SOURCE="HED">PART 304—ARBITRATION PROCEDURES FOR SMALL SUPERFUND COST RECOVERY CLAIMS</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECHD>Sec.</SECHD> <SECTNO>304.10</SECTNO> <SUBJECT>Purpose.</SUBJECT> <SECTNO>304.11</SECTNO> <SUBJECT>Scope and applicability.</SUBJECT> <SECTNO>304.12</SECTNO> <SUBJECT>Definitions.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Jurisdiction of Arbitrator, Referral of Claims, and Appointment of Arbitrator</HD> <SECTNO>304.20</SECTNO> <SUBJECT>Jurisdiction of Arbitrator.</SUBJECT> <SECTNO>304.21</SECTNO> <SUBJECT>Referral of claims.</SUBJECT> <SECTNO>304.22</SECTNO> <SUBJECT>Appointment of Arbitrator.</SUBJECT> <SECTNO>304.23</SECTNO> <SUBJECT>Disclosure and challenge procedures.</SUBJECT> <SECTNO>304.24</SECTNO> <SUBJECT>Intervention and withdrawal.</SUBJECT> <SECTNO>304.25</SECTNO> <SUBJECT> <E T="03">Ex parte</E> communication. </SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Hearings Before the Arbitrator</HD> <SECTNO>304.30</SECTNO> <SUBJECT>Filing of pleadings.</SUBJECT> <SECTNO>304.31</SECTNO> <SUBJECT>Pre-hearing conference.</SUBJECT> <SECTNO>304.32</SECTNO> <SUBJECT>Arbitral hearing.</SUBJECT> <SECTNO>304.33</SECTNO> <SUBJECT>Arbitral decision and public comment.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Other Provisions</HD> <SECTNO>304.40</SECTNO> <SUBJECT>Effect and enforcement of final decision.</SUBJECT> <SECTNO>304.41</SECTNO> <SUBJECT>Administrative fees, expenses, and Arbitrator's fee.</SUBJECT> <SECTNO>304.42</SECTNO> <SUBJECT>Miscellaneous provisions.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 9607(a) and 9622(h)(2), Executive Order No. 12580, 52 FR 2923 (January 29, 1987).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>54 FR 23179, May 30, 1989, unless otherwise noted.</P> </SOURCE> <SUBPART> <PRTPAGE P="349"/> <HD SOURCE="HED">Subpart A—General</HD> <SECTION> <SECTNO>§ 304.10</SECTNO> <SUBJECT>Purpose.</SUBJECT> <P>This regulation establishes and governs procedures for the arbitration of EPA cost recovery claims arising under section 107(a) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, 42 U.S.C. 9607(a), as amended by the Superfund Amendments and Reauthorization Act of 1986, Pub. L. 99-499, 100 Stat. 1613 (1986) (“CERCLA”), pursuant to the authority granted EPA by section 122(h)(2) of CERCLA, 42 U.S.C. 9622(h)(2), and Executive Order No. 12580, 52 FR 2923 (January 29, 1987).</P> </SECTION> <SECTION> <SECTNO>§ 304.11</SECTNO> <SUBJECT>Scope and applicability.</SUBJECT> <P>The procedures established by this regulation govern the arbitration of EPA claims for recovery, under section 107(a) of CERCLA, 42 U.S.C. 9607(a), of response costs incurred at or in connection with a facility by the United States pursuant to section 104 of CERCLA, 42 U.S.C. 9604. The procedures are applicable when:</P> <P>(a) The total past and projected response costs for the facility concerned do not exceed $500,000, excluding interest; and</P> <P>(b) The Administrator and one or more PRPs have submitted a joint request for arbitration pursuant to § 304.21 of this part.</P> </SECTION> <SECTION> <SECTNO>§ 304.12</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>Terms not defined in this section have the meaning given by section 101 of CERCLA, 42 U.S.C. 9601, or the National Oil and Hazardous Substances Pollution Contingency Plan, 40 CFR part 300. All time deadlines in this part are specified in calendar days and shall be computed in the manner described in Rule 6(a) of the Federal Rules of Civil Procedure.</P> <P>Except when otherwise specified, the following terms are defined for purposes of this part as follows:</P> <P> (a) <E T="03">CERCLA</E> means the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, 42 U.S.C. 9601, <E T="03">et seq.,</E> as amended by the Superfund Amendments and Reauthorization Act of 1986, Pub. L. 99-499, 100 Stat. 1613 (1986). </P> <P> (b) <E T="03">Administrator</E> means the EPA Administrator or his designee. </P> <P> (c) <E T="03">Arbitrator</E> means the person appointed in accordance with § 304.22 of this part and governed by the provisions of this part. </P> <P> (d) <E T="03">Association</E> means the organization offering arbitration services selected by EPA to conduct arbitrations pursuant to this part. </P> <P> (e) <E T="03">Claim</E> means the amount sought by EPA as recovery of response costs incurred and to be incurred by the United States at a facility, which does not exceed $500,000, excluding interest. </P> <P> (f) <E T="03">Ex parte communication</E> means any communication, written or oral, relating to the merits of the arbitral proceeding, between the Arbitrator and any interested person, which was not originally filed or stated in the administrative record of the proceeding. Such communication is not <E T="03">ex parte communication</E> if all parties to the proceeding have received prior written notice of the proposed communication and have been given the opportunity to be present and to participate therein. </P> <P> (g) <E T="03">Interested person</E> means the Administrator, any EPA employee, any party to the proceeding, any potentially responsible party associated with the facility concerned, any person who filed written comments in the proceeding, any participant or intervenor in the proceeding, all officers, directors, employees, consultants, and agents of any party, and any attorney of record for any of the foregoing persons. </P> <P> (h) <E T="03">National Contingency Plan</E> or <E T="03">NCP</E> means the National Oil and Hazardous Substances Pollution Contingency Plan, developed under section 311(c)(2) of the Federal Water Pollution Control Act, 33 U.S.C. 1251, <E T="03">et seq.,</E> as amended, revised periodically pursuant to section 105 of CERCLA, 42 U.S.C. 9605, and published at 40 CFR part 300. </P> <P> (i) <E T="03">National Panel of Environmental Arbitrators</E> or <E T="03">Panel</E> means a panel of environmental arbitrators selected and maintained by the Association to arbitrate cost recovery claims under this part. </P> <P> (j) <E T="03">Participating PRP</E> is any potentially responsible party who has agreed, pursuant to § 304.21 of this part, to submit one or more issues arising in <PRTPAGE P="350"/> an EPA claim for resolution pursuant to the procedures established by this part. </P> <P> (k) <E T="03">Party</E> means EPA and any person who has agreed, pursuant to § 304.21 of this part, to submit one or more issues arising in an EPA claim for resolution pursuant to the procedures established by this part, and any person who has been granted leave to intervene pursuant to § 304.24(a) of this part. </P> <P> (l) <E T="03">Persons</E> means an individual, firm, corporation, association, partnership, consortium, joint venture, commercial entity, United States Government, State, municipality, commission, political subdivision of a State, or any interstate body. </P> <P> (m) <E T="03">Potentially responsible party</E> or <E T="03">PRP</E> means any person who may be liable pursuant to section 107(a) of CERCLA, 42 U.S.C. 9607(a), for response costs incurred and to be incurred by the United States not inconsistent with NCP. </P> <P> (n) <E T="03">Response action</E> means remove, removal, remedy and remedial action, as those terms are defined by section 101 of CERCLA, 42 U.S.C. 9601, including enforcement activities related thereto. </P> <P> (o) <E T="03">Response costs</E> means all costs of removal or remedial action incurred and to be incurred by the United States at a facility pursuant to section 104 of CERCLA, 42 U.S.C. 9604, including, but not limited to, all costs of investigation and information gathering, planning and implementing a response action, administration, enforcement, litigation, interest and indirect costs. </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Jurisdiction of Arbitrator, Referral of Claims, and Appointment of Arbitrator</HD> <SECTION> <SECTNO>§ 304.20</SECTNO> <SUBJECT>Jurisdiction of Arbitrator.</SUBJECT> <P>(a) In accordance with the procedures established by this part, the Arbitrator is authorized to arbitrate one or more issues arising in an EPA claim when:</P> <P>(1) The total past and projected response costs for the facility concerned do not exceed $500,000, excluding interest; and</P> <P>(2) The Administrator and one or more PRPs have submitted a joint request for arbitration pursuant to § 304.21 of this part.</P> <P>(b)(1) If the total past and projected response costs for the facility concerned increase to a dollar amount in excess of $500,000, excluding interest, prior to the rendering of the final decision pursuant to § 304.33 of this part, the parties may mutually agree to continue the proceeding as non-binding arbitration pursuant to the procedures established by this part, except that §§ 304.33(e) and 304.40 of this part shall not apply.</P> <P>(2) If all of the parties agree to continue the proceeding as non-binding arbitration, the proposed decision rendered by the Arbitrator pursuant to § 304.33 of this part shall not be binding upon the parties, unless all of the parties agree to adopt the proposed decision as an administrative settlement pursuant to section 122(h)(1) of CERCLA, 42 U.S.C. 9622(h)(1). Any administrative settlement agreed upon in this manner shall be subject to the prior written approval of the Attorney General (or his designee) pursuant to section 122(h)(1) of CERCLA and shall be subject to public comment pursuant to section 122(i) of CERCLA, 42 U.S.C. 9622(i).</P> <P>(3) If the parties do not agree to continue the proceeding as non-binding arbitration, or if the administrative settlement agreed upon is not approved by the Attorney General (or his designee), or if EPA withdraws or withholds consent from the administrative settlement as a result of public comment, EPA shall withdraw from the proceeding and the Association shall assess or refund, as appropriate, any administrative fees, expenses, or Arbitrator's fees.</P> <P> (c) The Arbitrator's authority, as defined by paragraphs (d) and (e) of this section, to determine issues arising in EPA's claim is limited only to the issues submitted for resolution by the parties in the joint request for arbitration pursuant to § 304.21 of this part. Any issues arising in EPA's claim that are not submitted for resolution shall be deemed to be not in dispute and shall not be raised in any action seeking enforcement of the decision for the purpose of overturning or otherwise challenging the final decision, except as provided in § 304.40(c) of this part. <PRTPAGE P="351"/> </P> <P>(d)(1) If the issue of liability of any participating PRP has been submitted for resolution, the Arbitrator shall determine whether the participating PRP is liable pursuant to section 107(a) of CERCLA, 42 U.S.C. 9607(a), subject only to the defenses specifically enumerated in section 107(b) of CERCLA, 42 U.S.C. 9607(b).</P> <P>(2) If the issue of the dollar amount of response costs recoverable by EPA has been submitted for resolution, the Arbitrator shall determine, pursuant to paragraph (e) of this section, the dollar amount of response costs recoverable by EPA pursuant to section 107(a) of CERCLA, 42 U.S.C. 9607(a), and shall award the total amount of such costs to EPA.</P> <P>(3) Unless the Arbitrator finds that the actual or threatened harm at the facility is divisible, any participating PRP whom the Arbitrator determines to be liable shall be jointly and severally liable for the total amount of response costs awarded to EPA. If the Arbitrator finds that the actual or threatened harm is divisible, the Arbitrator shall allocate liability for payment of EPA's award among the participating PRPs based on the portion of the actual or threatened harm attributable to each participating PRP.</P> <P>(4) Notwithstanding the indivisibility of the actual or threatened harm, and without waiving the general applicability of the joint and several liability standard, as an alternative to paragraph (d)(3) of this section, the parties may request the Arbitrator to allocate responsibility for payment of response costs awarded to EPA among the participating PRPs whom the Arbitrator determines to be liable. Any such request shall be made in the joint request for arbitration pursuant to § 304.21 of this part. If such a request is made, the provisions of paragraphs (d)(4)(i), (d)(4)(ii), and (d)(4)(iii) of this section shall apply.</P> <P>(i) The joint request for arbitration may specify the factors to be applied by the arbitrator when allocating among the participating PRPs responsibility for payment of the response costs awarded to EPA. If the joint request does not specify such factors, the Arbitrator shall base the allocation on such factors as the arbitrator considers relevant, in his or her sole discretion, such as volume, toxicity, and mobility of the hazardous substances contributed to the facility by each participating PRP, ability to pay, and inequities and aggravating factors.</P> <P>(ii) The joint request for arbitration may specify that the Arbitrator may allocate among the participating PRPs less than all response costs awarded to EPA. If this is not specified, the Arbitrator shall allocate among the participating PRPs 100% of the response costs awarded to EPA.</P> <P>(iii) The burden of establishing the appropriate allocation of responsibility for payment of the response costs awarded to EPA shall rest entirely with the participating PRPs.</P> <P>(5) The parties may request that the Arbitrator perform an allocation even if the issue of the liability of the participating PRPs is not submitted for resolution in the joint request for arbitration. Such a request for allocation shall be made in the joint request for arbitration pursuant to § 304.21 of this part. If such a request is made, the provisions of paragraphs (d)(4)(i), (d)(4)(ii), and (d)(4)(iii) of this section shall apply.</P> <P>(e)(1) If any issue concerning the adequacy of EPA's response action has been submitted for resolution or arises during the Arbitrator's determination of the dollar amount of response costs recoverable by EPA, the Arbitrator shall uphold EPA's selection of the response action, unless any participating PRP can establish that the selection was inconsistent with the NCP. The Arbitrator's review of the adequacy of any response action taken by EPA shall be based upon the documents which formed the basis for the selection of the response action.</P> <P>(2) If the Arbitrator upholds EPA's selection of the response action in full, the Arbitrator shall award EPA all response costs incurred and to be incurred in connection with the response action, unless any participating PRP can establish that all or part of such costs were:</P> <P>(i) Not actually incurred or to be incurred; or</P> <P> (ii) Not actually incurred or to be incurred in connection with the response action; or <PRTPAGE P="352"/> </P> <P>(iii) Clearly excessive, taking into account the circumstances of the response action and relative to acceptable government procurement and contracting practices in light of the circumstances of the response action.</P> <P>(3) If the Arbitrator upholds EPA's selection of the response action only in part, the Arbitrator shall award EPA only those response costs incurred and to be incurred in connection with the portions of the response action that were upheld, unless any participating PRP can establish that all or part of such response costs were:</P> <P>(i) Not actually incurred or to be incurred; or</P> <P>(ii) Not actually incurred or to be incurred in connection with the portions of the response action that were upheld; or</P> <P>(iii) Clearly excessive, taking into account the circumstances of the response action and relative to acceptable government procurement and contracting practices in light of the circumstances of the response action.</P> <P>(4) The standard of review to be applied by the Arbitrator under paragraphs (e)(1), (e)(2), and (e)(3) of this section is arbitrary and capricious or otherwise not in accordance with law.</P> <P>(5) In reviewing any procedural errors alleged by any party, the Arbitrator may disallow response costs only if the errors were so serious and related to matters of such central relevance that the response action would have been significantly changed had such errors not been made.</P> </SECTION> <SECTION> <SECTNO>§ 304.21</SECTNO> <SUBJECT>Referral of claims.</SUBJECT> <P>(a) If EPA believes that a claim is an appropriate candidate for arbitration, EPA will notify all identified PRPs for the facility concerned and provide such PRPs with an opportunity to discuss referral of one or more issues arising in the claim for resolution pursuant to the procedures established by this part. Alternatively, one or more PRPs at a facility may propose to EPA use of arbitration, after receipt of a demand by EPA for payment of a claim, but prior to commencement of civil litigation of the claim. Where practicable, before an agreement to refer a claim for arbitration is made final under this alternative, either the PRPs or EPA shall notify the other PRPs at the facility of the potential use of arbitration.</P> <P>(b)(1) The Administrator and one or more PRPs associated with a facility may submit to the Association a joint request for arbitration of one or more issues arising in an EPA claim concerning the facility. The joint request shall be signed by all of the parties and shall include:</P> <P>(i) A brief description of the facility, the EPA response action taken at the facility, the EPA claim, and the parties;</P> <P>(ii) A statement of the issues arising in the claim that are being submitted by the parties for resolution by arbitration;</P> <P>(iii) A statement that the parties consent to resolution of the issues jointly submitted pursuant to the procedures established by this part by an Arbitrator appointed pursuant to § 304.22 of this part;</P> <P>(iv) A statement that the parties agree to be bound by the final decision on all issues jointly submitted by the parties for resolution and to pay any award made in the final decision, subject to the right to challenge the final decision solely on the grounds and in the manner prescribed by § 304.40(c) of this part;</P> <P>(v) A statement that the parties agree that the award made in the final decision may be enforced pursuant to § 304.40(c) of this part;</P> <P>(vi) A statement that the parties agree that the final decision shall be binding only with respect to the response costs at issue in the claim submitted for arbitration;</P> <P>(vii) A statement that the parties agree that the statute of limitations governing the EPA claim submitted shall be extended for a time period equal to the number of days from the date the joint request for arbitration is submitted to the Association to the date of resolution of any enforcement action relating to the final decision; and</P> <P> (viii) A statement that each signatory to the joint request is authorized to enter into the arbitration and to bind legally the party represented by him or her to the terms of the joint request. <PRTPAGE P="353"/> </P> <P>(2) The joint request shall also include the name, address and telephone number of each party, and, if a party is represented by an attorney, the attorney's name, address and telephone number. A party changing any of this information must promptly communicate the change in writing to the Association and all other parties. A party who fails to furnish such information or any changes thereto is deemed to have waived his or her right to notice and service under this part until such time as the party furnishes the missing information.</P> <P>(c) Any party may move to modify the joint request for arbitration to include one or more additional issues arising in the referred claim. To be effective, any such modification must be signed by the Arbitrator and all other parties. The joint request for arbitration may also be modified to add one or more additional parties, if such intervention is permitted by § 304.24(a) of this part. To be effective, any such modification must be signed by the Arbitrator, the intervening party or parties, and all other parties.</P> <P>(d) The statute of limitations governing the EPA claim submitted for arbitration shall be extended for a time period equal to the number of days from the date the joint request for arbitration is submitted to the Association to the date of resolution of any enforcement action relating to the final decision.</P> <P>(e) Prior to the selection of the Association, the Administrator and one or more PRPs associated with a facility may agree to submit one or more issues arising in an EPA claim for resolution by arbitration. Any such agreement shall be contained in a joint request for arbitration which meets all requirements of paragraph (b) of this section. In any such arbitration, the arbitrator shall be selected pursuant to § 304.22(e) of this part, and payment of all costs associated with the arbitration shall be made pursuant to § 304.41(e) of this part. Arbitrations agreed upon pursuant to this paragraph shall be governed by the procedures established by this part, except for those procedures which pertain specifically to the duties of the Association. All duties of the Association shall be performed in a manner agreed upon by all of the parties.</P> </SECTION> <SECTION> <SECTNO>§ 304.22</SECTNO> <SUBJECT>Appointment of Arbitrator.</SUBJECT> <P>(a) The Association shall establish and maintain a National Panel of Environmental Arbitrators.</P> <P>(b) Within ten days of the filing of the joint request for arbitration, the Association shall identify and submit simultaneously to all parties an indentical list of ten persons chosen from the National Panel of Environmental Arbitrators, whom the Association believes will not be subject to disqualification because of circumstances likely to affect impartiality pursuant to § 304.23 of this part. Each party shall have ten days from the date of receipt of the list to identify any persons objected to, to rank the remaining persons in the order of preference, and to return the list to the Association. If a party does not return the list within the time specified, all persons on the list are deemed acceptable to that party. From among the persons whom the parties have indicated as acceptable, and, in accordance with the designated order of mutual preference, if any, the Association shall invite an Arbitrator to serve. If the parties fail to mutually agree upon any of the persons named, or if the invited Arbitrator is unable to serve, or if for any other reason the appointment cannot be made from the submitted lists, the Association shall make the appointment from among the other members of the Panel. In no event shall appointment of the Arbitrator by the Association take longer than thirty days from the filing of the joint request for arbitration.</P> <P> (c) Within seven days of the appointment of the Arbitrator, the Association shall mail to each of the parties notice of the identity of the Arbitrator and the date of the appointment, together with a copy of these rules. The Arbitrator shall, within five days of his or her appointment, file a signed acceptance of the case with the Association. The Association shall, within seven days of receipt of the Arbitrator's acceptance, mail notice of such acceptance to the parties. <PRTPAGE P="354"/> </P> <P>(d) If any appointed Arbitrator should resign, die, withdraw, be disqualified or otherwise be unable to perform the duties of the office, the Association may, on satisfactory proof, declare the office vacant. Vacancies shall be filled in accordance with the applicable provisions of this section, and the matter shall be resumed.</P> <P> (e) If the Administrator and one or more PRPs associated with a facility enter into a joint request for arbitration prior to the selection of the Association ( <E T="03">see</E> § 304.21(e) of this part), the Administrator and the participating PRPs shall reach mutual agreement upon the selection and appointment of an Arbitrator on a case-by-case basis, and the Administrator shall obtain the services of that person using appropriate procurement procedures. Any person appointed as an Arbitrator pursuant to this paragraph shall make disclosures to the parties pursuant to § 304.23 of this part, shall resolve the issues submitted for resolution pursuant to the jurisdiction and authority granted to the Arbitrator in § 304.20 of this part, and shall otherwise conduct the arbitral proceeding pursuant to the procedures established by this part. </P> </SECTION> <SECTION> <SECTNO>§ 304.23</SECTNO> <SUBJECT>Disclosure and challenge procedures.</SUBJECT> <P>(a) A person appointed as an Arbitrator under § 304.22 of this part shall, within five days of receipt of his or her notice of appointment, disclose to the Association any circumstances likely to affect impartiality, including any bias or any financial or personal interest in the result of the arbitration, or any past or present relationship with the parties or their counsel, or any past or present relationship with any PRP to which the claim may relate.</P> <P>(b) Upon receipt of such information from an appointed Arbitrator or other source, the Association shall, within two days of receipt, communicate such information to the parties. Such communication may be made orally or in writing, but if made orally, shall be confirmed in writing.</P> <P>(c) If any party wishes to request disqualification of an Arbitrator, such party shall notify the Association and the other parties of such request and the basis therefor within seven days of receipt of the information on which such request is based.</P> <P>(d) The Association shall make a determination on any request for disqualification of an Arbitrator within seven days after the Association receives any such request, and shall notify the parties in writing of such determination. This determination shall be within the sole discretion of the Association, and its decision shall be final.</P> </SECTION> <SECTION> <SECTNO>§ 304.24</SECTNO> <SUBJECT>Intervention and withdrawal.</SUBJECT> <P> (a)(1) No later than thirty days prior to the pre-hearing conference ( <E T="03">see</E> § 304.31 of this part), any PRP associated with the facility which is the subject of the referred claim may move to intervene in the arbitral proceeding for the purpose of having one or more issues relating to his or her responsibility for payment of the referred claim resolved. </P> <P>(2) If the Arbitrator has been appointed, a motion to intervene shall be filed with the Arbitrator and a copy shall be served upon all parties. If the Arbitrator has not yet been appointed, a motion to intervene shall be submitted to the Association and a copy shall be served upon all parties.</P> <P>(3) Any such motion to intervene may be granted only upon the written approval of the Arbitrator and all of the parties in the form of a modification to the joint request for arbitration pursuant to § 304.21(c) of this part. by signing such a modification, the intervening party consents to be bound by the terms of the joint request for arbitration submitted pursuant to § 304.21(b) of this part and any modifications previously made thereto pursuant to § 304.21(c) of this part, and consents to be bound by such revisions to the time limits for the filing of pleadings as the Arbitrator may make to prevent delaying the pre-hearing conference.</P> <P> (b) Any party may move to withdraw from the arbitral proceeding within thirty days after receipt of the notice of appointment of the Arbitrator ( <E T="03">see</E> § 304.22 of this part). The Arbitrator may approve such withdrawal, without prejudice to the moving party, and shall assess such administrative fees and expenses ( <E T="03">see</E> § 304.41 of this part) against the withdrawing party as the <PRTPAGE P="355"/> Arbitrator deems appropriate. No party may withdraw from the arbitral proceedings after this thirty-day period, except that EPA may withdraw from the proceeding in accordance with § 304.20(b)(3) or § 304.33(e) of this part. </P> </SECTION> <SECTION> <SECTNO>§ 304.25</SECTNO> <SUBJECT> <E T="7462">Ex parte</E> communication. </SUBJECT> <P> (a) No interested person shall make or knowingly cause to be made to the Arbitrator an <E T="03">ex parte</E> communication. </P> <P> (b) The Arbitrator shall not make or knowingly cause to be made to any interested person an <E T="03">ex parte</E> communication. </P> <P> (c) The Association may remove the Arbitrator in any proceeding in which it is demonstrated to the Association's satisfaction that the Arbitrator has engaged in prohibited <E T="03">ex parte</E> communication to the prejudice of any party. If the Arbitrator is removed, the procedures in § 304.22(d) of this part shall apply. </P> <P> (d) Whenever an <E T="03">ex parte</E> communication in violation of this section is received by or made known to the Arbitrator, the Arbitrator shall immediately notify in writing all parties to the proceeding of the circumstances and substance of the communication and may require the party who made the communication or caused the communication to be made, or the party whose representative made the communication or caused the communication to be made, to show cause why that party's arguments or claim should not be denied, disregarded, or otherwise adversely affected on account of such violation. </P> <P>(e) The prohibitions of this section apply upon appointment of the Arbitrator and terminate on the date of the final decision.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Hearings Before the Arbitrator</HD> <SECTION> <SECTNO>§ 304.30</SECTNO> <SUBJECT>Filing of pleadings.</SUBJECT> <P>(a) Discovery shall be in accordance with this section and § 304.31 of this part.</P> <P> (b) Within thirty days after receipt of the notice of appointment of the Arbitrator ( <E T="03">see</E> § 304.22 of this part), EPA shall submit to the Arbitrator two copies of a written statement and shall serve a copy of the written statement upon all other parties. The written statement shall in all cases include the information requested in paragraphs (b)(1), (b)(6), and (b)(7) of this section, shall include the information requested in paragraph (b)(2) of this section if the issue of liability of any participating PRP has been submitted for resolution, shall include the information requested in paragraph (b)(3) of this section if any issue concerning the adequacy of EPA's response action has been submitted for resolution or may arise during the Arbitrator's determination of the dollar amount of response costs recoverable by EPA, shall include the information requested in paragraph (b)(4) of this section if the issue of the dollar amount of response costs recoverable by EPA has been submitted for resolution, and shall include the information requested in paragraph (b)(5) of this section if any issue concerning allocation of liability for payment of EPA's award has been submitted for resolution. </P> <P>(1) A statement of facts, including a description of the facility, the EPA response action taken at the facility, the response costs incurred and to be incurred by the United States in connection with the response action taken at the facility, and the parties;</P> <P>(2) A description of the evidence in support of the following four elements of liability of the participating PRP(s) whose liability pursuant to section 107(a) of CERCLA, 42 U.S.C. 9607(a), is at issue, and any supporting documentation therefor:</P> <P> (i) The site at which EPA's response action was taken is a <E T="03">facility</E> as defined by section 101(9) of CERCLA, 42 U.S.C. 9601(9); </P> <P> (ii) There was a <E T="03">release or threat of release</E> within the meaning of sections 101(22) and 104(a) of CERCLA, 42 U.S.C. 9601(22) and 9604(a), of a <E T="03">hazardous substance</E> as defined by section 101(14) of CERCLA, 42 U.S.C 9601(14), at the facility at which EPA's response action was taken; </P> <P> (iii) The release or threat of release caused the United States to incur <E T="03">response costs</E> as defined in § 304.12(o) of this part; and </P> <P> (iv) The participating PRP is in one of the categories of liable parties in <PRTPAGE P="356"/> section 107(a) of CERCLA, 42 U.S.C. 9607(a); </P> <P>(3) An index of any documents which formed the basis for the selection of the response action taken at the facility (all indexed documents shall be made available to any participating PRP);</P> <P>(4) A summary, broken down by category, of all response costs incurred and to be incurred by the United States in connection with the response action taken by EPA at the facility (supporting documentation for the summary shall be made available to any participating PRP pursuant to the procedures described in Rule 1006 of the Federal Rules of Evidence);</P> <P>(5) To the extent such information is available, the names and addresses of all identified PRPs for the facility, the volume and nature of the substances contributed to the facility by each identified PRP, and a ranking by volume of the substances contributed to the facility;</P> <P>(6) A recommended location for the pre-hearing conference and the arbitral hearing; and</P> <P>(7) Any other statement or documentation that EPA deems necessary to support its claim.</P> <P>(c) Within thirty days after receipt of EPA's written statement, each participating PRP shall submit to the Arbitrator two copies of an answer and shall serve a copy of the answer upon all other parties. The answer shall in all cases include the information requested in paragraphs (c)(1), (c)(6), and (c)(7) of this section, shall include the information requested in paragraph (c)(2) of this section if the issue of the liability of the answering participating PRP has been submitted for resolution, shall include the information requested in paragraph (c)(3) of this section if any issue concerning the adequacy of EPA's response action has been submitted for resolution or may arise during the Arbitrator's determination of the dollar amount of response costs recoverable by EPA, shall include the information requested in paragraph (c)(4) of this section if the issue of the dollar amount of response costs recoverable by EPA has been submitted for resolution, and shall include the information requested in paragraph (c)(5) of this section if any issue concerning the allocation of responsibility for payment of EPA's award has been submitted for resolution:</P> <P>(1) Any objections to the statement of facts in EPA's written statement, and, if so, a counterstatement of facts;</P> <P> (2) Any objections to EPA's position on the liability of the answering participating PRP pursuant to section 107(a) of CERCLA, 42 U.S.C. 9607(a), a description of the evidence in support of the defenses to liability of the answering participating PRP which are specifically enumerated in section 107(b) of CERCLA, 42 U.S.C. 9607(b) ( <E T="03">i.e.,</E> that the release or threat of release of a hazardous substance at the facility was caused solely by an act of God, an act of war, an act or omission of an unrelated third party, or any combination thereof), and any supporting documentation thereof; </P> <P>(3) Any objections to the response action taken by EPA at the facility based upon any documents which formed the basis for the selection of the response action;</P> <P>(4) Any objections to EPA's summary and supporting documentation for all response costs incurred and to be incurred by the United States in connection with the response action taken by EPA at the facility;</P> <P>(5) Any documentation which the participating PRP deems relevant to the allocation of responsibility for payment of EPA's award.</P> <P>(6) A recommended location for the pre-hearing conference and the arbitral hearing; and</P> <P>(7) Any other statement or documentation that the participating PRP deems necessary to support its claim.</P> <P>(d) EPA may file a response to any participating PRP's answer within twenty days of receipt of such answer. Two copies of any such response shall be served upon the Arbitrator, and a copy of any such response shall be served upon all parties.</P> <P>(e) If EPA files a response, any participating PRP may file a reply thereto within ten days after receipt of such response. Two copies of any such reply shall be served upon the Arbitrator, and a copy of any such reply shall be served upon all parties.</P> </SECTION> <SECTION> <PRTPAGE P="357"/> <SECTNO>§ 304.31</SECTNO> <SUBJECT>Pre-hearing conference.</SUBJECT> <P> (a) The Arbitrator and the parties shall exchange witness lists (with a brief summary of the testimony of each witness) and any exhibits or documents that the parties have not submitted in their pleadings pursuant to § 304.30 of this part, within 110 days after the appointment of the Arbitrator ( <E T="03">see</E> § 304.22 of this part) or within 10 days prior to the pre-hearing conference, whichever is earlier. </P> <P>(b) The Arbitrator shall select the location, date, and time for the pre-hearing conference, giving due consideration to any recommendations by the parties.</P> <P> (c) The pre-hearing conference shall be held within one hundred twenty days after the appointment of the Arbitrator ( <E T="03">see</E> § 304.22 of this part). </P> <P>(d) The Arbitrator shall mail to each party notice of the pre-hearing conference not later than twenty days in advance of such conference, unless the parties by mutual agreement waive such notice.</P> <P>(e) Any party may be represented by counsel at the pre-hearing conference. A party who intends to be so represented shall notify the other parties and the Arbitrator of the name, address and telephone number of counsel at least three days prior to the date set for the pre-hearing conference. When an attorney has initiated the arbitration by signing the joint request for arbitration on behalf of a party, or when an attorney has filed a pleading on behalf of a party, such notice is deemed to have been given.</P> <P>(f) The pre-hearing conference may proceed in the absence of any party who, after due notice, fails to appear.</P> <P>(g)(1) At the pre-hearing conference, the Arbitrator and the parties shall exchange witness statements, a stipulation of uncontested facts, a statement of disputed issues, and any other documents, including written direct testimony, that will assist in prompt resolution of the dispute and avoid unnecessary proof.</P> <P>(2) The Arbitrator and the parties shall consider the settlement of all or part of the claim. The Arbitrator may encourage further settlement discussions among the parties. Any settlement reached may be set forth in a proposed decision in accordance with § 304.33 of this part. If such a settlement is not set forth in a proposed decision, the settlement shall be treated as an administrative settlement pursuant to section 122(h)(1) of CERCLA, 42 U.S.C. 9622(h)(1), and shall be subject to public comment pursuant to section 122(i) of CERCLA, 42 U.S.C. 9622(i).</P> </SECTION> <SECTION> <SECTNO>§ 304.32</SECTNO> <SUBJECT>Arbitral hearing.</SUBJECT> <P>(a) The Arbitrator may, in his sole discretion, schedule a hearing with the parties on one or more of the disputed issues identified in the statement of disputed issues pursuant to § 304.31(g)(1) of this part.</P> <P>(b) The Arbitrator shall select the location, date, and time for the arbitral hearing, giving due consideration to any recommendations by the parties.</P> <P> (c) The hearing shall commence within forty-five days after the pre-hearing conference ( <E T="03">see</E> § 304.31 of this part). The Arbitrator may, upon a showing by the parties that settlement is likely, extend the date for the hearing for up to thirty additional days, if further settlement discussions have been held pursuant to § 304.31(g)(2) of this part. </P> <P>(d) The Arbitrator shall mail to each party notice of the hearing not later than twenty days in advance of the hearing, unless the parties by mutual agreement waive such notice. Such notice shall include a statement of the disputed issues to be addressed at the hearing. The Arbitrator need not mail a second notice to the parties if the date for the hearing is extended pursuant to paragraph (c) of this section.</P> <P>(e) Any party may be represented by counsel at the hearing. A party who intends to be so represented shall notify the other parties and the Arbitrator of the name, address and telephone number of counsel at least three days prior to the date set for the hearing. When an attorney has initiated the arbitration by signing the joint request on behalf of a party, or when an attorney has filed a pleading on behalf of a party, or when notice has been given pursuant to § 304.31(e) of this part, such notice is deemed to have been given.</P> <P> (f) The Arbitrator shall make the necessary arrangements for the making of a true and accurate record of the arbitral hearing. <PRTPAGE P="358"/> </P> <P>(g) The Arbitrator shall make the necessary arrangements for the services of an interpreter upon the request of one or more of the parties.</P> <P>(h) The Arbitrator may take adjournments upon the request of any party or upon the Arbitrator's own initiative and shall take such adjournment when all of the parties agree thereto.</P> <P>(i) The Arbitrator shall administer oaths to all witnesses before they testify at the arbitral hearing.</P> <P>(j)(1) A hearing shall be opened by the recording of the location, date, and time of the hearing, the presence of the Arbitrator and the parties, and counsel if any, and by the Arbitrator's acknowledgment for the record of all pleadings and all other documents that have been filed by the parties.</P> <P>(2) The hearing shall be conducted in accordance with the Arbitrator's jurisdiction as defined by § 304.20 of this part.</P> <P>(3) The Arbitrator may, at any time, require oral statements clarifying the issues to be addressed at the hearing.</P> <P>(4) The Arbitrator may require the parties to present witnesses for questioning by the Arbitrator and for direct and cross-examination by the parties on any of the disputed issues, except for any disputed issues concerning the selection or adequacy of the response action, which shall be governed by paragraph (j)(6) of this section.</P> <P>(5) The Arbitrator shall define the scope of oral testimony. A party may present oral direct testimony only upon a showing of good cause why such testimony could not have been submitted in written form, or upon consent of all of the parties.</P> <P>(6) Notwithstanding §§ 304.20(e)(1) and 304.20(e)(4) of this part, the Arbitrator may permit any party to supplement the documents which formed the basis for the selection of the response action (with additional documents, affidavits, or oral testimony), if any party demonstrates that supplementation is appropriate based upon applicable principles of administrative law.</P> <P>(k)(1) Except as provided in paragraph (j)(6) of this section, exhibits and other documentary evidence not included in a party's pleadings, not exchanged prior to the pre-hearing conference pursuant to § 304.31(a) of this part, or not exchanged at the pre-hearing conference pursuant to § 304.31(g)(1) of this part, may be introduced at the hearing only upon a showing of good cause by the moving party or upon consent of all of the parties.</P> <P>(2) Except as provided in paragraph (j)(6) of this section, witnesses not identified in a party's witness list may be presented at the hearing only upon a showing of good cause by the moving party or upon consent of all of the parties.</P> <P>(3) The Arbitrator shall be the judge of the relevance and materiality of the evidence offered during the proceeding and of the applicability of legal privileges. Conformity to legal rules of evidence shall not be required.</P> <P> (4) The Arbitrator may make such orders as may be necessary for <E T="03">in camera</E> consideration of evidence for reasons of business confidentiality as defined by 40 CFR 2.201(e) and as consistent with section 104(e)(7) of CERCLA, 42 U.S.C. 9604(e)(7). </P> <P>(l) The hearing may proceed in the absence of any party who, after due notice, fails to appear or fails to obtain an adjournment. If a party, after due notice, fails to appear or fails to obtain an adjournment, such party will be deemed to have waived the right to be present at the hearing.</P> <P>(m) After all disputed issues have been heard by the Arbitrator, the Arbitrator may permit the parties to make closing statements, after which the Arbitrator shall declare the hearing closed.</P> <P>(n) The hearing shall be completed within two weeks, unless the Arbitrator extends the hearing for good cause.</P> <P>(o) The Arbitrator may permit the parties to submit proposed findings of fact, rulings, or orders within ten days after receipt of the hearing transcript or such longer time upon a finding of good cause.</P> <P>(p) The parties may provide, by written agreement, for the waiver of the hearing.</P> </SECTION> <SECTION> <SECTNO>§ 304.33</SECTNO> <SUBJECT>Arbitral decision and public comment.</SUBJECT> <P> (a) The Arbitrator shall render a proposed decision within forty-five days after the hearing is closed, or within <PRTPAGE P="359"/> forty-five days after the pre-hearing conference if no hearing is held, unless the parties have settled the dispute prior to the rendering of the proposed decision. </P> <P>(b)(1) The proposed decision shall be in writing and shall be signed by the Arbitrator. It shall be limited in accordance with the Arbitrator's jurisdiction as defined by § 304.20 of this part, and shall, if such issues have been jointly submitted by the parties for resolution, contain the Arbitrator's determination of:</P> <P>(i) Which participating PRPs, if any, are liable pursuant to section 107(a) of CERCLA, 42 U.S.C. 9607(a);</P> <P>(ii) The dollar amount of response costs, if any, to be awarded to EPA; and</P> <P>(iii) The allocation of responsibility for payment of EPA's award, if any, among the participating PRPs.</P> <P> (2) The proposed decision shall also assess arbitration fees and expenses ( <E T="03">see</E> § 304.41 of this part) in favor of any party, or combination of parties, and, in the event any administrative fees or expenses are due the Association, in favor of the Association. </P> <P>(c) If the parties settle their dispute during the course of the proceeding, the Arbitrator may, upon the parties' request, set forth in the terms of the agreed settlement in a proposed decision. Except as provided in § 304.20(b) of this part, a proposed decision which embodies an agreed settlement shall be subject to all applicable provisions of this part, including, but not limited to, paragraph (e) of this section and § 304.40 of this part.</P> <P>(d) The parties shall accept as legal delivery of the proposed decision the placing in the United States mail of a true copy of the proposed decision, sent by certified mail, return receipt requested, addressed to each party's last known address or each party's attorney's last known address, or by personal service.</P> <P> (e)(1) Pursuant to section 122(i) of CERCLA, 42 U.S.C. 9622(i), notice of the proposed decision shall be published promptly by EPA in the <E T="04">Federal Register.</E> Such notice shall include the name and location of the facility concerned, the names of the parties to the proceeding, and a brief summary of the proposed decision, and shall provide persons who are not parties to the proceeding a thirty-day period in which to file written comments relating to the proposed decision. Any filed comments shall be made available to the participating PRPs and to the public. The participating PRPs shall have ten days from the close of the public comment period in which to submit to EPA in writing their views on the merits of any comments filed. EPA shall consider any comments filed, and shall, within thirty days after the close of the ten-day period during which the participating PRPs may submit their views on any comments filed, provide written notice to the Arbitrator and the participating PRPs. The written notice shall be made available to the public and shall include: </P> <P>(i) A summary of any comments filed;</P> <P>(ii) Responses to any comments filed;</P> <P>(iii) A discussion of whether any comments filed disclose to EPA facts or considerations which indicate the proposed decision is inappropriate, improper or inadequate; and</P> <P>(iv) EPA's determination as to whether modification of the proposed decision or withdrawal from the arbitral proceeding is necessary based upon such comments.</P> <P> (2) If EPA's written notice does not state that modification or withdrawal is necessary based upon public comments, then the proposed decision shall become final thirty days after the date of issuance of EPA's written notice. If EPA's written notice states that modification or withdrawal is necessary, the parties shall have thirty days from the date of issuance of EPA's written notice to modify the proposed decision so that it is no longer inappropriate, improper or inadequate and to set forth the proposed decision, as modified, in an agreed settlement. If an agreed settlement is reached, such agreed settlement shall be the final decision. If the parties do not modify the proposed decision in an agreed settlement within thirty days, the proposed decision shall be null and void and of no legal effect, EPA shall withdraw from the proceeding, and the Arbitrator shall assess such administrative fees and expenses ( <E T="03">see</E> § 304.41 of this part) against the <PRTPAGE P="360"/> parties as the Arbitrator deems appropriate. </P> <P>(f) Payment of EPA's award, if any, and any fees or expenses due pursuant to the final decision, shall be made within thirty days after the date of the final decision.</P> <P>(g) The Arbitrator shall, upon written request of any party, furnish to such party certified facsimiles of all papers in the Arbitrator's possession that may be required in judicial proceedings relating to the arbitration pursuant to § 304.40 of this part.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Other Provisions</HD> <SECTION> <SECTNO>§ 304.40</SECTNO> <SUBJECT>Effect and enforcement of final decision.</SUBJECT> <P>(a) Pursuant to section 122(h)(4) of CERCLA, 42 U.S.C. 9622(h)(4), any participating PRP who has resolved his or her liability for an EPA claim through a final decision reached pursuant to the procedures established by this part shall not be liable for claims for contributions regarding matters addressed by the final decision.</P> <P>(b) The final decision shall be binding and conclusive upon the parties as to issues that were jointly submitted by the parties for resolution and addressed in the decision.</P> <P>(c)(1) If any award made in the final decision is not paid within the time required by § 304.33(f) of this part, the final decision may be enforced as a settlement under section 122(h) of CERCLA, 42 U.S.C. 9622(h), by the Attorney General on behalf of EPA in any appropriate Federal district court pursuant to section 122(h)(3) of CERCLA, 42 U.S.C. 9622(h)(3). Pursuant to section 122(h)(3) of CERCLA, the terms of the final decision shall not be subject to review in any such action.</P> <P>(2) In any such enforcement action initiated by the United States, the final decision may be challenged by any party if:</P> <P>(i) It was achieved through fraud, misconduct, or partiality on the part of the Arbitrator;</P> <P>(ii) It was achieved through fraud or misconduct by one of the parties affecting the result;</P> <P>(iii) The Arbitrator exceeded his or her jurisdiction under § 304.20 of this part or failed to decide the claim within the bounds of his or her authority under this part; or</P> <P>(iv) It violates public policy.</P> <P>(3) Except as necessary to show such fraud, misconduct, partiality, excess of jurisdiction or authority, or violation of public policy, in any such enforcement action, a party may not raise, for the purpose of overturning or otherwise challenging the final decision, issues arising in the claim that were not submitted for resolution by arbitration.</P> <P>(d) Except as provided in paragraph (c) of this section, and except as necessary for a participating PRP to defend against an action seeking contribution for matters addressed by the final decision, no final decision shall be admissible as evidence of any issue of fact or law in any proceeding brought under any provision of CERCLA or any other provision of law.</P> <P>(e) Neither the initiation of an arbitral proceeding nor the rendering of a final decision on an EPA claim shall preclude or otherwise affect the ability of the United States, including EPA, to:</P> <P>(1) Seek injunctive relief against any participating PRP for further response action at the facility concerned pursuant to CERCLA or any other applicable statute, regulation or legal theory; or</P> <P>(2) Take further response action at the facility concerned pursuant to CERCLA or any other applicable statute, regulation or legal theory; or</P> <P>(3) Seek reimbursement from any participating PRP for any costs not the subject of the arbitral proceeding pursuant to CERCLA or any other applicable statute, regulation or legal theory; or</P> <P>(4) Seek any relief for any violation of criminal law from any participating PRP; or</P> <P>(5) Seek damages for injury to, destruction of, or loss of natural resources from any participating PRP; or</P> <P>(6) Seek any relief, civil or criminal, from any person not a party to the arbitral proceeding under CERCLA or any other applicable statute, regulation or legal theory.</P> </SECTION> <SECTION> <PRTPAGE P="361"/> <SECTNO>§ 304.41</SECTNO> <SUBJECT>Administrative fees, expenses, and Arbitrator's fee.</SUBJECT> <P>(a) The Association shall prescribe an Administrative Fee Schedule and a Refund Schedule, which shall be subject to the approval of EPA. The schedule in effect at the time of filing or the time of refund shall be applicable.</P> <P>(b) Expenses of witnesses shall be borne by the party producing such witnesses. The expense of the stenographic record and all transcripts thereof shall be prorated equally among all parties ordering copies, unless otherwise agreed by the parties, or unless the Arbitrator assesses such expenses or any part thereof against any specified party in the decision. The expense of an interpreter shall be borne by the party requesting the interpreter.</P> <P>(c) The Association shall establish the per diem fee for the Arbitrator, subject to the approval of EPA, prior to the commencement of any activities by the Arbitrator. Arrangements for compensation of the Arbitrator shall be made by the Association.</P> <P>(d) The Association shall make appropriate arrangements to pay the Arbitrator's fee and the administrative fee, and shall render an accounting to the parties in accordance with the Arbitrator's award, within thirty days after the date of the final decision.</P> <P> (e) In any arbitration conducted prior to the selection of the Association ( <E T="03">see</E> § 304.21(e) of this part), all fees and expenses of the arbitral proceeding, including the Arbitrator's fee, shall be divided equally among all parties, except that expenses of witnesses shall be borne by the party producing such witnesses, expenses of an interpreter shall be borne by the party requesting such interpreter, and the expense of the stenographic record and all transcripts thereof shall be prorated equally among all parties ordering copies. </P> </SECTION> <SECTION> <SECTNO>§ 304.42</SECTNO> <SUBJECT>Miscellaneous provisions.</SUBJECT> <P>(a) Any party who proceeds with the arbitration knowing that any provision or requirement of this part has not been complied with, and who fails to object thereto either orally or in writing in a timely manner, shall be deemed to have waived the right to object.</P> <P>(b) The original of any joint request for arbitration, modification to any joint request for arbitration, pleading, letter, or other document filed in the proceeding (except for exhibits and other documentary evidence) shall be signed by the filing party or by his or her attorney.</P> <P>(c) All papers associated with the proceeding that are served by a party to an opposing party shall be served by personal service, or by United States first class mail, or by United States certified mail, return receipt requested, addressed to the party's attorney, or if the party is not represented by an attorney or the attorney cannot be located, to the last known address of the party. All papers associated with the proceeding that are served by the Arbitrator or by the Association shall be served by personal service or by United States certified mail, return receipt requested, addressed to the party's attorney, or if the party is not represented by an attorney or the attorney cannot be located, to the last known address of the party.</P> <P>(d) If any provision of this part, or the application of any provision of this part to any person or circumstance, is held invalid, the application of such provision to other persons or circumstances and the remainder of this part shall not be affected thereby.</P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 305</EAR> <HD SOURCE="HED">PART 305—COMPREHENSIVE ENVIRONMENTAL RESPONSE, COMPENSATION, AND LIABILITY ACT (CERCLA) ADMINISTRATIVE HEARING PROCEDURES FOR CLAIMS AGAINST THE SUPERFUND</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECHD>Sec.</SECHD> <SECTNO>305.1</SECTNO> <SUBJECT>Scope.</SUBJECT> <SECTNO>305.2</SECTNO> <SUBJECT>Use of number and gender.</SUBJECT> <SECTNO>305.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>305.4</SECTNO> <SUBJECT>Powers and duties of the Review Officer and the Presiding Officer; disqualification.</SUBJECT> <SECTNO>305.5</SECTNO> <SUBJECT>Filing, service, and form of pleadings and documents.</SUBJECT> <SECTNO>305.6</SECTNO> <SUBJECT>Computation and extension of time.</SUBJECT> <SECTNO>305.7</SECTNO> <SUBJECT> <E T="03">Ex parte</E> discussion of proceeding. </SUBJECT> <SECTNO>305.8</SECTNO> <SUBJECT>Examination of documents filed.</SUBJECT> </SUBPART> <SUBPART> <PRTPAGE P="362"/> <HD SOURCE="HED">Subpart B—Parties and Appearances</HD> <SECTNO>305.10</SECTNO> <SUBJECT>Appearances.</SUBJECT> <SECTNO>305.11</SECTNO> <SUBJECT>Consolidation and severance.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Prehearing Procedures</HD> <SECTNO>305.20</SECTNO> <SUBJECT>Request for a hearing; contents.</SUBJECT> <SECTNO>305.21</SECTNO> <SUBJECT>Amendment of request for a hearing; withdrawal.</SUBJECT> <SECTNO>305.22</SECTNO> <SUBJECT>Answer to the request for a hearing.</SUBJECT> <SECTNO>305.23</SECTNO> <SUBJECT>Motions.</SUBJECT> <SECTNO>305.24</SECTNO> <SUBJECT>Default order.</SUBJECT> <SECTNO>305.25</SECTNO> <SUBJECT>Informal settlement; voluntary agreement.</SUBJECT> <SECTNO>305.26</SECTNO> <SUBJECT>Prehearing conference.</SUBJECT> <SECTNO>305.27</SECTNO> <SUBJECT>Accelerated order, order to dismiss.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Hearing Procedure</HD> <SECTNO>305.30</SECTNO> <SUBJECT>Scheduling the hearing.</SUBJECT> <SECTNO>305.31</SECTNO> <SUBJECT>Evidence.</SUBJECT> <SECTNO>305.32</SECTNO> <SUBJECT>Objections and offers of proof.</SUBJECT> <SECTNO>305.33</SECTNO> <SUBJECT>Burden of presentation; burden of persuasion.</SUBJECT> <SECTNO>305.34</SECTNO> <SUBJECT>Filing the transcript.</SUBJECT> <SECTNO>305.35</SECTNO> <SUBJECT>Proposed findings, conclusions, and order.</SUBJECT> <SECTNO>305.36</SECTNO> <SUBJECT>Final order; costs.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P> 42 U.S.C. 9601 <E T="03">et seq.;</E> E.O. 12580, 52 FR 2923, 3 CFR, 1987 Comp. p. 193. </P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>58 FR 7706, Feb. 8, 1993, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECTION> <SECTNO>§ 305.1</SECTNO> <SUBJECT>Scope.</SUBJECT> <P> (a)(1) This part governs all administrative proceedings for the total or partial denial of response claims asserted against the Hazardous Substance Superfund (the Fund) pursuant to sections 111(a)(2) and 122(b)(1) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), 42 U.S.C. 9601 <E T="03">et seq.</E> </P> <P>(2) Sections 111(a)(2) and 122(b)(1) of CERCLA authorize EPA, among other things, to use the Fund to reimburse certain persons who file claims for eligible response costs incurred in carrying out the National Oil and Hazardous Substances Pollution Contingency Plan (NCP), 40 CFR part 300. In the event that the Claims Official declines to pay all or part of a claim, a claimant may request an administrative hearing pursuant to § 305.4(a) within 30 days after receiving notice of the Claims Official's decision. The procedures governing such a proceeding are set forth in this part.</P> <P>(b) Procedural questions arising at any stage of the proceeding which are not addressed in this part shall be resolved at the discretion of the Claims Official, the Review Officer, or the Presiding Officer, as appropriate.</P> </SECTION> <SECTION> <SECTNO>§ 305.2</SECTNO> <SUBJECT>Use of number and gender.</SUBJECT> <P>As used in this part, words in the singular also include the plural and words in the masculine gender also include the feminine, as the case may require.</P> </SECTION> <SECTION> <SECTNO>§ 305.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>(a) The following definitions apply to this part:</P> <P> <E T="03">Administrative Law Judge</E> means an Administrative Law Judge appointed under 5 U.S.C. 3105. </P> <P> <E T="03">Agency</E> or <E T="03">EPA</E> means the United States Environmental Protection Agency. </P> <P> <E T="03">CERCLA</E> or <E T="03">the Act</E> means the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), 42 U.S.C. 9601 <E T="03">et seq.</E> </P> <P> <E T="03">Claim</E> means a demand in writing for a sum certain, which is presented to the Fund in accordance with CERCLA sections 111 and 112. </P> <P> <E T="03">Claimant</E> means any person who presents a claim to the Fund for reimbursement under CERCLA section 112(b)(1). </P> <P> <E T="03">Claims Official</E> means the Assistant Administrator or the Regional Administrator or his delegatee who makes the initial decision awarding or denying a claim in whole or in part. </P> <P> <E T="03">Confidential business information</E> or <E T="03">CBI</E> means business information for which a person has made a “business confidentiality claim” as defined in 40 CFR 2.201(h) and in accordance with all applicable provisions in 40 CFR part 2, subpart B, except insofar as the Administrator has denied the claim pursuant to the procedures in 40 CFR part 2, subpart B. </P> <P> <E T="03">Final order</E> means the decision of the Review Officer which has become final in accordance with § 305.4(a), or of the Presiding Officer, or in the case of a voluntary agreement (see § 305.25) of <PRTPAGE P="363"/> the parties, disposing of all legal and factual matters presented in the Request for a Hearing. A final order made by the Review Officer or the Presiding Officer shall contain findings of fact, conclusions of law, as well as the reasons therefore, and an order for an award of a sum certain, or an explanation of why no award is granted. The final order may consist of one or more of the following documents: the findings of fact, conclusions of law, and order of the Review Officer or the Presiding Officer; a voluntary agreement; an accelerated order; or a default order, if the default order provides for dismissal of the Request for a Hearing with prejudice. A final order is the final administrative decision of the Agency and (with the exception of a voluntary agreement) is appealable to the Federal district court for the district where the release or threat of release took place. </P> <P> <E T="03">Fund</E> or <E T="03">Superfund</E> means the Hazardous Substance Superfund established by section 9507 of the Internal Revenue Code of 1986. </P> <P> <E T="03">Hearing</E> means a hearing on the record open to the public and conducted under this part. </P> <P> <E T="03">Hearing Clerk</E> means the Hearing Clerk, A-110, United States Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460. </P> <P> <E T="03">National Contingency Plan</E> or <E T="03">NCP</E> means the National Oil and Hazardous Substances Pollution Contingency Plan developed under section 311(c) of the Clean Water Act and revised pursuant to section 105 of CERCLA (40 CFR part 300). </P> <P> <E T="03">Party</E> means EPA or any person that participates in a proceeding under this part as a Requestor. </P> <P> <E T="03">Preauthorization</E> means EPA's prior approval to submit a claim against the Fund for necessary response costs incurred as a result of carrying out the NCP. </P> <P> <E T="03">Presiding Officer</E> means the Administrative Law Judge designated by the Chief Administrative Law Judge, or the Chief Administrative Law Judge himself, in the absence of such designation, to conduct a hearing pursuant to this part. </P> <P> <E T="03">Proceeding</E> means the entire process of review of a claim conducted pursuant to this part that is initiated by a Request for a Hearing. A hearing is part of a proceeding. </P> <P> <E T="03">Request for a Hearing</E> means a written notice requesting an administrative hearing of the total or partial denial of a claim by the Claims Official. Such hearing shall be governed by this part. </P> <P> <E T="03">Requestor</E> is the party who files a Request for a Hearing. </P> <P> <E T="03">Review Officer</E> means the EPA Administrator or his delegatee who is authorized to exercise all powers and duties prescribed or delegated under the Act or this part to him. </P> <P> <E T="03">Voluntary agreement</E> (see § 305.25) means a written communication, signed by all the parties or their counsel or representatives, containing an order acceptable to both the Requestor and EPA. A voluntary agreement shall state that, for purposes of this proceeding, EPA consents to the award of a sum certain to the Requestor or such other consideration as the parties deem appropriate. A voluntary agreement is effective without approval of the Presiding Officer and is a final order as defined in this part. </P> <P>(b) Terms defined in CERCLA or in 40 CFR part 300 and not defined in this part are used consistent with the meanings given in CERCLA or 40 CFR part 300.</P> </SECTION> <SECTION> <SECTNO>§ 305.4</SECTNO> <SUBJECT>Powers and duties of the Review Officer and the Presiding Officer; disqualification.</SUBJECT> <P> (a) <E T="03">Review Officer.</E> The Review Officer is authorized to receive Requests for a Hearing; attempt to promote settlement; make the decision of the Agency on the claim if the claimant does not request referral of the Request for a Hearing to the Chief Administrative Law Judge; and refer a Request for a Hearing to the Chief Administrative Law Judge when necessary. The Review Officer shall make the decision of the Agency on the claim in writing and shall serve the Requestor and the Claims Official with a copy of his decision. The Review Officer may, <E T="03">sua sponte,</E> without ruling on the merits of the Request for a Hearing, refer it to the Chief Adminstrative Law Judge for <PRTPAGE P="364"/> decision. If the Requestor is not satisfied with the decision of the Review Officer, he may, within 10 days of service of such decision, request that the Review Officer refer the Request for a Hearing to the Chief Administrative Law Judge. The Requestor shall also serve such notice on the Claims Official. Otherwise the decision of the Review Officer is a final order. When referring a matter to the Chief Administrative Law Judge, the Review Officer shall include the Request for a Hearing, a copy of his decision, and any other pertinent documents. The Review Officer also shall notify the Requestor, the Hearing Clerk, and the Claims Official when he refers a Request for a Hearing to the Chief Administrative Law Judge. The Hearing Clerk, shall, upon receipt of the relevant documents, establish a file for the hearing. Thereafter, a copy of all pleadings must be filed with the Hearing Clerk. This requirement is in addition to the applicable service of documentation requirements contained in § 305.5(b)(2). The Review Officer shall exercise all other powers and duties prescribed or delegated to him under the Act or this part. </P> <P> (b) <E T="03">Presiding Officer.</E> Upon receipt from the Review Officer of the Request for a Hearing, the Chief Administrative Law Judge shall designate himself or another Administrative Law Judge as Presiding Officer and shall transmit all documents related to the Request for a Hearing to the Presiding Officer. The Presiding Officer shall then notify the parties of his assignment pursuant to § 305.4(c). The Presiding Officer shall conduct a fair and impartial proceeding, assure that the facts are fully elicited, adjudicate all issues, and avoid delay. The Presiding Officer shall have authority to: </P> <P>(1) Conduct administrative hearings under this part;</P> <P>(2) Rule upon motions, requests, and offers of proof, dispose of procedural requests, and issue all necessary orders;</P> <P>(3) Administer oaths and affirmations;</P> <P>(4) Examine witnesses and receive documentary or other evidence;</P> <P> (5) Order a party, or an officer or agent thereof, for good cause, upon motion, or <E T="03">sua sponte,</E> to produce testimony, documents, or other nonprivileged evidence, and failing the production thereof without good cause being shown, draw adverse inferences against that party; </P> <P>(6) Admit or exclude evidence;</P> <P>(7) Hear and decide questions of law and fact;</P> <P>(8) Require parties to attend conferences for the settlement or simplification of the issues, or the expedition of the proceedings;</P> <P>(9) Extend the time limit for a final order in the hearing for a period not to exceed 60 days;</P> <P>(10) Render findings of fact, conclusions of law, and a final order;</P> <P>(11) Assess costs of the proceeding pursuant to § 305.36(b);</P> <P>(12) Do all other acts and take all measures necessary for the maintenance of order and for the efficient and impartial adjudication of issues arising in proceedings governed by this part; and</P> <P>(13) Resolve all disputes based on the evidence and applicable law; see § 305.31 concerning evidence.</P> <P> (c) The Presiding Officer shall notify the parties that the Request for a Hearing has been assigned to him, and that he has received the case file from the Chief Administrative Law Judge. After ruling on any objections to jurisdiction, or final disposition of any objections to disqualification, the Presiding Officer shall render a final order within 90 days after he affirmatively accepts such jurisdiction. The Presiding Officer shall render a final order within the allotted time, unless all parties agree in writing to an extension, or unless, in his discretion, either upon motion of a party or <E T="03">sua sponte,</E> he allows an extension of time not to exceed 60 days. If all parties agree in writing to an extension of the time period within which the Presiding Officer must issue a final order, the extension shall be for the period agreed to in writing by all parties. There are no limits to such periods other than that to which the parties have agreed in writing. An agreement by the parties to extend the time limit does not preclude the Presiding Officer from extending the time limit to issue a final order <E T="03">sua sponte</E> or upon motion of a party, nor does an extension by the <PRTPAGE P="365"/> Presiding Officer preclude the parties from agreeing to an extension. </P> <P> (d) <E T="03">Disqualification; withdrawal.</E> (1) Neither the Review Officer nor the Presiding Officer may perform functions provided for in this part regarding any matter in which he: has a financial interest; or has any relationship with a party or with the subject matter that would make it inappropriate for him to act. A party shall, by motion presented within 5 days after receiving notice of the assignment of the Presiding Officer, make any objection to his assignment. Otherwise, any objections to the qualifications of the Presiding Officer are waived, unless such objections arise after the time for presenting objections allowed by this paragraph. In such case, any objection must be made within 5 days of the time within which it arose. Either party may appeal the Presiding Officer's ruling on a motion to disqualify him to the Chief Administrative Law Judge. The Chief Administrative Law Judge shall rule on such motion in a timely fashion. When the Chief Administrative Law Judge is the Presiding Officer, he shall refer any challenge to his qualification to hear the case to another Administrative Law Judge for decision. The Review Officer or the Presiding Officer may at any time withdraw from any proceeding in which he deems himself disqualified or unable to act for any reason. </P> <P>(2) If the Review Officer or the Presiding Officer is disqualified or withdraws from the proceeding, a qualified individual who has none of the infirmities listed in paragraph (d)(1) of this section shall be assigned to replace him. The Administrator shall appoint a new Review Officer. The Chief Administrative Law Judge shall assign a new Presiding Officer from among the available Administrative Law Judges.</P> <P>(3) The Chief Administrative Law Judge shall have the power to rule on motions for disqualification as described in paragraph (d)(1) of this section and may, at any stage in the hearing, reassign the case to an Administrative Law Judge other than the one originally assigned in the event of the unavailability of the Administrative Law Judge or where reassignment will result in efficiency in the scheduling of hearings and will not prejudice the parties.</P> </SECTION> <SECTION> <SECTNO>§ 305.5</SECTNO> <SUBJECT>Filing, service, and form of pleadings and documents.</SUBJECT> <P> (a) <E T="03">Filing of pleadings and documents.</E> (1) The original and one copy of the Request for a Hearing shall be served on the Review Officer. Service on the Review Officer shall be made in the manner prescribed by paragraph (b) of this section. The Requestor shall serve his Request for a Hearing on the Review Officer within 30 days of receipt of the Claims Official's decision. The Review Officer shall promptly notify the Claims Official of receipt of a Request for a Hearing and shall provide him a copy of such request. The original of all other pleadings and documents shall be filed with the appropriate official and a copy served on each party. </P> <P>(2) A certificate of service shall accompany each document filed or served. Except as otherwise provided, a party filing documents with the Hearing Clerk, after filing of the answer, shall serve copies thereof upon all other parties and the Presiding Officer. The Presiding Officer shall maintain a duplicate file during the course of the proceeding.</P> <P>(3) When the Presiding Officer corresponds directly with a party, the original of the correspondence shall be sent to the Hearing Clerk, a copy shall be maintained by the Presiding Officer in the duplicate file, and a copy shall be sent to all parties. A party who corresponds directly with the Presiding Officer shall, in addition to serving all other parties, send a copy of all such correspondence to the Hearing Clerk. A certificate of service shall accompany each document served under this paragraph.</P> <P> (b) <E T="03">Service of pleadings and documents</E> —(1) <E T="03">Service of Request for a Hearing.</E> Service of a signed original Request for a Hearing with copy thereof may be made on the Review Officer either personally or by certified mail, return receipt requested. The Review Officer shall assign a docket number to the Request for a Hearing, and shall notify the Requestor, the Hearing Clerk, and the Claims Official of such docket number. <PRTPAGE P="366"/> </P> <P> (2) <E T="03">Service of documents other than the Request for a Hearing.</E> (i) All documents other than the Request for a Hearing may be served on the appropriate official personally or by certified mail, return receipt requested, or by first class mail, postage pre-paid. After initiation of the hearing, a party serving any document must also submit a copy of such document to the Hearing Clerk. </P> <P>(ii) Service upon the Claims Official, the Review Officer, or the Hearing Clerk shall be made by delivering two copies of the document to the appropriate official in the manner prescribed in paragraph (b)(2)(i) of this section.</P> <P>(iii) Service upon a domestic or foreign corporation or upon a partnership or other unincorporated association that is subject to an action under a common name shall be made in the manner prescribed in paragraph (b)(2)(i) of this section, directed to an officer, partner, a managing or general agent, or to any other person authorized by appointment or by Federal or State law to receive service of process.</P> <P>(iv) Service upon a State or local unit of government, or a State or local officer, agency, department, corporation or other instrumentality shall be made by serving a copy of the document in the manner prescribed by the law of the State for the service of process on any such persons, or:</P> <P>(A) If upon a State or local unit of government, or a State or local department, agency, corporation or other instrumentality, by personal service or certified mail, as prescribed by paragraph (b)(1) of this section, directed to the Chief Executive Officer thereof;</P> <P>(B) If upon a State or local officer, by personal service or certified mail, as prescribed by paragraph (b)(1) of this section, to such officer.</P> <P>(v) Service upon an officer of agency of the United States shall be made by delivering a copy of the document to the officer or agency, or in any manner prescribed for service by applicable regulations. If the agency is a corporation, the document shall be served as prescribed in paragraph (b)(2)(iii) of this section.</P> <P> (c) <E T="03">Form of pleadings and documents.</E> (1) Except as provided herein, or by order of the Presiding Officer, there are no specific requirements as to the form of documents. </P> <P>(2) The first page of every pleading, letter, or other document shall contain a caption identifying the Requestor, the docket number assigned by the Review Officer, and the official to whom the document is directed. All pleadings greater than ten pages in length, and all legal briefs, shall contain a table of contents and a table of citations with page references.</P> <P>(3) The original of any pleading, letter or other document (other than exhibits) shall be signed by the party filing or by his counsel or other representative. The signature constitutes a representation by the signer that he has read the pleading, letter, or other document, that to the best of his knowledge, information and belief, the statements made therein are true, and that it is not interposed for delay.</P> <P>(4) The initial document filed by any party shall contain his name, address and telephone number. Any changes in this information shall be communicated promptly to the appropriate official, and all parties to the proceeding. A party who fails to furnish such information and any changes thereto shall be deemed to have waived his right to notice and service under this part.</P> <P>(5) The Claims Official, Review Officer, Presiding Officer, or Hearing Clerk may refuse to file any document which does not comply with paragraph (c) of this section. Written notice of such refusal, stating the reasons therefore, shall be promptly given to the party submitting the document. Such party may amend and resubmit any document refused for filing, if such amendment and resubmission is timely. If, for good cause shown, amendment and resubmission is not timely, a party may request an extension of the time in which to submit a document to the appropriate official.</P> <P> (d) <E T="03">Confidential Business Information.</E> (1) Any person filing or serving any pleading or document under this part containing information claimed as Confidential Business Information (CBI) shall assert the claim as specified in 40 CFR 2.203(b). The failure to assert a CBI claim in accordance with this section, at the time the pleading or <PRTPAGE P="367"/> document is filed or served, shall constitute a waiver of any rights to assert any CBI claim with respect to the business information in the pleading or document. </P> <P>(2) Any pleading or document containing CBI shall be filed in a double envelope. The outside envelope should not mention that CBI is contained. The inside envelope shall specify the envelope contains CBI.</P> <P>(3) For each original or copy of each pleading or document filed or served which contains CBI, the person shall submit two versions.</P> <P>(i) One version must be complete. In that version, the person shall mark the specific information claimed as CBI pursuant to this section.</P> <P>(ii) The CBI must be deleted in the second version, and all information claimed as CBI must be indicated in such version, as well as the nature of the information claimed as CBI, and the fact that another version containing the CBI has been filed pursuant to this section.</P> <P>(4) The Hearing Clerk shall not accept for filing any CBI pleading or document which does not comply with the requirements of paragraphs (d)(2) and (3) of this section.</P> <P>(5) All claims of CBI, and all information entitled to treatment as CBI, shall be governed by the provisions of 40 CFR part 2, subpart B, for CERCLA, as well as any other EPA regulatory provisions affecting the confidentiality of the information.</P> <CITA>[58 FR 7706, Feb. 8, 1993, as amended at 59 FR 26, Jan. 3, 1994]</CITA> </SECTION> <SECTION> <SECTNO>§ 305.6</SECTNO> <SUBJECT>Computation and extension of time.</SUBJECT> <P> (a) <E T="03">Computation.</E> In computing any period of time described or allowed in this part, except as otherwise provided, the day of the event from which the designated period begins to run shall not be included. Saturdays, Sundays, and Federal legal holidays shall be included. When a stated time expires on a Saturday, Sunday, or Federal legal holiday, the stated time period shall be extended to include the next business day. </P> <P> (b) <E T="03">Extension of time.</E> The Presiding Officer, or Review Officer as appropriate, may grant an extension of time for the filing of any pleading, document or motion upon timely motion of a party to the proceeding, for good cause shown, and after consideration of prejudice to other parties, or upon his own motion. Such a motion by a party may only be made after notice to all other parties, unless the movant can show good cause why serving notice is impracticable. The motion shall be filed in advance of the date on which the pleading, document or motion is due to be filed, unless the failure of a party to make timely motion for extension of time was the result of excusable neglect. </P> <P> (c) <E T="03">Service by mail.</E> Service of the Request for a Hearing is complete when the return receipt is signed by the Review Officer. Service of all other pleadings and documents is complete upon mailing. Where a pleading or document is served by mail, 5 days shall be added to the time allowed by this part for the filing of a responsive pleading or document. </P> </SECTION> <SECTION> <SECTNO>§ 305.7</SECTNO> <SUBJECT> <E T="7462">Ex parte</E> discussion of proceeding. </SUBJECT> <P> At no time after the Request for a Hearing is referred to the Presiding Officer shall the Presiding Officer discuss <E T="03">ex parte</E> the merits of the proceeding with any interested person outside the Agency, with any Agency staff member who performed a prosecutorial or investigative function in such proceeding or a factually related proceeding, or with any representative of such person. Any <E T="03">ex parte</E> memorandum or other communication addressed to the Presiding Officer during the pendency of the proceeding and relating to the merits thereof, by or on behalf of any party, shall be regarded as an argument made in the proceeding and shall be served upon all other parties. Any other party shall be given the opportunity to reply to such memorandum or communication. </P> </SECTION> <SECTION> <SECTNO>§ 305.8</SECTNO> <SUBJECT>Examination of documents filed.</SUBJECT> <P> (a) <E T="03">Inspection of Documents.</E> Subject to the provisions of law restricting public disclosure of confidential information, any person may, during Agency business hours, inspect and copy any document filed in any proceeding. <PRTPAGE P="368"/> Such documents shall be made available by the Claims Official, Review Officer, or Hearing Clerk, as appropriate. </P> <P> (b) <E T="03">Costs.</E> The cost of duplicating documents filed in any proceeding shall be borne by the person seeking copies of such documents. The Agency may waive this cost in appropriate cases. </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Parties and Appearances</HD> <SECTION> <SECTNO>§ 305.10</SECTNO> <SUBJECT>Appearances.</SUBJECT> <P>Any party may appear in person or by counsel or other representative. A partner may appear on behalf of a partnership and an officer may appear on behalf of a corporation. Persons who appear as counsel or other representative must conform to the standards of conduct and ethics required of practitioners before the courts of the United States.</P> </SECTION> <SECTION> <SECTNO>§ 305.11</SECTNO> <SUBJECT>Consolidation and severance.</SUBJECT> <P> (a) <E T="03">Consolidation.</E> The Presiding Officer may, by motion or <E T="03">sua sponte,</E> consolidate any or all matters at issue in two or more proceedings docketed under this part where: </P> <P>(1) There exist common parties or common questions of fact or law;</P> <P>(2) Consolidation would expedite and simplify consideration of the issues; and</P> <P>(3) Consolidation would not adversely affect the rights of parties engaged in otherwise separate proceedings.</P> <P> (b) <E T="03">Severance.</E> The Presiding Officer may, by motion or <E T="03">sua sponte,</E> for good cause shown, order any proceedings severed with respect to any or all parties or issues. </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Prehearing Procedures</HD> <SECTION> <SECTNO>§ 305.20</SECTNO> <SUBJECT>Request for a hearing; contents.</SUBJECT> <P>(a) Within 30 days after receiving notice that the Claims Official has declined to pay all or part of a claim, the claimant may file a Request for a Hearing with the Review Officer. The Request for a Hearing shall contain:</P> <P>(1) A statement of the authority for the Request for a Hearing;</P> <P>(2) A concise statement of the reasons that the Requestor disputes the Claims Official's denial of all or part of the claim;</P> <P>(3) A request for an administrative hearing concerning the Claims Official's total or partial denial of his claim pursuant to this part; and</P> <P>(4) A statement of amount that the Requestor demands to be awarded from the Fund.</P> <P>(b) The Requestor must file with the Request for a Hearing two copies of:</P> <P>(1) The Preauthorization Decision Document for the response work that is the subject of the claim;</P> <P>(2) The claim filed with EPA pursuant to CERCLA section 111(a)(2) or 122(b)(1); and</P> <P>(3) The written notice from the Claims Official denying all or part of the claim.</P> </SECTION> <SECTION> <SECTNO>§ 305.21</SECTNO> <SUBJECT>Amendment of request for a hearing; withdrawal.</SUBJECT> <P> (a) <E T="03">Amendment of Request for a Hearing.</E> The Requestor may amend the Request for a Hearing once as a matter of right at any time before the answer is filed. Otherwise the Requestor may amend the Request for a Hearing only upon motion granted by the Presiding Officer. The Claims Official shall have 10 additional days from the date of service of the amended claim to file his answer. </P> <P> (b) <E T="03">Withdrawal of Request for a Hearing.</E> The Requestor may withdraw the Request for a Hearing, or any part thereof, without prejudice one time before the answer has been filed. After one withdrawal without prejudice before the filing of an answer, or after the filing of an answer, the Requestor may withdraw the Request for a Hearing, or any part thereof, without prejudice, only upon motion granted by the Presiding Officer. In no case may a Request for a Hearing be filed more than 30 days after the Requestor has received notice that the Claims Official has declined to pay all or part of a claim. </P> </SECTION> <SECTION> <PRTPAGE P="369"/> <SECTNO>§ 305.22</SECTNO> <SUBJECT>Answer to the request for a hearing.</SUBJECT> <P> (a) <E T="03">General.</E> The Claims Official shall file an original and one copy of a written answer to the Request for a Hearing with the Hearing Clerk when he: contests any material fact upon which the Request for a Hearing is based; contends that the amount of money demanded in the Request for a Hearing is inappropriate; or contends that he is entitled to judgment as a matter of law. Any such answer to the Request for a Hearing must be filed with the Hearing Clerk and served on all parties within 15 days after the Presiding Officer has assumed jurisdiction over the case as provided by § 305.4(d). </P> <P> (b) <E T="03">Contents of the answer.</E> The answer shall clearly and directly admit, deny, or explain each of the factual allegations in the Request for a Hearing with regard to which the Claims Official has any knowledge. When the Claims Official has no knowledge of a particular allegation and so states, the allegation is deemed denied. The answer shall also state: </P> <P>(1) The circumstances or arguments which are alleged to constitute the grounds of defense; and</P> <P>(2) The facts which the Claims Official intends to place at issue.</P> <P> (c) <E T="03">Failure to admit, deny, or explain.</E> Failure of the Claims Official to admit, deny or explain any material factual allegation contained in the claim constitutes an admission of the allegation. </P> <P> (d) <E T="03">Amendment of the answer.</E> The Claims Official may amend the answer to the Request for a Hearing upon motion granted by the Presiding Officer. </P> </SECTION> <SECTION> <SECTNO>§ 305.23</SECTNO> <SUBJECT>Motions.</SUBJECT> <P> (a) <E T="03">General.</E> All motions, except those made orally on the record during a hearing, shall: be in writing; state the grounds therefor with particularity; set forth the relief sought and a proposed order; and be accompanied by an affidavit, certificate, other evidence, or legal memorandum relied upon. Such motions shall be served as provided by § 305.5(b)(2)(i). </P> <P> (b) <E T="03">Response to motions.</E> A party's response to any written motion must be filed within 10 days after service of such motion, unless additional time is allowed for such response. The response shall be accompanied by any affidavit, certificate, other evidence or legal memorandum relied upon. If no response is filed within the designated period, the parties may be deemed to have waived any objection to the granting of the motion. The Presiding Officer may set a shorter time for response, or make such other orders concerning the disposition of motions as he deems appropriate. </P> <P> (c) <E T="03">Decision.</E> The Presiding Officer, or Chief Administrative Law Judge, in the absence of a Presiding Officer, shall rule on all motions. Oral argument on motions will be permitted in the discretion of the Presiding Officer. See § 305.4(a) concerning motions to extend the time limit for final orders. </P> </SECTION> <SECTION> <SECTNO>§ 305.24</SECTNO> <SUBJECT>Default order.</SUBJECT> <P> (a) <E T="03">Default.</E> A party may be found to be in default: after motion, upon failure of the Claims Official to file a timely answer to the Request for a Hearing; after motion or <E T="03">sua sponte,</E> upon failure to comply with a prehearing or hearing order of the Presiding Officer; or after motion or <E T="03">sua sponte,</E> upon failure to appear at a conference or hearing without good cause being shown. No finding of default on the basis of failure to appear at a hearing shall be made against the Claims Official unless the Requestor presents sufficient evidence to the Presiding Officer to establish a prima facie case in support of his claim. Any motion for a default order shall include a proposed default order and shall be served upon all parties. The alleged defaulting party shall have 10 days from service to reply to the motion. Default by the Claims Official constitutes, for purposes of the pending action only, an admission of all facts alleged in the claim and a waiver of his right to a hearing on such factual allegations. Default by the Requestor may result in the dismissal of the Request for a Hearing with prejudice. </P> <P> (b) <E T="03">Procedures upon default.</E> When the Presiding Officer finds a default has occurred, he shall issue a default order against the defaulting party. The default order shall constitute the final order in the proceeding, and shall be filed with the Hearing Clerk. <PRTPAGE P="370"/> </P> <P> (c) <E T="03">Contents of a default order.</E> A default order shall include findings of fact showing the grounds for the order; conclusions regarding all material issues of law; costs to be assessed pursuant to § 305.36, if applicable; and, the amount to be awarded the claimant, if any. </P> <P> (d) <E T="03">Setting aside a default order.</E> For good cause shown, the Presiding Officer may set aside a default order. </P> </SECTION> <SECTION> <SECTNO>§ 305.25</SECTNO> <SUBJECT>Informal settlement; voluntary agreement.</SUBJECT> <P> (a) <E T="03">Settlement policy.</E> The Agency encourages settlement of a proceeding at any time if the settlement is consistent with the provisions and objectives of the Act and applicable regulations. Settlement conferences shall not affect the Claims Official's obligation to file a timely answer under § 305.22. </P> <P> (b) <E T="03">Voluntary agreement.</E> The voluntary agreement shall state that, for the purpose of this proceeding, the Claims Official consents to the award of a sum certain to the Requestor or in the case of no award, that both parties agree to settle the matter. The voluntary agreement shall include an order acceptable to both the Requestor and EPA, and shall be signed by all parties or their counsel or representatives. A voluntary agreement is effective without approval of the Presiding Officer and is a final order as defined in this part. </P> </SECTION> <SECTION> <SECTNO>§ 305.26</SECTNO> <SUBJECT>Prehearing conference.</SUBJECT> <P> (a) <E T="03">Purpose of prehearing conference.</E> Unless a conference appears unnecessary, the Presiding Officer, at any time before the hearing begins, shall direct the parties and their counsel or other representatives to appear at a conference before him to consider: </P> <P>(1) The settlement of the case;</P> <P>(2) The simplification of issues and stipulation of facts not in dispute;</P> <P>(3) The necessity or desirability of amendments to the pleadings;</P> <P>(4) The exchange of exhibits, documents, prepared testimony, and admissions or stipulations of fact which will avoid unnecessary proof;</P> <P>(5) The limitation of the number of expert or other witnesses;</P> <P>(6) Setting a time and place for the hearing; and</P> <P>(7) Any other matters which may expedite the disposition of the proceeding.</P> <P> (b) <E T="03">Exchange of witness lists and documents.</E> Unless otherwise ordered by the Presiding Officer, each party at the prehearing conference shall make available to all other parties: the names of the expert and other witnesses he intends to call, together with a brief narrative summary of their expected testimony; and copies of all documents and exhibits which each party intends to introduce into evidence. Documents and exhibits shall be marked for identification as ordered by the Presiding Officer. Documents that have not been exchanged and witnesses whose names have not been exchanged shall not be introduced into evidence or allowed to testify without permission of the Presiding Officer. The Presiding Officer shall allow the parties reasonable opportunity to review new evidence. </P> <P> (c) <E T="03">Record of the prehearing conference.</E> No transcript of a prehearing conference relating to settlement shall be made. With respect to other prehearing conferences, no transcript of any prehearing conferences shall be made unless ordered by the Presiding Officer upon motion of a party or <E T="03">sua sponte.</E> The Presiding Officer shall prepare and file for the record a written summary of the action taken at the conference and shall serve that summary on all parties in the manner provided in § 305.5(b)(2). The summary shall incorporate any written stipulations or agreements of the parties and all rulings and appropriate orders containing directions to the parties. </P> <P> (d) <E T="03">Location of the prehearing conference.</E> The prehearing conference shall be held in the county where the release occurred, in the city in which the EPA Regional Office is located (in the Region where the release or threat of release occurred), or in Washington, DC, unless the Presiding Officer determines that there is good cause to hold it at another location or by telephone. </P> <P> (e) <E T="03">Unavailability of a prehearing conference.</E> If a prehearing conference is unnecessary or impracticable, the Presiding Officer, on motion or <E T="03">sua sponte,</E> may direct the parties to correspond <PRTPAGE P="371"/> with him to accomplish any of the objectives set forth in this section. </P> <P> (f) <E T="03">Other discovery.</E> (1) Discovery shall include any of the methods described in rule 26(a) of the Federal Rules of Civil Procedure. </P> <P>(2) The parties may conduct any mutually agreed upon discovery without participation or determination of the Presiding Officer except that such voluntary discovery may be subject to such time limitations as the Presiding Officer deems appropriate.</P> <P>(3) Except as provided by paragraphs (b) and (f)(2) of this section, further discovery, under this section, shall be permitted only pursuant to order of the Presiding Officer. Any party to the proceeding desiring an order of discovery shall make a motion therefore. Such motion shall set forth:</P> <P>(i) The circumstances warranting the discovery;</P> <P>(ii) The nature of the information expected to be discovered; and</P> <P>(iii) The method of discovery sought, including, where relevant, the proposed time and place where the discovery will be conducted.</P> <P>(4) The Presiding Officer shall issue an order for discovery only upon a showing of good cause and upon a determination:</P> <P>(i) That such discovery will not in any way unreasonably delay the proceeding;</P> <P>(ii) That the information to be obtained is not otherwise obtainable; and</P> <P>(iii) That such information has significant probative value.</P> <FP>If the Presiding Officer determines that the motion should be granted, he shall issue an order for such discovery together with the conditions and terms thereof.</FP> <P>(5) The Presiding Officer shall order depositions upon oral questions only upon a finding that:</P> <P>(i) The information sought cannot be obtained by alternative methods of discovery; or</P> <P>(ii) There is a substantial reason to believe that relevant and probative evidence may otherwise not be preserved for presentation by a witness at the hearing.</P> <P>(6) When the information sought to be obtained is within the control of one of the parties, failure to comply with an order issued pursuant to this paragraph may lead to:</P> <P>(i) The inference that the information to be discovered would be adverse to the party from whom the information was sought; or</P> <P>(ii) The issuance of a default order under § 305.24(a).</P> <P> (g) <E T="03">Interpreters.</E> The Presiding Officer shall make the necessary arrangements for the services of an interpreter upon the motion of a party or <E T="03">sua sponte.</E> The cost of the interpreter shall normally be borne by the party requesting the service, but the Presiding Officer may apportion the cost among the parties as justice demands. </P> </SECTION> <SECTION> <SECTNO>§ 305.27</SECTNO> <SUBJECT>Accelerated order, order to dismiss.</SUBJECT> <P> (a) <E T="03">General.</E> The Presiding Officer, upon motion of any party or <E T="03">sua sponte,</E> may at any time render an accelerated order in favor of the Requestor or the Claims Official as to all or any part of the proceeding, without further hearing or upon such limited additional evidence, such as affidavits, as he may require, if no genuine issue of material fact exists and the party is entitled to judgment as a matter of law, as to all or any part of the proceeding. In addition, the Presiding Officer, upon motion of the Claims Official, may at any time dismiss a Request for a Hearing without further hearing or upon such limited additional evidence as he requires, on the basis of failure to establish a prima facie case or other grounds which show no right to relief on the part of the Requestor. </P> <P> (b) <E T="03">Effect.</E> (1) If an accelerated order or an order to dismiss is issued as to all the issues in the proceeding, the order constitutes the final order of the Presiding Officer, and shall be filed with the Hearing Clerk. </P> <P>(2) If an accelerated order or an order to dismiss is rendered on less than all issues in the proceeding, the Presiding Officer shall determine what material facts exist without substantial controversy and what material facts remain controverted in good faith. He shall thereupon issue an interlocutory order specifying the facts which appear substantially uncontroverted, and the issues upon which the hearing will proceed.</P> </SECTION> </SUBPART> <SUBPART> <PRTPAGE P="372"/> <HD SOURCE="HED">Subpart D—Hearing Procedure</HD> <SECTION> <SECTNO>§ 305.30</SECTNO> <SUBJECT>Scheduling the hearing.</SUBJECT> <P> (a) <E T="03">Filing of answer.</E> When an answer is filed, the Hearing Clerk shall forward such answer to the Presiding Officer. </P> <P> (b) <E T="03">Notice of hearing.</E> The Presiding Officer shall serve upon the parties a notice of hearing setting forth a time and place for the hearing. The Presiding Officer may issue the notice of hearing at any appropriate time, but not later than 20 days prior to the date set for the hearing. </P> <P> (c) <E T="03">Postponement of hearing.</E> No request for postponement of a hearing shall be granted except upon motion and for good cause shown. </P> <P> (d) <E T="03">Location of the hearing.</E> The location of the hearing shall be determined in accordance with the method of determining the location of a prehearing conference under § 305.26(d). </P> </SECTION> <SECTION> <SECTNO>§ 305.31</SECTNO> <SUBJECT>Evidence.</SUBJECT> <P> (a) <E T="03">General.</E> The Presiding Officer shall admit all evidence which is not irrelevant, immaterial, unduly repetitious, or otherwise unreliable or of little probative value, except that evidence which would be excluded in the Federal courts under Rule 408 of the Federal Rules of Evidence (28 U.S.C. appendix) is not admissible. In the presentation, admission, disposition, and use of evidence, the Presiding Officer shall follow the provisions regarding confidential business information of 40 CFR part 2, subpart B for CERCLA. The commercial or trade secret status of any information shall not, however, preclude its being introduced into evidence. The Presiding Officer may make such orders as may be necessary to consider such evidence <E T="03">in camera,</E> including the preparation of a supplemental final order to address questions of law or fact which arise out of that portion of the evidence which is confidential or which includes trade secrets. For the purpose of recording the hearing, the court reporter shall be considered “a person under contract or subcontract to EPA to perform work for EPA in connection with the Act or regulations which implement the Act” pursuant to 40 CFR 2.301(h)(2); unless the affected business, as defined in 40 CFR 2.201(d), agrees to some other procedures approved by the Presiding Officer. </P> <P> (b) <E T="03">Examination of witnesses.</E> Witnesses shall be examined orally, under oath or affirmation, except as otherwise provided in this part or by the Presiding Officer. A party shall have the right to cross-examine a witness who appears at the hearing provided that such cross-examination is not unduly repetitious. </P> <P> (c) <E T="03">Verified statements.</E> The Presiding Officer may admit and insert into the record as evidence, in lieu of oral testimony, statements of fact or opinions prepared by a witness. The admissibility of the evidence contained in the statement shall be subject to the same rules as if the testimony were produced under oral examination. Before any such statement is read or admitted into evidence, the witness shall deliver a copy of the statement to the Presiding Officer, the reporter, and opposing counsel. The witness presenting the statement shall swear to or affirm the statement and shall be subject to appropriate oral cross-examination upon the contents thereof. </P> <P> (d) <E T="03">Admission of affidavits and other statements where the witness is unavailable.</E> The Presiding Officer may admit into evidence affidavits and other verified written statements of witnesses who are unavailable. The term “unavailable” shall have the meaning accorded to it by rule 804(a) of the Federal Rules of Evidence. </P> <P> (e) <E T="03">Exhibits.</E> Where practicable, an original and one copy of each exhibit shall be filed with the Presiding Officer for the record and copy shall be furnished to each party. A true copy of any exhibit may be substituted for the original. </P> <P> (f) <E T="03">Official notice.</E> Official notice may be taken of any matter which may be judicially noticed in the Federal courts and of other facts within the specialized knowledge and experience of the Agency. Opposing parties shall be given adequate opportunity to show that such facts are erroneously noticed. </P> </SECTION> <SECTION> <SECTNO>§ 305.32</SECTNO> <SUBJECT>Objections and offers of proof.</SUBJECT> <P> (a) <E T="03">Objection.</E> Any objection concerning the conduct of the hearing may be stated orally or in writing during <PRTPAGE P="373"/> the hearing. The party raising the objection must supply a short statement of its grounds. The ruling by the Presiding Officer on any objection and the reasons given for it shall be part of the record. An exception to each objection overruled shall be automatic and is not waived by further participation in the hearing. </P> <P> (b) <E T="03">Offer of proof.</E> Whenever evidence is excluded from the record, the party offering the evidence may make an offer of proof, which shall be included in the record. The offer of proof for excluded oral testimony shall consist of a brief statement describing the nature of the evidence excluded. The offer of proof for excluded documents or exhibits shall consist of the insertion into the record of the documents or exhibits excluded. </P> </SECTION> <SECTION> <SECTNO>§ 305.33</SECTNO> <SUBJECT>Burden of presentation; burden of persuasion.</SUBJECT> <P>The Requestor has the burden of going forward with his case and of proving that the amount demanded in the Request for a Hearing is justified. Accordingly, the Requestor bears the burdens of presentation and persuasion. Following the establishment of a prima facie case, the Claims Official shall have the burden of presenting and of going forward with any defense to the allegations set forth in the Request for a Hearing. Each matter of controversy shall be determined by the Presiding Officer upon a preponderance of the evidence.</P> </SECTION> <SECTION> <SECTNO>§ 305.34</SECTNO> <SUBJECT>Filing the transcript.</SUBJECT> <P>The hearing shall be transcribed verbatim. Promptly following the taking of the last evidence, the reporter shall transmit to the Hearing Clerk the original and as many copies of the transcript of testimony as are called for in the reporter's contract with the Agency, and also shall transmit to the Presiding Officer a copy of the transcript. A certificate of service shall accompany each copy of the transcript. The Hearing Clerk shall notify all the parties of the availability of the transcript and shall furnish the Requestor with a copy of the transcript upon payment of the cost of reproduction, unless a Requestor can show that the cost is unduly burdensome. Any person not a party to the proceeding may receive a copy of the transcript upon payment of the reproduction fee, except for those parts of the transcript ordered to be kept confidential by the Presiding Officer. Any party may file a motion to correct the transcript in accordance with the provision of § 305.23.</P> </SECTION> <SECTION> <SECTNO>§ 305.35</SECTNO> <SUBJECT>Proposed findings, conclusions, and order.</SUBJECT> <P>Within 20 days after the parties are notified of the availability of the transcript, any party may submit for the consideration of the Presiding Officer proposed findings of fact, conclusions of law, and a proposed order, together with briefs in support thereof. The Presiding Officer shall set a time by which reply briefs may be submitted. The Presiding Officer may by order extend the time or change the schedule of such submissions or allow further submissions as may be appropriate. All submissions shall be in writing, shall be served upon all parties, and shall contain references to the record for all proposed findings of fact and appropriate citations for authorities relied upon.</P> </SECTION> <SECTION> <SECTNO>§ 305.36</SECTNO> <SUBJECT>Final order; costs.</SUBJECT> <P> (a) <E T="03">Filing and content.</E> The Presiding Officer shall issue and file with the Hearing Clerk a final order as soon as practicable after the period for filing reply briefs under § 305.35 has expired, but within the time allowed for issuance of a final order as prescribed by § 305.4(d). The final order shall contain his findings of fact, conclusions of law, as well as the reasons therefor, and an order for an award for a sum certain, or an explanation of why no award is granted. </P> <P> (b) <E T="03">Costs.</E> If the Presiding Officer concludes in writing that the Request for a Hearing was frivolous, he may direct the Hearing Clerk to assess all or part of the costs of the proceeding against the Requestor. In such case, the Hearing Clerk shall assess such costs as directed by the Presiding Officer, and shall serve notice of such direction and the amount of such costs on all parties. No later than 5 days after receipt of notice of assessment of costs, the Requestor may move that the Presiding Officer review the assessment of costs <PRTPAGE P="374"/> by the Hearing Clerk. The Presiding Officer may uphold, reverse, or modify the action of the Hearing Clerk in assessing costs. </P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 307</EAR> <HD SOURCE="HED">PART 307—COMPREHENSIVE ENVIRONMENTAL RESPONSE, COMPENSATION, AND LIABILITY ACT (CERCLA) CLAIMS PROCEDURES</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECHD>Sec.</SECHD> <SECTNO>307.10</SECTNO> <SUBJECT>Purpose.</SUBJECT> <SECTNO>307.11</SECTNO> <SUBJECT>Scope and applicability.</SUBJECT> <SECTNO>307.12</SECTNO> <SUBJECT>Use of number and gender.</SUBJECT> <SECTNO>307.13</SECTNO> <SUBJECT>Computation of time.</SUBJECT> <SECTNO>307.14</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>307.15</SECTNO> <SUBJECT>Penalties.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Eligible Claimants; Allowable Claims; Preauthorization</HD> <SECTNO>307.20</SECTNO> <SUBJECT>Who may present claims.</SUBJECT> <SECTNO>307.21</SECTNO> <SUBJECT>Nature of eligible claims.</SUBJECT> <SECTNO>307.22</SECTNO> <SUBJECT>Preauthorization of response actions.</SUBJECT> <SECTNO>307.23</SECTNO> <SUBJECT>EPA's review of preauthorization applications.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Procedures for Filing and Processing Response Claims</HD> <SECTNO>307.30</SECTNO> <SUBJECT>Requesting payment from the potentially responsible party.</SUBJECT> <SECTNO>307.31</SECTNO> <SUBJECT>Filing procedures.</SUBJECT> <SECTNO>307.32</SECTNO> <SUBJECT>Verification, award, and administrative hearings.</SUBJECT> <SECTNO>307.33</SECTNO> <SUBJECT>Records retention.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Payments and Subrogation</HD> <SECTNO>307.40</SECTNO> <SUBJECT>Payment of approved claims.</SUBJECT> <SECTNO>307.41</SECTNO> <SUBJECT>Subrogation of claimants' rights to the Fund.</SUBJECT> <SECTNO>307.42</SECTNO> <SUBJECT>Fund's obligation in the event of failure of remedial actions taken pursuant to CERCLA section 122.</SUBJECT> <APP>Appendix A to Part 307—Application for Preauthorization of a CERCLA Response Action</APP> <APP>Appendix B to Part 307—Claim for CERCLA Response Action</APP> <APP>Appendix C to Part 307—Notice of Limitations on the Payment of Claims for Response Actions, Which Is To Be Placed in the Federal Register Preamble Whenever Sites Are Added to the Final NPL</APP> <APP>Appendix D to Part 307—Notice of Limitations on the Payment of Claims for Response Actions Which Is To Be Placed in Public Dockets</APP> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P> 42 U.S.C. 9601 <E T="03">et seq.;</E> sections 4 and 9, E.O. 12580, 52 FR 2923, 3 CFR, 1987 Comp. p. 193. </P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>58 FR 5475, Jan. 21, 1993, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General</HD> <SECTION> <SECTNO>§ 307.10</SECTNO> <SUBJECT>Purpose.</SUBJECT> <P> This part prescribes the appropriate forms and procedures for presenting claims for necessary response costs as authorized by section 112(b)(1) of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA) (herein referred to as CERCLA, or the Act) (42 U.S.C. 9601 <E T="03">et seq.</E> ). Such claims may be presented to the Hazardous Substance Superfund (the Fund) established by section 9507 of the Internal Revenue Code of 1986. See section 101(11) of CERCLA. </P> </SECTION> <SECTION> <SECTNO>§ 307.11</SECTNO> <SUBJECT>Scope and applicability.</SUBJECT> <P> (a) The following may be submitted only through the procedures established by this part: claims for responses to a release or substantial threat of release of a hazardous substance into the environment; claims for responses to a release or substantial threat of release of any pollutants or contaminants into the environment, which may present an imminent and substantial danger to public health or welfare; and claims for response actions undertaken pursuant to settlement agreements in which the Federal Government agrees to reimburse a portion of the cost. Under this part, persons may bring claims for necessary costs incurred in carrying out the National Contingency Plan (NCP) (40 CFR part 300) developed under section 311(c) of the Federal Water Pollution Control Act (33 U.S.C. 1251 <E T="03">et seq.</E> ) and revised pursuant to section 105 of CERCLA. Only response actions that EPA has preauthorized are eligible for reimbursement through the claims process of section 112 of CERCLA. Authority for the payment of claims for response costs is provided by section 111(a)(2) of CERCLA. Authority for the reimbursement of certain costs incurred by parties to a settlement agreement entered pursuant to section 122 of CERCLA is provided by section 122(b) of CERCLA. </P> <P> (b) This part does not affect the terms and conditions contained in <PRTPAGE P="375"/> Preauthorization Decision Documents (PDDs) issued prior to the effective date of this part. However, a potential claimant may elect to comply with the provisions of this part, rather than the terms and conditions of a PDD issued prior to the effective date of this part, if he so chooses. Written notice of this election must be provided to EPA by the potential claimant prior to such provision taking effect, but not later than the time of the submittal of any claim to EPA. EPA will provide a written acknowledgement of the potential claimant's election and may revise the PDD as appropriate. </P> </SECTION> <SECTION> <SECTNO>§ 307.12</SECTNO> <SUBJECT>Use of number and gender.</SUBJECT> <P>As used in this part, words in the singular also include the plural and vice versa, and words in the masculine gender also include the feminine, as the case may require.</P> </SECTION> <SECTION> <SECTNO>§ 307.13</SECTNO> <SUBJECT>Computation of time.</SUBJECT> <P>In computing any period of time described or allowed in this part, except as otherwise provided, the day of the event from which the designated period begins to run shall not be included. Saturdays, Sundays, and Federal legal holidays shall be included. When a stated time expires on a Saturday, Sunday, or Federal legal holiday, the stated time period shall be extended to include the next business day.</P> </SECTION> <SECTION> <SECTNO>§ 307.14</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>Terms that are not defined in this section or restated herein, shall have the meaning set forth in section 101 of CERCLA or the 1990 NCP or any final revision thereto. As used in this part, the following words and terms shall have the meanings set forth below:</P> <P> <E T="03">Act</E> or <E T="03">CERCLA</E> both mean the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986. </P> <P> <E T="03">Administrative hearing</E> means an administrative adjudication required by section 112(b)(2) of CERCLA in the event a claimant contests a determination of his claim made by the U.S. Environmental Protection Agency (EPA). </P> <P> <E T="03">Assistance agreement</E> means the legal instrument EPA uses to transfer money, property, services, or anything of value to a recipient to accomplish a public purpose. It is either a grant or cooperative agreement (see 40 CFR part 35) and will specify: budget and project periods; the Federal share of eligible project costs; a description of the work to be accomplished; and any special conditions. </P> <P> <E T="03">Claim</E> means a demand in writing for a sum certain presented to the Fund in accordance with sections 111 and 112 of CERCLA. </P> <P> <E T="03">Claimant</E> means any person who presents a claim to the Fund for reimbursement under section 112(b)(1) of CERCLA. </P> <P> <E T="03">Contractor claim</E> means the disputed portion of a written demand or written assertion by any contractor who has contracted with a person ( <E T="03">i.e.</E> , the owner) for the conduct of a preauthorized response action, seeking as a matter of right, the payment of money, adjustment, or interpretation of contract terms, or other relief, arising under or related to a contract, which has been finally rejected or not acted upon by the owner and which is subsequently settled by the owner or is awarded by a third party in accordance with the disputes clause of the contract document. </P> <P> <E T="03">Eligible claim</E> means any claim that has satisfied the requirements set forth in § 307.21(b). </P> <P> <E T="03">Facility</E> as defined by section 101(9) of CERCLA, means any: </P> <P>(1) Building, structure, installation, equipment, pipe or pipeline (including any pipe into sewer or publicly owned treatment works), well, pit, pond, lagoon, impoundment, ditch, landfill, storage container, motor vehicle, rolling stock, or aircraft; or</P> <P>(2) Any site or area where a hazardous substance has been deposited, stored, disposed of, or placed, or otherwise come to be located; but does not include any consumer product in consumer use or any vessel.</P> <P> <E T="03">Fund</E> means the Hazardous Substance Superfund established by section 9507 of the Internal Revenue Code of 1986. </P> <P> <E T="03">Hazardous substance</E> as defined by section 101(14) of CERCLA, means: <PRTPAGE P="376"/> </P> <P> (1) Any substance designated pursuant to section 311(b)(2)(A) of the Federal Water Pollution Control Act (33 U.S.C. 1251 <E T="03">et seq.</E> ); </P> <P>(2) Any element, compound, mixture, solution, or substance designated pursuant to section 102 of CERCLA;</P> <P> (3) Any hazardous waste having the characteristics identified under or listed pursuant to section 3001 of the Solid Waste Disposal Act (42 U.S.C. 6801 <E T="03">et seq.</E> ) (but not including any waste the regulation of which under the Solid Waste Disposal Act has been suspended by Act of Congress); </P> <P>(4) Any toxic pollutant listed under section 307(a) of the Federal Water Pollution Control Act;</P> <P> (5) Any hazardous air pollutant listed under section 112 of the Clean Air Act (42 U.S.C. 7401 <E T="03">et seq.</E> ); and </P> <P> (6) Any imminently hazardous chemical substance or mixture with respect to which the Administrator of EPA (Administrator) has taken action pursuant to section 7 of the Toxic Substances Control Act (15 U.S.C. 2601 <E T="03">et seq.</E> ). The term does not include petroleum, including crude oil or any fraction thereof which is not otherwise specifically listed or designated as a hazardous substance under paragraphs (1) through (6) of this definition, and the term does not include natural gas, natural gas liquids, liquefied natural gas, or synthetic gas usable for fuel (or mixtures of natural gas and such synthetic gas). </P> <P> <E T="03">National Contingency Plan,</E> or <E T="03">NCP</E> means the National Oil and Hazardous Substances Pollution Contingency Plan (40 CFR part 300) developed under section 311(c) of the Federal Water Pollution Control Act and revised pursuant to section 105 of CERCLA. </P> <P> <E T="03">Necessary costs</E> means “necessary response costs” as required by section 111(a)(2) of CERCLA for Fund reimbursement of a preauthorized response action. Necessary response costs are costs determined to be: </P> <P>(1) Required (based upon the site-specific circumstances);</P> <P>(2) Reasonable (nature and amount do not exceed that estimated or which would be incurred by a prudent person);</P> <P>(3) Allocable (incurred specifically for the site at issue); and</P> <P>(4) Otherwise allowable (consistent with the limitations and exclusions under the appropriate Federal cost principles). See OMB Circular A-122 (non-profit organizations); OMB Circular A-87 (States and political subdivisions); and 48 CFR part 31, subparts 31.1 and 31.2 (profit-making organizations).</P> <P> <E T="03">NPL</E> means the National Priorities List established pursuant to section 105 of CERCLA and 40 CFR 300.425, which consists of uncontrolled hazardous substance facilities in the United States that need to be addressed under CERCLA authorities. Only NPL sites are eligible for Fund-financed remedial action. </P> <P> <E T="03">Operable unit</E> means a discrete action that comprises an incremental step toward comprehensively addressing site problems. This discrete portion of a remedial response manages migration, or eliminates or mitigates a release, threat of release, or pathway of exposure. The cleanup of a site can be divided into a number of operable units, depending on the complexity of the problems associated with the site. Operable units may address geographical portions of a site, specific site problems, or initial phases of an action, or may consist of any set of actions performed over time or any actions that are concurrent but located in different parts of a site. Operable units will not impede implementation of subsequent actions, including final action at the site. </P> <P> <E T="03">Party</E> means EPA or a claimant. </P> <P> <E T="03">Perfected</E> means the point at which EPA determines that the written demand for a sum certain ( <E T="03">i.e.</E> , claim) has the documentation necessary to substantiate the appropriateness of the amounts claimed; <E T="03">i.e.</E> , the claim is technically complete. </P> <P> <E T="03">Person</E> as defined by section 101(21) of CERCLA, means an individual, firm, corporation, association, partnership, consortium, joint venture, commercial entity, United States Government, State, municipality, commission, political subdivision of a State, or any interstate body. </P> <P> <E T="03">Political subdivision</E> means any general purpose unit of a local or State government. <PRTPAGE P="377"/> </P> <P> <E T="03">Pollutant</E> or <E T="03">Contaminant</E> as defined by section 101(33) of CERCLA, includes, but is not limited to, any element, substance, compound, or mixture, including disease-causing agents, which after release into the environment and upon exposure, ingestion, inhalation, or assimilation into any organism, either directly from the environment or indirectly by ingestion through food chains, will or may reasonably be anticipated to cause death, disease, behavioral abnormalities, cancer, genetic mutation, physiological malfunctions (including malfunctions in reproduction) or physical deformations in such organisms or their offspring. The term does not include petroleum, including crude oil and any fraction thereof which is not otherwise specifically listed or designated as a hazardous substance under section 101(14)(A) through (F) of the Act, nor does it include natural gas, liquefied natural gas, or synthetic gas of pipeline quality (or mixtures of natural gas and such synthetic gas). </P> <P> <E T="03">Preauthorization</E> means EPA's prior approval to submit a claim against the Fund for necessary response costs incurred as a result of carrying out the NCP. The process of preauthorization consists of three steps: </P> <P>(1) EPA's receipt of the application for preauthorization;</P> <P>(2) EPA's review and analysis of the application; and</P> <P>(3) EPA's issuance of the Preauthorization Decision Document, which sets forth the terms and conditions for reimbursement.</P> <P> <E T="03">Preauthorized</E> response actions are response actions approved through the preauthorization process. </P> <P> <E T="03">Respond</E> or <E T="03">Response</E> as defined by section 101(25) of CERCLA, means remove, removal, remedy, and remedial action, all such terms (including removal and remedial action) including enforcement activities related thereto. </P> <P> <E T="03">Response claim</E> means a preauthorized demand in writing for a sum certain for response costs referred to in section 111(a)(2) of CERCLA, including certain costs of actions referred to in section 122(b)(1) of CERCLA. </P> </SECTION> <SECTION> <SECTNO>§ 307.15</SECTNO> <SUBJECT>Penalties.</SUBJECT> <P>(a) If any person knowingly gives a material statement or representation in the application for preauthorization or in the claim that is false, misleading, misrepresented, or misstated, and EPA relies upon such a statement or representation in making its decision, the preauthorization or the award by EPA may be withdrawn following written notice to the claimant.</P> <P>(b) Any person who knowingly gives, or causes to be given, any false information as part of an application for preauthorization or of a claim (including any person who meets the conditions of paragraph (a) of this section) may, upon conviction, be fined or imprisoned in accordance with CERCLA section 112(b)(1) and other laws.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Eligible Claimants; Allowable Claims; Preauthorization</HD> <SECTION> <SECTNO>§ 307.20</SECTNO> <SUBJECT>Who may present claims.</SUBJECT> <P>(a) Subject to the provisions of this subpart, claims for the costs of response actions may be asserted against the Fund by any person other than the United States Government, States, and political subdivisions thereof, except to the extent the claimant is otherwise compensated for the loss. States and political subdivisions may assert such claims if they are potentially responsible parties subject to an agreement reached pursuant to section 122(b)(1) of CERCLA.</P> <P> (b) Claims presented by an individual must be signed by that individual. If, because of death, disability, or other reasons satisfactory to EPA, the foregoing requirement cannot be fulfilled, the claim may be filed by a duly authorized agent, executor, administrator, or other legal representative. A claim presented by an entity or an authorized agent, executor, administrator, or other legal representative must be presented in the name of the claimant. The claim must be signed by the authorized agent, executor, administrator, or other legal representative (including the title or legal capacity of the person signing) and be accompanied by evidence of the authority to present a claim on behalf of the claimant as <PRTPAGE P="378"/> authorized agent, executor, administrator, or other legal representative. </P> <P>(c) A claim for response costs as to which any release from liability was executed between the claimant and a potentially responsible party may be presented against the Fund to the extent that the claimant obtained EPA's approval prior to executing such release and provided that the other requirements of this part are met.</P> <P>(d) A foreign claimant may present a response claim to the Fund, to the same extent that a United States claimant may assert a claim, if:</P> <P>(1) The requirements of § 307.21 and § 307.22 are met; and</P> <P>(2) The release of a hazardous substance occurred in the navigable waters of the United States, including the territorial sea, or in or on the territorial sea or adjacent shoreline of a foreign country of which the claimant is a resident; and</P> <P>(3) The claimant is not otherwise compensated for the loss; and</P> <P> (4) The hazardous substance was released from a facility or from a vessel located adjacent to or within the navigable waters or was discharged in connection with activities conducted under the Outer Continental Shelf Lands Act, as amended (43 U.S.C. 1331 <E T="03">et seq.</E> ), or the Deepwater Port Act of 1974, as amended (33 U.S.C. 1501 <E T="03">et seq.</E> ); and </P> <P>(5) Recovery is authorized by a treaty or an executive agreement between the United States and the foreign country involved, or if the Secretary of State, in consultation with the Attorney General and other appropriate officials, certifies that such country provides a comparable remedy for United States claimants.</P> </SECTION> <SECTION> <SECTNO>§ 307.21</SECTNO> <SUBJECT>Nature of eligible claims.</SUBJECT> <P>(a) Claims may be asserted against the Fund for necessary costs incurred for response actions due to a release or substantial threat of release of a hazardous substance into the environment; a release or substantial threat of release of pollutants or contaminants into the environment that may present an imminent or substantial danger to public health or welfare; or actions taken by a potentially responsible party subject to an agreement reached pursuant to section 122(b)(1) of CERCLA. Claims must be filed in accordance with § 307.22. Claims may be asserted for the costs of removal actions, remedial planning activities, and remedial actions.</P> <P>(b) Costs will be considered to be eligible under this section if:</P> <P>(1) The response action is preauthorized by EPA pursuant to § 307.22;</P> <P>(2) The costs are incurred for activities within the scope of EPA's preauthorization;</P> <P>(3) The response action is conducted in a manner consistent with the NCP; and</P> <P>(4) The costs incurred are necessary costs pursuant to § 307.11 of this part.</P> <P>(c) Money in the Fund may be used for paying any claim under this section for expenses incurred for the payment of contractor claims either through settlement of such claims or an award by a third party to the extent EPA determines that:</P> <P>(1) The contractor claim arose from work within the scope of the contract at issue and the contract was for preauthorized response activities;</P> <P>(2) The contractor claim is meritorious;</P> <P>(3) The contractor claim was not caused by the mismanagement of the claimant;</P> <P>(4) The contractor claim was not caused by the claimant's vicarious liability for the improper actions of others;</P> <P>(5) The claimed amount is reasonable and necessary;</P> <P>(6) The claim for such costs is filed by the claimant within 5 years of completion of the preauthorized response action; and</P> <P>(7) Payment of such a claim will not result in total payments from the Fund in excess of the maximum amount for which claims were preauthorized.</P> <P>(d) An award by a third party on a contractor claim under paragraph (c) of this section should include:</P> <P>(1) Findings of fact;</P> <P>(2) Conclusions of law;</P> <P>(3) Allocation of responsibility for each issue;</P> <P>(4) Basis for the amount of award; and</P> <P> (5) The rationale for the decision. <PRTPAGE P="379"/> </P> <P>(e) Money in the Fund may not be used for paying any claim under this section for expenses incurred for procurement transactions that were not conducted in a manner that provided to the maximum extent practicable, open and free competition; unduly restricted or eliminated competition; and did not provide where applicable for the award of contracts to the lowest responsive, responsible bidder where the selection was made principally on the basis of price.</P> <P>(f) Money in the Fund may not be used for paying any claim under this section for expenses incurred by a person operating pursuant to a procurement contract or assistance agreement with the United States.</P> <P>(g) Money in the Fund may not be used for paying any claim under this section for expenses incurred for the payment of persons who are on the “List of Parties Excluded From Federal Procurement or Non-Procurement” at the time the contract is awarded, unless EPA approval is obtained in advance.</P> <P>(h) Unless EPA waives this requirement prior to the award of a construction contract, money in the Fund may not be used for paying any claim under this section for expenses incurred under such a construction contract that does not contain a “differing site conditions” clause equivalent to the following:</P> <P>(1) The contractor shall promptly, and before such conditions are disturbed, notify the claimant in writing of:</P> <P>(i) Subsurface or latent physical conditions at the site differing materially from those listed in this contract, or</P> <P>(ii) Unknown physical conditions at the site, of an unusual nature, differing materially from those ordinarily encountered and generally recognized as inherent in work of the character provided for in this contract.</P> <P>(2) Upon notification by the construction contractor, the claimant shall promptly investigate the conditions. If the claimant finds that conditions materially differ and will cause an increase or decrease in the contractor's cost or the time required to perform any part of the work under its contract, whether or not changed as a result of such conditions, the claimant shall make an equitable adjustment and modify the contract in writing.</P> <P>(3) No claim of the contractor under the differing site conditions clause shall be allowed unless the contractor has given the notice required in paragraph (h)(1) of this section. However, the claimant may extend the time prescribed in paragraph (h)(1) of this section.</P> <P>(4) No claim by the contractor for an equitable adjustment shall be allowed if asserted after final payment under this contract.</P> <P>(i) Where money in the Fund has been used to pay for any response costs under this section, no other claim may be paid out of the Fund for the same costs.</P> </SECTION> <SECTION> <SECTNO>§ 307.22</SECTNO> <SUBJECT>Preauthorization of response actions.</SUBJECT> <P>(a) No person may submit a claim to the Fund for a response action unless that person notifies the Administrator of EPA or his designee prior to taking such response action and receives preauthorization by EPA. In order to obtain preauthorization, any person intending to submit a claim to the Fund must fulfill the following requirements before commencing a response action:</P> <P>(1) Notify the lead agency through the National Response Center (as described in 40 CFR 300.125), if there is acute threat of fire, explosion, or direct human contact with hazardous substances, pollutants, or contaminants or other emergency situation, to determine if there is sufficient time to submit an application for preauthorization;</P> <P>(2) Submit an application for preauthorization (EPA Form 2075-3, found at appendix A of this part) to the Administrator or his designee; and</P> <P>(3) Obtain the approval of the Administrator or his designee before initiating the response action.</P> <P>(b) All applications for preauthorization must include, where available;</P> <P> (1) A description of the location and nature of the release or threatened release of a hazardous substance or pollutant or contaminant (e.g., type and location of vessel or facility, population at risk, routes of exposure); <PRTPAGE P="380"/> </P> <P>(2) A description of the nature and quantity of the hazardous substance or pollutant or contaminant which has been or may be released, including whether the substance is on the list of hazardous substances set forth pursuant to section 102 of CERCLA;</P> <P>(3) The identity of any potentially responsible parties known to the applicant (including the applicant), and any contact with such parties, including, but not limited to, any correspondence, agreements, or litigation with such parties;</P> <P>(4) Evidence of the applicant's eligibility to file a claim pursuant to § 307.20;</P> <P>(5) An explanation of why the proposed response action is necessary, and how the proposed action is consistent with 40 CFR 300.700(d)(4)(ii);</P> <P>(6) A description of the applicant's capability (including financial and technical capability) to implement the proposed response action;</P> <P>(7) Proposed schedule of activities;</P> <P>(8) Projected costs of response activities, with the basis for those projections (projections shall be based on actual anticipated costs without a contingency for unanticipated conditions);</P> <P>(9) Proposed schedule for the submission of claims;</P> <P>(10) The proposed contracting procedures;</P> <P>(11) Proposed procedures for project management, EPA oversight, and reporting of progress of the project; and</P> <P>(12) The assurances of timely initiation and completion.</P> <P>(c) Applications for preauthorization to undertake a removal action shall, in addition to the requirements in paragraph (b) of this section, include:</P> <P>(1) A summary or copy of the preliminary assessment; and</P> <P>(2) A description of the proposed removal action for which the claim will be made, which environmental requirements are applicable or relevant and appropriate, and how the removal will comply with such requirements.</P> <P>(d) Applications for preauthorization to undertake a remedial investigation and feasibility study shall, in addition to the requirements in paragraph (b) of this section, include:</P> <P>(1) The scope of the proposed study;</P> <P>(2) A proposed site sampling plan and quality assurance procedures;</P> <P>(3) The plan for the development of alternatives;</P> <P>(4) Approaches to consideration of alternatives to land disposal;</P> <P>(5) Plans for initial screening of alternatives;</P> <P>(6) Proposed procedures for the detailed analysis of alternatives; and</P> <P>(7) Proposed considerations in selection of the remedy.</P> <P>(e) Applications for preauthorization to undertake a remedial alternative other than that selected by EPA, or where EPA has not selected a remedy, shall, in addition to the requirements in paragraph (b) of this section, include a discussion of how the proposed remedy:</P> <P>(1) Differs from the one selected by EPA, if applicable;</P> <P>(2) Achieves protection of public health and welfare and the environment and complies with legally applicable or otherwise relevant and appropriate Federal, State, and local requirements pursuant to 40 CFR 300.400(g) or waivers to those requirements in 40 CFR 300.430(f)(1)(ii)(C). The application shall also include a discussion of pertinent Federal and State guidance, advisories, and criteria;</P> <P>(3) Will be cost-effective as set out in section 121(a) of CERCLA and 40 CFR 300.430(f)(1)(ii)(D);</P> <P>(4) Mitigates and minimizes future risks;</P> <P>(5) Improves the reliability of the remedy;</P> <P>(6) Utilizes new or innovative technology, if appropriate;</P> <P>(7) Employs treatment that reduces the volume, toxicity or mobility of the hazardous substances;</P> <P>(8) Impacts projected costs; and</P> <P>(9) Takes into account appendix D of 40 CFR part 300.</P> <P>(f) Applications for preauthorization to undertake a remedial action, including those described in paragraph (e) of this section, shall in addition to the requirements in paragraph (b) of this section, include:</P> <P>(1) A description of the proposed remedial action for which the claim will be made;</P> <P> (2) A proposed site sampling plan and quality assurance procedures; <PRTPAGE P="381"/> </P> <P>(3) Documentation of reasonable effort to obtain the cooperation of the State or Indian Tribe;</P> <P>(4) A bond or other financial assurance to cover the costs of necessary long-term operation and maintenance of the response action or written assurance from the State to provide such long-term operation and maintenance;</P> <P>(5) Proposed procedures using sealed bidding to select the construction contractor, or an explanation of why the applicant intends to use any other method; and</P> <P>(6) Documentation showing that the response will be carried out in accordance with applicable or relevant and appropriate environmental requirements. Documentation should include the potential impacts on any environmentally sensitive areas.</P> <P>(g) Claims of business confidentiality may be asserted for information submitted to EPA under this subpart. Information claimed confidential will be disclosed by EPA only to the extent permitted by CERCLA, this subpart, and part 2, subpart B, of this chapter.</P> <P>(1) Any claim of business confidentiality must accompany the information when it is submitted to EPA. Claims must be asserted as prescribed on the forms. Items claimed confidential on the forms and attachments to the forms must be clearly marked by circling or bracketing them.</P> <P>(2) The applicant or response claimant must provide EPA with two copies of its submittal if any information is claimed confidential.</P> <P>(i) One copy of the submittal must be complete, with items claimed confidential clearly marked in accordance with paragraph (g)(1) of this section.</P> <P>(ii) The second copy must be complete except that all information claimed as confidential in the first copy must be deleted. EPA may make this second copy available to the public.</P> <P>(iii) If the applicant does not provide a redacted copy, the application for preauthorization is incomplete. If the claimant does not provide a redacted copy, the claim against the Fund will not be perfected by EPA. EPA will not process such submittals until it receives the redacted copy.</P> <P>(3) If a submitter of a response claim or an application for preauthorization does not assert a claim of business confidentiality for information at the time the information is submitted to EPA, the Agency may make the information public without further notice to the submitter.</P> <P>(h) In addition to the foregoing, an application for preauthorization filed by a potentially responsible party for partial reimbursement of response costs shall include:</P> <P>(1) A copy of the settlement agreement, or the most recent draft of any pending agreement, reached between such parties and the Federal Government; and</P> <P>(2) If the application is to undertake a remedial investigation and feasibility study, an affirmation that the applicant will not directly or indirectly benefit from the preauthorization as a response action contractor, or as a person hired or retained by such a contractor with respect to the site at issue and an agreement to reimburse the Fund for any costs incurred under, or in connection with, the oversight contract or arrangement for the remedial investigation and feasibility study.</P> <P>(i) If it is subsequently determined that the preauthorized response actions require modification or if it appears that project costs will exceed approved costs, a revised application for preauthorization must be approved by EPA before different, or additional, actions can be undertaken, if such actions are to be eligible for compensation from the Fund.</P> <P>(j) Unless otherwise specified and agreed to by EPA, the terms, provisions, or requirements of a court judgment, Consent Decree, administrative order (whether unilateral or on consent), or any other consensual agreement with EPA requiring a response action do not constitute preauthorization to present a claim to the Fund.</P> </SECTION> <SECTION> <SECTNO>§ 307.23</SECTNO> <SUBJECT>EPA's review of preauthorization applications.</SUBJECT> <P> (a) EPA shall review each preauthorization application and will notify the applicant of the decision to <PRTPAGE P="382"/> grant or deny preauthorization. Decisions to grant preauthorization will be memorialized in a PDD. </P> <P>(b) Each application for preauthorization must include information sufficient for EPA to determine whether the response will be consistent with 40 CFR 300.700(d). EPA will evaluate applications based on the following non-exclusive list of criteria, as appropriate:</P> <P>(1) Whether the release is within the scope of CERCLA;</P> <P>(2) The seriousness of the problem or importance of the response activity when compared with competing demands on the Fund;</P> <P>(3) Whether there is sufficient time to process the request for preauthorization (e.g., if a removal action is proposed);</P> <P>(4) Whether the party liable for the release or threat of release of the hazardous substance is unknown, or if known, has been notified of the application for preauthorization and is unwilling or incapable of performing the response in a reasonable period of time;</P> <P>(5) Whether the State, a political subdivision, or an Indian Tribe is willing to undertake the response action through a contract or a cooperative agreement;</P> <P>(6) The cost and effectiveness of the proposed response actions when compared with other alternatives;</P> <P>(7) Whether proposed response can be carried out in accordance with the NCP and other environmental requirements;</P> <P>(8) The applicant's eligibility to file a claim; his capabilities, experience, and technical expertise; and his knowledge and familiarity with the NCP and relevant guidance;</P> <P>(9) Whether the party is proposing to conduct a cleanup through an administrative order or a Consent Decree with the Government regarding the site for which the request is made (if the applicant is a potentially responsible party);</P> <P>(10) Whether the applicant, if he is a potentially responsible party seeking to undertake a remedial investigation and feasibility study, has affirmed that he will not directly or indirectly benefit from the preauthorization as a response action contractor, or as a person hired or retained by such a contract with respect to the site at issue, and agrees to reimburse the Fund for any cost incurred under, or in connection with, the oversight contract or arrangement for the remedial investigation and feasibility study;</P> <P>(11) Whether the proposed costs are eligible and the applicant has proposed appropriate procurement, contract management, project management, financial management and documentation procedures;</P> <P>(12) Whether the applicant has met the necessary assurances, financial responsibilities, and other requirements;</P> <P>(13) Provisions for long-term operation and maintenance of the site, if appropriate;</P> <P>(14) Whether the applicant has consulted with the State or Indian Tribe on the proposed response action;</P> <P>(15) The applicant's proposed procedures for oversight and the reporting of project issues and progress;</P> <P>(16) Cooperation of the applicant at any earlier stage of response activity; and</P> <P>(17) Whether the proposed schedule for filing a claim(s) is based upon the completion of the project, an operable unit, or a discrete phase of the response work.</P> <P>(c) The Administrator may grant preauthorization for all or part of a proposed response action, but not less than a stage of an operable unit or of a response action.</P> <P>(1) The Administrator may set a limit on the amount that may be claimed as reimbursement from the Fund for any response action.</P> <P>(2) The Administrator may condition the preauthorization on such inspection, monitoring, reporting, safety, and long-term operation and maintenance requirements as he deems necessary. The costs of such requirements may not necessarily be reimbursed from the Fund.</P> <P>(3) The Administrator may condition the preauthorization on such time period for starting and completing the response action as he may deem necessary.</P> <P> (4) The Administrator may condition the preauthorization on such financial or other assurance from the claimant or other entity as he may deem necessary to ensure completion of work at the site. <PRTPAGE P="383"/> </P> <P>(5) The Administrator will not subject potentially responsible parties who may wish to undertake a remedial investigation and feasibility study to a lesser standard of liability nor will he give such parties preferential treatment in EPA's review of applications for preauthorization.</P> <P>(d) If EPA denies a preauthorization because of an insufficient balance in the Fund or the low priority assigned to the response action when weighed against other applications or uses of the Fund, the applicant may resubmit the application in another fiscal year. If preauthorization is denied because of the inability of the applicant to demonstrate his experience and capabilities, the applicant may resubmit the application form only after correcting the deficiencies, or by proposing an alternative approach.</P> <P>(e) If EPA grants preauthorization, the applicant may begin the approved response action subject to the terms and conditions contained in the PDD. The applicant, as a condition of preauthorization, shall assure that the lead agency shall have such site access as may be necessary for oversight and monitoring.</P> <P>(f) If the applicant is unable to initiate or complete the preauthorized response action, the applicant shall immediately notify EPA in writing.</P> <P>(g) EPA will not grant preauthorization for any response actions where:</P> <P>(1) The proposed action is not a response action authorized under CERCLA;</P> <P>(2) There is a significant threat to the public health or the environment caused by acute threat of fire, explosion, direct human contact with a hazardous substance, or other similar hazardous situations requiring immediate action, and there is insufficient time to process an application for preauthorization;</P> <P>(3) The proposed response is a remedial action and the site is not on the NPL; or</P> <P>(4) The action is to be performed by a State, political subdivision, Indian Tribe through an assistance agreement with the United States, or a person operating pursuant to a contract with the United States.</P> <P>(h) EPA will deny preauthorization to a person whom the Agency believes is a liable party under section 107 of CERCLA unless negotiations are underway aimed at reaching a judicial or administrative settlement. Such parties may be preauthorized under this paragraph to submit claims to the Fund for response costs up to the maximum amount specified in the PDD.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Procedures for Filing and Processing Response Claims</HD> <SECTION> <SECTNO>§ 307.30</SECTNO> <SUBJECT>Requesting payment from the potentially responsible party.</SUBJECT> <P>(a) A claimant must present all claims to any person who is known to the claimant and who may be liable under section 107 of CERCLA at least 60 days before filing a claim against the Fund. The presentation to the potentially responsible party must be a written request for payment, delivered either by certified mail (return receipt requested) or in such a manner as will establish the date of receipt. At a minimum this request must contain:</P> <P>(1) The name of the claimant (commercial entity or individual);</P> <P>(2) The name, title, and address of any authorized representative;</P> <P>(3) The location of the release and cleanup;</P> <P>(4) The date of the release, if known;</P> <P>(5) The owner of the property, if other than the claimant;</P> <P>(6) A description of the response action taken; and</P> <P>(7) The amount of the request (in dollars);</P> <P>(8) If applicable, notice of intent to file a subsequent application for preauthorization or claim against the Fund for additional operable units or for a stage of a response action.</P> <P> (b) Where the potentially responsible party is unknown, the claimant must make a good-faith effort to identify the potentially responsible party prior to submitting a claim. If the potentially responsible party is identified, the claimant must then comply with the procedures of § 307.30(a). Where a potentially responsible party cannot be identified, the claimant may submit a claim to the Fund pursuant to § 307.31. Claims submitted under this paragraph <PRTPAGE P="384"/> must be accompanied by documentation of efforts to identify potentially responsible parties. </P> <P>(c) If the claimant and the potentially responsible party agree to a settlement involving a release from liability, the claimant may submit a claim against the Fund for any costs that are not recovered provided the claimant complies with the provisions of § 307.20(c), which require EPA's prior approval of such releases from liability.</P> <P>(d) If the claim is denied by the potentially responsible party, or has not been satisfied after 60 days of presentation to such party, the claimant may submit a claim to the Fund in accordance with § 307.31.</P> <P>(e) If the first claim was denied by the potentially responsible party or not responded to, and EPA agrees that there is no reason to believe that subsequent claims would be honored by such potentially responsible party, the denial of the first claim, or lack of response, shall be considered denial of every subsequent claim.</P> </SECTION> <SECTION> <SECTNO>§ 307.31</SECTNO> <SUBJECT>Filing procedures.</SUBJECT> <P>(a) A response claim must be submitted on EPA Form 2075-4 and must include:</P> <P>(1) Documentation showing that the claimed response activities were preauthorized by EPA;</P> <P>(2) Documentation showing that the response activity was accomplished in a manner consistent with the PDD, noting any deviation from preauthorized activities;</P> <P>(3) Documentation that a search to identify potentially responsible parties was conducted in accordance with § 307.30 and of any contacts with such parties; and</P> <P>(4) Substantiation that all claimed costs are necessary costs.</P> <P>(b) Claimants (or their authorized representatives) may amend their claims at any time before final action by EPA. Amendment of claims after final action by EPA will be allowed only at EPA's discretion. Each amendment must be submitted in writing and must be signed by the claimant or authorized representative. The time limitations of § 307.32(i) refer to the date by which an amendment is filed.</P> <P>(c) Claimants may not pursue both an action in court against potentially responsible parties and a claim against the Fund at the same time for the same response costs. EPA will return claims presented under this subpart when the Agency determines that a claimant has initiated an action for recovery of the same response costs, in court, against a party potentially liable under section 107 of CERCLA.</P> </SECTION> <SECTION> <SECTNO>§ 307.32</SECTNO> <SUBJECT>Verification, award, and administrative hearings.</SUBJECT> <P>(a) Upon receipt of a response claim, EPA will verify that it complies with all filing requirements. Where the claim is incomplete or has significant defects, EPA will return the claim to the claimant with written notification of its deficiencies.</P> <P>(b) A claim returned to the claimant for failure to comply with the filing requirements may be resubmitted to EPA.</P> <P> (c) For purposes of this part, a response claim is deemed perfected when EPA determines that the claim complies fully with the specified filing requirements; <E T="03">i.e.</E> , the claim is technically complete. When the claim is perfected, a notice will be provided to the claimant of EPA's receipt and acceptance of the claim for evaluation. </P> <P>(d) EPA may adjust claims and in making a determination whether costs are allowable, EPA will be guided by the Federal cost principles (non-profit organizations—OMB Circular A-122; States and political subdivisions—OMB Circular A-87; profit-making organizations—48 CFR part 31, subparts 31.1 and 31.2).</P> <P> (e) In evaluating claims, EPA will determine whether the claimant has settled and satisfactorily completed in accordance with sound business judgment and good administrative practice all contractual and administrative matters arising out of agreements to perform preauthorized response actions. This includes the issuance of invitations for bids or requests for proposals, selection of contractors, approval of subcontracts, settlement of protests, claims disputes, and other related procurement matters. EPA will examine how the claimant assured (e.g., by the use of a subcontract administration <PRTPAGE P="385"/> system) that work was performed in accordance with the terms, conditions, and specifications of such agreements. </P> <P>(f) Awards will be made:</P> <P>(1) Only for necessary costs of completing the response action or stage of an operable unit or of a response action;</P> <P>(2) Only to the extent that the response actions were preauthorized by EPA pursuant to § 307.23;</P> <P>(3) Only to the extent that the cleanup was performed effectively, as provided in 40 CFR 300.120(e)(3) and 300.400(h); and</P> <P>(4) Only to the extent that the cleanup was performed in compliance with the terms and conditions of the PDD.</P> <P>(g) No award will be made on a claim where the claimant has purported to release a potentially responsible party from liability to the United States for the same costs unless EPA has approved the release in advance.</P> <P>(h) Where a response action is determined to have been ineffective due to acts or omissions of the claimant, his employees or agents, or any third party having a contractual relationship with the claimant, payment of the claim will be adjusted accordingly. EPA may require the claimant to submit any additional information needed to determine whether the actions taken were reasonable and necessary.</P> <P>(i) For claims submitted in connection with a settlement reached under section 122(b)(1) of CERCLA only, interest will be paid on amounts due if EPA fails to pay the amount within 60 days of a perfected claim.</P> <P>(1) Interest shall accrue on the amounts due the claimant where EPA fails to pay the claim for the preauthorized response action within 60 days of EPA's receipt of a perfected claim.</P> <P>(2) Where the claim is technically complete but EPA requires additional information in order to evaluate the amount claimed, the period as stated in paragraph (i)(1) of this section or the accrual of interest is suspended from the date the Agency requests the information from the claimant until the date the requested information is received.</P> <P>(3) Where a claim is denied in whole or in part by EPA, and the claimant requests an administrative hearing in accordance with paragraph (o) of this section, interest on the disputed amount begins to accrue 50 days after an award by the Administrative Law Judge, unless an appeal is filed. If either party files an appeal with a Federal district court, interest will not accrue until 20 days after the final judicial decision.</P> <P>(4) The rate of interest paid on a claim is the rate of interest on investments of the Fund established by Subchapter A of Chapter 98 of the Internal Revenue Code of 1954.</P> <P>(j) For claims submitted in connection with a settlement reached under section 122(b) of CERCLA, a preauthorized potentially responsible party will be entitled to full reimbursement only where the response action is conducted in complete satisfaction of the requirements set forth in the consent order or decree.</P> <P>(k) Future site-specific actions required by preauthorized potentially responsible parties, and any future obligations on the Fund, shall be governed by § 307.42.</P> <P>(l) Any withdrawal of preauthorization will be preceded by written notice from EPA. The application for preauthorization will be deemed invalid and no award will be made from the Fund where the claimant is determined by EPA to be liable under section 107 of CERCLA for the costs for which the claim is made, and the application for preauthorization did not disclose that the claimant may be a person described as follows:</P> <P>(1) The owner and operator of a vessel or a facility;</P> <P>(2) Any person, who at the time of disposal of any hazardous substance, owned or operated any facility at which such hazardous substances were disposed of;</P> <P> (3) Any person who by contract, agreement, or otherwise arranged for disposal or treatment, or arranged with a transporter for transport for disposal or treatment, of hazardous substances owned or possessed by such person, by any other party or entity, at any facility or incineration vessel owned or operated by another party or entity and containing such hazardous substance; or <PRTPAGE P="386"/> </P> <P>(4) Any person who accepts or accepted any hazardous substances for transport to disposal or treatment facilities, incineration vessels or sites selected by such person, from which there is a release, or a threatened release which causes the incurrence of response costs, of a hazardous substance.</P> <P>(m) If EPA determines that it cannot complete its evaluation of a claim because of insufficient information, it will request the necessary information from the claimant. If EPA determines that it cannot complete its evaluation of a claim because the records, documents, and other evidence were not maintained in accordance with generally accepted accounting principles and practices consistently applied, or were for any reason inadequate to demonstrate that claimed costs are necessary costs, EPA will adjust the claim accordingly. Further consideration of such amounts will depend on the adequacy of subsequent documentation. Any additional information requested by EPA must be submitted within 30 days, unless a different period of time is specified by EPA. The failure of the claimant to provide in a timely manner the requested information without reasonable cause may be cause for denial of the claim.</P> <P>(n) Once the claim is perfected, EPA will proceed to:</P> <P>(1) Make an award on the claim; or</P> <P>(2) Decline to make an award.</P> <P>(o) If the claimant is dissatisfied either with EPA's denial of a claim or with the amount of an award, the claimant may request that EPA arrange an administrative hearing in accordance with section 112(b) of CERCLA. The request for an administrative hearing must occur within 30 days of being notified of EPA's decision.</P> <P>(p) Notice of an award under paragraph (f) of this section will be given by First Class Mail within five (5) days of the date of the decision. Payment of approved claims will be made according to § 307.40.</P> </SECTION> <SECTION> <SECTNO>§ 307.33</SECTNO> <SUBJECT>Records retention.</SUBJECT> <P>A claimant receiving an award from the Fund is required to maintain all cost documentation and any other records relating to the claim, and to provide EPA with access to such records. These records must be maintained until cost recovery is initiated by EPA. If, after ten (10) years from the date of award of the final claim, EPA has not initiated a cost recovery action, the claimant need no longer retain the records. The claimant shall, however, notify EPA of the location of the records, and allow EPA the opportunity to take possession of the records before they are destroyed. The claimant shall cause to be inserted in all agreements between itself and contractors performing work at the site a clause providing for the same requirement to maintain records and to provide access to records as that required of the claimant.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Payments and Subrogation</HD> <SECTION> <SECTNO>§ 307.40</SECTNO> <SUBJECT>Payment of approved claims.</SUBJECT> <P>(a) Payment of claims will be made, as applicable, within:</P> <P>(1) 50 days of EPA's decision to make an award, if the claimant does not request an administrative hearing;</P> <P>(2) 50 days of an award by an administrative tribunal if no appeal of such award is taken; or</P> <P>(3) 20 days of the final judicial decision of any appeal taken.</P> <P>(b) Payment of a claim shall not be seen as EPA's final acceptance of the claimant's response action. Final acceptance shall await EPA's determination that the response action was conducted in accordance with the terms and conditions of the PDD or the consent order or decree, as applicable.</P> </SECTION> <SECTION> <SECTNO>§ 307.41</SECTNO> <SUBJECT>Subrogation of claimants' rights to the Fund.</SUBJECT> <P>(a) The United States acquires by subrogation all rights of the claimant to recover the amount of the claim paid by the Fund from the person or persons liable under section 107 of CERCLA for the release giving rise to the response action.</P> <P> (b) Claimants shall assist in any cost recovery action that may be initiated by the United States. The claimant and the claimant's contractors shall furnish the personnel, services, documents, and materials needed to assist EPA in the collection of evidence to <PRTPAGE P="387"/> document work performed and costs expended by the claimant or the claimant's contractors at the particular site in order to aid in cost recovery efforts. The claimant and the claimant's contractors shall also provide all requested assistance in the interpretation of documents detailing work and costs that may be needed as evidence, and shall testify on behalf of the United States in any judicial or administrative cost recovery proceeding regarding the response costs claimed. All of the claimant's contracts for implementing the PDD shall expressly require their contractors to provide this cost recovery assistance. </P> </SECTION> <SECTION> <SECTNO>§ 307.42</SECTNO> <SUBJECT>Fund's obligation in the event of failure of remedial actions taken pursuant to CERCLA section 122.</SUBJECT> <P>(a) In the case of the failure of a completed remedial action taken by a potentially responsible party pursuant to a remedial action preauthorized in connection with a settlement under section 122(b)(1) of CERCLA, the Fund shall be available for the costs of any new cleanup required, but shall not be obligated to a proportion exceeding that proportion contributed by the Fund for the original remedial action.</P> <P>(b) The Fund is not obligated by preauthorization of a response action to reimburse the claimant for subsequent remedial actions if those subsequent remedial actions are necessary as a result of the failure of the claimant, his employees or agents, or any third party having a contractual relationship with the claimant to properly perform authorized activities or otherwise comply with the terms and conditions of the PDD, and the Consent Decree or order regarding the site cleanup entered into by EPA and the claimant.</P> </SECTION> <APPENDIX> <PRTPAGE P="388"/> <EAR>Pt. 307, App. A</EAR> <HD SOURCE="HED">Appendix A to Part 307—Application for Preauthorization of a CERCLA Response Action</HD> <GPH SPAN="2" DEEP="453"> <GID>EC02AU92.021</GID> </GPH> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="389"/> <GID>EC02AU92.022</GID> </GPH> <GPH SPAN="2" DEEP="467"> <PRTPAGE P="390"/> <GID>EC02AU92.023</GID> </GPH> </APPENDIX> <APPENDIX> <PRTPAGE P="391"/> <EAR>Pt. 307, App. B</EAR> <HD SOURCE="HED">Appendix B to Part 307—Claim for CERCLA Response Action</HD> <GPH SPAN="2" DEEP="470"> <GID>EC02AU92.024</GID> </GPH> <GPH SPAN="2" DEEP="431"> <PRTPAGE P="392"/> <GID>EC02AU92.025</GID> </GPH> <GPH SPAN="2" DEEP="425"> <PRTPAGE P="393"/> <GID>EC02AU92.026</GID> </GPH> </APPENDIX> <APPENDIX> <PRTPAGE P="394"/> <EAR>Pt. 307, App. C</EAR> <HD SOURCE="HED">Appendix C to Part 307—Notice of Limitations on the Payment of Claims for Response Actions, Which Is To Be Placed in the Federal Register Preamble Whenever Sites Are Added to the Final NPL</HD> <P> <E T="03">Limitations on the Payment of Claims for Response Actions</E> </P> <P>Sections 111(a)(2) and 122(b)(1) of CERCLA authorize the Fund to reimburse certain parties for necessary costs of performing a response action. As is described in more detail at 58 FR 5460, Jan. 21, 1993, 40 CFR part 307, there are two major limitations placed on the payment of claims for response actions. First, only private parties, certain potentially responsible parties (including States and political subdivisions), and certain foreign entities are eligible to file such claims. Second, all response actions under sections 111(a)(2) and 122(b)(1) must receive prior approval, or “preauthorization,” from EPA.</P> </APPENDIX> <APPENDIX> <EAR>Pt. 307, App. D</EAR> <HD SOURCE="HED">Appendix D to Part 307—Notice of Limitations on the Payment of Claims for Response Actions Which Is To Be Placed in Public Dockets</HD> <HD SOURCE="HD2">Statutory Limitations on the Payment of Claims for Response Actions Filed Pursuant to Sections 111(a)(2) and 122(b)(1) of CERCLA</HD> <P> The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA) (42 U.S.C. 9601 <E T="03">et seq.</E> ) authorizes a number of mechanisms for responding to a release, or threat of release, of hazardous substances or pollutants or contaminants. One of these mechanisms is response claims. Section 111(a)(2) of CERCLA authorizes the Environmental Protection Agency (EPA or the Agency) to compensate claimants for necessary response costs if certain conditions are met. Section 122(b)(1) of CERCLA authorizes EPA to reimburse certain potentially responsible parties for a portion of the costs of response actions conducted pursuant to a settlement agreement. These conditions are outlined below. </P> <P>First, only private parties, parties to section 122(b)(1) agreements (including States and political subdivisions thereof) and foreign entities are eligible for payment through the response claims mechanism. Federal, State, and local government units, and Indian Tribes can receive funding for response activities through other authorities of section 111(a) or section 123 of CERCLA.</P> <P>Second, eligible claimants can only be reimbursed for costs that are incurred in carrying out the National Contingency Plan (NCP), 40 CFR part 300. In order to be in conformity with the NCP, all claims must receive prior approval, or “preauthorization,” from EPA. This means that before response work is initiated, the party must:</P> <P>(1) Notify EPA of its intent to file a claim;</P> <P>(2) Demonstrate that the release merits priority consideration;</P> <P>(3) Propose activities to remedy the release that can be carried out consistent with the NCP; and</P> <P>(4) Demonstrate the capabilities necessary to carry out such activities in a safe and effective manner.</P> <FP>In order for potentially responsible parties to be eligible for reimbursement they must conduct the response actions as specified in a Consent Decree or administrative order. Only if EPA preauthorizes a response action can the party begin work, and later file a claim for reimbursement of costs.</FP> <P>The limitations placed on the payment of claims for response actions and the procedures for filing such claims are described in more detail at 58 FR 5460, Jan. 21, 1993, 40 CFR part 307. Additional information can be obtained by contacting Phyllis Anderson, Office of Emergency and Remedial Response (5203 G), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460, (703) 603-8971, or the RCRA/CERCLA Hotline, (800) 424-9346 (or (703) 920-9810 in the Washington, DC metropolitan area).</P> <CITA>[58 FR 5475, Jan. 21, 1993, as amended at 65 FR 47325, Aug. 2, 2000]</CITA> </APPENDIX> </SUBPART> </PART> <PART> <EAR>Pt. 310</EAR> <HD SOURCE="HED">PART 310—REIMBURSEMENT TO LOCAL GOVERNMENTS FOR EMERGENCY RESPONSE TO HAZARDOUS SUBSTANCE RELEASES</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Information</HD> <SECHD>Sec.</SECHD> <SECTNO>310.1</SECTNO> <SUBJECT>What is the purpose of this part?</SUBJECT> <SECTNO>310.2</SECTNO> <SUBJECT>What is the statutory authority for this part?</SUBJECT> <SECTNO>310.3</SECTNO> <SUBJECT>What terms have specific definitions?</SUBJECT> <SECTNO>310.4</SECTNO> <SUBJECT>What abbreviations should I know?</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Provisions</HD> <SUBJGRP> <HD SOURCE="HED">Who Can Be Reimbursed?</HD> <SECTNO>310.5</SECTNO> <SUBJECT>Am I eligible for reimbursement?</SUBJECT> <SECTNO>310.6</SECTNO> <SUBJECT>Are states eligible?</SUBJECT> <SECTNO>310.7</SECTNO> <SUBJECT>Can more than one local agency or government be reimbursed for response to the same incident?</SUBJECT> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">What Can Be Reimbursed?</HD> <SECTNO>310.8</SECTNO> <SUBJECT> Can EPA reimburse the entire cost of my response? <PRTPAGE P="395"/> </SUBJECT> <SECTNO>310.9</SECTNO> <SUBJECT>If more than one local agency or government is involved, can each receive up to $25,000?</SUBJECT> <SECTNO>310.10</SECTNO> <SUBJECT>What are temporary emergency measures?</SUBJECT> <SECTNO>310.11</SECTNO> <SUBJECT>What costs are allowable?</SUBJECT> <SECTNO>310.12</SECTNO> <SUBJECT>What costs are NOT allowable?</SUBJECT> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How To Get Reimbursed</HD> <SECTNO>310.13</SECTNO> <SUBJECT>Do I need to notify anyone while the response is underway?</SUBJECT> <SECTNO>310.14</SECTNO> <SUBJECT>Must I try to recover my costs from those potentially responsible for the emergency?</SUBJECT> <SECTNO>310.15</SECTNO> <SUBJECT>How do I apply for reimbursement?</SUBJECT> <SECTNO>310.16</SECTNO> <SUBJECT>What kind of cost documentation is necessary?</SUBJECT> <SECTNO>310.17</SECTNO> <SUBJECT>Are there any other requirements?</SUBJECT> <SECTNO>310.18</SECTNO> <SUBJECT>How will EPA evaluate my application?</SUBJECT> <SECTNO>310.19</SECTNO> <SUBJECT>Under what conditions would EPA deny my request?</SUBJECT> <SECTNO>310.20</SECTNO> <SUBJECT>What are my options if EPA denies my request?</SUBJECT> <SECTNO>310.21</SECTNO> <SUBJECT>How does EPA resolve disputes?</SUBJECT> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">Other Things You Need To Know</HD> <SECTNO>310.22</SECTNO> <SUBJECT>What records must I keep?</SUBJECT> <SECTNO>310.23</SECTNO> <SUBJECT>How will EPA rank approved requests?</SUBJECT> <SECTNO>310.24</SECTNO> <SUBJECT>What happens if I provide incorrect or false information?</SUBJECT> <APP>Appendix I to Part 310—Frequently Asked Questions</APP> <APP>Appendix II to Part 310—EPA Regions and NRC Telephone Lines</APP> <APP>Appendix III to Part 310—Form: Application for Reimbursement to Local Governments for Emergency Response to Hazardous Substance Release Under CERCLA Sec. 123</APP> </SUBJGRP> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 9611(c)(11), 9623.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>63 FR 8286, Feb. 18, 1998, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Information</HD> <SECTION> <SECTNO>§ 310.1</SECTNO> <SUBJECT>What is the purpose of this part?</SUBJECT> <P>This part sets up procedures for EPA to reimburse local governments for certain emergency response costs. Local governments may receive up to $25,000 to help lighten financial burdens related to emergency response to hazardous substance releases. This reimbursement does NOT replace funding that local governments normally provide for emergency response.</P> </SECTION> <SECTION> <SECTNO>§ 310.2</SECTNO> <SUBJECT>What is the statutory authority for this part?</SUBJECT> <P>This part is authorized under section 123 of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA) (Pub. L. 96-510, 42 U.S.C. 9601-9675), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA) (Pub. L. 99-499, 42 U.S.C. 9601).</P> </SECTION> <SECTION> <SECTNO>§ 310.3</SECTNO> <SUBJECT>What terms have specific definitions?</SUBJECT> <P>For purposes of this part except when otherwise specified:</P> <P> (a) <E T="03">Application</E> means Form 9310-1, shown in appendix III of this part, including all documentation and additional information you submit to support a request for reimbursement. </P> <P> (b) <E T="03">Date of completion</E> means the date when you have completed all field work and you have received all deliverables (such as lab results, technical expert reports, or invoices) due under a contract or other agreement. </P> <P> (c) <E T="03">Emergency Planning and Community Right-to-Know Act of 1986</E> means Title III—Emergency Planning and Community Right-to-Know Act of the Superfund Amendments and Reauthorization Act of 1986 (EPCRA) (Pub. L. 99-499, 42 U.S.C. 11000-11050). </P> <P> (d) <E T="03">Federally-recognized Indian Tribe,</E> as defined by section 101(36) of CERCLA, means any Indian Tribe, band, nation, or other organized group or community, including any Alaska Native village but not including any Alaska Native regional or village corporation, which is recognized as eligible for the special programs and services provided by the United States to Indians because of their status as Indians. </P> <P> (e) <E T="03">General purpose unit of local government</E> means the governing body of a county, parish, municipality, city, town, township, Federally-recognized Indian tribe or similar governing body. This term does not include special purpose districts. </P> <P> (f) <E T="03">Hazardous substance.</E> (1) <E T="03">Hazardous substance,</E> as defined by section 101(14) of CERCLA, means: </P> <P> (i) Any substance designated pursuant to section 311(b)(2)(A) of the Federal Water Pollution Control Act (Pub. L. 101-380, 33 U.S.C. 1251 <E T="03">et seq.</E> ); <PRTPAGE P="396"/> </P> <P>(ii) Any element, compound, mixture, solution, or substance designated pursuant to section 102 of CERCLA;</P> <P> (iii) Any hazardous waste having the characteristics identified under or listed pursuant to section 3001 of the Solid Waste Disposal Act (Pub. L. 89-272, 42 U.S.C. 3259 <E T="03">et seq.</E> ) (but not including any waste the regulation of which under the Solid Waste Disposal Act has been suspended by Act of Congress); </P> <P> (iv) Any toxic pollutant listed under section 307(a) of the Federal Water Pollution Control Act (Pub. L. 101-380, 33 U.S.C. 1251 <E T="03">et seq.</E> ); </P> <P>(v) Any hazardous air pollutant listed under section 112 of the Clean Air Act (42 U.S.C. 7401-7642); and</P> <P>(vi) Any imminently hazardous chemical substance or mixture with respect to which the Administrator has taken action pursuant to section 7 of the Toxic Substances Control Act (Pub. L. 94-469, 15 U.S.C. 2601-2629).</P> <P>(2) The term does not include petroleum, including crude oil or any fraction thereof that is not otherwise specifically listed or designated as a hazardous substance under paragraphs (f)(1)(i) through (f)(1)(vi) of this section, and the term does not include natural gas, natural gas liquids, liquefied natural gas, or synthetic gas usable for fuel (or mixtures of natural gas and such synthetic gas).</P> <P> (g) <E T="03">Local emergency response plan</E> means the emergency plan prepared by the Local Emergency Planning Committee (LEPC) as required by section 303 of the Emergency Planning and Community Right-to-Know Act of 1986 (EPCRA or SARA Title III). </P> <P> (h) <E T="03">National Contingency Plan</E> means the National Oil and Hazardous Substances Pollution Contingency Plan (40 CFR part 300). </P> <P> (i) <E T="03">National Response Center</E> means the national communications center located in Washington, DC, that receives and relays notice of oil discharge or releases of hazardous substances to appropriate Federal officials. </P> <P> (j) <E T="03">Pollutant or contaminant,</E> as defined by section 104(a)(2) of CERCLA, includes, but is not limited to, any element, substance, compound, or mixture, including disease-causing agents, which after release into the environment and upon exposure, ingestion, inhalation, or assimilation into any organism, either directly from the environment or indirectly by ingestion through food chains, will or may reasonably be anticipated to cause death, disease, behavioral abnormalities, cancer, genetic mutation, physiological malfunctions (including malfunctions in reproduction) or physical deformations, in such organisms or their offspring. The term does not include petroleum, including crude oil and any fraction thereof that is not otherwise specifically listed or designated as a hazardous substance under section 101(14)(A) through (F) of CERCLA, nor does it include natural gas, liquefied natural gas, or synthetic gas of pipeline quality (or mixtures of natural gas and such synthetic gas). </P> <P> (k) <E T="03">Potentially responsible party</E> (PRP) means any person who may be liable under section 107 of CERCLA for a release or threatened release of hazardous substances or pollutants or contaminants. </P> <P> (l) <E T="03">Release,</E> as defined by section 101(22) of CERCLA, means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injection, escaping, leaching, dumping, or disposing into the environment, but excludes: any release that results in exposure to persons solely within a workplace, with respect to a claim that such persons may assert against the employer of such persons; emissions from the engine exhaust of a motor vehicle, rolling stock, aircraft, vessel, or pipeline pumping station engine; release of source, by-product or special nuclear materials from a nuclear incident, as those terms are defined in the Atomic Energy Act of 1954 (42 U.S.C. 2011 <E T="03">et seq.</E> ), if such release is subject to requirements with respect to financial protection established by the Nuclear Regulatory Commission under section 170 of such act, or, for the purpose of section 104 of CERCLA or any other response action, any release of source, by-product, or special nuclear material from any processing site designated under section 122(a)(1) or 302(a) of the Uranium Mill Tailings Radiation Control Act of 1978 (Pub. L. 95-604, 42 U.S.C. 2014 <E T="03">et seq.</E> ); and the normal application of fertilizer. For purposes of <PRTPAGE P="397"/> this part, release also means the threat of release. </P> <P> (m) <E T="03">Single response</E> means all of the concerted activities conducted in response to a single episode, incident, or threat causing or contributing to a release or threatened release of hazardous substances, or pollutants or contaminants. </P> </SECTION> <SECTION> <SECTNO>§ 310.4</SECTNO> <SUBJECT>What abbreviations should I know?</SUBJECT> <P>The following abbreviations appear in this part:</P> <EXTRACT> <FP SOURCE="FP-1">CERCLA—The Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (Pub. L. 96-510, 42 U.S.C. 9601-9675), as amended by the Superfund Amendments and Reauthorization Act of 1986, also known as Superfund.</FP> <FP SOURCE="FP-1">EPA or the Agency—Environmental Protection Agency.</FP> <FP SOURCE="FP-1">EPCRA—Emergency Planning and Community Right-to-Know Act of 1986 (Pub. L. 99-499, 42 U.S.C. 11000-11050).</FP> <FP SOURCE="FP-1">LEPC—Local Emergency Planning Committee.</FP> <FP SOURCE="FP-1">NCP—National Oil and Hazardous Substances Pollution Contingency Plan also known as the National Contingency Plan (40 CFR part 300).</FP> <FP SOURCE="FP-1">NRC—National Response Center.</FP> <FP SOURCE="FP-1">OMB—Office of Management and Budget.</FP> <FP SOURCE="FP-1">PRP—Potentially Responsible Party.</FP> <FP SOURCE="FP-1">SARA—The Superfund Amendments and Reauthorization Act of 1986 (Pub. L. 99-499, 42 U.S.C. 9601).</FP> <FP SOURCE="FP-1">SERC—State Emergency Response Commission.</FP> <FP SOURCE="FP-1">USCG—U.S. Coast Guard.</FP> </EXTRACT> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Provisions</HD> <SUBJGRP> <HD SOURCE="HED">Who Can Be Reimbursed?</HD> <SECTION> <SECTNO>§ 310.5</SECTNO> <SUBJECT>Am I eligible for reimbursement?</SUBJECT> <P>If you are the governing body of a county, parish, municipality, city, town, township, federally-recognized Indian tribe or general purpose unit of local government, you are eligible for reimbursement. This does not include special purpose districts.</P> </SECTION> <SECTION> <SECTNO>§ 310.6</SECTNO> <SUBJECT>Are states eligible?</SUBJECT> <P>States are NOT eligible for reimbursement under this part, and states may NOT request reimbursement on behalf of their local governments.</P> </SECTION> <SECTION> <SECTNO>§ 310.7</SECTNO> <SUBJECT>Can more than one local agency or government be reimbursed for response to the same incident?</SUBJECT> <P>No. EPA will accept only one reimbursement request for a single response. A single response includes all of the temporary emergency measures that ALL local governments or agencies conduct in response to a single hazardous substance release. If more than one local government or agency responds, you must decide among yourselves who will request reimbursement on behalf of all.</P> </SECTION> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">What Can Be Reimbursed?</HD> <SECTION> <SECTNO>§ 310.8</SECTNO> <SUBJECT>Can EPA reimburse the entire cost of my response?</SUBJECT> <P>Possibly not. EPA can only reimburse you for temporary emergency measures you take in response to releases of hazardous substances, pollutants, or contaminants. The statute allows reimbursement for only certain costs, and by statute, the total amount of the reimbursement may not exceed $25,000 for a single response.</P> </SECTION> <SECTION> <SECTNO>§ 310.9</SECTNO> <SUBJECT>If more than one local agency or government is involved, can each receive up to $25,000?</SUBJECT> <P>No. The maximum amount EPA can reimburse is $25,000 for a single response, which includes all activities by ALL local responders. If the costs incurred by multiple local governments or agencies exceed $25,000, you must decide among yourselves how the total reimbursement will be divided.</P> </SECTION> <SECTION> <SECTNO>§ 310.10</SECTNO> <SUBJECT>What are temporary emergency measures?</SUBJECT> <P>(a) Temporary emergency measures are actions taken to control or eliminate immediate threats to human health and the environment.</P> <P>(b) Examples of temporary emergency measures are:</P> <P>(1) Site security;</P> <P>(2) Controlling the source of contamination;</P> <P>(3) Containing the release to prevent spreading;</P> <P>(4) Neutralizing or treating pollutants released; and</P> <P>(5) Controlling contaminated runoff.</P> </SECTION> <SECTION> <PRTPAGE P="398"/> <SECTNO>§ 310.11</SECTNO> <SUBJECT>What costs are allowable?</SUBJECT> <P>(a) Reimbursement under this part does NOT supplant funds you normally provide for emergency response. Allowable costs are only those necessary for you to respond effectively to a specific incident that is beyond what you might normally respond to.</P> <P>(b) Examples of allowable costs are:</P> <P>(1) Disposable materials and supplies you acquired and used to respond to the specific incident;</P> <P>(2) Payment of unbudgeted wages for employees responding to the specific incident (for example, overtime pay for response personnel);</P> <P>(3) Rental or leasing of equipment you used to respond to the specific incident (for example, protective equipment or clothing, scientific and technical equipment) (Note: rental costs are only allowable for the duration of your response; once you complete the response to the specific incident, further rental costs are NOT allowable);</P> <P>(4) Replacement costs for equipment you own that is contaminated or damaged beyond reuse or repair, if you can demonstrate that the equipment is a total loss and that the loss occurred during the response (for example, self-contained breathing apparatus irretrievably contaminated during the response);</P> <P>(5) Decontamination of equipment contaminated during the response;</P> <P>(6) Special technical services specifically required for the response (for example, costs associated with the time and efforts of technical experts/specialists that are not on your staff);</P> <P>(7) Other special services specifically required for the response (for example, utilities);</P> <P>(8) Laboratory costs of analyzing samples that you took during the response;</P> <P>(9) Evacuation costs associated with the services, supplies, and equipment that you procured for a specific evacuation; and</P> <P>(10) Containerization or packaging cost and transportation and disposal of hazardous wastes.</P> <P>(c) To be allowable, costs must:</P> <P>(1) NOT be higher than what a careful person would spend for similar products or services in your area; and</P> <P>(2) Be consistent with CERCLA and the federal cost principles outlined in OMB Circular A-87, “Cost Principles for State and Local Governments.” (Copies of the circular are available from the Office of Administration, Publications Office, New Executive Office Building, 725 17th Street, NW., Room 2200, Washington, DC 20503.)</P> <P>(d) EPA will make final determinations on whether your costs are reasonable.</P> </SECTION> <SECTION> <SECTNO>§ 310.12</SECTNO> <SUBJECT>What costs are NOT allowable?</SUBJECT> <P>(a) Costs that are NOT allowable are expenditures you incur in providing what are traditionally local services and responsibilities. Examples include:</P> <P>(1) Routine firefighting;</P> <P>(2) Preparing contingency plans;</P> <P>(3) Training; and</P> <P>(4) Response drills and exercises.</P> <P>(b) Costs that are NOT allowable also include items such as supplies, equipment, and services that you routinely purchase to maintain your ability to respond effectively to hazardous releases when they occur. Examples of other costs that are NOT allowable are:</P> <P>(1) Purchase or routine maintenance of durable equipment expected to last one year or more, except when contaminated or damaged as described in § 310.11(b)(4) and (b)(5);</P> <P>(2) Materials and supplies you did NOT purchase specifically for the response;</P> <P>(3) Rental costs for equipment that you own or that another unit of local government owns;</P> <P>(4) Employee fringe benefits;</P> <P>(5) Administrative costs for filing reimbursement applications;</P> <P>(6) Employee out-of-pocket expenses normally provided for in your operating budget (for example, meals or fuel);</P> <P>(7) Legal expenses you may incur due to response activities, including efforts to recover costs from PRPs; and</P> <P>(8) Medical expenses you incur due to response activities.</P> </SECTION> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How to get Reimbursed</HD> <SECTION> <SECTNO>§ 310.13</SECTNO> <SUBJECT>Do I need to notify anyone while the response is underway?</SUBJECT> <P> No. You should notify EPA, the National Response Center, or use another <PRTPAGE P="399"/> established response communication channel, but it is not a requirement for reimbursement. Telephone numbers for EPA regional offices and the NRC are in appendix II to this part. </P> </SECTION> <SECTION> <SECTNO>§ 310.14</SECTNO> <SUBJECT>Must I try to recover my costs from those potentially responsible for the emergency?</SUBJECT> <P>Yes. Before applying for reimbursement from EPA, you must try to recover your costs from all known potentially responsible parties (PRPs). After you ask them for payment, you should give PRPs 60 days either to pay you, express their intent to pay you, or indicate willingness to negotiate. You must also try to get reimbursed by other sources (for example, your insurance company or your state). If you are not successful, you must certify on your reimbursement application that you made a good-faith, reasonable effort to recover your costs from other sources before applying to EPA. If you recover any portion of the costs from these sources after you receive reimbursement from us, you must return the recovered amount to EPA.</P> </SECTION> <SECTION> <SECTNO>§ 310.15</SECTNO> <SUBJECT>How do I apply for reimbursement?</SUBJECT> <P>(a) You must apply for reimbursement on EPA Form 9310-1, shown in appendix III to this part.</P> <P>(b) You must submit your request within one year of the date you complete the response for which you request reimbursement. If you submit your application late, you must include an explanation for the delay. We will consider late applications on a case-by-case basis.</P> <P>(c) Your application must be signed by the highest ranking official of your local government (for example, mayor or county executive), or you must include a letter of delegation authorizing a delegate to act on his or her behalf.</P> <P>(d) Mail your completed application and supporting data to the LGR Project Officer, (5401A), Office of Emergency Management, Office of Land and Emergency Management, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460.</P> <CITA>[63 FR 8286, Feb. 18, 1998, as amended at 70 FR 56577, Sept. 28, 2005; 80 FR 77578, Dec. 15, 2015]</CITA> </SECTION> <SECTION> <SECTNO>§ 310.16</SECTNO> <SUBJECT>What kind of cost documentation is necessary?</SUBJECT> <P>Cost documentation must be adequate for an audit. At a minimum, you must:</P> <P>(a) Include a description of the temporary emergency measures for which you request reimbursement;</P> <P>(b) Specify the local agency that incurred the cost, (such as, the Town Fire Department, the County Health Department, or the City Department of Public Works);</P> <P>(c) Include invoices, sales receipts, rental or leasing agreements, or other proof of costs you incurred; and</P> <P>(d) Certify that all costs are accurate and that you incurred them specifically for the response for which you are requesting reimbursement.</P> </SECTION> <SECTION> <SECTNO>§ 310.17</SECTNO> <SUBJECT>Are there any other requirements?</SUBJECT> <P>(a) You must certify that reimbursement under this regulation does not supplant local funds that you normally provide for emergency response. This means that the reimbursement you request is for costs you would not normally incur; rather, they are for significant, unanticipated costs related to a specific incident beyond what you normally respond to.</P> <P>(b) You must also certify that your response actions are not in conflict with CERCLA, the National Contingency Plan (NCP), and the local emergency response plan prepared by your Local Emergency Planning Committee, if there is one. If you need help with this requirement, contact the LGR Help line (800-431-9209) or your EPA regional office.</P> <P>(c) You, as a local government, should be included in the local emergency response plan completed by your LEPC, as section 303(a) of EPCRA requires. This does not apply if your State Emergency Response Commission (SERC) has not established an LEPC responsible for the emergency planning district(s) that encompasses your geographic boundaries.</P> </SECTION> <SECTION> <PRTPAGE P="400"/> <SECTNO>§ 310.18</SECTNO> <SUBJECT>How will EPA evaluate my application?</SUBJECT> <P>(a) When we receive your application, we will make sure it meets all requirements of this section. If your request is incomplete or has significant defects, we will contact you for additional information. You should provide any additional information within 90 days. If you don't provide requested information within a year, we may deny your application.</P> <P>(b) If your application meets all requirements, we will consider whether the costs claimed are allowable and reasonable. We will then send you written notification of our decision to award or deny reimbursement in full or in part.</P> </SECTION> <SECTION> <SECTNO>§ 310.19</SECTNO> <SUBJECT>Under what conditions would EPA deny my request?</SUBJECT> <P>We may deny your reimbursement request in full or in part if:</P> <P>(a) Your records, documents, or other evidence are not maintained according to generally accepted accounting principles and practices consistently applied;</P> <P>(b) The costs you claim are NOT reasonable or allowable, that is, they are higher than what a careful person would spend for similar products or services in your area; or</P> <P>(c) You do not supply additional information within one year from when we request it; and</P> <P>(d) Reimbursement would be inconsistent with CERCLA section 123, or the regulations in this part.</P> </SECTION> <SECTION> <SECTNO>§ 310.20</SECTNO> <SUBJECT>What are my options if EPA denies my request?</SUBJECT> <P>If we deny your request because you failed to meet a requirement in this regulation, you may request, in writing, that EPA grant an exception. You may also file a request for an exception with your initial application. In your request for an exception, you must state the requirement you cannot comply with and the reasons why EPA should grant an exception. We will grant exceptions only if you establish good cause for the exception and if granting the exception would be consistent with section 123 of CERCLA.</P> </SECTION> <SECTION> <SECTNO>§ 310.21</SECTNO> <SUBJECT>How does EPA resolve disputes?</SUBJECT> <P>(a) The EPA reimbursement official's decision is final EPA action unless you file a request for review by registered or certified mail within 60 calendar days of the date you receive our decision. Send your request for review to the address given in § 310.15(d).</P> <P>(b) You must file your request for review with the disputes decision official identified in the final written decision.</P> <P>(c) Your request for review must include:</P> <P>(1) A statement of the amount you dispute;</P> <P>(2) A description of the issues involved;</P> <P>(3) A statement of your objection to the final decision; and</P> <P>(4) Any additional information relevant to your objection to EPA's decision.</P> <P>(d) After filing for review:</P> <P>(1) You may request an informal conference with the EPA disputes decision official;</P> <P>(2) You may be represented by counsel and may submit documentary evidence and briefs to be included in a written record; and</P> <P>(3) You will receive a written decision by the disputes decision official within 45 days after we receive your final submission of information unless the official extends this period for good cause.</P> </SECTION> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">Other Things You Need To Know</HD> <SECTION> <SECTNO>§ 310.22</SECTNO> <SUBJECT>What records must I keep?</SUBJECT> <P>(a) If you receive reimbursement under the regulations in this part, for three years you must keep all cost documentation and any other records related to your application. You must also provide EPA access to those records if we need them.</P> <P>(b) After three years from the date of your reimbursement, if we have NOT begun a cost recovery action against a potentially responsible party, you may dispose of the records. You must notify EPA of your intent to dispose of the records 60 days before you do so, and allow us to take possession of these records beforehand.</P> </SECTION> <SECTION> <PRTPAGE P="401"/> <SECTNO>§ 310.23</SECTNO> <SUBJECT>How will EPA rank approved requests?</SUBJECT> <P>(a) If necessary, EPA will rank approved reimbursement requests according to the financial burden the response costs impose on the local governments. We will estimate your financial burden by calculating the ratio of your allowable response costs to your annual per capita income adjusted for population. We will make adjustments for population so that a large city with a low per capita income will not necessarily receive a higher rank than a small town with a slightly higher per capita income. We will also consider other relevant financial information you may supply.</P> <P> (b) We will use the per capita income and population statistics published by the U.S. Department of Commerce, Bureau of the Census, in Current Population Reports, Local Population Estimates, Series P-26, “1988 Population and 1987 Per Capita Income Estimates for Counties and Incorporated Places,” Vols. 88-S-SC, 88-ENC-SC, 88-NE-SC, 88-W-SC, 88-WNC-SC, March 1990. The Director of the Federal Register has approved this incorporation by reference in accordance with 5 U.S.C. 552(a) and 1 CFR Part 51. Copies are available from the Bureau of the Census, Office of Public Affairs, Department of Commerce, Constitution Avenue, NE., Washington, DC 20230 (1-202-763-4040). You may review a copy at the U.S. Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460 or at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: <E T="03">http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html.</E> </P> <P>(c) Larger ratios receive a higher rank. We will reimburse requests with the highest ranks first. Once we rank your request, we will either:</P> <P>(1) Reimburse the request; or</P> <P>(2) Hold the request for reconsideration once additional funding is available.</P> <P>(d) The EPA reimbursement official will give you a written decision on whether the request will be reimbursed or held for future reconsideration.</P> <CITA>[63 FR 8286, Feb. 18, 1998, as amended at 69 FR 18803, Apr. 9, 2004]</CITA> </SECTION> <SECTION> <SECTNO>§ 310.24</SECTNO> <SUBJECT>What happens if I provide incorrect or false information?</SUBJECT> <P>(a) You must not knowingly or recklessly make any statement or provide any information in your reimbursement application that is false, misleading, misrepresented, or misstated. If you do provide incorrect or false information, and EPA relies on that information in making a reimbursement decision, we may deny your application and withdraw or recover the full amount of your award. In such a case, we would give you written notice of our intentions.</P> <P>(b) If you, as a reimbursement applicant or someone providing information to the applicant, knowingly give any false statement or claim as part of any application for reimbursement under section 123 of CERCLA, you may be subject to criminal, civil, or administrative liability under the False Statement Act (Pub. L. 97-398, 18 U.S.C. 1001) the False Claims Act (Pub. L. 99-562, 31 U.S.C. 3729), and the Program Fraud and Civil Remedies Act (Pub. L. 99-509, 31 U.S.C. 3801).</P> </SECTION> </SUBJGRP> <APPENDIX> <EAR>Pt. 310, App. I</EAR> <HD SOURCE="HED">Appendix I to Part 310—Frequently Asked Questions</HD> <P>(1) Can I be reimbursed for hazmat team salaries?</P> <P>Generally, no; only unbudgeted overtime and/or extra time can be considered for reimbursement. (§ 310.11(b)(2))</P> <P>(2) Will I be reimbursed for the cost of a destroyed fire truck?</P> <P>Up to $25,000 of the cost of a lost fire truck can be considered an allowable cost and therefore, reimbursable. However, if the local government has insurance covering such losses, then we would not reimburse you for a destroyed fire truck. (§§ 310.11(b)(4) and 310.14)</P> <P>(3) If I have a release in an elementary school, can the school district apply for reimbursement?</P> <P> No, for purposes of the regulation in this part, a school district is considered a special purpose district of local government and therefore not eligible for reimbursement. The county or city where the incident happened may apply for reimbursement on behalf of the school district. (§§ 310.03(e) and 310.05) <PRTPAGE P="402"/> </P> <P>(4) Why are incidents that involve a release of petroleum not eligible?</P> <P>Because this program is authorized under CERCLA, and petroleum is excluded under CERCLA, we can't reimburse you for response to releases involving only petroleum. If, however, some hazardous substances are also involved, your incident may be reimbursed. (§ 310.03(f))</P> <P>(5) Can I be reimbursed for laying water lines to a community whose drinking water is affected by a release?</P> <P>No, laying water lines doesn't fall within the definition of temporary emergency measures. Providing bottled water on a temporary emergency basis is reimbursable. (§ 310.10(a))</P> <P>(6) What if EPA gets too many applications in one year?</P> <P>In the beginning of the program, there was a statutory limitation on the amount of the Superfund that could be used for reimbursements. That limitation was approximately $1,000,000. The limitation has expired, and EPA has only reimbursed slightly over $1,000,000 in ten years. There has not been a year where we received too many applications.</P> <P>(7) If I incur significant costs trying to recover from the PRP, can I be reimbursed by EPA for those costs?</P> <P>No, legal expenses are not allowable costs. (§ 310.12(b)(7)).</P> <P>(8) Can I add attachments to the Application Form?</P> <P>Yes, attach any additional information that you feel is necessary. EPA will review all the information that you send.</P> <P>(9) Do I have to notify EPA before I send an application in, or before I take a response action?</P> <P>No, you aren't required to notify EPA in either case. We do suggest that you call the National Response Center to report the hazardous substance release, or if you use other response reporting channels, use them. If you need some help before submitting your application, we do suggest you call the LGR Help line (800-431-9209).</P> <P>(10) If two incidents happen in my town, within hours of each other, do I have to submit two separate applications?</P> <P>You aren't required to submit separate applications in this case, but if your total response costs are more than $25,000, it may be in your interest to submit separate applications for each single response. (§ 310.9)</P> </APPENDIX> <APPENDIX> <EAR>Pt. 310, App. II</EAR> <HD SOURCE="HED">Appendix II to Part 310—EPA Regions and NRC Telephone Lines</HD> <GPOTABLE COLS="2" OPTS="L2,p1,6/7" CDEF="s25,15"> <ROW> <ENT I="01">National Response Center</ENT> <ENT>(800) 424-8802</ENT> </ROW> <ROW> <ENT I="22">EPA Regional Phone Numbers:</ENT> </ROW> <ROW> <ENT I="03">Region I (ME, NH, VT, MA, RI, CT)</ENT> <ENT>(617) 723-8928</ENT> </ROW> <ROW> <ENT I="03">Region II (NJ, NY, PR, VI)</ENT> <ENT>(800) 424-8802</ENT> </ROW> <ROW> <ENT I="03">Region III (PA, DE, MD, DC, VA, WV)</ENT> <ENT>(215) 814-3255</ENT> </ROW> <ROW> <ENT I="03">Region IV (NC, SC, TN, MS, AL, GA, FL, KY)</ENT> <ENT>(404) 562-8700</ENT> </ROW> <ROW> <ENT I="03">Region V (OH, IN, IL, WI, MN, MI)</ENT> <ENT>(312) 353-2318</ENT> </ROW> <ROW> <ENT I="03">Region VI (AR, LA, TX, OK, NM)</ENT> <ENT>(866) 372-7745</ENT> </ROW> <ROW> <ENT I="03">Region VII (IA, MO, KS, NE)</ENT> <ENT>(913) 281-0991</ENT> </ROW> <ROW> <ENT I="03">Region VIII (CO, UT, WY, MT, ND, SD)</ENT> <ENT>(303) 293-1788</ENT> </ROW> <ROW> <ENT I="03">Region IX (AZ, CA, NV, AS, HI, GU, TT)</ENT> <ENT>(800) 300-2193</ENT> </ROW> <ROW> <ENT I="03">Region X (ID, OR, WA, AK)</ENT> <ENT>(206) 553-1263</ENT> </ROW> </GPOTABLE> <CITA>[63 FR 8286, Feb. 18, 1998, as amended at 70 FR 56577, Sept. 28, 2005]</CITA> </APPENDIX> <APPENDIX> <PRTPAGE P="403"/> <EAR>Pt. 310, App. III</EAR> <HD SOURCE="HED">Appendix III to Part 310—Form: Application for Reimbursement to Local Governments for Emergency Response to Hazardous Substance Release Under CERCLA Sec. 123</HD> <GPH SPAN="2" DEEP="415"> <GID>ER18FE98.000</GID> </GPH> <GPH SPAN="2" DEEP="420"> <PRTPAGE P="404"/> <GID>ER18FE98.001</GID> </GPH> <GPOTABLE COLS="4" OPTS="L2" CDEF="xs40,xs80,r50,r50"> <TTITLE>Attachment 1 to Form 9310-1 Cost Element Codes and Comments</TTITLE> <TDESC>[Cost Element Codes for use in Table 1]</TDESC> <BOXHD> <CHED H="1">Code</CHED> <CHED H="1">Cost category</CHED> <CHED H="1">Cost element</CHED> <CHED H="1">Comments</CHED> </BOXHD> <ROW> <ENT I="01">PC</ENT> <ENT>Personnel Compensation</ENT> <ENT> PC1: Overtime—for services excess of the local agency's standard work day or work week <LI>PC2: Experts and consultants—for services rendered on a per diem or fee basis or for services of an intermittent, advisory nature</LI> </ENT> <ENT>Compensation of overtime costs incurred specifically for a response will be considered only if overtime is not otherwise provided for in the applicant's operating budget.</ENT> </ROW> <ROW> <PRTPAGE P="405"/> <ENT I="01">TR</ENT> <ENT>Transportation</ENT> <ENT> TR1: Passenger vehicle rental—for transportation of persons during evacuation <LI>TR2: Nonpassenger vehicle rental—for transportation of equipment or supplies</LI> </ENT> <ENT>Passenger and nonpassenger vehicle rental costs will be considered for private vehicles not owned or operated by the applicant or other unit of local government.</ENT> </ROW> <ROW> <ENT I="01">RC</ENT> <ENT>Utilities</ENT> <ENT>RC1: Utilities—for power, water, electricity and other services exclusive of transportation and communications</ENT> <ENT>Utility costs will be considered for private utilities not owned or operated by the applicant or other unit of local government.</ENT> </ROW> <ROW> <ENT I="01">OS</ENT> <ENT>Other Contractual Services</ENT> <ENT> OS1: Contracts for technical or scientific analysis—for tasks requiring specialized hazardous sustance response expertise <LI>OS2: Decontamination services—for specialized cleaning or decontamination procedures and supplies to restore clothing, equipment or other serviceable gear to normal functioning</LI> </ENT> <ENT>May include such items as specialized laboratory analyses and sampling.</ENT> </ROW> <ROW> <ENT I="01">SM</ENT> <ENT>Supplies and Materials</ENT> <ENT>SM1: Commodities—for protective gear and clothing, cleanup tools and supplies and similar materials purchased specifically for, and expended during, the response</ENT> <ENT>May include such items as chemical foam to suppress a fire; food purchased specifically for an evacuation; air purifying canisters for breathing apparatus; disposable, protective suits and gloves; and sampling supplies.</ENT> </ROW> <ROW> <ENT I="01">EQ</ENT> <ENT>Equipment</ENT> <ENT> EQ1: Replacement—for durable equipment declared a total loss as a result of contamination during the response <LI>EQ2: Rents—for use of equipment owned by others</LI> </ENT> <ENT> Equipment replacement costs will be considered if applicant can demonstrate total loss and proper disposal of contaminated equipment. <LI>Equipment rental costs will be considered for privately owned equipment not owned or operated by the applicant or other unit of local government.</LI> </ENT> </ROW> </GPOTABLE> <GPH SPAN="2" DEEP="437"> <PRTPAGE P="406"/> <GID>ER18FE98.002</GID> </GPH> <GPH SPAN="2" DEEP="433"> <PRTPAGE P="407"/> <GID>ER18FE98.003</GID> </GPH> </APPENDIX> </SUBPART> </PART> <PART> <EAR>Pt. 311</EAR> <HD SOURCE="HED">PART 311—WORKER PROTECTION</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>311.1</SECTNO> <SUBJECT>Scope and application.</SUBJECT> <SECTNO>311.2</SECTNO> <SUBJECT>Definition of employee.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>29 U.S.C. 655, Pub. L. 99-499.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>54 FR 26658, June 23, 1989, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 311.1</SECTNO> <SUBJECT>Scope and application.</SUBJECT> <P> The substantive provisions found at 29 CFR 1910.120 on and after March 6, 1990, and before March 6, 1990, found at 54 FR 9317 (March 6, 1989), apply to <PRTPAGE P="408"/> State and local government employees engaged in <E T="03">hazardous waste operations,</E> as defined in 29 CFR 1910.120(a), in States that do not have a State plan approved under section 18 of the Occupational Safety and Health Act of 1970. </P> </SECTION> <SECTION> <SECTNO>§ 311.2</SECTNO> <SUBJECT>Definition of employee.</SUBJECT> <P> <E T="03">Employee</E> in § 311.1 is defined as a compensated or non-compensated worker who is controlled directly by a State or local government, as contrasted to an independent contractor. </P> </SECTION> </PART> <PART> <EAR>Pt. 312</EAR> <HD SOURCE="HED">PART 312—INNOCENT LANDOWNERS, STANDARDS FOR CONDUCTING ALL APPROPRIATE INQUIRIES</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—Introduction</HD> <SECHD>Sec.</SECHD> <SECTNO>312.1</SECTNO> <SUBJECT>Purpose, applicability, scope, and disclosure obligations.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Definitions and References</HD> <SECTNO>312.10</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>312.11</SECTNO> <SUBJECT>References.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Standards and Practices</HD> <SECTNO>312.20</SECTNO> <SUBJECT>All appropriate inquiries.</SUBJECT> <SECTNO>312.21</SECTNO> <SUBJECT>Results of inquiry by an environmental professional.</SUBJECT> <SECTNO>312.22</SECTNO> <SUBJECT>Additional inquiries.</SUBJECT> <SECTNO>312.23</SECTNO> <SUBJECT>Interviews with past and present owners, operators, and occupants.</SUBJECT> <SECTNO>312.24</SECTNO> <SUBJECT>Reviews of historical sources of information.</SUBJECT> <SECTNO>312.25</SECTNO> <SUBJECT>Searches for recorded environmental cleanup liens.</SUBJECT> <SECTNO>312.26</SECTNO> <SUBJECT>Reviews of federal, state, tribal and local government records.</SUBJECT> <SECTNO>312.27</SECTNO> <SUBJECT>Visual inspections of the facility and of adjoining properties.</SUBJECT> <SECTNO>312.28</SECTNO> <SUBJECT>Specialized knowledge or experience on the part of the defendant.</SUBJECT> <SECTNO>312.29</SECTNO> <SUBJECT>The relationship of the purchase price to the value of the property, if the property was not contaminated.</SUBJECT> <SECTNO>312.30</SECTNO> <SUBJECT>Commonly known or reasonably ascertainable information about the property.</SUBJECT> <SECTNO>312.31</SECTNO> <SUBJECT>The degree of obviousness of the presence or likely presence of contamination at the property, and the ability to detect the contamination by appropriate investigation.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>Section 101(35)(B) of CERCLA, as amended, 42 U.S.C. 9601(35)(B).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>70 FR 66107, Nov. 1, 2005, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—Introduction</HD> <SECTION> <SECTNO>§ 312.1</SECTNO> <SUBJECT>Purpose, applicability, scope and disclosure obligations.</SUBJECT> <P> (a) <E T="03">Purpose.</E> The purpose of this section is to provide standards and practices for “all appropriate inquiries” for the purposes of CERCLA sections 101(35)(B)(i)(I) and 101(35)(B)(ii) and (iii). </P> <P> (b) <E T="03">Applicability.</E> The requirements of this part are applicable to: </P> <P>(1) Persons seeking to establish:</P> <P>(i) The innocent landowner defense pursuant to CERCLA sections 101(35) and 107(b)(3);</P> <P>(ii) The bona fide prospective purchaser liability protection pursuant to CERCLA sections 101(40) and 107(r);</P> <P>(iii) The contiguous property owner liability protection pursuant to CERCLA section 107(q); and</P> <P>(2) persons conducting site characterization and assessments with the use of a grant awarded under CERCLA section 104(k)(2)(B).</P> <P> (c) <E T="03">Scope.</E> (1) Persons seeking to establish one of the liability protections under paragraph (b)(1) of this section must conduct investigations as required in this part, including an inquiry by an environmental professional, as required under § 312.21, and the additional inquiries defined in § 312.22, to identify conditions indicative of releases or threatened releases, as defined in CERCLA section 101(22), of hazardous substances, as defined in CERCLA section 101(14). </P> <P>(2) Persons identified in paragraph (b)(2) of this section must conduct investigations required in this part, including an inquiry by an environmental professional, as required under § 312.21, and the additional inquiries defined in § 312.22, to identify conditions indicative of releases and threatened releases of hazardous substances, as defined in CERCLA section 101(22), and as applicable per the terms and conditions of the grant or cooperative agreement, releases and threatened releases of:</P> <P>(i) Pollutants and contaminants, as defined in CERCLA section 101(33);</P> <P> (ii) Petroleum or petroleum products excluded from the definition of “hazardous substance” as defined in CERCLA section 101(14); and <PRTPAGE P="409"/> </P> <P>(iii) Controlled substances, as defined in 21 U.S.C. 802.</P> <P> (d) <E T="03">Disclosure obligations.</E> None of the requirements of this part limits or expands disclosure obligations under any federal, state, tribal, or local law, including the requirements under CERCLA sections 101(40)(c) and 107(q)(1)(A)(vii) requiring persons, including environmental professionals, to provide all legally required notices with respect to the discovery of releases of hazardous substances. It is the obligation of each person, including environmental professionals, conducting the inquiry to determine his or her respective disclosure obligations under federal, state, tribal, and local law and to comply with such disclosure requirements. </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Definitions and References</HD> <SECTION> <SECTNO>§ 312.10</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>(a) Terms used in this part and not defined below, but defined in either CERCLA or 40 CFR part 300 (the National Oil and Hazardous Substances Pollution Contingency Plan) shall have the definitions provided in CERCLA or 40 CFR part 300.</P> <P>(b) When used in this part, the following terms have the meanings provided as follows:</P> <P> <E T="03">Abandoned property</E> means: property that can be presumed to be deserted, or an intent to relinquish possession or control can be inferred from the general disrepair or lack of activity thereon such that a reasonable person could believe that there was an intent on the part of the current owner to surrender rights to the property. </P> <P> <E T="03">Adjoining properties</E> means: any real property or properties the border of which is (are) shared in part or in whole with that of the subject property, or that would be shared in part or in whole with that of the subject property but for a street, road, or other public thoroughfare separating the properties. </P> <P> <E T="03">Data gap</E> means: a lack of or inability to obtain information required by the standards and practices listed in subpart C of this part despite good faith efforts by the environmental professional or persons identified under § 312.1(b), as appropriate, to gather such information pursuant to §§ 312.20(e)(1) and 312.20(e)(2). </P> <P> <E T="03">Date of acquisition or purchase date</E> means: the date on which a person acquires title to the property. </P> <P> <E T="03">Environmental Professional means:</E> </P> <P>(1) a person who possesses sufficient specific education, training, and experience necessary to exercise professional judgment to develop opinions and conclusions regarding conditions indicative of releases or threatened releases (see § 312.1(c)) on, at, in, or to a property, sufficient to meet the objectives and performance factors in § 312.20(e) and (f).</P> <P>(2) Such a person must:</P> <P>(i) Hold a current Professional Engineer's or Professional Geologist's license or registration from a state, tribe, or U.S. territory (or the Commonwealth of Puerto Rico) and have the equivalent of three (3) years of full-time relevant experience; or</P> <P>(ii) Be licensed or certified by the federal government, a state, tribe, or U.S. territory (or the Commonwealth of Puerto Rico) to perform environmental inquiries as defined in § 312.21 and have the equivalent of three (3) years of full-time relevant experience; or</P> <P>(iii) Have a Baccalaureate or higher degree from an accredited institution of higher education in a discipline of engineering or science and the equivalent of five (5) years of full-time relevant experience; or</P> <P>(iv) Have the equivalent of ten (10) years of full-time relevant experience.</P> <P>(3) An environmental professional should remain current in his or her field through participation in continuing education or other activities.</P> <P>(4) The definition of environmental professional provided above does not preempt state professional licensing or registration requirements such as those for a professional geologist, engineer, or site remediation professional. Before commencing work, a person should determine the applicability of state professional licensing or registration laws to the activities to be undertaken as part of the inquiry identified in § 312.21(b).</P> <P> (5) A person who does not qualify as an environmental professional under <PRTPAGE P="410"/> the foregoing definition may assist in the conduct of all appropriate inquiries in accordance with this part if such person is under the supervision or responsible charge of a person meeting the definition of an environmental professional provided above when conducting such activities. </P> <P> <E T="03">Relevant experience,</E> as used in the definition of environmental professional in this section, means: participation in the performance of all appropriate inquiries investigations, environmental site assessments, or other site investigations that may include environmental analyses, investigations, and remediation which involve the understanding of surface and subsurface environmental conditions and the processes used to evaluate these conditions and for which professional judgment was used to develop opinions regarding conditions indicative of releases or threatened releases (see § 312.1(c)) to the subject property. </P> <P> <E T="03">Good faith</E> means: the absence of any intention to seek an unfair advantage or to defraud another party; an honest and sincere intention to fulfill one's obligations in the conduct or transaction concerned. </P> <P> <E T="03">Institutional controls</E> means: non-engineered instruments, such as administrative and/or legal controls, that help to minimize the potential for human exposure to contamination and/or protect the integrity of a remedy. </P> </SECTION> <SECTION> <SECTNO>§ 312.11</SECTNO> <SUBJECT>References.</SUBJECT> <P>The following industry standards may be used to comply with the requirements set forth in §§ 312.23 through 312.31:</P> <P> (a) The procedures of ASTM International Standard E1527-21 entitled “Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process.” This standard is available from ASTM International at <E T="03">www.astm.org,</E> 1-610-832-9585. </P> <P> (b) The procedures of ASTM International Standard E2247-23 entitled “Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process for Forestland and Rural Property.” This standard is available from ASTM International at <E T="03">www.astm.org,</E> 1-610-832-9585. </P> <P> (c) Until February 13, 2024, the procedures of ASTM International Standard E1527-13 entitled “Standard Practice for Environmental Site Assessments: Phase I Environmental Site Assessment Process.” This standard is available from ASTM International at <E T="03">www.astm.org,</E> 1-610-832-9585. </P> <P> (d) Until June 24, 2025, the procedures of ASTM International Standard E2247-16 entitled “Standard Practice for Environmental Site Assessment Process for Forestland and Rural Property.” This standard is available from ASTM International at <E T="03">www.astm.org,</E> 1-610-832-9585. </P> <CITA>[70 FR 66107, Nov. 1, 2005, as amended at 73 FR 78655, Dec. 23, 2008; 78 FR 79324, Dec. 30, 2013; 79 FR 60090, Oct. 6, 2014; 82 FR 43312, Sept. 15, 2017; 87 FR 76581, Dec. 15, 2022; 89 FR 52389, June 24, 2024]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Standards and Practices</HD> <SECTION> <SECTNO>§ 312.20</SECTNO> <SUBJECT>All appropriate inquiries.</SUBJECT> <P>(a) “All appropriate inquiries” pursuant to CERCLA section 101(35)(B) must be conducted within one year prior to the date of acquisition of the subject property and must include:</P> <P>(1) An inquiry by an environmental professional (as defined in § 312.10), as provided in § 312.21;</P> <P>(2) The collection of information pursuant to § 312.22 by persons identified under § 312.1(b); and</P> <P>(3) Searches for recorded environmental cleanup liens, as required in § 312.25.</P> <P>(b) Notwithstanding paragraph (a) of this section, the following components of the all appropriate inquiries must be conducted or updated within 180 days of and prior to the date of acquisition of the subject property:</P> <P>(1) Interviews with past and present owners, operators, and occupants (see § 312.23);</P> <P>(2) Searches for recorded environmental cleanup liens (see § 312.25);</P> <P>(3) Reviews of federal, tribal, state, and local government records (see § 312.26);</P> <P> (4) Visual inspections of the facility and of adjoining properties (see § 312.27); and <PRTPAGE P="411"/> </P> <P>(5) The declaration by the environmental professional (see § 312.21(d)).</P> <P>(c) All appropriate inquiries may include the results of and information contained in an inquiry previously conducted by, or on the behalf of, persons identified under § 312.1(b) and who are responsible for the inquiries for the subject property, provided:</P> <P>(1) Such information was collected during the conduct of all appropriate inquiries in compliance with the requirements of CERCLA sections 101(35)(B), 101(40)(B) and 107(q)(A)(viii);</P> <P>(2) Such information was collected or updated within one year prior to the date of acquisition of the subject property;</P> <P>(3) Notwithstanding paragraph (b)(2) of this section, the following components of the inquiries were conducted or updated within 180 days of and prior to the date of acquisition of the subject property:</P> <P>(i) Interviews with past and present owners, operators, and occupants (see § 312.23);</P> <P>(ii) Searches for recorded environmental cleanup liens (see § 312.25);</P> <P>(iii) Reviews of federal, tribal, state, and local government records (see § 312.26);</P> <P>(iv) Visual inspections of the facility and of adjoining properties (see § 312.27); and</P> <P>(v) The declaration by the environmental professional (see § 312.21(d)).</P> <P>(4) Previously collected information is updated to include relevant changes in the conditions of the property and specialized knowledge, as outlined in § 312.28, of the persons conducting the all appropriate inquiries for the subject property, including persons identified in § 312.1(b) and the environmental professional, defined in § 312.10.</P> <P>(d) All appropriate inquiries can include the results of report(s) specified in § 312.21(c), that have been prepared by or for other persons, provided that:</P> <P>(1) The report(s) meets the objectives and performance factors of this regulation, as specified in paragraphs (e) and (f) of this section; and</P> <P>(2) The person specified in § 312.1(b) and seeking to use the previously collected information reviews the information and conducts the additional inquiries pursuant to §§ 312.28, 312.29 and 312.30 and the all appropriate inquiries are updated in paragraph (b)(3) of this section, as necessary.</P> <P> (e) <E T="03">Objectives.</E> The standards and practices set forth in this part for All Appropriate Inquiries are intended to result in the identification of conditions indicative of releases and threatened releases of hazardous substances on, at, in, or to the subject property. </P> <P>(1) In performing the all appropriate inquiries, as defined in this section and provided in the standards and practices set forth this subpart, the persons identified under § 312.1(b)(1) and the environmental professional, as defined in § 312.10, must seek to identify through the conduct of the standards and practices set forth in this subpart, the following types of information about the subject property:</P> <P>(i) Current and past property uses and occupancies;</P> <P>(ii) Current and past uses of hazardous substances;</P> <P>(iii) Waste management and disposal activities that could have caused releases or threatened releases of hazardous substances;</P> <P>(iv) Current and past corrective actions and response activities undertaken to address past and on-going releases of hazardous substances;</P> <P>(v) Engineering controls;</P> <P>(vi) Institutional controls; and</P> <P>(vii) Properties adjoining or located nearby the subject property that have environmental conditions that could have resulted in conditions indicative of releases or threatened releases of hazardous substances to the subject property.</P> <P> (2) In the case of persons identified in § 312.1(b)(2), the standards and practices for All Appropriate Inquiries set forth in this part are intended to result in the identification of conditions indicative of releases and threatened releases of hazardous substances, pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802) on, at, in, or to the subject property. In performing the all appropriate inquiries, as defined in this section and provided in the standards and practices set forth in this subpart, the persons identified under § 312.1(b) and the environmental professional, as defined in <PRTPAGE P="412"/> § 312.10, must seek to identify through the conduct of the standards and practices set forth in this subpart, the following types of information about the subject property: </P> <P>(i) Current and past property uses and occupancies;</P> <P>(ii) Current and past uses of hazardous substances, pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802);</P> <P>(iii) Waste management and disposal activities;</P> <P>(iv) Current and past corrective actions and response activities undertaken to address past and on-going releases of hazardous substances pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802);</P> <P>(v) Engineering controls;</P> <P>(vi) Institutional controls; and</P> <P>(vii) Properties adjoining or located nearby the subject property that have environmental conditions that could have resulted in conditions indicative of releases or threatened releases of hazardous substances, pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802) to the subject property.</P> <P> (f) <E T="03">Performance factors.</E> In performing each of the standards and practices set forth in this subpart and to meet the objectives stated in paragraph (e) of this section, the persons identified under § 312.1(b) or the environmental professional as defined in § 312.10 (as appropriate to the particular standard and practice) must seek to: </P> <P>(1) Gather the information that is required for each standard and practice listed in this subpart that is publicly available, obtainable from its source within reasonable time and cost constraints, and which can practicably be reviewed; and</P> <P>(2) Review and evaluate the thoroughness and reliability of the information gathered in complying with each standard and practice listed in this subpart taking into account information gathered in the course of complying with the other standards and practices of this subpart.</P> <P>(g) To the extent there are data gaps (as defined in § 312.10) in the information developed as part of the inquiries in paragraph (e) of this section that affect the ability of persons (including the environmental professional) conducting the all appropriate inquiries to identify conditions indicative of releases or threatened releases in each area of inquiry under each standard and practice such persons should identify such data gaps, identify the sources of information consulted to address such data gaps, and comment upon the significance of such data gaps with regard to the ability to identify conditions indicative of releases or threatened releases of hazardous substances [and in the case of persons identified in § 312.1(b)(2), hazardous substances, pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802)] on, at, in, or to the subject property. Sampling and analysis may be conducted to develop information to address data gaps.</P> <P>(h) Releases and threatened releases identified as part of the all appropriate inquiries should be noted in the report of the inquiries. These standards and practices however are not intended to require the identification in the written report prepared pursuant to § 312.21(c) of quantities or amounts, either individually or in the aggregate, of hazardous substances pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802) that because of said quantities and amounts, generally would not pose a threat to human health or the environment.</P> </SECTION> <SECTION> <SECTNO>§ 312.21</SECTNO> <SUBJECT>Results of inquiry by an environmental professional.</SUBJECT> <P>(a) Persons identified under § 312.1(b) must undertake an inquiry, as defined in paragraph (b) of this section, by an environmental professional, or conducted under the supervision or responsible charge of, an environmental professional, as defined in § 312.10. Such inquiry is hereafter referred to as “the inquiry of the environmental professional.”</P> <P> (b) The inquiry of the environmental professional must include the requirements set forth in §§ 312.23 (interviews with past and present owners * * *), <PRTPAGE P="413"/> 312.24 (reviews of historical sources * * *), 312.26 (reviews of government records), 312.27 (visual inspections), 312.30 (commonly known or reasonably ascertainable information), and 312.31 (degree of obviousness of the presence * * * and the ability to detect the contamination * * *). In addition, the inquiry should take into account information provided to the environmental professional as a result of the additional inquiries conducted by persons identified in § 312.1(b) and in accordance with the requirements of § 312.22. </P> <P>(c) The results of the inquiry by an environmental professional must be documented in a written report that, at a minimum, includes the following:</P> <P>(1) An opinion as to whether the inquiry has identified conditions indicative of releases or threatened releases of hazardous substances [and in the case of inquiries conducted for persons identified in § 312.1(b)(2) conditions indicative of releases and threatened releases of pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802)] on, at, in, or to the subject property;</P> <P>(2) An identification of data gaps (as defined in § 312.10) in the information developed as part of the inquiry that affect the ability of the environmental professional to identify conditions indicative of releases or threatened releases of hazardous substances [and in the case of inquiries conducted for persons identified in § 312.1(b)(2) conditions indicative of releases and threatened releases of pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802)] on, at, in, or to the subject property and comments regarding the significance of such data gaps on the environmental professional's ability to provide an opinion as to whether the inquiry has identified conditions indicative of releases or threatened releases on, at, in, or to the subject property. If there are data gaps such that the environmental professional cannot reach an opinion regarding the identification of conditions indicative of releases and threatened releases, such data gaps must be noted in the environmental professional's opinion in paragraph (c)(1) of this section; and</P> <P>(3) The qualifications of the environmental professional(s).</P> <P>(d) The environmental professional must place the following statements in the written document identified in paragraph (c) of this section and sign the document:</P> <EXTRACT> <P>“[I, We] declare that, to the best of [my, our] professional knowledge and belief, [I, we] meet the definition of Environmental Professional as defined in § 312.10 of this part.”</P> <P>“[I, We] have the specific qualifications based on education, training, and experience to assess a property of the nature, history, and setting of the subject property. [I, We] have developed and performed the all appropriate inquiries in conformance with the standards and practices set forth in 40 CFR Part 312.”</P> </EXTRACT> </SECTION> <SECTION> <SECTNO>§ 312.22</SECTNO> <SUBJECT>Additional inquiries.</SUBJECT> <P>(a) Persons identified under § 312.1(b) must conduct the inquiries listed in paragraphs (a)(1) through (a)(4) below and may provide the information associated with such inquiries to the environmental professional responsible for conducting the activities listed in § 312.21:</P> <P>(1) As required by § 312.25 and if not otherwise obtained by the environmental professional, environmental cleanup liens against the subject property that are filed or recorded under federal, tribal, state, or local law;</P> <P>(2) As required by § 312.28, specialized knowledge or experience of the person identified in § 312.1(b);</P> <P>(3) As required by § 312.29, the relationship of the purchase price to the fair market value of the subject property, if the property was not contaminated; and</P> <P>(4) As required by § 312.30, and if not otherwise obtained by the environmental professional, commonly known or reasonably ascertainable information about the subject property.</P> </SECTION> <SECTION> <SECTNO>§ 312.23</SECTNO> <SUBJECT>Interviews with past and present owners, operators, and occupants.</SUBJECT> <P> (a) Interviews with owners, operators, and occupants of the subject property must be conducted for the purposes of achieving the objectives and performance factors of § 312.20(e) and (f). <PRTPAGE P="414"/> </P> <P>(b) The inquiry of the environmental professional must include interviewing the current owner and occupant of the subject property. If the property has multiple occupants, the inquiry of the environmental professional shall include interviewing major occupants, as well as those occupants likely to use, store, treat, handle or dispose of hazardous substances [and in the case of inquiries conducted for persons identified in § 312.1(b)(2) pollutants, contaminants, petroleum and petroleum products, and controlled substances (as defined in 21 U.S.C. 802)], or those who have likely done so in the past.</P> <P>(c) The inquiry of the environmental professional also must include, to the extent necessary to achieve the objectives and performance factors of § 312.20(e) and (f), interviewing one or more of the following persons:</P> <P>(1) Current and past facility managers with relevant knowledge of uses and physical characteristics of the property;</P> <P>(2) Past owners, occupants, or operators of the subject property; or</P> <P>(3) Employees of current and past occupants of the subject property.</P> <P>(d) In the case of inquiries conducted at “abandoned properties,” as defined in § 312.10, where there is evidence of potential unauthorized uses of the subject property or evidence of uncontrolled access to the subject property, the environmental professional's inquiry must include interviewing one or more (as necessary) owners or occupants of neighboring or nearby properties from which it appears possible to have observed uses of, or releases at, such abandoned properties for the purpose of gathering information necessary to achieve the objectives and performance factors of § 312.20(e) and (f).</P> </SECTION> <SECTION> <SECTNO>§ 312.24</SECTNO> <SUBJECT>Reviews of historical sources of information.</SUBJECT> <P>(a) Historical documents and records must be reviewed for the purposes of achieving the objectives and performance factors of § 312.20(e) and (f). Historical documents and records may include, but are not limited to, aerial photographs, fire insurance maps, building department records, chain of title documents, and land use records.</P> <P>(b) Historical documents and records reviewed must cover a period of time as far back in the history of the subject property as it can be shown that the property contained structures or from the time the property was first used for residential, agricultural, commercial, industrial, or governmental purposes. For the purpose of achieving the objectives and performance factors of § 312.20(e) and (f), the environmental professional may exercise professional judgment in context of the facts available at the time of the inquiry as to how far back in time it is necessary to search historical records.</P> </SECTION> <SECTION> <SECTNO>§ 312.25</SECTNO> <SUBJECT>Searches for recorded environmental cleanup liens.</SUBJECT> <P>(a) All appropriate inquiries must include a search for the existence of environmental cleanup liens against the subject property that are filed or recorded under federal, tribal, state, or local law.</P> <P>(b) All information collected regarding the existence of such environmental cleanup liens associated with the subject property by persons to whom this part is applicable per § 312.1(b) and not by an environmental professional, may be provided to the environmental professional or retained by the applicable party.</P> </SECTION> <SECTION> <SECTNO>§ 312.26</SECTNO> <SUBJECT>Reviews of Federal, State, Tribal, and local government records.</SUBJECT> <P>(a) Federal, tribal, state, and local government records or data bases of government records of the subject property and adjoining properties must be reviewed for the purposes of achieving the objectives and performance factors of § 312.20(e) and (f).</P> <P>(b) With regard to the subject property, the review of federal, tribal, and state government records or data bases of such government records and local government records and data bases of such records should include:</P> <P>(1) Records of reported releases or threatened releases, including site investigation reports for the subject property;</P> <P> (2) Records of activities, conditions, or incidents likely to cause or contribute to releases or threatened releases as defined in § 312.1(c), including <PRTPAGE P="415"/> landfill and other disposal unit location records and permits, storage tank records and permits, hazardous waste handler and generator records and permits, federal, tribal and state government listings of sites identified as priority cleanup sites, and spill reporting records; </P> <P>(3) CERCLIS records;</P> <P>(4) Public health records;</P> <P>(5) Emergency Response Notification System records;</P> <P>(6) Registries or publicly available lists of engineering controls; and</P> <P>(7) Registries or publicly available lists of institutional controls, including environmental land use restrictions, applicable to the subject property.</P> <P>(c) With regard to nearby or adjoining properties, the review of federal, tribal, state, and local government records or databases of government records should include the identification of the following:</P> <P>(1) Properties for which there are government records of reported releases or threatened releases. Such records or databases containing such records and the associated distances from the subject property for which such information should be searched include the following:</P> <P>(i) Records of NPL sites or tribal- and state-equivalent sites (one mile);</P> <P>(ii) RCRA facilities subject to corrective action (one mile);</P> <P>(iii) Records of federally-registered, or state-permitted or registered, hazardous waste sites identified for investigation or remediation, such as sites enrolled in state and tribal voluntary cleanup programs and tribal- and state-listed brownfields sites (one-half mile);</P> <P>(iv) Records of leaking underground storage tanks (one-half mile); and</P> <P>(2) Properties that previously were identified or regulated by a government entity due to environmental concerns at the property. Such records or databases containing such records and the associated distances from the subject property for which such information should be searched include the following:</P> <P>(i) Records of delisted NPL sites (one-half mile);</P> <P>(ii) Registries or publicly available lists of engineering controls (one-half mile); and</P> <P>(iii) Records of former CERCLIS sites with no further remedial action notices (one-half mile).</P> <P>(3) Properties for which there are records of federally-permitted, tribal-permitted or registered, or state-permitted or registered waste management activities. Such records or data bases that may contain such records include the following:</P> <P>(i) Records of RCRA small quantity and large quantity generators (adjoining properties);</P> <P>(ii) Records of federally-permitted, tribal-permitted, or state-permitted (or registered) landfills and solid waste management facilities (one-half mile); and</P> <P>(iii) Records of registered storage tanks (adjoining property).</P> <P>(4) A review of additional government records with regard to sites identified under paragraphs (c)(1) through (c)(3) of this section may be necessary in the judgment of the environmental professional for the purpose of achieving the objectives and performance factors of § 312.20(e) and (f).</P> <P>(d) The search distance from the subject property boundary for reviewing government records or databases of government records listed in paragraph (c) of this section may be modified based upon the professional judgment of the environmental professional. The rationale for such modifications must be documented by the environmental professional. The environmental professional may consider one or more of the following factors in determining an alternate appropriate search distance:</P> <P>(1) The nature and extent of a release;</P> <P>(2) Geologic, hydrogeologic, or topographic conditions of the subject property and surrounding environment;</P> <P>(3) Land use or development densities;</P> <P>(4) The property type;</P> <P>(5) Existing or past uses of surrounding properties;</P> <P>(6) Potential migration pathways (e.g., groundwater flow direction, prevalent wind direction); or</P> <P>(7) Other relevant factors.</P> </SECTION> <SECTION> <PRTPAGE P="416"/> <SECTNO>§ 312.27</SECTNO> <SUBJECT>Visual inspections of the facility and of adjoining properties.</SUBJECT> <P>(a) For the purpose of achieving the objectives and performance factors of § 312.20(e) and (f), the inquiry of the environmental professional must include:</P> <P>(1) A visual on-site inspection of the subject property and facilities and improvements on the subject property, including a visual inspection of the areas where hazardous substances may be or may have been used, stored, treated, handled, or disposed. Physical limitations to the visual inspection must be noted.</P> <P>(2) A visual inspection of adjoining properties, from the subject property line, public rights-of-way, or other vantage point (e.g., aerial photography), including a visual inspection of areas where hazardous substances may be or may have been stored, treated, handled or disposed. Physical limitations to the inspection of adjacent properties must be noted.</P> <P>(b) Persons conducting site characterization and assessments using a grant awarded under CERCLA section 104(k)(2)(B) must include in the inquiries referenced in § 312.27(a) visual inspections of areas where hazardous substances, and may include, as applicable per the terms and conditions of the grant or cooperative agreement, pollutants and contaminants, petroleum and petroleum products, and controlled substances as defined in 21 U.S.C. 802 may be or may have been used, stored, treated, handled or disposed at the subject property and adjoining properties.</P> <P>(c) Except as noted in this subsection, a visual on-site inspection of the subject property must be conducted. In the unusual circumstance where an on-site visual inspection of the subject property cannot be performed because of physical limitations, remote and inaccessible location, or other inability to obtain access to the property, provided good faith (as defined in § 312.10) efforts have been taken to obtain such access, an on-site inspection will not be required. The mere refusal of a voluntary seller to provide access to the subject property does not constitute an unusual circumstance. In such unusual circumstances, the inquiry of the environmental professional must include:</P> <P>(1) Visually inspecting the subject property via another method (such as aerial imagery for large properties), or visually inspecting the subject property from the nearest accessible vantage point (such as the property line or public road for small properties);</P> <P>(2) Documentation of efforts undertaken to obtain access and an explanation of why such efforts were unsuccessful; and</P> <P>(3) Documentation of other sources of information regarding releases or threatened releases at the subject property that were consulted in accordance with § 312.20(e). Such documentation should include comments by the environmental professional on the significance of the failure to conduct a visual on-site inspection of the subject property with regard to the ability to identify conditions indicative of releases or threatened releases on, at, in, or to the subject property, if any.</P> </SECTION> <SECTION> <SECTNO>§ 312.28</SECTNO> <SUBJECT>Specialized knowledge or experience on the part of the defendant.</SUBJECT> <P>(a) Persons to whom this part is applicable per § 312.1(b) must take into account, their specialized knowledge of the subject property, the area surrounding the subject property, the conditions of adjoining properties, and any other experience relevant to the inquiry, for the purpose of identifying conditions indicative of releases or threatened releases at the subject property, as defined in § 312.1(c).</P> <P>(b) All appropriate inquiries, as outlined in § 312.20, are not complete unless the results of the inquiries take into account the relevant and applicable specialized knowledge and experience of the persons responsible for undertaking the inquiry (as described in § 312.1(b)).</P> </SECTION> <SECTION> <SECTNO>§ 312.29</SECTNO> <SUBJECT>The relationship of the purchase price to the value of the property, if the property was not contaminated.</SUBJECT> <P>(a) Persons to whom this part is applicable per § 312.1(b) must consider whether the purchase price of the subject property reasonably reflects the fair market value of the property, if the property were not contaminated.</P> <P> (b) Persons who conclude that the purchase price of the subject property <PRTPAGE P="417"/> does not reasonably reflect the fair market value of that property, if the property were not contaminated, must consider whether or not the differential in purchase price and fair market value is due to the presence of releases or threatened releases of hazardous substances. </P> <P>(c) Persons conducting site characterization and assessments with the use of a grant awarded under CERCLA section 104(k)(2)(B) and who know that the purchase price of the subject property does not reasonably reflect the fair market value of that property, if the property were not contaminated, must consider whether or not the differential in purchase price and fair market value is due to the presence of releases or threatened releases of hazardous substances, pollutants, contaminants, petroleum and petroleum products, or controlled substances as defined in 21 U.S.C. 802.</P> </SECTION> <SECTION> <SECTNO>§ 312.30</SECTNO> <SUBJECT>Commonly known or reasonably ascertainable information about the property.</SUBJECT> <P>(a) Throughout the inquiries, persons to whom this part is applicable per § 312.1(b) and environmental professionals conducting the inquiry must take into account commonly known or reasonably ascertainable information within the local community about the subject property and consider such information when seeking to identify conditions indicative of releases or threatened releases, as set forth in § 312.1(c), at the subject property.</P> <P>(b) Commonly known information may include information obtained by the person to whom this part applies in § 312.1(b) or by the environmental professional about releases or threatened releases at the subject property that is incidental to the information obtained during the inquiry of the environmental professional.</P> <P>(c) To the extent necessary to achieve the objectives and performance factors of § 312.20(e) and (f), persons to whom this part is applicable per § 312.1(b) and the environmental professional must gather information from varied sources whose input either individually or taken together may provide commonly known or reasonably ascertainable information about the subject property; the environmental professional may refer to one or more of the following sources of information:</P> <P>(1) Current owners or occupants of neighboring properties or properties adjacent to the subject property;</P> <P>(2) Local and state government officials who may have knowledge of, or information related to, the subject property;</P> <P>(3) Others with knowledge of the subject property; and</P> <P>(4) Other sources of information (e.g., newspapers, Web sites, community organizations, local libraries and historical societies).</P> </SECTION> <SECTION> <SECTNO>§ 312.31</SECTNO> <SUBJECT>The degree of obviousness of the presence or likely presence of contamination at the property, and the ability to detect the contamination by appropriate investigation.</SUBJECT> <P>(a) Persons to whom this part is applicable per § 312.1(b) and environmental professionals conducting an inquiry of a property on behalf of such persons must take into account the information collected under § 312.23 through 312.30 in considering the degree of obviousness of the presence of releases or threatened releases at the subject property.</P> <P>(b) Persons to whom this part is applicable per § 312.1(b) and environmental professionals conducting an inquiry of a property on behalf of such persons must take into account the information collected under § 312.23 through 312.30 in considering the ability to detect contamination by appropriate investigation. The inquiry of the environmental professional should include an opinion regarding additional appropriate investigation, if any.</P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 350</EAR> <HD SOURCE="HED">PART 350—TRADE SECRECY CLAIMS FOR EMERGENCY PLANNING AND COMMUNITY RIGHT-TO-KNOW INFORMATION: AND TRADE SECRET DISCLOSURES TO HEALTH PROFESSIONALS</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—Trade Secrecy Claims</HD> <SECHD>Sec.</SECHD> <SECTNO>350.1</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>350.3</SECTNO> <SUBJECT>Applicability of subpart; priority where provisions conflict; interaction with 40 CFR part 2.</SUBJECT> <SECTNO>350.5</SECTNO> <SUBJECT> Assertion of claims of trade secrecy. <PRTPAGE P="418"/> </SUBJECT> <SECTNO>350.7</SECTNO> <SUBJECT>Substantiating claims of trade secrecy.</SUBJECT> <SECTNO>350.9</SECTNO> <SUBJECT>Initial action by EPA.</SUBJECT> <SECTNO>350.11</SECTNO> <SUBJECT>Review of claim.</SUBJECT> <SECTNO>350.13</SECTNO> <SUBJECT>Sufficiency of assertions.</SUBJECT> <SECTNO>350.15</SECTNO> <SUBJECT>Public petitions requesting disclosure of chemical identity claimed as trade secret.</SUBJECT> <SECTNO>350.16</SECTNO> <SUBJECT>Address to send trade secrecy claims and petitions requesting disclosure.</SUBJECT> <SECTNO>350.17</SECTNO> <SUBJECT>Appeals.</SUBJECT> <SECTNO>350.18</SECTNO> <SUBJECT>Release of chemical identity determined to be non-trade secret; notice of intent to release chemical identity.</SUBJECT> <SECTNO>350.19</SECTNO> <SUBJECT>Provision of information to States.</SUBJECT> <SECTNO>350.21</SECTNO> <SUBJECT>Adverse health effects.</SUBJECT> <SECTNO>350.23</SECTNO> <SUBJECT>Disclosure to authorized representatives.</SUBJECT> <SECTNO>350.25</SECTNO> <SUBJECT>Disclosure in special circumstances.</SUBJECT> <SECTNO>350.27</SECTNO> <SUBJECT>Substantiation form to accompany claims of trade secrecy, instructions to substantiation form.</SUBJECT> <APP>Appendix A to Subpart A of Part 350—Restatement of Torts Section 757, Comment b</APP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Disclosure of Trade Secret Information to Health Professionals</HD> <SECTNO>350.40</SECTNO> <SUBJECT>Disclosure to health professionals.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 11042, 11043 and 11048 Pub. L. 99-499, 100 Stat. 1747.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>53 FR 28801, July 29, 1988, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—Trade Secrecy Claims</HD> <SECTION> <SECTNO>§ 350.1</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P> <E T="03">Administrator</E> and <E T="03">General Counsel</E> mean the EPA officers or employees occupying the positions so titled. </P> <P> <E T="03">Business confidentiality</E> or <E T="03">confidential business information</E> includes the concept of trade secrecy and other related legal concepts which give (or may give) a business the right to preserve the confidentiality of business information and to limit its use or disclosure by others in order that the business may obtain or retain business advantages it derives from its right in the information. The definition is meant to encompass any concept which authorizes a Federal agency to withhold business information under 5 U.S.C. 552(b)(4), as well as any concept which requires EPA to withhold information from the public for the benefit of a business under 18 U.S.C. 1905. </P> <P> <E T="03">Chief Executive Officer of the tribe</E> means the person who is recognized by the Bureau of Indian Affairs as the chief elected administrative officer of the tribe. </P> <P> <E T="03">Claimant</E> means a person submitting a claim of trade secrecy to EPA in connection with a chemical otherwise required to be disclosed in a report or other filing made under Title III. </P> <P> <E T="03">Commission</E> means the emergency response commission for the State in which the facility is located except where the facility is located in Indian Country, in which case, <E T="03">commission</E> means the emergency response commission for the tribe under whose jurisdiction the facility is located. In the absence of an emergency response commission, the Governor and the chief executive officer, respectively, shall be the commission. Where there is a cooperative agreement between a State and a Tribe, the commission shall be the entity identified in the agreement. </P> <P> <E T="03">Facility</E> means all buildings, equipment, structure, and other stationary items that are located on a single site or on contiguous or adjacent sites and which are owned or operated by the same person (or by any person which controls, is controlled by, or under common control with, such person). <E T="03">Facility</E> shall include man-made structures as well as all natural structures in which chemicals are purposefully placed or removed through human means such that it functions as a containment structure for human use. For purposes of emergency release notification, the term includes motor vehicles, rolling stock, and aircraft. </P> <P> <E T="03">Indian Country</E> means <E T="03">Indian country</E> as defined in 18 U.S.C. 1151. That section defines Indian country as: </P> <P>(a) All land within the limits of any Indian reservation under the jurisdiction of the United States government, notwithstanding the issuance of any patent, and including rights-of-way running through the reservation;</P> <P>(b) All dependent Indian communities within the borders of the United States whether within the original or subsequently acquired territory thereof, and whether within or without the limits of a State; and</P> <P> (c) All Indian allotments, the Indian titles to which have not been extinguished, including rights-of-way running through the same. <PRTPAGE P="419"/> </P> <P> <E T="03">Indian tribe</E> means those tribes federally recognized by the Secretary of the Interior. </P> <P> <E T="03">Local emergency planning committee</E> or <E T="03">committee</E> means the local emergency planning committee appointed by the emergency response commission. </P> <P> <E T="03">Petitioner</E> is any person who submits a petition under this regulation requesting disclosure of a chemical identity claimed as trade secret. </P> <P> <E T="03">Sanitized</E> means a version of a document from which information claimed as trade secret or confidential has been omitted or withheld. </P> <P> <E T="03">Senior management official</E> means an official with management responsibility for the person or persons completing the report, or the manager of environmental programs for the facility or establishments, or for the corporation owning or operating the facility or establishments responsible for certifying similar reports under other environmental regulatory requirements. </P> <P> <E T="03">Specific chemical identity</E> means the chemical name, Chemical Abstracts Service (CAS) Registry Number, or any other information that reveals the precise chemical designation of the substance. Where the trade name is reported in lieu of the specific chemical identity, the trade name will be treated as the specific chemical identity for purposes of this part. </P> <P> <E T="03">State</E> means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the United States Virgin Islands, the Northern Mariana Islands, and any other territory or possession over which the United States has jurisdiction and Indian Country. </P> <P> <E T="03">Submitter</E> means a person filing a required report or making a claim of trade secrecy to EPA under sections 303 (d)(2) and (d)(3), 311, 312, and 313 of Title III. </P> <P> <E T="03">Substantiation</E> means the written answers submitted to EPA by a submitter to the specific questions set forth in this regulation in support of a claim that chemical identity is a trade secret. </P> <P> <E T="03">Title III</E> means Title III of the Superfund Amendments and Reauthorization Act of 1986, also titled the Emergency Planning and Community Right-to-Know Act of 1986. </P> <P> <E T="03">Trade secrecy claim</E> is a submittal under sections 303 (d)(2) or (d)(3), 311, 312 or 313 of Title III in which a chemical identity is claimed as trade secret, and is accompanied by a substantiation in support of the claim of trade secrecy for chemical identity. </P> <P> <E T="03">Trade secret</E> means any confidential formula, pattern, process, device, information or compilation of information that is used in a submitter's business, and that gives the submitter an opportunity to obtain an advantage over competitors who do not know or use it. EPA intends to be guided by the Restatement of Torts, Section 757, Comment b. </P> <P> <E T="03">Unsanitized</E> means a version of a document from which information claimed as trade secret or confidential has not been withheld or omitted. </P> <P> <E T="03">Working day</E> is any day on which Federal government offices are open for normal business. Saturdays, Sundays, and official Federal holidays are not working days; all other days are. </P> <CITA>[53 FR 28801, July 29, 1988, as amended at 55 FR 30644, July 26, 1990]</CITA> </SECTION> <SECTION> <SECTNO>§ 350.3</SECTNO> <SUBJECT>Applicability of subpart; priority where provisions conflict; interaction with 40 CFR part 2.</SUBJECT> <P> (a) <E T="03">Applicability of subpart.</E> Sections 350.1 through 350.27 establish rules governing assertion of trade secrecy claims for chemical identity information collected under the authority of sections 303 (d)(2) and (d)(3), 311, 312 and 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986, and for trade secrecy or business confidentiality claims for information submitted in a substantiation under sections 303 (d)(2) and (d)(3), 311, 312, and 313 of Title III. This subpart also establishes rules governing petitions from the public requesting the disclosure of chemical identity claimed as trade secret, and determinations by EPA of whether this information is entitled to trade secret treatment. Claims for confidentiality of the location of a hazardous chemical under section 312(d)(2)(F) of Title III are not subject to the requirements of this subpart. <PRTPAGE P="420"/> </P> <P> (b) <E T="03">Priority where provisions conflict.</E> Where information subject to the requirements of this subpart is also collected under another statutory authority, the confidentiality provisions of that authority shall be used to claim that information as trade secret or confidential when submitting it to EPA under that statutory authority. </P> <P> (c) <E T="03">Interaction with 40 CFR part 2, EPA's Freedom of Information Act procedures.</E> (1) No trade secrecy or business confidentiality claims other than those allowed in this subpart are permitted for information collected under sections 303 (d)(2) and (d)(3), 311, 312 and 313 of Title III. </P> <P>(2) Except as provided in § 350.25 of this subpart, request for access to chemical identities withheld as trade secret under this regulation is solely through this regulation and procedures hereunder, not through EPA's Freedom of Information Act procedures set forth at 40 CFR part 2.</P> <P>(3) Request for access to information other than chemical identity submitted to EPA under this regulation is through EPA's Freedom of Information Act regulations at 40 CFR part 2.</P> </SECTION> <SECTION> <SECTNO>§ 350.5</SECTNO> <SUBJECT>Assertion of claims of trade secrecy.</SUBJECT> <P>(a) A claim of trade secrecy may be made only for the specific chemical identity of an extremely hazardous substance under sections 303 (d)(2) and (d)(3), a hazardous chemical under sections 311 and 312, and a toxic chemical under section 313.</P> <P>(b) Method of asserting claims of trade secrecy for information submitted under sections 303 (d)(2) and (d)(3).</P> <P>(1) In submitting information to the local emergency planning committee under sections 303 (d)(2) or (d)(3), the submitter may claim as trade secret the specific chemical identity of any chemical subject to reporting under section 303.</P> <P>(2) To make a claim, the submitter shall submit to EPA the following:</P> <P>(i) A copy of the information which is being submitted under sections 303 (d)(2) or (d)(3) to the local emergency planning committee, with the chemical identity or identities claimed trade secret deleted, and the generic class or category of the chemical identity or identities inserted in its place. The method of choosing generic class or category is set forth in paragraph (f) of this section.</P> <P>(ii) A sanitized and unsanitized substantiation in accordance with § 350.7 for each chemical identity claimed as trade secret.</P> <P>(3) If the submitter wishes to claim information in the substantiation as trade secret or business confidential, it shall do so in accordance with § 350.7(d).</P> <P>(4) Section 303 claims shall be sent to the address specified in § 350.16 of this regulation.</P> <P>(c) Method of asserting claims of trade secrecy for information submitted under section 311.</P> <P>(1) Submitters may claim as trade secret the specific chemical identity of any chemical subject to reporting under section 311 on the material safety data sheet or chemical list under section 311.</P> <P>(2) To assert a claim for a chemical identity on a material safety data sheet under section 311, the submitter shall submit to EPA the following:</P> <P>(i) One copy of the material safety data sheet which is being submitted to the State emergency response commission, the local emergency planning committee and the local fire department, which shall make it available to the public. In place of the specific chemical identity claimed as trade secret, the generic class or category of the chemical claimed as trade secret shall be inserted. The method of choosing generic class or category is set forth in paragraph (f) of this section.</P> <P>(ii) A sanitized and unsanitized substantiation in accordance with § 350.7 for every chemical identity claimed as trade secret.</P> <P>(3) To assert a claim for a chemical identity on a list under section 311, the submitter shall submit to EPA the following:</P> <P> (i) An unsanitized copy of the chemical list under section 311. The submitter shall clearly indicate the specific chemical identity claimed as trade secret, and shall label it <E T="03">“Trade Secret.”</E> The generic class or category of the chemical claimed as trade secret shall be inserted directly below the claimed chemical identity. The method <PRTPAGE P="421"/> of choosing generic class or category is set forth in paragraph (f) of this section. </P> <P>(ii) A sanitized copy of the chemical list under section 311. This copy shall be identical to the document in paragraph (c)(3)(i) of this section except that the submitter shall delete the chemical identity claimed as trade secret, leaving in place the generic class or category of the chemical claimed as trade secret. This copy shall be sent by the submitter to the State emergency response commission, the local emergency planning committee and the local fire department, which shall make it available to the public.</P> <P>(iii) A sanitized and unsanitized substantiation in accordance with § 350.7 for every chemical identity claimed as trade secret.</P> <P>(4) If the submitter wishes to claim information in the substantiation as trade secret or business confidential, it shall do so in accordance with § 350.7(d).</P> <P>(5) Section 311 claims shall be sent to the address specified in § 350.16 of this regulation.</P> <P>(d) Method of asserting claims of trade secrecy for information submitted under section 312.</P> <P>(1) Submitters may claim as trade secret the specific chemical identity of any chemical subject to reporting under section 312.</P> <P>(2) To assert a claim the submitter shall submit to EPA the following:</P> <P>(i) An unsanitized copy of the Tier II emergency and hazardous chemical inventory form under section 312. (The Tier I emergency and hazardous chemical inventory form does not require the reporting of specific chemical identity and therefore no trade secrecy claims may be made with respect to that form.) The submitter shall clearly indicate the specific chemical identity claimed as trade secret by checking the box marked “trade secret” next to the claimed chemical identity.</P> <P>(ii) A sanitized copy of the Tier II emergency and hazardous chemical inventory form. This copy shall be identical to the document in paragraph (d)(2)(i) of this section except that the submitter shall delete the chemical identity or identities claimed as trade secret and include instead the generic class or category of the chemical claimed as trade secret. The method of choosing generic class or category is set forth in paragraph (f) of this section. The sanitized copy shall be sent by the submitter to the State emergency response commission, local emergency planning committee or the local fire department, whichever entity requested the information.</P> <P>(iii) A sanitized and unsanitized substantiation in accordance with § 350.7 for every chemical identity claimed as trade secret.</P> <P>(3) If the submitter wishes to claim information in the substantiation as trade secret or business confidential, it shall do so in accordance with § 350.7(d).</P> <P>(4) Section 312 claims shall be sent to the address specified in § 350.16 of this regulation.</P> <P>(e) Method of asserting claims of trade secrecy for information submitted under section 313.</P> <P>(1) Submitters may claim as trade secret the specific chemical identity of any chemical subject to reporting under section 313.</P> <P>(2) To make a claim, the submitter shall submit to EPA the following:</P> <P>(i) An unsanitized copy of the toxic release inventory form under section 313 with the information claimed as trade secret clearly identified. To do this, the submitter shall check the box on the form indicating that the chemical identity is being claimed as trade secret. The submitter shall enter the generic class or category that is structurally descriptive of the chemical, as specified in paragraph (f) of this section.</P> <P>(ii) A sanitized copy of the toxic release inventory form. This copy shall be identical to the document in paragraph (e)(2)(i) of this section except that the submitter shall delete the chemical identity claimed as trade secret. This copy shall also be submitted to the State official or officials designated to receive this information.</P> <P>(iii) A sanitized and unsanitized substantiation in accordance with § 350.7 for every chemical identity claimed as trade secret.</P> <P> (3) If the submitter wishes to claim information in the substantiation as trade secret or business confidential, it shall do so in accordance with § 350.7(d). <PRTPAGE P="422"/> </P> <P>(4) Section 313 claims shall be sent to the address specified in § 350.16 of this regulation.</P> <P>(f) Method of choosing generic class or category for sections 303, 311, 312 and 313. A facility owner or operator claiming chemical identity as trade secret should choose a generic class or category for the chemical that is structurally descriptive of the chemical.</P> <P>(g) If a specific chemical identity is submitted under Title III to EPA, or to a State emergency response commission, designated State agency, local emergency planning committee or local fire department, without asserting a trade secrecy claim, the chemical identity shall be considered to have been voluntarily disclosed, and non-trade secret.</P> <P>(h) A submitter making a trade secrecy claim under this section shall submit to entities other than EPA (e.g., a designated State agency, local emergency planning committee and local fire department) only the sanitized or public copy of the submission and substantiation.</P> </SECTION> <SECTION> <SECTNO>§ 350.7</SECTNO> <SUBJECT>Substantiating claims of trade secrecy.</SUBJECT> <P> (a) Claims of trade secrecy must be substantiated by providing a specific answer including, where applicable, specific facts, to each of the following questions with submission to which the trade secrecy claim pertains. Submitters must answer these questions on the form entitled “Substantiation to Accompany Claims of Trade Secrecy.” The form and instructions are posted on the EPA program websites, <E T="03">http://www.epa.gov/epcra</E> and <E T="03">http://www.epa.gov/tri/rfi.</E> </P> <P>(1) Describe the specific measures you have taken to safeguard the confidentiality of the chemical identity claimed as trade secret, and indicate whether these measures will continue in the future.</P> <P>(2) Have you disclosed the information claimed as trade secret to any other person (other than a member of a local emergency planning committee, officer or employee of the United States or a State or local government, or your employee) who is not bound by a confidentiality agreement to refrain from disclosing this trade secret information to others?</P> <P>(3) List all local, State, and Federal government entities to which you have disclosed the specific chemical identity. For each, indicate whether you asserted a confidentiality claim for the chemical identity and whether the government entity denied that claim.</P> <P>(4) In order to show the validity of a trade secrecy claim, you must identify your specific use of the chemical claimed as trade secret and explain why it is a secret of interest to competitors. Therefore:</P> <P>(i) Describe the specific use of the chemical claimed as trade secret, identifying the product or process in which it is used. (If you use the chemical other than as a component of a product or in a manufacturing process, identify the activity where the chemical is used.)</P> <P>(ii) Has your company or facility identity been linked to the specific chemical identity claimed as trade secret in a patent, or in publications or other information sources available to the public or your competitors (of which you are aware)? If so, explain why this knowledge does not eliminate the justification for trade secrecy.</P> <P>(iii) If this use of the chemical claimed as trade secret is unknown outside your company, explain how your competitors could deduce this use from disclosure of the chemical identity together with other information on the Title III submittal form.</P> <P>(iv) Explain why your use of the chemical claimed as trade secret would be valuable information to your competitors.</P> <P>(5) Indicate the nature of the harm to your competitive position that would likely result from disclosure of the specific chemical identity, and indicate why such harm would be substantial.</P> <P>(6)(i) To what extent is the chemical claimed as trade secret available to the public or your competitors in products, articles, or environmental releases?</P> <P> (ii) Describe the factors which influence the cost of determining the identity of the chemical claimed as trade secret by chemical analysis of the product, article, or waste which contains the chemical (e.g., whether the <PRTPAGE P="423"/> chemical is in pure form or is mixed with other substances). </P> <P> (b) The answers to the substantiation questions listed in paragraph (a) of this section are to be submitted on the form entitled “Substantiation to Accompany Claims of Trade Secrecy” and included with a submitter's trade secret claim. The form is posted on the EPA program websites, <E T="03">http://www.epa.gov/epcra</E> and <E T="03">http://www.epa.gov/tri/rfi,</E> </P> <P> (c) An owner, operator, or senior official with management responsibility shall sign the certification at the end of the form entitled “Substantiation to Accompany Claims of Trade Secrecy,” which is posted on the EPA program websites, <E T="03">http://www.epa.gov/epcra</E> and <E T="03">http://www.epa.gov/tri/rfi.</E> The certification in both the sanitized and unsanitized versions of the substantiation must bear an original signature. </P> <P> (d) <E T="03">Claims of confidentiality in the substantiation.</E> (1) The submitter may claim as confidential any trade secret or confidential business information contained in the substantiation. Such claims for material in the substantiation are not limited to claims of trade secrecy for specific chemical identity, but may also include claims of confidentiality for any confidential business information. To claim this material as confidential, the submitter shall clearly designate those portions of the substantiation to be claimed as confidential by marking those portions “Confidential,” or “Trade Secret.” Information not so marked will be treated as public and may be disclosed without notice to the submitter. </P> <P> (2) An owner, operator, or senior official with management responsibility shall sign the certification stating that those portions of the substantiation claimed as confidential would, if disclosed, reveal the chemical identity being claimed as a trade secret, or would reveal other confidential business or trade secret information. This certification is combined on the substantiation form found on EPA program websites, <E T="03">http://www.epa.gov/epcra</E> and <E T="03">http://www.epa.gov/tri/rfi,</E> with the certification described in paragraph (c) of this section. </P> <P>(3) The submitter shall submit to EPA two copies of the substantiation, one of which shall be the unsanitized version, and the other shall be the sanitized version.</P> <P>(i) The unsanitized copy shall contain all of the information claimed as trade secret or business confidential, marked as indicated in paragraph (d)(1) of this section.</P> <P>(ii) The second copy shall be identical to the unsanitized substantiation except that it will be a sanitized version, in which all of the information claimed as trade secret or confidential shall be deleted. If any of the information claimed as trade secret in the substantiation is the chemical identity which is the subject of the substantiation, the submitter shall include the appropriate generic class or category of the chemical claimed as trade secret. This sanitized copy shall be submitted to the State emergency response commission, a designated State agency, the local emergency planning committee and the local fire department, as appropriate, and made publicly available.</P> <P> (e) <E T="03">Supplemental information.</E> (1) EPA may request supplemental information from the submitter in support of its trade secret claim, pursuant to § 350.11(a)(1). EPA may specify the kind of information to be submitted, or the submitter may submit any additional detailed information which further supports the truth of the information previously supplied to EPA in its initial substantiation, under this section. </P> <P>(2) The submitter may claim as confidential any trade secret or confidential business information contained in the supplemental information. To claim this material as confidential, the submitter shall clearly designate those portions of the supplemental information to be claimed as confidential by marking those portions “Confidential,” or “Trade Secret.” Information not so marked will be treated as public and may be disclosed without notice to the submitter.</P> <P> (3) If portions of the supplementary information are claimed confidential, an owner, operator, or senior official with management responsibility of the submitter shall certify that those portions of the supplemental information claimed as confidential would, if disclosed, reveal the chemical identity being claimed as confidential or would <PRTPAGE P="424"/> reveal other confidential business or trade secret information. </P> <P>(4) If supplemental information is requested by EPA and the submitter claims portions of it as trade secret or confidential, then the submitter shall submit to EPA two copies of the supplemental information, an unsanitized and a sanitized version.</P> <P>(i) The unsanitized version shall contain all of the information claimed as trade secret or business confidential, marked as indicated above in paragraph (e)(2) of this section.</P> <P>(ii) The second copy shall be identical to the unsanitized substantiation except that it will be a sanitized version, in which all of the information claimed as trade secret or confidential shall be deleted. If any of the information claimed as trade secret in the supplemental information is the chemical identity which is the subject of the substantiation, the submitter shall include the appropriate generic class or category of the chemical claimed as trade secret.</P> <CITA>[53 FR 28801, July 29, 1988, as amended at 85 FR 44772, July 24, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 350.9</SECTNO> <SUBJECT>Initial action by EPA.</SUBJECT> <P>(a) When a claim of trade secrecy, made in accordance with § 350.5 of this part, is received by EPA, that information is treated as confidential until a contrary determination is made.</P> <P>(b) A determination as to the validity of a trade secrecy claim shall be initiated upon receipt by EPA of a petition under § 350.15 or may be initiated at any time by EPA if EPA desires to determine whether chemical identity information claimed as trade secret is entitled to trade secret treatment, even though no request for release of the information has been received.</P> <P>(c) If EPA initiates a determination as to the validity of a trade secrecy claim, the procedures set forth in §§ 350.11, 350.15, and 350.17 shall be followed in making the determination.</P> <P>(d) When EPA receives a petition requesting disclosure of trade secret chemical identity or if EPA decides to initiate a determination of the validity of a trade secrecy claim for chemical identity, EPA shall first make a determination that the chemical identity claimed as trade secret is not the subject of a prior trade secret determination by EPA concerning the same submitter and facility, or if it is, that the prior determination upheld the submitter's claim of trade secrecy for that chemical identity at that facility.</P> <P>(1) If EPA determines that the chemical identity claimed as trade secret is not the subject of a prior trade secret determination by EPA concerning the same submitter and the same facility, or if it is, that the prior determination upheld the submitter's claim of trade secrecy, then EPA shall review the submitter's claim according to § 350.1l.</P> <P>(2) If such a prior determination held that the submitter's claim for that chemical identity is invalid, and such determination was not challenged by appeal to the General Counsel, or by review in the District Court, or, if challenged, was upheld, EPA shall notify the submitter by certified mail (return receipt requested) that the chemical identity claimed as trade secret is the subject of a prior, final Agency determination concerning the same facility in which it was held that such a claim was invalid. In this notification EPA shall include notice of intent to disclose chemical identity within 10 days pursuant to § 350.18(c) of this subpart. EPA shall also notify the petitioner by regular mail of the action taken pursuant to this section.</P> </SECTION> <SECTION> <SECTNO>§ 350.11</SECTNO> <SUBJECT>Review of claim.</SUBJECT> <P> (a) <E T="03">Determination of sufficiency.</E> When EPA receives a petition submitted pursuant to § 350.15, or if EPA initiates a determination of the validity of a trade secrecy claim for chemical identity, and EPA has made a determination, as required in paragraph (d)(1) of § 350.9, then EPA shall determine whether the submitter has presented sufficient support for its claim of trade secrecy in its substantiation. EPA must make such a determination within 30 days of receipt of a petition. A claim of trade secrecy for chemical identity will be considered sufficient if, assuming all of the information presented in the substantiation is true, this supporting information could support a valid claim of trade secrecy. A claim is sufficient if it meets the criteria set forth in § 350.13. </P> <P> (1) <E T="03">Sufficient claim.</E> If the claim meets the criteria of sufficiency set forth in <PRTPAGE P="425"/> § 350.13, EPA shall notify the submitter in writing, by certified mail (return receipt requested), that it has 30 days from the date of receipt of the notice to submit supplemental information in writing in accordance with § 350.7(e), to support the truth of the facts asserted in the substantiation. EPA will not accept any supplemental information, in response to this notice, submitted after the 30 day period has expired. The notice required by this section shall include the address to which supplemental information must be sent. The notice may specifically request supplemental information in particular areas relating to the submitter's claim. The notice must also inform the submitter of his right to claim any trade secret or confidential business information as confidential, and shall include a reference to § 350.7(e) of this regulation as the source for the proper procedure for claiming trade secrecy for trade secret or confidential business information submitted in the supplemental information requested by EPA. </P> <P> (2) <E T="03">Insufficient claim.</E> If the claim does not meet the criteria of sufficiency set forth in § 350.13, EPA shall notify the submitter in writing of this fact by certified mail (return receipt requested). Upon receipt of this notice, the submitter may either file an appeal of the matter to the General Counsel under paragraph (a)(2)(i) of this section, or, for good cause shown, submit additional material in support of its claim of trade secrecy to EPA under paragraph (a)(2)(ii) of this section. The notice required by this section shall include the reasons for EPA's decision that the submitter's claim is insufficient, and shall inform the submitter of its rights within 30 days of receiving notice to file an appeal with EPA's General Counsel or to amend its original substantiation for good cause shown. The notice shall include the address of the General Counsel, and the address of the office to which an amendment for good cause shown should be sent. The notice shall also include a reference to § 350.11(a)(2)(i)-(iv) of this subpart as the source on the proper procedures for filing an appeal or for amending the original substantiation. </P> <P> (i) <E T="03">Appeal.</E> The submitter may file an appeal of a determination of insufficiency with the General Counsel within 30 days of receipt of the notice of insufficiency, in accordance with the procedures set forth in § 350.17. </P> <P> (ii) <E T="03">Good Cause.</E> In lieu of an appeal to the General Counsel, the submitter may send additional material in support of its trade secrecy claim, for good cause shown, within 30 days of receipt of the notice of insufficiency. To do so, the submitter shall notify EPA by letter of its contentions as to good cause, and shall include in that letter the additional supporting material. </P> <P>(iii) Good cause is limited to one or more of the following reasons:</P> <P>(A) The submitter was not aware of the facts underlying the additional information at the time the substantiation was submitted, and could not reasonably have known the facts at that time; or</P> <P>(B) EPA regulations and other EPA guidance did not call for such information at the time the substantiation was submitted; or</P> <P>(C) The submitter had made a good faith effort to submit a complete substantiation, but failed to do so due to an inadvertent omission or clerical error.</P> <P>(iv) If EPA determines that the submitter has met the standard for good cause, then EPA shall decide, pursuant to paragraph (a) of this section, whether the submitter's claim meets the Agency's standards of sufficiency set forth in § 350.13.</P> <P>(A) If after receipt of additional material for good cause, EPA decides the claim is sufficient, EPA will determine whether the claim presents a valid claim of trade secrecy according to the procedures set forth in paragraph (b) of this section.</P> <P> (B) If after receipt of additional material for good cause, EPA decides the claim is insufficient, EPA will notify the submitter by certified mail (return receipt requested) and the submitter may seek review in U.S. District Court within 30 days of receipt of the notice. The notice required by this paragraph shall include EPA's reasons for its determination, and shall inform the submitter of its right to seek review in U.S. District Court within 30 days of <PRTPAGE P="426"/> receipt of the notice. The petitioner shall be notified of EPA's decision by regular mail. </P> <P>(v) If EPA determines that the submitter has not met the standard for good cause, then EPA shall notify the submitter by certified mail (return receipt requested). The submitter may seek review of EPA's decision in U.S. District Court within 30 days of receipt of the notice. The notice required in this paragraph shall include EPA's reasons for its determination, and shall inform the submitter of its right to seek review in U.S. District Court within 30 days of receipt of the notice. The petitioner shall be notified of EPA's decision by regular mail.</P> <P>(b) Determination of trade secrecy. Once a claim has been determined to be sufficient under paragraph (a) of this section, EPA must decide whether the claim is entitled to trade secrecy.</P> <P>(1) If EPA determines that the information submitted in support of the trade secrecy claim is true and that the chemical identity is a trade secret, the petitioner shall be notified by certified mail (return receipt requested) of EPA's determination and may bring an action in U.S. District Court within 30 days of receipt of such notice. The notice required in this paragraph shall include the reasons why EPA has determined that the chemical identity is a trade secret and shall inform the petitioner of its right to seek review in U.S. District Court within 30 days of receipt of the notice. The submitter shall be notified of EPA's decision by regular mail.</P> <P>(2) If EPA decides that the information submitted in support of the trade secrecy claim is not true and that the chemical identity is not a trade secret:</P> <P>(i) The submitter shall be notified by certified mail (return receipt requested) of EPA's determination and may appeal to the General Counsel within 30 days of receipt of such notice, in accordance with the procedures set forth in § 350.17. The notice required by this paragraph shall include the reasons why EPA has determined that the chemical identity is not a trade secret and shall inform the submitter of its appeal rights to EPA's General Counsel. The notice shall include the address to which an appeal should be sent and the procedure for filing an appeal, as set forth in § 350.17(a) of this subpart. The petitioner shall be notified of EPA's decision by regular mail.</P> <P>(ii) The General Counsel shall notify the submitter by certified mail (return receipt requested) of its decision on appeal pursuant to the requirements in § 350.17. The notice required by this paragraph shall include the reasons for EPA's determination. If the General Counsel affirms the decision that the chemical identity is not a trade secret, then the submitter shall have 30 days from the date it receives notice of the General Counsel's decision to bring an action in U.S. District Court. If the General Counsel decides that the chemical identity is a trade secret, then EPA shall follow the procedure set forth in paragraph (b)(1) of this section.</P> </SECTION> <SECTION> <SECTNO>§ 350.13</SECTNO> <SUBJECT>Sufficiency of assertions.</SUBJECT> <P>(a) A substantiation submitted under § 350.7 will be determined to be insufficient to support a claim of trade secrecy unless the answers to the questions in the substantiation submitted under § 350.7 support all of the following conclusions. This substantiation must include, where applicable, specific facts.</P> <P>(1) The submitter has not disclosed the information to any other person, other than a member of a local emergency planning committee, an officer or employee of the United States or a State or local government, an employee of such person, or a person who is bound by a confidentiality agreement, and such person has taken reasonable measures to protect the confidentiality of such information and intends to continue to take such measures. To support this conclusion, the facts asserted must show all of the following:</P> <P>(i) The submitter has taken reasonable measures to prevent unauthorized disclosure of the specific chemical identity and will continue to take such measures.</P> <P>(ii) The submitter has not disclosed the specific chemical identity to any person who is not bound by an agreement to refrain from disclosing the information.</P> <P> (iii) The submitter has not previously disclosed the specific chemical identity <PRTPAGE P="427"/> to a local, State, or Federal government entity without asserting a confidentiality claim. </P> <P>(2) The information is not required to be disclosed, or otherwise made available, to the public under any other Federal or State law.</P> <P>(3) Disclosure of the information is likely to cause substantial harm to the competitive position of such person. To support this conclusion, the facts asserted must show all of the following:</P> <P> (i) <E T="03">Either:</E> (A) Competitors do not know or the submitter is not aware that competitors know that the chemical whose identity is being claimed trade secret can be used in the fashion that the submitter uses it, and competitors cannot easily duplicate the specific use of this chemical through their own research and development activities; or </P> <P>(B) Competitors are not aware or the submitter does not know whether competitors are aware that the submitter is using this chemical in this fashion.</P> <P>(ii) The fact that the submitter manufactures, imports or otherwise uses this chemical in a particular fashion is not contained in any publication or other information source (of which the submitter is aware) available to competitors or the public.</P> <P>(iii) The non-confidential version of the submission under this title does not contain sufficient information to enable competitors to determine the specific chemical identity withheld therefrom.</P> <P>(iv) The information referred to in paragraph (a)(3)(i)(A) of this section, is of value to competitors.</P> <P>(v) Competitors are likely to use this information to the economic detriment of the submitter and are not precluded from doing so by a United States patent.</P> <P>(vi) The resulting harm to submitter's competitive position would be substantial.</P> <P>(4) The chemical identity is not readily discoverable through reverse engineering. To support this conclusion, the facts asserted must show that competitors cannot readily discover the specific chemical identity by analysis of the submitter's products or environmental releases.</P> <P>(b) The sufficiency of the trade secrecy claim shall be decided entirely upon the information submitted under § 350.7, or § 350.11(a)(2)(ii).</P> </SECTION> <SECTION> <SECTNO>§ 350.15</SECTNO> <SUBJECT>Public petitions requesting disclosure of chemical identity claimed as trade secret.</SUBJECT> <P>(a) The public may request the disclosure of chemical identity claimed as trade secret by submitting a written petition to the address specified in § 350.16.</P> <P>(b) The petition shall include:</P> <P>(1) The name, address, and telephone number of the petitioner;</P> <P>(2) The name and address of the company claiming the chemical identity as trade secret; and</P> <P>(3) A copy of the submission in which the submitter claimed chemical identity as trade secret, with a specific indication as to which chemical identity the petitioner seeks disclosed.</P> <P>(c) EPA shall acknowledge, by letter to the petitioner, the receipt of the petition.</P> <P>(d) Incomplete petitions. If the information contained in the petition is not sufficient to allow EPA to identify which chemical identity the petitioner is seeking to have released, EPA shall notify the petitioner that the petition cannot be further processed until additional information is furnished. EPA will make every reasonable effort to assist a petitioner in providing sufficient information for EPA to identify the chemical identity the petitioner is seeking to have released.</P> <P>(e) EPA shall make a determination on a petition requesting disclosure, in accordance with § 350.11 and § 350.17, within nine months of receipt of such petition.</P> </SECTION> <SECTION> <SECTNO>§ 350.16</SECTNO> <SUBJECT>Address to send trade secrecy claims and petitions requesting disclosure.</SUBJECT> <P> The address and location to send all claims of trade secrecy under sections 303(d)(2) and (d)(3), 311, 312, and 313 of Title III and all public petitions requesting disclosure of chemical identities claimed as trade secret are posted on the following EPA program websites, <E T="03">http://www.epa.gov/epcra</E> and <PRTPAGE P="428"/> <E T="03">http://www.epa.gov/tri/rfi.</E> Any subsequent changes to the address and location will be announced in <E T="04">Federal Register</E> Notices as these changes occur. Also, the changes will be posted on these websites. Submitters may also contact the EPCRA, RMP & Oil Information Center at (800) 424-9346 or (703) 348-5070, <E T="03">https://www.epa.gov/epcra/forms/contact-us-about-emergency-planning-and-community-right-know-act-epcra</E> to obtain this information. </P> <CITA>[85 FR 44772, July 24, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 350.17</SECTNO> <SUBJECT>Appeals.</SUBJECT> <P> (a) <E T="03">Procedure for filing appeal.</E> A submitter may appeal an EPA determination under § 350.11(a)(2)(i) or (b)(2)(i), by filing an appeal with the General Counsel. The appeal shall be addressed to: The Office of General Counsel, U.S. Environmental Protection Agency, Mailcode 2310A, 1200 Pennsylvania Avenue, NW., Washington DC 20460. </P> <FP>The appeal shall contain the following:</FP> <P>(1) A letter requesting review of the appealed decision; and</P> <P>(2) A copy of the letter containing EPA's decision upon which appeal is requested.</P> <P>(b) Appeal of determination of insufficient claim.</P> <P>(1) Where a submitter appeals a determination by EPA under § 350.11(a)(2)(i) that the trade secrecy claim presents insufficient support for a finding of trade secrecy, the General Counsel shall make one of the following determinations:</P> <P>(i) The trade secrecy claim at issue meets the standards of sufficiency set forth in § 350.13; or</P> <P>(ii) The trade secrecy claim at issue does not meet the standards of sufficiency set forth in § 350.13.</P> <P>(2) If the General Counsel reverses the decision made by the EPA office handling the claim, the claim shall be processed according to § 350.11(a)(1). The General Counsel shall notify the submitter of the determination on appeal in writing, by certified mail (return receipt requested). The appeal determination shall include the date the appeal was received by the General Counsel, a statement of the decision appealed from, a statement of the decision on appeal and the reasons for such decision.</P> <P>(3) If the General Counsel upholds the determination of insufficiency made by the EPA office handling the claim, the submitter may seek review in U.S. District Court within 30 days after receipt of notice of the General Counsel's determination. The General Counsel shall notify the submitter of its determination on appeal in writing, by certified mail (return receipt requested). The appeal determination shall include the date the appeal was received by the General Counsel, a statement of the decision appealed from, a statement of the decision on appeal and the reasons for such decision, and a statement of the submitter's right to seek review in U.S. District Court within 30 days of receipt of such notice. The petitioner shall be notified by regular mail.</P> <P> (c) <E T="03">Appeal of determination of no trade secret.</E> (1) If a submitter appeals from a determination by EPA under § 350.11(b)(2) that the specific chemical identity at issue is not a trade secret, the General Counsel shall make one of the following determinations: </P> <P>(i) The assertions supporting the claim of trade secrecy are true and the chemical identity is a trade secret; or</P> <P>(ii) The assertions supporting the claim of trade secrecy are not true and the chemical identity is not a trade secret.</P> <P>(2) If the General Counsel reverses the decision made by the EPA office handling the claim, the General Counsel shall notify the submitter of its determination on appeal in writing, by certified mail (return receipt requested). The appeal determination shall include the date the appeal was received by the General Counsel, a statement of the decision appealed from, a statement of the decision on appeal and the reasons for such decision. The General Counsel shall send the petitioner the notice required in § 350.11(b)(1).</P> <P> (3) If the General Counsel upholds the decision of the EPA office which made the trade secret determination, the submitter may seek review in U.S. District Court within 30 days of receipt of notice of the General Counsel's decision. The General Counsel shall notify the submitter of the determination on <PRTPAGE P="429"/> appeal in writing, by certified mail (return receipt requested). The notice shall include the date the appeal was received by the General Counsel, a statement of the decision appealed from, the basis for the appeal determination, that it constitutes final Agency action concerning the chemical identity trade secrecy claim, and that such final Agency action may be subject to review in U.S. District Court within 30 days of receipt of such notice. The General Counsel shall notify the petitioner by regular mail. </P> <CITA>[53 FR 28801, July 29, 1988, as amended at 68 FR 64724, Nov. 14, 2003]</CITA> </SECTION> <SECTION> <SECTNO>§ 350.18</SECTNO> <SUBJECT>Release of chemical identity determined to be non-trade secret; notice of intent to release chemical identity.</SUBJECT> <P>(a) Where a submitter fails to seek review within U.S. District Court within 20 days of receiving notice of a determination of the General Counsel under § 350.17(b)(3) of this subpart that the trade secrecy claim is insufficient, or under § 350.17(c)(3) of this subpart that chemical identity claimed as trade secret is not entitled to trade secret protection, EPA may furnish notice of intent to disclose the chemical identity claimed as trade secret within 10 days by furnishing the submitter with the notice set forth in paragraph (d) of this section by certified mail (return receipt requested).</P> <P>(b) Where a submitter fails to seek review within U.S. District Court within 20 days of receiving notice of an EPA determination under § 350.11(a)(2)(iv)(B), or § 350.11(a)(2)(v) of this regulation, or fails to pursue appeal to the General Counsel within 20 days after being notified of its right to do so under § 350.11(a)(2)(i) or § 350.11(b)(2)(i), EPA may furnish notice of intent to disclose the chemical identity claimed as trade secret within 10 days by furnishing the submitter with the notice set forth in paragraph (d) of this section by certified mail (return receipt requested).</P> <P>(c) Where EPA, upon initial review under § 350.9(d), determines that the chemical identity claimed as trade secret in a submittal submitted pursuant to this part is the subject of a prior final Agency determination concerning a claim of trade secrecy for the same chemical identity for the same facility, in which such claim was held invalid, EPA shall furnish notice of intent to disclose chemical identity within l0 days by furnishing the submitter with the notice set forth in paragraph (d) of this section by certified mail (return receipt requested).</P> <P>(d) EPA shall furnish notice of its intent to release chemical identity claimed as trade secret by sending the following notification to submitters, under the circumstances set forth in paragraphs (a), (b), and (c) of this section. The notice shall state that EPA will make the chemical identity available to the petitioner and the public on the tenth working day after the date of the submitter's receipt of written notice (or on such later date as the Office of General Counsel may establish), unless the Office of General Counsel has first been notified of the submitter's commencement of an action in Federal court to obtain judicial review of the determination at issue, and to obtain preliminary injunctive relief against disclosure, or, where applicable, as described in paragraph (b) of this section, of commencement of an appeal to the General Counsel. The notice shall further state that if Federal court action is timely commenced, EPA may nonetheless make the information available to the petitioner and the public (in the absence of an order by the court to the contrary), once the court has denied a motion for a preliminary injunction in the action or has otherwise upheld the EPA determination, or, that if Federal court action or appeal to the General Counsel is timely commenced, EPA may nonetheless make the information available to the petitioner and the public whenever it appears to the General Counsel, after reasonable notice to the submitter, that the submitter is not taking appropriate measures to obtain a speedy resolution of the action.</P> </SECTION> <SECTION> <SECTNO>§ 350.19</SECTNO> <SUBJECT>Provision of information to States.</SUBJECT> <P> (a) Any State may request access to trade secrecy claims, substantiations, supplemental substantiations, and additional information submitted to <PRTPAGE P="430"/> EPA. EPA shall release this information, even if claimed confidential, to any State requesting access if: </P> <P>(1) The request is in writing;</P> <P>(2) The request is from the Governor of the State; and</P> <P>(3) The State agrees to safeguard the information with procedures equivalent to those which EPA uses to safeguard the information.</P> <P>(b) The Governor of a State which receives access to trade secret information under this section may disclose such information only to State employees.</P> </SECTION> <SECTION> <SECTNO>§ 350.21</SECTNO> <SUBJECT>Adverse health effects.</SUBJECT> <P>The Governor or State emergency response commission shall identify the adverse health effects associated with each of the chemicals claimed as trade secret and shall make this information available to the public. The material safety data sheets submitted to the State emergency response commissions may be used for this purpose.</P> </SECTION> <SECTION> <SECTNO>§ 350.23</SECTNO> <SUBJECT>Disclosure to authorized representatives.</SUBJECT> <P>(a) Under section 322(f) of the Act, EPA possesses the authority to disclose to any authorized representative of the United States any information to which this section applies, notwithstanding the fact that the information might otherwise be entitled to trade secret or confidential treatment under this part. Such authority may be exercised only in accordance with paragraph (b) of this section.</P> <P>(b)(1) A person under contract or subcontract to EPA or a grantee who performs work for EPA in connection with Title III or regulations which implement Title III may be considered an authorized representative of the United States for purposes of this § 350.23. Subject to the limitations in this § 350.23(b), information to which this section applies may be disclosed to such a person if the EPA program office managing the contract, subcontract, or grant first determines in writing that such disclosure is necessary in order that the contractor, subcontractor or grantee may carry out the work required by the contract, subcontract or grant.</P> <P>(2) No information shall be disclosed under this § 350.23(b) unless this contract, subcontract, or grant in question provides:</P> <P>(i) That the contractor, subcontractor or the grantee and the contractor's, subcontractor's, or grantee's employees shall use the information only for the purpose of carrying out the work required by the contract, subcontract, or grant, and shall refrain from disclosing the information to anyone other than EPA without the prior written approval of each affected submitter or of an EPA legal office, and shall return to EPA all copies of the information (and any abstracts or extracts therefrom) upon request by the EPA program office, whenever the information is no longer required by the contractor, subcontractor or grantee for the performance of the work required under the contract, subcontract or grant, or upon completion of the contract, subcontract or grant;</P> <P>(ii) That the contractor, subcontractor or grantee shall obtain a written agreement to honor such terms of the contract or subcontract from each of the contractor's, subcontractor's or grantee's employees who will have access to the information, before such employee is allowed such access; and</P> <P>(iii) That the contractor, subcontractor or grantee acknowledges and agrees that the contract, subcontract or grant provisions concerning the use and disclosure of confidential business information are included for the benefit of, and shall be enforceable by, both EPA and any covered facility having an interest in information concerning it supplied to the contractor, subcontractor or grantee by EPA under the contract or subcontract or grant.</P> <P> (3) No information shall be disclosed under this § 350.23(b) until each affected submitter has been furnished notice of the contemplated disclosure by the EPA program office and has been afforded a period found reasonable by that office (not less than 5 working days) to submit its comments. Such notice shall include a description of the information to be disclosed, the identity of the contractor, subcontractor or grantee, the contract, subcontract or grant number, if any, and <PRTPAGE P="431"/> the purposes to be served by the disclosure. This notice may be published in the <E T="04">Federal Register</E> or may be sent to individual submitters. </P> <P>(4) The EPA program office shall prepare a record of disclosures under this § 350.23(b). The EPA program office shall maintain the record of disclosure and the determination of necessity prepared under paragraph (b)(1) of this section for a period of not less than 36 months after the date of the disclosure.</P> </SECTION> <SECTION> <SECTNO>§ 350.25</SECTNO> <SUBJECT>Disclosure in special circumstances.</SUBJECT> <P>Other disclosure of specific chemical identity may be made in accordance with 40 CFR 2.209.</P> </SECTION> <SECTION> <SECTNO>§ 350.27</SECTNO> <SUBJECT>Substantiation form to accompany claims of trade secrecy, instructions to substantiation form.</SUBJECT> <P> (a) The substantiation form to accompany claims of trade secrecy must be completed and submitted as required in § 350.7(a). The form and instructions are posted on the Emergency Planning and Community Right-to-Know Act (EPCRA) website, <E T="03">http://www.epa.gov/epcra</E> and the Toxics Release Inventory Program Division website, <E T="03">http://www.epa.gov/tri/rfi.</E> Submitters may also contact the National Service Center for Environmental Publications (NSCEP) at (800) 490-9198 or <E T="03">https://www.epa.gov/nscep</E> to obtain the form. The address to send all trade secrecy claims is posted on the following EPA Program websites, <E T="03">http://www.epa.gov/epcra</E> and <E T="03">http://www.epa.gov/tri/rfi.</E> This information can also be obtained by contacting the EPCRA, RMP & Oil Information Center at (800) 424-9346 or (703) 348-5070, or <E T="03">https://www.epa.gov/epcra/forms/contact-us-about-emergency-planning-and-community-right-know-act-epcra.</E> </P> <P>(b) [Reserved]</P> <CITA>[53 FR 28801, July 29, 1988, as amended at 68 FR 64724, Nov. 14, 2003; 85 FR 44772, July 24, 2020]</CITA> </SECTION> <APPENDIX> <EAR>Pt. 350, Subpt. A, App. A</EAR> <HD SOURCE="HED">Appendix A to Subpart A of Part 350—Restatement of Torts Section 757, Comment b</HD> <P>b. Definition of trade secret. A trade secret may consist of any formula, pattern, device or compilation of information which is used in one's business, and which gives him an opportunity to obtain an advantage over competitors who do not know or use it. It may be a formula for a chemical compound, a process of manufacturing, treating or preserving materials, a pattern for a machine or other device, or a list of customers. It differs from other secret information in a business (see section 759) in that it is not simply information as to single or ephemeral events in the conduct of the business, as, for example, the amount or other terms of a secret bid for a contract or the salary of certain employees, or the security investments made or contemplated, or the date fixed for the announcement of a new policy or for bringing out a new model or the like. A trade secret is a process or device for continuous use in the operation of the business. Generally it relates to the production of goods, as, for example, a machine or formula for the production of an article. It may, however, relate to the sale of goods or to other operations in the business, such as a code for determining discounts, rebates or other concessions in a price list or catalogue, or a list of specialized customers, or a method of bookkeeping or other office management.</P> <P>Secrecy. The subject matter of a trade secret must be secret. Matters of public knowledge or of general knowledge in an industry cannot be appropriated by one as his secret. Matters which are completely disclosed by the goods which one markets cannot be his secret. Substantially, a trade secret is known only in the particular business in which it is used. It is not requisite that only the proprietor of the business know it. He may, without losing his protection, communicate it to employees involved in its use. He may likewise communicate it to others pledged to secrecy. Others may also know of it independently, as, for example, when they have discovered the process or formula by independent invention and are keeping it secret. Nevertheless, a substantial element of secrecy must exist, so that, except by the use of improper means, there would be difficulty in acquiring the information. An exact definition of a trade secret is not possible. Some factors to be considered in determining whether given information is one's trade secret are: (1) The extent to which the information is known outside of his business; (2) the extent to which it is known by employees and others involved in his business; (3) the extent of measures taken by him to guard the secrecy of the information; (4) the value of the information to him and to his competitors; (5) the amount of effort or money expended by him in developing the information; (6) the ease or difficulty with which the information could be properly acquired or duplicated by others.</P> <P> Novelty and prior art. A trade secret may be a device or process which is patentable; but it need not be that. It may be a device or process which is clearly anticipated in the <PRTPAGE P="432"/> prior art or one which is merely a mechanical improvement that a good mechanic can make. Novelty and invention are not requisite for a trade secret as they are for patentability. These requirements are essential to patentability because a patent protects against unlicensed use of the patented device or process even by one who discovers it properly through independent research. The patent monopoly is a reward to the inventor. But such is not the case with a trade secret. Its protection is not based on a policy of rewarding or otherwise encouraging the development of secret processes or devices. The protection is merely against breach of faith and reprehensible means of learning another's secret. For this limited protection it is not appropriate to require also the kind of novelty and invention which is a requisite of patentability. The nature of the secret is, however, an important factor in determining the kind of relief that is appropriate against one who is subject to liability under the rule stated in this section. Thus, if the secret consists of a device or process which is a novel invention, one who acquires the secret wrongfully is ordinarily enjoined from further use of it and is required to account for the profits derived from his past use. If, on the other hand, the secret consists of mechanical improvements that a good mechanic can make without resort to the secret, the wrongdoer's liability may be limited to damages, and an injunction against future use of the improvements made with the aid of the secret may be inappropriate. </P> </APPENDIX> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Disclosure of Trade Secret Information to Health Professionals</HD> <SECTION> <SECTNO>§ 350.40</SECTNO> <SUBJECT>Disclosure to health professionals.</SUBJECT> <P> (a) <E T="03">Definitions. Medical emergency</E> means any unforeseen condition which a health professional would judge to require urgent and unscheduled medical attention. Such a condition is one which results in sudden and/or serious symptom(s) constituting a threat to a person's physical or psychological well-being and which requires immediate medical attention to prevent possible deterioration, disability, or death. </P> <P>(b) The specific chemical identity, including the chemical name of a hazardous chemical, extremely hazardous substance, or a toxic chemical, is made available to health professionals, in accordance with the applicable provisions of this section.</P> <P> (c) <E T="03">Diagnosis or Treatment by Health Professionals in Non-Emergency Situations.</E> (1) An owner or operator of a facility which is subject to the requirements of sections 311, 312, and 313, shall, upon request, provide the specific chemical identity, if known, of a hazardous chemical, extremely hazardous substance, or a toxic chemical to a health professional if: </P> <P>(i) The request is in writing;</P> <P>(ii) The request describes why the health professional has a reasonable basis to suspect that:</P> <P>(A) The specific chemical identity is needed for purposes of diagnosis or treatment of an individual,</P> <P>(B) The individual or individuals being diagnosed or treated have been exposed to the chemical concerned, and</P> <P>(C) Knowledge of the specific chemical identity of such chemical will assist in diagnosis or treatment.</P> <P>(iii) The request contains a confidentiality agreement which includes:</P> <P>(A) A description of the procedures to be used to maintain the confidentiality of the disclosed information; and</P> <P>(B) A statement by the health professional that he will not use the information for any purpose other than the health needs asserted in the statement of need authorized in paragraph (c)(1)(ii) of this section and will not release the information under any circumstances, except as authorized by the terms of the confidentiality agreement or by the owner or operator of the facility providing such information.</P> <P>(iv) The request includes a certification signed by the health professional stating that the information contained in the statement of need is true.</P> <P>(2) Following receipt of a written request, the facility owner or operator to whom such request is made shall provide the requested information to the health professional promptly.</P> <P> (d) <E T="03">Preventive Measures and Treatment by Local Health Professionals.</E> (1) An owner or operator of a facility subject to the requirements of sections 311, 312, or 313 shall provide the specific chemical identity, if known, of a hazardous chemical, an extremely hazardous substance, or a toxic chemical to any health professional (such as a physician, toxicologist, epidemiologist, or nurse) if: <PRTPAGE P="433"/> </P> <P>(i) The requester is a local government employee or a person under contract with the local government;</P> <P>(ii) The request is in writing;</P> <P>(iii) The request describes with reasonable detail one or more of the following health needs for the information:</P> <P>(A) To assess exposure of persons living in a local community to the hazards of the chemical concerned.</P> <P>(B) To conduct or assess sampling to determine exposure levels of various population groups.</P> <P>(C) To conduct periodic medical surveillance of exposed population groups.</P> <P>(D) To provide medical treatment to exposed individuals or population groups.</P> <P>(E) To conduct studies to determine the health effects of exposure.</P> <P>(F) To conduct studies to aid in the identification of chemicals that may reasonably be anticipated to cause an observed health effect.</P> <P>(iv) The request contains a confidentiality agreement which includes:</P> <P>(A) A description of the procedures to be used to maintain the confidentiality of the disclosed information; and</P> <P>(B) A statement by the health professional that he will not use the information for any purpose other than the health needs asserted in the statement of need authorized in paragraph (d)(1)(iii) of this section and will not release the information under any circumstances except as may otherwise be authorized by the terms of such agreement or by the owner or operator of the facility person providing such information.</P> <P>(v) The request includes a certification signed by the health professional stating that the information contained in the statement of need is true.</P> <P>(2) Following receipt of a written request, the facility owner or operator to whom such request is made shall promptly provide the requested information to the local health professional.</P> <P> (e) <E T="03">Medical Emergency.</E> (1) An owner or operator of a facility which is subject to the requirements of sections 311, 312, or 313 must provide a copy of a material safety data sheet, an inventory form, or a toxic chemical release form, including the specific chemical identity, if known, of a hazardous chemical, extremely hazardous substance, or a toxic chemical, to any treating physician or nurse who requests such information if the treating physician or nurse determines that: </P> <P>(i) A medical emergency exists as to the individual or individuals being diagnosed or treated;</P> <P>(ii) The specific chemical identity of the chemical concerned is necessary for or will assist in emergency or first-aid diagnosis or treatment; and,</P> <P>(iii) The individual or individuals being diagnosed or treated have been exposed to the chemical concerned.</P> <P>(2) Owners or operators of facilities must provide the specific chemical identity to the requesting treating physician or nurse immediately following the request, without requiring a written statement of need or a confidentiality agreement in advance.</P> <P>(3) The owner or operator may require a written statement of need and a written confidentiality agreement as soon as circumstances permit. The written statement of need shall describe in reasonable detail the factors set forth in paragraph (e)(1) of this section. The written confidentiality agreement shall be in accordance with paragraphs (c)(1)(iii) and (f) of this section.</P> <P> (f) <E T="03">Confidentiality Agreement.</E> (1) The confidentiality agreement authorized in paragraphs (c)(1)(iii), (d)(1)(iv) and (e)(3) of this section: </P> <P>(i) May restrict the use of the information to the health purposes indicated in the written statement of need;</P> <P>(ii) May provide for appropriate legal remedies in the event of a breach of the agreement; and</P> <P>(iii) May not include requirements for the posting of a penalty bond.</P> <P>(g) Nothing in this regulation is meant to preclude the parties from pursuing any non-contractual remedies to the extent permitted by law, or from pursuing the enforcement remedy provided in section 325(e) of Title III.</P> <P> (h) The health professional receiving the trade secret information may disclose it to EPA only under the following circumstances: The health professional must believe that such disclosure is necessary in order to learn from the Agency additional information about the chemical necessary to assist <PRTPAGE P="434"/> him in carrying out the responsibilities set forth in paragraphs (c), (d), and (e) of this section. Such information comprises facts regarding adverse health and environmental effects. </P> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 355</EAR> <HD SOURCE="HED">PART 355—EMERGENCY PLANNING AND NOTIFICATION</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Information</HD> <SECHD>Sec.</SECHD> <SECTNO>355.1</SECTNO> <SUBJECT>What is the purpose of this part?</SUBJECT> <SECTNO>355.2</SECTNO> <SUBJECT>Who do “you,” “I,” and “your” refer to in this part?</SUBJECT> <SECTNO>355.3</SECTNO> <SUBJECT>Which section contains the definitions of the keywords used in this part?</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Emergency Planning</HD> <SUBJGRP> <HD SOURCE="HED">Who Must Comply</HD> <SECTNO>355.10</SECTNO> <SUBJECT>Must my facility comply with the emergency planning requirements of this subpart?</SUBJECT> <SECTNO>355.11</SECTNO> <SUBJECT>To what substances do the emergency planning requirements of this subpart apply?</SUBJECT> <SECTNO>355.12</SECTNO> <SUBJECT>What quantities of extremely hazardous substances trigger emergency planning requirements?</SUBJECT> <SECTNO>355.13</SECTNO> <SUBJECT>How do I calculate the quantity of an extremely hazardous substance present in mixtures?</SUBJECT> <SECTNO>355.14</SECTNO> <SUBJECT>Do I have to aggregate extremely hazardous substances to determine the total quantity present?</SUBJECT> <SECTNO>355.15</SECTNO> <SUBJECT>Which threshold planning quantity do I use for an extremely hazardous substance present at my facility in solid form?</SUBJECT> <SECTNO>355.16</SECTNO> <SUBJECT>How do I determine the quantity of extremely hazardous substances present for certain forms of solids?</SUBJECT> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How To Comply</HD> <SECTNO>355.20</SECTNO> <SUBJECT>If this subpart applies to my facility, what information must I provide, who must I submit it to, and when is it due?</SUBJECT> <SECTNO>355.21</SECTNO> <SUBJECT>In what format should the information be submitted?</SUBJECT> </SUBJGRP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Emergency Release Notification</HD> <SUBJGRP> <HD SOURCE="HED">Who Must Comply</HD> <SECTNO>355.30</SECTNO> <SUBJECT>What facilities must comply with the emergency release notification requirements of this subpart?</SUBJECT> <SECTNO>355.31</SECTNO> <SUBJECT>What types of releases are exempt from the emergency release notification requirements of this subpart?</SUBJECT> <SECTNO>355.32</SECTNO> <SUBJECT>Which emergency release notification requirements apply to continuous releases?</SUBJECT> <SECTNO>355.33</SECTNO> <SUBJECT>What release quantities of EHSs and CERCLA hazardous substances trigger the emergency release notification requirements of this subpart?</SUBJECT> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How To Comply</HD> <SECTNO>355.40</SECTNO> <SUBJECT>What information must I provide?</SUBJECT> <SECTNO>355.41</SECTNO> <SUBJECT>In what format should the information be submitted?</SUBJECT> <SECTNO>355.42</SECTNO> <SUBJECT>To whom must I submit the information?</SUBJECT> <SECTNO>355.43</SECTNO> <SUBJECT>When must I submit the information?</SUBJECT> </SUBJGRP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Additional Provisions</HD> <SECTNO>355.60</SECTNO> <SUBJECT>What is the relationship between the emergency release notification requirements of this part and the release notification requirements of CERCLA?</SUBJECT> <SECTNO>355.61</SECTNO> <SUBJECT>How are keywords in this part defined?</SUBJECT> <APP>Appendix A to Part 355—The List of Extremely Hazardous Substances and Their Threshold Planning Quantities (Alphabetical Order)</APP> <APP>Appendix B to Part 355—The List of Extremely Hazardous Substances and Their Threshold Planning Quantities (CAS Number Order)</APP> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>Sections 302, 303, 304, 325, 327, 328, and 329 of the Emergency Planning and Community Right-to-Know Act of 1986 (EPCRA) (42 U.S.C. 11002, 11003, 11004, 11045, 11047, 11048, and 11049).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>73 FR 65462, Nov. 3, 2008, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Information</HD> <SECTION> <SECTNO>§ 355.1</SECTNO> <SUBJECT>What is the purpose of this part?</SUBJECT> <P>(a) This part (40 CFR part 355) establishes requirements for a facility to provide information necessary for developing and implementing State and local chemical emergency response plans, and requirements for emergency notification of chemical releases. This part also lists Extremely Hazardous Substances (EHSs) and Threshold Planning Quantities (TPQs) in Appendices A and B, which are used in determining if you are subject to these requirements.</P> <P> (b) This part is written in a special format to make it easier to understand the regulatory requirements. Like other Environmental Protection Agency (EPA) regulations, this part establishes enforceable legal requirements. Information considered non-binding guidance under EPCRA is indicated in <PRTPAGE P="435"/> this regulation by the word “note” and a smaller typeface. Such notes are provided for information purposes only and are not considered legally binding under this part. </P> </SECTION> <SECTION> <SECTNO>§ 355.2</SECTNO> <SUBJECT>Who do “you,” “I,” and “your” refer to in this part?</SUBJECT> <P>Throughout this part, “you,” “I,” and “your” refer to the owner or operator of a facility.</P> </SECTION> <SECTION> <SECTNO>§ 355.3</SECTNO> <SUBJECT>Which section contains the definitions of the key words used in this part?</SUBJECT> <P>The definitions of key words used in this part are in § 355.61. It is important to read the definitions for these key words because the definition explains the word's specific meaning associated with the regulations in this part.</P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Emergency Planning</HD> <SUBJGRP> <HD SOURCE="HED">Who Must Comply</HD> <SECTION> <SECTNO>§ 355.10</SECTNO> <SUBJECT>Must my facility comply with the emergency planning requirements of this subpart?</SUBJECT> <P>You must comply with the emergency planning requirements in this subpart if your facility meets either of the following two conditions:</P> <P>(a) Any extremely hazardous substance (EHS) is present at your facility in an amount equal to or greater than its threshold planning quantity (TPQ), or</P> <P>(b) Your facility has been designated for emergency planning purposes, after public notice and opportunity for comment, by one of the following three entities:</P> <P>(1) The State Emergency Response Commission (SERC).</P> <P>(2) The Governor of the State in which your facility is located.</P> <P>(3) The Chief Executive Officer of the Tribe for the Indian Tribe under whose jurisdiction your facility is located.</P> </SECTION> <SECTION> <SECTNO>§ 355.11</SECTNO> <SUBJECT>To what substances do the emergency planning requirements of this subpart apply?</SUBJECT> <P>The emergency planning requirements of this subpart apply to any EHS listed in Appendices A and B of this part. Additionally, if a facility is designated for emergency planning purposes, as provided in § 355.10(b), substances that are not EHSs at this facility may become subject to the emergency planning requirements.</P> </SECTION> <SECTION> <SECTNO>§ 355.12</SECTNO> <SUBJECT>What quantities of extremely hazardous substances trigger emergency planning requirements?</SUBJECT> <P>Any EHS present at your facility in an amount equal to or greater than its TPQ triggers the emergency planning requirements of this subpart. The TPQs are listed in Appendices A and B of this part in the column labeled “threshold planning quantity.”</P> </SECTION> <SECTION> <SECTNO>§ 355.13</SECTNO> <SUBJECT>How do I calculate the quantity of an extremely hazardous substance present in mixtures?</SUBJECT> <P>If an EHS is present in a mixture in a particular container, determine the quantity (in pounds) of the EHS in that container by multiplying the concentration of the EHS (in weight percent) by the weight (in pounds) of the mixture in the container. If the concentration of an EHS is less than or equal to one percent in the mixture, you do not have to count that EHS. Here is an example calculation:</P> <EXAMPLE> <HD SOURCE="HED">Example:</HD> <P>You have 150 pounds of a mixture that contains 20 weight percent of a certain EHS. The quantity of EHS present in the mixture is:</P> <FP>EHS (in pounds)</FP> <FP SOURCE="FP-2"> = (weight percent of EHS) × (weight of mixture)</FP> <FP SOURCE="FP-2"> = (20 percent) × (150 pound mixture)</FP> <FP> = (0.20) × (150)</FP> <FP>EHS (in pounds)</FP> <FP> = 30 pounds</FP> </EXAMPLE> </SECTION> <SECTION> <SECTNO>§ 355.14</SECTNO> <SUBJECT>Do I have to aggregate extremely hazardous substances to determine the total quantity present?</SUBJECT> <P> You must aggregate ( <E T="03">i.e.</E> , add together) the amounts of each EHS at your facility to determine if a TPQ is present. This means that, for a particular EHS, you must determine the total amount present at any one time at your facility by adding together the quantity of pure EHS and the quantity contained in all mixtures, regardless of location, number of containers, or method of storage. You do not have to count an EHS in a mixture if the concentration of that EHS is less than or equal to one percent. </P> </SECTION> <SECTION> <PRTPAGE P="436"/> <SECTNO>§ 355.15</SECTNO> <SUBJECT>Which threshold planning quantity do I use for an extremely hazardous substance present at my facility in solid form?</SUBJECT> <P>EHSs that are in solid form are subject to one of two different TPQs (for example, TPQs may be listed as 500/10,000 pounds), both of which are listed in Appendices A and B of this part. Here is how to determine which of the two listed TPQs you must use for an EHS present at your facility in solid form:</P> <P>(a) Use the lower TPQ from Appendices A and B of this part if the solid:</P> <P>(1) Is in powdered form and has a particle size less than 100 microns;</P> <P>(2) Is in solution;</P> <P>(3) Is in molten form; or</P> <P>(4) Meets the criteria for a National Fire Protection Association (NFPA) rating of 2, 3 or 4 for reactivity.</P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">a</E> ): </HD> <P>Use the instructions in § 355.16 to calculate the quantity present for the categories of solids listed in paragraphs (a)(1), (2) and (3) of this section.</P> </NOTE> <P>(b) If the solid does not meet one of the criteria in paragraph (a) of this section, then the TPQ is 10,000 pounds.</P> </SECTION> <SECTION> <SECTNO>§ 355.16</SECTNO> <SUBJECT>How do I determine the quantity of extremely hazardous substances present for certain forms of solids?</SUBJECT> <P>For the three forms of solids that are listed in § 355.15(a)(1) through (3), use these instructions to determine the quantity of extremely hazardous substance present:</P> <P> (a) <E T="03">Solid in powdered form with a particle size less than 100 microns.</E> Multiply the weight percent of solid with a particle size less than 100 microns in a particular container by the total weight of solid in the container. </P> <P> (b) <E T="03">Solid in solution.</E> Multiply the weight percent of the non-reactive solid in solution in a particular container by the total weight of solution in that container. Then multiply by 0.2. </P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">b</E> ): </HD> <P>This reduction in quantity must not be used to determine the amount present at one-time at a facility for reporting under 40 CFR 370.10.</P> </NOTE> <P> (c) <E T="03">Solid in molten form.</E> Multiply the weight of the non-reactive solid in molten form by 0.3. </P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">c</E> ): </HD> <P>This reduction in quantity must not be used to determine the amount present at one-time at a facility for reporting under 40 CFR 370.10.</P> </NOTE> <CITA>[73 FR 65462, Nov. 3, 2008, as amended at 77 FR 16688, Mar. 22, 2012]</CITA> </SECTION> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How to Comply</HD> <SECTION> <SECTNO>§ 355.20</SECTNO> <SUBJECT>If this subpart applies to my facility, what information must I provide, who must I submit it to, and when is it due?</SUBJECT> <P>Use this table to determine the information you must provide, who to provide it to, and when:</P> <GPOTABLE COLS="4" OPTS="L2" CDEF="s50,r50,r50,r50"> <BOXHD> <CHED H="1">What types of emergency planning notification are required?</CHED> <CHED H="1">What information must I provide?</CHED> <CHED H="1"> To whom must I provide the <LI>information?</LI> </CHED> <CHED H="1">When must I provide the information?</CHED> </BOXHD> <ROW> <ENT I="01">(a) Emergency planning notification</ENT> <ENT>You must provide notice that your facility is subject to the emergency planning requirements of this subpart</ENT> <ENT>To the SERC and the LEPC</ENT> <ENT>Within 60 days after your facility first becomes subject to the requirements of this subpart. If no LEPC exists for your facility at the time you are required to provide emergency planning notification, then you should report to the LEPC within 30 days after an LEPC is established for the emergency planning district in which your facility is located.</ENT> </ROW> <ROW> <PRTPAGE P="437"/> <ENT I="01">(b) Facility emergency coordinator</ENT> <ENT>You must designate a facility representative who will participate in the local emergency planning process as a facility emergency response coordinator. You must provide notice of this facility representative</ENT> <ENT>To the LEPC (or the SERC if there is no LEPC, or the Governor if there is no SERC)</ENT> <ENT>Within 60 days after your facility first becomes subject to the requirements of this subpart. If no LEPC exists when you first report, then provide an additional report to the LEPC within 30 days after such LEPC is established for the emergency planning district in which your facility is located.</ENT> </ROW> <ROW> <ENT I="01">(c) Changes relevant to emergency planning</ENT> <ENT>You must provide notice of any changes occurring at your facility that may be relevant to emergency planning</ENT> <ENT>To the LEPC</ENT> <ENT>Within 30 days after the changes have occurred.</ENT> </ROW> <ROW> <ENT I="01">(d) Requested information</ENT> <ENT>You must provide any information necessary for developing or implementing the local emergency plan if the LEPC requests it</ENT> <ENT>To the LEPC</ENT> <ENT>Promptly. Note: The LEPC may specify a time frame for this information.</ENT> </ROW> </GPOTABLE> </SECTION> <SECTION> <SECTNO>§ 355.21</SECTNO> <SUBJECT>In what format should the information be submitted?</SUBJECT> <P>EPA does not require any specific format. EPA recommends that you submit the information described in § 355.20 in writing in order to insure appropriate documentation. The SERC or LEPC may request that this information be submitted in a specific format.</P> </SECTION> </SUBJGRP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Emergency Release Notification</HD> <SUBJGRP> <HD SOURCE="HED">Who Must Comply</HD> <SECTION> <SECTNO>§ 355.30</SECTNO> <SUBJECT>What facilities must comply with the emergency release notification requirements of this subpart?</SUBJECT> <P>You must comply with the emergency release notification requirements in this subpart if both of these two conditions are met:</P> <P>(a) You produce, use, or store a hazardous chemical at your facility; and</P> <P>(b) You release a reportable quantity (RQ) of any EHS or of a hazardous substance as defined by the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA Hazardous Substance) at your facility. Certain releases are exempted from these requirements. Exempted releases are listed in § 355.31.</P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">b</E> ): </HD> <P>In addition to the emergency release notification requirements of this subpart, releases of CERCLA hazardous substances are subject to the notification requirements under CERCLA. This is explained further in subpart D of this part.</P> </NOTE> </SECTION> <SECTION> <SECTNO>§ 355.31</SECTNO> <SUBJECT>What types of releases are exempt from the emergency release notification requirements of this subpart?</SUBJECT> <P>You do not have to provide emergency release notification under this subpart for any of the following six types of releases of EHSs or CERCLA hazardous substances that occur at your facility:</P> <P>(a) Any release that results in exposure to persons solely within the boundaries of your facility.</P> <P>(b) Any release that is a federally permitted release as defined in section 101(10) of CERCLA.</P> <P>(c) Any release of a pesticide product that is exempt from reporting under section 103(e) of CERCLA.</P> <P>(d) Any release that does not meet the definition of release under section 101(22) of CERCLA and is therefore exempt from CERCLA section 103(a) reporting.</P> <P>(e) Any radionuclide release that occurs:</P> <P>(1) Naturally in soil from land holdings such as parks, golf courses, or other large tracts of land.</P> <P> (2) Naturally from land disturbance activities, including farming, construction, and land disturbance incidental to extraction during mining activities, except that which occurs at uranium, <PRTPAGE P="438"/> phosphate, tin, zircon, hafnium, vanadium, monazite, and rare earth mines. Land disturbance incidental to extraction includes: Land clearing; overburden removal and stockpiling; excavating, handling, transporting, and storing ores and other raw (not beneficiated or processed) materials; and replacing in mined-out areas coal ash, earthen materials from farming or construction, or overburden or other raw materials generated from the exempted mining activities. </P> <P>(3) From the dumping and transportation of coal and coal ash (including fly ash, bottom ash, and boiler slags), including the dumping and land spreading operations that occur during coal ash uses.</P> <P>(4) From piles of coal and coal ash, including fly ash, bottom ash, and boiler slags.</P> <P>(f) Any release less than 1,000 pounds per 24 hours of nitrogen oxide or nitrogen dioxide to the air which is the result of combustion and combustion related activities.</P> <P>(g) Air emissions from animal waste (including decomposing animal waste) at a farm.</P> <CITA>[73 FR 65462, Nov. 3, 2008, as amended at 73 FR 76960, Dec. 18, 2008; 83 FR 37446, Aug. 1, 2018; 84 FR 27452, June 13, 2019]</CITA> </SECTION> <SECTION> <SECTNO>§ 355.32</SECTNO> <SUBJECT>Which emergency release notification requirements apply to continuous releases?</SUBJECT> <P>If the release of an EHS or CERCLA hazardous substance is continuous and stable in quantity and rate at your facility as defined in 40 CFR 302.8(b), then the release qualifies for reduced reporting requirements under this subpart. Under these reduced reporting requirements, you do not need to provide the notifications required under § 355.40. However, in addition to the notifications required under 40 CFR 302.8, you must make all of the following notifications to the community emergency coordinator for the LEPC for any area likely to be affected by the release and to the SERC of any State likely to be affected by the release:</P> <P>(a) Initial notifications as specified in 40 CFR 302.8 (d) and (e).</P> <P>(b) Notification of a “statistically significant increase,” defined in 40 CFR 302.8(b) as any increase above the upper bound of the reported normal range.</P> <P>(c) Notification of a “new release” as specified in 40 CFR 302.8(g)(1).</P> <P>(d) Notification of a change in the normal range of the release as specified under 40 CFR 302.8(g)(2).</P> </SECTION> <SECTION> <SECTNO>§ 355.33</SECTNO> <SUBJECT>What release quantities of EHSs and CERCLA hazardous substances trigger the emergency release notification requirements of this subpart?</SUBJECT> <P>The release of a reportable quantity (RQ) of an EHS or CERCLA hazardous substance within any 24-hour period triggers the emergency release notification requirements. RQs for EHSs are listed in Appendices A and B of this part in the column labeled “reportable quantity.” RQs for CERCLA hazardous substances are listed in Table 302.4 of 40 CFR 302.4 in the column labeled “final RQ.”</P> </SECTION> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How To Comply</HD> <SECTION> <SECTNO>§ 355.40</SECTNO> <SUBJECT>What information must I provide?</SUBJECT> <P>You must make two separate notifications to comply with the emergency release notification requirements of this subpart: an immediate notification, and as soon as practicable thereafter a written follow-up emergency notification (or notifications, as more information becomes available).</P> <P> (a) <E T="03">Immediate notification.</E> The notice required under this section shall include as much of the following information known at the time. However, the retrieval of this information should not cause a delay in the notification on the emergency response. </P> <P>(1) The chemical name or identity of any substance involved in the release.</P> <P>(2) Indicate whether the substance is an EHS.</P> <P>(3) Provide an estimate of the quantity of any such substance that was released into the environment.</P> <P>(4) State the time and duration of the release.</P> <P>(5) The medium or media into which the release occurred.</P> <P> (6) Any known or anticipated acute or chronic health risks associated with the emergency and, where appropriate, advice regarding medical attention necessary for exposed individuals. <PRTPAGE P="439"/> </P> <P>(7) Proper precautions to take as a result of the release, including evacuation (unless such information is readily available to the community emergency coordinator pursuant to the emergency plan).</P> <P>(8) The name and telephone number of the individual (or individuals) to be contacted for further information.</P> <P> (b) <E T="03">Written follow-up emergency notification.</E> Except for releases that occur during transportation or from storage incident to transportation, you must provide a written follow-up emergency notice (or notices, as more information becomes available), as soon as practicable after the release. In the written follow-up emergency notice, you must provide and update the information required in the immediate notification and include additional information with respect to all of the following: </P> <P>(1) Actions taken to respond and contain the release.</P> <P>(2) Any known or anticipated acute or chronic health risks associated with the release.</P> <P>(3) Where appropriate, advice regarding medical attention necessary for exposed individuals.</P> <P>(c) You are not required to submit a written follow-up notification for a release that occurred during transportation or from storage incident to transportation. See § 355.42(b) for requirements for reporting such releases.</P> </SECTION> <SECTION> <SECTNO>§ 355.41</SECTNO> <SUBJECT>In what format should the information be submitted?</SUBJECT> <P>The immediate notification, described in § 355.40(a), should be oral. The follow-up emergency notification, described in § 355.40(b), shall be in writing. EPA does not specify a particular format for the written follow-up emergency notification.</P> <NOTE> <HD SOURCE="HED">Note 1 to § 355.41:</HD> <P>The SERC and LEPC may request a specific format for this information.</P> </NOTE> <CITA>[73 FR 65462, Nov. 3, 2008, as amended at 85 FR 44772, July 24, 2020]</CITA> </SECTION> <SECTION> <SECTNO>§ 355.42</SECTNO> <SUBJECT>To whom must I submit the information?</SUBJECT> <P>(a) You must provide the immediate emergency release notification information and the written follow-up notification to:</P> <P>(1) The community emergency coordinator for the LEPC of any area likely to be affected by the release (if there is no LEPC, notify the relevant local emergency response personnel); and</P> <P>(2) The SERC of any State likely to be affected by the release.</P> <P>(b) For a release that occurs during transportation or from storage incident to transportation, you may meet the requirements of this subpart by notifying the 911 operator (or in the absence of a 911 emergency telephone number, the operator) of the immediate notification information listed in § 355.40(a). You are not required under this subpart to submit a written follow-up notification, as described in § 355.40(b), for such a release.</P> </SECTION> <SECTION> <SECTNO>§ 355.43</SECTNO> <SUBJECT>When must I submit the information?</SUBJECT> <P>(a) You must provide the required emergency release notification information described under § 355.40(a), immediately.</P> <P>(b) You must provide the written follow-up emergency notice (or notices, as more information becomes available) described under § 355.40(b), as soon as practicable after the release.</P> </SECTION> </SUBJGRP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Additional Provisions</HD> <SECTION> <SECTNO>§ 355.60</SECTNO> <SUBJECT>What is the relationship between the emergency release notification requirements of this part and the release notification requirements of CERCLA?</SUBJECT> <P> The emergency release notification requirements of this part are in addition to the release notification requirements of CERCLA. If you have a release of a CERCLA hazardous substance, you must comply with the emergency release notification requirements of this part and the release notification requirements of CERCLA section 103, codified at 40 CFR part 302. Use this table to determine which emergency release notification requirements apply to your release: <PRTPAGE P="440"/> </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s60,r60,r60"> <BOXHD> <CHED H="1">If a reportable quantity of a substance is released within a 24-hour period at your facility</CHED> <CHED H="1">And if the release is reportable under EPCRA Section 304, you must</CHED> <CHED H="1">And if the release is reportable under CERCLA Section 103, you must</CHED> </BOXHD> <ROW> <ENT I="01">(a) And the substance is on BOTH the list of EHSs (Appendices A and B of this part) AND the list of CERCLA Hazardous Substances (40 CFR 302.4)</ENT> <ENT>Notify the LEPC and the SERC in accordance with §§ 355.40 through 355.43 of this part (except for a release during transportation or from storage incident to transportation; see § 355.42(b))</ENT> <ENT>Comply with the release notification requirements of CERCLA section 103 and its implementing regulations (40 CFR part 302). Call the NRC at 800-424-8802.</ENT> </ROW> <ROW> <ENT I="01">(b) And the substance is on the list of CERCLA Hazardous Substances (40 CFR 302.4) and not on the list of EHSs (Appendices A and B of this part)</ENT> <ENT>Notify the LEPC and the SERC, in accordance with §§ 355.40 through 355.43 of this part (except for a release during transportation or from storage incident to transportation; see in § 355.42(b))</ENT> <ENT>Comply with the release notification requirements of CERCLA section 103 and its implementing regulations (40 CFR part 302). Call the NRC at 800-424-8802.</ENT> </ROW> <ROW> <ENT I="01">(c) And the substance is on the list of EHSs (Appendices A and B of this part) and not the list of CERCLA Hazardous Substances (40 CFR 302.4)</ENT> <ENT>Notify the LEPC and the SERC in accordance with §§ 355.40 through 355.43 of this part (except for a release during transportation or from storage incident to transportation; see § 355.42(b))</ENT> </ROW> <TNOTE> <E T="02">Note:</E> This table only applies to reportable releases, not to exempt releases. </TNOTE> </GPOTABLE> </SECTION> <SECTION> <SECTNO>§ 355.61</SECTNO> <SUBJECT>How are key words in this part defined?</SUBJECT> <P> <E T="03">Animal waste</E> means feces, urine, or other excrement, digestive emission, urea, or similar substances emitted by animals (including any form of livestock, poultry, or fish). This term includes animal waste that is mixed or commingled with bedding, compost, feed, soil, or any other material typically found with such waste. </P> <P> <E T="03">CERCLA</E> means the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended. </P> <P> <E T="03">CERCLA hazardous substance</E> means a substance defined in section 101(14) of CERCLA and listed in Table 302.4 of 40 CFR 302.4. </P> <P> <E T="03">Chief Executive Officer of the Tribe</E> means the person who is recognized by the Bureau of Indian Affairs as the chief elected administrative officer of the Tribe. </P> <P> <E T="03">Environment</E> includes water, air, and land and the interrelationship that exists among and between water, air, and land and all living things. </P> <P> <E T="03">EPCRA</E> means the Emergency Planning and Community Right-To-Know Act of 1986. </P> <P> <E T="03">Extremely hazardous substance (EHS)</E> means a substance listed in Appendices A and B of this part. </P> <P> <E T="03">Facility</E> means all buildings, equipment, structures, and other stationary items that are located on a single site or on contiguous or adjacent sites and that are owned or operated by the same person (or by any person that controls, is controlled by, or under common control with, such person). <E T="03">Facility</E> includes manmade structures, as well as all natural structures in which chemicals are purposefully placed or removed through human means such that it functions as a containment structure for human use. For purposes of emergency release notification, the term includes motor vehicles, rolling stock, and aircraft. </P> <P> <E T="03">Farm</E> means a site or area (including associated structures) that— </P> <P>(1) Is used for—</P> <P>(i) The production of a crop; or</P> <P>(ii) The raising or selling of animals (including any form of livestock, poultry, or fish); and</P> <P>(2) Under normal conditions, produces during a farm year any agricultural products with a total value equal to not less than $1,000.</P> <P> <E T="03">Hazardous chemical</E> means any hazardous chemical as defined under 29 CFR 1910.1200(c), except that this term does not include: </P> <P>(1) Any food, food additive, color additive, drug, or cosmetic regulated by the Food and Drug Administration.</P> <P>(2) Any substance present as a solid in any manufactured item to the extent exposure to the substance does not occur under normal conditions of use.</P> <P>(3) Any substance to the extent it is used:</P> <P> (i) For personal, family, or household purposes, or is present in the same <PRTPAGE P="441"/> form and concentration as a product packaged for distribution and use by the general public. Present in the same form and concentration as a product packaged for distribution and use by the general public means a substance packaged in a similar manner and present in the same concentration as the substance when packaged for use by the general public, whether or not it is intended for distribution to the general public or used for the same purpose as when it is packaged for use by the general public; </P> <P>(ii) In a research laboratory or hospital or other medical facility under the direct supervision of a technically qualified individual; or</P> <P>(iii) In routine agricultural operations or is a fertilizer held for sale by a retailer to the ultimate customer.</P> <P> <E T="03">Indian Country</E> means Indian country defined in 18 U.S.C. 1151 as: </P> <P>(1) All land within the limits of any Indian reservation under the jurisdiction of the United States government, notwithstanding the issuance of any patent, and, including rights-of-way running through the reservation;</P> <P>(2) All dependent Indian communities within the borders of the United States whether within the original or subsequently acquired territory thereof, and whether within or without the limits of a State; and</P> <P>(3) All Indian allotments, the Indian titles to which have not been extinguished, including rights-of-way running through the same.</P> <P> <E T="03">Indian Tribe or Tribe</E> means those Tribes federally recognized by the Secretary of the Interior. </P> <P> <E T="03">LEPC</E> means the Local Emergency Planning Committee appointed by the State Emergency Response Commission. </P> <P> <E T="03">Medium or media</E> means the environment ( <E T="03">i.e.</E> , air, water, land). </P> <P> <E T="03">Mixture</E> means, for the purposes of 40 CFR part 355, a heterogeneous association of substances where the various individual substances retain their identities and can usually be separated by mechanical means. This definition includes, for the purposes of 40 CFR part 355, solutions but does not include alloys or amalgams. </P> <P> <E T="03">Non-reactive solid</E> means any substance listed in Appendix A or B of this part with two threshold planning quantity values, the higher TPQ being 10,000 pounds. </P> <P> <E T="03">Person</E> means any individual, trust, firm, joint stock company, corporation (including a government corporation), partnership, association, State, municipality, commission, political subdivision of a State, or interstate body. </P> <P> <E T="03">Reactive solid</E> means any extremely hazardous substance denoted with “a” in the “Notes” column in Appendix A or B of this part. </P> <P> <E T="03">Release</E> means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, or disposing into the environment (including the abandonment or discarding of barrels, containers, and other closed receptacles) of any hazardous chemical, EHS, or CERCLA hazardous substance. </P> <P> <E T="03">Reportable quantity</E> means, for any CERCLA hazardous substance, the quantity established in Table 302.4 of 40 CFR 302.4, for such substance. For any EHS, reportable quantity means the quantity established in Appendices A and B of this part for such substance. Unless and until superseded by regulations establishing a reportable quantity for newly listed EHSs or CERCLA hazardous substances, a weight of 1 pound shall be the reportable quantity. </P> <P> <E T="03">SERC</E> means the State Emergency Response Commission for the State in which the facility is located except where the facility is located in Indian Country, in which case, SERC means the Emergency Response Commission for the Tribe under whose jurisdiction the facility is located. In the absence of a SERC for a State or Indian Tribe, the Governor or the chief executive officer of the tribe, respectively, shall be the SERC. Where there is a cooperative agreement between a State and a Tribe, the SERC shall be the entity identified in the agreement. </P> <P> <E T="03">Solution</E> means any aqueous or organic solutions, slurries, viscous solutions, suspensions, emulsions, or pastes. </P> <P> <E T="03">State</E> means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the United States Virgin Islands, the Northern Mariana <PRTPAGE P="442"/> Islands, any other territory or possession over which the United States has jurisdiction and Indian Country. </P> <P> <E T="03">Threshold planning quantity</E> means, for a substance listed in Appendices A and B of this part, the quantity listed in the column “threshold planning quantity” for that substance. </P> <CITA>[73 FR 65462, Nov. 3, 2008, as amended at 73 FR 76960, Dec. 18, 2008; 77 FR 16688, Mar. 22, 2012; 83 FR 37466, Aug. 1, 2018; 84 FR 27542, June 13, 2019]</CITA> </SECTION> <APPENDIX> <EAR>Pt. 355, App. A</EAR> <HD SOURCE="HED">Appendix A to Part 355—The List of Extremely Hazardous Substances and Their Threshold Planning Quantities</HD> <GPOTABLE COLS="5" OPTS="L2" CDEF="s35,r100,xs36,12,15"> <TDESC>[Alphabetical Order]</TDESC> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Chemical name</CHED> <CHED H="1">Notes</CHED> <CHED H="1"> Reportable quantity * <LI>(pounds)</LI> </CHED> <CHED H="1"> Threshold planning quantity <LI>(pounds)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">75-86-5</ENT> <ENT>Acetone Cyanohydrin</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">1752-30-3</ENT> <ENT>Acetone Thiosemicarbazide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">107-02-8</ENT> <ENT>Acrolein</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">79-06-1</ENT> <ENT>Acrylamide</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">107-13-1</ENT> <ENT>Acrylonitrile</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">814-68-6</ENT> <ENT>Acrylyl Chloride</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">111-69-3</ENT> <ENT>Adiponitrile</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">116-06-3</ENT> <ENT>Aldicarb</ENT> <ENT>b</ENT> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">309-00-2</ENT> <ENT>Aldrin</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">107-18-6</ENT> <ENT>Allyl Alcohol</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">107-11-9</ENT> <ENT>Allylamine</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">20859-73-8</ENT> <ENT>Aluminum Phosphide</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">54-62-6</ENT> <ENT>Aminopterin</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">78-53-5</ENT> <ENT>Amiton</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3734-97-2</ENT> <ENT>Amiton Oxalate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7664-41-7</ENT> <ENT>Ammonia</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">300-62-9</ENT> <ENT>Amphetamine</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">62-53-3</ENT> <ENT>Aniline</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">88-05-1</ENT> <ENT>Aniline, 2,4,6-Trimethyl-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7783-70-2</ENT> <ENT>Antimony Pentafluoride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1397-94-0</ENT> <ENT>Antimycin A</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">86-88-4</ENT> <ENT>ANTU</ENT> <ENT/> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1303-28-2</ENT> <ENT>Arsenic Pentoxide</ENT> <ENT/> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1327-53-3</ENT> <ENT>Arsenous Oxide</ENT> <ENT>d</ENT> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7784-34-1</ENT> <ENT>Arsenous Trichloride</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7784-42-1</ENT> <ENT>Arsine</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">2642-71-9</ENT> <ENT>Azinphos-Ethyl</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">86-50-0</ENT> <ENT>Azinphos-Methyl</ENT> <ENT/> <ENT>1</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">98-87-3</ENT> <ENT>Benzal Chloride</ENT> <ENT/> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">98-16-8</ENT> <ENT>Benzenamine, 3-(Trifluoromethyl)-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">100-14-1</ENT> <ENT>Benzene, 1-(Chloromethyl)-4-Nitro-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">98-05-5</ENT> <ENT>Benzenearsonic Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">3615-21-2</ENT> <ENT>Benzimidazole, 4,5-Dichloro-2-(Trifluoromethyl)-</ENT> <ENT>c</ENT> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">98-07-7</ENT> <ENT>Benzotrichloride</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">100-44-7</ENT> <ENT>Benzyl Chloride</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">140-29-4</ENT> <ENT>Benzyl Cyanide</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">15271-41-7</ENT> <ENT>Bicyclo[2.2.1]Heptane-2-Carbonitrile, 5-Chloro-6-((((Methylamino)Carbonyl)Oxy)Imino)-, (1s-(1-alpha,2-beta,4-alpha,5-alpha,6E))-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">534-07-6</ENT> <ENT>Bis(Chloromethyl) Ketone</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">4044-65-9</ENT> <ENT>Bitoscanate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">10294-34-5</ENT> <ENT>Boron Trichloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7637-07-2</ENT> <ENT>Boron Trifluoride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">353-42-4</ENT> <ENT>Boron Trifluoride Compound With Methyl Ether (1:1)</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">28772-56-7</ENT> <ENT>Bromadiolone</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7726-95-6</ENT> <ENT>Bromine</ENT> <ENT>f</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1306-19-0</ENT> <ENT>Cadmium Oxide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2223-93-0</ENT> <ENT>Cadmium Stearate</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">7778-44-1</ENT> <ENT>Calcium Arsenate</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">8001-35-2</ENT> <ENT>Camphechlor</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">56-25-7</ENT> <ENT>Cantharidin</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">51-83-2</ENT> <ENT>Carbachol Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">26419-73-8</ENT> <ENT>Carbamic Acid, Methyl-, O-(((2,4-Dimethyl-1, 3-Dithiolan-2-yl)Methylene)Amino)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1563-66-2</ENT> <ENT>Carbofuran</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">75-15-0</ENT> <ENT>Carbon Disulfide</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">786-19-6</ENT> <ENT>Carbophenothion</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">57-74-9</ENT> <ENT>Chlordane</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000</ENT> </ROW> <ROW> <PRTPAGE P="443"/> <ENT I="01">470-90-6</ENT> <ENT>Chlorfenvinfos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7782-50-5</ENT> <ENT>Chlorine</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">24934-91-6</ENT> <ENT>Chlormephos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">999-81-5</ENT> <ENT>Chlormequat Chloride</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">79-11-8</ENT> <ENT>Chloroacetic Acid</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">107-07-3</ENT> <ENT>Chloroethanol</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">627-11-2</ENT> <ENT>Chloroethyl Chloroformate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">67-66-3</ENT> <ENT>Chloroform</ENT> <ENT>f</ENT> <ENT>10</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">542-88-1</ENT> <ENT>Chloromethyl Ether</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">107-30-2</ENT> <ENT>Chloromethyl Methyl Ether</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">3691-35-8</ENT> <ENT>Chlorophacinone</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1982-47-4</ENT> <ENT>Chloroxuron</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">21923-23-9</ENT> <ENT>Chlorthiophos</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10025-73-7</ENT> <ENT>Chromic Chloride</ENT> <ENT/> <ENT>1</ENT> <ENT>1/10,000</ENT> </ROW> <ROW> <ENT I="01">62207-76-5</ENT> <ENT>Cobalt, ((2,2′-(1,2-Ethanediylbis (Nitrilomethylidyne)) Bis(6-Fluorophenolato))(2-)-N,N′,O,O′)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">10210-68-1</ENT> <ENT>Cobalt Carbonyl</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">64-86-8</ENT> <ENT>Colchicine</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">56-72-4</ENT> <ENT>Coumaphos</ENT> <ENT/> <ENT>10</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">5836-29-3</ENT> <ENT>Coumatetralyl</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">95-48-7</ENT> <ENT>Cresol, o-</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">535-89-7</ENT> <ENT>Crimidine</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">4170-30-3</ENT> <ENT>Crotonaldehyde</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">123-73-9</ENT> <ENT>Crotonaldehyde, (E)-</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">506-68-3</ENT> <ENT>Cyanogen Bromide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">506-78-5</ENT> <ENT>Cyanogen Iodide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">2636-26-2</ENT> <ENT>Cyanophos</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">675-14-9</ENT> <ENT>Cyanuric Fluoride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">66-81-9</ENT> <ENT>Cycloheximide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">108-91-8</ENT> <ENT>Cyclohexylamine</ENT> <ENT>f</ENT> <ENT>10,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">17702-41-9</ENT> <ENT>Decaborane(14)</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">8065-48-3</ENT> <ENT>Demeton</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">919-86-8</ENT> <ENT>Demeton-S-Methyl</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10311-84-9</ENT> <ENT>Dialifor</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">19287-45-7</ENT> <ENT>Diborane</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">111-44-4</ENT> <ENT>Dichloroethyl ether</ENT> <ENT/> <ENT>10</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">149-74-6</ENT> <ENT>Dichloromethylphenylsilane</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">62-73-7</ENT> <ENT>Dichlorvos</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">141-66-2</ENT> <ENT>Dicrotophos</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">1464-53-5</ENT> <ENT>Diepoxybutane</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">814-49-3</ENT> <ENT>Diethyl Chlorophosphate</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">71-63-6</ENT> <ENT>Digitoxin</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2238-07-5</ENT> <ENT>Diglycidyl Ether</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">20830-75-5</ENT> <ENT>Digoxin</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">115-26-4</ENT> <ENT>Dimefox</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">60-51-5</ENT> <ENT>Dimethoate</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2524-03-0</ENT> <ENT>Dimethyl Phosphorochloridothioate</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">77-78-1</ENT> <ENT>Dimethyl sulfate</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">75-78-5</ENT> <ENT>Dimethyldichlorosilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">57-14-7</ENT> <ENT>Dimethylhydrazine</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">99-98-9</ENT> <ENT>Dimethyl-p-Phenylenediamine</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">644-64-4</ENT> <ENT>Dimetilan</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">534-52-1</ENT> <ENT>Dinitrocresol</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">88-85-7</ENT> <ENT>Dinoseb</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1420-07-1</ENT> <ENT>Dinoterb</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">78-34-2</ENT> <ENT>Dioxathion</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">82-66-6</ENT> <ENT>Diphacinone</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">152-16-9</ENT> <ENT>Diphosphoramide, Octamethyl-</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">298-04-4</ENT> <ENT>Disulfoton</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">514-73-8</ENT> <ENT>Dithiazanine Iodide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">541-53-7</ENT> <ENT>Dithiobiuret</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">316-42-7</ENT> <ENT>Emetine, Dihydrochloride</ENT> <ENT>d</ENT> <ENT>1</ENT> <ENT>1/10,000</ENT> </ROW> <ROW> <ENT I="01">115-29-7</ENT> <ENT>Endosulfan</ENT> <ENT/> <ENT>1</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">2778-04-3</ENT> <ENT>Endothion</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">72-20-8</ENT> <ENT>Endrin</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">106-89-8</ENT> <ENT>Epichlorohydrin</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">2104-64-5</ENT> <ENT>EPN</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">50-14-6</ENT> <ENT>Ergocalciferol</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">379-79-3</ENT> <ENT>Ergotamine Tartrate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1622-32-8</ENT> <ENT>Ethanesulfonyl Chloride, 2-Chloro-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10140-87-1</ENT> <ENT>Ethanol, 1,2-Dichloro-, Acetate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <PRTPAGE P="444"/> <ENT I="01">563-12-2</ENT> <ENT>Ethion</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">13194-48-4</ENT> <ENT>Ethoprophos</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">538-07-8</ENT> <ENT>Ethylbis(2-Chloroethyl)Amine</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">371-62-0</ENT> <ENT>Ethylene Fluorohydrin</ENT> <ENT>b, d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">75-21-8</ENT> <ENT>Ethylene Oxide</ENT> <ENT>f</ENT> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">107-15-3</ENT> <ENT>Ethylenediamine</ENT> <ENT/> <ENT>5,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">151-56-4</ENT> <ENT>Ethyleneimine</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">542-90-5</ENT> <ENT>Ethylthiocyanate</ENT> <ENT/> <ENT>10,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">22224-92-6</ENT> <ENT>Fenamiphos</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">115-90-2</ENT> <ENT>Fensulfothion</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">4301-50-2</ENT> <ENT>Fluenetil</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7782-41-4</ENT> <ENT>Fluorine</ENT> <ENT>e</ENT> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">640-19-7</ENT> <ENT>Fluoroacetamide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">144-49-0</ENT> <ENT>Fluoroacetic Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">359-06-8</ENT> <ENT>Fluoroacetyl Chloride</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">51-21-8</ENT> <ENT>Fluorouracil</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">944-22-9</ENT> <ENT>Fonofos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">50-00-0</ENT> <ENT>Formaldehyde</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">107-16-4</ENT> <ENT>Formaldehyde Cyanohydrin</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">23422-53-9</ENT> <ENT>Formetanate Hydrochloride</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2540-82-1</ENT> <ENT>Formothion</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">17702-57-7</ENT> <ENT>Formparanate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">21548-32-3</ENT> <ENT>Fosthietan</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3878-19-1</ENT> <ENT>Fuberidazole</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">110-00-9</ENT> <ENT>Furan</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">13450-90-3</ENT> <ENT>Gallium Trichloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">77-47-4</ENT> <ENT>Hexachlorocyclopentadiene</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">4835-11-4</ENT> <ENT>Hexamethylenediamine, N,N′-Dibutyl-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">302-01-2</ENT> <ENT>Hydrazine</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">74-90-8</ENT> <ENT>Hydrocyanic Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7647-01-0</ENT> <ENT>Hydrogen Chloride (gas only)</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7664-39-3</ENT> <ENT>Hydrogen Fluoride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7722-84-1</ENT> <ENT>Hydrogen Peroxide (Conc >52%)</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">7783-07-5</ENT> <ENT>Hydrogen Selenide</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">7783-06-4</ENT> <ENT>Hydrogen Sulfide</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">123-31-9</ENT> <ENT>Hydroquinone</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">13463-40-6</ENT> <ENT>Iron, Pentacarbonyl-</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">297-78-9</ENT> <ENT>Isobenzan</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">78-82-0</ENT> <ENT>Isobutyronitrile</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">102-36-3</ENT> <ENT>Isocyanic Acid, 3,4-Dichlorophenyl Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">465-73-6</ENT> <ENT>Isodrin</ENT> <ENT/> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">55-91-4</ENT> <ENT>Isofluorphate</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">4098-71-9</ENT> <ENT>Isophorone Diisocyanate</ENT> <ENT>g</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">108-23-6</ENT> <ENT>Isopropyl Chloroformate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">119-38-0</ENT> <ENT>Isopropylmethyl-pyrazolyl Dimethylcarbamate</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">78-97-7</ENT> <ENT>Lactonitrile</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">21609-90-5</ENT> <ENT>Leptophos</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">541-25-3</ENT> <ENT>Lewisite</ENT> <ENT>b, d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">58-89-9</ENT> <ENT>Lindane</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">7580-67-8</ENT> <ENT>Lithium Hydride</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">109-77-3</ENT> <ENT>Malononitrile</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">12108-13-3</ENT> <ENT>Manganese, Tricarbonyl Methylcyclopentadienyl</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">51-75-2</ENT> <ENT>Mechlorethamine</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">950-10-7</ENT> <ENT>Mephosfolan</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1600-27-7</ENT> <ENT>Mercuric Acetate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">7487-94-7</ENT> <ENT>Mercuric Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">21908-53-2</ENT> <ENT>Mercuric Oxide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">10476-95-6</ENT> <ENT>Methacrolein Diacetate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">760-93-0</ENT> <ENT>Methacrylic Anhydride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">126-98-7</ENT> <ENT>Methacrylonitrile</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">920-46-7</ENT> <ENT>Methacryloyl Chloride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">30674-80-7</ENT> <ENT>Methacryloyloxyethyl Isocyanate</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">10265-92-6</ENT> <ENT>Methamidophos</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">558-25-8</ENT> <ENT>Methanesulfonyl Fluoride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">950-37-8</ENT> <ENT>Methidathion</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2032-65-7</ENT> <ENT>Methiocarb</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">16752-77-5</ENT> <ENT>Methomyl</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">151-38-2</ENT> <ENT>Methoxyethylmercuric Acetate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">80-63-7</ENT> <ENT>Methyl 2-Chloroacrylate</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">74-83-9</ENT> <ENT>Methyl Bromide</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">79-22-1</ENT> <ENT>Methyl Chloroformate</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <PRTPAGE P="445"/> <ENT I="01">60-34-4</ENT> <ENT>Methyl Hydrazine</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">624-83-9</ENT> <ENT>Methyl Isocyanate</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">556-61-6</ENT> <ENT>Methyl Isothiocyanate</ENT> <ENT>a</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">74-93-1</ENT> <ENT>Methyl Mercaptan</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3735-23-7</ENT> <ENT>Methyl Phenkapton</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">676-97-1</ENT> <ENT>Methyl Phosphonic Dichloride</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">556-64-9</ENT> <ENT>Methyl Thiocyanate</ENT> <ENT/> <ENT>10,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">78-94-4</ENT> <ENT>Methyl Vinyl Ketone</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">502-39-6</ENT> <ENT>Methylmercuric Dicyanamide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">75-79-6</ENT> <ENT>Methyltrichlorosilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1129-41-5</ENT> <ENT>Metolcarb</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7786-34-7</ENT> <ENT>Mevinphos</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">315-18-4</ENT> <ENT>Mexacarbate</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">50-07-7</ENT> <ENT>Mitomycin C</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">6923-22-4</ENT> <ENT>Monocrotophos</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">2763-96-4</ENT> <ENT>Muscimol</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">505-60-2</ENT> <ENT>Mustard Gas</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">13463-39-3</ENT> <ENT>Nickel Carbonyl</ENT> <ENT/> <ENT>10</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">54-11-5</ENT> <ENT>Nicotine</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">65-30-5</ENT> <ENT>Nicotine Sulfate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7697-37-2</ENT> <ENT>Nitric Acid</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">10102-43-9</ENT> <ENT>Nitric Oxide</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">98-95-3</ENT> <ENT>Nitrobenzene</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">1122-60-7</ENT> <ENT>Nitrocyclohexane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10102-44-0</ENT> <ENT>Nitrogen Dioxide</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">62-75-9</ENT> <ENT>Nitrosodimethylamine</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">991-42-4</ENT> <ENT>Norbormide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01"> </ENT> <ENT>Organorhodium Complex (PMN-82-147)</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">630-60-4</ENT> <ENT>Ouabain</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">23135-22-0</ENT> <ENT>Oxamyl</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">78-71-7</ENT> <ENT>Oxetane, 3,3-Bis(Chloromethyl)-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2497-07-6</ENT> <ENT>Oxydisulfoton</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10028-15-6</ENT> <ENT>Ozone</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">1910-42-5</ENT> <ENT>Paraquat Dichloride</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">2074-50-2</ENT> <ENT>Paraquat Methosulfate</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">56-38-2</ENT> <ENT>Parathion</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">298-00-0</ENT> <ENT>Parathion-Methyl</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">12002-03-8</ENT> <ENT>Paris Green</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">19624-22-7</ENT> <ENT>Pentaborane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2570-26-5</ENT> <ENT>Pentadecylamine</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">79-21-0</ENT> <ENT>Peracetic Acid</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">594-42-3</ENT> <ENT>Perchloromethylmercaptan</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">108-95-2</ENT> <ENT>Phenol</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">4418-66-0</ENT> <ENT>Phenol, 2,2′-Thiobis(4-Chloro-6-Methyl)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">64-00-6</ENT> <ENT>Phenol, 3-(1-Methylethyl)-, Methylcarbamate</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">58-36-6</ENT> <ENT>Phenoxarsine, 10,10′-Oxydi-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">696-28-6</ENT> <ENT>Phenyl Dichloroarsine</ENT> <ENT>d</ENT> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">59-88-1</ENT> <ENT>Phenylhydrazine Hydrochloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">62-38-4</ENT> <ENT>Phenylmercury Acetate</ENT> <ENT/> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2097-19-0</ENT> <ENT>Phenylsilatrane</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">103-85-5</ENT> <ENT>Phenylthiourea</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">298-02-2</ENT> <ENT>Phorate</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">4104-14-7</ENT> <ENT>Phosacetim</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">947-02-4</ENT> <ENT>Phosfolan</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">75-44-5</ENT> <ENT>Phosgene</ENT> <ENT>f</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">13171-21-6</ENT> <ENT>Phosphamidon</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7803-51-2</ENT> <ENT>Phosphine</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2703-13-1</ENT> <ENT>Phosphonothioic Acid, Methyl-, O-Ethyl O-(4-(Methylthio) Phenyl) Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">50782-69-9</ENT> <ENT>Phosphonothioic Acid, Methyl-, S-(2-(Bis(1Methylethyl)Amino)Ethyl) O-Ethyl Ester</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">2665-30-7</ENT> <ENT>Phosphonothioic Acid, Methyl-, O-(4-Nitrophenyl) O-Phenyl Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3254-63-5</ENT> <ENT>Phosphoric Acid, Dimethyl 4-(Methylthio)Phenyl Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2587-90-8</ENT> <ENT>Phosphorothioic Acid, O,O-Dimethyl-S-(2-Methylthio) Ethyl Ester</ENT> <ENT>b, c</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7723-14-0</ENT> <ENT>Phosphorus</ENT> <ENT>a, d</ENT> <ENT>1</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">10025-87-3</ENT> <ENT>Phosphorus Oxychloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10026-13-8</ENT> <ENT>Phosphorus Pentachloride</ENT> <ENT>a</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7719-12-2</ENT> <ENT>Phosphorus Trichloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <PRTPAGE P="446"/> <ENT I="01">57-47-6</ENT> <ENT>Physostigmine</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">57-64-7</ENT> <ENT>Physostigmine, Salicylate (1:1)</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">124-87-8</ENT> <ENT>Picrotoxin</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">110-89-4</ENT> <ENT>Piperidine</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">23505-41-1</ENT> <ENT>Pirimifos-Ethyl</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">10124-50-2</ENT> <ENT>Potassium Arsenite</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">151-50-8</ENT> <ENT>Potassium Cyanide</ENT> <ENT>a</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">506-61-6</ENT> <ENT>Potassium Silver Cyanide</ENT> <ENT>a</ENT> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2631-37-0</ENT> <ENT>Promecarb</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">106-96-7</ENT> <ENT>Propargyl Bromide</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">57-57-8</ENT> <ENT>Propiolactone, Beta-</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">107-12-0</ENT> <ENT>Propionitrile</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">542-76-7</ENT> <ENT>Propionitrile, 3-Chloro-</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">70-69-9</ENT> <ENT>Propiophenone, 4-Amino-</ENT> <ENT>c</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">109-61-5</ENT> <ENT>Propyl Chloroformate</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">75-56-9</ENT> <ENT>Propylene Oxide</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">75-55-8</ENT> <ENT>Propyleneimine</ENT> <ENT/> <ENT>1</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">2275-18-5</ENT> <ENT>Prothoate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">129-00-0</ENT> <ENT>Pyrene</ENT> <ENT>b</ENT> <ENT>5,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">140-76-1</ENT> <ENT>Pyridine, 2-Methyl-5-Vinyl-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">504-24-5</ENT> <ENT>Pyridine, 4-Amino-</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1124-33-0</ENT> <ENT>Pyridine, 4-Nitro-,l-Oxide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">53558-25-1</ENT> <ENT>Pyriminil</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">14167-18-1</ENT> <ENT>Salcomine</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">107-44-8</ENT> <ENT>Sarin</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">7783-00-8</ENT> <ENT>Selenious Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">7791-23-3</ENT> <ENT>Selenium Oxychloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">563-41-7</ENT> <ENT>Semicarbazide Hydrochloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">3037-72-7</ENT> <ENT>Silane, (4-Aminobutyl)Diethoxymethyl-</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">7631-89-2</ENT> <ENT>Sodium Arsenate</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">7784-46-5</ENT> <ENT>Sodium Arsenite</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">26628-22-8</ENT> <ENT> Sodium Azide (Na(N <E T="52">3</E> )) </ENT> <ENT>a</ENT> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">124-65-2</ENT> <ENT>Sodium Cacodylate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">143-33-9</ENT> <ENT>Sodium Cyanide (Na(CN))</ENT> <ENT>a</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">62-74-8</ENT> <ENT>Sodium Fluoroacetate</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">13410-01-0</ENT> <ENT>Sodium Selenate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">10102-18-8</ENT> <ENT>Sodium Selenite</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">10102-20-2</ENT> <ENT>Sodium Tellurite</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">900-95-8</ENT> <ENT>Stannane, Acetoxytriphenyl-</ENT> <ENT>c</ENT> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">57-24-9</ENT> <ENT>Strychnine</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">60-41-3</ENT> <ENT>Strychnine Sulfate</ENT> <ENT/> <ENT>10</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">3689-24-5</ENT> <ENT>Sulfotep</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3569-57-1</ENT> <ENT>Sulfoxide, 3-Chloropropyl Octyl</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7446-09-5</ENT> <ENT>Sulfur Dioxide</ENT> <ENT>f</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7783-60-0</ENT> <ENT>Sulfur Tetrafluoride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7446-11-9</ENT> <ENT>Sulfur Trioxide</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7664-93-9</ENT> <ENT>Sulfuric Acid</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">77-81-6</ENT> <ENT>Tabun</ENT> <ENT>b, d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">7783-80-4</ENT> <ENT>Tellurium Hexafluoride</ENT> <ENT>e</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">107-49-3</ENT> <ENT>TEPP</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">13071-79-9</ENT> <ENT>Terbufos</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">78-00-2</ENT> <ENT>Tetraethyllead</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">597-64-8</ENT> <ENT>Tetraethyltin</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">75-74-1</ENT> <ENT>Tetramethyllead</ENT> <ENT>b, f</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">509-14-8</ENT> <ENT>Tetranitromethane</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10031-59-1</ENT> <ENT>Thallium Sulfate</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">6533-73-9</ENT> <ENT>Thallous Carbonate</ENT> <ENT>b, d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7791-12-0</ENT> <ENT>Thallous Chloride</ENT> <ENT>b, d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2757-18-8</ENT> <ENT>Thallous Malonate</ENT> <ENT>b, d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7446-18-6</ENT> <ENT>Thallous Sulfate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2231-57-4</ENT> <ENT>Thiocarbazide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">39196-18-4</ENT> <ENT>Thiofanox</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">297-97-2</ENT> <ENT>Thionazin</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">108-98-5</ENT> <ENT>Thiophenol</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">79-19-6</ENT> <ENT>Thiosemicarbazide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">5344-82-1</ENT> <ENT>Thiourea, (2-Chlorophenyl)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">614-78-8</ENT> <ENT>Thiourea, (2-Methylphenyl)-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">7550-45-0</ENT> <ENT>Titanium Tetrachloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">584-84-9</ENT> <ENT>Toluene 2,4-Diisocyanate</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">91-08-7</ENT> <ENT>Toluene 2,6-Diisocyanate</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">110-57-6</ENT> <ENT>Trans-1,4-Dichlorobutene</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <PRTPAGE P="447"/> <ENT I="01">1031-47-6</ENT> <ENT>Triamiphos</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">24017-47-8</ENT> <ENT>Triazofos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">76-02-8</ENT> <ENT>Trichloroacetyl Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">115-21-9</ENT> <ENT>Trichloroethylsilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">327-98-0</ENT> <ENT>Trichloronate</ENT> <ENT>e</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">98-13-5</ENT> <ENT>Trichlorophenylsilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1558-25-4</ENT> <ENT>Trichloro(Chloromethyl)Silane</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">27137-85-5</ENT> <ENT>Trichloro(Dichlorophenyl) Silane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">998-30-1</ENT> <ENT>Triethoxysilane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">75-77-4</ENT> <ENT>Trimethylchlorosilane</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">824-11-3</ENT> <ENT>Trimethylolpropane Phosphite</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1066-45-1</ENT> <ENT>Trimethyltin Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">639-58-7</ENT> <ENT>Triphenyltin Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">555-77-1</ENT> <ENT>Tris(2-Chloroethyl)Amine</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">2001-95-8</ENT> <ENT>Valinomycin</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">1314-62-1</ENT> <ENT>Vanadium Pentoxide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">108-05-4</ENT> <ENT>Vinyl Acetate Monomer</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">81-81-2</ENT> <ENT>Warfarin</ENT> <ENT/> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">129-06-6</ENT> <ENT>Warfarin Sodium</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">28347-13-9</ENT> <ENT>Xylylene Dichloride</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">58270-08-9</ENT> <ENT>Zinc, Dichloro(4,4-Dimethyl-5((((Methylamino)Carbonyl) Oxy)Imino)Pentanenitrile)-, (T-4)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1314-84-7</ENT> <ENT>Zinc Phosphide</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <TNOTE>* Only the statutory or final RQ is shown. For more information, see 40 CFR 355.61.</TNOTE> <TNOTE>Notes:</TNOTE> <TNOTE>a. This material is a reactive solid. The TPQ does not default to 10,000 pounds for non-powder, non-molten, non-solution form.</TNOTE> <TNOTE>b. The calculated TPQ changed after technical review as described in a technical support document for the final rule, April 22, 1987.</TNOTE> <TNOTE>c. Chemicals added by final rule, April 22, 1987.</TNOTE> <TNOTE>d. Revised TPQ based on new or re-evaluated toxicity data, April 22, 1987.</TNOTE> <TNOTE>e. The TPQ was revised due to calculation error, April 22, 1987.</TNOTE> <TNOTE>f. Chemicals on the original list that do not meet toxicity criteria but because of their acute lethality, high production volume and known risk are considered chemicals of concern (“Other chemicals”), November 17, 1986 and February 15, 1990.</TNOTE> <TNOTE>g. The TPQ was recalculated (September 8, 2003) since it was mistakenly calculated in the April 22, 1987 final rule under the wrong assumption that this chemical is a reactive solid, when in fact it is a liquid. RQ for this chemical was adjusted on September 11, 2006.</TNOTE> </GPOTABLE> </APPENDIX> <APPENDIX> <EAR>Pt. 355, App. B</EAR> <HD SOURCE="HED">Appendix B to Part 355—The List of Extremely Hazardous Substances and Their Threshold Planning Quantities</HD> <GPOTABLE COLS="5" OPTS="L2" CDEF="s35,r100,xs36,12,15"> <TDESC>[CAS Number Order]</TDESC> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Chemical name</CHED> <CHED H="1">Notes</CHED> <CHED H="1"> Reportable quantity * <LI>(pounds)</LI> </CHED> <CHED H="1"> Threshold planning quantity <LI>(pounds)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">0</ENT> <ENT>Organorhodium Complex (PMN-82-147)</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">50-00-0</ENT> <ENT>Formaldehyde</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">50-07-7</ENT> <ENT>Mitomycin C</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">50-14-6</ENT> <ENT>Ergocalciferol</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">51-21-8</ENT> <ENT>Fluorouracil</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">51-75-2</ENT> <ENT>Mechlorethamine</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">51-83-2</ENT> <ENT>Carbachol Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">54-11-5</ENT> <ENT>Nicotine</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">54-62-6</ENT> <ENT>Aminopterin</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">55-91-4</ENT> <ENT>Isofluorphate</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">56-25-7</ENT> <ENT>Cantharidin</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">56-38-2</ENT> <ENT>Parathion</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">56-72-4</ENT> <ENT>Coumaphos</ENT> <ENT/> <ENT>10</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">57-14-7</ENT> <ENT>Dimethylhydrazine</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">57-24-9</ENT> <ENT>Strychnine</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">57-47-6</ENT> <ENT>Physostigmine</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">57-57-8</ENT> <ENT>Propiolactone, Beta-</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">57-64-7</ENT> <ENT>Physostigmine, Salicylate (1:1)</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">57-74-9</ENT> <ENT>Chlordane</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">58-36-6</ENT> <ENT>Phenoxarsine, 10,10′-Oxydi-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">58-89-9</ENT> <ENT>Lindane</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">59-88-1</ENT> <ENT>Phenylhydrazine Hydrochloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">60-34-4</ENT> <ENT>Methyl Hydrazine</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">60-41-3</ENT> <ENT>Strychnine sulfate</ENT> <ENT/> <ENT>10</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">60-51-5</ENT> <ENT>Dimethoate</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <PRTPAGE P="448"/> <ENT I="01">62-38-4</ENT> <ENT>Phenylmercury Acetate</ENT> <ENT/> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">62-53-3</ENT> <ENT>Aniline</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">62-73-7</ENT> <ENT>Dichlorvos</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">62-74-8</ENT> <ENT>Sodium Fluoroacetate</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">62-75-9</ENT> <ENT>Nitrosodimethylamine</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">64-00-6</ENT> <ENT>Phenol, 3-(1-Methylethyl)-, Methylcarbamate</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">64-86-8</ENT> <ENT>Colchicine</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">65-30-5</ENT> <ENT>Nicotine sulfate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">66-81-9</ENT> <ENT>Cycloheximide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">67-66-3</ENT> <ENT>Chloroform</ENT> <ENT>f</ENT> <ENT>10</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">70-69-9</ENT> <ENT>Propiophenone, 4-Amino-</ENT> <ENT>c</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">71-63-6</ENT> <ENT>Digitoxin</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">72-20-8</ENT> <ENT>Endrin</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">74-83-9</ENT> <ENT>Methyl Bromide</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">74-90-8</ENT> <ENT>Hydrocyanic Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">74-93-1</ENT> <ENT>Methyl Mercaptan</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">75-15-0</ENT> <ENT>Carbon Disulfide</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">75-21-8</ENT> <ENT>Ethylene Oxide</ENT> <ENT>f</ENT> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">75-44-5</ENT> <ENT>Phosgene</ENT> <ENT>f</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">75-55-8</ENT> <ENT>Propyleneimine</ENT> <ENT/> <ENT>1</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">75-56-9</ENT> <ENT>Propylene Oxide</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">75-74-1</ENT> <ENT>Tetramethyllead</ENT> <ENT>b, f</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">75-77-4</ENT> <ENT>Trimethylchlorosilane</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">75-78-5</ENT> <ENT>Dimethyldichlorosilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">75-79-6</ENT> <ENT>Methyltrichlorosilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">75-86-5</ENT> <ENT>Acetone Cyanohydrin</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">76-02-8</ENT> <ENT>Trichloroacetyl Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">77-47-4</ENT> <ENT>Hexachlorocyclopentadiene</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">77-78-1</ENT> <ENT>Dimethyl Sulfate</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">77-81-6</ENT> <ENT>Tabun</ENT> <ENT>b, d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">78-00-2</ENT> <ENT>Tetraethyllead</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">78-34-2</ENT> <ENT>Dioxathion</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">78-53-5</ENT> <ENT>Amiton</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">78-71-7</ENT> <ENT>Oxetane, 3,3-Bis(Chloromethyl)-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">78-82-0</ENT> <ENT>Isobutyronitrile</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">78-94-4</ENT> <ENT>Methyl Vinyl Ketone</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">78-97-7</ENT> <ENT>Lactonitrile</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">79-06-1</ENT> <ENT>Acrylamide</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">79-11-8</ENT> <ENT>Chloroacetic Acid</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">79-19-6</ENT> <ENT>Thiosemicarbazide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">79-21-0</ENT> <ENT>Peracetic Acid</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">79-22-1</ENT> <ENT>Methyl Chloroformate</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">80-63-7</ENT> <ENT>Methyl 2-Chloroacrylate</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">81-81-2</ENT> <ENT>Warfarin</ENT> <ENT/> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">82-66-6</ENT> <ENT>Diphacinone</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">86-50-0</ENT> <ENT>Azinphos-Methyl</ENT> <ENT/> <ENT>1</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">86-88-4</ENT> <ENT>ANTU</ENT> <ENT/> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">88-05-1</ENT> <ENT>Aniline, 2,4,6-Trimethyl-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">88-85-7</ENT> <ENT>Dinoseb</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">91-08-7</ENT> <ENT>Toluene 2,6-Diisocyanate</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">95-48-7</ENT> <ENT>Cresol, o-</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">98-05-5</ENT> <ENT>Benzenearsonic Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">98-07-7</ENT> <ENT>Benzotrichloride</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">98-13-5</ENT> <ENT>Trichlorophenylsilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">98-16-8</ENT> <ENT>Benzenamine, 3-(Trifluoromethyl)-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">98-87-3</ENT> <ENT>Benzal Chloride</ENT> <ENT/> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">98-95-3</ENT> <ENT>Nitrobenzene</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">99-98-9</ENT> <ENT>Dimethyl-p-Phenylenediamine</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">100-14-1</ENT> <ENT>Benzene, 1-(Chloromethyl)-4-Nitro-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">100-44-7</ENT> <ENT>Benzyl Chloride</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">102-36-3</ENT> <ENT>Isocyanic Acid, 3,4-Dichlorophenyl Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">103-85-5</ENT> <ENT>Phenylthiourea</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">106-89-8</ENT> <ENT>Epichlorohydrin</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">106-96-7</ENT> <ENT>Propargyl Bromide</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">107-02-8</ENT> <ENT>Acrolein</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">107-07-3</ENT> <ENT>Chloroethanol</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">107-11-9</ENT> <ENT>Allylamine</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">107-12-0</ENT> <ENT>Propionitrile</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">107-13-1</ENT> <ENT>Acrylonitrile</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">107-15-3</ENT> <ENT>Ethylenediamine</ENT> <ENT/> <ENT>5,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">107-16-4</ENT> <ENT>Formaldehyde Cyanohydrin</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <PRTPAGE P="449"/> <ENT I="01">107-18-6</ENT> <ENT>Allyl Alcohol</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">107-30-2</ENT> <ENT>Chloromethyl Methyl Ether</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">107-44-8</ENT> <ENT>Sarin</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">107-49-3</ENT> <ENT>TEPP</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">108-05-4</ENT> <ENT>Vinyl Acetate Monomer</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">108-23-6</ENT> <ENT>Isopropyl Chloroformate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">108-91-8</ENT> <ENT>Cyclohexylamine</ENT> <ENT>f</ENT> <ENT>10,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">108-95-2</ENT> <ENT>Phenol</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">108-98-5</ENT> <ENT>Thiophenol</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">109-61-5</ENT> <ENT>Propyl Chloroformate</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">109-77-3</ENT> <ENT>Malononitrile</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">110-00-9</ENT> <ENT>Furan</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">110-57-6</ENT> <ENT>Trans-1,4-Dichlorobutene</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">110-89-4</ENT> <ENT>Piperidine</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">111-44-4</ENT> <ENT>Dichloroethyl Ether</ENT> <ENT/> <ENT>10</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">111-69-3</ENT> <ENT>Adiponitrile</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">115-21-9</ENT> <ENT>Trichloroethylsilane</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">115-26-4</ENT> <ENT>Dimefox</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">115-29-7</ENT> <ENT>Endosulfan</ENT> <ENT/> <ENT>1</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">115-90-2</ENT> <ENT>Fensulfothion</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">116-06-3</ENT> <ENT>Aldicarb</ENT> <ENT>b</ENT> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">119-38-0</ENT> <ENT>Isopropylmethyl-pyrazolyl Dimethylcarbamate</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">123-31-9</ENT> <ENT>Hydroquinone</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">123-73-9</ENT> <ENT>Crotonaldehyde, (E)-</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">124-65-2</ENT> <ENT>Sodium Cacodylate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">124-87-8</ENT> <ENT>Picrotoxin</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">126-98-7</ENT> <ENT>Methacrylonitrile</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">129-00-0</ENT> <ENT>Pyrene</ENT> <ENT>b</ENT> <ENT>5,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">129-06-6</ENT> <ENT>Warfarin Sodium</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">140-29-4</ENT> <ENT>Benzyl Cyanide</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">140-76-1</ENT> <ENT>Pyridine, 2-Methyl-5-Vinyl-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">141-66-2</ENT> <ENT>Dicrotophos</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">143-33-9</ENT> <ENT>Sodium Cyanide (Na(CN))</ENT> <ENT>a</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">144-49-0</ENT> <ENT>Fluoroacetic Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">149-74-6</ENT> <ENT>Dichloromethylphenylsilane</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">151-38-2</ENT> <ENT>Methoxyethylmercuric Acetate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">151-50-8</ENT> <ENT>Potassium Cyanide</ENT> <ENT>a</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">151-56-4</ENT> <ENT>Ethyleneimine</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">152-16-9</ENT> <ENT>Diphosphoramide, Octamethyl-</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">297-78-9</ENT> <ENT>Isobenzan</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">297-97-2</ENT> <ENT>Thionazin</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">298-00-0</ENT> <ENT>Parathion-Methyl</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">298-02-2</ENT> <ENT>Phorate</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">298-04-4</ENT> <ENT>Disulfoton</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">300-62-9</ENT> <ENT>Amphetamine</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">302-01-2</ENT> <ENT>Hydrazine</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">309-00-2</ENT> <ENT>Aldrin</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">315-18-4</ENT> <ENT>Mexacarbate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">316-42-7</ENT> <ENT>Emetine, Dihydrochloride</ENT> <ENT>d</ENT> <ENT>1</ENT> <ENT>1/10,000</ENT> </ROW> <ROW> <ENT I="01">327-98-0</ENT> <ENT>Trichloronate</ENT> <ENT>e</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">353-42-4</ENT> <ENT>Boron Trifluoride Compound With Methyl Ether (1:1)</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">359-06-8</ENT> <ENT>Fluoroacetyl Chloride</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">371-62-0</ENT> <ENT>Ethylene Fluorohydrin</ENT> <ENT>b, d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">379-79-3</ENT> <ENT>Ergotamine Tartrate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">465-73-6</ENT> <ENT>Isodrin</ENT> <ENT/> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">470-90-6</ENT> <ENT>Chlorfenvinfos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">502-39-6</ENT> <ENT>Methylmercuric Dicyanamide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">504-24-5</ENT> <ENT>Pyridine, 4-Amino-</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">505-60-2</ENT> <ENT>Mustard Gas</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">506-61-6</ENT> <ENT>Potassium Silver Cyanide</ENT> <ENT>a</ENT> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">506-68-3</ENT> <ENT>Cyanogen Bromide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">506-78-5</ENT> <ENT>Cyanogen Iodide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">509-14-8</ENT> <ENT>Tetranitromethane</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">514-73-8</ENT> <ENT>Dithiazanine Iodide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">534-07-6</ENT> <ENT>Bis(Chloromethyl) Ketone</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">534-52-1</ENT> <ENT>Dinitrocresol</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">535-89-7</ENT> <ENT>Crimidine</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">538-07-8</ENT> <ENT>Ethylbis(2-Chloroethyl)Amine</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">541-25-3</ENT> <ENT>Lewisite</ENT> <ENT>b, d</ENT> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">541-53-7</ENT> <ENT>Dithiobiuret</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">542-76-7</ENT> <ENT>Propionitrile, 3-Chloro-</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <PRTPAGE P="450"/> <ENT I="01">542-88-1</ENT> <ENT>Chloromethyl Ether</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">542-90-5</ENT> <ENT>Ethylthiocyanate</ENT> <ENT/> <ENT>10,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">555-77-1</ENT> <ENT>Tris(2-Chloroethyl)Amine</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">556-61-6</ENT> <ENT>Methyl Isothiocyanate</ENT> <ENT>a</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">556-64-9</ENT> <ENT>Methyl Thiocyanate</ENT> <ENT/> <ENT>10,000</ENT> <ENT>10,000</ENT> </ROW> <ROW> <ENT I="01">558-25-8</ENT> <ENT>Methanesulfonyl Fluoride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">563-12-2</ENT> <ENT>Ethion</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">563-41-7</ENT> <ENT>Semicarbazide Hydrochloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">584-84-9</ENT> <ENT>Toluene 2,4-Diisocyanate</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">594-42-3</ENT> <ENT>Perchloromethylmercaptan</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">597-64-8</ENT> <ENT>Tetraethyltin</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">614-78-8</ENT> <ENT>Thiourea, (2-Methylphenyl)-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">624-83-9</ENT> <ENT>Methyl Isocyanate</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">627-11-2</ENT> <ENT>Chloroethyl Chloroformate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">630-60-4</ENT> <ENT>Ouabain</ENT> <ENT>b</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">639-58-7</ENT> <ENT>Triphenyltin Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">640-19-7</ENT> <ENT>Fluoroacetamide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">644-64-4</ENT> <ENT>Dimetilan</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">675-14-9</ENT> <ENT>Cyanuric Fluoride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">676-97-1</ENT> <ENT>Methyl Phosphonic Dichloride</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">696-28-6</ENT> <ENT>Phenyl Dichloroarsine</ENT> <ENT>d</ENT> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">760-93-0</ENT> <ENT>Methacrylic Anhydride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">786-19-6</ENT> <ENT>Carbophenothion</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">814-49-3</ENT> <ENT>Diethyl Chlorophosphate</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">814-68-6</ENT> <ENT>Acrylyl Chloride</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">824-11-3</ENT> <ENT>Trimethylolpropane Phosphite</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">900-95-8</ENT> <ENT>Stannane, Acetoxytriphenyl-</ENT> <ENT>c</ENT> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">919-86-8</ENT> <ENT>Demeton-S-Methyl</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">920-46-7</ENT> <ENT>Methacryloyl Chloride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">944-22-9</ENT> <ENT>Fonofos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">947-02-4</ENT> <ENT>Phosfolan</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">950-10-7</ENT> <ENT>Mephosfolan</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">950-37-8</ENT> <ENT>Methidathion</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">991-42-4</ENT> <ENT>Norbormide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">998-30-1</ENT> <ENT>Triethoxysilane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">999-81-5</ENT> <ENT>Chlormequat Chloride</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1031-47-6</ENT> <ENT>Triamiphos</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1066-45-1</ENT> <ENT>Trimethyltin Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1122-60-7</ENT> <ENT>Nitrocyclohexane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1124-33-0</ENT> <ENT>Pyridine, 4-Nitro-,1-Oxide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1129-41-5</ENT> <ENT>Metolcarb</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1303-28-2</ENT> <ENT>Arsenic Pentoxide</ENT> <ENT/> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1306-19-0</ENT> <ENT>Cadmium Oxide</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1314-62-1</ENT> <ENT>Vanadium Pentoxide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1314-84-7</ENT> <ENT>Zinc Phosphide</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1327-53-3</ENT> <ENT>Arsenous Oxide</ENT> <ENT>d</ENT> <ENT>1</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">1397-94-0</ENT> <ENT>Antimycin A</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">1420-07-1</ENT> <ENT>Dinoterb</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1464-53-5</ENT> <ENT>Diepoxybutane</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1558-25-4</ENT> <ENT>Trichloro(Chloromethyl)Silane</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">1563-66-2</ENT> <ENT>Carbofuran</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">1600-27-7</ENT> <ENT>Mercuric Acetate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">1622-32-8</ENT> <ENT>Ethanesulfonyl Chloride, 2-Chloro-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">1752-30-3</ENT> <ENT>Acetone Thiosemicarbazide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">1910-42-5</ENT> <ENT>Paraquat Dichloride</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">1982-47-4</ENT> <ENT>Chloroxuron</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2001-95-8</ENT> <ENT>Valinomycin</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">2032-65-7</ENT> <ENT>Methiocarb</ENT> <ENT/> <ENT>10</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2074-50-2</ENT> <ENT>Paraquat Methosulfate</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">2097-19-0</ENT> <ENT>Phenylsilatrane</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2104-64-5</ENT> <ENT>EPN</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2223-93-0</ENT> <ENT>Cadmium Stearate</ENT> <ENT>b</ENT> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">2231-57-4</ENT> <ENT>Thiocarbazide</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">2238-07-5</ENT> <ENT>Diglycidyl Ether</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">2275-18-5</ENT> <ENT>Prothoate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2497-07-6</ENT> <ENT>Oxydisulfoton</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2524-03-0</ENT> <ENT>Dimethyl Phosphorochloridothioate</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2540-82-1</ENT> <ENT>Formothion</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">2570-26-5</ENT> <ENT>Pentadecylamine</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2587-90-8</ENT> <ENT>Phosphorothioic Acid, O,O-Dimethyl-S-(2-Methylthio) Ethyl Ester</ENT> <ENT>b, c</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <PRTPAGE P="451"/> <ENT I="01">2631-37-0</ENT> <ENT>Promecarb</ENT> <ENT>d</ENT> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2636-26-2</ENT> <ENT>Cyanophos</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">2642-71-9</ENT> <ENT>Azinphos-Ethyl</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2665-30-7</ENT> <ENT>Phosphonothioic Acid, Methyl-, O-(4-Nitrophenyl) O-Phenyl Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2703-13-1</ENT> <ENT>Phosphonothioic Acid, Methyl-, O-Ethyl O-(4-(Methylthio)Phenyl) Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">2757-18-8</ENT> <ENT>Thallous Malonate</ENT> <ENT>b, d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">2763-96-4</ENT> <ENT>Muscimol</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">2778-04-3</ENT> <ENT>Endothion</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">3037-72-7</ENT> <ENT>Silane, (4-Aminobutyl)Diethoxymethyl-</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">3254-63-5</ENT> <ENT>Phosphoric Acid, Dimethyl 4-(Methylthio)Phenyl Ester</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3569-57-1</ENT> <ENT>Sulfoxide, 3-Chloropropyl Octyl</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3615-21-2</ENT> <ENT>Benzimidazole, 4,5-Dichloro-2-(Trifluoromethyl)-</ENT> <ENT>c</ENT> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">3689-24-5</ENT> <ENT>Sulfotep</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3691-35-8</ENT> <ENT>Chlorophacinone</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">3734-97-2</ENT> <ENT>Amiton Oxalate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">3735-23-7</ENT> <ENT>Methyl Phenkapton</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">3878-19-1</ENT> <ENT>Fuberidazole</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">4044-65-9</ENT> <ENT>Bitoscanate</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">4098-71-9</ENT> <ENT>Isophorone Diisocyanate</ENT> <ENT>g</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">4104-14-7</ENT> <ENT>Phosacetim</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">4170-30-3</ENT> <ENT>Crotonaldehyde</ENT> <ENT/> <ENT>100</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">4301-50-2</ENT> <ENT>Fluenetil</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">4418-66-0</ENT> <ENT>Phenol, 2,2′-Thiobis(4-Chloro-6-Methyl)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">4835-11-4</ENT> <ENT>Hexamethylenediamine, N,N′-Dibutyl-</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">5344-82-1</ENT> <ENT>Thiourea, (2-Chlorophenyl)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">5836-29-3</ENT> <ENT>Coumatetralyl</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">6533-73-9</ENT> <ENT>Thallous Carbonate</ENT> <ENT>b, d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">6923-22-4</ENT> <ENT>Monocrotophos</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">7446-09-5</ENT> <ENT>Sulfur Dioxide</ENT> <ENT>f</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7446-11-9</ENT> <ENT>Sulfur Trioxide</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7446-18-6</ENT> <ENT>Thallous Sulfate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7487-94-7</ENT> <ENT>Mercuric Chloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">7550-45-0</ENT> <ENT>Titanium Tetrachloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7580-67-8</ENT> <ENT>Lithium Hydride</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7631-89-2</ENT> <ENT>Sodium Arsenate</ENT> <ENT/> <ENT>1</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">7637-07-2</ENT> <ENT>Boron Trifluoride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7647-01-0</ENT> <ENT>Hydrogen Chloride (gas only)</ENT> <ENT>f</ENT> <ENT>5,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7664-39-3</ENT> <ENT>Hydrogen Fluoride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7664-41-7</ENT> <ENT>Ammonia</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7664-93-9</ENT> <ENT>Sulfuric Acid</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">7697-37-2</ENT> <ENT>Nitric Acid</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">7719-12-2</ENT> <ENT>Phosphorus Trichloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">7722-84-1</ENT> <ENT>Hydrogen Peroxide (Conc >52%)</ENT> <ENT>f</ENT> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">7723-14-0</ENT> <ENT>Phosphorus</ENT> <ENT>a, d</ENT> <ENT>1</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7726-95-6</ENT> <ENT>Bromine</ENT> <ENT>f</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7778-44-1</ENT> <ENT>Calcium Arsenate</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">7782-41-4</ENT> <ENT>Fluorine</ENT> <ENT>e</ENT> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7782-50-5</ENT> <ENT>Chlorine</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7783-00-8</ENT> <ENT>Selenious Acid</ENT> <ENT/> <ENT>10</ENT> <ENT>1,000/10,000</ENT> </ROW> <ROW> <ENT I="01">7783-06-4</ENT> <ENT>Hydrogen Sulfide</ENT> <ENT>f</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7783-07-5</ENT> <ENT>Hydrogen Selenide</ENT> <ENT/> <ENT>10</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">7783-60-0</ENT> <ENT>Sulfur Tetrafluoride</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7783-70-2</ENT> <ENT>Antimony Pentafluoride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7783-80-4</ENT> <ENT>Tellurium Hexafluoride</ENT> <ENT>e</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7784-34-1</ENT> <ENT>Arsenous Trichloride</ENT> <ENT/> <ENT>1</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7784-42-1</ENT> <ENT>Arsine</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">7784-46-5</ENT> <ENT>Sodium Arsenite</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">7786-34-7</ENT> <ENT>Mevinphos</ENT> <ENT/> <ENT>10</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7791-12-0</ENT> <ENT>Thallous Chloride</ENT> <ENT>b, d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">7791-23-3</ENT> <ENT>Selenium Oxychloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">7803-51-2</ENT> <ENT>Phosphine</ENT> <ENT/> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">8001-35-2</ENT> <ENT>Camphechlor</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">8065-48-3</ENT> <ENT>Demeton</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10025-73-7</ENT> <ENT>Chromic Chloride</ENT> <ENT/> <ENT>1</ENT> <ENT>1/10,000</ENT> </ROW> <ROW> <ENT I="01">10025-87-3</ENT> <ENT>Phosphorus Oxychloride</ENT> <ENT/> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10026-13-8</ENT> <ENT>Phosphorus Pentachloride</ENT> <ENT>a</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10028-15-6</ENT> <ENT>Ozone</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">10031-59-1</ENT> <ENT>Thallium Sulfate</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <PRTPAGE P="452"/> <ENT I="01">10102-18-8</ENT> <ENT>Sodium Selenite</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">10102-20-2</ENT> <ENT>Sodium Tellurite</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">10102-43-9</ENT> <ENT>Nitric Oxide</ENT> <ENT>b</ENT> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">10102-44-0</ENT> <ENT>Nitrogen Dioxide</ENT> <ENT/> <ENT>10</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">10124-50-2</ENT> <ENT>Potassium Arsenite</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">10140-87-1</ENT> <ENT>Ethanol, 1,2-Dichloro-, Acetate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">10210-68-1</ENT> <ENT>Cobalt Carbonyl</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">10265-92-6</ENT> <ENT>Methamidophos</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">10294-34-5</ENT> <ENT>Boron Trichloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">10311-84-9</ENT> <ENT>Dialifor</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">10476-95-6</ENT> <ENT>Methacrolein Diacetate</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">12002-03-8</ENT> <ENT>Paris Green</ENT> <ENT/> <ENT>1</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">12108-13-3</ENT> <ENT>Manganese, Tricarbonyl Methylcyclopentadienyl</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">13071-79-9</ENT> <ENT>Terbufosh</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">13171-21-6</ENT> <ENT>Phosphamidon</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">13194-48-4</ENT> <ENT>Ethoprophos</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">13410-01-0</ENT> <ENT>Sodium Selenate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">13450-90-3</ENT> <ENT>Gallium Trichloride</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">13463-39-3</ENT> <ENT>Nickel Carbonyl</ENT> <ENT/> <ENT>10</ENT> <ENT>1</ENT> </ROW> <ROW> <ENT I="01">13463-40-6</ENT> <ENT>Iron, Pentacarbonyl-</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">14167-18-1</ENT> <ENT>Salcomine</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">15271-41-7</ENT> <ENT>Bicyclo[2.2.1]Heptane-2-Carbonitrile, 5-Chloro-6-((((Methylamino)Carbonyl)Oxy)Imino)-, (1s-(1-alpha,2-beta,4-alpha,5-alpha,6E))-</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">16752-77-5</ENT> <ENT>Methomyl</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">17702-41-9</ENT> <ENT>Decaborane(14)</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">17702-57-7</ENT> <ENT>Formparanate</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">19287-45-7</ENT> <ENT>Diborane</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">19624-22-7</ENT> <ENT>Pentaborane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">20830-75-5</ENT> <ENT>Digoxin</ENT> <ENT>d</ENT> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">20859-73-8</ENT> <ENT>Aluminum Phosphide</ENT> <ENT>a</ENT> <ENT>100</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">21548-32-3</ENT> <ENT>Fosthietan</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">21609-90-5</ENT> <ENT>Leptophos</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">21908-53-2</ENT> <ENT>Mercuric Oxide</ENT> <ENT/> <ENT>500</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">21923-23-9</ENT> <ENT>Chlorthiophos</ENT> <ENT>d</ENT> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">22224-92-6</ENT> <ENT>Fenamiphos</ENT> <ENT/> <ENT>10</ENT> <ENT>10/10,000</ENT> </ROW> <ROW> <ENT I="01">23135-22-0</ENT> <ENT>Oxamyl</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">23422-53-9</ENT> <ENT>Formetanate Hydrochloride</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>500/10,000</ENT> </ROW> <ROW> <ENT I="01">23505-41-1</ENT> <ENT>Pirimifos-Ethyl</ENT> <ENT/> <ENT>1,000</ENT> <ENT>1,000</ENT> </ROW> <ROW> <ENT I="01">24017-47-8</ENT> <ENT>Triazofos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">24934-91-6</ENT> <ENT>Chlormephos</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">26419-73-8</ENT> <ENT>Carbamic Acid, Methyl-, O-(((2,4-Dimethyl-1, 3-Dithiolan-2-yl)Methylene)Amino)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">26628-22-8</ENT> <ENT> Sodium Azide (Na(N <E T="52">3</E> )) </ENT> <ENT>a</ENT> <ENT>1,000</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">27137-85-5</ENT> <ENT>Trichloro(Dichlorophenyl)Silane</ENT> <ENT/> <ENT>500</ENT> <ENT>500</ENT> </ROW> <ROW> <ENT I="01">28347-13-9</ENT> <ENT>Xylylene Dichloride</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">28772-56-7</ENT> <ENT>Bromadiolone</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">30674-80-7</ENT> <ENT>Methacryloyloxyethyl Isocyanateh</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">39196-18-4</ENT> <ENT>Thiofanox</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">50782-69-9</ENT> <ENT>Phosphonothioic Acid, Methyl-, S-(2-(Bis(1-Methylethyl)Amino)Ethyl) O-Ethyl Ester</ENT> <ENT/> <ENT>100</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">53558-25-1</ENT> <ENT>Pyriminil</ENT> <ENT>d</ENT> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">58270-08-9</ENT> <ENT>Zinc, Dichloro(4,4-Dimethyl-5((((Methylamino) Carbonyl)Oxy)Imino)Pentanenitrile)-, (T-4)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <ROW> <ENT I="01">62207-76-5</ENT> <ENT>Cobalt, ((2,2′-(1,2-Ethanediylbis (Nitrilomethylidyne)) Bis(6-Fluorophenolato)) (2-)-N,N′,O,O′)-</ENT> <ENT/> <ENT>100</ENT> <ENT>100/10,000</ENT> </ROW> <TNOTE> * Only the statutory or final RQ is shown. For more information, <E T="03">see</E> 40 CFR 355.61. </TNOTE> <TNOTE> <E T="02">Notes:</E> </TNOTE> <TNOTE>a. This material is a reactive solid. The TPQ does not default to 10,000 pounds for non-powder, non-molten, non-solution form.</TNOTE> <TNOTE>b. The calculated TPQ changed after technical review as described in a technical support document for the final rule, April 22, 1987.</TNOTE> <TNOTE>c. Chemicals added by final rule, April 22, 1987.</TNOTE> <TNOTE>d. Revised TPQ based on new or re-evaluated toxicity data, April 22, 1987.</TNOTE> <TNOTE>e. The TPQ was revised due to calculation error, April 22, 1987.</TNOTE> <TNOTE>f. Chemicals on the original list that do not meet toxicity criteria but because of their acute lethality, high production volume and known risk are considered chemicals of concern (“Other chemicals”). (November 17, 1986, and February 15, 1990.)</TNOTE> <TNOTE>g. The TPQ was recalculated (September 8, 2003) since it was mistakenly calculated in the April 22, 1987, final rule under the wrong assumption that this chemical is a reactive solid, when in fact it is a liquid. RQ for this chemical was adjusted on September 11, 2006.</TNOTE> </GPOTABLE> </APPENDIX> </SUBPART> </PART> <PART> <PRTPAGE P="453"/> <EAR>Pt. 370</EAR> <HD SOURCE="HED">PART 370—HAZARDOUS CHEMICAL REPORTING: COMMUNITY RIGHT-TO-KNOW</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Information</HD> <SECHD>Sec.</SECHD> <SECTNO>370.1</SECTNO> <SUBJECT>What is the purpose of this part?</SUBJECT> <SECTNO>370.2</SECTNO> <SUBJECT>Who do “you,” “I,” and “your” refer to in this part?</SUBJECT> <SECTNO>370.3</SECTNO> <SUBJECT>Which section contains the definitions of the key words used in this part?</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Who Must Comply</HD> <SECTNO>370.10</SECTNO> <SUBJECT>Who must comply with the hazardous chemical reporting requirements of this part?</SUBJECT> <SECTNO>370.11</SECTNO> <SUBJECT>[Reserved]</SUBJECT> <SECTNO>370.12</SECTNO> <SUBJECT>What hazardous chemicals must I report under this part?</SUBJECT> <SECTNO>370.13</SECTNO> <SUBJECT>What substances are exempt from these reporting requirements?</SUBJECT> <SECTNO>370.14</SECTNO> <SUBJECT>How do I report mixtures containing hazardous chemicals?</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Reporting Requirements</HD> <SECTNO>370.20</SECTNO> <SUBJECT>What are the reporting requirements of this part?</SUBJECT> <SUBJGRP> <HD SOURCE="HED">How to Comply With MSDS Reporting</HD> <SECTNO>370.30</SECTNO> <SUBJECT>What information must I provide and what format must I use?</SUBJECT> <SECTNO>370.31</SECTNO> <SUBJECT>Do I have to update the information?</SUBJECT> <SECTNO>370.32</SECTNO> <SUBJECT>To whom must I submit the information?</SUBJECT> <SECTNO>370.33</SECTNO> <SUBJECT>When must I submit the information?</SUBJECT> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How To Comply With Inventory Reporting</HD> <SECTNO>370.40</SECTNO> <SUBJECT>What information must I provide and what format must I use?</SUBJECT> <SECTNO>370.41</SECTNO> <SUBJECT>What is Tier I inventory information?</SUBJECT> <SECTNO>370.42</SECTNO> <SUBJECT>What is Tier II inventory information?</SUBJECT> <SECTNO>370.43</SECTNO> <SUBJECT>What codes are used to report Tier I and Tier II inventory information?</SUBJECT> <SECTNO>370.44</SECTNO> <SUBJECT>To whom must I submit the inventory information?</SUBJECT> <SECTNO>370.45</SECTNO> <SUBJECT>When must I submit the inventory information?</SUBJECT> </SUBJGRP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Community Access to Information</HD> <SECTNO>370.60</SECTNO> <SUBJECT>How does a person obtain MSDS information about a specific facility?</SUBJECT> <SECTNO>370.61</SECTNO> <SUBJECT>How does a person obtain inventory information about a specific facility?</SUBJECT> <SECTNO>370.62</SECTNO> <SUBJECT>What information may a State or local official request from a facility?</SUBJECT> <SECTNO>370.63</SECTNO> <SUBJECT>What responsibilities do the SERC and the LEPC have to make requested information available?</SUBJECT> <SECTNO>370.64</SECTNO> <SUBJECT>What information can I claim as trade secret or confidential?</SUBJECT> <SECTNO>370.65</SECTNO> <SUBJECT>Must I allow the local fire department to inspect my facility and must I provide specific location information about hazardous chemicals at my facility?</SUBJECT> <SECTNO>370.66</SECTNO> <SUBJECT>How are key words in this part defined?</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>Sections 302, 311, 312, 322, 324, 325, 327, 328, and 329 of the Emergency Planning and Community Right-To-Know Act of 1986 (EPCRA) (Pub. L. 99-499, 100 Stat. 1613, 42 U.S.C. 11002, 11021, 11022, 11042, 11044, 11045, 11047, 11048, and 11049).</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>73 FR 65478, Nov. 3, 2008, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Information</HD> <SECTION> <SECTNO>§ 370.1</SECTNO> <SUBJECT>What is the purpose of this part?</SUBJECT> <P>(a) This part (40 CFR part 370) establishes reporting requirements for providing the public with important information on the hazardous chemicals in their communities. Reporting raises community awareness of chemical hazards and aids in the development of State and local emergency response plans. The reporting requirements established under this part consist of Material Safety Data Sheet (MSDS) or Safety Data Sheet (SDS) reporting and inventory reporting.</P> <P>(b) This part is written in a special format to make it easier to understand the regulatory requirements. Like other Environmental Protection Agency (EPA) regulations, this part establishes enforceable legal requirements. Information considered non-binding guidance under EPCRA is indicated in this regulation by the word “note” and a smaller typeface. Such notes are provided for information purposes only and are not considered legally binding under this part.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.2</SECTNO> <SUBJECT>Who do “you,” “I,” and “your” refer to in this part?</SUBJECT> <P>Throughout this part, “you,” “I,” and “your” refer to the owner or operator of a facility.</P> </SECTION> <SECTION> <SECTNO>§ 370.3</SECTNO> <SUBJECT>Which section contains the definitions of the key words used in this part?</SUBJECT> <P> The definitions of key words used in this part are in § 370.66. It is important <PRTPAGE P="454"/> to read the definitions for key words because the definition explains the word's specific meaning in the regulations in this part. </P> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Who Must Comply</HD> <SECTION> <SECTNO>§ 370.10</SECTNO> <SUBJECT>Who must comply with the hazardous chemical reporting requirements of this part?</SUBJECT> <P>(a) You must comply with the reporting requirements of this part if the Occupational Safety and Health Administration's (OSHA) Hazard Communication Standard (HCS) require your facility to prepare or have available a Material Safety Data Sheet (MSDS) (or Safety Data Sheet (SDS)) for a hazardous chemical and if either of the following conditions is met:</P> <P>(1) A hazardous chemical that is an Extremely Hazardous Substance (EHS) is present at your facility at any one time in an amount equal to or greater than 500 pounds (227 kg—approximately 55 gallons) or the Threshold Planning Quantity (TPQ), whichever is lower. EHSs and their TPQs are listed in Appendices A and B of 40 CFR part 355.</P> <P>(2) A hazardous chemical that is not an EHS is present at your facility at any one time in an amount equal to or greater than the threshold level for that hazardous chemical. Threshold levels for such hazardous chemicals are:</P> <P>(i) For any hazardous chemical that does not meet the criteria in paragraph (a)(2)(ii) or (iii) of this section, the threshold level is 10,000 pounds (or 4,540 kg).</P> <P>(ii) For gasoline at a retail gas station (For purposes of this part, retail gas station means a retail facility engaged in selling gasoline and/or diesel fuel principally to the public, for motor vehicle use on land.), the threshold level is 75,000 gallons (approximately 283,900 liters) (all grades combined). This threshold is only applicable for gasoline that was in tank(s) entirely underground and was in compliance at all times during the preceding calendar year with all applicable Underground Storage Tank (UST) requirements at 40 CFR part 280 or requirements of the state UST program approved by the Agency under 40 CFR part 281.</P> <P>(iii) For diesel fuel at a retail gas station (For purposes of this part, retail gas station means a retail facility engaged in selling gasoline and/or diesel fuel principally to the public, for motor vehicle use on land.), the threshold level is 100,000 gallons (approximately 378,500 liters) (all grades combined). This threshold is only applicable for diesel fuel that was in tank(s) entirely underground and was in compliance at all times during the preceding calendar year with all applicable Underground Storage Tank (UST) requirements at 40 CFR part 280 or requirements of the state UST program approved by the Agency under 40 CFR part 281.</P> <P>(b) The threshold level for responding to the following requests is zero.</P> <P>(1) If your LEPC requests that you submit an MSDS (or SDS) for a hazardous chemical for which you have not submitted an MSDS (or SDS) to your LEPC; or</P> <P>(2) If your LEPC, SERC, or the fire department with jurisdiction over your facility requests that you submit Tier II information.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.11</SECTNO> <RESERVED>[Reserved]</RESERVED> </SECTION> <SECTION> <SECTNO>§ 370.12</SECTNO> <SUBJECT>What hazardous chemicals must I report under this part?</SUBJECT> <P>(a) You must report any hazardous chemical for which you are required to prepare or have available an MSDS (or SDS) under OSHA HCS that is present at your facility equal to or above the applicable threshold specified in § 370.10. (Specific exemptions from reporting are in § 370.13.)</P> <P>(b) The EPA has not issued a list of hazardous chemicals subject to reporting under this part. A substance is a hazardous chemical if it is required to have an MSDS (or SDS) and meets the definition of hazardous chemical under the OSHA regulations found at 29 CFR 1910.1200(c).</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.13</SECTNO> <SUBJECT>What substances are exempt from these reporting requirements?</SUBJECT> <P> You do not have to report substances for which you are not required to have <PRTPAGE P="455"/> an MSDS (or SDS) under the OSHA regulations, or that are excluded from the definition of hazardous chemical under EPCRA section 311(e). Each of the following substances are excluded under EPCRA section 311(e): </P> <P>(a) Any food, food additive, color additive, drug, or cosmetic regulated by the Food and Drug Administration.</P> <P>(b) Any substance present as a solid in any manufactured item to the extent exposure to the substance does not occur under normal conditions of use.</P> <P>(c) Any substance to the extent it is used:</P> <P>(1) For personal, family, or household purposes, or is present in the same form and concentration as a product packaged for distribution and use by the general public. Present in the same form and concentration as a product packaged for distribution and use by the general public means a substance packaged in a similar manner and present in the same concentration as the substance when packaged for use by the general public, whether or not it is intended for distribution to the general public or used for the same purpose as when it is packaged for use by the general public;</P> <P>(2) In a research laboratory or hospital or other medical facility under the direct supervision of a technically qualified individual; or</P> <P>(3) In routine agricultural operations or is a fertilizer held for sale by a retailer to the ultimate customer.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.14</SECTNO> <SUBJECT>How do I report mixtures containing hazardous chemicals?</SUBJECT> <P>(a) For a mixture containing a hazardous chemical, use the following table to determine if a reporting threshold is equaled or exceeded, and to determine how to report:</P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s50,xl100,r100"> <BOXHD> <CHED H="1">If your mixture contains a hazardous chemical</CHED> <CHED H="1">To determine if the threshold level for that hazardous chemical is equaled or exceeded you must</CHED> <CHED H="1">If the threshold level for that hazardous chemical is exceeded then you must</CHED> </BOXHD> <ROW> <ENT I="01">(1) That is an EHS</ENT> <ENT>Determine the total quantity of the EHS present throughout your facility at any one time, by adding together the quantity present as a component in all mixtures and all other quantities of the EHS (you must include the quantity present in a mixture even if you are also counting the quantity of that particular mixture toward the threshold level for that mixture).</ENT> <ENT>Report the EHS component—submit an MSDS (or SDS) for the EHS (or include the EHS on the list of chemicals submitted in lieu of the MSDSs) (or SDSs), as provided under § 370.30, and submit Tier I (or Tier II) information for the EHS, as provided under § 370.40 or report the mixture itself—submit an MSDS (or SDS) for the mixture (or include the mixture on the list of chemicals submitted in lieu of the MSDSs) (or SDSs), as provided under § 370.30, and submit Tier I (or Tier II) information for the mixture, as provided under § 370.40.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT>If you report the mixture itself, then provide the total quantity of that mixture.</ENT> </ROW> <ROW> <ENT I="01">(2) That is not an EHS</ENT> <ENT>Determine either: The total quantity of the hazardous chemical present throughout your facility at any one time by adding together the quantity present as a component in all mixtures and all other quantities of the hazardous chemical (you must include the quantity present in a mixture even if you are also applying that particular mixture as a whole toward the threshold level for that mixture) or the total quantity of that mixture present throughout your facility at any one time.</ENT> <ENT>Report the non-EHS hazardous chemical component—submit an MSDS (or SDS) for the non-EHS hazardous chemical (or include the non-EHS on the list of chemicals submitted in lieu of the MSDSs) (or SDSs), as provided under § 370.30, and submit Tier I (or Tier II) information for the non-EHS hazardous chemical as provided under § 370.40 or report the mixture itself—submit an MSDS (or SDS) for the mixture (or include the mixture on the list of chemicals submitted in lieu of MSDSs) (or SDSs), as provided under § 370.30, and submit Tier I (or Tier II) information for the mixture, as provided under § 370.40.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT O="xl"/> <ENT>If you report the mixture itself, then provide the total quantity of that mixture.</ENT> </ROW> </GPOTABLE> <P> (b) For each specific mixture, the reporting option used must be consistent for both MSDS (or SDS) and inventory reporting, unless it is not possible to do so. This means that if you report on a specific mixture as a whole for MSDS (or SDS) reporting, you must report on that mixture as a whole for inventory <PRTPAGE P="456"/> reporting too (unless it is not possible). MSDS (or SDS) reporting and inventory reporting are discussed in detail in subpart C of this part. </P> <P>(c) To determine the quantity of an EHS or a non-EHS hazardous chemical component present in a mixture, multiply the concentration of the hazardous chemical component (in weight percent) by the weight of the mixture (in pounds). You do not have to count a hazardous chemical present in a mixture if the concentration is less than or equal to 1%, or less than or equal to 0.1% for a carcinogenic chemical.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Reporting Requirements</HD> <SECTION> <SECTNO>§ 370.20</SECTNO> <SUBJECT>What are the reporting requirements of this part?</SUBJECT> <P>The reporting requirements of this part consist of MSDS (or SDS) reporting and inventory reporting. If you are the owner or operator of a facility subject to the reporting requirements of this part then you must comply with both types of reporting requirements. MSDS (or SDS) reporting requirements are addressed in §§ 370.30 through 370.33. Inventory reporting requirements are addressed in §§ 370.40 through 370.45.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SUBJGRP> <HD SOURCE="HED">How to Comply With MSDS (or SDS) Reporting</HD> <SECTION> <SECTNO>§ 370.30</SECTNO> <SUBJECT>What information must I provide and what format must I use?</SUBJECT> <P>(a) You must report the hazardous chemicals present at your facility that meet or exceed the applicable threshold levels (threshold levels are in § 370.10) by either:</P> <P>(1) Submitting an MSDS (or SDS) for each hazardous chemical present at your facility that meet or exceed its applicable threshold level; or</P> <P>(2) Submitting a list of all hazardous chemicals present at your facility at or above the applicable threshold levels. The hazardous chemicals on your list must be grouped by the specific health and physical hazards as defined in § 370.66. The list must contain the chemical or common name of each hazardous chemical as provided on the MSDS (or SDS).</P> <P>(b) Within 30 days of a request by the LEPC (as provided in § 370.10(b)), you must also submit an MSDS (or SDS) for any hazardous chemical present at your facility for which you have not submitted an MSDS (or SDS).</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38109, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.31</SECTNO> <SUBJECT>Do I have to update the information?</SUBJECT> <P>MSDS (or SDS) reporting stated in § 370.30 is a one-time requirement. However, you must update the information in all of the following ways:</P> <P>(a) Submit a revised MSDS (or SDS) after you discover significant new information concerning a hazardous chemical for which an MSDS (or SDS) was submitted.</P> <P>(b) Submit an MSDS (or SDS), or a list as described in § 370.30(a), for any new hazardous chemical for which you become subject to these reporting requirements.</P> <P>(c) Submit, as requested by the LEPC, an MSDS (or SDS) for any hazardous chemical present at your facility which you have not already submitted, as provided in § 370.30(b).</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.32</SECTNO> <SUBJECT>To whom must I submit the information?</SUBJECT> <P>(a) You must submit an MSDS (or SDS) or list, as provided in § 370.30(a), to the LEPC, the SERC, and the fire department with jurisdiction over your facility.</P> <P>(b) You must submit an MSDS (or SDS) requested by the LEPC, as provided in § 370.30(b), to the LEPC.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.33</SECTNO> <SUBJECT>When must I submit the information?</SUBJECT> <P> (a) You must submit an MSDS (or SDS) or a list, as provided in § 370.30(a), for a hazardous chemical subject to the reporting requirements of this part by October 17, 1987, or within 3 months after you first become subject to the <PRTPAGE P="457"/> reporting requirements of this part (as provided in §§ 370.30 and 370.31(b)). </P> <P>(b) You must submit a revised MSDS (or SDS), as provided in § 370.31(a), within 3 months after discovering significant new information about a hazardous chemical for which an MSDS(or SDS) was submitted.</P> <P>(c) You must submit an MSDS (or SDS) requested by the LEPC, as provided in §§ 370.30(b) and 370.31(c), within 30 days of receiving the request.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> </SUBJGRP> <SUBJGRP> <HD SOURCE="HED">How to Comply With Inventory Reporting</HD> <SECTION> <SECTNO>§ 370.40</SECTNO> <SUBJECT>What information must I provide and what format must I use?</SUBJECT> <P>(a) If you are required to comply with the hazardous chemical reporting requirements of this part, then by March 1 every year you must submit inventory information regarding any hazardous chemical present at your facility at any time during the previous calendar year in an amount equal to or in excess of its threshold level. Threshold levels are provided in § 370.10.</P> <P> (b) Tier I information is the minimum information that you must report to be in compliance with the inventory reporting requirements of this part as described in § 370.41. You may choose to report the Tier II information described in § 370.42 for any hazardous chemical at your facility. You must submit Tier II information to the SERC, LEPC, or fire department having jurisdiction over your facility if they request it. EPA publishes Tier I and Tier II Inventory Forms that provide uniform formats for reporting the Tier I and Tier II information. You may use a State or local format for reporting inventory information if the State or local format contains at least the Tier I information described in § 370.41. EPA's Tier I and Tier II forms are available at <E T="03">http://www.epa.gov/epcra</E> . </P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">b</E> ): </HD> <P>Some States require Tier II information annually under State law.</P> </NOTE> <P>(c) You should contact the SERC to determine that State's requirements for inventory reporting formats, procedures, and to obtain inventory forms.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108 38109, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.41</SECTNO> <SUBJECT>What is Tier I inventory information?</SUBJECT> <P>Tier I information provides State and local officials and the public with information on the general types and locations of hazardous chemicals present at your facility during the previous calendar year. The Tier I information is the minimum information that you must provide to be in compliance with the inventory reporting requirements of this part. If you are reporting Tier I information, you must report aggregate information on hazardous chemicals by hazard categories. The hazard categories (physical and health hazards) are defined in § 370.66. Tier I inventory form includes the following data elements:</P> <P>(a) Certification. The owner or operator or the officially designated representative of the owner or operator must certify that all information included in the Tier I submission is true, accurate, and complete as follows: “I certify under penalty of law that I have personally examined and am familiar with the information and that based on my inquiry of those individuals responsible for obtaining the information, I believe that the submitted information is true, accurate, and complete.” This certification shall be accompanied by your full name, official title, signature, date signed, and total number of pages in the submission including all attachments. All other pages must also contain your signature or signature stamp, the date you signed the certification, and the total number of pages in the submission.</P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">a</E> ): </HD> <P>Some states require electronic reporting (on-line or via diskettes) and electronic certification. Contact your state for the specific requirements in that state.</P> </NOTE> <P>(b) The calendar year for the reporting period.</P> <P> (c) An indication whether the information being reported on page one of the form is identical to that submitted last year. <PRTPAGE P="458"/> </P> <P>(d) The complete name and address of the location of your facility (include the full street address or state road, city, county, State and zip code), latitude and longitude.</P> <P>(e) An indication if the location of your facility is manned or unmanned.</P> <P>(f) An estimate of the maximum number of occupants present at any one time. If the location of your facility is unmanned, check the box marked N/A, not applicable.</P> <P>(g) The phone number of your facility (optional).</P> <P>(h) The North American Industry Classification System (NAICS) code for your facility.</P> <P>(i) The Dun & Bradstreet number of your facility.</P> <P>(j) Facility identification numbers assigned under the Toxic Release Inventory (TRI) and Risk Management Program. If your facility has not been assigned an identification number under these programs or if your facility is not subject to reporting under these programs, check the box marked N/A, not applicable.</P> <P>(k) An indication whether your facility is subject to the emergency planning notification requirement under EPCRA section 302, codified in 40 CFR part 355.</P> <P>(l) An indication whether your facility is subject to the chemical accident prevention requirements under Section 112(r) of the Clean Air Act, codified in 40 CFR part 68, also known as the Risk Management Program.</P> <P>(m) The name, mailing address, phone number and email address of the owner or operator of the facility.</P> <P>(n) The name, mailing address, phone number, Dun & Bradstreet number and email address of the facility's parent company. These are optional data elements.</P> <P>(o) The name, title, phone number, 24-hour phone number, and email address of the facility emergency coordinator, if applicable.</P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">o</E> ): </HD> <P>EPCRA Section 303(d)(1) requires facilities subject to the emergency planning notification requirement under EPCRA section 302 (including additional facilities designated by the Governor or the SERC under EPCRA section 302(b)(2)) to designate a facility representative who will participate in the local emergency planning process as a facility emergency coordinator. EPA encourages facilities not subject to the emergency planning notification requirement also to provide this information, if available, for effective emergency planning in your community.</P> </NOTE> <P>(p) The name, title, phone number, and email address of the person to contact for the information contained in the Tier I form.</P> <P>(q) The name, title, phone number and email address of at least one local individual that can act as a referral if emergency responders need assistance in responding to a chemical accident at your facility. You must also provide an emergency phone number which will be available 24 hours a day, every day.</P> <P>(r) An indication whether the information being reported on page two of the form is identical to that submitted last year.</P> <P>(s) An estimate (in ranges) of the maximum amount of hazardous chemicals in each hazard category present at your facility at any time during the preceding calendar year. You must use codes that correspond to different ranges. The range codes are provided in § 370.43.</P> <P>(t) An estimate (in ranges) of the average daily amount of hazardous chemicals in each hazard category present at your facility during the preceding calendar year. You must use codes that correspond to different ranges. The range codes are provided in § 370.43.</P> <P>(u) The maximum number of days that any single hazardous chemical within each hazard category was present at your facility during the reporting period.</P> <P>(v) The general location of hazardous chemicals in each hazard category within your facility. General locations should include the names or identification of buildings, tank fields, lots, sheds or other such areas. You may also attach one or more of the following with your Tier I inventory form:</P> <P> (1) A <E T="03">site plan</E> with site indicated for buildings, lots, areas, etc. throughout your facility. </P> <P> (2) A <E T="03">list of site coordinate abbreviations</E> that correspond to buildings, lots, areas, etc., throughout your facility. <PRTPAGE P="459"/> </P> <P> (3) A <E T="03">description of dikes and other safeguard measures</E> for storage locations throughout your facility. </P> <P>(w) An indication whether you are including any attachments (optional).</P> <CITA>[77 FR 41313, July 13, 2012, as amended at 81 FR 38109, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.42</SECTNO> <SUBJECT>What is Tier II inventory information?</SUBJECT> <P>Tier II information provides State and local officials and the public with specific information on the amounts and locations of hazardous chemicals present at your facility during the previous calendar year. Some states may require you to use a state reporting format including electronic reporting and certification for submitting your hazardous chemical inventory. Contact your state for the specific requirements in that state. Tier II inventory form includes the following data elements:</P> <P>(a) Certification. The owner or operator or the officially designated representative of the owner or operator must certify that all information included in the Tier II submission is true, accurate, and complete as follows: “I certify under penalty of law that I have personally examined and am familiar with the information and that based on my inquiry of those individuals responsible for obtaining the information, I believe that the submitted information is true, accurate, and complete.” This certification must be accompanied by your full name, official title, signature, date signed, and total number of pages in the submission including all Confidential and Non-Confidential Information Sheets and all attachments. All other pages must also contain your signature or signature stamp, the date you signed the certification, and the total number of pages in the submission.</P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">a</E> ): </HD> <P>Some states require electronic reporting (on-line or via diskettes) and electronic certification. Contact your state for the specific requirements in that state.</P> </NOTE> <P>(b) The calendar year of the reporting period.</P> <P>(c) An indication whether the information being reported on page one of the form is identical to that submitted last year.</P> <P>(d) The complete name and address of the location of your facility (include the full street address or state road, city, county, State and zip code), latitude and longitude.</P> <P>(e) An indication if the location of your facility is manned or unmanned.</P> <P>(f) An estimate of the maximum number of occupants present at any one time. If the location of your facility is unmanned, check the box marked N/A, not applicable.</P> <P>(g) The phone number of your facility (optional).</P> <P>(h) The North American Industry Classification System (NAICS) code for your facility.</P> <P>(i) The Dun & Bradstreet number of your facility.</P> <P>(j) Facility identification numbers assigned under the Toxic Release Inventory (TRI) and Risk Management Program. If your facility has not been assigned an identification number under these programs or if your facility is not subject to reporting under these programs, check the box marked N/A, not applicable.</P> <P>(k) An indication if your facility is subject to the emergency planning notification requirement under section 302 of EPCRA, codified in 40 CFR part 355.</P> <P>(l) An indication whether your facility is subject to the chemical accident prevention requirements under section 112(r) of the Clean Air Act (CAA), codified in 40 CFR part 68, Chemical Accident Prevention Provisions, also known as the Risk Management Program.</P> <P>(m) The name, mailing address, phone number and email address of the owner or operator of the facility.</P> <P>(n) The name, mailing address, phone number, Dun & Bradstreet number and email address of the facility's parent company. These are optional data elements.</P> <P>(o) The name, title, phone number, 24-hour phone number and email address of the facility emergency coordinator, if applicable.</P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">o</E> ): </HD> <P> Section 303(d)(1) of EPCRA requires facilities subject to the <PRTPAGE P="460"/> emergency planning notification requirement (including additional facilities designated by the Governor or the SERC under EPCRA section 302(b)(2)) to designate a facility representative who will participate in the local emergency planning process as a facility emergency coordinator. EPA encourages facilities not subject to the emergency planning notification requirement also to provide <E T="03">this information, if available, for effective emergency planning in your community.</E> </P> </NOTE> <P>(p) The name, title, phone number and email address of the person to contact regarding information contained in the Tier II form.</P> <P>(q) The name, title, phone number and email address of at least one local individual that can act as a referral if emergency responders need assistance in responding to a chemical accident at your facility. You must also provide an emergency phone number which will be available 24 hours a day, every day.</P> <P>(r) An indication whether the information being reported on page two of the form is identical to that submitted last year.</P> <P>(s) For each hazardous chemical that you are required to report, you must:</P> <P> (1) <E T="03">Pure Chemical:</E> Provide the chemical name (or the common name of the chemical) as provided on the Material Safety Data Sheet (MSDS) (or Safety Data Sheet (SDS)) and provide the Chemical Abstract Service (CAS) registry number of the chemical provided on the MSDS (or SDS). </P> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">s</E> )(1): </HD> <P>If you are withholding the name in accordance with trade secret criteria, you must provide the generic class or category that is structurally descriptive of the chemical and indicate that the name is withheld because of trade secrecy. Trade secret criteria are addressed in § 370.64(a).</P> </NOTE> <P>(2) Indicate whether the chemical is a solid, liquid, or gas; and whether the chemical is an EHS.</P> <P> (3) <E T="03">Mixture.</E> If you are reporting a mixture, enter the mixture name, product name or trade name as provided on the Material Safety Data Sheet (MSDS) (or Safety Data Sheet (SDS)) and provide the Chemical Abstract Service (CAS) registry number of the mixture provided on the MSDS (or SDS). If there is no CAS number provided or it is not known, check the box “Not Available.” </P> <P>(4) If the mixture you are reporting contains EHS(s), provide the name(s) of each EHS in the mixture. As provided in § 370.14(a), you also have an option to report the non-EHS hazardous components in the mixture.</P> <P> (5) <E T="03">Pure Chemical or Mixture:</E> Indicate which hazard categories (or hazard classes) apply to the chemical or the mixture. The hazard categories (or physical and health hazards) are defined in § 370.66. </P> <P>(6) Provide an estimate (in ranges) of the maximum amount of the hazardous chemical present at your facility on any single day during the preceding calendar year. If you are reporting a mixture, provide an estimate of the total amount of the mixture present at your facility on any single day during the preceding calendar year. If the mixture contains any EHS, provide the total amount of each EHS in that mixture. You must use the codes that correspond to different ranges. The amounts and associated range codes are in § 370.43.</P> <P>(7) Provide an estimate (in ranges) of the average daily amount of the hazardous chemical present at your facility during the preceding calendar year. If you are reporting a mixture, provide an estimate of the average daily amount of the mixture. You must use the codes that correspond to different ranges. The amounts and associated range codes are in § 370.43.</P> <P>(8) Provide the maximum number of days that the hazardous chemical or mixture was present at your facility during the preceding calendar year.</P> <P>(9) Provide the type of storage for the hazardous chemical or the mixture containing the hazardous chemical at your facility. Examples for types of storage: Above-ground tank, plastic or non-metallic drum, steel drum, cylinder, rail car, etc.</P> <P>(10) Provide the storage conditions for the hazardous chemical or the mixture containing the hazardous chemical at your facility. Examples for types of storage conditions: Ambient pressure, ambient temperature, less than ambient temperature/pressure, cryogenic conditions, etc.</P> <NOTE> <PRTPAGE P="461"/> <HD SOURCE="HED"> Note to paragraphs ( <E T="01">s</E> )(9) and (10): </HD> <P>Your SERC or LEPC may have specific instructions for reporting types of storage and/or storage conditions.</P> </NOTE> <P>(11) Provide a brief description of the precise location(s) of the hazardous chemical(s) or the mixture(s) at your facility. You may also attach one of the following with your Tier II inventory form:</P> <P> (i) A <E T="03">site plan</E> with site coordinates indicated for buildings, lots, areas, etc. throughout your facility. </P> <P> (ii) A <E T="03">list of site coordinate abbreviations</E> that correspond to buildings, lots, areas, etc., throughout your facility. </P> <P> (iii) A <E T="03">description of dikes and other safeguard measures</E> for storage locations throughout your facility. </P> <P>(12) Under EPCRA section 324, you may choose to withhold from disclosure to the public the location information for a specific chemical. If you choose to withhold the location information from disclosure to the public, you must clearly indicate that the information is “confidential.” You must provide the confidential location information on a separate sheet from the other Tier II information (which will be disclosed to the public), and attach the Confidential Location Information Sheet to the other Tier II information. Indicate any attachments you are including.</P> <P>(13) You may provide additional reporting. For example, if your State or local agencies require you to provide inventory information on additional chemicals or if you wish to report any hazardous chemical below the reporting thresholds specified in § 370.10, check the appropriate box.</P> <P>(t) An indication whether you are including any attachments (optional).</P> <CITA>[77 FR 41314, July 13, 2012, as amended at 81 FR 38109, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.43</SECTNO> <SUBJECT>What codes are used to report Tier I and Tier II inventory information?</SUBJECT> <P> (a) <E T="03">Weight range codes.</E> Except as provided in paragraph (b) of this section, you must use the following codes to report the maximum amount and average daily amount when reporting Tier I or Tier II inventory information: </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s25,11,11"> <BOXHD> <CHED H="1">Range codes</CHED> <CHED H="1">Weight range in pounds</CHED> <CHED H="2">From</CHED> <CHED H="2">To</CHED> </BOXHD> <ROW> <ENT I="01">01</ENT> <ENT>0</ENT> <ENT>99</ENT> </ROW> <ROW> <ENT I="01">02</ENT> <ENT>100</ENT> <ENT>499</ENT> </ROW> <ROW> <ENT I="01">03</ENT> <ENT>500</ENT> <ENT>999</ENT> </ROW> <ROW> <ENT I="01">04</ENT> <ENT>1,000</ENT> <ENT>4,999</ENT> </ROW> <ROW> <ENT I="01">05</ENT> <ENT>5,000</ENT> <ENT>9,999</ENT> </ROW> <ROW> <ENT I="01">06</ENT> <ENT>10,000</ENT> <ENT>24,999</ENT> </ROW> <ROW> <ENT I="01">07</ENT> <ENT>25,000</ENT> <ENT>49,999</ENT> </ROW> <ROW> <ENT I="01">08</ENT> <ENT>50,000</ENT> <ENT>74,999</ENT> </ROW> <ROW> <ENT I="01">09</ENT> <ENT>75,000</ENT> <ENT>99,999</ENT> </ROW> <ROW> <ENT I="01">10</ENT> <ENT>100,000</ENT> <ENT>499,999</ENT> </ROW> <ROW> <ENT I="01">11</ENT> <ENT>500,000</ENT> <ENT>999,999</ENT> </ROW> <ROW> <ENT I="01">12</ENT> <ENT>1,000,000</ENT> <ENT>9,999,999</ENT> </ROW> <ROW> <ENT I="01">13</ENT> <ENT>10,000,000</ENT> <ENT>(*)</ENT> </ROW> <TNOTE>* Greater than 10 million</TNOTE> </GPOTABLE> <NOTE> <HD SOURCE="HED"> Note to paragraph ( <E T="01">a</E> ): </HD> <P>To convert gas or liquid volume to weight in pounds, multiply by an appropriate density factor.</P> </NOTE> <P>(b) Your SERC or LEPC may provide other range codes for reporting maximum amount and average daily amount, or may require reporting of specific amounts. You may use your SERC's or LEPC's range codes (or specific amounts) provided the ranges are not broader than the ranges in paragraph (a) of this section.</P> <CITA>[77 FR 41315, July 13, 2012]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.44</SECTNO> <SUBJECT>To whom must I submit the inventory information?</SUBJECT> <P>You must submit the required inventory information to your SERC, LEPC, and fire department with jurisdiction over your facility.</P> </SECTION> <SECTION> <SECTNO>§ 370.45</SECTNO> <SUBJECT>When must I submit the inventory information?</SUBJECT> <P>(a) You must submit the required inventory information on or before March 1 (beginning in 1988 or beginning after your facility first becomes subject to this part), and on or before by March 1 of each year afterwards. Your submission must contain the required inventory information on hazardous chemicals present at your facility during the preceding calendar year at or above the threshold levels. Threshold levels are in § 370.10. The minimum required inventory information under EPCRA section 312 is Tier I information. Tier I information requirements are described in § 370.41.</P> <P> (b) You must submit Tier II information within 30 days of the receipt of a request from the SERC, LEPC, or the fire department having jurisdiction over your facility, as provided in <PRTPAGE P="462"/> § 370.10(b). Tier II information requirements are described in § 370.42. </P> </SECTION> </SUBJGRP> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Community Access to Information</HD> <SECTION> <SECTNO>§ 370.60</SECTNO> <SUBJECT>How does a person obtain MSDS (or SDS) information about a specific facility?</SUBJECT> <P>Any person may obtain an MSDS (or SDS) for a specific facility by writing to the LEPC and asking for it.</P> <P>(a) If the LEPC has the MSDS, (or SDS) it must provide it to the person making the request.</P> <P>(b) If the LEPC does not have the MSDS (or SDS), (or (SDS) it must request the MSDS (or SDS) from the facility's owner or operator.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.61</SECTNO> <SUBJECT>How does a person obtain inventory information about a specific facility?</SUBJECT> <P>(a) Any person may request Tier II information for a specific facility by writing to the SERC or the LEPC and asking for such information.</P> <P>(1) If the SERC or LEPC has the Tier II information, the SERC or LEPC must provide it to the person making the request.</P> <P>(2) If the SERC or LEPC does not have the Tier II information, it must request it from the facility owner or operator in either of the following cases:</P> <P>(i) The person making the request is a State or local official acting in his or her official capacity.</P> <P>(ii) The request is for hazardous chemicals in amounts greater than 10,000 pounds stored at the facility at any time during the previous calendar year.</P> <P>(3) If the SERC or LEPC does not have the Tier II information, it may request it from the facility owner or operator when neither condition in paragraph (a)(2) of this section is met, but the person's request includes a general statement of need.</P> <P>(b) A SERC or LEPC must respond to a request for Tier II information under this section within 45 days of receiving such a request.</P> </SECTION> <SECTION> <SECTNO>§ 370.62</SECTNO> <SUBJECT>What information may a State or local official request from a facility?</SUBJECT> <P>The LEPC may ask a facility owner or operator to submit an MSDS (or SDS) for a hazardous chemical present at the facility. The SERC, LEPC, or fire department having jurisdiction over a facility may ask a facility owner or operator to submit Tier II information. The owner or operator must provide the MSDS (or SDS) (unless the owner or operator has already submitted an MSDS (or SDS) to the LEPC for that hazardous chemical) or Tier II information within 30 days of receipt of such request.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.63</SECTNO> <SUBJECT>What responsibilities do the SERC and the LEPC have to make request information available?</SUBJECT> <P>Under this subpart, the SERC or LEPC must make the following information (except for confidential location information discussed in § 370.64(b)) available if a person requests it:</P> <P>(a) All information obtained from an owner or operator in response to a request under this subpart.</P> <P>(b) Any requested Tier II information or MSDS (or SDS) otherwise in possession of the SERC or the LEPC.</P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.64</SECTNO> <SUBJECT>What information can I claim as trade secret or confidential?</SUBJECT> <P> (a) <E T="03">Trade secrets.</E> You may be able to withhold the name of a specific chemical when submitting MSDS (or SDS) reporting or inventory reporting information if that chemical name is claimed as a trade secret. The requirements for withholding trade secret information are set forth in EPCRA section 322 and implemented in 40 CFR part 350. If you are withholding the name of a specific chemical as a trade secret in accordance with trade secrecy requirements, you must report the generic class or category that is structurally descriptive of the chemical <PRTPAGE P="463"/> along with all other required information. You must also submit the withheld information to EPA and must adequately substantiate your claim. A Form for substantiating trade secret claims is available at the Agency Web site at <E T="03">http://www.epa.gov/epcra</E> . </P> <P> (b) <E T="03">Confidential location information.</E> You may request that the SERC or the LEPC not disclose to the public the location of any specific chemical required to be submitted in Tier II information. If you make such a request, the SERC or LEPC must not disclose the location of the specific chemical. If you use the Tier II Form to report your inventory information, you can choose to report confidential location information for a specific chemical on the Confidential Location Information Sheet, which must be attached to the other Tier II information you are reporting. Although you may request that location information with respect to a specific chemical be withheld from the public, you may not withhold this information from the SERC, the LEPC, or the local fire department. The Confidential Location Information Sheet is available on the Agency Web site at <E T="03">http://www.epa.gov/epcra</E> . </P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, 38109, June 13, 2016]</CITA> </SECTION> <SECTION> <SECTNO>§ 370.65</SECTNO> <SUBJECT>Must I allow the local fire department to inspect my facility and must I provide specific location information about hazardous chemicals at my facility?</SUBJECT> <P>If you are the owner or operator of a facility that has submitted inventory information under this part, you must comply with the following two requirements upon request by the fire department with jurisdiction over your facility:</P> <P>(a) You must allow the fire department to conduct an on-site inspection of your facility; and</P> <P>(b) You must provide the fire department with information about the specific locations of hazardous chemicals at your facility.</P> </SECTION> <SECTION> <SECTNO>§ 370.66</SECTNO> <SUBJECT>How are key words in this part defined?</SUBJECT> <P> <E T="03">Chief Executive Officer of the Tribe</E> means the person who is recognized by the Bureau of Indian Affairs as the chief elected administrative officer of the Tribe. </P> <P> <E T="03">Environment</E> includes water, air, and land and the interrelationship that exists among and between water, air, and land and all living things. </P> <P> <E T="03">EPCRA</E> means the Emergency Planning and Community Right-To-Know Act of 1986. </P> <P> <E T="03">Extremely hazardous substance (EHS)</E> means a substance listed in appendices A and B of 40 CFR part 355. </P> <P> <E T="03">Facility</E> means all buildings, equipment, structures, and other stationary items that are located on a single site or on contiguous or adjacent sites and that are owned or operated by the same person (or by any person that controls, is controlled by, or under common control with, such person). </P> <P> <E T="03">Facility</E> includes manmade structures, as well as all natural structures in which chemicals are purposefully placed or removed through human means such that it functions as a containment structure for human use. </P> <P> <E T="03">Hazard category</E> is divided into two categories, health and physical hazards. </P> <P>(1) Health hazard means a chemical which poses one of the following hazardous effects: Carcinogenicity; acute toxicity (any route of exposure); aspiration hazard; reproductive toxicity; germ cell mutagenicity; skin corrosion or irritation; respiratory or skin sensitization; serious eye damage or eye irritation; specific target organ toxicity (single or repeated exposure); simple asphyxiant; and hazard not otherwise classified (HNOC).</P> <P>(2) Physical hazard means a chemical which poses one of the following hazardous effects: Flammable (gases, aerosols, liquids or solids); gas under pressure; explosive; self-heating; pyrophoric (liquid or solid); pyrophoric gas; oxidizer (liquid, solid or gas); organic peroxide; self-reactive; in contact with water emits flammable gas; combustible dust; corrosive to metal; and hazard not otherwise classified (HNOC).</P> <P> <E T="03">Hazardous chemical</E> means any hazardous chemical as defined under 29 CFR 1910.1200(c), except that such term does not include: </P> <P> (1) Any food, food additive, color additive, drug, or cosmetic regulated by the Food and Drug Administration. <PRTPAGE P="464"/> </P> <P>(2) Any substance present as a solid in any manufactured item to the extent exposure to the substance does not occur under normal conditions of use.</P> <P>(3) Any substance to the extent it is used:</P> <P>(i) For personal, family, or household purposes, or is present in the same form and concentration as a product packaged for distribution and use by the general public. Present in the same form and concentration as a product packaged for distribution and use by the general public means a substance packaged in a similar manner and present in the same concentration as the substance when packaged for use by the general public, whether or not it is intended for distribution to the general public or used for the same purpose as when it is packaged for use by the general public;</P> <P>(ii) In a research laboratory or a hospital or other medical facility under the direct supervision of a technically qualified individual; or</P> <P>(iii) In routine agricultural operations or is a fertilizer held for sale by a retailer to the ultimate customer.</P> <P> <E T="03">Indian Country</E> means Indian country as defined in 18 U.S.C. 1151 as: </P> <P>(1) All land within the limits of any Indian reservation under the jurisdiction of the United States government, notwithstanding the issuance of any patent, and including rights-of-way running through the reservation;</P> <P>(2) All dependent Indian communities within the borders of the United States whether within the original or subsequently acquired territory thereof, and whether within or without the limits of a State; and</P> <P>(3) All Indian allotments, the Indian titles to which have not been extinguished, including rights-of-way running through the same.</P> <P> <E T="03">Indian Tribe or Tribe</E> means those Tribes federally recognized by the Secretary of the Interior. </P> <P> <E T="03">Inventory form</E> means the uniform Tier I and Tier II emergency and hazardous chemical inventory forms published by EPA. These forms can be used for reporting inventory information, as described in 40 CFR 370.40 through 370.45. </P> <P> <E T="03">LEPC</E> means the Local Emergency Planning Committee appointed by the State Emergency Response Commission. </P> <P> <E T="03">Material Safety Data Sheet or MSDS (or SDS)</E> means the sheet required to be developed under 29 CFR 1910.1200(g). </P> <P> <E T="03">Mixture</E> means mixture as defined under the Occupational Safety and Health Administration's Hazard Communication Standard in 29 CFR 1910.1200(c). </P> <P> <E T="03">OSHA</E> means the U.S. Occupational Safety and Health Administration. </P> <P> <E T="03">Person</E> means any individual, trust, firm, joint stock company, corporation (including a government corporation), partnership, association, State, municipality, commission, political subdivision of a State, or interstate body. </P> <P> <E T="03">Safety Data Sheet or SDS</E> means the sheet required to be developed under 29 CFR 1910.1200(g). This term means the same as the term “material safety data sheet or MSDS” defined in this section. </P> <P> <E T="03">SERC</E> means the State Emergency Response Commission for the State in which the facility is located except when the facility is located in Indian Country, in which case, SERC means the Emergency Response Commission for the Tribe under whose jurisdiction the facility is located. In the absence of a SERC for a State or an Indian Tribe, the Governor or the chief executive officer of the tribe, respectively, shall be the SERC. Where there is a cooperative agreement between a State and a Tribe, the SERC shall be the entity identified in the agreement. </P> <P> <E T="03">State</E> means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the United States Virgin Islands, the Northern Mariana Islands, any other territory or possession over which the United States has jurisdiction and Indian Country. </P> <P> <E T="03">Threshold planning quantity (TPQ)</E> means, for a substance listed in Appendices A and B of 40 CFR part 355, the quantity listed in the column “threshold planning quantity” for that substance. </P> <CITA>[73 FR 65478, Nov. 3, 2008, as amended at 81 FR 38108, 38109, June 13, 2016; 81 FR 47312, July 21, 2016]</CITA> </SECTION> </SUBPART> </PART> <PART> <PRTPAGE P="465"/> <EAR>Pt. 372</EAR> <HD SOURCE="HED">PART 372—TOXIC CHEMICAL RELEASE REPORTING: COMMUNITY RIGHT-TO-KNOW</HD> <CONTENTS> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECHD>Sec.</SECHD> <SECTNO>372.1</SECTNO> <SUBJECT>Scope and purpose.</SUBJECT> <SECTNO>372.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <SECTNO>372.5</SECTNO> <SUBJECT>Persons subject to this part.</SUBJECT> <SECTNO>372.10</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <SECTNO>372.18</SECTNO> <SUBJECT>Compliance and enforcement.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Reporting Requirements</HD> <SECTNO>372.20</SECTNO> <SUBJECT>Process for modifying covered chemicals and facilities.</SUBJECT> <SECTNO>372.22</SECTNO> <SUBJECT>Covered facilities for toxic chemical release reporting.</SUBJECT> <SECTNO>372.23</SECTNO> <SUBJECT>SIC and NAICS codes to which this Part applies.</SUBJECT> <SECTNO>372.25</SECTNO> <SUBJECT>Thresholds for reporting.</SUBJECT> <SECTNO>372.27</SECTNO> <SUBJECT>Alternate threshold and certification.</SUBJECT> <SECTNO>372.28</SECTNO> <SUBJECT>Lower thresholds for chemicals of special concern.</SUBJECT> <SECTNO>372.30</SECTNO> <SUBJECT>Reporting requirements and schedule for reporting.</SUBJECT> <SECTNO>372.38</SECTNO> <SUBJECT>Exemptions.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Supplier Notification Requirements</HD> <SECTNO>372.45</SECTNO> <SUBJECT>Notification about toxic chemicals.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Specific Toxic Chemical Listings</HD> <SECTNO>372.65</SECTNO> <SUBJECT>Chemicals and chemical categories to which this part applies.</SUBJECT> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart E—Forms and Instructions</HD> <SECTNO>372.85</SECTNO> <SUBJECT>Toxic chemical release reporting form and instructions.</SUBJECT> <SECTNO>372.95</SECTNO> <SUBJECT>Alternate threshold certification and instructions.</SUBJECT> </SUBPART> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 11023 and 11048.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>53 FR 4525, Feb. 16, 1988, unless otherwise noted.</P> </SOURCE> <SUBPART> <HD SOURCE="HED">Subpart A—General Provisions</HD> <SECTION> <SECTNO>§ 372.1</SECTNO> <SUBJECT>Scope and purpose.</SUBJECT> <P>This part sets forth requirements for the submission of information relating to the release of toxic chemicals under section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986. The information collected under this part is intended to inform the general public and the communities surrounding covered facilities about releases of toxic chemicals, to assist research, to aid in the development of regulations, guidelines, and standards, and for other purposes. This part also sets forth requirements for suppliers to notify persons to whom they distribute mixtures or trade name products containing toxic chemicals that they contain such chemicals.</P> </SECTION> <SECTION> <SECTNO>§ 372.3</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>Terms defined in sections 313(b)(1)(c) and 329 of Title III and not explicitly defined herein are used with the meaning given in Title III. For the purpose of this part:</P> <P> <E T="03">Acts</E> means Title III. </P> <P> <E T="03">Article</E> means a manufactured item: (1) Which is formed to a specific shape or design during manufacture; (2) which has end use functions dependent in whole or in part upon its shape or design during end use; and (3) which does not release a toxic chemical under normal conditions of processing or use of that item at the facility or establishments. </P> <P> <E T="03">Beneficiation</E> means the preparation of ores to regulate the size (including crushing and grinding) of the product, to remove unwanted constituents, or to improve the quality, purity, or grade of a desired product. </P> <P> <E T="03">Boiler</E> means an enclosed device using controlled flame combustion and having the following characteristics: </P> <P>(1)(i) The unit must have physical provisions for recovering and exporting thermal energy in the form of steam, heated fluids, or heated gases; and</P> <P> (ii) The unit's combustion chamber and primary energy recovery sections(s) must be of integral design. To be of integral design, the combustion chamber and the primary energy recovery section(s) (such as waterwalls and superheaters) must be physically formed into one manufactured or assembled unit. A unit in which the combustion chamber and the primary energy recovery section(s) are joined only by ducts or connections carrying flue gas is not integrally designed; however, secondary energy recovery equipment (such as economizers or air preheaters) need not be physically formed into the same unit as the combustion chamber <PRTPAGE P="466"/> and the primary energy recovery section. The following units are not precluded from being boilers solely because they are not of integral design: process heaters (units that transfer energy directly to a process stream), and fluidized bed combustion units; and </P> <P>(iii) While in operation, the unit must maintain a thermal energy recovery efficiency of at least 60 percent, calculated in terms of the recovered energy compared with the thermal value of the fuel; and</P> <P>(iv) The unit must export and utilize at least 75 percent of the recovered energy, calculated on an annual basis. In this calculation, no credit shall be given for recovered heat used internally in the same unit. (Examples of internal use are the preheating of fuel or combustion air, and the driving of induced or forced draft fans or feedwater pumps); or</P> <P>(2) The unit is one which the Regional Administrator has determined, on a case-by-case basis, to be a boiler, after considering the standards in § 260.32 of this chapter.</P> <P> <E T="03">Coal extraction</E> means the physical removal or exposure of ore, coal, minerals, waste rock, or overburden prior to beneficiation, and encompasses all extraction-related activities prior to beneficiation. Extraction does not include beneficiation (including coal preparation), mineral processing, in situ leaching or any further activities. </P> <P> <E T="03">Customs territory of the United States</E> means the 50 States, the District of Columbia, and Puerto Rico. </P> <P> <E T="03">Disposal</E> means any underground injection, placement in landfills/surface impoundments, land treatment, or other intentional land disposal. </P> <P> <E T="03">EPA</E> means the United States Environmental Protection Agency. </P> <P> <E T="03">Establishment</E> means an economic unit, generally at a single physical location, where business is conducted or where services or industrial operations are performed. </P> <P> <E T="03">Facility</E> means all buildings, equipment, structures, and other stationary items which are located on a single site or on contiguous or adjacent sites and which are owned or operated by the same person (or by any person which controls, is controlled by, or under common control with such person). A facility may contain more than one establishment. </P> <P> <E T="03">Full-time employee</E> means 2,000 hours per year of full-time equivalent employment. A facility would calculate the number of full-time employees by totaling the hours worked during the calendar year by all employees, including contract employees, and dividing that total by 2,000 hours. </P> <P> <E T="03">Import</E> means to cause a chemical to be imported into the customs territory of the United States. For purposes of this definition, to cause means to intend that the chemical be imported and to control the identity of the imported chemical and the amount to be imported. </P> <P> <E T="03">Indian Country</E> means <E T="03">Indian country</E> as defined in 18 U.S.C. 1151. That section defines Indian country as: </P> <P>(a) All land within the limits of any Indian reservation under the jurisdiction of the United States government, notwithstanding the issuance of any patent, and including rights-of-way running through the reservation;</P> <P>(b) All dependent Indian communities within the borders of the United States whether within the original or subsequently acquired territory thereof, and whether within or without the limits of a State; and</P> <P>(c) All Indian allotments, the Indian titles to which have not been extinguished, including rights-of-way running through the same.</P> <P> <E T="03">Indian tribe</E> means those tribes federally recognized by the Secretary of the Interior. </P> <P> <E T="03">Industrial furnace</E> means any of the following enclosed devices that are integral components of manufacturing processes and that use thermal treatment to accomplish recovery of materials or energy: </P> <P>(1) Cement kilns.</P> <P>(2) Lime kilns.</P> <P>(3) Aggregate kilns.</P> <P>(4) Phosphate kilns.</P> <P>(5) Coke ovens.</P> <P>(6) Blast furnaces.</P> <P>(7) Smelting, melting and refining furnaces (including pyrometallurgical devices such as cupolas, reverberator furnaces, sintering machine, roasters, and foundry furnaces).</P> <P> (8) Titanium dioxide chloride process oxidation reactors. <PRTPAGE P="467"/> </P> <P>(9) Methane reforming furnaces.</P> <P>(10) Pulping liquor recovery furnaces.</P> <P>(11) Combustion devices used in the recovery of sulfur values from spent sulfuric acid.</P> <P>(12) Halogen acid furnaces (HAFs) for the production of acid from halogenated hazardous waste generated by chemical production facilities where the furnace is located on the site of a chemical production facility, the acid product has a halogen acid content of at least 3%, the acid product is used in a manufacturing process, and, except for hazardous waste burned as fuel, hazardous waste fed to the furnace has a minimum halogen content of 20% as-generated.</P> <P>(13) Such other devices as the Administrator may, after notice and comment, add to this list on the basis of one or more of the following factors:</P> <P>(i) The design and use of the device primarily to accomplish recovery of material products;</P> <P>(ii) The use of the device to burn or reduce raw materials to make a material product;</P> <P>(iii) The use of the device to burn or reduce secondary materials as effective substitutes for raw materials, in processes using raw materials as principal feedstocks;</P> <P>(iv) The use of the device to burn or reduce secondary materials as ingredients in an industrial process to make a material product;</P> <P>(v) The use of the device in common industrial practice to produce a material product; and</P> <P>(vi) Other factors, as appropriate.</P> <P> <E T="03">Manufacture</E> means to produce, prepare, import, or compound a toxic chemical. Manufacture also applies to a toxic chemical that is produced coincidentally during the manufacture, processing, use, or disposal of another chemical or mixture of chemicals, including a toxic chemical that is separated from that other chemical or mixture of chemicals as a byproduct, and a toxic chemical that remains in that other chemical or mixture of chemicals as an impurity. </P> <P> <E T="03">Mixture</E> means any combination of two or more chemicals, if the combination is not, in whole or in part, the result of a chemical reaction. However, if the combination was produced by a chemical reaction but could have been produced without a chemical reaction, it is also treated as a mixture. A mixture also includes any combination which consists of a chemical and associated impurities. </P> <P> <E T="03">Otherwise use</E> means any use of a toxic chemical, including a toxic chemical contained in a mixture or other trade name product or waste, that is not covered by the terms “manufacture” or “process.” Otherwise use of a toxic chemical does not include disposal, stabilization (without subsequent distribution in commerce), or treatment for destruction unless: </P> <P>(1) The toxic chemical that was disposed, stabilized, or treated for destruction was received from off-site for the purposes of futher waste management; or</P> <P>(2) The toxic chemical that was disposed, stabilized, or treated for destruction was manufactured as a result of waste management activities on materials received from off-site for the purposes of further waste management activities. Relabeling or redistributing of the toxic chemical where no repackaging of the toxic chemical occurs does not constitute otherwise use or processing of the toxic chemical.</P> <P> <E T="03">Overburden</E> means the unconsolidated material that overlies a deposit of useful materials or ores. It does not include any portion of ore or waste rock. </P> <P> <E T="03">Parent company</E> means the highest-level company (or companies) of the facility's ownership hierarchy as of December 31 of the year for which data are being reported according to the following instructions. The <E T="03">U.S. parent company</E> is located within the United States while the <E T="03">foreign parent company</E> is located outside the United States: </P> <P>(1) If the facility is entirely owned by a single U.S. company that is not owned by another company, that single company is the U.S. parent company.</P> <P> (2) If the facility is entirely owned by a single U.S. company that is, itself, owned by another U.S.-based company ( <E T="03">e.g.,</E> it is a division or subsidiary of a higher-level company), the highest-level company in the ownership hierarchy is the U.S. parent company. If there is a higher-level parent company that is outside of the United States, the highest-level foreign company in <PRTPAGE P="468"/> the ownership hierarchy is the foreign parent company. </P> <P> (3) If the facility is owned by more than one company ( <E T="03">e.g.,</E> company A owns 40 percent, company B owns 35 percent, and company C owns 25 percent), the highest-level U.S. company with the largest ownership interest in the facility is the U.S. parent company. If there is a higher-level foreign company in the ownership hierarchy, that company is the foreign parent company. </P> <P>(4) If the facility is owned by a 50:50 joint venture or a cooperative, the joint venture or cooperative is its own parent company.</P> <P> (5) If the facility is entirely owned by a foreign company ( <E T="03">i.e.,</E> without a U.S.-based subsidiary within the facility's ownership hierarchy), the highest-level foreign parent company is the facility's foreign parent company. </P> <P>(6) If the facility is federally owned, the highest-level Federal agency or department operating the facility is the U.S. parent company.</P> <P> (7) If the facility is owned by a non-Federal public entity ( <E T="03">e.g.,</E> a State, municipal, or tribal government), that entity is the U.S. parent company. </P> <P> <E T="03">Previously classified</E> means properly classified, according to § 372.22(b) under a given Standard Industrial Classification (SIC) code, as identified in the Standard Industrial Classification Manual, 1987, Executive Office of the President, Office of Management and Budget. </P> <P> <E T="03">Process</E> means the preparation of a toxic chemical, after its manufacture, for distribution in commerce: </P> <P>(1) In the same form or physical state as, or in a different form or physical state from, that in which it was received by the person so preparing such substance, or</P> <P>(2) As part of an article containing the toxic chemical. Process also applies to the processing of a toxic chemical contained in a mixture or trade name product.</P> <P> <E T="03">RCRA approved test method</E> includes Test Method 9095 (Paint Filter Liquids Test) in “Test Methods for Evaluating Solid Waste, Physical/Chemical Methods,” EPA Publication No. SW-846, Third Edition, September 1986, as amended by Update I, November 15, 1992. </P> <P> <E T="03">Release</E> means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, or disposing into the environment (including the abandonment or discarding of barrels, containers, and other closed receptacles) of any toxic chemical. </P> <P> <E T="03">Senior management official</E> means an official with management responsibility for the person or persons completing the report, or the manager of environmental programs for the facility or establishments, or for the corporation owning or operating the facility or establishments responsible for certifying similar reports under other environmental regulatory requirements. </P> <P> <E T="03">State</E> means any State of the United States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, American Samoa, the United States Virgin Islands, the Commonwealth of the Northern Mariana Islands, and any other territory or possession over which the United States has jurisdiction. </P> <P> <E T="03">Title III</E> means Title III of the Superfund Amendments and Reauthorization Act of 1986, also titled the Emergency Planning and Community Right-To-Know Act of 1986. </P> <P> <E T="03">Toxic chemical</E> means a chemical or chemical category listed in § 372.65. </P> <P> <E T="03">Trade name product</E> means a chemical or mixture of chemicals that is distributed to other persons and that incorporates a toxic chemical component that is not identified by the applicable chemical name or Chemical Abstracts Service Registry number listed in § 372.65. </P> <P> <E T="03">Treatment for destruction</E> means the destruction of a toxic chemical in waste such that the substance is no longer the toxic chemical subject to reporting under EPCRA section 313. Treatment for destruction does not include the destruction of a toxic chemical in waste where the toxic chemical has a heat value greater than 5,000 British thermal units and is combusted in any device that is an industrial furnace or boiler. <PRTPAGE P="469"/> </P> <P> <E T="03">Tribal Chairperson or equivalent elected official</E> means the person who is recognized by the Bureau of Indian Affairs as the chief elected administrative officer of the Tribe. </P> <P> <E T="03">Waste stabilization</E> means any physical or chemical process used to either reduce the mobility of hazardous constitutents in a hazardous waste or eliminate free liquid as determined by a RCRA approved test method for evaluating solid waste as defined in this section. A waste stabilization process includes mixing the hazardous waste with binders or other materials, and curing the resulting hazardous waste and binder mixture. Other synonymous terms used to refer to this process are “stabilization,” “waste fixation,” or “waste solidification.” </P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 55 FR 30656, July 26, 1990; 62 FR 23891, May 1, 1997; 71 FR 32474, June 6, 2006; 73 FR 76960, Dec. 18, 2008; 77 FR 23418, Apr. 19, 2012; 87 FR 63955, Oct. 21, 2022]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.5</SECTNO> <SUBJECT>Persons subject to this part.</SUBJECT> <P>Owners and operators of facilities described in §§ 372.22 and 372.45 are subject to the requirements of this part. If the owner and operator of a facility are different persons, only one need report under § 372.30 or provide a notice under § 372.45 for each toxic chemical in a mixture or trade name product distributed from the facility. However, if no report is submitted or notice provided, EPA will hold both the owner and the operator liable under section 325(c) of Title III, except as provided in §§ 372.38(e) and 372.45(g).</P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 73 FR 32470, June 9, 2008]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.10</SECTNO> <SUBJECT>Recordkeeping.</SUBJECT> <P>(a) Each person subject to the reporting requirements of this part must retain the following records for a period of 3 years from the date of the submission of a report under § 372.30:</P> <P>(1) A copy of each report submitted by the person under § 372.30.</P> <P>(2) All supporting materials and documentation used by the person to make the compliance determination that the facility or establishments is a covered facility under § 372.22 or § 372.45.</P> <P>(3) Documentation supporting the report submitted under § 372.30 including:</P> <P>(i) Documentation supporting any determination that a claimed allowable exemption under § 372.38 applies.</P> <P>(ii) Data supporting the determination of whether a threshold under § 372.25 applies for each toxic chemical.</P> <P>(iii) Documentation supporting the calculations of the quantity of each toxic chemical released to the environment or transferred to an off-site location.</P> <P>(iv) Documentation supporting the use indications and quantity on site reporting for each toxic chemical, including dates of manufacturing, processing, or use.</P> <P>(v) Documentation supporting the basis of estimate used in developing any release or off-site transfer estimates for each toxic chemical.</P> <P>(vi) Receipts or manifests associated with the transfer of each toxic chemical in waste to off-site locations.</P> <P>(vii) Documentation supporting reported waste treatment methods, estimates of treatment efficiencies, ranges of influent concentration to such treatment, the sequential nature of treatment steps, if applicable, and the actual operating data, if applicable, to support the waste treatment efficiency estimate for each toxic chemical.</P> <P>(b) Each person subject to the notification requirements of this part must retain the following records for a period of 3 years from the date of the submission of a notification under § 372.45.</P> <P>(1) All supporting materials and documentation used by the person to determine whether a notice is required under § 372.45.</P> <P>(2) All supporting materials and documentation used in developing each required notice under § 372.45 and a copy of each notice.</P> <P>(c) Records retained under this section must be maintained at the facility to which the report applies or from which a notification was provided. Such records must be readily available for purposes of inspection by EPA.</P> <P> (d) Each owner or operator who determines that the owner operator may apply the alternate threshold as specified under § 372.27(a) must retain the following records for a period of 3 years from the date of the submission of the certification statement as required under § 372.27(b): <PRTPAGE P="470"/> </P> <P>(1) A copy of each certification statement submitted by the person under § 372.27(b).</P> <P>(2) All supporting materials and documentation used by the person to make the compliance determination that the facility or establishment is eligible to apply the alternate threshold as specified in § 372.27.</P> <P>(3) Documentation supporting the certification statement submitted under § 372.27(b) including:</P> <P>(i) Data supporting the determination of whether the alternate threshold specified under § 372.27(a) applies for each toxic chemical.</P> <P>(ii) Documentation supporting the calculation of annual reportable amount, as defined in § 372.27(a), for each toxic chemical, including documentation supporting the calculations and the calculations of each data element combined for the annual reportable amount.</P> <P>(iii) Receipts or manifests associated with the transfer of each chemical in waste to off-site locations.</P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 59 FR 61501, Nov. 30, 1994; 71 FR 76944, Dec. 22, 2006; 74 FR 19005, Apr. 27, 2009]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.18</SECTNO> <SUBJECT>Compliance and enforcement.</SUBJECT> <P>Violators of the requirements of this part shall be liable for a civil penalty in an amount not to exceed $25,000 each day for each violation as provided in section 325(c) of Title III. The civil monetary penalty amount listed in this section may not reflect recent inflation adjustments EPA is required to make. The current maximum and minimum statutory civil penalty amounts are located in § 19.4.</P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 89 FR 88656, Nov. 8, 2024]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart B—Reporting Requirements</HD> <SECTION> <SECTNO>§ 372.20</SECTNO> <SUBJECT>Process for modifying covered chemicals and facilities.</SUBJECT> <P>(a) Request to add a facility to the TRI list of covered facilities.</P> <P>(b) The Administrator, on his own motion or at the request of a Governor of a State (with regard to facilities located in that State) or a Tribal Chairperson or equivalent elected official (with regard to facilities located in the Indian country of that Tribe), may apply the requirements of section 313 of Title III to the owners and operators of any particular facility that manufactures, processes, or otherwise uses a toxic chemical listed under subsection (c) of section 313 of Title III if the Administrator determines that such action is warranted on the basis of toxicity of the toxic chemical, proximity to other facilities that release the toxic chemical or to population centers, the history of releases of such chemical at such facility, or such other factors as the Administrator deems appropriate.</P> <P>(c) Petition to add or delete a chemical from TRI list of covered chemicals.</P> <P> (d) <E T="03">In general.</E> (1) Any person may petition the Administrator to add or delete a chemical to or from the list described in subsection (c) of section 313 of Title III on the basis of the criteria in subparagraph (A) or (B) of subsection (d)(2) and (d)(3) of section 313 of Title III. Within 180 days after receipt of a petition, the Administrator shall take one of the following actions: </P> <P>(i) Initiate a rulemaking to add or delete the chemical to or from the list, in accordance with subsection (d)(2) or (d)(3) of section 313 of Title III.</P> <P>(ii) Publish an explanation of why the petition is denied.</P> <P> (2) <E T="03">State and Tribal petitions.</E> A State Governor, or a Tribal Chairperson or equivalent elected official, may petition the Administrator to add or delete a chemical to or from the list described in subsection (c) of section 313 of Title III on the basis of the criteria in subparagraph (A), (B), or (C) of subsection (d)(2) of section 313 of Title III. In the case of such a petition from a State Governor, or a Tribal Chairperson or equivalent elected official, to delete a chemical, the petition shall be treated in the same manner as a petition received under paragraph (d)(1) of this section. In the case of such a petition from a State Governor, or a Tribal Chairperson or equivalent elected official, to add a chemical, the chemical will be added to the list within 180 days after receipt of the petition, unless the Administrator: </P> <P> (i) Initiates a rulemaking to add the chemical to the list, in accordance <PRTPAGE P="471"/> with subsection (d)(2) of section 313 of Title III, or </P> <P>(ii) Publishes an explanation of why the Administrator believes the petition does not meet the requirement of subsection (d)(2) of section 313 of Title III for adding a chemical to the list.</P> <CITA>[77 FR 23418, Apr. 19, 2012]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.22</SECTNO> <SUBJECT>Covered facilities for toxic chemical release reporting.</SUBJECT> <P>A facility is a covered facility for a particular calendar year, and must report under § 372.30, if the facility meets either all of the criteria in paragraphs (a), (b), and (c) of this section, or all of the criteria in paragraphs (c) and (d) of this section, for that calendar year.</P> <P>(a) The facility has 10 or more full-time employees.</P> <P>(b) The facility is in a Standard Industrial Classification (SIC) (as in effect on January 1, 1987) major group or industry code listed in § 372.23(a), for which the corresponding North American Industry Classification System (NAICS) (as in effect on January 1, 2022, for reporting year 2022 and thereafter) subsector and industry codes are listed in §§ 372.23(b) and 372.23(c) by virtue of the fact that it meets one of the following criteria:</P> <P>(1) The facility is an establishment with a primary SIC major group or industry code listed in § 372.23(a), or a primary NAICS subsector or industry code listed in § 372.23(b) or § 372.23(c).</P> <P>(2) The facility is a multi-establishment complex where all establishments have primary SIC major group or industry codes listed in § 372.23(a), or primary NAICS subsector or industry codes listed in § 372.23(b) or § 372.23(c).</P> <P>(3) The facility is a multi-establishment complex in which one of the following is true:</P> <P>(i) The sum of the value of services provided and/or products shipped and/or produced from those establishments that have primary SIC major group or industry codes listed in § 372.23(a), or primary NAICS subsector or industry codes listed in § 372.23(b) or § 372.23(c) is greater than 50 percent of the total value of all services provided and/or products shipped from and/or produced by all establishments at the facility.</P> <P>(ii) One establishment having a primary SIC major group or industry code listed in § 372.23(a), or a primary NAICS subsector or industry code listed in § 372.23(b) or § 372.23(c) contributes more in terms of value of services provided and/or products shipped from and/or produced at the facility than any other establishment within the facility.</P> <P>(c) The facility manufactured (including imported), processed, or otherwise used a toxic chemical in excess of an applicable threshold quantity of that chemical set forth in §§ 372.25, 372.27, or 372.28.</P> <P>(d) The Administrator determined that applying the 42 U.S.C. 11023 requirements to the facility was warranted, pursuant to 42 U.S.C. 11023(b)(2) and § 372.20(b).</P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 59 FR 61501, Nov. 30, 1994; 62 FR 23892, May 1, 1997; 64 FR 58750, Oct. 29, 1999; 71 FR 32474, June 6, 2006; 73 FR 32470, June 9, 2008; 78 FR 42882, July 18, 2013; 82 FR 39041, Aug. 17, 2017; 82 FR 60909, Dec. 26, 2017; 85 FR 37357, June 22, 2020; 87 FR 72896, Nov. 28, 2022; 87 FR 74518, Dec. 6, 2022; 88 FR 74368, Oct. 31, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.23</SECTNO> <SUBJECT>SIC and NAICS codes to which this Part applies.</SUBJECT> <P>The requirements of this part apply to facilities in the following SIC and NAICS codes. This section contains three listings. Paragraph (a) of this section lists the SIC codes to which this part applies. Paragraph (b) of this section lists the NAICS codes that correspond to SIC codes 20 through 39 to which this part applies. Paragraph (c) of this section lists the NAICS codes that correspond to SIC codes other than SIC codes 20 through 39 to which this part applies.</P> <P>(a) SIC codes.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s60,r200"> <BOXHD> <CHED H="1">Major group or industry code</CHED> <CHED H="1">Exceptions and/or limitations</CHED> </BOXHD> <ROW> <ENT I="01">10</ENT> <ENT>Except 1011, 1081, and 1094.</ENT> </ROW> <ROW> <ENT I="01">12</ENT> <ENT>Except 1241.</ENT> </ROW> <ROW> <ENT I="22">20 through 39</ENT> </ROW> <ROW> <ENT I="01">1321</ENT> </ROW> <ROW> <ENT I="01">4911, 4931, 4939</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <PRTPAGE P="472"/> <ENT I="01">4953</ENT> <ENT> Limited to facilities regulated under the Resource Conservation and Recovery Act, 42 U.S.C. 6921, <E T="03">et seq.</E> </ENT> </ROW> <ROW> <ENT I="22">5169</ENT> </ROW> <ROW> <ENT I="22">5171</ENT> </ROW> <ROW> <ENT I="01">7389</ENT> <ENT>Limited to facilities primarily engaged in solvent recovery services on a contract or fee basis.</ENT> </ROW> </GPOTABLE> <P>(b) NAICS codes that correspond to SIC codes 20-39.</P> <GPOTABLE COLS="2" OPTS="L2,nj,tp0,p1,7/8" CDEF="s50,r150"> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01">311—Food Manufacturing</ENT> <ENT>Except 311119—Exception is limited to facilities previously classified under SIC 0723, Crop Preparation Services for Market, Except Cotton Ginning.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 311340—Exception is limited to facilities previously classified under SIC 5441, Candy, Nut, and Confectionery Stores.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 311352—Exception is limited to facilities previously classified under SIC 5441, Candy, Nut, and Confectionery Stores.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 311611—Exception is limited to facilities previously classified under SIC 0751, Livestock Services, Except Veterinary.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 311612—Exception is limited to facilities previously classified under SIC 5147, Meats and Meat Products.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 311811—Exception is limited to facilities previously classified under SIC 5461, Retail Bakeries.</ENT> </ROW> <ROW> <ENT I="01">312—Beverage and Tobacco Product Manufacturing</ENT> <ENT>Except 312112—Exception is limited to facilities previously classified under SIC 5149, Groceries and Related Products, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 312230—Exception is limited to facilities previously classified under SIC 7389, Business Services, Not Elsewhere Classified, except facilities primarily engaged in solvent recovery services on a contract or fee basis.</ENT> </ROW> <ROW> <ENT I="01">313—Textile Mills</ENT> <ENT>Except 313310—Exception is limited to facilities previously classified under SIC 5131, Piece Goods, Notions, and Other Dry Goods; and facilities previously classified under SIC 7389, Business Services, Not Elsewhere Classified, except facilities primarily engaged in solvent recovery services on a contract or fee basis.</ENT> </ROW> <ROW> <ENT I="01">314—Textile Product Mills</ENT> <ENT>Except 314120—Exception is limited to facilities previously classified under SIC 5714, Drapery, Curtain, and Upholstery Stores.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 314999—Exception is limited to facilities previously classified under SIC 7389, Business Services, Not Elsewhere Classified, except facilities primarily engaged in solvent recovery services on a contract or fee basis.</ENT> </ROW> <ROW> <ENT I="01">315—Apparel Manufacturing</ENT> <ENT>Except 315290—Exception is limited to facilities previously classified under SIC 5699, Miscellaneous Apparel and Accessory Stores.</ENT> </ROW> <ROW> <ENT I="01">316—Leather and Allied Product Manufacturing</ENT> </ROW> <ROW> <ENT I="01">321—Wood Product Manufacturing</ENT> </ROW> <ROW> <ENT I="01">322—Paper Manufacturing</ENT> </ROW> <ROW> <ENT I="01">323—Printing and Related Support Activities</ENT> <ENT>Except 323111—Exception is limited to facilities previously classified under SIC 7334, Photocopying and Duplicating Services.</ENT> </ROW> <ROW> <ENT I="01">324—Petroleum and Coal Products Manufacturing</ENT> </ROW> <ROW> <ENT I="01">325—Chemical Manufacturing</ENT> <ENT>Except 325998—Exception is limited to facilities previously classified under SIC 7389, Business Services, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">326—Plastics and Rubber Products Manufacturing</ENT> <ENT>Except 326212—Exception is limited to facilities previously classified under SIC 7534, Tire Retreading and Repair Shops.</ENT> </ROW> <ROW> <ENT I="01">327—Nonmetallic Mineral Product Manufacturing</ENT> <ENT>Except 327110—Exception is limited to facilities previously classified under SIC 5719, Miscellaneous Home Furnishings Stores.</ENT> </ROW> <ROW> <ENT I="01">331—Primary Metal Manufacturing</ENT> </ROW> <ROW> <ENT I="01">332—Fabricated Metal Product Manufacturing</ENT> </ROW> <ROW> <ENT I="01">333—Machinery Manufacturing</ENT> </ROW> <ROW> <ENT I="01">334—Computer and Electronic Product Manufacturing</ENT> <ENT>Except 334610—Exception is limited to facilities previously classified under SIC 7372, Prepackaged Software; and to facilities previously classified under SIC 7819, Services Allied to Motion Picture Production.</ENT> </ROW> <ROW> <ENT I="01">335—Electrical Equipment, Appliance, and Component Manufacturing</ENT> <ENT>Except 335312—Exception is limited to facilities previously classified under SIC 7694, Armature Rewinding Shops.</ENT> </ROW> <ROW> <PRTPAGE P="473"/> <ENT I="01">336—Transportation Equipment Manufacturing</ENT> </ROW> <ROW> <ENT I="01">337—Furniture and Related Product Manufacturing</ENT> <ENT>Except 337110—Exception is limited to facilities previously classified under SIC 5712, Furniture Stores.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 337121—Exception is limited to facilities previously classified under SIC 5712, Furniture Stores.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 337122—Exception is limited to facilities previously classified under SIC 5712, Furniture Stores.</ENT> </ROW> <ROW> <ENT I="01">339—Miscellaneous Manufacturing</ENT> <ENT>Except 339113—Exception is limited to facilities previously classified under SIC 5999, Miscellaneous Retail Stores, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 339115—Exception is limited to lens grinding facilities previously classified under SIC 5995, Optical Goods Stores.</ENT> </ROW> <ROW> <ENT I="22"> </ENT> <ENT>Except 339116—Exception is limited to facilities previously classified under SIC 8072, Dental Laboratories.</ENT> </ROW> <ROW> <ENT I="01">111998—All Other Miscellaneous Crop Farming</ENT> <ENT>Limited to facilities previously classified under SIC 2099, Food Preparations, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">113310—Logging</ENT> </ROW> <ROW> <ENT I="01">211130—Natural Gas Extraction</ENT> <ENT>Limited to facilities that recover sulfur from natural gas and previously classified under SIC 2819, Industrial Inorganic Chemicals, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">212323—Kaolin, Clay, and Ceramic and Refractory Minerals Mining</ENT> <ENT>Limited to facilities operating without a mine or quarry and previously classified under SIC 3295, Minerals and Earths, Ground or Otherwise Treated.</ENT> </ROW> <ROW> <ENT I="01">212390—Other Nonmetallic Mineral Mining and Quarrying</ENT> <ENT>Limited to facilities previously classified under SIC 3295, Minerals and Earths, Ground or Otherwise Treated.</ENT> </ROW> <ROW> <ENT I="01">488390—Other Support Activities for Water Transportation</ENT> <ENT>Limited to facilities previously classified under SIC 3731, Shipbuilding and Repairing.</ENT> </ROW> <ROW> <ENT I="01">512230—Music Publishers</ENT> <ENT>Except facilities previously classified under SIC 8999, Services, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">512250—Record Production and Distribution</ENT> <ENT>Limited to facilities previously classified under SIC 3652, Phonograph Records and Prerecorded Audio Tapes and Disks.</ENT> </ROW> <ROW> <ENT I="01">5131—Newspaper, Periodical, Book, and Directory Publishers</ENT> <ENT>Except for facilities primarily engaged in web search portals and except for facilities previously classified under SIC 7331, Direct Mail Advertising Services and SIC 8999, Services Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">516210—Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers</ENT> <ENT>Limited to Internet publishing facilities previously classified under SIC 2711, Newspapers: Publishing, or Publishing and Printing; facilities previously classified under SIC 2721, Periodicals: Publishing, or Publishing and Printing; facilities previously classified under SIC 2731, Books: Publishing, or Publishing and Printing; facilities previously classified under SIC 2741, Miscellaneous Publishing; facilities previously classified under SIC 2771, Greeting Cards; Except for facilities primarily engaged in web search portals.</ENT> </ROW> <ROW> <ENT I="01">519290—Web Search Portals and All Other Information Services</ENT> <ENT>Limited to Internet publishing facilities previously classified under SIC 2711, Newspapers: Publishing, or Publishing and Printing; facilities previously classified under SIC 2721, Periodicals: Publishing, or Publishing and Printing; facilities previously classified under SIC 2731, Books: Publishing, or Publishing and Printing; facilities previously classified under SIC 2741, Miscellaneous Publishing; facilities previously classified under SIC 2771, Greeting Cards; Except for facilities primarily engaged in web search portals.</ENT> </ROW> <ROW> <ENT I="01">541713—Research and Development in Nanotechnology</ENT> <ENT>Limited to facilities previously classified under SIC 3764, Guided Missile and Space Vehicle Propulsion Units and Propulsion Unit Parts; and facilities previously classified under SIC 3769, Guided Missile and Space Vehicle Parts and Auxiliary Equipment, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">541715—Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)</ENT> <ENT>Limited to facilities previously classified under SIC 3764, Guided Missile and Space Vehicle Propulsion Units and Propulsion Unit Parts; and facilities previously classified under SIC 3769, Guided Missile and Space Vehicle Parts and Auxiliary Equipment, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">811490—Other Personal and Household Goods Repair and Maintenance</ENT> <ENT>Limited to facilities previously classified under SIC 3732, Boat Building and Repairing.</ENT> </ROW> </GPOTABLE> <P> (c) NAICS codes that correspond to SIC codes other than SIC codes 20-39. <PRTPAGE P="474"/> </P> <GPOTABLE COLS="2" OPTS="L2,nj,tp0,p1,7/8" CDEF="s50,r150"> <BOXHD> <CHED H="1"> </CHED> <CHED H="1"> </CHED> </BOXHD> <ROW> <ENT I="01">211130—Natural Gas Extraction</ENT> <ENT>Limited to facilities classified under SIC 1321, Natural Gas Liquids.</ENT> </ROW> <ROW> <ENT I="01">212114—Surface Coal Mining</ENT> </ROW> <ROW> <ENT I="01">212115—Underground Coal Mining</ENT> </ROW> <ROW> <ENT I="01">212220—Gold Ore and Silver Ore Mining</ENT> </ROW> <ROW> <ENT I="01">212230—Copper, Nickel, Lead and Zinc Mining</ENT> </ROW> <ROW> <ENT I="01">212290—Other Metal Ore Mining</ENT> <ENT>Limited to facilities previously classified under SIC 1061, Ferroalloy Ores, Except Vanadium (nickel); and facilities previously classified under SIC 1099, Miscellaneous Metal Ores, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">221111—Hydroelectric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221112—Fossil Fuel Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221113—Nuclear Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221114—Solar Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221115—Wind Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221116—Geothermal Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221117—Biomass Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221118—Other Electric Power Generation</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221121—Electric Bulk Power Transmission and Control</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221122—Electric Power Distribution</ENT> <ENT>Limited to facilities that combust coal and/or oil for the purpose of generating power for distribution in commerce.</ENT> </ROW> <ROW> <ENT I="01">221210—Natural Gas Distribution</ENT> <ENT>Limited to facilities previously classified under SIC 4931, Electric and Other Services Combined and facilities previously classified under SIC 4939, Combination Utilities, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">221330—Steam and Air Conditioning Supply</ENT> <ENT>Limited to facilities previously classified under SIC 4939, Combination Utilities, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">424690—Other Chemical and Allied Products Merchant Wholesalers</ENT> </ROW> <ROW> <ENT I="01">424710—Petroleum Bulk Stations and Terminals</ENT> </ROW> <ROW> <ENT I="01">425120—Wholesale Trade Agents and Brokers</ENT> <ENT>Limited to facilities previously classified in SIC 5169, Chemicals and Allied Products, Not Elsewhere Classified.</ENT> </ROW> <ROW> <ENT I="01">562112—Hazardous Waste Collection</ENT> <ENT>Limited to facilities primarily engaged in solvent recovery services on a contract or fee basis and previously classified under SIC 7389, Business Services, Not Elsewhere Classified;</ENT> </ROW> <ROW> <ENT I="01">562211—Hazardous Waste Treatment and Disposal</ENT> <ENT> Limited to facilities regulated under the Resource Conservation and Recovery Act, subtitle C, 42 U.S.C. 6921 <E T="03">et seq.</E> </ENT> </ROW> <ROW> <ENT I="01">562212—Solid Waste Landfill</ENT> <ENT> Limited to facilities regulated under the Resource Conservation and Recovery Act, subtitle C, 42 U.S.C. 6921 <E T="03">et seq.</E> </ENT> </ROW> <ROW> <ENT I="01">562213—Solid Waste Combustors and Incinerators</ENT> <ENT> Limited to facilities regulated under the Resource Conservation and Recovery Act, subtitle C, 42 U.S.C. 6921 <E T="03">et seq.</E> </ENT> </ROW> <ROW> <ENT I="01">562219—Other Nonhazardous Waste Treatment and Disposal</ENT> <ENT> Limited to facilities regulated under the Resource Conservation and Recovery Act, subtitle C, 42 U.S.C. 6921 <E T="03">et seq.</E> </ENT> </ROW> <ROW> <ENT I="01">562920—Materials Recovery Facilities</ENT> <ENT> Limited to facilities regulated under the Resource Conservation and Recovery Act, subtitle C, 42 U.S.C. 6921 <E T="03">et seq.</E> </ENT> </ROW> </GPOTABLE> <CITA>[71 FR 32474, June 6, 2006, as amended at 73 FR 32470, June 9, 2008; 78 FR 42882, July 18, 2013; 82 FR 60909, Dec. 26, 2017; 86 FR 66964, Nov. 24, 2021; 87 FR 72896, Nov. 28, 2022]</CITA> </SECTION> <SECTION> <PRTPAGE P="475"/> <SECTNO>§ 372.25</SECTNO> <SUBJECT>Thresholds for reporting.</SUBJECT> <P>Except as provided in §§ 372.27 and 372.28, the threshold amounts for purposes of reporting under § 372.30 for toxic chemicals are as follows:</P> <P>(a) With respect to a toxic chemical manufactured (including imported) or processed at a facility during the following calendar years:</P> <EXTRACT> <FP SOURCE="FP-1">1987—75,000 pounds of the chemical manufactured or processed for the year.</FP> <FP SOURCE="FP-1">1988—50,000 pounds of the chemical manufactured or processed for the year.</FP> <FP SOURCE="FP-1">1989 and thereafter—25,000 pounds of the chemical manufactured or processed for the year.</FP> </EXTRACT> <P>(b) With respect to a chemical otherwise used at a facility, 10,000 pounds of the chemical used for the applicable calendar year.</P> <P>(c) With respect to activities involving a toxic chemical at a facility, when more than one threshold applies to the activities, the owner or operator of the facility must report if it exceeds any applicable threshold and must report on all activities at the facility involving the chemical, except as provided in § 372.38.</P> <P>(d) When a facility manufactures, processes, or otherwise uses more than one member of a chemical category listed in § 372.65(c), the owner or operator of the facility must report if it exceeds any applicable threshold for the total volume of all the members of the category involved in the applicable activity. Any such report must cover all activities at the facility involving members of the category.</P> <P>(e) A facility may process or otherwise use a toxic chemical in a recycle/reuse operation. To determine whether the facility has processed or used more than an applicable threshold of the chemical, the owner or operator of the facility shall count the amount of the chemical added to the recycle/reuse operation during the calendar year. In particular, if the facility starts up such an operation during a calendar year, or in the event that the contents of the whole recycle/reuse operation are replaced in a calendar year, the owner or operator of the facility shall also count the amount of the chemical placed into the system at these times.</P> <P>(f) A toxic chemical may be listed in § 372.65 with the notation that only persons who manufacture the chemical, or manufacture it by a certain method, are required to report. In that case, only owners or operators of facilities that manufacture that chemical as described in § 372.65 in excess of the threshold applicable to such manufacture in this section or §§ 372.27 or 372.28 are required to report. In completing the reporting form, the owner or operator is only required to account for the quantity of the chemical so manufactured and releases associated with such manufacturing, but not releases associated with subsequent processing or use of the chemical at that facility. Owners and operators of facilities that solely process or use such a chemical are not required to report for that chemical.</P> <P>(g) A toxic chemical may be listed in § 372.65 with the notation that it is in a specific form (e.g., fume or dust, solution, or friable) or of a specific color (e.g., yellow or white). In that case, only owners or operators of facilities that manufacture, process, or use that chemical in the form or of the color, specified in § 372.65 in excess of the threshold applicable to such activity in this section or §§ 372.27 or 372.28 are required to report. In completing the reporting form, the owner or operator is only required to account for the quantity of the chemical manufactured, processed, or used in the form or color specified in § 372.65 and for releases associated with the chemical in that form or color. Owners or operators of facilities that solely manufacture, process, or use such a chemical in a form or color other than those specified by § 372.65 are not required to report for that chemical.</P> <P> (h) Metal compound categories are listed in § 372.65(c). For purposes of determining whether any of the thresholds specified in this section or §§ 372.27 or 372.28 are met for metal compound category, the owner or operator of a facility must make the threshold determination based on the total amount of all members of the metal compound category manufactured, processed, or used at the facility. In completing the release portion of the reporting form for releases of the metal compounds, the owner or operator is only required to account for the weight of the parent metal released. Any contribution to <PRTPAGE P="476"/> the mass of the release attributable to other portions of each compound in the category is excluded. </P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 59 FR 61502, Nov. 30, 1994; 64 FR 58750, Oct. 29, 1999; 85 FR 37357, June 22, 2020; 88 FR 74368, Oct. 31, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.27</SECTNO> <SUBJECT>Alternate threshold and certification.</SUBJECT> <P>(a) Except as provided in paragraph (e) of this section, with respect to the manufacture, process, or otherwise use of a toxic chemical, the owner or operator of a facility may apply an alternate threshold of 1 million pounds per year to that chemical if the owner or operator calculates that the facility would have an annual reportable amount of that toxic chemical not exceeding 500 pounds for the combined total quantities released at the facility, disposed within the facility, treated at the facility (as represented by amounts destroyed or converted by treatment processes), recovered at the facility as a result of recycle operations, combusted for the purpose of energy recovery at the facility, and amounts transferred from the facility to off-site locations for the purpose of recycle, energy recovery, treatment, and/or disposal. These volumes correspond to the sum of amounts reportable for data elements on EPA Form R (EPA Form 9350-1; Rev. 12/4/93) as Part II column B or sections 8.1 (quantity released), 8.2 (quantity used for energy recovery on-site), 8.3 (quantity used for energy recovery off-site), 8.4 (quantity recycled on-site), 8.5 (quantity recycled off-site), 8.6 (quantity treated on-site), and 8.7 (quantity treated off-site).</P> <P>(b) If an owner or operator of a facility determines that the owner or operator may apply the alternate reporting threshold specified in paragraph (a) of this section for a specific toxic chemical, the owner or operator is not required to submit a report for that chemical under § 372.30, but must submit a certification statement that contains the information required in § 372.95. The owner or operator of the facility must also keep records as specified in § 372.10(d).</P> <P>(c) Threshold determination provisions of § 372.25 and exemptions pertaining to threshold determinations in § 372.38 are applicable to the determination of whether the alternate threshold has been met.</P> <P>(d) Each certification statement under this section for activities involving a toxic chemical that occurred during a calendar year at a facility must be submitted to EPA and to the State in which the facility is located on or before July 1 of the next year. If the covered facility is located in Indian country, the facility shall submit the certification statement as described above to EPA and to the official designated by the Tribal Chairperson or equivalent elected official of the relevant Indian Tribe, instead of to the State.</P> <P>(e) The provisions of this section do not apply to any chemicals listed in § 372.28.</P> <CITA>[59 FR 61502, Nov. 30, 1994, as amended at 64 FR 58750, Oct. 29, 1999; 71 FR 76944, Dec. 22, 2006; 74 FR 19005, Apr. 27, 2009; 77 FR 23418, Apr. 19, 2012]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.28</SECTNO> <SUBJECT>Lower thresholds for chemicals of special concern.</SUBJECT> <P>(a) Notwithstanding § 372.25 or § 372.27, for the toxic chemicals set forth in this section, the threshold amounts for manufacturing (including importing), processing, and otherwise using such toxic chemicals are as set forth in this section.</P> <P>(1) Chemical listing in alphabetic order.</P> <GPOTABLE COLS="3" OPTS="L1" CDEF="s100,12,12"> <TTITLE> Table 1 to Paragraph ( <E T="01">a</E> )(1) </TTITLE> <BOXHD> <CHED H="1">Chemical name</CHED> <CHED H="1">CAS No.</CHED> <CHED H="1"> Reporting <LI>threshold</LI> <LI>(in pounds)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Aldrin</ENT> <ENT O="xl">00309-00-2</ENT> <ENT O="xl">100</ENT> </ROW> <ROW> <ENT I="01">Benzo(g,h,i)perylene</ENT> <ENT O="xl">00191-24-2</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Chlordane</ENT> <ENT O="xl">00057-74-9</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Heptachlor</ENT> <ENT O="xl">00076-44-8</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Hexachlorobenzene</ENT> <ENT O="xl">00118-74-1</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran</ENT> <ENT>1222-05-5</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Isodrin</ENT> <ENT O="xl">00465-73-6</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <PRTPAGE P="477"/> <ENT I="01" O="xl">Lead (this lower threshold does not apply to lead when contained in a stainless steel, brass or bronze alloy)</ENT> <ENT>7439-92-1</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Mercury</ENT> <ENT O="xl">07439-97-6</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Methoxychlor</ENT> <ENT O="xl">00072-43-5</ENT> <ENT O="xl">100</ENT> </ROW> <ROW> <ENT I="01">Octachlorostyrene</ENT> <ENT O="xl">29082-74-4</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Pendimethalin</ENT> <ENT O="xl">40487-42-1</ENT> <ENT O="xl">100</ENT> </ROW> <ROW> <ENT I="01">Pentachlorobenzene</ENT> <ENT O="xl">00608-93-5</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Per- and polyfluoroalkyl substances (Individually listed per- and polyfluoroalkyl substances added by 15 U.S.C. 8921(b)(1) and (c)(1)). (EPA periodically updates the lists of covered chemicals at § 372.65(d) and (e) to reflect chemicals that have been added by 15 U.S.C. 8921)</ENT> <ENT>see § 372.65(d) and (e)</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Polychlorinated biphenyl (PCBs)</ENT> <ENT O="xl">01336-36-3</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Tetrabromobisphenol A</ENT> <ENT O="xl">00079-94-7</ENT> <ENT O="xl">100</ENT> </ROW> <ROW> <ENT I="01">Toxaphene</ENT> <ENT O="xl">08001-35-2</ENT> <ENT O="xl">10</ENT> </ROW> <ROW> <ENT I="01">Trifluralin</ENT> <ENT O="xl">01582-09-8</ENT> <ENT O="xl">100</ENT> </ROW> </GPOTABLE> <P>(2) Chemical categories in alphabetic order.</P> <GPOTABLE COLS="2" OPTS="L2" CDEF="s200,xs80"> <TTITLE> Table 2 to Paragraph ( <E T="01">a</E> )(2) </TTITLE> <BOXHD> <CHED H="1">Category name</CHED> <CHED H="1"> Reporting threshold <LI>(in pounds unless</LI> <LI>otherwise noted)</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Dioxin and dioxin-like compounds (Manufacturing; and the processing or otherwise use of dioxin and dioxin-like compounds if the dioxin and dioxin-like compounds are present as contaminants in a chemical and if they were created during the manufacturing of that chemical) (see § 372.65(c) for a list of chemicals covered by this category)</ENT> <ENT>0.1 grams.</ENT> </ROW> <ROW> <ENT I="01">Hexabromocyclododecane (see § 372.65(c) for a list of chemicals covered by this category)</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Lead Compounds</ENT> <ENT>100</ENT> </ROW> <ROW> <ENT I="01">Mercury compounds</ENT> <ENT>10</ENT> </ROW> <ROW> <ENT I="01">Polycyclic aromatic compounds (PACs) (see § 372.65(c) for a list of chemicals covered by this category)</ENT> <ENT>100</ENT> </ROW> </GPOTABLE> <P>(b) The threshold determination provisions under § 372.25(c) through (h) and the exemptions under § 372.38(b) through (h) are applicable to the toxic chemicals listed in paragraph (a) of this section.</P> <CITA>[64 FR 58750, Oct. 29, 1999, as amended at 66 FR 4527, Jan. 17, 2001; 75 FR 72733, Nov. 26, 2010; 81 FR 85444, Nov. 28, 2016; 85 FR 42314, July 14, 2020; 87 FR 73486, Nov. 30, 2022; 88 FR 74368, Oct. 31, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.30</SECTNO> <SUBJECT>Reporting requirements and schedule for reporting.</SUBJECT> <P>(a) For each toxic chemical known by the owner or operator to be manufactured (including imported), processed, or otherwise used in excess of an applicable threshold quantity in §§ 372.25, 372.27, or 372.28 at its covered facility described in § 372.22 for a calendar year, the owner or operator must submit to EPA and to the State in which the facility is located a completed EPA Form R (EPA Form 9350-1), EPA Form A (EPA Form 9350-2), and, for the dioxin and dioxin-like compounds category, EPA Form R Schedule 1 (EPA Form 9350-3) in accordance with the instructions referred to in subpart E of this part. If the covered facility is located in Indian country, the facility shall submit (to the extent applicable) a completed EPA Form R, Form A, and Form R Schedule 1 as described above to EPA and to the official designated by the Tribal Chairperson or equivalent elected official of the relevant Indian Tribe, instead of to the State.</P> <P> (b)(1) The owner or operator of a covered facility is required to report as described in paragraph (a) of this section on a toxic chemical that the owner or operator knows is present as a component of a mixture or trade name product which the owner or operator receives from another person, if that chemical is imported, processed, or <PRTPAGE P="478"/> otherwise used by the owner or operator in excess of an applicable threshold quantity in §§ 372.25, 372.27, or 372.28 at the facility as part of that mixture or trade name product. </P> <P>(2) The owner or operator knows that a toxic chemical is present as a component of a mixture or trade name product (i) if the owner or operator knows or has been told the chemical identity or Chemical Abstracts Service Registry Number of the chemical and the identity or Number corresponds to an identity or Number in § 372.65, or (ii) if the owner or operator has been told by the supplier of the mixture or trade name product that the mixture or trade name product contains a toxic chemical subject to section 313 of the Act or this part.</P> <P>(3) To determine whether a toxic chemical which is a component of a mixture or trade name product has been imported, processed, or otherwise used in excess of an applicable threshold in §§ 372.25, 372.27, or 372.28 at the facility, the owner or operator shall consider only the portion of the mixture or trade name product that consists of the toxic chemical and that is imported, processed, or otherwise used at the facility, together with any other amounts of the same toxic chemical that the owner or operator manufactures, imports, processes, or otherwise uses at the facility as follows:</P> <P>(i) If the owner or operator knows the specific chemical identity of the toxic chemical and the specific concentration at which it is present in the mixture or trade name product, the owner or operator shall determine the weight of the chemical imported, processed, or otherwise used as part of the mixture or trade name product at the facility and shall combine that with the weight of the toxic chemical manufactured (including imported), processed, or otherwise used at the facility other than as part of the mixture or trade name product. After combining these amounts, if the owner or operator determines that the toxic chemical was manufactured, processed, or otherwise used in excess of an applicable threshold in §§ 372.25, 372.27, or 372.28, the owner or operator shall report the specific chemical identity and all releases of the toxic chemical on EPA Form R in accordance with the instructions referred to in subpart E of this part.</P> <P>(ii) If the owner or operator knows the specific chemical identity of the toxic chemical and does not know the specific concentration at which the chemical is present in the mixture or trade name product, but has been told the upper bound concentration of the chemical in the mixture or trade name product, the owner or operator shall assume that the toxic chemical is present in the mixture or trade name product at the upper bound concentration, shall determine whether the chemical has been manufactured, processed, or otherwise used at the facility in excess of an applicable threshold as provided in paragraph (b)(3)(i) of this section, and shall report as provided in paragraph (b)(3)(i) of this section.</P> <P>(iii) If the owner or operator knows the specific chemical identity of the toxic chemical, does not know the specific concentration at which the chemical is present in the mixture or trade name product, has not been told the upper bound concentration of the chemical in the mixture or trade name product, and has not otherwise developed information on the composition of the chemical in the mixture or trade name product, then the owner or operator is not required to factor that chemical in that mixture or trade name product into threshold and release calculations for that chemical.</P> <P> (iv) If the owner or operator has been told that a mixture or trade name product contains a toxic chemical, does not know the specific chemical identity of the chemical and knows the specific concentration at which it is present in the mixture or trade name product, the owner or operator shall determine the weight of the chemical imported, processed, or otherwise used as part of the mixture or trade name product at the facility. Since the owner or operator does not know the specific identity of the toxic chemical, the owner or operator shall make the threshold determination only for the weight of the toxic chemical in the mixture or trade name product. If the owner or operator determines that the toxic chemical was imported, processed, or otherwise used as part of the <PRTPAGE P="479"/> mixture or trade name product in excess of an applicable threshold in §§ 372.25, 372.27, or 372.28, the owner or operator shall report the generic chemical name of the toxic chemical, or a trade name if the generic chemical name is not known, and all releases of the toxic chemical on EPA Form R in accordance with the instructions referred to in subpart E of this part. </P> <P>(v) If the owner or operator has been told that a mixture or trade name product contains a toxic chemical, does not know the specific chemical identity of the chemical, and does not know the specific concentration at which the chemical is present in the mixture or trade name product, but has been told the upper bound concentration of the chemical in the mixture or trade name product, the owner or operator shall assume that the toxic chemical is present in the mixture or trade name product at the upper bound concentration, shall determine whether the chemical has been imported, processed, or otherwise used at the facility in excess of an applicable threshold as provided in paragraph (b)(3)(iv) of this section, and shall report as provided in paragraph (b)(3)(iv) of this section.</P> <P>(vi) If the owner or operator has been told that a mixture or trade name product contains a toxic chemical, does not know the specific chemical identity of the chemical, does not know the specific concentration at which the chemical is present in the mixture or trade name product, including information they have themselves developed, and has not been told the upper bound concentration of the chemical in the mixture or trade name product, the owner or operator is not required to report with respect to that toxic chemical.</P> <P>(c) A covered facility may consist of more than one establishment. The owner or operator of such a facility at which a toxic chemical was manufactured (including imported), processed, or otherwise used in excess of an applicable threshold may submit a separate Form R for each establishment or for each group of establishments within the facility to report the activities involving the toxic chemical at each establishment or group of establishments, provided that activities involving that toxic chemical at all the establishments within the covered facility are reported. If each establishment or group of establishments files separate reports then for all other chemicals subject to reporting at that facility they must also submit separate reports. However, an establishment or group of establishments does not have to submit a report for a chemical that is not manufactured (including imported), processed, otherwise used, or released at that establishment or group of establishments.</P> <P>(d) Each report under this section for activities involving a toxic chemical that occurred during a calendar year at a covered facility must be submitted on or before July 1 of the next year. The first such report for calendar year 1987 activities must be submitted on or before July 1, 1988.</P> <CITA>[53 FR 4525, Feb. 16, 1988; 53 FR 12748, Apr. 18, 1988, as amended at 56 FR 29185, June 26, 1991; 64 FR 58751, Oct. 29, 1999; 72 FR 26553, May 10, 2007; 77 FR 23418, Apr. 19, 2012; 85 FR 37357, June 22, 2020; 88 FR 74368, Oct. 31, 2023]</CITA> </SECTION> <SECTION> <SECTNO>§ 372.38</SECTNO> <SUBJECT>Exemptions.</SUBJECT> <P> (a) <E T="03">De minimis concentrations of a toxic chemical in a mixture.</E> (1) If a toxic chemical is present in a mixture of chemicals at a covered facility and the toxic chemical is in a concentration in the mixture which is below 1 percent of the mixture, or 0.1 percent of the mixture in the case of a toxic chemical which is a carcinogen, a person is not required to consider the quantity of the toxic chemical present in such mixture when determining whether an applicable threshold has been met under § 372.25 or determining the amount of release to be reported under § 372.30. For purposes of the exemption in this paragraph (a), the following sources establish a chemical as a carcinogen or potential carcinogen: </P> <P>(i) National Toxicology Program (NTP), Annual Report on Carcinogens (latest edition);</P> <P>(ii) International Agency for Research on Cancer (IARC) Monographs (latest editions); or</P> <P> (iii) 29 CFR part 1910, subpart Z, Toxic and Hazardous Substances, Occupational Safety and Health Administration. <PRTPAGE P="480"/> </P> <P>(2) The exemption in this paragraph (a) applies whether the person received the mixture from another person, or the person produced the mixture, either by mixing the chemicals involved or by causing a chemical reaction which resulted in the creation of the toxic chemical in the mixture. However, this exemption applies only to the quantity of the toxic chemical present in the mixture. If the toxic chemical is also manufactured (including imported), processed, or otherwise used at the covered facility other than as part of the mixture or in a mixture at higher concentrations, in excess of an applicable threshold quantity set forth in § 372.25, the person is required to report under § 372.30. This exemption does not apply to toxic chemicals listed in § 372.28.</P> <P> (b) <E T="03">Articles.</E> If a toxic chemical is present in an article at a covered facility, a person is not required to consider the quantity of the toxic chemical present in such article when determining whether an applicable threshold has been met under §§ 372.25, 372.27, or 372.28 or determining the amount of release to be reported under § 372.30. This exemption applies whether the person received the article from another person or the person produced the article. However, this exemption applies only to the quantity of the toxic chemical present in the article. If the toxic chemical is manufactured (including imported), processed, or otherwise used at the covered facility other than as part of the article, in excess of an applicable threshold quantity set forth in § 372.25, § 372.27, or § 372.28, the person is required to report under § 372.30. Persons potentially subject to this exemption should carefully review the definitions of <E T="03">article</E> and <E T="03">release</E> in § 372.3. If a release of a toxic chemical occurs as a result of the processing or use of an item at the facility, that item does not meet the definition of <E T="03">article.</E> </P> <P> (c) <E T="03">Uses.</E> If a toxic chemical is used at a covered facility for a purpose described in this paragraph (c), a person is not required to consider the quantity of the toxic chemical used for such purpose when determining whether an applicable threshold has been met under §§ 372.25, 372.27, or 372.28 or determining the amount of releases to be reported under § 372.30. However, this exemption only applies to the quantity of the toxic chemical used for the purpose described in this paragraph (c). If the toxic chemical is also manufactured (including imported), processed, or otherwise used at the covered facility other than as described in this paragraph (c), in excess of an applicable threshold quantity set forth in § 372.25, § 372.27, or § 372.28, the person is required to report under § 372.30. </P> <P>(1) Use as a structural component of the facility.</P> <P>(2) Use of products for routine janitorial or facility grounds maintenance. Examples include use of janitorial cleaning supplies, fertilizers, and pesticides similar in type or concentration to consumer products.</P> <P>(3) Personal use by employees or other persons at the facility of foods, drugs, cosmetics, or other personal items containing toxic chemicals, including supplies of such products within the facility such as in a facility operated cafeteria, store, or infirmary.</P> <P>(4) Use of products containing toxic chemicals for the purpose of maintaining motor vehicles operated by the facility.</P> <P>(5) Use of toxic chemicals present in process water and non-contact cooling water as drawn from the environment or from municipal sources, or toxic chemicals present in air used either as compressed air or as part of combustion.</P> <P> (d) <E T="03">Activities in laboratories.</E> If a toxic chemical is manufactured, processed, or used in a laboratory at a covered facility under the supervision of a technically qualified individual as defined in § 720.3 of this title, a person is not required to consider the quantity so manufactured, processed, or used when determining whether an applicable threshold has been met under §§ 372.25, 372.27, or 372.28 or determining the amount of release to be reported under § 372.30. This exemption does not apply in the following cases: </P> <P>(1) Specialty chemical production.</P> <P>(2) Manufacture, processing, or use of toxic chemicals in pilot plant scale operations.</P> <P> (3) Activities conducted outside the laboratory. <PRTPAGE P="481"/> </P> <P> (e) <E T="03">Certain owners of leased property.</E> The owner of a covered facility is not subject to reporting under § 372.30 if such owner's only interest in the facility is ownership of the real estate upon which the facility is operated. This exemption applies to owners of facilities such as industrial parks, all or part of which are leased to persons who operate establishments in any SIC code or NAICS code in § 372.23 that is subject to the requirements of this part, where the owner has no other business interest in the operation of the covered facility. </P> <P> (f) <E T="03">Reporting by certain operators of establishments on leased property such as industrial parks.</E> If two or more persons, who do not have any common corporate or business interest (including common ownership or control), operate separate establishments within a single facility, each such person shall treat the establishments it operates as a facility for purposes of this part. The determinations in §§ 372.22 and 372.25 shall be made for those establishments. If any such operator determines that its establishment is a covered facility under § 372.22 and that a toxic chemical has been manufactured (including imported), processed, or otherwise used at the establishment in excess of an applicable threshold in §§ 372.25, 372.27, or 372.28 for a calendar year, the operator shall submit a report in accordance with § 372.30 for the establishment. For purposes of this paragraph (f), a common corporate or business interest includes ownership, partnership, joint ventures, ownership of a controlling interest in one person by the other, or ownership of a controlling interest in both persons by a third person. </P> <P> (g) <E T="03">Coal extraction activities.</E> If a toxic chemical is manufactured, processed, or otherwise used in extraction by facilities in SIC code 12, or in NAICS codes 212111, 212112 or 212113, a person is not required to consider the quantity of the toxic chemical so manufactured, processed, or otherwise used when determining whether an applicable threshold has been met under §§ 372.25, 372.27, or 372.28, or determining the amounts to be reported under § 372.30. </P> <P> (h) <E T="03">Metal mining overburden.</E> If a toxic chemical that is a constituent of overburden is processed or otherwise used by facilities in SIC code 10, or in NAICS codes 212221, 212222, 212230 or 212299, a person is not required to consider the quantity of the toxic chemical so processed, or otherwise used when determining whether an applicable threshold has been met under §§ 372.25, 372.27, or 372.28, or determining the amounts to be reported under § 372.30. </P> <CITA>[53 FR 4525, Feb. 16, 1988, as amended at 62 FR 23892, May 1, 1997; 64 FR 58751, Oct. 29, 1999; 71 FR 32477, June 6, 2006; 82 FR 60911, Dec. 26, 2017; 85 FR 37357, June 22, 2020; 85 FR 42314, July 14, 2020; 88 FR 74368, Oct. 31, 2023; 89 FR 102789, Dec. 18, 2024]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart C—Supplier Notification Requirements</HD> <SECTION> <SECTNO>§ 372.45</SECTNO> <SUBJECT>Notification about toxic chemicals.</SUBJECT> <P>(a) Except as provided in paragraphs (c), (d), and (e) of this section and § 372.65, a person who owns or operates a facility or establishment which:</P> <P>(1) Is in SIC codes 20 through 39 or a NAICS code that corresponds to SIC codes 20 through 39 as set forth in § 372.23(b),</P> <P>(2) Manufactures (including imports) or processes a toxic chemical, and</P> <P>(3) Sells or otherwise distributes a mixture or trade name product containing the toxic chemical, to (i) a facility described in § 372.22, or (ii) to a person who in turn may sell or otherwise distributes such mixture or trade name product to a facility described in § 372.22(b), must notify each person to whom the mixture or trade name product is sold or otherwise distributed from the facility or establishment in accordance with paragraph (b) of this section.</P> <P>(b) The notification required in paragraph (a) of this section shall be in writing and shall include:</P> <P>(1) A statement that the mixture or trade name product contains a toxic chemical or chemicals subject to the reporting requirements of section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 and 40 CFR part 372.</P> <P> (2) The name of each toxic chemical, and the associated Chemical Abstracts Service registry number of each chemical if applicable, as set forth in § 372.65. <PRTPAGE P="482"/> </P> <P>(3) The percent by weight of each toxic chemical in the mixture or trade name product.</P> <P>(c) Notification under this section shall be provided as follows:</P> <P>(1) For a mixture or trade name product containing a toxic chemical listed in § 373.65 with an effective date of January 1, 1987, the person shall provide the written notice described in paragraph (b) of this section to each recipient of the mixture or trade name product with at least the first shipment of each mixture or trade name product to each recipient in each calendar year beginning January 1, 1989.</P> <P>(2) For a mixture or trade name product containing a toxic chemical listed in § 372.65 with an effective date of January 1, 1989 or later, the person shall provide the written notice described in paragraph (b) of this section to each recipient of the mixture or trade name product with at least the first shipment of the mixture or trade name product to each recipient in each calendar year beginning with the applicable effective date.</P> <P>(3) If a person changes a mixture or trade name product for which notification was previously provided under paragraph (b) of this section by adding a toxic chemical, removing a toxic chemical, or changing the percent by weight of a toxic chemical in the mixture or trade name product, the person shall provide each recipient of the changed mixture or trade name product a revised notification reflecting the change with the first shipment of the changed mixture or trade name product to the recipient.</P> <P>(4) If a person discovers (i) that a mixture or trade name product previously sold or otherwise distributed to another person during the calendar year of the discovery contains one or more toxic chemicals and (ii), that any notification provided to such other persons in that calendar year for the mixture or trade name product either did not properly identify any of the toxic chemicals or did not accurately present the percent by weight of any of the toxic chemicals in the mixture or trade name product, the person shall provide a new notification to the recipient within 30 days of the discovery which contains the information described in paragraph (b) of this section and identifies the prior shipments of the mixture or product in that calendar year to which the new notification applies.</P> <P>(5) If a Material Safety Data Sheet (MSDS) is required to be prepared and distributed for the mixture or trade name product in accordance with 29 CFR 1910.1200, the notification must be attached to or otherwise incorporated into such MSDS. When the notification is attached to the MSDS, the notice must contain clear instructions that the notifications must not be detached from the MSDS and that any copying and redistribution of the MSDS shall include copying and redistribution of the notice attached to copies of the MSDS subsequently redistributed.</P> <P>(d) Notifications are not required in the following instances:</P> <P> (1) If a mixture or trade name product contains no toxic chemical in excess of the applicable <E T="03">de minimis</E> concentration as specified in § 372.38(a), except for chemicals listed in § 372.28(a), which are excluded from the <E T="03">de minimis</E> exemption. </P> <P>(2) If a mixture or trade name product is one of the following:</P> <P> (i) An <E T="03">article</E> as defined in § 372.3 </P> <P>(ii) Foods, drugs, cosmetics, alcoholic beverages, tobacco, or tobacco products packaged for distribution to the general public.</P> <P> (iii) Any consumer product as the term is defined in the Consumer Product Safety Act (15 U.S.C. 1251 <E T="03">et seq.</E> ) packaged for distribution to the general public. </P> <P>(e) If the person considers the specific identity of a toxic chemical in a mixture or trade name product to be a trade secret under provisions of 29 CFR 1910.1200, the notice shall contain a generic chemical name that is descriptive of that toxic chemical.</P> <P> (f) If the person considers the specific percent by weight composition of a toxic chemical in the mixture or trade name product to be a trade secret under applicable State law or under the Restatement of Torts section 757, comment b, the notice must contain a statement that the chemical is present at a concentration that does not exceed a specified upper bound concentration value. For example, a mixture contains <PRTPAGE P="483"/> 12 percent of a toxic chemical. However, the supplier considers the specific concentration of the toxic chemical in the product to be a trade secret. The notice would indicate that the toxic chemical is present in the mixture in a concentration of no more than 15 percent by weight. The upper bound value chosen must be no larger than necessary to adequately protect the trade secret. </P> <P>(g) A person is not subject to the requirements of this section to the extent the person does not know that the facility or establishment(s) is selling or otherwise distributing a toxic chemical to another person in a mixture or trade name product. However, for purposes of this section, a person has such knowledge if the person receives a notice under this section from a supplier of a mixture or trade name product and the person in turn sells or otherwise distributes that mixture or trade name product to another person.</P> <P>(h) If two or more persons, who do not have any common corporate or business interest (including common ownership or control), as described in § 372.38(f), operate separate establishments within a single facility, each such persons shall treat the establishment(s) it operates as a facility for purposes of this section. The determination under paragraph (a) of this section shall be made for those establishments.</P> <CITA>[53 FR 4525, Feb. 16, 1988; 53 FR 12748, Apr. 18, 1988; 71 FR 32477, June 6, 2006; 88 FR 74368, Oct. 31, 2023]</CITA> </SECTION> </SUBPART> <SUBPART> <HD SOURCE="HED">Subpart D—Specific Toxic Chemical Listings</HD> <SECTION> <SECTNO>§ 372.65</SECTNO> <SUBJECT>Chemicals and chemical categories to which this part applies.</SUBJECT> <P>The requirements of this part apply to the chemicals and chemical categories listed in this section. This section contains five listings. Paragraph (a) of this section is an alphabetical order listing of those chemicals that have an associated Chemical Abstracts Service (CAS) Registry number. Paragraph (b) of this section contains a CAS number order list of the same chemicals listed in paragraph (a) of this section. Paragraph (c) of this section contains the chemical categories for which reporting is required. These chemical categories are listed in alphabetical order and do not have CAS numbers. Paragraph (d) of this section is an alphabetical order listing of the per- and polyfluoroalkyl substances and their associated CAS Registry number. Paragraph (e) of this section contains a CAS number order list of the same chemicals listed in paragraph (d) of this section. Each listing identifies the effective date for reporting under § 372.30.</P> <P> (a) <E T="03">Alphabetical listing.</E> </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="s140,12,7"> <TTITLE> Table 1 to Paragraph <E T="01">(a)</E> </TTITLE> <BOXHD> <CHED H="1">Chemical name</CHED> <CHED H="1">CAS No.</CHED> <CHED H="1">Effective date</CHED> </BOXHD> <ROW> <ENT I="01">Abamectin</ENT> <ENT>71751-41-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Acephate</ENT> <ENT>30560-19-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Acetaldehyde</ENT> <ENT>75-07-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acetamide</ENT> <ENT>60-35-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acetonitrile</ENT> <ENT>75-05-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acetophenone</ENT> <ENT>98-86-2</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">2-Acetylaminofluorene</ENT> <ENT>53-96-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acifluorfen, sodium salt</ENT> <ENT>62476-59-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Acrolein</ENT> <ENT>107-02-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acrylamide</ENT> <ENT>79-06-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acrylic acid</ENT> <ENT>79-10-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Acrylonitrile</ENT> <ENT>107-13-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Alachlor</ENT> <ENT>15972-60-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Aldicarb</ENT> <ENT>116-06-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Aldrin</ENT> <ENT>309-00-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">d-trans</E> -Allethrin </ENT> <ENT>28434-00-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Allyl alcohol</ENT> <ENT>107-18-6</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">Allylamine</ENT> <ENT>107-11-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Allyl chloride</ENT> <ENT>107-05-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Aluminum (fume or dust)</ENT> <ENT>7429-90-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Aluminum oxide (fibrous forms) (Alumina)</ENT> <ENT>1344-28-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <PRTPAGE P="484"/> <ENT I="01">Aluminum phosphide</ENT> <ENT>20859-73-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Ametryn</ENT> <ENT>834-12-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Aminoanthraquinone</ENT> <ENT>117-79-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4-Aminoazobenzene</ENT> <ENT>60-09-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4-Aminobiphenyl</ENT> <ENT>92-67-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1-Amino-2,4-dibromoanthraquinone</ENT> <ENT>81-49-2</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">1-Amino-2-methylanthraquinone</ENT> <ENT>82-28-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Amitraz</ENT> <ENT>33089-61-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Amitrole</ENT> <ENT>61-82-5</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Ammonia (includes anhydrous ammonia and aqueous ammonia from water dissociable ammonium salts and other sources; 10 percent of total aqueous ammonia is reportable under this listing)</ENT> <ENT>7664-41-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Anilazine</ENT> <ENT>101-05-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Aniline</ENT> <ENT>62-53-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Anisidine </ENT> <ENT>90-04-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Anisidine </ENT> <ENT>104-94-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Anisidine hydrochloride </ENT> <ENT>134-29-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Anthracene</ENT> <ENT>120-12-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Antimony</ENT> <ENT>7440-36-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Arsenic</ENT> <ENT>7440-38-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Asbestos (friable)</ENT> <ENT>1332-21-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Atrazine</ENT> <ENT>1912-24-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Barium</ENT> <ENT>7440-39-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Bendiocarb</ENT> <ENT>22781-23-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Benfluralin</ENT> <ENT>1861-40-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Benomyl</ENT> <ENT>17804-35-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Benzal chloride</ENT> <ENT>98-87-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzamide</ENT> <ENT>55-21-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzene</ENT> <ENT>71-43-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzidine</ENT> <ENT>92-87-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzo[g,h,i]perylene</ENT> <ENT>191-24-2</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">Benzoic trichloride (Benzotrichloride)</ENT> <ENT>98-07-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzoyl chloride</ENT> <ENT>98-88-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzoyl peroxide</ENT> <ENT>94-36-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Benzyl chloride</ENT> <ENT>100-44-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Beryllium</ENT> <ENT>7440-41-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Bifenthrin</ENT> <ENT>82657-04-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Biphenyl</ENT> <ENT>92-52-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,2-Bis(bromomethyl)-1,3-propanediol</ENT> <ENT>3296-90-0</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Bis(2-chloroethoxy)methane</ENT> <ENT>111-91-1</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Bis(2-chloroethyl) ether</ENT> <ENT>111-44-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Bis(chloromethyl) ether</ENT> <ENT>542-88-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Bis(2-chloro-1-methylethyl) ether</ENT> <ENT>108-60-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Bis(tributyltin) oxide</ENT> <ENT>56-35-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Boron trichloride</ENT> <ENT>10294-34-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Boron trifluoride</ENT> <ENT>7637-07-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Bromacil</ENT> <ENT>314-40-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Bromacil, lithium salt</ENT> <ENT>53404-19-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Bromine</ENT> <ENT>7726-95-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile</ENT> <ENT>35691-65-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Bromochlorodifluoromethane (Halon 1211)</ENT> <ENT>353-59-3</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">Bromoform (Tribromomethane)</ENT> <ENT>75-25-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Bromomethane (Methyl bromide)</ENT> <ENT>74-83-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1-Bromopropane</ENT> <ENT>106-94-5</ENT> <ENT>1/1/16</ENT> </ROW> <ROW> <ENT I="01">Bromotrifluoromethane (Halon 1301)</ENT> <ENT>75-63-8</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">Bromoxynil</ENT> <ENT>1689-84-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Bromoxynil octanoate</ENT> <ENT>1689-99-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Brucine</ENT> <ENT>357-57-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,3-Butadiene</ENT> <ENT>106-99-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Butyl acrylate</ENT> <ENT>141-32-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">n</E> -Butyl alcohol (1-Butanol) </ENT> <ENT>71-36-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">sec</E> -Butyl alcohol (2-Butanol) </ENT> <ENT>78-92-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">tert</E> -Butyl alcohol (tert-Butanol) </ENT> <ENT>75-65-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,2-Butylene oxide</ENT> <ENT>106-88-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Butyraldehyde</ENT> <ENT>123-72-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Acid Green 3</ENT> <ENT>4680-78-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Acid Red 114</ENT> <ENT>6459-94-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">C.I. Basic Green 4 (Malachite green)</ENT> <ENT>569-64-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Basic Red 1</ENT> <ENT>989-38-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Direct Black 38</ENT> <ENT>1937-37-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Direct Blue 6</ENT> <ENT>2602-46-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Direct Blue 218</ENT> <ENT>28407-37-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="485"/> <ENT I="01">C.I. Direct Brown 95</ENT> <ENT>16071-86-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Disperse Yellow 3</ENT> <ENT>2832-40-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Food Red 5</ENT> <ENT>3761-53-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Food Red 15 (Rhodamine B)</ENT> <ENT>81-88-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Solvent Orange 7</ENT> <ENT>3118-97-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Solvent Yellow 3</ENT> <ENT>97-56-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Solvent Yellow 14</ENT> <ENT>842-07-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Solvent Yellow 34 (Auramine)</ENT> <ENT>492-80-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">C.I. Vat Yellow 4</ENT> <ENT>128-66-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cadmium</ENT> <ENT>7440-43-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Calcium cyanamide</ENT> <ENT>156-62-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Captan</ENT> <ENT>133-06-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Carbaryl</ENT> <ENT>63-25-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Carbofuran</ENT> <ENT>1563-66-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Carbon disulfide</ENT> <ENT>75-15-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Carbon tetrachloride</ENT> <ENT>56-23-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Carbonyl sulfide</ENT> <ENT>463-58-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Carboxin</ENT> <ENT>5234-68-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Catechol</ENT> <ENT>120-80-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chinomethionate</ENT> <ENT>2439-01-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chloramben</ENT> <ENT>133-90-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chlordane</ENT> <ENT>57-74-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chlorendic acid</ENT> <ENT>115-28-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorimuron-ethyl</ENT> <ENT>90982-32-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorine</ENT> <ENT>7782-50-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chlorine dioxide</ENT> <ENT>10049-04-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chloroacetic acid</ENT> <ENT>79-11-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2-Chloroacetophenone</ENT> <ENT>532-27-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride</ENT> <ENT>4080-31-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Chloroaniline </ENT> <ENT>106-47-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorobenzene</ENT> <ENT>108-90-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chlorobenzilate</ENT> <ENT>510-15-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1-Chloro-1,1-difluoroethane (HCFC-142b)</ENT> <ENT>75-68-3</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Chlorodifluoromethane (HCFC-22)</ENT> <ENT>75-45-6</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Chloroethane</ENT> <ENT>75-00-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chloroform</ENT> <ENT>67-66-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chloromethane</ENT> <ENT>74-87-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Chloromethyl methyl ether</ENT> <ENT>107-30-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3-Chloro-2-methyl-1-propene</ENT> <ENT>563-47-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Chlorophenyl isocyanate </ENT> <ENT>104-12-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chloropicrin</ENT> <ENT>76-06-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chloroprene</ENT> <ENT>126-99-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3-Chloropropionitrile</ENT> <ENT>542-76-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorotetrafluoroethane</ENT> <ENT>63938-10-3</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">1-Chloro-1,1,2,2-tetrafluoroethane (HCFC-124a)</ENT> <ENT>354-25-6</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">2-Chloro-1,1,1,2-tetrafluoroethane (HCFC-124)</ENT> <ENT>2837-89-0</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Chlorothalonil</ENT> <ENT>1897-45-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Chloro- <E T="03">o</E> -toluidine (4-Chloro-2-methylaniline) </ENT> <ENT>95-69-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Chloro-1,1,1-trifluoroethane (HCFC-133a)</ENT> <ENT>75-88-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorotrifluoromethane (CFC-13)</ENT> <ENT>75-72-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3-Chloro-1,1,1-trifluoropropane (HCFC-253fb)</ENT> <ENT>460-35-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorpyrifos-methyl</ENT> <ENT>5598-13-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chlorsulfuron</ENT> <ENT>64902-72-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Chromium</ENT> <ENT>7440-47-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cobalt</ENT> <ENT>7440-48-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Copper</ENT> <ENT>7440-50-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Creosote</ENT> <ENT>8001-58-9</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Cresidine </ENT> <ENT>120-71-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cresol (mixed isomers)</ENT> <ENT>1319-77-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">m</E> -Cresol </ENT> <ENT>108-39-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Cresol </ENT> <ENT>95-48-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Cresol </ENT> <ENT>106-44-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Crotonaldehyde</ENT> <ENT>4170-30-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Cumene</ENT> <ENT>98-82-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cumene hydroperoxide</ENT> <ENT>80-15-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cupferron</ENT> <ENT>135-20-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cyanazine</ENT> <ENT>21725-46-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Cycloate</ENT> <ENT>1134-23-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Cyclohexane</ENT> <ENT>110-82-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Cyclohexanol</ENT> <ENT>108-93-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Cyfluthrin</ENT> <ENT>68359-37-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="486"/> <ENT I="01">Cyhalothrin</ENT> <ENT>68085-85-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D</ENT> <ENT>94-75-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dazomet</ENT> <ENT>533-74-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dazomet, sodium salt</ENT> <ENT>53404-60-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-DB</ENT> <ENT>94-82-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D 2-butoxyethyl ester</ENT> <ENT>1929-73-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D butyl ester</ENT> <ENT>94-80-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D chlorocrotyl ester</ENT> <ENT>2971-38-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Decabromodiphenyl oxide</ENT> <ENT>1163-19-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Desmedipham</ENT> <ENT>13684-56-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D 2-ethylhexyl ester</ENT> <ENT>1928-43-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D 2-ethyl-4-methylpentyl ester</ENT> <ENT>53404-37-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Diallate</ENT> <ENT>2303-16-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4-Diaminoanisole</ENT> <ENT>615-05-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4-Diaminoanisole sulfate</ENT> <ENT>39156-41-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4,4′-Diaminodiphenyl ether</ENT> <ENT>101-80-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diaminotoluene (mixed isomers) (Toluenediamine)</ENT> <ENT>25376-45-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4-Diaminotoluene (2,4-Toluenediamine)</ENT> <ENT>95-80-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diazinon</ENT> <ENT>333-41-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Diazomethane</ENT> <ENT>334-88-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dibenzofuran</ENT> <ENT>132-64-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,2-Dibromo-3-chloropropane</ENT> <ENT>96-12-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> 2,2-Dibromo-3-nitrilopropionamide  <SU>1</SU> </ENT> <ENT>10222-01-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2-Dibromoethane (Ethylene dibromide)</ENT> <ENT>106-93-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dibromotetrafluoroethane (1,2-Dibromo-1,1,2,2-tetrafluoroethane)</ENT> <ENT>124-73-2</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">Dibutyl phthalate</ENT> <ENT>84-74-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dibutyltin dichloride</ENT> <ENT>683-18-1</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Dicamba</ENT> <ENT>1918-00-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dichloran</ENT> <ENT>99-30-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dichlorobenzene (mixed isomers)</ENT> <ENT>25321-22-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> 1,2-Dichlorobenzene ( <E T="03">o</E> -Dichlorobenzene) </ENT> <ENT>95-50-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> 1,3-Dichlorobenzene ( <E T="03">m</E> -Dichlorobenzene) </ENT> <ENT>541-73-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> 1,4-Dichlorobenzene ( <E T="03">p</E> -Dichlorobenzene) </ENT> <ENT>106-46-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dichlorobenzidine</ENT> <ENT>91-94-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dichlorobenzidine dihydrochloride</ENT> <ENT>612-83-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dichlorobenzidine sulfate</ENT> <ENT>64969-34-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dichlorobromomethane</ENT> <ENT>75-27-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,4-Dichloro-2-butene</ENT> <ENT>764-41-0</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">trans</E> -1,4-Dichloro-2-butene </ENT> <ENT>110-57-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloro-1,1-difluoroethane (HCFC-132b)</ENT> <ENT>1649-08-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dichlorodifluoromethane (CFC-12)</ENT> <ENT>75-71-8</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloroethane</ENT> <ENT>107-06-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloroethylene</ENT> <ENT>540-59-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,1-Dichloro-1-fluoroethane (HCFC-141b)</ENT> <ENT>1717-00-6</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Dichlorofluoromethane (HCFC-21)</ENT> <ENT>75-43-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dichloromethane (Methylene chloride)</ENT> <ENT>75-09-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dichloropentafluoropropane</ENT> <ENT>127564-92-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,1-Dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc)</ENT> <ENT>13474-88-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,1-Dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb)</ENT> <ENT>111512-56-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225bb)</ENT> <ENT>422-44-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloro-1,1,3,3,3-pentafluoropropane (HCFC-225da)</ENT> <ENT>431-86-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,3-Dichloro-1,1,2,2,3-pentafluoropropane (HCFC-225cb)</ENT> <ENT>507-55-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,3-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea)</ENT> <ENT>136013-79-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,2-Dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa)</ENT> <ENT>128903-21-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,3-dichloro-1,1,1,2,3-pentafluoropropane (HCFC-225ba)</ENT> <ENT>422-48-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3,3-Dichloro-1,1,1,2,2-pentafluoropropane (HCFC-225ca)</ENT> <ENT>422-56-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dichlorophene</ENT> <ENT>97-23-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-Dichlorophenol</ENT> <ENT>120-83-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloropropane</ENT> <ENT>78-87-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,3-Dichloro-2-propanol</ENT> <ENT>96-23-1</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2,3-Dichloropropene</ENT> <ENT>78-88-6</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">trans</E> -1,3-Dichloropropene </ENT> <ENT>10061-02-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,3-Dichloropropylene (1,3-Dichloropropene)</ENT> <ENT>542-75-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dichlorotetrafluoroethane (CFC-114)</ENT> <ENT>76-14-2</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">Dichlorotrifluoroethane</ENT> <ENT>34077-87-7</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Dichloro-1,1,2-trifluoroethane</ENT> <ENT>90454-18-5</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">1,1-Dichloro-1,2,2-trifluoroethane (HCFC-123b)</ENT> <ENT>812-04-4</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">1,2-Dichloro-1,1,2-trifluoroethane (HCFC-123a)</ENT> <ENT>354-23-4</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123)</ENT> <ENT>306-83-2</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Dichlorvos</ENT> <ENT>62-73-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diclofop methyl</ENT> <ENT>51338-27-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="487"/> <ENT I="01">Dicofol</ENT> <ENT>115-32-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dicyclopentadiene</ENT> <ENT>77-73-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Diepoxybutane</ENT> <ENT>1464-53-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diethanolamine</ENT> <ENT>111-42-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diethatyl ethyl</ENT> <ENT>38727-55-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Di(2-ethylhexyl) phthalate</ENT> <ENT>117-81-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diethyl sulfate</ENT> <ENT>64-67-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diflubenzuron</ENT> <ENT>35367-38-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Diglycidyl resorcinol ether</ENT> <ENT>101-90-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dihydrosafrole</ENT> <ENT>94-58-6</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Dimethipin</ENT> <ENT>55290-64-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dimethoate</ENT> <ENT>60-51-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethoxybenzidine</ENT> <ENT>119-90-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethoxybenzidine dihydrochloride</ENT> <ENT>20325-40-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethoxybenzidine monohydrochloride</ENT> <ENT>111984-09-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dimethylamine</ENT> <ENT>124-40-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dimethylamine dicamba</ENT> <ENT>2300-66-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">4-Dimethylaminoazobenzene</ENT> <ENT>60-11-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N,N</E> -Dimethylaniline </ENT> <ENT>121-69-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethylbenzidine</ENT> <ENT>119-93-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethylbenzidine dihydrochloride</ENT> <ENT>612-82-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3,3′-Dimethylbenzidine dihydrofluoride</ENT> <ENT>41766-75-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dimethylcarbamoyl chloride</ENT> <ENT>79-44-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dimethyl chlorothiophosphate</ENT> <ENT>2524-03-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N,N</E> -Dimethylformamide </ENT> <ENT>68-12-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,1-Dimethylhydrazine</ENT> <ENT>57-14-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4-Dimethylphenol</ENT> <ENT>105-67-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dimethyl phthalate</ENT> <ENT>131-11-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dimethyl sulfate</ENT> <ENT>77-78-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">m</E> -Dinitrobenzene </ENT> <ENT>99-65-0</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Dinitrobenzene </ENT> <ENT>528-29-0</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Dinitrobenzene </ENT> <ENT>100-25-4</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">Dinitrobutyl phenol (Dinoseb)</ENT> <ENT>88-85-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">4,6-Dinitro-o-cresol</ENT> <ENT>534-52-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4-Dinitrophenol</ENT> <ENT>51-28-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4-Dinitrotoluene</ENT> <ENT>121-14-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,6-Dinitrotoluene</ENT> <ENT>606-20-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dinitrotoluene (mixed isomers)</ENT> <ENT>25321-14-6</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">Dinocap</ENT> <ENT>39300-45-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,4-Dioxane</ENT> <ENT>123-91-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Diphenamid</ENT> <ENT>957-51-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Diphenylamine</ENT> <ENT>122-39-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2-Diphenylhydrazine</ENT> <ENT>122-66-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Dipotassium endothall</ENT> <ENT>2164-07-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dipropyl isocinchomeronate</ENT> <ENT>136-45-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Disodium cyanodithioimidocarbonate</ENT> <ENT>138-93-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D isopropyl ester</ENT> <ENT>94-11-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-Dithiobiuret (Dithiobiuret)</ENT> <ENT>541-53-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Diuron</ENT> <ENT>330-54-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Dodine</ENT> <ENT>2439-10-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-DP (Dichlorprop)</ENT> <ENT>120-36-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D propylene glycol butyl ether ester (2,4-D 2-butoxymethylethyl ester)</ENT> <ENT>1320-18-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2,4-D sodium salt</ENT> <ENT>2702-72-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Epichlorohydrin</ENT> <ENT>106-89-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethoprop</ENT> <ENT>13194-48-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Ethoxyethanol</ENT> <ENT>110-80-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethyl acrylate</ENT> <ENT>140-88-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethylbenzene</ENT> <ENT>100-41-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethyl chloroformate</ENT> <ENT>541-41-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">S</E> -Ethyl dipropylthiocarbamate </ENT> <ENT>759-94-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Ethylene</ENT> <ENT>74-85-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethylene glycol</ENT> <ENT>107-21-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethyleneimine (Aziridine)</ENT> <ENT>151-56-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethylene oxide</ENT> <ENT>75-21-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethylene thiourea</ENT> <ENT>96-45-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Ethylidene dichloride (1,1-Dichloroethane)</ENT> <ENT>75-34-3</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Famphur</ENT> <ENT>52-85-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fenarimol</ENT> <ENT>60168-88-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fenbutatin oxide</ENT> <ENT>13356-08-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fenoxaprop-ethyl</ENT> <ENT>66441-23-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fenoxycarb</ENT> <ENT>72490-01-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="488"/> <ENT I="01">Fenpropathrin</ENT> <ENT>39515-41-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fenthion</ENT> <ENT>55-38-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fenvalerate</ENT> <ENT>51630-58-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Ferbam</ENT> <ENT>14484-64-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fluazifop-butyl</ENT> <ENT>69806-50-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fluometuron</ENT> <ENT>2164-17-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Fluorine</ENT> <ENT>7782-41-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fluorouracil (5-Fluorouracil)</ENT> <ENT>51-21-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fluvalinate</ENT> <ENT>69409-94-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Folpet</ENT> <ENT>133-07-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Fomesafen</ENT> <ENT>72178-02-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Formaldehyde</ENT> <ENT>50-00-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Formamide</ENT> <ENT>75-12-7</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Formic acid</ENT> <ENT>64-18-6</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Freon 113 (CFC-113)</ENT> <ENT>76-13-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Furan</ENT> <ENT>110-00-9</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Glycidol</ENT> <ENT>556-52-5</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Heptachlor</ENT> <ENT>76-44-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hexachlorobenzene</ENT> <ENT>118-74-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hexachloro-1,3-butadiene (Hexachlorobutadiene)</ENT> <ENT>87-68-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">alpha</E> -Hexachlorocyclohexane </ENT> <ENT>319-84-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Hexachlorocyclopentadiene</ENT> <ENT>77-47-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hexachloroethane</ENT> <ENT>67-72-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hexachloronaphthalene</ENT> <ENT>1335-87-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hexachlorophene</ENT> <ENT>70-30-4</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran</ENT> <ENT>1222-05-5</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Hexamethylphosphoramide</ENT> <ENT>680-31-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">n</E> -Hexane (Hexane) </ENT> <ENT>110-54-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Hexazinone</ENT> <ENT>51235-04-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Hydramethylnon</ENT> <ENT>67485-29-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Hydrazine</ENT> <ENT>302-01-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hydrazine sulfate (1:1)</ENT> <ENT>10034-93-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hydrochloric acid (acid aerosols including mists, vapors, gas, fog, and other airborne forms of any particle size)</ENT> <ENT>7647-01-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hydrogen cyanide</ENT> <ENT>74-90-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hydrogen fluoride (Hydrofluoric acid)</ENT> <ENT>7664-39-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Hydrogen sulfide</ENT> <ENT>7783-06-4</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Hydroquinone</ENT> <ENT>123-31-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">N-Hydroxyethylethylenediamine</ENT> <ENT>111-41-1</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Imazalil</ENT> <ENT>35554-44-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3-Iodo-2-propynyl butylcarbamate</ENT> <ENT>55406-53-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Iron pentacarbonyl</ENT> <ENT>13463-40-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Isobutyraldehyde</ENT> <ENT>78-84-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Isodrin</ENT> <ENT>465-73-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Isofenphos</ENT> <ENT>25311-71-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Isoprene</ENT> <ENT>78-79-5</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Isopropyl alcohol (Isopropanol) (only persons who manufacture by the strong acid process are subject, no supplier notification)</ENT> <ENT>67-63-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4,4′-Isopropylidenediphenol</ENT> <ENT>80-05-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Isosafrole</ENT> <ENT>120-58-1</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">Lactofen</ENT> <ENT>77501-63-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Lead</ENT> <ENT>7439-92-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Lindane</ENT> <ENT>58-89-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Linuron</ENT> <ENT>330-55-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Lithium carbonate</ENT> <ENT>554-13-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Malathion</ENT> <ENT>121-75-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Maleic anhydride</ENT> <ENT>108-31-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Malononitrile</ENT> <ENT>109-77-3</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Maneb</ENT> <ENT>12427-38-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Manganese</ENT> <ENT>7439-96-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Mecoprop</ENT> <ENT>93-65-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Mercaptobenzothiazole</ENT> <ENT>149-30-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Mercury</ENT> <ENT>7439-97-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Merphos</ENT> <ENT>150-50-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methacrylonitrile</ENT> <ENT>126-98-7</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Metham sodium (Sodium methyldithiocarbamate)</ENT> <ENT>137-42-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methanol</ENT> <ENT>67-56-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methazole</ENT> <ENT>20354-26-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methiocarb</ENT> <ENT>2032-65-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methoxone (MCPA)</ENT> <ENT>94-74-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methoxone sodium salt</ENT> <ENT>3653-48-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="489"/> <ENT I="01">Methoxychlor</ENT> <ENT>72-43-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2-Methoxyethanol</ENT> <ENT>109-86-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl acrylate</ENT> <ENT>96-33-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl tert-butyl ether</ENT> <ENT>1634-04-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl chlorocarbonate</ENT> <ENT>79-22-1</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">4,4′-Methylenebis(2-chloroaniline)</ENT> <ENT>101-14-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> 4,4′-Methylenebis( <E T="03">N,N</E> -dimethyl)benzenamine (4,4′-Methylenebis[ <E T="03">N,N</E> -dimethylaniline]) </ENT> <ENT>101-61-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methylene bromide (Dibromomethane)</ENT> <ENT>74-95-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4,4′-Methylenedianiline</ENT> <ENT>101-77-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyleugenol</ENT> <ENT>93-15-2</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Methyl hydrazine</ENT> <ENT>60-34-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl iodide</ENT> <ENT>74-88-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl isobutyl ketone</ENT> <ENT>108-10-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl isocyanate</ENT> <ENT>624-83-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Methyl isothiocyanate</ENT> <ENT>556-61-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Methyllactonitrile (Acetone cyanohydrin)</ENT> <ENT>75-86-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methyl mercaptan</ENT> <ENT>74-93-1</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Methyl methacrylate</ENT> <ENT>80-62-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Methylolacrylamide </ENT> <ENT>924-42-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Methyl parathion</ENT> <ENT>298-00-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Methylpyridine</ENT> <ENT>109-06-8</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Methyl-2-pyrrolidone </ENT> <ENT>872-50-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Metiram</ENT> <ENT>9006-42-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Metribuzin</ENT> <ENT>21087-64-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Mevinphos</ENT> <ENT>7786-34-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Michler's ketone</ENT> <ENT>90-94-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Molinate</ENT> <ENT>2212-67-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Molybdenum trioxide</ENT> <ENT>1313-27-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Monochloropentafluoroethane (CFC-115)</ENT> <ENT>76-15-3</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">Monuron</ENT> <ENT>150-68-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Mustard gas</ENT> <ENT>505-60-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Myclobutanil</ENT> <ENT>88671-89-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Nabam</ENT> <ENT>142-59-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Naled</ENT> <ENT>300-76-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Naphthalene</ENT> <ENT>91-20-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">alpha</E> -Naphthylamine (1-Naphthalenamine) </ENT> <ENT>134-32-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">beta</E> -Naphthylamine (2-Naphthalenamine) </ENT> <ENT>91-59-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nickel</ENT> <ENT>7440-02-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitrapyrin</ENT> <ENT>1929-82-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Nitric acid</ENT> <ENT>7697-37-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitrilotriacetic acid</ENT> <ENT>139-13-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitrilotriacetic acid trisodium salt</ENT> <ENT>5064-31-3</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Nitroaniline </ENT> <ENT>100-01-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> 5-Nitro- <E T="03">o</E> -anisidine (2-Methoxy-5-nitroaniline) </ENT> <ENT>99-59-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Nitroanisole </ENT> <ENT>91-23-6</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Nitrobenzene</ENT> <ENT>98-95-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4-Nitrobiphenyl</ENT> <ENT>92-93-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitrofen</ENT> <ENT>1836-75-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitrogen mustard (HN-2)</ENT> <ENT>51-75-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitroglycerin</ENT> <ENT>55-63-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Nitromethane</ENT> <ENT>75-52-5</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01"> 2-Nitrophenol ( <E T="03">o</E> -Nitrophenol) </ENT> <ENT>88-75-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> 4-Nitrophenol ( <E T="03">p</E> -Nitrophenol) </ENT> <ENT>100-02-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2-Nitropropane</ENT> <ENT>79-46-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosodi- <E T="03">n</E> -butylamine </ENT> <ENT>924-16-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosodiethylamine </ENT> <ENT>55-18-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosodimethylamine </ENT> <ENT>62-75-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosodiphenylamine </ENT> <ENT>86-30-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Nitrosodiphenylamine </ENT> <ENT>156-10-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosodi- <E T="03">n</E> -propylamine </ENT> <ENT>621-64-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitroso- <E T="03">N</E> -ethylurea </ENT> <ENT>759-73-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitroso- <E T="03">N</E> -methylurea </ENT> <ENT>684-93-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosomethylvinylamine </ENT> <ENT>4549-40-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosomorpholine </ENT> <ENT>59-89-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosonornicotine </ENT> <ENT>16543-55-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">N</E> -Nitrosopiperidine </ENT> <ENT>100-75-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Nitrotoluene </ENT> <ENT>88-72-2</ENT> <ENT>1/1/14</ENT> </ROW> <ROW> <ENT I="01"> 5-Nitro- <E T="03">o</E> -toluidine (2-Methyl-5-nitroaniline) </ENT> <ENT>99-55-8</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Norflurazon</ENT> <ENT>27314-13-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Octachloronaphthalene</ENT> <ENT>2234-13-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Octachlorostyrene</ENT> <ENT>29082-74-4</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <PRTPAGE P="490"/> <ENT I="01">Oryzalin</ENT> <ENT>19044-88-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Osmium tetroxide</ENT> <ENT>20816-12-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Oxydemeton-methyl</ENT> <ENT>301-12-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Oxadiazon</ENT> <ENT>19666-30-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Oxyfluorfen</ENT> <ENT>42874-03-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Ozone</ENT> <ENT>10028-15-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Paraldehyde</ENT> <ENT>123-63-7</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Paraquat dichloride</ENT> <ENT>1910-42-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Parathion</ENT> <ENT>56-38-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Pebulate</ENT> <ENT>1114-71-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Pendimethalin</ENT> <ENT>40487-42-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Pentachlorobenzene</ENT> <ENT>608-93-5</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">Pentachloroethane</ENT> <ENT>76-01-7</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Pentachlorophenol</ENT> <ENT>87-86-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Pentobarbital sodium</ENT> <ENT>57-33-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Peracetic acid</ENT> <ENT>79-21-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Perchloromethyl mercaptan</ENT> <ENT>594-42-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Permethrin</ENT> <ENT>52645-53-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Phenanthrene</ENT> <ENT>85-01-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Phenol</ENT> <ENT>108-95-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Phenolphthalein (3,3-Bis(4-hydroxyphenyl)phthalide)</ENT> <ENT>77-09-8</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Phenothrin</ENT> <ENT>26002-80-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Phenylenediamine </ENT> <ENT>106-50-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,2-Phenylenediamine</ENT> <ENT>95-54-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,3-Phenylenediamine</ENT> <ENT>108-45-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2-Phenylenediamine dihydrochloride</ENT> <ENT>615-28-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,4-Phenylenediamine dihydrochloride</ENT> <ENT>624-18-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2-Phenylphenol</ENT> <ENT>90-43-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Phenytoin</ENT> <ENT>57-41-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Phosgene</ENT> <ENT>75-44-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Phosphine</ENT> <ENT>7803-51-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Phosphorus (yellow or white)</ENT> <ENT>12185-10-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Phthalic anhydride</ENT> <ENT>85-44-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Picloram</ENT> <ENT>1918-02-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Picric acid</ENT> <ENT>88-89-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Piperonyl butoxide</ENT> <ENT>51-03-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Pirimiphos-methyl</ENT> <ENT>29232-93-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Polychlorinated biphenyls</ENT> <ENT>1336-36-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Potassium bromate</ENT> <ENT>7758-01-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Potassium dimethyldithiocarbamate</ENT> <ENT>128-03-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> Potassium <E T="03">N</E> -methyldithiocarbamate </ENT> <ENT>137-41-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Profenofos</ENT> <ENT>41198-08-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Prometryn</ENT> <ENT>7287-19-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Pronamide</ENT> <ENT>23950-58-5</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Propachlor</ENT> <ENT>1918-16-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,3-Propane sultone</ENT> <ENT>1120-71-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Propanil</ENT> <ENT>709-98-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Propargite</ENT> <ENT>2312-35-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Propargyl alcohol</ENT> <ENT>107-19-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Propetamphos</ENT> <ENT>31218-83-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Propiconazole</ENT> <ENT>60207-90-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">beta</E> -Propiolactone </ENT> <ENT>57-57-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Propionaldehyde</ENT> <ENT>123-38-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Propoxur</ENT> <ENT>114-26-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Propylene</ENT> <ENT>115-07-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Propyleneimine</ENT> <ENT>75-55-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Propylene oxide</ENT> <ENT>75-56-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Pyridine</ENT> <ENT>110-86-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Quinoline</ENT> <ENT>91-22-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Quinone</ENT> <ENT>106-51-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Quintozene (Pentachloronitrobenzene)</ENT> <ENT>82-68-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Quizalofop-ethyl</ENT> <ENT>76578-14-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Resmethrin</ENT> <ENT>10453-86-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Saccharin (only persons who manufacture are subject, no supplier notification)</ENT> <ENT>81-07-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Safrole</ENT> <ENT>94-59-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Selenium</ENT> <ENT>7782-49-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Sethoxydim</ENT> <ENT>74051-80-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Silver</ENT> <ENT>7440-22-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Simazine</ENT> <ENT>122-34-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Sodium azide</ENT> <ENT>26628-22-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Sodium dicamba</ENT> <ENT>1982-69-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="491"/> <ENT I="01">Sodium dimethyldithiocarbamate</ENT> <ENT>128-04-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Sodium fluoroacetate</ENT> <ENT>62-74-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Sodium nitrite</ENT> <ENT>7632-00-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Sodium pentachlorophenate</ENT> <ENT>131-52-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> Sodium <E T="03">o</E> -phenylphenoxide </ENT> <ENT>132-27-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Styrene</ENT> <ENT>100-42-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Styrene oxide</ENT> <ENT>96-09-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Sulfuric acid (acid aerosols including mists, vapors, gas, fog, and other airborne forms of any particle size)</ENT> <ENT>7664-93-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Sulfuryl fluoride</ENT> <ENT>2699-79-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Sulprofos</ENT> <ENT>35400-43-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tebuthiuron</ENT> <ENT>34014-18-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Temephos</ENT> <ENT>3383-96-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Terbacil</ENT> <ENT>5902-51-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tetrabromobisphenol A</ENT> <ENT>79-94-7</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">1,1,1,2-Tetrachloroethane</ENT> <ENT>630-20-6</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrachloroethane</ENT> <ENT>79-34-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Tetrachloroethylene</ENT> <ENT>127-18-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,1,1,2-Tetrachloro-2-fluoroethane (HCFC-121a)</ENT> <ENT>354-11-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrachloro-1-fluoroethane (HCFC-121)</ENT> <ENT>354-14-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tetrachlorvinphos</ENT> <ENT>961-11-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Tetracycline hydrochloride</ENT> <ENT>64-75-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tetrafluoroethylene (Tetrafluoroethene)</ENT> <ENT>116-14-3</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Tetramethrin</ENT> <ENT>7696-12-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">p-(1,1,3,3-Tetramethylbutyl)phenol</ENT> <ENT>140-66-9</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Tetranitromethane</ENT> <ENT>509-14-8</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Thallium</ENT> <ENT>7440-28-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Thiabendazole</ENT> <ENT>148-79-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Thioacetamide</ENT> <ENT>62-55-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Thiobencarb</ENT> <ENT>28249-77-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">4,4′-Thiodianiline</ENT> <ENT>139-65-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Thiodicarb</ENT> <ENT>59669-26-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Thiophanate-ethyl</ENT> <ENT>23564-06-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Thiophanate-methyl</ENT> <ENT>23564-05-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Thiosemicarbazide</ENT> <ENT>79-19-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Thiourea</ENT> <ENT>62-56-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Thiram</ENT> <ENT>137-26-8</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Thorium dioxide</ENT> <ENT>1314-20-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Titanium tetrachloride</ENT> <ENT>7550-45-0</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Toluene</ENT> <ENT>108-88-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Toluene-2,4-diisocyanate</ENT> <ENT>584-84-9</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Toluene-2,6-diisocyanate</ENT> <ENT>91-08-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Toluene diisocyanate (mixed isomers)</ENT> <ENT>26471-62-5</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Toluidine </ENT> <ENT>95-53-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Toluidine hydrochloride </ENT> <ENT>636-21-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Toxaphene</ENT> <ENT>8001-35-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Triadimefon</ENT> <ENT>43121-43-3</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Triallate</ENT> <ENT>2303-17-5</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Triaziquone</ENT> <ENT>68-76-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Tribenuron-methyl</ENT> <ENT>101200-48-0</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tributyltin fluoride</ENT> <ENT>1983-10-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tributyltin methacrylate</ENT> <ENT>2155-70-6</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">S,S,S</E> -Tributyltrithiophosphate (Tribufos) </ENT> <ENT>78-48-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Trichlorfon</ENT> <ENT>52-68-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Trichloroacetyl chloride</ENT> <ENT>76-02-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1,2,3-Trichlorobenzene</ENT> <ENT>87-61-6</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">1,2,4-Trichlorobenzene</ENT> <ENT>120-82-1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,1,1-Trichloroethane</ENT> <ENT>71-55-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,1,2-Trichloroethane</ENT> <ENT>79-00-5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Trichloroethylene</ENT> <ENT>79-01-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Trichlorofluoromethane (CFC-11)</ENT> <ENT>75-69-4</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">2,4,5-Trichlorophenol</ENT> <ENT>95-95-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,4,6-Trichlorophenol</ENT> <ENT>88-06-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1,2,3-Trichloropropane</ENT> <ENT>96-18-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Triclopyr-triethylammonium salt</ENT> <ENT>57213-69-1</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Triethylamine</ENT> <ENT>121-44-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Trifluralin</ENT> <ENT>1582-09-8</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Triforine</ENT> <ENT>26644-46-2</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Triglycidyl isocyanurate</ENT> <ENT>2451-62-9</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">1,2,4-Trimethylbenzene</ENT> <ENT>95-63-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,3,5-Trimethylphenyl methylcarbamate</ENT> <ENT>2655-15-4</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="492"/> <ENT I="01">Triphenyltin chloride</ENT> <ENT>639-58-7</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Triphenyltin hydroxide</ENT> <ENT>76-87-9</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Tris(2-chloroethyl) phosphate</ENT> <ENT>115-96-8</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Tris(2,3-dibromopropyl) phosphate</ENT> <ENT>126-72-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Tris(1,3-dichloro-2-propyl) phosphate</ENT> <ENT>13674-87-8</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Tris(dimethylphenol) phosphate</ENT> <ENT>25155-23-1</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Trypan blue</ENT> <ENT>72-57-1</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">Urethane</ENT> <ENT>51-79-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Vanadium (except when contained in an alloy)</ENT> <ENT>7440-62-2</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">Vinclozolin</ENT> <ENT>50471-44-8</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">Vinyl acetate</ENT> <ENT>108-05-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Vinyl bromide</ENT> <ENT>593-60-2</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Vinyl chloride</ENT> <ENT>75-01-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Vinyl fluoride</ENT> <ENT>75-02-5</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">Vinylidene chloride (1,1-Dichloroethylene)</ENT> <ENT>75-35-4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Xylene (mixed isomers)</ENT> <ENT>1330-20-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">m</E> -Xylene </ENT> <ENT>108-38-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">o</E> -Xylene </ENT> <ENT>95-47-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01"> <E T="03">p</E> -Xylene </ENT> <ENT>106-42-3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2,6-Xylidine</ENT> <ENT>87-62-7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Zinc (fume or dust)</ENT> <ENT>7440-66-6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">Zineb</ENT> <ENT>12122-67-7</ENT> <ENT>1/1/87</ENT> </ROW> <TNOTE> <SU>1</SU>  The listing of 2,2-dibromo-3-nitrilopropionamide (CAS No. 10222-01-2) is stayed. The stay will remain in effect until further administrative action is taken. </TNOTE> </GPOTABLE> <P> (b) <E T="03">CAS Number listing.</E> </P> <GPOTABLE COLS="3" OPTS="L2" CDEF="12,r150,7"> <TTITLE> Table 2 to Paragraph ( <E T="01">b</E> ) </TTITLE> <BOXHD> <CHED H="1">CAS No.</CHED> <CHED H="1">Chemical name</CHED> <CHED H="1">Effective date</CHED> </BOXHD> <ROW> <ENT I="01">50-00-0</ENT> <ENT>Formaldehyde</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">51-03-6</ENT> <ENT>Piperonyl butoxide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">51-21-8</ENT> <ENT>Fluorouracil (5-Fluorouracil)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">51-28-5</ENT> <ENT>2,4-Dinitrophenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">51-75-2</ENT> <ENT>Nitrogen mustard (HN-2)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">51-79-6</ENT> <ENT>Urethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">52-68-6</ENT> <ENT>Trichlorfon</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">52-85-7</ENT> <ENT>Famphur</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">53-96-3</ENT> <ENT>2-Acetylaminofluorene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">55-18-5</ENT> <ENT> <E T="03">N</E> -Nitrosodiethylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">55-21-0</ENT> <ENT>Benzamide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">55-38-9</ENT> <ENT>Fenthion</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">55-63-0</ENT> <ENT>Nitroglycerin</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">56-23-5</ENT> <ENT>Carbon tetrachloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">56-35-9</ENT> <ENT>Bis(tributyltin) oxide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">56-38-2</ENT> <ENT>Parathion</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">57-14-7</ENT> <ENT>1,1-Dimethylhydrazine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">57-33-0</ENT> <ENT>Pentobarbital sodium</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">57-41-0</ENT> <ENT>Phenytoin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">57-57-8</ENT> <ENT> <E T="03">beta</E> -Propiolactone </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">57-74-9</ENT> <ENT>Chlordane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">58-89-9</ENT> <ENT>Lindane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">59-89-2</ENT> <ENT> <E T="03">N</E> -Nitrosomorpholine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">60-09-3</ENT> <ENT>4-Aminoazobenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">60-11-7</ENT> <ENT>4-Dimethylaminoazobenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">60-34-4</ENT> <ENT>Methyl hydrazine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">60-35-5</ENT> <ENT>Acetamide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">60-51-5</ENT> <ENT>Dimethoate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">61-82-5</ENT> <ENT>Amitrole</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">62-53-3</ENT> <ENT>Aniline</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">62-55-5</ENT> <ENT>Thioacetamide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">62-56-6</ENT> <ENT>Thiourea</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">62-73-7</ENT> <ENT>Dichlorvos</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">62-74-8</ENT> <ENT>Sodium fluoroacetate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">62-75-9</ENT> <ENT> <E T="03">N</E> -Nitrosodimethylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">63-25-2</ENT> <ENT>Carbaryl</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">64-18-6</ENT> <ENT>Formic acid</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <PRTPAGE P="493"/> <ENT I="01">64-67-5</ENT> <ENT>Diethyl sulfate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">64-75-5</ENT> <ENT>Tetracycline hydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">67-56-1</ENT> <ENT>Methanol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">67-63-0</ENT> <ENT>Isopropyl alcohol (Isopropanol) (only persons who manufacture by the strong acid process are subject, no supplier notification)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">67-66-3</ENT> <ENT>Chloroform</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">67-72-1</ENT> <ENT>Hexachloroethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">68-12-2</ENT> <ENT> <E T="03">N,N</E> -Dimethylformamide </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">68-76-8</ENT> <ENT>Triaziquone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">70-30-4</ENT> <ENT>Hexachlorophene</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">71-36-3</ENT> <ENT> <E T="03">n</E> -Butyl alcohol (1-Butanol) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">71-43-2</ENT> <ENT>Benzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">71-55-6</ENT> <ENT>1,1,1-Trichloroethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">72-43-5</ENT> <ENT>Methoxychlor</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">72-57-1</ENT> <ENT>Trypan blue</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">74-83-9</ENT> <ENT>Bromomethane (Methyl bromide)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">74-85-1</ENT> <ENT>Ethylene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">74-87-3</ENT> <ENT>Chloromethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">74-88-4</ENT> <ENT>Methyl iodide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">74-90-8</ENT> <ENT>Hydrogen cyanide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">74-93-1</ENT> <ENT>Methyl mercaptan</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">74-95-3</ENT> <ENT>Methylene bromide (Dibromomethane)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-00-3</ENT> <ENT>Chloroethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-01-4</ENT> <ENT>Vinyl chloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-02-5</ENT> <ENT>Vinyl fluoride</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">75-05-8</ENT> <ENT>Acetonitrile</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-07-0</ENT> <ENT>Acetaldehyde</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-09-2</ENT> <ENT>Dichloromethane (Methylene chloride)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-12-7</ENT> <ENT>Formamide</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">75-15-0</ENT> <ENT>Carbon disulfide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-21-8</ENT> <ENT>Ethylene oxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-25-2</ENT> <ENT>Bromoform (Tribromomethane)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-27-4</ENT> <ENT>Dichlorobromomethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-34-3</ENT> <ENT>Ethylidene dichloride (1,1-Dichloroethane)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">75-35-4</ENT> <ENT>Vinylidene chloride (1,1-Dichloroethylene)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-43-4</ENT> <ENT>Dichlorofluoromethane (HCFC-21)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">75-44-5</ENT> <ENT>Phosgene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-45-6</ENT> <ENT>Chlorodifluoromethane (HCFC-22)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">75-52-5</ENT> <ENT>Nitromethane</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">75-55-8</ENT> <ENT>Propyleneimine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-56-9</ENT> <ENT>Propylene oxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-63-8</ENT> <ENT>Bromotrifluoromethane (Halon 1301)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">75-65-0</ENT> <ENT> <E T="03">tert</E> -Butyl alcohol (tert-Butanol) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">75-68-3</ENT> <ENT>1-Chloro-1,1-difluoroethane (HCFC-142b)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">75-69-4</ENT> <ENT>Trichlorofluoromethane (CFC-11)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">75-71-8</ENT> <ENT>Dichlorodifluoromethane (CFC-12)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">75-72-9</ENT> <ENT>Chlorotrifluoromethane (CFC-13)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">75-86-5</ENT> <ENT>2-Methyllactonitrile (Acetone cyanohydrin)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">75-88-7</ENT> <ENT>2-Chloro-1,1,1-trifluoroethane (HCFC-133a)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">76-01-7</ENT> <ENT>Pentachloroethane</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">76-02-8</ENT> <ENT>Trichloroacetyl chloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">76-06-2</ENT> <ENT>Chloropicrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">76-13-1</ENT> <ENT>Freon 113 (CFC-113)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">76-14-2</ENT> <ENT>Dichlorotetrafluoroethane (CFC-114)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">76-15-3</ENT> <ENT>Monochloropentafluoroethane (CFC-115)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">76-44-8</ENT> <ENT>Heptachlor</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">76-87-9</ENT> <ENT>Triphenyltin hydroxide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">77-09-8</ENT> <ENT>Phenolphthalein (3,3-Bis(4-hydroxyphenyl)phthalide)</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">77-47-4</ENT> <ENT>Hexachlorocyclopentadiene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">77-73-6</ENT> <ENT>Dicyclopentadiene</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">77-78-1</ENT> <ENT>Dimethyl sulfate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">78-48-8</ENT> <ENT> <E T="03">S,S,S</E> -Tributyltrithiophosphate (Tribufos) </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">78-79-5</ENT> <ENT>Isoprene</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">78-84-2</ENT> <ENT>Isobutyraldehyde</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">78-87-5</ENT> <ENT>1,2-Dichloropropane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">78-88-6</ENT> <ENT>2,3-Dichloropropene</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">78-92-2</ENT> <ENT> <E T="03">sec</E> -Butyl alcohol (2-Butanol) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-00-5</ENT> <ENT>1,1,2-Trichloroethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-01-6</ENT> <ENT>Trichloroethylene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-06-1</ENT> <ENT>Acrylamide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-10-7</ENT> <ENT>Acrylic acid</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <PRTPAGE P="494"/> <ENT I="01">79-11-8</ENT> <ENT>Chloroacetic acid</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-19-6</ENT> <ENT>Thiosemicarbazide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">79-21-0</ENT> <ENT>Peracetic acid</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-22-1</ENT> <ENT>Methyl chlorocarbonate</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">79-34-5</ENT> <ENT>1,1,2,2-Tetrachloroethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-44-7</ENT> <ENT>Dimethylcarbamoyl chloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-46-9</ENT> <ENT>2-Nitropropane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">79-94-7</ENT> <ENT>Tetrabromobisphenol A</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">80-05-7</ENT> <ENT>4,4′-Isopropylidenediphenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">80-15-9</ENT> <ENT>Cumene hydroperoxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">80-62-6</ENT> <ENT>Methyl methacrylate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">81-07-2</ENT> <ENT>Saccharin (only persons who manufacture are subject, no supplier notification)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">81-49-2</ENT> <ENT>1-Amino-2,4-dibromoanthraquinone</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">81-88-9</ENT> <ENT>C.I. Food Red 15 (Rhodamine B)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">82-28-0</ENT> <ENT>1-Amino-2-methylanthraquinone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">82-68-8</ENT> <ENT>Quintozene (Pentachloronitrobenzene)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">84-74-2</ENT> <ENT>Dibutyl phthalate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">85-01-8</ENT> <ENT>Phenanthrene</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">85-44-9</ENT> <ENT>Phthalic anhydride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">86-30-6</ENT> <ENT> <E T="03">N</E> -Nitrosodiphenylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">87-61-6</ENT> <ENT>1,2,3-Trichlorobenzene</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">87-62-7</ENT> <ENT>2,6-Xylidine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">87-68-3</ENT> <ENT>Hexachloro-1,3-butadiene (Hexachlorobutadiene)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">87-86-5</ENT> <ENT>Pentachlorophenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">88-06-2</ENT> <ENT>2,4,6-Trichlorophenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">88-72-2</ENT> <ENT> <E T="03">o</E> -Nitrotoluene </ENT> <ENT>1/1/14</ENT> </ROW> <ROW> <ENT I="01">88-75-5</ENT> <ENT> 2-Nitrophenol ( <E T="03">o</E> -Nitrophenol) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">88-85-7</ENT> <ENT>Dinitrobutyl phenol (Dinoseb)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">88-89-1</ENT> <ENT>Picric acid</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">90-04-0</ENT> <ENT> <E T="03">o</E> -Anisidine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">90-43-7</ENT> <ENT>2-Phenylphenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">90-94-8</ENT> <ENT>Michler's ketone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">91-08-7</ENT> <ENT>Toluene-2,6-diisocyanate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">91-20-3</ENT> <ENT>Naphthalene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">91-22-5</ENT> <ENT>Quinoline</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">91-23-6</ENT> <ENT> <E T="03">o</E> -Nitroanisole </ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">91-59-8</ENT> <ENT> <E T="03">beta</E> -Naphthylamine (2-Naphthalenamine) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">91-94-1</ENT> <ENT>3,3′-Dichlorobenzidine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">92-52-4</ENT> <ENT>Biphenyl</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">92-67-1</ENT> <ENT>4-Aminobiphenyl</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">92-87-5</ENT> <ENT>Benzidine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">92-93-3</ENT> <ENT>4-Nitrobiphenyl</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">93-15-2</ENT> <ENT>Methyleugenol</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">93-65-2</ENT> <ENT>Mecoprop</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">94-11-1</ENT> <ENT>2,4-D isopropyl ester</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">94-36-0</ENT> <ENT>Benzoyl peroxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">94-58-6</ENT> <ENT>Dihydrosafrole</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">94-59-7</ENT> <ENT>Safrole</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">94-74-6</ENT> <ENT>Methoxone (MCPA)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">94-75-7</ENT> <ENT>2,4-D</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">94-80-4</ENT> <ENT>2,4-D butyl ester</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">94-82-6</ENT> <ENT>2,4-DB</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">95-47-6</ENT> <ENT> <E T="03">o</E> -Xylene </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">95-48-7</ENT> <ENT> <E T="03">o</E> -Cresol </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">95-50-1</ENT> <ENT> 1,2-Dichlorobenzene ( <E T="03">o</E> -Dichlorobenzene) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">95-53-4</ENT> <ENT> <E T="03">o</E> -Toluidine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">95-54-5</ENT> <ENT>1,2-Phenylenediamine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">95-63-6</ENT> <ENT>1,2,4-Trimethylbenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">95-69-2</ENT> <ENT> <E T="03">p</E> -Chloro- <E T="03">o</E> -toluidine (4-Chloro-2-methylaniline) </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">95-80-7</ENT> <ENT>2,4-Diaminotoluene (2,4-Toluenediamine)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">95-95-4</ENT> <ENT>2,4,5-Trichlorophenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">96-09-3</ENT> <ENT>Styrene oxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">96-12-8</ENT> <ENT>1,2-Dibromo-3-chloropropane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">96-18-4</ENT> <ENT>1,2,3-Trichloropropane</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">96-23-1</ENT> <ENT>1,3-Dichloro-2-propanol</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">96-33-3</ENT> <ENT>Methyl acrylate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">96-45-7</ENT> <ENT>Ethylene thiourea</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">97-23-4</ENT> <ENT>Dichlorophene</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">97-56-3</ENT> <ENT>C.I. Solvent Yellow 3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">98-07-7</ENT> <ENT>Benzoic trichloride (Benzotrichloride)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">98-82-8</ENT> <ENT>Cumene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <PRTPAGE P="495"/> <ENT I="01">98-86-2</ENT> <ENT>Acetophenone</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">98-87-3</ENT> <ENT>Benzal chloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">98-88-4</ENT> <ENT>Benzoyl chloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">98-95-3</ENT> <ENT>Nitrobenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">99-30-9</ENT> <ENT>Dichloran</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">99-55-8</ENT> <ENT> 5-Nitro- <E T="03">o</E> -toluidine (2-Methyl-5-nitroaniline) </ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">99-59-2</ENT> <ENT> 5-Nitro- <E T="03">o</E> -anisidine (2-Methoxy-5-nitroaniline) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">99-65-0</ENT> <ENT> <E T="03">m</E> -Dinitrobenzene </ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">100-01-6</ENT> <ENT> <E T="03">p</E> -Nitroaniline </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">100-02-7</ENT> <ENT> 4-Nitrophenol ( <E T="03">p</E> -Nitrophenol) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">100-25-4</ENT> <ENT> <E T="03">p</E> -Dinitrobenzene </ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">100-41-4</ENT> <ENT>Ethylbenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">100-42-5</ENT> <ENT>Styrene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">100-44-7</ENT> <ENT>Benzyl chloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">100-75-4</ENT> <ENT> <E T="03">N</E> -Nitrosopiperidine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">101-05-3</ENT> <ENT>Anilazine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">101-14-4</ENT> <ENT>4,4′-Methylenebis(2-chloroaniline)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">101-61-1</ENT> <ENT> 4,4′-Methylenebis( <E T="03">N,N</E> -dimethyl)benzenamine (4,4′-Methylenebis[ <E T="03">N,N</E> -dimethylaniline]) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">101-77-9</ENT> <ENT>4,4′-Methylenedianiline</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">101-80-4</ENT> <ENT>4,4′-Diaminodiphenyl ether</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">101-90-6</ENT> <ENT>Diglycidyl resorcinol ether</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">104-12-1</ENT> <ENT> <E T="03">p</E> -Chlorophenyl isocyanate </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">104-94-9</ENT> <ENT> <E T="03">p</E> -Anisidine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">105-67-9</ENT> <ENT>2,4-Dimethylphenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-42-3</ENT> <ENT> <E T="03">p</E> -Xylene </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-44-5</ENT> <ENT> <E T="03">p</E> -Cresol </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-46-7</ENT> <ENT> 1,4-Dichlorobenzene ( <E T="03">p</E> -Dichlorobenzene) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-47-8</ENT> <ENT> <E T="03">p</E> -Chloroaniline </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">106-50-3</ENT> <ENT> <E T="03">p</E> -Phenylenediamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-51-4</ENT> <ENT>Quinone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-88-7</ENT> <ENT>1,2-Butylene oxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-89-8</ENT> <ENT>Epichlorohydrin</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-93-4</ENT> <ENT>1,2-Dibromoethane (Ethylene dibromide)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">106-94-5</ENT> <ENT>1-Bromopropane</ENT> <ENT>1/1/16</ENT> </ROW> <ROW> <ENT I="01">106-99-0</ENT> <ENT>1,3-Butadiene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">107-02-8</ENT> <ENT>Acrolein</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">107-05-1</ENT> <ENT>Allyl chloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">107-06-2</ENT> <ENT>1,2-Dichloroethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">107-11-9</ENT> <ENT>Allylamine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">107-13-1</ENT> <ENT>Acrylonitrile</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">107-18-6</ENT> <ENT>Allyl alcohol</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">107-19-7</ENT> <ENT>Propargyl alcohol</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">107-21-1</ENT> <ENT>Ethylene glycol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">107-30-2</ENT> <ENT>Chloromethyl methyl ether</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-05-4</ENT> <ENT>Vinyl acetate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-10-1</ENT> <ENT>Methyl isobutyl ketone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-31-6</ENT> <ENT>Maleic anhydride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-38-3</ENT> <ENT> <E T="03">m</E> -Xylene </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-39-4</ENT> <ENT> <E T="03">m</E> -Cresol </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-45-2</ENT> <ENT>1,3-Phenylenediamine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">108-60-1</ENT> <ENT>Bis(2-chloro-1-methylethyl) ether</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-88-3</ENT> <ENT>Toluene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-90-7</ENT> <ENT>Chlorobenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">108-93-0</ENT> <ENT>Cyclohexanol</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">108-95-2</ENT> <ENT>Phenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">109-06-8</ENT> <ENT>2-Methylpyridine</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">109-77-3</ENT> <ENT>Malononitrile</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">109-86-4</ENT> <ENT>2-Methoxyethanol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">110-00-9</ENT> <ENT>Furan</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">110-54-3</ENT> <ENT> <E T="03">n</E> -Hexane (Hexane) </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">110-57-6</ENT> <ENT> <E T="03">trans</E> -1,4-Dichloro-2-butene </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">110-80-5</ENT> <ENT>2-Ethoxyethanol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">110-82-7</ENT> <ENT>Cyclohexane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">110-86-1</ENT> <ENT>Pyridine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">111-41-1</ENT> <ENT>N-Hydroxyethylethylenediamine</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">111-42-2</ENT> <ENT>Diethanolamine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">111-44-4</ENT> <ENT>Bis(2-chloroethyl) ether</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">111-91-1</ENT> <ENT>Bis(2-chloroethoxy)methane</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">114-26-1</ENT> <ENT>Propoxur</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">115-07-1</ENT> <ENT>Propylene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">115-28-6</ENT> <ENT>Chlorendic acid</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="496"/> <ENT I="01">115-32-2</ENT> <ENT>Dicofol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">115-96-8</ENT> <ENT>Tris(2-chloroethyl) phosphate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">116-06-3</ENT> <ENT>Aldicarb</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">116-14-3</ENT> <ENT>Tetrafluoroethylene (Tetrafluoroethene)</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">117-79-3</ENT> <ENT>2-Aminoanthraquinone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">117-81-7</ENT> <ENT>Di(2-ethylhexyl) phthalate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">118-74-1</ENT> <ENT>Hexachlorobenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">119-90-4</ENT> <ENT>3,3′-Dimethoxybenzidine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">119-93-7</ENT> <ENT>3,3′-Dimethylbenzidine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">120-12-7</ENT> <ENT>Anthracene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">120-36-5</ENT> <ENT>2,4-DP (Dichlorprop)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">120-58-1</ENT> <ENT>Isosafrole</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">120-71-8</ENT> <ENT> <E T="03">p</E> -Cresidine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">120-80-9</ENT> <ENT>Catechol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">120-82-1</ENT> <ENT>1,2,4-Trichlorobenzene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">120-83-2</ENT> <ENT>2,4-Dichlorophenol</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">121-14-2</ENT> <ENT>2,4-Dinitrotoluene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">121-44-8</ENT> <ENT>Triethylamine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">121-69-7</ENT> <ENT> <E T="03">N,N</E> -Dimethylaniline </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">121-75-5</ENT> <ENT>Malathion</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">122-34-9</ENT> <ENT>Simazine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">122-39-4</ENT> <ENT>Diphenylamine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">122-66-7</ENT> <ENT>1,2-Diphenylhydrazine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">123-31-9</ENT> <ENT>Hydroquinone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">123-38-6</ENT> <ENT>Propionaldehyde</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">123-63-7</ENT> <ENT>Paraldehyde</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">123-72-8</ENT> <ENT>Butyraldehyde</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">123-91-1</ENT> <ENT>1,4-Dioxane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">124-40-3</ENT> <ENT>Dimethylamine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">124-73-2</ENT> <ENT>Dibromotetrafluoroethane (1,2-Dibromo-1,1,2,2-tetrafluoroethane)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">126-72-7</ENT> <ENT>Tris(2,3-dibromopropyl) phosphate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">126-98-7</ENT> <ENT>Methacrylonitrile</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">126-99-8</ENT> <ENT>Chloroprene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">127-18-4</ENT> <ENT>Tetrachloroethylene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">128-03-0</ENT> <ENT>Potassium dimethyldithiocarbamate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">128-04-1</ENT> <ENT>Sodium dimethyldithiocarbamate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">128-66-5</ENT> <ENT>C.I. Vat Yellow 4</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">131-11-3</ENT> <ENT>Dimethyl phthalate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">131-52-2</ENT> <ENT>Sodium pentachlorophenate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">132-27-4</ENT> <ENT> Sodium <E T="03">o</E> -phenylphenoxide </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">132-64-9</ENT> <ENT>Dibenzofuran</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">133-06-2</ENT> <ENT>Captan</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">133-07-3</ENT> <ENT>Folpet</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">133-90-4</ENT> <ENT>Chloramben</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">134-29-2</ENT> <ENT> <E T="03">o</E> -Anisidine hydrochloride </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">134-32-7</ENT> <ENT> <E T="03">alpha</E> -Naphthylamine (1-Naphthalenamine) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">135-20-6</ENT> <ENT>Cupferron</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">136-45-8</ENT> <ENT>Dipropyl isocinchomeronate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">137-26-8</ENT> <ENT>Thiram</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">137-41-7</ENT> <ENT> Potassium <E T="03">N</E> -methyldithiocarbamate </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">137-42-8</ENT> <ENT>Metham sodium (Sodium methyldithiocarbamate)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">138-93-2</ENT> <ENT>Disodium cyanodithioimidocarbonate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">139-13-9</ENT> <ENT>Nitrilotriacetic acid</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">139-65-1</ENT> <ENT>4,4′-Thiodianiline</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">140-66-9</ENT> <ENT>p-(1,1,3,3-Tetramethylbutyl)phenol</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">140-88-5</ENT> <ENT>Ethyl acrylate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">141-32-2</ENT> <ENT>Butyl acrylate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">142-59-6</ENT> <ENT>Nabam</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">148-79-8</ENT> <ENT>Thiabendazole</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">149-30-4</ENT> <ENT>2-Mercaptobenzothiazole</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">150-50-5</ENT> <ENT>Merphos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">150-68-5</ENT> <ENT>Monuron</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">151-56-4</ENT> <ENT>Ethyleneimine (Aziridine)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">156-10-5</ENT> <ENT> <E T="03">p</E> -Nitrosodiphenylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">156-62-7</ENT> <ENT>Calcium cyanamide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">191-24-2</ENT> <ENT>Benzo[g,h,i]perylene</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">298-00-0</ENT> <ENT>Methyl parathion</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">300-76-5</ENT> <ENT>Naled</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">301-12-2</ENT> <ENT>Oxydemeton-methyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">302-01-2</ENT> <ENT>Hydrazine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">306-83-2</ENT> <ENT>2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <PRTPAGE P="497"/> <ENT I="01">309-00-2</ENT> <ENT>Aldrin</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">314-40-9</ENT> <ENT>Bromacil</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">319-84-6</ENT> <ENT> <E T="03">alpha</E> -Hexachlorocyclohexane </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">330-54-1</ENT> <ENT>Diuron</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">330-55-2</ENT> <ENT>Linuron</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">333-41-5</ENT> <ENT>Diazinon</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">334-88-3</ENT> <ENT>Diazomethane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">353-59-3</ENT> <ENT>Bromochlorodifluoromethane (Halon 1211)</ENT> <ENT>7/8/90</ENT> </ROW> <ROW> <ENT I="01">354-11-0</ENT> <ENT>1,1,1,2-Tetrachloro-2-fluoroethane (HCFC-121a)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">354-14-3</ENT> <ENT>1,1,2,2-Tetrachloro-1-fluoroethane (HCFC-121)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">354-23-4</ENT> <ENT>1,2-Dichloro-1,1,2-trifluoroethane (HCFC-123a)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">354-25-6</ENT> <ENT>1-Chloro-1,1,2,2-tetrafluoroethane (HCFC-124a)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">357-57-3</ENT> <ENT>Brucine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">422-44-6</ENT> <ENT>1,2-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225bb)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">422-48-0</ENT> <ENT>2,3-dichloro-1,1,1,2,3-pentafluoropropane (HCFC-225ba)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">422-56-0</ENT> <ENT>3,3-Dichloro-1,1,1,2,2-pentafluoropropane (HCFC-225ca)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">431-86-7</ENT> <ENT>1,2-Dichloro-1,1,3,3,3-pentafluoropropane (HCFC-225da)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">460-35-5</ENT> <ENT>3-Chloro-1,1,1-trifluoropropane (HCFC-253fb)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">463-58-1</ENT> <ENT>Carbonyl sulfide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">465-73-6</ENT> <ENT>Isodrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">492-80-8</ENT> <ENT>C.I. Solvent Yellow 34 (Auramine)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">505-60-2</ENT> <ENT>Mustard gas</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">507-55-1</ENT> <ENT>1,3-Dichloro-1,1,2,2,3-pentafluoropropane (HCFC-225cb)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">509-14-8</ENT> <ENT>Tetranitromethane</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">510-15-6</ENT> <ENT>Chlorobenzilate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">528-29-0</ENT> <ENT> <E T="03">o</E> -Dinitrobenzene </ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">532-27-4</ENT> <ENT>2-Chloroacetophenone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">533-74-4</ENT> <ENT>Dazomet</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">534-52-1</ENT> <ENT> 4,6-Dinitro- <E T="03">o</E> -cresol </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">540-59-0</ENT> <ENT>1,2-Dichloroethylene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">541-41-3</ENT> <ENT>Ethyl chloroformate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">541-53-7</ENT> <ENT>2,4-Dithiobiuret (Dithiobiuret)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">541-73-1</ENT> <ENT> 1,3-Dichlorobenzene ( <E T="03">m</E> -Dichlorobenzene) </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">542-75-6</ENT> <ENT>1,3-Dichloropropylene (1,3-Dichloropropene)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">542-76-7</ENT> <ENT>3-Chloropropionitrile</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">542-88-1</ENT> <ENT>Bis(chloromethyl) ether</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">554-13-2</ENT> <ENT>Lithium carbonate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">556-52-5</ENT> <ENT>Glycidol</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">556-61-6</ENT> <ENT>Methyl isothiocyanate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">563-47-3</ENT> <ENT>3-Chloro-2-methyl-1-propene</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">569-64-2</ENT> <ENT>C.I. Basic Green 4 (Malachite green)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">584-84-9</ENT> <ENT>Toluene-2,4-diisocyanate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">593-60-2</ENT> <ENT>Vinyl bromide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">594-42-3</ENT> <ENT>Perchloromethyl mercaptan</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">606-20-2</ENT> <ENT>2,6-Dinitrotoluene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">608-93-5</ENT> <ENT>Pentachlorobenzene</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">612-82-8</ENT> <ENT>3,3′-Dimethylbenzidine dihydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">612-83-9</ENT> <ENT>3,3′-Dichlorobenzidine dihydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">615-05-4</ENT> <ENT>2,4-Diaminoanisole</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">615-28-1</ENT> <ENT>1,2-Phenylenediamine dihydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">621-64-7</ENT> <ENT> <E T="03">N</E> -Nitrosodi- <E T="03">n</E> -propylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">624-18-0</ENT> <ENT>1,4-Phenylenediamine dihydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">624-83-9</ENT> <ENT>Methyl isocyanate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">630-20-6</ENT> <ENT>1,1,1,2-Tetrachloroethane</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">636-21-5</ENT> <ENT> <E T="03">o</E> -Toluidine hydrochloride </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">639-58-7</ENT> <ENT>Triphenyltin chloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">680-31-9</ENT> <ENT>Hexamethylphosphoramide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">683-18-1</ENT> <ENT>Dibutyltin dichloride</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">684-93-5</ENT> <ENT> <E T="03">N</E> -Nitroso- <E T="03">N</E> -methylurea </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">709-98-8</ENT> <ENT>Propanil</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">759-73-9</ENT> <ENT> <E T="03">N</E> -Nitroso- <E T="03">N</E> -ethylurea </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">759-94-4</ENT> <ENT> <E T="03">S</E> -Ethyl dipropylthiocarbamate </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">764-41-0</ENT> <ENT>1,4-Dichloro-2-butene</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">812-04-4</ENT> <ENT>1,1-Dichloro-1,2,2-trifluoroethane (HCFC-123b)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">834-12-8</ENT> <ENT>Ametryn</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">842-07-9</ENT> <ENT>C.I. Solvent Yellow 14</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">872-50-4</ENT> <ENT> <E T="03">N</E> -Methyl-2-pyrrolidone </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">924-16-3</ENT> <ENT> <E T="03">N</E> -Nitrosodi- <E T="03">n</E> -butylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">924-42-5</ENT> <ENT> <E T="03">N</E> -Methylolacrylamide </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">957-51-7</ENT> <ENT>Diphenamid</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">961-11-5</ENT> <ENT>Tetrachlorvinphos</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <PRTPAGE P="498"/> <ENT I="01">989-38-8</ENT> <ENT>C.I. Basic Red 1</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1114-71-2</ENT> <ENT>Pebulate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1120-71-4</ENT> <ENT>1,3-Propane sultone</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1134-23-2</ENT> <ENT>Cycloate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1163-19-5</ENT> <ENT>Decabromodiphenyl oxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1222-05-5</ENT> <ENT>1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">1313-27-5</ENT> <ENT>Molybdenum trioxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1314-20-1</ENT> <ENT>Thorium dioxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1319-77-3</ENT> <ENT>Cresol (mixed isomers)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1320-18-9</ENT> <ENT>2,4-D propylene glycol butyl ether ester (2,4-D 2-butoxymethylethyl ester)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1330-20-7</ENT> <ENT>Xylene (mixed isomers)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1332-21-4</ENT> <ENT>Asbestos (friable)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1335-87-1</ENT> <ENT>Hexachloronaphthalene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1336-36-3</ENT> <ENT>Polychlorinated biphenyls</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1344-28-1</ENT> <ENT>Aluminum oxide (fibrous forms) (Alumina)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1464-53-5</ENT> <ENT>Diepoxybutane</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1563-66-2</ENT> <ENT>Carbofuran</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1582-09-8</ENT> <ENT>Trifluralin</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1634-04-4</ENT> <ENT> Methyl <E T="03">tert</E> -butyl ether </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1649-08-7</ENT> <ENT>1,2-Dichloro-1,1-difluoroethane (HCFC-132b)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1689-84-5</ENT> <ENT>Bromoxynil</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1689-99-2</ENT> <ENT>Bromoxynil octanoate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1717-00-6</ENT> <ENT>1,1-Dichloro-1-fluoroethane (HCFC-141b)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">1836-75-5</ENT> <ENT>Nitrofen</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1861-40-1</ENT> <ENT>Benfluralin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1897-45-6</ENT> <ENT>Chlorothalonil</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1910-42-5</ENT> <ENT>Paraquat dichloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1912-24-9</ENT> <ENT>Atrazine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1918-00-9</ENT> <ENT>Dicamba</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1918-02-1</ENT> <ENT>Picloram</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1918-16-7</ENT> <ENT>Propachlor</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1928-43-4</ENT> <ENT>2,4-D 2-ethylhexyl ester</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1929-73-3</ENT> <ENT>2,4-D 2-butoxyethyl ester</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1929-82-4</ENT> <ENT>Nitrapyrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1937-37-7</ENT> <ENT>C.I. Direct Black 38</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">1982-69-0</ENT> <ENT>Sodium dicamba</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">1983-10-4</ENT> <ENT>Tributyltin fluoride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2032-65-7</ENT> <ENT>Methiocarb</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2155-70-6</ENT> <ENT>Tributyltin methacrylate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2164-07-0</ENT> <ENT>Dipotassium endothall</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2164-17-2</ENT> <ENT>Fluometuron</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2212-67-1</ENT> <ENT>Molinate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2234-13-1</ENT> <ENT>Octachloronaphthalene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2300-66-5</ENT> <ENT>Dimethylamine dicamba</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2303-16-4</ENT> <ENT>Diallate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2303-17-5</ENT> <ENT>Triallate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2312-35-8</ENT> <ENT>Propargite</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2439-01-2</ENT> <ENT>Chinomethionate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2439-10-3</ENT> <ENT>Dodine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2451-62-9</ENT> <ENT>Triglycidyl isocyanurate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2524-03-0</ENT> <ENT>Dimethyl chlorothiophosphate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2602-46-2</ENT> <ENT>C.I. Direct Blue 6</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2655-15-4</ENT> <ENT>2,3,5-Trimethylphenyl methylcarbamate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2699-79-8</ENT> <ENT>Sulfuryl fluoride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2702-72-9</ENT> <ENT>2,4-D sodium salt</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">2832-40-8</ENT> <ENT>C.I. Disperse Yellow 3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">2837-89-0</ENT> <ENT>2-Chloro-1,1,1,2-tetrafluoroethane (HCFC-124)</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">2971-38-2</ENT> <ENT>2,4-D chlorocrotyl ester</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3118-97-6</ENT> <ENT>C.I. Solvent Orange 7</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">3296-90-0</ENT> <ENT>2,2-Bis(bromomethyl)-1,3-propanediol</ENT> <ENT>1/1/11</ENT> </ROW> <ROW> <ENT I="01">3383-96-8</ENT> <ENT>Temephos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3653-48-3</ENT> <ENT>Methoxone sodium salt</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">3761-53-3</ENT> <ENT>C.I. Food Red 5</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4080-31-3</ENT> <ENT>1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">4170-30-3</ENT> <ENT>Crotonaldehyde</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">4549-40-0</ENT> <ENT> <E T="03">N</E> -Nitrosomethylvinylamine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">4680-78-8</ENT> <ENT>C.I. Acid Green 3</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">5064-31-3</ENT> <ENT>Nitrilotriacetic acid trisodium salt</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">5234-68-4</ENT> <ENT>Carboxin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">5598-13-0</ENT> <ENT>Chlorpyrifos-methyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">5902-51-2</ENT> <ENT>Terbacil</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="499"/> <ENT I="01">6459-94-5</ENT> <ENT>C.I. Acid Red 114</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7287-19-6</ENT> <ENT>Prometryn</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7429-90-5</ENT> <ENT>Aluminum (fume or dust)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7439-92-1</ENT> <ENT>Lead</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7439-96-5</ENT> <ENT>Manganese</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7439-97-6</ENT> <ENT>Mercury</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-02-0</ENT> <ENT>Nickel</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-22-4</ENT> <ENT>Silver</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-28-0</ENT> <ENT>Thallium</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-36-0</ENT> <ENT>Antimony</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-38-2</ENT> <ENT>Arsenic</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-39-3</ENT> <ENT>Barium</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-41-7</ENT> <ENT>Beryllium</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-43-9</ENT> <ENT>Cadmium</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-47-3</ENT> <ENT>Chromium</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-48-4</ENT> <ENT>Cobalt</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-50-8</ENT> <ENT>Copper</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7440-62-2</ENT> <ENT>Vanadium (except when contained in an alloy)</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">7440-66-6</ENT> <ENT>Zinc (fume or dust)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7550-45-0</ENT> <ENT>Titanium tetrachloride</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7632-00-0</ENT> <ENT>Sodium nitrite</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7637-07-2</ENT> <ENT>Boron trifluoride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7647-01-0</ENT> <ENT>Hydrochloric acid (acid aerosols including mists, vapors, gas, fog, and other airborne forms of any particle size)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7664-39-3</ENT> <ENT>Hydrogen fluoride (Hydrofluoric acid)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7664-41-7</ENT> <ENT>Ammonia (includes anhydrous ammonia and aqueous ammonia from water dissociable ammonium salts and other sources; 10 percent of total aqueous ammonia is reportable under this listing)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7664-93-9</ENT> <ENT>Sulfuric acid (acid aerosols including mists, vapors, gas, fog, and other airborne forms of any particle size)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7696-12-0</ENT> <ENT>Tetramethrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7697-37-2</ENT> <ENT>Nitric acid</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7726-95-6</ENT> <ENT>Bromine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7758-01-2</ENT> <ENT>Potassium bromate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7782-41-4</ENT> <ENT>Fluorine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7782-49-2</ENT> <ENT>Selenium</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7782-50-5</ENT> <ENT>Chlorine</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">7783-06-4</ENT> <ENT>Hydrogen sulfide</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">7786-34-7</ENT> <ENT>Mevinphos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">7803-51-2</ENT> <ENT>Phosphine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">8001-35-2</ENT> <ENT>Toxaphene</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">8001-58-9</ENT> <ENT>Creosote</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">9006-42-2</ENT> <ENT>Metiram</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">10028-15-6</ENT> <ENT>Ozone</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">10034-93-2</ENT> <ENT>Hydrazine sulfate (1:1)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">10049-04-4</ENT> <ENT>Chlorine dioxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">10061-02-6</ENT> <ENT> <E T="03">trans</E> -1,3-Dichloropropene </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">10222-01-2</ENT> <ENT> 2,2-Dibromo-3-nitrilopropionamide <SU>1</SU> </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">10294-34-5</ENT> <ENT>Boron trichloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">10453-86-8</ENT> <ENT>Resmethrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">12122-67-7</ENT> <ENT>Zineb</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">12185-10-3</ENT> <ENT>Phosphorus (yellow or white)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">12427-38-2</ENT> <ENT>Maneb</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">13194-48-4</ENT> <ENT>Ethoprop</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">13356-08-6</ENT> <ENT>Fenbutatin oxide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">13463-40-6</ENT> <ENT>Iron pentacarbonyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">13474-88-9</ENT> <ENT>1,1-Dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">13674-87-8</ENT> <ENT>Tris(1,3-dichloro-2-propyl) phosphate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">13684-56-5</ENT> <ENT>Desmedipham</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">14484-64-1</ENT> <ENT>Ferbam</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">15972-60-8</ENT> <ENT>Alachlor</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">16071-86-6</ENT> <ENT>C.I. Direct Brown 95</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">16543-55-8</ENT> <ENT> <E T="03">N</E> -Nitrosonornicotine </ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">17804-35-2</ENT> <ENT>Benomyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">19044-88-3</ENT> <ENT>Oryzalin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">19666-30-9</ENT> <ENT>Oxadiazon</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">20325-40-0</ENT> <ENT>3,3′-Dimethoxybenzidine dihydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">20354-26-1</ENT> <ENT>Methazole</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">20816-12-0</ENT> <ENT>Osmium tetroxide</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">20859-73-8</ENT> <ENT>Aluminum phosphide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">21087-64-9</ENT> <ENT>Metribuzin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">21725-46-2</ENT> <ENT>Cyanazine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="500"/> <ENT I="01">22781-23-3</ENT> <ENT>Bendiocarb</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">23564-05-8</ENT> <ENT>Thiophanate-methyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">23564-06-9</ENT> <ENT>Thiophanate-ethyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">23950-58-5</ENT> <ENT>Pronamide</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">25155-23-1</ENT> <ENT>Tris(dimethylphenol) phosphate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">25311-71-1</ENT> <ENT>Isofenphos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">25321-14-6</ENT> <ENT>Dinitrotoluene (mixed isomers)</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">25321-22-6</ENT> <ENT>Dichlorobenzene (mixed isomers)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">25376-45-8</ENT> <ENT>Diaminotoluene (mixed isomers) (Toluenediamine)</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">26002-80-2</ENT> <ENT>Phenothrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">26471-62-5</ENT> <ENT>Toluene diisocyanate (mixed isomers)</ENT> <ENT>1/1/90</ENT> </ROW> <ROW> <ENT I="01">26628-22-8</ENT> <ENT>Sodium azide</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">26644-46-2</ENT> <ENT>Triforine</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">27314-13-2</ENT> <ENT>Norflurazon</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">28249-77-6</ENT> <ENT>Thiobencarb</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">28407-37-6</ENT> <ENT>C.I. Direct Blue 218</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">28434-00-6</ENT> <ENT> <E T="03">d-trans</E> -Allethrin </ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">29082-74-4</ENT> <ENT>Octachlorostyrene</ENT> <ENT>1/1/00</ENT> </ROW> <ROW> <ENT I="01">29232-93-7</ENT> <ENT>Pirimiphos-methyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">30560-19-1</ENT> <ENT>Acephate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">31218-83-4</ENT> <ENT>Propetamphos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">33089-61-1</ENT> <ENT>Amitraz</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">34014-18-1</ENT> <ENT>Tebuthiuron</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">34077-87-7</ENT> <ENT>Dichlorotrifluoroethane</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">35367-38-5</ENT> <ENT>Diflubenzuron</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">35400-43-2</ENT> <ENT>Sulprofos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">35554-44-0</ENT> <ENT>Imazalil</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">35691-65-7</ENT> <ENT>1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">38727-55-8</ENT> <ENT>Diethatyl ethyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">39156-41-7</ENT> <ENT>2,4-Diaminoanisole sulfate</ENT> <ENT>1/1/87</ENT> </ROW> <ROW> <ENT I="01">39300-45-3</ENT> <ENT>Dinocap</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">39515-41-8</ENT> <ENT>Fenpropathrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">40487-42-1</ENT> <ENT>Pendimethalin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">41198-08-7</ENT> <ENT>Profenofos</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">41766-75-0</ENT> <ENT>3,3′-Dimethylbenzidine dihydrofluoride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">42874-03-3</ENT> <ENT>Oxyfluorfen</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">43121-43-3</ENT> <ENT>Triadimefon</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">50471-44-8</ENT> <ENT>Vinclozolin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">51235-04-2</ENT> <ENT>Hexazinone</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">51338-27-3</ENT> <ENT>Diclofop methyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">51630-58-1</ENT> <ENT>Fenvalerate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">52645-53-1</ENT> <ENT>Permethrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">53404-19-6</ENT> <ENT>Bromacil, lithium salt</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">53404-37-8</ENT> <ENT>2,4-D 2-ethyl-4-methylpentyl ester</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">53404-60-7</ENT> <ENT>Dazomet, sodium salt</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">55290-64-7</ENT> <ENT>Dimethipin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">55406-53-6</ENT> <ENT>3-Iodo-2-propynyl butylcarbamate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">57213-69-1</ENT> <ENT>Triclopyr-triethylammonium salt</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">59669-26-0</ENT> <ENT>Thiodicarb</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">60168-88-9</ENT> <ENT>Fenarimol</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">60207-90-1</ENT> <ENT>Propiconazole</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">62476-59-9</ENT> <ENT>Acifluorfen, sodium salt</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">63938-10-3</ENT> <ENT>Chlorotetrafluoroethane</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">64902-72-3</ENT> <ENT>Chlorsulfuron</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">64969-34-2</ENT> <ENT>3,3′-Dichlorobenzidine sulfate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">66441-23-4</ENT> <ENT>Fenoxaprop-ethyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">67485-29-4</ENT> <ENT>Hydramethylnon</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">68085-85-8</ENT> <ENT>Cyhalothrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">68359-37-5</ENT> <ENT>Cyfluthrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">69409-94-5</ENT> <ENT>Fluvalinate</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">69806-50-4</ENT> <ENT>Fluazifop-butyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">71751-41-2</ENT> <ENT>Abamectin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">72178-02-0</ENT> <ENT>Fomesafen</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">72490-01-8</ENT> <ENT>Fenoxycarb</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">74051-80-2</ENT> <ENT>Sethoxydim</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">76578-14-8</ENT> <ENT>Quizalofop-ethyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">77501-63-4</ENT> <ENT>Lactofen</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">82657-04-3</ENT> <ENT>Bifenthrin</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">88671-89-0</ENT> <ENT>Myclobutanil</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">90454-18-5</ENT> <ENT>Dichloro-1,1,2-trifluoroethane</ENT> <ENT>1/1/94</ENT> </ROW> <ROW> <ENT I="01">90982-32-4</ENT> <ENT>Chlorimuron-ethyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <PRTPAGE P="501"/> <ENT I="01">101200-48-0</ENT> <ENT>Tribenuron-methyl</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">111512-56-2</ENT> <ENT>1,1-Dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">111984-09-9</ENT> <ENT>3,3′-Dimethoxybenzidine monohydrochloride</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">127564-92-5</ENT> <ENT>Dichloropentafluoropropane</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">128903-21-9</ENT> <ENT>2,2-Dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa)</ENT> <ENT>1/1/95</ENT> </ROW> <ROW> <ENT I="01">136013-79-1</ENT> <ENT>1,3-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea)</ENT> <ENT>1/1/95</ENT> </ROW> <TNOTE> <SU>1</SU>  The listing of 2,2-dibromo-3-nitrilopropionamide (CAS No. 10222-01-2) is stayed. The stay will remain in effect until further administrative action is taken. </TNOTE> </GPOTABLE> <P> (c) <E T="03">Chemical categories in alphabetical order.</E> </P> <HD SOURCE="HD1">Table 3 to Paragraph (c)</HD> <GPH SPAN="2" DEEP="408"> <PRTPAGE P="502"/> <GID>ER02MY24.352</GID> </GPH> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="503"/> <GID>ER02MY24.353</GID> </GPH> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="504"/> <GID>ER02MY24.354</GID> </GPH> <GPH SPAN="2" DEEP="470"> <PRTPAGE P="505"/> <GID>ER02MY24.355</GID> </GPH> <GPH SPAN="2" DEEP="390"> <PRTPAGE P="506"/> <GID>ER02MY24.356</GID> </GPH> <P> (d) <E T="03">Per- and polyfluoroalkyl substances alphabetical listing.</E> </P> <GPOTABLE COLS="3" OPTS="L2,nj" CDEF="s200,12,12"> <TTITLE> Table 4 to Paragraph <E T="01">(d)</E> </TTITLE> <BOXHD> <CHED H="1">Chemical name</CHED> <CHED H="1"> CASRN  <SU>1</SU> </CHED> <CHED H="1"> Effective <LI>date</LI> </CHED> </BOXHD> <ROW> <ENT I="01">Acetamide, N-(2-aminoethyl)-, 2-[(γ-ω-perfluoro-C4-20-alkyl)thio] derivs., polymers with N1,N1-dimethyl-1,3-propanediamine, epichlorohydrin and ethylenediamine, oxidized</ENT> <ENT>2742694-36-4</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Acetamide, N-[3-(dimethylamino)propyl]-, 2-[(γ-ω-perfluoro-C4-20-alkyl)thio] derivs.</ENT> <ENT>2738952-61-7</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, 2-[(γ-ω-perfluoro-C4-20-alkyl)thio] derivs., 2-hydroxypropyl esters</ENT> <ENT>2744262-09-5</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Acetic acid, [(γ-ω-perfluoro-C8-10-alkyl)thio] derivs., Bu esters</ENT> <ENT>3030471-22-5</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">Alcohols, C8-14, γ-ω-perfluoro</ENT> <ENT>68391-08-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Alcohols, C8-16, γ-ω-perfluoro, reaction products with 1,6-diisocyanatohexane, glycidol and stearyl alc.</ENT> <ENT>2728655-42-1</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <PRTPAGE P="507"/> <ENT I="01">Alkenes, C8-14 α-, δ-ω-perfluoro</ENT> <ENT>97659-47-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Alkyl iodides, C4-20, γ-ω-perfluoro</ENT> <ENT>68188-12-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ammonium perfluorobutanoate</ENT> <ENT>10495-86-0</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Ammonium perfluorodecanoate (PFDA NH4)</ENT> <ENT>3108-42-7</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">Ammonium perfluorohexanoate</ENT> <ENT>21615-47-4</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">Ammonium perfluorooctanoate</ENT> <ENT>3825-26-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,4-Benzenedicarboxylic acid, dimethyl ester, reaction products with bis(2-hydroxyethyl)terephthalate, ethylene glycol, α-fluoro-ω-(2-hydroxyethyl)poly(difluoromethylene), hexakis(methoxymethyl)melamine and polyethylene glycol</ENT> <ENT>68515-62-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Betaines, dimethyl(γ-ω-perfluoro-γ-hydro-C8-18-alkyl)</ENT> <ENT>2816091-53-7</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">Butanoic acid, 4-[[3-(dimethylamino)propyl]amino]-4-oxo-, 2(or 3)-[(γ-ω-perfluoro-C6-20-alkyl)thio] derivs.</ENT> <ENT>68187-25-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-[Butyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl acrylate</ENT> <ENT>383-07-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Chromium(III) perfluorooctanoate</ENT> <ENT>68141-02-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Cyclohexanesulfonic acid, decafluoro(pentafluoroethyl)-, potassium salt</ENT> <ENT>67584-42-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Cyclohexanesulfonic acid, decafluoro(trifluoromethyl)-, potassium salt</ENT> <ENT>68156-07-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Cyclohexanesulfonic acid, nonafluorobis(trifluoromethyl)-, potassium salt</ENT> <ENT>68156-01-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Cyclohexanesulfonic acid, undecafluoro-, potassium salt</ENT> <ENT>3107-18-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Decane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluoro-10-iodo-</ENT> <ENT>2043-53-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Decanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heneicosafluoro-, ammonium salt</ENT> <ENT>67906-42-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Decanesulfonyl chloride, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-</ENT> <ENT>27619-90-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-</ENT> <ENT>678-39-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Disulfides, bis(γ-ω-perfluoro-C6-20-alkyl)</ENT> <ENT>118400-71-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Dodecane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-heneicosafluoro-12-iodo-</ENT> <ENT>2043-54-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Dodecanesulfonyl chloride, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluoro-</ENT> <ENT>27619-91-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Dodecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluoro-</ENT> <ENT>865-86-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Eicosanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18, 18,19,19,20,20,20-heptatriacontafluoro-</ENT> <ENT>65104-65-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ethanaminium, N,N-diethyl-N-methyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, methyl sulfate, polymer with 2-ethylhexyl 2-methyl-2-propenoate, α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]poly(difluoromethylene), 2-hydroxyethyl 2-methyl-2-propenoate and N-(hydroxymethyl)-2-propenamide</ENT> <ENT>65636-35-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ethanaminium, N,N,N-triethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-1-octanesulfonic acid (1:1)</ENT> <ENT>56773-42-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ethaneperoxoic acid, reaction products with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl thiocyanate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl thiocyanate</ENT> <ENT>182176-52-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ethanol, 2,2′-iminobis-, compd. with α-fluoro-ω-[2-(phosphonooxy)ethyl]poly(difluoromethylene) (1:1)</ENT> <ENT>65530-74-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ethanol, 2,2′-iminobis-, compd. with α-fluoro-ω-[2-(phosphonooxy)ethyl]poly(difluoromethylene) (2:1)</ENT> <ENT>65530-63-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Ethanol, 2,2′-iminobis-, compd. with α,α′-[phosphinicobis(oxy-2,1-ethanediyl)]bis[ω-fluoropoly(difluoromethylene)] (1:1)</ENT> <ENT>65530-64-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">N-Ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide</ENT> <ENT>1691-99-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-[Ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl acrylate</ENT> <ENT>423-82-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-[Ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl methacrylate</ENT> <ENT>376-14-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Fatty acids, C6-18, perfluoro, ammonium salts</ENT> <ENT>72623-77-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Fatty acids, C7-13, perfluoro, ammonium salts</ENT> <ENT>72968-38-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Fatty acids, linseed-oil, γ-ω-perfluoro-C8-14-alkyl esters</ENT> <ENT>178535-23-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">6:2 Fluorotelomer sulfonate acid</ENT> <ENT>27619-97-2</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">6:2 Fluorotelomer sulfonate ammonium salt</ENT> <ENT>59587-39-2</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">6:2 Fluorotelomer sulfonate anion</ENT> <ENT>425670-75-3</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">6:2 Fluorotelomer sulfonate potassium salt</ENT> <ENT>59587-38-1</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">6:2 Fluorotelomer sulfonate sodium salt</ENT> <ENT>27619-94-9</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">Glycine, N-ethyl-N-[(heptadecafluorooctyl)sulfonyl]-, potassium salt</ENT> <ENT>2991-51-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Glycine, N-[(heptadecafluorooctyl)sulfonyl]-N-propyl-, potassium salt</ENT> <ENT>55910-10-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Glycine, N-ethyl-N-[(pentadecafluoroheptyl)sulfonyl]-, potassium salt</ENT> <ENT>67584-62-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Glycine, N-ethyl-N-[(tridecafluorohexyl)sulfonyl]-, potassium salt</ENT> <ENT>67584-53-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Glycine, N-ethyl-N-[(undecafluoropentyl)sulfonyl]-, potassium salt</ENT> <ENT>67584-52-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">3-[[(Heptadecafluorooctyl)sulfonyl]amino]-N,N,N-trimethyl-1-propanaminium iodide</ENT> <ENT>1652-63-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-[[(Heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate</ENT> <ENT>25268-77-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>68555-76-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-</ENT> <ENT>68957-62-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, ammonium salt</ENT> <ENT>68259-07-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>70225-15-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, potassium salt</ENT> <ENT>60270-55-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Heptanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-</ENT> <ENT>335-71-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Hexadecane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14-nonacosafluoro-16-iodo-</ENT> <ENT>65510-55-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="508"/> <ENT I="01">1-Hexadecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluoro-</ENT> <ENT>60699-51-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Hexafluoropropylene oxide dimer acid</ENT> <ENT>13252-13-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Hexafluoropropylene oxide dimer acid ammonium salt</ENT> <ENT>62037-80-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Hexane, 1,6-diisocyanato-, homopolymer, γ-ω-perfluoro-C6-20-alc.-blocked</ENT> <ENT>135228-60-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>68555-75-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, ammonium salt</ENT> <ENT>68259-08-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, potassium salt</ENT> <ENT>3871-99-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>70225-16-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Lithium bis[(trifluoromethyl)sulfonyl] azanide</ENT> <ENT>90076-65-6</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">Lithium (perfluorooctane)sulfonate</ENT> <ENT>29457-72-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Methyl perfluorooctanoate</ENT> <ENT>376-27-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Nonanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-nonadecafluoro-, ammonium salt</ENT> <ENT>17202-41-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Octadecanoic acid, pentatriacontafluoro-</ENT> <ENT>16517-11-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octadecanol, 3,3,4,4,5,5,6,6,7,7, 8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15, 16,16,17,17,18,18,18-tritriacontafluoro-</ENT> <ENT>65104-67-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-methyl-</ENT> <ENT>31506-32-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>24448-09-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonamide, N-butyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(2-hydroxyethyl)-</ENT> <ENT>2263-09-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-[3-(trimethoxysilyl)propyl]-</ENT> <ENT>61660-12-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonamide, N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, potassium salt</ENT> <ENT>178094-69-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-[2-(phosphonooxy)ethyl]-, diammonium salt</ENT> <ENT>67969-69-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, ammonium salt</ENT> <ENT>29081-56-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>70225-14-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Octanoyl fluoride, pentadecafluoro-</ENT> <ENT>335-66-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>68555-74-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Pentanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, potassium salt</ENT> <ENT>3872-25-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Pentanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, ammonium salt</ENT> <ENT>68259-09-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Pentanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>70225-17-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Pentanoic acid, 4,4-bis[(γ-ω-perfluoro-C8-20-alkyl)thio] derivs.</ENT> <ENT>71608-60-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorobutane sulfonic acid</ENT> <ENT>375-73-5</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">Perfluorobutanesulfonate</ENT> <ENT>45187-15-3</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">Perfluorobutanoate</ENT> <ENT>45048-62-2</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Perfluorobutanoic acid</ENT> <ENT>375-22-4</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Perfluorodecanoic acid</ENT> <ENT>335-76-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorododecanoic acid</ENT> <ENT>307-55-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorohexanesulfonic acid</ENT> <ENT>355-46-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorohexanoic acid</ENT> <ENT>307-24-4</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">Perfluoro-3-methoxypropanoic acid</ENT> <ENT>377-73-1</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">Perfluorononanoic acid</ENT> <ENT>375-95-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorooctane sulfonic acid</ENT> <ENT>1763-23-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorooctanoic acid</ENT> <ENT>335-67-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorooctyl Ethylene</ENT> <ENT>21652-58-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluorooctyl iodide</ENT> <ENT>507-63-1</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">Perfluorooctylsulfonyl fluoride</ENT> <ENT>307-35-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluoropalmiticacid</ENT> <ENT>67905-19-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Perfluoropropanoic acid</ENT> <ENT>422-64-0</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">Perfluorotetradecanoic acid</ENT> <ENT>376-06-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Phosphinic acid, bis(perfluoro-C6-12-alkyl) derivs.</ENT> <ENT>68412-69-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Phosphonic acid, perfluoro-C6-12-alkyl derivs.</ENT> <ENT>68412-68-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Phosphoric acid, γ-ω-perfluoro-C8-16-alkyl esters, compds. with diethanolamine</ENT> <ENT>74499-44-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-[2-(acetyloxy)-3-[(carboxymethyl)dimethylammonio]propyl]-ω-fluoro-, inner salt</ENT> <ENT>123171-68-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-[2-[(2-carboxyethyl)thio]ethyl]-ω-fluoro-</ENT> <ENT>65530-83-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-[2-[(2-carboxyethyl)thio]ethyl]-ω-fluoro-, lithium salt</ENT> <ENT>65530-69-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, dihydrogen 2-hydroxy-1,2,3-propanetricarboxylate</ENT> <ENT>65605-56-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, hydrogen 2-hydroxy-1,2,3-propanetricarboxylate</ENT> <ENT>65605-57-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (3:1)</ENT> <ENT>65530-59-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]-</ENT> <ENT>65530-66-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-[(1-oxo-2-propenyl)oxy]ethyl]-, homopolymer</ENT> <ENT>65605-73-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="509"/> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-[(1-oxooctadecyl)oxy]ethyl]-</ENT> <ENT>65530-65-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-</ENT> <ENT>65530-61-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-, ammonium salt</ENT> <ENT>95144-12-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-, diammonium salt</ENT> <ENT>65530-72-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-, monoammonium salt</ENT> <ENT>65530-71-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α-fluoro-ω-[2-sulphoethyl)-</ENT> <ENT>80010-37-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α,α′-[phosphinicobis(oxy-2,1-ethanediyl)]bis[ω-fluoro-</ENT> <ENT>65530-62-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(difluoromethylene), α,α′-[phosphinicobis(oxy-2,1-ethanediyl)]bis[ω-fluoro-, ammonium salt</ENT> <ENT>65530-70-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(tridecafluorohexyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>56372-23-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>29117-08-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl]-ω-methoxy-</ENT> <ENT>68958-60-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl]-ω-methoxy-</ENT> <ENT>68958-61-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>68298-80-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>68298-81-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with α-fluoro-ω-(2-hydroxyethyl)poly(difluoromethylene) (1:1)</ENT> <ENT>65545-80-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-, 2-hydroxy-3-[(γ-ω-perfluoro-C6-20-alkyl)thio]propyl ethers</ENT> <ENT>70983-59-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>37338-48-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>68259-39-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(tridecafluorohexyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>68259-38-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>68310-17-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Potassium heptafluorobutanoate</ENT> <ENT>2966-54-3</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Potassium perfluorobutane sulfonate</ENT> <ENT>29420-49-3</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">Potassium perfluorooctanesulfonate</ENT> <ENT>2795-39-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Potassium perfluorooctanoate</ENT> <ENT>2395-00-8</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-[2-[(γ-ω-perfluoro-C4-20-alkyl)thio]acetyl] derivs., inner salts</ENT> <ENT>1078715-61-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, 3-[[(heptadecafluorooctyl)sulfonyl]amino]-N,N,N-trimethyl-, chloride</ENT> <ENT>38006-74-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-, 3-[(γ-ω-perfluoro-C6-20-alkyl)thio] derivs., chlorides</ENT> <ENT>70983-60-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, N,N,N-trimethyl-3-[[(tridecafluorohexyl)sulfonyl]amino]-, chloride</ENT> <ENT>52166-82-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, iodide</ENT> <ENT>67584-58-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, chloride</ENT> <ENT>68555-81-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, N,N,N-trimethyl-3-[[(tridecafluorohexyl)sulfonyl]amino]-, iodide</ENT> <ENT>68957-58-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, N,N,N-trimethyl-3-[[(undecafluoropentyl)sulfonyl]amino]-, chloride</ENT> <ENT>68957-55-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanaminium, N,N,N-trimethyl-3-[[(undecafluoropentyl)sulfonyl]amino]-, iodide</ENT> <ENT>68957-57-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Propanedioic acid, mono(γ-ω-perfluoro-C8-12-alkyl) derivs., bis[4-(ethenyloxy)butyl] esters</ENT> <ENT>238420-80-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Propanedioic acid, mono(γ-ω-perfluoro-C8-12-alkyl) derivs., di-me esters</ENT> <ENT>238420-68-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C10-20-alkyl)thio]methyl] derivs., phosphates, ammonium salts</ENT> <ENT>148240-89-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C4-10-alkyl)thio]methyl] derivs., phosphates, ammonium salts</ENT> <ENT>148240-85-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C6-12-alkyl)thio]methyl] derivs., phosphates, ammonium salts</ENT> <ENT>148240-87-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C6-12-alkyl)thio]methyl] derivs., polymers with 2,2-bis[[(γ-ω-perfluoro-C10-20-alkyl)thio]methyl]-1,3-propanediol, 1,6-diisocyanato-2,2,4(or 2,4,4)-trimethylhexane, 2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentylcyclohexane and 2,2′-(methylimino)bis[ethanol]</ENT> <ENT>1078142-10-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Propanesulfonic acid, 2-methyl-, 2-[[1-oxo-3-[(γ-ω-perfluoro-C4-16-alkyl)thio]propyl]amino] derivs., sodium salts</ENT> <ENT>68187-47-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, butyl ester, telomer with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl 2-propenoate, 2-[methyl[(nonafluorobutyl)sulfonyl]amino]ethyl 2-propenoate, α-(2-methyl-1-oxo-2-propenyl)-ω-hydroxypoly(oxy-1,4-butanediyl), α-(2-methyl-1-oxo-2-propenyl)-ω-[(2-methyl-1-oxo-2-propenyl)oxy]poly(oxy-1,4-butanediyl), 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl 2-propenoate and 1-octanethiol</ENT> <ENT>68227-96-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-[butyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl ester, telomer with 2-[butyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-propenoate, methyloxirane polymer with oxirane di-2-propenoate, methyloxirane polymer with oxirane mono-2-propenoate and 1-octanethiol</ENT> <ENT>68298-62-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, esters, 2-methyl-, dodecyl ester, polymer with α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]poly(difluoromethylene)</ENT> <ENT>65605-58-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester</ENT> <ENT>59071-10-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="510"/> <ENT I="01">2-Propenoic acid, 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl ester, polymer with 2-[methyl[(nonafluorobutyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl 2-propenoate and α-(1-oxo-2-propenyl)-ω-methoxypoly(oxy-1,2-ethanediyl)</ENT> <ENT>68867-60-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymers with Bu acrylate, γ-ω-perfluoro-C8-14-alkyl acrylate and polyethylene glycol monomethacrylate, 2,2′-azobis[2,4-dimethylpentanenitrile]-initiated</ENT> <ENT>150135-57-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymers with γ-ω-perfluoro-C10-16-alkyl acrylate and vinyl acetate, acetates</ENT> <ENT>196316-34-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]poly(difluoromethylene) and N-(hydroxymethyl)-2-propenamide</ENT> <ENT>65605-59-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 2-ethylhexyl ester, polymer with α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]poly(difluoromethylene), 2-hydroxyethyl 2-methyl-2-propenoate and N-(hydroxymethyl)-2-propenamide</ENT> <ENT>68239-43-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl ester, polymer with 2-[ethyl[(nonafluorobutyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate, 2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate, 2-[ethyl[(tridecafluorohexyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate, 2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate and octadecyl 2-methyl-2-propenoate</ENT> <ENT>68555-91-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl ester</ENT> <ENT>2144-54-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl ester, polymer with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl 2-methyl-2-propenoate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-methyl-2-propenoate</ENT> <ENT>65104-45-2</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl ester</ENT> <ENT>1996-88-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, hexadecyl ester, polymers with 2-hydroxyethyl methacrylate, .gamma.-.omega.-perfluoro-C10-6-alkyl acrylate and stearyl methacrylate</ENT> <ENT>203743-03-7</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluorohexadecyl ester</ENT> <ENT>4980-53-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, octadecyl ester, polymer with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl 2-propenoate, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-propenoate and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl 2-propenoate</ENT> <ENT>142636-88-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester</ENT> <ENT>68084-62-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9, 10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl ester</ENT> <ENT>6014-75-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-methyl-, polymer with butyl 2-methyl-2-propenoate, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-propenoate, 2-hydroxyethyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate</ENT> <ENT>200513-42-4</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl ester</ENT> <ENT>67584-57-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2-Propenoic acid, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl ester</ENT> <ENT>67584-56-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Pyridinium, 1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-, salt with 4-methylbenzenesulfonic acid (1:1)</ENT> <ENT>61798-68-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Silane, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)trimethoxy-</ENT> <ENT>83048-65-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Silane, trichloro(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-</ENT> <ENT>78560-44-8</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01"> Silicic acid (H <E T="52">4</E> SiO <E T="52">4</E> ), disodium salt, reaction products with chlorotrimethylsilane and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol </ENT> <ENT>125476-71-3</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Siloxanes and Silicones, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)oxy Me, hydroxy Me, Me octyl, ethers with polyethylene glycol mono-Me ether</ENT> <ENT>143372-54-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Silver(I) perfluorooctanoate</ENT> <ENT>335-93-3</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">Sodium perfluorobutanoate</ENT> <ENT>2218-54-4</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">Sodium perfluorodecanoate (PFDA-Na)</ENT> <ENT>3830-45-3</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">Sodium perfluorohexanoate</ENT> <ENT>2923-26-4</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">Sodium perfluorooctanoate</ENT> <ENT>335-95-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Sulfluramid</ENT> <ENT>4151-50-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Sulfonic acids, C6-12-alkane, γ-ω-perfluoro, ammonium salts</ENT> <ENT>180582-79-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Tetradecane, 1,1,1,2,2,3,3,4,4,5, 5,6,6,7,7,8,8,9,9,10,10,11,11,12,12-pentacosafluoro-14-iodo-</ENT> <ENT>30046-31-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Tetradecanesulfonyl chloride, 3,3,4,4,5,5,6, 6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluoro-</ENT> <ENT>68758-57-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1-Tetradecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluoro-</ENT> <ENT>39239-77-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrahydroperfluorodecyl acrylate</ENT> <ENT>27905-45-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrahydroperfluorododecyl acrylate</ENT> <ENT>17741-60-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrahydroperfluorohexadecyl acrylate</ENT> <ENT>34362-49-7</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,1,2,2-Tetrahydroperfluorotetradecyl acrylate</ENT> <ENT>34395-24-9</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="511"/> <ENT I="01">Thiocyanic acid, γ-ω-perfluoro-C4-20-alkyl esters</ENT> <ENT>97553-95-2</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Thiols, C4-10, γ-ω-perfluoro</ENT> <ENT>68140-18-1</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Thiols, C4-20, γ-ω-perfluoro, telomers with acrylamide and acrylic acid, sodium salts</ENT> <ENT>1078712-88-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Thiols, C6-12, γ-ω-perfluoro</ENT> <ENT>68140-20-5</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Thiols, C8-20, γ-ω-perfluoro, telomers with acrylamide</ENT> <ENT>70969-47-0</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">Thiols, C10-20, γ-ω-perfluoro</ENT> <ENT>68140-21-6</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1,1,1-Trifluoro-N-[(trifluoromethyl)sulfonyl] methanesulfonamide</ENT> <ENT>82113-65-3</ENT> <ENT>1/1/24</ENT> </ROW> <TNOTE> <SU>1</SU>  CASRN means Chemical Abstracts Service Registry Number. </TNOTE> </GPOTABLE> <P> (e) <E T="03">Per- and polyfluoroalkyl substances CAS number listing.</E> </P> <GPOTABLE COLS="3" OPTS="L2,nj" CDEF="xs60,r200,12"> <TTITLE> Table 5 to Paragraph <E T="01">(e)</E> </TTITLE> <BOXHD> <CHED H="1"> CASRN  <SU>1</SU> </CHED> <CHED H="1">Chemical name</CHED> <CHED H="1"> Effective <LI>date</LI> </CHED> </BOXHD> <ROW> <ENT I="01">307-24-4</ENT> <ENT>Perfluorohexanoic acid</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">307-35-7</ENT> <ENT>Perfluorooctylsulfonyl fluoride</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">307-55-1</ENT> <ENT>Perfluorododecanoic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">335-66-0</ENT> <ENT>Octanoyl fluoride, pentadecafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">335-67-1</ENT> <ENT>Perfluorooctanoic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">335-71-7</ENT> <ENT>1-Heptanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">335-76-2</ENT> <ENT>Perfluorodecanoic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">335-93-3</ENT> <ENT>Silver(I) perfluorooctanoate</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">335-95-5</ENT> <ENT>Sodium perfluorooctanoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">355-46-4</ENT> <ENT>Perfluorohexanesulfonic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">375-22-4</ENT> <ENT>Perfluorobutanoic acid</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">375-73-5</ENT> <ENT>Perfluorobutane sulfonic acid</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">375-95-1</ENT> <ENT>Perfluorononanoic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">376-06-7</ENT> <ENT>Perfluorotetradecanoic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">376-14-7</ENT> <ENT>2-[Ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl methacrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">376-27-2</ENT> <ENT>Methyl perfluorooctanoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">377-73-1</ENT> <ENT>Perfluoro-3-methoxypropanoic acid</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">383-07-3</ENT> <ENT>2-[Butyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">422-64-0</ENT> <ENT>Perfluoropropanoic acid</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">423-82-5</ENT> <ENT>2-[Ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">507-63-1</ENT> <ENT>Perfluorooctyl iodide</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">678-39-7</ENT> <ENT>1-Decanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">865-86-1</ENT> <ENT>1-Dodecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1652-63-7</ENT> <ENT>3-[[(Heptadecafluorooctyl)sulfonyl]amino]-N,N,N-trimethyl-1-propanaminium iodide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1691-99-2</ENT> <ENT>N-Ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1763-23-1</ENT> <ENT>Perfluorooctane sulfonic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1996-88-9</ENT> <ENT>2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2043-53-0</ENT> <ENT>Decane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-heptadecafluoro-10-iodo-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2043-54-1</ENT> <ENT>Dodecane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-heneicosafluoro-12-iodo-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2144-54-9</ENT> <ENT>2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2218-54-4</ENT> <ENT>Sodium perfluorobutanoate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2263-09-4</ENT> <ENT>1-Octanesulfonamide, N-butyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(2-hydroxyethyl)-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2395-00-8</ENT> <ENT>Potassium perfluorooctanoate</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">2795-39-3</ENT> <ENT>Potassium perfluorooctanesulfonate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2923-26-4</ENT> <ENT>Sodium perfluorohexanoate</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">2966-54-3</ENT> <ENT>Potassium heptafluorobutanoate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2991-51-7</ENT> <ENT>Glycine, N-ethyl-N-[(heptadecafluorooctyl)sulfonyl]-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">3107-18-4</ENT> <ENT>Cyclohexanesulfonic acid, undecafluoro-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">3108-42-7</ENT> <ENT>Ammonium perfluorodecanoate (PFDA NH4)</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">3825-26-1</ENT> <ENT>Ammonium perfluorooctanoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">3830-45-3</ENT> <ENT>Sodium perfluorodecanoate (PFDA-Na)</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">3871-99-6</ENT> <ENT>1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">3872-25-1</ENT> <ENT>1-Pentanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">4151-50-2</ENT> <ENT>Sulfluramid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">4980-53-4</ENT> <ENT> 2-Propenoic acid, 2-methyl-, <LI>3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-</LI> <LI>nonacosafluorohexadecyl ester</LI> </ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="512"/> <ENT I="01">6014-75-1</ENT> <ENT>2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14- pentacosafluorotetradecyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">10495-86-0</ENT> <ENT>Ammonium perfluorobutanoate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">13252-13-6</ENT> <ENT>Hexafluoropropylene oxide dimer acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">16517-11-6</ENT> <ENT>Octadecanoic acid, pentatriacontafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">17202-41-4</ENT> <ENT> 1-Nonanesulfonic acid, <LI>1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-</LI> <LI>nonadecafluoro-, ammonium salt</LI> </ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">17741-60-5</ENT> <ENT>1,1,2,2-Tetrahydroperfluorododecyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">21615-47-4</ENT> <ENT>Ammonium perfluorohexanoate</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">21652-58-4</ENT> <ENT>Perfluorooctyl Ethylene</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">24448-09-7</ENT> <ENT>1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">25268-77-3</ENT> <ENT>2-[[(Heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">27619-90-5</ENT> <ENT> 1-Decanesulfonyl chloride, <LI>3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-</LI> </ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">27619-91-6</ENT> <ENT> 1-Dodecanesulfonyl chloride, <LI>3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluoro-</LI> </ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">27619-94-9</ENT> <ENT>6:2 Fluorotelomer sulfonate sodium salt</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">27619-97-2</ENT> <ENT>6:2 Fluorotelomer sulfonate acid</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">27905-45-9</ENT> <ENT>1,1,2,2-Tetrahydroperfluorodecyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">29081-56-9</ENT> <ENT> 1-Octanesulfonic acid, <LI>1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, ammonium salt</LI> </ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">29117-08-6</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(heptadecafluorooctyl) sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">29420-49-3</ENT> <ENT>Potassium perfluorobutane sulfonate</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">29457-72-5</ENT> <ENT>Lithium (perfluorooctane)sulfonate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">30046-31-2</ENT> <ENT>Tetradecane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12-pentacosafluoro-14-iodo-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">31506-32-8</ENT> <ENT>1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8- heptadecafluoro-N-methyl-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">34362-49-7</ENT> <ENT>1,1,2,2-Tetrahydroperfluorohexadecyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">34395-24-9</ENT> <ENT>1,1,2,2-Tetrahydroperfluorotetradecyl acrylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">37338-48-0</ENT> <ENT>Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(heptadecafluorooctyl) sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">38006-74-5</ENT> <ENT>1-Propanaminium, 3-[[(heptadecafluorooctyl) sulfonyl]amino]-N,N,N- trimethyl-, chloride</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">39239-77-5</ENT> <ENT>1-Tetradecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">45048-62-2</ENT> <ENT>Perfluorobutanoate</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">45187-15-3</ENT> <ENT>Perfluorobutane sulfonate</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">52166-82-2</ENT> <ENT>1-Propanaminium, N,N,N-trimethyl-3-[[(tridecafluorohexyl) sulfonyl]amino]-, chloride</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">55910-10-6</ENT> <ENT>Glycine, N-[(heptadecafluorooctyl) sulfonyl]-N-propyl-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">56372-23-7</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(tridecafluorohexyl) sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">56773-42-3</ENT> <ENT>Ethanaminium, N,N,N-triethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8- heptadecafluoro-1-octanesulfonic acid (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">59071-10-2</ENT> <ENT>2-Propenoic acid, 2-[ethyl[(pentadecafluoroheptyl) sulfonyl]amino]ethyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">59587-38-1</ENT> <ENT>6:2 Fluorotelomer sulfonate potassium salt</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">59587-39-2</ENT> <ENT>6:2 Fluorotelomer sulfonate ammonium salt</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">60270-55-5</ENT> <ENT>1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">60699-51-6</ENT> <ENT>1-Hexadecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">61660-12-6</ENT> <ENT>1-Octanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-[3-(trimethoxysilyl)propyl]-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">61798-68-3</ENT> <ENT>Pyridinium, 1-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-, salt with 4-methylbenzenesulfonic acid (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">62037-80-3</ENT> <ENT>Hexafluoropropylene oxide dimer acid ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65104-45-2</ENT> <ENT>2-Propenoic acid, 2-methyl-, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl ester, polymer with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-methyl-2-propenoate, methyl 2-methyl-2-propenoate, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl 2-methyl-2-propenoate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-methyl-2-propenoate</ENT> <ENT>1/1/21</ENT> </ROW> <ROW> <ENT I="01">65104-65-6</ENT> <ENT>1-Eicosanol, 3,3,4,4,5,5,6,6,7,7,8,8,9, 9,10,10,11,11,12,12,13,13, 14,14,15,15,16,16,17,17,18, 18,19,19,20,20,20-heptatriacontafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65104-67-8</ENT> <ENT>1-Octadecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9, 9,10,10,11,11,12,12,13,13, 14,14,15,15,16,16,17,17,18,18,18-tritriacontafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65510-55-6</ENT> <ENT>Hexadecane, 1,1,1,2,2,3,3,4,4,5,5, 6,6,7,7,8,8,9,9,10,10,11,11, 12,12,13,13,14,14-nonacosafluoro-16-iodo-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="513"/> <ENT I="01">65530-59-8</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (3:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-61-2</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-62-3</ENT> <ENT>Poly(difluoromethylene), α,α′-[phosphinicobis(oxy-2,1-ethanediyl)]bis[ω-fluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-63-4</ENT> <ENT>Ethanol, 2,2′-iminobis-, compd. with α-fluoro-ω-[2-(phosphonooxy)ethyl]poly(difluoromethylene) (2:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-64-5</ENT> <ENT>Ethanol, 2,2′-iminobis-, compd. with α,α′-[phosphinicobis(oxy-2,1-ethanediyl)]bis[ω-fluoropoly(difluoromethylene)] (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-65-6</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-[(1-oxooctadecyl)oxy]ethyl]-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-66-7</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-69-0</ENT> <ENT>Poly(difluoromethylene), α-[2-[(2-carboxyethyl)thio]ethyl]-ω-fluoro-, lithium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-70-3</ENT> <ENT>Poly(difluoromethylene), α,α′-[phosphinicobis(oxy-2,1-ethanediyl)]bis[ω-fluoro-, ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-71-4</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-, monoammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-72-5</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-, diammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-74-7</ENT> <ENT>Ethanol, 2,2′-iminobis-, compd. with α-fluoro-ω-[2-(phosphonooxy)ethyl]poly(difluoromethylene) (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65530-83-8</ENT> <ENT>Poly(difluoromethylene), α-[2-[(2-carboxyethyl)thio]ethyl]-ω-fluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65545-80-4</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with α-fluoro-ω-(2-hydroxyethyl)poly(difluoromethylene) (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65605-56-3</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, dihydrogen 2-hydroxy-1,2,3-propanetricarboxylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65605-57-4</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-(2-hydroxyethyl)-, hydrogen 2-hydroxy-1,2,3-propanetricarboxylate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65605-58-5</ENT> <ENT>2-Propenoic acid, esters, 2-methyl-, dodecyl ester, polymer with α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]poly(difluoromethylene)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65605-59-6</ENT> <ENT>2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]poly(difluoromethylene) and N-(hydroxymethyl)-2-propenamide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65605-73-4</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-[(1-oxo-2-propenyl)oxy]ethyl]-, homopolymer</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">65636-35-3</ENT> <ENT>Ethanaminium, N,N-diethyl-N-methyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, methyl sulfate, polymer with 2-ethylhexyl 2-methyl-2-propenoate, α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]poly(difluoromethylene), 2-hydroxyethyl 2-methyl-2-propenoate and N-(hydroxymethyl)-2-propenamide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-42-3</ENT> <ENT>Cyclohexanesulfonic acid, decafluoro(pentafluoroethyl)-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-52-5</ENT> <ENT>Glycine, N-ethyl-N-[(undecafluoropentyl)sulfonyl]-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-53-6</ENT> <ENT>Glycine, N-ethyl-N-[(tridecafluorohexyl)sulfonyl]-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-56-9</ENT> <ENT>2-Propenoic acid, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-57-0</ENT> <ENT>2-Propenoic acid, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-58-1</ENT> <ENT>1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, iodide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67584-62-7</ENT> <ENT>Glycine, N-ethyl-N-[(pentadecafluoroheptyl)sulfonyl]-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67905-19-5</ENT> <ENT>Perfluoropalmitic acid</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67906-42-7</ENT> <ENT>1-Decanesulfonic acid, 1,1,2,2,3,3,4,4,5,5, 6,6,7,7,8,8,9,9,10,10,10- heneicosafluoro-, ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">67969-69-1</ENT> <ENT>1-Octanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5, 6,6,7,7,8,8,8-heptadecafluoro-N-[2-(phosphonooxy)ethyl]-, diammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68084-62-8</ENT> <ENT>2-Propenoic acid, 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68140-18-1</ENT> <ENT>Thiols, C4-10, γ-ω-perfluoro</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68140-20-5</ENT> <ENT>Thiols, C6-12, γ-ω-perfluoro</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68140-21-6</ENT> <ENT>Thiols, C10-20, γ-ω-perfluoro</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68141-02-6</ENT> <ENT>Chromium(III) perfluorooctanoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68156-01-4</ENT> <ENT>Cyclohexanesulfonic acid, nonafluorobis(trifluoromethyl)-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68156-07-0</ENT> <ENT>Cyclohexanesulfonic acid, decafluoro(trifluoromethyl)-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68187-25-7</ENT> <ENT>Butanoic acid, 4-[[3-(dimethylamino)propyl]amino]-4-oxo-, 2(or 3)-[(γ-ω-perfluoro-C6-20-alkyl)thio] derivs.</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68187-47-3</ENT> <ENT>1-Propanesulfonic acid, 2-methyl-, 2-[[1-oxo-3-[(γ-ω-perfluoro-C4-16-alkyl)thio]propyl]amino] derivs., sodium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68188-12-5</ENT> <ENT>Alkyl iodides, C4-20, γ-ω-perfluoro</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68227-96-3</ENT> <ENT>2-Propenoic acid, butyl ester, telomer with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl 2-propenoate, 2-[methyl[(nonafluorobutyl)sulfonyl]amino]ethyl 2-propenoate, α-(2-methyl-1-oxo-2-propenyl)-ω-hydroxypoly(oxy-1,4-butanediyl), α-(2-methyl-1-oxo-2-propenyl)-ω-[(2-methyl-1-oxo-2-propenyl)oxy]poly(oxy-1,4-butanediyl), 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl 2-propenoate and 1-octanethiol</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68239-43-0</ENT> <ENT>2-Propenoic acid, 2-methyl-, 2-ethylhexyl ester, polymer with α-fluoro-ω-[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl]poly(difluoromethylene), 2-hydroxyethyl 2-methyl-2-propenoate and N-(hydroxymethyl)-2-propenamide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68259-07-4</ENT> <ENT>1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68259-08-5</ENT> <ENT>1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <PRTPAGE P="514"/> <ENT I="01">68259-09-6</ENT> <ENT>1-Pentanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68259-38-1</ENT> <ENT>Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(tridecafluorohexyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68259-39-2</ENT> <ENT>Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68298-62-4</ENT> <ENT>2-Propenoic acid, 2-[butyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl ester, telomer with 2-[butyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-propenoate, methyloxirane polymer with oxirane di-2-propenoate, methyloxirane polymer with oxirane mono-2-propenoate and 1-octanethiol</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68298-80-6</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68298-81-7</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68310-17-8</ENT> <ENT>Poly[oxy(methyl-1,2-ethanediyl)], α-[2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl]-ω-hydroxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68391-08-2</ENT> <ENT>Alcohols, C8-14, γ-ω-perfluoro</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68412-68-0</ENT> <ENT>Phosphonic acid, perfluoro-C6-12-alkyl derivs.</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68412-69-1</ENT> <ENT>Phosphinic acid, bis(perfluoro-C6-12-alkyl) derivs.</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68515-62-8</ENT> <ENT>1,4-Benzenedicarboxylic acid, dimethyl ester, reaction products with bis(2-hydroxyethyl)terephthalate, ethylene glycol, α-fluoro-ω-(2-hydroxyethyl)poly(difluoromethylene), hexakis(methoxymethyl)melamine and polyethylene glycol</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68555-74-8</ENT> <ENT>1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68555-75-9</ENT> <ENT>1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68555-76-0</ENT> <ENT>1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-hydroxyethyl)-N-methyl-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68555-81-7</ENT> <ENT>1-Propanaminium, N,N,N-trimethyl-3-[[(pentadecafluoroheptyl)sulfonyl]amino]-, chloride</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68555-91-9</ENT> <ENT>2-Propenoic acid, 2-methyl-, 2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl ester, polymer with 2-[ethyl[(nonafluorobutyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate, 2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate, 2-[ethyl[(tridecafluorohexyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate, 2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl 2-methyl-2-propenoate and octadecyl 2-methyl-2-propenoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68758-57-6</ENT> <ENT>1-Tetradecanesulfonyl chloride, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68867-60-7</ENT> <ENT>2-Propenoic acid, 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl ester, polymer with 2-[methyl[(nonafluorobutyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl 2-propenoate, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl 2-propenoate and α-(1-oxo-2-propenyl)-ω-methoxypoly(oxy-1,2-ethanediyl)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68957-55-1</ENT> <ENT>1-Propanaminium, N,N,N-trimethyl-3-[[(undecafluoropentyl)sulfonyl]amino]-, chloride</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68957-57-3</ENT> <ENT>1-Propanaminium, N,N,N-trimethyl-3-[[(undecafluoropentyl)sulfonyl]amino]-, iodide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68957-58-4</ENT> <ENT>1-Propanaminium, N,N,N-trimethyl-3-[[(tridecafluorohexyl)sulfonyl]amino]-, iodide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68957-62-0</ENT> <ENT>1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68958-60-1</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl]-ω-methoxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">68958-61-2</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-[2-[ethyl[(heptadecafluorooctyl)sulfonyl]amino]ethyl]-ω-methoxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70225-14-8</ENT> <ENT>1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70225-15-9</ENT> <ENT>1-Heptanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70225-16-0</ENT> <ENT>1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70225-17-1</ENT> <ENT>1-Pentanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-, compd. with 2,2′-iminobis[ethanol] (1:1)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70969-47-0</ENT> <ENT>Thiols, C8-20, γ-ω-perfluoro, telomers with acrylamide</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70983-59-4</ENT> <ENT>Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-, 2-hydroxy-3-[(γ-ω-perfluoro-C6-20-alkyl)thio]propyl ethers</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">70983-60-7</ENT> <ENT>1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-, 3-[(γ-ω-perfluoro-C6-20-alkyl)thio] derivs., chlorides</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">71608-60-1</ENT> <ENT>Pentanoic acid, 4,4-bis[(γ-ω-perfluoro-C8-20-alkyl)thio] derivs.</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">72623-77-9</ENT> <ENT>Fatty acids, C6-18, perfluoro, ammonium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">72968-38-8</ENT> <ENT>Fatty acids, C7-13, perfluoro, ammonium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">74499-44-8</ENT> <ENT>Phosphoric acid, γ-ω-perfluoro-C8-16-alkyl esters, compds. with diethanolamine</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">78560-44-8</ENT> <ENT>Silane, trichloro(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">80010-37-3</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-sulphoethyl)-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">82113-65-3</ENT> <ENT>1,1,1-Trifluoro-N-[(trifluoromethyl)sulfonyl] methanesulfonamide</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <PRTPAGE P="515"/> <ENT I="01">83048-65-1</ENT> <ENT>Silane, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)trimethoxy-</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">90076-65-6</ENT> <ENT>Lithium bis[(trifluoromethyl)sulfonyl] azanide</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">95144-12-0</ENT> <ENT>Poly(difluoromethylene), α-fluoro-ω-[2-(phosphonooxy)ethyl]-, ammonium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">97553-95-2</ENT> <ENT>Thiocyanic acid, γ-ω-perfluoro-C4-20-alkyl esters</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">97659-47-7</ENT> <ENT>Alkenes, C8-14 α-, δ-ω-perfluoro</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">118400-71-8</ENT> <ENT>Disulfides, bis(γ-ω-perfluoro-C6-20-alkyl)</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">123171-68-6</ENT> <ENT>Poly(difluoromethylene), α-[2-(acetyloxy)-3-[(carboxymethyl)dimethylammonio]propyl]-ω-fluoro-, inner salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">125476-71-3</ENT> <ENT> Silicic acid (H <E T="52">4</E> SiO <E T="52">4</E> ), disodium salt, reaction products with chlorotrimethylsilane and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol </ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">135228-60-3</ENT> <ENT>Hexane, 1,6-diisocyanato-, homopolymer, γ-ω-perfluoro-C6-20-alc.-blocked</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">142636-88-2</ENT> <ENT>2-Propenoic acid, 2-methyl-, octadecyl ester, polymer with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heneicosafluorododecyl 2-propenoate, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-propenoate and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl 2-propenoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">143372-54-7</ENT> <ENT>Siloxanes and Silicones, (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)oxy Me, hydroxy Me, Me octyl, ethers with polyethylene glycol mono-Me ether</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">148240-85-1</ENT> <ENT>1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C4-10-alkyl)thio]methyl] derivs., phosphates, ammonium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">148240-87-3</ENT> <ENT>1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C6-12-alkyl)thio]methyl] derivs., phosphates, ammonium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">148240-89-5</ENT> <ENT>1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C10-20-alkyl)thio]methyl] derivs., phosphates, ammonium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">150135-57-2</ENT> <ENT>2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymers with Bu acrylate, γ-ω-perfluoro-C8-14-alkyl acrylate and polyethylene glycol monomethacrylate, 2,2′-azobis[2,4-dimethylpentanenitrile]-initiated</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">178094-69-4</ENT> <ENT>1-Octanesulfonamide, N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, potassium salt</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">178535-23-4</ENT> <ENT>Fatty acids, linseed-oil, γ-ω-perfluoro-C8-14-alkyl esters</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">180582-79-0</ENT> <ENT>Sulfonic acids, C6-12-alkane, γ-ω-perfluoro, ammonium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">182176-52-9</ENT> <ENT>Ethaneperoxoic acid, reaction products with 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl thiocyanate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl thiocyanate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">196316-34-4</ENT> <ENT>2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymers with γ-ω-perfluoro-C10-16-alkyl acrylate and vinyl acetate, acetates</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">200513-42-4</ENT> <ENT>2-Propenoic acid, 2-methyl-, polymer with butyl 2-methyl-2-propenoate, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-propenoate, 2-hydroxyethyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">203743-03-7</ENT> <ENT>2-Propenoic acid, 2-methyl-, hexadecyl ester, polymers with 2-hydroxyethyl methacrylate, .gamma.-.omega.-perfluoro-C10-6-alkyl acrylate and stearyl methacrylate</ENT> <ENT>1/1/22</ENT> </ROW> <ROW> <ENT I="01">238420-68-3</ENT> <ENT>Propanedioic acid, mono(γ-ω-perfluoro-C8-12-alkyl) derivs., di-me esters</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">238420-80-9</ENT> <ENT>Propanedioic acid, mono(γ-ω-perfluoro-C8-12-alkyl) derivs., bis[4-(ethenyloxy)butyl] esters</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">425670-75-3</ENT> <ENT>6:2 Fluorotelomer sulfonate anion</ENT> <ENT>1/1/25</ENT> </ROW> <ROW> <ENT I="01">1078142-10-5</ENT> <ENT>1,3-Propanediol, 2,2-bis[[(γ-ω-perfluoro-C6-12-alkyl)thio]methyl] derivs., polymers with 2,2-bis[[(γ-ω-perfluoro-C10-20-alkyl)thio]methyl]-1,3-propanediol, 1,6-diisocyanato-2,2,4(or 2,4,4)-trimethylhexane, 2-heptyl-3,4-bis(9-isocyanatononyl)-1-pentylcyclohexane and 2,2′-(methylimino)bis[ethanol]</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1078712-88-5</ENT> <ENT>Thiols, C4-20, γ-ω-perfluoro, telomers with acrylamide and acrylic acid, sodium salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">1078715-61-3</ENT> <ENT>1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-[2-[(γ-ω-perfluoro-C4-20-alkyl)thio]acetyl] derivs., inner salts</ENT> <ENT>1/1/20</ENT> </ROW> <ROW> <ENT I="01">2728655-42-1</ENT> <ENT>Alcohols, C8-16, γ-ω-perfluoro, reaction products with 1,6-diisocyanatohexane, glycidol and stearyl alc</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2738952-61-7</ENT> <ENT>Acetamide, N-[3-(dimethylamino)propyl]-, 2-[(γ-ω-perfluoro-C4-20-alkyl)thio] derivs</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2742694-36-4</ENT> <ENT>Acetamide, N-(2-aminoethyl)-, 2-[(γ-ω-perfluoro-C4-20-alkyl)thio] derivs., polymers with N1,N1-dimethyl-1,3-propanediamine, epichlorohydrin and ethylenediamine, oxidized</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2744262-09-5</ENT> <ENT>Acetic acid, 2-[(γ-ω-perfluoro-C4-20-alkyl)thio] derivs., 2-hydroxypropyl esters</ENT> <ENT>1/1/23</ENT> </ROW> <ROW> <ENT I="01">2816091-53-7</ENT> <ENT>Betaines, dimethyl(γ-ω-perfluoro-γ-hydro-C8-18-alkyl)</ENT> <ENT>1/1/24</ENT> </ROW> <ROW> <ENT I="01">3030471-22-5</ENT> <ENT>Acetic acid, [(γ-ω-perfluoro-C8-10-alkyl)thio] derivs., Bu esters</ENT> <ENT>1/1/25</ENT> </ROW> <TNOTE> <SU>1</SU>  CASRN means Chemical Abstracts Service Registry Number. </TNOTE> </GPOTABLE> <CITA>[53 FR 4525, Feb. 16, 1988; 53 FR 12748, Apr. 18, 1988]</CITA> <EDNOTE> <HD SOURCE="HED">Editorial Notes:</HD> <P> For <E T="04">Federal Register</E> citations affecting § 372.65, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at <E T="03">www.govinfo.gov.</E> </P> </EDNOTE> <EAR>§ 372.65, Nt.</EAR> <EFFDNOT> <HD SOURCE="HED">Effective Date Note:</HD> <P>At 59 FR 43050, Aug. 22, 1994, in § 372.65, in paragraph (a), the methyl mercaptan entry and in paragraph (b), the entry for CAS No. 74-93-1 were stayed indefinitely.</P> </EFFDNOT> </SECTION> </SUBPART> <SUBPART> <PRTPAGE P="516"/> <HD SOURCE="HED">Subpart E—Forms and Instructions</HD> <SECTION> <SECTNO>§ 372.85</SECTNO> <SUBJECT>Toxic chemical release reporting form and instructions.</SUBJECT> <P> (a) <E T="03">Availability of reporting form and instructions.</E> The most current version of Form R and Form R Schedule 1 may be found on the following EPA Program Web site, <E T="03">http://www.epa.gov/tri.</E> Any subsequent changes to the Form R or Form R Schedule 1 will be posted on this Web site. Submitters may also contact the TRI Program at (202) 564-9554 to obtain this information. </P> <P> (b) <E T="03">Form elements.</E> Information elements reportable on EPA Form R and Form R Schedule 1 include the following: </P> <P>(1) An indication of whether the report:</P> <P>(i) Claims chemical identity as trade secret.</P> <P>(ii) Covers the entire facility or part of a facility.</P> <P>(2) Signature of a senior management official certifying the following: “I hereby certify that I have reviewed the attached documents and, to the best of my knowledge and belief, the submitted information is true and complete and that amounts and values in this report are accurate based upon reasonable estimates using data available to the preparer of the report.”</P> <P>(3) Facility name and address including the toxic chemical release inventory facility identification number if known.</P> <P>(4) Name and telephone number for both a technical contact and a public contact.</P> <P>(5) The four-digit SIC code(s) for the facility or establishments in the facility until the reporting year ending December 31, 2005, for which reporting forms are due July 1, 2006. Beginning with the reporting year ending December 31, 2006, for which reporting forms are due July 1, 2007, and for each subsequent reporting year, the six-digit NAICS code(s) for the facility or establishments in the facility.</P> <P>(6) Dun and Bradstreet identification number.</P> <P>(7) The name(s) of receiving stream(s) or water body to which the chemical is released.</P> <P>(8) Name of the facility's parent company, including:</P> <P>(i) Legal name of the facility's highest-level U.S.-based parent company and its Dun and Bradstreet identification number, when applicable.</P> <P>(ii) Beginning with the reporting year ending December 31, 2023, for which reporting forms are due July 1, 2024, and for each subsequent reporting year, the legal name of the facility's highest-level foreign parent company and its Dun and Bradstreet identification number, when applicable.</P> <P>(iii) The facility must report using the standardized conventions for the naming of a parent company as provided in the toxic chemical release inventory reporting instructions identified in paragraph (a) of this section.</P> <P>(9) Name and CAS number (if applicable) of the chemical reported.</P> <P>(10) If the chemical identity is claimed trade secret, a generic name for the chemical.</P> <P>(11) A mixture component identity if the chemical identity is not known.</P> <P>(12) An indication of the activities and uses of the chemical at the facility.</P> <P>(13) An indication of the maximum amount of the chemical on site at any point in time during the reporting year.</P> <P>(14) Information on releases of the chemical to the environment as follows:</P> <P>(i) An estimate of total releases in pounds (except for dioxin and dioxin-like compounds, which shall be reported in grams) per year (releases of less than 1,000 pounds per year may be indicated in ranges, except for chemicals set forth in § 372.28) from the facility plus an indication of the basis of estimate for the following:</P> <P>(A) Fugitive or non-point air emissions.</P> <P>(B) Stack or point air emissions.</P> <P>(C) Discharges to receiving streams or water bodies including an indication of the percent of releases due to stormwater.</P> <P>(D) Underground injection on site.</P> <P>(E) Releases to land on site.</P> <P>(ii) Additional Reporting for the dioxin and dioxin-like compounds category.</P> <P> (A) For reports pertaining to a reporting year ending on or before December 31, 2007, report a distribution of <PRTPAGE P="517"/> the chemicals included in the dioxin and dioxin-like compounds category. Such distribution shall either represent the distribution of the total quantity of dioxin and dioxin-like compounds released to all media from the facility; or its one best media-specific distribution. </P> <P>(B) For reports pertaining to a reporting year ending after December 31, 2007, report the quantity of each member of the dioxin and dioxin-like compounds category in units of grams per year on Form R Schedule 1.</P> <P>(15) Information on transfers of the chemical in wastes to off-site locations as follows:</P> <P>(i) For transfers to Publicly Owned Treatment Works (POTW):</P> <P>(A) The name and address (including county) of each POTW to which the chemical is transferred.</P> <P>(B) An estimate of the amount of the chemical transferred in pounds (except for dioxin and dioxin-like compounds, which shall be reported in grams) per year (transfers of less than 1,000 pounds per year may be indicated as a range, except for chemicals set forth in § 372.28) and an indication of the basis of the estimate. In addition, for reports pertaining to a reporting year ending after December 31, 2007, report the quantity of each member of the dioxin and dioxin-like compounds category in units of grams per year on Form R Schedule 1.</P> <P>(ii) For transfers to other off-site locations:</P> <P>(A) The name, address (including county), and EPA identification number (RCRA I.D. Number) of each off-site location, including an indication of whether the location is owned or controlled by the reporting facility or its parent company.</P> <P>(B) An estimate of the amount of the chemical transferred in pounds (except for dioxin and dioxin-like compounds, which shall be reported in grams) per year (transfers of less than 1,000 pounds per year may be indicated as a range, except for chemicals set forth in § 372.28) and an indication of the basis of the estimate. In addition, for reports pertaining to a reporting year ending after December 31, 2007, report the quantity of each member of the dioxin and dioxin-like compounds category in units of grams per year on Form R Schedule 1.</P> <P>(16) The following information relative to waste treatment:</P> <P>(i) An indication of the general type of wastestream containing the reported chemical.</P> <P>(ii) The treatment method applied to the wastestream.</P> <P>(iii) An estimate of the efficiency of the treatment, which shall be indicated by a range.</P> <P>(iv) An indication (use is optional) of whether treatments listed are part of a treatment sequence.</P> <P> (c) <E T="03">Filing Requirements.</E> Effective January 21, 2014, facilities that submit TRI reporting forms (without claiming a trade secret), including revisions and withdrawals of TRI reporting forms, to EPA must prepare, certify, and submit their data to EPA electronically, using the TRI online-reporting software provided by EPA. </P> <P>(1) EPA will no longer accept non-trade-secret TRI reports, revisions, or withdrawals on paper reporting forms, magnetic media, or CD-ROMs. Information and instructions regarding online reporting are available on the TRI Web site.</P> <P>(2) Facilities must submit electronically any revisions or withdrawals of previously submitted TRI reporting forms. Facilities may submit, revise, or withdraw TRI reporting forms for reporting years 1991 through the present reporting year.</P> <P>(3) The only exception to this TRI electronic reporting requirement of paragraph (c) relates to TRI submissions that claim a trade secret (including sanitized and unsanitized reporting forms) and revisions and withdrawals of such TRI submissions, which must be submitted to EPA on paper. Facilities may submit, revise, or withdraw these paper trade secret (including sanitized and unsanitized) TRI reporting forms for reporting years 1991 through the present reporting year.</P> <CITA>[56 FR 29186, June 26, 1991, as amended at 64 FR 58753, Oct. 29, 1999; 70 FR 39949, July 12, 2005; 71 FR 32477, June 6, 2006; 72 FR 26553, May 10, 2007; 78 FR 52867, Aug. 27, 2013; 87 FR 63955, Oct. 21, 2022]</CITA> </SECTION> <SECTION> <PRTPAGE P="518"/> <SECTNO>§ 372.95</SECTNO> <SUBJECT>Alternate threshold certification and instructions.</SUBJECT> <P> (a) <E T="03">Availability of the alternate threshold certification statement and instructions.</E> Availability of the alternate threshold certification statement and instructions is the same as provided in § 372.85(a) for availability of the reporting form and instructions. </P> <P> (b) <E T="03">Alternate threshold certification statement elements.</E> The following information must be reported on an alternate threshold certification statement pursuant to § 372.27(b): </P> <P>(1) Reporting year.</P> <P>(2) An indication of whether the chemical identified is being claimed as trade secret.</P> <P>(3) Chemical name and CAS number (if applicable) of the chemical, or the category name.</P> <P>(4) Signature of a senior management official certifying the following: pursuant to 40 CFR 372.27, “I hereby certify that to the best of my knowledge and belief for the toxic chemical listed in this statement, the annual reportable amount, as defined in 40 CFR 372.27(a), did not exceed 500 pounds for this reporting year and that the chemical was manufactured, or processed, or otherwise used in an amount not exceeding 1 million pounds during this reporting year.”</P> <P>(5) Date signed.</P> <P>(6) Facility name and address.</P> <P>(7) Mailing address of the facility if different than paragraph (b)(6) of this section.</P> <P>(8) Toxic chemical release inventory facility identification number if known.</P> <P>(9) Name and telephone number of a technical contact.</P> <P>(10) The four-digit SIC code(s) for the facility or establishments in the facility until the reporting year ending December 31, 2005, for which reporting forms are due July 1, 2006. Beginning with the reporting year ending December 31, 2006, for which reporting forms are due July 1, 2007, and for each subsequent reporting year, the six-digit NAICS code(s) for the facility or establishments in the facility.</P> <P>(11) Dun and Bradstreet Number of the facility.</P> <P>(12) Name of the facility's parent company, including:</P> <P>(i) Legal name of the facility's highest-level U.S.-based parent company and its Dun and Bradstreet identification number, when applicable.</P> <P>(ii) Beginning with the reporting year ending December 31, 2023, for which reporting forms are due July 1, 2024, and for each subsequent reporting year, the legal name of the facility's highest-level foreign parent company and its Dun and Bradstreet identification number, when applicable.</P> <P>(iii) The facility must report using the standardized conventions for the naming of a parent company as provided in the toxic chemical release inventory reporting instructions identified in paragraph (a) of this section.</P> <P>(13) Parent company's Dun and Bradstreet Number.</P> <CITA>[59 FR 61502, Nov. 30, 1994, as amended at 70 FR 39949, July 12, 2005; 71 FR 32477, June 6, 2006; 71 FR 76945, Dec. 22, 2006; 74 FR 19006, Apr. 27, 2009; 87 FR 63955, Oct. 21, 2022]</CITA> </SECTION> </SUBPART> </PART> <PART> <EAR>Pt. 373</EAR> <HD SOURCE="HED">PART 373—REPORTING HAZARDOUS SUBSTANCE ACTIVITY WHEN SELLING OR TRANSFERRING FEDERAL REAL PROPERTY</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>373.1</SECTNO> <SUBJECT>General requirement.</SUBJECT> <SECTNO>373.2</SECTNO> <SUBJECT>Applicability.</SUBJECT> <SECTNO>373.3</SECTNO> <SUBJECT>Content of notice.</SUBJECT> <SECTNO>373.4</SECTNO> <SUBJECT>Definitions.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 9620.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>55 FR 14212, Apr. 16, 1990, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 373.1</SECTNO> <SUBJECT>General requirement.</SUBJECT> <P> After the last day of the six-month period beginning on April 16, 1990, whenever any department, agency or instrumentality of the United States enters into any contract for the sale or other transfer of real property which is owned by the United States and at which any hazardous substance was stored for one year or more, known to have been released, or disposed of, the head of such department, agency or instrumentality must include in such contract notice of the type and quantity of such hazardous substance and notice of the time at which such storage, release or disposal took place, to <PRTPAGE P="519"/> the extent such information is available on the basis of a complete search of agency files. </P> <CITA>[60 FR 33915, June 29, 1995]</CITA> </SECTION> <SECTION> <SECTNO>§ 373.2</SECTNO> <SUBJECT>Applicability.</SUBJECT> <P>(a) Except as otherwise provided in this section, the notice required by 40 CFR 373.1 applies whenever the United States enters into any contract for the sale or other transfer of real property which is owned by the United States and on which any hazardous substance was stored for one year or more, known to have been released, or disposed of.</P> <P>(b) The notice required by 40 CFR 373.1 for the storage for one year or more of hazardous substances applies only when hazardous substances are or have been stored in quantities greater than or equal to 1000 kilograms or the hazardous substance's CERCLA reportable quantity found at 40 CFR 302.4, whichever is greater. Hazardous substances that are also listed under 40 CFR 261.30 as acutely hazardous wastes, and that are stored for one year or more, are subject to the notice requirement when stored in quantities greater than or equal to one kilogram.</P> <P>(c) The notice required by 40 CFR 373.1 for the known release of hazardous substances applies only when hazardous substances are or have been released in quantities greater than or equal to the substance's CERCLA reportable quantity found at 40 CFR 302.4.</P> </SECTION> <SECTION> <SECTNO>§ 373.3</SECTNO> <SUBJECT>Content of notice.</SUBJECT> <P>The notice required by 40 CFR 373.1 must contain the following information:</P> <P>(a) The name of the hazardous substance; the Chemical Abstracts Services Registry Number (CASRN) where applicable; the regulatory synonym for the hazardous substance, as listed in 40 CFR 302.4, where applicable; the RCRA hazardous waste number specified in 40 CFR 261.30, where applicable; the quantity in kilograms and pounds of the hazardous substance that has been stored for one year or more, or known to have been released, or disposed of, on the property, and the date(s) that such storage, release, or disposal took place.</P> <P>(b) The following statement, prominently displayed: “The information contained in this notice is required under the authority of regulations promulgated under section 120(h) of the Comprehensive Environmental Response, Liability, and Compensation Act (CERCLA or “Superfund”) 42 U.S.C. section 9620(h).”</P> </SECTION> <SECTION> <SECTNO>§ 373.4</SECTNO> <SUBJECT>Definitions.</SUBJECT> <P>For the purposes of implementing this regulation, the following definitions apply:</P> <P> (a) <E T="03">Hazardous substances</E> means that group of substances defined as hazardous under CERCLA 101(14), and that appear at 40 CFR 302.4. </P> <P> (b) <E T="03">Storage</E> means the holding of hazardous substances for a temporary period, at the end of which the hazardous substance is either used, neutralized, disposed of, or stored elsewhere. </P> <P> (c) <E T="03">Release</E> is defined as specified by CERCLA 101(22). </P> <P> (d) <E T="03">Disposal</E> means the discharge, deposit, injection, dumping, spilling, leaking or placing of any hazardous substance into or on any land or water so that such hazardous substance or any constituent thereof may enter the environment or be emitted into the air or discharged into any waters, including groundwater. </P> </SECTION> </PART> <PART> <EAR>Pt. 374</EAR> <HD SOURCE="HED">PART 374—PRIOR NOTICE OF CITIZEN SUITS</HD> <CONTENTS> <SECHD>Sec.</SECHD> <SECTNO>374.1</SECTNO> <SUBJECT>Purpose.</SUBJECT> <SECTNO>374.2</SECTNO> <SUBJECT>Service of notice.</SUBJECT> <SECTNO>374.3</SECTNO> <SUBJECT>Contents of notice.</SUBJECT> <SECTNO>374.4</SECTNO> <SUBJECT>Timing of notice.</SUBJECT> <SECTNO>374.5</SECTNO> <SUBJECT>Copy of complaint.</SUBJECT> <SECTNO>374.6</SECTNO> <SUBJECT>Addresses.</SUBJECT> </CONTENTS> <AUTH> <HD SOURCE="HED">Authority:</HD> <P>42 U.S.C. 9659.</P> </AUTH> <SOURCE> <HD SOURCE="HED">Source:</HD> <P>57 FR 55040, Nov. 23, 1992, unless otherwise noted.</P> </SOURCE> <SECTION> <SECTNO>§ 374.1</SECTNO> <SUBJECT>Purpose.</SUBJECT> <P> Section 310 of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), as amended by the Superfund Amendments and Reauthorization Act of 1986 (SARA), authorizes civil actions by any person to enforce the Act. These civil actions may be brought against any person (including the United States, and any <PRTPAGE P="520"/> other governmental instrumentality or agency, to the extent permitted by the Eleventh Amendment to the Constitution), that is alleged to become effective pursuant to the Act (including any provision of an agreement under section 120 of the Act, relating to Federal facilities); and against the President or any other officer of the United States (including the Administrator of the Environmental Protection Agency and the Administrator of the Agency for Toxic Substances and Disease Registry) where there is alleged a failure to perform any act or duty under this Act, which is not discretionary with the President or such other officer, including an act or duty under section 120 of the Act (relating to Federal facilities), but not including any act or duty under section 311 of the Act (relating to research, development, and demonstration). These civil actions under section 310 of the Act are to be filed in accordance with the rules of the district court in which the action is instituted. The purpose of this part is to prescribe procedures governing the notice requirements of subsections (d) and (e) of section 310 of the Act as a prerequisite to the commencement of such actions. </P> </SECTION> <SECTION> <SECTNO>§ 374.2</SECTNO> <SUBJECT>Service of notice.</SUBJECT> <P> (a) <E T="03">Violation of standard, regulation, condition, requirement, or order.</E> Notice of intent to file suit under subsection 310(a)(1) of the Act shall be served by personal service upon, or by certified mail, return receipt requested, addressed to the alleged violator of any standard, regulation, condition, requirement, or order which has become effective pursuant to this Act in the following manner: </P> <P>(1) If the alleged violator is a private individual or corporation, notice shall be served by personal service upon, or by certified mail, return receipt requested, addressed to the person alleged to be in violation. If the alleged violator is a corporation, a copy of the notice shall also be served by personal service upon or by certified mail, return receipt requested, addressed to the registered agent, if any, of that corporation in the State in which the violation is alleged to have occurred. A copy of the notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the United States Attorney General; to the Attorney General of the State in which the violation is alleged to have occurred; and to the head of the Federal agency with delegated responsibility for the CERCLA provision allegedly violated, pursuant to Executive Order 12580, 3 CFR, 1987 Comp., p. 193, as amended by Executive Order 12777, 3 CFR, 1991 Comp., p. 351. If the Environmental Protection Agency has responsibility for the CERCLA provision allegedly violated, then a copy of the notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the Administrator of the Environmental Protection Agency, and to the Regional Administrator of the Environmental Protection Agency for the Region in which the violation is alleged to have occurred. A list of addresses that may be useful in providing notice of citizen suits is provided at § 374.6. Note that these addresses are subject to change and must be verified prior to use.</P> <P> (2) If the alleged violator is a State or local agency, notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the head of that agency. A copy of the notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the United States Attorney General; to the Attorney General of the State in which the violation is alleged to have occurred; and to the head of the Federal agency with delegated responsibility, pursuant to Executive Order 12580, for the CERCLA provision allegedly violated. If the Environmental Protection Agency has the delegated responsibility for the CERCLA provision allegedly violated, then a copy of the notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the Administrator of the Environmental Protection Agency, and to the Regional Administrator of the Environmental Protection Agency for the Region in which the violation is alleged to have occurred. A list of addresses that may be useful in providing notice of citizen suits is provided at <PRTPAGE P="521"/> § 374.6. Note that these addresses are subject to change and must be verified prior to use. </P> <P>(3) If the alleged violator is a Federal agency, notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the head of the agency. A copy of the notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the United States Attorney General; to the Attorney General of the State in which the violation is alleged to have occurred; and to the head of the Federal agency with delegated responsibility, pursuant to Executive Order 12580, for the CERCLA provision allegedly violated. If the Environmental Protection Agency has the delegated responsibility for the CERCLA provision allegedly violated, then a copy of the notice shall be served by personal service upon or by certified mail, return receipt requested, addressed to the Administrator of the Environmental Protection Agency, and to the Regional Administrator of the Environmental Protection Agency for the Region in which the violation is alleged to have occurred. A list of addresses that may be useful in providing notice of citizen suits is provided at § 374.6. These addresses are subject to change and must be verified prior to use.</P> <P> (b) <E T="03">Failure to act.</E> Service of notice of intent to file suit under subsection 310(a)(2) of the Act shall be accomplished by personal service upon or by certified mail, return receipt requested, addressed to the United States Attorney General and to the head of the agency of the United States (including the Administrator of the Environmental Protection Agency or the Administrator of the Agency for Toxic Substances and Disease Registry), who is alleged to have failed to perform an act or duty which is not discretionary. </P> <P> (c) <E T="03">Date of service.</E> Notice given in accordance with the provisions of this part shall be considered to have been served on the date of receipt. If notice or copy of notice is required to be served on more than one entity, notice shall be considered to have been served on the date of receipt by the last entity served. If service was accomplished by mail, the date of receipt will be considered to be the date noted on the return receipt card. </P> </SECTION> <SECTION> <SECTNO>§ 374.3</SECTNO> <SUBJECT>Contents of notice.</SUBJECT> <P> (a) <E T="03">Violation of standard, regulation, condition, requirement, or order.</E> Notice regarding an alleged violation of a standard, regulation, condition, requirement, or order (including any provision of an agreement under section 120 of the Act, relating to Federal facilities) which has become effective under this Act shall include sufficient information to allow the recipient to identify the specific standard, regulation, condition, requirement, or order (including any provision of an agreement under section 120 of the Act, relating to Federal facilities) which has allegedly been violated; the activity or failure to act alleged to constitute a violation; the name and address of the site and facility alleged to be in violation, if known; the person or persons responsible for the alleged violation; the date or dates of the violation; and the full name, address, and telephone number of the person giving notice. </P> <P> (b) <E T="03">Failure to act.</E> Notice regarding an alleged failure of the President or other officer of the United States to perform an act or duty which is not discretionary under the Act shall identify the provisions of the Act which require such act or create such duty; shall describe with reasonable specificity the action taken or not taken by the President or other officer that is claimed to constitute a failure to perform the act or duty; shall identify the Agency and name and title of the officers allegedly failing to perform the act or duty; and shall state the full name, address, and telephone number of the person giving the notice. </P> <P> (c) <E T="03">Identification of counsel.</E> All notices shall state the name, address, and telephone number of the legal counsel, if any, representing the person giving the notice. </P> <CITA>[57 FR 55040, Nov. 23, 1992; 57 FR 61612, Dec. 28, 1992]</CITA> </SECTION> <SECTION> <SECTNO>§ 374.4</SECTNO> <SUBJECT>Timing of notice.</SUBJECT> <P> (a) <E T="03">Violation of standard, regulation, condition, requirement, or order.</E> No action may be commenced under subsection 310(a)(1) of the Act before sixty (60) days after the plaintiff has served <PRTPAGE P="522"/> notice of the violation as specified in § 374.2(c). No action may be commenced under subsection 310(a)(1) of the Act if the President or his or her delegatee has commenced and is diligently prosecuting an action under the Act or under the Resource Conservation and Recovery Act (RCRA), 42 U.S.C. 6901 <E T="03">et seq.</E> , to require compliance with the CERCLA standard, regulation, condition, requirement, or order concerned (including any provision of an agreement under section 120 of the Act). </P> <P> (b) <E T="03">Failure to act.</E> No action may be commenced under subsection 310(a)(2) of the Act before sixty (60) days after the plaintiff has given notice of the failure to act as specified in this part. </P> </SECTION> <SECTION> <SECTNO>§ 374.5</SECTNO> <SUBJECT>Copy of complaint.</SUBJECT> <P>At the time of filing an action under this Act, the plaintiff must provide a copy of the complaint to the Attorney General of the United States and to the Administrator of the Environmental Protection Agency.</P> </SECTION> <SECTION> <SECTNO>§ 374.6</SECTNO> <SUBJECT>Addresses.</SUBJECT> <GPOTABLE COLS="2" OPTS="L2" CDEF="s50,r150"> <TTITLE>Table 1 to § 374.6</TTITLE> <BOXHD> <CHED H="1">Addressee</CHED> <CHED H="1">Address</CHED> </BOXHD> <ROW> <ENT I="01">Administrator</ENT> <ENT>U.S. Environmental Protection Agency, 1200 Pennsylvania Ave. NW (1101), Washington, DC 20460.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region I</ENT> <ENT>U.S. Environmental Protection Agency, 5 Post Office Square—Suite 100, Boston, MA 02109-3912.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region II</ENT> <ENT>U.S. Environmental Protection Agency, 26 Federal Plaza, Room 930, New York, NY 10278.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region III</ENT> <ENT>U.S. Environmental Protection Agency, 841 Chestnut Street, Philadelphia, PA 19107.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region IV</ENT> <ENT>U.S. Environmental Protection Agency, 61 Forsyth Street SW, Atlanta, Georgia 30303-8960.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region V</ENT> <ENT>U.S. Environmental Protection Agency, 77 West Jackson Boulevard, Chicago, IL 60604.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region VI</ENT> <ENT>U.S. Environmental Protection Agency, 1201 Elm Street, Suite 500, Dallas, Texas 75270-2102.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region VII</ENT> <ENT>U.S. Environmental Protection Agency, 11201 Renner Boulevard, Lenexa, Kansas 66219.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region VIII</ENT> <ENT>U.S. Environmental Protection Agency, 999 18th Street, Suite 500, Denver, CO 80202-2405.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region IX</ENT> <ENT>U.S. Environmental Protection Agency, 75 Hawthorne Street, San Francisco, CA 94105.</ENT> </ROW> <ROW> <ENT I="01">Regional Administrator, Region X</ENT> <ENT>U.S. Environmental Protection Agency, 1200 Sixth Avenue, Seattle, WA 98101.</ENT> </ROW> <ROW> <ENT I="01">Administrator</ENT> <ENT>Agency for Toxic Substances and Disease Registry, Center for Disease Control, 200 Independence Avenue SW, Washington, DC 20201.</ENT> </ROW> <ROW> <ENT I="01">Attorney General</ENT> <ENT>United States Department of Justice, Tenth and Pennsylvania Avenues NW, Washington, DC 20530.</ENT> </ROW> </GPOTABLE> <CITA>[57 FR 55040, Nov. 23, 1992, as amended at 65 FR 47325, Aug. 2, 2000; 76 FR 49674, Aug. 11, 2011; 78 FR 37978, June 25, 2013; 84 FR 44232, Aug. 23, 2019; 89 FR 86750, Oct. 31, 2024]</CITA> </SECTION> </PART> <PART> <RESERVED>PARTS 375-399 [RESERVED]</RESERVED> </PART> </SUBCHAP> </CHAPTER> FINDING AIDS

A list of CFR titles, subtitles, chapters, subchapters and parts and an alphabetical list of agencies publishing in the CFR are included in the CFR Index and Finding Aids volume to the Code of Federal Regulations which is published separately and revised annually.

Table of CFR Titles and Chapters

Alphabetical List of Agencies Appearing in the CFR

List of CFR Sections Affected

 Chap. Table of CFR Titles and Chapters (Revised as of July 1, 2025) Title 1—General Provisions I Administrative Committee of the Federal Register (Parts 1—49) II Office of the Federal Register (Parts 50—299) III Administrative Conference of the United States (Parts 300—399) IV Miscellaneous Agencies (Parts 400—599) VI National Capital Planning Commission (Parts 600—699) Title 2—Federal Financial Assistance Subtitle A—Office of Management and Budget Guidance for Federal Financial Assistance I Office of Management and Budget Governmentwide Guidance for Grants and Agreements (Parts 2—199) II Office of Management and Budget Guidance (Parts 200—299) Subtitle B—Federal Agency Regulations for Grants and Agreements III Department of Health and Human Services (Parts 300—399) IV Department of Agriculture (Parts 400—499) VI Department of State (Parts 600—699) VII Agency for International Development (Parts 700—799) VIII Department of Veterans Affairs (Parts 800—899) IX Department of Energy (Parts 900—999) X Department of the Treasury (Parts 1000—1099) XI Department of Defense (Parts 1100—1199) XII Department of Transportation (Parts 1200—1299) XIII Department of Commerce (Parts 1300—1399) XIV Department of the Interior (Parts 1400—1499) XV Environmental Protection Agency (Parts 1500—1599) XVI U.S. International Development Finance Corporation (Parts 1600—1699) XVIII National Aeronautics and Space Administration (Parts 1800—1899) XIX U.S. Agency for Global Media (Parts 1900—1999) XX United States Nuclear Regulatory Commission (Parts 2000—2099) XXII Corporation for National and Community Service (Parts 2200—2299) XXIII Social Security Administration (Parts 2300—2399) XXIV Department of Housing and Urban Development (Parts 2400—2499) XXV National Science Foundation (Parts 2500—2599) XXVI National Archives and Records Administration (Parts 2600—2699) XXVII Small Business Administration (Parts 2700—2799) XXVIII Department of Justice (Parts 2800—2899) XXIX Department of Labor (Parts 2900—2999) XXX Department of Homeland Security (Parts 3000—3099) XXXI Institute of Museum and Library Services (Parts 3100—3199) XXXII National Endowment for the Arts (Parts 3200—3299) XXXIII National Endowment for the Humanities (Parts 3300—3399) XXXIV Department of Education (Parts 3400—3499) XXXV Export-Import Bank of the United States (Parts 3500—3599) XXXVI Office of National Drug Control Policy, Executive Office of the President (Parts 3600—3699) XXXVII Peace Corps (Parts 3700—3799) LVIII Election Assistance Commission (Parts 5800—5899) LIX Gulf Coast Ecosystem Restoration Council (Parts 5900—5999) LX Federal Communications Commission (Parts 6000—6099) Title 3—The President I Executive Office of the President (Parts 100—199) Title 4—Accounts I Government Accountability Office (Parts 1—199) Title 5—Administrative Personnel I Office of Personnel Management (Parts 1—1199) II Merit Systems Protection Board (Parts 1200—1299) III Office of Management and Budget (Parts 1300—1399) IV Office of Personnel Management and Office of the Director of National Intelligence (Parts 1400—1499) V The International Organizations Employees Loyalty Board (Parts 1500—1599) VI Federal Retirement Thrift Investment Board (Parts 1600—1699) VIII Office of Special Counsel (Parts 1800—1899) IX Appalachian Regional Commission (Parts 1900—1999) XI Armed Forces Retirement Home (Parts 2100—2199) XIV Federal Labor Relations Authority, General Counsel of the Federal Labor Relations Authority and Federal Service Impasses Panel (Parts 2400—2499) XVI Office of Government Ethics (Parts 2600—2699) XXI Department of the Treasury (Parts 3100—3199) XXII Federal Deposit Insurance Corporation (Parts 3200—3299) XXIII Department of Energy (Parts 3300—3399) XXIV Federal Energy Regulatory Commission (Parts 3400—3499) XXV Department of the Interior (Parts 3500—3599) XXVI Department of Defense (Parts 3600—3699) XXVIII Department of Justice (Parts 3800—3899) XXIX Federal Communications Commission (Parts 3900—3999) XXX Farm Credit System Insurance Corporation (Parts 4000—4099) XXXI Farm Credit Administration (Parts 4100—4199) XXXIII U.S. International Development Finance Corporation (Parts 4300—4399) XXXIV Securities and Exchange Commission (Parts 4400—4499) XXXV Office of Personnel Management (Parts 4500—4599) XXXVI Department of Homeland Security (Parts 4600—4699) XXXVII Federal Election Commission (Parts 4700—4799) XL Interstate Commerce Commission (Parts 5000—5099) XLI Commodity Futures Trading Commission (Parts 5100—5199) XLII Department of Labor (Parts 5200—5299) XLIII National Science Foundation (Parts 5300—5399) XLV Department of Health and Human Services (Parts 5500—5599) XLVI Postal Rate Commission (Parts 5600—5699) XLVII Federal Trade Commission (Parts 5700—5799) XLVIII Nuclear Regulatory Commission (Parts 5800—5899) XLIX Federal Labor Relations Authority (Parts 5900—5999) L Department of Transportation (Parts 6000—6099) LII Export-Import Bank of the United States (Parts 6200—6299) LIII Department of Education (Parts 6300—6399) LIV Environmental Protection Agency (Parts 6400—6499) LV National Endowment for the Arts (Parts 6500—6599) LVI National Endowment for the Humanities (Parts 6600—6699) LVII General Services Administration (Parts 6700—6799) LVIII Board of Governors of the Federal Reserve System (Parts 6800—6899) LIX National Aeronautics and Space Administration (Parts 6900—6999) LX United States Postal Service (Parts 7000—7099) LXI National Labor Relations Board (Parts 7100—7199) LXII Equal Employment Opportunity Commission (Parts 7200—7299) LXIII Inter-American Foundation (Parts 7300—7399) LXIV Merit Systems Protection Board (Parts 7400—7499) LXV Department of Housing and Urban Development (Parts 7500—7599) LXVI National Archives and Records Administration (Parts 7600—7699) LXVII Institute of Museum and Library Services (Parts 7700—7799) LXVIII Commission on Civil Rights (Parts 7800—7899) LXIX Tennessee Valley Authority (Parts 7900—7999) LXX Court Services and Offender Supervision Agency for the District of Columbia (Parts 8000—8099) LXXI Consumer Product Safety Commission (Parts 8100—8199) LXXIII Department of Agriculture (Parts 8300—8399) LXXIV Federal Mine Safety and Health Review Commission (Parts 8400—8499) LXXVI Federal Retirement Thrift Investment Board (Parts 8600—8699) LXXVII Office of Management and Budget (Parts 8700—8799) LXXX Federal Housing Finance Agency (Parts 9000—9099) LXXXIII Special Inspector General for Afghanistan Reconstruction (Parts 9300—9399) LXXXIV Bureau of Consumer Financial Protection (Parts 9400—9499) LXXXVI National Credit Union Administration (Parts 9600—9699) XCVII Department of Homeland Security Human Resources Management System (Department of Homeland Security—Office of Personnel Management) (Parts 9700—9799) XCVIII Council of the Inspectors General on Integrity and Efficiency (Parts 9800—9899) XCIX Military Compensation and Retirement Modernization Commission (Parts 9900—9999) C National Council on Disability (Parts 10000—10049) CI National Mediation Board (Parts 10100—10199) CII U.S. Office of Special Counsel (Parts 10200—10299) CIII U.S. Office of Federal Mediation and Conciliation Service (Parts 10300—10399) CIV Office of the Intellectual Property Enforcement Coordinator (Part 10400—10499) Title 6—Domestic Security I Department of Homeland Security, Office of the Secretary (Parts 1—199) X Privacy and Civil Liberties Oversight Board (Parts 1000—1099) Title 7—Agriculture Subtitle A—Office of the Secretary of Agriculture (Parts 0—26) Subtitle B—Regulations of the Department of Agriculture I Agricultural Marketing Service (Standards, Inspections, Marketing Practices), Department of Agriculture (Parts 27—209) II Food and Nutrition Service, Department of Agriculture (Parts 210—299) III Animal and Plant Health Inspection Service, Department of Agriculture (Parts 300—399) IV Federal Crop Insurance Corporation, Department of Agriculture (Parts 400—499) V Agricultural Research Service, Department of Agriculture (Parts 500—599) VI Natural Resources Conservation Service, Department of Agriculture (Parts 600—699) VII Farm Service Agency, Department of Agriculture (Parts 700—799) VIII Agricultural Marketing Service (Federal Grain Inspection Service, Fair Trade Practices Program), Department of Agriculture (Parts 800—899) IX Agricultural Marketing Service (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), Department of Agriculture (Parts 900—999) X Agricultural Marketing Service (Marketing Agreements and Orders; Milk), Department of Agriculture (Parts 1000—1199) XI Agricultural Marketing Service (Marketing Agreements and Orders; Miscellaneous Commodities), Department of Agriculture (Parts 1200—1299) XIV Commodity Credit Corporation, Department of Agriculture (Parts 1400—1499) XV Foreign Agricultural Service, Department of Agriculture (Parts 1500—1599) XVI [Reserved] XVII Rural Utilities Service, Department of Agriculture (Parts 1700—1799) XVIII Rural Housing Service, Rural Business-Cooperative Service, Rural Utilities Service, and Farm Service Agency, Department of Agriculture (Parts 1800—2099) XX [Reserved] XXI Office of Energy and Environmental Policy, Department of Agriculture (Part 2100) XXV Office of Advocacy and Outreach, Department of Agriculture (Parts 2500—2599) XXVI Office of Inspector General, Department of Agriculture (Parts 2600—2699) XXVII Office of Information Resources Management, Department of Agriculture (Parts 2700—2799) XXVIII Office of Operations, Department of Agriculture (Parts 2800—2899) XXIX Office of Energy Policy and New Uses, Department of Agriculture (Parts 2900—2999) XXX Office of the Chief Financial Officer, Department of Agriculture (Parts 3000—3099) XXXI Office of Environmental Quality, Department of Agriculture (Parts 3100—3199) XXXII Office of Procurement and Property Management, Department of Agriculture (Parts 3200—3299) XXXIII Office of Transportation, Department of Agriculture (Parts 3300—3399) XXXIV National Institute of Food and Agriculture (Parts 3400—3499) XXXV Rural Housing Service, Department of Agriculture (Parts 3500—3599) XXXVI National Agricultural Statistics Service, Department of Agriculture (Parts 3600—3699) XXXVII Economic Research Service, Department of Agriculture (Parts 3700—3799) XXXVIII World Agricultural Outlook Board, Department of Agriculture (Parts 3800—3899) XLI [Reserved] XLII Rural Business-Cooperative Service, Department of Agriculture (Parts 4200—4299) L Rural Business-Cooperative Service, Rural Housing Service, and Rural Utilities Service, Department of Agriculture (Parts 5000—5099) Title 8—Aliens and Nationality I Department of Homeland Security (Parts 1—499) V Executive Office for Immigration Review, Department of Justice (Parts 1000—1399) Title 9—Animals and Animal Products I Animal and Plant Health Inspection Service, Department of Agriculture (Parts 1—199) II Agricultural Marketing Service (Fair Trade Practices Program), Department of Agriculture (Parts 200—299) III Food Safety and Inspection Service, Department of Agriculture (Parts 300—599) Title 10—Energy I Nuclear Regulatory Commission (Parts 0—199) II Department of Energy (Parts 200—699) III Department of Energy (Parts 700—999) X Department of Energy (General Provisions) (Parts 1000—1099) XIII Nuclear Waste Technical Review Board (Parts 1300—1399) XVII Defense Nuclear Facilities Safety Board (Parts 1700—1799) XVIII Northeast Interstate Low-Level Radioactive Waste Commission (Parts 1800—1899) Title 11—Federal Elections I Federal Election Commission (Parts 1—9099) II Election Assistance Commission (Parts 9400—9499) Title 12—Banks and Banking I Comptroller of the Currency, Department of the Treasury (Parts 1—199) II Federal Reserve System (Parts 200—299) III Federal Deposit Insurance Corporation (Parts 300—399) IV Export-Import Bank of the United States (Parts 400—499) V (Parts 500—599) [Reserved] VI Farm Credit Administration (Parts 600—699) VII National Credit Union Administration (Parts 700—799) VIII Federal Financing Bank (Parts 800—899) IX (Parts 900—999)[Reserved] X Consumer Financial Protection Bureau (Parts 1000—1099) XI Federal Financial Institutions Examination Council (Parts 1100—1199) XII Federal Housing Finance Agency (Parts 1200—1299) XIII Financial Stability Oversight Council (Parts 1300—1399) XIV Farm Credit System Insurance Corporation (Parts 1400—1499) XV Department of the Treasury (Parts 1500—1599) XVI Office of Financial Research, Department of the Treasury (Parts 1600—1699) XVII Office of Federal Housing Enterprise Oversight, Department of Housing and Urban Development (Parts 1700—1799) XVIII Community Development Financial Institutions Fund, Department of the Treasury (Parts 1800—1899) Title 13—Business Credit and Assistance I Small Business Administration (Parts 1—199) III Economic Development Administration, Department of Commerce (Parts 300—399) IV Emergency Steel Guarantee Loan Board (Parts 400—499) V Emergency Oil and Gas Guaranteed Loan Board (Parts 500—599) Title 14—Aeronautics and Space I Federal Aviation Administration, Department of Transportation (Parts 1—199) II Office of the Secretary, Department of Transportation (Aviation Proceedings) (Parts 200—399) III Commercial Space Transportation, Federal Aviation Administration, Department of Transportation (Parts 400—1199) V National Aeronautics and Space Administration (Parts 1200—1299) VI Air Transportation System Stabilization (Parts 1300—1399) Title 15—Commerce and Foreign Trade Subtitle A—Office of the Secretary of Commerce (Parts 0—29) Subtitle B—Regulations Relating to Commerce and Foreign Trade I Bureau of the Census, Department of Commerce (Parts 30—199) II National Institute of Standards and Technology, Department of Commerce (Parts 200—299) III International Trade Administration, Department of Commerce (Parts 300—399) IV Foreign-Trade Zones Board, Department of Commerce (Parts 400—499) VII Bureau of Industry and Security, Department of Commerce (Parts 700—799) VIII Bureau of Economic Analysis, Department of Commerce (Parts 800—899) IX National Oceanic and Atmospheric Administration, Department of Commerce (Parts 900—999) XI National Technical Information Service, Department of Commerce (Parts 1100—1199) XIII East-West Foreign Trade Board (Parts 1300—1399) XIV Minority Business Development Agency (Parts 1400—1499) XV Office of the Under-Secretary for Economic Affairs, Department of Commerce (Parts 1500—1599) Subtitle C—Regulations Relating to Foreign Trade Agreements XX Office of the United States Trade Representative (Parts 2000—2099) Subtitle D—Regulations Relating to Telecommunications and Information XXIII National Telecommunications and Information Administration, Department of Commerce (Parts 2300—2399) [Reserved] Title 16—Commercial Practices I Federal Trade Commission (Parts 0—999) II Consumer Product Safety Commission (Parts 1000—1799) Title 17—Commodity and Securities Exchanges I Commodity Futures Trading Commission (Parts 1—199) II Securities and Exchange Commission (Parts 200—399) IV Department of the Treasury (Parts 400—499) Title 18—Conservation of Power and Water Resources I Federal Energy Regulatory Commission, Department of Energy (Parts 1—399) III Delaware River Basin Commission (Parts 400—499) VI Water Resources Council (Parts 700—799) VIII Susquehanna River Basin Commission (Parts 800—899) XIII Tennessee Valley Authority (Parts 1300—1399) Title 19—Customs Duties I U.S. Customs and Border Protection, Department of Homeland Security; Department of the Treasury (Parts 0—199) II United States International Trade Commission (Parts 200—299) III International Trade Administration, Department of Commerce (Parts 300—399) IV U.S. Immigration and Customs Enforcement, Department of Homeland Security (Parts 400—599) [Reserved] Title 20—Employees' Benefits I Office of Workers' Compensation Programs, Department of Labor (Parts 1—199) II Railroad Retirement Board (Parts 200—399) III Social Security Administration (Parts 400—499) IV Employees' Compensation Appeals Board, Department of Labor (Parts 500—599) V Employment and Training Administration, Department of Labor (Parts 600—699) VI Office of Workers' Compensation Programs, Department of Labor (Parts 700—799) VII Benefits Review Board, Department of Labor (Parts 800—899) VIII Joint Board for the Enrollment of Actuaries (Parts 900—999) IX Office of the Assistant Secretary for Veterans' Employment and Training Service, Department of Labor (Parts 1000—1099) Title 21—Food and Drugs I Food and Drug Administration, Department of Health and Human Services (Parts 1—1299) II Drug Enforcement Administration, Department of Justice (Parts 1300—1399) III Office of National Drug Control Policy (Parts 1400—1499) Title 22—Foreign Relations I Department of State (Parts 1—199) II Agency for International Development (Parts 200—299) III Peace Corps (Parts 300—399) IV International Joint Commission, United States and Canada (Parts 400—499) V United States Agency for Global Media (Parts 500—599) VII U.S. International Development Finance Corporation (Parts 700—799) IX Foreign Service Grievance Board (Parts 900—999) X Inter-American Foundation (Parts 1000—1099) XI International Boundary and Water Commission, United States and Mexico, United States Section (Parts 1100—1199) XII United States International Development Cooperation Agency (Parts 1200—1299) XIII Millennium Challenge Corporation (Parts 1300—1399) XIV Foreign Service Labor Relations Board; Federal Labor Relations Authority; General Counsel of the Federal Labor Relations Authority; and the Foreign Service Impasse Disputes Panel (Parts 1400—1499) XV African Development Foundation (Parts 1500—1599) XVI Japan-United States Friendship Commission (Parts 1600—1699) XVII United States Institute of Peace (Parts 1700—1799) Title 23—Highways I Federal Highway Administration, Department of Transportation (Parts 1—999) II National Highway Traffic Safety Administration and Federal Highway Administration, Department of Transportation (Parts 1200—1299) III National Highway Traffic Safety Administration, Department of Transportation (Parts 1300—1399) Title 24—Housing and Urban Development Subtitle A—Office of the Secretary, Department of Housing and Urban Development (Parts 0—99) Subtitle B—Regulations Relating to Housing and Urban Development I Office of Assistant Secretary for Equal Opportunity, Department of Housing and Urban Development (Parts 100—199) II Office of Assistant Secretary for Housing-Federal Housing Commissioner, Department of Housing and Urban Development (Parts 200—299) III Government National Mortgage Association, Department of Housing and Urban Development (Parts 300—399) IV Office of Housing and Office of Multifamily Housing Assistance Restructuring, Department of Housing and Urban Development (Parts 400—499) V Office of Assistant Secretary for Community Planning and Development, Department of Housing and Urban Development (Parts 500—599) VII Office of the Secretary, Department of Housing and Urban Development (Housing Assistance Programs and Public and Indian Housing Programs) (Parts 700—799) VIII Office of the Assistant Secretary for Housing—Federal Housing Commissioner, Department of Housing and Urban Development (Section 8 Housing Assistance Programs, Section 202 Direct Loan Program, Section 202 Supportive Housing for the Elderly Program and Section 811 Supportive Housing for Persons With Disabilities Program) (Parts 800—899) IX Office of Assistant Secretary for Public and Indian Housing, Department of Housing and Urban Development (Parts 900—1699) XII Office of Inspector General, Department of Housing and Urban Development (Parts 2000—2099) XX Office of Assistant Secretary for Housing—Federal Housing Commissioner, Department of Housing and Urban Development (Parts 3200—3899) XXV Neighborhood Reinvestment Corporation (Parts 4100—4199) Title 25—Indians I Bureau of Indian Affairs, Department of the Interior (Parts 1—299) II Indian Arts and Crafts Board, Department of the Interior (Parts 300—399) III National Indian Gaming Commission, Department of the Interior (Parts 500—599) IV Office of Navajo and Hopi Indian Relocation (Parts 700—899) V Bureau of Indian Affairs, Department of the Interior, and Indian Health Service, Department of Health and Human Services (Part 900—999) VI Office of the Assistant Secretary, Indian Affairs, Department of the Interior (Parts 1000—1199) VII Office of the Special Trustee for American Indians, Department of the Interior (Parts 1200—1299) Title 26—Internal Revenue I Internal Revenue Service, Department of the Treasury (Parts 1—End) Title 27—Alcohol, Tobacco Products and Firearms I Alcohol and Tobacco Tax and Trade Bureau, Department of the Treasury (Parts 1—399) II Bureau of Alcohol, Tobacco, Firearms, and Explosives, Department of Justice (Parts 400—799) Title 28—Judicial Administration I Department of Justice (Parts 0—299) III Federal Prison Industries, Inc., Department of Justice (Parts 300—399) V Bureau of Prisons, Department of Justice (Parts 500—599) VI Offices of Independent Counsel, Department of Justice (Parts 600—699) VII Office of Independent Counsel (Parts 700—799) VIII Court Services and Offender Supervision Agency for the District of Columbia (Parts 800—899) IX National Crime Prevention and Privacy Compact Council (Parts 900—999) XI Department of Justice and Department of State (Parts 1100—1199) Title 29—Labor Subtitle A—Office of the Secretary of Labor (Parts 0—99) Subtitle B—Regulations Relating to Labor I National Labor Relations Board (Parts 100—199) II Office of Labor-Management Standards, Department of Labor (Parts 200—299) III National Railroad Adjustment Board (Parts 300—399) IV Office of Labor-Management Standards, Department of Labor (Parts 400—499) V Wage and Hour Division, Department of Labor (Parts 500—899) IX Construction Industry Collective Bargaining Commission (Parts 900—999) X National Mediation Board (Parts 1200—1299) XII Federal Mediation and Conciliation Service (Parts 1400—1499) XIV Equal Employment Opportunity Commission (Parts 1600—1699) XVII Occupational Safety and Health Administration, Department of Labor (Parts 1900—1999) XX Occupational Safety and Health Review Commission (Parts 2200—2499) XXV Employee Benefits Security Administration, Department of Labor (Parts 2500—2599) XXVII Federal Mine Safety and Health Review Commission (Parts 2700—2799) XL Pension Benefit Guaranty Corporation (Parts 4000—4999) Title 30—Mineral Resources I Mine Safety and Health Administration, Department of Labor (Parts 1—199) II Bureau of Safety and Environmental Enforcement, Department of the Interior (Parts 200—299) IV Geological Survey, Department of the Interior (Parts 400—499) V Bureau of Ocean Energy Management, Department of the Interior (Parts 500—599) VII Office of Surface Mining Reclamation and Enforcement, Department of the Interior (Parts 700—999) XII Office of Natural Resources Revenue, Department of the Interior (Parts 1200—1299) Title 31—Money and Finance: Treasury Subtitle A—Office of the Secretary of the Treasury (Parts 0—50) Subtitle B—Regulations Relating to Money and Finance I Monetary Offices, Department of the Treasury (Parts 51—199) II Fiscal Service, Department of the Treasury (Parts 200—399) IV Secret Service, Department of the Treasury (Parts 400—499) V Office of Foreign Assets Control, Department of the Treasury (Parts 500—599) VI Bureau of Engraving and Printing, Department of the Treasury (Parts 600—699) VII Federal Law Enforcement Training Center, Department of the Treasury (Parts 700—799) VIII Office of Investment Security, Department of the Treasury (Parts 800—899) IX Federal Claims Collection Standards (Department of the Treasury—Department of Justice) (Parts 900—999) X Financial Crimes Enforcement Network, Department of the Treasury (Parts 1000—1099) Title 32—National Defense Subtitle A—Department of Defense I Office of the Secretary of Defense (Parts 1—399) V Department of the Army (Parts 400—699) VI Department of the Navy (Parts 700—799) VII Department of the Air Force (Parts 800—1099) Subtitle B—Other Regulations Relating to National Defense XII Department of Defense, Defense Logistics Agency (Parts 1200—1299) XVI Selective Service System (Parts 1600—1699) XVII Office of the Director of National Intelligence (Parts 1700—1799) XVIII National Counterintelligence Center (Parts 1800—1899) XIX Central Intelligence Agency (Parts 1900—1999) XX Information Security Oversight Office, National Archives and Records Administration (Parts 2000—2099) XXI National Security Council (Parts 2100—2199) XXIV Office of Science and Technology Policy (Parts 2400—2499) XXVII Office for Micronesian Status Negotiations (Parts 2700—2799) XXVIII Office of the Vice President of the United States (Parts 2800—2899) Title 33—Navigation and Navigable Waters I Coast Guard, Department of Homeland Security (Parts 1—199) II Corps of Engineers, Department of the Army, Department of Defense (Parts 200—399) IV Great Lakes St. Lawrence Seaway Development Corporation, Department of Transportation (Parts 400—499) Title 34—Education Subtitle A—Office of the Secretary, Department of Education (Parts 1—99) Subtitle B—Regulations of the Offices of the Department of Education I Office for Civil Rights, Department of Education (Parts 100—199) II Office of Elementary and Secondary Education, Department of Education (Parts 200—299) III Office of Special Education and Rehabilitative Services, Department of Education (Parts 300—399) IV Office of Career, Technical, and Adult Education, Department of Education (Parts 400—499) V Office of Bilingual Education and Minority [Reserved] VI Office of Postsecondary Education, Department of Education (Parts 600—699) VII Office of Educational Research and Improvement, Department of Education (Parts 700—799) [Reserved] Subtitle C—Regulations Relating to Education XI [Reserved] XII National Council on Disability (Parts 1200—1299) Title 35 [Reserved] Title 36—Parks, Forests, and Public Property I National Park Service, Department of the Interior (Parts 1—199) II Forest Service, Department of Agriculture (Parts 200—299) III Corps of Engineers, Department of the Army (Parts 300—399) IV American Battle Monuments Commission (Parts 400—499) V Smithsonian Institution (Parts 500—599) VI [Reserved] VII Library of Congress (Parts 700—799) VIII Advisory Council on Historic Preservation (Parts 800—899) IX Pennsylvania Avenue Development Corporation (Parts 900—999) X Presidio Trust (Parts 1000—1099) XI Architectural and Transportation Barriers Compliance Board (Parts 1100—1199) XII National Archives and Records Administration (Parts 1200—1299) XV Oklahoma City National Memorial Trust (Parts 1500—1599) XVI Morris K. Udall Scholarship and Excellence in National Environmental Policy Foundation (Parts 1600—1699) Title 37—Patents, Trademarks, and Copyrights I United States Patent and Trademark Office, Department of Commerce (Parts 1—199) II U.S. Copyright Office, Library of Congress (Parts 200—299) III Copyright Royalty Board, Library of Congress (Parts 300—399) IV National Institute of Standards and Technology, Department of Commerce (Parts 400—599) Title 38—Pensions, Bonuses, and Veterans' Relief I Department of Veterans Affairs (Parts 0—199) II Armed Forces Retirement Home (Parts 200—299) Title 39—Postal Service I United States Postal Service (Parts 1—999) III Postal Regulatory Commission (Parts 3000—3099) Title 40—Protection of Environment I Environmental Protection Agency (Parts 1—1099) IV Environmental Protection Agency and Department of Justice (Parts 1400—1499) V Council on Environmental Quality (Parts 1500—1599) VI Chemical Safety and Hazard Investigation Board (Parts 1600—1699) VII Environmental Protection Agency and Department of Defense; Uniform National Discharge Standards for Vessels of the Armed Forces (Parts 1700—1799) VIII Gulf Coast Ecosystem Restoration Council (Parts 1800—1899) IX Federal Permitting Improvement Steering Council (Part 1900) Title 41—Public Contracts and Property Management Subtitle A—Federal Procurement Regulations System [Note] Subtitle B—Other Provisions Relating to Public Contracts 50 Public Contracts, Department of Labor (Parts 50-1—50-999) 51 Committee for Purchase From People Who Are Blind or Severely Disabled (Parts 51-1—51-99) 60 Office of Federal Contract Compliance Programs, Equal Employment Opportunity, Department of Labor (Parts 60-1—60-999) 61 Office of the Assistant Secretary for Veterans' Employment and Training Service, Department of Labor (Parts 61-1—61-999) 62—100 [Reserved] Subtitle C—Federal Property Management Regulations System 101 Federal Property Management Regulations (Parts 101-1—101-99) 102 Federal Management Regulation (Parts 102-1—102-299) 103—104 [Reserved] 105 General Services Administration (Parts 105-1—105-999) 109 Department of Energy Property Management Regulations (Parts 109-1—109-99) 114 Department of the Interior (Parts 114-1—114-99) 115 Environmental Protection Agency (Parts 115-1—115-99) 128 Department of Justice (Parts 128-1—128-99) 129—200 [Reserved] Subtitle D—Federal Acquisition Supply Chain Security 201 Federal Acquisition Security Council (Parts 201-1—201-99) Subtitle E [Reserved] Subtitle F—Federal Travel Regulation System 300 General (Parts 300-1—300-99) 301 Temporary Duty (TDY) Travel Allowances (Parts 301-1—301-99) 302 Relocation Allowances (Parts 302-1—302-99) 303 Payment of Expenses Connected with the Death of Certain Employees (Part 303-1—303-99) 304 Payment of Travel Expenses from a Non-Federal Source (Parts 304-1—304-99) Title 42—Public Health I Public Health Service, Department of Health and Human Services (Parts 1—199) II—III [Reserved] IV Centers for Medicare & Medicaid Services, Department of Health and Human Services (Parts 400—699) V Office of Inspector General-Health Care, Department of Health and Human Services (Parts 1000—1099) Title 43—Public Lands: Interior Subtitle A—Office of the Secretary of the Interior (Parts 1—199) Subtitle B—Regulations Relating to Public Lands I Bureau of Reclamation, Department of the Interior (Parts 400—999) II Bureau of Land Management, Department of the Interior (Parts 1000—9999) III Utah Reclamation Mitigation and Conservation Commission (Parts 10000—10099) Title 44—Emergency Management and Assistance I Federal Emergency Management Agency, Department of Homeland Security (Parts 0—399) IV Department of Commerce and Department of Transportation (Parts 400—499) Title 45—Public Welfare Subtitle A—Department of Health and Human Services (Parts 1—199) Subtitle B—Regulations Relating to Public Welfare II Office of Family Assistance (Assistance Programs), Administration for Children and Families, Department of Health and Human Services (Parts 200—299) III Office of Child Support Services, Administration of Families and Services, Department of Health and Human Services (Parts 300—399) IV Office of Refugee Resettlement, Administration for Children and Families, Department of Health and Human Services (Parts 400—499) V Foreign Claims Settlement Commission of the United States, Department of Justice (Parts 500—599) VI National Science Foundation (Parts 600—699) VII Commission on Civil Rights (Parts 700—799) VIII Office of Personnel Management (Parts 800—899) IX Denali Commission (Parts 900—999) X Office of Community Services, Administration for Children and Families, Department of Health and Human Services (Parts 1000—1099) XI National Foundation on the Arts and the Humanities (Parts 1100—1199) XII Corporation for National and Community Service (Parts 1200—1299) XIII Administration for Children and Families, Department of Health and Human Services (Parts 1300—1399) XVI Legal Services Corporation (Parts 1600—1699) XVII National Commission on Libraries and Information Science (Parts 1700—1799) XVIII Harry S. Truman Scholarship Foundation (Parts 1800—1899) XXI Commission of Fine Arts (Parts 2100—2199) XXIII Arctic Research Commission (Parts 2300—2399) XXIV James Madison Memorial Fellowship Foundation (Parts 2400—2499) XXV Corporation for National and Community Service (Parts 2500—2599) Title 46—Shipping I Coast Guard, Department of Homeland Security (Parts 1—199) II Maritime Administration, Department of Transportation (Parts 200—399) III Coast Guard (Great Lakes Pilotage), Department of Homeland Security (Parts 400—499) IV Federal Maritime Commission (Parts 500—599) Title 47—Telecommunication I Federal Communications Commission (Parts 0—199) II Office of Science and Technology Policy and National Security Council (Parts 200—299) III National Telecommunications and Information Administration, Department of Commerce (Parts 300—399) IV National Telecommunications and Information Administration, Department of Commerce, and National Highway Traffic Safety Administration, Department of Transportation (Parts 400—499) V The First Responder Network Authority (Parts 500—599) Title 48—Federal Acquisition Regulations System 1 Federal Acquisition Regulation (Parts 1—99) 2 Defense Acquisition Regulations System, Department of Defense (Parts 200—299) 3 Health and Human Services (Parts 300—399) 4 Department of Agriculture (Parts 400—499) 5 General Services Administration (Parts 500—599) 6 Department of State (Parts 600—699) 7 Agency for International Development (Parts 700—799) 8 Department of Veterans Affairs (Parts 800—899) 9 Department of Energy (Parts 900—999) 10 Department of the Treasury (Parts 1000—1099) 12 Department of Transportation (Parts 1200—1299) 13 Department of Commerce (Parts 1300—1399) 14 Department of the Interior (Parts 1400—1499) 15 Environmental Protection Agency (Parts 1500—1599) 16 Office of Personnel Management, Federal Employees Health Benefits Acquisition Regulation (Parts 1600—1699) 17 Office of Personnel Management (Parts 1700—1799) 18 National Aeronautics and Space Administration (Parts 1800—1899) 19 Broadcasting Board of Governors (Parts 1900—1999) 20 Nuclear Regulatory Commission (Parts 2000—2099) 21 Office of Personnel Management, Federal Employees Group Life Insurance Federal Acquisition Regulation (Parts 2100—2199) 23 Social Security Administration (Parts 2300—2399) 24 Department of Housing and Urban Development (Parts 2400—2499) 25 National Science Foundation (Parts 2500—2599) 28 Department of Justice (Parts 2800—2899) 29 Department of Labor (Parts 2900—2999) 30 Department of Homeland Security, Homeland Security Acquisition Regulation (HSAR) (Parts 3000—3099) 34 Department of Education Acquisition Regulation (Parts 3400—3499) 51 Department of the Army Acquisition Regulations (Parts 5100—5199) [Reserved] 52 Department of the Navy Acquisition Regulations (Parts 5200—5299) 53 Department of the Air Force Federal Acquisition Regulation Supplement (Parts 5300—5399) [Reserved] 54 Defense Logistics Agency, Department of Defense (Parts 5400—5499) 57 African Development Foundation (Parts 5700—5799) 61 Civilian Board of Contract Appeals, General Services Administration (Parts 6100—6199) 99 Cost Accounting Standards Board, Office of Federal Procurement Policy, Office of Management and Budget (Parts 9900—9999) Title 49—Transportation Subtitle A—Office of the Secretary of Transportation (Parts 1—99) Subtitle B—Other Regulations Relating to Transportation I Pipeline and Hazardous Materials Safety Administration, Department of Transportation (Parts 100—199) II Federal Railroad Administration, Department of Transportation (Parts 200—299) III Federal Motor Carrier Safety Administration, Department of Transportation (Parts 300—399) IV Coast Guard, Department of Homeland Security (Parts 400—499) V National Highway Traffic Safety Administration, Department of Transportation (Parts 500—599) VI Federal Transit Administration, Department of Transportation (Parts 600—699) VII National Railroad Passenger Corporation (AMTRAK) (Parts 700—799) VIII National Transportation Safety Board (Parts 800—999) X Surface Transportation Board (Parts 1000—1399) XI Research and Innovative Technology Administration, Department of Transportation (Parts 1400—1499) [Reserved] XII Transportation Security Administration, Department of Homeland Security (Parts 1500—1699) Title 50—Wildlife and Fisheries I United States Fish and Wildlife Service, Department of the Interior (Parts 1—199) II National Marine Fisheries Service, National Oceanic and Atmospheric Administration, Department of Commerce (Parts 200—299) III International Fishing and Related Activities (Parts 300—399) IV Joint Regulations (United States Fish and Wildlife Service, Department of the Interior and National Marine Fisheries Service, National Oceanic and Atmospheric Administration, Department of Commerce); Endangered Species Committee Regulations (Parts 400—499) V Marine Mammal Commission (Parts 500—599) VI Fishery Conservation and Management, National Oceanic and Atmospheric Administration, Department of Commerce (Parts 600—699) Alphabetical List of Agencies Appearing in the CFR (Revised as of July 1, 2025) Agency CFR Title, Subtitle or Chapter Administrative Conference of the United States 1, III Advisory Council on Historic Preservation 36, VIII Advocacy and Outreach, Office of 7, XXV Afghanistan Reconstruction, Special Inspector General for 5, LXXXIII African Development Foundation 22, XV Federal Acquisition Regulation 48, 57 Agency for International Development 2, VII; 22, II Federal Acquisition Regulation 48, 7 Agricultural Marketing Service 7, I, VIII, IX, X, XI; 9, II Agricultural Research Service 7, V Agriculture, Department of 2, IV; 5, LXXIII Advocacy and Outreach, Office of 7, XXV Agricultural Marketing Service 7, I, VIII, IX, X, XI; 9, II Agricultural Research Service 7, V Animal and Plant Health Inspection Service 7, III; 9, I Chief Financial Officer, Office of 7, XXX Commodity Credit Corporation 7, XIV Economic Research Service 7, XXXVII Energy and Environmental Policy, Office of 7, XXI Energy Policy and New Uses, Office of 2, IX; 7, XXIX Environmental Quality, Office of 7, XXXI Farm Service Agency 7, VII, XVIII Federal Acquisition Regulation 48, 4 Federal Crop Insurance Corporation 7, IV Food and Nutrition Service 7, II Food Safety and Inspection Service 9, III Foreign Agricultural Service 7, XV Forest Service 36, II Information Resources Management, Office of 7, XXVII Inspector General, Office of 7, XXVI National Agricultural Library 7, XLI National Agricultural Statistics Service 7, XXXVI National Institute of Food and Agriculture 7, XXXIV Natural Resources Conservation Service 7, VI Operations, Office of 7, XXVIII Procurement and Property Management, Office of 7, XXXII Rural Business-Cooperative Service 7, XVIII, XLII Rural Development Administration 7, XLII Rural Housing Service 7, XVIII, XXXV Rural Utilities Service 7, XVII, XVIII, XLII Secretary of Agriculture, Office of 7, Subtitle A Transportation, Office of 7, XXXIII World Agricultural Outlook Board 7, XXXVIII Air Force, Department of 32, VII Federal Acquisition Regulation Supplement 48, 53 Air Transportation Stabilization Board 14, VI Alcohol and Tobacco Tax and Trade Bureau 27, I Alcohol, Tobacco, Firearms, and Explosives, Bureau of 27, II AMTRAK 49, VII American Battle Monuments Commission 36, IV American Indians, Office of the Special Trustee 25, VII Animal and Plant Health Inspection Service 7, III; 9, I Appalachian Regional Commission 5, IX Architectural and Transportation Barriers Compliance Board 36, XI Arctic Research Commission 45, XXIII Armed Forces Retirement Home 5, XI; 38, II Army, Department of 32, V Engineers, Corps of 33, II; 36, III Federal Acquisition Regulation 48, 51 Benefits Review Board 20, VII Bilingual Education and Minority Languages Affairs, Office of 34, V Blind or Severely Disabled, Committee for Purchase from People Who Are 41, 51 Broadcasting Board of Governors Federal Acquisition Regulation 48, 19 Career, Technical, and Adult Education, Office of 34, IV Census Bureau 15, I Centers for Medicare & Medicaid Services 42, IV Central Intelligence Agency 32, XIX Chemical Safety and Hazard Investigation Board 40, VI Chief Financial Officer, Office of 7, XXX Child Support Services, Office of 45, III Children and Families, Administration for 45, II, IV, X, XIII Civil Rights, Commission on 5, LXVIII; 45, VII Civil Rights, Office for 34, I Coast Guard 33, I; 46, I; 49, IV Coast Guard (Great Lakes Pilotage) 46, III Commerce, Department of 2, XIII; 44, IV; 50, VI Census Bureau 15, I Economic Affairs, Office of the Under-Secretary for 15, XV Economic Analysis, Bureau of 15, VIII Economic Development Administration 13, III Emergency Management and Assistance 44, IV Federal Acquisition Regulation 48, 13 Foreign-Trade Zones Board 15, IV Industry and Security, Bureau of 15, VII International Trade Administration 15, III; 19, III National Institute of Standards and Technology 15, II; 37, IV National Marine Fisheries Service 50, II, IV National Oceanic and Atmospheric Administration 15, IX; 50, II, III, IV, VI National Technical Information Service 15, XI National Telecommunications and Information Administration 15, XXIII; 47, III, IV National Weather Service 15, IX Patent and Trademark Office, United States 37, I Secretary of Commerce, Office of 15, Subtitle A Commercial Space Transportation 14, III Commodity Credit Corporation 7, XIV Commodity Futures Trading Commission 5, XLI; 17, I Community Planning and Development, Office of Assistant Secretary for 24, V Community Services, Office of 45, X Comptroller of the Currency 12, I Construction Industry Collective Bargaining Commission 29, IX Consumer Financial Protection Bureau 5, LXXXIV; 12, X Consumer Product Safety Commission 5, LXXI; 16, II Copyright Royalty Board 37, III Corporation for National and Community Service 2, XXII; 45, XII, XXV Cost Accounting Standards Board 48, 99 Council on Environmental Quality 40, V Council of the Inspectors General on Integrity and Efficiency 5, XCVIII Court Services and Offender Supervision Agency for the District of Columbia 5, LXX; 28, VIII Customs and Border Protection 19, I Defense, Department of 2, XI; 5, XXVI; 32, Subtitle A; 40, VII Advanced Research Projects Agency 32, I Air Force Department 32, VII Army Department 32, V; 33, II; 36, III; 48, 51 Defense Acquisition Regulations System 48, 2 Defense Intelligence Agency 32, I Defense Logistics Agency 32, I, XII; 48, 54 Engineers, Corps of 33, II; 36, III National Imagery and Mapping Agency 32, I Navy, Department of 32, VI; 48, 52 Secretary of Defense, Office of 2, XI; 32, I Defense Contract Audit Agency 32, I Defense Intelligence Agency 32, I Defense Logistics Agency 32, XII; 48, 54 Defense Nuclear Facilities Safety Board 10, XVII Delaware River Basin Commission 18, III Denali Commission 45, IX Disability, National Council on 5, C; 34, XII District of Columbia, Court Services and Offender Supervision Agency for the 5, LXX; 28, VIII Drug Enforcement Administration 21, II East-West Foreign Trade Board 15, XIII Economic Affairs, Office of the Under-Secretary for 15, XV Economic Analysis, Bureau of 15, VIII Economic Development Administration 13, III Economic Research Service 7, XXXVII Education, Department of 2, XXXIV; 5, LIII Bilingual Education and Minority Languages Affairs, Office of 34, V Career, Technical, and Adult Education, Office of 34, IV Civil Rights, Office for 34, I Educational Research and Improvement, Office of 34, VII Elementary and Secondary Education, Office of 34, II Federal Acquisition Regulation 48, 34 Postsecondary Education, Office of 34, VI Secretary of Education, Office of 34, Subtitle A Special Education and Rehabilitative Services, Office of 34, III Educational Research and Improvement, Office of 34, VII Election Assistance Commission 2, LVIII; 11, II Elementary and Secondary Education, Office of 34, II Emergency Oil and Gas Guaranteed Loan Board 13, V Emergency Steel Guarantee Loan Board 13, IV Employee Benefits Security Administration 29, XXV Employees' Compensation Appeals Board 20, IV Employees Loyalty Board 5, V Employment and Training Administration 20, V Employment Policy, National Commission for 1, IV Employment Standards Administration 20, VI Endangered Species Committee 50, IV Energy, Department of 2, IX; 5, XXIII; 10, II, III, X Federal Acquisition Regulation 48, 9 Federal Energy Regulatory Commission 5, XXIV; 18, I Property Management Regulations 41, 109 Energy, Office of 7, XXIX Energy and Environmental Policy, Office of 7, XXI Engineers, Corps of 33, II; 36, III Engraving and Printing, Bureau of 31, VI Environmental Protection Agency 2, XV; 5, LIV; 40, I, IV, VII Federal Acquisition Regulation 48, 15 Property Management Regulations 41, 115 Environmental Quality, Office of 7, XXXI Equal Employment Opportunity Commission 5, LXII; 29, XIV Equal Opportunity, Office of Assistant Secretary for 24, I Executive Office of the President 3, I Environmental Quality, Council on 40, V Management and Budget, Office of 2, Subtitle A; 5, III, LXXVII; 14, VI; 48, 99 National Drug Control Policy, Office of 2, XXXVI; 21, III National Security Council 32, XXI; 47, II Presidential Documents 3 Science and Technology Policy, Office of 32, XXIV; 47, II Trade Representative, Office of the United States 15, XX Export-Import Bank of the United States 2, XXXV; 5, LII; 12, IV Families and Services, Administration of 45, III Family Assistance, Office of 45, II Farm Credit Administration 5, XXXI; 12, VI Farm Credit System Insurance Corporation 5, XXX; 12, XIV Farm Service Agency 7, VII, XVIII Federal Acquisition Regulation 48, 1 Federal Acquisition Security Council 41, 201 Federal Aviation Administration 14, I Commercial Space Transportation 14, III Federal Claims Collection Standards 31, IX Federal Communications Commission 2, LX; 5, XXIX; 47, I Federal Contract Compliance Programs, Office of 41, 60 Federal Crop Insurance Corporation 7, IV Federal Deposit Insurance Corporation 5, XXII; 12, III Federal Election Commission 5, XXXVII; 11, I Federal Emergency Management Agency 44, I Federal Employees Group Life Insurance Federal Acquisition Regulation 48, 21 Federal Employees Health Benefits Acquisition Regulation 48, 16 Federal Energy Regulatory Commission 5, XXIV; 18, I Federal Financial Institutions Examination Council 12, XI Federal Financing Bank 12, VIII Federal Highway Administration 23, I, II Federal Home Loan Mortgage Corporation 1, IV Federal Housing Enterprise Oversight Office 12, XVII Federal Housing Finance Agency 5, LXXX; 12, XII Federal Labor Relations Authority 5, XIV, XLIX; 22, XIV Federal Law Enforcement Training Center 31, VII Federal Management Regulation 41, 102 Federal Maritime Commission 46, IV Federal Mediation and Conciliation Service 5, CIII; 29, XII Federal Mine Safety and Health Review Commission 5, LXXIV; 29, XXVII Federal Motor Carrier Safety Administration 49, III Federal Permitting Improvement Steering Council 40, IX Federal Prison Industries, Inc. 28, III Federal Procurement Policy Office 48, 99 Federal Property Management Regulations 41, 101 Federal Railroad Administration 49, II Federal Register, Administrative Committee of 1, I Federal Register, Office of 1, II Federal Reserve System 12, II Board of Governors 5, LVIII Federal Retirement Thrift Investment Board 5, VI, LXXVI Federal Service Impasses Panel 5, XIV Federal Trade Commission 5, XLVII; 16, I Federal Transit Administration 49, VI Federal Travel Regulation System 41, Subtitle F Financial Crimes Enforcement Network 31, X Financial Research Office 12, XVI Financial Stability Oversight Council 12, XIII Fine Arts, Commission of 45, XXI Fiscal Service 31, II Fish and Wildlife Service, United States 50, I, IV Food and Drug Administration 21, I Food and Nutrition Service 7, II Food Safety and Inspection Service 9, III Foreign Agricultural Service 7, XV Foreign Assets Control, Office of 31, V Foreign Claims Settlement Commission of the United States 45, V Foreign Service Grievance Board 22, IX Foreign Service Impasse Disputes Panel 22, XIV Foreign Service Labor Relations Board 22, XIV Foreign-Trade Zones Board 15, IV Forest Service 36, II General Services Administration 5, LVII; 41, 105 Contract Appeals, Board of 48, 61 Federal Acquisition Regulation 48, 5 Federal Management Regulation 41, 102 Federal Property Management Regulations 41, 101 Federal Travel Regulation System 41, Subtitle F General 41, 300 Payment From a Non-Federal Source for Travel Expenses 41, 304 Payment of Expenses Connected With the Death of Certain Employees 41, 303 Relocation Allowances 41, 302 Temporary Duty (TDY) Travel Allowances 41, 301 Geological Survey 30, IV Government Accountability Office 4, I Government Ethics, Office of 5, XVI Government National Mortgage Association 24, III Grain Inspection, Packers and Stockyards Administration 7, VIII; 9, II Great Lakes St. Lawrence Seaway Development Corporation 33, IV Gulf Coast Ecosystem Restoration Council 2, LIX; 40, VIII Harry S. Truman Scholarship Foundation 45, XVIII Health and Human Services, Department of 2, III; 5, XLV; 45, Subtitle A Centers for Medicare & Medicaid Services 42, IV Child Support Services, Office of 45, III Children and Families, Administration for 45, II, IV, X, XIII Community Services, Office of 45, X Families and Services, Administration of 45, III Family Assistance, Office of 45, II Federal Acquisition Regulation 48, 3 Food and Drug Administration 21, I Indian Health Service 25, V Inspector General (Health Care), Office of 42, V Public Health Service 42, I Refugee Resettlement, Office of 45, IV Homeland Security, Department of 2, XXX; 5, XXXVI; 6, I; 8, I Coast Guard 33, I; 46, I; 49, IV Coast Guard (Great Lakes Pilotage) 46, III Customs and Border Protection 19, I Federal Emergency Management Agency 44, I Human Resources Management and Labor Relations Systems 5, XCVII Immigration and Customs Enforcement Bureau 19, IV Transportation Security Administration 49, XII Housing and Urban Development, Department of 2, XXIV; 5, LXV; 24, Subtitle B Community Planning and Development, Office of Assistant Secretary for 24, V Equal Opportunity, Office of Assistant Secretary for 24, I Federal Acquisition Regulation 48, 24 Federal Housing Enterprise Oversight, Office of 12, XVII Government National Mortgage Association 24, III Housing—Federal Housing Commissioner, Office of Assistant Secretary for 24, II, VIII, XX Housing, Office of, and Multifamily Housing Assistance Restructuring, Office of 24, IV Inspector General, Office of 24, XII Public and Indian Housing, Office of Assistant Secretary for 24, IX Secretary, Office of 24, Subtitle A, VII Housing—Federal Housing Commissioner, Office of Assistant Secretary for 24, II, VIII, XX Housing, Office of, and Multifamily Housing Assistance Restructuring, Office of 24, IV Immigration and Customs Enforcement Bureau 19, IV Immigration Review, Executive Office for 8, V Independent Counsel, Office of 28, VII Independent Counsel, Offices of 28, VI Indian Affairs, Bureau of 25, I, V Indian Affairs, Office of the Assistant Secretary 25, VI Indian Arts and Crafts Board 25, II Indian Health Service 25, V Industry and Security, Bureau of 15, VII Information Resources Management, Office of 7, XXVII Information Security Oversight Office, National Archives and Records Administration 32, XX Inspector General Agriculture Department 7, XXVI Health and Human Services Department 42, V Housing and Urban Development Department 24, XII Institute of Peace, United States 22, XVII Intellectual Property Enforcement Coordinator, Office of 5, CIV Inter-American Foundation 5, LXIII; 22, X Interior, Department of 2, XIV American Indians, Office of the Special Trustee 25, VII Endangered Species Committee 50, IV Federal Acquisition Regulation 48, 14 Federal Property Management Regulations System 41, 114 Fish and Wildlife Service, United States 50, I, IV Geological Survey 30, IV Indian Affairs, Bureau of 25, I, V Indian Affairs, Office of the Assistant Secretary 25, VI Indian Arts and Crafts Board 25, II Land Management, Bureau of 43, II National Indian Gaming Commission 25, III National Park Service 36, I Natural Resource Revenue, Office of 30, XII Ocean Energy Management, Bureau of 30, V Reclamation, Bureau of 43, I Safety and Environmental Enforcement, Bureau of 30, II Secretary of the Interior, Office of 2, XIV; 43, Subtitle A Surface Mining Reclamation and Enforcement, Office of 30, VII Internal Revenue Service 26, I International Boundary and Water Commission, United States and Mexico, United States Section 22, XI International Development, United States Agency for 22, II Federal Acquisition Regulation 48, 7 International Development Cooperation Agency, United States 22, XII International Development Finance Corporation, U.S. 2, XVI; 5, XXXIII; 22, VII International Joint Commission, United States and Canada 22, IV International Organizations Employees Loyalty Board 5, V International Trade Administration 15, III; 19, III International Trade Commission, United States 19, II Interstate Commerce Commission 5, XL Investment Security, Office of 31, VIII James Madison Memorial Fellowship Foundation 45, XXIV Japan-United States Friendship Commission 22, XVI Joint Board for the Enrollment of Actuaries 20, VIII Justice, Department of 2, XXVIII; 5, XXVIII; 28, I, XI; 40, IV Alcohol, Tobacco, Firearms, and Explosives, Bureau of 27, II Drug Enforcement Administration 21, II Federal Acquisition Regulation 48, 28 Federal Claims Collection Standards 31, IX Federal Prison Industries, Inc. 28, III Foreign Claims Settlement Commission of the United States 45, V Immigration Review, Executive Office for 8, V Independent Counsel, Offices of 28, VI Prisons, Bureau of 28, V Property Management Regulations 41, 128 Labor, Department of 2, XXIX; 5, XLII Benefits Review Board 20, VII Employee Benefits Security Administration 29, XXV Employees' Compensation Appeals Board 20, IV Employment and Training Administration 20, V Federal Acquisition Regulation 48, 29 Federal Contract Compliance Programs, Office of 41, 60 Federal Procurement Regulations System 41, 50 Labor-Management Standards, Office of 29, II, IV Mine Safety and Health Administration 30, I Occupational Safety and Health Administration 29, XVII Public Contracts 41, 50 Secretary of Labor, Office of 29, Subtitle A Veterans' Employment and Training Service, Office of the Assistant Secretary for 41, 61; 20, IX Wage and Hour Division 29, V Workers' Compensation Programs, Office of 20, I, VI Labor-Management Standards, Office of 29, II, IV Land Management, Bureau of 43, II Legal Services Corporation 45, XVI Libraries and Information Science, National Commission on 45, XVII Library of Congress 36, VII Copyright Royalty Board 37, III U.S. Copyright Office 37, II Management and Budget, Office of 2, Subpart A; 5, III, LXXVII; 14, VI; 48, 99 Marine Mammal Commission 50, V Maritime Administration 46, II Merit Systems Protection Board 5, II, LXIV Micronesian Status Negotiations, Office for 32, XXVII Military Compensation and Retirement Modernization Commission 5, XCIX Millennium Challenge Corporation 22, XIII Mine Safety and Health Administration 30, I Minority Business Development Agency 15, XIV Miscellaneous Agencies 1, IV Monetary Offices 31, I Morris K. Udall Scholarship and Excellence in National Environmental Policy Foundation 36, XVI Museum and Library Services, Institute of 2, XXXI National Aeronautics and Space Administration 2, XVIII; 5, LIX; 14, V Federal Acquisition Regulation 48, 18 National Agricultural Library 7, XLI National Agricultural Statistics Service 7, XXXVI National and Community Service, Corporation for 2, XXII; 45, XII, XXV National Archives and Records Administration 2, XXVI; 5, LXVI; 36, XII Information Security Oversight Office 32, XX National Capital Planning Commission 1, IV, VI National Counterintelligence Center 32, XVIII National Credit Union Administration 5, LXXXVI; 12, VII National Crime Prevention and Privacy Compact Council 28, IX National Drug Control Policy, Office of 2, XXXVI; 21, III National Endowment for the Arts 2, XXXII National Endowment for the Humanities 2, XXXIII National Foundation on the Arts and the Humanities 45, XI National Geospatial-Intelligence Agency 32, I National Highway Traffic Safety Administration 23, II, III; 47, VI; 49, V National Imagery and Mapping Agency 32, I National Indian Gaming Commission 25, III National Institute of Food and Agriculture 7, XXXIV National Institute of Standards and Technology 15, II; 37, IV National Intelligence, Office of Director of 5, IV; 32, XVII National Labor Relations Board 5, LXI; 29, I National Marine Fisheries Service 50, II, IV National Mediation Board 5, CI; 29, X National Oceanic and Atmospheric Administration 15, IX; 50, II, III, IV, VI National Park Service 36, I National Railroad Adjustment Board 29, III National Railroad Passenger Corporation (AMTRAK) 49, VII National Science Foundation 2, XXV; 5, XLIII; 45, VI Federal Acquisition Regulation 48, 25 National Security Council 32, XXI; 47, II National Technical Information Service 15, XI National Telecommunications and Information Administration 15, XXIII; 47, III, IV, V National Transportation Safety Board 49, VIII Natural Resource Revenue, Office of 30, XII Natural Resources Conservation Service 7, VI Navajo and Hopi Indian Relocation, Office of 25, IV Navy, Department of 32, VI Federal Acquisition Regulation 48, 52 Neighborhood Reinvestment Corporation 24, XXV Northeast Interstate Low-Level Radioactive Waste Commission 10, XVIII Nuclear Regulatory Commission 2, XX; 5, XLVIII; 10, I Federal Acquisition Regulation 48, 20 Occupational Safety and Health Administration 29, XVII Occupational Safety and Health Review Commission 29, XX Ocean Energy Management, Bureau of 30, V Oklahoma City National Memorial Trust 36, XV Operations Office 7, XXVIII Patent and Trademark Office, United States 37, I Payment From a Non-Federal Source for Travel Expenses 41, 304 Payment of Expenses Connected With the Death of Certain Employees 41, 303 Peace Corps 2, XXXVII; 22, III Pennsylvania Avenue Development Corporation 36, IX Pension Benefit Guaranty Corporation 29, XL Personnel Management, Office of 5, I, IV, XXXV; 45, VIII Federal Acquisition Regulation 48, 17 Federal Employees Group Life Insurance Federal Acquisition Regulation 48, 21 Federal Employees Health Benefits Acquisition Regulation 48, 16 Human Resources Management and Labor Relations Systems, Department of Homeland Security 5, XCVII Pipeline and Hazardous Materials Safety Administration 49, I Postal Regulatory Commission 5, XLVI; 39, III Postal Service, United States 5, LX; 39, I Postsecondary Education, Office of 34, VI President's Commission on White House Fellowships 1, IV Presidential Documents 3 Presidio Trust 36, X Prisons, Bureau of 28, V Privacy and Civil Liberties Oversight Board 6, X Procurement and Property Management, Office of 7, XXXII Public and Indian Housing, Office of Assistant Secretary for 24, IX Public Contracts, Department of Labor 41, 50 Public Health Service 42, I Railroad Retirement Board 20, II Reclamation, Bureau of 43, I Refugee Resettlement, Office of 45, IV Relocation Allowances 41, 302 Research and Innovative Technology Administration 49, XI Rural Business-Cooperative Service 7, XVIII, XLII, L Rural Housing Service 7, XVIII, XXXV, L Rural Utilities Service 7, XVII, XVIII, XLII, L Safety and Environmental Enforcement, Bureau of 30, II Science and Technology Policy, Office of 32, XXIV; 47, II Secret Service 31, IV Securities and Exchange Commission 5, XXXIV; 17, II Selective Service System 32, XVI Small Business Administration 2, XXVII; 13, I Smithsonian Institution 36, V Social Security Administration 2, XXIII; 20, III; 48, 23 Soldiers' and Airmen's Home, United States 5, XI Special Counsel, Office of 5, VIII Special Education and Rehabilitative Services, Office of 34, III State, Department of 2, VI; 22, I; 28, XI Federal Acquisition Regulation 48, 6 Surface Mining Reclamation and Enforcement, Office of 30, VII Surface Transportation Board 49, X Susquehanna River Basin Commission 18, VIII Tennessee Valley Authority 5, LXIX; 18, XIII Trade Representative, United States, Office of 15, XX Transportation, Department of 2, XII; 5, L Commercial Space Transportation 14, III Emergency Management and Assistance 44, IV Federal Acquisition Regulation 48, 12 Federal Aviation Administration 14, I Federal Highway Administration 23, I, II Federal Motor Carrier Safety Administration 49, III Federal Railroad Administration 49, II Federal Transit Administration 49, VI Great Lakes St. Lawrence Seaway Development Corporation 33, IV Maritime Administration 46, II National Highway Traffic Safety Administration 23, II, III; 47, IV; 49, V Pipeline and Hazardous Materials Safety Administration 49, I Secretary of Transportation, Office of 14, II; 49, Subtitle A Transportation Statistics Bureau 49, XI Transportation, Office of 7, XXXIII Transportation Security Administration 49, XII Transportation Statistics Bureau 49, XI Travel Allowances, Temporary Duty (TDY) 41, 301 Treasury, Department of the 2, X; 5, XXI; 12, XV; 17, IV; 31, IX Alcohol and Tobacco Tax and Trade Bureau 27, I Community Development Financial Institutions Fund 12, XVIII Comptroller of the Currency 12, I Customs and Border Protection 19, I Engraving and Printing, Bureau of 31, VI Federal Acquisition Regulation 48, 10 Federal Claims Collection Standards 31, IX Federal Law Enforcement Training Center 31, VII Financial Crimes Enforcement Network 31, X Fiscal Service 31, II Foreign Assets Control, Office of 31, V Internal Revenue Service 26, I Investment Security, Office of 31, VIII Monetary Offices 31, I Secret Service 31, IV Secretary of the Treasury, Office of 31, Subtitle A Truman, Harry S. Scholarship Foundation 45, XVIII United States Agency for Global Media 2, XIX; 22, V United States and Canada, International Joint Commission 22, IV United States and Mexico, International Boundary and Water Commission, United States Section 22, XI U.S. Copyright Office 37, II U.S. Office of Special Counsel 5, CII Utah Reclamation Mitigation and Conservation Commission 43, III Veterans Affairs, Department of 2, VIII; 38, I Federal Acquisition Regulation 48, 8 Veterans' Employment and Training Service, Office of the Assistant Secretary for 41, 61; 20, IX Vice President of the United States, Office of 32, XXVIII Wage and Hour Division 29, V Water Resources Council 18, VI Workers' Compensation Programs, Office of 20, I, VI World Agricultural Outlook Board 7, XXXVIII 40 CFR (7-1-25 Edition) List of CFR Sections Affected List of CFR Sections Affected

All changes in this volume of the Code of Federal Regulations (CFR) that were made by documents published in the Federal Register since January 1, 2020 are enumerated in the following list. Entries indicate the nature of the changes effected. Page numbers refer to Federal Register pages. The user should consult the entries for chapters, parts and subparts as well as sections for revisions.

For changes to this volume of the CFR prior to this listing, consult the annual edition of the monthly List of CFR Sections Affected (LSA). The LSA is available at www.govinfo.gov. For changes to this volume of the CFR prior to 2001, see the “List of CFR Sections Affected, 1949-1963, 1964-1972, 1973-1985, and 1986-2000” published in 11 separate volumes. The “List of CFR Sections Affected 1986-2000” is available at www.govinfo.gov.

2020 40 CFR 85 FR Page Chapter I 300 Authority citation revised 22342, 50787, 54935 300 National Priorities List 31389, 44002 300.5 Amended 22342 300 Appendix B amended 5579, 40908, 43708, 44005, 45109, 50787, 54935, 61613 300 Appendix B amended; eff. 8-24-20 37576, 37777 300 Appendix E amended 22342 302 Authority citation revised 22342 302.3 Amended 22342 320 Policy statements 77384 350.7 (a) introductory text, (b), (c), and (d)(2) revised 44772 350.16 Revised 44772 350.27 (a) revised; (b) removed 44772 355.41 Note amended 44772 372.22 (c) amended 37357 372.25 Introductory text, (f), (g), and (h) amended 37357 372.28 (a)(1) table heading amended; (a)(2) table revised 42314 372.29 Added 37357 372.30 (a), (b)(1), (3) introductory text, (i), and (iv) amended 37357 372.38 (b), (c), (d), (f), (g), and (h) amended 37357 372.38 (a) revised 42314 372.65 Introductory text revised; (d) and (e) added 37357 372.65 (a) table, (b) table, and (c) table amended 42314 2021 40 CFR 86 FR Page Chapter I 300.913 Added 40263 300 Appendix B amended 26421, 50483, 51012 302 Authority citation revised 62737 302.8 (e) introductory text, (1) introductory text, (f) introductory text, (g)(2)(i), (ii), (3), (4), (j) introductory text, and (l) revised 62737 372.23 (a) table and (c) table amended 66964 372.65 (d) table 4 and (e) table 5 amended; eff. 7-6-21 29701 2022 40 CFR 87 FR Page Chapter I 300 Appendix B amended 14812, 16104 302.4 Heading and Appendix A revised; (b) note removed; Note I and Note II preceding Table 302.4 amended 20725 312.11 (c) added 14177 312.11 Regulation at 87 FR 14177 withdrawn 25572 2023 40 CFR 88 FR Page Chapter I 300 Appendix B amended 55584, 61475 302.4 CFR correction: Appendix B reinstated 87723 372.22 (c) amended 74368 372.25 Introductory text and (f) through (h) amended 74368 372.28 (a)(1) Table 1 amended 74368 372.29 Removed 74368 372.30 (a), (b)(1), (3) introductory text, (i), and (iv) amended 74368 372.38 (a)(2), (b) through (d), and (f) through (h) amended 74368 372.45 (d)(1) revised 74368 372.65 (c) Table 3 amended 45097 2024 40 CFR 89 FR Page Chapter I 300.185 (a) revised 21966 300.211 (c) revised 21966 300.400 (d)(4)(iv)(D) amended 88656 300.411 Added 21966 300 Appendix B amended 12248, 16468 300 Appendix B amended 66614, 72336, 100756 302.4 Table and Appendix A amended; eff. 7-8-24 39191 312.11 (b) revised; (d) added 52389 372.18 Amended 88656 372.38 (d) amended 102789 372.65 Correction: (c) Table 3 amended 35749 372.65 (d) Table 4 and (e) Table 5 amended 43334 374.6 Revised 86750 2025 (Regulations published from January 1, 2025, through July 1, 2025) 40 CFR 90 FR Page Chapter I 300 Appendix B amended 11220 372.65 (d) table 4 and (e) table 5 amended 576 372.65 Regulation at 90 FR 576 eff. date delayed 9010 ○